PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Maggio, DM; Chatzipanteli, K; Masters, N; Patel, SP; Dietrich, WD; Pearse, DD				Maggio, Dominic M.; Chatzipanteli, Katina; Masters, Neil; Patel, Samik P.; Dietrich, W. Dalton; Pearse, Damien D.			Acute Molecular Perturbation of Inducible Nitric Oxide Synthase with an Antisense Approach Enhances Neuronal Preservation and Functional Recovery after Contusive Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						neuronal cell death; nitric oxide; nitric oxide synthase; oligonucleotides; spinal cord injury	OLFACTORY ENSHEATHING GLIA; TRAUMATIC BRAIN-INJURY; LIPID-PEROXIDATION; OXIDATIVE DAMAGE; SCHWANN-CELLS; MOUSE MODEL; PEROXYNITRITE; INHIBITION; MICE; INOS	Inducible nitric oxide synthase (iNOS) is a key mediator of inflammation and oxidative stress produced during pathological conditions, including neurodegenerative diseases and central nervous system (CNS) injury. iNOS is responsible for the formation of high levels of nitric oxide (NO). The production of highly reactive and cytotoxic NO species, such as peroxynitrite, plays an important role in secondary tissue damage. We have previously demonstrated that acute administration of iNOS antisense oligonucleotides (ASOs) 3 h after moderate contusive spinal cord injury (SCI) potently inhibits iNOS-mediated increases in NO levels, leading to reduced blood spinal cord barrier permeability, decreased neutrophil accumulation, and less neuronal cell death. In the current study we investigated if iNOS ASOs could also provide long-term (10-week) histological and behavioral improvements after moderate thoracic 18 contusive SCI. Adult rats were randomly assigned to three groups (n = 10/group): SCI alone, SCI and mixed base control oligonucleotides (MBOs), or SCI and iNOS ASOs (200 nM). Oligonucleotides were administered by spinal superfusion 3 h after injury. Behavioral analysis (Basso-Beattie-Bresnahan [BBB] score and subscore) was employed weekly for 10 weeks post-SCI. Although animals treated with iNOS ASOs demonstrated no significant differences in BBB scores compared to controls, subscore analysis revealed a significant improvement in foot positioning, trunk stability, and tail clearance. Histologically, while no gross improvement in preserved white and gray matter was observed, greater numbers of surviving neurons were present adjacent to the lesion site in iNOS ASO-treated animals than controls. These results support the effectiveness of targeting iNOS acutely as a therapeutic approach after SCI.	[Pearse, Damien D.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Maggio, Dominic M.; Chatzipanteli, Katina; Masters, Neil; Patel, Samik P.; Dietrich, W. Dalton; Pearse, Damien D.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Neurosci Program,Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	Pearse, DD (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace, Miami, FL 33136 USA.	DPearse@med.miami.edu	Pearse, Damien D/D-3176-2011	Pearse, Damien D/0000-0003-1783-221X	NIH National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [POI NS38665]; Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038665] Funding Source: NIH RePORTER	We gratefully acknowledge the Miami Project Animal Core Facility for performing spinal cord contusion injuries and providing post-operative animal care and functional testing, in particular Alexander Marcillo, Paulo Diaz, Santiago Castro, Denise Koivisto, Kim Loor, and Rosa Abril. In addition, we thank Devin Bustin for help with histology, Raisa Puzis for immunohistochemistry, and Wai-Man Chan for proofreading. This work was supported by NIH National Institute of Neurological Disorders and Stroke (NINDS) grant POI NS38665, The Miami Project to Cure Paralysis, and The Buoniconti Fund.	Armstrong R, 2001, INT IMMUNOPHARMACOL, V1, P1501, DOI 10.1016/S1567-5769(01)00094-7; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BELENKY SN, 1993, J LEUKOCYTE BIOL, V53, P498; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Carrico KM, 2009, J NEUROTRAUM, V26, P1369, DOI [10.1089/neu.2008.0870, 10.1089/neu.2008-0870]; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; Cifone MG, 1999, BLOOD, V93, P3876, DOI 10.1182/blood.V93.11.3876.411k25_3876_3884; DASH P, 1987, P NATL ACAD SCI USA, V84, P7896, DOI 10.1073/pnas.84.22.7896; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Genovese T, 2009, FREE RADICAL RES, V43, P631, DOI 10.1080/10715760902954126; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GRUNER JA, 1992, J NEUROTRAUM, V9, P126; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Iadecola C, 1997, J NEUROSCI, V17, P9157; Isaksson J, 2005, SPINAL CORD, V43, P167, DOI 10.1038/sj.sc.3101672; Karras JG, 2007, AM J RESP CELL MOL, V36, P276, DOI 10.1165/rcmb.2005-0456OC; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Laroux FS, 2001, ACTA PHYSIOL SCAND, V173, P113, DOI 10.1046/j.1365-201X.2001.00891.x; Liu C, 2001, Chin J Traumatol, V4, P231; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; ODonnell VB, 1997, BIOCHEMISTRY-US, V36, P15216, DOI 10.1021/bi971891z; Okamura T, 2001, HYPERTENS RES, V24, P47, DOI 10.1291/hypres.24.47; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Parmentier-Batteur S, 2001, J CEREBR BLOOD F MET, V21, P15, DOI 10.1097/00004647-200101000-00003; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Pearse DD, 2004, J NEUROTRAUM, V21, P1223, DOI 10.1089/0897715041953876; Pearse DD, 2003, J NEUROPATH EXP NEUR, V62, P1096, DOI 10.1093/jnen/62.11.1096; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Rubbo H, 2008, BBA-GEN SUBJECTS, V1780, P1318, DOI 10.1016/j.bbagen.2008.03.007; Satake K, 2000, MOL BRAIN RES, V85, P114, DOI 10.1016/S0169-328X(00)00253-9; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Schwab ME, 1996, PHYSIOL REV, V76, P319; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Sipski ML, 2006, NAT CLIN PRACT NEURO, V2, P402, DOI 10.1038/ncpneuro0221; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; TAYLOR WF, 1993, AM J PHYSIOL, V264, pH1355; Wen WY, 2006, NEUROSCI RES, V55, P87, DOI 10.1016/j.neures.2006.02.004; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323	45	16	16	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2012	29	12					2244	2249		10.1089/neu.2012.2371			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	993KZ	WOS:000307859900011	22708918	Green Published			2021-06-18	
J	Pielmeier, U; Rousing, ML; Andreassen, S; Nielsen, BS; Haure, P				Pielmeier, Ulrike; Rousing, Mark Lillelund; Andreassen, Steen; Nielsen, Birgitte Steenfeldt; Haure, Pernille			Decision support for optimized blood glucose control and nutrition in a neurotrauma intensive care unit: preliminary results of clinical advice and prediction accuracy of the Glucosafe system	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Hyperglycemia; Blood glucose; Decision support; Nutrition; Insulin therapy; Critical care; Prediction error	GLYCEMIC CONTROL; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; CRITICAL ILLNESS; ABSORPTION; SECRETION; INDIVIDUALS; THERAPY; SEPSIS; HUMANS	Assessment of glycemic control with model-based decision support ("Glucosafe") in neurotrauma intensive care patients in an ongoing randomized controlled trial with a blood glucose (BG) target of 5-8 mmol/L. Assessment of BG prediction accuracy of the model and assessment of the effect that two potential model extensions would have on prediction accuracy in this trial. In the intervention group insulin infusion rates and nutrition are varied based on Glucosafe's decision support. In the control group, the caloric target is 25-30 kcal/kg per day and insulin is regulated according to department rules. BG concentrations, insulin infusion rates, and feed rates are compared from the data of 12 consecutive patients. BG measurements are predicted retrospectively and the mean relative prediction error is calculated using (1) the current model from the trial, (2) the current model modified by using a BG-dependent variable endogenous insulin appearance rate, (3) the current model modified by a patient-specific carbohydrate absorption factor. BG control was improved by Glucosafe. 76 % of BG measurements in Glucosafe patients were in the 5-8 mmol/L band (Controls: 51 %). BG means (log-normal) +/- A SD were 7.0 +/- A 1.19 mmol/L in Glucosafe patients compared to 8.0 +/- A 1.24 mmol/L in controls (P = 0.05). Mean caloric intake was 93.5 +/- A 15 % of resting energy expenditure in Glucosafe patients (Controls: 129 +/- A 29 %). The BG-dependent variable insulin appearance rate had no measurable effect on prediction accuracy. The patient-specific carbohydrate absorption factor improved prediction accuracy significantly (P = 0.001). Glucosafe advice reduces hyperglycemia in neurotrauma intensive care patients. Further parameterization can improve model prediction accuracy.	[Pielmeier, Ulrike; Rousing, Mark Lillelund; Andreassen, Steen] Aalborg Univ, Ctr Model Based Med Decis Support, DK-9220 Aalborg, Denmark; [Nielsen, Birgitte Steenfeldt; Haure, Pernille] Aalborg Hosp, Neuroorthotrauma Intens Care Unit, Aalborg, Denmark	Pielmeier, U (corresponding author), Aalborg Univ, Ctr Model Based Med Decis Support, Fredrik Bajers Vej 7, DK-9220 Aalborg, Denmark.	upiel@hst.aau.dk; mlr@hst.aau.dk; sa@hst.aau.dk		Andreassen, Steen/0000-0001-5379-7373; Pielmeier, Ulrike/0000-0002-5987-8331			Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Chapman MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8021; Chase JG, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-11; Dalla Man C, 2005, DIABETES, V54, P3265, DOI 10.2337/diabetes.54.11.3265; Dalla Man C, 2004, AM J PHYSIOL-ENDOC M, V287, pE637, DOI 10.1152/ajpendo.00319.2003; Deane AM, 2011, CRIT CARE MED, V39, P1282, DOI 10.1097/CCM.0b013e31820ee21f; Ellger B, 2008, ANAESTHESIST, V57, P43, DOI 10.1007/s00101-007-1285-7; Gale SC, 2007, AM SURGEON, V73, P454; Kalfon P, 2008, CRIT CARE, V12, DOI 10.1186/cc6915; Krishnan JA, 2003, CHEST, V124, P297, DOI 10.1378/chest.124.1.297; Kronenberg HM, 2008, WILLIAMS TXB ENDOCRI, P1348; Kuo P, 2010, J CLIN ENDOCR METAB, V95, P3893, DOI 10.1210/jc.2009-2514; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Mehta RL, 2007, J AM SOC NEPHROL, V18, P2623, DOI 10.1681/ASN.2007010109; Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241; Pielmeier U., 2010, UKACC INT C CONTR CO, P839; Pielmeier U, 2010, IFAC P SERIES, P67; Pielmeier U, 2010, J CRIT CARE, V25, P97, DOI 10.1016/j.jcrc.2009.10.003; Pielmeier U, 2010, COMPUT METH PROG BIO, V97, P211, DOI 10.1016/j.cmpb.2009.06.004; Rady MY, 2005, MAYO CLIN PROC, V80, P1558, DOI 10.4065/80.12.1558; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Thompson B Taylor, 2008, J Diabetes Sci Technol, V2, P357; THORSTEINSSON B, 1990, DAN MED BULL, V37, P143; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Waeschle RM, 2008, CRIT CARE, V12, DOI 10.1186/cc7097; Wallia A, 2011, ENDOCR PRACT, V17, P546, DOI 10.4158/EP10343.OR; Wilson M, 2007, DIABETES CARE, V30, P1005, DOI 10.2337/dc06-1964	28	16	16	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307			J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	AUG	2012	26	4					319	328		10.1007/s10877-012-9364-y			10	Anesthesiology	Anesthesiology	970KZ	WOS:000306128800009	22581038				2021-06-18	
J	Conneeley, AL				Conneeley, Anne Louise			Transitions and Brain Injury: A Qualitative Study Exploring the Journey of People with Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						Traumatic brain injury; transitions; occupation; identity; rehabilitation; qualitative research	COMMUNITY INTEGRATION; SELF-AWARENESS; PERSPECTIVES; EXPERIENCE; OUTCOMES	This qualitative study aimed to explore transitions from hospital to the home over a period of one year. Methods and procedures: A longitudinal, phenomenological approach was employed and 18 individuals with severe traumatic brain injury, their family members and rehabilitation professionals were interviewed using semistructured interviews, when the person with brain injury was discharged from the ward, after 6 months and again after one year. Results: Themes identified within the data included returning home, getting back to normal, moving forward and the role of rehabilitation in the transitional period. Further subthemes were also identified including issues of life-course disruption, self-identity, status and reconstruction. Conclusions: Data suggested that access to rehabilitation programs employing individualised, contextual interventions following discharge to the home were integral in enabling the transition through to autonomy and independence. Consideration of issues of identity and status can enable a different and potentially important perspective on the experience of transitions for those with brain injury. Reclaiming personal autonomy and control appeared to be central to the reconstruction of a coherent sense of self, enabling a meaningful life after brain injury.	Coventry Univ, Fac Hlth & Life Sci, Coventry CV1 5FB, W Midlands, England	Conneeley, AL (corresponding author), Coventry Univ, Fac Hlth & Life Sci, Priory St, Coventry CV1 5FB, W Midlands, England.	l.conneeley@coventry.ac.uk					Agnihotri S, 2010, DEV NEUROREHABIL, V13, P369, DOI 10.3109/17518423.2010.499409; Arber A, 2006, J RES NURS, V11, P147, DOI 10.1177/1744987106056956; Arber S, 1999, GENDER INEQUALITIES IN HEALTH, P123; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Banja J., 1994, J HEAD TRAUMA REHAB, V9, P70; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CAPLAN AL, 1988, ARCH PHYS MED REHAB, V69, P312; Carpenter C., 2008, QUALITATIVE RES OCCU; Chew-Graham C.A., 2002, FAM PRACT, V19, P185; Conneeley A. L., 2003, BRIT J OCCUPATIONAL, V66, P440; Conneeley AL., 2002, BRIT J OCCUP THER, V65, P185, DOI [10.1177/030802260206500406, DOI 10.1177/030802260206500406]; Conneeley AL, 2004, BR J OCCUP THER, V67, P248, DOI DOI 10.1177/030802260406700603; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Exley C, 2001, HEALTH, V5, P112, DOI 10.1177/136345930100500106; Finlay L., 2003, REFLEXIVITY; Fleming JM, 2006, BRAIN IMPAIR, V7, DOI [10.1375/brim.7.2.83, DOI 10.1375/BRIM.7.2.83]; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Giddens A., 1991, MODERNITY SELF IDENT; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Griffen JA, 2010, REHABIL PSYCHOL, V55, P292, DOI 10.1037/a0020503; Hoogerdijk B, 2011, SCAND J OCCUP THER, V18, P122, DOI 10.3109/11038121003645985; Hwan K., 2010, AM J OCCUPATIONAL TH, V64, P709; JOHANSEN RK, 2002, LISTENING SILENCE SE; Kirsh B, 2009, WORK, V32, P391, DOI 10.3233/WOR-2009-0851; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Lefebvre H., 2006, ILLNESS CRISIS LOSS, V14, P337, DOI DOI 10.1177/105413730601400403; Letherby G, 1999, WOMEN STUD INT FORUM, V22, P359, DOI 10.1016/S0277-5395(99)00028-X; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 2000, ARCH PHYS MED REHAB, V81, P817, DOI 10.1053/apmr.2000.5567; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Playford E.D., 2000, CLIN REHABIL, V4, P49; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Shaw LR, 1997, BRAIN INJURY, V11, P219; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sloan S, 2009, BRAIN IMPAIR, V10, P282, DOI 10.1375/brim.10.3.282; Taylor M.C., 2007, EVIDENCE BASED PRACT, V2nd; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2011, NEUROPSYCHOL REHABIL, V21, P64, DOI 10.1080/09602011.2010.527747; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 2001, INT CLASS FUNCT DIS	47	16	16	0	21	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	JUL	2012	13	1			SI		72	84		10.1017/BrImp.2012.3			13	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	964VQ	WOS:000305725200007					2021-06-18	
J	Kaldoja, ML; Kolk, A				Kaldoja, Mari-Liis; Kolk, Anneli			Social-emotional behaviour in infants and toddlers with mild traumatic brain injury	BRAIN INJURY			English	Article						Mild brain injury; outcome; paediatric; traumatic brain injury; behaviour; prevention	CHILDHOOD HEAD-INJURY; NEUROBEHAVIORAL RECOVERY; CHILDREN; IMPACT; AGE; ADOLESCENTS; DISORDERS; MODERATE; OUTCOMES	Background: Paediatric head trauma is a serious health concern often leading to neurological, behavioural and cognitive impairments. In Estonia head trauma incidence is especially high in children up to 4 years. Objective: The aim was to investigate young children's pre-injury social-emotional behaviour to discover potential risk signs for brain trauma and to study social-emotional outcome 9 months post-injury. Methods: Thirty-five 3-65 month old children with mild traumatic brain injury (MTBI) and 70 matched controls were retrospectively assessed with child monitoring system Ages and Stages Questionnaires: Social-Emotional. During follow-up 27 patients and 54 controls were re-assessed after 9 months. Results: Children with MTBI showed altered social-emotional development already before the injury. Deficits were evident in self-regulation and autonomy. Age-specific social-emotional risk signs for MTBI were found. Compared to controls more pre-injury affective problems were seen in 12-month olds, self-regulation, and communication difficulties in 30-month olds and autonomy disturbances in 60-month old children. 9 months post-injury impairments in autonomy and self-regulation were still present and new difficulties in interaction had developed. Conclusions: Childhood MTBI has a serious negative effect on further development of interaction skills. To prevent possible traumas, parents should be informed of different age-specific pre-injury social-emotional risk signs.	[Kaldoja, Mari-Liis; Kolk, Anneli] Tartu Univ Hosp, Dept Neurol & Neurorehabil, Childrens Clin, EE-51014 Tartu, Estonia; [Kaldoja, Mari-Liis] Univ Tartu, Inst Psychol, EE-50090 Tartu, Estonia; [Kolk, Anneli] Univ Tartu, Dept Pediat, EE-50090 Tartu, Estonia	Kaldoja, ML (corresponding author), Tartu Univ Hosp, Dept Neurol & Neurorehabil, Childrens Clin, Lunini 6-B422, EE-51014 Tartu, Estonia.	mari-liis.kaldoja@kliinikum.ee		Kaldoja, Mari-Liis/0000-0002-7471-5813	European Social Fund's Doctoral Studies and Internationalisation programme DoRa; Estonian Ministry of Education and ResearchMinistry of Education and Research, Estonia [TARLA 2695]	The work was supported by European Social Fund's Doctoral Studies and Internationalisation programme DoRa and by the Estonian Ministry of Education and Research TARLA 2695. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Baumeister AA, 1997, JAMA-J AM MED ASSOC, V277, P1278; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Ministry of Social Affairs, 1995, INT STAT CLASS DIS R; Posne MI, 2001, DEV PSYCHOPATHOL, V12, P427; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Squires J, 2001, EARLY CHILD RES Q, V16, P405, DOI 10.1016/S0885-2006(01)00115-6; Squires J., 2003, ASQ SE USERS GUIDE A; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	31	16	17	0	34	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2012	26	7-8					1005	1013		10.3109/02699052.2012.660516			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	957CB	WOS:000305135100012	22632684				2021-06-18	
J	Kung, WM; Lin, FH; Hsiao, SH; Chiu, WT; Chyau, CC; Lu, SH; Hwang, B; Lee, JH; Lin, MS				Kung, Woon-Man; Lin, Feng-Huei; Hsiao, Sheng-Huang; Chiu, Wen-Ta; Chyau, Charng-Cherng; Lu, Shing-Hwa; Hwang, Betau; Lee, Jia-Hua; Lin, Muh-Shi			New Reconstructive Technologies after Decompressive Craniectomy in Traumatic Brain Injury: The Role of Three-Dimensional Titanium Mesh	JOURNAL OF NEUROTRAUMA			English	Article						cosmesis; decompressive craniectomy; head injury; quality of life; reconstruction; three-dimensional titanium mesh	HYDROXYAPATITE CEMENT; CRANIOFACIAL SURGERY; SKULL DEFECTS; CRANIOPLASTY; COMPLICATIONS; EXPERIENCE; CHILDREN; REPAIR; BONE	Functional and aesthetic reconstruction after wide decompressive craniectomy directly correlates with subsequent quality of life. Advancements in the development of biomaterials have now made three-dimensional (3-D) titanium mesh a new option for the repair of skull defects after craniectomy. The purpose of this study was to review aesthetic and surgical outcomes and complications of patients who had skull defects repaired with 3-D titanium mesh. The records of 40 adult patients (31 unilateral craniectomies and 9 bilateral craniectomies) who underwent a computer-assisted designed titanium mesh implant at a university hospital from January 2008 to January 2010 were retrospectively reviewed. Aesthetic outcomes, cranial nerve V and VII function, and complications (hardware extrusions, meningitis, osteomyelitis, brain abscess, and pneumocephalus) were evaluated. The craniofacial symmetry, implant stability, and functional outcomes were excellent for all patients. No patients had trigeminal or facial dysfunction. All had excellent cosmetic results as measured by post-reduction radiographs and personal and family perceptions of the forehead contour. Two patients had delayed wound healing and subsequent subclinical wound infections, which resolved after treatment with antibiotics for 2 weeks. Craniofacial skeletal reconstruction with 3-D titanium mesh results in excellent forehead contour and cosmesis, and subsequently a better quality of life with few complications. Titanium mesh reconstruction offers a favorable alternative to other graft materials in the repair of large skull defects.	[Kung, Woon-Man; Lin, Feng-Huei] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Kung, Woon-Man; Lin, Feng-Huei] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Kung, Woon-Man; Chyau, Charng-Cherng] Hungkuang Univ, Coll Med & Nursing, Dept Biotechnol, Taichung, Taiwan; [Kung, Woon-Man] Chang Bing Show Chwan Mem Hosp, Dept Neurosurg, Changhua, Taiwan; [Lin, Feng-Huei] Natl Hlth Res Inst, Div Med Engn, Miaoli, Taiwan; [Hsiao, Sheng-Huang; Lee, Jia-Hua] Taipei City Hosp, Renai Branch, Dept Neurosurg, Taipei, Taiwan; [Lu, Shing-Hwa] Dept Urol, Taipei, Taiwan; [Hwang, Betau] Dept Pediat, Taipei, Taiwan; Taipei City Hosp, Zhong Xiao Branch, Taipei, Taiwan; [Lin, Muh-Shi] New Taipei City Hosp, Dept Neurosurg, Taipei 115, Taiwan; [Lu, Shing-Hwa; Lin, Muh-Shi] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei 112, Taiwan; [Chiu, Wen-Ta; Lin, Muh-Shi] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Hwang, Betau] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Pediat, Taipei 112, Taiwan	Lin, MS (corresponding author), New Taipei City Hosp, Dept Neurosurg, 87 Tongde Rd, Taipei 115, Taiwan.	neurosurgery2005@yahoo.com.tw	Kung, Woon-Man/Q-3012-2019; Lin, Feng-Huei/E-3970-2010; LLM, 林牧熹 醫學博士 法學碩士 Muh-Shi Lin MD PhD/U-7004-2019	Kung, Woon-Man/0000-0001-8311-2902; LLM, 林牧熹 醫學博士 法學碩士 Muh-Shi Lin MD PhD/0000-0002-9798-8160			Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Agner C, 1997, CRIT REV NEUROSURG, V7, P365, DOI 10.1007/s003290050048; Bandyopadhyay T K, 2005, Med J Armed Forces India, V61, P36, DOI 10.1016/S0377-1237(05)80116-9; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Chang S., 2003, BARROW Q, V19, P9; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01290.8E; Eufinger H, 1998, PLAST RECONSTR SURG, V102, P300, DOI 10.1097/00006534-199808000-00002; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396; Ju DT, 2008, ACTA NEUROCHIR SUPPL, V101, P169; KAISER A, 1993, EUR J PEDIATR SURG, V3, P236, DOI 10.1055/s-2008-1063551; Kuttenberger JJ, 2001, J CRANIO MAXILL SURG, V29, P75, DOI 10.1054/jcms.2001.0197; Lakhani RS, 2001, ARCH OTOLARYNGOL, V127, P665, DOI 10.1001/archotol.127.6.665; Lee JW, 2011, J KOREAN NEUROSURG S, V50, P231, DOI 10.3340/jkns.2011.50.3.231; Magni G, 2007, J NEUROSURG ANESTH, V19, P229, DOI 10.1097/ANA.0b013e31806e5f5a; MALIS LI, 1989, NEUROSURGERY, V25, P351, DOI 10.1227/00006123-198909000-00005; Marbacher S, 2008, J CRANIOFAC SURG, V19, P490, DOI 10.1097/SCS.0b013e3181534ae8; Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055; Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012; PSILLAKIS JM, 1979, PLAST RECONSTR SURG, V64, P827, DOI 10.1097/00006534-197912000-00023; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Scholz M, 2007, J CRANIO MAXILL SURG, V35, P388, DOI 10.1016/j.jcms.2007.06.006; Seyithanoglu H, 2006, J INSTANB FAC MED, V69, P44; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Timmons RL, 1982, NEUROLOGICAL SURGERY, V4, P2228; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Winn H.R., 2011, YOUMANS NEUROLOGICAL, V1; Zonenshayn M, 2004, J NEUROSURG, V100, P537, DOI 10.3171/ped.2004.100.5.0537	31	16	18	0	11	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	11					2030	2037		10.1089/neu.2011.2220			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	983CX	WOS:000307095800004	22452382				2021-06-18	
J	Li, WL; Jiang, DY				Li, Wenlin; Jiang, Deyong			Effect of Resveratrol on Bcl-2 and VEGF Expression in Oxygen-Induced Retinopathy of Prematurity	JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; TUMOR-GROWTH; KAPPA-B; CANCER; HYPOXIA; ANGIOGENESIS; APOPTOSIS; CELLS; SUPPRESSION	Purpose: To explore the effect of resveratrol on B-cell leukemia/lymphoma-2 (Bcl-2) and vascular endothelial growth factor (VEGF) expression in rats with oxygen-induced retinopathy of prematurity (ROP). Methods: Seven-day-old Sprague-Dawley rats (N = 60) were randomly assigned to five groups. Group A received normal partial oxygen pressure and groups B, C, D, and E received 75% +/- 2% oxygen for 5 days to induce ROP. The rats in groups C, D, and E were intragastrically treated with resveratrol (10, 30, and 60 mg/kg/d, respectively) once daily for 5 days. Rats were killed at 17 days of age and the retina was collected. Results: Western blot analysis revealed increased Bcl-2 protein expression in group B versus group A. Levels of Bcl-2 decreased with the increase of resveratrol concentration in groups C, D, and E. The optical density of Bcl-2 protein expression in group B was four times higher than that in group A (P < .01). When compared with group B, expression of Bcl-2 and VEGF in groups C, D, and E decreased in a dose-dependent manner. Significant differences in expression of Bcl-2 and VEGF were also noted among the three treatment groups with resveratrol (P < .01). After treatment with resveratrol at 10, 30, and 60 mg/kg/d, the inhibition rate of Bcl-2 expression was 11.1%, 38.1%, and 69.8% and that of VEGF expression was 3.4%, 23.0%, and 43.7%, respectively. Conclusion: Resveratrol can significantly inhibit expression of Bcl-2 and VEGF in the retina of neonatal rats with oxygen-induced ROP. It may provide a protective effect on retinal neovascular diseases, including ROP.	[Li, Wenlin] Shenzhen Childrens Hosp, Dept Ophthalmol, Shenzhen, Peoples R China; [Jiang, Deyong] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China	Li, WL (corresponding author), Shenzhen Childrens Hosp, Dept Ophthalmol, 7019 Yitian Rd, Shenzhen, Peoples R China.	wenlinli6688@hotmail.com			Shenzhen Science and Technology Projects, China [200603162]	Supported by the Shenzhen Science and Technology Projects (200603162), China.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Arakawa M, 2007, LIFE SCI, V80, P2076, DOI 10.1016/j.lfs.2007.03.012; Baek JH, 2000, ONCOGENE, V19, P4621, DOI 10.1038/sj.onc.1203814; Brakenhielm E, 2001, FASEB J, V15, P1798, DOI 10.1096/fj.01-0028fje; Burke C, 2006, BRAIN RES, V1098, P19, DOI 10.1016/j.brainres.2006.04.129; Burkitt MJ, 2000, ARCH BIOCHEM BIOPHYS, V381, P253, DOI 10.1006/abbi.2000.1973; Cao ZX, 2004, CLIN CANCER RES, V10, P5253, DOI 10.1158/1078-0432.CCR-03-0588; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Chen JC, 2006, ANTICANCER RES, V26, P1237; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen MK, 2008, HEAD NECK-J SCI SPEC, V30, P1052, DOI 10.1002/hed.20839; Contu Paulo C., 2006, Arq. Gastroenterol., V43, P284, DOI 10.1590/S0004-28032006000400008; Das S, 2006, FREE RADICAL RES, V40, P1066, DOI 10.1080/10715760600833085; Dieudonne SC, 2007, OPHTHALMIC RES, V39, P148, DOI 10.1159/000103234; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Fujiuchi Y, 2003, ONCOL REP, V10, P1001; Gao DK, 2006, LIFE SCI, V78, P2564, DOI 10.1016/j.lfs.2005.10.030; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gobe G, 1999, IMMUNOL CELL BIOL, V77, P279, DOI 10.1046/j.1440-1711.1999.00826.x; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314; Hua J, 2011, INVEST OPHTH VIS SCI, V52, P2809, DOI 10.1167/iovs.10-6496; Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4; Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje; Jay SM, 2008, FASEB J, V22, P2949, DOI 10.1096/fj.08-108803; Khor LY, 2007, CLIN CANCER RES, V13, P3585, DOI 10.1158/1078-0432.CCR-06-2972; Kienle K, 2005, TRANSPL P, V37, P439, DOI 10.1016/j.transproceed.2004.12.268; Kroon PA, 2010, CURR MED CHEM, V17, P2442; Lee EO, 2006, CARCINOGENESIS, V27, P2059, DOI 10.1093/carcin/bgl055; Lee KH, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-63; Li C, 2010, NEUROCHEM INT, V56, P495, DOI 10.1016/j.neuint.2009.12.009; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Nor JE, 2001, CANCER RES, V61, P2183; O'Connor DJ, 2011, PHYTOTHER RES, V25, P1727, DOI 10.1002/ptr.3501; Olas B, 2002, THROMB RES, V106, P143, DOI 10.1016/S0049-3848(02)00101-9; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Raymond MA, 2002, BIOCHEM BIOPH RES CO, V291, P261, DOI 10.1006/bbrc.2002.6449; Reynolds JD, 2001, PEDIATR DRUGS, V3, P263, DOI 10.2165/00128072-200103040-00003; Robinson GS, 1998, INT OPHTHALMOL CLIN, V38, P89, DOI 10.1097/00004397-199838020-00007; Roemer K, 2002, DRUG TODAY, V38, P571, DOI 10.1358/dot.2002.38.8.820097; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Sharma R, 2007, J TROP PEDIATRICS, V53, P52, DOI 10.1093/tropej/fml071; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Sun CY, 2006, CANCER GENET CYTOGEN, V165, P9, DOI 10.1016/j.cancergencyto.2005.06.016; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wirostko BM, 2007, OPHTHALMOLOGY, V114, P1954, DOI 10.1016/j.ophtha.2007.05.018; Wu HZ, 2008, BIOMED PHARMACOTHER, V62, P613, DOI 10.1016/j.biopha.2008.06.036; Yu H, 2007, CHINESE MED J-PEKING, V120, P1672, DOI 10.1097/00029330-200710010-00006	53	16	16	2	8	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0191-3913	1938-2405		J PEDIAT OPHTH STRAB	J. Pediatr. Ophthalmol. Strabismus.	JUL-AUG	2012	49	4					230	235		10.3928/01913913-20111129-01			6	Ophthalmology; Pediatrics	Ophthalmology; Pediatrics	981OM	WOS:000306977700007	22148982				2021-06-18	
J	Lin, TK; Tsai, HC; Hsieh, TC				Lin, Tzu-Kang; Tsai, Hong-Chieh; Hsieh, Tsung-Che			The impact of traumatic subarachnoid hemorrhage on outcome: A study with grouping of traumatic subarachnoid hemorrhage and transcranial Doppler sonography	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Classification; outcome; transcranial Doppler sonography; traumatic subarachnoid hemorrhage	CEREBRAL BLOOD-FLOW; BRAIN-INJURY; HEAD-INJURY; INTRAVENTRICULAR HEMORRHAGE; VASOSPASM; MULTICENTER; ULTRASOUND; ADMISSION; VELOCITY; SCAN	BACKGROUND: To clarify the clinical role of traumatic subarachnoid hemorrhage (tSAH), stratified analysis with grouping of tSAH was performed. Their blood flow changes and correlations with outcome were assayed. METHODS: One hundred seventeen tSAH patients were classified into several groups according to their initial computerized tomography scans. Group I included patients with tSAH only in the posterior interhemispheric fissure, whereas Group II contained patients with tSAH located elsewhere. Group II was further subdivided into IIa, little SAH; IIb, extensive SAH; IIc, little SAH with intraventricular hemorrhage (IVH); and IId, extensive SAH with IVH. The cerebral blood flow velocity was monitored using transcranial Doppler sonography (TCD). RESULTS: Both age and initial coma scale were independent predictors of poor outcome. The poor outcome rates in various subgroups of tSAH increased stepwise from group I to group IId (I, 7.4%; IIa, 18.4%; IIb, 33.3%; IIc, 62.5%; and IId, 90.9%) (p = 0.0010). Stratified analyses revealed that patients with extensive tSAH (group IIb + IId) were more likely to have unfavorable outcomes (47.7%) than patients with little tSAH (group IIa + IIc) (26.1%) (p = 0.0185); patients with IVH (group IIc + IId) also displayed a higher incidence (78.9%) of poor outcomes than patients without IVH (group IIa + IIb) (25.4%) (p = 0.0030). TCD study demonstrated that patients with extensive tSAH (group IIb + IId) were more likely to have the vasospasm based on TCD criteria than did patients in group I and group IIa + IIc (37.5% vs. 5.9% and 7.7%, p = 0.0105). Notably, there was a tendency of worse outcome in patients with vasospasm on the basis of TCD-derived criteria than those without, with the unfavorable outcome rates being 47.4% and 24.7% (p = 0.0799). CONCLUSIONS: Age, initial coma scale, extensive tSAH, and IVH are independent predictors of poor outcome in the cohort of tSAH patients. Statistically, patients with extensive tSAH are significantly more likely to have vasospasm. (J Trauma Acute Care Surg. 2012; 73: 131-136. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Lin, Tzu-Kang; Tsai, Hong-Chieh] Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan 333, Taiwan; [Hsieh, Tsung-Che] St Pauls Hosp, Dept Neurosurg, Tao Yuan, Taiwan	Lin, TK (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, 5 Fu Hsing St, Tao Yuan 333, Taiwan.	tklin100@cgmh.org.tw		Tsai, Hong-Chieh/0000-0003-3994-1601	National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 88-2314-B-182A-099]	Supported by grant NSC 88-2314-B-182A-099 from the National Science Council, Taiwan.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; CHAN KH, 1992, NEUROSURGERY, V30, P697; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; HASHIMOTO T, 1992, Neurological Surgery, V20, P209; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; LEE JP, 1991, CAN J NEUROL SCI, V18, P458, DOI 10.1017/S0317167100032157; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Morris GF, 1997, ACTA NEUROCHIR S, V71, P382; Nahed BV, 2009, J NEUROSURG-PEDIATR, V3, P311, DOI 10.3171/2008.12.PEDS08206; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; Zubkov ZY, 2000, SURG NEUROL, V53, P126	25	16	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2012	73	1					131	136		10.1097/TA.0b013e31824aff74			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	979JU	WOS:000306814100019	22743382				2021-06-18	
J	Prins, ML				Prins, Mayumi L.			Cerebral ketone metabolism during development and injury	EPILEPSY RESEARCH			English	Article						Brain; Development; Ketones; Injury; Metabolism; Neuroprotection	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; FUNCTION IMPROVING AGENT; D-BETA-HYDROXYBUTYRATE; KETOGENIC DIET; RAT-BRAIN; ADULT RATS; GLUCOSE-UTILIZATION; JUVENILE RATS; IN-VIVO	Cerebral metabolism of ketones is a normal part of the process of brain development. While the mature brain relies on glucose as a primary fuel source, metabolism of ketone bodies remains an alternative energy source under conditions of starvation. The neuroprotective properties of brain ketone metabolism make this alternative substrate a viable therapeutic option for various pathologies. Since the ability to revert to utilizing ketones as an alternative substrate is greatest in the younger post-weaned brain, this particular therapeutic approach remains an untapped resource particularly for pediatric pathological conditions. Published by Elsevier B.V.	Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA	Prins, ML (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Dept Neurosurg, Semel Room 18-228,Box 957039, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110757, P01 NS058489-01A2, P01 NS058489, R01 NS104311] Funding Source: Medline		Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; BOOTH RFG, 1980, J NEUROCHEM, V34, P17, DOI 10.1111/j.1471-4159.1980.tb04616.x; CREMER JE, 1976, BIOCHIM BIOPHYS ACTA, V448, P633, DOI 10.1016/0005-2736(76)90120-6; DAHLQUIST G, 1976, PEDIATR RES, V10, P910, DOI 10.1203/00006450-197611000-00002; Deng-Bryant Y., 2011, J NEUROTRAU IN PRESS; Deng-Bryant Y, 2009, J NEUROTRAUM, V26, pA80; Haces ML, 2008, EXP NEUROL, V211, P85, DOI 10.1016/j.expneurol.2007.12.029; Hasselbalch SG, 1996, AM J PHYSIOL-ENDOC M, V270, pE746; HASSELBALCH SG, 1994, J CEREBR BLOOD F MET, V14, P125, DOI 10.1038/jcbfm.1994.17; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; KAMMULA RG, 1976, AM J PHYSIOL, V231, P1490; Kim DY, 2010, J NEUROCHEM, V114, P130, DOI 10.1111/j.1471-4159.2010.06728.x; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; LEONG SF, 1984, BIOCHEM J, V218, P131, DOI 10.1042/bj2180131; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; MILLER AL, 1986, METAB BRAIN DIS, V1, P53, DOI 10.1007/BF00998477; MOORE TJ, 1976, AM J PHYSIOL, V230, P619; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; NEHLIG A, 1988, J NEUROSCI, V8, P2321; NISSELBA.JS, 1969, ANAL BIOCHEM, V27, P212, DOI 10.1016/0003-2697(69)90025-6; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins M, 2007, J NEUROTRAUM, V24, P1267; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI [10.1089/neu.2008.0769, 10.1089/neu.2008-0769]; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Randle P J, 1966, Recent Prog Horm Res, V22, P1; REDIES C, 1989, AM J PHYSIOL, V256, pE805; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Ritter AM, 1996, J NEUROTRAUM, V13, P473, DOI 10.1089/neu.1996.13.473; RUDERMAN NB, 1974, BIOCHEM J, V138, P1; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; SAUDUBRAY JM, 1981, J PEDIATR-US, V98, P904, DOI 10.1016/S0022-3476(81)80583-5; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Stafford P., 2010, NUTR METAB, V11, P710; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Yamada KA, 2005, NEUROSCI LETT, V385, P210, DOI 10.1016/j.neulet.2005.05.038; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Ziegler DR, 2003, NEUROCHEM RES, V28, P1793, DOI 10.1023/A:1026107405399	55	16	16	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	JUL	2012	100	3			SI		218	223		10.1016/j.eplepsyres.2011.09.027			6	Clinical Neurology	Neurosciences & Neurology	988ZQ	WOS:000307530400004	22104087	Green Accepted			2021-06-18	
J	Chen, Y; Huang, W; Constantini, S				Chen, Yun; Huang, Wei; Constantini, Shlomi			Blast Shock Wave Mitigation Using the Hydraulic Energy Redirection and Release Technology	PLOS ONE			English	Article							INJURY; TSUNAMIS; PRESSURE; PHYSICS	A hydraulic energy redirection and release technology has been developed for mitigating the effects of blast shock waves on protected objects. The technology employs a liquid-filled plastic tubing as a blast overpressure transformer to transfer kinetic energy of blast shock waves into hydraulic energy in the plastic tubings. The hydraulic energy is redirected through the plastic tubings to the openings at the lower ends, and then is quickly released with the liquid flowing out through the openings. The samples of the specifically designed body armor in which the liquid-filled plastic tubings were installed vertically as the outer layer of the body armor were tested. The blast test results demonstrated that blast overpressure behind the body armor samples was remarkably reduced by 97% in 0.2 msec after the liquid flowed out of its appropriate volume through the openings. The results also suggested that a volumetric liquid surge might be created when kinetic energy of blast shock wave was transferred into hydraulic energy to cause a rapid physical movement or displacement of the liquid. The volumetric liquid surge has a strong destructive power, and can cause a noncontact, remote injury in humans (such as blast-induced traumatic brain injury and post-traumatic stress disorder) if it is created in cardiovascular system. The hydraulic energy redirection and release technology can successfully mitigate blast shock waves from the outer surface of the body armor. It should be further explored as an innovative approach to effectively protect against blast threats to civilian and military personnel.	[Chen, Yun] BrightstarTech Inc, Clarksburg, MD USA; [Huang, Wei] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Constantini, Shlomi] Tel Aviv Univ, Tel Aviv Med Ctr, Dana Childrens Hosp, Dept Pediat Neurosurg, IL-69978 Tel Aviv, Israel	Chen, Y (corresponding author), BrightstarTech Inc, Clarksburg, MD USA.	yun.chen@brightstartechinc.com			BrightstarTech, Inc.	This work was supported in part by BrightstarTech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Azenkot A, 2004, IRRIGATION SYSTEM DE; Bailey JL, 2006, ADA443885 DTIC; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Cannon L, 2001, J R Army Med Corps, V147, P87; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen HX, 2011, US patent, Patent No. [13/285049, 13285049]; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Choe SH, 2010, NY TIMES; Courtney AC, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3702803; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Glasstone S., 1977, The Effects of Nuclear Weapons; Haugen KB, 2005, MAR PETROL GEOL, V22, P209, DOI 10.1016/j.marpetgeo.2004.10.016; HIRSCH AE, 1972, J NEUROSURG, V37, P95, DOI 10.3171/jns.1972.37.1.0095; Kailasanath K, 2002, ADA400620 DTIC; Krehl POK, 2011, EUR PHYS J H, V36, P85, DOI 10.1140/epjh/e2011-10037-x; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Margaritondo G, 2005, EUR J PHYS, V26, P401, DOI 10.1088/0143-0807/26/3/007; Pudasaini SP, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041308; Reid WD, 1996, DSTOGD0109 DEP DEF S; Rice D, 2000, TACTICAL EDGE J  SUM, P53; Rinehart SA, 2010, DESIGN CONSIDERATION; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Schwer D, 2006, ADA452669 DTIC; Stuhmiller JH, 2008, BIQPJHSCH10 ARM MED; VOIT SS, 1987, ANNU REV FLUID MECH, V19, P217, DOI 10.1146/annurev.fluid.19.1.217; Willauer HD, 2009, J HAZARD MATER, V165, P1068, DOI 10.1016/j.jhazmat.2008.10.130	26	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39353	10.1371/journal.pone.0039353			8	Multidisciplinary Sciences	Science & Technology - Other Topics	964KK	WOS:000305693200067	22745740	DOAJ Gold, Green Published			2021-06-18	
J	Mayer, F; Bonaventura, K; Cassel, M; Mueller, S; Weber, J; Scharhag-Rosenberger, F; Carlsohn, A; Baur, H; Scharhag, J				Mayer, Frank; Bonaventura, Klaus; Cassel, Michael; Mueller, Steffen; Weber, Josefine; Scharhag-Rosenberger, Friederike; Carlsohn, Anja; Baur, Heiner; Scharhag, Juergen			Medical results of preparticipation examination in adolescent athletes	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SPORT-RELATED CONCUSSION; RECOMMENDATIONS; STATEMENT; PREVENTION; INJURY	Background Preparticipation examinations (PPE) are frequently used to evaluate eligibility for competitive sports in adolescent athletes. Nevertheless, the effectiveness of these examinations is under debate since costs are high and its validity is discussed controversial. Purpose To analyse medical findings and consequences in adolescent athletes prior to admission to a sports school. Methods In 733 adolescent athletes (318 girls, 415 boys, age 12.3+/-0.4, 16 sports disciplines), history and clinical examination (musculoskeletal, cardiovascular, general medicine) was performed to evaluate eligibility. PPE was completed by determination of blood parameters, ECG at rest and during ergometry, echocardiography and x-rays and ultrasonography if indicated. Eligibility was either approved or rated with restriction. Recommendations for therapy and/or prevention were given to the athletes and their parents. Results Historical (h) and clinical (c) findings (eg, pain, verified pathologies) were more frequent regarding the musculoskeletal system (h: 120, 16.4%; c: 247, 33.7%) compared to cardiovascular (h: 9, 1.2%; c: 23, 3.1%) or general medicine findings (h: 116, 15.8%; c: 71, 9.7%). ECG at rest was moderately abnormal in 46 (6.3%) and severely abnormal in 25 athletes (3.4%). Exercise ECG was suspicious in 25 athletes (3.4%). Relevant echocardiographic abnormalities were found in 17 athletes (2.3%). In 52 of 358 cases (14.5%), x-rays led to diagnosis (eg, Spondylolisthesis). Eligibility was temporarily restricted in 41 athletes (5.6%). Three athletes (0.4%) had to be excluded from competitive sports. Therapy (eg, physiotherapy, medication) and/or prevention (sensorimotor training, vaccination) recommendations were deduced due to musculoskeletal (t:n = 76,10.3%; p:n = 71,9.8%) and general medicine findings (t:n = 80, 10.9%; p:n = 104, 14.1%). Conclusion Eligibility for competitive sports is restricted in only 5.5% of adolescent athletes at age 12. Eligibility refusals are rare. However, recommendations for therapy and prevention are frequent, mainly regarding the musculoskeletal system. In spite of time and cost consumption, adolescent preparticipation before entering a career in high-performance sports is supported.	[Mayer, Frank; Bonaventura, Klaus; Cassel, Michael; Mueller, Steffen; Weber, Josefine; Scharhag-Rosenberger, Friederike; Carlsohn, Anja; Scharhag, Juergen] Univ Potsdam, Dept Sports Med, Potsdam, Germany; [Scharhag-Rosenberger, Friederike] Deutsch Hsch Pravent & Gesundheitsmanagement, Saarbrucken, Germany; [Baur, Heiner] Bern Univ Appl Sci, Dept Hlth, Bern, Switzerland; [Scharhag, Juergen] Univ Clin, Heidelberg, Germany	Mayer, F (corresponding author), Univ Outpatient Clin, Ctr Sports Med, Neuen Palais 10, D-14469 Potsdam, Germany.	fmayer@uni-potsdam.de	Baur, Heiner/M-9995-2019; Baur, Heiner/A-8673-2017	Baur, Heiner/0000-0002-4780-225X; Baur, Heiner/0000-0002-4780-225X			Abernethy L, 2007, BRIT J SPORT MED, V41, P627, DOI 10.1136/bjsm.2007.035691; Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; [American Medical Association Board of Trustees Group on Science and technology], 1992, ARCH PEDIAT ADOLESC, V148, P93; [Anonymous], 2001, MED SCI SPORT EXER, V33, P1789; Baggish AL, 2010, ANN INTERN MED, V152, P269, DOI 10.7326/0003-4819-152-5-201003020-00004; Beck CK, 2000, MED SCI SPORT EXER, V32, pS431, DOI 10.1097/00005768-200007001-00008; Behera SK, 2011, CURR SPORT MED REP, V10, P90, DOI 10.1249/JSR.0b013e3182141c1e; Burns RD, 2004, J AM DIET ASSOC, V104, P246, DOI 10.1016/j.jada.2003.11.013; Carek PJ, 2003, BJM, V327, P170; Casa Douglas J, 2005, Curr Sports Med Rep, V4, P115; Corrado D, 2010, EUR HEART J, V31, P243, DOI 10.1093/eurheartj/ehp473; Davis KW, 2010, RADIOL CLIN N AM, V48, P1199, DOI 10.1016/j.rcl.2010.07.020; Davis KW, 2010, RADIOL CLIN N AM, V48, P1213, DOI 10.1016/j.rcl.2010.07.004; Delise Pietro, 2005, Ital Heart J, V6, P661; Demorest Rebecca A, 2003, Curr Sports Med Rep, V2, P337; Dickinson DF, 2005, HEART, V91, P1626, DOI 10.1136/hrt.2004.057307; Donnelly Diane K, 2006, Curr Sports Med Rep, V5, P67; Earnest Conrad, 2002, Curr Sports Med Rep, V1, P172, DOI 10.1249/00149619-200206000-00008; Faigenbaum AD, 2000, PEDIATR ANN, V29, P156, DOI 10.3928/0090-4481-20000301-08; Garrick JG, 2004, CLIN J SPORT MED, V14, P123, DOI 10.1097/00042752-200405000-00003; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hubscher M, 2010, MED SCI SPORT EXER, V42, P413, DOI 10.1249/MSS.0b013e3181b88d37; Iwamoto J, 2005, SCAND J MED SCI SPOR, V15, P163, DOI 10.1111/j.1600-0838.2004.00414.x; Kurowski K, 2000, AM FAM PHYSICIAN, V61, P2683; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Ljungqvist A, 2009, BRIT J SPORT MED, V43, P631, DOI 10.1136/bjsm.2009.064394; Mason JW, 2007, J ELECTROCARDIOL, V40, P228, DOI 10.1016/j.jelectrocard.2006.09.003; Metzl J D, 2001, Pediatr Rev, V22, P227, DOI 10.1542/pir.22-7-227; Metzl J D, 2001, Pediatr Rev, V22, P199, DOI 10.1542/pir.22-6-199; Nesmith J Darrell, 2010, J Ark Med Soc, V107, P111; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; Pelliccia A, 2000, CIRCULATION, V102, P278; Rao AL, 2010, ARCH PHYS MED REHAB, V91, P958, DOI 10.1016/j.apmr.2010.02.006; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Steffen K, 2010, EUR J SPORT SCI, V10, P223, DOI 10.1080/17461390903585173; Steffen K, 2010, BRIT J SPORT MED, V44, P485, DOI 10.1136/bjsm.2010.073833; Unnithan Viswanath B, 2004, Curr Sports Med Rep, V3, P206, DOI 10.1249/00149619-200408000-00006	37	16	16	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2012	46	7					524	530		10.1136/bjsports-2011-090966			7	Sport Sciences	Sport Sciences	958ZW	WOS:000305280500014	22576783				2021-06-18	
J	Strutt, AM; Scott, BM; Lozano, VJ; Tieu, PG; Peery, S				Strutt, Adriana M.; Scott, Bonnie M.; Lozano, Veronica J.; Tieu, Phoebe G.; Peery, Shelley			Assessing sub-optimal performance with the Test of Memory Malingering in Spanish speaking patients with TBI	BRAIN INJURY			English	Article						Spanish speakers; suspect effort/motivation; traumatic brain injury; symptom validity testing; TOMM	SYMPTOM VALIDITY TESTS; SUSPECT EFFORT; BASE RATES; TOMM; POPULATION; SCORES; SAMPLE	Primary objectives: To examine the clinical utility of the Test of Memory Malingering (TOMM) with US Spanish speaking patients diagnosed with traumatic brain injury (TBI). Research design: The demographic characteristics and neuropsychological functioning of Spanish speaking patients with TBI with valid vs suboptimal performance were compared. Methods and procedures: Demographic and neuropsychological data were retrospectively collected from charts of patients who underwent neurocognitive evaluations for clinical, med-legal and workmen's compensation purposes. Slick et al. criteria for malingered neurocognitive dysfunction were employed for clinical determination of the validity of participants' neuropsychological profiles, resulting in 16 valid and four suboptimal performers. Main outcomes and results: Valid performers obtained significantly greater scores than suboptimal performers on all trials of the TOMM and generally demonstrated less impairment across neuropsychological domains. The traditional cut-off score for the TOMM misclassified 18.8% of participants not suspected of malingering and lower levels of education appeared to reduce performance on this measure within the valid group. Conclusions: The current findings generally support the use of the TOMM with US primarily Spanish speaking patients diagnosed with TBI. However, caution is recommended when utilizing this measure with individuals having minimal levels of education. Future research with a larger sample and a non-neurological age-and education-matched sample should investigate lower cut-off scores for use with such patients.	[Strutt, Adriana M.; Scott, Bonnie M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Lozano, Veronica J.] TIRR Mem Hermann, Dept Psychol Neupsychol, Houston, TX USA	Strutt, AM (corresponding author), 6550 Fannin,Suite 1801, Houston, TX 77030 USA.	adrianam@bcm.edu	Peery, Shelley/AAA-8090-2019	Scott, Bonnie/0000-0002-4868-6238			Acevedo A, 2007, J CLIN EXP NEUROPSYC, V29, P530, DOI 10.1080/13803390600814740; [Anonymous], 2003, HDB REY OST COMPL FI; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Ardila A, 2003, HDB REY OSTERRIETH C; Artiola i Fortuny L., 1999, MANUAL NORMAS PROCED; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Beck A.T., 1993; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Brandt J., 2001, HOPKINS VERBAL LEARN; Bureau. USC, 2006, AM COMM SURV DEM HOU; Bureau. USC, 2009, AM COMM SURV DEM HOU; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Duncan A, 2005, ASSESSMENT, V12, P123, DOI 10.1177/1073191105275512; Ediciones T, 2004, WMS 3 ESCALA MEMORIA; Ediciones T, 2001, WAIS 3 ESCALA INTELI; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moderno EEM, 2003, WAIS 3 ESCALA WECHSL; Ostrosky-Solis F, 2003, NEUROPSY ATENCION ME; Ostrosky-Solis F, 1997, NEUROPSI EVALUACION; Ramirez RM, 2004, REV NEUROLOGIA, V38, P28, DOI 10.33588/rn.3801.2003533; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reyes B, 2009, DISS ABSTR INT A, V70, P1; Schmidt M., 1996, REY AUDITORY VERBAL; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P109, DOI 10.1076/clin.16.2.109.13237; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh TN, 1996, TEST MEMORY MALINGER; Vilar-Lopez R, 2008, J CLIN EXP NEUROPSYC, V30, P710, DOI 10.1080/13803390701684562; Vilar-Lopez R, 2008, ARCH CLIN NEUROPSYCH, V23, P365, DOI 10.1016/j.acn.2008.01.007; Vilar-Lopez R, 2007, ARCH CLIN NEUROPSYCH, V22, P379, DOI 10.1016/j.acn.2007.01.012	41	16	16	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2012	26	6					853	863		10.3109/02699052.2012.655366			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500007	22583176				2021-06-18	
J	Yelleswarapu, NK; Tay, JK; Fryer, WM; Shah, MA; Garcia, AN; Cheng, JP; Kline, AE				Yelleswarapu, Narayana K.; Tay, Justin K.; Fryer, William M.; Shah, Mansi A.; Garcia, Alexandra N.; Cheng, Jeffrey P.; Kline, Anthony E.			Elucidating the role of 5-HT1A and 5-HT7 receptors on 8-OH-DPAT-induced behavioral recovery after experimental traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Controlled cortical impact; Functional recovery; Learning and memory; Morris water maze; Neurobehavior; Serotonin receptor agonists; Traumatic brain injury	BAY X 3702; AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; NEUROPROTECTIVE PROPERTIES; NEUROBEHAVIORAL BENEFIT; COGNITIVE DEFICITS; HYPOTHERMIA; ANTAGONIST; INDUCTION; EFFICACY	8-OH-DPAT is a 5-HT1A/7 receptor agonist that enhances behavioral recovery after traumatic brain injury (TBI). This study is a first attempt to decipher whether the benefits induced by 8-OH-DPAT after TBI are mediated by 5-HT1A or 5-HT7 receptors. A single i.p. injection of 8-OH-DPAT (0.5 mg/kg) alone or co-administered with either the 5-HT1A or 5-HT7 receptor antagonists WAY 100635 (0.5 mg/kg) or SB 269970 HCI (2.0 mg/kg), respectively, or vehicle control (1.0 mL/kg) was given 15 min after cortical impact or sham injury. Function was assessed by established motor and cognitive tests. No difference in motor performance was observed among the TBI groups. Spatial acquisition was enhanced, relative to vehicle controls, by 8-OH-DPAT alone and when co-administered with WAY 100635, but not when combined with SB 269970 HCI. These data imply that 5-HT1A receptor antagonism does not abate the 8-OH-DPAT-induced cognitive benefits, but 5-HT7 recepi:or antagonism does, which suggests that the 8-OH-DPAT-induced benefits in this single administration, paradigm may be mediated more by 5-HT7 versus 5-HT1A receptors. Evaluation of a specific 5-HT7 receptor agonist will further elucidate the contribution of 5-HTIA and 5-HT7 receptors on behavioral recovery conferred by acute 8-OH-DPAT treatment after TBI. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Yelleswarapu, Narayana K.; Tay, Justin K.; Fryer, William M.; Shah, Mansi A.; Garcia, Alexandra N.; Cheng, Jeffrey P.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Shah, Mansi A.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA	Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 5th Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Cheng, Jeffrey/0000-0001-8285-3207	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD043851, HD046700, NS060005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD046700, R03HD043851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005] Funding Source: NIH RePORTER	Supported, in part, by NIH grants HD043851, HD046700, and NS060005 (AEK)	Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berends AC, 2005, CNS DRUG REV, V11, P379; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2007, NEUROSCI LETT, V416, P165, DOI 10.1016/j.neulet.2007.02.006; Cryan JF, 1999, J PSYCHOPHARMACOL, V13, P278, DOI 10.1177/026988119901300310; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; De Vry J, 1998, J PHARMACOL EXP THER, V284, P1082; De Vry Jean, 1997, Drugs of the Future, V22, P341; Eriksson TM, 2008, EUR J PHARMACOL, V596, P107, DOI 10.1016/j.ejphar.2008.08.026; Gasbarri A, 2008, BEHAV BRAIN RES, V195, P164, DOI 10.1016/j.bbr.2007.12.020; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hedlund PB, 2004, EUR J PHARMACOL, V487, P125, DOI 10.1016/j.ejphar.2004.01.031; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Landry ES, 2006, EUR J NEUROSCI, V24, P535, DOI 10.1111/j.1460-9568.2006.04917.x; Lapointe NP, 2008, J NEUROPHYSIOL, V100, P160, DOI 10.1152/jn.90339.2008; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; Meneses A, 2007, NEUROSCI BIOBEHAV R, V31, P705, DOI 10.1016/j.neubiorev.2007.02.001; MILLAN MJ, 1993, J PHARMACOL EXP THER, V264, P1364; Naumenko VS, 2011, NEUROPHARMACOLOGY, V61, P1360, DOI 10.1016/j.neuropharm.2011.08.022; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; PREHN JHM, 1991, EUR J PHARMACOL, V203, P213, DOI 10.1016/0014-2999(91)90717-5; Roberts AJ, 2004, EUR J NEUROSCI, V19, P1913, DOI 10.1111/j.1460-9568.2004.03288.x; Semkova I, 1998, EUR J PHARMACOL, V359, P251, DOI 10.1016/S0014-2999(98)00634-7	27	16	16	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 2	2012	515	2					153	156		10.1016/j.neulet.2012.03.033			4	Neurosciences	Neurosciences & Neurology	936YD	WOS:000303625000011	22465320	Green Accepted			2021-06-18	
J	Chen, YH; Keller, JJ; Kang, JH; Lin, HC				Chen, Yi-Hua; Keller, Joseph J.; Kang, Jiunn-Horng; Lin, Herng-Ching			Association between Traumatic Brain Injury and the Subsequent Risk of Brain Cancer	JOURNAL OF NEUROTRAUMA			English	Article						epidemiology; malignant brain tumors; TBI	OF-THE-LITERATURE; HEAD TRAUMA; POSTTRAUMATIC GLIOMA; TUMORS; ADULTS; EPIDEMIOLOGY; POPULATION; CHINA	This population-based study in Taiwan aimed to investigate the risk of having a diagnosis of malignant brain tumors within 3 years after a traumatic brain injury (TBI). This study used data from the Traumatic Brain Injury Registry and the National Health Insurance Research Database. The study cohort comprised 5007 patients who had visited ambulatory care centers or had been hospitalized with a diagnosis of TBI between 2001 and 2002. The comparison cohort was 25,035 randomly selected enrollees. Each patient's brain cancer status was individually tracked for a 3-year period following their index date. Stratified Cox proportional hazards regressions were performed for analyses. During the 3 years of follow-up, nine patients in each cohort, both the TBI and the non-TBI cohort, were diagnosed with brain cancer. As compared to those patients without TBI, patients with TBI were more likely to receive a diagnosis of malignant brain tumors within the 3-year period following their index date: the incidence rate of malignant brain tumors was 6.28 (95% CI: 3.06-11.53) per 10,000 person-years in patients with TBI and 1.25 (95% CI: 0.61-2.29) per 10,000 person-years in patients without TBI. After adjusting for sociodemographic characteristics, the hazard of being diagnosed with malignant brain tumors during the 3-year follow-up period was 4.67 (95% CI: 1.84-11.83) times greater for those who sustained a TBI than for patients in the comparison cohort. In addition, we found an association between TBI severity and malignant brain tumor among patients with TBI (p = 0.033). Our findings suggest a positive correlation between TBI and the relatively short-term development of malignant neoplasms of the brain.	[Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Coll Publ Hlth & Nutr, Taipei 110, Taiwan; [Chen, Yi-Hua] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei 110, Taiwan; [Keller, Joseph J.] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei 110, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Dept Phys Med & Rehabil, Taipei 110, Taiwan	Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Coll Publ Hlth & Nutr, 250 Wu Hsing St, Taipei 110, Taiwan.	henry11111@tmu.edu.tw					ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; Anselmi E, 2006, TUMORI J, V92, P175, DOI 10.1177/030089160609200215; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; BURCH JD, 1987, J NATL CANCER I, V78, P601; CARPENTER AV, 1987, AM J PUBLIC HEALTH, V77, P1180, DOI 10.2105/AJPH.77.9.1180; Davis Faith S, 2007, Expert Rev Anticancer Ther, V7, pS3, DOI 10.1586/14737140.7.12s.S3; Hennekens CH, 1987, EPIDEMIOLOGY MED; Henry PT, 2000, BRIT J NEUROSURG, V14, P64; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; Hu JF, 1998, CANCER DETECT PREV, V22, P100, DOI 10.1046/j.1525-1500.1998.CDOA22.x; Hwang Shiuh-Lin, 1992, Kaohsiung Journal of Medical Sciences, V8, P656; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; Inskip PD, 1995, EPIDEMIOL REV, V17, P382; KEPES JJ, 1984, SURG NEUROL, V22, P149, DOI 10.1016/0090-3019(84)90043-0; LAWS ER, 1993, CA-CANCER J CLIN, V43, P263, DOI 10.3322/canjclin.43.5.263; Magnavita N, 2003, NEUROL SCI, V24, P31, DOI 10.1007/s100720300018; Nygren C, 2001, CANCER CAUSE CONTROL, V12, P733, DOI 10.1023/A:1011227617256; Preston-Martin S, 1998, INT J EPIDEMIOL, V27, P579, DOI 10.1093/ije/27.4.579; PRESTONMARTIN S, 1989, CANCER RES, V49, P6137; Rothman K. J., 1986, MODERN EPIDEMIOLOGY; SCHLEHOFER B, 1992, CANCER, V69, P2541, DOI 10.1002/1097-0142(19920515)69:10<2541::AID-CNCR2820691025>3.0.CO;2-H; Wrensch M, 2000, NEUROEPIDEMIOLOGY, V19, P234, DOI 10.1159/000026261; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278; ZAMPIERI P, 1994, J NEURO-ONCOL, V19, P61, DOI 10.1007/BF01051049; Zhou B, 2010, INT J MED SCI, V7, P248; Zulch KJ, 1965, BRAIN TUMORS THEIR B	26	16	17	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1328	1333		10.1089/neu.2011.2235			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600006	22320191				2021-06-18	
J	Harris, NG; Mironova, YA; Chen, SF; Richards, HK; Pickard, JD				Harris, Neil G.; Mironova, Yevgeniya A.; Chen, Szu-Fu; Richards, Hugh K.; Pickard, John D.			Preventing Flow-Metabolism Uncoupling Acutely Reduces Axonal Injury after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						autoradiography; blood flow; cortical contusion injury; glucose metabolism; uncoupling	CEREBRAL-BLOOD-FLOW; CONTROLLED CORTICAL IMPACT; POSITRON-EMISSION-TOMOGRAPHY; HEAD-INJURY; NEUROFILAMENT COMPACTION; AXOLEMMAL PERMEABILITY; CEREBROVASCULAR REACTIVITY; CYTOCHEMICAL EVIDENCE; STRETCH INJURY; NERVE-FIBERS	We have previously presented evidence that the development of secondary traumatic axonal injury is related to the degree of local cerebral blood flow (LCBF) and flow-metabolism uncoupling. We have now tested the hypothesis that augmenting LCBF in the acute stages after brain injury prevents further axonal injury. Data were acquired from rats with or without acetazolamide (ACZ) that was administered immediately following controlled cortical impact injury to increase cortical LCBF. Local cerebral metabolic rate for glucose (LCMRglc) and LCBF measurements were obtained 3 h post-trauma in the same rat via F-18-fluorodeoxyglucose and C-14-iodoantipyrine co-registered autoradiographic images, and compared to the density of damaged axonal profiles in adjacent sections, and in additional groups at 24 h used to assess different populations of injured axons stereologically. ACZ treatment significantly and globally elevated LCBF twofold above untreated-injured rats at 3 h (p < 0.05), but did not significantly affect LCMRglc. As a result, ipsilateral LCMRglc: LCBF ratios were reduced by twofold to sham-control levels, and the density of beta-APP-stained axons at 24 h was significantly reduced in most brain regions compared to the untreated-injured group (p < 0.01). Furthermore, early LCBF augmentation prevented the injury-associated increase in the number of stained axons from 3-24 h. Additional robust stereological analysis of impaired axonal transport and neurofilament compaction in the corpus callosum and cingulum underlying the injury core confirmed the amelioration of beta-APP axon density, and showed a trend, but no significant effect, on RMO14-positive axons. These data underline the importance of maintaining flow-metabolism coupling immediately after injury in order to prevent further axonal injury, in at least one population of injured axons.	[Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Richards, Hugh K.; Pickard, John D.] Univ Cambridge, Ctr Brain Repair, Cambridge, England; [Richards, Hugh K.; Pickard, John D.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England	Harris, NG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Box 957039, Los Angeles, CA 90095 USA.	ngharris@mednet.ucla.edu	Chen, Szu-Fu/K-5040-2012	Harris, Neil/0000-0002-1965-6750	Medical Research Council of the United KingdomUK Research & Innovation (UKRI)Medical Research Council UK (MRC); National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS055910]; UCLA Brain Injury Research Center; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0001237, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055910] Funding Source: NIH RePORTER	This work was supported by the Medical Research Council of the United Kingdom, National Institutes of Health/National Institute of Neurological Disorders and Stroke award no. NS055910 and the UCLA Brain Injury Research Center. The Overseas Research Council and Merck Sharp & Dohme funded S. F. C. and N.G.H., respectively. We would also like to thank Ms. Marcia Nogueira for her assistance with the experiments.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BICKLER PE, 1988, J APPL PHYSIOL, V65, P422; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Gallyas F, 2006, ACTA NEUROPATHOL, V111, P229, DOI 10.1007/s00401-006-0034-3; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hamm RJ, 1996, J NEUROTRAUM, V13, P325, DOI 10.1089/neu.1996.13.325; Harris N, 2009, J NEUROTRAUM, V26, pA37; Harris NG, 2001, NEUROIMAGE, V13, P339, DOI 10.1006/nimg.2000.0689; Harris NG, 2000, J CEREBR BLOOD F MET, V20, P28, DOI 10.1097/00004647-200001000-00006; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; INGVAR M, 1991, J CEREBR BLOOD F MET, V11, P926, DOI 10.1038/jcbfm.1991.157; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; LEAR JL, 1989, METAB BRAIN DIS, V4, P95, DOI 10.1007/BF00999387; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; NIXON RA, 1994, NEUROCHEM RES, V19, P1445, DOI 10.1007/BF00972474; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; PAXINOS G, 1997, RAT BRAIN STEREOTAXI; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Povlishock JT, 1996, ACT NEUR S, V66, P81; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Schurr A, 1999, J NEUROSCI, V19, P34; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; SUNAMI, 1989, NEUROSURG REV, V12, P400; SUTTON RL, 1994, ACTA NEUROCHIR, P446; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yang JT, 2001, NEUROREPORT, V12, P3589, DOI 10.1097/00001756-200111160-00043; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	69	16	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1469	1482		10.1089/neu.2011.2161			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600019	22321027	Green Published			2021-06-18	
J	Schmidt, AT; Hanten, GR; Li, XQ; Vasquez, AC; Wilde, EA; Chapman, SB; Levin, HS				Schmidt, Adam T.; Hanten, Gerri R.; Li, Xiaoqi; Vasquez, Ana C.; Wilde, Elisabeth A.; Chapman, Sandra B.; Levin, Harvey S.			Decision making after pediatric traumatic brain injury: trajectory of recovery and relationship to age and gender	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Child; TBI; Adolescent risk; Gambling task; Decision making	VENTROMEDIAL PREFRONTAL CORTEX; IOWA GAMBLING TASK; CHILDHOOD HEAD-INJURY; WORKING-MEMORY; SHORT-TERM; CHILDREN; PERFORMANCE; ADOLESCENTS; PERSONALITY; SEVERITY	The aim of the study was to examine longitudinal patterns of decision making based on risk and reward using a modified version of the Iowa Gambling Task (IGT) in children who had sustained traumatic brain injury (TBI) and children with orthopedic injury (01). Participants were 135 children and adolescents with TB! (n = 71) or 01 (n = 64) who were 7-17 years at the time of injury were enrolled and assessed prospectively at baseline and at follow-up intervals of 3, 12, 18, and 24 months after injury. Groups were similar in age, socioeconomic status, and gender. Participants chose from four decks of cards with the aim of maximizing earnings across 100 trials. Two of the decks offered relatively small rewards and relatively small losses, but were advantageous over the course of the experiment. The other two decks offered large rewards, but also introduced occasional large losses, and were considered disadvantageous over the course of the experiment. The variable of interest was the proportion of advantageous decks chosen across trials. Longitudinal analysis of the pattern of change across 2 years revealed a three-way interaction among injury group, age, and the quadratic term of interval-since-injury. In this interaction, the effect of age weakened in the TBI group across time, as compared to the 01 group, which showed stronger quadratic patterns across the recovery intervals that differed by age. The 01 group generally outperformed the TBI group. In addition, analyses revealed a three-way interaction among group, gender and the cubic term of post-injury interval, such that overall, males improved a great deal with time, but females showed small gains, regardless of injury group. (C) 2011 ISDN. Published by Elsevier Ltd. All rights reserved.	[Schmidt, Adam T.; Hanten, Gerri R.; Li, Xiaoqi; Vasquez, Ana C.; Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Hanten, Gerri R.] Rice Univ, Houston, TX 77251 USA; [Chapman, Sandra B.] Univ Texas Dallas, Ctr BrainHlth, Richardson, TX 75083 USA	Hanten, GR (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	ghanten@bcm.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research was supported by Grant Number R01NS021889 from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health.	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Crone EA, 2005, CHILD NEUROPSYCHOL, V11, P245, DOI 10.1080/092970490911261; Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Garon N, 2004, BRAIN COGNITION, V55, P158, DOI 10.1016/s0278-2626(03)00272-0; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2006, NEUROCASE, V12, P247, DOI 10.1080/13554790600910490; Hooper CJ, 2008, PERS INDIV DIFFER, V44, P598, DOI 10.1016/j.paid.2007.09.021; Hooper CJ, 2004, DEV PSYCHOL, V40, P1148, DOI 10.1037/0012-1649.40.6.1148; Huizenga HM, 2007, DEVELOPMENTAL SCI, V10, P814, DOI 10.1111/j.1467-7687.2007.00621.x; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; Kim YT, 2006, ALCOHOL CLIN EXP RES, V30, P466, DOI 10.1111/j.1530-0277.2006.00051.x; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Krueger RF, 2011, ARCH GEN PSYCHIAT, V68, P10, DOI 10.1001/archgenpsychiatry.2010.188; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levin IP, 2003, J BEHAV DECIS MAKING, V16, P397, DOI 10.1002/bdm.453; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Romer D, 2009, NEUROPSYCHOLOGIA, V47, P2916, DOI 10.1016/j.neuropsychologia.2009.06.019; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Suhr JA, 2007, PERS INDIV DIFFER, V43, P27, DOI 10.1016/j.paid.2006.11.004; TEASDALE G, 1974, LANCET, V2, P81; Van Leijenhorst L, 2008, DEV NEUROPSYCHOL, V33, P179, DOI 10.1080/87565640701884287; van Leijenhorst L, 2006, NEUROPSYCHOLOGIA, V44, P2158, DOI 10.1016/j.neuropsychologia.2006.02.002; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	40	16	17	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748			INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	MAY	2012	30	3			SI		225	230		10.1016/j.ijdevneu.2011.11.003			6	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	936XH	WOS:000303622800008	22138008	Green Accepted			2021-06-18	
J	Corrigan, F; Vink, R; Blumbergs, PC; Masters, CL; Cappai, R; van den Heuvel, C				Corrigan, Frances; Vink, Robert; Blumbergs, Peter C.; Masters, Colin L.; Cappai, Roberto; van den Heuvel, Corinna			Evaluation of the effects of treatment with sAPP alpha on functional and histological outcome following controlled cortical impact injury in mice	NEUROSCIENCE LETTERS			English	Article						Amyloid precursor protein; sAPP alpha; Traumatic brain injury	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; SECRETED FORMS; HIPPOCAMPAL-NEURONS; HEAD-INJURY; DOMAIN; RATS; NEURODEGENERATION; PATHOPHYSIOLOGY; NEUTRALIZATION	Treatment with sAPP alpha, the product of non-amyloidogenic processing of the amyloid precursor protein (APP) has been shown to be protective following diffuse traumatic brain injury (TBI), by improving motor outcome and reducing axonal injury. However the effects of treatment with sAPP alpha following a focal TBI have yet to be determined. To investigate this, mice were subjected to a controlled cortical impact injury and treated with either sAPP alpha or its vehicle at 30 min post-injury. Following treatment with sAPP alpha the mice showed a significant improvement in motor and cognitive function early following injury, as determined on the ledged beam and Barnes Maze, respectively, relating to a more rapid rate of recovery. However the effect of treatment with sAPP alpha was not as dramatic as that seen previously following a diffuse injury. Nonetheless, these improvements in functional outcome were acompanied by a small but significant improvement in the amount of cortical and hippocampal at 7 days post-injury, and provide further support for the efficacy of sAPP alpha as a potential neuroprotective agent following TBI. Crown Copyright (C) 2012 Published by Elsevier Ireland Ltd. All rights reserved.	[Corrigan, Frances; Vink, Robert; Blumbergs, Peter C.; van den Heuvel, Corinna] Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia; [Corrigan, Frances; Vink, Robert; Blumbergs, Peter C.; van den Heuvel, Corinna] Hanson Inst, Ctr Neurol Dis, Adelaide, SA 5005, Australia; [Masters, Colin L.] Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Cappai, Roberto] Univ Melbourne, Mol Sci & BioTechnol Inst Bio21, Melbourne, Vic 3010, Australia	Corrigan, F (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	corinna.vandenheuvel@adelaide.edu.au	AM, Robert Vink/S-5616-2019; Vink, Robert/J-7351-2012; Cappai, Roberto/B-3347-2010	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Cappai, Roberto/0000-0002-9505-8496; , Corinna/0000-0003-0664-8935; Corrigan, Frances/0000-0001-6150-8893	Brain Foundation; Neurological Research Foundation	We thank Dr Mark Habgood for his assistance in setting up the controlled cortical impact model. This work was funded in part by grants from the Brain Foundation and the Neurological Research Foundation. Roberto Cappai is a National Health and Medical Research Council Senior Research Fellow.	Bell K.F., 2006, NEUROBIOL AGING; BHASIN R, 1991, P NATL ACAD SCI USA, V88, P10307, DOI 10.1073/pnas.88.22.10307; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cheng GJ, 2002, EXP NEUROL, V175, P407, DOI 10.1006/exnr.2002.7920; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Furukawa K, 1998, NEUROSCIENCE, V83, P429, DOI 10.1016/S0306-4522(97)00398-9; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Han X., 2011, J NEUROTRAUMA; Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Koopmans G, 2003, PHYSIOL BEHAV, V79, P683, DOI 10.1016/S0031-9384(03)00171-9; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Ohsawa I, 1997, BIOCHEM BIOPH RES CO, V236, P59, DOI 10.1006/bbrc.1997.6903; Paxinos G, 2007, MOUSE BRAIN STEREOTA; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Siopi E., 2011, J NEUROTRAUMA; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44	34	16	17	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	APR 25	2012	515	1					50	54		10.1016/j.neulet.2012.03.017			5	Neurosciences	Neurosciences & Neurology	932LW	WOS:000303293600010	22445885				2021-06-18	
J	Bolouri, H; Saljo, A; Viano, DC; Hamberger, A				Bolouri, H.; Saljo, A.; Viano, D. C.; Hamberger, A.			Animal model for sport-related concussion; ICP and cognitive function	ACTA NEUROLOGICA SCANDINAVICA			English	Article						cognitive function; intracranial pressure; Morris Water Maze; open field activity	TRAUMATIC BRAIN-INJURY; LATERAL FLUID-PERCUSSION; PROFESSIONAL FOOTBALL; INTRACRANIAL-PRESSURE; WATER-MAZE; STRESS; RATS; GAME	Background - We have recently developed and characterized a rat model of mild traumatic brain injury which simulates the concussive injuries frequently encountered by players in American professional football. Objectives - To study the effect of multiple impacts to the head on intracranial pressure, cognitive function, and exploratory behavior. Materials and methods - The model was employed to cause concussion. Intracranial pressure, cognitive function, and exploratory behavior were examined following the multiple impacts of a 50 or 100 g projectile at a velocity of 9.3 or 11.2 m/s to the helmet protected head. Results - Intracranial pressure measured at 6 and 10 h, and 1, 2, 3, 5, and 7 days. It was maximally elevated 10 h after impact and returned to the control levels 7 days later. Morris Water Maze assessment, 48 h after impact, revealed impaired cognitive function. Open field testing 2-4 days and 1 and 2 weeks after impacts indicated consistently reduced spontaneous exploratory activity. Conclusion - Multiple impacts to the head raise intracranial pressure and impair cognitive function and exploratory activity in this animal model.	[Bolouri, H.; Saljo, A.; Hamberger, A.] Univ Gothenburg, Dept Med Chem & Cell Biol, Sahlgren Acad, Inst Biomed, SE-40530 Gothenburg, Sweden; [Bolouri, H.] Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgren Acad, SE-40530 Gothenburg, Sweden; [Viano, D. C.] Pro Biomech, Bloomfield Hills, MI USA	Bolouri, H (corresponding author), Univ Gothenburg, Dept Med Chem & Cell Biol, Sahlgren Acad, Inst Biomed, SE-40530 Gothenburg, Sweden.	hayde.bolouri@gu.se	Lachance, Claude/A-4214-2012	Lachance, Claude/0000-0002-1974-1787	National Football League charities (USA)	The authors want to express their gratitude to Mr. Berndt Svensson, Karlsborg, Sweden, for independently performing the ICP measurements. This work was supported by grants from the National Football League charities (USA).	Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GIULIAN D, 1975, PHYSIOL BEHAV, V14, P109, DOI 10.1016/0031-9384(75)90150-X; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Jantzen JPAH, 2007, BEST PRACT RES-CLIN, V21, P517, DOI 10.1016/j.bpa.2007.09.001; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Patel PM, 1998, ANESTH ANALG, V86, P773, DOI 10.1097/00000539-199804000-00018; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2004, NEUROSURGERY, V55, P303; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Vallee M, 1997, J NEUROSCI, V17, P2626; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Vink R, 2003, ACT NEUR S, V86, P257	35	16	16	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	APR	2012	125	4					241	247		10.1111/j.1600-0404.2011.01614.x			7	Clinical Neurology	Neurosciences & Neurology	904UJ	WOS:000301223100006	22034961				2021-06-18	
J	Ward, AB; Gutenbrunner, C; Giustini, A; Delarque, A; Fialka-Moser, V; Kiekens, C; Berteanu, M; Christodoulou, N				Ward, Anthony B.; Gutenbrunner, Christoph; Giustini, Alessandro; Delarque, Alain; Fialka-Moser, Veronika; Kiekens, Carlotte; Berteanu, Mihai; Christodoulou, Nicolas			A POSITION PAPER ON PHYSICAL & REHABILITATION MEDICINE PROGRAMMES IN POST-ACUTE SETTINGS	JOURNAL OF REHABILITATION MEDICINE			English	Article						rehabilitation; post acute settings; physical & rehabilitation medicine programmes; clinical pathways	INPATIENT NEUROREHABILITATION SERVICES; TRAUMATIC BRAIN-INJURY; CARE PATHWAYS PATIENTS; ACTION PLAN; SPECIALIST REHABILITATION; WHITE BOOK; PRM; SECTION; UK; EFFICIENCY	Physical & Rehabilitation Medicine (PRM) programmes in post-acute settings cover interventions for the rehabilitation of people with a variety of disabling health conditions. The setting of the intervention is more important than the timing and these programmes can be carried out in a variety of facilities. This paper describes the role of PRM services and of PRM specialists in delivering rehabilitation programmes to people, who have initially been admitted to hospital. The emphasis is on improving patients' activities and addressing participation issues. PRM programmes in post-acute settings provide a range of treatments and have a major influence in the long-term on the pace and extent of return of function and recovery from ill-health. This paper will define the meaning of post-acute settings and will describe the patient's journey through the post-acute setting. In particular, it addresses the standards of care across Europe that patients should expect. This paper also examines the general principles of funding such programmes within the context of different health care systems across Europe. Coordinated care improves outcomes and economic profiles for both payers and providers of services. This paper describes the value of PRM interventions and PRM specialist-led teams in promoting better outcomes for people with disabilities with complex needs.	[Ward, Anthony B.] Haywood Hosp, N Staffordshire Rehabil Ctr, UEMS Sect PRM, Stoke On Trent ST6 7AG, Staffs, England; [Gutenbrunner, Christoph] Hannover Med Sch, Profess Practice Comm, UEMS Sect PRM, Dept Rehabil Med, D-30623 Hannover, Germany; [Giustini, Alessandro] Rehabil Hosp San Pancrazio KosGrp Santo, European Soc PRM, Arco Felice Napoli, Trento, Italy; [Delarque, Alain] CHU Timone, UEMS Sect PRM, Dept Med Phys & Readaptat, Marseille, France; [Fialka-Moser, Veronika] Allgemeines Krankenhaus Stadt Wien, UEMS Sect PRM, Univ Klin Phys Med & Rehabil, Vienna, Austria; [Berteanu, Mihai] Univ Hosp Elias, Profess Practice Comm, UEMS Sect PRM, Dept Phys & Rehabil Med, Bucharest, Romania; [Christodoulou, Nicolas] European Univ Cyprus, Sch Sci, UEMS Sect PRM, Nicosia, Cyprus	Ward, AB (corresponding author), Haywood Hosp, N Staffordshire Rehabil Ctr, UEMS Sect PRM, High Lane, Stoke On Trent ST6 7AG, Staffs, England.	anthony@bward2.freeserve.co.uk	Kiekens, Carlotte/V-7545-2018	Kiekens, Carlotte/0000-0001-8500-7751; Gutenbrunner, Christoph/0000-0002-6522-1942			[Anonymous], 2004, 2004280 DHOSSDO01DGS; [Anonymous], 2011, NAT STROK REH PROGR; [Anonymous], 1998, MIN HLTH OFF B; [Anonymous], 2010, REH FOLL ACQ BRAIN I; [Anonymous], 2011, ITALIAN REPUBLIC OFF, V50-S.O.; Bade MJ, 2011, J ORTHOP SPORT PHYS, V41, P932, DOI 10.2519/jospt.2011.3734; Barnes M, 2000, TXB REHABILITATION M; British Society of Rehabilitation Medicine, 2009, BSRM STAND REH SERV; Calmels P., 2011, Annals of Physical and Rehabilitation Medicine, V54, P501, DOI 10.1016/j.rehab.2011.10.001; Cannon S, 2002, J INTEGRATED CARE S1, V5, P2; Collin C, 2010, REHABILITATION MED 2; De Korvin G., 2010, Annals of Physical and Rehabilitation Medicine, V53, P352, DOI 10.1016/j.rehab.2010.03.008; Delarque A, 2010, EUR J PHYS REHAB MED, V46, P1; Delarque A, 2009, EUR J PHYS REHAB MED, V45, P265; Delarque A, 2010, J REHABIL MED, V42, P1, DOI 10.2340/16501977-0494; Department of Health, 2009, SPEC SERV NAT DEF SE; Department of Health, 2005, NAT SERV FRAM LONG T; DeVivo M, 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; FEDMER, 1999, CHART MPR SIGN 15 OC; [FEDMER Groupe-Rhone-Alpes], 2005, CRIT PRIS CHARG MED; Grill E, 2011, J REHABIL MED, V43, P1131; Grill E, 2007, J REHABIL MED, V39, P591, DOI 10.2340/16501977-0093; Gutenbrunner C., 2011, Annals of Physical and Rehabilitation Medicine, V54, P298, DOI 10.1016/j.rehab.2011.05.001; Gutenbrunner C, 2010, Ann Phys Rehabil Med, V53, P593, DOI 10.1016/j.rehab.2010.10.005; Gutenbrunner C, 2009, EUR J PHYS REHAB MED, V45, P275; Gutenbrunner C, 2007, J REHABIL MED S45, pS1; Gutenbrunner C, 2006, EURA MEDICOPHYS, V40, P287; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Krokowski GD, 2009, EUR J PHYS REHAB MED, V45, P281; Lohmann S, 2011, J REHABIL MED, V43, P151, DOI 10.2340/16501977-0657; Lysens R, 2011, TOP SPINAL CORD INJ, V16, P43; MAHONEY F I, 1965, Md State Med J, V14, P61; McElligott J, 2011, AM J PHYS MED REHAB, V90, P74, DOI 10.1097/PHM.0b013e318201744e; Moslavac S, 2010, Ann Phys Rehabil Med, V53, P451, DOI 10.1016/j.rehab.2010.07.004; Neumann V, 2010, J REHABIL MED, V42, P4, DOI 10.2340/16501977-0483; Ribinik P., 2011, Annals of Physical and Rehabilitation Medicine, V54, P496, DOI 10.1016/j.rehab.2011.09.007; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Stier-Jarmer M, 2011, J REHABIL MED, V43, P113, DOI [10.2340/16501977-0617, 10.2340/16501977-0659]; Stucki G, 2007, J REHABIL MED, V39, P278; Teasell Robert, 2005, Top Stroke Rehabil, V12, P46; Turner Stokes L, 2002, CLIN REHABIL S1, V16, P9; Turner-Stokes L, 2000, CLIN REHABIL, V14, P468, DOI 10.1191/0269215500cr349oa; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2005, CLIN MED, V5, P203, DOI 10.7861/clinmedicine.5-3-203; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 1999, CLIN REHABIL, V13, P3, DOI 10.1191/026921599673346206; Turner-Stokes L, 2007, CLIN MED, V7, P593, DOI 10.7861/clinmedicine.7-6-593; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Turner-Stokes L, 2012, CLIN REHABIL, V26, P264, DOI 10.1177/0269215511417467; Turner-Stokes L, 2012, CLIN REHABIL, V26, P256, DOI 10.1177/0269215511417469; Viton JM, 2009, EUR J PHYS REHAB MED, V45, P271; Ward AB, 1993, ADVICE PURCHASERS RE; Ward AB, 2010, J REHABIL MED, V42, P417, DOI 10.2340/16501977-0565; World Health Organization, 2001, INT CLASS FUNCT DIS; Yelnik A. -P., 2011, Annals of Physical and Rehabilitation Medicine, V54, P506, DOI 10.1016/j.rehab.2011.09.004	56	16	16	1	8	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2012	44	4					289	298		10.2340/16501977-0960			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	939WS	WOS:000303850800001	22453770	DOAJ Gold			2021-06-18	
J	Zouridakis, G; Patidar, U; Situ, N; Rezaie, R; Castillo, EM; Levin, HS; Papanicolaou, AC				Zouridakis, George; Patidar, Udit; Situ, Ning; Rezaie, Roozbeh; Castillo, Eduardo M.; Levin, Harvey S.; Papanicolaou, Andrew C.			FUNCTIONAL CONNECTIVITY CHANGES IN MILD TRAUMATIC BRAIN INJURY ASSESSED USING MAGNETOENCEPHALOGRAPHY	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Functional connectivity; traumatic brain injury; Granger causality; MEG	SMALL-WORLD NETWORKS; COHERENT OSCILLATIONS; COMPLEX NETWORKS; DYNAMICS; BEHAVIOR; SYNCHRONIZATION	In this study, we analyzed brain connectivity profiles from 10 mild traumatic brain injury (mTBI) patients and 10 age- and gender-matched normal controls. We computed Granger causality measures from magnetoencephalographic (MEG) activity obtained at the resting state, in an attempt to understand how the default network is affected by mTBI. A connectivity matrix was computed for each subject individually and then group templates were estimated by averaging all matrices in each group. Furthermore, we performed classification of the subjects using support vector machines and Fisher's criterion to rank the features and identify the best subset for maximum separation of the groups. Our results show that a combined model based on connectivity matrices and graph theory measures can provide a minimum of 85% classification accuracy in separating the two groups, with a sensitivity and specificity of 90% and 80%, respectively. These findings suggest that analysis of functional connectivity patterns may provide a valuable tool for early detection of mTBI.	[Zouridakis, George; Patidar, Udit; Situ, Ning] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; [Rezaie, Roozbeh; Castillo, Eduardo M.; Papanicolaou, Andrew C.] Univ Texas Med Sch, Ctr Clin Neurosci, Houston, TX USA; [Levin, Harvey S.] Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA	Zouridakis, G (corresponding author), Univ Houston, Dept Comp Sci, 218 Philip G Hoffman Hall, Houston, TX 77204 USA.	zouridakis@uh.edu	Zouridakis, George/R-8876-2019	Zouridakis, George/0000-0002-7770-9857; Rezaie, Roozbeh/0000-0002-7494-339X	GEAR; Institute for Space Systems Operations; Texas Learning and Computation Center at the University of Houston; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202]; Mission Connect Translational Research Consortium from the Department of Defense [PTO74693P2]	This work was supported in part by a GEAR award, the Institute for Space Systems Operations, and the Texas Learning and Computation Center at the University of Houston, by Award P01NS056202 from the National Institute of Neurological Disorders and Stroke, and award PTO74693P2 Mission Connect Translational Research Consortium from the Department of Defense.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; [Anonymous], MISSION CONNECT MILD; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Classen J, 1998, J NEUROPHYSIOL, V79, P1567; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fallani FDV, 2008, IEEE T NEUR SYS REH, V16, P442, DOI 10.1109/TNSRE.2008.2006196; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; *NAT I NEUR DIS ST, 2002, NIH PUBL, V2158; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Patidar U, 2010, THESIS U HOUSTON; Pollonini L, 2010, BRAIN TOPOGR, V23, P221, DOI 10.1007/s10548-010-0139-9; Pollonini P, 2010, 2010 ANN INT C IEEE, P1730; Rappelsberger P., 1994, Brain Topography, V7, P121, DOI 10.1007/BF01186770; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Singer W, 1999, NATURE, V397, P391, DOI 10.1038/17021; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zouridakis George, 2007, 2007 Joint Meeting of the 6th International Symposium on Noninvasive Functional Source Imaging of the Brain and Heart and the International Conference on Functional Biomedical Imaging, P323, DOI 10.1109/NFSI-ICFBI.2007.4387765	37	16	16	2	7	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	APR	2012	12	2							1240006	10.1142/S0219519412400064			13	Biophysics; Engineering, Biomedical	Biophysics; Engineering	925BA	WOS:000302733800006					2021-06-18	
J	Gong, DS; Hao, M; Liu, L; Liu, CX; Dong, JF; Cui, Z; Sun, L; Su, SB; Zhang, JN				Gong, Dasen; Hao, Mu; Liu, Li; Liu, Chunxiang; Dong, Jingfei; Cui, Zhuang; Sun, Lin; Su, Shaobo; Zhang, Jianning			Prognostic relevance of circulating endothelial progenitor cells for severe traumatic brain injury	BRAIN INJURY			English	Article						EPCs; TBI; VEGF; MMP-9; prognosis	ACUTE MYOCARDIAL-INFARCTION; PERIPHERAL-BLOOD; CD34(+) CELLS; PRACTICAL SCALE; NEOVASCULARIZATION; TRANSPLANTATION; ANGIOGENESIS; MOBILIZATION; VASCULOGENESIS; RECRUITMENT	Objective: Traumatic brain injury (TBI) promotes the recruitment of endothelial progenitor cells (EPCs) into the injured tissue where EPCs play an important role in repairing injured vasculature. However, the repair mechanism and prognostic significance of EPCs after TBI remain poorly understood. Methods: Blood samples were collected from 21 patients with severe TBI and 20 healthy subjects. EPCs were quantified by flow cytometry and serum VEGF and MMP-9 level measured by ELISA on days 1, 4, 7, 14 and 21 after TBI. Results: EPCs in the patients decreased originally, then increased to the peak level at 7 days and was significantly correlated with GOS scores 6 months after TBI. VEGF and MMP-9 were significantly increased during the follow-up period after TBI. EPCs was also positively correlated with GCS score 1 day after TBI and with MMP-9 and VEGF 7 days and 14 days after TBI. Conclusion: The data demonstrate that TBI led to an increase of EPCs, VEGF and MMP-9, suggesting that increased VEGF and MMP-9 may mediate the recruitment of bone marrow-derived EPCs into the circulation. The association of EPCs with nerve functional recovery in patients provides evidence that EPCs may be a potential biomarker to monitor TBI angiogenesis and prognosis.	[Gong, Dasen; Liu, Li; Liu, Chunxiang; Sun, Lin; Su, Shaobo; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin Neurol Inst,Minist Educ,Tianjin Key Lab I, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Hao, Mu] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Hao, Mu] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Hao, Mu] Peking Union Med Coll, Tianjin, Peoples R China; [Dong, Jingfei] Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; [Cui, Zhuang] Tianjin Med Univ, Coll Publ Hyg, Tianjin, Peoples R China	Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin Neurol Inst,Minist Educ,Tianjin Key Lab I, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772229]; 973 ProjectNational Basic Research Program of China [2005CB522600]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL71895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071895] Funding Source: NIH RePORTER	The work is supported by grants from the National Natural Science Foundation of China 30772229, 973 Project 2005CB522600 and NIH grant HL71895. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Beaudry P, 2005, CLIN CANCER RES, V11, P3514, DOI 10.1158/1078-0432.CCR-04-2271; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; JENNETT B, 1975, LANCET, V1, P480; Jeon O, 2007, J BIOMED SCI, V14, P323, DOI 10.1007/s11373-007-9145-7; Jung S, 2006, J NEURO-ONCOL, V76, P257, DOI 10.1007/s11060-005-6876-z; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Li B, 2010, BRAIN RES, V1327, P91, DOI 10.1016/j.brainres.2010.02.030; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Nakayama D, 2010, EUR J NEUROSCI, V31, P90, DOI 10.1111/j.1460-9568.2009.07043.x; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Rookmaaker MB, 2005, ARTERIOSCL THROM VAS, V25, P1843, DOI 10.1161/01.ATV.0000177808.92494.14; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; TEASDALE G, 1974, LANCET, V2, P81; Tei K, 2008, STEM CELLS, V26, P819, DOI 10.1634/stemcells.2007-0671; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Xu Qing-Bo, 2005, Shengli Xuebao, V57, P1; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281	27	16	20	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2012	26	3					291	297		10.3109/02699052.2011.648710			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	899XD	WOS:000300849100009	22372416				2021-06-18	
J	Grabiec, U; Koch, M; Kallendrusch, S; Kraft, R; Hill, K; Merkwitz, C; Ghadban, C; Lutz, B; Straiker, A; Dehghani, F				Grabiec, Urszula; Koch, Marco; Kallendrusch, Sonja; Kraft, Robert; Hill, Kerstin; Merkwitz, Claudia; Ghadban, Chalid; Lutz, Beat; Straiker, Alex; Dehghani, Faramarz			The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB1)	NEUROPHARMACOLOGY			English	Article						CB1 cannabinoid receptor 1; NADA N-arachidonoyldopamine; NMDA N-methyl-D-aspartate; OHSC organotypic hippocampal slice cultures; CB2 cannabinoid receptor 2; TRPV1 transient receptor potential channel V1; TRPA1 transient receptor potential channel A1	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SLICE CULTURES; ACTIVATED MICROGLIAL CELLS; ACID AMIDE HYDROLASE; IN-VITRO; INTERNATIONAL UNION; LIPID MEDIATORS; RAT-BRAIN; ANANDAMIDE; DOPAMINE	Endocannabinoids exert numerous effects in the CNS under physiological and pathological conditions. The aim of the present study was to examine whether the endocannabinoid N-arachidonoyldopamine (NADA) may protect neurons in excitotoxically lesioned organotypic hippocampal slice cultures (OHSC). OHSC were excitotoxically lesioned by application of N-methyl-D-aspartate (NMDA, 50 mu M) for 4 h and subsequently treated with different NADA concentrations (0.1 pM-50 mu M) alone or in combination with cannabinoid receptor antagonists. NADA protected dentate gyrus granule cells and caused a slight reduction in the number of microglial cells. The number of degenerated neurons significantly decreased between 100 pM and 10 mu M NADA (p < 0.05). To identify the responsive receptor type of NADA mediated neuroprotection, we applied the cannabinoid (CB) receptor 1 (CB1) inverse agonist/antagonist AM251, CB2 inverse agonist/antagonist AM630, abnormal-cannabidiol (abn-CBD)-sensitive receptor antagonist O-1918, transient receptor potential channel V1 (1'RPV1) antagonist 6-iodonordihydrocapsaicin and Al (TRPA1) antagonist HC-030031. Neuroprotective properties of low (1 nM) but not high (10 mu M) NADA concentrations were solely blocked by AM251 and were absent in CB1-/- mice. AM630, O-1918, 6-iodonordihydrocapsaicin and HC-030031 showed no effects at all NADA concentrations applied. Our findings demonstrate that NADA protects dentate gyrus granule cells by acting via CB1. NADA reduced the number of microglial cells at distinct concentrations. TRPV1 and TRPA1 were not involved in NADA mediated neuroprotection. Thus, our data implicate that NADA mediated activation of neuronal CB1 may serve as a novel pharmacological target to mitigate symptoms of neuronal damage. (c) 2011 Elsevier Ltd. All rights reserved.	[Grabiec, Urszula; Koch, Marco; Kallendrusch, Sonja; Merkwitz, Claudia; Ghadban, Chalid; Dehghani, Faramarz] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Kraft, Robert] Univ Leipzig, Carl Ludwig Inst Physiol, D-04103 Leipzig, Germany; [Hill, Kerstin] Rudolf Boehm Inst Pharmakol & Toxikol, D-04107 Leipzig, Germany; [Lutz, Beat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, D-55128 Mainz, Germany; [Straiker, Alex] Gill Ctr Biomol Med, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Dehghani, F (corresponding author), Univ Leipzig, Inst Anat, Liebigstr 13, D-04103 Leipzig, Germany.	Faramarz.Dehghani@medizin.uni-leipzig.de	Kraft, Robert/E-9199-2011; Hohmann, Urszula/ABB-7323-2020; Kallendrusch, Sonja/AAV-7179-2020	Kraft, Robert/0000-0002-5774-6001; 	BMBFFederal Ministry of Education & Research (BMBF); DFGGerman Research Foundation (DFG)European Commission [KR 3408/2-1]	The authors would like to thank Oliver Ullrich for providing the BV2 cell line. The authors would further like to thank Dana Tschierske, Angela Ehrlich and Constanze Hobusch for excellent technical assistance and Ingo Bechmann for continuous support. This study was supported by BMBF project Tierversuchsersatzmethoden. R.K. is supported by a grant from the DFG (KR 3408/2-1).	BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Bjorklund E, 2010, BRIT J PHARMACOL, V161, P1512, DOI 10.1111/j.1476-5381.2010.00974.x; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bobrov MY, 2008, NEUROSCI LETT, V431, P6, DOI 10.1016/j.neulet.2007.11.010; Bradshaw HB, 2005, BRIT J PHARMACOL, V144, P459, DOI 10.1038/sj.bjp.0706093; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crawford DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008166; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cui M, 2006, J NEUROSCI, V26, P9385, DOI 10.1523/JNEUROSCI.1246-06.2006; Davies JW, 2010, BRIT J ANAESTH, V104, P596, DOI 10.1093/bja/aeq067; Dehghani F, 2003, EUR J NEUROSCI, V18, P1061, DOI 10.1046/j.1460-9568.2003.02821.x; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Harrison S, 2003, EUR J PHARMACOL, V475, P107, DOI 10.1016/S0014-2999(03)02114-9; Heppner FL, 1998, EUR J NEUROSCI, V10, P3284, DOI 10.1046/j.1460-9568.1998.00379.x; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hu SSJ, 2009, PROSTAG LEUKOTR ESS, V81, P291, DOI 10.1016/j.plefa.2009.05.026; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kim SR, 2006, J IMMUNOL, V177, P4322, DOI 10.4049/jimmunol.177.7.4322; Koch M, 2011, HIPPOCAMPUS, V21, P554, DOI 10.1002/hipo.20772; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kreutz S, 2007, EXP NEUROL, V203, P246, DOI 10.1016/j.expneurol.2006.08.010; Kreutz S, 2009, GLIA, V57, P286, DOI 10.1002/glia.20756; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ludanyi A, 2011, NEUROSCIENCE, V174, P50, DOI 10.1016/j.neuroscience.2010.10.062; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Millns PJ, 2006, EUR J NEUROSCI, V24, P3489, DOI 10.1111/j.1460-9568.2006.05236.x; Missale C, 2010, J RECEPT SIG TRANSD, V30, P347, DOI 10.3109/10799893.2010.506192; Moesgaard B, 2003, LIPIDS, V38, P387, DOI 10.1007/s11745-003-1073-1; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Navarrete CM, 2010, BIOCHEM PHARMACOL, V79, P1805, DOI 10.1016/j.bcp.2010.02.014; Navarrete CM, 2009, J NEUROCHEM, V109, P452, DOI 10.1111/j.1471-4159.2009.05966.x; O'Sullivan SE, 2004, BRIT J PHARMACOL, V141, P803, DOI 10.1038/sj.bjp.0705643; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Sagar DR, 2004, EUR J NEUROSCI, V20, P175, DOI 10.1111/j.1460-9568.2004.03481.x; Sasamura T, 1998, NEUROREPORT, V9, P2045, DOI 10.1097/00001756-199806220-00025; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Straiker A, 2011, BRIT J PHARMACOL, V164, P1672, DOI 10.1111/j.1476-5381.2011.01486.x; Sun Y, 2007, BRIT J PHARMACOL, V152, P734, DOI 10.1038/sj.bjp.0707478; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Wang J, 2009, PROSTAG OTH LIPID M, V89, P112, DOI 10.1016/j.prostaglandins.2008.12.002; White R, 2001, BRIT J PHARMACOL, V134, P921, DOI 10.1038/sj.bjp.0704333	65	16	16	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	MAR	2012	62	4					1797	1807		10.1016/j.neuropharm.2011.11.023			11	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	904TT	WOS:000301221500021	22186081				2021-06-18	
J	Juranek, J; Johnson, CP; Prasad, MR; Kramer, LA; Saunders, A; Filipek, PA; Swank, PR; Cox, CS; Ewing-Cobbs, L				Juranek, Jenifer; Johnson, Chad P.; Prasad, Mary R.; Kramer, Larry A.; Saunders, Ann; Filipek, Pauline A.; Swank, Paul R.; Cox, Charles S., Jr.; Ewing-Cobbs, Linda			Mean diffusivity in the amygdala correlates with anxiety in pediatric TBI	BRAIN IMAGING AND BEHAVIOR			English	Article						Anxiety; Amygdala; DTI; TBI; Children	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD INJURY; QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; HIPPOCAMPAL VOLUME; CHILDREN; ADOLESCENTS; SYMPTOMS; TENSOR	Traumatic brain injury (TBI) and orthopedic injury (OI) patients are prone to anxiety and mood disorders. In the present study, we integrated anatomical and diffusion tensor neuroimaging to investigate structural properties of the amygdala and hippocampus, gray matter regions implicated in anxiety and mood disorders. Children and adolescents were evaluated during the late sub-acute phase of recovery following trauma resulting from either moderate to severe TBI or OI. Mean diffusivity (MD) of the amygdala and hippocampus was elevated following TBI. An interaction of hemisphere, structure, and group revealed that MD of the right amygdala was elevated in females with TBI. Self-reported anxiety scores were not related to either volume or microstructure of the hippocampus, or to volume or fractional anisotropy of the amygdala. Left amygdala MD in the TBI group accounted for 17.5% of variance in anxiety scores. Anxiety symptoms may be mediated by different mechanisms in patients with TBI or OI.	[Juranek, Jenifer; Prasad, Mary R.; Filipek, Pauline A.; Swank, Paul R.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Childrens Learning Inst, Houston, TX 77030 USA; [Kramer, Larry A.] Univ Texas Hlth Sci Ctr Houston, Dept Radiol, Houston, TX 77030 USA; [Saunders, Ann; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Johnson, Chad P.] Univ Houston, Dept Psychol, Houston, TX USA	Juranek, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Childrens Learning Inst, 7000 Fannin,Ste 2411, Houston, TX 77030 USA.	Jenifer.Juranek@uth.tmc.edu			Department of Pediatrics;  [NIH-NINDS-R01-NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This work was funded by NIH-NINDS-R01-NS046308 awarded to LEC. Additional intramural funding from the Department of Pediatrics awarded to JJ.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Birmaher B, 1999, J AM ACAD CHILD PSY, V38, P1230, DOI 10.1097/00004583-199910000-00011; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bock AS, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00149; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Campbell-Sills L, 2011, NEUROIMAGE, V54, P689, DOI 10.1016/j.neuroimage.2010.07.041; Carrion VG, 2002, J AM ACAD CHILD PSY, V41, P166, DOI 10.1097/00004583-200202000-00010; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hasan K., 2005, MEDICAMUNDI, V49; Holbrook TL, 2005, J TRAUMA, V59, P1126, DOI 10.1097/01.ta.0000196433.61423.f2; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Jonovska S, 2008, COLLEGIUM ANTROPOL, V32, P1121; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kantarci K, 2005, NEUROLOGY, V64, P902, DOI 10.1212/01.WNL.0000153076.46126.E9; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langer DA, 2010, CHILD PSYCHIAT HUM D, V41, P549, DOI 10.1007/s10578-010-0187-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Manassis K, 2009, J CAN ACAD CHILD ADO, V18, P103; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Monk CS, 2008, DEV PSYCHOPATHOL, V20, P1231, DOI 10.1017/S095457940800059X; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pine DS, 2008, J AM ACAD CHILD PSY, V47, P1217, DOI 10.1097/CHI.0b013e318185dad0; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; TEASDALE G, 1974, LANCET, V2, P81; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Winston FK, 2005, ARCH PEDIAT ADOL MED, V159, P1074, DOI 10.1001/archpedi.159.11.1074; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	60	16	16	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	MAR	2012	6	1					36	48		10.1007/s11682-011-9140-5			13	Neuroimaging	Neurosciences & Neurology	896OC	WOS:000300576500004	21979818	Green Accepted			2021-06-18	
J	Praeger, AJ; Westbrook, AJ; Nichol, AD; Wijemunige, R; Davies, AR; Lyon, SM; Wills, JL; Bailey, M; Rosenfeld, JV; Cooper, DJ				Praeger, Adrian J.; Westbrook, Andrew J.; Nichol, Alistair D.; Wijemunige, Ruwan; Davies, Andrew R.; Lyon, Stuart M.; Wills, Judy L.; Bailey, Michael; Rosenfeld, Jeffrey V.; Cooper, D. James			Deep vein thrombosis and pulmonary embolus in patients with traumatic brain injury: a prospective observational study	CRITICAL CARE AND RESUSCITATION			English	Article							VENOUS THROMBOEMBOLISM; MAJOR TRAUMA; PROPHYLAXIS; HEPARIN	Background: Intensive care patients with traumatic brain injury (TBI) are at high risk of developing deep vein thrombosis (DVT). A high rate of DVT was reported before routine thromboprophylaxis, but the current DVT rate in TBI patients receiving best-practice mechanical and pharmacological prophylaxis is unknown. Objectives: To determine the prevalence of DVT among TBI patients. Design, participants and setting: A prospective observational pilot study of adult patients admitted to the intensive care unit of a level 1 trauma centre within 72 hours of sustaining a TBI (Glasgow Coma Scale score <= 14). Main outcome measures: Rate of DVT determined using twice-weekly compression ultrasound; rate of pulmonary embolism (PE) and length of stay. Results: 36 patients (28 men; mean age, 40.3 years) were included. Six had moderate and 21 had severe TBI. Two patients (6%) developed a DVT and two patients (6%) developed a PE. The proximal leg DVT rate was 3%, but the overall venous thromboembolism rate was 11% (4 patients). Conclusions: Mechanical and pharmacological prophylaxis appeared to be effective. The incidence of clinically identified PE is of concern and suggests that thromboembolic sources other than large leg veins may not be being adequately controlled by modern thromboprophylaxis regimens.	[Praeger, Adrian J.; Westbrook, Andrew J.; Nichol, Alistair D.; Wijemunige, Ruwan; Davies, Andrew R.; Bailey, Michael; Cooper, D. James] Monash Univ, Dept Epidemiol & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Praeger, Adrian J.; Wijemunige, Ruwan; Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Nichol, Alistair D.] Alfred Hosp, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Lyon, Stuart M.; Wills, Judy L.] Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia	Cooper, DJ (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia.	jamie.cooper@monash.edu	Cooper, D. James/G-7961-2013; Rosenfeld, Jeffrey V/B-7249-2011; Bailey, Michael J/A-4499-2012	Cooper, D. James/0000-0002-5872-9051; Bailey, Michael J/0000-0002-5551-1401; Nichol, Alistair Dualta/0000-0002-4771-5615; Nichol, Alistair/0000-0002-4689-1238; Praeger, Adrian/0000-0003-0010-6238	Intensive Care Foundation (Australia); Tattersall's George Adams Foundation - National Trauma Research Institute Foundation	We acknowledge the financial support of the Intensive Care Foundation (Australia) and a Tattersall's George Adams Foundation - National Trauma Research Institute Foundation Fellowship.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; HIRSCH DR, 1995, JAMA-J AM MED ASSOC, V274, P335, DOI 10.1001/jama.274.4.335; KAKKAR VV, 1969, LANCET, V2, P230; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Moore EM, 2011, ANAESTH INTENS CARE, V39, P356, DOI 10.1177/0310057X1103900306; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers Frederick, 2007, J Intensive Care Med, V22, P26, DOI 10.1177/0885066606295291	14	16	18	0	3	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	MAR	2012	14	1					10	13					4	Critical Care Medicine	General & Internal Medicine	904PL	WOS:000301210300003	22404055				2021-06-18	
J	Dreer, LE; DeVivo, MJ; Novack, TA; Marson, DC				Dreer, Laura E.; DeVivo, Michael J.; Novack, Thomas A.; Marson, Daniel C.			Financial Capacity Following Traumatic Brain Injury: A Six-Month Longitudinal Study	REHABILITATION PSYCHOLOGY			English	Article						financial capacity; financial decision making; competency; traumatic brain injury; head injury	DECISION-MAKING CAPACITY; SPINAL-CORD-INJURY; ALZHEIMER-DISEASE; MODERATE; IMPAIRMENT; COMPETENCE; BANKRUPTCY; ABILITIES; RECOVERY; MILD	Objective: To longitudinally investigate financial capacity (FC) following traumatic brain injury (TBI). Design: Longitudinal study comparing FC in cognitively healthy adults and persons with moderate to severe TBI at time of acute hospitalization (Time 1) and at 6 months postinjury (Time 2). Setting: Inpatient brain injury rehabilitation unit. Participants: Twenty healthy adult controls and 24 adult persons with moderate to severe TBI. Main Outcome Measures: Participants were administered the Financial Capacity Instrument (FCI-9), a standardized instrument that measures performance on 18 financial tasks, 9 domains, and 2 global scores. Between- and within-group differences were examined for each FCI-9 domain and global scores. Using control group referenced cut scores, participants with TBI were also assigned an impairment rating (intact, marginal, or impaired) on each domain and global score. Results: At Time I, participants with TBI performed significantly below controls on the majority of financial variables tested. At Time 2, participants with TBI demonstrated within group improvement on both simple and complex financial domains, but continued to perform below adult controls on complex financial domains and both global scores. Group by time interactions were significant for four domains and both global scores. At Time I, high percentages of participants with TBI were assigned either "marginal" or "impaired" ratings on the domains and global scores, with significant percentage increases of "intact" ratings at Time 2. Conclusions: Immediately following acute injury, persons with moderate to severe TBI show global impairment of FC. Findings indicate improvement of both simple and complex financial skills over a 6-month period, but continued impairment on more complex financial skills. Future studies should examine loss and recovery of FC following TBI over longer time periods and a wider range of injury severity.	[Marson, Daniel C.] Univ Alabama, Dept Neurol, Sparks Ctr 650K, Birmingham, AL 35233 USA; [Dreer, Laura E.] Univ Alabama, Dept Ophthalmol, Birmingham, AL 35233 USA; [DeVivo, Michael J.; Novack, Thomas A.] Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL 35233 USA; [Marson, Daniel C.] Univ Alabama, Alzheimers Dis Ctr, Birmingham, AL 35233 USA	Marson, DC (corresponding author), Univ Alabama, Dept Neurol, Sparks Ctr 650K, 1530 3rd Ave S, Birmingham, AL 35233 USA.	dmarson@uab.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074, T32HD007420] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23EY017327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG031054, R01AG021927] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23 EY017327-04, K23 EY017327] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [2R01AG02192, R01 AG021927, P30 AG031054, P30AG031054] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074, T32HD07420, R01 HD053074, T32 HD007420] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A980010] Funding Source: Medline		Anderson TP, 1989, J HEAD TRAUMA REHAB, V4, P57, DOI DOI 10.1097/00001199-198903000-00008; Crowe SF, 2004, ARCH CLIN NEUROPSYCH, V19, P673, DOI 10.1016/j.acn.2003.09.002; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fong K., 2010, NEUROREHABILITATION, V7, P19; Gaudette M, 2002, BRAIN INJURY, V16, P133, DOI 10.1080/02699050110102068; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Griffith HR, 2003, NEUROLOGY, V60, P449, DOI 10.1212/WNL.60.3.449; HAFFEY WJ, 1989, J HEAD TRAUMA REHAB, V4, P43, DOI DOI 10.1097/00001199-198903000-00007; Hollingworth W, 2007, MED CARE, V45, P702, DOI 10.1097/MLR.0b013e318041f765; Hoskin K. M., 2005, PSYCHIAT PSYCHOL LAW, V12, P56, DOI [http://dx.doi.org/10.1375/pplt.2005.12.1.56, DOI 10.1375/PPLT.2005.12.1.56]; Kane R. A., 1981, ASSESSING ELDERLY PR; Lundqvist A, 2001, BRAIN INJURY, V15, P981, DOI 10.1080/02699050110065637; Marson D., 2001, INT J LAW PSYCHIAT, V8, P109; Marson D., 2007, CLIN DIAGNOSIS MANAG, P323; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; Martin RC, 2003, ARCH NEUROL-CHICAGO, V60, P1585, DOI 10.1001/archneur.60.11.1585; Mukherjee D, 2001, REHABIL PSYCHOL, V46, P82, DOI 10.1037/0090-5550.46.1.82; Pressman Helaine Tobey, 2007, Phys Med Rehabil Clin N Am, V18, P165, DOI 10.1016/j.pmr.2006.11.006; Reid-Proctor GM, 2001, BRAIN INJURY, V15, P377, DOI 10.1080/02699050010005977; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; TEASDALE G, 1974, LANCET, V2, P81	25	16	17	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2012	57	1					5	12		10.1037/a0025818			8	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	901JX	WOS:000300964300002	22369113	Green Accepted			2021-06-18	
J	Maguen, S; Madden, E; Lau, KM; Seal, K				Maguen, Shira; Madden, Erin; Lau, Karen M.; Seal, Karen			The impact of head injury mechanism on mental health symptoms in veterans: Do number and type of exposures matter?	JOURNAL OF TRAUMATIC STRESS			English	Article							TRAUMATIC BRAIN-INJURY; AUDIT-C; AFGHANISTAN; IRAQ; DEPLOYMENT	This study examined the association between screening results for mental health problems and the number and type of head injuries in 1,082 Iraq and Afghanistan War veterans who received population-based screening for traumatic brain injury at a Veterans Administration health care facility. Nearly one third of all veterans reported multiple types of head injuries (median = 1 among those with any head injury, range = 16 types of head injury). Veterans reporting multiple head injury mechanisms had 6 times the odds of screening positive for posttraumatic stress disorder (PTSD), adjusted odds ratio (OR) = 6.15, 95% confidence interval (CI) [4.4, 8.7], p < .001, over 4 times the odds of screening positive for depression, adjusted OR = 4.09, 95% CI [2.8, 5.9], p < .001, and about twice the odds of screening positive for alcohol misuse, adjusted OR = 1.64, 95% CI [1.19, 2.3], p = .003, compared to those without head injuries. Veterans reporting a blast plus another head injury mechanism had higher odds of screening positive for all mental health outcomes than any other group (e.g., compared to no head injury group): PTSD, adjusted OR = 6.52, 95% CI [4.6, 9.3], p < .001; depression, adjusted OR = 4.42, 95% CI [3.0, 6.4], p < .001; alcohol misuse, adjusted OR =1.59, 95% CI [1.14, 2.2], p = .006. Given their association with a variety of mental health outcomes, number and type of head injury mechanism should be considered as part of any postdeployment evaluation.	[Maguen, Shira; Madden, Erin; Lau, Karen M.; Seal, Karen] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Maguen, Shira] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Seal, Karen] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Maguen, S (corresponding author), San Francisco VA Med Ctr, 4150 Clement St 116-P, San Francisco, CA 94121 USA.	Shira.Maguen@va.gov					Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Dougall AL, 2000, J CONSULT CLIN PSYCH, V68, P290, DOI 10.1037/0022-006X.68.2.290; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141	19	16	16	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	FEB	2012	25	1					3	9		10.1002/jts.21669			7	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	897VA	WOS:000300685800002	22354503				2021-06-18	
J	Davis, JJ; McHugh, TS; Axelrod, BN; Hanks, RA				Davis, Jeremy J.; McHugh, Tara S.; Axelrod, Bradley N.; Hanks, Robin A.			Performance Validity and Neuropsychological Outcomes in Litigants and Disability Claimants	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; Effort assessment; Forensic neuropsychology; Traumatic brain injury	ADULT INTELLIGENCE SCALE; RECOGNITION MEMORY TEST; TEST-SCORES; NONCLINICAL SAMPLE; BRAIN-INJURY; HEAD-INJURY; TESTS; DEFICITS; VALIDATION	This study examined the relationship of performance validity and neuropsychological outcomes in a sample of individuals referred for independent neuropsychological examination in the context of reported traumatic brain injury (82% mild). Archival data were examined on 175 participants aged 20 to 65 who were administered at least two performance validity measures. Participants who passed all effort measures (Pass; n = 61) outperformed those who failed two or more (Fail; n = 70) on the majority of tests in the neuropsychological battery. The Fail group showed a higher percentage of impaired test scores than the Pass group with impairment defined at three levels (T scores < 40, 35, and 30). At the most conservative impairment cutoff (T < 30), 16% of the Pass group demonstrated impaired scores on more than three measures, while 79% of the Fail group showed impaired scores on more than three measures. The number of effort measures failed correlated highly with the overall test battery mean (r = -.73). On cognitive domain summary scores, effect sizes based on levels of effort (d = 1.12 to 1.86) were higher than those based on injury severity (d = 0.03 to 0.36).	[Davis, Jeremy J.; McHugh, Tara S.] Rehabil Inst Michigan, Detroit, MI USA; [Axelrod, Bradley N.] John Dingell VA Med Ctr, Detroit, MI USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Detroit, MI USA	Davis, JJ (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, 30 North 1900 East,1R55, Salt Lake City, UT 84132 USA.	jeremy.davis@hsc.utah.edu					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2008, APPL NEUROPSYCHOL, V15, P170, DOI 10.1080/09084280802324184; Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Boone, 2007, ASSESSMENT FEIGNED C; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Fox D. D., 2009, MANUAL COMPUTERIZED; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gladsjo JA, 1999, NORMS LETT CATEGORY; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2002, GREENS WORD MEMORY T; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; Heaton R., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1991, COMPREHENSIVE NORMS; Heaton R. K, 1981, WISCONSIN CARD SORTI; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heaton RK, 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Matthews C, 1964, INSTRUCTION MANUAL A; Meyers J., 1995, REY COMPLEX FIGURE T; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Partington JE., 1949, PSYCHOL SERV CTR J, V1, P11; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; Tombaugh TN, 1996, TEST MEMORY MALINGER; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME, V3; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wolfson D., 1993, HALSTEAD REITAN NEUR	51	16	16	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	5					850	865		10.1080/13854046.2012.686631			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	970EU	WOS:000306111700006	22630329				2021-06-18	
J	Hargrave, DD; Nupp, JM; Erickson, RJ				Hargrave, David D.; Nupp, Jason M.; Erickson, Rey J.			Two brief measures of executive function in the prediction of driving ability after acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Stroke; Brain injury; Driving; Prediction; Executive functioning; Rehabilitation	FRONTAL ASSESSMENT BATTERY; STROKE; FITNESS; FAB; VALIDITY; DISEASE; TESTS	The question of fitness to drive following acquired brain injury is commonly encountered in rehabilitation settings. Pre-driving assessments are usually performed prior to on-road assessments, but there is no uniformity as to the instruments employed. Neuropsychological tests are often employed to assess different functional domains. One domain that has been suggested to be critical to driving is executive functioning. The present study examined the utility of the Frontal Assessment Battery (FAB) and the Trail Making Test Part B (TMTB) in predicting on-road driving performance after stroke or traumatic brain injury. While the TMTB has previously been demonstrated to be useful in this regard, the FAB has never been examined for this purpose. Participants were 76 patients referred for driving assessment after diagnosis of stroke or traumatic brain injury. Results indicated that scores on the TMTB, but not the FAB, were significantly predictive of on-road driving performance (p<.05). A cutoff score of 90 seconds or greater on the TMTB correctly identified 77% of those failing on-road evaluation. Implications and limitations are discussed.	[Hargrave, David D.; Nupp, Jason M.; Erickson, Rey J.] HealthONE Spalding Rehabil Hosp, Aurora, CO USA	Hargrave, DD (corresponding author), Univ Kansas, Sch Med, Dept Psychiat & Behav Sci, 7859 E Rockhill,Suite 105, Wichita, KS 67206 USA.	dhargrave@kumc.edu					Akinwuntan AE, 2006, NEUROREHAB NEURAL RE, V20, P417, DOI 10.1177/1545968306287157; Barrash J, 2010, J INT NEUROPSYCH SOC, V16, P679, DOI 10.1017/S1355617710000470; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Devos H, 2011, NEUROLOGY, V76, P747, DOI 10.1212/WNL.0b013e31820d6300; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fisk GD, 1998, BRAIN INJURY, V12, P683; GRIGSBY J, 1992, PERCEPT MOTOR SKILL, V74, P883, DOI 10.2466/PMS.74.3.883-892; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Lipton AM, 2005, NEUROLOGY, V65, P726, DOI 10.1212/01.wnl.0000174437.73416.7b; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Lunqvist A., 2000, APPL COGNITIVE PSYCH, V14, P135; Marshall S. C., 2007, TOPICS STROKE REHABI, V19; Matsui H, 2006, J GERIATR PSYCH NEUR, V19, P41, DOI 10.1177/0891988705284714; McKenna P, 2004, BRIT J CLIN PSYCHOL, V43, P325, DOI 10.1348/0144665031752952; Paviour DC, 2005, NEUROCASE, V11, P274, DOI 10.1080/13554790590962933; Prigatano GP, 2010, CLIN NEUROPSYCHOL, V24, P468, DOI 10.1080/13854040802585048; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Slachevsky A, 2004, ARCH NEUROL-CHICAGO, V61, P1104, DOI 10.1001/archneur.61.7.1104; Soderstrom ST, 2006, SCAND J PSYCHOL, V47, P419, DOI 10.1111/j.1467-9450.2006.00550.x; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Yale S. H., 2003, CLIN MED RES, V1, P77	30	16	16	0	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2012	22	4					489	500		10.1080/09602011.2012.662333			12	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	995SC	WOS:000308031600001	22360153				2021-06-18	
J	Kiewel, NA; Wisdom, NM; Bradshaw, MR; Pastorek, NJ; Strutt, AM				Kiewel, Nicole A.; Wisdom, Nick M.; Bradshaw, Major R.; Pastorek, Nicholas J.; Strutt, Adriana M.			A Retrospective Review of Digit Span-Related Effort Indicators in Probable Alzheimer's Disease Patients	CLINICAL NEUROPSYCHOLOGIST			English	Article						Malingering; Symptom validity testing; Forensic neuropsychology; Dementia assessment; Professional issues	SYMPTOM VALIDITY TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; CLASSIFICATION ACCURACY; MEMORY IMPAIRMENT; TEST-PERFORMANCE; WAIS-III; COGNITIVELY INTACT; NORMATIVE DATA; TEST-SCORES	There has been extensive research on the use of both stand-alone and embedded measures of effort in neuropsychological testing; however, relatively few studies have reported on their utility in the context of dementia. Previous studies that have examined the specificity of traditionally used cut-scores on embedded measures of effort with dementia samples have largely found high rates of false positive errors. The present study examined the specificity of several Digit Span derived embedded measures of effort in a large clinical sample of patients with probable Alzheimer's disease stratified by level of dementia severity. Of the measures that were examined, only the Vocabulary - Digit Span score demonstrated promising specificity through the moderate level of dementia severity. All of the remaining indices, including Reliable Digit Span, Digit Span Age-Corrected Scaled Score, and Longest Digits Forward (1 & 2 Trials), yielded unacceptable rates of false positive errors as dementia severity increased. The implications for these findings are discussed, including the limitations of importing methods of assessing effort from one sample to another.	[Bradshaw, Major R.; Strutt, Adriana M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Kiewel, Nicole A.] Univ Houston, Dept Psychol, Houston, TX USA; [Wisdom, Nick M.] Mental Hlth Care Line, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX USA; [Wisdom, Nick M.; Strutt, Adriana M.] Baylor Coll Med, Menninger Dept Psychiat, Houston, TX 77030 USA; [Pastorek, Nicholas J.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Pastorek, Nicholas J.] Rehabil Care Line, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX USA	Strutt, AM (corresponding author), Baylor Coll Med, Dept Neurol, 6550 Fannin,Smith Tower 1801, Houston, TX 77030 USA.	adrianam@bcm.edu					Ardila A, 2007, ARCH CLIN NEUROPSYCH, V22, P1003, DOI 10.1016/j.acn.2007.08.004; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Doody R, 2005, DEMENT GERIATR COGN, V20, P198, DOI 10.1159/000087300; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Hirschman KB, 2004, J GERIATR PSYCH NEUR, V17, P55, DOI 10.1177/0891988704264540; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; KASZNIAK AW, 1979, CORTEX, V15, P285, DOI 10.1016/S0010-9452(79)80032-5; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Prigatano GP, 1997, ARCH CLIN NEUROPSYCH, V12, P609, DOI 10.1016/S0887-6177(97)00020-6; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Slick DJ, 2003, CLIN NEUROPSYCHOL, V17, P390, DOI 10.1076/clin.17.3.390.18090; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; STORANDT M, 1986, HDB CLIN MEMORY ASSE; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Wechsler D, 1997, WAIS 3 ADM SCORING M	35	16	17	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	6					965	974		10.1080/13854046.2012.694478			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	984ZK	WOS:000307232300008	22703555				2021-06-18	
J	Kolakowsky-Hayner, SA; Wright, J; Shem, K; Medel, R; Duong, T				Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Shem, Kazuko; Medel, Robert; Thao Duong			An effective community-based mentoring program for return to work and school after brain and spinal cord injury	NEUROREHABILITATION			English	Article						Mentoring; peer support; community-based; traumatic brain injury; spinal cord injury	PORTLAND ADAPTABILITY INVENTORY; DISABILITY RATING-SCALE; YOUNG-ADULTS; SELF-ESTEEM; REHABILITATION; TRANSITION; PARTICIPATION; EMPLOYMENT; INDEPENDENCE; INDIVIDUALS	Information is presented on a community-based mentoring program, developed to work with existing community agencies and provide structure to the frequently confusing network of services for young adults, ages 16 to 26 years, with a recently acquired disability including TBI, SCI, and other neurological disorders. The over-arching goal of the Mentoring Program was to improve the ability of individuals with disabilities to access and maximally utilize the services and programs that are available in the community. The two objectives of this study were: 1) to demonstrate continuing increases in standardized measures of community integration from the time of enrollment in the program to the time of exit from the program, and 2) to improve the percentage of youth and young adults with disabilities who successfully access post-secondary education or employment opportunities. 53 participants had post-secondary education as a goal. 12 participants had an employment goal. 12 participants had both education and employment as a combined goal. It was not uncommon for participants to change goals. Of those with education goals, 23/53 achieved educational goals and 7/53 achieved employment goals. Of those with vocational goals, 5/12 achieved vocational goals and 1/12 achieved educational goals. Of those with both goals, 5/12 achieved educational goals and 1/12 achieved vocational goals. Significant community integration and independence improvements were noted for program participants (CHART Mobility and Cognitive Independence, M2PI, DRS, and SRS). Overall, findings suggest that mentoring can be beneficial toward achieving the goals of post-secondary education, employment and community independence for individuals with disabilities; specifically those with traumatic brain injury, spinal cord injury and other neurological disorders.	[Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Medel, Robert] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Shem, Kazuko; Thao Duong] Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, San Jose, CA 95128 USA	Kolakowsky-Hayner, SA (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bacom Ave, San Jose, CA 95128 USA.	Stephanie.Hayner@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909			Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; *AM YOUTH POL FOR, 2002, 25 YEARS ED CHILDR D; Anderson D, 2007, J VOCAT REHABIL, V27, P57; Becky J., 2000, LONGITUDINAL STUDY V; Bjorkdahl A, 2010, BRAIN INJURY, V24, P1061, DOI 10.3109/02699052.2010.494588; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Cullen LA, 1998, INT J REHABIL RES, V21, P389, DOI 10.1097/00004356-199812000-00005; Davies PS, 2009, J VOCAT REHABIL, V30, P133, DOI 10.3233/JVR-2009-0459; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Fadyl JK, 2010, J OCCUP REHABIL, V20, P69, DOI 10.1007/s10926-009-9204-1; Fraas M, 2010, BRAIN INJURY, V24, P50, DOI 10.3109/02699050903446781; Fraker T, 2009, J VOCAT REHABIL, V30, P223, DOI 10.3233/JVR-2009-0463; Gilworth G, 2009, WORK, V34, P95, DOI 10.3233/WOR-2009-0906; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hamzat TK, 2008, SCAND J DISABIL RES, V10, P166, DOI 10.1080/15017410802120964; Hasnain R, 2009, J VOCAT REHABIL, V31, P175, DOI 10.3233/JVR-2009-0487; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Horn L., 1999, STUD DIS POSTS ED PR; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Lidal IB, 2007, DISABIL REHABIL, V29, P1341, DOI 10.1080/09638280701320839; Luecking RG, 2009, J VOCAT REHABIL, V30, P241, DOI 10.3233/JVR-2009-0464; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF., 2005, The Mayo-Portland Adaptability Inventory; Murphy GC, 2003, J REHABIL MED, V35, P276, DOI 10.1080/16501970310015209; Oddson B, 2006, DEV MED CHILD NEUROL, V48, P918, DOI 10.1017/S0012162206002003; Osgood DW, 2010, FUTURE CHILD, V20, P209; Ottomanelli L, 2009, J SPINAL CORD MED, V32, P503, DOI 10.1080/10790268.2009.11754553; Ownsworth T, 2010, WORK, V36, P381, DOI 10.3233/WOR-2010-1041; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rutkowski S, 2009, PHYS MED REH CLIN N, V20, P535, DOI 10.1016/j.pmr.2009.06.003; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shandra CL, 2008, J VOCAT REHABIL, V29, P117; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; U. S. Department of Labor Office of Disability Employment Policy, 2010, EMPL STAT CIV POP SE; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; VITALIANO PP, 1991, PSYCHOL AGING, V6, P392, DOI 10.1037/0882-7974.6.3.392; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	51	16	16	0	37	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	1					63	73		10.3233/NRE-2012-0775			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	976SU	WOS:000306605900007	22523017				2021-06-18	
J	Kuni, BJ; Banwell, BL; Till, C				Kuni, Bravina J.; Banwell, Brenda L.; Till, Christine			Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM)	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							PERFORMANCE-TEST PERFORMANCE; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; CHILDREN; FEATURES; DEFICITS; IMPACT; MRI; AGE; MS	We describe cognitive and behavioral outcomes in 12 males and 7 females diagnosed with acute disseminated encephalomyelitis (ADEM) in childhood. Age at assessment ranged from 6 to 23 years and all participants were at least 2 years post-ADEM presentation (mean 5.4 years). Performance was compared with 18 control subjects. Three of 19 ADEM patients met criteria for cognitive impairment, defined as performance falling <= 1.5 SD on at least three tests. Age at ADEM-onset was not associated with outcome. Despite the transient nature of the illness and absence of persistent physical disability, cognitive sequelae occur in some individuals following childhood ADEM.	[Kuni, Bravina J.; Till, Christine] York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; [Banwell, Brenda L.; Till, Christine] Univ Toronto, Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Banwell, Brenda L.] Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada	Till, C (corresponding author), York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	ctill@yorku.ca		Till, Christine/0000-0001-5030-3155	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Multiple Sclerosis Society of Canada; Canadian Multiple Sclerosis Scientific Research Foundation	Funding for this research was provided in part by the Canadian Institutes of Health Research (CIHR), Multiple Sclerosis Society of Canada, and the Canadian Multiple Sclerosis Scientific Research Foundation. No conflict of interest is declared.	Anderson PJ, 2004, DEV MED CHILD NEUROL, V46, P230, DOI [10.1017/S0012162204000386, 10.1017/S001212204000386]; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Banwell B, 2009, NEUROLOGY, V72, P232, DOI 10.1212/01.wnl.0000339482.84392.bd; Beery KE, 1997, BEERY BUKTENICA DEV; Callen DJA, 2009, NEUROLOGY, V72, P968, DOI 10.1212/01.wnl.0000338630.20412.45; Conners C., 2000, CONNERS CONTINUOUS P; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; Dale RC, 2000, BRAIN, V123, P2407, DOI 10.1093/brain/123.12.2407; Deery B, 2010, DEV NEUROPSYCHOL, V35, P506, DOI 10.1080/87565641.2010.494921; Edgin JO, 2008, J INT NEUROPSYCH SOC, V14, P90, DOI 10.1017/S1355617708080053; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Gioia G.A., 2000, BEHAV RATING INVENTO; Hahn CD, 2003, PEDIATR NEUROL, V29, P117, DOI 10.1016/S0887-8994(03)00143-7; Heaton R., 1993, WISCONSIN CARD SORTI; Hynson JL, 2001, NEUROLOGY, V56, P1308, DOI 10.1212/WNL.56.10.1308; Idrissova ZR, 2003, EUR J NEUROL, V10, P537, DOI 10.1046/j.1468-1331.2003.00639.x; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Jacobs RK, 2004, PEDIATR NEUROL, V31, P191, DOI 10.1016/j.pediatrneurol.2004.03.008; Jayakrishnan MP, 2010, J PEDIATR NEUROSCI, V5, P111, DOI 10.4103/1817-1745.76098; Krupp LB, 2007, NEUROLOGY, V68, pS7, DOI 10.1212/01.wnl.0000259422.44235.a8; Morey LC., 2007, PERSONALITY ASSESSME; Mulhern RK, 2001, J CLIN ONCOL, V19, P472, DOI 10.1200/JCO.2001.19.2.472; Murthy SNK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e21; Pohl D, 2007, NEUROLOGY, V68, pS54, DOI 10.1212/01.wnl.0000259407.40023.ab; Reddick WE, 2006, CANCER-AM CANCER SOC, V106, P941, DOI 10.1002/cncr.21679; Reitan R, 1959, MANUAL ADM SCORING T; Reynolds C. R., 2007, TEST MEMORY LEARNING; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS; Rostasy K, 2009, NEUROPEDIATRICS, V40, P211, DOI 10.1055/s-0030-1247518; Roth R.M., 2005, BEHAV RATING INVENTO; Ryland H. K., 2010, CHILD ADOLESCENT PSY, V4, P1; Smith A., 1991, SYMBOL DIGIT MODALIT; Tenembaum S, 2002, NEUROLOGY, V59, P1224, DOI 10.1212/WNL.59.8.1224; Till C, 2011, NEUROPSYCHOLOGY, V25, P319, DOI 10.1037/a0022051; Varier S, 2011, J INT NEUROPSYCH SOC, V17, P1030, DOI 10.1017/S1355617711000993; Wechsler D., 2011, WECHLSER ABBREVIATED; Woodcock RW, 2001, WOODCOCK JOHNSON 3 N; Woodcock RW, 2007, WOODCOCK JOHNSON 3 W; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Young NP, 2008, SEMIN NEUROL, V28, P84, DOI 10.1055/s-2007-1019130	40	16	16	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2012	37	8					682	696		10.1080/87565641.2012.690799			15	Psychology, Developmental; Psychology; Psychology, Experimental	Psychology	041NE	WOS:000311407700003	23145566				2021-06-18	
J	Pluck, G; Lee, KH; David, R; Spence, SA; Parks, RW				Pluck, Graham; Lee, Kwang Hyuk; David, Rajan; Spence, Sean A.; Parks, Randolph W.			Neuropsychological and Cognitive Performance of Homeless Adults	CANADIAN JOURNAL OF BEHAVIOURAL SCIENCE-REVUE CANADIENNE DES SCIENCES DU COMPORTEMENT			English	Article						cognition; homelessness; intelligence; IQ; memory; premorbid	TRAUMATIC BRAIN-INJURY; SUBSTANCE MISUSE; WECHSLER TEST; INTELLIGENCE; HOSTEL; MEN; CHILDREN; WELFARE; PEOPLE; ABUSE	Many homeless people may have been exposed to events and situations that could potentially produce neuropsychological impairments. In the current study, 80 homeless participants underwent a battery of tests designed to 1) estimate long-standing established memory and intelligence, which was assumed to indicate prehomeless function and 2) measure current memory and intelligence function. Mental health screening and substance misuse data were also obtained. Results indicated that current memory and IQ were significantly lower than the estimated normal population means and also their prehomeless estimates. The memory score change was from 100.5 to 90.3 (p < .001) and IQ change from 98.8 to 95.6 (p = .038). The interaction between task type (memory or IQ) and measure (prehomeless or current) was also significant (p = .003), signifying that there was a greater change in the domain of memory function than in IQ. Many participants reported substance misuse and clinically significant mental health concerns. We conclude that the homeless individuals in our sample appear to have suffered a reduction in cognitive function, which may have occurred either during homelessness or prior to it.	[Pluck, Graham] Univ Sheffield, Longley Ctr, Sheffield S5 7JT, S Yorkshire, England; [David, Rajan] Sheffield Care Trust, Homeless Assessment & Support Team, Sheffield, S Yorkshire, England	Pluck, G (corresponding author), Univ Sheffield, Longley Ctr, Norwood Grange Dr, Sheffield S5 7JT, S Yorkshire, England.	g.pluck@sheffield.ac.uk	Lee, Kwang-Hyuk/B-5808-2009; Pluck, Graham/C-6482-2008	Pluck, Graham/0000-0002-0368-0051			Adams CE, 1996, BRIT J PSYCHIAT, V168, P82, DOI 10.1192/bjp.168.1.82; American Psychological Association, 2010, HELP PEOPL HOM REP 2; Avramov D., 1999, COPING HOMELESSNESS; Backer Thomas Earl, 2007, J Prim Prev, V28, P375, DOI 10.1007/s10935-007-0100-1; Berger PS, 1999, J SOC DISTRESS HOMEL, V8, P1, DOI 10.1023/A:1022994107792; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Bousman CA, 2010, J NERV MENT DIS, V198, P790, DOI 10.1097/NMD.0b013e3181f97dff; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Caplan B, 2006, SCHIZOPHR RES, V83, P77, DOI 10.1016/j.schres.2005.11.013; Evans N, 1996, NUTR FOOD SCI, V96, P5, DOI 10. 1108/00346659610114699; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Gilchrist G, 2005, EUR J PUBLIC HEALTH, V15, P587, DOI 10.1093/eurpub/cki036; Gonzalez EA, 2001, J NERV MENT DIS, V189, P176, DOI 10.1097/00005053-200103000-00006; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hwang SW, 1999, CAN MED ASSOC J, V160, P1021; Jarrett C, 2010, PSYCHOLOGIST, V23, P284; KENWAY P., 2003, MANY MUCH SINGLE HOM; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LOUKS JL, 1988, HOSP COMMUNITY PSYCH, V39, P670; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Morey L. C., 1997, PERSONALITY ASSESSME; Morris PG, 2005, BRIT J CLIN PSYCHOL, V44, P209, DOI 10.1348/014466505X34174; Murphy Barbara, 2000, STREET WE CREATED HO; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Oakes PM, 2008, J INTELLECT DISABILI, V12, P325, DOI 10.1177/1744629508100496; Parks RW, 2007, J ROY SOC MED, V100, P46, DOI 10.1258/jrsm.100.1.46; Pluck G, 2008, J PSYCHOL, V142, P159, DOI 10.3200/JRLP.142.2.159-168; Pluck G, 2007, CAN MED ASSOC J, V176, P489, DOI 10.1503/cmaj.1060229; Pluck G, 2011, BRIT J CLIN PSYCHOL, V50, P33, DOI 10.1348/014466510X490253; Rindermann H, 2008, INTELLIGENCE, V36, P127, DOI 10.1016/j.intell.2007.02.002; Schretlen DJ, 2005, J INT NEUROPSYCH SOC, V11, P784, DOI 10.1017/S1355617705050939; Seidman LJ, 2003, PSYCHIAT SERV, V54, P905, DOI 10.1176/appi.ps.54.6.905; Seidman LJ, 1997, J NERV MENT DIS, V185, P3, DOI 10.1097/00005053-199701000-00002; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Spence SA, 2006, PSYCHIAT CLIN NEUROS, V60, P259, DOI 10.1111/j.1440-1819.2006.01496.x; Spence SA, 2009, PSYCHIATR BULL, V33, P64, DOI 10.1192/pb.bp.107.018994; Toro PA, 2007, J SOC ISSUES, V63, P461, DOI 10.1111/j.1540-4560.2007.00519.x; Vostanis P, 1998, BRIT MED J, V316, P899, DOI 10.1136/bmj.316.7135.899; Wechsler D., 2002, WECHSLER MEMORY SCAL; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 2001, WECHSLER TEST ADULT; Wilson, 1991, NATL ADULT READING T	45	16	16	0	7	CANADIAN PSYCHOLOGICAL  ASSOC	OTTAWA	141 LAURIER AVE WEST, STE 702, OTTAWA, ONTARIO K1P 5J3, CANADA	0008-400X			CAN J BEHAV SCI	Can. J. Behav. Sci.-Rev. Can. Sci. Comport.	JAN	2012	44	1					9	15		10.1037/a0025382			7	Psychology, Multidisciplinary	Psychology	878FW	WOS:000299241900002					2021-06-18	
J	Wells, DL; Swanson, JM; Wood, GC; Magnotti, LJ; Boucher, BA; Croce, MA; Harrison, CG; Muhlbauer, MS; Fabian, TC				Wells, Diana L.; Swanson, Joseph M.; Wood, G. Christopher; Magnotti, Louis J.; Boucher, Bradley A.; Croce, Martin A.; Harrison, Charles G.; Muhlbauer, Michael S.; Fabian, Timothy C.			The relationship between serum sodium and intracranial pressure when using hypertonic saline to target mild hypernatremia in patients with head trauma	CRITICAL CARE			English	Article							BRAIN-INJURY; CEREBRAL EDEMA; MANNITOL; HYPERTENSION; MANAGEMENT; INFUSION; CHLORIDE; IMPACT	Introduction: Limited data suggest mild hypernatremia may be related to lower intracranial pressure (ICP) in patients with traumatic brain injury (TBI). The practice at the study center has been to use hypertonic saline (HTS) to generate a targeted serum sodium of 145 to 155 mEq/l in patients with TBI. The purpose of this study was to determine the relationship between serum sodium values and ICP, and to evaluate the acute effect of HTS on ICP. Methods: A retrospective review of patients who were admitted to the trauma ICU for TBI, had an ICP monitor placed, and received at least one dose of HTS between January 2006 and March 2011 was performed. Data were collected for up to 120 hours after ICP monitor placement. The primary outcome was the relationship between serum sodium and maximum ICP. Secondary outcomes were the relationship between serum sodium and the mean number of daily interventions for ICP control, and the acute effect of HTS on ICP during the 6 hours after each dose. Linear regression was used to analyze the primary outcome. Analysis of variance on ranks and repeated measures analysis of variance were used to evaluate the number of interventions and the acute effect of HTS on ICP, respectively. Results: Eighty-one patients were enrolled with mean +/- standard deviation age of 36 +/- 15 years and median Glasgow Coma Scale score of 7 (interquartile range, 4 to 7). A total of 1,230 serum sodium values (range, 118 to 174 mEq/l) and 7,483 ICP values (range, 0 to 159 mmHg) were collected. There was no correlation between serum sodium and maximum ICP (R-2 = 0.0052). The overall mean +/- standard deviation number of interventions for elevated ICP per day was 4.2 +/- 2.9, 2.9 +/- 2.0, and 2.6 +/- 2.3 for patients with a mean serum sodium of < 145, 145 to 155, and > 155 mEq/l, respectively (P < 0.001). Regarding the acute effect of HTS on ICP, there was no statistical difference in mean ICP compared with baseline during hours 1 through 6 following HTS doses (baseline, 13.7 +/- 8.4 mmHg; hour 1, 13.6 +/- 8.3 mmHg; hour 2, 13.5 +/- 8.8 mmHg; hour 3, 13.3 +/- 8.7 mmHg; hour 4, 13.4 +/- 8.7 mmHg; hour 5, 13.4 +/- 8.3 mmHg; hour 6, 13.5 +/- 8.3 mmHg; P = 0.84). Conclusions: Serum sodium concentrations did not correlate with ICP values. These results warrant further evaluation and possible reassessment of sodium goals for ICP management in patients with TBI.	[Wells, Diana L.] Auburn Univ, Harrison Sch Pharm, Dept Pharm Practice, Auburn, AL 36849 USA; [Swanson, Joseph M.; Wood, G. Christopher; Boucher, Bradley A.; Harrison, Charles G.] Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm, Memphis, TN 38163 USA; [Magnotti, Louis J.; Croce, Martin A.; Fabian, Timothy C.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA; [Muhlbauer, Michael S.] Univ Tennessee, Hlth Sci Ctr, Dept Neurosurg, Memphis, TN 38163 USA	Wells, DL (corresponding author), Auburn Univ, Harrison Sch Pharm, Dept Pharm Practice, 1321 Walker Bldg, Auburn, AL 36849 USA.	dlw0022@auburn.edu					Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; KOFKE WA, 1993, J NEUROSURG ANESTH, V5, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lindsey KA, 2010, NUTRITION, V26, P784, DOI 10.1016/j.nut.2009.08.013; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	22	16	17	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2012	16	5							R193	10.1186/cc11678			8	Critical Care Medicine	General & Internal Medicine	124WT	WOS:000317499900030	23068293	DOAJ Gold, Green Published			2021-06-18	
J	Whiteside, DM; Galbreath, J; Brown, M; Turnbull, J				Whiteside, Douglas M.; Galbreath, Jennifer; Brown, Michelle; Turnbull, Jane			Differential response patterns on the Personality Assessment Inventory (PAI) in compensation-seeking and non-compensation-seeking mild traumatic brain injury patients	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Personality Assessment Inventory; Mild traumatic brain injury; Neuropsychological assessment; Personality assessment; Compensation seeking	CLOSED-HEAD INJURY; VALIDITY SCALES; MMPI-2 VALIDITY; INDIVIDUALS; PERFORMANCE; SYMPTOMS; SPECIFICITY; SENSITIVITY; INDICATORS; OFFENDERS	There is relatively little research on the Personality Assessment Inventory (PAI) with mild traumatic brain injury (MTBI) populations. There is also little research on how compensation-seeking status affects personality assessment results in MTBI patients. The current study examined the PAI scales and subscales in two MTBI groups, one composed of compensation-seeking MTBI patients and the other consisting of non-compensation-seeking MTBI patients. Results indicated significant differences on several scales and subscales between the two MTBI groups, with the compensation-seeking MTBI patients having significantly higher elevations on scales related to somatic preoccupation (Somatic Complaint Scale, SOM), emotional distress (Anxiety Scale, ANX; Anxiety Related Disorders Scale, ARD; Depression Scale, DEP), and the Negative Impression Management, NIM, validity scale. All the SOM subscales and the Anxiety Cognitive (ANX-C) and ANX Affective, ANX-A, subscales were also elevated in the compensation-seeking group. Results indicated that several scales on the PAI were sensitive to group differences in compensation-seeking status in MTBI patients.	[Whiteside, Douglas M.] Adler Sch Profess Psychol, Dept Clin Psychol, Chicago, IL 60602 USA; [Galbreath, Jennifer; Brown, Michelle; Turnbull, Jane] Argosy Univ, Washington Sch Profess Psychol, Seattle, WA USA	Whiteside, DM (corresponding author), Adler Sch Profess Psychol, Dept Clin Psychol, 17 N Dearborn St, Chicago, IL 60602 USA.	dwhiteside@adler.edu	Whiteside, Douglas/AAK-6396-2020	Whiteside, Douglas/0000-0002-8454-4413			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BLACK FW, 1974, J CLIN PSYCHOL, V30, P571, DOI 10.1002/1097-4679(197410)30:4<571::AID-JCLP2270300432>3.0.CO;2-W; Boccaccini MT, 2010, PSYCHOL ASSESSMENT, V22, P142, DOI 10.1037/a0017818; Butcher, 1989, MINNESOTA MULTIPHASI; Caperton JD, 2004, PSYCHOL ASSESSMENT, V16, P187, DOI 10.1037/1040-3590.16.2.187; Cohen J, 1988, STAT POWER BEHAV SCI; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; FalsStewart W, 1996, PSYCHOL ASSESSMENT, V8, P60; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; Hopwood CJ, 2008, J PERS ASSESS, V90, P76, DOI 10.1080/00223890701693785; Hopwood CJ, 2007, REHABIL PSYCHOL, V52, P443, DOI 10.1037/0090-5550.52.4.443; Karlin BE, 2005, J CLIN PSYCHOL, V61, P1571, DOI 10.1002/jclp.20209; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kurcharski L. T., 2007, J PERS ASSESS, V88, P25; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LaChapelle DL, 2005, APPL NEUROPSYCHOL, V12, P143, DOI 10.1207/S15324826AN1203_4; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McCrea M, 2008, MILD TRAUMATIC BRAIN; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Morey L. C., 1991, PERSONALITY ASSESSME; Morey L.C., 1996, INTERPRETATIVE GUIDE; Morey LC, 2002, INT J OFFENDER THER, V46, P333, DOI 10.1177/03024X02046003007; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Piotrowski C, 2000, PSYCHOL REP, V86, P65, DOI 10.2466/PR0.86.1.65-66; Rayls KR, 2000, CLIN NEUROPSYCHOL, V14, P546, DOI 10.1076/clin.14.4.546.7194; Ross SR, 2006, J CLIN EXP NEUROPSYC, V28, P111, DOI 10.1080/13803390590929270; Ruttan LA, 2003, J CLIN EXP NEUROPSYC, V25, P407, DOI 10.1076/jcen.25.3.407.13812; SHAW DJ, 1965, J CLIN PSYCHOL, V21, P405, DOI 10.1002/1097-4679(196510)21:4<405::AID-JCLP2270210416>3.0.CO;2-I; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Till C, 2009, BRAIN INJURY, V23, P655, DOI 10.1080/02699050902970794; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wang EW, 1997, BEHAV SCI LAW, V15, P469, DOI 10.1002/(SICI)1099-0798(199723/09)15:4<469::AID-BSL279>3.0.CO;2-A; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169	42	16	16	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	2					172	182		10.1080/13803395.2011.630648			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	916EC	WOS:000302079900006	22136511				2021-06-18	
J	Sharma, R; Vannabouathong, C; Bains, S; Marshall, A; MacDonald, SJ; Parvizi, J; Bhandari, M				Sharma, Rajrishi; Vannabouathong, Christopher; Bains, Simrit; Marshall, Amanda; MacDonald, Steven J.; Parvizi, Javad; Bhandari, Mohit			Meta-Analyses in joint Arthroplasty: A Review of Quantity, Quality, and Impact	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							RANDOMIZED CONTROLLED-TRIALS; TRAUMATIC BRAIN-INJURY; SYSTEMATIC REVIEWS; ORTHOPEDIC-SURGERY; HYPOTHERMIA; ARTICLES; CARE		[Sharma, Rajrishi] McMaster Univ, Dept Surg, Div Orthopaed Surg, Hamilton, ON L8L 2X2, Canada	Sharma, R (corresponding author), McMaster Univ, Dept Surg, Div Orthopaed Surg, 293 Wellington St N,Suite 110, Hamilton, ON L8L 2X2, Canada.	rajrishisharma@gmail.com	MacDonald, Steven J/B-6173-2015	Vannabouathong, Christopher/0000-0002-9694-6364			Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Bereza BG, 2008, ANN PHARMACOTHER, V42, P1402, DOI 10.1345/aph.1L204; Bhandari M, 2004, J BONE JOINT SURG AM, V86A, P1012, DOI 10.2106/00004623-200405000-00019; Bhandari M, 2001, J BONE JOINT SURG AM, V83A, P15, DOI 10.2106/00004623-200101000-00003; Breslow N.E., 1980, STAT METHODS CANC RE, V1; Celermajer DS, 2001, MED J AUSTRALIA, V174, P293, DOI 10.5694/j.1326-5377.2001.tb143274.x; Christensen E, 2001, J HEPATOL, V34, P342, DOI 10.1016/S0168-8278(00)00002-7; COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P167, DOI 10.1016/0895-4356(94)00172-M; Crowther Mark A, 2007, Hematology Am Soc Hematol Educ Program, P493; Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; Dijkman BG, 2010, J BONE JOINT SURG AM, V92A, P48, DOI 10.2106/JBJS.I.00251; Dixon E, 2005, ANN SURG, V241, P450, DOI 10.1097/01.sla.0000154258.30305.df; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; Glass G.V., 1976, EDUC RES, P3, DOI DOI 10.3102/0013189X005010003; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2000, ONKOLOGIE, V23, P597, DOI 10.1159/000055014; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1016/j.ijsu.2010.02.007]; Mulrow CD, 1997, ANN INTERN MED, V126, P389, DOI 10.7326/0003-4819-126-5-199703010-00008; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; Oxman AD, 1988, CMAJ, V138, P679; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Sacks HS, 1996, MT SINAI J MED, V63, P216; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184	32	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	DEC 21	2011	93A	24					2304	2309		10.2106/JBJSJ.01289			6	Orthopedics; Surgery	Orthopedics; Surgery	871WV	WOS:000298769300010	22258777				2021-06-18	
J	Moreira, MS; Velasco, IT; Ferreira, LS; Ariga, SKK; Abatepaulo, F; Grinberg, LT; Marques, MM				Moreira, Maria S.; Velasco, Irineu T.; Ferreira, Leila S.; Ariga, Suely K. K.; Abatepaulo, Fatima; Grinberg, Lea Tenenholz; Marques, Marcia M.			Effect of laser phototherapy on wound healing following cerebral ischemia by cryogenic injury	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY			English	Article						Brain injury; Leukocytes; Low power laser; Lymphocytes; Macrophages; Glial cells	TRAUMATIC BRAIN-INJURY; ADHESION MOLECULES; 780 NM; THERAPY; IRRADIATION; REGENERATION; STROKE; MECHANISMS; EXPRESSION; INCREASES	Laser phototherapy emerges as an alternative or auxiliary therapy for acute ischemic stroke, traumatic brain injury, degenerative brain disease, spinal cord injury, and peripheral nerve regeneration, but its effects are still controversial. We have previously found that laser phototherapy immunomodulates the response to focal brain damage. Following direct cortical cryogenic injury the effects of laser phototherapy on inflammation and repair was assessed after cryogenic injury (Cl) to the central nervous system (CNS) of rats. The laser phototherapy was carried out with a 780 nm AlGaAs diode laser. The irradiation parameters were: power of 40 mW, beam area of 0.04 cm(2), energy density of 3 J/cm(2) (3 s) in two points (0.12 J per point). Two irradiations were performed at 3 h-intervals, in contact mode. Rats (20 non-irradiated - controls and 20 irradiated) were used. The wound healing in the CNS was followed in 6 h, 1,7 and 14 days after the last irradiation. The size of the lesions, the neuron cell viability percentages and the amount of positive GFAP labeling were statistically compared by ANOVA complemented by Tukey's test (p < 0.05). The distribution of lymphocytes, leukocytes and macrophages were also analyzed. Cl created focal lesions in the cortex represented by necrosis, edema, hemorrhage and inflammatory infiltrate. The most striking findings were: lased lesions showed smaller tissue loss than control lesions in 6 h. During the first 24 h the amount of viable neurons was significantly higher in the lased group. There was a remarkable increase in the amount of GFAP in the control group by 14 days. Moreover, the lesions of irradiated animals had fewer leukocytes and lymphocytes in the first 24 h than controls. Considering the experimental conditions of this study it was concluded that laser phototherapy exerts its effect in wound healing following Cl by controlling the brain damage, preventing neuron death and severe astrogliosis that could indicate the possibility of a better clinical outcome. (C) 2011 Elsevier B.V. All rights reserved.	[Moreira, Maria S.; Ferreira, Leila S.; Marques, Marcia M.] Univ Sao Paulo, Sch Dent, BR-05508000 Sao Paulo, Brazil; [Moreira, Maria S.; Velasco, Irineu T.; Ariga, Suely K. K.; Abatepaulo, Fatima] Univ Sao Paulo, Sch Med, LIM 51, BR-05508000 Sao Paulo, Brazil; [Moreira, Maria S.] Ibirapuera Univ UNIB, Postgrad Program Biodent, Sao Paulo, Brazil; [Grinberg, Lea Tenenholz] FMUSP, Discipline Expt Physiopathol, Sao Paulo, Brazil; [Grinberg, Lea Tenenholz] UCSF San Francisco, Dept Neurol, Sao Paulo, Brazil	Marques, MM (corresponding author), Univ Sao Paulo, Sch Dent, BR-05508000 Sao Paulo, Brazil.	mmmarques@usp.br	Moreira, Maria Stella N A/F-8054-2014; Marques, Marcia M/F-3780-2012	Moreira, Maria Stella N A/0000-0002-4533-4544; Marques, Marcia M/0000-0002-9398-1252; grinberg, lea/0000-0002-6809-0618	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brasilia, DF, BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	We thank the staffs of the Labs: LIM51 at the Medicine School and LELO (Special Laboratory of Lasers in Dentistry) at the School of Dentistry, University of Sao Paulo, Brazil. We also thank Professor Livia Ribeiro de Assis for your suggestions. We are also grateful to ours grants sponsors Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, Brazil and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brasilia, DF, Brazil.	Ad N, 2001, INT J CARDIOL, V80, P109, DOI 10.1016/S0167-5273(01)00503-4; Anders JJ, 2004, NEUROL RES, V26, P233, DOI 10.1179/016164104225013914; Aronowski J, 1999, J CEREBR BLOOD F MET, V19, P652, DOI 10.1097/00004647-199906000-00008; Avni D, 2005, PHOTOMED LASER SURG, V23, P273, DOI 10.1089/pho.2005.23.273; Back T, 1998, CELL MOL NEUROBIOL, V18, P621, DOI 10.1023/A:1020265701407; Benedicenti S, 2008, PHOTOMED LASER SURG, V26, P451, DOI 10.1089/pho.2007.2218; Boschi ES, 2008, LASER SURG MED, V40, P500, DOI 10.1002/lsm.20658; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Damante CA, 2009, LASER MED SCI, V24, P885, DOI 10.1007/s10103-008-0582-y; de Lima FM, 2011, LASER MED SCI, V26, P389, DOI 10.1007/s10103-010-0874-x; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Eduardo FD, 2008, LASER SURG MED, V40, P433, DOI 10.1002/lsm.20646; Eduardo FP, 2007, LASER SURG MED, V39, P365, DOI 10.1002/lsm.20481; Engel S, 1996, ACT NEUR S, V66, P87; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; Fujihara NA, 2006, LASER SURG MED, V38, P332, DOI 10.1002/lsm.20298; GebickeHaerter PJ, 1996, NEUROCHEM INT, V29, P1; GIULIAN D, 1989, J NEUROSCI, V9, P4416; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HOLMIN S, 1995, NEUROSCI LETT, V194, P97, DOI 10.1016/0304-3940(95)11737-H; Iadecola C, 1997, ANN NY ACAD SCI, V835, P203, DOI 10.1111/j.1749-6632.1997.tb48631.x; Kaufmann AM, 1999, STROKE, V30, P93, DOI 10.1161/01.STR.30.1.93; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Kujawa J, 2004, J CLIN LASER MED SUR, V22, P111, DOI 10.1089/104454704774076163; KUMAR V, 2005, ROBBINS COTRAN PATHO, P1525; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; Meneguzzo DT, 2008, PROC SPIE, V6846, DOI 10.1117/12.761220; Meneguzzo DT, 2007, PROC SPIE, V6428, DOI 10.1117/12.702252; Mirsky N, 2002, ANTIOXID REDOX SIGN, V4, P785, DOI 10.1089/152308602760598936; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Moriyama Y, 2009, LASER SURG MED, V41, P227, DOI 10.1002/lsm.20745; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron U, 2007, PHOTOMED LASER SURG, V25, P180, DOI 10.1089/pho.2007.2064; Oron U, 2010, PHOTOMED LASER SURG, V28, P675, DOI 10.1089/pho.2009.2756; Leal ECP, 2010, EUR J APPL PHYSIOL, V108, P1083, DOI 10.1007/s00421-009-1321-1; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P436, DOI 10.1089/pho.2007.2093; Sawasaki I, 2009, LASER MED SCI, V24, P113, DOI 10.1007/s10103-007-0531-1; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SCHOTT RJ, 1989, ANN EMERG MED, V18, P517, DOI 10.1016/S0196-0644(89)80836-4; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Soares HD, 1995, J NEUROSCI, V15, P8223; Sousa LR, 2009, PHOTOMED LASER SURG, V27, P37, DOI 10.1089/pho.2007.2220; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Streeter J, 2004, MITOCHONDRION, V4, P569, DOI 10.1016/j.mito.2004.07.037; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tuby H, 2006, LASER SURG MED, V38, P682, DOI 10.1002/lsm.20377; Yaakobi T, 2001, J APPL PHYSIOL, V90, P2411	58	16	16	0	6	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1011-1344			J PHOTOCH PHOTOBIO B	J. Photochem. Photobiol. B-Biol.	DEC 2	2011	105	3					207	215		10.1016/j.jphotobiol.2011.09.005			9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	859QV	WOS:000297891800007	22024356				2021-06-18	
J	Barberan, S; McNair, K; Iqbal, K; Smith, NC; Prendergast, GC; Stone, TW; Cobb, SR; Morris, BJ				Barberan, Sara; McNair, Kara; Iqbal, Khalil; Smith, Nicola C.; Prendergast, George C.; Stone, Trevor W.; Cobb, Stuart R.; Morris, Brian J.			Altered apoptotic responses in neurons lacking RhoB GTPase	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						cortex; hippocampus; mice; neurodegeneration; Rho GTPase; TUNEL	SPINAL-CORD-INJURY; TRANSIENT CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; LONG-TERM DEPRESSION; NF-KAPPA-B; FARNESYLTRANSFERASE INHIBITORS; CORTICAL-NEURONS; CELL-DEATH; CNS INJURY; SYNAPTIC-TRANSMISSION	Caspase 3 activation has been linked to the acute neurotoxic effects of central nervous system damage, as in traumatic brain injury or cerebral ischaemia, and also to the early events leading to long-term neurodegeneration, as in Alzheimers disease. However, the precise mechanisms activating caspase 3 in neuronal injury are unclear. RhoB is a member of the Rho GTPase family that is dramatically induced by cerebral ischaemia or neurotrauma, both in preclinical models and clinically. In the current study, we tested the hypothesis that RhoB might directly modulate caspase 3 activity and apoptotic or necrotic responses in neurons. Over-expression of RhoB in the NG108-15 neuronal cell line or in cultured corticohippocampal neurons elevated caspase 3 activity without inducing overt toxicity. Cultured corticohippocampal neurons from RhoB knockout mice did not show any differences in sensitivity to a necrotic stimulus acute calcium ionophore exposure compared with neurons from wild-type mice. However, corticohippocampal neurons lacking RhoB exhibited a reduction in the degree of DNA fragmentation and caspase 3 activation induced by the apoptotic agent staurosporine, in parallel with increased neuronal survival. Staurosporine induction of caspase 9 activity was also suppressed. RhoB knockout mice showed reduced basal levels of caspase 3 activity in the adult brain. These data directly implicate neuronal RhoB in caspase 3 activation and the initial stages of programmed cell death, and suggest that RhoB may represent an attractive target for therapeutic intervention in conditions involving elevated caspase 3 activity in the central nervous system.	[Barberan, Sara; McNair, Kara; Iqbal, Khalil; Smith, Nicola C.; Stone, Trevor W.; Cobb, Stuart R.; Morris, Brian J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland; [Prendergast, George C.] Lankenau Inst Med Res, Wynnewood, PA USA	Morris, BJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland.	brian.morris@glasgow.ac.uk	Stone, Trevor/M-7904-2015	Stone, Trevor/0000-0002-5532-0031	BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C001028/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA100123] Funding Source: NIH RePORTER	This work was supported by the BBSRC. We thank Dr H. Mellor (University of Bristol) for the gift of the constitutively active RhoB vector.	Ader I, 2002, ONCOGENE, V21, P5998, DOI 10.1038/sj.onc.1205746; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Andreau K, 2004, J BIOL CHEM, V279, P55937, DOI 10.1074/jbc.M406411200; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Brabeck C, 2003, ARCH NEUROL-CHICAGO, V60, P1245, DOI 10.1001/archneur.60.9.1245; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Caballero-Benitez A, 2003, J NEUROSCI RES, V71, P383, DOI 10.1002/jnr.10493; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Chen J, 1998, J NEUROSCI, V18, P4914; Citron BA, 2008, SPINE, V33, P2269, DOI 10.1097/BRS.0b013e3181831f7e; Clark CJ, 2007, J NEUROCHEM, V102, P1024, DOI 10.1111/j.1471-4159.2007.04601.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Conway AM, 2004, EXP CELL RES, V300, P35, DOI 10.1016/j.yexcr.2004.06.022; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; DeWard AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007102; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Erdo F, 2004, ACTA NEUROPATHOL, V107, P127, DOI 10.1007/s00401-003-0789-8; Focking M, 2004, NEUROSCI LETT, V355, P41, DOI 10.1016/j.neulet.2003.10.022; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harada J, 1999, BRAIN RES, V842, P311, DOI 10.1016/S0006-8993(99)01808-9; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156; Hutchison N, 2009, CELL SIGNAL, V21, P1522, DOI 10.1016/j.cellsig.2009.05.012; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Johansson T, 2007, J STEROID BIOCHEM, V104, P215, DOI 10.1016/j.jsbmb.2007.03.024; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Li YD, 2011, J CELL PHYSIOL, V226, P729, DOI 10.1002/jcp.22394; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma SA, 2011, MOL CELL NEUROSCI, V46, P573, DOI 10.1016/j.mcn.2010.12.008; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Mannherz HG, 2006, EUR J CELL BIOL, V85, P785, DOI 10.1016/j.ejcb.2006.02.012; Martin LJ, 2009, CEREB CORTEX, V19, P1273, DOI 10.1093/cercor/bhn167; McDermott CJ, 2003, J NEUROCHEM, V86, P383, DOI 10.1046/j.1471-4159.2003.01853.x; McNair K, 2010, J NEUROSCI, V30, P3508, DOI 10.1523/JNEUROSCI.5386-09.2010; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Moore JD, 2002, BRIT J PHARMACOL, V135, P1069, DOI 10.1038/sj.bjp.0704538; MORRIS BJ, 1995, J BIOL CHEM, V270, P24740; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Movsesyan VA, 2002, BIOCHEM BIOPH RES CO, V299, P201, DOI 10.1016/S0006-291X(02)02593-7; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; O'Kane EM, 2003, MOL BRAIN RES, V114, P1, DOI 10.1016/S0169-328X(03)00121-9; O'Kane EM, 2003, J NEUROCHEM, V87, P1309, DOI 10.1046/j.1471-4159.2003.02102.x; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Prendergast GC, 2000, CURR OPIN CELL BIOL, V12, P166, DOI 10.1016/S0955-0674(99)00072-1; Prendergast GC, 2001, HISTOL HISTOPATHOL, V16, P269, DOI 10.14670/HH-16.269; Rakhit S, 2005, MOL PHARMACOL, V67, P1158, DOI 10.1124/mol.104.005447; Sanno H, 2010, J NEUROSCI, V30, P4221, DOI 10.1523/JNEUROSCI.3318-09.2010; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Sebti SM, 2000, EXPERT OPIN INV DRUG, V9, P2767, DOI 10.1517/13543784.9.12.2767; Sherstnev V V, 2006, Neurosci Behav Physiol, V36, P915, DOI 10.1007/s11055-006-0107-8; Simpson CS, 2000, J BIOL CHEM, V275, P16879, DOI 10.1074/jbc.275.22.16879; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tomiyoshi G, 2004, GENES CELLS, V9, P591, DOI 10.1111/j.1356-9597.2004.00745.x; Trapp T, 2003, MOL CELL NEUROSCI, V23, P302, DOI 10.1016/S1044-7431(03)00013-7; Trapp T, 2001, MOL CELL NEUROSCI, V17, P883, DOI 10.1006/mcne.2001.0971; West T, 2006, NEUROBIOL DIS, V22, P523, DOI 10.1016/j.nbd.2005.12.017; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yoshimori Atsushi, 2007, BMC Pharmacology, V7, P8, DOI 10.1186/1471-2210-7-8; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181; Zeron MM, 2004, MOL CELL NEUROSCI, V25, P469, DOI 10.1016/j.mcn.2003.11.014; Zhan RZ, 2001, J CEREBR BLOOD F MET, V21, P529, DOI 10.1097/00004647-200105000-00007; Zhang YJ, 2007, EUR J NEUROSCI, V25, P1341, DOI 10.1111/j.1460-9568.2007.05404.x	85	16	18	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	DEC	2011	34	11					1737	1746		10.1111/j.1460-9568.2011.07891.x			10	Neurosciences	Neurosciences & Neurology	854AB	WOS:000297465800004	22098422	Green Accepted			2021-06-18	
J	Connon, FF; Namdarian, B; Ee, JLC; Drummond, KJ; Miller, JA				Connon, Francis F.; Namdarian, Benjamin; Ee, Joanne L. C.; Drummond, Katharine J.; Miller, Julie A.			Do Routinely Repeated Computed Tomography Scans in Traumatic Brain Injury Influence Management? A Prospective Observational Study in a Level 1 Trauma Center	ANNALS OF SURGERY			English	Article							MINIMAL HEAD-INJURY; CT; MODERATE; UTILITY	Objective: To prospectively examine the clinical role of routine repeat computed tomographic scans of the brain (CTB) in patients with traumatic head injury. Summary Background Data: The use of routine serial CTB after traumatic head injury is recommended by some authors, but remains controversial. Methods: From March 2007 to October 2008, all patients with traumatic head injury admitted to the Royal Melbourne Hospital, a metropolitan, Level I trauma center, were prospectively studied. After the initial computed tomography brain scans, any subsequent CTBs were assessed and were recorded as being either "clinically indicated" or "routine" and ensuing medical and surgical management. Inpatient information was recorded and comparisons made according to indication for CTB, Glasgow Coma Scale, and management changes. Results: A total of 651 patients were admitted with traumatic head injury over the 20-month study period. Of those, 39 underwent immediate craniotomy/craniectomy and were excluded from analysis. Another 25 were excluded due to incomplete data, leaving 591 patients for analysis. Of the 591 assessed, 401 were discharged with no further computed tomography investigation. One hundred and ninety patients underwent a total of 305 repeat brain scans, of which 149 were clinically indicated, whereas 156 were obtained as a "routine" investigation with no deterioration in patients' neurological status. Of the repeated scans, 71 were improved, 169 were unchanged, and 64 were worse. None of the 156 patients who received a "routine" CTB required a change in management. The 149 CTB performed for clinical deterioration resulted in a change in management in 28 patients (19%). The patients who underwent "indicated" computed tomographic scans and subsequently required a change in management were on average younger (P < 0.001) and more severely head injured (P = 0.001) than the patients not requiring a change in management. Conclusions: No patients from our cohort with a "routine" repeat CTB required a change in management. Given the costs and potential risks of routine repeat CTB, and lack of demonstrable benefit, the practice should be reconsidered. Repeat CTB is clearly indicated in patients with deteriorating neurological status, especially younger and more severely head-injured patients.	[Connon, Francis F.; Namdarian, Benjamin; Ee, Joanne L. C.; Miller, Julie A.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia; [Drummond, Katharine J.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia	Miller, JA (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia.	Julie.miller@mh.org.au		Namdarian, Benjamin/0000-0002-4209-1639			Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; National Research Council, 2006, HLTH RISKS EXP LOW L; ROBERSON FC, 1979, SURG NEUROL, V12, P161; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	14	16	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-4932			ANN SURG	Ann. Surg.	DEC	2011	254	6					1028	1031		10.1097/SLA.0b013e318219727f			4	Surgery	Surgery	852RM	WOS:000297375200029	22112983				2021-06-18	
J	Gilley, JA; Kernie, SG				Gilley, Jennifer A.; Kernie, Steven G.			Excitatory amino acid transporter 2 and excitatory amino acid transporter 1 negatively regulate calcium-dependent proliferation of hippocampal neural progenitor cells and are persistently upregulated after injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						glutamate; hippocampus; Mus musculus; neural stem cells; neuroregeneration	TRAUMATIC BRAIN-INJURY; METABOTROPIC GLUTAMATE RECEPTORS; STEM/PROGENITOR CELLS; DENTATE GYRUS; NEUROGENESIS; MICE; NEUROPROTECTION; EXPRESSION; ISCHEMIA; RAT	Using a transgenic mouse (Mus musculus) in which nestin-expressing progenitors are labeled with enhanced green fluorescent protein, we previously characterized the expression of excitatory amino acid transporter 2 (GltI) and excitatory amino acid transporter 1 (Glast) on early neural progenitors in vivo. To address their functional role in this cell population, we manipulated their expression in P7 neurospheres isolated from the dentate gyrus. We observed that knockdown of GltI or Glast was associated with decreased bromodeoxyuridine incorporation and neurosphere formation. Moreover, we determined that both glutamate transporters regulated progenitor proliferation in a calcium-dependent and metabotropic glutamate receptor-dependent manner. To address the relevance of this in vivo, we utilized models of acquired brain injury, which are known to induce hippocampal neurogenesis. We observed that GltI and Glast were specifically upregulated in progenitors following brain injury, and that this increased expression was maintained for many weeks. Additionally, we found that recurrently injured animals with increased expression of glutamate transporters within the progenitor population were resistant to subsequent injury-induced proliferation. These findings demonstrate that GltI and Glast negatively regulate calcium-dependent proliferation in vitro and that their upregulation after injury is associated with decreased proliferation after brain trauma.	[Gilley, Jennifer A.; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Gilley, Jennifer A.; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	Kernie, SG (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	sk3516@columbia.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS048192]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048192] Funding Source: NIH RePORTER	This work was supported by NIH grant R01 NS048192 (S. G. Kernie). The authors have no other financial interest to disclose. The authors would like to thank Gui Zhang, Kyle Lieppman and Darryl Miles for their technical support and assistance with this publication.	ANDINE P, 1991, DEV BRAIN RES, V64, P115, DOI 10.1016/0165-3806(91)90214-4; Bigdeli MR, 2009, J STROKE CEREBROVASC, V18, P336, DOI 10.1016/j.jstrokecerebrovasdis.2008.12.005; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Brazel CY, 2005, NEUROSCIENCE, V131, P55, DOI 10.1016/j.neuroscience.2004.10.038; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHOI DW, 1988, J NEUROSCI, V8, P185; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Cimarosti H, 2005, NEUROSCI LETT, V385, P52, DOI 10.1016/j.neulet.2005.05.006; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; DIETER P, 1993, BIOL CHEM H-S, V374, P171, DOI 10.1515/bchm3.1993.374.1-6.171; Fonnum F, 2004, J NEUROCHEM, V88, P513, DOI 10.1046/j.1471-4159.2003.02211.x; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gilley JA, 2011, HIPPOCAMPUS, V21, P33, DOI 10.1002/hipo.20719; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Jensen FE, 2002, INT J DEV NEUROSCI, V20, P339, DOI 10.1016/S0736-5748(02)00012-6; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Luk KC, 2003, J NEUROSCI, V23, P2239; Maragakis NJ, 2004, GLIA, V45, P133, DOI 10.1002/glia.10310; Matsugami TR, 2006, P NATL ACAD SCI USA, V103, P12161, DOI 10.1073/pnas.0509144103; Melchiorri D, 2007, NEUROPHARMACOLOGY, V53, P473, DOI 10.1016/j.neuropharm.2007.05.031; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Miles DK, 2006, PROG BRAIN RES, V157, P187, DOI 10.1016/S0079-6123(06)57012-8; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nacher J, 2007, NEUROSCIENCE, V144, P855, DOI 10.1016/j.neuroscience.2006.10.021; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Romera C, 2007, J CEREBR BLOOD F MET, V27, P1327, DOI 10.1038/sj.jcbfm.9600438; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Shi J, 2007, EUR J NEUROSCI, V25, P3499, DOI 10.1111/j.1460-9568.2007.05624.x; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Suzuki M, 2006, EUR J NEUROSCI, V24, P645, DOI 10.1111/j.1460-9568.2006.04957.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Weller ML, 2008, NEUROSCIENCE, V155, P1204, DOI 10.1016/j.neuroscience.2008.05.059; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	45	16	16	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	DEC	2011	34	11					1712	1723		10.1111/j.1460-9568.2011.07888.x			12	Neurosciences	Neurosciences & Neurology	854AB	WOS:000297465800002	22092549	Green Accepted			2021-06-18	
J	Ley, EJ; Singer, MB; Clond, MA; Gangi, A; Mirocha, J; Bukur, M; Brown, CV; Salim, A				Ley, Eric J.; Singer, Matthew B.; Clond, Morgan A.; Gangi, Alexandra; Mirocha, Jim; Bukur, Marko; Brown, Carlos V.; Salim, Ali			Elevated Admission Systolic Blood Pressure After Blunt Trauma Predicts Delayed Pneumonia and Mortality	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	41st Annual Meeting of the Western-Trauma-Association	FEB 27-MAR 05, 2011	Big Sky, MO	Western Trauma Assoc		Trauma; Traumatic brain injury; Elevated blood pressure; Pneumonia; Mortality; Hypertension; Sympathetic hyperactivity; Adrenergic activation	BETA-BLOCKER EXPOSURE; SERUM ETHANOL LEVELS; BRAIN-INJURY TBI; CEREBRAL PERFUSION; IMPROVED SURVIVAL; IMPROVED OUTCOMES; NERVOUS-SYSTEM; PROPRANOLOL; STRESS; ACTIVATION	Background: Although avoiding hypotension is a primary focus after trauma, elevated systolic blood pressure (SBP) is frequently disregarded. The purpose of this study was to determine the association between elevated admission SBP and delayed outcomes after trauma. Methods: The Los Angeles County Trauma System Database was queried for all patients between 2003 and 2008 with blunt injuries who survived for at least 2 days after admission. Demographics and outcomes (pneumonia and mortality) were compared at various admission SBP subgroups (>= 160 mm Hg, >= 170 mm Hg, >= 180 mm Hg, >= 190 mm Hg, >= 200 mm Hg,>= 210 mm Hg, and >= 220 mm Hg). Patients with moderate-to-severe traumatic brain injury (TBI), defined as head Abbreviated Injury Score >= 3, were then identified and compared with those without using multivariable logistic regression. Results: Data accessed from 14,382 blunt trauma admissions identified 2,601 patients with moderate-to-severe TBI (TBI group) and 11,781 without moderate-to-severe TBI (non-TBI group) who were hospitalized >= 2 days. Overall mortality was 2.9%, 7.1% for TBI patients, and 1.9% for non-TBI patients. Overall pneumonia was 4.6%, 9.5% for TBI patients, and 3.6% for non-TBI patients. Regression modeling determined SBP >= 160 mm Hg was a significant predictor of mortality in TBI patients (adjusted odds ratio [AOR], 1.59; confidence interval [CI], 1.10-2.29; p = 0.03) and non-TBI patients (AOR, 1.47; CI, 1.14-1.90; p = 0.003). Similarly, SBP >= 160 mm Hg was a significant predictor for increased pneumonia in TBI patients (AOR, 1.79; CI, 1.30-2.46; p = 0.0004), compared with non-TBI patients (AOR, 1.28; CI, 0.97-1.69; p = 0.08). Conclusions: In blunt trauma patients with or without TBI, elevated admission SBP was associated with worse delayed outcomes. Prospective research is necessary to determine whether algorithms that manage elevated blood pressure after trauma, especially after TBI, affect mortality or pneumonia.	[Ley, Eric J.; Singer, Matthew B.; Clond, Morgan A.; Gangi, Alexandra; Mirocha, Jim; Bukur, Marko; Brown, Carlos V.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA	Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215,North Tower, Los Angeles, CA 90048 USA.	eric.ley@cshs.org		Bukur, Marko/0000-0002-1850-7147; Gangi, Afshin/0000-0002-0952-7760; Clond, Morgan/0000-0002-3036-4193			[Anonymous], WISQARS FATAL INJURI; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Arima H, 2010, HYPERTENSION, V56, P852, DOI 10.1161/HYPERTENSIONAHA.110.154328; Ballard-Croft C, 2002, SHOCK, V18, P38, DOI 10.1097/00024382-200207000-00008; Beiermeister KA, 2010, J TRAUMA, V69, P338, DOI 10.1097/TA.0b013e3181e5d35e; BENEDICT CR, 1979, BRIT HEART J, V42, P214; Berry C, 2010, AM SURGEON, V76, P1067; BRYAN RM, 1990, AM J PHYSIOL, V259, pH269; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chi OZ, 1999, ANESTH ANALG, V89, P690, DOI 10.1097/00000539-199909000-00030; Chiu W, 2007, J TRAUMA, V63, P510; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Enderson BL, 2007, J TRAUMA, V62, P33; Friese RS, 2008, J TRAUMA, V64, P1061, DOI 10.1097/TA.0b013e3181684cf0; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Minino Arialdi M, 2006, Natl Vital Stat Rep, V54, P1; Muthu K, 2009, J BURN CARE RES, V30, P8, DOI 10.1097/BCR.0b013e3181921f22; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Platzer C, 2000, J NEUROIMMUNOL, V105, P31, DOI 10.1016/S0165-5728(00)00205-8; Pryor JP, 2007, J TRAUMA, V62, P61; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	35	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1689	1693		10.1097/TA.0b013e31823cc5df			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	869RT	WOS:000298616400044	22182876				2021-06-18	
J	Sun, LJ; Wang, L; Jiang, MH; Huang, JX; Lin, H				Sun, Lingjun; Wang, Lin; Jiang, Minghu; Huang, Juxiang; Lin, Hong			Glycogen Debranching Enzyme 6 (AGL), Enolase 1 (ENOSF1), Ectonucleotide Pyrophosphatase 2 (ENPP2_1), Glutathione S-Transferase 3 (GSTM3_3) and Mannosidase (MAN2B2) Metabolism Computational Network Analysis Between Chimpanzee and Human Left Cerebrum	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 computational network; Metabolism; Chimpanzee left cerebrum; Human left cerebrum	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; ALPHA-MANNOSIDASE; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; K562 CELLS; MU CLASS; IN-VIVO	We identified significantly higher expression of the genes glycogen debranching enzyme 6 (AGL), enolase 1 (ENOSF1), ectonucleotide pyrophosphatase 2 (ENPP2_1), glutathione S-transferase 3 (GSTM3_3) and mannosidase (MAN2B2) from human left cerebrums versus chimpanzees. Yet the distinct low- and high-expression AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism networks between chimpanzee and human left cerebrum remain to be elucidated. Here, we constructed low- and high-expression activated and inhibited upstream and downstream AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism network between chimpanzee and human left cerebrum in GEO data set by gene regulatory network inference method based on linear programming and decomposition procedure, under covering AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 pathway and matching metabolism enrichment analysis by CapitalBio MAS 3.0 integration of public databases, including Gene Ontology, KEGG, BioCarta, GenMapp, Intact, UniGene, OMIM, etc. Our results show that the AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism network has more activated and less inhibited molecules in chimpanzee, but less activated and more inhibited in the human left cerebrum. We inferred stronger carbohydrate, glutathione and proteoglycan metabolism, ATPase activity, but weaker base excision repair, arachidonic acid and drug metabolism as a result of inducing cell growth in low-expression AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism network of chimpanzee left cerebrum; whereas stronger lipid metabolism, amino acid catabolism, DNA repair but weaker inflammatory response, cell proliferation, glutathione and carbohydrate metabolism as a result of inducing cell differentiation in high-expression AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism network of human left cerebrum. Our inferences are consistent with recent reports and computational activation and inhibition gene number patterns, respectively.	[Sun, Lingjun; Wang, Lin; Huang, Juxiang; Lin, Hong] Beijing Univ Posts & Telecommun, Biomed Ctr, Sch Elect Engn, Beijing 100876, Peoples R China; [Jiang, Minghu] Tsinghua Univ, Lab Computat Linguist, Sch Humanities & Social Sci, Beijing 100084, Peoples R China	Wang, L (corresponding author), Beijing Univ Posts & Telecommun, Biomed Ctr, Sch Elect Engn, Beijing 100876, Peoples R China.	wanglin98@tsinghua.org.cn			National Natural Science Foundation in ChinaNational Natural Science Foundation of China (NSFC) [60871100]; Returned Overseas Chinese Scholars for Scientific research Foundation of State Education Ministry [2009ZX08012-001B]; State Key Lab of Pattern Recognition Open Foundation	This work was supported by the National Natural Science Foundation in China (No.60871100), the Returned Overseas Chinese Scholars for Scientific research Foundation of State Education Ministry, Significant Science and Technology Project for New Transgenic Biological Species (2009ZX08012-001B), and State Key Lab of Pattern Recognition Open Foundation.	Agarwal V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002337; Baroukh NN, 2009, FEBS J, V276, P6509, DOI 10.1111/j.1742-4658.2009.07353.x; Baumforth KRN, 2005, BLOOD, V106, P2138, DOI 10.1182/blood-2005-02-0471; Brody F, 2007, SURG ENDOSC, V21, P941, DOI 10.1007/s00464-006-9098-3; Buxhoeveden DP, 2002, BRAIN BEHAV EVOLUT, V60, P125, DOI 10.1159/000065935; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; CAMMER W, 1992, J COMP NEUROL, V321, P33, DOI 10.1002/cne.903210104; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; DALY JM, 1991, CARCINOGENESIS, V12, P1237, DOI 10.1093/carcin/12.7.1237; Deloulme JC, 1996, J NEUROCHEM, V66, P936; Deng XG, 2000, CHINESE MED J-PEKING, V113, P198; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Farias S, 2009, J NEUROTRAUM, V26, P1977, DOI 10.1089/neu.2009.0877; Fiaux H, 2005, J MED CHEM, V48, P4237, DOI 10.1021/jm0409019; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; GRIGNON DJ, 1994, MODERN PATHOL, V7, P186; Gu JY, 2003, TRENDS GENET, V19, P63, DOI 10.1016/S0168-9525(02)00040-9; Han SH, 2010, MOL BIOL REP, V37, P467, DOI 10.1007/s11033-009-9644-x; Helbok R, 2009, CRIT CARE MED, V37, pA155; Hiramoto S, 1997, BIOCHEM BIOPH RES CO, V241, P439, DOI 10.1006/bbrc.1997.7768; HUANG J, 2010, OPEN GENOMICS J, V3, P1; Huang JX, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-50; Huang RQ, 2009, J CEREBR BLOOD F MET, V29, P1914, DOI 10.1038/jcbfm.2009.104; Inoue H, 1997, EXP HEMATOL, V25, P935; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Jiang Dong-dong, 2007, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V29, P528; Jowsey IR, 2003, BIOCHEM BIOPH RES CO, V312, P1226, DOI 10.1016/j.bbrc.2003.11.068; Kaminsky Y, 2009, BRAIN RES, V1294, P193, DOI 10.1016/j.brainres.2009.07.082; Koebmann B, 2006, IEE P SYST BIOL, V153, P346, DOI 10.1049/ip-syb:20060022; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; LAMANDE N, 1995, MOL REPROD DEV, V41, P306, DOI 10.1002/mrd.1080410305; Li QA, 2006, BIOCHEM BIOPH RES CO, V340, P845, DOI 10.1016/j.bbrc.2005.12.067; MATRANGA V, 1993, CELL MOL NEUROBIOL, V13, P137, DOI 10.1007/BF00735370; Odetallah NH, 2002, POULTRY SCI, V81, P1322, DOI 10.1093/ps/81.9.1322; OKAMURA N, 1995, MOL REPROD DEV, V42, P141, DOI 10.1002/mrd.1080420203; PETERSON CA, 1992, DEV BIOL, V151, P626, DOI 10.1016/0012-1606(92)90201-Q; Preuss TM, 2002, CEREB CORTEX, V12, P671, DOI 10.1093/cercor/12.7.671; Racanicchi L, 2008, MOL CELL BIOCHEM, V308, P17, DOI 10.1007/s11010-007-9606-3; Scharmach E, 2009, TOXICOLOGY, V265, P122, DOI 10.1016/j.tox.2009.09.017; SCHILLING K, 1989, J NEUROSCI RES, V24, P347, DOI 10.1002/jnr.490240302; Schnekenburger M, 2006, LEUKEMIA RES, V30, P561, DOI 10.1016/j.leukres.2005.08.023; Schnekenburger M, 2004, BIOCHEM PHARMACOL, V68, P1269, DOI 10.1016/j.bcp.2004.03.047; Sha J, 2003, MICROB PATHOGENESIS, V34, P195, DOI 10.1016/S0882-4010(03)00028-7; Shield AJ, 2001, ENVIRON MOL MUTAGEN, V37, P285, DOI 10.1002/em.1034; Stefan C, 1998, HEPATOLOGY, V28, P1497, DOI 10.1002/hep.510280608; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; SUN Y, 2008, FRONTIERS ELECT ELEC, V3, P381, DOI DOI 10.1007/SCIENCE11460-008-0086-3; Sun Y, 2010, CELL BIOCHEM BIOPHYS, V56, P59, DOI 10.1007/s12013-009-9071-6; Tamura Y, 2007, NEUROSCIENCE, V148, P535, DOI 10.1016/j.neuroscience.2007.06.026; Teste MA, 2000, FEMS MICROBIOL LETT, V193, P105, DOI 10.1111/j.1574-6968.2000.tb09410.x; Tian Y, 2008, CANCER SCI, V99, P2428, DOI 10.1111/j.1349-7006.2008.01019.x; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Van Den Heuvel RL, 1999, TOXICOL IN VITRO, V13, P605, DOI 10.1016/S0887-2333(99)00019-3; Vecchini F, 1997, CELL GROWTH DIFFER, V8, P261; Wang L, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/726728; Wang L, 2011, J CELL BIOCHEM, V112, P1286, DOI 10.1002/jcb.23030; Wang L, 2010, CELL PHYSIOL BIOCHEM, V26, P303, DOI 10.1159/000320553; Wang L, 2010, TUMOR BIOL, V31, P417, DOI 10.1007/s13277-010-0050-8; Wang L, 2009, CANCER INVEST, V27, P816, DOI 10.1080/07357900802672753; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Yu IT, 2008, CHEM-BIOL INTERACT, V174, P118, DOI 10.1016/j.cbi.2008.05.011; Yue W, 2004, INT J CANCER, V108, P189, DOI 10.1002/ijc.11536; Zhu LA, 2009, EXP MOL PATHOL, V87, P27, DOI 10.1016/j.yexmp.2009.05.002	64	16	16	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	DEC	2011	61	3					493	505		10.1007/s12013-011-9232-2			13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	849ZE	WOS:000297163300004	21735130				2021-06-18	
J	Vandromme, MJ; Melton, SM; Griffin, R; McGwin, G; Weinberg, JA; Minor, M; Rue, LW; Kerby, JD				Vandromme, Marianne J.; Melton, Sherry M.; Griffin, Russell; McGwin, Gerald; Weinberg, Jordan A.; Minor, Michael; Rue, Loring W., III; Kerby, Jeffrey D.			Intubation Patterns and Outcomes in Patients With Computed Tomography-Verified Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Intubation; Prehospital care	GLASGOW COMA SCALE; PREHOSPITAL ENDOTRACHEAL INTUBATION; SCORE; FIELD; CLASSIFICATION; MORTALITY; SURVIVAL; ALCOHOL	Background: Studies evaluating traumatic brain injury (TBI) patients have shown an association between prehospital (PH) intubation and worse outcomes. However, previous studies have used surrogates, e. g., Glasgow Coma Scale (GCS) score <= 8 and Abbreviated Injury Severity Scale (AIS) score >= 3, which may overestimate the true presence of TBI. This study evaluated the impact of PH intubation in patients with PH GCS score <8 and radiographically proven TBI. Methods: Trauma patients routed to a Level I trauma center over a 3-year period with blunt injury and PH GCS score <= 8 were included. PH and in-hospital records were linked and head computed tomography scans were assigned a Marshall Score (MS). Patients with TBI (MS >1) were categorized into groups based on intubation status (PH, emergency department [ED], and no intubation). Comparisons were made using analysis of variance and chi(2) statistics. Mortality differences, crude and adjusted risk ratios (RRs), and 95% confidence intervals (CIs) were calculated using proportions hazards modeling. Results: Of 334 patients with PH GCS score <= 8, 149 (50%) had TBI by MS. Among the TBI patients, 42.7% of patients were PH intubated, 47.7% were ED intubated, and 9.4% were not intubated during the initial resuscitation. Intubated patients had lower ED GCS score (PH: 4.1 and ED: 5.9 vs. 14.0; p < 0.0001) compared with patients not intubated. Also PH intubated patients had higher mean Injury Severity Score (38.0 vs. 33.7 vs. 23.5, p < 0.001) when compared with ED intubated and nonintubated patients. None of the nonintubated patients had a MS >2. Mortality for TBI patients who required PH intubation was 46.9% and 41.4% among ED-intubated patients. The crude RR of mortality for PH compared with ED intubation was 1.13 (95% CI, 0.68 - 1.89), and remained nonsignificant (RR, 0.68; 95% CI, 0.36 - 1.19) when adjusted for key markers of injury severity. Conclusions: Patients with PH GCS score <= 8 and proven TBI had a high overall rate of intubation (>90%). PH intubation seems to be a marker for more severe injury and conveyed no increased risk for mortality over ED intubation.	[Vandromme, Marianne J.; Melton, Sherry M.; Griffin, Russell; McGwin, Gerald; Rue, Loring W., III; Kerby, Jeffrey D.] Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA; [Weinberg, Jordan A.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN USA; [Minor, Michael] Univ Alabama Birmingham, Birmingham Reg Emergency Med Serv Syst, Birmingham, AL 35294 USA	Kerby, JD (corresponding author), Univ Alabama Birmingham, Dept Surg Emergency Med & Mech Engn, Alabama Resuscitat Ctr, Sect Trauma Burns & Crit Care, LHRB 112,701 19th St S, Birmingham, AL 35294 USA.	jeffrey.kerby@ccc.uab.edu					Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baker CC, 2005, J TRAUMA, V58, P723; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Chesnut RM, 2008, J TRAUMA, V65, P500, DOI 10.1097/TA.0b013e31818020b3; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	24	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1615	1619		10.1097/TA.0b013e31822a30a1			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	869RT	WOS:000298616400031	21841511				2021-06-18	
J	Baker, AJ; Topolovec-Vranic, J; Michalak, A; Pollmann-Mudryj, MA; Ouchterlony, D; Cheung, B; Tien, HC				Baker, Andrew J.; Topolovec-Vranic, Jane; Michalak, Alicja; Pollmann-Mudryj, Mary-Ann; Ouchterlony, Donna; Cheung, Bob; Tien, Homer C.			Controlled Blast Exposure During Forced Explosive Entry Training and Mild Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Adult; Blast injuries; Humans; Traumatic brain injury	POSTURAL STABILITY; HEAD-INJURY; PERFORMANCE; HISTORY	Background: There is a paucity of data regarding the pathophysiology and short- and long-term neurologic consequences of primary blast injury in humans. The purpose of this investigation was to test the feasibility of implementing a research protocol in the context of a forced explosive entry training course. Methods: Instructors (n = 4) and students (n = 10) completing the Police Explosives Technicians-Forced Entry Instructors course were recruited to participate in the study. Participants underwent a physical examination, tests of postural stability and vestibular ataxia, and a neurocognitive battery 1 day before and 10 days following practical forced explosive entry exercises. Results: The instructors reported significantly more blast exposures in their careers than the students (p < 0.05). Seventy-five percent of the instructors and 50% of the students reported a history of trauma to the head. A minority of the participants had deficits on cranial nerve, vestibular ataxia, and neurocognitive tests which did not change significantly postexposure. All the instructors and most of the students (90%) demonstrated postural stability deficits at baseline which did not change significantly postexposure. Conclusions: Studying the effects of blast exposure on the human brain in a controlled experimental setting is not possible. Forced explosive entry training courses afford an opportunity to begin examining this issue in real time in a controlled setting. This study underscores the importance of baseline testing of troops, of the consideration of subclinical implications of blast exposure, and of continued studies of the effects of blast exposures, including repeated exposures on the human brain.	[Tien, Homer C.] Sunnybrook Hlth Sci Ctr, Trauma Program, Dept Surg, Toronto, ON M4N 3M5, Canada; [Baker, Andrew J.] Univ Toronto, Dept Anesthesia, Interdept Div Crit Care Med, Toronto, ON, Canada; [Baker, Andrew J.] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane; Michalak, Alicja; Pollmann-Mudryj, Mary-Ann; Ouchterlony, Donna] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Cheung, Bob] Def Res & Dev Canada, Toronto, ON, Canada	Tien, HC (corresponding author), Sunnybrook Hlth Sci Ctr, Trauma Program, Dept Surg, H186-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	homer.tien@sunnybrook.ca	Pollmann-Mudryj, Mary Ann/AAC-9047-2019; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212; Pollmann-Mudryj, Mary Ann/0000-0003-2244-8116	Canadian Forces Health Services	Supported by Canadian Forces Health Services.	ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Benton A., 1994, MULTILINGUAL APHASIA; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI 10.1089/neu.2009-0885; CAEYENBERGHS K, 2009, HUM BRAIN MAPP; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Graybiel A, 1966, Acta Otolaryngol, V61, P292, DOI 10.3109/00016486609127066; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Halstead WC, 1985, HALSTEAD REITAN NEUR; Heaton RK, 2004, REVISED COMPREHENSIV; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; McHugh T, 2006, BRAIN COGNITION, V60, P209; McMinn M. R., 1988, CLIN NEUROPSYCHOL, V2, P67, DOI [10.1080/13854048808520087, DOI 10.1080/13854048808520087]; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Smith A., 1991, SYMBOL DIGIT MODALIT; STRAUS E, 2006, COMPENDIUM NEUROPSYC; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Westerman R, 2001, ADF HLTH, V2, P29	32	16	16	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71			1			S472	S477		10.1097/TA.0b013e318232e7da			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	849GE	WOS:000297112800015	22072006				2021-06-18	
J	Debenham, S; Sabit, B; Saluja, RS; Lamoureux, J; Bajsarowicz, P; Maleki, M; Marcoux, J				Debenham, Sierra; Sabit, Behzad; Saluja, Rajeet S.; Lamoureux, Julie; Bajsarowicz, Paul; Maleki, Mohammad; Marcoux, Judith			A Critical Look at Phenytoin Use for Early Post-Traumatic Seizure Prophylaxis	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; RISK-FACTORS; TOMOGRAPHY; EPILEPSY; CLASSIFICATION	Backround: The American Academy of Neurology recommended using phenytoin or carbamazepine to prevent early post-traumatic seizures (PTS) in severe traumatic brain injuries (TBI). In this study, we examined the effects of using phenytoin prophylaxis on mild, moderate, and severe TBIs. There have been no studies looking at compliance rate and side effects of systematic use of phenytoin at a large population scale. The goal of this study is to determine 1) the proportion of TBI patients receiving phenytoin prophylaxis; 2) which parameters decided when to decide administer phenytoin; 3) prophylaxis efficacy and complication rate. Methods: We retrospectively studied all patients admitted with a TBI over a two year-period and collected the following information: age, GCS score, CT-scan Marshall grade, incidence of early PTS, incidence of phenytoin use and time delay, side effects, and incidence of over-dosage or under-dosage. Results: 1008 patients were included. 5.4% had early PTS, 2.3 % while on prophylaxis and 3.1% while not on prophylaxis, 1.9% before reaching the hospital and 1.2% prior to phenytoin administration while in hospital. Delay of administration was 5 hours. 64.8% received prophylaxis and physicians used positive CT scan as the primary decision-making parameter (p<.001). Compliance with guidelines was 99.7%. Adverse reactions occurred in 0.5%. Levels were drawn in 42.2% (52% therapeutic, 41% low, 7% high). Conclusions: Phenytoin is used according to guidelines, with CT scan being the main decision factor for its use. The frequency of early PTS rate is low and side effects are rare. However, earlier administration of phenytoin and adequate levels could further prevent early PTS.	[Maleki, Mohammad; Marcoux, Judith] McGill Univ, Dept Neurosurg, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Sabit, Behzad] McGill Univ, Fac Med, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Saluja, Rajeet S.] McGill Univ, Montreal Neurol Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Bajsarowicz, Paul] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Debenham, Sierra] Bringham Young Univ, Provo, UT USA	Marcoux, J (corresponding author), McGill Univ, Dept Neurosurg, Montreal Gen Hosp, Ctr Hlth, 1650 Cedar Ave,Room L7-524, Montreal, PQ H3G 1A4, Canada.						Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; *BRAIN TRAUM FDN G, 2007, J NEUROTRAUM S1, pS83; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Grisar T, 2005, ACTA NEUROL BELG, V105, P5; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; Hess Dean R, 2004, Respir Care, V49, P1171; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jacka MJ, 2007, CAN J NEUROL SCI, V34, P307, DOI 10.1017/S0317167100006727; Khan AA, 2010, INT J EMERG MED, V3, P187, DOI 10.1007/s12245-010-0180-1; Liberman M, 2004, J TRAUMA, V56, P1330, DOI 10.1097/01.TA.0000071297.76727.8B; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; *MIN HLTH SERV, 2002, GUID PLANN BRAIN INJ; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; TEASDALE G, 1974, LANCET, V2, P81; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006	26	16	17	0	4	CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC	CALGARY	709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2011	38	6					896	901		10.1017/S031716710001249X			6	Clinical Neurology	Neurosciences & Neurology	853AE	WOS:000297397800017	22030429	Bronze			2021-06-18	
J	Barabasz, AF; Barabasz, M; Watkins, JG				Barabasz, Arreed F.; Barabasz, Marianne; Watkins, John G.			SINGLE-SESSION MANUALIZED EGO STATE THERAPY (EST) FOR COMBAT STRESS INJURY, PTSD, AND ASD, PART 1: The Theory	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL HYPNOSIS			English	Article							POSTTRAUMATIC-STRESS; AGE REGRESSION; DISORDER; HYPNOSIS; HYPNOTIZABILITY	Ego state therapy (EST) evolved from a psychodynamic understanding of personality as a product of an individual's ego states to a conceptualization of how ego-energized and object-energized elements are bound together to cope with a traumatic event. Neurobiological studies now substantiate Watkins's war neuroses conceptualizations. Because of their severity, trauma memories are encoded in the subcortical-subconscious brain regions that are accessed by the single-session manualized EST procedure but not by the popular cognitive-behavioral management therapies. The imprint of the trauma is not accessible or resolvable by such top-down verbal understanding or reframing; EST is a bottom-up therapy. Abreactive hypnosis facilitates ego state expression at physiologically and psychologically intense levels sufficient to activate subcortical processes to release affect in the presence of the therapist, who adds ego strength to the patient. This is followed by interpretation and reintegration. The result is a reconstructed personality that is adaptive and resilient.	[Barabasz, Arreed F.; Barabasz, Marianne] Washington State Univ, Pullman, WA 99163 USA; [Watkins, John G.] Univ Montana, Missoula, MT 59812 USA	Barabasz, AF (corresponding author), Washington State Univ, Cleveland Hall,POB 642136, Pullman, WA 99163 USA.	arreed_barabasz@wsu.edu					Abramowitz EG, 2010, INT J CLIN EXP HYP, V58, P316, DOI 10.1080/00207141003760926; Barabasz A., 2008, 5 GERM NEP INT MED C; BARABASZ A, INT J CLIN IN PRESS; Barabasz A., 2008, GERM ANN NAT HYPN C; Barabasz A., 2011, EGO STATE THERAPY MA; Barabasz A, 2006, AM J CLIN HYPN, V48, P251, DOI 10.1080/00029157.2006.10401532; Barabasz A, 2010, MEDICAL HYPNOSIS PRIMER: CLINICAL AND RESEARCH EVIDENCE, P1; Christensen C., INT J CLIN IN PRESS; Christensen C, 2009, INT J CLIN EXP HYP, V57, P402, DOI 10.1080/00207140903098817; Connor K. M., 2003, FOCUS, VI, P247, DOI DOI 10.1176/F0C.1.3.247; Emmerson G., 2003, EGO STATE THERAPY; Emmerson G., 2006, ADV SKILLS INTERVENT; Everly G. S., 1999, CRITICAL INCIDENT ST; Federn P, 1952, EGO PSYCHOL PSYCHOSE; Figley C.R., 2007, COMBAT STRESS INJURY; Foa EB, 2007, PROLONGED EXPOSURE T; Frederick C, 2005, INT J CLIN EXP HYP, V53, P339, DOI 10.1080/00207140591007518; Hilgard E. R, 1986, DIVIDED CONSCIOUSNES; Hinterberger T, 2011, INT J CLIN EXP HYP, V59, P165, DOI 10.1080/00207144.2011.546188; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Hunter M., 2008, HEALING SCRIPTS USIN; JACKSON JH, 1958, SELECTED WRITINGS J, P45; Keuroghlian AS, 2010, INT J CLIN EXP HYP, V58, P39, DOI 10.1080/00207140903310790; Krakauer S, 2008, INT J CLIN EXP HYP, V57, P47, DOI 10.1080/00207140802463633; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P853, DOI 10.1016/j.biopsych.2004.08.003; LITZ BT, 1992, CLIN PSYCHOL REV, V12, P417, DOI 10.1016/0272-7358(92)90125-R; Lynn SJ, 2007, INT J CLIN EXP HYP, V55, P167, DOI 10.1080/00207140601177905; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Panksepp J., 1994, TXB BIOL PSYCHIAT, P319; Patterson DR, 2010, INT J CLIN EXP HYP, V58, P288, DOI 10.1080/00207141003760595; Spiegel D, 1992, Psychiatr Med, V10, P21; Spiegel D., 2007, AM SOC CLIN HYPN ASC; Spiegel H, 2004, TRANCE TREATMENT CLI; Tobis IP, 2010, INT J CLIN EXP HYP, V58, P367, DOI 10.1080/00207144.2010.499330; Van der Kolk B., 2007, I ADV HUM BEH SEATTL; Vermetten E, 2010, MEDICAL HYPNOSIS PRIMER: CLINICAL AND RESEARCH EVIDENCE, P41; Watkins H. H., 1978, THERAPEUTIC SELF, P360; Watkins J. G., 1982, NEWER THERAPIES SOUR, P137; Watkins J. G., 1979, SHORT TERM APPROACHE, P176; Watkins J. G., 1951, J PERS, V1, P318; Watkins J. G., 1949, HYPNOTHERAPY WAR NEU; Watkins J. G., 1997, EGO STATES THEORY TH; Watkins J. G., 2008, ADV HYPNOTHERAPY HYP; Watkins J. G., 1986, HDB STATES CONSCIOUS, P133; Watkins JG, 1942, J CONSULT PSYCHOL, V6, P117, DOI 10.1037/h0056480; Weiss E., 1960, STRUCTURE DYNAMICS H; Yard SS, 2008, INT J CLIN EXP HYP, V56, P334, DOI 10.1080/00207140802042007	48	16	17	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7144	1744-5183		INT J CLIN EXP HYP	Int. J. Clin. Exp. Hypn.	OCT-DEC	2011	59	4					379	391		10.1080/00207144.2011.595349			13	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	826YT	WOS:000295392200001	21867374				2021-06-18	
J	Harned, ME; Salles, SS; Grider, JS				Harned, Michael E.; Salles, Sara S.; Grider, Jay S.			An Introduction to Trialing Intrathecal Baclofen in Patients with Hemiparetic Spasticity: A Description of 3 Cases	PAIN PHYSICIAN			English	Article						Baclofen; intrathecal drug delivery; spasticity; multiple sclerosis; traumatic brain injury	CEREBRAL-PALSY; THERAPY; MANAGEMENT; CHILDREN; PUMP; METHYLPREDNISOLONE; GUIDELINES; WITHDRAWAL; ZICONOTIDE; EFFICACY	Background: Intrathecal baclofen has been an effective therapy in the management of spasticity. As interventional pain physicians are rapidly becoming the experts in intrathecal drug delivery, they are now frequently asked to trial and implant intrathecal baclofen therapy. While some physicians might be very comfortable with the process of trialing and implanting, others will have next to no experience until the first consult appears on their desks. While uncomplicated lower extremity spasticity can usually be trialed with a single-shot bolus injection, more complicated cases of upper and lower extremities or hemiparetic spasticity need a more delicate approach. This is the first case series in the literature reporting a trial using an indwelling temporary catheter and inpatient admission. Moreover, while the technical aspects of intrathecal therapy trialing and implantation might be familiar for the interventional physician, we review the indications and goals of therapy, about which the physician may be less familiar. Objective: To present a technique for trialing intrathecal baclofen in patients with severe upper and lower extremities spasticity complication for which a single shot technique may be inadequate. Design: Case report of three patients. Setting: Tertiary-care referral medical center. Patients: A 30-year-old man with severe spasticity of the right upper and lower extremities with preserved left-sided function due to diffuse axonal injury. A 45-year-old woman with traumatic brain injury and severe spasticity of the left upper extremity with minimal dysfunction in the right upper extremity. A 34-year-old woman with Multiple Sclerosis and severe spasticity in the right upper extremity and bilateral lower extremities. Intervention: Placement of a temporary intrathecal catheter and an inpatient trial of intrathecal baclofen. Results: In all patients, there was significant improvement in spasticity as documented by decreased Modified Ashworth Scale scores while preserving motor strength and coordination in the unaffected extremities. Limitations: Retrospective review of 3 cases in a single center. Conclusions: Trialing for baclofen is usually performed as a single shot bolus. For patients with severe hemiparetic spasticity or in patients where weakness in the unaffected limb might significantly affect quality of life, this trialing technique may be inadequate. In these patients, placement of a temporary intrathecal catheter and inpatient admission may be a more effective trial method.	[Harned, Michael E.] Univ Kentucky, Coll Med, Dept Anesthesiol, Div Pain Med, Lexington, KY 40536 USA; [Salles, Sara S.] Univ Kentucky, Dept Phys Med & Rehabil, Lexington, KY 40536 USA	Harned, ME (corresponding author), Univ Kentucky, Coll Med, Dept Anesthesiol, Div Pain Med, 800 Rose St,Suite N 201, Lexington, KY 40536 USA.	meharn2@email.uky.edu					ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; ALBRIGHT AL, 1995, CNS DRUGS, V4, P17, DOI 10.2165/00023210-199504010-00003; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Awaad Y, 2003, J CHILD NEUROL, V18, P26, DOI 10.1177/08830738030180010701; Burton AW, 2010, PAIN PHYSICIAN, V13, P23; Coffey RJ, 2002, ARCH PHYS MED REHAB, V83, P735, DOI 10.1053/apmr.2002.32820; Damiano DL, 2002, DEV MED CHILD NEUROL, V44, P112, DOI 10.1017/S0012162201001761; Deer T, 2009, PAIN PHYSICIAN, V12, pE291; Deer TR, 2011, PAIN PHYSICIAN, V14, pE283; Deer TR, 2010, PAIN PHYSICIAN, V13, pE1750; Dureja GP, 2010, PAIN PHYSICIAN, V13, P213; Fluckiger B, 2008, SPINAL CORD, V46, P639, DOI 10.1038/sc.2008.24; Grabb PA, 1999, NEUROSURGERY, V45, P833, DOI 10.1097/00006123-199910000-00020; Green LB, 1999, ARCH PHYS MED REHAB, V80, P1600, DOI 10.1016/S0003-9993(99)90337-4; Haley SM, 1990, PRACTICAL MANAGEMENT, P115; Hayek SM, 2011, PAIN PHYSICIAN, V14, P219; Kapoor R, 2010, PAIN PHYSICIAN, V13, pE321; Krach LE, 2001, J CHILD NEUROL, V16, P31, DOI 10.1177/088307380101600106; Lima RM, 2010, PAIN PHYSICIAN, V13, P493; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P699; Murphy NA, 2002, ARCH PHYS MED REHAB, V83, P1721, DOI 10.1053/apmr.2002.36068; Patel VB, 2009, PAIN PHYSICIAN, V12, P345; PENN RD, 1984, LANCET, V1, P1078; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Raffaeli W, 2011, PAIN PHYSICIAN, V14, P15; Rawicki B, 1999, J NEUROSURG, V91, P733, DOI 10.3171/jns.1999.91.5.0733; Ruan XL, 2010, PAIN PHYSICIAN, V13, P337; Steinbok P, 2000, Clin Neurosurg, V47, P440; Wilkes D, 2010, PAIN PHYSICIAN, V13, P151	30	16	16	0	1	AM SOC INTERVENTIONAL PAIN PHYSICIANS	PADUCAH	81 LAKEVIEW DR, PADUCAH, KY 42001 USA	1533-3159			PAIN PHYSICIAN	Pain Physician	SEP-OCT	2011	14	5					483	489					7	Anesthesiology; Clinical Neurology	Anesthesiology; Neurosciences & Neurology	885MW	WOS:000299784100017	21927053				2021-06-18	
J	Ranaivo, HR; Zunich, SM; Choi, N; Hodge, JN; Wainwright, MS				Ranaivo, Hantamalala Ralay; Zunich, Samantha M.; Choi, Nicole; Hodge, Jessica N.; Wainwright, Mark S.			Mild Stretch-Induced Injury Increases Susceptibility to Interleukin-1 beta-Induced Release of Matrix Metalloproteinase-9 from Astrocytes	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; interleukin-1 beta; mechanical stretch; metalloproteinease-9; mitogen protein-activated kinase	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; ACTIVATED PROTEIN-KINASE; GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; PROINFLAMMATORY CYTOKINE; CULTURED ASTROCYTES; REACTIVE ASTROCYTES; EXTRACELLULAR ATP; BARRIER	Traumatic brain injury (TBI) results in the activation of glia and the release of proinflammatory cytokines, including interleukin (IL)-1 beta. The response of astrocytes to mild TBI has not been well studied. We used an in vitro model of cell stretch to investigate the effects of mild mechanical insult on astrocyte injury (lactate dehydrogenase and propidium iodide), and on mediators of inflammation including IL-1 beta, the chemokine CX3CL1, and nitrite. Here, we tested the hypothesis that a mild mechanical insult would increase susceptibility of astrocytes to delayed exposure to IL-1 beta, including enhanced release of the matrix metalloproteinease-9 (MMP-9). We investigated the role of the mitogen protein-activated kinase (MAPK) pathway in these responses. Cells subjected to a mild stretch show an increase in activation of the ERK1/2 and JNK pathways, and an increase in lactate dehydrogenase (LDH), but no change in the levels of inflammatory mediators. An early increase in LDH was dependent on ERK activation. Exposure to IL-1 beta, or to stretch alone, did not increase MMP-9. In contrast, the combination of mild stretch followed by IL-1 beta resulted in greater activation of the ERK pathway compared to either stimulus alone, and also resulted in an increase in the production of MMP-9 by astrocytes. Inhibition of the ERK pathway suppressed the increase in MMP-9 induced by the combination of stretch and IL-1 beta treatment. These results suggest that a primary mild mechanical injury renders astrocytes more susceptible to a secondary exposure to a proinflammatory cytokine such as IL-1 beta via the activation of the ERK pathway, and suggest a mechanism by which a mild head injury may confer increased susceptibility to neurologic injury caused by a subsequent insult.	[Ranaivo, Hantamalala Ralay; Zunich, Samantha M.; Choi, Nicole; Hodge, Jessica N.; Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Neurol, Chicago, IL 60611 USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Crit Care Med, Chicago, IL 60611 USA; [Ranaivo, Hantamalala Ralay; Zunich, Samantha M.; Choi, Nicole; Hodge, Jessica N.; Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Ctr Interdisciplinary Res Pediat Crit Illness & I, Chicago, IL 60611 USA	Wainwright, MS (corresponding author), Childrens Mem Hosp, Div Neurol 51, 2300 Childrens Plaza, Chicago, IL 60614 USA.	m-wainwright@northwestern.edu		Rubens, Jessica/0000-0001-9198-9149	Medical Research Junior Board Foundation; Lyndsey Whittingham Foundation	Dr. Wainwright is supported by the Medical Research Junior Board Foundation, and by the Lyndsey Whittingham Foundation.	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Asahi M, 2001, J NEUROSCI, V21, P7724; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Floyd CL, 2004, J NEUROTRAUM, V21, P205, DOI 10.1089/089771504322778668; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Heida JG, 2005, EPILEPSIA, V46, P1906, DOI 10.1111/j.1528-1167.2005.00294.x; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hooper C, 2009, J NEUROCHEM, V109, P694, DOI 10.1111/j.1471-4159.2009.05953.x; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee J, 2002, NEUROMOL MED, V2, P29; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neary JT, 2005, IUBMB LIFE, V57, P711, DOI 10.1080/15216540500319143; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Ranaivo HR, 2010, EXP NEUROL, V226, P310, DOI 10.1016/j.expneurol.2010.09.005; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; TOTH M, 2001, METASTASIS RES PROTO, P163; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zhou H, 2011, NEUROCHEM RES, V36, P17, DOI 10.1007/s11064-010-0254-8; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	55	16	17	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1757	1766		10.1089/neu.2011.1799			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000009	21732764				2021-06-18	
J	Shi, J; Tu, JL; Gale, SD; Baxter, L; Vollmer, TL; Campagnolo, DI; Tyry, TM; Zhuang, Y; Kuniyoshi, SM				Shi, Jiong; Tu, Jiang-Long; Gale, Shawn D.; Baxter, Leslie; Vollmer, Timothy L.; Campagnolo, Denise I.; Tyry, Tuula M.; Zhuang, Yi; Kuniyoshi, Sandra M.			APOE epsilon 4 Is Associated With Exacerbation of Cognitive Decline in Patients With Multiple Sclerosis	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						multiple sclerosis; cognition; apolipoprotein E; neuroimmunology	APOLIPOPROTEIN-E EPSILON-4; TRAUMATIC BRAIN-INJURY; GREY-MATTER PATHOLOGY; DEEP GRAY-MATTER; ALZHEIMERS-DISEASE; VOLUME CHANGES; E GENOTYPE; FOLLOW-UP; IMPAIRMENT; ATROPHY	Background: In previous studies we and others have demonstrated an association with apolipoprotein (APOE) epsilon 4 genotype and the presence of cognitive deficits in multiple sclerosis (MS). In this follow-up study, we have assessed whether APOE epsilon 4 status exacerbates progression of cognitive deficits in MS. Methods: A total of 197 patients with MS were assessed for APOE genotype, and baseline cognitive performance was measured using a standardized battery of tests. One hundred seventy patients (86.3%) were clinically followed up for 1 year and were assessed for progression of cognitive deficits. Results: The APOE epsilon 4 allele was present in 24.7% of patients. During 1-year follow-up, significant progression of cognitive deficits was found in APOE epsilon 4 carriers (P = 0.001) after logistic regression analysis controlling for sex, ethnicity, age, education, disease duration, severity, and subtype. Conclusions: APOE epsilon 4 carriers with MS have worsening progression of cognitive deficits than noncarriers. APOE epsilon 4 carrier status predicts cognitive decline in verbal learning and memory.	[Shi, Jiong; Tu, Jiang-Long; Campagnolo, Denise I.; Tyry, Tuula M.] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA; [Gale, Shawn D.; Baxter, Leslie] St Josephs Hosp, Barrow Neurol Inst, Div Neuropsychol, Phoenix, AZ 85013 USA; Med Ctr, Phoenix, AZ 85013 USA; [Shi, Jiong; Zhuang, Yi; Kuniyoshi, Sandra M.] Arizona State Univ, Dept Biostat, Tempe, AZ 85287 USA; [Vollmer, Timothy L.] Univ Colorado Hlth Sci, Dept Neurol, Denver, CO USA	Shi, J (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 500 W Thomas Rd,Suite 720, Phoenix, AZ 85013 USA.	jiong.shi@chw.edu	Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society; Barrow Neurological Foundation	Supported by a Pilot Research Award from the National Multiple Sclerosis Society and Barrow Neurological Foundation.	Achiron A, 2005, J NEUROL NEUROSUR PS, V76, P744, DOI 10.1136/jnnp.2004.045518; Agosta F, 2009, P NATL ACAD SCI USA, V106, P2018, DOI 10.1073/pnas.0812697106; Amato MP, 2008, NEUROLOGY, V70, P1891, DOI 10.1212/01.wnl.0000312276.23177.fa; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; AMATO MP, 1995, ARCH NEUROL-CHICAGO, V52, P168, DOI 10.1001/archneur.1995.00540260072019; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Bakshi R, 2002, ARCH NEUROL-CHICAGO, V59, P62, DOI 10.1001/archneur.59.1.62; Ballard CG, 2004, NEUROLOGY, V63, P1399; Bircher A U, 1975, Nurs Forum, V14, P11; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Bo L, 2007, ARCH NEUROL-CHICAGO, V64, P76, DOI 10.1001/archneur.64.1.76; Burwick RM, 2006, NEUROLOGY, V66, P1373, DOI 10.1212/01.wnl.0000210531.19498.3f; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chard DT, 2003, J NEUROL NEUROSUR PS, V74, P1551, DOI 10.1136/jnnp.74.11.1551; Corona T, 2010, REV NEUROLOGIA, V50, P19, DOI 10.33588/rn.5001.2008129; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; Devanand DP, 2005, ARCH NEUROL-CHICAGO, V62, P975, DOI 10.1001/archneur.62.6.975; Duquin JA, 2008, J INT NEUROPSYCH SOC, V14, P494, DOI 10.1017/S1355617708080624; Ely EW, 2007, CRIT CARE MED, V35, P112, DOI 10.1097/01.CCM.0000251925.18961.CA; Evangelou N, 1999, J NEUROL NEUROSUR PS, V67, P203, DOI 10.1136/jnnp.67.2.203; Fazekas F, 2001, NEUROLOGY, V57, P853, DOI 10.1212/WNL.57.5.853; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; FISNIKU LK, 2008, ANN NEUROL; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Ghaffar O, 2010, NEUROLOGY, V74, P1611, DOI 10.1212/WNL.0b013e3181e074a7; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guerrero AL, 2008, ACTA NEUROL SCAND, V117, P21, DOI 10.1111/j.1600-0404.2007.00908.x; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; HIXSON JE, 1990, J LIPID RES, V31, P545; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Hoyt BD, 2005, ARCH NEUROL-CHICAGO, V62, P454, DOI 10.1001/archneur.62.3.454; Koutsis G, 2007, NEUROLOGY, V68, P546, DOI 10.1212/01.wnl.0000254468.51973.44; MacPherson D, 2007, CANCER RES, V67, P7547, DOI 10.1158/0008-5472.CAN-07-0276; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Marrie RA, 2007, MULT SCLER, V13, P770, DOI 10.1177/1352458506075031; Martins CAR, 2005, NEUROLOGY, V65, P1888, DOI 10.1212/01.wnl.0000188871.74093.12; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Parmenter BA, 2007, MULT SCLER J, V13, P25, DOI 10.1177/1352458506070682; Peterson LK, 2007, J NEUROIMMUNOL, V184, P37, DOI 10.1016/j.jneuroim.2006.11.015; Pham T, 2005, BIOCHEMISTRY-US, V44, P7577, DOI 10.1021/bi0472696; Pirko I, 2007, NEUROLOGY, V68, P634, DOI 10.1212/01.wnl.0000250267.85698.7a; Portaccio E, 2009, ACTA NEUROL SCAND, V120, P439, DOI 10.1111/j.1600-0404.2009.01278.x; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1995, CURR OPIN NEUROL, V8, P216, DOI 10.1097/00019052-199506000-00010; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Rudick RA, 2009, J NEUROL SCI, V282, P106, DOI 10.1016/j.jns.2008.11.018; Sedano MJ, 2006, MULT SCLER J, V12, P13, DOI 10.1191/135248506ms1243oa; Shi J, 2008, NEUROLOGY, V70, P185, DOI 10.1212/01.wnl.0000264004.62612.44; Stadelmann C, 2008, CURR OPIN NEUROL, V21, P229, DOI 10.1097/01.wco.0000318863.65635.9a; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tiberio M, 2005, NEUROLOGY, V64, P1001, DOI 10.1212/01.WNL.0000154526.22878.30; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tu JL, 2009, BIOCHEM BIOPH RES CO, V384, P466, DOI 10.1016/j.bbrc.2009.04.153; van der Walt A, 2009, NEUROLOGY, V73, P1018, DOI 10.1212/WNL.0b013e3181b9c85e; Vercellino M, 2005, J NEUROPATH EXP NEUR, V64, P1101, DOI 10.1097/01.jnen.0000190067.20935.42; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Wagle J, 2009, DEMENT GERIATR COGN, V27, P525, DOI 10.1159/000223230; Weisgraber KH, 1996, FASEB J, V10, P1485; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zivadinov R, 2001, J NEUROL NEUROSUR PS, V70, P773, DOI 10.1136/jnnp.70.6.773	66	16	19	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1543-3633			COGN BEHAV NEUROL	Cogn. Behav. Neurol.	SEP	2011	24	3					128	133		10.1097/WNN.0b013e31823380b5			6	Behavioral Sciences; Clinical Neurology	Behavioral Sciences; Neurosciences & Neurology	823YB	WOS:000295162800004	21945984				2021-06-18	
J	Wildner, G; Pauker, N; Archan, S; Gemes, G; Rigaud, M; Pocivalnik, M; Prause, G				Wildner, Gernot; Pauker, Nina; Archan, Sylvia; Gemes, Geza; Rigaud, Marcel; Pocivalnik, Mirjam; Prause, Gerhard			Arterial line in prehospital emergency settings - A feasibility study in four physician-staffed emergency medical systems	RESUSCITATION			English	Article						Advanced life support (ALS); Shock; Blood pressure; Blood gases; Monitoring; Emergency medical services	TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; HOSPITAL CARDIAC-ARREST; VENTILATION; CATHETERS; HYPOXIA; IMPACT; CARE; HYPERVENTILATION; CANNULATION		[Wildner, Gernot; Archan, Sylvia; Gemes, Geza; Rigaud, Marcel; Prause, Gerhard] Med Univ Graz, Dept Anaesthesiol & Intens Care Med, A-8036 Graz, Austria; [Pauker, Nina; Pocivalnik, Mirjam] Austrian Red Cross, Med Corps Graz, A-8010 Graz, Austria	Wildner, G (corresponding author), Med Univ Graz, Dept Anaesthesiol & Intens Care Med, Auenbruggerpl 29, A-8036 Graz, Austria.	gernot.wildner@medunigraz.at		Rigaud, Marcel/0000-0003-4015-0006			Abella BS, 2007, RESUSCITATION, V73, P54, DOI 10.1016/j.resuscitation.2006.10.027; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barone JE, 2006, J TRAUMA, V61, P468, DOI 10.1097/01.ta.0000229815.43871.59; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; Brzezinski M, 2009, ANESTH ANALG, V109, P1763, DOI 10.1213/ANE.0b013e3181bbd416; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Gerber DR, 1996, CHEST, V109, P761, DOI 10.1378/chest.109.3.761; GRONBECK C, 1993, CHEST, V104, P1716, DOI 10.1378/chest.104.6.1716; Konrad C, 1998, ANESTH ANALG, V86, P635; McSwain NE, 2004, J TRAUMA, V57, P8; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; PETERSON LH, 1949, AM HEART J, V37, P771, DOI 10.1016/0002-8703(49)90175-1; Prause G, 1998, ANAESTHESIST, V47, P400, DOI 10.1007/s001010050576; Prause G, 2001, RESUSCITATION, V51, P297, DOI 10.1016/S0300-9572(01)00424-5; Prause G, 1997, RESUSCITATION, V35, P145, DOI 10.1016/S0300-9572(97)00043-9; PRAUSE G, 2010, AM J EMERG MED, V28; Scheer BV, 2002, CRIT CARE, V6, P198, DOI 10.1186/cc1489; Shiver S, 2006, ACAD EMERG MED, V13, P1275, DOI 10.1197/j.aem.2006.07.015; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Tegtmeyer Ken, 2006, N Engl J Med, V354, pe13, DOI 10.1056/NEJMvcm044149; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Wildner G, 2008, NOTFALL RETTUNGSMED, V11, P353, DOI 10.1007/s10049-008-1091-z; Yeung J, 2009, RESUSCITATION, V80, P743, DOI 10.1016/j.resuscitation.2009.04.012	26	16	17	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	SEP	2011	82	9					1198	1201		10.1016/j.resuscitation.2011.05.002			4	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	820MO	WOS:000294910200020	21621893				2021-06-18	
J	Roscigno, CI; Swanson, KM; Vavilala, MS; Solchany, J				Roscigno, Cecelia I.; Swanson, Kristen M.; Vavilala, Monica S.; Solchany, Joanne			Children's longing for everydayness: Life following traumatic brain injury in the USA	BRAIN INJURY			English	Article						Adjustment; children; community integration; disability; head injury; psychology	QUALITY-OF-LIFE; DOWN-SYNDROME; INDIVIDUALS; PEDIATRICIANS; DISABILITY; MENINGOMYELOCELE; PROGNOSTICATIONS; PROFESSIONALS; SATISFACTION; SUICIDALITY	Primary objective: Little is known about life after traumatic brain injury (TBI) from the child's perspective. Research design: This descriptive phenomenological investigation explored themes of children's experiences following moderate-to-severe TBI. Research design: This descriptive phenomenological investigation explored themes of children's experiences following moderate-to-severe TBI. Methods and procedures: Inclusion criteria: (1) 6--18 years of age at injury; (2) moderate-to-severe TBI; (3) < a parts per thousand currency sign3 years since injury; and (4) English speaking and could participate in an interview. Children participated (n == 39) in two interviews at least 1 year apart. A preliminary model was developed and shared for participants'' input. Main outcomes and results: Six themes emerged: (1) it is like waking up in a bad dream; (2) I thought going home would get me back to my old life, but it did not; (3) everything is such hard work; (4) you feel like you will never be like the person you were before; (5) it is not all bad; and (6) some people get it, but many people do not. Conclusions: Social support was important to how children adjusted to changes or losses. Most children did adjust to functional changes by second interviews. Children had a more difficult time adjusting to how others defined them and limited their possibilities for a meaningful life.	[Roscigno, Cecelia I.] Univ Illinois, Coll Nursing, Chicago, IL USA; [Swanson, Kristen M.] Univ N Carolina, Sch Nursing, Chapel Hill, NC USA; [Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Solchany, Joanne] Univ Washington, Sch Nursing, Seattle, WA 98195 USA	Roscigno, CI (corresponding author), 845 S Damen Ave MC 802, Chicago, IL 60612 USA.	roscigno@uic.edu			Integra LifeSciences Corporation; NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [1 F31 NR009599-02]; Psi Chapter of Sigma Theta Tau Grant; American Nurses Foundation; University of Washington School of NursingUniversity of Washington; University of WashingtonUniversity of Washington [6 T73 MC 00041-11-03]; Irving B. Harris Foundation Faculty Scholars Initiative; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR009599, T32NR007091] Funding Source: NIH RePORTER	The first author received grant funding from Integra LifeSciences Corporation, but the authors alone are responsible for the research and content of this paper.; The authors would also like to acknowledge the following for their assistance with recruitment: the Rehabilitation Department at Seattle Children's; the University of Washington's Rehabilitation Department; the Florida Department of Health's Brain and Spinal Cord Injury Program (Ft. Lauderdale Region); the Harborview Medical Center Pediatric Trauma Registry; and the Brain Injury Association of USA. The authors would like to acknowledge Pamela Mitchell for her participation on the author's dissertation committee. Most of all, the authors would like to thank the children who shared their insights about living with TBI. The study received funding support from: a NINR Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02); a Psi Chapter of Sigma Theta Tau Grant; a 2006 American Nurses Foundation Martha E. Brill Scholars Award; a University of Washington School of Nursing Hester McLaws Scholarship Fund; a University of Washington LEND Training Grant (TG # 6 T73 MC 00041-11-03); the University of Washington Gatzert Child Welfare Fellowship; and an Integra LifeSciences Grant. The first author's postdoctoral training, in which this manuscript was written, was funded by the Irving B. Harris Foundation Faculty Scholars Initiative.	ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; BACH JR, 1994, ARCH PHYS MED REHAB, V75, P626, DOI 10.1016/0003-9993(94)90183-X; Bier JAB, 1996, CLIN PEDIATR, V35, P113, DOI 10.1177/000992289603500301; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Chisholm J, 2001, Axone, V23, P12; Colaizzi PF., 1978, EXISTENTIAL PHENOMEN, P48; COOLEY WC, 1990, AM J DIS CHILD, V144, P1112, DOI 10.1001/archpedi.1990.02150340056023; Cremeens J, 2007, CHILD CARE HLTH DEV, V33, P83, DOI 10.1111/j.1365-2214.2006.00665.x; CUSHMAN LA, 1990, ARCH PHYS MED REHAB, V71, P191; Dunn DS, 2008, REHABIL PSYCHOL, V53, P413, DOI 10.1037/a0013749; Fox RC, 2005, NEW ENGL J MED, V353, P1316, DOI 10.1056/NEJMp058066; GERHART KA, 1994, ANN EMERG MED, V23, P807, DOI 10.1016/S0196-0644(94)70318-3; GOODE D, 1994, QUALITY LIFE PERSONS; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Griffin J, 1986, WELL BEING ITS MEANI; Haley Stephen M, 2004, J Intensive Care Med, V19, P205, DOI 10.1177/0885066604265798; Hawley C A, 2005, Pediatr Rehabil, V8, P117; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Husserl E, 1965, PHENOMENOLOGY CRISIS; Janvier A, 2008, J PERINATOL, V28, P821, DOI 10.1038/jp.2008.103; Kao Hsueh-Fen S, 2004, J Neurosci Nurs, V36, P73; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V75; LONGMORE PK, 1995, J LAW MED ETHICS, V23, P82, DOI 10.1111/j.1748-720X.1995.tb01335.x; MARRIS P, 1975, GARDEN CITY; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; Patton MQ, 2002, QUALITATIVE RES EVAL, P37; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Ravens-Sieberer U, 2002, RESTOR NEUROL NEUROS, V20, P151; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; SIPERSTEIN GN, 1988, J PEDIATR-US, V113, P835, DOI 10.1016/S0022-3476(88)80010-6; SIPERSTEIN GN, 1994, AM J MENT RETARD, V98, P519; Thomasgard M, 2004, CLIN PEDIATR, V43, P119, DOI 10.1177/000992280404300201; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; WOLRAICH ML, 1991, DEV MED CHILD NEUROL, V33, P336; WOLRAICH ML, 1987, PEDIATRICS, V80, P643; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; World Health Organization, 1993, MEAS QUAL LIF CHILDR; Wright B. A., 1988, ATTITUDES PERSONS DI, P3; WRIGHT BA, 1960, ATTITUDES PERSONS DI	44	16	16	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2011	25	9					882	894		10.3109/02699052.2011.581638			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	790CY	WOS:000292567300008	21631183	Green Accepted			2021-06-18	
J	Salehpour, F; Bazzazi, AM; Porhomayon, J; Nader, ND				Salehpour, Firooz; Bazzazi, Amir Mohammad; Porhomayon, Jahan; Nader, Nader D.			Correlation between coagulopathy and outcome in severe head trauma in neurointensive care and trauma units	JOURNAL OF CRITICAL CARE			English	Article						Coagulopathy; Severe head trauma; Glasgow coma scale; Glasgow outcome scale	DISSEMINATED INTRAVASCULAR COAGULATION; PROGRESSIVE BRAIN INJURY; SEVERE CEREBRAL TRAUMA; POSTTRAUMA COAGULATION; HEMOSTATIC ACTIVATION; CHILDREN; DISORDERS; DISTURBANCES; FIBRINOLYSIS; MARKERS	Background: Abnormal blood coagulation after traumatic brain injury is a common finding. Some studies have proposed these changes as useful predictors of outcome in patients with head trauma. This study aimed at evaluating the association of the routine tests of blood coagulation within the first hours after severe head trauma with prognosis of patients with severe head trauma. Materials and Methods: A total of 52 patients with severe head trauma (Glasgow Coma Scale [GCS], <= 8) were admitted at Tabriz University Hospital for 1 year. Patients with major accompanying trauma were excluded. On admission, serum levels of hemoglobin and hematocrit as well as the platelet count, prothrombin time (PT), partial thromboplastin time (PTT), and international normalized ratio (INR) were documented. The relation between these parameters with final outcome and also with GCS at admission, 24 hours, 48 hours, and 1 week after admission and discharge time and Glasgow Outcome Scale (GOS) were studied. Results: Thirty three patients were discharged, and 19 died. There were significant negative correlations between PT, PTT, and INR with all GCS and GOS scores. These correlations were significant and positive between the platelet count and all GCS and GOS scores. Median PT, PTT, and INR were significantly higher in nonsurvivors. Median serum platelets count was significantly lower in nonsurvivors. Conclusion: On-admission PT, PTT, INR and platelet count may be used as predictors of outcome and prognosis of patients with severe head trauma. Published by Elsevier Inc.	[Nader, Nader D.] SUNY Buffalo, Div Cardiothorac Anesthesia & Pain Med, VA Western New York Healthcare Syst, Sch Med & Biomed Sci,Dept Anesthesiol, Buffalo, NY 14215 USA; [Salehpour, Firooz] Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran; [Bazzazi, Amir Mohammad] Urmia Univ Med Sci, Dept Neurosurg, Orumiyeh, Iran; [Porhomayon, Jahan] SUNY Buffalo, Div Crit Care & Pain Med, VA Western New York Healthcare Syst, Sch Med & Biomed Sci,Dept Anesthesiol, Buffalo, NY 14215 USA	Nader, ND (corresponding author), SUNY Buffalo, Div Cardiothorac Anesthesia & Pain Med, VA Western New York Healthcare Syst, Sch Med & Biomed Sci,Dept Anesthesiol, Buffalo, NY 14215 USA.	nnader@buffalo.edu	Nader, Nader/AAO-9442-2020; salehpour, firooz/L-8833-2017	Nader, Nader/0000-0002-5744-7319; porhomayon,, jahan/0000-0001-7096-1825; salehpour, firooz/0000-0003-0693-6400			AUER L, 1978, ACTA NEUROCHIR, V43, P51, DOI 10.1007/BF01809225; AUER LM, 1979, ACTA NEUROCHIR, V49, P219, DOI 10.1007/BF01808961; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Becker S, 1999, EUR J PEDIATR, V158, pS197, DOI 10.1007/PL00014355; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; COPES WS, 1993, P 33 ANN M ASS ADV A, P205; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Goodnight S H Jr, 1977, Compr Ther, V3, P25; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LUSTENBERGER T, 2010, INJURY; May AK, 1997, AM SURGEON, V63, P233; MAY AK, 1997, AM SURGEON, V63, P236; Murshid WR, 2002, BRIT J NEUROSURG, V16, P362, DOI 10.1080/0268869021000007597; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PENICK G D, 1960, Int Rec Med, V173, P491; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pondaag W, 1979, Acta Neurochir Suppl (Wien), V28, P98; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; SORENSEN JV, 1993, SCAND J CLIN LAB INV, V53, P659, DOI 10.3109/00365519309092568; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	37	16	17	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	AUG	2011	26	4					352	356		10.1016/j.jcrc.2010.12.005			5	Critical Care Medicine	General & Internal Medicine	816NG	WOS:000294608400005	21273031				2021-06-18	
J	Ueno, M; Yamashita, T				Ueno, Masaki; Yamashita, Toshihide			Kinematic analyses reveal impaired locomotion following injury of the motor cortex in mice	EXPERIMENTAL NEUROLOGY			English	Article						Cortical injury; Kinematic analyses; Locomotion; Mice; Motor cortex; Treadmill	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; QUADRUPEDAL LOCOMOTION; CORTICOSPINAL TRACT; AXONAL PLASTICITY; STROKE RECOVERY; C-FOS; MOUSE; NEURONS; RAT	Brain injury in the motor cortex can result in deleterious functional deficits of skilled and fine motor functions. However, in contrast to humans, the destruction of cortex and its descending fibers has been thought not to cause remarkable deficits in simple locomotion in quadropedal animals. In the present study, we aimed to investigate in detail how lesion of the sensorimotor cortex affected locomotion ability in mice using the KinemaTracer system, a novel video-based kinematic analyzer. We found that traumatic injury to the left sensorimotor cortex induced several apparent deficits in the movement of contralesional right limbs during treadmill locomotion. The step length of right limbs decreased, and the speed in the forward direction was abrogated in the swing phase. The coordinates and angle of each joint were also changed after the injury. Some of the abnormal values in these parameters gradually recovered near the control level. The number of cFos-expressing neurons following locomotion significantly decreased in the right side of the spinal cord in injured mice, suggesting a role for cortex and descending fibers in locomotion. In contrast, interlimb coordination did not change remarkably even after the injury, supporting the notion that the basic locomotor pattern was determined by intraspinal neural circuits. These results indicate that the motor cortex and its descending fibers regulate several aspects of fine limb movement during locomotion. Our findings provide practical parameters to assess motor deficits and recovery following cortical injury in mice. (C) 2011 Elsevier Inc. All rights reserved.	[Ueno, Masaki; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan	Ueno, M (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ms-ueno@molneu.med.osaka-u.ac.jp; yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Yamashita, Toshihide/0000-0003-4559-7018	JSPSMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science	This study was supported by a Grant-in-Aid for Young Scientists (S) from JSPS to T.Y., and a Grant-in-Aid for Young Scientists (B) to M.U.	Ahn SN, 2006, SPINAL CORD, V44, P547, DOI 10.1038/sj.sc.3101862; Asante CO, 2010, J NEUROPHYSIOL, V104, P3189, DOI 10.1152/jn.00671.2010; Ballion B, 2001, EUR J NEUROSCI, V14, P1727, DOI 10.1046/j.0953-816x.2001.01794.x; Barriere G, 2008, J NEUROSCI, V28, P3976, DOI 10.1523/JNEUROSCI.5692-07.2008; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Clarke KA, 1999, PHYSIOL BEHAV, V66, P723, DOI 10.1016/S0031-9384(98)00343-6; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Dai X, 2005, J NEUROPHYSIOL, V93, P3442, DOI 10.1152/jn.00578.2004; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; DREW T, 1988, BRAIN RES, V457, P181, DOI 10.1016/0006-8993(88)90073-X; Drew T, 2002, BRAIN RES REV, V40, P178, DOI 10.1016/S0165-0173(02)00200-X; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Hantman AW, 2010, NAT NEUROSCI, V13, P1233, DOI 10.1038/nn.2637; Herbin M, 2004, J COMP PHYSIOL A, V190, P895, DOI 10.1007/s00359-004-0545-0; Herbin M, 2007, BEHAV BRAIN RES, V181, P173, DOI 10.1016/j.bbr.2007.04.001; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Krajacic A, 2010, BEHAV BRAIN RES, V214, P323, DOI 10.1016/j.bbr.2010.05.053; Leblond H, 2003, J NEUROSCI, V23, P11411; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Metz GAS, 1998, BEHAV BRAIN RES, V96, P37, DOI 10.1016/S0166-4328(97)00195-2; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Orlovsky G. N., 1999, NEURONAL CONTROL LOC; Pearson KG, 2005, J NEUROSCI METH, V148, P36, DOI 10.1016/j.jneumeth.2005.04.006; ROSSIGNOL, 1996, HDB PHYSL, V12, P173; Serradj N, 2009, BEHAV BRAIN RES, V201, P59, DOI 10.1016/j.bbr.2009.01.030; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	35	16	16	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	AUG	2011	230	2					280	290		10.1016/j.expneurol.2011.05.006			11	Neurosciences	Neurosciences & Neurology	783CF	WOS:000292058400014	21619878				2021-06-18	
J	Zakzanis, KK; Yeung, E				Zakzanis, Konstantine K.; Yeung, Emily			Base Rates of Post-concussive Symptoms in a Nonconcussed Multicultural Sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Post-concussive syndrome; Base rates; Cross cultural/minority	POSTCONCUSSION-LIKE SYMPTOMS; TRAUMATIC BRAIN-INJURY; HEALTH	The purpose of this preliminary study was to investigate differences in base rates of post-concussion syndrome (PCS) symptomatology in healthy individuals separated by cultural identity and language. In this study, we sought to determine if differences exist in terms of base-rate endorsement of PCS symptomatology in healthy individuals and whether culture and language-based specific clusters of PCS symptomatology exist in healthy individuals. A total of 151 participants, consisting of 33 Caucasians, 49 Chinese, Filipinos, and Southeast Asians, 43 Arabs, West Asians, and South Asians, and 26 participants of African descent completed four questionnaires and two subtests of a test of verbal ability. We found that the occurrence of PCS symptoms did not differ by culture and language-based groups in general, but that there were differences between groups in the base rates of individual symptom endorsement. Our preliminary findings illustrate that cultural and linguistic background may play a moderating role in the endorsement of PCS symptomatology and that false-positive conclusions may be reached disproportionally between groups. Our results underscore the importance of considering the influence of culture and language, in conjunction with a growing list of factors that can influence, maintain, and/or mimic persistent PCS.	[Zakzanis, Konstantine K.; Yeung, Emily] Univ Toronto Scarborough, Dept Psychol, Toronto, ON M1C 1A4, Canada	Zakzanis, KK (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	zakzanis@utsc.utoronto.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Beck A. T., 1996, BECK DEPRESSION INVE, VII; BECK AT, 1993, DEPRESSION ANXIETY I; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Grandner MA, 2010, SLEEP MED, V11, P470, DOI 10.1016/j.sleep.2009.10.006; Hayes JS, 1998, ARCH CLIN NEUROPSYCH, V13, P27; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange R. T., 2010, J CLIN EXPT NEUROPSY, V30, P1; LEEHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203; Manzoni Gian Camillo, 2010, Handb Clin Neurol, V97, P3, DOI 10.1016/S0072-9752(10)97001-2; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Rabow MW, 2005, PAIN MED, V6, P235, DOI 10.1111/j.1526-4637.2005.05037.x; Riolo SA, 2005, AM J PUBLIC HEALTH, V95, P998, DOI 10.2105/AJPH.2004.047225; Szanton SL, 2010, SOC SCI MED, V71, P259, DOI 10.1016/j.socscimed.2010.04.001; Treiber FA, 2002, PSYCHOSOM MED, V64, P707, DOI 10.1097/01.PSY.0000021952.59258.1C; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th	25	16	16	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2011	26	5					461	465		10.1093/arclin/acr021			5	Psychology, Clinical; Psychology	Psychology	799QC	WOS:000293300200010	21642664	Bronze			2021-06-18	
J	Risher, WC; Lee, MR; Fomitcheva, IV; Hess, DC; Kirov, SA				Risher, W. Christopher; Lee, Mark R.; Fomitcheva, Ioulia V.; Hess, David C.; Kirov, Sergei A.			Dibucaine Mitigates Spreading Depolarization in Human Neocortical Slices and Prevents Acute Dendritic Injury in the Ischemic Rodent Neocortex	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INTRINSIC OPTICAL SIGNALS; IN-VIVO; ANOXIC DEPOLARIZATION; PERIINFARCT DEPOLARIZATIONS; HIPPOCAMPAL SLICES; BRAIN-SLICES; GLUCOSE DEPRIVATION; LOCAL-ANESTHETICS; NA+ CHANNELS	Background: Spreading depolarizations that occur in patients with malignant stroke, subarachnoid/intracranial hemorrhage, and traumatic brain injury are known to facilitate neuronal damage in metabolically compromised brain tissue. The dramatic failure of brain ion homeostasis caused by propagating spreading depolarizations results in neuronal and astroglial swelling. In essence, swelling is the initial response and a sign of the acute neuronal injury that follows if energy deprivation is maintained. Choosing spreading depolarizations as a target for therapeutic intervention, we have used human brain slices and in vivo real-time two-photon laser scanning microscopy in the mouse neocortex to study potentially useful therapeutics against spreading depolarization-induced injury. Methodology/Principal Findings: We have shown that anoxic or terminal depolarization, a spreading depolarization wave ignited in the ischemic core where neurons cannot repolarize, can be evoked in human slices from pediatric brains during simulated ischemia induced by oxygen/glucose deprivation or by exposure to ouabain. Changes in light transmittance (LT) tracked terminal depolarization in time and space. Though spreading depolarizations are notoriously difficult to block, terminal depolarization onset was delayed by dibucaine, a local amide anesthetic and sodium channel blocker. Remarkably, the occurrence of ouabain-induced terminal depolarization was delayed at a concentration of 1 mu M that preserves synaptic function. Moreover, in vivo two-photon imaging in the penumbra revealed that, though spreading depolarizations did still occur, spreading depolarization-induced dendritic injury was inhibited by dibucaine administered intravenously at 2.5 mg/kg in a mouse stroke model. Conclusions/Significance: Dibucaine mitigated the effects of spreading depolarization at a concentration that could be well-tolerated therapeutically. Hence, dibucaine is a promising candidate to protect the brain from ischemic injury with an approach that does not rely on the complete abolishment of spreading depolarizations.	[Risher, W. Christopher] Georgia Hlth Sci Univ, Grad Program Neurosci, Augusta, GA USA; [Lee, Mark R.; Fomitcheva, Ioulia V.; Kirov, Sergei A.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA; [Hess, David C.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA; [Risher, W. Christopher; Hess, David C.; Kirov, Sergei A.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA	Risher, WC (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	skirov@georgiahealth.edu	Risher, W Christopher/AAZ-3982-2020	Risher, W Christopher/0000-0002-2230-2865	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS064753, NS057113, NS062154]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS064753, R01NS057113, R21NS062154] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants NS064753 (W.C.R.), NS057113 (S.A.K.), and NS062154 (S.A.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514; ALEXANDER JT, 1975, J APPL PHYSIOL, V39, P1041; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Davies ML, 2007, J NEUROSCI METH, V166, P203, DOI 10.1016/j.jneumeth.2007.07.012; Dayan PS, 1996, ANN EMERG MED, V28, P442, DOI 10.1016/S0196-0644(96)70013-6; Dietz RM, 2009, J NEUROCHEM, V109, P145, DOI 10.1111/j.1471-4159.2009.05853.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Donnan GA, 2008, STROKE, V39, P242, DOI 10.1161/STROKEAHA.107.493296; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Fung ML, 1999, NEUROSCI LETT, V275, P41, DOI 10.1016/S0304-3940(99)00728-4; Hartings JA, 2003, J NEUROSCI, V23, P11602; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Jarvis CR, 1999, NEUROIMAGE, V10, P357, DOI 10.1006/nimg.1999.0473; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; JIANG C, 1992, J NEUROPHYSIOL, V68, P2165; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; Momota Y, 2000, ANESTH ANALG, V91, P362, DOI 10.1097/00000539-200008000-00024; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; PARDRIDGE WM, 1983, J CLIN INVEST, V71, P900, DOI 10.1172/JCI110844; Petzold GC, 2005, STROKE, V36, P1270, DOI 10.1161/01.STR.0000166023.51307.e0; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; SHIBATA M, 1994, REGION ANESTH, V19, P255; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Somjen GG., 2004, IONS BRAIN NORMAL FU; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; TAYLOR CP, 1995, TRENDS PHARMACOL SCI, V16, P309, DOI 10.1016/S0165-6147(00)89060-4; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, CHANNELS, V2, P81, DOI 10.4161/chan.2.2.6003; Urenjak J, 1996, PHARMACOL REV, V48, P21; WEBER ML, 1994, BRAIN RES, V664, P167, DOI 10.1016/0006-8993(94)91967-4; WESTER P, 1995, STROKE, V26, P444, DOI 10.1161/01.STR.26.3.444; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; Yamada A, 2004, NEUROSCI RES, V50, P291, DOI 10.1016/j.neures.2004.07.008; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	59	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22351	10.1371/journal.pone.0022351			9	Multidisciplinary Sciences	Science & Technology - Other Topics	793HT	WOS:000292811700042	21789251	DOAJ Gold, Green Published			2021-06-18	
J	Al Nimer, F; Beyeen, AD; Lindblom, R; Strom, M; Aeinehband, S; Lidman, O; Piehl, F				Al Nimer, Faiez; Beyeen, Amennai Daniel; Lindblom, Rickard; Strom, Mikael; Aeinehband, Shahin; Lidman, Olle; Piehl, Fredrik			Both MHC and non-MHC genes regulate inflammation and T-cell response after traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; MHC class II; T-cells; Inflammation; Genes; Ciita; Rat strains	CENTRAL-NERVOUS-SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; SPINAL-CORD-INJURY; CLASS-II; MULTIPLE-SCLEROSIS; HEAD-INJURY; ACTIVE IMMUNIZATION; PARKINSONS-DISEASE; CNS; NEUROPROTECTION	Genetic regulation of autoimmune neuroinflammation is a well known phenomenon, but genetic influences on inflammation following traumatic nerve injuries have received little attention. In this study we examined the inflammatory response in a rat traumatic brain injury (TBI) model, with a particular focus on major histocompatibility class II (MHC II) presentation, in two inbred rat strains that have been extensively characterized in experimental autoimmune encephalomyelitis (EAE); DA and PVC. In addition, MHC and Vra4 congenic strains on these backgrounds were studied to give information on MHC and non-MHC gene contribution. Thus, allelic differences in Vra4, harboring the Ciita gene, was found to regulate expression of the invariant chain at the mRNA level, with a much smaller effect exerted by the MHC locus itself. Notably, however, at the protein level the MHC congenic PVG-RT1(av1) strain displayed much stronger MHCII+ presentation, as shown both by immunolabeling and flow cytometry, than the PVC strain, dwarfing the effect of Ciita. The PVG-RT1(av1) strain had significantly more T-cell influx than both DA and PVC, suggesting regulation both by MHC and non-MHC genes. Finally, in terms of outcome, the EAE susceptible DA strain displayed a significantly smaller resulting lesion volume than the resistant PVG-RT1(av1) strain. These results provide additional support for a role of adaptive immune response after neurotrauma and demonstrate that outcome is significantly affected by host genetic factors. (C) 2010 Elsevier Inc. All rights reserved.	[Al Nimer, Faiez; Beyeen, Amennai Daniel; Lindblom, Rickard; Strom, Mikael; Aeinehband, Shahin; Lidman, Olle; Piehl, Fredrik] Karolinska Univ Hosp, Neuroimmunol Unit, Dept Clin Neurosci, S-17176 Stockholm, Sweden	Al Nimer, F (corresponding author), Karolinska Univ Hosp, Neuroimmunol Unit, Dept Clin Neurosci, S-17176 Stockholm, Sweden.	faiez.al.nimer@ki.se	Nimer, Faiez Al/ABB-9465-2020; Piehl, Fredrik/E-3451-2013	Al Nimer, Faiez/0000-0003-0937-5995; Lindblom, Rickard/0000-0001-7913-4981	European UnionEuropean Commission [LSHM-CT-2005-018637, LSHG-CT-2005019015]; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; GV80 Foundation; Swedish Association of Persons with Neurological Disabilities	We would like to thank Professor Tomas Olsson for expert scientific advice. This study was supported by the 6'th Framework Program of the European Union, NeuroproMiSe, LSHM-CT-2005-018637 and EURATools, LSHG-CT-2005019015, the Swedish Research Council, the Swedish Brain Foundation, the GV80 Foundation and the Swedish Association of Persons with Neurological Disabilities.	Abrams MB, 2007, EUR J NEUROSCI, V26, P1118, DOI 10.1111/j.1460-9568.2007.05725.x; Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Aloisi F, 1998, J IMMUNOL, V160, P4671; Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Ankeny DP, 2007, EUR J NEUROSCI, V25, P2053, DOI 10.1111/j.1460-9568.2007.05458.x; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Becher B, 2000, GLIA, V29, P293; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; Diez M, 2009, J NEUROIMMUNOL, V212, P82, DOI 10.1016/j.jneuroim.2009.05.004; Dominguez CA, 2008, PAIN, V136, P313, DOI 10.1016/j.pain.2007.07.009; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hammarberg H, 2000, J NEUROSCI, V20, P5283, DOI 10.1523/JNEUROSCI.20-14-05283.2000; Harnesk K, 2008, J IMMUNOL, V180, P3289, DOI 10.4049/jimmunol.180.5.3289; Harnesk K, 2009, J NEUROIMMUNOL, V212, P44, DOI 10.1016/j.jneuroim.2009.04.019; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Jones TB, 2004, J NEUROSCI, V24, P3752, DOI 10.1523/JNEUROSCI.0406-04.2004; Kipnis J, 2000, P NATL ACAD SCI USA, V97, P7446, DOI 10.1073/pnas.97.13.7446; Kipnis J, 2003, J NEUROTRAUM, V20, P559, DOI 10.1089/089771503767168483; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lidman O, 2003, J NEUROSCI, V23, P9817; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Oehmichen M., 2009, Legal Medicine, V11, P118, DOI 10.1016/j.legalmed.2008.11.003; OLSSON T, 1993, J NEUROL SCI, V117, P130, DOI 10.1016/0022-510X(93)90165-U; OLSSON T, 1992, AUTOIMMUNITY, V13, P117, DOI 10.3109/08916939209001912; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Rudehill S, 2006, ACTA NEUROCHIR, V148, P199, DOI 10.1007/s00701-005-0673-5; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Schwartz M, 2009, NEUROSCIENCE, V158, P1133, DOI 10.1016/j.neuroscience.2008.12.013; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; Wolf SA, 2002, J NEUROIMMUNOL, V133, P72, DOI 10.1016/S0165-5728(02)00367-3; Zota V, 2009, J IMMUNOL, V183, P3522, DOI 10.4049/jimmunol.0900620	48	16	16	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JUL	2011	25	5			SI		981	990		10.1016/j.bbi.2010.10.017			10	Immunology; Neurosciences; Psychiatry	Immunology; Neurosciences & Neurology; Psychiatry	780EF	WOS:000291836600019	20974248				2021-06-18	
J	Hassett, LM; Tate, RL; Moseley, AM; Gillett, LE				Hassett, Leanne M.; Tate, Robyn L.; Moseley, Anne M.; Gillett, Lauren E.			Injury severity, age and pre-injury exercise history predict adherence to a home-based exercise programme in adults with traumatic brain injury	BRAIN INJURY			English	Article						Exercise; brain injuries; physical therapy (specialty); patient compliance	PHYSICAL-ACTIVITY PARTICIPATION; PSYCHOMETRIC PROPERTIES; FITNESS; PEOPLE; DISABILITIES; MAINTENANCE; RELIABILITY; EFFICACY; CAPACITY; VALIDITY	Purpose: To explore factors that may influence exercise adherence in adults with traumatic brain injury (TBI) within the International Classification of Functioning, Disability and Health (ICF) theoretical model. Participants: Thirty participants with TBI who had been randomized to a home-based exercise programme in a recently conducted randomized controlled trial. Methods: Impairments in body functions, environmental factors and personal factors were explored as predictors for exercise adherence. Significant variables were entered into binary logistic regression analyses to determine their combined power to predict exercise adherence. Results: Greater injury severity, older age and a pre-injury exercise history of walking or jogging positively influenced exercise adherence. As a combined set the three predictor variables accurately classified 82% of participants as adherent or non-adherent and were able to explain 49% of the variance (sensitivity = 67%; specificity = 89%). Conclusion: These results demonstrate people with severe injuries are able to exercise independently and suggest that in order to maximize adherence to an exercise programme, clinicians need to consider exercise history when prescribing the type of exercise. The results also provide factors within the ICF theoretical model to investigate in a large-scale study of exercise adherence after TBI.	[Hassett, Leanne M.; Gillett, Lauren E.] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Tate, Robyn L.] Univ Sydney, Sydney Sch Med, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Moseley, Anne M.] George Inst Global Hlth, Sydney, NSW, Australia	Hassett, LM (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	leanne.hassett@sswahs.nsw.gov.au		Hassett, Leanne/0000-0002-3546-1822	Motor Accidents Authority of New South Wales, Australia; Menzies Foundation	This research was funded by a grant from the Motor Accidents Authority of New South Wales, Australia; and a scholarship from the Menzies Foundation to the first author.	BECKER E, 1978, SCAND J REHABIL MED, V10, P47; Benton AL, 1978, MULTILINGUAL APHASIA; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; FINLAY O, 1993, PHYSIOTHERAPY, V79, P845; Forkan R, 2006, PHYS THER, V86, P401, DOI 10.1093/ptj/86.3.401; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hassett LM, 2007, BRAIN INJURY, V21, P1069, DOI 10.1080/02699050701630375; Hassett LM, 2009, J REHABIL MED, V41, P247, DOI 10.2340/16501977-0316; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; KING AC, 1988, AM J CARDIOL, V61, P628, DOI 10.1016/0002-9149(88)90778-3; KING AC, 1991, JAMA-J AM MED ASSOC, V266, P1535, DOI 10.1001/jama.266.11.1535; KING AC, 1994, ADV EXERCISE ADHEREN, P183; Kinne S, 1999, DISABIL REHABIL, V21, P15, DOI 10.1080/096382899298052; Lovibond S., 1996, MANUAL DEPRESSION AN; Malina RM, 1996, RES Q EXERCISE SPORT, V67, pS48, DOI 10.1080/02701367.1996.10608853; MUTRIE N, 1999, ADHERENCE ISSUES SPO, P75; Palmer-McLean K, 2003, ACSMS EXERCISE MANAG, P238; Ready AE, 2005, J SPORT MED PHYS FIT, V45, P199; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Resnick B, 2000, NURS RES, V49, P154, DOI 10.1097/00006199-200005000-00007; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; Rimmer JH, 2000, ARCH PHYS MED REHAB, V81, P182; Romberg A, 2004, NEUROLOGY, V63, P2034, DOI 10.1212/01.WNL.0000145761.38400.65; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Sallis JF, 1997, RES Q EXERCISE SPORT, V68, P345, DOI 10.1080/02701367.1997.10608015; Simpson G, 2001, J HEAD TRAUMA REHAB, V16, P556, DOI 10.1097/00001199-200112000-00004; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Tabachnick BG, 2013, USING MULTIVARIATE S; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; Watts R, 1999, BRAIN INJURY, V13, P113, DOI 10.1080/026990599121773; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; World Health Organization, 2001, INT CLASS FUNCT DIS; ZENCIUS A H, 1991, Brain Injury, V5, P369, DOI 10.3109/02699059109008109	39	16	17	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					698	706		10.3109/02699052.2011.579934			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600006	21604929				2021-06-18	
J	Lok, J; Leung, WD; Zhao, S; Pallast, S; van Leyen, K; Guo, SZ; Wang, XY; Yalcin, A; Lo, EH				Lok, Josephine; Leung, Wendy; Zhao, Song; Pallast, Stefanie; van Leyen, Klaus; Guo, Shuzhen; Wang, Xiaoying; Yalcin, Ayfer; Lo, Eng H.			Gamma-glutamylcysteine ethyl ester protects cerebral endothelial cells during injury and decreases blood-brain barrier permeability after experimental brain trauma	JOURNAL OF NEUROCHEMISTRY			English	Article						blood-brain barrier; endothelial; GCEE; glutathione; neuroprotection; oxidative stress	INDUCED OXIDATIVE STRESS; PARKINSONS-DISEASE; THERAPEUTIC STRATEGY; GLUTATHIONE; NEURODEGENERATION; ELEVATION; MICE; MONOCHLOROBIMANE; EXCITOTOXICITY; METABOLISM	Oxidative stress is a pathway of injury that is common to almost all neurological conditions. Hence, methods to scavenge radicals have been extensively tested for neuroprotection. However, saving neurons alone may not be sufficient in treating CNS disease. In this study, we tested the cytoprotective actions of the glutathione precursor gamma-glutamylcysteine ethyl ester (GCEE) in brain endothelium. First, oxidative stress was induced in a human brain microvascular endothelial cell line by exposure to H(2)O(2). Addition of GCEE significantly reduced formation of reactive oxygen species, restored glutathione levels which were reduced in the presence of H(2)O(2), and decreased cell death during H(2)O(2)-mediated injury. Next, we asked whether GCEE can also protect brain endothelial cells against oxygen-glucose deprivation OGD). As expected, OGD disrupted mitochondrial membrane potentials. GCEE was able to ameliorate these mitochondrial effects. Concomitantly, GCEE significantly decreased endothelial cell death after OGD. Lastly, our in vivo experiments using a mouse model of brain trauma show that post-trauma (10 min after controlled cortical impact) administration of GCEE by intraperitoneal injection results in a decrease in acute blood-brain barrier permeability. These data suggest that the beneficial effects of GCEE on brain endothelial cells and microvessels may contribute to its potential efficacy as a neuroprotective agent in traumatic brain injury.	[Lok, Josephine; Leung, Wendy; Zhao, Song; Pallast, Stefanie; van Leyen, Klaus; Guo, Shuzhen; Wang, Xiaoying; Lo, Eng H.] Massachusetts Gen Hosp, Neuroprotect Res Lab, Boston, MA 02114 USA; [Lok, Josephine; Leung, Wendy] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Zhao, Song] Jilin Univ, Hosp 1, Spine Div, Dept Orthoped, Changchun 130023, Jilin, Peoples R China; [Yalcin, Ayfer] Ege Univ, Fac Pharm, Dept Biochem, Izmir, Turkey; [Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Lok, J (corresponding author), Massachusetts Gen Hosp, Neuroprotect Res Lab, 175 Cambridge St,5th Floor, Boston, MA 02114 USA.	jlok1@partners.org	Yalcin, Ayfer/AAK-3010-2020; Yalcin, Ayfer/AAE-5332-2019; Yalcin, Ayfer/AAK-6337-2021; van Leyen, Klaus/C-9126-2013	Yalcin, Ayfer/0000-0003-0407-3218; van Leyen, Klaus/0000-0003-1032-3754	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08NS057339, R01NS049430, R01NS53560, P01NS555104]; American Heart AssociationAmerican Heart Association; Fulbright Program; Technological and Scientific Council of TurkeyTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [SBAG-K69-104S280]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049430, R01NS053560, K08NS057339] Funding Source: NIH RePORTER	This study was supported by NIH grants (K08NS057339 to J.L., R01NS049430 to K.v.L., R01NS53560 and P01NS555104 to E.H.L.), a Scientist Development Grant from the American Heart Association (to K.v.L.), a fellowship from the Fulbright Program (to A.Y.), and by the Technological and Scientific Council of Turkey (SBAG-K69-104S280 to A.Y). The authors thank Dr Michael J. Whalen for helpful discussions regarding the CCI model. The authors declare no conflicts of interest.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Anderson ME, 1998, SEMIN LIVER DIS, V18, P415, DOI 10.1055/s-2007-1007174; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Boyd-Kimball D, 2005, J NEUROSCI RES, V79, P707, DOI 10.1002/jnr.20393; Butterfield DA, 2002, DRUG DEVELOP RES, V56, P428, DOI 10.1002/ddr.10095; Callahan MK, 2004, J NEUROIMMUNOL, V153, P150, DOI 10.1016/j.jneuroim.2004.05.004; Chinta SJ, 2006, NEUROSCI LETT, V402, P137, DOI 10.1016/j.neulet.2006.03.056; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271; Drake J, 2003, J NEUROSCI RES, V74, P917, DOI 10.1002/jnr.10810; Drake J, 2002, J NEUROSCI RES, V68, P776, DOI 10.1002/jnr.10266; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Fernandez-Gomez FJ, 2005, NEUROBIOL DIS, V20, P384, DOI 10.1016/j.nbd.2005.03.019; FERNANDEZCHECA JC, 1990, ANAL BIOCHEM, V190, P212, DOI 10.1016/0003-2697(90)90183-A; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Huet O, 2008, CRIT CARE MED, V36, P2328, DOI 10.1097/CCM.0b013e3181800387; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kwon KJ, 2010, J CLIN NEUROL, V6, P127, DOI 10.3988/jcn.2010.6.3.127; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nishida K, 1996, BBA-MOL CELL RES, V1313, P47, DOI 10.1016/0167-4889(96)00054-7; PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Roberts RA, 2009, TOXICOL SCI, V112, P4, DOI 10.1093/toxsci/kfp179; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; SHRIEVE DC, 1988, J BIOL CHEM, V263, P14107; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sun XJ, 2006, J BIOL CHEM, V281, P17420, DOI 10.1074/jbc.M601567200; Turunc E, 2010, J PHARM PHARMACOL, V62, P1010, DOI 10.1111/j.2042-7158.2010.01122.x; Yalcin A, 2010, FREE RADICAL RES, V44, P513, DOI 10.3109/10715761003645964; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	40	16	16	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3042			J NEUROCHEM	J. Neurochem.	JUL	2011	118	2					248	255		10.1111/j.1471-4159.2011.07294.x			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	791HH	WOS:000292655300009	21534958	Bronze, Green Accepted			2021-06-18	
J	Kompanje, EJO; de Groot, YJ; Bakker, J				Kompanje, Erwin J. O.; de Groot, Yorick J.; Bakker, Jan			Is Organ Donation From Brain Dead Donors Reaching an Inescapable and Desirable Nadir?	TRANSPLANTATION			English	Article						Transplantation; Brain death; Organ donation	ANEURYSMAL SUBARACHNOID HEMORRHAGE; CARDIAC DEATH; INTRACRANIAL ANEURYSM; SINGLE-CENTER; CASE-FATALITY; RISK-FACTORS; TRANSPLANTATION; POPULATION; MORTALITY; POINT	The brain dead patient is the ideal multiorgan donor. Conversely, brain death (BD) is an undesirable outcome of critical care medicine. Conditions that can lead to the state of BD are limited. An analysis showed that a (aneurysmal) subarachnoid hemorrhage, traumatic brain injury, or intracerebral hemorrhage in 83% precede the state of BD. Because of better prevention and treatment options, we should anticipate on an inescapable and desirable decline of BD. In this article, we offer arguments for this statement and discuss alternatives to maintain a necessary level of donor organs for transplantation.	[Kompanje, Erwin J. O.; de Groot, Yorick J.; Bakker, Jan] Erasmus MC Univ Med Ctr, Dept Intens Care Med, NL-3000 CA Rotterdam, Netherlands	Kompanje, EJO (corresponding author), Erasmus MC Univ Med Ctr, Dept Intens Care Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl	Bakker, Jan/A-4011-2009	Bakker, Jan/0000-0003-2236-7391			Alshekhlee A, 2010, STROKE, V41, P1471, DOI 10.1161/STROKEAHA.110.580647; ANTOMMARIA AH, 1902, JAMA-J AM MED ASSOC, P301; Bernat JL, 2010, CHEST, V138, P13, DOI 10.1378/chest.10-0649; Bernat JL, 2010, HASTINGS CENT REP, V40, P3, DOI 10.1353/hcr.0.0258; Boucek MM, 2008, NEW ENGL J MED, V359, P709, DOI 10.1056/NEJMoa0800660; Connolly E S Jr, 1999, J Stroke Cerebrovasc Dis, V8, P248, DOI 10.1016/S1052-3057(99)80074-3; Davis CL, 2011, TRANSPL INT, V24, P344, DOI 10.1111/j.1432-2277.2010.01212.x; de Groot YJ, 2009, JAMA-J AM MED ASSOC, V302, P845; de Groot YJ, 2010, INTENS CARE MED, V36, P1488, DOI 10.1007/s00134-010-1848-y; de Groot YJ, 2009, JAMA-J AM MED ASSOC, V302, P844, DOI 10.1001/jama.2009.1207; De Oliveira NC, 2010, J THORAC CARDIOV SUR, V139, P1306, DOI 10.1016/j.jtcvs.2010.02.004; Dorhout Mees SM, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3; Dubbeld J, 2010, BRIT J SURG, V97, P744, DOI 10.1002/bjs.7043; Glynn LG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub4; Gortmaker SL, 1996, CRIT CARE MED, V24, P432, DOI 10.1097/00003246-199603000-00012; Halpern SD, 2010, JAMA-J AM MED ASSOC, V304, P2592, DOI 10.1001/jama.2010.1824; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Kirste G, 2010, CHIRURG, V81, P778, DOI 10.1007/s00104-009-1871-0; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; KOMPANJE EJO, 2009, HUMAN RIGHTS BIOMEDI, P235; Kopits E, 2008, J TRANSP ECON POLICY, V42, P129; Koshy L, 2010, CEREBROVASC DIS, V29, P268, DOI 10.1159/000275501; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Jimenez-Yepes CM, 2008, STROKE, V39, P1344, DOI 10.1161/STROKEAHA.107.504019; Mascia L, 2010, JAMA-J AM MED ASSOC, V304, P2620, DOI 10.1001/jama.2010.1796; Meers C, 2009, TRANSPL P, V41, P572, DOI 10.1016/j.transproceed.2008.12.029; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; National Highway Traffic Safety Administration, 2010, EARL EST MOT VEH TRA; Opdam HI, 2004, INTENS CARE MED, V30, P1390, DOI 10.1007/s00134-004-2185-9; Peden M, 2004, WORLD REPORT ROAD TR, p[217, xv]; Prager LM, 2006, J HEART LUNG TRANSPL, V25, P1206, DOI 10.1016/j.healun.2006.06.014; Rodriguez-Arias D, 2010, LANCET, V376, P1109, DOI 10.1016/S0140-6736(10)61342-6; Saidi RF, 2010, AM J TRANSPLANT, V10, P2536, DOI 10.1111/j.1600-6143.2010.03215.x; Sandvei MS, 2009, STROKE, V40, P1958, DOI 10.1161/STROKEAHA.108.539544; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Stegmayr B, 2004, STROKE, V35, P2059, DOI 10.1161/01.STR.0000138451.07853.b6; Truog RD, 2008, NEW ENGL J MED, V359, P674, DOI 10.1056/NEJMp0804474; van der Schaaf I, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003085.pub2; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Veatch RM, 2008, NEW ENGL J MED, V359, P672, DOI 10.1056/NEJMp0805451; Weber M, 2002, NEW ENGL J MED, V347, P248, DOI 10.1056/NEJMoa020274; *WHO, 2010, AG IT 11 21 HUM ORG; WILKINSON D, 2010, BIOETHICS; Woo D, 2009, NEUROLOGY, V72, P695, DOI 10.1212/01.wnl.0000342999.99907.fd	47	16	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0041-1337			TRANSPLANTATION	Transplantation	JUN 15	2011	91	11					1177	1180		10.1097/TP.0b013e3182180567			4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	769JN	WOS:000291008800004	21494178				2021-06-18	
J	Gong, D; Zhang, S; Liu, L; Dong, JF; Guo, XB; Hao, M; Tu, Y; Diao, YF; Zhang, JN				Gong, Dasen; Zhang, Sai; Liu, Li; Dong, Jingfei; Guo, Xinbin; Hao, Mu; Tu, Yue; Diao, Yunfeng; Zhang, Jianning			Dynamic Changes of Vascular Endothelial Growth Factor and Angiopoietin-1 in Association With Circulating Endothelial Progenitor Cells After Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Vascular endothelial growth factor; Angiopoietin-1; Endothelial progenitor cells; Traumatic brain injury	TIE2 RECEPTOR; CD34(+) CELLS; EXPRESSION; ANGIOGENESIS; BLOOD; VEGF; STROKE; LIGAND	Background: Vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang-1) can promote angiogenesis and vascular stability after brain injury. Circulating endothelial progenitor cells (EPCs) also play a crucial role in neovascularization and tissue repair after traumatic brain injury (TBI). We sought to compare the expression of VEGF and Ang-1 in serum and the circulating EPCs in patients after severe TBI with that of healthy control subjects. Methods: We obtained peripheral blood and serum samples from 21 patients with severe TBI and 11 healthy control subjects. EPCs in blood samples from severe TBI patients and healthy controls were quantified by flow cytometry 1 day, 4 days, 7 days, 14 days, and 21 days after severe TBI. VEGF and Ang-1 were measured by enzyme linked immunosorbent assay at the same time points. Results: Compared with control subjects, circulating EPCs in patients with severe TBI decreased 4 days (p < 0.05), but increased 7 days and 14 days (p < 0.05) after TBI. VEGF increased significantly during the follow-up period (p < 0.05). Ang-1 increased gradually and reached peak at 7 days and 14 days after TBI. The circulating EPCs were significantly correlated with VEGF and Ang-1 at 7 days and 14 days after severe TBI. Conclusions: Our results suggest that the increased VEGF and Ang-1 are closely related to increase in circulating EPCs in response to severe TBI, which may be needed for vascular repairs after severe TBI.	[Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China; [Zhang, Sai; Tu, Yue; Diao, Yunfeng] Wujing Med Coll, Affiliated Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Dong, Jingfei] Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; [Guo, Xinbin] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent, Zhengzhou, Henan, Peoples R China; [Hao, Mu] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; Peking Union Med Coll, Tianjin, Peoples R China; Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China	Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772229]; National 973 ProjectNational Basic Research Program of China [2005CB522600]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL 71895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071895] Funding Source: NIH RePORTER	Supported by National Natural Science Foundation of China Grant 30772229; National 973 Project Grant 2005CB522600; and the NIH Grant HL 71895.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Beck L, 1997, FASEB J, V11, P365; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Gu WG, 2001, ACTA NEUROPATHOL, V102, P216; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Martinez A, 2006, CANCER LETT, V236, P157, DOI 10.1016/j.canlet.2005.04.008; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6	25	16	20	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2011	70	6					1480	1484		10.1097/TA.0b013e31821ac9e1			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	775QR	WOS:000291478500037	21817986				2021-06-18	
J	Jeon, SW; Choi, JH; Jang, TW; Moon, SM; Hwang, HS; Jeong, JH				Jeon, Sei Woong; Choi, Jong Hun; Jang, Tae Won; Moon, Seung-Myung; Hwang, Hyung-Sik; Jeong, Je Hoon			Risk Factors Associated with Subdural Hygroma after Decompressive Craniectomy in Patients with Traumatic Brain Injury: A Comparative Study	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Subdural hygroma; Decompressive craniectomy; Traumatic brain injury; Risk factor; Cerebrospinal fluid	SURGICAL DECOMPRESSION; PATHOGENESIS; SPACE; HYDROCEPHALUS; COMPLICATIONS; SECONDARY; EFFUSION; FLUID	Objective : Subdural hygroma (SDG) is a complication occurring after head trauma that may occur secondary to decompressive craniectomy (DC). However, the mechanism underlying SDG formation, is not fully understood. Also, the relationship between the operative technique of DC or the decompressive effect and the occurrence and pathophysiology of SDG has not been clarified. Purpose of this study was to investigate the risk factors of SDG after DC in our series. Methods : From January 2004 to December 2008, DC was performed in 85 patients who suffered from traumatic brain injury. We retrospectively reviewed the clinical and radiological features. For comparative analysis, we divided the patients into 2 groups : one group with SDG after craniectomy (19 patients; 28.4% of the total sample), the other group without SDG (48 patients; 71.6%). The risk factors for developing SDG were then analyzed. Results : The mean Glasgow Outcome Scale (GOS) scores at discharge of the groups with and without SDG were 2.8 and 3.1, respectively (p<0.0001). Analysis of radiological factors showed that a midline shift in excess of 5 mm on CT scans was present in 19 patients (100%) in the group with SDG and in 32 patients (66.7%) in the group without SDG (p<0.05). An accompanying subarachnoid hemorrhage (SAH) was seen in 17 patients (89.5%) in the group with SDG and in 29 patients (60.4%) in the group without SDG (p<0.05). Delayed hydrocephalus accompanied these findings in 10 patients (52.6%) in the group with SDG, versus 5 patients (10.4%) in the group without SDG (p<0.05). On CT, compression of basal cisterns was observed in 14 members (73.7%) in the group with SDG and in 18 members of the group without SDG (37.5%) (p<0.007). Furthermore, tearing of the arachnoid membrane, as observed on CT, was more common in all patients in the group with SDG (100%) than in the group without SDG (31 patients; 64.6%) (p<0.05). Conclusion : GOS showed statistically significant difference in the clinical risk factors for SDG between the group with SDG and the group without SDG. Analysis of radiological factors indicated that a midline shifting exceeding 5 mm, SAH, delayed hydrocephalus, compression of basal cisterns, and tearing of the arachnoid membrane were significantly more common in patients with SDG.	[Jeon, Sei Woong; Choi, Jong Hun; Moon, Seung-Myung; Hwang, Hyung-Sik; Jeong, Je Hoon] Hallym Univ, Coll Med, Dept Neurosurg, Seoul 150030, South Korea; [Jang, Tae Won] Hallym Univ, Coll Med, Dept Occupat & Environm Med, Seoul 150030, South Korea	Jeong, JH (corresponding author), Hallym Univ, Coll Med, Dept Neurosurg, 94-195 Yeongdeungpo Dong, Seoul 150030, South Korea.	neuri71@gmail.com		MOON, Seung-Myung/0000-0001-6248-9049			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; CSERR HF, 1974, EXP NEUROL, V45, P50, DOI 10.1016/0014-4886(74)90099-5; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Johnston I, 2000, CHILD NERV SYST, V16, P776, DOI 10.1007/s003810000383; Kawaguchi T, 1998, NEUROSURGERY, V43, P1033, DOI 10.1097/00006123-199811000-00017; Lang JK, 1999, SURG NEUROL, V52, P630, DOI 10.1016/S0090-3019(99)00144-5; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Liu YG, 2009, INJURY, V40, P968, DOI 10.1016/j.injury.2009.01.006; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; OHNO K, 1987, J NEUROL NEUROSUR PS, V50, P1694, DOI 10.1136/jnnp.50.12.1694; SCHACHENMAYR W, 1978, AM J PATHOL, V92, P53; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc	24	16	21	0	1	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	JUN	2011	49	6					355	358		10.3340/jkns.2011.49.6.355			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	787YR	WOS:000292413100008	21887394	DOAJ Gold, Green Published			2021-06-18	
J	Rahimi-Movaghar, V; Saadat, S; Rasouli, MR; Ghahramani, M; Eghbali, A				Rahimi-Movaghar, Vafa; Saadat, Soheil; Rasouli, Mohammad Reza; Ghahramani, Maryam; Eghbali, Aliashraf			The Incidence of Traumatic Brain Injury in Tehran, Iran: A Population Based Study	AMERICAN SURGEON			English	Article									[Rahimi-Movaghar, Vafa; Saadat, Soheil; Ghahramani, Maryam; Eghbali, Aliashraf] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Rasouli, Mohammad Reza] Thomas Jefferson Univ, Rothman Inst Orthoped, Philadelphia, PA 19107 USA	Rahimi-Movaghar, V (corresponding author), Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran.	v_rahimi@sina.tums.ac.ir	Saadat, Soheil/J-1595-2014	Saadat, Soheil/0000-0002-2744-7983			Annoni J M, 1992, Disabil Rehabil, V14, P23; Rahimi-Movaghar V, 2009, INT J INJ CONTROL SA, V16, P179, DOI 10.1080/17457300903024277; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wrightson P, 1998, NEW ZEAL MED J, V111, P99	4	16	17	0	5	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	JUN	2011	77	6					E112	E114					3	Surgery	Surgery	775ZC	WOS:000291501400040	21679621				2021-06-18	
J	Reinstrup, P; Nordstrom, CH				Reinstrup, Peter; Nordstrom, Carl-Henrik			Prostacyclin Infusion May Prevent Secondary Damage in Pericontusional Brain Tissue	NEUROCRITICAL CARE			English	Article						Brain trauma; Neuro critical care; Microdialysis; Prostacyclin	LOW-DOSE PROSTACYCLIN; INTRACEREBRAL MICRODIALYSIS; INJURY; THERAPY; TRAUMA; RAT	Background Prostacyclin is a potent vasodilator, inhibitor of leukocyte adhesion, and platelet aggregation, and has been suggested as therapy for cerebral ischemia. A case of focal traumatic brain lesion that was monitored using intracerebral microdialysis, and bedside analysis and display is reported here. When biochemical signs of cerebral ischemia progressed, i.v. infusion of prostacyclin was started. Methods Two microdialysis catheters were placed in the penumbra zones surrounding evacuated focal brain contusions. The samples were analyzed for glucose, pyruvate, lactate, glutamate, and glycerol. Results When biochemical deterioration indicated progressive secondary ischemia (increase in lactate/pyruvate ratio, decrease in glucose, and increase in glutamate levels), continuous infusion of prostacyclin (0.5-1.0 ng kg(-1) min(-1) i.v.) was started. The treatment resulted in an improvement of the lactate/pyruvate ratios and a normalization of the interstitial levels of glucose and glutamate. The glycerol levels remained within normal limits indicating that degradation of cellular membranes had not occurred. Conclusion The above case supports the view that new therapies directed toward protection of the sensitive biochemical penumbra zones surrounding focal brain lesions may be evaluated by intracerebral microdialysis.	[Nordstrom, Carl-Henrik] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense, Denmark; [Reinstrup, Peter] Univ Lund Hosp, Dept Intens & Perioperat Care, S-22185 Lund, Sweden	Nordstrom, CH (corresponding author), Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense, Denmark.	carl-henrik.nordstrom@med.lu.se			Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [14X-003574-28D]; Lund University Hospital	The study was supported by grants from the Swedish Medical Research Council (14X-003574-28D), and Lund University Hospital. We thank Katarina Nielsen, Department of Neurosurgery, Lund University Hospital, for her help with the microdialysis equipment and biochemical analyses.	BATH P, 2004, COCHRANE DB SYST REV, V3; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; BRANDT L, 1981, J NEUROSURG, V55, P877, DOI 10.3171/jns.1981.55.6.0877; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Gardenfors F, 2004, ACTA ANAESTH SCAND, V48, P1316, DOI 10.1111/j.1399-6576.2004.00522.x; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; GRYGLEWSKI RJ, 1983, STROKE, V14, P197, DOI 10.1161/01.STR.14.2.197; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; JORGENSEN MB, 1982, ACTA NEUROL SCAND, V66, P536; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; MONCADA S, 1983, STROKE, V14, P157, DOI 10.1161/01.STR.14.2.157; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; NORDSTROM CH, 1996, BRAIN PROTECTION SEV, P117; NORDSTROM CH, 2003, NEUROSURG FOCUS, V15, P1; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; TEASDALE G, 1974, LANCET, V2, P81	24	16	22	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2011	14	3					441	446		10.1007/s12028-010-9486-3			6	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	759FT	WOS:000290226800019	21161698				2021-06-18	
J	Zhao, W; Yang, J; Shi, W; Wu, XJ; Shao, B; Wu, QY; Chen, J; Ni, LC				Zhao, Wei; Yang, Jiao; Shi, Wei; Wu, Xiujie; Shao, Bai; Wu, Qiyun; Chen, Jian; Ni, Lanchun			Upregulation of p21-activated Kinase 6 in rat brain cortex after traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Traumatic brain injury; PAK6; Glial cells; Proliferation; Apoptotic; Rats	ANDROGEN RECEPTOR; REACTIVE ASTROCYTES; GLIAL PROLIFERATION; MECHANISMS; NEUROPROTECTION; NEUROGENESIS; INHIBITION; ACTIVATION; ROLES; ALPHA	p21-activated Kinase 6 (PAK6) is a serine/threonine kinase belonging to the p21-activated kinase (PAK) family. PAK kinases are well-known regulators of a wide variety of cellular functions, including regulation of cytoskeleton rearrangement, cell survival, apoptosis and the mitogen-activated protein kinase signaling pathway. To elucidate the expressions and possible functions of PAK6 in central nervous system (CNS) lesion and repair, we performed a traumatic brain injury (TBI) model in adult rats. Western blot analysis revealed that PAK6 level significantly increased at day 3 after damage, and then declined during the following days. Besides, double immunofluorescence staining showed PAK6 was primarily expressed in the neurons and a few of glial cells in the normal group. While after injury, the expression of PAK6 was increased significantly in the astrocytes and neurons, and the astrocytes had largely proliferated. We also examined the expression of proliferating cell nuclear antigen (PCNA) whose change was correlated with the expression of PAK6. Importantly, double immunofluorescence staining revealed that cell proliferation evaluated by PCNA appeared in many PAK6-expressing cells at day 3 after injury. In addition, injury-induced expression of PAK6 was co-labeled by active caspase-3 during neuronal apoptosis after injury. Collectively, we hypothesized PAK6 may play important roles in CNS pathophysiology after TBI and further research is needed to have a good understanding of its function and mechanism.	[Zhao, Wei; Yang, Jiao; Shi, Wei; Wu, Xiujie; Shao, Bai; Wu, Qiyun; Chen, Jian; Ni, Lanchun] Nantong Univ, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Peoples R China	Chen, J (corresponding author), Nantong Univ, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Peoples R China.	chenjian0100@163.com; Nilangchun@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770488, 30870320, 31070723, 81070275]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009157, BK2009161, BK2010169]; Nature Science Foundation of Jiangsu Colleges and Universities [09KJB320011]	This work was supported by the National Natural Science Foundation of China (No. 30770488, No. 30870320, No. 31070723 and No. 81070275); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009157, No. BK2009161, and No. BK2010169); Nature Science Foundation of Jiangsu Colleges and Universities Grant (09KJB320011).	Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Erhardt L, 1996, EUR HEART J, V17, P1781; Hammond J, 2001, J NEUROCHEM, V77, P1319, DOI 10.1046/j.1471-4159.2001.00345.x; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kaur R, 2005, J BIOL CHEM, V280, P3323, DOI 10.1074/jbc.M406701200; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Konigsmark BW, 1970, CONT RES METHODS NEU, P315, DOI DOI 10.1007/978-3-642-85986-1_14; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li LZ, 2011, NEUROCHEM INT, V58, P126, DOI 10.1016/j.neuint.2010.11.006; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Patel T, 1996, FASEB J, V10, P587; Pearl-Yafe M, 2004, BIOCHEM PHARMACOL, V67, P539, DOI 10.1016/j.bcp.2003.09.024; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wen XQ, 2009, UROLOGY, V73, P1407, DOI 10.1016/j.urology.2008.09.041; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	46	16	18	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	JUN	2011	42	3					195	203		10.1007/s10735-011-9324-8			9	Cell Biology	Cell Biology	793QP	WOS:000292838500001	21541790				2021-06-18	
J	La Fountaine, MF; Gossett, JD; De Meersman, RE; Bauman, WA				La Fountaine, Michael F.; Gossett, James D.; De Meersman, Ronald E.; Bauman, William A.			Increased QT Interval Variability in 3 Recently Concussed Athletes: An Exploratory Observation	JOURNAL OF ATHLETIC TRAINING			English	Article						autonomic nervous system; heart; cardiovascular system; return to play	HEART-RATE-VARIABILITY; AUTONOMIC NERVOUS-SYSTEM; POWER SPECTRAL-ANALYSIS; EXERCISE; MODULATION; CASCADE	Context: The QT interval variability index (QTVI) is a noninvasive measure of beat-to-beat fluctuations of the QT interval as seen from a single electrocardiographic lead. It represents the relationship between the respective variabilities of the QT and R-R intervals. Recently, the QTVI was demonstrated to be an index of vagal cardiac autonomic modulation in resting conditions. Objective: To determine whether QTVI varied in athletes at 48 hours, 1 week, and 2 weeks after a concussive head injury. Design: Case series. Setting: Testing facility. Patients or Other Participants: Three athletes with recent concussions and 3 uninjured athletes with similar demographic factors. Main Outcome Measure(s): Continuous 3-lead electrocardiograms were obtained in a seated, resting position over 2 successive weeks. Separate, unpaired t tests were performed to determine whether group-visit differences were present in the QTVI at 48 hours, 1 week, or 2 weeks. Results: No demographic differences were present between groups. At 48 hours, the QTVI was greater in the concussion group than in the matched controls. At weeks 1 and 2, the QTVI in the concussion group was lower than at 48 hours and not different from that of the control group. Conclusions: Vagal cardiac autonomic modulation, as quantified by the QTVI, appeared to be negatively affected in concussed athletes within 48 hours of injury, resolved within 1 week, and remained at control group levels 2 weeks later. Serial assessments of QTVI may be of clinical utility in identifying suspected cases of acute concussion and may provide helpful information for determining when an athlete can return to play safely.	[La Fountaine, Michael F.; Bauman, William A.] James J Peters VA Med Ctr, Ctr Excellence Med Consequences Spinal Cord Injur, Bronx, NY 10468 USA; [La Fountaine, Michael F.; Bauman, William A.] James J Peters VA Med Ctr, SCI Serv, Bronx, NY 10468 USA; [La Fountaine, Michael F.; Bauman, William A.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Gossett, James D.] Columbia Univ, Dept Sports Med, New York, NY USA; [De Meersman, Ronald E.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Bauman, William A.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA	La Fountaine, MF (corresponding author), James J Peters VA Med Ctr, Ctr Excellence Med Consequences Spinal Cord Injur, Room 7A-13M,130 W Kingsbridge Rd, Bronx, NY 10468 USA.	michael.lafountaine@va.gov	La Fountaine, Michael/Q-6769-2019				AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ARAI Y, 1989, AM J PHYSIOL, V256, pH132; Atiga WL, 1998, J CARDIOVASC ELECTR, V9, P899, DOI 10.1111/j.1540-8167.1998.tb00130.x; Berger RD, 2009, J AM COLL CARDIOL, V54, P851, DOI 10.1016/j.jacc.2009.06.007; Borresen J, 2008, SPORTS MED, V38, P633, DOI 10.2165/00007256-200838080-00002; BREUER HWM, 1993, BRIT HEART J, V70, P144; BROWNE KF, 1982, AM J CARDIOL, V50, P1099, DOI 10.1016/0002-9149(82)90425-8; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Laowattana S, 2006, NEUROLOGY, V66, P477, DOI 10.1212/01.wnl.0000202684.29640.60; MaisonBlanche P, 1997, PACE, V20, P2614, DOI 10.1111/j.1540-8159.1997.tb06111.x; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; Mine T, 2008, ANN NONINVAS ELECTRO, V13, P228, DOI 10.1111/j.1542-474X.2008.00225.x; Moak JP, 2007, HEART RHYTHM, V4, P1523, DOI 10.1016/j.hrthm.2007.07.019; NAKAMURA Y, 1993, J APPL PHYSIOL, V74, P875; OPPENHEIMER S, 1993, STROKE, V24, pI3; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PERINI R, 1990, EUR J APPL PHYSIOL O, V61, P143, DOI 10.1007/BF00236709; Piccirillo G, 2001, CLIN SCI, V101, P429, DOI 10.1042/CS20000310; Piccirillo G, 2007, EUR HEART J, V28, P1344, DOI 10.1093/eurheartj/ehl367; Piccirillo G, 2009, J AM COLL CARDIOL, V54, P840, DOI 10.1016/j.jacc.2009.06.008; SHIN K, 1995, CLIN CARDIOL, V18, P664, DOI 10.1002/clc.4960181114; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408	32	16	16	1	6	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY-JUN	2011	46	3					230	233					4	Sport Sciences	Sport Sciences	770YC	WOS:000291123400002	21669090				2021-06-18	
J	Wagner, BP; Ammann, RA; Bachmann, DCG; Born, S; Schibler, A				Wagner, Bendicht P.; Ammann, Roland A.; Bachmann, Denis C. G.; Born, Susanne; Schibler, Andreas			Rapid Assessment of Cerebral Autoregulation by Near-Infrared Spectroscopy and a Single Dose of Phenylephrine	PEDIATRIC RESEARCH			English	Article							BOLUS TRANSIT DETECTION; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW ASSESSMENT; INDOCYANINE GREEN; CEREBROVASCULAR AUTOREGULATION; SPONTANEOUS FLUCTUATIONS; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; HEAD-INJURY; REACTIVITY	Rapid bedside determination of cerebral blood pressure autoregulation (AR) may improve clinical utility. We tested the hypothesis that cerebral Hb oxygenation (Hb(Diff)) and cerebral Hb volume (Hb(Total)) measured by near-infrared spectroscopy (NIRS) would correlate with cerebral blood flow (CBF) after single dose phenylephrine (PE). Critically ill patients requiring artificial ventilation and arterial lines were eligible. During rapid blood pressure rise induced by i.v. PE bolus, Delta Hb(Diff) and Delta Hb(Total) were calculated by subtracting values at baseline (normotension) from values at peak blood pressure elevation (hypertension). With the aid of NIRS and bolus injection of indocyanine green, relative measures of CBF, called blood flow index (BFI), were determined during normotension and during hypertension. BFI during hypertension was expressed as percentage from BFI during normotension (BFI%). Autoregulation indices (ARIs) were calculated by dividing BFI%, Delta Hb(Diff), and Delta Hb(Total) by the concomitant change in blood pressure. In 24 patients (11 newborns and 13 children), significant correlations between BFI% and Delta Hb(Diff) (or Delta Hb(Total)) were found. In addition, the associations between Hb-based ARI and BFI%-based ART were significant with correlation coefficients of 0.73 (or 0.72). Rapid determination of dynamic AR with the aid of cerebral Hb signals and PE bolus seems to be reliable. (Pediatr Res 69: 436-441, 2011)	[Wagner, Bendicht P.] Univ Bern, Inselspital, Dept Pediat, Div Pediat Intens Care, CH-3010 Bern, Switzerland; [Schibler, Andreas] Mater Misericordiae Univ Hosp, Mater Childrens Hosp Mater, Dept Pediat, Brisbane, Qld 4101, Australia	Wagner, BP (corresponding author), Univ Bern, Inselspital, Dept Pediat, Div Pediat Intens Care, CH-3010 Bern, Switzerland.	bendicht.wagner@insel.ch	Schibler, Andreas/C-3503-2012; Schibler, Andreas/D-8876-2015; Ammann, Roland A/I-4716-2019	Ammann, Roland A/0000-0002-1902-2352; Schibler, Andreas/0000-0002-0791-5938	Department of Clinical Research; University of Berne; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32-51078.97]	Supported by the Department of Clinical Research, University of Berne, and the Swiss National Science Foundation (grant 32-51078.97).	Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bein B, 2006, CRIT CARE, V10, DOI 10.1186/cc3980; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; De Visscher G, 2002, COMP BIOCHEM PHYS A, V132, P87, DOI 10.1016/S1095-6433(01)00533-5; GODDARD J, 1980, J PEDIATR-US, V96, P1057, DOI 10.1016/S0022-3476(80)80641-X; GREEN HD, 1964, CIRC RES, V15, pS11; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hudetz AG, 1998, ADV EXP MED BIOL, V454, P551; Keller E, 2002, J NEUROSCI METH, V117, P23, DOI 10.1016/S0165-0270(02)00044-4; Kuebler WM, 1998, J CEREBR BLOOD F MET, V18, P445, DOI 10.1097/00004647-199804000-00013; Kuebler WM, 2008, J APPL PHYSIOL, V104, P905, DOI 10.1152/japplphysiol.00106.2008; Kurth CD, 2002, J CEREBR BLOOD F MET, V22, P335, DOI 10.1097/00004647-200203000-00011; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Meybohm P, 2008, ANESTH ANALG, V106, P795, DOI 10.1213/ane.0b013e31816173b4; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PERBECK L, 1985, CLIN PHYSIOL, V5, P281; Pryds A, 2005, PEDIATR RES, V57, P294, DOI 10.1203/01.PDR.0000148714.51310.5E; Schytz HW, 2009, EUR J NEUROL, V16, P461, DOI 10.1111/j.1468-1331.2008.02398.x; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Soul JS, 2000, PEDIATR RES, V48, P445, DOI 10.1203/00006450-200010000-00005; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Wagner BP, 2002, CRIT CARE MED, V30, P2014, DOI 10.1097/00003246-200209000-00010; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487	36	16	16	0	2	INT PEDIATRIC RESEARCH FOUNDATION, INC	BALTIMORE	351 W CAMDEN ST, BALTIMORE, MD 21201-2436 USA	0031-3998			PEDIATR RES	Pediatr. Res.	MAY	2011	69	5	1				436	441		10.1203/PDR.0b013e3182110177			6	Pediatrics	Pediatrics	753WN	WOS:000289811000012	21258266	Bronze			2021-06-18	
J	Mandalari, G; Genovese, T; Bisignano, C; Mazzon, E; Wickham, MSJ; Di Paola, R; Bisignano, G; Cuzzocrea, S				Mandalari, G.; Genovese, T.; Bisignano, C.; Mazzon, E.; Wickham, M. S. J.; Di Paola, R.; Bisignano, G.; Cuzzocrea, S.			Neuroprotective effects of almond skins in experimental spinal cord injury	CLINICAL NUTRITION			English	Article						Almond skins; Trauma; Inflammation; Oxidative stress; Apoptosis	NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; IMPROVES FUNCTIONAL RECOVERY; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; CELL-DEATH; GENE-EXPRESSION; ACTIVATION; DECOMPRESSION; MODULATION	Background & Aims: Functional deficits following spinal cord injury (SCI) arise from both mechanical injury and from secondary tissue reactions involving inflammation. Natural almond skins (NS) were tested to evaluate anti-inflammatory effects on an animal model of SO. Methods: SCI was induced by the application of vascular clips to the dura via a four-level T5-T8 laminectomy. In the present study, to elucidate whether the protective effects of NS are related to the total phenolic content, we also investigated the effect of a blanched (BS) almond skins (industrially obtained by removing bran from the nut) in SCI. NS and BS (30 mg/kg respectively) were administered per os, 1 h and 6 h, after SCI. Results: SCI in mice resulted in severe injury characterized by edema, tissue damage, production of inflammatory mediators and apoptosis (measured by Bax, Bcl-2 and Tunel assay). NS treatment, 1 and 6 h after SCI, reduced all parameters of inflammation as neutrophil infiltration, NF-kappa B activation, PAR formation, iNOS expression and apoptosis. However, treatment with BS did not exert any protective effect. Conclusions: Our results suggest that NS treatment, reducing the development of inflammation and tissue injury, may be useful in the treatment of SCI. (C) 2010 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	[Genovese, T.; Mazzon, E.; Di Paola, R.; Cuzzocrea, S.] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, I-98100 Messina, Italy; [Mandalari, G.; Bisignano, C.; Bisignano, G.] Univ Messina, Pharmacobiol Dept, I-98100 Messina, Italy; [Mandalari, G.; Wickham, M. S. J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Cuzzocrea, S.] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	Cuzzocrea, S (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Policlin Univ Via C Valeria, I-98100 Messina, Italy.	salvator@unime.it	Mazzon, Emanuela/AAL-4334-2020; di paola, rosanna/U-4356-2019	Bisignano, Giuseppe/0000-0002-9201-7867; mazzon, emanuela/0000-0002-5073-717X; di paola, rosanna/0000-0001-6725-8581; GENOVESE, Tiziana/0000-0002-3335-7327	IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy	This study was supported by a grant from IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy (SC). We thank Carmelo La Spada for excellent technical assistance during this study, Caterina Cutrona for secretarial assistance and Valentina Malvagni for editorial assistance with the paper. Natural almond and blanched almond skins were supplied by the Almond Board California.	Adler JE, 2009, PAIN MED, V10, P1229, DOI 10.1111/j.1526-4637.2009.00708.x; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Bao F, 2006, NEUROSCIENCE, V140, P1011, DOI 10.1016/j.neuroscience.2006.02.061; Bao F, 2003, J NEUROSCI RES, V71, P220, DOI 10.1002/jnr.10481; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 1998, J NEUROSCI, V18, P3251; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V319, P127, DOI 10.1124/jpet.106.108076; DOLAN EJ, 1980, J NEUROSURG, V53, P749, DOI 10.3171/jns.1980.53.6.0749; Genovese T, 2005, J PINEAL RES, V38, P198, DOI 10.1111/j.1600-079X.2004.00194.x; Genovese T, 2006, J NEUROSURG-SPINE, V4, P145, DOI 10.3171/spi.2006.4.2.145; Genovese T, 2008, BENEFICIAL EFFECTS E; Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471; GUHA A, 1987, PARAPLEGIA, V25, P324, DOI 10.1038/sc.1987.61; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Kasahara K, 2006, SPINE, V31, P2059, DOI 10.1097/01.brs.0000231893.21964.f2; Knekt P, 2002, AM J CLIN NUTR, V76, P560; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311; Lee DY, 2006, BIOCHEM BIOPH RES CO, V346, P727, DOI 10.1016/j.bbrc.2006.05.174; Lipton SA, 1997, NAT MED, V3, P20, DOI 10.1038/nm0197-20; Liu CL, 2002, CHINESE MED J-PEKING, V115, P740; Liu DX, 2005, J NEUROTRAUM, V22, P1123, DOI 10.1089/neu.2005.22.1123; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Mandalari G, 2010, FOOD CHEM, V122, P1083, DOI 10.1016/j.foodchem.2010.03.079; Mandalari G, 2010, J FOOD COMPOS ANAL, V23, P166, DOI 10.1016/j.jfca.2009.08.015; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Milbury PE, 2006, J AGR FOOD CHEM, V54, P5027, DOI 10.1021/jf0603937; Mir M, 2008, J NEUROIMMUNOL, V204, P101, DOI 10.1016/j.jneuroim.2008.07.002; Mullane K, 1989, Prog Clin Biol Res, V301, P39; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pellegrini M, 1999, J CLIN IMMUNOL, V19, P365, DOI 10.1023/A:1020598632068; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Qiu JX, 2004, J NEUROSCI RES, V77, P108, DOI 10.1002/jnr.20156; Reiter RJ, 2007, J PHYSIOL PHARMACOL, V58, P5; Salvemini D, 1998, DRUG NEWS PERSPECT, V11, P204; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Scott GS, 1999, ANN NEUROL, V45, P120, DOI 10.1002/1531-8249(199901)45:1<120::AID-ART18>3.0.CO;2-I; Shackelford DA, 2003, MOL BRAIN RES, V115, P173, DOI 10.1016/S0169-328X(03)00206-7; Shiva S, 2004, BIOCHEM SOC SYMP, V71, P107; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Turker M, 2005, ARCH ORTHOP TRAUM SU, V125, P336, DOI 10.1007/s00402-005-0816-4; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; White FA, 1998, J NEUROSCI, V18, P1428; Winkler T, 2002, AMINO ACIDS, V23, P273, DOI 10.1007/s00726-001-0138-y; Wu KL, 2009, J NEUROTRAUMA; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Zhao XR, 2001, J NEUROSCI RES, V64, P121, DOI 10.1002/jnr.1059	61	16	17	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	APR	2011	30	2					221	233		10.1016/j.clnu.2010.08.002			13	Nutrition & Dietetics	Nutrition & Dietetics	756KJ	WOS:000290009800014	20864228				2021-06-18	
J	Benech, A; Arcuri, F; Baragiotta, N; Nicolotti, M; Brucoli, M				Benech, Arnaldo; Arcuri, Francesco; Baragiotta, Nicola; Nicolotti, Matteo; Brucoli, Matteo			Retroauricular Transmeatal Approach to Manage Mandibular Condylar Head Fractures	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Condylar head fractures; retroauricular approach; transmeatal access; facial nerve	OPEN REDUCTION; INTERNAL-FIXATION; CLOSED TREATMENT; RETROMANDIBULAR APPROACH; INTRACAPSULAR FRACTURES; TEMPOROMANDIBULAR-JOINT; SURGICAL-TREATMENT; FOLLOW-UP; MOTION; SCREW	Background: There is a multitude of reported surgical approaches and technical variants with some unresolved technical problems to gain direct access to mandibular condylar head fractures; they can be divided into 2 groups: intraoral and extraoral. In 2005, Neff et al (Mund Kiefer Gesichtschir 2005;9:80), supported by a previous experimental work, reported a successful clinical study of condylar head fractures treated by a retroauricular approach; this article is in German, and the later English-language literature does not mention about this approach to open reduction and internal fixation of mandibular condylar fractures. The retroauricular transmeatal access, selected and performed by the senior author to treat 14 patients affected by highly located condylar head fracture, is illustrated in details. Methods: We collected data of 14 consecutive adult patients who, after the discussion about all options, had consented to have 16 mandibular condylar head fractures treated with open reduction and internal fixation by miniplates and screws via a retroauricular transmeatal approach. We exposed the temporomandibular joint area easily and better by dissecting via a retroauricular route with identification, ligation, and transection of the retromandibular vein; because of the posterior access, the frontal branch of the facial nerve and the auriculotemporal nerve are located and protected within the substance of the anteriorly retracted flap, superficial to the retromandibular vein. The follow-up clinical examination showed temporary weakness of the frontal branch of the facial nerve in 1 case with a recovery to normal function of 1.6 months; no patients had permanent weakness of the facial nerve or injury of the auriculotemporal nerve. There was absence of any salivary fistula, sialocele, and Frey syndrome; hearing was preserved in all cases, without any auditory stenosis or aesthetic deformity, and there was absence of any infections, hematoma, or scarring. Conclusions: Retroauricular approach provides good exposure of the temporomandibular joint and satisfactory protection from nerve injuries and vascular lesions, allowing an adequate osteosynthesis. The scar is hidden behind the ear, and the morbidity is low in terms of auditory stenosis, aesthetic deformity, and salivary fistulas.	[Benech, Arnaldo; Arcuri, Francesco; Baragiotta, Nicola; Nicolotti, Matteo; Brucoli, Matteo] Univ Piemonte Orientale Amedeo Avogadro, Azienda Osped Maggiore della Carita, Dept Maxillofacial Surg, Novara, Italy	Arcuri, F (corresponding author), Osped Maggiore della Carita, SCDU Chirurgia Maxillofacciale, Corso Mazzini 18, I-28100 Novara, Italy.	fraarcuri@libero.it		BRUCOLI, Matteo/0000-0002-2867-1936; BENECH, Arnaldo/0000-0003-1905-1089			Anastassov GE, 1997, J CRANIO MAXILL SURG, V25, P9, DOI 10.1016/S1010-5182(97)80018-2; Biglioli F, 2008, J CRANIO MAXILL SURG, V36, P378, DOI 10.1016/j.jcms.2008.05.001; BLAIR VP, 1913, S SURG GYNECOL, V26, P436; Bos RRM, 1999, BRIT J ORAL MAX SURG, V37, P87; Cascone P, 2003, J CRANIOFAC SURG, V14, P184, DOI 10.1097/00001665-200303000-00009; Choi BH, 1997, INT J ORAL MAX SURG, V26, P344, DOI 10.1016/S0901-5027(97)80794-1; Eckelt U., 1995, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V96, P158; Eckelt U, 2006, J CRANIO MAXILL SURG, V34, P306, DOI 10.1016/j.jcms.2006.03.003; Ellis E, 2000, J ORAL MAXIL SURG, V58, P950, DOI 10.1053/joms.2000.8734; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; Ellis E, 2000, J ORAL MAXIL SURG, V58, P260, DOI 10.1016/S0278-2391(00)90047-8; ELLIS E, 1993, ORAL SURG ORAL MED O, V76, P6, DOI 10.1016/0030-4220(93)90285-C; Ellis E 3rd, 2000, Facial Plast Surg, V16, P193, DOI 10.1055/s-2000-12579; Ellis ED, 2001, J ORAL MAXIL SURG, V59, P389, DOI 10.1053/joms.2001.21873; Eulert S, 2007, ANN ANAT, V189, P377, DOI 10.1016/j.aanat.2007.02.010; Gerbino G, 2009, J ORAL MAXIL SURG, V67, P1009, DOI 10.1016/j.joms.2008.06.009; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Haug RH, 2007, PLAST RECONSTR SURG, V120, p90S, DOI 10.1097/01.prs.0000260730.43870.1b; He D, 2008, J ORAL MAXIL SURG, V66, P77, DOI 10.1016/j.joms.2007.08.013; He DM, 2010, J ORAL MAXIL SURG, V68, P1578, DOI 10.1016/j.joms.2009.07.076; He DM, 2009, J ORAL MAXIL SURG, V67, P1672, DOI 10.1016/j.joms.2009.02.012; Hlawitschka M, 2005, INT J ORAL MAX SURG, V34, P597, DOI 10.1016/j.ijom.2005.02.004; Hlawitschka M, 2002, J ORAL MAXIL SURG, V60, P784, DOI 10.1053/joms.2002.33246; Hovinga J, 1999, INT J ORAL MAX SURG, V28, P429, DOI 10.1034/j.1399-0020.1999.280606.x; Jacobovicz J, 1998, PLAST RECONSTR SURG, V101, P437, DOI 10.1097/00006534-199802000-00030; Jensen T, 2006, J ORAL MAXIL SURG, V64, P1771, DOI 10.1016/j.joms.2005.12.069; KALLELA I, 1995, J ORAL MAXIL SURG, V53, P1397, DOI 10.1016/0278-2391(95)90663-0; KELLMAN RM, 2009, FACIAL PLAST SURG, V25; Kermer C, 1998, INT J ORAL MAX SURG, V27, P191, DOI 10.1016/S0901-5027(98)80008-8; Loukota RA, 2007, BRIT J ORAL MAX SURG, V45, P399, DOI 10.1016/j.bjoms.2005.12.002; Loukota RA, 2006, BRIT J ORAL MAX SURG, V44, P480, DOI 10.1016/j.bjoms.2005.11.019; MACLENNAN WD, 1952, BRIT J PLAST SURG, V5, P122; MALKIN M, 1964, Oral Surg Oral Med Oral Pathol, V17, P152, DOI 10.1016/0030-4220(64)90133-1; Manisali M, 2003, INT J ORAL MAX SURG, V32, P253, DOI 10.1054/ijom.2002.0270; Martin Mark, 2003, Atlas Oral Maxillofac Surg Clin North Am, V11, P169, DOI 10.1016/S1061-3315(02)00025-2; Narayanan V, 2009, INT J ORAL MAX SURG, V38, P835, DOI 10.1016/j.ijom.2009.04.008; Neff A, 2005, Mund Kiefer Gesichtschir, V9, P80, DOI 10.1007/s10006-005-0600-1; Neff A, 2004, Mund Kiefer Gesichtschir, V8, P63, DOI 10.1007/s10006-004-0529-9; Palmieri C, 1999, J ORAL MAXIL SURG, V57, P764, DOI 10.1016/S0278-2391(99)90810-8; Pilling E, 2006, J ORAL MAXIL SURG, V64, P868, DOI 10.1016/j.joms.2005.11.049; Schneider M, 2007, J CRANIO MAXILL SURG, V35, P151, DOI 10.1016/j.jcms.2007.01.003; Schoen R, 2008, INT J ORAL MAX SURG, V37, P111, DOI 10.1016/j.ijom.2007.06.017; SILVENNOINEN U, 1992, J ORAL MAXIL SURG, V50, P1032, DOI 10.1016/0278-2391(92)90484-H; TASANEN A, 1976, Journal of Maxillofacial Surgery, V4, P200, DOI 10.1016/S0301-0503(76)80036-7; Throckmorton GS, 2004, J ORAL MAXIL SURG, V62, P127, DOI 10.1016/j.joms.2003.01.003; Throckmorton GS, 2000, INT J ORAL MAX SURG, V29, P421, DOI 10.1034/j.1399-0020.2000.290605.x; Vesnaver A, 2005, J CRANIO MAXILL SURG, V33, P169, DOI 10.1016/j.jcms.2005.01.008; Vesnaver A, 2008, J ORAL MAXIL SURG, V66, P2123, DOI 10.1016/j.joms.2008.06.010; Wilson AW, 2005, BRIT J ORAL MAX SURG, V43, P57, DOI 10.1016/j.bjoms.2004.09.011; Ziccardi VB, 1997, J ORAL MAXIL SURG, V55, P602, DOI 10.1016/S0278-2391(97)90492-4	50	16	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR	2011	22	2					641	647		10.1097/SCS.0b013e318207f495			7	Surgery	Surgery	736ZT	WOS:000288535800063	21403547				2021-06-18	
J	Lotocki, G; Vaccari, JD; Alonso, O; Molano, JS; Nixon, R; Dietrich, WD; Bramlett, HM				Lotocki, George; Vaccari, Juan de Rivero; Alonso, Ofelia; Molano, Juliana Sanchez; Nixon, Ryan; Dietrich, W. Dalton; Bramlett, Helen M.			Oligodendrocyte Vulnerability Following Traumatic Brain Injury in Rats: Effect of Moderate Hypothermia	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article								The purpose of this study was to document patterns of oligodendrocyte vulnerability to traumatic brain injury (TBI) and determine whether post-traumatic hypothermia prevents oligodendrocyte cell loss. Sprague-Dawley rats underwent moderate fluid percussion brain injury. Thirty minutes after TBI, brain temperature was reduced to 33 degrees C for 4 hours or maintained at normothermic levels (37 degrees C). Animals were perfusion-fixed for quantitative immunohistochemical analysis at 3 (n = 9) or 7 (n = 9) days post-TBI. Within the cerebral cortex, external capsule, and corpus callosum, numbers of APC-CC1 immunoreactive oligodendrocytes at 3 and 7 days following TBI were significantly decreased compared with sham-operated rats (p < 0.02). Double-labeling studies showed that vulnerable oligodendrocytes expressed increased Caspase 3 activation compared with sham. Post-traumatic hypothermia significantly reduced the number of CC1-positive oligodendrocytes lost after normothermia TBI in white matter tracts (p < 0.01). This model of TBI leads to quantifiable regional patterns of oligodendrocyte vulnerability. Post-traumatic hypothermia protects oligodendrocytes by interfering with Caspase 3-mediated cell death mechanisms. Therapeutic hypothermia may improve functional outcome by attenuating trauma-induced oligodendrocyte cell death, subsequent demyelination, and circuit dysfunction.	[Lotocki, George; Vaccari, Juan de Rivero; Alonso, Ofelia; Molano, Juliana Sanchez; Nixon, Ryan; Dietrich, W. Dalton; Bramlett, Helen M.] Univ Miami Miller Sch Med, Miami Project Cure Paralysis, Miami, FL USA; [Vaccari, Juan de Rivero; Dietrich, W. Dalton; Bramlett, Helen M.] Univ Miami Miller Sch Med, Dept Neurol Surg, Miami, FL USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs, Med Ctr, Miami, FL USA	Bramlett, HM (corresponding author), Univ Miami Miller Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace LPLC 3-18, Miami, FL 33136 USA.	hbramlett@miami.edu		de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834	 [NS030291];  [NS042133]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS042133] Funding Source: NIH RePORTER	The authors thank Jeremy Lytle for help and editorial assistance with the article. This work was supported by NS030291 and NS042133.	ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Bhat RV, 1996, GLIA, V17, P169; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dietrich WD, 1996, ADV NEUROL, V71, P177; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gootjes L, 2004, DEMENT GERIATR COGN, V18, P180, DOI 10.1159/000079199; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kujala P, 1997, BRAIN, V120, P289, DOI 10.1093/brain/120.2.289; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Mabbott DJ, 2006, NEUROIMAGE, V33, P936, DOI 10.1016/j.neuroimage.2006.07.024; McDonald JW, 1996, ANN NEUROL, V40, P750, DOI 10.1002/ana.410400511; McDonald JW, 2002, NEUROSCIENCE, V115, P931, DOI 10.1016/S0306-4522(02)00342-1; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schulz R, 2008, CELL TISSUE RES, V334, P327, DOI 10.1007/s00441-008-0714-5; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Yu WR, 2009, NEUROBIOL DIS, V33, P149, DOI 10.1016/j.nbd.2008.09.024	49	16	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	MAR 1	2011	1	1								10.1089/ther.2010.0011			10	Critical Care Medicine	General & Internal Medicine	V38PS	WOS:000209355900003	23336085	Green Accepted, Green Published			2021-06-18	
J	Ostberg, A; Virta, J; Rinne, JO; Oikonen, V; Luoto, P; Nagren, K; Arponen, E; Tenovuo, O				Ostberg, A.; Virta, J.; Rinne, J. O.; Oikonen, V.; Luoto, P.; Nagren, K.; Arponen, E.; Tenovuo, O.			Cholinergic dysfunction after traumatic brain injury Preliminary findings from a PET study	NEUROLOGY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HEAD-INJURY; ACETYLCHOLINESTERASE ACTIVITY; ALZHEIMERS-DISEASE; BASAL FOREBRAIN; IN-VIVO; RIVASTIGMINE; DONEPEZIL; IMPAIRMENT; PROPIONATE	Objective: There is evidence that the cholinergic system is frequently involved in the cognitive consequences of traumatic brain injury (TBI). We studied whether the brain cholinergic function is altered after TBI in vivo using PET. Methods: Cholinergic function was assessed with [methyl-C-11]N-methylpiperidyl-4-acetate, which reflects the acetylcholinesterase (AChE) activity, in 17 subjects more than 1 year after a TBI and in 12 healthy controls. All subjects had been without any centrally acting drugs for at least 4 weeks. Results: The AChE activity was significantly lower in subjects with TBI compared to controls in several areas of the neocortex (-5.9% to -10.8%, p = 0.053 to 0.004). Conclusions: Patients with chronic cognitive symptoms after TBI show widely lowered AChE activity across the neocortex. Neurology (R) 2011;76:1046-1050	[Ostberg, A.; Tenovuo, O.] Univ Turku, Dept Neurol, FIN-20251 Turku, Finland; [Virta, J.; Rinne, J. O.; Oikonen, V.; Luoto, P.; Nagren, K.; Arponen, E.] Univ Turku, Turku Positron Emiss Tomog Ctr, FIN-20251 Turku, Finland; Turku Univ, Cent Hosp, Turku, Finland	Tenovuo, O (corresponding author), Univ Turku, Dept Neurol, POB 52, FIN-20251 Turku, Finland.	olli.tenovuo@tyks.fi	Nagren, Kjell/AAE-7039-2019	Oikonen, Vesa/0000-0002-1947-0219	Hospital District of Southwest Finland; NovartisNovartis; Turku Imanet Oy (subsidiary of GE Healthcare); Orion Corporation; Bayer Schering PharmaBayer AG; Turku University Foundation	Supported by Hospital District of Southwest Finland Research grant from the hospital's research funding resources.; Dr. Ostberg reports no disclosures. Dr. Virta has received funding for travel from Novartis and received research support from Turku Imanet Oy (subsidiary of GE Healthcare), Orion Corporation, and Bayer Schering Pharma. Dr. Rinne serves on scientific advisory boards for Lundbeck Inc. and Boehringer Ingelheim; serves as an Associate Editor for Journal of Alzheimer's Disease; and receives research support from GE Healthcare and its subsidiary Turku Imanet Oy, Bristol-Myers Squibb, Roche, Wyeth, AC Immune SA, the Academy of Finland, and the Sigrid Juselius Foundation. Dr. Oikonen, P. Luoto, Dr. Nagren, and E. Arponen report no disclosures. Dr. Tenovuo receives research support from Turku University Foundation.	[Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; Bohnen NI, 2005, NEUROSCI LETT, V380, P127, DOI 10.1016/j.neulet.2005.01.031; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; DEKKER AJAM, 1991, NEUROSCI BIOBEHAV R, V15, P299, DOI 10.1016/S0149-7634(05)80008-9; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Kaasinen V, 2002, J CLIN PSYCHOPHARM, V22, P615, DOI 10.1097/00004714-200212000-00012; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kilbourn MR, 1996, SYNAPSE, V22, P123, DOI 10.1002/(SICI)1098-2396(199602)22:2<123::AID-SYN5>3.0.CO;2-F; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Kuhl DE, 2002, J CLIN PSYCHOPHARM, V22, P615; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Meyer JH, 1999, NEUROIMAGE, V9, P545, DOI 10.1006/nimg.1999.0431; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Nagatsuka S, 2001, J CEREBR BLOOD F MET, V21, P1354, DOI 10.1097/00004647-200111000-00011; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sato K, 2004, J CEREBR BLOOD F MET, V24, P600, DOI 10.1097/01.WCB.0000117689.98763.6A; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Semba K, 2000, BEHAV BRAIN RES, V115, P115, DOI 10.1016/S0166-4328(00)00253-9; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Snyder SE, 2001, J CEREBR BLOOD F MET, V21, P132, DOI 10.1097/00004647-200102000-00004; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Tenovuo OS, 2006, CURR DRUG THER, V1, P187, DOI 10.2174/157488506776930932; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	37	16	18	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR	2011	76	12					1046	1050		10.1212/WNL.0b013e318211c1c4			5	Clinical Neurology	Neurosciences & Neurology	741GW	WOS:000288853200008	21422456				2021-06-18	
J	Zatzick, DF; Grossman, DC				Zatzick, Douglas F.; Grossman, David C.			Association Between Traumatic Injury and Psychiatric Disorders and Medication Prescription to Youths Aged 10-19	PSYCHIATRIC SERVICES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD INJURY; QUALITY-OF-LIFE; BRAIN-INJURY; CHILDREN; SYMPTOMS; ADOLESCENTS; CARE; PREDICTORS; PTSD	Objective: Few clinical epidemiologic investigations have assessed whether youths exposed to a traumatic injury demonstrate elevations in the full spectrum of provider-recognized psychiatric disorders compared with unexposed, noninjured youths. Methods: In a population-based prospective cohort study, data for children and adolescents aged ten to 19 who were enrolled in the Group Health Cooperative health plan were screened for injury visits in the index year of 2001 (N=20,507). Psychiatric diagnoses, including anxiety and acute stress, depressive, substance use, and disruptive behavior disorders, given to these youths over the next three years (2002-2004) were documented, as were psychotropic medication prescriptions. Regression analyses assessed for an independent association between injury and psychiatric disorders and prescription of psychotropic medication. Results: In adjusted regression analyses, injury in the index year was independently associated with significantly increased odds of receiving a diagnosis of anxiety or acute stress (odds ratio [OR]=1.21, 95% confidence interval [CI]=1.02-1.44), depression (OR=1.30, CI=1.10-1.53), and a substance use disorder (OR=1.56, CI=1.21-2.00) and of receiving a psychotropic medication prescription (OR=1.37, CI=1.20-1.57). Youths with traumatic brain injuries also were significantly more likely to receive psychotropic medication prescriptions. Conclusions: Traumatic injury was independently associated with an increased risk of receiving a full spectrum of anxiety, depressive, and substance use diagnoses among youths aged ten to 19. Population-based surveillance procedures that incorporate screening and stepped-care interventions targeting the spectrum of postinjury emotional disturbances have the potential to improve the quality of mental health care for youths treated in general medical settings. (Psychiatric Services 62:264-271, 2011)	[Zatzick, Douglas F.] Univ Washington, Harborview Med Ctr, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Grossman, David C.] Univ Washington, Sch Med, Grp Hlth Res Inst, Seattle, WA 98104 USA; [Grossman, David C.] Univ Washington, Sch Med, Dept Hlth Sci, Seattle, WA 98104 USA	Zatzick, DF (corresponding author), Univ Washington, Harborview Med Ctr, Dept Psychiat & Behav Sci, 325 9th Ave, Seattle, WA 98104 USA.	dzatzick@u.washington.edu			National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH073613, K24-MH086914]; National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49-CCR316840]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K24MH086814, R01MH073613] Funding Source: NIH RePORTER	This work was supported by grants R01-MH073613 and K24-MH086914 from the National Institute of Mental Health and by grant R49-CCR316840 from the National Center for Injury Prevention and Control and the Centers for Disease Control and Prevention.	Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; American College of Surgeons Committee on Trauma, 2006, RES OPT CAR INJ PAT; [Anonymous], 2006, CDC INJ FACT BOOK; *ASS ADV AUT MED C, 1990, ABBR INJ SCAL 1990 R; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bonnie R.J., 1999, REDUCING BURDEN INJU; Borse N. N., 2008, PATTERNS UNINTENTION; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Butler J, 2001, CENTRAL NERVOUS SYST; Civil I.D., 1985, ABBREVIATED INJURY S; Cohen JA, 2008, ARCH PEDIAT ADOL MED, V162, P447, DOI 10.1001/archpedi.162.5.447; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Cox CM, 2008, J SPEC PEDIATR NURS, V13, P98, DOI 10.1111/j.1744-6155.2008.00141.x; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; Dunn C, 2008, J TRAUMA, V65, P736, DOI 10.1097/TA.0b013e31817de40f; Ehlers A, 2003, BEHAV RES THER, V41, P1, DOI 10.1016/S0005-7967(01)00126-7; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Grossman DC, 2000, FUTURE CHILD, V10, P23, DOI 10.2307/1602824; Grupp-Phelan J, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-12; Holbrook TL, 2007, J TRAUMA, V62, P577, DOI 10.1097/TA.0b013e318031aa97; Hosmer D, 1989, APPL LOGISTIC REGRES; Institute of Medicine Committee on the Future of Emergency Care in the United States Health System, 2006, EM CAR CHILDR GROW P; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; KEENAN HT, 2008, BRIT MED J, V7680, P1208; Kenardy JA, 2006, PEDIATRICS, V118, P1002, DOI 10.1542/peds.2006-0406; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Koenen KC, 2008, J ABNORM PSYCHOL, V117, P460, DOI 10.1037/0021-843X.117.2.460; Koepsell TD, 2003, EPIDEMIOLOGIC METHOD; Langeland W, 2008, NEUROSCI BIOBEHAV R, V32, P161, DOI 10.1016/j.neubiorev.2007.07.002; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; MAX JE, 1998, J NERV MENT DIS, V186, P446; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Mirza KAH, 1998, BRIT J PSYCHIAT, V172, P443, DOI 10.1192/bjp.172.5.443; Mueser KT, 2008, PSYCHIAT SERV, V59, P627, DOI 10.1176/appi.ps.59.6.627; Owens PL, 2008, AMBUL PEDIATR, V8, P219, DOI 10.1016/j.ambp.2008.03.032; RIVARA FP, 1989, AM J PUBLIC HEALTH, V79, P990, DOI 10.2105/AJPH.79.8.990; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; Sabin JA, 2006, PEDIATRICS, V117, P130, DOI 10.1542/peds.2005-1042; Saxe GN, 2005, AM J PSYCHIAT, V162, P1299; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shemesh E, 2003, PSYCHIAT SERV, V54, P1277, DOI 10.1176/appi.ps.54.9.1277; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Stein BD, 2007, PSYCHIAT SERV, V58, P1563, DOI 10.1176/appi.ps.58.12.1563; Stein MB, 2006, PSYCHIAT SERV, V57, P673, DOI 10.1176/appi.ps.57.5.673; Stoddard FJ, 2006, J AM ACAD CHILD PSY, V45, P87, DOI 10.1097/01.chi.0000184934.71917.3a; Stoddard FJ, 2001, J AM ACAD CHILD PSY, V40, P1128, DOI 10.1097/00004583-200110000-00007; Sturms LM, 2005, CLIN REHABIL, V19, P312, DOI 10.1191/0269215505cr867oa; Terrell F, 2008, J AM COLL SURGEONS, V207, P630, DOI 10.1016/j.jamcollsurg.2008.05.021; Thurman DJ., 1995, GUIDELINES SURVEILLA; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Winston FK, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e90; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642; Zatzick DF, 2006, J AM ACAD CHILD PSY, V45, P1188, DOI 10.1097/01.chi.0000231975.21096.45; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zink Kathleen A, 2003, J Spec Pediatr Nurs, V8, P99, DOI 10.1111/j.1088-145X.2003.00099.x	66	16	16	0	6	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	MAR	2011	62	3					264	271		10.1176/appi.ps.62.3.264			8	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	728AL	WOS:000287845800005	21363897	Green Accepted			2021-06-18	
J	Saban, KL; Smith, BM; Collins, EG; Pape, TLB				Saban, Karen L.; Smith, Bridget M.; Collins, Eileen G.; Pape, Theresa Louise-Bender			Sex Differences in Perceived Life Satisfaction and Functional Status One Year After Severe Traumatic Brain Injury	JOURNAL OF WOMENS HEALTH			English	Article							QUALITY-OF-LIFE; GENDER-DIFFERENCES; INDEPENDENCE MEASURE; CEREBRAL-ISCHEMIA; SELF-EFFICACY; 1ST YEAR; PROGESTERONE; OUTCOMES; FEMALE; ESTROGEN	Aims: The primary aim of this study was to describe and compare perceived life satisfaction and perceived functional motor and cognitive status 1 year after severe traumatic brain injury (TBI) in males and females, adjusting for demographics and severity of injury. Methods: Data of 297 participants were abstracted from the National Institute on Disability Rehabilitation and Research (NIDRR)-funded Traumatic Brain Injury Model Systems (TBIMS). Participants were aged 16-50, enrolled in the TBIMS study between the years 1998 and 2008, diagnosed with severe TBI (defined as having an initial Glasgow Coma Scale [GCS] score between 3 and 8), and with perceived life satisfaction and functional status data available at 1 year postinjury. Multiple linear regression models were used to estimate the association between sex, demographic variables, severity of injury, and the outcome variables. Results: Our findings indicate that sex did not significantly influence perceived satisfaction with life or motor function 1 year after severe TBI. However, females had significantly better (p = 0.031) cognitive outcomes compared to males 1 year after severe TBI, after controlling for demographics and severity of injury. Conclusions: Findings suggest that females may have better perceived cognitive functional outcomes than males 1 year after severe TBI. Further longitudinal research, including measurement of hormonal levels, is needed to determine if hormones influence outcomes of severe TBI as well as the trajectory of these outcomes. A better understanding of sex differences in outcomes after TBI will help clinicians improve strategies for rehabilitation.	[Saban, Karen L.] Loyola Univ Chicago, Marcella Niehoff Sch Nursing, Dept Hlth Management & Risk Reduct, Maywood, IL 60153 USA; [Saban, Karen L.; Smith, Bridget M.; Collins, Eileen G.; Pape, Theresa Louise-Bender] Edward Hines Jr VA Hosp, Ctr Management Complex Chron Care, Hines, IL USA; [Smith, Bridget M.] Loyola Univ Chicago, Stritch Sch Med, Hlth Serv Res Program, Maywood, IL 60153 USA; [Collins, Eileen G.] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Feinburg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Saban, KL (corresponding author), Loyola Univ Chicago, Marcella Niehoff Sch Nursing, Dept Hlth Management & Risk Reduct, Maguire Bldg,Room 2840,2160 S 1st Ave, Maywood, IL 60153 USA.	ksaban@luc.edu	Saban, Karen/H-4837-2011	Saban, Karen/0000-0001-5767-5453; Bender Pape, Theresa/0000-0001-7738-5963	Veterans Affairs (VA) Health Service Research and Development (HSRD)US Department of Veterans Affairs [TPN-42-001]; Rehabilitation Research & Development (RR&D), Department of Veterans AffairsUS Department of Veterans Affairs; VA RR&D Career Development Transition Award; VA HSRD	The TBIMS National Database was supported by the U.S. Department of Education, NIDRR, in collaboration with the TBIMS Centers. However, these contents do not necessarily reflect the opinions or views of the TBIMS Centers, NIDRR, or the U. S. Department of Education.; K. L. S. is supported by a 3-year Veterans Affairs (VA) Health Service Research and Development (HSR&D) Postdoctoral Fellowship (TPN-42-001). B. M. S. is supported by funding through VAHSR&D. E. G. C. is supported by a Research Career Scientist Award, Rehabilitation Research & Development (RR&D), Department of Veterans Affairs. T.L.-B.P. is supported by a 3-year VA RR&D Career Development Transition Award and an RR&D merit grant as well as a VA HSR&D merit grant. The views expressed do not necessarily reflect the position or policy of the Department of Veterans Affairs. The authors thank the blinded reviewers for their thoughtful suggestions that strengthened the article.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Beal CC, 2010, J NEUROSCI NURS, V42, P80, DOI 10.1097/JNN.0b013e3181ce5c70; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cain KC, 2009, DIGEST DIS SCI, V54, P1542, DOI 10.1007/s10620-008-0516-3; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Frisch M, 1994, MANUAL TREATMENT GUI; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Gulinello M, 2006, HORM BEHAV, V49, P246, DOI 10.1016/j.yhbeh.2005.07.010; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; HURN PD, 1995, J CEREBR BLOOD F MET, V15, P666, DOI 10.1038/jcbfm.1995.82; Kraus J F, 2000, Neurosurg Focus, V8, pe5; KumeKick J, 1996, BRAIN RES, V738, P8, DOI 10.1016/0006-8993(96)00744-5; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Liu R, 2005, BRAIN RES, V1060, P55, DOI 10.1016/j.brainres.2005.08.048; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; MENDELSON ME, 1994, CURR OPIN CARDIOL, V9, P619, DOI 10.1097/00001573-199409000-00018; Merrill SS, 1997, J GERONTOL A-BIOL, V52, pM19, DOI 10.1093/gerona/52A.1.M19; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Suzuki S, 2007, J COMP NEUROL, V500, P1064, DOI 10.1002/cne.21240; TEASDALE G, 1974, LANCET, V2, P81; Thomas MD, 2009, BRAIN INJURY, V23, P516, DOI 10.1080/02699050902926333; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	49	16	18	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	FEB	2011	20	2					179	186		10.1089/jwh.2010.2334			8	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	720TU	WOS:000287306100003	21314444				2021-06-18	
J	Thakor, DK; Teng, YD; Obata, H; Nagane, K; Saito, S; Tabata, Y				Thakor, Devang K.; Teng, Yang D.; Obata, Hideaki; Nagane, Kentaro; Saito, Shigeru; Tabata, Yasuhiko			Nontoxic Genetic Engineering of Mesenchymal Stem Cells Using Serum-Compatible Pullulan-Spermine/DNA Anioplexes	TISSUE ENGINEERING PART C-METHODS			English	Article							SPINAL-CORD-INJURY; STEM/PROGENITOR CELLS; STROMAL CELLS; PLASMID DNA; TRANSGENE EXPRESSION; PALMITIC ACID; DELIVERY; ADULT; TRANSFECTION; TRANSPLANTATION	Genetic modification of stem cells could be applied to initiate/enhance their secretion of therapeutic molecules, alter their biological properties, or label them for in vivo tracking. We recently developed a negatively charged gene carrier ("anioplex") based on pullulan-spermine, a conjugate prepared from a natural polysaccharide and polyamine. In rat mesenchymal stem cells (MSCs), anioplex-derived reporter gene activity was comparable to or exceeded that obtained using a commercial cationic lipid reagent. Transfection in the growth medium with 15% serum and antibiotics was approximately sevenfold more effective than in serum-free conditions. Cytotoxicity was essentially indiscernible after 24 h of anioplex transfection with 20 mu g/mL DNA, in contrast to cationic lipid transfection that resulted in 40%-60% death of target MSCs. Anioplex-derived reporter gene activity persisted throughout the entire 3-week study, with post-transfection MSCs appearing to maintain osteogenic, adipogenic, and chondrogenic multipotency. In particular, chondrogenic pellet formation of differentiating human MSCs was significantly inhibited after lipofection but not after aniofection, which further indicates the biological inertness of pullulan-spermine/DNA anioplexes. Collectively, these data introduce a straightforward technology for genetic engineering of adult stem/progenitor cells under physiological niche-like conditions. Moreover, reporter gene activity was observed in rat spinal cords after minimally invasive intrathecal implantation, suggesting effective engraftment of donor MSCs. It is therefore plausible that anioplex-transfected MSCs or other stem/progenitor cells with autologous potential could be applied to disorders such as neurotrauma or neuropathic pain that involve the spinal cord and brain.	[Thakor, Devang K.; Teng, Yang D.] Boston VA Healthcare Syst, Div SCI Res, Boston, MA 02132 USA; [Thakor, Devang K.; Nagane, Kentaro; Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Thakor, Devang K.; Teng, Yang D.] Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA USA; [Thakor, Devang K.; Teng, Yang D.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Obata, Hideaki; Saito, Shigeru] Gunma Univ, Sch Med, Dept Anesthesiol, Maebashi, Gunma 371, Japan	Teng, YD (corresponding author), Boston VA Healthcare Syst, Div SCI Res, 1400 VFW Pkwy,Bldg 3,Room 2B110, Boston, MA 02132 USA.	yang_teng@hms.harvard.edu; yasuhiko@frontier.kyoto-u.ac.jp			Japan Society for the Promotion of Science, as well as the TakanawakaiMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Clinical Implant Society of Japan; VAUS Department of Veterans Affairs; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; CIMIT-DOD; State of Massachusetts	D. K. T. has been supported by a foreign postdoctoral fellowship and grant-in-aid from the Japan Society for the Promotion of Science, as well as the Takanawakai, the Clinical Implant Society of Japan, and a VA Biomedical Merit Grant. Work at Y.D.T.'s labs are supported by VA, NIH, CIMIT-DOD, and the State of Massachusetts. We thank Dr. Jun-Ichiro Jo, Mr. Masataka Yoshida, and Mr. Norio Doi of Kyoto University for assistance in the preparation of pullulan-spermine. We thank Dr. Jyunichi Miyazaki of Osaka University for kindly providing luciferase. We thank Dr. Masaru Tobe of Gunma University for assistance with animal experiments. We thank Mr. Nirav Thakor for assistance with figure preparation.	Ahn HH, 2008, BIOMATERIALS, V29, P2415, DOI 10.1016/j.biomaterials.2008.02.006; Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Brinchmann JE, 2008, J NEUROL SCI, V265, P127, DOI 10.1016/j.jns.2007.05.006; Callera F, 2006, EXP HEMATOL, V34, P130, DOI 10.1016/j.exphem.2005.11.006; Castellanos DA, 2002, CELL TRANSPLANT, V11, P297; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Clements BA, 2007, BIOMATERIALS, V28, P4693, DOI 10.1016/j.biomaterials.2007.07.023; Clements BA, 2006, BIOMACROMOLECULES, V7, P1481, DOI 10.1021/bm060073w; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0; Dokka S, 2000, PHARMACEUT RES, V17, P521, DOI 10.1023/A:1007504613351; Duplan H, 2004, NEUROSCI LETT, V370, P1, DOI 10.1016/j.neulet.2004.07.017; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Hayase M, 2009, J CEREBR BLOOD F MET, V29, P1409, DOI 10.1038/jcbfm.2009.62; Hoelters J, 2005, J GENE MED, V7, P718, DOI 10.1002/jgm.731; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008; Incani V, 2007, J BIOMED MATER RES A, V81A, P493, DOI 10.1002/jbm.a.31249; Jaderstad J, 2010, P NATL ACAD SCI USA, V107, P5184, DOI 10.1073/pnas.0915134107; Jo J, 2007, J CONTROL RELEASE, V118, P389, DOI 10.1016/j.jconrel.2007.01.005; Jo JI, 2007, TISSUE ENG, V13, P313, DOI 10.1089/ten.2006.0133; Kimelman N, 2007, TISSUE ENG, V13, P1135, DOI 10.1089/ten.2007.0096; Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009; Mitsui T, 2005, EXP NEUROL, V194, P410, DOI 10.1016/j.expneurol.2005.02.022; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nagane K, 2009, TISSUE ENG PT A, V15, P1655, DOI 10.1089/ten.tea.2008.0453; Nair RR, 2002, MOL THER, V5, P455, DOI 10.1006/mthe.2002.0567; Nakahara Y, 1996, CELL TRANSPLANT, V5, P191, DOI 10.1016/0963-6897(95)02028-4; Nishikawa M, 2001, HUM GENE THER, V12, P861, DOI 10.1089/104303401750195836; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Okazaki A, 2007, TISSUE ENG, V13, P245, DOI 10.1089/ten.2006.0185; Papapetrou EP, 2005, GENE THER, V12, pS118, DOI 10.1038/sj.gt.3302626; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Phillips MI, 2008, ADV DRUG DELIVER REV, V60, P160, DOI 10.1016/j.addr.2007.08.035; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rivera FT, 2006, STEM CELLS, V24, P2209, DOI 10.1634/stemcells.2005-0614; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Takamoto T, 2007, J BIOMAT SCI-POLYM E, V18, P865, DOI 10.1163/156856207781367738; Tanaka T, 2005, BIOL PHARM BULL, V28, P560, DOI 10.1248/bpb.28.560; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tey SK, 2007, MOL THER, V15, P666, DOI 10.1038/sj.mt.6300109; Thakor DK, 2009, BIOMATERIALS, V30, P1815, DOI 10.1016/j.biomaterials.2008.12.032; Thomas M, 2003, APPL MICROBIOL BIOT, V62, P27, DOI 10.1007/s00253-003-1321-8; Vacanti V, 2005, J CELL PHYSIOL, V205, P194, DOI 10.1002/jcp.20376; Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Wang L, 2004, MOL THER, V9, P729, DOI 10.1016/j.ymthe.2004.02.009; Werkmeister JA, 2002, J PEPT RES, V60, P232, DOI 10.1034/j.1399-3011.2002.21011.x; Yang F, 2009, GENE THER, V16, P533, DOI 10.1038/gt.2008.182; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807	56	16	16	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	FEB	2011	17	2					131	144		10.1089/ten.tec.2010.0120			14	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Cell Biology; Engineering; Materials Science	713GR	WOS:000286723900002	20698746	Green Published			2021-06-18	
J	Yunusova, Y; Green, JR; Wang, J; Pattee, G; Zinman, L				Yunusova, Yana; Green, Jordan R.; Wang, Jun; Pattee, Gary; Zinman, Lorne			A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 48; speech; assessment; subsystems; bulbar function; amyotrophic lateral sclerosis	NASALANCE; SPEECH; JUDGMENTS	Improved methods for assessing bulbar impairment are necessary for expediting diagnosis of bulbar dysfunction in ALS, for predicting disease progression across speech subsystems, and for addressing the critical need for sensitive outcome measures for ongoing experimental treatment trials. To address this need, we are obtaining longitudinal profiles of bulbar impairment in 100 individuals based on a comprehensive instrumentation-based assessment that yield objective measures. Using instrumental approaches to quantify speech-related behaviors is very important in a field that has primarily relied on subjective, auditory-perceptual forms of speech assessment(1). Our assessment protocol measures performance across all of the speech subsystems, which include respiratory, phonatory (laryngeal), resonatory (velopharyngeal), and articulatory. The articulatory subsystem is divided into the facial components (jaw and lip), and the tongue. Prior research has suggested that each speech subsystem responds differently to neurological diseases such as ALS. The current protocol is designed to test the performance of each speech subsystem as independently from other subsystems as possible. The speech subsystems are evaluated in the context of more global changes to speech performance. These speech system level variables include speaking rate and intelligibility of speech. The protocol requires specialized instrumentation, and commercial and custom software. The respiratory, phonatory, and resonatory subsystems are evaluated using pressure-flow (aerodynamic) and acoustic methods. The articulatory subsystem is assessed using 3D motion tracking techniques. The objective measures that are used to quantify bulbar impairment have been well established in the speech literature and show sensitivity to changes in bulbar function with disease progression. The result of the assessment is a comprehensive, across-subsystem performance profile for each participant. The profile, when compared to the same measures obtained from healthy controls, is used for diagnostic purposes. Currently, we are testing the sensitivity and specificity of these measures for diagnosis of ALS and for predicting the rate of disease progression. In the long term, the more refined endophenotype of bulbar ALS derived from this work is expected to strengthen future efforts to identify the genetic loci of ALS and improve diagnostic and treatment specificity of the disease as a whole. The objective assessment that is demonstrated in this video may be used to assess a broad range of speech motor impairments, including those related to stroke, traumatic brain injury, multiple sclerosis, and Parkinson disease.	[Yunusova, Yana] Univ Toronto, Dept Speech Language Pathol, Toronto, ON M5S 1A1, Canada; [Yunusova, Yana; Zinman, Lorne] Sunnybrook Hlth Sci Ctr, ALS MN Clin, Toronto, ON, Canada; [Green, Jordan R.; Wang, Jun] Univ Nebraska Lincoln, Dept Special Educ & Commun Disorders, Lincoln, NE USA; [Pattee, Gary] Univ Nebraska Med Ctr, Munroe Meyer Inst, Dept Neurol, Lincoln, NE USA; [Zinman, Lorne] Univ Toronto, Dept Neurol, Toronto, ON M5S 1A1, Canada	Yunusova, Y (corresponding author), Univ Toronto, Dept Speech Language Pathol, Toronto, ON M5S 1A1, Canada.	yana.yunusova@utoronto.ca	Green, Jordan/N-3585-2019; Wang, Jun/G-8572-2015; Yunusova, Yana/E-3428-2010	Green, Jordan/0000-0002-1464-1373; Yunusova, Yana/0000-0002-2353-2275	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DCO09890-02]; Canadian Foundation for InnovationCanada Foundation for Innovation [15704]; Connaught FoundationUniversity of Toronto; University of TorontoUniversity of Toronto	This work has been supported by the National Institute of Health, National Institute on Deafness and Other Communication Disorders, Grant R01DCO09890-02, Canadian Foundation for Innovation (CFI-LOF #15704), and Connaught Foundation, University of Toronto. The authors would like to thank Cynthia Didion, Mili Kuruvilla, Krista Rudy, and Lori Synhorst for assistance with data collection and analysis; and Cara Ullman for creating video clips.	Baken R.J., 2000, CLIN MEASUREMENT SPE; Ball LJ, 2001, J NEUROL SCI, V191, P43, DOI 10.1016/S0022-510X(01)00623-2; Beukelman D., 2007, SPEECH INTELLIGIBILI; Bressmann T, 2000, CLEFT PALATE-CRAN J, V37, P248, DOI 10.1597/1545-1569(2000)037<0248:NDARTN>2.3.CO;2; Delorey R, 1999, J MED SPEECH-LANG PA, V7, P19; FLETCHER SG, 1976, CLEFT PALATE J, V13, P31; Gauster A, 2010, CLIN LINGUIST PHONET, V24, P576, DOI 10.3109/02699200903581042; Green JR, 2006, DEV PSYCHOBIOL, V48, P16, DOI 10.1002/dev.20112; Green JR, 2004, J MED SPEECH-LANG PA, V12, P149; Hakkesteegt M. M., 2007, J VOICE, V4, P529; Hakkesteegt MM, 2006, FOLIA PHONIATR LOGO, V58, P264, DOI 10.1159/000093183; HARDIN MA, 1992, CLEFT PALATE-CRAN J, V29, P346, DOI 10.1597/1545-1569(1992)029<0346:CBNSAL>2.3.CO;2; Lyall RA, 2001, BRAIN, V124, P2000, DOI 10.1093/brain/124.10.2000; Robert D, 1999, ACTA OTO-LARYNGOL, V119, P724; Sapienza CM, 1997, J VOICE, V11, P195, DOI 10.1016/S0892-1997(97)80078-1; SMITHERAN JR, 1981, J SPEECH HEAR DISORD, V46, P138, DOI 10.1044/jshd.4602.138; STATHOPOULOS ET, 1986, J SPEECH HEAR RES, V29, P71, DOI 10.1044/jshr.2901.71; Tasko SM, 2004, J PHONETICS, V32, P65, DOI 10.1016/S0095-4470(03)00006-8; Wang Y., BEHAV RES M IN PRESS; Yunusova Y, 2010, J COMMUN DISORD, V43, P6, DOI 10.1016/j.jcomdis.2009.07.003; Yunusova Y, 2009, J SPEECH LANG HEAR R, V52, P547, DOI 10.1044/1092-4388(2008/07-0218)	21	16	17	0	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	FEB	2011		48							e2422	10.3791/2422			5	Multidisciplinary Sciences	Science & Technology - Other Topics	V36LG	WOS:000209212900016	21372794	Green Published, Bronze			2021-06-18	
J	Darrah, SH; Chuang, J; Mohler, LM; Chen, XB; Cummings, EE; Burnett, T; Reyes-Littaua, MC; Galang, GN; Wagner, AK				Darrah, Shaun H.; Chuang, Jerry; Mohler, Laura M.; Chen, Xiangbai; Cummings, Erin E.; Burnett, Tiffany; Reyes-Littaua, M. Christina; Galang, Gary N.; Wagner, Amy K.			Dilantin Therapy in an Experimental Model of Traumatic Brain Injury: Effects of Limited versus Daily Treatment on Neurological and Behavioral Recovery	JOURNAL OF NEUROTRAUMA			English	Article						CCI; cognition; Dilantin; neuroplasticity; phenytoin; post-traumatic seizures; TBI	CONTROLLED CORTICAL IMPACT; CHRONIC METHYLPHENIDATE TREATMENT; WATER MAZE PERFORMANCE; ENVIRONMENTAL ENRICHMENT; GLUTAMATE NEUROTOXICITY; POSTTRAUMATIC SEIZURES; MODERATE HYPOTHERMIA; GENDER ASSOCIATIONS; CEREBROSPINAL-FLUID; COGNITIVE DEFICITS	The mechanisms by which Dilantin confers anticonvulsant benefits may also be neuroprotective by attenuating the acute excitatory insult in cortical and subcortical structures when the drug is given in the acute phase after traumatic brain injury (TBI). However, when Dilantin is used for prolonged periods, we hypothesized that it may impede recovery, synaptic plasticity may be impaired, and neuroprotective benefits may be lost. As such, we assessed the effect of daily chronic administration (75mg/kg day 0 followed by 50mg/kg daily i.p.) and acute administration (75mg/kg day 0 followed by 50mg/kg i.p. day 1) of Dilantin in young adult male rats on motor performance, y-maze exploration, Morris Water Maze (MWM), hippocampal (HC) cell survival, contusion size, and regional expression of neuroplasticity markers after controlled cortical impact (CCI) injury. Chronic daily Dilantin administration resulted in beam walking impairments on day 6, whereas acute Dilantin administration resulted in beam walking impairments on days 3 and 4. Chronic Dilantin administration also resulted in worse MWM performance, more HC cell loss and no increases in neuroplasticity markers compared to rats with CCI receiving chronic vehicle. Conversely, rats receiving acute Dilantin administration exhibited more novel arm exploration in the y-maze, greater HC cell sparing, and greater growth-associated protein 43 (GAP-43) expression in the HC ipsilateral to the CCI, compared to injured rats receiving vehicle. MWM was not influenced by acute Dilantin administration. These results suggest that there are beneficial effects of limited acute Dilantin therapy after TBI, and that extended daily Dilantin therapy has deleterious effects on neural recovery. These findings support clinical guidelines for limited use of Dilantin in seizure prophylaxis after TBI.	[Darrah, Shaun H.; Mohler, Laura M.; Chen, Xiangbai; Cummings, Erin E.; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Darrah, Shaun H.; Chuang, Jerry; Mohler, Laura M.; Chen, Xiangbai; Cummings, Erin E.; Burnett, Tiffany; Reyes-Littaua, M. Christina; Galang, Gary N.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu			Foundation for PMR; University of Pittsburgh Department of Physical Medicine and Rehabilitation	This work was supported by The Foundation for PM&R and the University of Pittsburgh Department of Physical Medicine and Rehabilitation.	Arckens L, 2000, EUR J NEUROSCI, V12, P4222, DOI 10.1046/j.0953-816X.2000.01328.x; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bergmann M, 1997, EXP BRAIN RES, V117, P80, DOI 10.1007/s002210050201; BOXER PA, 1990, STROKE, V21, P47; BRAILOWSKY S, 1986, BRAIN RES, V376, P71, DOI 10.1016/0006-8993(86)90900-5; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; BROWN CM, 1995, BRIT J PHARMACOL, V115, P1425, DOI 10.1111/j.1476-5381.1995.tb16633.x; CARP JS, 1979, ARCH INT PHARMACOD T, V237, P139; Chan SA, 1998, ACTA NEUROCHIR, V140, P175, DOI 10.1007/s007010050080; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1987, J NEUROSCI, V7, P357; Churchill JD, 2003, INTEGR PHYS BEH SCI, V38, P91, DOI 10.1007/BF02688828; CHWEH AY, 1986, PHARMACOL BIOCHEM BE, V24, P1301, DOI 10.1016/0091-3057(86)90188-7; Cunningham MO, 2000, NEUROSCIENCE, V95, P343; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; MATTSON MP, 1989, BRAIN RES, V478, P337, DOI 10.1016/0006-8993(89)91514-X; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; PULLIAINEN V, 1995, EPILEPSIA, V36, P1195, DOI 10.1111/j.1528-1157.1995.tb01062.x; Ragsdale DS, 1998, BRAIN RES REV, V26, P16, DOI 10.1016/S0165-0173(97)00054-4; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; RUNDFELDT C, 1993, J PHARMACOL EXP THER, V266, P216; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schumacher TB, 1998, EPILEPSIA, V39, P355, DOI 10.1111/j.1528-1157.1998.tb01387.x; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Sitges M, 2007, NEUROPHARMACOLOGY, V52, P598, DOI 10.1016/j.neuropharm.2006.09.002; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; TAFT WC, 1989, BRAIN RES, V483, P143, DOI 10.1016/0006-8993(89)90045-0; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	54	16	16	0	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					43	55		10.1089/neu.2010.1521			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800005	20964534				2021-06-18	
J	Echemendia, RJ; Iverson, GL; McCrea, M; Broshek, DK; Gioia, GA; Sautter, SW; Macciocchi, SN; Barr, WB				Echemendia, Ruben J.; Iverson, Grant L.; McCrea, Michael; Broshek, Donna K.; Gioia, Gerard A.; Sautter, Scott W.; Macciocchi, Stephen N.; Barr, William B.			Role of Neuropsychologists in the Evaluation and Management of Sport-related Concussion: An Inter-Organization Position Statement	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; Traumatic Brain Injury; Children; Legislation	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; FOOTBALL PLAYERS; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; SEX-DIFFERENCES; RECOVERY; SYMPTOMS; IMPACT; DEFICITS	Over the past 20 years, clinical neuropsychologists have been at the forefront of both scientific and clinical initiatives aimed at developing evidence-based approaches to the evaluation and management of sport-related concussion. These efforts have directly impacted current policy on strategies for injury assessment and return-to-play by athletes after concussion. Many states are considering legislation requiring (a) education of athletes, parents, coaches, and school/organization officials on the recognition, evaluation, and management of sport-related concussions; (b) removal from play of any youth athlete that is suspected of having sustained a concussion; and (c) not allowing the student to return to participation until the student is evaluated and cleared for return to participation in writing by an appropriate healthcare professional. It is the official position of the American Academy of Clinical Neuropsychology (AACN), American Board of Neuropsychology (ABN), Division 40 (Neuropsychology) of the American Psychological Association (APA), and the National Academy of Neuropsychology (NAN) that neuropsychologists should be included among the licensed health care professionals authorized to evaluate, clinically manage, and provide return to play clearance for athletes who sustain a sport-related concussion.	[Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA USA; [Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [McCrea, Michael] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Broshek, Donna K.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Gioia, Gerard A.] Childrens Natl Med Ctr, Rockville, MD USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Rockville, MD USA; [Sautter, Scott W.] Hampton Rd Neuropsychol Inc, Virginia Beach, VA USA; [Macciocchi, Stephen N.] Shepherd Ctr, Atlanta, GA USA; [Barr, William B.] NYU, Sch Med, New York, NY 10003 USA	Echemendia, RJ (corresponding author), 204 E Calder Way,Ste 205, State Coll, PA 16801 USA.	rechemendia@comcast.net	Echemendia, Ruben/R-6939-2019	Echemendia, Ruben/0000-0001-6116-8462; Barr, William/0000-0001-7711-7758; Iverson, Grant/0000-0001-7348-9570			Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 2003, ARCH CLIN NEUROPSYCH, V18, P551, DOI 10.1016/S0887-6177(02)00146-4; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2006, SPORTS NEUROPSYCHOLO; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M, 1999, SPORTS RELATED CONCU; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; LOVELL MR, 1996, NEW DEV SPORTS REL C; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	43	16	16	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	8					1289	1294		10.1080/13854046.2011.618466			6	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	882JM	WOS:000299559900001	22171535	Bronze			2021-06-18	
J	Garnock-Jones, KP				Garnock-Jones, Karly P.			Dextromethorphan/Quinidine In Pseudobulbar Affect	CNS DRUGS			English	Article							EMOTIONAL EXPRESSION DISORDER; MULTIPLE-SCLEROSIS; QUINIDINE INHIBITION; PHARMACOKINETICS; PATHOPHYSIOLOGY; HUMANS; TRIAL	Pseudobulbar affect is characterized by uncontrollable, inappropriate laughing and/or crying that is either unrelated or out of proportion to the emotions felt by the patient and occurs in patients with neurological disorders, such as amyotrophic lateral sclerosis (ALS), multiple sclerosis or traumatic brain injury. Dextromethorphan/quinidine is indicated in the US for the treatment of pseudobulbar affect. Dextromethorphan, when its metabolism is inhibited by the coadministration of quinidine, has been shown to have a positive effect on the symptoms of pseudobulbar affect. Dextromethorphan/quinidine 20 mg/10 mg twice daily was associated with a significantly greater decrease in the rate of pseudobulbar affect episodes per day (primary endpoint) than placebo in the 12-week, randomized, double-blind, placebo-controlled, multicentre STAR trial (Safety, Tolerability, And efficacy Results trial of AVP-923 in PBA [pseudobulbar affect]) involving patients with pseudobulbar affect and ALS or multiple sclerosis. Moreover, the mean change from baseline in Center for Neurologic Study-Lability Scale score at 12 weeks was significantly greater among recipients of dextromethorphan/quinidine 20 mg/10 mg twice daily than those receiving placebo. Dextromethorphan/quinidine 20 mg/10 mg twice daily was generally well tolerated. The drug has been shown to cause dosage-dependent corrected QT interval (QTc) prolongation; however, in the STAR trial, dextromethorphan/quinidine 20 mg/10 mg twice daily appeared to be well tolerated with regard to QTc prolongation.	Adis Int Ltd, Auckland 0754, New Zealand	Garnock-Jones, KP (corresponding author), Adis Int Ltd, 41 Centorian Dr,Private Bag 65901, Auckland 0754, New Zealand.	demail@adis.co.nz		Garnock-Jones, Karly/0000-0002-1109-9945			*AV PHARM INC NEUD, DEXTR HYDR QUIN SULF; Brooks BR, 2004, NEUROLOGY, V63, P1364; BROOKS BR, 2009, 20 INT S AM LAT SCLE; Capon DA, 1996, CLIN PHARMACOL THER, V60, P295, DOI 10.1016/S0009-9236(96)90056-9; Haiman G, 2009, J CLIN PSYCHOPHARM, V29, P444, DOI 10.1097/JCP.0b013e3181b5ae5c; Martin Caren McHenry, 2007, Consult Pharm, V22, P732, DOI 10.4140/TCP.n.2007.732; Miller A, 2006, J NEUROL SCI, V245, P153, DOI 10.1016/j.jns.2005.09.018; Moghadamnia AA, 2003, BRIT J CLIN PHARMACO, V56, P57, DOI 10.1046/j.1365-2125.2003.01853.x; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; Pioro E, 2010, NEUROLOGY, V75, P380; Pioro EP, 2010, ANN NEUROL, V68, P693, DOI 10.1002/ana.22093; POPE L, 2010, 163 ANN M AM PSYCH A; Pope LE, 2004, J CLIN PHARMACOL, V44, P1132, DOI 10.1177/0091270004269521; Rabins PV, 2007, CNS SPECTRUMS, V12, P17, DOI 10.1017/S1092852900025979; Rosen H, 2008, DRUG TODAY, V44, P661, DOI 10.1358/dot.2008.44.9.1258664; Rosen HJ, 2007, ANN NEUROL, V61, P92, DOI 10.1002/ana.21056; SCHADEL M, 1995, J CLIN PSYCHOPHARM, V15, P263, DOI 10.1097/00004714-199508000-00005; Strowd RE, 2010, J NEUROL, V257, P1382, DOI 10.1007/s00415-010-5550-3; Werling LL, 2007, EXP NEUROL, V207, P248, DOI 10.1016/j.expneurol.2007.06.013; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; WYNN D, 2010, 135 ANN M AM NEUR AS; WYNN D, 2010, 24 ANN M CONS MULT S; Zawertailo LA, 2010, HUM PSYCHOPHARM CLIN, V25, P71, DOI 10.1002/hup.1086	24	16	17	0	7	ADIS INT LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW ZEALAND	1172-7047			CNS DRUGS	CNS Drugs		2011	25	5					435	445		10.2165/11207260-000000000-00000			11	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	772ZH	WOS:000291276300007	21476614				2021-06-18	
J	Kim, JH; Park, SH; Kim, YW; Ha, JM; Bae, SS; Lee, GS; Cho, SI; Choi, BT; Shin, HK				Kim, Ji Hyun; Park, Sun Haeng; Kim, Young Whan; Ha, Jung Min; Bae, Sun Sik; Lee, Guem San; Cho, Su In; Choi, Byung Tae; Shin, Hwa Kyoung			The Traditional Herbal Medicine, Dangkwisoo-San, Prevents Cerebral Ischemic Injury through Nitric Oxide-Dependent Mechanisms	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							BLOOD-FLOW; SYNTHASE; DAMAGE; MICE	Dangkwisoo-San (DS) is an herbal extract that is widely used in traditional Korean medicine to treat traumatic ecchymosis and pain by promoting blood circulation and relieving blood stasis. However, the effect of DS in cerebrovascular disease has not been examined experimentally. The protective effects of DS on focal ischemic brain were investigated in a mouse model. DS stimulated nitric oxide (NO) production in human brain microvascular endothelial cells (HBMECs). DS (10-300 mu g/mL) produced a concentration-dependent relaxation in mouse aorta, which was significantly attenuated by the nitric oxide synthase (NOS) inhibitor L-NAME, suggesting that DS causes vasodilation via a NO-dependent mechanism. DS increased resting cerebral blood flow (CBF), although it caused mild hypotension. To investigate the effect of DS on the acute cerebral injury, C57/BL6J mice received 90 min of middle cerebral artery occlusion followed by 22.5 h of reperfusion. DS administered 3 days before arterial occlusion significantly reduced cerebral infarct size by 53.7% compared with vehicle treatment. However, DS did not reduce brain infarction in mice treated with the relatively specific endothelial NOS (eNOS) inhibitor, N-5-(1-iminoethyl)-L-ornithine, suggesting that the neuroprotective effect of DS is primarily endothelium-dependent. This correlated with increased phosphorylation of eNOS in the brains of DS-treated mice. DS acutely improves CBF in eNOS-dependent vasodilation and reduces infarct size in focal cerebral ischemia. These data provide causal evidence that DS is cerebroprotective via the eNOS-dependent production of NO, which ameliorates blood circulation.	[Kim, Ji Hyun; Park, Sun Haeng; Choi, Byung Tae; Shin, Hwa Kyoung] Pusan Natl Univ, Div Meridian & Struct Med, Sch Korean Med, Yangsan 626870, South Korea; [Kim, Young Whan; Ha, Jung Min; Bae, Sun Sik] Pusan Natl Univ, Dept Pharmacol, Sch Med, Yangsan 626870, South Korea; [Lee, Guem San; Cho, Su In] Pusan Natl Univ, Div Pharmacol, Sch Korean Med, Yangsan 626870, South Korea	Shin, HK (corresponding author), Pusan Natl Univ, Div Meridian & Struct Med, Sch Korean Med, Yangsan 626870, South Korea.	julie@pusan.ac.kr			Pusan National UniversityPusan National University	This work was supported for two years by Pusan National University Research Grant.	Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Endres M, 2004, TRENDS NEUROSCI, V27, P283, DOI 10.1016/j.tins.2004.03.009; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hua Q, 2008, BIOL PHARM BULL, V31, P633, DOI 10.1248/bpb.31.633; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Kim H, 2005, NEUROL RES, V27, P287, DOI 10.1179/016164105X25234; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Li RP, 2006, J ETHNOPHARMACOL, V107, P143, DOI 10.1016/j.jep.2006.04.024; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MIN HJ, 2002, BRAIN RES, V946, P139; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Park WH, 2005, PHYTOTHER RES, V19, P846, DOI 10.1002/ptr.1700; Qiu Jane, 2007, Nat Rev Drug Discov, V6, P506; Rehni AK, 2008, FUND CLIN PHARMACOL, V22, P179, DOI 10.1111/j.1472-8206.2008.00567.x; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang NY, 2004, AM J CHINESE MED, V32, P587, DOI 10.1142/S0192415X04002223; Wolff DJ, 1998, EUR J PHARMACOL, V350, P325, DOI 10.1016/S0014-2999(98)00267-2; ZHANG FY, 1994, J CEREBR BLOOD F MET, V14, P217, DOI 10.1038/jcbfm.1994.28	22	16	17	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.		2011	2011						1	8		10.1155/2011/718302			8	Integrative & Complementary Medicine	Integrative & Complementary Medicine	802SK	WOS:000293531100001	21423636	DOAJ Gold, Green Published			2021-06-18	
J	Krave, U; Al-Olama, M; Hansson, HA				Krave, Ulrika; Al-Olama, Mohamed; Hansson, Hans-Arne			Rotational Acceleration Closed Head Flexion Trauma Generates More Extensive Diffuse Brain Injury than Extension Trauma	JOURNAL OF NEUROTRAUMA			English	Article						astrocytosis; beta-amyloid precursor protein; diffuse axonal injury; mild traumatic brain injury; neurofilaments	ADULT; DEFORMATION; PRESSURE; STRAIN; MODEL; BIOMECHANICS; IMPACT; DAMAGE; WAVE	Our aim was to investigate if seemingly identical head and neck trauma would generate differing types of brain damage. We experimentally evaluated induced brain injuries immediately after trauma exposure, and at 1 week post-injury. Anesthetized rabbits were exposed once to a sagittal rotational acceleration head and neck injury at either a high or a low load level, using either flexion or extension. A high-load extension trauma induced scattered meningeal petechial hemorrhages and no deaths, in contrast to a flexion trauma of the same level, which resulted in extensive parenchymal and meningeal hemorrhages, and all animals succumbed immediately. A low-level flexion trauma induced scattered meningeal petechiae, but no gross damage, while extension at the same force generated no macroscopically visible acute brain injury. Immunohistochemical investigations carried out at 7 days disclosed that a low-level flexion trauma, as well as both low-and high-level extension exposures, all induced diffuse brain injuries in the cerebral cortex and white matter, corpus callosum, hippocampus, brainstem, and cerebellum, as revealed by abnormal distribution of neurofilaments, a prevalence of beta-amyloid precursor protein, and astrogliosis. The diffuse brain injury seen after a low-level flexion trauma was equal to or more extensive than that seen after a high-level extension trauma. A low-level extension trauma induced only minor histopathological abnormalities. We conclude that a sagittal rotational acceleration trauma of the head and neck induced diffuse brain injury, and that flexion caused more extensive damage than extension at the same applied load.	[Al-Olama, Mohamed; Hansson, Hans-Arne] Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Krave, Ulrika] Chalmers Univ Technol, Div Vehicle Safety, S-41296 Gothenburg, Sweden; [Al-Olama, Mohamed] Sahlgrens Univ Hosp, Dept Neurosurg, Gothenburg, Sweden	Hansson, HA (corresponding author), Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, POB 440, SE-40530 Gothenburg, Sweden.	hans-arne.hansson@gu.se			Swedish federal government [71570]; Sahlgrenska University Hospital, VinnovaVinnova [83030]; Ministry of High Education United Arab Emirates; Magnus Bergvall Foundation; W. and M. Lundgren Foundation; Frimurare-Barnhus direktionen; Goteborg Medical Society; AB Nectin; Lantmannen AS-Faktor AB	This study was funded in part by the Swedish federal government (grant no. 71570), Sahlgrenska University Hospital (grant no. 83030), Vinnova, the Ministry of High Education United Arab Emirates, the Magnus Bergvall Foundation, the W. and M. Lundgren Foundation, Frimurare-Barnhus direktionen, the Goteborg Medical Society, AB Nectin, and Lantmannen AS-Faktor AB.	Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elsayed NM, 2008, EXPLOSION BLAST RELA; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Faul M., 2010, TRAUMATIC BRAIN INJU, P1; GOSCH HH, 1970, J TRAUM, V10, P370, DOI 10.1097/00005373-197005000-00002; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Greenberg MS., 2010, HDB NEUROSURGERY, V7th; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; KOPATKA MJ, 1991, J NEUROTRAUM, V8, P247; Krave U, 2005, EUR J NEUROSCI, V21, P2876, DOI 10.1111/j.1460-9568.2005.04115.x; KRAVE U, 2010, IMPORTANCE IMP UNPUB; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Leestma JE., 2008, FORENSIC NEUROPATHOL, V2nd; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; NOLTE J, 2008, HUMAN BRAIN; OEHMICHEN M, 2005, FORENSIC NEUROPATHOL; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Palay SL, 1974, CEREBELLAR CORTEX CY; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; REILLY PL, 2005, HEAD INJUNY PATHOPHY; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; Wisniewski H. M, 1986, ATLAS RABBIT BRAIN S; Zhu H, 2005, BRAIN RES, V1036, P7, DOI 10.1016/j.brainres.2004.12.053; Zhu H, 2003, BRAIN RES, V977, P180, DOI 10.1016/S0006-8993(03)02627-1	47	16	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					57	70		10.1089/neu.2010.1431			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800006	21047148				2021-06-18	
J	Kuo, JR; Lo, CJ; Chang, CP; Lin, MT; Chio, CC				Kuo, Jinn-Rung; Lo, Chong-Jeh; Chang, Ching-Ping; Lin, Mao-Tsun; Chio, Chung-Ching			Attenuation of Brain Nitrosative and Oxidative Damage by Brain Cooling during Experimental Traumatic Brain Injury	JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY			English	Article							THERAPEUTIC HYPOTHERMIA; STRESS; ISCHEMIA; INFUSION; STROKE; RATS; NEUROPROTECTION; DYSFUNCTION; APOPTOSIS; LESSONS	The aim of the present study was to ascertain whether brain cooling causes attenuation of traumatic brain injury by reducing brain nitrostative and oxidative damage. Brain cooling was accomplished by infusion of 5mL of 4 degrees C saline over 5 minutes via the external jugular vein. Immediately after the onset of traumatic brain injury, rats were randomized into two groups and given 37 degrees C or 4 degrees C normal saline. Another group of rats were used as sham operated controls. Behavioral and biochemical assessments were conducted on 72 hours after brain injury or sham operation. As compared to those of the sham-operated controls, the 37 degrees C saline-treated brain injured animals displayed motor deficits, higher cerebral contusion volume and incidence, higher oxidative damage (e. g., lower values of cerebral superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase, but higher values of cerebral malondialdehyde), and higher nitrostative damage (e. g., higher values of neuronal nitric oxide synthase and 3-nitrotyrosine). All the motor deficits and brain nitrostative and oxidative damage were significantly reduced by retrograde perfusion of 4 degrees C saline via the jugular vein. Our data suggest that brain cooling may improve the outcomes of traumatic brain injury in rats by reducing brain nitrostative and oxidative damage.	[Lin, Mao-Tsun] Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan; [Kuo, Jinn-Rung; Lo, Chong-Jeh] Natl Cheng Kung Univ, Inst Clin Med, Sch Med, Tainan 704, Taiwan; [Kuo, Jinn-Rung; Chang, Ching-Ping] So Taiwan Univ, Dept Biotechnol, Tainan 710, Taiwan; [Kuo, Jinn-Rung; Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Tainan 710, Taiwan; [Lo, Chong-Jeh] Chang Gung Mem Hosp, Div Trauma & Emergency Surg, Kaohsiung 833, Taiwan; [Lo, Chong-Jeh] Kaohsiung Med Ctr, Kaohsiung 833, Taiwan; [Lin, Mao-Tsun] Taipei Med Univ, Grad Inst Dis Prevent & Control, Taipei 112, Taiwan	Lin, MT (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan.	891201@mail.chimei.org.tw; chiocc@ms28.hinet.net			National Science Council of the TaiwanMinistry of Science and Technology, Taiwan [NSC96-2314-B-384-002, NSC96-2314-B-384-003-MY3]	Financial support for this paper was provided in part by grants from the National Science Council of the Taiwan (NSC96-2314-B-384-002 and NSC96-2314-B-384-003-MY3).	Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bivin W. S., 1979, The laboratory rat. Volume I. Biology and diseases., P73; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chio CC, 2007, SHOCK, V28, P284, DOI 10.1097/SHK.0b013e3180311e60; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; DeKosky ST, 2004, J NEUROCHEM, V90, P998, DOI 10.1111/j.1471-4159.2004.02575.x; Ding YC, 2004, NEUROSURGERY, V54, P956, DOI 10.1227/01.NEU.0000114513.96704.29; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Guven H, 2002, J TRAUMA, V53, P66, DOI 10.1097/00005373-200207000-00014; GUYTON AC, 1991, TXB MED PHYSL, P679; Guyton AC., 1991, TXB MED PHYSL, V8th ed, P274; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; Hsu SF, 2006, SHOCK, V26, P210, DOI 10.1097/01.shk.0000223124.49265.10; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Peluffo H, 2004, J NEUROCHEM, V89, P602, DOI 10.1046/j.1471-4159.2004.02363.x; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Wang JL, 2005, SHOCK, V23, P161, DOI 10.1097/01.shk.0000150779.47107.d5; Wang Y, 1997, J NEUROSCI, V17, P4341; Wen YS, 2005, J TRAUMA, V58, P577, DOI 10.1097/01.TA.0000152635.99243.30; Wright JE, 2005, CRIT CARE NURS Q, V28, P150, DOI 10.1097/00002727-200504000-00007; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	32	16	16	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1110-7243	1110-7251		J BIOMED BIOTECHNOL	J. Biomed. Biotechnol.		2011									145214	10.1155/2011/145214			8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	744IA	WOS:000289086900001		DOAJ Gold, Green Published			2021-06-18	
J	Monroe, KW; Thrash, C; Sorrentino, A; King, WD				Monroe, Kathy W.; Thrash, Chris; Sorrentino, Annalise; King, William D.			Most Common Sports-Related Injuries in a Pediatric Emergency Department	CLINICAL PEDIATRICS			English	Article						sports; football; basketball; injuries; emergency department	CHILDREN	Background: Participation in sports is a popular activity for children across the country. Prevention of sports-related injuries can be improved if details of injuries are documented and studied. Methods: A retrospective medical record review of injuries that occurred as a direct result of sports participation (both organized and non-organized play) from November 2006 to November 2007. Because the vast majority of injuries were a result of participation in football or basketball, these injuries were focused upon. The injuries specifically examined were closed head injury (CHI), lacerations and fractures. Results: There were 350 football and 196 basketball injuries (total 546). Comparing injuries between the two groups fractures were found to be more prevalent in football compared to basketball (z = 2.14; p = 0.03; 95%CI (0.01, 0.16)). Lacerations were found to be less prevalent among helmeted patients than those without helmets. (z = 2.39; p = 0.02; 95%CI (-0.17,-0.03)). CHI was more prevalent among organized play compared to non-organized (z = 3.9; p<0.001; 95%CI (0.06, 0.16)). Among basketball related visits, non-organized play had a higher prevalence of injury compared to organized play. (z = 2.87; p = 0.004; 95%CI (0.04, 0.21)). Among football related visits, organized play had a higher prevalence of injury compared to non-organized play (z = 2.87; p = 0.004; 95%CI (0.04,. 0.21)). No differences in fracture or laceration prevalence were found between organized and non-organized play. Conclusions: Football and basketball related injuries are common complaints in a pediatric Emergency Department. Frequently seen injuries include CHI, fractures and lacerations. In our institution, fractures were more prevalent among football players and CHI was more prevalent among organized sports participants.		Monroe, KW (corresponding author), Univ Alabama, Childrens Hosp, Suite 210 CPP,1600 7th Ave S, Birmingham, AL 35233 USA.	kmonroe@peds.uab.edu					Babul S, 2007, Int J Inj Contr Saf Promot, V14, P192, DOI 10.1080/17457300701440659; Committee on Trauma Research, 1985, INJ AM CONT PUBL HLT; Halperin W, 1998, PUBLIC HEALTH REP, V113, P424; JINGZHEN Y, 2007, PEDIATRICS, V119, pE813; Moll EK, 2002, INJ PREV, V8, P165, DOI 10.1136/ip.8.2.165; Monroe K, 2008, PEDIATR EMERG CARE, V24, P448, DOI 10.1097/PEC.0b013e31817de348; Ni H, 2002, INJURY PREV, V8, P60, DOI 10.1136/ip.8.1.60; *NIH, 1992, SPORTS INJ YOUTH SUR; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Simon TD, 2006, PEDIATR EMERG CARE, V22, P309, DOI 10.1097/01.pec.0000215139.29039.5c; 2002, US TODAY KIDS S 1018	11	16	16	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228			CLIN PEDIATR	Clin. Pediatr.	JAN	2011	50	1					17	20		10.1177/0009922810378735			4	Pediatrics	Pediatrics	693CV	WOS:000285203100003	20837621				2021-06-18	
J	Nelson, NW; Hoelzle, JB; McGuire, KA; Sim, AH; Goldman, DJ; Ferrier-Auerbach, AG; Charlesworth, MJ; Arbisi, PA; Sponheim, SR				Nelson, Nathaniel W.; Hoelzle, James B.; McGuire, Kathryn A.; Sim, Anita H.; Goldman, Daniel J.; Ferrier-Auerbach, Amanda G.; Charlesworth, Molly J.; Arbisi, Paul A.; Sponheim, Scott R.			Self-Report of Psychological Function Among OEF/OIF Personnel Who Also Report Combat-Related Concussion	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; Symptom validity; Operations Enduring Freedom and Iraqi Freedom	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MMPI-2 VALIDITY SCALES; MULTIPHASIC PERSONALITY INVENTORY-2; FAKE-BAD SCALE; HEAD-INJURY; RESTRUCTURED FORM; FORENSIC SETTINGS; RC SCALES; VALIDATION	MMPI-2 RF profiles of 128 U. S. soldiers and veterans with history of concussion were examined. Participants evaluated in forensic (n = 42) and clinical (n = 43) settings showed significantly higher validity and clinical elevations relative to a research group (n = 43). In the full sample, a multivariate GLM identified main effects for disability claim status and Axis I diagnosis across numerous MMPI-2 RF scales. Participants with co-morbid PTSD and concussion showed significant Restructured Clinical and Specific Problem scale elevations relative to those without Axis I diagnosis. Participants with PTSD and active disability claims were especially prone to elevate on FBS/FBS-r and RBS. Implications for neuropsychologists who routinely administer the MMPI-2/RF in the context of combatrelated concussion are discussed.	[Nelson, Nathaniel W.] Univ St Thomas, Grad Sch Profess Psychol, Minneapolis, MN 55403 USA; [Nelson, Nathaniel W.; McGuire, Kathryn A.; Sim, Anita H.; Ferrier-Auerbach, Amanda G.; Charlesworth, Molly J.; Arbisi, Paul A.; Sponheim, Scott R.] Minneapolis VA Med Ctr, Minneapolis, MN USA; [Hoelzle, James B.] Marquette Univ, Milwaukee, WI 53233 USA; [McGuire, Kathryn A.; Ferrier-Auerbach, Amanda G.; Arbisi, Paul A.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Goldman, Daniel J.; Arbisi, Paul A.; Sponheim, Scott R.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	Nelson, NW (corresponding author), Univ St Thomas, Grad Sch Profess Psychol, 1000 LaSalle Ave, Minneapolis, MN 55403 USA.	nels0600@stthomas.edu	Sponheim, Scott/J-3857-2017	Sponheim, Scott/0000-0002-2782-0856	Congressionally Directed Medical Research ProgramsUnited States Department of Defense [PT074550, W81XWH-08-2-0038]; Minnesota Veterans Research Institute (MVRI)	This study was supported in part by Grants funded by the Congressionally Directed Medical Research Programs (number PT074550, contract W81XWH-08-2-0038) to Scott R. Sponheim Ph.D. and the Minnesota Veterans Research Institute (MVRI) to Nathaniel W. Nelson, Ph.D.	Arbisi PA, 1999, NEUROREHABILITATION, V13, P117; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Ben-Porath Y. S., 2008, MINNESOTA MULTIPHASI; Blake D. D., 1990, BEHAV THER, V13, P187; Boone, 2007, ASSESSMENT FEIGNED C; Bury AS, 2002, PSYCHOL ASSESSMENT, V14, P472, DOI 10.1037//1040-3590.14.4.472; Butcher JN, 1989, MANUAL ADM SCORING M; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Elhai JD, 2000, J PERS ASSESS, V75, P449, DOI 10.1207/S15327752JPA7503_06; Elhai JD, 2004, ASSESSMENT, V11, P139, DOI 10.1177/1073191104264965; FINN S, 1996, MANUAL USING MMPI 2; First M.B., 2007, STRUCTURED CLIN INTE; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Graham J. R., 2006, MMPI 2 ASSESSING PER; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Hoelzle J. B., 2010, ANN C AM AC CLIN NEU; Hoelzle JB, 2008, J PERS ASSESS, V90, P443, DOI 10.1080/00223890802248711; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kaemmer B, 2001, MMPI-2: Manual for Administration and Scoring; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rogers R., 2008, CLIN ASSESSMENT MALI; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P22, DOI 10.1037/a0018222; Simms LJ, 2005, PSYCHOL ASSESSMENT, V17, P345, DOI 10.1037/1040-3590.17.3.345; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Smart CM, 2008, J INT NEUROPSYCH SOC, V14, P842, DOI 10.1017/S1355617708081034; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Tellegen A., 2003, MMPI 2 RESTRUCTURED; Tellegen A., 2008, MMPI 2 RF MINNESOTA; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wygant D. B., 2004, 39 ANN S REC DEV MMP; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	55	16	16	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	5					716	740		10.1080/13854046.2011.579174			25	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	882JE	WOS:000299559000003	21722045				2021-06-18	
J	Paiva, WS; Bezerra, DAF; Amorim, RLO; Figueiredo, EG; Tavares, WM; De Andrade, AF; Teixeira, MJ				Paiva, Wellingson Silva; Franca Bezerra, Douglas Alexandre; Oliveira Amorim, Robson Luis; Figueiredo, Eberval Gadelha; Tavares, Wagner Malago; De Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen			Serum sodium disorders in patients with traumatic brain injury	THERAPEUTICS AND CLINICAL RISK MANAGEMENT			English	Article						brain trauma; hypernatremia; hyponatremia	ANEURYSMAL SUBARACHNOID HEMORRHAGE; ATRIAL-NATRIURETIC-PEPTIDE; SALT WASTING SYNDROME; SYMPTOMATIC HYPONATREMIA; HEAD-INJURY; PATHOPHYSIOLOGY; HYPERNATREMIA	Sodium disorders are the most common and most poorly understood electrolyte disorders in neurological patients. The aim of this study was to determine the incidence of sodium disorders and its association with different traumatic brain injuries. This prospective study was conducted in 80 patients diagnosed with moderate and severe traumatic brain injuries. All patients underwent cerebral computed tomography. Incidence of sodium disorders, presence of injuries in the first computed tomography after traumatic brain injury, and level of consciousness were analyzed. Patients that presented other potential causes of sodium disorders and systemic trauma were excluded from the study. The incidence of sodium disturbances was 45%: 20 patients presented hypernatremia and 16 hyponatremia. Refers to all patients with sodium disturbances 53% were detected in the first sample. We recorded at least one measurement <125 mEq/L in 50% of the patients with hyponatremia. A greater incidence of sodium disorders was found in patients with subdural, intracerebral hematoma and with diffuse axonal injury. The incidence of sodium disorders among the patients with diffuse lesions was greater than in the group of patients with brain contusion (P = 0.022). The incidence of sodium disorders is higher in patients with diffuse traumatic brain injuries. No association was found between focal lesions and proportion of sodium disorders. Keywords: brain trauma, hypernatremia, hyponatremia	[Paiva, Wellingson Silva; Franca Bezerra, Douglas Alexandre; Oliveira Amorim, Robson Luis; Figueiredo, Eberval Gadelha; Tavares, Wagner Malago; De Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Intens Care Unit, Div Neurosurg, Hosp Das Clin, BR-05403010 Sao Paulo, Brazil	Paiva, WS (corresponding author), Univ Sao Paulo, Intens Care Unit, Div Neurosurg, Hosp Das Clin, Eneas Aguiar St N 255,Off 4080, BR-05403010 Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Teixeira, Manoel J/E-3110-2012; Paiva, Wellingson S/G-5517-2013; Figueiredo, Eberval Gadelha/H-3488-2012; Amorim, Robson/AAK-1368-2021; Figueiredo, Eberval G/E-2071-2016	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519; 			ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; Belvins LS, 1992, CRIT CARE MED, V20, P69; Coenraad Minneke J., 2003, Eur J Intern Med, V14, P302, DOI 10.1016/S0953-6205(03)00100-6; DIRINGER MN, 1991, STROKE, V22, P577, DOI 10.1161/01.STR.22.5.577; Doc ZIT, 1981, NEUROSURGERY, V9, P394; Donati-Genet PCM, 2001, J PEDIATR SURG, V36, P1094, DOI 10.1053/jpsu.2001.24770; GOLDSMITH MF, 1987, JAMA-J AM MED ASSOC, V257, P287, DOI 10.1001/jama.257.3.287; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; Horn LJ, 1982, J HEAD TRAUMA REHAB, V3, P86; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Marshall SB, 1991, J NEUROSURG S, V75, P14; Mizobata Y, 2001, J TRAUMA, V50, P871, DOI 10.1097/00005373-200105000-00016; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Revilla-Pacheco FR, 2005, NEUROL RES, V27, P418, DOI 10.1179/016164105X17152; RICHARDS AM, 1985, HYPERTENSION, V7, P812, DOI 10.1161/01.HYP.7.5.812; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819; STERNS RH, 1987, ANN INTERN MED, V107, P656, DOI 10.7326/0003-4819-107-5-656; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Taikkanen I, 1986, J CLIN INVEST, V77, P734; TEASDALE G, 1974, LANCET, V2, P81; WIJDICKS EFM, 1991, STROKE, V22, P1519, DOI 10.1161/01.STR.22.12.1519	22	16	17	0	9	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-203X			THER CLIN RISK MANAG	Therap. Clin. Risk Manag.		2011	7						345	349		10.2147/TCRM.S17692			5	Health Care Sciences & Services	Health Care Sciences & Services	879OD	WOS:000299339100040	21941440	DOAJ Gold, Green Published			2021-06-18	
J	Tjaden, K; Wilding, G				Tjaden, Kris; Wilding, Greg			The Impact of Rate Reduction and Increased Loudness on Fundamental Frequency Characteristics in Dysarthria	FOLIA PHONIATRICA ET LOGOPAEDICA			English	Article						Dysarthria; Fundamental frequency; Speaking rate; Loudness	TRAUMATIC BRAIN-INJURY; SOUND PRESSURE LEVEL; CONVERSATIONAL SPEECH; PARKINSONS-DISEASE; ACOUSTIC CHARACTERISTICS; MULTIPLE-SCLEROSIS; AMERICAN ENGLISH; SPEAKING RATE; CLEAR SPEECH; INTELLIGIBILITY	Objective: This study examined the extent to which articulatory rate reduction and increased loudness were associated with adjustments in utterance-level measures of fundamental frequency (F(0)) variability for speakers with dysarthria and healthy controls that have been shown to impact on intelligibility in previously published studies. More generally, the current study sought to compare and contrast how a slowerthan-normal rate and increased vocal loudness impact on a variety of utterance-level F(0) characteristics for speakers with dysarthria and healthy controls. Patients and Methods: Eleven speakers with Parkinson's disease, 15 speakers with multiple sclerosis, and 14 healthy control speakers were audio recorded while reading a passage in habitual, loud, and slow conditions. Magnitude production was used to elicit variations in rate and loudness. Acoustic measures of duration, intensity and F(0) were obtained. Results and Conclusions: For all speaker groups, a slower-than-normalarticulatory rate and increased vocal loudness had distinct effects on F(0) relative to the habitual condition, including a tendency for measures of F(0) variation to be greater in the loud condition and reduced in the slow condition. These results suggest implications for the treatment of dysarthria. Copyright (C) 2010 S. Karger AG, Basel	[Tjaden, Kris] SUNY Buffalo, Dept Commun Disorders & Sci, Buffalo, NY 14214 USA; [Wilding, Greg] SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA	Tjaden, K (corresponding author), SUNY Buffalo, Dept Commun Disorders & Sci, 122 Cary Hall,3435 Main St, Buffalo, NY 14214 USA.	Tjaden@buffalo.edu			NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC004689]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC004689] Funding Source: NIH RePORTER	We thank Beth Hilczmayer and Erin Szajta for their assistance with the acoustic analyses as well as Miranda Crumb and Grace Liu for their assistance with data reduction and entry. Portions of this study were reported at the 2008 Conference on Motor Speech. Research supported by NIDCD R01DC004689.	Beukelman DR, 2002, J MED SPEECH-LANG PA, V10, P237; Binns C, 2007, J ACOUST SOC AM, V122, P1765, DOI 10.1121/1.2751394; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; Bunton K, 2001, CLIN LINGUIST PHONET, V15, P181; Bunton K, 2006, FOLIA PHONIATR LOGO, V58, P323, DOI 10.1159/000094567; Cooper W., 1981, FUNDAMENTAL FREQUENC; Dromey C, 1998, J SPEECH LANG HEAR R, V41, P1003, DOI 10.1044/jslhr.4105.1003; Dromey C, 2000, J MED SPEECH-LANG PA, V8, P155; Duffy JR, 2019, MOTOR SPEECH DISORDE; Ferguson SH, 2007, J SPEECH LANG HEAR R, V50, P1241, DOI 10.1044/1092-4388(2007/087); Goberman AM, 2005, J COMMUN DISORD, V38, P215, DOI 10.1016/j.jcomdis.2004.10.001; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; Kain AB, 2007, SPEECH COMMUN, V49, P743, DOI 10.1016/j.specom.2007.05.001; KIM HH, 1994, THESIS U WISCONSIN M; Kleinow J, 2001, J SPEECH LANG HEAR R, V44, P1041, DOI 10.1044/1092-4388(2001/082); Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; Ladd DR, 1999, J ACOUST SOC AM, V106, P1543, DOI 10.1121/1.427151; Laures JS, 1999, J SPEECH LANG HEAR R, V42, P1148, DOI 10.1044/jslhr.4205.1148; LEDORZE G, 1992, EUR J DISORDER COMM, V27, P313; LIEBERMAN P, 1985, J ACOUST SOC AM, V77, P649, DOI 10.1121/1.391883; Lieberman P., 1967, INTONATION PERCEPTIO; Liss J. M., 2007, MOTOR SPEECH DISORDE, P187; MASSEN B, 1984, J ACOUST SOC AM, V76, P1673; McHenry MA, 2003, J SPEECH LANG HEAR R, V46, P702, DOI 10.1044/1092-4388(2003/055); McHenry MA, 2006, J MED SPEECH-LANG PA, V14, P197; MILENKOVIC P, 2003, TF32 COMPUTER PROGRA; MILENKOVIC P, 1997, CSPEECH VERSION 4 0; Patel R, 2008, J SPEECH LANG HEAR R, V51, P209, DOI 10.1044/1092-4388(2008/016); PICHENY MA, 1986, J SPEECH HEAR RES, V29, P434, DOI 10.1044/jshr.2904.434; Sapir S, 2001, J MED SPEECH-LANG PA, V9, P141; Spitzer SM, 2007, J ACOUST SOC AM, V122, P3678, DOI 10.1121/1.2801545; STATHOPOULOS ET, 1993, J SPEECH HEAR RES, V36, P64, DOI 10.1044/jshr.3601.64; Stathopoulos ET, 1997, J SPEECH LANG HEAR R, V40, P595, DOI 10.1044/jslhr.4003.595; Steppling ML, 2002, PERCEPT PSYCHOPHYS, V64, P451, DOI 10.3758/BF03194717; Tjaden K, 2005, J SPEECH LANG HEAR R, V48, P261, DOI 10.1044/1092-4388(2005/018); Tjaden K, 2004, J SPEECH LANG HEAR R, V47, P766, DOI 10.1044/1092-4388(2004/058); TURNER GS, 1993, J SPEECH HEAR RES, V36, P1134, DOI 10.1044/jshr.3606.1134; Wang YT, 2005, FOLIA PHONIATR LOGO, V57, P59, DOI 10.1159/000083569; Watson PJ, 2008, AM J SPEECH-LANG PAT, V17, P348, DOI 10.1044/1058-0360(2008/07-0048); Weismer G, 2001, FOLIA PHONIATR LOGO, V53, P1, DOI 10.1159/000052649; WINGFIELD A, 1984, J SPEECH HEAR RES, V27, P125; YORKSTON K, 2003, J SPEECH LANG HEAR R, V46, P80; Yorkston KM, 2007, J MED SPEECH-LANG PA, V15, pXI	43	16	16	0	13	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7762			FOLIA PHONIATR LOGO	Folia Phoniatr. Logop.		2011	63	4					178	186		10.1159/000316315			9	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	854AE	WOS:000297466100002	20938199	Bronze, Green Published			2021-06-18	
J	Tlustos, SJ; Chiu, CYP; Walz, NC; Holland, SK; Bernard, L; Wade, SL				Tlustos, Sarah J.; Chiu, C. -Y. Peter; Walz, Nicolay Chertkoff; Holland, Scott K.; Bernard, Lori; Wade, Shari L.			Neural Correlates of Interference Control in Adolescents with Traumatic Brain Injury: Functional Magnetic Resonance Imaging Study of the Counting Stroop Task	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Childhood brain disorder; Inhibition; Executive functions; Brain imaging; Adolescent; Head injury	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANTERIOR CINGULATE CORTEX; WORKING-MEMORY; COGNITIVE-CONTROL; RETROSPECTIVE ESTIMATION; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; EARLY-CHILDHOOD; HEAD-INJURY; ACTIVATION	Difficulty in inhibition or cognitive control is a common and significant sequela of pediatric traumatic brain injury (TBI). The present study used functional MRI to examine one specific inhibitory function, interference control, in 11 adolescents, aged 12-16 years, (mean age, 15.7 years) with TBI who were at least 1 year postinjury and 11 age-matched typically developing control participants (TC) (mean age, 15.2 years). Participants completed a Counting Stroop task with 2 main conditions: (I) a neutral condition requiring the counting of animal words and (2) an interference condition in which mismatched number words were counted. Both TBI and TC adolescents activated similar networks of brain regions relevant to interference control, but the TBI group showed higher levels of activation relative to the TC group in multiple brain areas within this network, including predominantly right frontal and parietal regions. Findings of greater activation of the relevant neural network in the TBI group are consistent with recent fMRI findings using other interference control paradigms with individuals with a history of TBI. (JINS, 2011, 17, 181-189)	[Tlustos, Sarah J.; Chiu, C. -Y. Peter] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Chiu, C. -Y. Peter] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH 45221 USA; [Walz, Nicolay Chertkoff; Holland, Scott K.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH USA; [Holland, Scott K.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH USA; [Bernard, Lori; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH USA	Chiu, CYP (corresponding author), Univ Cincinnati, Dept Psychol, 101A Dyer Hall,ML 0376, Cincinnati, OH 45221 USA.	peter.chiu@uc.edu		Holland, Scott/0000-0003-3719-0875	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [RO1-MH073764]; National Institute on Disability and Rehabilitation Research in the Department of Education [H133G050239]; Ohio Department of Public Safety; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by (I) NIH grant RO1-MH073764 from the National Institute of Mental Health; (2) H133G050239 from the National Institute on Disability and Rehabilitation Research in the Department of Education, and (3) EMS/Trauma grant from the Ohio Department of Public Safety. The information in this manuscript is an original contribution to the literature and has not previously been published, electronically or in print. The authors certify that we know of no conflict of interest, and we adhere to the ethical guidelines of the Helsinki Declaration. We thank three anonymous reviewers for providing numerous helpful comments and suggestions for improving the manuscript. The order of the first two authors was determined by a coin toss.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.3.CO;2-H; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Crosnoe R, 2008, J RES ADOLESCENCE, V18, P23, DOI 10.1111/j.1532-7795.2008.00549.x; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dunn L., 2007, PEABODY PICTURE VOCA, V4th ed.; E-Prime, E PRIM COMP SOFTW; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Guy S.C., 2004, BRIEF SR BEHAV RATIN; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Kramer ME, 2009, J PEDIATR REHAB MED, V2, P255, DOI 10.3233/PRM-2009-0091; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Le TH, 1996, MAGNET RESON MED, V35, P290, DOI 10.1002/mrm.1910350305; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; PENNINGTON BF, 1994, MAC FDN MEN, P243; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schmithorst VJ, 2007, NEUROIMAGE, V35, P406, DOI 10.1016/j.neuroimage.2006.11.046; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Talairach J., 1988, COPLANAR STEREOTACTI; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wechsler D., 2003, WECHSLER INTELLIGENC; Wigfield A., 1994, J EARLY ADOLESC, V14, P102, DOI [https://doi.org/10.1177/027243169401400202, DOI 10.1177/027243169401400202]; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	58	16	16	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2011	17	1					181	189		10.1017/S1355617710001414			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	702KX	WOS:000285894700020	21092356	Green Accepted			2021-06-18	
J	Moon, Y; Choi, SY; Kim, K; Kim, H; Sun, W				Moon, Younghye; Choi, So Yoen; Kim, Kyungjin; Kim, Hyun; Sun, Woong			Expression of connexin29 and 32 in the penumbra region after traumatic brain injury of mice	NEUROREPORT			English	Article						connexin; gap junction; hemichannel; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; GAP-JUNCTION PROTEINS; GLOBAL-ISCHEMIA; GLIAL-CELLS; CX32; OLIGODENDROCYTES; COLOCALIZATION; VULNERABILITY; ASTROCYTES; CHANNELS	Connexins (Cx) are transmembrane proteins forming vertebrate gap junction channels for direct cell-cell communication. We found that the expressions of two Cx family members, Cx29 and Cx32, were progressively increased in the sharp border of injury penumbra regions after cryotraumatic brain injury. Although these two Cxs are expressed exclusively in the oligodendrocytes in the normal cerebral cortex, their expressions were increased in the astrocytes and microglia localized in the injury border. Highly selective induction of Cxs in the injury border suggests that altered Cxs may contribute to the propagations of injury-related and/or regeneration signals after acute brain injury. NeuroReport 21: 1135-1139 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Choi, So Yoen; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Dept Anat, Div Brain Korea Biomed Sci 21, Seoul 136705, South Korea; [Moon, Younghye; Kim, Kyungjin] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Brain & Neuroendocrine Lab, Seoul 151742, South Korea	Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, Div Brain Korea Biomed Sci 21, 126-1 Anam Dong, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Choi, So Yoen/AAV-1947-2020	Moon, Younghye/0000-0002-3737-0043	Korea Ministry of Science and TechnologyMinistry of Science and Technology (MOST) Korea; National Research LaboratoryKorea Science and Engineering Foundation [2009K001259]	This study was supported by grants 2009K001259 from National Research Laboratory and Brain Research Center of the 21st Century Frontier Program in Neuroscience from Korea Ministry of Science and Technology.	Ahn M, 2008, J NEUROSCI RES, V86, P992, DOI 10.1002/jnr.21561; Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Altevogt BM, 2002, J NEUROSCI, V22, P6458; Chandross KJ, 1996, MOL CELL NEUROSCI, V7, P501, DOI 10.1006/mcne.1996.0036; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; HOSSAIN MZ, 1994, BRAIN RES, V652, P311, DOI 10.1016/0006-8993(94)90242-9; Kleopa KA, 2004, GLIA, V47, P346, DOI 10.1002/glia.20043; Leung DSY, 2002, INT J DEV NEUROSCI, V20, P63, DOI 10.1016/S0736-5748(01)00056-9; Murru MR, 2006, NEUROL SCI, V27, P18, DOI 10.1007/s10072-006-0560-8; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nagy JI, 2003, J COMP NEUROL, V464, P356, DOI 10.1002/cne.10797; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; Nakase T, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/147946; Oguro K, 2001, J NEUROSCI, V21, P7534; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Paciaroni M, 2009, EUR NEUROL, V61, P321, DOI 10.1159/000210544; ROHLMANN A, 1993, NEUROSCI LETT, V154, P206, DOI 10.1016/0304-3940(93)90208-3; Sohl G, 2004, BRAIN RES REV, V47, P245, DOI 10.1016/j.brainresrev.2004.05.006; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007	25	16	16	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	DEC 29	2010	21	18					1135	1139		10.1097/WNR.0b013e32834051c7			5	Neurosciences	Neurosciences & Neurology	685DL	WOS:000284607500001	20926974				2021-06-18	
J	Fabrizio, KS; Keltner, NL				Fabrizio, Katherine S.; Keltner, Norman L.			Traumatic Brain Injury in Operation Enduring Freedom/Operation Iraqi Freedom: A Primer	NURSING CLINICS OF NORTH AMERICA			English	Article						Brain injury; Blast; Military; Veterans	POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; PART II; AFGHANISTAN; SOLDIERS; WAR; CONSEQUENCES; DEPRESSION; RECOVERY; LONG	In greater numbers than in prior conflicts, service members deployed as part of Operation Enduring Freedom and Operation Iraqi Freedom have an increased risk of experiencing a traumatic brain injury (TBI). The basics of TBI are discussed, with particular attention paid to blast-related events, as this is a common mechanism of injury in this population. Particular attention is focused on the pharmacologic treatment of the sequlae of TBI and common comorbid conditions.	[Fabrizio, Katherine S.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35233 USA; [Keltner, Norman L.] Univ Alabama, Sch Nursing, Birmingham, AL 35294 USA	Fabrizio, KS (corresponding author), Birmingham Vet Affairs Med Ctr, Phys Med & Rehabil 117,700 S 19th St, Birmingham, AL 35233 USA.	Katherine.Fabrizio@va.gov					Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Cooke BB, 2008, PERSPECT PSYCHIATR C, V44, P54, DOI 10.1111/j.1744-6163.2008.00148.x; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [10.1097/00001199-198909000-00008, DOI 10.1097/00001199-198909000-00008]; Davidson JRT, 2006, J CLIN PSYCHIAT, V67, P34; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dowben JS, 2007, PERSPECT PSYCHIATR C, V43, P146, DOI 10.1111/j.1744-6163.2007.00124.x; Fischer J. S., 2004, NEUROPSYCHOLOGICAL A; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; KELTNER NL, 2011, PSYCHIAT NURSING, P489; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; McCrea M, 2008, MILD TRAUMATIC BRAIN; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; PARKER RS, 2001, CONCUSSIVE BRAIN TRA; RICHARDSON JTE, 2000, CLIN NEUROPSYCHOLOGI; Schwab KA, 2007, J REHABIL RES DEV, V44, pXIII; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Tanielian T, 2008, INVISIBLE WOUNDS WAR; TEESDALE G, 1974, LANCET, V2, P81; TENOVUO O, 2006, TRAUMA REHABILITATIO, V52, P2; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	39	16	16	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0029-6465			NURS CLIN N AM	Nurs. Clin. North Am.	DEC	2010	45	4					569	+		10.1016/j.cnur.2010.06.003			13	Nursing	Nursing	683AI	WOS:000284443700006	20971337				2021-06-18	
J	Thaler, NS; Bello, DT; Randall, C; Goldstein, G; Mayfield, J; Allen, DN				Thaler, Nicholas S.; Bello, Danielle T.; Randall, Carol; Goldstein, Gerald; Mayfield, Joan; Allen, Daniel N.			IQ Profiles Are Associated with Differences in Behavioral Functioning Following Pediatric Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Childhood brain insult; Intelligence; Statistical methods	WECHSLER INTELLIGENCE SCALE; INDEX SCORE PATTERNS; GLASGOW COMA SCALE; WISC-III; EXECUTIVE FUNCTION; PROCESSING SPEED; CLUSTER SUBTYPES; YOUNG-CHILDREN; HEAD-INJURY; PERFORMANCE	Research suggests that IQ profiles identify subgroups of children with traumatic brain injury (TBI) based on sparing and impairment of cognitive abilities, but little information is available regarding whether these subgroups are differentiated on variables that are important for TBI outcome, such as behavioral functioning. The current study examined behavioral disturbances in 123 children with TBI in association with profiles of intellectual abilities identified using cluster analysis. On the basis of prior research, four clusters were hypothesized. Consistent with the hypothesis, cluster analysis identified four IQ clusters in the current sample. Comparisons among the clusters on behavior variables assessed from the Behavioral Assessment System for Children parent ratings indicated significant differences among the four IQ clusters, with the most impaired cluster exhibiting the severest disturbances. Results of the current study indicate that subgroups of children with TBI can be identified using IQ tests and that these subgroups are stable across different samples, and more importantly are moderately associated with behavioral disturbances that persist during the recovery period.	[Allen, Daniel N.] Univ Nevada, Neuropsychol Res Program, Dept Psychol, Las Vegas, NV 89154 USA; [Goldstein, Gerald] VA Pittsburgh Healthcare Syst, MIRECC, Pittsburgh, PA USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA	Allen, DN (corresponding author), Univ Nevada, Neuropsychol Res Program, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Aldenderfer M.S., 1984, CLUSTER ANAL; Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; ALLEN DN, ARCH CLIN N IN PRESS; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; BARNEY SJ, CLIN NEUROP IN PRESS; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; Bishop D, 2008, DEV MED CHILD NEUROL, V50, P324, DOI 10.1111/j.1469-8749.2008.00324.x; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P249, DOI 10.1080/13854049708400453; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DEBILDT A, 2005, J INTELL DISABIL RES, V49, P572; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dietz KR, 1997, J CLIN CHILD PSYCHOL, V26, P99, DOI 10.1207/s15374424jccp2601_10; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; EVERITT S, 2001, CLUSTER ANAL; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hanten G, 2009, TOP LANG DISORD, V29, P236, DOI 10.1097/TLD.0b013e3181b531f0; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Heaton R.K., 1991, COMPREHENSIVE NORMS; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jansen PW, 2007, AM J MED GENET A, V143A, P574, DOI 10.1002/ajmg.a.31623; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Naglieri JA, 2005, ARCH CLIN NEUROPSYCH, V20, P385, DOI 10.1016/j.acn.2004.09.008; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Reynolds C.R., 1994, TEST MEMORY LEARNING; Reynolds C.R., 1992, BEHAV ASSESSMENT SYS; Reynolds CR., 2004, BEHAV ASSESSMENT SYS, V2nd; Romesburg CH, 1984, CLUSTER ANAL RES; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Smith RJ, 1998, HUMAN BRAIN FUNCT, P135; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; TEASDALE G, 1974, LANCET, V2, P81; TONKS J, 2007, BRAIN IMPAIR, V8, P143, DOI DOI 10.1375/BRIM.8.2.143; Tramontana M G, 1988, Arch Clin Neuropsychol, V3, P369; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wechsler D, 2003, WISC 4 TECHNICAL INT; Wechsler D., 1991, MANUAL WECHSLER INTE; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Worthington A., 2008, PSYCHOL APPROACHES R; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Young S, 2005, BRIT J CLIN PSYCHOL, V44, P47, DOI 10.1348/014466504X197769	64	16	16	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2010	25	8					781	790		10.1093/arclin/acq073			10	Psychology, Clinical; Psychology	Psychology	679KE	WOS:000284159500008	20876194	Bronze, Green Published			2021-06-18	
J	Chhabra, G; Rangarajan, K; Subramanian, A; Agrawal, D; Sharma, S; Mukhopadhayay, AK				Chhabra, Gaurav; Rangarajan, Kanchana; Subramanian, Arulselvi; Agrawal, Deepak; Sharma, Subhadra; Mukhopadhayay, A. K.			Hypofibrinogenemia in isolated traumatic brain injury in Indian patients	NEUROLOGY INDIA			English	Article						Coagulopathy; head injury; hypofibrinogenemia	COAGULOPATHY	Coagulation abnormalities are common in patients with head injuries. However, the effect of brain injury on fibrinogen levels has not been well studied prospectively to assess coagulation abnormalities in patients with moderate and severe head injuries and correlate these abnormalities with the neurologic outcome. Consecutive patients with moderate (Glasgow Comma Scale (GCS),9-12) and severe (GCS <= 8) head injuries were the subjects of this pilot study, All patients had coagulation parameters, including plasma fibrinogen levels measured. Clinical and computed tomography (CT) scan findings and immediate clinical outcome were analyzed. Of the 100 patients enrolled, only seven (7) patients had hypofibrinogenemia (fibrinogen <= 200 mg/dL). The head injury was moderate in two patients and severe in five patients. Fibrinogen levels showed a progressively increasing trend in four patients (three with severe head injuries and one with moderate head injury). CT scan revealed subdural hematoma in five patients; extradural hematoma in one; and subarachnoid hemorrhage in another patient. Of the seven patients, two patients died during hospital. Large-scale prospective studies are needed to assess the fibrinogen level in patients with head injury and its impact on outcome.	[Chhabra, Gaurav; Rangarajan, Kanchana; Subramanian, Arulselvi; Sharma, Subhadra; Mukhopadhayay, A. K.] AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Lab Med, Delhi, India; [Agrawal, Deepak] AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Neurosurg, Delhi, India	Subramanian, A (corresponding author), AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Lab Med, Delhi, India.	arulselvi.jpnatc@gmail.com	/AAG-3032-2021; Subramanian, arulselvi/AAG-1670-2020	/0000-0002-5499-0746; Subramanian, arulselvi/0000-0001-7797-6683			Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; UEDA S, 1985, J NEUROL NEUROSUR PS, V48, P58, DOI 10.1136/jnnp.48.1.58	6	16	17	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	SEP-OCT	2010	58	5					756	757		10.4103/0028-3886.72175			2	Neurosciences	Neurosciences & Neurology	676OU	WOS:000283922600018	21045504				2021-06-18	
J	LeBlanc, J; Shultz, JR; Seresova, A; de Guise, E; Lamoureux, J; Fong, N; Marcoux, J; Maleki, M; Khwaja, K				LeBlanc, Joanne; Shultz, Judith Robillard; Seresova, Alena; de Guise, Elaine; Lamoureux, Julie; Fong, Nancy; Marcoux, Judith; Maleki, Mohammad; Khwaja, Kosar			Outcome in Tracheostomized Patients With Severe Traumatic Brain Injury Following Implementation of a Specialized Multidisciplinary Tracheostomy Team	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						early rehabilitation; speaking valves; tracheostomy; team; traumatic brain injury	SYSTEM; SCALE	Objective: To evaluate the effect of a specialized multidisciplinary tracheostomy team on outcome of patients with severe traumatic brain injury (sTBI). Design: Retrospective study with historical controls. Participants: Twenty-seven patients with sTBI tracheostomized before implementation of the tracheostomy team approach and 34 patients followed by the team. Setting: A regional level 1 tertiary care trauma center, McGill University Health Centre-Montreal General Hospital. Main outcome measures: Time to decannulation, length of stay (LOS), Passy-Muir speaking valve use, and extended Glasgow Outcome Scale (GOS-E) scores given at acute care discharge. Results: The groups were similar for injury severity, age, and premorbid health conditions. Postteam patients had a significantly shorter LOS (P = .025) and more of them used Passy-Muir speaking valves (P = .004). Furthermore, there was a trend toward decreased time to decannulation in the postteam group. GOS-E scores did not differ significantly between groups (P > .05). Conclusion: Implementation of the tracheostomy team appears to have had positive clinical benefits for this population.	[LeBlanc, Joanne] McGill Univ Hlth Ctr, Dept Speech Language Pathol & Audiol, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ H3C 3J7, Canada; [de Guise, Elaine; Marcoux, Judith; Maleki, Mohammad] McGill Univ Hlth Ctr, Dept Neurol & Neurosurg, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Khwaja, Kosar] McGill Univ Hlth Ctr, Dept Surg & Crit Care Med, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada	LeBlanc, J (corresponding author), McGill Univ Hlth Ctr, Dept Speech Language Pathol & Audiol, Montreal Gen Hosp, A2-141,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca					BAKER S, 1975, J TRAUMA INJURY INFE, V14, P187; BELLOMO R, 2007, 3 INT C RAP RESP SYS; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; DEMESTRAL C, 2008, ANN CONV CAN ASS GEN; Frank U, 2007, DYSPHAGIA, V22, P20, DOI 10.1007/s00455-006-9036-5; GURKIN MA, 2001, 44 ANN M MIDW SURG A; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Norwood MGA, 2004, POSTGRAD MED J, V80, P478, DOI 10.1136/pgmj.2003.016956; RAUTELA L, 2007, WORLD PHYS THER JUN; TEASDALE G, 1974, LANCET, V2, P81; Tobin AE, 2008, CRIT CARE, V12, DOI 10.1186/cc6864	13	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2010	25	5					362	365		10.1097/HTR.0b013e3181cd67ea			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	649JR	WOS:000281765400009	20134335				2021-06-18	
J	Wyen, H; Jakob, H; Wutzler, S; Lefering, R; Laurer, HL; Marzi, I; Lehnert, M				Wyen, Hendrik; Jakob, Heike; Wutzler, Sebastian; Lefering, Rolf; Laurer, Helmut L.; Marzi, Ingo; Lehnert, Mark		Trauma Registry DGU	Prehospital and Early Clinical Care of Infants, Children, and Teenagers Compared to an Adult Cohort Analysis of 2,961 Children in Comparison to 21,435 Adult Patients from the Trauma Registry of DGU in a 15-Year Period	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Polytrauma management including prehospital and shockroom; Pediatric; Prehospital care; Multiple trauma; Pediatric trauma	MULTIPLE INJURIES; RESUSCITATION; AIR	Background: Although the incidence of pediatric patients in emergency services is as low as 5-10%, trauma remains one of the leading causes of death during childhood. Only a few reports exist about the quality of the initial treatment of pediatric trauma patients. Therefore, we tested the hypothesis of whether pre-hospital treatment and emergency management in pediatric trauma patients is similar to the treatment that is provided for adult patients. Materials and Methods: We performed a retrospective data analysis of the German Trauma Registry of the DGU from January 1993 to December 2007. Exclusion criteria were missing information about injury severity and/or age and patients older than 50 years. All pediatric patients were subdivided into five groups (infants 0-1 year, toddlers 2-5 years, children 6-9 years, pupils 10-13 years, teenagers 14-17 years) with regard to their age and were compared with the adult cohort (18-50 years). From 24,396 patients, 2,961 were below 18 years of age, thus, about 12% of the whole population of injured patients below the age of 50 years. Results: 66.4% of infants sustained relevant head injuries (Abbreviated Injury Scale [AIS] >= 3), and this rate declined with increasing age. The mean Injury Severity Score (ISS) increased from 21.0 (+/-11.6) in the group of infants to 26.7 (+/-13.9) in the adult cohort. In all groups, the majority of patients were male. The injury pattern differed according to age, with predominant traumatic brain injury (TBI) in infants. During the preclinical treatment, infants were less often intubated and this was contrasted by a higher rate of cardiopulmonary resuscitation in this group (infants 16.2%, toddlers 6.8%, adults 3.1%). Diagnostic multislice computed tomography (CT) examination was less often performed in infants as compared to the other groups (infants 57.1%, toddlers 77.2%, adults 77.8%). Mortality and quality indicators such as timelines show no significant differences between children and adults. Conclusion: We observed typical age-dependent differences regarding the injury pattern and severity and differences referring to the preclinical and initial treatment. With respect to the high rate of serious TBI in the infants and toddlers age groups, a more focused education and training of emergency physicians and paramedics should be considered.	[Wyen, Hendrik; Jakob, Heike; Wutzler, Sebastian; Laurer, Helmut L.; Marzi, Ingo; Lehnert, Mark] Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med, IFOM, Cologne, Germany	Wyen, H (corresponding author), Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	wyen@trauma.uni-frankfurt.de					Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; [Anonymous], 1998, ABBR INJ SCAL AIS 19; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Capizzani AR, 2010, J PEDIATR SURG, V45, P903, DOI 10.1016/j.jpedsurg.2010.02.014; Chwals WJ, 2008, J PEDIATR SURG, V43, P2268, DOI 10.1016/j.jpedsurg.2008.08.061; COWLEY RA, 1976, CLIN MED/US, V83, P16; Dykes EH, 1999, BRIT J ANAESTH, V83, P130; Gatzka C, 2005, UNFALLCHIRURG, V108, P470, DOI 10.1007/s00113-005-0921-4; Hammad AMM, 2009, EUR J TRAUMA EMERG S, V35, P31, DOI 10.1007/s00068-008-8025-9; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Jakob H, 2009, UNFALLCHIRURG, V112, P951, DOI 10.1007/s00113-009-1682-2; Kanz KG, 2006, UNFALLCHIRURG, V109, P278, DOI 10.1007/s00113-006-1061-1; Laurer H, 2009, UNFALLCHIRURG, V112, P771, DOI 10.1007/s00113-009-1589-y; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Meyer PG, 2000, PAEDIATR ANAESTH, V10, P253, DOI 10.1046/j.1460-9592.2000.00496.x; Nagele P, 2004, WIEN KLIN WOCHENSCHR, V116, P398, DOI 10.1007/BF03040921; Paul TR, 1999, J TRAUMA, V47, P455, DOI 10.1097/00005373-199909000-00004; Ruchholtz S, 2007, Chirurg, VSuppl, P266; Schelhase T., 2006, WIRTSCHAFT STAT, V6, P614; Schlechtriemen T, 2006, ANAESTHESIST, V55, P255, DOI 10.1007/s00101-005-0922-2; Schmidt FL, 2002, HUM PERFORM, V15, P187, DOI 10.1207/S15327043HUP1501&02_12; Schmidt U, 2002, UNFALLCHIRURG, V105, P1000, DOI 10.1007/s00113-002-0520-6; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Soreide K, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-3; Suominen P, 1998, J PEDIATR SURG, V33, P1388, DOI 10.1016/S0022-3468(98)90014-8; TEASDALE G, 1974, LANCET, V2, P81; Weiss M, 2001, ANAESTHESIST, V50, P150, DOI 10.1007/s001010170030; Wilson JRF, 2009, EUR J TRAUMA EMERG S, V35, P176, DOI 10.1007/s00068-008-8095-8; Wutzler S, 2008, UNFALLCHIRURG, V111, P592, DOI 10.1007/s00113-008-1448-2; Wyen H, 2009, EUR J TRAUMA EMERG S, V35, P448, DOI 10.1007/s00068-009-9140-y	30	16	16	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2010	36	4					300	307		10.1007/s00068-010-1124-4			8	Emergency Medicine	Emergency Medicine	639AP	WOS:000280943500003	26816034				2021-06-18	
J	Finley, DS; Chang, A; Morales, B; Osann, K; Skarecky, D; Ahlering, T				Finley, David S.; Chang, Alexandra; Morales, Blanca; Osann, Kathryn; Skarecky, Douglas; Ahlering, Thomas			Impact of Regional Hypothermia on Urinary Continence and Potency After Robot-Assisted Radical Prostatectomy	JOURNAL OF ENDOUROLOGY			English	Article; Proceedings Paper	27th World Congress of Endourology	OCT 06-10, 2009	Munich, GERMANY	Endourol Soc			TRAUMATIC BRAIN-INJURY; PENILE ERECTION; APOPTOTIC PATHWAYS; SURGICAL MARGINS; MECHANISM; NEUROINFLAMMATION; HEMODYNAMICS; ACTIVATION; NEURONS	Background and Purpose: This is the third publication that updates clinical outcomes using a novel technique to apply locoregional hypothermia to the pelvis during robot-assisted radical prostatectomy (RARP) to reduce inflammatory injury. This report updates urinary and sexual clinical outcomes with a minimum of 1 year follow-up. Patients and Methods: Regional pelvic cooling (<300 degrees C) was achieved with a prototype endorectal cooling balloon (ECB) during the course of RARP. All clinical data were entered prospectively into an electronic database for historic (cases 1-666) and hypothermic groups (115 pts). Urinary and sexual outcomes were obtained using self-administered validated questionnaires. Continence was defined as no pads, and potency was defined as two affirmative answers to "erections adequate for penetration'' and "were the erections satisfactory.'' Results: Six patients were excluded: three ECB malfunction, three previous radiation/surgery. Median time to zero pad use was 39 days vs 62 days (hypothermic vs controls, P = 0.0003). At 1 year, overall pad-free continence was 96.3% (105/109) vs controls of 86.6%, P < 0.001. Potency was evaluated in all men (40-78 years) with preoperative International Index of Erectile Function-5 scores of 22 to 25. At 3 months, potency results were unchanged between groups: 24% vs 23%. At 15 months, the potency rates were significantly better for the hypothermic group, 83% vs controls 66%, P = 0.045. No difference in oncologic outcome was noted with cooling. Conclusions: Using a prototype cooling balloon, hypothermic RARP significantly improved time to continence and overall continence. Hypothermia also resulted in a modest but statistically significant improvement in potency at 15 months. Once cooling parameters have been optimized, a randomized multicenter clinical trial will be needed for validation.	[Chang, Alexandra; Morales, Blanca; Osann, Kathryn; Skarecky, Douglas; Ahlering, Thomas] Univ Calif Irvine, Dept Urol, Orange, CA 92868 USA; [Finley, David S.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Urol Oncol, Los Angeles, CA 90095 USA	Ahlering, T (corresponding author), Univ Calif Irvine, Dept Urol, 101 City Dr,Bldg 26,Route 81, Orange, CA 92868 USA.	tahlerin@uci.edu		Skarecky, Douglas/0000-0002-9234-6716; Ahlering, Thomas/0000-0002-6492-4910			ABOSEIF SR, 1988, CARDIOVASC INTER RAD, V11, P185, DOI 10.1007/BF02577002; Adachi M, 2001, PEDIATR RES, V50, P590, DOI 10.1203/00006450-200111000-00010; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; BENOIT G, 1987, SURG RADIOL ANAT, V9, P263, DOI 10.1007/BF02105295; Borin JF, 2007, UROLOGY, V70, P173, DOI 10.1016/j.urology.2007.03.050; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120; Finley DS, 2009, J ENDOUROL, V23, P1443, DOI 10.1089/end.2009.0411; Finley DS, 2009, UROLOGY, V73, P691, DOI 10.1016/j.urology.2008.09.085; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Godbout JP, 2006, NEUROL CLIN, V24, P521, DOI 10.1016/j.ncl.2006.03.010; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; GOLDSTEIN AMB, 1985, BRIT J UROL, V57, P574, DOI 10.1111/j.1464-410X.1985.tb05869.x; Hildebrand Frank, 2005, Surg Technol Int, V14, P41; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lue T F, 1986, Semin Urol, V4, P217; LUE TF, 1983, J UROLOGY, V130, P1237, DOI 10.1016/S0022-5347(17)51768-1; Morgan TE, 1999, NEUROSCIENCE, V89, P687, DOI 10.1016/S0306-4522(98)00334-0; NEWMAN HF, 1981, UROLOGY, V17, P399, DOI 10.1016/0090-4295(81)90177-1; Ning XH, 2002, J APPL PHYSIOL, V92, P2200, DOI 10.1152/japplphysiol.01035.2001; PERRY VH, 1993, GLIA, V7, P60, DOI 10.1002/glia.440070111; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Povlishock JT, 1999, ACT NEUR S, V73, P15; SEDDON HJ, 1948, J NERV MENT DIS, V108, P160; SIROKY MB, 1979, SURG FORUM, V30, P545; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; WALSH PC, 1983, PROSTATE, V4, P473, DOI 10.1002/pros.2990040506; WALSH PC, 1982, J UROLOGY, V128, P492, DOI 10.1016/S0022-5347(17)53012-8; Weiss H D, 1973, Med Aspects Hum Sex, V7, P35; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Yee DS, 2009, J ENDOUROL, V23, P1461, DOI 10.1089/end.2009.0144	35	16	17	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0892-7790			J ENDOUROL	J. Endourol.	JUL	2010	24	7					1111	1116		10.1089/end.2010.0122			6	Urology & Nephrology	Urology & Nephrology	623WZ	WOS:000279779300013	20624082				2021-06-18	
J	Fornander, L; Nyman, T; Hansson, T; Ragnehed, M; Brismar, T				Fornander, Lotta; Nyman, Torbjorn; Hansson, Thomas; Ragnehed, Mattias; Brismar, Tom			Age- and time-dependent effects on functional outcome and cortical activation pattern in patients with median nerve injury: a functional magnetic resonance imaging study Clinical article	JOURNAL OF NEUROSURGERY			English	Article						median nerve; hand injury; neuronal plasticity; functional magnetic resonance imaging	PRIMARY SOMATOSENSORY CORTEX; TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; SENSORIMOTOR CORTEX; SENSORY STIMULATION; TACTILE STIMULATION; ADULT MONKEYS; HAND FUNCTION; REORGANIZATION; REPAIR	Object. The authors conducted a study to determine age- and time-dependent effects on the functional outcome after median nerve injury and repair and how such effects are related to changes in the pattern of cortical activation in response to tactile stimulation of the injured hand. Methods. The authors studied 11 patients with complete unilateral median nerve injury at the wrist repaired with epineural suture. In addition, 8 patients who were reported on in a previous study were included in the statistical analysis. In the entire study cohort, the mean age at injury was 23.3 +/- 13.4 years (range 7-57 years) and the time after injury ranged from 1 to 11 years. Sensory perception was measured with the static 2-point discrimination test and monofilaments. Functional MR imaging was conducted during tactile stimulation (brush strokes) of Digits II-III and IV-V of both hands, respectively. Results. Tactile sensation was diminished in the median territory in all patients. The strongest predictor of 2-point discrimination was age at injury (p < 0.0048), and when this was accounted for in the regression analysis, the other age- and time-dependent predictors had no effect. The activation ratios (injured/healthy hand) for Digit II-III and Digit IV-V stimulation were positively correlated (rho 0.59, p < 0.011). The activation ratio for Digit II-III stimulation correlated weakly with time after injury (p < 0.041). The activation ratio of Digits IV-V correlated weakly with both age at injury (p < 0.048) and time after injury (p < 0.033), but no predictor reached significance in the regression model. The mean ratio of ipsi- and contralateral hemisphere activation after stimulation of the injured hand was 0.55, which was not significantly different from the corresponding ratio of the healthy hand (0.66). Conclusions. Following a median nerve injury (1-11 years after injury) there may be an initial increase in the volume of the cortical representation, which subsequently declines during the restoration phase. These dynamic changes may involve both median and ulnar nerve cortical representation, because both showed negative correlation with time after injury. These findings are in agreement with animal studies showing that cortical plasticity is an important mechanism for functional recovery after peripheral nerve injury and repair. (DOI: 10.3171/2009.10.JNS09698)	[Fornander, Lotta; Brismar, Tom] Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; Vrinnevi Hosp, Dept Orthopaed, Norrkoping, Sweden; [Ragnehed, Mattias] Linkoping Univ, Div Radiol Sci, IMH, Linkoping, Sweden; [Fornander, Lotta; Hansson, Thomas] Univ Hosp, Dept Plast Surg, Dept Hand Surg & Burns, Linkoping, Sweden; [Nyman, Torbjorn] Univ Hosp, Dept Anaesthesiol, Linkoping, Sweden	Fornander, L (corresponding author), Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden.	lotta.b.fornander@lio.se		Fornander, Lotta/0000-0003-2077-8445	Ostergotlands Lans Landsting	Ostergotlands Lans Landsting provided financial support.	Allan CH, 2000, HAND CLIN, V16, P67; *AM SOC SURG HAND, 1978, HAND EX DIAGN; BELLKROTOSKI J, 1991, HAND CLIN, V7, P527; Blatow M, 2007, NEUROIMAGE, V37, P927, DOI 10.1016/j.neuroimage.2007.05.038; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; CALFORD MB, 1990, SCIENCE, V249, P805, DOI 10.1126/science.2389146; Callahan AD., 2002, REHABILITATION HAND; Duteille F, 2001, J HAND SURG-BRIT EUR, V26, P58, DOI 10.1054/jhsb.2000.0493; Florence SL, 1996, NATURE, V381, P69, DOI 10.1038/381069a0; FRAHM J, 1993, MAGNET RESON MED, V29, P139, DOI 10.1002/mrm.1910290126; GELBERMAN RH, 1983, J BONE JOINT SURG AM, V65, P632, DOI 10.2106/00004623-198365050-00008; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Guerra WKW, 2007, ZBL NEUROCHIR, V68, P195, DOI 10.1055/s-2007-985859; HALLIN RG, 1981, EXP NEUROL, V73, P90, DOI 10.1016/0014-4886(81)90047-9; HAMMEKE TA, 1994, NEUROSURGERY, V35, P677, DOI 10.1227/00006123-199410000-00014; Hansson T, 1999, NEUROSCI LETT, V271, P29, DOI 10.1016/S0304-3940(99)00508-X; Hansson T, 2003, J NEUROSURG, V99, P100, DOI 10.3171/jns.2003.99.1.0100; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Hudson DA, 1997, J HAND SURG-BRIT EUR, V22B, P54, DOI 10.1016/S0266-7681(97)80017-4; Koller R, 1998, Handchir Mikrochir Plast Chir, V30, P109; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lee S K, 2000, J Am Acad Orthop Surg, V8, P243; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lin WL, 1996, J MAGN RESON IMAGING, V6, P565, DOI 10.1002/jmri.1880060402; Lundborg G, 2007, ACTA PHYSIOL, V189, P207, DOI 10.1111/j.1748-1716.2006.01653.x; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; MOBERG E, 1958, J BONE JOINT SURG BR, V40, P454; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ONNE L, 1962, Acta Chir Scand Suppl, VSuppl 300, P1; Pelled G, 2007, NEUROIMAGE, V37, P262, DOI 10.1016/j.neuroimage.2007.03.069; Porro CA, 2004, MAGN RESON IMAGING, V22, P1539, DOI 10.1016/j.mri.2004.10.003; PUCE A, 1995, J NEUROSURG, V83, P262, DOI 10.3171/jns.1995.83.2.0262; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rossini PM, 2000, BRAIN RES REV, V33, P131, DOI 10.1016/S0169-328X(00)00090-5; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; RUMEAU C, 1994, AM J NEURORADIOL, V15, P567; Shin HC, 1997, NEUROSCI LETT, V230, P137, DOI 10.1016/S0304-3940(97)00486-2; Silva AC, 1996, J COMP NEUROL, V366, P700, DOI 10.1002/(SICI)1096-9861(19960318)366:4<700::AID-CNE9>3.0.CO;2-8; Soros P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-48; Staudt M, 2002, BRAIN, V125, P2222, DOI 10.1093/brain/awf227; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Tomei F, 2000, Chir Main, V19, P23, DOI 10.1016/S1297-3203(00)73456-1; WALL JT, 1986, J NEUROSCI, V6, P218; Wall JT, 2002, BRAIN RES REV, V39, P181, DOI 10.1016/S0165-0173(02)00192-3; Ward NS, 2006, ARCH PHYS MED REHAB, V87, pS30, DOI 10.1016/j.apmr.2006.08.334; YETKIN FZ, 1995, NEUROSURGERY, V36, P921, DOI 10.1227/00006123-199505000-00005; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	48	16	16	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2010	113	1					122	128		10.3171/2009.10.JNS09698			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	615BX	WOS:000279107300030	19911892				2021-06-18	
J	Nakajima, Y; Horiuchi, Y; Kamata, H; Yukawa, M; Kuwabara, M; Tsubokawa, T				Nakajima, Yuko; Horiuchi, Yutaka; Kamata, Hiroshi; Yukawa, Masayoshi; Kuwabara, Masato; Tsubokawa, Takashi			Distinct Time Courses of Secondary Brain Damage in the Hippocampus Following Brain Concussion and Contusion in Rats	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						secondary brain damage; apoptosis; brain concussion; brain contusion; rat	CLOSED-HEAD-INJURY; APOPTOSIS; EXPRESSION; SEVERITY	Secondary brain damage (SBD) is caused by apoptosis after traumatic brain injury that is classified into concussion and contusion. Brain concussion is temporary unconsciousness or confusion caused by a blow on the head without pathological changes, and contusion is a brain injury with hemorrhage and broad extravasations. In this study, we investigated the time-dependent changes of apoptosis in hippocampus after brain concussion and contusion using rat models. We generated the concussion by dropping a plumb on the dura from a height of 3.5 cm and the contusion by cauterizing the cerebral cortex. SBD was evaluated in the hippocampus by histopathological analyses and measuring caspase-3 activity that induces apoptotic neuronal cell death. The frequency of abnormal neuronal cells with vacuolation or nuclear condensation, or those with DNA fragmentation was remarkably increased at 1 hr after concussion (about 30% for each abnormality) from the pre-injury level (0%) and reached the highest level (about 50% for each) by 48 hrs, whereas the frequency of abnormal neuronal cells was increased at 1 hr after contusion (about 10%) and reached the highest level (about 40%) by 48 hrs. In parallel, caspase-3 activity was increased sevenfold in the hippocampus at 1 hr after concussion and returned to the pre-injury level by 48 hrs, whereas after contusion, caspase-3 activity was continuously increased to the highest level at 48 hrs (fivefold). Thus, anti-apoptotic-cell-death treatment to prevent SBD must be performed by 1 hr after concussion and at latest by 48 hrs after contusion.	[Nakajima, Yuko; Horiuchi, Yutaka; Kamata, Hiroshi; Yukawa, Masayoshi; Kuwabara, Masato] Nihon Univ, Dept Vet Med, Coll Bioresonance Bioresource Sci, Kanagawa 2528510, Japan; [Tsubokawa, Takashi] Nihon Univ, Sch Med, Dept Neurosurg, Tokyo, Japan	Nakajima, Y (corresponding author), Nihon Univ, Dept Vet Med, Coll Bioresonance Bioresource Sci, 1866 Kameino, Kanagawa 2528510, Japan.	y09064823383@yahoo.co.jp					BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Hong Jun, 2002, Chin J Traumatol, V5, P36; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; KAIJSER A, 1955, Nord Med, V54, P1308; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KUWABARA M, 2002, NEUROTRAUMA RES, V14, P41; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Luo Chun, 2002, Chin J Traumatol, V5, P24; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Nag S, 2005, LAB INVEST, V85, P1189, DOI 10.1038/labinvest.3700325; NAKAJIMA Y, 2004, NEUROTRAUMA RES, V16, P60; RINK A, 1995, AM J PATHOL, V147, P1575; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; SERGIENKO TM, 1990, ZH VOPR NEIROKHIR, V4, P6; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; UCHIDA H, 2008, J JPN SOC INTENSIVE, V15, P21; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; YNAG SY, 2004, CHIN J TRAUMATOL, V7, P159	23	16	16	0	3	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	JUL	2010	221	3					229	235		10.1620/tjem.221.229			7	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	621ZC	WOS:000279624600009	20562525	Bronze			2021-06-18	
J	Nichol, AD; Bailey, M; Cooper, DJ				Nichol, A. D.; Bailey, M.; Cooper, D. J.		POLAR Investigator; EPO Investigators	Challenging issues in randomised controlled trials	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article; Proceedings Paper	Annual Trauma Research Methods Workshop	NOV 19, 2009	Monash Univ, Melbourne, AUSTRALIA	Australian Natl Trauma Res Inst	Monash Univ	Randomised controlled trial; Intensive care; Research; Education	TRAUMATIC BRAIN-INJURY; CONSORT STATEMENT; QUALITY; RESUSCITATION; SALINE; SIZE	What this topic is about: Randomised controlled trials (RCTs) are the most rigorous way of determining whether a cause-effect relation exists between treatment and outcome and are an integral component in the hierarchy of evidence which guide current clinical practice. Whether ensuring the success of a RCT or interpreting the medical literature, it is important to understand the key components of RCT design to assess their quality and therefore the weight which should be attributed to its findings. This article will highlight some of these key components by using a number of ongoing trauma studies being coordinated by the Australian and New Zealand Intensive Care Research Centre, Monash University. Common problems and challenges: The quality of many RCTs could be improved by avoiding some common pitfalls, such as (i) unclear hypotheses and multiple objectives, (ii) poor selection of endpoints, (iii) inappropriate subject selection criteria, (iv) non-clinically relevant or feasible treatment/intervention regimens, (v) inadequate randomisation, stratification, blinding, (vi) lack of stratification in small RCTs (vii) inadequate blinding of trials, (viii) insufficient sample size/power, (ix) failure to use intention to treat analysis and (x) failure to anticipate common practical problems encountered during the conduct of a RCT. Tips for researchers: The RCTs most likely to be funded and/or be of high quality always address these issues. (C) 2010 Elsevier Ltd. All rights reserved.	[Nichol, A. D.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Nichol, A. D.; Cooper, D. J.] Alfred Hosp, Melbourne, Vic 3004, Australia	Nichol, AD (corresponding author), Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Alfred Hosp Campus,89 Commercial Rd, Melbourne, Vic 3004, Australia.	alistair.nichol@med.monash.edu.au	Bailey, Michael J/A-4499-2012; Cooper, D. James/G-7961-2013	Bailey, Michael J/0000-0002-5551-1401; Cooper, D. James/0000-0002-5872-9051; Nichol, Alistair Dualta/0000-0002-4771-5615; Nichol, Alistair/0000-0002-4689-1238			Altman DG, 1996, BRIT MED J, V313, P570; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; *BRAIN TRAUM FDN, 2007, J NEUROTRAUM, P24; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P319, DOI 10.1001/jama.279.4.319; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Stolberg HO, 2004, AM J ROENTGENOL, V183, P1539, DOI 10.2214/ajr.183.6.01831539; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181; 1992, JAMA, V268, P2420	17	16	16	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JUL	2010	41			1			20	23		10.1016/j.injury.2010.03.033			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	617ZV	WOS:000279321600007	20413119				2021-06-18	
J	Bae, JW; Kim, MJ; Jang, CG; Lee, SY				Bae, Jung-Woo; Kim, Mi-Jeong; Jang, Choon-Gon; Lee, Seok-Yong			Protective effects of heme oxygenase-1 against MPP+-induced cytotoxicity in PC-12 cells	NEUROLOGICAL SCIENCES			English	Article						Heme oxygenase-1 (HO-1); Cytotoxicity; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinium (MPP+); PC-12 cell	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; NITRIC-OXIDE; INTRACEREBRAL HEMORRHAGE; CARBON-MONOXIDE; BILIRUBIN; NEURONS; HO-1; 1-METHYL-4-PHENYLPYRIDINIUM; OVEREXPRESSION	Heme oxygenase-1 (HO-1) catalyses the rate-limiting step of heme degradation to biliverdin, which is in turn reduced to bilirubin, CO and free iron. HO-1 can be induced by several harmful stimuli including oxidative stress, and it has a protective role against the cytotoxicity in different cells. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinium (MPP+) is a neurotoxic substance that induces the degeneration of dopaminergic neurons. This study examined whether HO-1 can be induced by MPP+ and whether HO-1 has a protective role against the MPP+-induced cytotoxicity in PC-12 cells. MPP+ triggered a relatively rapid induction of HO-1. The MPP+-induced cytotoxicity and reactive oxygen species (ROS) production markedly increased by HO-1 inhibitor, zinc protoporphyrin-IX (ZnPP-IX). The increase of ROS production by ZnPP-IX was completely abrogated by either two products of HO (biliverdin or bilirubin) while the increase of cytotoxicity by ZnPP-IX was attenuated partially. These suggest that HO-1 expression might have some cytoprotective effect against MPP+-induced cytotoxicity.	[Bae, Jung-Woo; Kim, Mi-Jeong; Jang, Choon-Gon; Lee, Seok-Yong] Sungkyunkwan Univ, Pharmacol Lab, Coll Pharm, Suwon 440746, South Korea	Lee, SY (corresponding author), Sungkyunkwan Univ, Pharmacol Lab, Coll Pharm, Suwon 440746, South Korea.	sylee@skku.ac.kr	LEE, SEOK-YONG/A-8012-2012				ADAMS JD, 1991, FREE RADICAL BIO MED, V10, P161, DOI 10.1016/0891-5849(91)90009-R; Ahmad AS, 2006, NEUROSCIENCE, V141, P1703, DOI 10.1016/j.neuroscience.2006.05.035; Asad SF, 2001, CHEM-BIOL INTERACT, V137, P59, DOI 10.1016/S0009-2797(01)00209-5; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; BATES TE, 1994, J NEUROCHEM, V63, P640; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; CHAN P, 1991, J NEUROCHEM, V57, P348, DOI 10.1111/j.1471-4159.1991.tb02134.x; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Chlopicki S, 2006, CARDIOVASC RES, V71, P393, DOI 10.1016/j.cardiores.2006.03.011; Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Hartsfield CL, 1997, AM J PHYSIOL-LUNG C, V273, pL980; Huang E, 2005, J NEUROSCI RES, V80, P268, DOI 10.1002/jnr.20444; Jing CR, 2005, J NEUROSCI RES, V82, P802, DOI 10.1002/jnr.20681; KADOYA C, 1995, STROKE, V26, P1035, DOI 10.1161/01.STR.26.6.1035; Koeppen AH, 2004, J NEUROPATH EXP NEUR, V63, P587, DOI 10.1093/jnen/63.6.587; KRUEGER MJ, 1990, BIOCHEM BIOPH RES CO, V169, P123, DOI 10.1016/0006-291X(90)91442-U; LANGSTON JW, 1986, CLIN NEUROPHARMACOL, V9, P485, DOI 10.1097/00002826-198612000-00001; Le W, 1999, J NEUROSCI RES, V56, P652; Lee DW, 2006, TOXICOL SCI, V90, P159, DOI 10.1093/toxsci/kfj052; Lin Y, 2007, J CEREBR BLOOD F MET, V27, P1010, DOI 10.1038/sj.jcbfm.9600412; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MINISINI MP, 1994, MUTAT RES-DNA REPAIR, V315, P169, DOI 10.1016/0921-8777(94)90016-7; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Panahian N, 1999, J NEUROCHEM, V72, P1187; Panizzon KL, 1996, NEUROREPORT, V7, P662, DOI 10.1097/00001756-199601310-00067; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Snyder SH, 1998, BRAIN RES REV, V26, P167, DOI 10.1016/S0165-0173(97)00032-5; Takeda A, 2000, J BIOL CHEM, V275, P5395, DOI 10.1074/jbc.275.8.5395; Tanaka T, 2000, J CARDIOVASC PHARM, V36, pS1, DOI 10.1097/00005344-200000006-00002; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Yuan Y, 2008, EUR J PHARMACOL, V586, P100, DOI 10.1016/j.ejphar.2008.02.033	34	16	18	1	4	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2010	31	3					307	313		10.1007/s10072-010-0216-6			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	595WP	WOS:000277644700009	20127499				2021-06-18	
J	Bremmer, R; de Jong, BM; Wagemakers, M; Regtien, JG; van der Naalt, J				Bremmer, Rosette; de Jong, Bauke M.; Wagemakers, Michiel; Regtien, Joost G.; van der Naalt, Joukje			The Course of Intracranial Pressure in Traumatic Brain Injury: Relation with Outcome and CT-characteristics	NEUROCRITICAL CARE			English	Article						Intracranial pressure (ICP); Traumatic brain injury; ICP profiles; Opening pressure; CT-scan characteristics; Outcome	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; HYPERTENSION; GUIDELINES; PATTERNS; SCALE	One of the predictive factors of outcome in traumatic brain injury is high intracranial pressure (ICP). Recently, the time course of ICP has been described but few data are available on the relation of these ICP profiles and outcome. The aim of this study is to investigate the relation of the time course of ICP with CT-findings and outcome. Retrospective analysis of prospectively collected data of 246 patients with traumatic brain injury admitted to the neurosurgical intensive care unit. Early rise in ICP (within the first 2 days) was present in 32%, an intermediate rise (between days 3 and 5) in 34% and a late rise (after day 5) in 34% of patients. Half of the patients with a normal opening pressure (76%) developed intermediate or late ICP rise profiles. More mass lesions and sub/epidural hematomas were present in the late rise group. Patients with a late ICP rise required significant more intensive treatment (65% vs. 37 and 33%) when compared to the early and intermediate rise groups. In multiple regression analysis both ICP profiles and extracranial hematomas were related to outcome. With late ICP rise more unfavorable outcome (46 vs. 17%, P < 0.001) was seen although one in four patients showed a favorable outcome. During ICP monitoring different ICP profiles are present over time. These profiles are related to CT-characteristics and outcome. The importance of early and late monitoring of ICP is underlined.	[Bremmer, Rosette; de Jong, Bauke M.; van der Naalt, Joukje] Univ & Med Ctr Groningen, Dept Neurol, NL-9713 GZ Groningen, Netherlands; [Wagemakers, Michiel] Univ & Med Ctr Groningen, Dept Neurosurg, NL-9713 GZ Groningen, Netherlands; [Regtien, Joost G.] Univ & Med Ctr Groningen, Dept Crit Care, NL-9713 GZ Groningen, Netherlands	van der Naalt, J (corresponding author), Univ & Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	j.van.der.naalt@neuro.umcg.nl					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Souter MJ, 1999, CRIT CARE MED, V27, P177, DOI 10.1097/00003246-199901000-00048; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	20	16	16	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2010	12	3					362	368		10.1007/s12028-009-9329-2			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	590RJ	WOS:000277244700009	20087687				2021-06-18	
J	Christensen, HM; Dikranian, K; Li, AM; Baysac, KC; Walls, KC; Olney, JW; Roth, KA; Harris, DA				Christensen, Heather M.; Dikranian, Krikor; Li, Aimin; Baysac, Kathleen C.; Walls, Ken C.; Olney, John W.; Roth, Kevin A.; Harris, David A.			A Highly Toxic Cellular Prion Protein Induces a Novel, Nonapoptotic Form of Neuronal Death	AMERICAN JOURNAL OF PATHOLOGY			English	Article							DEFICIENT PURKINJE-CELLS; DOPPEL-INDUCED APOPTOSIS; TRAUMATIC BRAIN-INJURY; TRANSGENIC MICE; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE-1; CEREBELLAR DEGENERATION; CASPASE-3 ACTIVATION; TRUNCATED PRION; RAT-BRAIN	Several different deletions within the N-terminal tail of the prion protein (PrP) induce massive neuronal death when expressed in transgenic mice. This toxicity is dose-dependently suppressed by coexpression of full-length PrP, suggesting that it results from subversion of a normal physiological activity of cellular PrP. We performed a combined biochemical and morphological analysis of Tg(Delta CR) mice, which express PrP carrying a 21-aa deletion (residues 105-125) within a highly conserved region of the protein. Death of cerebellar granule neurons in Tg(Delta CR) mice is not accompanied by activation of either caspase-3 or caspase-8 or by increased levels of the autophagy marker, LC3-II. In electron micrographs, degenerating granule neurons displayed a unique morphology characterized by heterogeneous condensation of the nuclear matrix without formation of discrete chromatin masses typical of neuronal apoptosis. Our data demonstrate that perturbations in PrP functional activity induce a novel, nonapoptotic, nonautophagic form of neuronal death whose morphological features are reminiscent of those associated with excitotoxic stress. (Am J Pathol 2010, 176:2695-2706; DOI: 10.2353/ajpath.2010.091007)	[Christensen, Heather M.; Li, Aimin; Baysac, Kathleen C.; Harris, David A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Dikranian, Krikor] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Olney, John W.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Walls, Ken C.; Roth, Kevin A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu	Christensen, Helen/F-5053-2012	Christensen, Helen/0000-0003-0435-2065; Roth, Kevin/0000-0002-0643-995X; Harris, David/0000-0002-6985-5790; Lamb, Heather/0000-0002-8060-0633	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD 37100, NS035107, N5057098, NS052526, NS040975, NS04691003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD037100, R01HD037100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065244, R01NS052526, P30NS057098, R01NS040975, R01NS035107] Funding Source: NIH RePORTER	Supported by grants from the National Institutes of Health (HD 37100, to J.W.O.; NS035107 and N5057098, to K.A.R.; and NS052526 and NS040975, to D.A.H.). H.M.C. was supported by a predoctoral fellowship (NS04691003) from the National Institutes of Health.	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAMPAGNE MV, 1995, EUR J NEUROSCI, V7, P1627; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Coulpier M, 2006, NEUROBIOL DIS, V23, P603, DOI 10.1016/j.nbd.2006.05.013; Curtin JF, 2003, CELL SIGNAL, V15, P983, DOI 10.1016/S0898-6568(03)00093-7; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Dikranian K, 2001, NEUROBIOL DIS, V8, P359, DOI 10.1006/nbdi.2001.0411; Dong JX, 2007, AM J PATHOL, V171, P599, DOI 10.2353/ajpath.2007.070262; Gill R, 2002, J CEREBR BLOOD F MET, V22, P420, DOI 10.1097/00004647-200204000-00006; Heitz S, 2008, DEV NEUROBIOL, V68, P332, DOI 10.1002/dneu.20555; Heitz S, 2007, DEV NEUROBIOL, V67, P670, DOI 10.1002/dneu.20366; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ishimaru MJ, 1999, J COMP NEUROL, V408, P461; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Nicolas O, 2007, FASEB J, V21, P3107, DOI 10.1096/fj.06-7827com; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Prusiner S. B., 2004, Prion biology and diseases; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Selimi F, 2000, J NEUROSCI, V20, P5339, DOI 10.1523/JNEUROSCI.20-14-05339.2000; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Slagsvold HH, 2003, BRAIN RES, V984, P111, DOI 10.1016/S0006-8993(03)03119-6; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Steele AD, 2007, J NEUROSCI, V27, P13022, DOI 10.1523/JNEUROSCI.3290-07.2007; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Uo T, 2005, J BIOL CHEM, V280, P9065, DOI 10.1074/jbc.M413030200; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; West T, 2006, NEUROBIOL DIS, V22, P523, DOI 10.1016/j.nbd.2005.12.017; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	52	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUN	2010	176	6					2695	2706		10.2353/ajpath.2010.091007			12	Pathology	Pathology	609WU	WOS:000278689700013	20472884	Green Published, Bronze			2021-06-18	
J	Dash, PK; Redell, JB; Hergenroeder, G; Zhao, J; Clifton, GL; Moore, A				Dash, Pramod K.; Redell, John B.; Hergenroeder, Georgene; Zhao, Jing; Clifton, Guy L.; Moore, Anthony			Serum Ceruloplasmin and Copper Are Early Biomarkers for Traumatic Brain Injury-Associated Elevated Intracranial Pressure	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain swelling; biomarker; iron oxidase; plasma; brain trauma	DISEASE; IDENTIFICATION; MECHANISMS; EXPRESSION; DIAGNOSIS; DAMAGE; COMA	High intracranial pressure (ICP) is a prominent secondary pathology after traumatic brain injury (TBI) and is a major contributor to morbidity and mortality. Currently, there are no clinically proven methods for predicting which TBI patients will develop high ICP In the present study, we examined whether the serum levels of the copper-binding protein ceruloplasmin are differentially altered in patients with elevated ICP (>= 25 mmHg) vs. those whose ICP remained below 20 mmHg throughout the study period. Consistent with its role as an acute-phase reactant, we found that ceruloplasnnin levels were significantly increased by 3 days post-TBI compared with healthy volunteers. However, prior to this delayed increase, ceruloplasmin levels during the first 24 hr following injury were found to be significantly reduced in patients who subsequently developed high ICP This decrease was found to have prognostic accuracy in delineating TBI patients based on their ICP status (cutoff of 140 mu g/ml; sensitivity: 87%, specificity: 73%), Likewise, low total serum copper (below 1.32 mu g/ml) was also found to be predictive of high ICP (sensitivity 86%, specificity 73%). These results suggest that initial serum ceruloplasmin/copper levels may have diagnostic value in predicting patients at risk for developing high intracranial pressure. (C) 2010 Wiley-Liss, Inc.	[Dash, Pramod K.; Redell, John B.; Zhao, Jing; Moore, Anthony] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Hergenroeder, Georgene; Clifton, Guy L.] Univ Texas Houston, Sch Med, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA; [Hergenroeder, Georgene; Clifton, Guy L.] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX 77225 USA	Dash, PK (corresponding author), Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Hergenroeder, Georgene/0000-0002-6170-2191; Dash, Pramod/0000-0001-6746-1002	Mission Connect/TIRR Foundation	Contract grant sponsor: Mission Connect/TIRR Foundation.	ABE A, 1989, CLIN CHEM, V35, P552; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bullock R, 1995, New Horiz, V3, P448; CHAN PH, 1995, J NEUROTRAUM, V12, P815, DOI 10.1089/neu.1995.12.815; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Choi SY, 2000, BIOCHIMIE, V82, P175, DOI 10.1016/S0300-9084(00)00380-1; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; GITLIN D, 1960, NATURE, V185, P693, DOI 10.1038/185693a0; GOLDSTEIN IM, 1982, ANN NY ACAD SCI, V389, P368, DOI 10.1111/j.1749-6632.1982.tb22150.x; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hlatky Roman, 2003, Neurosurg Focus, V14, pe2; Hoffman Richard M, 2002, BMC Fam Pract, V3, P19, DOI 10.1186/1471-2296-3-19; Incerti J, 2005, NEPHROL DIAL TRANSPL, V20, P2402, DOI 10.1093/ndt/gfi074; Kang JH, 2001, BBA-GEN SUBJECTS, V1568, P30, DOI 10.1016/S0304-4165(01)00198-2; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuhlow CJ, 2003, GLIA, V44, P76, DOI 10.1002/glia.10273; MARMONT AM, 1992, BONE MARROW TRANSPL, V9, P1; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Medeiros LR, 2009, EUR J OBSTET GYN R B, V142, P99, DOI 10.1016/j.ejogrb.2008.08.011; MENKES JH, 1988, BRAIN DEV-JPN, V10, P77, DOI 10.1016/S0387-7604(88)80074-3; Nusier MK, 2006, J HEALTH SCI, V52, P180, DOI 10.1248/jhs.52.180; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; REBHUN J, 1991, ANN ALLERGY, V66, P335; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; TEASDALE G, 1974, LANCET, V2, P81; Tomas E, 1986, Virologie, V37, P279; Vassiliev V, 2005, BRAIN RES REV, V49, P633, DOI 10.1016/j.brainresrev.2005.03.003; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Xu XY, 2004, ANN NY ACAD SCI, V1012, P299, DOI 10.1196/annals.1306.024; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; ZWEIG MH, 1993, CLIN CHEM, V39, P561	43	16	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2010	88	8					1719	1726		10.1002/jnr.22336			8	Neurosciences	Neurosciences & Neurology	590RQ	WOS:000277245500010	20091772				2021-06-18	
J	Mao, Q; Jia, F; Zhang, XH; Qiu, YM; Ge, JW; Bao, WJ; Luo, QZ; Jiang, JY				Mao, Qing; Jia, Feng; Zhang, Xiao-hua; Qiu, Yong-ming; Ge, Jian-wei; Bao, Wen-jing; Luo, Qi-zhong; Jiang, Ji-yao			The Up-Regulation of Voltage-Gated Sodium Channel Na(V)1.6 Expression Following Fluid Percussion Traumatic Brain Injury in Rats	NEUROSURGERY			English	Article						mRNA; Na-v 1.6; Protein; Rat; Sodium channel; Traumatic brain injury	NERVOUS-SYSTEM; MODEL; NA+; NEUROPROTECTION; LOCALIZATION; FOS	BACKGROUND: The influx of Na+ and the depolarization mediated by voltage-gated sodium channels (VGSCs) is an early event in traumatic brain injury (TBI) induced cellular abnormalities and is therefore well positioned as an upstream target for pharmacologic modulation of the pathological responses to TBI. Alteration in the expression of the VGSC a-subunit has occurred in a variety of neuropathological states including focal cerebral ischemia, spinal injury, and epilepsy. OBJECTIVE: In this study, changes in Na(v)1.6 mRNA and protein expression were investigated in rat hippocampus after TBI. METHODS: Forty-eight adult male Sprague Dawley rats were randomly assigned to control or TBI groups. TBI was induced with a lateral fluid percussion device. Expression of mRNA and protein for Nav1.6 in the bilateral hippocampus was examined at 2, 12, 24, and 72 hours after injury by real-time quantitative polymerase chain reaction and Western blot. Immunofluorescence was performed to localize the expression of Nav1.6 protein in the hippocampus. RESULTS: Expression of Nav1.6 mRNA was significantly up-regulated in the bilateral hippocampus at 2 and 12 hours post-TBI. Significant up-regulation of Nav1.6 protein was identified in the ipsilateral hippocampus from 2 to 72 hours post-TBI and in the contralateral hippocampus from 2 to 24 hours post-TBI. Expression of Nav1.6 occurred predominantly in neurons in the hippocampus. CONCLUSION: Results of the study showed significant up-regulation of mRNA and protein for Nav1.6 in rat hippocampal neurons after TBI.	[Mao, Qing; Jia, Feng; Zhang, Xiao-hua; Qiu, Yong-ming; Ge, Jian-wei; Luo, Qi-zhong; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Shanghai RenJi Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China; [Mao, Qing] Shanghai Punan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Bao, Wen-jing] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China	Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai RenJi Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.	Jiangjyb@online.sh.cn			National Key Basic Research ProjectNational Basic Research Program of China [2005CB522604]; National Science and Nature Grant [30973086]; Science and Technology Committee of ShanghaiShanghai Science & Technology Committee [07JC14038]; Program for Shanghai Outstanding Medical Academic Leader	This work was supported by grants from National Key Basic Research Project (No. 2005CB522604), National Science and Nature Grant (No. 30973086), Science and Technology Committee of Shanghai (No. 07JC14038), and the Program for Shanghai Outstanding Medical Academic Leader. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Ates O, 2007, NEUROL RES, V29, P317, DOI 10.1179/016164107X159225; Blumenfeld H, 2008, EPILEPSIA, V49, P400, DOI 10.1111/j.1528-1167.2007.01458.x; CHAUDHURI A, 1997, NEUROREPORT, V8, P13; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Goldin AL, 2002, J EXP BIOL, V205, P575; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hains BC, 2003, J NEUROSCI, V23, P8881; Hemmings HC, 2004, J NEUROSURG ANESTH, V16, P100, DOI 10.1097/00008506-200401000-00022; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ravens U, 1999, PHARMACOL RES, V39, P167, DOI 10.1006/phrs.1998.0416; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Taylor C P, 1997, Adv Pharmacol, V39, P47, DOI 10.1016/S1054-3589(08)60069-1; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Whitaker W, 1999, NEUROREPORT, V10, P3703, DOI 10.1097/00001756-199911260-00044; Wilson Y, 2002, P NATL ACAD SCI USA, V99, P3252, DOI 10.1073/pnas.042701199; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yao C, 2005, LIFE SCI, V77, P1116, DOI 10.1016/j.lfs.2005.02.008; Yao C, 2002, NEUROTOX RES, V4, P67, DOI 10.1080/10298420290007646; Zhou W, 2004, BIOPHYS J, V87, P3862, DOI 10.1529/biophysj.104.045963	24	16	18	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUN	2010	66	6					1134	1139		10.1227/01.NEU.0000369612.31946.A2			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	600RY	WOS:000278006200037	20421839				2021-06-18	
J	Pourrier, SD; Nieuwstraten, W; Van Cranenburgh, B; Schreuders, TAR; Stam, HJ; Selles, RW				Pourrier, Salima D.; Nieuwstraten, Wilbert; Van Cranenburgh, Ben; Schreuders, Ton A. R.; Stam, Henk J.; Selles, Ruud W.			THREE CASES OF REFERRED SENSATION IN TRAUMATIC NERVE INJURY OF THE HAND: IMPLICATIONS FOR UNDERSTANDING CENTRAL NERVOUS SYSTEM REORGANIZATION	JOURNAL OF REHABILITATION MEDICINE			English	Article						referred sensation; arm injury; neuroplasticity	UPPER EXTREMITY AMPUTEES; REGIONAL PAIN SYNDROME; PHANTOM LIMB PAIN; CORTICAL REORGANIZATION; SOMATOSENSORY CORTEX; PLASTICITY; STIMULATION; AMPUTATION; BRAIN	Objective: The aim of this observational study was to explore whether patients with traumatic peripheral nerve injury of the hand perceive referred sensations; sensations that are perceived to emanate from other areas of the body than the part being stimulated. Referred sensations have been reported following amputation, somatosensory deafferentation, local anaesthesia, stroke, brachial plexus avulsion injury, spinal cord injury and complex regional pain syndrome type 1. Design: Ten patients with ulnar or median nerve injuries underwent sensory testing of the face, upper body and legs, involving light touch with a cotton swab. Patients were asked to describe the location of the stimulated site, the sensations emanating from it and any other sensations experienced. Three patients with referred sensations were identified and followed over a period of time. Results: Clear and reproducible referred sensations were found in 3 out of 10 patients examined. Conclusion: Referred sensations were found in traumatic nerve injury, providing evidence of reorganization of the central nervous system after peripheral injury.	[Pourrier, Salima D.; Schreuders, Ton A. R.; Stam, Henk J.; Selles, Ruud W.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Rehabil, NL-3000 CA Rotterdam, Netherlands; [Selles, Ruud W.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Reconstruct & Hand Surg, NL-3000 CA Rotterdam, Netherlands; [Pourrier, Salima D.; Nieuwstraten, Wilbert] Rehabil Ctr Sophia Revalidatie, The Hague, Netherlands; [Nieuwstraten, Wilbert; Van Cranenburgh, Ben] Inst Appl Neurosci ITON, Haarlem, Netherlands	Selles, RW (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Rehabil Med, Room H016,POB 2040, NL-3000 CA Rotterdam, Netherlands.	rselles@erasmusmc.nl	Selles, Ruud/N-9665-2019; Selles, Ruud W/B-5209-2009	Selles, Ruud/0000-0002-2432-6756; 			AGLIOTI S, 1994, P BIOL SCI, V1344, P273; Borsook D, 1998, NEUROREPORT, V9, P1013, DOI 10.1097/00001756-199804200-00011; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; FINGER S, 1982, BRAIN DAMAGE RECOVER; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7; Htut M, 2006, J HAND SURG-BRIT EUR, V31B, P596, DOI 10.1016/j.jhsb.2006.04.027; Kaas J., 2001, MUTABLE BRAIN DYNAMI; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Knecht S, 1998, BRAIN, V121, P717, DOI 10.1093/brain/121.4.717; Lundborg G, 2003, J PERIPHER NERV SYST, V8, P209, DOI 10.1111/j.1085-9489.2003.03027.x; Lundborg G, 2006, SCAND J PLAST RECONS, V40, P234, DOI 10.1080/02844310600787005; Maihofner C, 2006, J NEUROL, V253, P772, DOI 10.1007/s00415-006-0117-z; McCabe CS, 2003, RHEUMATOLOGY, V42, P1067, DOI 10.1093/rheumatology/keg298; MERZENICH MM, 1983, NEUROSCIENCE, V10, P639, DOI 10.1016/0306-4522(83)90208-7; Moore CI, 2000, P NATL ACAD SCI USA, V97, P14703, DOI 10.1073/pnas.250348997; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rivers WHR, 1908, BRAIN, V31, P323, DOI 10.1093/brain/31.3.323; Turton AJ, 2001, NEUROCASE, V7, P397, DOI 10.1076/neur.7.5.397.16251; Wall JT, 2002, BRAIN RES REV, V39, P181, DOI 10.1016/S0165-0173(02)00192-3	20	16	16	0	6	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2010	42	4					357	361		10.2340/16501977-0526			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	598HY	WOS:000277827500011	20461338	DOAJ Gold			2021-06-18	
J	Johnson-Greene, D				Johnson-Greene, Doug			Informed Consent Issues in Traumatic Brain Injury Research: Current Status of Capacity Assessment and Recommendations for Safeguards	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							RACISM		Univ Miami, Leonard M Miller Sch Med, Dept Rehabil Med, Miami, FL 33157 USA	Johnson-Greene, D (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Rehabil Med, 1120 NW 14th St,Clin Res Bldg,Ste 954, Miami, FL 33157 USA.	djgreene@med.miami.edu					[Anonymous], 1979, NAT COMM PROT HUM SU; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Appelbaum PS, 2002, AM J GERIAT PSYCHIAT, V10, P120, DOI 10.1176/appi.ajgp.10.2.120; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Ayala C, 2001, AM J EPIDEMIOL, V154, P1057, DOI 10.1093/aje/154.11.1057; Berg JW, 2001, INFORM CONSENT LEGAL; BRANDT AM, 1978, HASTINGS CENT REP, V8, P21, DOI 10.2307/3561468; del Carmen MG, 2005, ONCOLOGIST, V10, P636, DOI 10.1634/theoncologist.10-8-636; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Dunn LB, 2001, NEUROPSYCHOPHARMACOL, V24, P595, DOI 10.1016/S0893-133X(00)00218-9; FADEN RR, 1986, HISTORY THEORY INFOR; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; Karlawish JHT, 2003, NEW ENGL J MED, V348, P1389, DOI 10.1056/NEJMsb030172; Karlsen S, 2002, SOCIOL HEALTH ILL, V24, P1, DOI 10.1111/1467-9566.00001; Lederer Susan E., 1995, SUBJECTED SCI HUMAN; LEVINE RJ, 1995, ETHICS, V2, P1241; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; *NAT CANC I, 1999, GUID REP ADV DRUG RE, P1; Okonkwo OC, 2008, J INT NEUROPSYCH SOC, V14, P297, DOI 10.1017/S1355617708080338; Palmer BW, 2007, J INT NEUROPSYCH SOC, V13, P1047, DOI 10.1017/S1355617707071299; Sturman ED, 2005, CLIN PSYCHOL REV, V25, P954, DOI 10.1016/j.cpr.2005.04.010; Sugarman J, 2005, CLIN TRIALS, V2, P34, DOI 10.1191/1740774505cn066oa; Sugarman J, 2007, J AM GERIATR SOC, V55, P556, DOI 10.1111/j.1532-5415.2007.01101.x; Titus SL, 1996, J CLIN ETHIC, V7, P60; U.S. Department of Health and Human Services, 1991, FED REGISTER, V56, P28012; Wendler D, 2001, ANN INTERN MED, V135, P514, DOI 10.7326/0003-4819-135-7-200110020-00011; Winslade WJ, 2004, J HEAD TRAUMA REHAB, V19, P513, DOI 10.1097/00001199-200411000-00008; Winslade WJ, 2004, J HEAD TRAUMA REHAB, V19, P178, DOI 10.1097/00001199-200403000-00008; 1964, 18 WORLD MED ASS JUN; 2007, FED REG, V72, P50966	30	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2010	25	2					145	150		10.1097/HTR.0b013e3181d8287d			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	578EJ	WOS:000276276000010	20234229				2021-06-18	
J	Lee, J; Yoo, MS; Jung, D				Lee, J.; Yoo, M. S.; Jung, D.			Caregiving appraisal of family caregivers for older stroke patients in Korea	INTERNATIONAL NURSING REVIEW			English	Article						Disease Process; Family Health Nursing; International Issues; Stroke	TRAUMATIC BRAIN-INJURY; DEMENTIA CAREGIVERS; FUNCTIONAL STATUS; FILIAL PIETY; BURDEN; TRANSLATION; SURVIVORS; AMERICAN; DISTRESS; RACE	Purpose: The purpose of this study was to investigate factors related to caregiving appraisal for family caregivers of older stroke patients in Korea. Method: A descriptive, cross-sectional survey of a sample of 242 family caregivers (95.7% response rate) was conducted in Korea from 1 January 2005 to 4 January 2007. Data were collected from outpatient stroke centres at three hospitals and two home health agencies located in Seoul, the capital city of Korea, its suburban area of Kyunggi-do, and the rural areas Gyeongsangbuk-do and Chungcheongbuk-do. The questionnaire was self-administered. spss 13.0 (SPSS, Inc., Chicago, IL, USA) was used to perform frequency, percentage, mean standard deviation, t-test or analysis of variance, and Pearson's correlation calculations. Results: Caregiving appraisal was statistically different based on the caregiver's location of residency and the relationship between the caregiver and the recipient. The caregivers who resided in urban areas reported higher scores of caregiving appraisal compared with those who resided in rural areas. With regard to the caregiver-recipient relationship, spouses reported the highest caregiving distress status, followed by daughters-in-law, sons and, finally, daughters. In addition, caregiving distress significantly correlated with age (r = 0.151, P = 0.022), the number of caregiving hours per week (r = 0.198, P = 0.003) and filial obligations (r = 0.336, P = 0.000). Discussion: The study results helped to better understand the caregiving process of Korean family caregivers. The data emphasized the importance of examining the expression of cultural roles and individual values on the caregivers' quality of life in diverse cultures. The knowledge gained from this study will be utilized to develop culture-specific interventions and social policies to directly support Korean family caregivers and to indirectly support stroke patients.	[Jung, D.] Ewha Womans Univ, Div Nursing Sci, Coll Hlth Sci, Seoul 120750, South Korea; [Lee, J.] Yonsei Univ, Coll Nursing, Seoul 120749, South Korea; [Yoo, M. S.] Catholic Univ Daegu, Coll Nursing, Taegu, South Korea	Jung, D (corresponding author), Ewha Womans Univ, Div Nursing Sci, Coll Hlth Sci, 11-1 Deahyun Dong, Seoul 120750, South Korea.	dyjung@ewha.ac.kr		Lee, JuHee/0000-0002-2805-1622			BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; CHOI H, 1993, GERONTOLOGIST, V33, P8, DOI 10.1093/geront/33.1.8; Cicirelli V. G., 1991, FAMILY CAREGIVING AU; CICIRELLI VG, 1993, PSYCHOL AGING, V8, P144, DOI 10.1037/0882-7974.8.2.144; Clark Patricia C, 2003, J Gerontol Nurs, V29, P45; Dilworth-Anderson P, 2002, GERONTOLOGIST, V42, P237, DOI 10.1093/geront/42.2.237; Farran C J, 2001, J Gerontol Nurs, V27, P38; Farran CJ, 1997, J AGING HEALTH, V9, P316, DOI 10.1177/089826439700900303; Foster M, 2003, SCAND J CARING SCI, V17, P205, DOI 10.1046/j.1471-6712.2003.00230.x; Grant JS, 2004, INT J REHABIL RES, V27, P105, DOI 10.1097/01.mrr.0000127639.47494.e3; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; IM MY, 2007, J WELFARE AGED, V34, P169; Kim JH, 2007, HEALTH PSYCHOL, V26, P564, DOI 10.1037/0278-6133.26.5.564; King RB, 2006, J GERONTOL NURS, V32, P37, DOI 10.3928/00989134-20060401-07; Kington RS, 1997, AM J PUBLIC HEALTH, V87, P805, DOI 10.2105/AJPH.87.5.805; KOH JY, 1987, GERONTOLOGIST, V27, P66, DOI 10.1093/geront/27.1.66; Lawton MP, 2000, GERONTOLOGIST, V40, P437, DOI 10.1093/geront/40.4.437; Lee J, 2007, J ADV NURS, V59, P407, DOI 10.1111/j.1365-2648.2007.04346.x; Lee YR, 1998, INT J AGING HUM DEV, V46, P125, DOI 10.2190/PM2C-V93R-NE8H-JWGV; Peters-Davis ND, 1999, GERONTOLOGIST, V39, P66, DOI 10.1093/geront/39.1.66; Sander AM, 2007, NEUROREHABILITATION, V22, P9; SEELBACH WC, 1977, GERONTOLOGIST, V17, P492, DOI 10.1093/geront/17.6.492; SUNG KT, 1995, GERONTOLOGIST, V35, P240, DOI 10.1093/geront/35.2.240; SUNG KT, 1990, GERONTOLOGIST, V30, P610, DOI 10.1093/geront/30.5.610; Yoon H. K, 2000, J KOREAN ASS SCI ED, V20, P137; Youn GY, 1999, PSYCHOL AGING, V14, P355, DOI 10.1037/0882-7974.14.3.355	26	16	16	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-8132	1466-7657		INT NURS REV	Int. Nurs. Rev.	MAR	2010	57	1					107	112		10.1111/j.1466-7657.2009.00751.x			6	Nursing	Nursing	552UI	WOS:000274318700023	20487482				2021-06-18	
J	Semenas, E; Nozari, A; Sharma, HS; Basu, S; Rubertsson, S; Wiklund, L				Semenas, E.; Nozari, A.; Sharma, H. S.; Basu, S.; Rubertsson, S.; Wiklund, L.			Sex differences in cerebral injury after severe haemorrhage and ventricular fibrillation in pigs	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							CATALYZED LIPID-PEROXIDATION; TRAUMATIC CARDIAC-ARREST; PERINATAL BRAIN-INJURY; NITRIC-OXIDE; BLOOD-FLOW; CARDIOPULMONARY-RESUSCITATION; GENDER-DIFFERENCES; HYPERTONIC SALINE; OXIDATIVE INJURY; METHYLENE-BLUE	Background Experimental studies of haemorrhagic shock have documented a superior haemodynamic response and a better outcome in female animals as compared with male controls. Such sexual dimorphism has, nevertheless, not been reported after circulatory arrest that follows exsanguination and shock. We aimed to study differences in cerebral injury markers after exsanguination cardiac arrest in pre-pubertal piglets. The hypothesis was that cerebral injury is less extensive in female animals, and that this difference is independent of sexual hormones or choice of resuscitative fluid. Methods Thirty-two sexually immature piglets (14 males and 18 females) were subjected to 5 min of haemorrhagic shock followed by 2 min of ventricular fibrillation and 8 min of cardiopulmonary resuscitation, using three resuscitation fluid regimens (whole blood, hypertonic saline and dextran, or acetated Ringers' solution plus whole blood and methylene blue). Haemodynamic values, cellular markers of brain injury and brain histology were studied. Results After successful resuscitation, female piglets had significantly greater cerebral cortical blood flow, tended to have lower S-100 beta values and a lower cerebral oxygen extraction ratio. Besides, in female animals, systemic and cerebral venous acidosis were mitigated. Female piglets exhibited a significantly smaller increase in neuronal nitric oxide synthase (nNOS) and inducible nitric oxide synthase (iNOS) expression in their cerebral cortex, smaller blood-brain-barrier (BBB) disruption and significantly smaller neuronal injury. Conclusion After resuscitation from haemorrhagic circulatory arrest, cerebral reperfusion is greater, and BBB permeability and neuronal injury is smaller in female piglets. An increased cerebral cortical iNOS and nNOS expression in males implies a mechanistic relationship with post-resuscitation neuronal injury and warrants further investigation.	[Semenas, E.; Sharma, H. S.; Rubertsson, S.; Wiklund, L.] Univ Uppsala Hosp, Dept Surg Sci Anesthesiol & Intens Care, Fac Med, S-75185 Uppsala, Sweden; [Nozari, A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia & Crit Care, Boston, MA USA; [Basu, S.] Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci Clin Nutr & Metab, Fac Med, S-75185 Uppsala, Sweden	Semenas, E (corresponding author), Univ Uppsala Hosp, Dept Surg Sci Anesthesiol & Intens Care, Fac Med, S-75185 Uppsala, Sweden.	egidijus.semenas@gmail.com	Sharma, Aruna/D-4430-2011; Nozari, Ala/AAH-6070-2021	Semenas, Egidijus/0000-0002-3543-5261	Laerdal Foundation for Acute Medicine, Stavanger, Norway	The research was supported, in part, by the Laerdal Foundation for Acute Medicine, Stavanger, Norway.	Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P319, DOI 10.1016/S0952-3278(98)90042-4; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P347, DOI 10.1016/S0952-3278(98)90070-9; Bellamy R, 1996, CRIT CARE MED, V24, pS24; Bender R, 2007, RESUSCITATION, V72, P74, DOI 10.1016/j.resuscitation.2006.05.019; BLASS N, 1976, ANESTHESIOLOGY, V45, P458, DOI 10.1097/00000542-197610000-00020; BURROWS GE, 1984, J VET PHARMACOL THER, V7, P225, DOI 10.1111/j.1365-2885.1984.tb00904.x; Buunk G, 2000, NETH J MED, V57, P106, DOI 10.1016/S0300-2977(00)00059-0; Castren M, 2009, ACTA ANAESTH SCAND, V53, P280, DOI 10.1111/j.1399-6576.2008.01881.x; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fischer M, 2002, RESUSCITATION, V54, P269, DOI 10.1016/S0300-9572(02)00151-X; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Kelner M J, 1988, Basic Life Sci, V49, P895; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; Krep H, 2004, RESUSCITATION, V63, P73, DOI 10.1016/j.resuscitation.2004.03.023; Lang JT, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-33; Liu XL, 2003, ACTA ANAESTH SCAND, V47, P958, DOI 10.1034/j.1399-6576.2003.00189.x; Lockey D, 2006, ANN EMERG MED, V48, P240, DOI 10.1016/j.annemergmed.2006.03.015; Malorni W, 2007, ANTIOXID REDOX SIGN, V9, P1779, DOI 10.1089/ars.2007.1596; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Midescu A, 2006, CRIT CARE MED, V34, P2806, DOI 10.1097/01.CCM.0000242517.23324.27; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; Rocha-e-Silva Mauricio, 2005, Clinics, V60, P159, DOI 10.1590/S1807-59322005000200013; ROSEMURGY AS, 1993, J TRAUMA, V35, P468, DOI 10.1097/00005373-199309000-00022; SCHLEIEN CL, 1991, STROKE, V22, P477, DOI 10.1161/01.STR.22.4.477; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Sharma HS, 1997, ANN NY ACAD SCI, V813, P581, DOI 10.1111/j.1749-6632.1997.tb51749.x; SHARMA HS, 1990, ACT NEUR S, V51, P383; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; VOORHEES WD, 1987, RESUSCITATION, V15, P113, DOI 10.1016/0300-9572(87)90022-0; Wiklund L, 2005, ANN NY ACAD SCI, V1053, P205, DOI 10.1196/annals.1344.019; Zhang F, 2004, NEUROL RES, V26, P835, DOI 10.1179/016164104X3824	40	16	16	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	MAR	2010	54	3					343	353		10.1111/j.1399-6576.2009.02125.x			11	Anesthesiology	Anesthesiology	552SF	WOS:000274313000012	19764903				2021-06-18	
J	Waibel, BH; Durham, CA; Newell, MA; Schlitzkus, LL; Sagraves, SG; Rotondo, MF				Waibel, Brett H.; Durham, Chris A.; Newell, Mark A.; Schlitzkus, Lisa L.; Sagraves, Scott G.; Rotondo, Michael F.			Impact of hypothermia in the rural, pediatric trauma patient	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hypothermia; pediatric trauma; multivariate analysis; complications; length of stay; outcomes	UNCONTROLLED HEMORRHAGIC-SHOCK; MODERATE HYPOTHERMIA; BRAIN-INJURY; NEONATAL ENCEPHALOPATHY; SYSTEMIC HYPOTHERMIA; MILD HYPOTHERMIA; ADENOSINE-TRIPHOSPHATE; IMPROVES SURVIVAL; DEATH RATES; RESUSCITATION	Objective: Hypothermia is an independent predictor of mortality in adult trauma studies. However, the impact of hypothermia on the pediatric trauma population has not been described. The purpose of this study is to evaluate hypothermia as a cofactor to mortality, complications, and among survivors, hospital length of stay parameters in the pediatric trauma population. Design: Retrospective review of a prospectively collected database (National Trauma Registry of the American College of Surgeons) over a 5-yr period (July 2002 to June 2007). Setting: A rural, level I trauma center. Patients: One thousand six hundred twenty-nine pediatric patients admitted with a traumatic injury. Interventions: None. Measurements and Main Results: Multivariate regression models were used to evaluate the association of hypothermia with mortality, infectious complications, organ dysfunction, and among survivors, hospital length of stay parameters. Of 1,629 pediatric trauma patients admitted, 182 (11.1%) patients were hypothermic (temperature below 36 C) on admission. Hypothermia had an adjusted odds ratio (AOR) of 2.41 (95% confidence interval [CI], 1.12-5.22, p = .025) for mortality. After controlling for covariates, hypothermia had associations with developing pneumonia (AOR, 0.185, 95% CI, 0.040-0.853; p = .031) and a bleeding diathesis (AOR, 3.14, 95% CI, 1.04-9.44; p = .042). The median days in the hospital, intensive care unit (ICU), and ventilator were longer in the hypothermic cohort; however, after controlling for covariates, hypothermia was not associated with differences in hospital days, ICU days, or ventilator days. Conclusions: Hypothermia is a common problem at admission among pediatric trauma patients. Hypothermia is associated with an increase in the odds of death and the development of a bleeding diathesis, while having decreased odds for developing pneumonia. While the length of stay indicators were longer in the hypothermic cohort among survivors, no significant association was noted with hypothermia for hospital, ICU, or ventilator days after controlling for confounders. (Pediatr Crit Care Med 2010; 11: 199-204)	[Waibel, Brett H.; Durham, Chris A.; Newell, Mark A.; Schlitzkus, Lisa L.; Sagraves, Scott G.; Rotondo, Michael F.] E Carolina Univ, Dept Surg, Div Trauma & Surg Crit Care, Brody Sch Med, Greenville, NC 27858 USA	Waibel, BH (corresponding author), E Carolina Univ, Dept Surg, Div Trauma & Surg Crit Care, Brody Sch Med, Greenville, NC 27858 USA.	Brett.Waibel@pcmh.com					Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Arthurs Z, 2006, AM J SURG, V191, P610, DOI 10.1016/j.amjsurg.2006.02.010; Badjatia N, 2009, CRIT CARE MED, V37, P1893, DOI 10.1097/CCM.0b013e31819fffd3; BAKER SP, 1987, NEW ENGL J MED, V316, P1384, DOI 10.1056/NEJM198705283162206; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Boodhwani M, 2006, CIRCULATION, V114, pI461, DOI 10.1161/CIRCULATIONAHA.105.001354; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; CRIPPEN D, 1991, RESUSCITATION, V21, P271, DOI 10.1016/0300-9572(91)90052-Z; Eastridge BJ, 2006, J TRAUMA, V61, P1366, DOI 10.1097/01.ta.0000245894.78941.90; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; EIDELMAN Y, 1994, J TRAUMA, V37, P677, DOI 10.1097/00005373-199410000-00025; FIELD JM, 2005, HDB EMERGENCY CARDIO, P16; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; GUBLER KD, 1994, J TRAUMA, V36, P847, DOI 10.1097/00005373-199406000-00015; Hachimi-Idrissi S, 2008, RESUSCITATION, V79, P185, DOI 10.1016/j.resuscitation.2008.09.004; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Husum Hans, 2002, Prehosp Disaster Med, V17, P23; Hutchison JS, 2008, PEDIATR CLIN N AM, V55, P529, DOI 10.1016/j.pcl.2008.02.011; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Inder TE, 2004, J PEDIATR-US, V145, P835, DOI 10.1016/j.jpeds.2004.07.034; JOHANNIGMAN JA, 1992, J TRAUMA, V32, P190, DOI 10.1097/00005373-199202000-00014; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Jurkovich GJ, 2007, SURG CLIN N AM, V87, P247, DOI 10.1016/j.suc.2006.10.003; Kettner SC, 2003, ANESTH ANALG, V96, P1772, DOI 10.1213/01.ANE.0000062520.65192.C9; Kim SH, 1998, J TRAUMA, V44, P485, DOI 10.1097/00005373-199803000-00010; Kim SH, 1997, J TRAUMA, V42, P213, DOI 10.1097/00005373-199702000-00006; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Maathuis MHJ, 2007, TRANSPLANTATION, V83, P1289, DOI 10.1097/01.tp.0000265586.66475.cc; Mack WJ, 2007, NEUROSURGERY, V60, P815, DOI 10.1227/01.NEU.0000255452.20602.C9; Mann NC, 2001, MED CARE, V39, P643, DOI 10.1097/00005650-200107000-00001; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; MESSICK WJ, 1992, J TRAUMA, V33, P850, DOI 10.1097/00005373-199212000-00010; MEYER DM, 1988, ANN SURG, V207, P462, DOI 10.1097/00000658-198804000-00015; Mizushima Y, 2000, J TRAUMA, V48, P58, DOI 10.1097/00005373-200001000-00010; Muelleman RL, 2007, J TRAUMA, V62, P221, DOI 10.1097/01.ta.0000231696.65548.06; Nussmeier NA, 2005, TEX HEART I J, V32, P472; Prueckner S, 2001, J TRAUMA, V50, P253, DOI 10.1097/00005373-200102000-00010; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Rogers FB, 1999, J TRAUMA, V47, P802, DOI 10.1097/00005373-199910000-00038; RUTLEDGE R, 1994, ANN SURG, V219, P205, DOI 10.1097/00000658-199402000-00013; RUTLEDGE R, 1992, J TRAUMA, V33, P29, DOI 10.1097/00005373-199207000-00007; Sagraves SG, 2002, J TRAUMA, V53, P1209; Schneider A, 2009, ANESTH ANALG, V108, P971, DOI 10.1213/ane.0b013e318193ca99; Seekamp A, 1999, J TRAUMA, V47, P673, DOI 10.1097/00005373-199910000-00011; Shafi NI, 2006, PEDIATR CRIT CARE ME, V7, P468, DOI 10.1097/01.PCC.0000235258.79253.8C; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Takasu A, 2000, CRIT CARE MED, V28, P2465, DOI 10.1097/00003246-200007000-00047; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Wu XR, 2003, J TRAUMA, V55, P308, DOI 10.1097/01.TA.0000079366.23533.1E; Wu XR, 2003, CRIT CARE MED, V31, P195, DOI 10.1097/00003246-200301000-00030; Wu XR, 2002, J TRAUMA, V53, P654, DOI 10.1097/00005373-200210000-00006	58	16	16	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2010	11	2					199	204		10.1097/PCC.0b013e3181b80500			6	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	566YZ	WOS:000275410700004	19794329				2021-06-18	
J	Chang, CY; Lee, YH; Leu, SJ; Wang, CY; Wei, CP; Hung, KS; Pai, MH; Tsai, MD; Wu, CH				Chang, C. -Y.; Lee, Y. -H.; Leu, S. -J.; Wang, C. -Y.; Wei, C. -P.; Hung, K. -S.; pai, M. -H; Tsai, M. -D.; Wu, C. -H.			CC-CHEMOKINE LIGAND 18/PULMONARY ACTIVATION-REGULATED CHEMOKINE EXPRESSION IN THE CNS WITH SPECIAL REFERENCE TO TRAUMATIC BRAIN INJURIES AND NEOPLASTIC DISORDERS	NEUROSCIENCE			English	Article						CC-chemokine; glia; microglia; macrophages; glioma; source; lesion	CENTRAL-NERVOUS-SYSTEM; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MESSENGER-RNA EXPRESSION; HUMAN-MALIGNANT GLIOMA; RECEPTOR EXPRESSION; CEREBROSPINAL-FLUID; HUMAN ASTROCYTOMAS; CELL INFILTRATION; DENDRITIC CELLS; MACROPHAGES	Pulmonary activation-regulated chemokine (PARC) now designated CC-chemokine ligand 18 (CCL18) has been shown to play a significant role in the pathogenesis of various tissue injuries and diseases in a proinflammatory or immune suppressive way to limit or support the inflammation or disease. While much is known about the roles of CCL18/PARC in non-neural tissues, its expression in the CNS has remained largely unexplored and controversial. Using reverse transcription polymerase chain reaction (RT-PCR) and double immunohistochemical staining, we analyzed the expression of CCL18/PARC in the human brain with special reference to traumatic brain injuries and tumors. The RT-PCR analysis revealed the expression of CCL18/PARC mRNA both in the traumatic brain and glioma tissues examined. Immunoexpression of CCL18/PARC protein was consistently detected in all cases of traumatic brain injuries examined by immunohistochemical staining. Double immunofluorescence labeling has extended the study that CCL18/PARC positive cells were macrophages/microglia, astrocytes or neurons. The CCL18/PARC expression was localized in macrophage-like cells in two of eight glioblastoma tissues whose cancer cells were CCL18/PARC negative. Unexpectedly, CCL18/PARC mRNA weakly and constitutively expressed by glioblastoma cell line was upregulated after endotoxin stimulation. The present results indicated a significant production of CCL18/PARC in different CNS traumatic and neoplasm tissues by specific cellular elements expressing the chemokine. An anti-inflammatory mechanism jointly exerted by these cells via CCL18/PARC may be involved in the CNS immunity after traumatic injury and tumorigenesis. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wei, C. -P.; Tsai, M. -D.] Shin Kong Wu Ho Su Mem Hosp, Dept Neurosurg, Taipei 111, Taiwan; [Chang, C. -Y.; Lee, Y. -H.; Wu, C. -H.] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Chang, C. -Y.; pai, M. -H] Taipei Med Univ, Coll Med, Dept Anat, Taipei, Taiwan; [Lee, Y. -H.; Wang, C. -Y.] Taipei Med Univ, Coll Med, Dept Physiol, Taipei, Taiwan; [Leu, S. -J.] Taipei Med Univ, Dept Microbiol & Immunol, Taipei, Taiwan; [Hung, K. -S.] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Tsai, M. -D.] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Wu, C. -H.] Natl Def Med Ctr, Dept Biol & Anat, Taipei 114, Taiwan; [Wu, C. -H.] Natl Def Med Ctr, Inst Biol & Anat, Taipei 114, Taiwan	Tsai, MD (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Neurosurg, 95 Wen Chang Rd, Taipei 111, Taiwan.	M000727@ms.skh.org.tw; microgli@mail.ndmctsgh.edu.tw			Shin-Kong WHS Memorial Hospital [SKH-TMU-95-15]; National Science CouncilMinistry of Science and Technology, Taiwan [NSC96-2320-B-016-010]	This work serves as the doctoral thesis of CY Chang. The study was supported in part by grants SKH-TMU-95-15 from Shin-Kong WHS Memorial Hospital and NSC96-2320-B-016-010 from National Science Council.	Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; de Haas AH, 2007, MOL NEUROBIOL, V36, P137, DOI 10.1007/s12035-007-0036-8; DESBAILLETS I, 1994, INT J CANCER, V58, P240, DOI 10.1002/ijc.2910580216; GHIMIKAR RS, 1996, J NEUROSCI RES, V46, P727; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Guan P, 1999, GENOMICS, V56, P296, DOI 10.1006/geno.1998.5635; Guo H, 1998, SCAND J IMMUNOL, V48, P502; Hausler KG, 2002, EUR J NEUROSCI, V16, P2113, DOI 10.1046/j.1460-9568.2002.02287.x; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Hieshima K, 1997, J IMMUNOL, V159, P1140; HITCHCOCK ER, 1988, J NEUROSURG, V68, P432, DOI 10.3171/jns.1988.68.3.0432; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Ishii N, 1998, J NEURO-ONCOL, V37, P17, DOI 10.1023/A:1005959719927; Ito A, 1999, J IMMUNOL, V162, P4260; Karpus WJ, 2001, J NEUROVIROL, V7, P493, DOI 10.1080/135502801753248079; Kastenbauer S, 2005, J NEUROIMMUNOL, V164, P134, DOI 10.1016/j.jneuroim.2005.03.009; Kaukola T, 2004, ANN NEUROL, V55, P186, DOI 10.1002/ana.10809; Kimura T, 2002, INT J ONCOL, V21, P707; Kodelja V, 1998, J IMMUNOL, V160, P1411; le Blanc LMP, 2006, NEUROSCI LETT, V397, P145, DOI 10.1016/j.neulet.2005.12.029; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Leung SY, 1997, ACTA NEUROPATHOL, V93, P518, DOI 10.1007/s004010050647; Lindhout E, 2001, J IMMUNOL, V166, P3284, DOI 10.4049/jimmunol.166.5.3284; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Maru SV, 2008, J NEUROIMMUNOL, V199, P35, DOI 10.1016/j.jneuroim.2008.04.029; McManus CM, 2000, GLIA, V29, P273, DOI 10.1002/(SICI)1098-1136(20000201)29:3<273::AID-GLIA8>3.0.CO;2-9; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Mrazek F, 2002, IMMUNOL LETT, V84, P17, DOI 10.1016/S0165-2478(02)00130-X; Pardo A, 2001, J LEUKOCYTE BIOL, V70, P610; Pivarcsi A, 2004, J IMMUNOL, V173, P5810, DOI 10.4049/jimmunol.173.9.5810; Platten M, 2003, ANN NEUROL, V54, P388, DOI 10.1002/ana.10679; Quan N, 2000, J NEUROSCI, V20, P6473, DOI 10.1523/JNEUROSCI.20-17-06473.2000; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Schraufstatter I, 2004, AM J PHYSIOL-LUNG C, V286, pL494, DOI 10.1152/ajplung.00323.2002; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Strik HM, 2004, ANTICANCER RES, V24, P37; Struyf S, 2003, AM J PATHOL, V163, P2065, DOI 10.1016/S0002-9440(10)63564-X; TAKESHIMA H, 1994, J NEUROSURG, V80, P1056, DOI 10.3171/jns.1994.80.6.1056; Vogel TW, 2005, CLIN CANCER RES, V11, P3624, DOI 10.1158/1078-0432.CCR-04-2115; Vulcano M, 2003, J IMMUNOL, V170, P3843, DOI 10.4049/jimmunol.170.7.3843; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	50	16	17	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 17	2010	165	4					1233	1243		10.1016/j.neuroscience.2009.11.050			11	Neurosciences	Neurosciences & Neurology	549VD	WOS:000274081500021	19958819				2021-06-18	
J	Shin, BS; Won, SJ; Yoo, BH; Kauppinen, TM; Suh, SW				Shin, Byung Seop; Won, Seok Joon; Yoo, Byung Hoon; Kauppinen, Tiina M.; Suh, Sang Won			Prevention of hypoglycemia-induced neuronal death by hypothermia	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						hypoglycemia; hypothermia; hyperthermia; zinc; superoxide; microglia	TRAUMATIC BRAIN-INJURY; HISTOCHEMICALLY REACTIVE ZINC; NITRIC-OXIDE; MICROGLIAL ACTIVATION; COGNITIVE IMPAIRMENT; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; MILD HYPOTHERMIA; FOCAL ISCHEMIA; CELL-DEATH	Hypothermia reduces neuronal damage after cerebral ischemia and traumatic brain injury, while hyperthermia exacerbates damage from these insults. Previously we have shown that temperature-dependent modulation of excitotoxic neuronal death is mediated in part by temperature-dependent changes in the synaptic release/translocation of Zn2+. In this study, we hypothesize that brain temperature also affects hypoglycemia-induced neuronal death by modulation of vesicular Zn2+ release from presynaptic terminals. To test our hypothesis, we used a rat model of insulin-induced hypoglycemia. Here we found that hypoglycemia-induced neuronal injury was significantly affected by brain temperature, that is, hypothermia inhibited while hyperthermia aggravated neuronal death. To investigate the mechanism of temperature-dependent neuronal death after hypoglycemia, we measured zinc release/translocation, reactive oxygen species (ROS) production, and microglia activation. Here we found that hypoglycemia-induced Zn2+ release/translocation, ROS production, and microglia activation were inhibited by hypothermia but aggravated by hyperthermia. Even when the insult was accompanied by hyperthermic conditions, zinc chelation inhibited ROS production and microglia activation. Zinc chelation during hyperthermia reduced neuronal death, superoxide production, and microglia activation, which was comparable to the protective effects of hypothermia. We conclude that neuronal death after hypoglycemia is temperature-dependent and is mediated by increased Zn2+ release, superoxide production, and microglia activation. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 390-402; doi: 10.1038/jcbfm.2009.229; published online 28 October 2009	[Shin, Byung Seop; Won, Seok Joon; Yoo, Byung Hoon; Kauppinen, Tiina M.; Suh, Sang Won] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Shin, Byung Seop] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol, Seoul, South Korea; [Shin, Byung Seop] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pain Med, Seoul, South Korea; [Yoo, Byung Hoon] Inje Univ, Sch Med, Sanggye Paik Hosp, Dept Anesthesiol, Seoul, South Korea; [Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea	Suh, SW (corresponding author), UCSF, VAMC, Dept Neurol 127, 4150 Clement St, San Francisco, CA 94121 USA.	sang.suh@ucsf.edu	Kauppinen, Tiina/I-1009-2019	Kauppinen, Tiina/0000-0001-7219-9862	Juvenile Diabetes Research FoundationJuvenile Diabetes Research Foundation [2-2006-113, SWS, KOSEF2009-0078399]	We greatly appreciate Dr Midori Yenari's critical comments on this study, and technical assistance provided by Aaron Hamby. This work was supported by the Juvenile Diabetes Research Foundation (2-2006-113, SWS.) and KOSEF2009-0078399 (SWS).	AGARDH CD, 1992, ACTA NEUROPATHOL, V83, P379, DOI 10.1007/BF00713529; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; ARAI H, 1993, NEUROSCI LETT, V163, P132, DOI 10.1016/0304-3940(93)90363-P; AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; AUER RN, 1986, STROKE, V17, P442, DOI 10.1161/01.STR.17.3.442; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHAO CC, 1992, J IMMUNOL, V149, P2736; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1992, J CHEM NEUROANAT, V5, P521, DOI 10.1016/0891-0618(92)90007-D; Friberg H, 1998, J NEUROSCI, V18, P5151; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Han HS, 2002, J NEUROSCI, V22, P3921, DOI 10.1523/JNEUROSCI.22-10-03921.2002; Inamasu J, 2000, J NEUROIMMUNOL, V109, P66, DOI 10.1016/S0165-5728(00)00211-3; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar K, 1997, NEUROREPORT, V8, P947, DOI 10.1097/00001756-199703030-00026; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; MCCRIMMON RJ, 1994, DIABETES METAB, V20, P503; Murakami K, 1998, J NEUROSCI, V18, P205; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; SELTZER HS, 1989, ENDOCRIN METAB CLIN, V18, P163, DOI 10.1016/S0889-8529(18)30395-5; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2000, BRAIN RES, V879, P7, DOI 10.1016/S0006-8993(00)02675-5; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2005, DIABETES, V54, P1452, DOI 10.2337/diabetes.54.5.1452; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2003, J NEUROSCI, V23, P10681; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; VAUGHAN DW, 1974, J NEUROCYTOL, V3, P405, DOI 10.1007/BF01098730; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Yanamoto H, 2001, STROKE, V32, P232, DOI 10.1161/01.STR.32.1.232	41	16	21	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2010	30	2					390	402		10.1038/jcbfm.2009.229			13	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	551TS	WOS:000274233800015	19861976	Bronze, Green Published			2021-06-18	
J	Chow, JW; Yablon, SA; Horn, TS; Stokic, DS				Chow, John W.; Yablon, Stuart A.; Horn, Terry S.; Stokic, Dobrivoje S.			Temporospatial characteristics of gait in patients with lower limb muscle hypertonia after traumatic brain injury	BRAIN INJURY			English	Article						Gait analysis; walking; brain injuries; muscle spasticity; lower extremity	BOTULINUM TOXIN INJECTION; STEP WIDTH MEASUREMENT; INTERRATER RELIABILITY; INTRATHECAL BACLOFEN; CONCURRENT VALIDITY; WALKING SPEED; SPASTICITY; PEOPLE; LENGTH; KINEMATICS	Objective: To characterize gait characteristics of adults with traumatic brain injury (TBI) and lower limb muscle hypertonia, distinguishing gait adaptations inherent to TBI motor impairment from those of healthy subjects walking at slower speed. Methods: Temporospatial and kinematic data of 31 patients with TBI (41 +/- 30 months post-injury) walking at self-selected speed (free speed) were compared with 31 healthy subjects walking at free and very slow speeds using an optoelectronic motion analysis system. Results: All step parameters differed (p < 0.05) between more affected (MA) and less affected (LA) sides in TBI except foot angle and toe clearance. Significant differences existed between TBI and controls in most parameters regardless of speed. These differences frequently involved the LA side. In TBI, most temporospatial parameters significantly correlated with stride velocity, whereas the averaged lower limb Ashworth score on the MA side (2.1 +/- 0.4) showed few significant correlations. Conclusions: Gait deviations in subjects with TBI and lower limb muscle hypertonia cannot be solely explained by slower walking. The preponderance of changes involving the LA side particularly suggests prevalent use of compensatory walking strategies. Temporospatial gait parameters are not closely related to static measures of muscle hypertonia after TBI.	[Chow, John W.; Yablon, Stuart A.; Horn, Terry S.; Stokic, Dobrivoje S.] Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS 39216 USA	Chow, JW (corresponding author), Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, 1350 E Woodrow Wilson Dr, Jackson, MS 39216 USA.	jchow@mmrcrehab.org		Stokic, Dobrivoje/0000-0002-1891-5730	Wilson Research Foundation, Jackson, MS; Medtronic Inc. Minneapolis, MNMedtronic	We thank Mark Hemleben for assistance in data collection and processing. This study was supported in part by the Wilson Research Foundation, Jackson, MS.; The authors have received funding from Medtronic Inc. Minneapolis, MN for research not directly related to this manuscript.	BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BOHANNON RW, 1990, ARCH PHYS MED REHAB, V71, P330; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cimolin V, 2007, Eura Medicophys, V43, P303; Cioni M, 2006, AM J PHYS MED REHAB, V85, P600, DOI 10.1097/01.phm.0000223216.50068.bc; Damiano DL, 1996, DEV MED CHILD NEUROL, V38, P389; Feve A, 1997, J NEUROL NEUROSUR PS, V63, P575, DOI 10.1136/jnnp.63.5.575; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; GRACIES JM, 2001, CLINICS, V12, P747; Gutierrez GM, 2005, ARCH PHYS MED REHAB, V86, P1824, DOI 10.1016/j.apmr.2005.04.008; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kerrigan DCC, 1999, J HEAD TRAUMA REHAB, V14, P136, DOI 10.1097/00001199-199904000-00004; Lance J. W., 1980, SPASTICITY DISORDERE, P485; Lin PY, 2006, ARCH PHYS MED REHAB, V87, P562, DOI 10.1016/j.apmr.2005.12.042; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Norton B J, 1975, Phys Ther, V55, P355; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Remy-Neris O, 2003, ARCH PHYS MED REHAB, V84, P643, DOI 10.1016/S0003-9993(02)04906-7; Robertson JVG, 2009, GAIT POSTURE, V29, P108, DOI 10.1016/j.gaitpost.2008.07.005; Rousseaux M, 2008, EUR J NEUROL, V15, P506, DOI 10.1111/j.1468-1331.2008.02112.x; Stewart John D, 2008, Pract Neurol, V8, P158, DOI 10.1136/jnnp.2008.149393; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; van Loo MA, 2003, DISABIL REHABIL, V25, P1195, DOI 10.1080/09638280310001599989; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Westberry DE, 2008, J PEDIATR ORTHOPED, V28, P352, DOI 10.1097/BPO.0b013e318168d996; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, GAIT POSTURE, V29, P454, DOI 10.1016/j.gaitpost.2008.11.005; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wilson DJ, 1997, BRAIN INJURY, V11, P157, DOI 10.1080/026990597123610; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	38	16	16	0	16	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	13-14					1575	1584		10.3109/02699052.2010.523053			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800007	20973631				2021-06-18	
J	Cohen, M; Ylvisaker, M; Hamilton, J; Kemp, L; Claiman, B				Cohen, Michelle; Ylvisaker, Mark; Hamilton, Joanna; Kemp, Lisa; Claiman, Barb			Errorless learning of functional life skills in an individual with three aetiologies of severe memory and executive function impairment	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Errorless learning; Memory treatment; Community rehabilitation; Cost-effective long-term intervention; Cognitive-Communication	COGNITIVE-BEHAVIORAL SUPPORTS; TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; TBI; REHABILITATION; AMNESIA; REPLICATION; HM	Errorless learning (EL) procedures have been shown to be effective in teaching new information and new procedures to individuals with severe memory impairment. The published studies have been based on comparatively short-term interventions delivered to individuals with relatively circumscribed impairments. In this single case study, we explore the usefulness of errorless learning procedures used for seven years with an adult with profound and complicated memory and executive function impairments associated with three distinct aetiologies. In primary functional areas targeted by the intervention, outcome was documented by behavioural descriptions and a frequency rating scale. Caregiver burden was documented with qualitative descriptors. A financial cost-benefit analysis is also provided. In the absence of change in underlying neuropsychological impairments, DI's everyday functioning in critical areas improved substantially, with corresponding reduction in supports and improved quality of life. Caregiver burden was reduced to acceptable levels and cost-benefit analysis demonstrates substantial ongoing cost savings.	[Cohen, Michelle] Michelle Cohen & Associates, Toronto, ON, Canada; [Ylvisaker, Mark] Coll St Rose Albany, New York, NY USA	Cohen, M (corresponding author), CASLPO S LP C, 35 Denlow Blvd, Don Mills, ON M3B 1P6, Canada.	mcohen101@rogers.com					BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Brush JA, 1998, THERAPY TECHNIQUE IM; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P386, DOI 10.1037/0278-7393.11.2.386; GUGER S, 2001, 29 ANN M INT NEUR SO; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; IZARD CE, 1993, PSYCHOL REV, V100, P68; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Komatsu S, 2000, NEUROPSYCHOL REHABIL, V10, P113, DOI 10.1080/096020100389200; Korsakoff S., 1889, REV PHILOS, V5, P501; Mesulam M.-M., 2002, PRINCIPLES FRONTAL L, P8, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0002; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; MOFFAT N, 1992, CLIN MANAGEMENT MEMO, P86, DOI DOI 10.1007/978-1-4899-4523-5_4; Ostergaard Arne L., 1993, P327; SALMON DP, 1995, CURR OPIN NEUROBIOL, V5, P184, DOI 10.1016/0959-4388(95)80025-5; SCHACTER DL, 1996, SEARCHING MEMORY BRA; SHIMAMURA AP, 1993, IMPLICIT MEMORY NEW, P327; Squire Larry R., 1994, P203; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1987, MEMORY BRAIN; Stark C, 2005, NEUROPSYCHOLOGY, V19, P139, DOI 10.1037/0894-4105.19.2.139; Sternberg RJ., 1993, TRANSFER TRIAL INTEL; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Turkstra LS, 2005, J MED SPEECH-LANG PA, V13, P205; World Health Organization, 2001, INT CLASS FUNCT DIS; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2002, FORGET IT SOURCES TH, P147; YLVISAKER M, 2007, BRAIN IMPAIR, V8, P1	37	16	18	0	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	3					355	376	PII 918620014	10.1080/09602010903309401			22	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	598RZ	WOS:000277857200003	20077313				2021-06-18	
J	Handratta, V; Hsu, E; Vento, J; Yang, C; Tanev, K				Handratta, Venkatesh; Hsu, Ellen; Vento, John; Yang, Clifford; Tanev, Kaloyan			Neuroimaging findings and brain-behavioral correlates in a former boxer with chronic traumatic brain injury	NEUROCASE			English	Article						Chronic traumatic brain injury; Dementia; Traumatic brain injury; Dementia pugilistica; Neuroimaging; Neuropsychiatry; Brain behavior relationships	CAVUM SEPTI PELLUCIDI; NATIONAL-FOOTBALL-LEAGUE; CORTICAL CELL-CULTURE; GLUTAMATE NEUROTOXICITY; BIPOLAR DISORDER; RAT; SCHIZOPHRENIA; PREVALENCE; VERGAE; ENCEPHALOPATHY	Chronic traumatic brain injury (CTBI) is associated with contact sports such as boxing. CTBI results from repetitive blows to the head rather than from a single impact. CTBI individuals present with motor symptoms (incoordination, spasticity, parkinsonism), cognitive impairment (executive dysfunction, memory deficits) and neuropsychiatric symptoms (irritability, affective disturbances). The structural and functional neuroimaging findings and clinical presentation of a CTBI case are described. We propose hypotheses about the pathophysiology of the observed neuroimaging findings and their relationship to the neuropsychiatric symptoms of the patients.	[Handratta, Venkatesh; Hsu, Ellen; Vento, John; Yang, Clifford; Tanev, Kaloyan] Univ Connecticut, Ctr Hlth, Farmington, CT USA	Tanev, K (corresponding author), Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	ktanev@partners.org					ADAMS CWM, 1989, J NEUROL NEUROSUR PS, V52, P600, DOI 10.1136/jnnp.52.5.600; Aminov M, 1995, Vestn Rentgenol Radiol, P5; Arciniegas DB, 2001, NEUROPSYCHIATRY INTR; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bodensteiner JB, 1998, J CHILD NEUROL, V13, P120, DOI 10.1177/088307389801300305; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Bruyn GW, 1977, HDB CLIN NEUROLOGY, P299; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P357; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY E, 1937, MED ANN, P318; Cummings JL, 2003, NEUROPSYCHIATRY BEHA; DEGREEF G, 1992, PSYCHIAT RES-NEUROIM, V45, P1, DOI 10.1016/0925-4927(92)90009-S; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Flashman LA, 2007, PSYCHIAT RES-NEUROIM, V154, P147, DOI 10.1016/j.pscychresns.2006.09.001; Fujiwara S, 1993, Nihon Hoigaku Zasshi, V47, P387; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; HUGHES RA, 1955, ARCH NEURO PSYCHIATR, V74, P259, DOI 10.1001/archneurpsyc.1955.02330150025004; Isaksson J, 2001, ACTA NEUROPATHOL, V102, P246; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; KASTE M, 1982, LANCET, V2, P1186; Kim MJ, 2007, BIPOLAR DISORD, V9, P274, DOI 10.1111/j.1399-5618.2007.00442.x; Kubota H, 1968, Nihon Geka Hokan, V37, P437; LARROCHE JC, 1961, BIOL NEONATORUM, V3, P193; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McCrory P, 2002, BRIT J SPORT MED, V36, P157, DOI 10.1136/bjsm.36.3.157; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mustafa B, 2005, J NEUROPSYCH CLIN N, V17, P122, DOI 10.1176/appi.neuropsych.17.1.122; Nopoulos P, 1997, BIOL PSYCHIAT, V41, P1102, DOI 10.1016/S0006-3223(96)00209-0; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; OTERUELO FT, 1986, ANAT ANZEIGER, V162, P271; Pearce JMS, 2008, EUR NEUROL, V59, P332, DOI 10.1159/000121428; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rajarethinam R, 2001, SCHIZOPHR RES, V48, P201, DOI 10.1016/S0920-9964(00)00110-9; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBINSON RG, 2000, NEUROPSYCHIATRY TRAU, P219; Scoffings DJ, 2008, CLIN RADIOL, V63, P210, DOI 10.1016/j.crad.2007.07.008; SHAW CM, 1969, BRAIN, V92, P213, DOI 10.1093/brain/92.1.213; Shioiri T, 1996, PSYCHOL MED, V26, P431, DOI 10.1017/S0033291700034838; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Takahashi T, 2007, PROG NEURO-PSYCHOPH, V31, P1235, DOI 10.1016/j.pnpbp.2007.04.019; Unterharnscheidt F, 1995, Rev Neurol, V23, P1027; Van Wagenen WP, 1934, AM J CANCER, V20, P539; Yang D N, 1997, J Am Optom Assoc, V68, P519; Zazryn T, 2007, SPORTS MED, V37, P467; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52; Zhu S G, 1991, Zhonghua Wai Ke Za Zhi, V29, P244; ZHU SG, 1991, ZHONGHUA WAI KE ZA Z, V29, P271	63	16	16	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2010	16	2					125	134		10.1080/13554790903329166			10	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	569LY	WOS:000275599800004	19967598				2021-06-18	
J	Ivins, BJ				Ivins, Brian J.			Hospitalization associated with traumatic brain injury in the active duty US Army: 2000-2006	NEUROREHABILITATION			English	Article						Traumatic brain injury; incidence rates; US Army; blasts; war-related	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIONAL SYNDROME; OPERATION-IRAQI-FREEDOM; POSTCONCUSSION SYNDROME; HEAD-INJURY; SYMPTOMS; CARE; AFGHANISTAN; DEPLOYMENT; MORTALITY	Objective: to determine the potential impacts of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) on the incidence of TBI-related hospitalization in the active duty US Army. Methods: All active duty Army personnel hospitalized with a TBI diagnosis during fiscal years 2000 through 2006 were identified in an administrative database. Annual crude incidence rates were calculated. Two-year adjusted incidence rates were calculated to compare TBI-related hospitalization rates in the Army to rates in the age-comparable segment of the US civilian population. Results: The overall incidence of TBI-related hospitalization in the active duty Army increased 105% from FY2000 to FY2006. There was a 60-fold increase in the hospitalization rate for TBIs attributed to weapons. The increases in TBI hospitalizations coincided with the occurrence of OEF/OIF. During OEF/OIF, the Army's hospitalization rates for moderate and severe TBIs were lower than civilian rates; however, the Army's hospitalization rate for mild TBIs was higher than civilian rates. Conclusion: OEF/OIF appear to have had a substantial impact on TBI-related hospitalization rates in the active duty US Army but differences between Army and civilian rates were not as excessive as expected.	Def & Vet Brain Injury Ctr, Rockville, MD 20852 USA	Ivins, BJ (corresponding author), Def & Vet Brain Injury Ctr, 11300 Rockville Pike,Suite 707, Rockville, MD 20852 USA.	brian.ivins@us.army.mil					Aharonson-Daniel L, 2006, ANN SURG, V244, P1018, DOI 10.1097/01.sla.0000225355.06362.0f; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Amoroso PJ, 2000, AM J PREV MED, V18, P174, DOI 10.1016/S0749-3797(00)00110-0; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Bochicchio GV, 2008, AM SURGEON, V74, P267; Brenner L. A., J HEAD TRAU IN PRESS; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; CAREY ME, 1987, MIL MED, V152, P6; Davis TP, 2003, J TRAUMA, V55, P1022, DOI 10.1097/01.TA.00000100837.38530.D1; DENNISON C, 2000, VITAL HLTH STAT, V1; Gerberich SG, 1997, NEUROEPIDEMIOLOGY, V16, P1, DOI 10.1159/000109665; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; *IOM, 2009, GULF WAR HLTH, V7, pCH11; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; *J HOPK U TRIAN IN, 1998, ICDMAP90 J HOPK U TR; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kahn H. A., 1989, STAT METHODS EPIDEMI; Kashuk JL, 2009, J AM COLL SURGEONS, V209, P134, DOI 10.1016/j.jamcollsurg.2009.01.049; Keegan J., 1994, HIST WARFARE; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; *MIL AG STAND, 1989, STANAG 2050 MED STAN; MOORE DF, 2008, FUTURE NEUROL, V3, P1; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peleg K, 2004, ANN SURG, V239, P311, DOI 10.1097/01.sla.0000114012.84732.be; Powell GE, 2008, J NEUROL NEUROSUR PS, V79, P237, DOI 10.1136/jnnp.2007.131722; ROPP THEODORE, 1962, WAR MODERN WORLD; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; STUHMILLER JH, 1990, CONVENTIONAL WARFARE, pCH7; TABOR KH, 2006, J NEUROPSYCHIATRY CL, V18, P141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Wood RL, 2007, J NEUROL NEUROSUR PS, V78, P552, DOI 10.1136/jnnp.2006.113845	52	16	16	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2010	26	3					199	212		10.3233/NRE-2010-0556			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	603OQ	WOS:000278218300004	20448310				2021-06-18	
J	Siddiqui, MA; Sim, L; Koh, J; Fook-Chong, S; Tan, C; Sen Howe, T				Siddiqui, Mashfiqul A.; Sim, Lynette; Koh, Joyce; Fook-Chong, Stephanie; Tan, Carol; Sen Howe, Tet			Stress Levels amongst Caregivers of Patients with Osteoporotic Hip Fractures - A Prospective Cohort Study	ANNALS ACADEMY OF MEDICINE SINGAPORE			English	Article						Caregiver strain index; Hip fractures	TRAUMATIC BRAIN-INJURY; BURDEN; DEPRESSION; DEMENTIA; ANXIETY; PEOPLE; STROKE; CARE	Introduction: We evaluated if there was significant stress in caregivers of elderly patients with osteoporotic hip fractures and determine any contributory factors. Materials and Methods: A prospective cohort study was performed from June 2005 to June 2006 in a single tertiary hospital. Patients admitted during this period and their primary caregivers were interviewed on admission and at 6 months. Information on patient's demographics, comorbidities, functional and mental status, placement post-discharge and financial strain were noted. Caregiver stress was measured using the caregiver strain index (CSI). Relationships between key variables were analysed to derive possible correlations. Results: The study comprised caregivers of 76 patients with a mean age of 77 years (range, 50 to 95; SD, 11). Within I week of admission, 45 of the 76 caregivers (59.2%) were significantly stressed based on the CSI while at 6 months, 30 of the caregivers (50%) were significantly stressed. The mean CSI within I week of admission and at 6 months post-admission was 7.18 and 6.25 respectively (P = 0.042). The most significant contributory factor to stress was financial strain (P = 0.01) attributable to medical bills, rehabilitation costs and transport expenses. Conclusion: There is a significant amount of stress that is experienced by caregivers of elderly patients with hip fractures which commences from admission of the patient and it remains high at 6-months post-fracture. Financial strain has been found to be the only significant cause on both univariate and multivariate analysis. Adequate resources should be available to caregivers of patients with osteoporotic hip fractures.	[Siddiqui, Mashfiqul A.; Koh, Joyce; Sen Howe, Tet] Singapore Gen Hosp, Dept Orthopaed Surg, Singapore 169608, Singapore; [Sim, Lynette] OzWorks Therapy Pte Ltd, Singapore, Singapore; [Fook-Chong, Stephanie] Singapore Gen Hosp, Dept Clin Res, Singapore 169608, Singapore; [Tan, Carol] KK Womens & Childrens Hosp, Geriatr Serv, Singapore, Singapore	Siddiqui, MA (corresponding author), Singapore Gen Hosp, Dept Orthopaed Surg, Outram Rd, Singapore 169608, Singapore.	mohd.mashfiqul@gmail.com					Bandeira DR, 2007, AGING MENT HEALTH, V11, P14, DOI 10.1080/13607860600640814; Bond J, 1998, INT J GERIATR PSYCH, V13, P601, DOI 10.1002/(SICI)1099-1166(199809)13:9<601::AID-GPS827>3.0.CO;2-B; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Dorra HH, 2002, INT J PSYCHIAT MED, V32, P249, DOI 10.2190/6REK-NYYD-MAXF-TD34; Gruffydd Emma, 2006, Community Pract, V79, P15; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hirakawa Y, 2008, ARCH GERONTOL GERIAT, V46, P367, DOI 10.1016/j.archger.2007.05.011; JOHANSSON I, 1988, AGING, V10, P377; JONGJIT K, 2003, SE ASIAN J TROP MED, V34, P670; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mehta KK, 2005, J CROSS-CULT GERONTO, V20, P319, DOI 10.1007/s10823-006-9009-z; Onishi J, 2005, ARCH GERONTOL GERIAT, V41, P159, DOI 10.1016/j.archger.2005.01.004; Post MWM, 2005, SPINAL CORD, V43, P311, DOI 10.1038/sj.sc.3101704; Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHELBY J, 1992, Journal of Burn Care and Rehabilitation, V13, P58, DOI 10.1097/00004630-199201000-00013; SULLIVAN TM, MODIFIED CAREGIVER S	20	16	19	1	8	ACAD MEDICINE SINGAPORE	REPUBLIC SINGAPORE	142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE	0304-4602			ANN ACAD MED SINGAP	Ann. Acad. Med. Singap.	JAN	2010	39	1					38	42					5	Medicine, General & Internal	General & Internal Medicine	558ME	WOS:000274746200009	20126813				2021-06-18	
J	Wright, J; Zhang, G; Yu, TS; Kernie, SG				Wright, Jamie; Zhang, Gui; Yu, Tzong-Shiue; Kernie, Steven G.			Age-Related Changes in the Oligodendrocyte Progenitor Pool Influence Brain Remodeling after Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Neural stem cell; White matter; Oligodendrocyte progenitor cells; Traumatic brain injury; Platelet-derived growth factor receptor-alpha	PERINATAL WHITE-MATTER; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; FOREBRAIN NEUROGENESIS; SUBVENTRICULAR ZONE; CELLS; VULNERABILITY; MECHANISMS; PLASTICITY; LINEAGE	Brain remodeling occurs after all forms of brain injury, though the mechanisms underlying this phenomenon are mostly unknown. Neural stem and progenitor cells are one source of endogenous cells that may contribute to brain remodeling and subsequent recovery. In addition, certain populations of progenitors are particularly susceptible to injury, and their depletion may lead to the impairment of developmental processes that vary with age. We particularly focus on glial progenitors, which are more abundant postnatally and particularly susceptible to acquired brain injuries such as traumatic brain injury. We have recently characterized a novel transgenic mouse that expresses herpes thymidine kinase under the control of the neural-progenitor-specific nestin promoter and allows for temporally induced ablation of dividing progenitors. By genetically depleting dividing cortical progenitors at various times, we identify postnatal day 7 (P7) to P14 as a critical period for oligodendrogenesis. Targeted ablation of dividing progenitors during this window leads to cell-specific depletion of oligodendrocyte precursors expressing platelet-derived growth factor receptor-alpha and corresponding myelination and motor deficits. This modeling provides insight into how the age at which white matter injury occurs influences both injury severity and subsequent recovery. Copyright (C) 2010 S. Karger AG, Basel	[Wright, Jamie; Zhang, Gui; Yu, Tzong-Shiue; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Wright, Jamie; Zhang, Gui; Yu, Tzong-Shiue; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	Kernie, SG (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.kernie@utsouthwestern.edu	Kernie, Steven/AAT-9912-2020; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Kernie, Steven/0000-0003-1371-0549; Wright, Jamie/0000-0001-5053-3583; Yu, Tzong-Shiue/0000-0003-4277-6213	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS048192]; Seay Endowed Fund for Research on Brain and Spinal Cord Injuries in Children; Green Fellowship Program; University of Texas at Dallas and UT Southwestern; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048192] Funding Source: NIH RePORTER	This study was supported by NIH grant R01 NS048192 (S.G.K.) and the Seay Endowed Fund for Research on Brain and Spinal Cord Injuries in Children (S.G.K.) and by the Green Fellowship Program, the University of Texas at Dallas and UT Southwestern (J.W.).	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Baumann N, 2001, PHYSIOL REV, V81, P871; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Goold D, 2009, J TRAUMA, V67, P71, DOI 10.1097/TA.0b013e3181b021ae; Gourevitch R, 2004, BEHAV PHARMACOL, V15, P287, DOI 10.1097/01.fbp.0000135703.48799.71; He YT, 2009, NEUROSCI RES, V65, P272, DOI 10.1016/j.neures.2009.07.011; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Ness JK, 2004, GLIA, V46, P183, DOI 10.1002/glia.10360; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rothstein RP, 2005, DEV NEUROSCI-BASEL, V27, P149, DOI 10.1159/000085987; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takashima S, 2009, SEMIN PEDIATR NEUROL, V16, P226, DOI 10.1016/j.spen.2009.09.004; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Woodruff RH, 2001, INT J DEV NEUROSCI, V19, P379, DOI 10.1016/S0736-5748(00)00083-6; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	42	16	16	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866			DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					499	509		10.1159/000322081			11	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900018	21160162	Green Published, Bronze			2021-06-18	
J	Yantz, CL; Johnson-Greene, D; Higginson, C; Emmerson, L				Yantz, Christine L.; Johnson-Greene, Doug; Higginson, Christopher; Emmerson, Lindsay			Functional cooking skills and neuropsychological functioning in patients with stroke: An ecological validity study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Ecological validity; Predictive validity; Neuropsychological assessment; Cerebrovascular accidents; Activities of daily living; Cooking	TRAUMATIC BRAIN-INJURY; PERFORMING ACTIVITIES; COGNITIVE IMPAIRMENT; EXECUTIVE DEFICITS; COMPLEX FIGURE; TESTS; INDIVIDUALS; SATISFACTION; PREDICTION; BATTERY	Efforts to relate neuropsychological performance to real-world task functioning have predominantly yielded lackluster results, typically with neuropsychological performance accounting for modest amounts of variance in function. Nonetheless, the ecological validity of neuropsychological measures for predicting functional abilities remains a strong research interest and clinical necessity. This study relates neuropsychological performance to performance on a standardised cooking task (Rabideau Kitchen Evaluation - Revised; RKE-R) in persons with stroke. Results showed that while the composite score of mean neuropsychological performance had the largest association with meal preparation, several neuropsychological measures were significantly related to the RKE-R. Groups of left and right hemisphere stroke patients were not significantly different in terms of RKE-R performance. These results suggest that functional cooking task performance is related to intact cognitive abilities in delayed verbal memory, simple auditory attention, and visuospatial skills, as well as overall cognitive performance. Implications for neuropsychologists are discussed.	[Yantz, Christine L.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Yantz, Christine L.] Div Rehabil Psychol & Neuropsychol, Dept Phys Med & Rehabil, Baltimore, MD USA; [Johnson-Greene, Doug] Univ Miami, Leonard M Miller Sch Med, Dept Rehabil Med, Miami, FL 33136 USA; [Higginson, Christopher] Loyola Coll Maryland, Dept Psychol, Baltimore, MD USA; [Emmerson, Lindsay] VA San Diego Healthcare Syst, San Diego, CA USA	Johnson-Greene, D (corresponding author), Univ Miami, Miller Sch Med, Clin Res Bldg C-206,1120 NW 14th St, Miami, FL 33136 USA.	djgreen@med.miami.edu	Higginson, Christopher I/A-9163-2009		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AA013898]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K23AA013898] Funding Source: NIH RePORTER	This research was supported by NIH grant AA013898. The authors would like to thank Laura McGinnis for her assistance with collecting the Rabideau Kitchen Examination-Revised (RKE-R) data for this project.	Axelrod B. N., 1994, ASSESSMENT, V1, P269, DOI DOI 10.1177/107319119400100307; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Brandt J., 2001, HOPKINS VERBAL LEARN; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cahn-Weiner DA, 2000, CLIN NEUROPSYCHOL, V14, P187, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT187; Cahn-Weiner DA, 2007, J INT NEUROPSYCH SOC, V13, P747, DOI 10.1017/S1355617707070853; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; Farias ST, 2003, ARCH CLIN NEUROPSYCH, V18, P655, DOI 10.1016/S0887-6177(02)00159-2; Farmer J E, 1995, Appl Neuropsychol, V2, P107, DOI 10.1207/s15324826an0203&4_2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Goodglass H., 1983, ASSESSMENT APHASIA R; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hartman-Maeir A, 2007, DISABIL REHABIL, V29, P559, DOI 10.1080/09638280600924996; Higginson CI, 2000, ARCH CLIN NEUROPSYCH, V15, P185, DOI 10.1016/S0887-6177(99)00004-9; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kaplan E, 1976, BOSTON NAMING TEST E; Katz N, 2000, OCCUP THER J RES, V20, P3, DOI 10.1177/153944920002000101; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Man DWK, 2006, BRAIN INJURY, V20, P205, DOI 10.1080/02699050500454621; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Meyers J., 1995, MEYERS SCORING SYSTE; NEISTADT ME, 1994, AM J OCCUP THER, V48, P431, DOI 10.5014/ajot.48.5.431; NEISTADT ME, 1992, OCCUP THER J RES, V12, P242, DOI 10.1177/153944929201200404; Okonkwo OC, 2006, J AM GERIATR SOC, V54, P1745, DOI 10.1111/j.1532-5415.2006.00916.x; Rabin LA, 2007, CLIN NEUROPSYCHOL, V21, P727, DOI 10.1080/13854040600888776; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Ruff RM, 2003, ARCH CLIN NEUROPSYCH, V18, P847, DOI 10.1016/j.acn.2003.07.002; Rybarczyk B, 1996, AM J GERIAT PSYCHIAT, V4, P131, DOI 10.1097/00019442-199621420-00005; Schretlen D, 1997, BRIEF TEST ATTENTION; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Silverberg ND, 2007, J INT NEUROPSYCH SOC, V13, P898, DOI 10.1017/S1355617707071135; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Spencer RJ, 2009, J CLIN EXP NEUROPSYC, V31, P373, DOI 10.1080/13803390802206398; Uniform Data System for Medical Rehabilitation, 1997, GUID UN DAT SET MED; Watanabe K, 2005, BRAIN DEV-JPN, V27, P564, DOI 10.1016/j.braindev.2005.02.007; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065	41	16	17	0	17	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	5					725	738	PII 922717775	10.1080/09602011003765690			14	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	648YB	WOS:000281730300005	20521203	Green Accepted			2021-06-18	
J	Kobbe, P; Lichte, P; Wellmann, M; Hildebrand, F; Nast-Kolb, D; Waydhas, C; Oberbeck, R				Kobbe, P.; Lichte, P.; Wellmann, M.; Hildebrand, F.; Nast-Kolb, D.; Waydhas, C.; Oberbeck, R.			Impact of hypothermia on the severely injured patient	UNFALLCHIRURG			German	Article						Hypothermia; Polytrauma; Coagulopathy; Rewarming; Systemic inflammatory response syndrome (SIRS)	TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; THERAPEUTIC HYPOTHERMIA; RATS; COAGULOPATHY; METAANALYSIS; MANAGEMENT; SURVIVAL	Accidental hypothermia is a common complication in severely injured patients. Risk factors include environmental exposure of the patient at the accident site or in the clinic, infusion of cold fluids, hemorrhagic shock and anesthetics which influence thermoregulation. In contrast to animal studies, human studies and clinical experiences have identified accidental hypothermia of the severely injured patient to be associated with increased complication and mortality rates. As a consequence, hypothermia together with acidosis and coagulopathy, have been coined the lethal triad in severely injured patients. On a cellular level hypothermia reduces cellular activity and metabolism resulting in reduced oxygen consumption, which is therapeutically used in patients following cardiac arrest. However, the activity of important enzymes, such as those of the coagulation pathway, is simultaneously down regulated. Hypothermia-induced coagulopathy, which is refractory to substitution of coagulation factors, is a major complication of hypothermia in traumatized patients. Therefore, hypothermic trauma patients with hemodynamic instability require aggressive rewarming.	[Kobbe, P.; Lichte, P.; Nast-Kolb, D.; Waydhas, C.; Oberbeck, R.] Univ Klinikum Essen, Unfallchirurg Klin, D-45127 Essen, Germany; [Wellmann, M.] Hannover Med Sch, Klin Orthopadie, Hannover, Germany; [Hildebrand, F.] Hannover Med Sch, Unfallchirurg Klin, Hannover, Germany	Kobbe, P (corresponding author), Univ Klinikum Essen, Unfallchirurg Klin, Hufelandstr 55, D-45127 Essen, Germany.	Kobbe.Philipp@uk-essen.de	Lichte, Philipp/AAG-2263-2020; Hildebrand, Frank/J-3176-2017; Kobbe, Philipp/F-5515-2010				ALDERSON R, 2004, COCHRANE DB SYST REV; BEIIMAN GJ, 2009, ANN SURG, V249, P845; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; DANZL DF, 1987, ANN EMERG MED, V16, P1042, DOI 10.1016/S0196-0644(87)80757-6; GACLKARY CS, 2002, COCHRANE DB SYST REV; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; GUBLER KD, 1994, J TRAUMA, V36, P847, DOI 10.1097/00005373-199406000-00015; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Heinius G, 2002, J SURG RES, V108, P7, DOI 10.1006/jsre.2002.6470; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Hildebrand Frank, 2005, Surg Technol Int, V14, P41; JOHNSTON TD, 1994, J TRAUMA, V37, P413, DOI 10.1097/00005373-199409000-00014; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Kermode JC, 1999, BLOOD, V94, P199, DOI 10.1182/blood.V94.1.199.413k14_199_207; Krause KR, 2000, AM SURGEON, V66, P348; Lee SL, 2001, J SURG RES, V100, P150, DOI 10.1006/jsre.2001.6230; Leonov Y, 2002, RESUSCITATION, V52, P193, DOI 10.1016/S0300-9572(01)00453-1; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MICHELSON AD, 1994, THROMB HAEMOSTASIS, V71, P633; Peng RY, 1999, J AM COLL SURGEONS, V188, P685, DOI 10.1016/S1072-7515(99)00035-6; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85; Schneider A, 2008, ANAESTHESIST, V57, P197, DOI 10.1007/s00101-008-1311-4; Seekamp A, 1999, J TRAUMA, V47, P673, DOI 10.1097/00005373-199910000-00011; STERNEMANN S, 1990, J TRAUMA, V30, P200; Tisherman Samuel A, 2004, Curr Opin Crit Care, V10, P512; Tsuei BJ, 2004, INJURY, V35, P7, DOI 10.1016/S0020-1383(03)00309-7; Vaagenes P, 2003, RESUSCITATION, V58, P103, DOI 10.1016/S0300-9572(03)00102-3; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Winkler M, 2000, ANESTH ANALG, V91, P978, DOI 10.1097/00000539-200010000-00039; Wu XR, 2003, J TRAUMA, V55, P308, DOI 10.1097/01.TA.0000079366.23533.1E; YENARI MA, 1995, THROMB RES, V77, P475, DOI 10.1016/0049-3848(95)93883-2	34	16	20	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	DEC	2009	112	12					1055	1059		10.1007/s00113-009-1711-1			5	Emergency Medicine; Surgery	Emergency Medicine; Surgery	530DI	WOS:000272568700005	19998020				2021-06-18	
J	Tandon, A; Suri, A; Kasliwal, MK; Mahapatra, AK; Mehta, VS; Garg, A; Sarkar, C; Dogra, TD; Pandey, RM				Tandon, Asheesh; Suri, Ashish; Kasliwal, Manish Kumar; Mahapatra, Ashok Kumar; Mehta, Veer Singh; Garg, Ajay; Sarkar, Chitra; Dogra, T. D.; Pandey, R. M.			Assessment of endocrine abnormalities in severe traumatic brain injury: a prospective study	ACTA NEUROCHIRURGICA			English	Article						Endocrine; Hormone; Head injury; Pituitary	THYROTROPIN-RELEASING-HORMONE; HEAD-INJURY; POSTTRAUMATIC HYPOPITUITARISM; PANHYPOPITUITARISM; INSUFFICIENCY; PROLACTIN; SECONDARY; CORTISOL; FRACTURE; AXIS	The frequency and pattern of endocrine abnormalities among patients with traumatic brain injury have been the subject matter of very few studies. This study was intended to assess the pattern of endocrine dysfunction following severe head injury. Severe head injury patients admitted to the Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, from January to December in 1 year formed the study group. Apart from clinical assessment, NCCT of the head was performed on all patients on admission. A complete anterior pituitary hormone analysis was performed within 24 h of injury and was repeated at 2 weeks, 3 months and 6 months amongst patients who survived. A total of 99 patients were included in the study. Forty of our patients succumbed in the hospital. Rest of the patients were followed up for 6 months. Elevations of cortisol followed by prolactin were the most common hormonal derangements at admission. Midline shift on CT scans was inversely related to cortisol elevation and directly related to GH elevation. Infarct on CT scans was inversely related to cortisol and LH elevation. A significant alteration was found in the decreasing trend of the mean T4 values and normalisation or a decreasing trend from initially elevated mean cortisol and GH levels during follow-up (p < 0.05). This study reveals that abnormalities in hormonal profiles appear to be relatively common in severe traumatic brain injury and fluctuate significantly over at least 6 months; there is a correlation with age and radiological findings. Performance of hormonal analysis evaluation should be considered in patients with severe brain injury so that appropriate hormonal replacement can be done to optimise the clinical outcome.	[Suri, Ashish] All India Inst Med Sci, Ctr Neurosci, New Delhi 110029, India; [Tandon, Asheesh; Suri, Ashish; Kasliwal, Manish Kumar; Mahapatra, Ashok Kumar; Mehta, Veer Singh] All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India; [Garg, Ajay] All India Inst Med Sci, Dept Neuroradiol, New Delhi 110029, India; [Dogra, T. D.] All India Inst Med Sci, Dept Forens Med, New Delhi 110029, India; [Sarkar, Chitra] All India Inst Med Sci, Dept Neuropathol, New Delhi 110029, India; [Pandey, R. M.] All India Inst Med Sci, Dept Biostat, New Delhi 110029, India	Suri, A (corresponding author), All India Inst Med Sci, Ctr Neurosci, New Delhi 110029, India.	surineuro@hotmail.com	GARG, RAKESH/H-4591-2011; Garg, Ajay/AAM-2603-2020; Dogra, Tirath Das/R-6517-2019	GARG, RAKESH/0000-0001-5842-8024; Garg, Ajay/0000-0002-9385-291X; Dogra, Tirath Das/0000-0002-5398-2285			Acerini CL, 2008, J PEDIATR ENDOCR MET, V21, P611; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; ALTMAN R, 1961, ANN INTERN MED, V55, P149, DOI 10.7326/0003-4819-55-1-149; BARRECA T, 1980, J CLIN ENDOCR METAB, V51, P1270; BECKPECCOZ P, 1985, NEW ENGL J MED, V312, P1085, DOI 10.1056/NEJM198504253121703; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; CHILDER MK, 1990, BRAIN INJURY, V12, P517; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; CLARK JDA, 1992, CLIN ENDOCRINOL, V36, P481, DOI 10.1111/j.1365-2265.1992.tb02249.x; CUMMING DC, 1983, J CLIN ENDOCR METAB, V57, P671, DOI 10.1210/jcem-57-3-671; De Marinis L, 1999, CLIN ENDOCRINOL, V50, P741; DESAI D, 1989, J TRAUMA, V29, P719, DOI 10.1097/00005373-198906000-00003; EDWARDS OM, 1986, MEDICINE, V65, P281; JAMBART S, 1980, ACTA ENDOCRINOL-COP, V93, P264, DOI 10.1530/acta.0.0930264; KANADE A, 1978, J ENDOCRINOL INVEST, V1, P263, DOI 10.1007/BF03350391; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KING LR, 1981, NEUROSURGERY, V9, P229, DOI 10.1227/00006123-198109000-00002; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; LIDDLE GW, 1962, RECENT PROG HORM RES, V18, P125; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; MATSUURA H, 1985, NEUROSURGERY, V16, P791, DOI 10.1227/00006123-198506000-00009; MOSES AM, 1968, J CLIN ENDOCR METAB, V28, P1581, DOI 10.1210/jcem-28-11-1581; MULLER EE, 1979, CLIN ENDOCRINOL, V11, P645, DOI 10.1111/j.1365-2265.1979.tb03120.x; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; OPPENHEIMER IH, 1961, J CLIN ENDOCR, V21, P1023; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; SOULES MR, 1979, SOUTHERN MED J, V72, P1592, DOI 10.1097/00007611-197912000-00029; VALENTA LJ, 1980, AM J MED, V68, P614, DOI 10.1016/0002-9343(80)90314-9; WARTOFSKY L, 1982, ENDOCR REV, V3, P164, DOI 10.1210/edrv-3-2-164; WEISS SR, 1982, AM J MED, V72, P861; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011	36	16	17	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2009	151	11					1411	1417		10.1007/s00701-009-0444-9			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	514NQ	WOS:000271402000009	19597761				2021-06-18	
J	Lundberg, J; Le Blanc, K; Soderman, M; Andersson, T; Holmin, S				Lundberg, Johan; Le Blanc, Katarina; Soderman, Mikael; Andersson, Tommy; Holmin, Staffan			Endovascular transplantation of stem cells to the injured rat CNS	NEURORADIOLOGY			English	Article						Trauma; Mesenchymal; MAB 1281; Intra-arterial	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; PROGENITOR CELLS; STROKE; MIGRATION; DIFFERENTIATION; RESPONSES; RECOVERY; MODEL	Transplantation procedures using intraparenchymal injection of stem cells result in tissue injury in addition to associated surgical risks. Intravenous injection of mesenchymal stem cells gives engraftment to lesions, but the method has low efficiency and specificity. In traumatic brain injuries (TBI), there is a transient breakdown of the blood-brain barrier and an inflammatory response, which increase migration of cells from blood to parenchyma. The aim of this investigation was to analyze the effect of intra-arterial administration on cellular engraftment. Experimental TBI was produced in a rat model. Endovascular technique was used to administer human mesenchymal stem cells in the ipsilateral internal carotid artery. Evaluation of engraftment and side effects were performed by immunohistochemical analysis of the brain and several other organs. The results were compared to intravenous administration of stem cells. Intra-arterial transplantion of mesenchymal stem cells resulted in central nervous system (CNS) engraftment without thromboembolic ischemia. We observed a significantly higher number of transplanted cells in the injured hemisphere after intra-arterial compared to intravenous administration both 1 day (p < 0.01) and 5 days (p < 0.05) after the transplantation. Some cells were also detected in the spleen but not in the other organs analyzed. Selective intra-arterial administration of mesenchymal stem cells to the injured CNS is a minimally invasive method for transplantation. The method is significantly more efficient than the intravenous route and causes no side effects in the current model. The technique can potentially be used for repeated transplantation to the CNS after TBI and in other diseases.	[Lundberg, Johan; Soderman, Mikael; Andersson, Tommy; Holmin, Staffan] Karolinska Univ Hosp, Dept Neuroradiol, Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [Le Blanc, Katarina] Karolinska Univ Hosp, Dept Clin Immunol, Karolinska Inst, Dept Stem Cell Res, S-17176 Stockholm, Sweden	Holmin, S (corresponding author), Karolinska Univ Hosp, Dept Neuroradiol, Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden.	staffan.holmin@karolinska.se	Le Blanc, Katarina/L-4631-2019	Holmin, Staffan/0000-0002-1628-1615			Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Grinnemo KH, 2006, ANN MED, V38, P144, DOI 10.1080/07853890500422982; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; John D. B., 1996, THEORY PRACTICE HIST; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu WP, 2008, NEUROSCI LETT, V434, P160, DOI 10.1016/j.neulet.2007.12.067; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Politi LS, 2007, NEURORADIOLOGY, V49, P523, DOI 10.1007/s00234-007-0219-z; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088	21	16	18	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	OCT	2009	51	10					661	667		10.1007/s00234-009-0551-6			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	494ZW	WOS:000269859800005	19562330				2021-06-18	
J	Lemoyne, R; Coroian, C; Mastroianni, T; Grundfest, W				Lemoyne, Robert; Coroian, Cristian; Mastroianni, Timothy; Grundfest, Warren			WIRELESS ACCELEROMETER ASSESSMENT OF GAIT FOR QUANTIFIED DISPARITY OF HEMIPARETIC LOCOMOTION	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Wireless accelerometers; gait analysis; gait rehabilitation; locomotion; hemiparetic gait; traumatic brain injury	RELIABILITY; WALKING; STROKE	Assessment of locomotion quality subsequent to neurological trauma, such as stroke or traumatic brain injury is imperative for the correct allocation of therapy dosage and strategy. In light of the limited amount of medical professionals in contrast with the rising number of people with neurological disorders; a new paradigm for addressing therapeutic strategies for neurological trauma is advocated. An important aspect for therapy of neuro-motor disorders is the characterization of gait. There are devices presently used for evaluating gait, such as EMG, optical sensors, electrogoniometers, metabolic energy expenditure devices, foot stride analyzers, and ground reaction force sensors. These devices have inherent issues, such as spatial constraints, line of sight requirements, and specialization requirements. A solution for improved autonomy of gait assessment is demonstrated by the use of fully wireless 3D MEMS accelerometers, which are light weight and minimally intrusive. To minimize specialization issues, the accelerometers may be positioned at a standard anatomical anchor. The role of traumatic brain injury with respect to gait dysfunction is addressed. Enclosed is the initial test and evaluation of a wireless 3D MEMS accelerometer for gait analysis. The gait analysis is conducted in outdoor conditions, while walking on a sidewalk.	[Lemoyne, Robert; Grundfest, Warren] Univ Calif Los Angeles, Biomed Engn IDP, Los Angeles, CA 90095 USA; [Coroian, Cristian] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mastroianni, Timothy] Cognit Engn, Pittsburgh, PA USA	Lemoyne, R (corresponding author), Univ Calif Los Angeles, Biomed Engn IDP, 5121 Engn 5,Box 951600, Los Angeles, CA 90095 USA.	rlemoyne@ucla.edu	LeMoyne, Robert/AAI-9686-2020	LeMoyne, Robert/0000-0003-3587-3250			Bamberg SJM, 2008, IEEE T INF TECHNOL B, V12, P413, DOI 10.1109/TITB.2007.899493; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Culhane KM, 2005, AGE AGEING, V34, P556, DOI 10.1093/ageing/afi192; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Dobkin B.H., 2003, CLIN SCI NEUROLOGIC; Finney R. L., 1990, CALCULUS; Jafari R, 2005, PROCEEDINGS OF MOBIQUITOUS 2005, P479; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; Lee JA, 2007, P ANN INT IEEE EMBS, P483, DOI 10.1109/IEMBS.2007.4352328; LEMOYNE R, 2008, 16 INT C MECH MED BI; LEMOYNE R, 2007, 3 ANN THER STRAT NEU; LEMOYNE R, 2007, IGERT STUDENT RES S; LEMOYNE R, 2007, 37 SOC NEUROSCIENCE; LEMOYNE R, 2006, 15 INT C MECH MED BI; LEMOYNE R, 2007, UCLA BRAIN RES I 200; LEMOYNE R, 2006, 36 SOC NEUROSCIENCE; Lemoyne R, 2008, J MECH MED BIOL, V8, P75, DOI 10.1142/S0219519408002462; LeMoyne R, 2008, IEEE ENG MED BIO, P4238, DOI 10.1109/IEMBS.2008.4650145; Lemoyne R, 2008, J MECH MED BIOL, V8, P317, DOI 10.1142/S0219519408002693; Lord SE, 2005, STROKE, V36, P1457, DOI 10.1161/01.STR.0000170698.20376.2e; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; NAKAMURA S, 1996, NUMERICAL ANAL GRAPH; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Saremi K, 2006, NEUROREHAB NEURAL RE, V20, P297, DOI 10.1177/1545968306287171	24	16	16	0	8	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	SEP	2009	9	3					329	343		10.1142/S0219519409003024			15	Biophysics; Engineering, Biomedical	Biophysics; Engineering	497FD	WOS:000270041400005					2021-06-18	
J	Moon, RJ; Wilson, P; Kirkham, FJ; Davies, JH				Moon, R. J.; Wilson, P.; Kirkham, F. J.; Davies, J. H.			Growth monitoring following traumatic brain injury	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							PITUITARY-FUNCTION; DEFICIENCY; CHILDREN	Hypopituitarism is an important consequence of traumatic brain injury (TBI). Growth monitoring can be used as an indicator of pituitary function in children. A retrospective audit of case notes of 123 children who required intensive care unit admission with TBI found that only 71 (33%) of 212 attendances in 38 of 85 children followed up had documented height and weight measurements. Children were reviewed in 11 different specialty clinics, which showed a wide variation in the frequency of growth monitoring. Serial growth measurements were available for only 22 patients (17%), which showed a reduction in height standard deviation scores (0.17 (SD 0.33), p=0.017) over a mean follow-up period of 25.2 (SD 21.6) months. In conclusion, growth monitoring following TBI was poorly performed in this cohort, highlighting the need for a co-ordinated approach by primary and secondary care and all departments in tertiary centres involved in the follow-up of children with TBI.	[Wilson, P.] Southampton Univ Hosp NHS Trust, Paediat Intens Care Unit, Southampton, Hants, England	Davies, JH (corresponding author), Southampton Univ Hosp Trust, Child Hlth Directorate, MP 43,Tremona Rd, Southampton SO16 3JE, Hants, England.	justin.davies@suht.swest.nhs.uk	Kirkham, Fenella/C-2442-2009	Kirkham, Fenella/0000-0002-2443-7958; Davies, Justin/0000-0001-7560-6320			Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; McDonald A, 2008, J PEDIATR-US, V152, P590, DOI 10.1016/j.jpeds.2007.12.046; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137	7	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	SEP	2009	94	9					699	701		10.1136/adc.2008.145235			3	Pediatrics	Pediatrics	486AQ	WOS:000269168200011	19036759				2021-06-18	
J	Petracca, GM; Jorge, RE; Acion, L; Weintraub, D; Robinson, RG				Petracca, Gustavo M.; Jorge, Ricardo E.; Acion, Laura; Weintraub, Daniel; Robinson, Robert G.			Frequency and Correlates of Involuntary Emotional Expression Disorder in Parkinson's Disease	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							WHITE-MATTER HYPERINTENSITIES; TRAUMATIC BRAIN-INJURY; PATHOLOGICAL LAUGHTER; ALZHEIMERS-DISEASE; RATING-SCALE; DEPRESSION; PREVALENCE; DIAGNOSIS; SCLEROSIS	Involuntary emotional expression disorder (IEED) is a syndrome characterized by involuntary episodes of emotional expression, particularly crying or laughing, that occur in patients with a neurological illness, including neuro-degenerative diseases. The authors assessed the frequency and clinical correlates of IEED among 131 patients with Parkinson's disease. IEED was present in 16.8% of patients overall and in 15.3% of depressed patients. The only clinical correlate of IEED diagnosis was greater severity of Parkinson's disease. The lack of an association between IEED and depression suggests that, in spite of some symptom overlap, the two disorders are distinct neuropsychiatric syndromes in Parkinson's disease. (The Journal of Neuropsychiatry and Clinical Neurosciences 2009; 21:406-412)	[Petracca, Gustavo M.] Inst Neurosci Buenos Aires, Buenos Aires, DF, Argentina; [Jorge, Ricardo E.; Acion, Laura; Robinson, Robert G.] Univ Iowa, Dept Psychiat, Roy C & Lucille A Coll Med, Iowa City, IA 52242 USA; [Weintraub, Daniel] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	Jorge, RE (corresponding author), 200 Hawkins Dr,W278 GH, Iowa City, IA 52242 USA.	ricardo-jorge@uiowa.edu	Weintraub, Daniel/AAC-5232-2020; Weintraub, Daniel/AAD-8309-2020	Weintraub, Daniel/0000-0003-0633-7168; Acion, Laura/0000-0001-5213-6012			Arciniegas David B, 2005, Am J Geriatr Pharmacother, V3 Suppl A, P4, DOI 10.1016/S1543-5946(05)80031-5; ARCINIEGAS DB, 2005, AM J GERIATR PHAR SA, V3, P16; ARROYO S, 1993, BRAIN, V116, P757, DOI 10.1093/brain/116.4.757; Beyer MK, 2006, MOVEMENT DISORD, V21, P223, DOI 10.1002/mds.20704; Burton EJ, 2006, AM J GERIAT PSYCHIAT, V14, P842, DOI 10.1097/01.JGP.0000236596.56982.1c; Chemerinski E, 1998, J NEUROPSYCH CLIN N, V10, P421, DOI 10.1176/jnp.10.4.421; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Feinstein A, 1999, MULT SCLER, V5, P69, DOI 10.1177/135245859900500201; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Forer S., 1987, FUNCTIONAL INDEPENDE; GALLAGHER JP, 1989, ACTA NEUROL SCAND, V80, P114, DOI 10.1111/j.1600-0404.1989.tb03851.x; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Hachinski V, 1985, ACUTE STROKE; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Martinez-Martin P, 2006, VALUE HEALTH, V9, P386, DOI 10.1111/j.1524-4733.2006.00131.x; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; McCullagh S, 1999, J NEUROL SCI, V169, P43, DOI 10.1016/S0022-510X(99)00214-2; McDonald WA, 2003, BIOL PSYCHIAT, V54, P363, DOI 10.1016/S0006-3223(03)00530-4; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; PARVIZI J, 2007, MOV DISORD; PICCINI P, 1995, ARCH NEUROL-CHICAGO, V52, P191, DOI 10.1001/archneur.1995.00540260097023; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Spitzer R. l., 1995, STRUCTURED CLIN INTE; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Thumler BH, 2003, J NEUROL, V250, P1107, DOI 10.1007/s00415-003-0075-7; Weintraub D, 2005, AM J GERIAT PSYCHIAT, V13, P844, DOI 10.1176/appi.ajgp.13.10.844; Woolley JD, 2004, NEUROLOGY, V63, P1740, DOI 10.1212/01.WNL.0000143054.54412.5B; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160	37	16	16	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2009	21	4					406	412					7	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	526RR	WOS:000272311300007	19996249				2021-06-18	
J	Saganova, K; Orendacova, J; Sulla, I; Filipcik, P; Cizkova, D; Vanicky, I				Saganova, Kamila; Orendacova, Judita; Sulla, Igor, Jr.; Filipcik, Peter; Cizkova, Dasa; Vanicky, Ivo			Effects of Long-Term FK506 Administration on Functional and Histopathological Outcome after Spinal Cord Injury in Adult Rat	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Tacrolimus; Compression; Secondary injury; White/gray matter; Neuroprotection	MAGNETIC-RESONANCE TRACKING; TRANSIENT FOCAL ISCHEMIA; GLOBAL CEREBRAL-ISCHEMIA; THERAPEUTIC TIME WINDOW; TRAUMATIC BRAIN-INJURY; EMBRYONIC STEM-CELLS; TACROLIMUS FK506; CYCLOSPORINE-A; IMMUNOSUPPRESSANT FK506; NEUROPROTECTIVE ACTION	FK506 (tacrolimus), a potent immunosuppressive drug primarily used for reduction of allograft rejection in organ transplantation, also offers neuroprotection after central nervous system injury. FK506-mediated immunosuppression and neuroprotection may occur through different mechanisms that could affect neurological recovery and the severity of spinal lesions where cells transplantation therapy is combined with FK506 application. We assessed effects of long-term FK506 administration using the same dose regiment (1 mg/kg/day for 6 weeks) as is used in spinal cord transplantation studies following a balloon-compression induced spinal cord injury (SCI). Body weight and locomotor recovery quantified by the BBB (Basso-Beattie-Bresnehan) locomotor rating scale were evaluated for up to 42 days post-injury. The area of the preserved spinal cord tissue within a 13 mm segment of the spinal cord (lesion epicenter and 6 mm rostral-caudal) was examined histologically. The results showed no significant effects of FK506 on spinal cord tissue sparing or improvement of locomotor recovery. However, body weight fell significantly (P < 0.05) with FK506 treatment when compared with placebo from day 7 until sacrifice. In our experimental design, long-term FK506 treatment did not affect the parameters of outcome following balloon-compression SCI in the rat; however, multiple effects of FK506 should be taken into account when evaluating the outcomes in transplantation studies.	[Saganova, Kamila; Orendacova, Judita; Cizkova, Dasa; Vanicky, Ivo] Slovak Acad Sci, Inst Neurobiol, Ctr Excellence, Dept Neuromorphol, Kosice 04001, Slovakia; [Sulla, Igor, Jr.] Univ Vet Med, Dept Anat Histol & Physiol, Kosice, Slovakia; [Filipcik, Peter] Slovak Acad Sci, Inst Neuroimmunol, Ctr Excellence, Bratislava, Slovakia	Saganova, K (corresponding author), Slovak Acad Sci, Inst Neurobiol, Ctr Excellence, Dept Neuromorphol, Soltesovej 6, Kosice 04001, Slovakia.	sagan@saske.sk	Cizkova, Dasa/AAF-8976-2019	Filipcik, Peter/0000-0001-8919-5964; cizkova, dasa/0000-0002-2504-3993	Slovak Academy of Sciences [VEGA/2/0092/08, VEGA/2/0058/08, VEGA/2/0019/08, VEGA/2//6212/27, APVV 51-0314-06]	This research was supported by grants from the Slovak Academy of Sciences VEGA/2/0092/08, VEGA/2/0058/08, VEGA/2/0019/08, VEGA/2//6212/27 and APVV 51-0314-06 grant.	Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Arii T, 2001, NEUROL RES, V23, P755, DOI 10.1179/016164101101199135; Bareyre FM, 2008, J NEUROL SCI, V265, P63, DOI 10.1016/j.jns.2007.05.004; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; Benetoli A, 2007, PHARMACOL BIOCHEM BE, V88, P28, DOI 10.1016/j.pbb.2007.07.001; Cizkova D, 2007, NEUROSCIENCE, V147, P546, DOI 10.1016/j.neuroscience.2007.02.065; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Furuichi Y, 2004, BRAIN RES, V1014, P120, DOI 10.1016/j.brainres.2004.04.031; Furuichi Y, 2003, BRAIN RES, V965, P137, DOI 10.1016/S0006-8993(02)04151-3; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hayashi Y, 2005, J NEUROTRAUM, V22, P1267, DOI 10.1089/neu.2005.22.1267; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopez-Vales R, 2006, NEUROBIOL DIS, V24, P443, DOI 10.1016/j.nbd.2006.08.001; LYONS WE, 1994, P NATL ACAD SCI USA, V91, P3191, DOI 10.1073/pnas.91.8.3191; Madsen JR, 1998, EXP NEUROL, V154, P673, DOI 10.1006/exnr.1998.6974; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Marsala M, 2004, EUR J NEUROSCI, V20, P2401, DOI 10.1111/j.1460-9568.2004.03702.x; Matsuda S, 2000, EMBO REP, V1, P428, DOI 10.1093/embo-reports/kvd090; Nito C, 2004, BRAIN RES, V1008, P179, DOI 10.1016/j.brainres.2004.02.031; Nottingham S, 2002, EXP NEUROL, V177, P242, DOI 10.1006/exnr.2002.7975; Ondrejcak T, 2004, BRAIN RES, V995, P267, DOI 10.1016/j.brainres.2003.10.009; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Saganova K, 2008, NEUROSCI LETT, V433, P246, DOI 10.1016/j.neulet.2008.01.041; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; Sosa I, 2005, EXP NEUROL, V195, P7, DOI 10.1016/j.expneurol.2005.04.016; Sykova E, 2005, ANN NY ACAD SCI, V1049, P146, DOI 10.1196/annals.1334.014; Tachibana T, 2005, J THORAC CARDIOV SUR, V129, P123, DOI 10.1016/j.jtcvs.2004.04.047; Takamatsu H, 2001, J NUCL MED, V42, P1833; Tokime T, 1996, NEUROSCI LETT, V206, P81, DOI 10.1016/S0304-3940(96)12438-1; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Vanicky I, 2002, NEUROSCI RES COMMUN, V31, P183, DOI 10.1002/nrc.10051; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Voda J, 2005, J NEUROTRAUM, V22, P1150, DOI 10.1089/neu.2005.22.1150; Voda J, 2007, NEUROSCI RES, V58, P95, DOI 10.1016/j.neures.2007.02.004; Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028; Yagita Y, 1996, LIFE SCI, V59, P1643, DOI 10.1016/0024-3205(96)00495-X; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092	42	16	18	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	SEP	2009	29	6-7					1045	1051		10.1007/s10571-009-9395-1			7	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	476YI	WOS:000268482300031	19350383				2021-06-18	
J	Wen, L; Liu, WG; Ma, L; Zhan, RY; Li, G; Yang, XF				Wen, L.; Liu, W. G.; Ma, L.; Zhan, R. Y.; Li, G.; Yang, X. F.			Spontaneous rapid resolution of acute subdural hematoma after head trauma: Is it truly rare?	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Acute subdural hematoma; Spontaneous resolution; Traumatic brain injury	REDISTRIBUTION; PATIENT	Spontaneous rapid resolution of acute subdural hematoma (ASDH) is a rare phenomenon for this severe insult after head trauma. We present a 22-year-old patient who developed ASDH with a moderate midline shift and compression of lateral ventricle after a truncal collision but without a direct beat on the head. Conservative management was performed under close monitoring because of unexpected improvement of clinical signs and symptoms. Unexpectedly, the ASDH resolved spontaneously within 13 h after the trauma, and he was discharged 1 week later without any neurological deficit. In addition, similar cases reported in literature were reviewed. Because most of the patients developing ASDH underwent emergent surgical intervention, the incidence of this phenomenon may be underestimated. Although emergent surgical removal remains the first choice for the treatment of ASDH, conservative management with careful monitoring may also work out in selected patients who show neurologic and radiologic improvements.	[Wen, L.; Zhan, R. Y.; Li, G.; Yang, X. F.] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, W. G.; Ma, L.] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Wen, L.; Liu, W. G.; Ma, L.; Zhan, R. Y.; Li, G.; Yang, X. F.] Zhejiang Univ, Inst Brain Med, Hangzhou 310003, Zhejiang, Peoples R China	Yang, XF (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com					Berker M, 2003, ACTA NEUROCHIR, V145, P715, DOI 10.1007/s00701-003-0090-6; Cohen JE, 1998, SURG NEUROL, V50, P241, DOI 10.1016/S0090-3019(97)00026-8; Erol FS, 2004, PEDIATR NEUROSURG, V40, P238, DOI 10.1159/000082299; Huang Shu-Hung, 2005, Kaohsiung Journal of Medical Sciences, V21, P291; Imai K, 2003, NEUROL MED-CHIR, V43, P125, DOI 10.2176/nmc.43.125; Inamasu J, 2002, AM J EMERG MED, V20, P376, DOI 10.1053/ajem.2002.33955; JURAN V, 1997, CLIN NEUROL NEURO S1, V99, pS73; Kato N, 2001, NEUROL MED-CHIR, V41, P140, DOI 10.2176/nmc.41.140; Kundra SN, 2005, NEUROL INDIA, V53, P124, DOI 10.4103/0028-3886.15083; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; Niikawa S, 1989, Neurol Med Chir (Tokyo), V29, P820, DOI 10.2176/nmc.29.820; Tsui EYK, 2000, EUR J RADIOL, V36, P53, DOI 10.1016/S0720-048X(99)00167-9	13	16	19	2	3	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	SEP	2009	178	3					367	371		10.1007/s11845-008-0168-5			5	Medicine, General & Internal	General & Internal Medicine	480YB	WOS:000268772100026	18807104				2021-06-18	
J	Wang, JP; Jiang, C; Li, X; Liu, CL; Cheng, NN; Hao, YJ				Wang, Jianping; Jiang, Chao; Li, Xin; Liu, Chunling; Cheng, Ningning; Hao, Yujin			RETRACTED: The protective mechanism of progesterone on blood-brain barrier in cerebral ischemia in rats (Retracted article. See vol. 81, pg. 524, 2010)	BRAIN RESEARCH BULLETIN			English	Article; Retracted Publication						Cerebral ischemia; Progesterone; Tumor necrosis factor alpha; Matrix metalloproteinase-9; Claudin5; Blood-brain barrier	TUMOR-NECROSIS-FACTOR; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSE; ARTERY OCCLUSION; FACTOR-ALPHA; CELL-DEATH; INJURY; EXPRESSION; ALLOPREGNANOLONE; EDEMA	Recent studies demonstrate that progesterone (PROG) significantly reduces cerebral edema and enhances functional recovery from traumatic brain injury (TBI) and stroke in several animal models, but its concrete mechanism is still unknown. This study was designed to investigate the inhibitory effects of PROG on inflammatory response after stroke and its influence on the structure of blood-brain barrier (BBB). In the treatment group, PROG was dissolved in 22.5% 2-hydroxypropyl-bcyclodextrin and given in a dose of 8 mg/kg by intraperitoneal injection 1 h and 6 h after permanent occlusion of middle cerebral artery (pMCAO). Additional injections of 15 mg/kg were administered subcutaneously once a day after pMCAO. The expression of tumor necrosis factor-alpha (TNF-alpha), matrix metalloproteinase-9 (MMP-9) and claudin5 was measured by western blot technique. Evan's blue extravasation and brain water content in the ipsilateral hemisphere was also detected to evaluate the permeability of BBB. Western blot analysis revealed that the expression of TNF-alpha and MMP-9 were reduced while claudin5 was up-regulated in brain tissues of PROG-treated rats. In addition, examination of BBB permeability also showed that administration of PROG significantly reduced Evan's blue extravasation and brain water content in the ipsilateral hemisphere compared to vehicle-treated rats. Our findings reveal that PROG inhibited the inflammatory response after experimental stroke and mitigated the severity of brain damage, suggesting a role for PROG in the integrity of the BBB and subsequent edema formation following cerebral ischemia. (C) 2009 Elsevier Inc. All rights reserved.	[Wang, Jianping; Jiang, Chao; Li, Xin; Liu, Chunling; Cheng, Ningning; Hao, Yujin] Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou 450014, Henan, Peoples R China	Wang, JP (corresponding author), Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou 450014, Henan, Peoples R China.	jcmd666@126.com					Abdallah Y, 2007, CARDIOVASC RES, V73, P568, DOI 10.1016/j.cardiores.2006.11.027; Begley DJ, 2003, PROG DRUG RES, V61, P39; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dziewulska D, 2003, CLIN NEUROPATHOL, V22, P35; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; GOTTSCHALL PE, 1995, J NEUROCHEM, V64, P1513; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hu ZY, 2009, CURR MED CHEM, V16, P1418, DOI 10.2174/092986709787846523; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Mani SK, 2006, MOL ENDOCRINOL, V20, P1322, DOI 10.1210/me.2005-0466; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Meistrell ME, 1997, SHOCK, V8, P341; Nawashiro H, 1997, BRAIN RES, V778, P265, DOI 10.1016/S0006-8993(97)00981-5; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schaeffer V, 2008, NEUROCHEM INT, V52, P948, DOI 10.1016/j.neuint.2008.01.010; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Shen J, 2007, EUR J PHARMACOL, V558, P88, DOI 10.1016/j.ejphar.2006.11.059; SMITH SS, 2004, CLIN J MED S, V2, pS4; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tsukita S, 1998, GENES CELLS, V3, P569, DOI 10.1046/j.1365-2443.1998.00212.x; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Xi G, 2002, ACT NEUR S, V81, P253	40	16	21	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	AUG 14	2009	79	6					426	430		10.1016/j.brainresbull.2009.05.018			5	Neurosciences	Neurosciences & Neurology	478UR	WOS:000268614400015	19477244				2021-06-18	
J	Low, D; Kuralmani, V; Ng, SK; Lee, KK; Ng, I; Ang, BT				Low, David; Kuralmani, Vellaisamy; Ng, See Kiong; Lee, Kah Keow; Ng, Ivan; Ang, Beng Ti			Prediction of Outcome Utilizing Both Physiological and Biochemical Parameters in Severe Head Injury	JOURNAL OF NEUROTRAUMA			English	Article						decision tree; head injury prediction; logistic regression; severe traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL VASOMOTOR REACTIVITY; PRESSURE; OXYGEN; TREE	Traumatic brain injury is a major socioeconomic burden, and the use of statistical models to predict outcomes after head injury can help to allocate limited health resources. Earlier prediction models analyzing admission data have been used to achieve prediction accuracies of up to 80%. Our aim was to design statistical models utilizing a combination of both physiological and biochemical variables obtained from multimodal monitoring in the neurocritical care setting as a complement to earlier models. We used decision tree and logistic regression analysis on variables including intracranial pressure (ICP), mean arterial pressure (MAP), cerebral perfusion pressure (CPP), and pressure reactivity index (PRx), as well as multimodal monitoring parameters to assess brain tissue oxygenation (PbtO(2)), and microdialysis parameters to predict outcomes based on a dichotomized Glasgow Outcome Score. Further analysis was carried out on various subgroup combinations of physiological and biochemical parameters. The reliability of the head injury models was assessed using a 10-fold cross-validation technique. In addition, the confusion matrix was also used to assess the sensitivity, specificity, and the F-ratio. In all, 2,413 time series records were extracted from 26 patients treated at our neurocritical care unit over a 1-year period. Decision tree analysis was found to be superior to logistic regression analysis in predictive accuracy of outcome. The combined use of microdialysis variables and PbtO(2), in addition to ICP, MAP, and CPP was found have the best predictive accuracy. The use of physiological and biochemical variables based on a decision tree analysis model has shown to provide an improvement in predictive accuracy compared with other previous models. The potential application is for outcome prediction in the multivariate setting of advanced multimodality monitoring, and validates the use of multimodal monitoring in the neurocritical care setting to have a potential benefit in predicting outcomes of patients with severe head injury.	[Low, David; Lee, Kah Keow; Ng, Ivan; Ang, Beng Ti] Natl Inst Neurosci, Dept Neurosurg, Singapore 308433, Singapore; [Kuralmani, Vellaisamy; Ng, See Kiong] Inst Infocomm Res, Singapore, Singapore	Ang, BT (corresponding author), Natl Inst Neurosci, Dept Neurosurg, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	beng_ti_ang@nni.com.sg			National Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [NMRC/0578/2001, NMRC/0778/2003]	This study was supported by the National Medical Research Council grants NMRC/0578/2001 and NMRC/0778/2003, awarded to Dr. Ivan Ng. We also appreciate the contributions made by our neurosurgical intensive care unit nurses to this study.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1996, NEUROTRAUMA, P779; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; JOHNSTON AJ, 2002, MICRODIALYSIS CURR O, V81, P121; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Quinlan R., 1993, C4 5 PROGRAMS MACHIN; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257	17	16	17	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1177	1182		10.1089/neu.2008.0841			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900001	19371145				2021-06-18	
J	Chapon, C; Franconi, F; Lacoeuille, F; Hindre, F; Saulnier, P; Benoit, JP; Le Jeune, JJ; Lemaire, L				Chapon, Catherine; Franconi, Florence; Lacoeuille, Franck; Hindre, Francois; Saulnier, Patrick; Benoit, Jean-Pierre; Le Jeune, Jean-Jacques; Lemaire, Laurent			Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent	MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE			English	Article						Brain; Trauma; Selectin; MRI; SPIO	EARLY ENDOTHELIAL ACTIVATION; IN-VIVO; CARBOHYDRATE INTERACTIONS; ADHESION MOLECULES; PUBLIC-HEALTH; HEAD-INJURY; MRI; INFLAMMATION; ACCUMULATION; ARTHRITIS	The aim of this work was to map E-selectin expression in a traumatic brain injury model using a newly-designed MR contrast agent. Iron cores, responsible for susceptibility effects and therefore used as T2* contrast agents, need to be coated in order to be stabilized and need to be targeted to be useful. We have designed a molecule coating composed, at one end, of bisphosphonate to ensure anchorage of the coating on the iron core and, at the other end, of Fukuda's defined heptapeptide known to target selectin binding sites. The synthesized nanoparticles were able to non-invasively target the traumatic brain lesion, inducing a specific T2* decrease of about 25% up to at least 70 min post-injection of the targeted contrast agent.	[Chapon, Catherine; Lacoeuille, Franck; Hindre, Francois; Saulnier, Patrick; Benoit, Jean-Pierre; Le Jeune, Jean-Jacques; Lemaire, Laurent] Univ Angers, UMR S646, F-49100 Angers, France; [Chapon, Catherine; Lacoeuille, Franck; Hindre, Francois; Saulnier, Patrick; Benoit, Jean-Pierre; Le Jeune, Jean-Jacques; Lemaire, Laurent] INSERM, U646, F-49100 Angers, France; [Franconi, Florence] Univ Angers, Serv Commun Anal Spect, Angers, France	Lemaire, L (corresponding author), Univ Angers, UMR S646, F-49100 Angers, France.	laurent.lemaire@univ-angers.fr	SAULNIER, Patrick/K-4271-2015; LACOEUILLE, Franck/K-4430-2015; hindre, francois/K-5613-2015; FRANCONI, Florence/K-4258-2015; LEMAIRE, Laurent/A-3100-2011; Benoit, Jean-Pierre/K-4387-2015	LACOEUILLE, Franck/0000-0002-7070-7664; FRANCONI, Florence/0000-0001-6725-0803; LEMAIRE, Laurent/0000-0002-1308-9345; BENOIT, Jean-Pierre/0000-0002-6178-7199; Hindre, Francois/0000-0002-2727-7996; Saulnier, Patrick/0000-0002-6408-3533	Fondation des Gueules Cassees, Paris, France	We would like to thank the technicians from I'animalerie Hospitalo-Universitaire d'Angers for the housing and care of the animals used in this study, Ms. Joelle Dorat for the synthesis of the nanoparticles and Dr. David Rees for editing the manuscript. This work was partly funded by a grant from la Fondation des Gueules Cassees, Paris, France.	Babes L, 1999, J COLLOID INTERF SCI, V212, P474, DOI 10.1006/jcis.1998.6053; Barber PA, 2004, ANN NEUROL, V56, P116, DOI 10.1002/ana.20162; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Beduneau A, 2008, J CONTROL RELEASE, V126, P44, DOI 10.1016/j.jconrel.2007.11.001; Boutry S, 2005, MAGN RESON MED, V53, P800, DOI 10.1002/mrm.20403; Canet-Soulas E, 2007, MAGN RESON MATER PHY, V20, P129, DOI 10.1007/s10334-007-0078-y; CHAPMAN PT, 1994, ARTHRITIS RHEUM, V37, P1752, DOI 10.1002/art.1780371207; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dardzinski BJ, 2001, MAGN RESON IMAGING, V19, P1209, DOI 10.1016/S0730-725X(01)00448-9; Franconi F, 2006, NMR BIOMED, V19, P527, DOI 10.1002/nbm.1014; Frijns CJM, 2002, STROKE, V33, P2115, DOI 10.1161/01.STR.0000021902.33129.69; Fukuda MN, 2000, CANCER RES, V60, P450; Funovics M, 2005, NEOPLASIA, V7, P904, DOI 10.1593/neo.05352; Gellissen J, 1999, MAGN RESON IMAGING, V17, P557, DOI 10.1016/S0730-725X(98)00206-9; Ham ASW, 2007, BIOTECHNOL BIOENG, V96, P596, DOI 10.1002/bit.21153; Kang HW, 2002, BIOCONJUGATE CHEM, V13, P122, DOI 10.1021/bc0155521; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kneuer C, 2006, DRUG DISCOV TODAY, V11, P1034, DOI 10.1016/j.drudis.2006.09.004; LASKY LA, 1995, ANNU REV BIOCHEM, V64, P113, DOI 10.1146/annurev.bi.64.070195.000553; Laurent S, 2004, BIOCONJUGATE CHEM, V15, P99, DOI 10.1021/bc034114m; Ley K, 2003, J EXP MED, V198, P1285, DOI 10.1084/jem.20031664; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Lythgoe MF, 1997, MAGN RESON MED, V38, P662, DOI 10.1002/mrm.1910380421; MARTENS CL, 1995, J BIOL CHEM, V270, P21129, DOI 10.1074/jbc.270.36.21129; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; MCAFEE JG, 1983, INVEST RADIOL, V18, P479, DOI 10.1097/00004424-198309000-00014; McEver RP, 1997, GLYCOCONJUGATE J, V14, P585, DOI 10.1023/A:1018584425879; Mowat P, 2007, NMR BIOMED, V20, P21, DOI 10.1002/nbm.1084; Ohshima H, 2000, J COLLOID INTERF SCI, V228, P190, DOI 10.1006/jcis.2000.6942; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Renkonen R, 2002, TRANSPLANTATION, V74, P2, DOI 10.1097/00007890-200207150-00002; Reynolds PR, 2006, RADIOLOGY, V241, P469, DOI 10.1148/radiol.2412050490; Runnels JM, 2006, MOL IMAGING, V5, P31, DOI 10.2310/7290.2006.00004; Sibson NR, 2004, MAGN RESON MED, V51, P248, DOI 10.1002/mrm.10723; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vonarbourg A, 2005, ELECTROPHORESIS, V26, P2066, DOI 10.1002/elps.200410145; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WELLER G, 2003, BIOTECHNOL BIOENG, V92, P780; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Zinn KR, 1999, ARTHRITIS RHEUM, V42, P641, DOI 10.1002/1529-0131(199904)42:4<641::AID-ANR6>3.0.CO;2-T	52	16	19	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0968-5243	1352-8661		MAGN RESON MATER PHY	Magn. Reson. Mat. Phys. Biol. Med.	JUN	2009	22	3					167	174		10.1007/s10334-008-0161-z			8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	458OG	WOS:000267032800004	19107536	Green Accepted			2021-06-18	
J	Luo, YH; Li, ZD; Liu, LX; Dong, GH				Luo, Yu-Hong; Li, Zheng-Dong; Liu, Li-Xin; Dong, Gao-Hong			Pretreatment with erythropoietin reduces hepatic ischemia-reperfusion injury	HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL			English	Article						erythropoietin; ischemia-reperfusion injury; heme oxygenase-1	TRAUMATIC BRAIN-INJURY; SICKLE-CELL-DISEASE; HEME OXYGENASE-1; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; PROTECTS; HO-1; ISCHEMIA/REPERFUSION; INDUCTION; FAILURE	BACKGROUND: During hepatectomy, a period of ischemia and restoration of the blood supply can result in hepatic ischemia-reperfusion injury (IRI). Current research indicates that erythropoietin (EPO) has a protective effect in animal models of cerebral ischemia, myocardial infarction, and renal IRI. However there is lack of research into the role of EPO in hepatic IRI. This study aimed to explore the role of EPO in hepatic IRI and its possible mechanism of action. METHODS: Thirty male Sprague-Dawley rats were divided into three groups: (1) ten rats in the experimental group were given 1000 IU/kg EPO one day before the operation; (2) ten rats in a control group were given normal saline preoperatively as a placebo; and (3) ten rats served as a sham-operated group. Hepatic IRI was induced by occluding the hepatic arteries of the three cephalad hepatic segments and the portal vein for about 45 minutes, while in the sham-operated group only laparotomy was performed. The levels of ALT and AST were tested 24 hours pre- and post-operation. All rats were sacrificed 24 hours after the operation to assess the pathologic changes in the liver and measure the expression of heme oxygenase-1 (HO-1) through Western blotting and RT-PCR. RESULTS: Hepatic IRI was markedly mitigated in the experimental group as compared with the control group. Moreover, the expression of HO-1 at the level of both transcription and protein increased prominently (P<0.05) in the experimental group. CONCLUSION: These results demonstrate that EPO can up-regulate HO-1 in liver tissues and accordingly decrease hepatic injury through its anti-inflammatory property. (Hepatobiliary Pancreat Dis Int 2009; 8: 294-299)	[Luo, Yu-Hong; Li, Zheng-Dong; Liu, Li-Xin; Dong, Gao-Hong] Jinan Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou 510630, Peoples R China	Luo, YH (corresponding author), Jinan Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou 510630, Peoples R China.	Lubuson@126.com					Alcaraz MJ, 2004, BRIT J PHARMACOL, V142, P1191, DOI 10.1038/sj.bjp.0705821; Baan C, 2004, AM J TRANSPLANT, V4, P811, DOI 10.1111/j.1600-6143.2004.00420.x; Bahlmann FH, 2004, CIRCULATION, V110, P1006, DOI 10.1161/01.CIR.0000139335.04152.F3; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Blydt-Hansen TD, 2003, J AM SOC NEPHROL, V14, P745, DOI 10.1097/01.ASN.0000050760.87113.25; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Burger D, 2009, AM J PHYSIOL-HEART C, V296, pH84, DOI 10.1152/ajpheart.00372.2008; Calo LA, 2003, INT J CLIN PHARM TH, V41, P187; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; CARLINI RG, 1995, KIDNEY INT, V47, P740, DOI 10.1038/ki.1995.113; Cerami A, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_1.8; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Gueler F, 2004, KIDNEY INT, V66, P523, DOI 10.1111/j.1523-1755.2004.761_11.x; Haller H, 1996, KIDNEY INT, V50, P481, DOI 10.1038/ki.1996.339; Kacimi R, 2000, CARDIOVASC RES, V46, P139, DOI 10.1016/S0008-6363(00)00007-9; Lipsic E, 2004, J CARDIOVASC PHARM, V44, P473, DOI 10.1097/01.fjc.0000140209.04675.c3; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Nath KA, 2004, MICROCIRCULATION, V11, P179, DOI 10.1080/10739680490278592; Nath KA, 1999, J CLIN INVEST, V104, P1485, DOI 10.1172/JCI8827; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; Ono K, 2004, ATHEROSCLEROSIS, V173, P315, DOI 10.1016/j.atherosclerosis.2003.11.021; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Sepodes B, 2006, TRANSPL INT, V19, P919, DOI 10.1111/j.1432-2277.2006.00366.x; Shimizu H, 2000, CRIT CARE MED, V28, P809, DOI 10.1097/00003246-200003000-00033; Sola A, 2005, PEDIATR RES, V57, p110R, DOI 10.1203/01.PDR.0000159571.50758.39; Takahashi T, 2004, ANTIOXID REDOX SIGN, V6, P867, DOI 10.1089/1523086041798123	28	16	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1499-3872	2352-9377		HEPATOB PANCREAT DIS	Hepatob. Pancreatic. Dis. Int.	JUN	2009	8	3					294	299					6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	457AW	WOS:000266898100011	19502171				2021-06-18	
J	Coles, JP; Cunningham, AS; Salvador, R; Chatfield, DA; Carpenter, A; Pickard, JD; Menon, DK				Coles, Jonathan P.; Cunningham, Alison S.; Salvador, Raymond; Chatfield, Doris A.; Carpenter, Adrian; Pickard, John D.; Menon, David K.			Early metabolic characteristics of lesion and nonlesion tissue after head injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cerebral blood flow; cerebral contusions; cerebral metabolism; magnetic resonance imaging; positron emission tomography; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; MAGNETIC-RESONANCE-SPECTROSCOPY; COMBINED MICRODIALYSIS; REGIONAL OXYGENATION; N-ACETYLASPARTATE; ISCHEMIA; VOLUME; DYSFUNCTION; DAMAGE	We defined lesion and structurally normal regions using magnetic resonance imaging at follow-up in patients recovering from head injury. Early metabolic characteristics in these regions of interest (ROIs) were compared with physiology in healthy volunteers. Fourteen patients with severe head injury had positron emission tomography within 72 h, and magnetic resonance imaging at 3 to 18 months after injury. Cerebral blood flow (CBF), oxygen utilization (CMRO2), and oxygen extraction fraction (OEF) were all lower in lesion ROIs, compared with nonlesion and control ROIs (P < 0.001); however, there was substantial overlap in physiology. Control ROIs showed close coupling among CBF, blood volume (CBV), and CMRO2, whereas relationships within lesion and nonlesion ROIs were abnormal. The relationship between CBF and CMRO2 generally remained coupled but the slope was reduced; that for CBF and OEF was variable; whereas that between CBF and CBV was highly variable. There was considerable heterogeneity between and within patients. Although irreversibly damaged tissue is characterized by marked derangements in physiology, a more detailed analysis shows acute changes in physiology and physiologic relationships within regions of the brain that appear structurally normal at follow-up. Such pathophysiological derangements may result in selective neuronal loss and impact on functional outcome. Journal of Cerebral Blood Flow & Metabolism (2009) 29, 965-975; doi:10.1038/jcbfm.2009.22; published online 18 March 2009	[Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Div Anaesthesia, Cambridge CB2 2QQ, England; [Coles, Jonathan P.; Cunningham, Alison S.; Salvador, Raymond; Chatfield, Doris A.; Carpenter, Adrian; Pickard, John D.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; [Salvador, Raymond] CASM, Barcelona, Spain; [Salvador, Raymond] CIBERSAM, Barcelona, Spain; [Pickard, John D.] Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England	Menon, DK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Div Anaesthesia, Box 63,Hills Rd, Cambridge CB2 2QQ, England.	dkm13@wbic.cam.ac.uk		Salvador, Raymond/0000-0001-5557-1562	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Royal College of Anaesthetists/British Journal of Anaesthesia; Academy of Medical Sciences/Health Foundation; Cambridge NIHR Biomedical Research CentreNational Institute for Health Research (NIHR); Spanish health ministryInstituto de Salud Carlos IIISpanish Government [CP07/00048]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G9439390, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	These studies were supported by the Medical Research Council, a Technology Foresight from the UK Government and by a Royal College of Anaesthetists/British Journal of Anaesthesia project grant. Dr Coles is funded by an Academy of Medical Sciences/Health Foundation Clinician Scientist award and the Cambridge NIHR Biomedical Research Centre. The contribution by Raymond Salvador was partially funded by the project CP07/00048 from the Spanish health ministry.	Alian Aymen A, 2008, J Clin Monit Comput, V22, P169, DOI 10.1007/s10877-008-9118-z; Barker PB, 2004, CLINICAL MR NEUROIMAGING: DIFFUSION, PERFUSION AND SPECTROSCOPY, P7, DOI 10.1017/CBO9780511544958.003; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bouma GJ, 1998, ACT NEUR S, V71, P272; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; GRAHAM DI, 1971, LANCET, V1, P265; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; LEBRUNGRANDIE P, 1983, ARCH NEUROL-CHICAGO, V40, P230, DOI 10.1001/archneur.1983.04050040060010; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marchal G, 1999, BRAIN, V122, P2387, DOI 10.1093/brain/122.12.2387; MARCHAL G, 1992, ARCH NEUROL-CHICAGO, V49, P1013, DOI 10.1001/archneur.1992.00530340029014; MARCOUX FW, 1982, STROKE, V13, P339, DOI 10.1161/01.STR.13.3.339; Marmarou A, 2005, ACT NEUR S, V95, P149; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Sakoh M, 2000, J NEUROSURG, V93, P647, DOI 10.3171/jns.2000.93.4.0647; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Smielewski Peter, 2002, J Clin Monit Comput, V17, P427, DOI 10.1023/A:1026293611455; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Stengel A, 2004, MAGN RESON MED, V52, P228, DOI 10.1002/mrm.20171; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	44	16	16	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2009	29	5					965	975		10.1038/jcbfm.2009.22			11	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	439PU	WOS:000265640300010	19293825	Bronze			2021-06-18	
J	Dise-Lewis, JE; Lewis, HC; Reichardt, CS				Dise-Lewis, Jeanne E.; Lewis, Hal C.; Reichardt, Charles S.			BrainSTARS: Pilot Data on a Team-Based Intervention Program for Students Who Have Acquired Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						consultation; education; family; intervention; pediatric; traumatic brain injury	YOUNG-CHILDREN; REHABILITATION; TBI; RECOMMENDATIONS; ADOLESCENTS; OUTCOMES; MODEL; CARE	Objective: To conduct and evaluate an educational/consultation program for parents and teachers of children who have acquired brain injury (ABI). Participants: Parents, regular and special educators, and related school personnel of 30 students who had ABI and serious school problems. Intervention: BrainSTARS (Brain Injury: Strategies for Teams and Re-education for Students), an individualized consultation program that includes a comprehensive manual on pediatric ABI. The intervention included 3 meetings in the school of the child identified with ABI. Design: A pre/post single group design assessed the impact of BrainSTARS on ABI-related competencies in the adult participants as well as on measures of child behaviors. Results: Significant improvement was shown in the participants' self-rated proficiency in working with children who have ABI as well as on their ratings of student performance in targeted neurodevelopmental areas. There was no significant change on standardized measures of child behavior (the Behavior Rating Inventory of Executive Functions and the Behavior Assessment System for Children). Conclusions: BrainSTARS appears to increase the competencies of parents and educators related to students who have ABI; further study of BrainSTARS' impact on student performance and capacity to produce long-standing results is called for.	[Dise-Lewis, Jeanne E.] Univ Colorado Denver, Childrens Hosp, Aurora, CO 80045 USA; [Lewis, Hal C.] Univ Colorado Denver, JFK Partners, Aurora, CO 80045 USA; [Reichardt, Charles S.] Univ Denver, Dept Psychol, Denver, CO 80208 USA	Dise-Lewis, JE (corresponding author), Univ Colorado Denver, Childrens Hosp, Box B-285,13123 E 16th Ave, Aurora, CO 80045 USA.				US Department of EducationUS Department of Education [H324M9900602003]	This study was funded by the US Department of Education Model Demonstration Projects for Children and Youth with Disabilities grant H324M9900602003. The authors thank the contributions of the entire project team, in particular those of Margaret Lohr Calvery, PhD.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; [Anonymous], 1994, DIAGNOSTIC STAT MANU, V4th; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; *BRAIN INJ RES CTR, FACT SHEET; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; CHAPMAN SB, 2007, BRAIN INJ PROF, V3, P10; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cook T. D., 2002, EXPT QUASIEXPERIMENT; Davis AS, 2004, J SCHOOL PSYCHOL, V42, P87, DOI 10.1016/j.jsp.2003.11.001; Dise-Lewis JE, 2006, BRAINSTARS BRAIN INJ; DISELEWIS JE, 2003, BRAINSTARS BRAIN INJ; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Erikson EH., 1964, CHILDHOOD SOC, V2d; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fischer K, 1994, HUMAN BEHAV DEV BRAI; Gillett J, 2004, NEUROREHABILITATION, V19, P207; Gioia G.A., 2003, BEHAV RATING INVENTO; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2006, J HEAD TRAUMA REHAB, V21, P411, DOI 10.1097/00001199-200609000-00013; Hardy P, 2002, DEV MED CHILD NEUROL, V44, P436; Hendryx P. M., 1995, J COGN REHABIL, V13, P9; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Langlois JA, 2000, TRAUMATIC BRAIN INJU; Lehr E, 1990, PSYCHOL MANAGEMENT T; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Piaget J., 1936, ORIGINS INTELLIGENCE; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; REICHARDT CS, 2004, HDB PRACTICAL PROGRA; REICHARDT CS, 2007, SCALE UP ED, V1; Reynolds C.R., 1992, BEHAV ASSESSMENT SYS; SAVAGE R, 1999, CHILDS BRAIN; Savage R. C., 1995, ED MANUAL; SZEKERES S, 1985, HEAD INJURY REHABILI; *US DEP HHS, 2006, 04064 US DEP HHS HRS; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Whyte J, 2006, J HEAD TRAUMA REHAB, V21, P99, DOI 10.1097/00001199-200603000-00003; Whyte J, 2006, J HEAD TRAUMA REHAB, V21, P97, DOI 10.1097/00001199-200603000-00001; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU	47	16	16	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2009	24	3					166	177		10.1097/HTR.0b013e3181a7ecb0			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	448HD	WOS:000266252800003	19461364				2021-06-18	
J	Manolakaki, D; Velmahos, GC; Spaniolas, K; de Moya, M; Alam, HB				Manolakaki, Dimitra; Velmahos, George C.; Spaniolas, Konstantinos; de Moya, Marc; Alam, Hasan B.			Early Magnetic Resonance Imaging Is Unnecessary In Patients With Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Magnetic resonance imaging; Traumatic brain injury; head CT scan	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY	Introduction: Computed tomography (CT) is routinely performed in traumatic brain injury (TBI). Magnetic resonance imaging (MRI) is considered more sensitive than CT for subtle abnormalities. Because CT does not always explain the posttraumatic neurologic examination, MRI is being performed with increasing frequency. Although MRI at a later stage may be of significant prognostic value, the role of early MRI is questionable. Our objective was to evaluate the role of early MRI in the initial management of patients with TBI. Methods: This is a 3-year prospective study (January 2005-December 2007) of adult patients with TBI who, in addition to CT, had MRI of the head within 48 hours of admission to the hospital. The findings from the two imaging studies were compared. The outcome was any change in management based on MRI findings. Results: We identified 123 trauma patients who had MRI within 18 hours +/- 14.5 hours of CT (median: 12 hours). In 82 (67%) patients, the findings of CT and MRI were identical. In the remaining 41 patients there were discrepancies between CT and MRI 35 patients had slight differences in the location or size of the lesions found and six had minor brain lesion detected by MRI and not CT. Compared with patients who had identical CT and MRI, those who showed differences in the two tests had higher severity of head in-jury, lower initial blood pressure, and a higher rate of intubation. Based on CT findings, 78 (63%) patients received TBI-related interventions: 8 craniotomies, 12 intracranial pressure monitoring catheters, 14 mannitol infusions, and 72 antiepileptic medications. There was no change in treatment because of MRI. Conclusion: Early MRI may be superior to CT in describing subtle TBI findings, but this information does not affect management. Head CT is the only imaging test necessary in the first 48 hours after TBI.	Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Velmahos, GC (corresponding author), 165 Cambridge St,Suite 810, Boston, MA 02114 USA.	gvelmahos@partners.org					Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Furlow Bryant, 2006, Radiol Technol, V78, P145; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hollingworth W, 2000, CLIN RADIOL, V55, P825, DOI 10.1053/crad.2000.0546; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; PITTS LH, 1991, ANN EMERG MED, V20, P1387, DOI 10.1016/S0196-0644(05)81089-3; Schuster R, 2005, AM SURGEON, V71, P701; SKLAR EML, 1992, RADIOL CLIN N AM, V30, P353; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007	12	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2009	66	4					1008	1012		10.1097/TA.0b013e31819adba2			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	431KI	WOS:000265059800011	19359907				2021-06-18	
J	Hu, K; Lo, MT; Peng, CK; Novak, V; Schmidt, EA; Kumar, A; Czosnyka, M				Hu, Kun; Lo, Men-Tzung; Peng, C. K.; Novak, Vera; Schmidt, Eric A.; Kumar, Ajay; Czosnyka, Marek			Nonlinear Pressure-Flow Relationship Is Able to Detect Asymmetry of Brain Blood Circulation Associated with Midline Shift	JOURNAL OF NEUROTRAUMA			English	Article						blood flow velocity; blood pressure oscillations; multimodal pressure flow analysis; traumatic brain injury	HEAD-INJURED PATIENTS; CEREBRAL AUTOREGULATION; TRANSCRANIAL DOPPLER; DIABETES-MELLITUS; VELOCITY; FLUCTUATIONS; ARTERIAL	Reliable and noninvasive assessment of cerebral blood flow regulation is a major challenge in acute care monitoring. This study assessed dynamics of flow regulation and its relationship to asymmetry of initial computed tomography (CT) scan using multimodal pressure flow (MMPF) analysis. Data of 27 patients (38 +/- 15 years old) with traumatic brain injury (TBI) were analyzed. Patients were selected from bigger cohort according to criteria of having midline shift on initial CT scan and intact skull (no craniotomy or bone flap). The MMPF analysis was used to extract the oscillations in cerebral perfusion pressure (CPP) and blood flow velocity (BFV) signals at frequency of artificial ventilation, and to calculate the instantaneous phase difference between CPP and BFV oscillations. Mean CPP-BFV phase difference was used to quantify pressure and flow relationship. The TBI subjects had smaller mean BP-BFV phase shifts (left, 8.7 +/- 9.6; right 10.2 +/- 8.3 MCAs, mean +/- SD) than values previously obtained in healthy subjects (left, 37.3 +/- 7.6 degrees; right, 38.0 +/- 8.9 degrees; p < 0.0001), suggesting impaired blood flow regulation after TBI. The difference in phase shift between CPP and BFV in the left and right side was strongly correlated to the midline shift (R = 0.78; p < 0.0001). These findings indicate that the MMPF method allows reliable assessment of alterations in pressure and flow relationship after TBI. Moreover, mean pressure-flow phase shift is sensitive to the displacement of midline of the brain, and may potentially serve as a marker of asymmetry of cerebral autoregulation.	[Hu, Kun; Lo, Men-Tzung; Novak, Vera] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA; [Lo, Men-Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Chungli 32054, Taiwan; [Peng, C. K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Peng, C. K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Margret & HA Rey Inst Nonlinear Dynam Med, Boston, MA 02215 USA; [Schmidt, Eric A.] Hop Pourpan, Dept Neurosurg, Toulouse, France; [Czosnyka, Marek] Addenbrookes Hosp, Acad Neurosurg Unit, Cambridge, England	Hu, K (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gerontol, 330 Brookline Ave,Stoneman 812, Boston, MA 02215 USA.	khu@bidmc.harvard.edu	Peng, Chung-Kang/N-1308-2019; huang, yuting/T-4341-2019; Peng, Chung-Kang/E-1489-2011; Hu, Kun/AAJ-1897-2020	Peng, Chung-Kang/0000-0003-3666-9833; Peng, Chung-Kang/0000-0003-3666-9833; , Kun/0000-0003-0350-3132	NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS045745]; NIH-NINDS STTRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R41NS053128-01A2]; NIH Older American Independence CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2P60 AG08812]; General Clinical Research CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [MO1-RR01302]; James S. McDonnell Foundation; Ellison Medical Foundation Senior Scholar in Aging AwardLawrence Ellison Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01EB008577]; MRC, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, ID 65883]; NSC Taiwan, ROCMinistry of Science and Technology, Taiwan [97-2627-B-008-006]; CGH [CNJRF-96CGH-NCU-A3]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U01EB008577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045745, R41NS053128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P60AG008812] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0001237, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	This study was supported by NIH-NINDS (R01-NS045745 to V.N.), NIH-NINDS STTR (grant 1R41NS053128-01A2 to V.N. in collaboration with DynaDx, Inc.), NIH Older American Independence Center (grant 2P60 AG08812), and General Clinical Research Center (GCRC; grant MO1-RR01302). C. K. P. was supported by the James S. McDonnell Foundation, the Ellison Medical Foundation Senior Scholar in Aging Award, the G. Harold and Leila Y. Mathers Charitable Foundation, the Defense Advanced Research Projects Agency, and the NIH grant U01EB008577). M. C. was supported by MRC, UK (grant G9439390, ID 65883). M. L. was supported by NSC Taiwan, ROC (Grant 97-2627-B-008-006), and joint foundation of CGH and NCU (Grant CNJRF-96CGH-NCU-A3). We especially thank Chris Peng who helped with data pre-processing and analysis.	AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Asil T, 2007, CLIN NEUROL NEUROSUR, V109, P1, DOI 10.1016/j.clineuro.2006.03.010; Chen Z, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031915; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; ENEVOLDSEN EM, 1977, ACTA NEUROL SCAND, V56, P514; Gabor D., 1946, Journal of the Institution of Electrical Engineers. III. Radio and Communication Engineering, V93, P429; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Hu K, 2008, PHYSICA A, V387, P2279, DOI 10.1016/j.physa.2007.11.052; Huang W, 1998, P NATL ACAD SCI USA, V95, P4816, DOI 10.1073/pnas.95.9.4816; JENNETT B, 1975, LANCET, V1, P480; Kumar A, 2005, J NEUROL NEUROSUR PS, V76, P1570, DOI 10.1136/jnnp.2004.059493; Lo MT, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/785243; Novak V, 1998, STROKE, V29, P1876, DOI 10.1161/01.STR.29.9.1876; Novak V, 2003, NEUROLOGY, V60, P1657, DOI 10.1212/01.WNL.0000068023.14587.06; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Steiner LA, 2003, ANESTH ANALG, V97, P572, DOI 10.1213/01.ANE.0000070234.17226.B0; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; ZWEIG MH, 1993, CLIN CHEM, V39, P561	26	16	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2009	26	2					227	233		10.1089/neu.2008.0643			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	410NS	WOS:000263585100005	19196074	Green Published, Green Accepted			2021-06-18	
J	Wostyn, P; Audenaert, K; De Deyn, PP				Wostyn, Peter; Audenaert, Kurt; De Deyn, Peter Paul			The Valsalva Maneuver and Alzheimer's Disease: Is there a link?	CURRENT ALZHEIMER RESEARCH			English	Article						Valsalva maneuver; Alzheimer's disease; Intracranial pressure; Intraocular pressure; Mechanical load; Hippocampus; Choroid plexus; Cerebral blood flow	NORMAL-PRESSURE HYDROCEPHALUS; CEREBROSPINAL-FLUID PRODUCTION; TRANSIENT GLOBAL AMNESIA; AMYLOID PRECURSOR PROTEIN; HIPPOCAMPAL-NEURONS; CHOROID-PLEXUS; NA-K-2CL COTRANSPORTER; INTRAOCULAR-PRESSURE; MECHANICAL STRETCH; CASPASE ACTIVATION	Recent research findings provide evidence for Alzheimer's disease-related changes in brain diseases, such as normal pressure hydrocephalus and traumatic brain injury, and in glaucoma at the level of the retinal ganglion cells. This is a group of diseases that affect central nervous system tissue and are characterized by elevation of intracranial or intraocular pressure and/or local shear stress and strain. This strengthens the possibility that Alzheimer-type changes in these diseases may result at least in part from exposure of central nervous system tissue to elevated mechanical load. As activities or diseases with significant Valsalva effort can generate increased intracranial pressures, we hypothesize that individuals who frequently perform strong Valsalva maneuvers (e. g., long hours of repetitive heavy lifting, sequences of blows during the playing of a wind instrument, forceful and repetitive cough, bearing-down efforts during parturition) may be more susceptible to developing Alzheimer's disease. In this paper, we discuss three hypotheses about the mechanisms by which extensive use of the Valsalva maneuver might contribute to the neuropathogenesis of Alzheimer's disease: via mechanical stress-induced events in the hippocampus and/or via changes in the secretory process of the choroid plexus and/or via hemodynamic changes in cerebral blood flow. If confirmed, this hypothesis could have implications in clinical practice.	[Wostyn, Peter] PC Sint Amandus, Dept Psychiat, B-8730 Beemem, Belgium; [Audenaert, Kurt] Ghent Univ Hosp, Dept Psychiat, B-9000 Ghent, Belgium; [De Deyn, Peter Paul] Middelheim Gen Hosp ZNA, Dept Neurol & Memory Clin, B-2020 Antwerp, Belgium; [De Deyn, Peter Paul] Univ Antwerp, Inst Born Bunge, Lab Neurochem & Behav, B-2610 Antwerp, Belgium	Wostyn, P (corresponding author), PC Sint Amandus, Dept Psychiat, Reigerlostr 10, B-8730 Beemem, Belgium.	wostyn.peter@skynet.be					ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; ATTUBATO MJ, 1994, AM J CARDIOL, V74, P408, DOI 10.1016/0002-9149(94)90417-0; Bech RA, 1999, ACTA NEUROCHIR, V141, P633, DOI 10.1007/s007010050353; BEERI MS, 2007, NEUROBIOL A IN PRESS; Bejvan SM, 1996, AM J ROENTGENOL, V166, P1041, DOI 10.2214/ajr.166.5.8615238; BORGIA JF, 1975, J OCCUP ENVIRON MED, V17, P696; Boycott HE, 2007, BIOCHEM BIOPH RES CO, V364, P100, DOI 10.1016/j.bbrc.2007.09.102; Bret P, 2002, J NEUROL NEUROSUR PS, V73, P9, DOI 10.1136/jnnp.73.1.9; Bullock R, 2003, ALZ DIS ASSOC DIS, V17, pS80, DOI 10.1097/00002093-200307003-00004; Calandre L, 1996, HEADACHE, V36, P251, DOI 10.1046/j.1526-4610.1996.3604251.x; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; COMPTON D, 1973, LANCET, V2, P1234; Cotman CW, 2005, J NEUROPATH EXP NEUR, V64, P104, DOI 10.1093/jnen/64.2.104; Czosnyka M, 2003, J NEUROSURG, V99, P206; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; de la Torre JC, 2000, ANN NY ACAD SCI, V924, P136; de Quervain DJF, 2004, HUM MOL GENET, V13, P47, DOI 10.1093/hmg/ddg361; Edwards ME, 2001, BIOTECHNOL PROGR, V17, P760, DOI 10.1021/bp010040m; Ertl-Wagner BB, 2001, EUR RADIOL, V11, P1998, DOI 10.1007/s003300100941; Fasulo L, 2000, J NEUROCHEM, V75, P624, DOI 10.1046/j.1471-4159.2000.0750624.x; Fletcher NH, 1999, J ACOUST SOC AM, V105, P874, DOI 10.1121/1.426276; Fritsch-Yelle JM, 1999, J APPL PHYSIOL, V86, P1852; Gastard MC, 2003, ANN NEUROL, V54, P393, DOI 10.1002/ana.10680; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Golomb J, 2000, J NEUROL NEUROSUR PS, V68, P778, DOI 10.1136/jnnp.68.6.778; Grant WB, 2002, J ALZHEIMERS DIS, V4, P179, DOI 10.3233/JAD-2002-4308; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; HOCHWALD GM, 1969, EXP NEUROL, V25, P190, DOI 10.1016/0014-4886(69)90043-0; Jiang G, 2004, AM J PHYSIOL-HEART C, V286, pH1552, DOI 10.1152/ajpheart.00695.2003; Johanson CE, 2002, EUR J PEDIATR SURG, V12, pS47; Johanson Conrad, 2004, Cerebrospinal Fluid Res, V1, P3, DOI 10.1186/1743-8454-1-3; JOHNSON RT, 1968, J NEUROPATH EXP NEUR, V27, P591; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kahlon B, 2002, J NEUROL NEUROSUR PS, V73, P721, DOI 10.1136/jnnp.73.6.721; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kizu O, 2001, AM J NEURORADIOL, V22, P1659; Klotzsch C, 1996, ARCH NEUROL-CHICAGO, V53, P504, DOI 10.1001/archneur.1996.00550060046014; KNUCKEY NW, 1993, BRAIN RES, V618, P313, DOI 10.1016/0006-8993(93)91282-W; Laakso MP, 1998, NEUROBIOL AGING, V19, P23, DOI 10.1016/S0197-4580(98)00006-2; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Levine DN, 1999, B MATH BIOL, V61, P875, DOI 10.1006/bulm.1999.0116; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; Matsuda H, 2001, ANN NUCL MED, V15, P85, DOI 10.1007/BF02988596; MATTLE HP, 1995, NEUROLOGY, V45, P498, DOI 10.1212/WNL.45.3.498; MAY C, 1990, NEUROLOGY, V40, P500, DOI 10.1212/WNL.40.3_Part_1.500; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Mehta NR, 2000, AM J ROENTGENOL, V175, P221, DOI 10.2214/ajr.175.1.1750221; Mielke MM, 2007, NEUROLOGY, V69, P1850, DOI 10.1212/01.wnl.0000279520.59792.fe; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nedelmann M, 2005, J NEUROL, V252, P1482, DOI 10.1007/s00415-005-0894-9; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Nixon RA, 2000, ANN NY ACAD SCI, V924, P117; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; PORTH CJM, 1984, HEART LUNG, V13, P507; Pott F, 2000, J APPL PHYSIOL, V88, P1545; Robertson NP, 1999, J NEUROL NEUROSUR PS, V66, P111, DOI 10.1136/jnnp.66.1.111; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Sander D, 2000, LANCET, V356, P1982, DOI 10.1016/S0140-6736(00)03313-4; Sander K, 2005, LANCET NEUROL, V4, P437, DOI 10.1016/S1474-4422(05)70121-6; Savolainen S, 1999, ACTA NEUROCHIR, V141, P849, DOI 10.1007/s007010050386; Sbeity ZH, 2004, GRAEF ARCH CLIN EXP, V242, P428, DOI 10.1007/s00417-003-0848-9; Schuman JS, 2000, OPHTHALMOLOGY, V107, P127, DOI 10.1016/S0161-6420(99)00015-9; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Shimohama S, 2000, APOPTOSIS, V5, P9, DOI 10.1023/A:1009625323388; Silverberg GD, 2004, BRAIN, V127, P947, DOI 10.1093/brain/awh178; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Silverberg GD, 2002, J NEUROSURG, V97, P1271, DOI 10.3171/jns.2002.97.6.1271; Silverberg GD, 2002, NEUROLOGY, V59, P1139, DOI 10.1212/01.WNL.0000031794.42077.A1; Silverberg GD, 2001, NEUROLOGY, V57, P1763, DOI 10.1212/WNL.57.10.1763; Silverberg Gerald D, 2004, Expert Rev Neurother, V4, P97, DOI 10.1586/14737175.4.1.97; SIMONEAUX SF, 1990, AM J SPORT MED, V18, P647, DOI 10.1177/036354659001800617; Singer W, 2001, CLIN SCI, V100, P433, DOI 10.1042/CS20000208; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; TIECKS FP, 1995, STROKE, V26, P1386, DOI 10.1161/01.STR.26.8.1386; Triyoso DH, 1999, J PHYSIOL-LONDON, V515, P355, DOI 10.1111/j.1469-7793.1999.355ac.x; UMEMURA A, 1992, STROKE, V23, P1163, DOI 10.1161/01.STR.23.8.1163; van Alem AP, 2001, CATHETER CARDIO INTE, V52, P110, DOI 10.1002/1522-726X(200101)52:1<110::AID-CCD1027>3.0.CO;2-Z; van Lieshout JJ, 2003, J APPL PHYSIOL, V94, P833, DOI 10.1152/japplphysiol.00260.2002; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; WILLIAMS B, 1981, ACTA NEUROCHIR, V58, P167, DOI 10.1007/BF01407124; Wostyn P, 2008, CLIN NEUROL NEUROSUR, V110, P101, DOI 10.1016/j.clineuro.2007.10.011; Zhang R, 2004, STROKE, V35, P843, DOI 10.1161/01.STR.0000120309.84666.AE; Zhao M, 2003, NEUROBIOL DIS, V14, P391, DOI 10.1016/j.nbd.2003.07.006	95	16	17	0	7	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050			CURR ALZHEIMER RES	Curr. Alzheimer Res.	FEB	2009	6	1					59	68		10.2174/156720509787313943			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	406HT	WOS:000263286300008	19199876				2021-06-18	
J	Ichihara, K; Venkatasubramanian, G; Abbas, JJ; Jung, R				Ichihara, Kazuhiko; Venkatasubramanian, Ganapriya; Abbas, James J.; Jung, Ranu			Neuromuscular electrical stimulation of the hindlimb muscles for movement therapy in a rodent model	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Isometric joint torque; Muscle recruitment and strength duration curves; Intramuscular electrodes; Joint angle measurements; Rehabilitation; Hindlimb	SPINAL-CORD-INJURY; WALKING ABILITY; LOCOMOTION; REGENERATION; RECRUITMENT; PROMOTES; RECOVERY; EXERCISE; LIMBS; SCI	Neuromuscular electrical stimulation (NMES) can provide functional movements in people after central nervous system injury. The neuroplastic effects of long-term NMES-induced repetitive limb movement are not well understood. A rodent model of neurotrauma in which NMES can be implemented may be effective for such investigations. We present a rodent model for NMES of the flexor and extensor muscles of the hip, knee, and ankle hindlimb muscles. Custom fabricated intramuscular stimulating electrodes for rodents were implanted near identified motor points of targeted muscles in ten adult, female Long Evans rats. The effects of altering NMES pulse stimulation parameters were characterized using strength duration curves, isometric joint torque recruitment curves and joint angle measures. The data indicate that short pulse widths have the advantage of producing graded torque recruitment curves when current is used as the control parameter. A stimulus frequency of 75 Hz or more produces fused contractions. The data demonstrate ability to accurately implant the electrodes and obtain selective, graded, repeatable, strong muscle contractions. Knee and ankle angular excursions comparable to those obtained in normal treadmill walking in the same rodent species can be obtained by stimulating the target muscles. joint torques (normalized to body weight) obtained were larger than those reported in the literature for small tailed therian mammals and for peak isometric ankle plantarflexion in a different rodent species. This model system could be used for investigations of NMES assisted hindlimb movement therapy. (C) 2008 Elsevier B.V. All rights reserved.	[Ichihara, Kazuhiko; Venkatasubramanian, Ganapriya; Abbas, James J.; Jung, Ranu] Ctr Adapt Neural Syst, Tempe, AZ 85287 USA; [Venkatasubramanian, Ganapriya; Abbas, James J.; Jung, Ranu] Harrington Dept Bioengn, Tempe, AZ 85287 USA; [Abbas, James J.] Banner Good Samaritan Med Ctr, Phoenix, AZ 85006 USA	Jung, R (corresponding author), Arizona State Univ, POB 874404, Tempe, AZ 85287 USA.	blomechi@yamaguchi-u.ac.jp; ganapriya@gmail.com; james.abbas@asu.edu; ranu.jung@asu.edu	Jung, Ranu/AAA-5112-2019	Jung, Ranu/0000-0003-2042-0638; Abbas, James/0000-0002-3647-7041	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HD40335]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD040335] Funding Source: NIH RePORTER	We thank Alana Labelle and Elizabeth Ashton for assistance with data collection and analysis. This work was supported by a grant from the National Institutes of Health R01-HD40335.	Al-Majed AA, 2004, CELL MOL NEUROBIOL, V24, P379, DOI 10.1023/B:CEMN.0000022770.66463.f7; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Bajd T, 1999, ARTIF ORGANS, V23, P403, DOI 10.1046/j.1525-1594.1999.06360.x; Barbeau H, 2002, BRAIN RES REV, V40, P274, DOI 10.1016/S0165-0173(02)00210-2; Beaumont E, 2004, MUSCLE NERVE, V29, P234, DOI 10.1002/mus.10539; Burke R.E., 1981, HDB PHYSL NERVOUS SY, V11, P345; Colombo G, 2000, J REHABIL RES DEV, V37, P693; CRAGO PE, 1974, ANN BIOMED ENG, V2, P252, DOI 10.1007/BF02368496; *CTR NSCIS, 2006, 2006 ANN STAT REP MO; Daly JJ, 2006, STROKE, V37, P172, DOI 10.1161/01.STR.0000195129.95220.77; DURFEE WK, 1989, IEEE T BIO-MED ENG, V36, P654, DOI 10.1109/10.32097; Ettema GJC, 1997, ANAT REC, V247, P1, DOI 10.1002/(SICI)1097-0185(199701)247:1<1::AID-AR1>3.0.CO;2-3; Field-Fote EC, 2001, ARCH PHYS MED REHAB, V82, P818, DOI 10.1053/apmr.2001.23752; Gazula VR, 2004, J COMP NEUROL, V476, P130, DOI 10.1002/cne.20204; Geremia NM, 2007, EXP NEUROL, V205, P347, DOI 10.1016/j.expneurol.2007.01.040; Gorassini M, 2000, J NEUROPHYSIOL, V83, P2002; Gramsbergen A, 1996, EXP NEUROL, V137, P34, DOI 10.1006/exnr.1996.0004; Greene EC., 1955, ANATOMY RAT; Grill W M Jr, 1996, IEEE Trans Rehabil Eng, V4, P49, DOI 10.1109/86.506402; GRILL WM, 2004, NEUROPROSTHETICS THE, P319; GRUNER J A, 1989, Journal of Rehabilitation Research and Development, V26, P1; Hesse S, 2004, SPINAL CORD, V42, P346, DOI 10.1038/sj.sc.3101595; Hicks AL, 2005, SPINAL CORD, V43, P291, DOI 10.1038/sj.sc.3101710; JUNG R, 2006, 11 ANN C INT FUNCT E, P118; Kanchiku T, 2008, J NEUROSCI METH, V167, P317, DOI 10.1016/j.jneumeth.2007.08.002; Kim SJ, 2007, J NEUROTRAUM, V24, P1288; LAN N, 1992, J BIOMECH, V25, P1075, DOI 10.1016/0021-9290(92)90043-Z; Lynskey JV, 2008, J REHABIL RES DEV, V45, P229, DOI 10.1682/JRRD.2007.03.0047; MARTIN TP, 1992, J APPL PHYSIOL, V72, P1401; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Mohr T, 1997, CALCIFIED TISSUE INT, V61, P22, DOI 10.1007/s002239900286; MUIR GD, 1995, J NEUROPHYSIOL, V74, P358; Mushahwar VK, 2000, IEEE T REHABIL ENG, V8, P11, DOI 10.1109/86.830944; NANNINI N, 1991, IEEE T BIO-MED ENG, V38, P769, DOI 10.1109/10.83589; Nash MS, 1997, ARCH PHYS MED REHAB, V78, P808, DOI 10.1016/S0003-9993(97)90192-1; Popovic MR, 2006, SPINAL CORD, V44, P143, DOI 10.1038/sj.sc.3101822; Riess J, 2001, IEEE T NEUR SYS REH, V9, P326, DOI 10.1109/7333.948462; Sheffler LR, 2007, MUSCLE NERVE, V35, P562, DOI 10.1002/mus.20758; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thota AK, 2005, J NEUROTRAUM, V22, P442, DOI 10.1089/neu.2005.22.442; VENKATASUBRAMAN.G, 2006, FUNCTIONAL ELECT STI; Venkatasubramanian G, 2005, J NEUROTRAUM, V22, P1241; Warren GL, 2004, EUR J APPL PHYSIOL, V93, P130, DOI 10.1007/s00421-004-1185-3; Witte H, 2002, J EXP BIOL, V205, P1339; WUERKER RB, 1965, J NEUROPHYSIOL, V28, P85	46	16	16	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 30	2009	176	2					213	224		10.1016/j.jneumeth.2008.09.015			12	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	398UX	WOS:000262758100023	18848960	Green Accepted			2021-06-18	
J	Anderson, SW; Wisnowski, JL; Barrash, J; Damasio, H; Tranel, D				Anderson, Steven W.; Wisnowski, Jessica L.; Barrash, Joe; Damasio, Hanna; Tranel, Daniel			Consistency of neuropsychological outcome following damage to prefrontal cortex in the first years of life	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Prefrontal; Lesion; Development; Social; History	TRAUMATIC BRAIN-INJURY; BEHAVIOR; CHILDREN; LESIONS; PREDICTORS	The consistency of neuropsychological outcome following circumscribed damage to the prefrontal cortex (PFC) in the first years of life has not been systematically investigated. On the basis of a single well-studied case, Ackerly and Benton (1948) postulated that the core profile involves development of a primary social defect in the context of generally normal intellectual abilities. We evaluated the consistency of this profile across all patients in our registry who had focal PFC damage acquired between the prenatal period and 62 months of age (N = 7). Clinical ratings based on detailed evaluations, parental ratings, and neuropsychological testing confirmed this general profile in 5 of the 7 patients. The impairments of social function were evident in early childhood and persisted into adult life. Of the 2 patients who did not fit this profile, 1 had significant social impairment in the context of broader cognitive deficits, and 1 had no significant impairment of social or intellectual function. The profile was not observed in a comparison group with childhood-onset nonfrontal lesions. These findings support the notion that focal damage to PFC in the first years of life leads to the development of substantial impairment of social competencies, albeit with some variability in outcome. Further, the findings highlight the importance of emotional dysfunction and poor behavior regulation in the development of these impairments. Our studies recapitulate and confirm the core messages set forth by Ackerly and Benton more than a half-century ago.	[Anderson, Steven W.; Barrash, Joe; Damasio, Hanna; Tranel, Daniel] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA USA; [Wisnowski, Jessica L.; Damasio, Hanna] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA; [Wisnowski, Jessica L.; Damasio, Hanna] Univ So Calif, Dornsife Cognit Neurosci Imaging Ctr, Los Angeles, CA USA	Anderson, SW (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, Benton Neuropsychol Lab, Iowa City, IA 52242 USA.	steven-anderson@uiowa.edu		Anderson, Steven/0000-0002-7364-1680; Barrash, Joseph/0000-0001-9827-0110; Tranel, Daniel/0000-0002-1338-1389	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P019632]; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA022549]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA022549] Funding Source: NIH RePORTER	Supported by National Institute of Neurological Disorders and Stroke (NINDS) P019632 and National Institute on Drug Abuse (NIDA) R01 DA022549.	ACKERLY SS, 1947, RES PUBL ASSOC RES N, V27, P479; ACKERLY SS, 1964, FRONTAL GRANULAR COR; Anderson SW, 2007, CORTEX, V43, P806, DOI 10.1016/S0010-9452(08)70508-2; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Anderson SW, 1999, NAT NEUROSCI, V2, P1032; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; DAMASIO H, 1992, ARCH NEUROL-CHICAGO, V49, P137, DOI 10.1001/archneur.1992.00530260037016; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643	15	16	18	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2009	31	2					170	179	PII 906311719	10.1080/13803390802360526			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	397FG	WOS:000262647600004	19051128	Green Accepted			2021-06-18	
J	Casanueva, FF; Castro, AI; Micic, D; Kelestimur, F; Dieguez, C				Casanueva, Felipe F.; Castro, Ana I.; Micic, Dragan; Kelestimur, Fahrettin; Dieguez, Carlos			New Guidelines for the Diagnosis of Growth Hormone Deficiency in Adults	HORMONE RESEARCH			English	Article; Proceedings Paper	40th International Symposium on Endocrinology and Metabolism	APR 23-MAY 24, 2008	Paris, FRANCE			Insulin tolerance test; Growth hormone-releasing hormone (GHRH)-arginine; Growth hormone releasing hexapeptide; Glucagon; Insulin like growth factor I	GH-RELEASING HORMONE; (GH)-RELEASING HORMONE; STIMULATION TEST; SECRETION; ARGININE; TESTS	Background: The task of diagnosing growth hormone deficiency (GHD) in adults is cumbersome because of the paucity of biological endpoints. Consequently, over the past decade different organizations have attempted to develop homogeneous criteria and methodology for worldwide use. GHD should be biochemically confirmed within an appropriate clinical context-but only if there is the intention to treat. Clinically, patients investigated for GHD should include those with signs and symptoms or a past history of hypo-thalamo-pituitary dysfunction and those with a history of cranial irradiation, tumour treatment, traumatic brain injury or subarachnoid haemorrhage. Conclusions: Subjects with >= 3 pituitary hormone deficiencies plus a low insulin-like growth factor I level do not need provocative testing. For those who must be tested, arguably the most commonly used provocative tests are the insulin tolerance test and the glucagon, GH-releasing hormone (GHRH) + arginine and GHRH + GH-releasing hexapeptide tests. Cutoffs differ across tests and results may be influenced by gender, age, body mass index and the assay reference preparation. Copyright (C) 2009 S. Karger AG, Basel	[Casanueva, Felipe F.; Castro, Ana I.] Univ Santiago, Complejo Hosp, Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr,Dept Med, Santiago De Compostela, Spain; [Dieguez, Carlos] Univ Santiago de Compostela, Sch Med, Dept Physiol, ES-15780 Santiago De Compostela, Spain; [Micic, Dragan] Univ Childrens Hosp, Dept Endocrinol, Belgrade, Serbia; [Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol, Kayseri, Turkey	Casanueva, FF (corresponding author), Univ Santiago de Compostela, Univ Hosp, Dept Med, Div Endocrine, Calle San Francisco SN,POB 563, ES-15780 Santiago De Compostela, Spain.	meffcasa@usc.es					Abs R, 2005, GROWTH HORM IGF RES, V15, P349, DOI 10.1016/j.ghir.2005.06.018; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; CASANUEVA FF, 2004, GROWTH HORMONE DEFIC, P91; Clemmons DR, 2001, HORM RES, V55, P73, DOI 10.1159/000063480; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; Gharib Hossein, 2003, Endocr Pract, V9, P64; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HOFFMAN DM, 1994, LANCET, V344, P482, DOI 10.1016/S0140-6736(94)91821-X; Jansson C, 1997, CLIN CHEM, V43, P950; JORGENSEN JOL, 1989, LANCET, V1, P1221; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; POPOVIC V, 1995, J CLIN ENDOCR METAB, V80, P942, DOI 10.1210/jc.80.3.942; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005	21	16	16	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0301-0163	1663-2826		HORM RES	Horm. Res.		2009	71			1			112	115		10.1159/000178051			4	Endocrinology & Metabolism	Endocrinology & Metabolism	395UI	WOS:000262548600025	19153519				2021-06-18	
J	Chalton, LD; McMillan, TM				Chalton, L. D.; McMillan, T. M.			Can 'partial' PTSD explain differences in diagnosis of PTSD by questionnaire self-report and interview after head injury?	BRAIN INJURY			English	Article						Post-traumatic stress disorder; head injury; trauma; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; VIETNAM VETERANS; SCALE; VALIDATION; FLASHBACKS; SURVIVORS; ERRORS	Objective: Can the concept of 'partial' PTSD explain the disparity between the relatively high incidence of PTSD found using self-report questionnaires and the relatively low incidence using structured interview? It was hypothesized that self-report of greater PTSD symptom severity is associated with increased heart rate and movement when responding to questions about the traumatic event, if 'partial' PTSD is an explanation. Research design: A within participants single group design. Methods: Twenty-one adults with head injury underwent self-report (Post-traumatic Stress Disorder Scale) and interview (Clinical Assessment of PTSD) assessments of PTSD, the Traumatic Memory Interview, self-report of mood (Hospital Anxiety and Depression Scale) and cognitive assessment (Wechsler Test of Adult Reading, Auditory Verbal Learning Test, Hayling Test, Digit Symbol Test), during which heart rate and motor activity were recorded. Results: Self-report of greater PTSD symptom severity was not associated with increases in heart rate or movement during questions about the traumatic event. In fact, heart rate decreased from baseline in those with higher self-report scores for PTSD, consistent with curiosity about the traumatic event and not 'partial' PTSD. Conclusion: These preliminary findings agree with an emerging theme suggesting that, although PTSD can occur after head injury, it is easily over-diagnosed.	[Chalton, L. D.] Bridgeton Hlth Ctr, Clin Psychol, Glasgow, Lanark, Scotland; [McMillan, T. M.] Univ Glasgow, Psychol Med, Fac Med, Glasgow, Lanark, Scotland; [Chalton, L. D.] Bridgeton Hlth Ctr, Glasgow, Lanark, Scotland; [McMillan, T. M.] Univ Glasgow, Fac Med, Glasgow, Lanark, Scotland	McMillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Fac Med, 1055 Great Western Rd, Glasgow G12 OXH, Lanark, Scotland.	t.m.mcmillan@clinmed.gla.ac.uk			NHS Education Scotland	This study was completed in part fulfilment of the Doctorate in Clinical Psychology at the University of Glasgow, funded by NHS Education Scotland.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Blanchard E B, 1982, Psychiatr Q, V54, P220, DOI 10.1007/BF01064817; BLANCHARD EB, 1986, BEHAV THER, V17, P592, DOI 10.1016/S0005-7894(86)80097-1; Blanchard EB, 1999, POSTTRAUMATIC STRESS DISORDER, P248; Bryant RA, 2004, PSYCHOSOM MED, V66, P760, DOI 10.1097/01.psy.0000138121.13198.84; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Buckley TC, 2001, PSYCHOSOM MED, V63, P585, DOI 10.1097/00006842-200107000-00011; Coughlan AK, 1986, ADULT MEMORY INFORM; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Halligan SL, 2006, J TRAUMA STRESS, V19, P721, DOI 10.1002/jts.20167; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hellawell SJ, 2002, BEHAV RES THER, V40, P1143, DOI 10.1016/S0005-7967(01)00080-8; Hopper JW, 2006, J PSYCHOSOM RES, V60, P83, DOI 10.1016/j.jpsychores.2005.06.002; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; MALLOY PF, 1983, J CONSULT CLIN PSYCH, V51, P488, DOI 10.1037/0022-006X.51.4.488; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050150209110; Pitman RK, 1996, COMPR PSYCHIAT, V37, P409, DOI 10.1016/S0010-440X(96)90024-3; Sanchez-Navarro JP, 2006, INT J PSYCHOPHYSIOL, V61, P34, DOI 10.1016/j.ijpsycho.2005.10.023; Sbordone RJ, 1999, NEUROREHABILITATION, V13, P69; Shallice, 1997, HAYLING BRIXTON TEST; Stekelenburg JJ, 2002, PSYCHOPHYSIOLOGY, V39, P707, DOI 10.1111/1469-8986.3960707; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; van der Hart Onno, 2005, J Trauma Dissociation, V6, P55, DOI 10.1300/J229v06n01_04; VANDERKOLK BA, 1990, TRAUMATIC MEMO UNPUB; Veazey CH, 2004, APPL PSYCHOPHYS BIOF, V29, P51, DOI 10.1023/B:APBI.0000017863.35714.a1; Weschler D., 2001, WESCHLER TEST ADULT; WESCHLER D, 1997, WESCHLER ADULT INTEL, V3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	16	16	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	2					77	82	PII 908438598	10.1080/02699050802635273			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	403LD	WOS:000263083200001	19191086				2021-06-18	
J	Dressler, D; Pils, P				Dressler, Dominique; Pils, Peter			A qualitative study on cross-cultural communication in post-accident in-patient rehabilitation of migrant and ethnic minority patients in Austria	DISABILITY AND REHABILITATION			English	Article; Proceedings Paper	International Conference on Toward Culturally Responsive Disability Services	OCT, 2008	Niagara Fall, NY	Natl Inst Disabil & Rehabil Res, US Dept Educ		Post-accident rehabilitation; migrant; ethnic minority; cross-cultural communication; language; culture; Austria	TRAUMATIC BRAIN-INJURY; HEALTH-CARE	Purpose. The objective of this study was to examine how the staff of a post-accident in-patient rehabilitation centre in Austria perceived cross-cultural communication between the staff and migrant and ethnic minority patients. Methods. A qualitative study was conducted with 28 semi-structured expert interviews with staff members in a post-accident in-patient rehabilitation centre in Austria. The interviews were conducted along the pathway of rehabilitation. Results. Migrant and ethnic minority patients constitute about one-third of the patients, and often speak little or no German. Staff members (apart from those with migrant/ethnic minority origin) do not speak the languages of the majority of migrant and ethnic minority patients. The language barriers affect the whole rehabilitation process. The staff is unsure whether patients understand; it is difficult to explain the aim of therapies or rehabilitation, and therapies therefore hampered or impossible. To overcome these barriers, non-trained persons are used as interpreters, but the resulting communication is often perceived as unsatisfactory. External professional interpreters are used rarely because they are costly and difficult to organise. Cultural aspects also affect cross-cultural communication. Aspects mostly relating to daily life are dealt with in a pragmatic way. However, cultural aspects directly impacting rehabilitation, and particularly pain behaviour, are seen as more difficult to deal with. Conclusions. Effective and intensive communication between the individual patient and the rehabilitation team is essential for the outcome of rehabilitation, as patients must undertake their own rehabilitation and the rehabilitation team must be able to investigate the objectives, views and dreams of the individual patient to establish rehabilitation objectives in keeping with the patient's wishes.	[Dressler, Dominique] Austrian Workers Compensat Board AUVA, Dept Int Relat, A-1200 Vienna, Austria	Dressler, D (corresponding author), Austrian Workers Compensat Board AUVA, Dept Int Relat, Adalbert Stifter Str 65, A-1200 Vienna, Austria.	dominique.dressler@auva.at					*ALLG UNF, WE CAR YOUR SAF; Anderson LM, 2003, AM J PREV MED, V24, P68, DOI 10.1016/S0749-3797(02)00657-8; [Anonymous], AMSTERDAM DECLARATIO; *AUSTR MUS SOC EC, 2008, WELL INS SOC SEC AUS; Bischoff A, 2003, CARING MIGRANT MINOR; Bogner A., 2005, EXPERTENINTERVIEW TH, P33; BOLLPALIEVSKAYA D, 2005, DTSCH ARZTEBLATT, V102; Borbasi S, 2008, DISABIL REHABIL, V30, P837, DOI 10.1080/09638280701419359; BORDE T, THESIS TU BERLIN; Bowen S, 2001, LANGUAGE BARRIERS AC; BRUNS M, 2004, ERGOTHERAPIE REHABIL, V8, P6; *BUND GES FRAU, 2005, INT KOMP GES; *COLL NURS ONT, 2005, CULT SENS CAR; *COUNC EUR REC, 2006, 18 COMM MIN MEMB STA; CRABTREE JL, 2006, CULTURE REHABILITATI, P1; *CROSS CULT HLTH C, MOD INT SERV; CSITKOVICS M, 1997, GESUNDHEITLICHE SITU; DOWNING B, 2002, MODELS PROVISION LAN; Drei<ss>ig V, 2005, INTERKULTURELLE KOMM; EICHBAUER H, 2004, GELEBTE INTEGRATION; Elderkin-Thompson V, 2001, SOC SCI MED, V52, P1343, DOI 10.1016/S0277-9536(00)00234-3; ELLIOT T, 2000, PHYS MED REHABILITAT, P1820; Esser H., 2006, SPRACHE INTEGRATION; Groce NE., 1999, CROSS CULTURAL REHAB, P37; Helman C., 1986, CULTURE HLTH ILLNESS; *INT FRAU DSCH, MARH MUSL UNS SPIT; JACOBS B, 1995, J ROY SOC MED, V88, P474; JENNINGS B, 1993, AM J PHYS MED REHABI, V72, P25; Juckett G, 2005, AM FAM PHYSICIAN, V72, P2267; KELLY N, 2007, ATA CHRONICLE, V6, P18; KENTENICH H, 2001, MIGRATION GESUNDHEIT, P121; KOHNEN N, 2003, SCHMERZLICHKEIT SCHM; KREPLER R, 2002, RECHT KRANKENHAUSALL; Kvaren C, 2004, ADV PHYSIOTHER, V6, P2; Mead H., 2008, RACIAL ETHNIC DISPAR; Meuser M., 2005, EXPERTENINTERVIEW TH, P257; Meuser M., 2005, EXPERTENINTERVIEW TH, P71; Moffett Jennifer A. Klaber, 1997, Physiotherapy Theory and Practice, V13, P89; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; Niemeier JP, 2003, ARCH PHYS MED REHAB, V84, P1240, DOI 10.1016/S0003-9993(03)00295-8; Normann T, 2004, HOLISTIC APPROACH RE; POCHHACKER F, 1997, KOMMUNIKATION NICHTD; POCHHACKER F, 1999, TRANSLATOR, V5, P161, DOI DOI 10.1080/13556509.1999; Saladin P, 2006, DIVERSITAT CHANCENGL; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; SMART J, 1995, J REHABIL, P14; USKE H, 2001, RISIKO MIGRA TION KR; Wimmer B, 2001, WIEN KLIN WOCHENSCHR, V113, P616; Yildrim-Fahlbusch Y, 2003, DTSCH ARZTEBLATT, V5, P213; 2007, MAGISTRAT STADT WIEN	50	16	16	0	9	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2009	31	14					1181	1190		10.1080/09638280902773786			10	Rehabilitation	Rehabilitation	473MV	WOS:000268212000009	19479576				2021-06-18	
J	Erkmen, N; Taskin, H; Kaplan, T; Sanioglu, A				Erkmen, Nurtekin; Taskin, Halil; Kaplan, Turgut; Sanioglu, Ahmet			The effect of fatiguing exercise on balance performance as measured by the balance error scoring system	ISOKINETICS AND EXERCISE SCIENCE			English	Article						Balance; BESS; exertion; fatigue; treadmill	UNILATERAL POSTURAL CONTROL; HEALTHY-SUBJECTS; MUSCLE FATIGUE; PERCEIVED EXERTION; STANDING BALANCE; SPONTANEOUS-SWAY; STABILITY; CONCUSSION; RELIABILITY; DEFICITS	The aim of the study was to investigate whether a fatiguing exercise on treadmill affects balance performance in recreationally active men and women. Nineteen subjects, aged 18-26 years, were assessed before and after a fatiguing exercise, using the Balance Error Scoring System (BESS). Fatiguing exercise was performed on treadmill using the Bruce protocol. A significant effect of fatigue was present in men ( P < 0.05) and women ( P < 0.05). Women performed at a significantly lower total BESS scores than men at both pretest ( P < 0.05) and posttest ( P < 0.05). The mean difference (posttest-pretest) between men and women was not significant ( P > 0.05). These findings suggest that a fatiguing exercise induced by means of treadmill increases postural sway in healthy subjects, and that this increase in postural sway is sex-independent.	[Erkmen, Nurtekin; Taskin, Halil; Kaplan, Turgut; Sanioglu, Ahmet] Selcuk Univ, Sch Phys Educ & Sport, TR-42079 Konya, Turkey	Taskin, H (corresponding author), Selcuk Univ, Sch Phys Educ & Sport, Alaaddin Keykubat Kampusu, TR-42079 Konya, Turkey.	htaskin@selcuk.edu.tr	Erkmen, Nurtekin/L-2341-2018	Erkmen, Nurtekin/0000-0002-5220-887X			Adlerton AK, 1996, SCAND J MED SCI SPOR, V6, P211; Arnold BL, 1998, J ATHL TRAINING, V33, P323; BALESTRA C, 1992, ELECTROEN CLIN NEURO, V85, P46, DOI 10.1016/0168-5597(92)90101-G; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BROOKS GA, 1996, EXERCISE PHYSL; Bruce RA, 1972, HDB PHYS; COLLEDGE NR, 1994, GERONTOLOGY, V40, P273, DOI 10.1159/000213596; Crowell DH, 2001, J ATHL TRAIN S2, V36, P33; Davidson BS, 2004, EUR J APPL PHYSIOL, V93, P183, DOI 10.1007/s00421-004-1195-1; EKDAHL C, 1989, SCAND J REHABIL MED, V21, P187; Era P, 1996, J GERONTOL A-BIOL, V51, pM53, DOI 10.1093/gerona/51A.2.M53; Erkmen N, 2007, SPORMETRE, VV, P115; Gioftsidou A, 2006, EUR J APPL PHYSIOL, V96, P659, DOI 10.1007/s00421-005-0123-3; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Gribble PA, 2004, J ATHL TRAINING, V39, P321; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hansen MS, 2000, KNEE SURG SPORT TR A, V8, P180, DOI 10.1007/s001670050211; Hoffman M, 1998, J ATHL TRAINING, V33, P319; Kinzey SJ, 1998, J ORTHOP SPORT PHYS, V27, P356, DOI 10.2519/jospt.1998.27.5.356; Lee C T, 1998, SPUMS J, V28, P125; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; Levine D, 1996, J REHABIL RES DEV, V33, P36; LUNDIN TM, 1993, J APPL BIOMECH, V9, P191, DOI 10.1123/jab.9.3.191; Mahon AD, 1997, MED SCI SPORT EXER, V29, P1332, DOI 10.1097/00005768-199710000-00009; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Matheson AJ, 1999, J VESTIBUL RES-EQUIL, V9, P261; MCCOMAS AJ, 1996, FORM FUNCTION, P230; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mihalik JP, 2008, J SPORT REHABIL, V17, P38, DOI 10.1123/jsr.17.1.38; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; NASHNER LM, 1982, J NEUROSCI, V2, P536; Onate JA, 2007, J ATHL TRAINING, V42, P446; Palmieri RM, 2003, ARCH PHYS MED REHAB, V84, P1076, DOI 10.1016/S0003-9993(03)00129-1; PANZER VP, 1995, ARCH PHYS MED REHAB, V76, P151, DOI 10.1016/S0003-9993(95)80024-7; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robertson RJ, 2000, MED SCI SPORT EXER, V32, P2120, DOI 10.1097/00005768-200012000-00024; Rogind H, 2003, CLIN PHYSIOL FUNCT I, V23, P171, DOI 10.1046/j.1475-097X.2003.00492.x; Rowe A, 1999, J ORTHOP SPORT PHYS, V29, P455, DOI 10.2519/jospt.1999.29.8.455; Rozzi SL, 1999, J ATHL TRAINING, V34, P106; Surenkok O, 2006, ISOKINET EXERC SCI, V14, P301, DOI 10.3233/IES-2006-0238; Tripp BL, 2007, J ATHL TRAINING, V42, P90; Valovich TC, 2003, J ATHL TRAINING, V38, P51; WATSON JDG, 1984, BEHAV BRAIN RES, V13, P267, DOI 10.1016/0166-4328(84)90169-4; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Wilson EL, 2006, GAIT POSTURE, V23, P348, DOI 10.1016/j.gaitpost.2005.04.005; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	53	16	16	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0959-3020	1878-5913		ISOKINET EXERC SCI	Isokinetics Exerc. Sci.		2009	17	2					121	127		10.3233/IES-2009-0343			7	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	470CN	WOS:000267950800011					2021-06-18	
J	Orgado, JM; Fernandez-Ruiz, J; Romero, J				Martinez Orgado, Jose; Fernandez-Ruiz, Javier; Romero, Julian			The endocannabinoid system in neuropathological states	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							CANNABINOID AGONIST WIN-55212; CLOSED-HEAD INJURY; PARKINSONS-DISEASE; IN-VIVO; ALZHEIMER-DISEASE; BASAL GANGLIA; CB2 RECEPTORS; BRAIN-DAMAGE; RAT MODEL; CANNABIDIOL	The endocannabinoid system (ECS) exerts important modulatory functions in the central nervous system (CNS), particularly the retrograde control of excitatory or inhibitory synapses, which enables this system to participate in the control of important neurobiological processes in healthy conditions. However, this physiological relevance acquires a maximal interest in neuropathological conditions affecting either the function or the structures of specific areas of the brain, conditions that have been associated with important changes in the activity of this modulatory system (e.g. losses of CB1 receptors (CB1R), up-regulation of CB2 receptors (CB2R), generation of endocannabinoids) that are susceptible to pharmacological adaptation. Among the group of brain disorders that have been associated with the endocannabinoid system, a special interest has been concentrated in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and ischemia. These three disorders will be reviewed here from the perspective of the types of changes experienced by the cannabinoid signalling in humans and cellular or animal models, and from a possible usefulness of certain cannabinoid compounds to alleviate symptoms and/or to delay their progression.	[Martinez Orgado, Jose; Romero, Julian] Fdn Hosp Alcorcon CIBERNED, Laboratorio Apoyo Investigac, Madrid, Spain; [Fernandez-Ruiz, Javier] Univ Complutense, Facultad Medicina, Dept Bioquim Biol Mol CIBERNED, Madrid, Spain; [Martinez Orgado, Jose; Romero, Julian] CIBERNED, Fdn Hosp Alcorcon, Lab Apoyo Invest, Madrid, Spain; [Fernandez-Ruiz, Javier] Univ Complutense, Fac Med, Dept Bioquim & Biol Mol, CIBERNED, E-28040 Madrid, Spain	Orgado, JM (corresponding author), Hosp Univ Fdn Alcorcon, Lab Apoyo Invest, C Budapest 1, Madrid 28922, Spain.	jromero@fhalcorcon.es	ROMERO PAREDES, JULIAN/F-4772-2016; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018	ROMERO, JULIAN/0000-0002-2897-606X; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604			Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3; Allam MF, 2005, NEUROL RES, V27, P206, DOI 10.1179/016164105X22057; Alvarez FJ, 2008, PEDIATR RES, V64, P653, DOI 10.1203/PDR.0b013e318186e5dd; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Carlsson A, 2002, J NEURAL TRANSM, V109, P777, DOI 10.1007/s007020200064; Carroll CB, 2004, NEUROLOGY, V63, P1245, DOI 10.1212/01.WNL.0000140288.48796.8E; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Di Monte DA, 2003, LANCET NEUROL, V2, P531; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Esposito Ennio, 2007, Expert Rev Neurother, V7, P677, DOI 10.1586/14737175.7.6.677; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Eubanks LM, 2006, MOL PHARMACEUT, V3, P773, DOI 10.1021/mp060066m; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Fernandez-Lopez D, 2007, PEDIATR RES, V62, P255, DOI 10.1203/PDR.0b013e318123fbb8; Fernandez-Lopez D, 2006, PEDIATR RES, V60, P169, DOI 10.1203/01.pdr.0000228839.00122.6c; Fernandez-Ruiz J, 2005, MIL DRUG TH, P79; Franklin A, 2003, EUR J PHARMACOL, V474, P195, DOI 10.1016/S0014-2999(03)02074-0; Galve-Roperh I, 2007, NEUROSCIENTIST, V13, P109, DOI 10.1177/1073858406296407; Garcia-Arencibia M, 2007, BRAIN RES, V1134, P162, DOI 10.1016/j.brainres.2006.11.063; GARCIAARENCIBIA M, 2009, CURRENT DRU IN PRESS; GARCIAARENCIBIA M, 2009, J NEURAL TR IN PRESS; GLASS M, 1993, NEUROSCIENCE, V56, P523, DOI 10.1016/0306-4522(93)90352-G; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Jimenez-Del-Rio M, 2008, NEUROSCI RES, V61, P404, DOI 10.1016/j.neures.2008.04.011; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.3.CO;2-G; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Lastres-Becker I, 2005, NEUROBIOL DIS, V19, P96, DOI 10.1016/j.nbd.2004.11.009; Lastres-Becker I, 2001, EUR J NEUROSCI, V14, P1827, DOI 10.1046/j.0953-816x.2001.01812.x; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1007/BF03206570; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Martinez-Orgado J, 2003, MOL BRAIN RES, V114, P132, DOI 10.1016/S0169-328X(03)00163-3; Martinez-Orgado Jose, 2007, Recent Pat CNS Drug Discov, V2, P131; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Molina-Holgado F, 2003, J NEUROSCI, V23, P6470; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Olanow CW, 2007, MOVEMENT DISORD, V22, pS335, DOI 10.1002/mds.21675; Passmore MJ, 2008, INT J GERIATR PSYCH, V23, P116, DOI 10.1002/gps.1828; Pisani A, 2005, ANN NEUROL, V57, P777, DOI 10.1002/ana.20462; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Sagredo O, 2007, MOL NEUROBIOL, V36, P82, DOI 10.1007/s12035-007-0004-3; Sagredo O, 2007, EUR J NEUROSCI, V26, P843, DOI 10.1111/j.1460-9568.2007.05717.x; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sethi KD, 2002, CURR OPIN NEUROL, V15, P457, DOI 10.1097/00019052-200208000-00009; Sieradzan KA, 2001, NEUROLOGY, V57, P2108, DOI 10.1212/WNL.57.11.2108; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Venderova K, 2004, MOVEMENT DISORD, V19, P1102, DOI 10.1002/mds.20111; Volicer L, 1997, INT J GERIATR PSYCH, V12, P913, DOI 10.1002/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.3.CO;2-4; Volpe JJ, 2001, NEUROLOGY NEWBORN, P331; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walther S, 2006, PSYCHOPHARMACOLOGY, V185, P524, DOI 10.1007/s00213-006-0343-1; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Zdanys K, 2008, PROG NEURO-PSYCHOPH, V32, P1362, DOI 10.1016/j.pnpbp.2008.01.008; Zhang M, 2008, NEUROSCIENCE, V152, P753, DOI 10.1016/j.neuroscience.2008.01.022; Zygmunt PM, 1999, NATURE, V400, P452	66	16	17	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.		2009	21	2					172	180	PII 910429548	10.1080/09540260902782828			9	Psychiatry	Psychiatry	435HA	WOS:000265333500010	19367511				2021-06-18	
J	Munoz-Sanchez, MA; Murillo-Cabezas, F; Cayuela-Dominguez, A; Rincon-Ferrari, MD; Amaya-Villar, R; Leon-Carrion, J				Munoz-Sanchez, M. A.; Murillo-Cabezas, F.; Cayuela-Dominguez, A.; Rincon-Ferrari, M. D.; Amaya-Villar, R.; Leon-Carrion, J.			Skull fracture, with or without clinical signs, in mTBI is an independent risk marker for neurosurgically relevant intracranial lesion: A cohort study	BRAIN INJURY			English	Article						Mild traumatic head injury; skull fracture; intracranial haemorrhagic injury; Injury Severity Score; Glasgow Coma Scale	MILD HEAD-INJURY; COMPUTED-TOMOGRAPHY; MANAGEMENT; RADIOGRAPHY; GUIDELINES; ADMISSION; TRAUMA; ADULTS; SCALE; SCORE	Primary objective: To explore the possibility of identifying skull fracture, with or without clinical signs, as a predictor of positive CT scans in mild traumatic brain injury (mTBI). Research design: Prospective cohort study, matched 1:1 for five potential confounding variables (age, sex, symptoms, mechanism of injury and extracranial trauma severity). Methods and procedures: The study was performed on patients with mTBI (Glasgow Coma Scale 15-14), with or without radiologically demonstrated skull fracture. The cohort with skull fracture included 155 patients selected from a sample of 5097 mTBI patients treated during 1998 at the Critical Care and Emergency Department of the Trauma Centre. The cohort without skull fracture was prospectively recruited from patients with mTBI treated in the same department from 2002-2005. Main outcomes and results: The percentage of patients with intracranial lesion (IL) was significantly higher in mTBI patients with skull fracture than in those without. The risk of requiring neurosurgery was 5-fold higher when skull fracture was present. Of mTBI patients with skull fracture and IL, 63.2% showed no clinical signs of bone injury. Conclusions: Skull fracture, with or without clinical signs, in mTBI patients is associated with an increased risk of neurosurgically-relevant intracranial lesion.	[Cayuela-Dominguez, A.] Virgen Rocio Univ Hosp, Res Unit, Seville, Spain; [Leon-Carrion, J.] Univ Seville, Human Neuropsychol Lab, Seville, Spain; [Munoz-Sanchez, M. A.; Murillo-Cabezas, F.; Rincon-Ferrari, M. D.; Amaya-Villar, R.] Virgen Rocio Univ Hosp, Crit Care & Emergency Dept, Seville, Spain	Munoz-Sanchez, MA (corresponding author), C Pablo Ruiz Picasso 4, Seville 41909, Spain.	angeles.munoz.sspa@juntadeandalucia.es	Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016		The Andalusian Health Service	Supported by Grant of The Andalusian Health Service.	*AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; BORZUCK P, 1995, ANN EMERG MED, V25, P731; COOPER PR, 1983, NEUROSURGERY, V13, P136, DOI 10.1227/00006123-198308000-00005; DELACEY G, 1990, BRIT J RADIOL, V63, P14, DOI 10.1259/0007-1285-63-745-14; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Graham DI, 1996, NEUROPATH APPL NEURO, V22, P505, DOI 10.1111/j.1365-2990.1996.tb01125.x; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Hutchinson PJA, 1998, J ACCID EMERG MED, V15, P84; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JENNETT B, 1980, CLIN RADIOL, V31, P463, DOI 10.1016/S0009-9260(80)80195-4; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; MACLAREN RE, 1993, ARCH EMERG MED, V10, P138; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Munoz-Sanchez M, 2005, CHILD NERV SYST, V21, P128, DOI 10.1007/s00381-004-1036-x; Munoz-Sanchez MA, 2006, STUD NEUROPSYCH DEV, P17; MUNOZSANCHEZ MA, 1997, MED INTENSIVA, V21, P378; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; TEASDALE G, 1974, LANCET, V2, P81; Viola L, 2000, ACTA NEUROCHIR, V142, P1281, DOI 10.1007/s007010070026; Yavuz MS, 2003, AM J FOREN MED PATH, V24, P339, DOI 10.1097/01.paf.0000103011.14578.c3	30	16	16	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	1					39	44	PII 906993469	10.1080/02699050802590346			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	399FY	WOS:000262787000008	19096969				2021-06-18	
J	Strandberg, T				Strandberg, Thomas			Adults with Acquired Traumatic Brain Injury: Experiences of a Changeover Process and Consequences in Everyday Life	SOCIAL WORK IN HEALTH CARE			English	Article; Proceedings Paper	5th international Conference of Social Work in Health and Mental Health	DEC 10-14, 2006	Hong Kong, PEOPLES R CHINA			traumatic brain injury; changeover process; everyday life; content analysis	REHABILITATION; DISABILITY; SELF; EPIDEMIOLOGY; NARRATIVES; PEOPLE	The purpose of this study is to illuminate the changeover process, support, and consequences experienced by adults who acquired traumatic brain injury (TBI). Fifteen persons were in-depth interviewed using a semi-structured interview guide. Data were analyzed by latent-content analysis and structured into six themes. Consequences were negative as well as positive. Significant others were important as a driving force for training and life-situation. The informants were initially satisfied with social supports but in the longer term became more critical regarding accessibility to such supports. The majority had difficulties in returning to working life after injury. The outcomes seemed to be a prolonged process, probably never-ending, which gradually became integrated as a part of life.	[Strandberg, Thomas] Univ Orebro, SIDR, SE-70215 Orebro, Sweden; [Strandberg, Thomas] Malardalen Univ, Dept Social Sci, Vasteras, Sweden	Strandberg, T (corresponding author), Univ Orebro, SIDR, SE-70215 Orebro, Sweden.	thomas.strandberg@hi.oru.se					Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; BERNER B, 2005, SAMHALLSVETENSKAPENS, P117; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Campbell M., 2000, REHABILITATION TRAUM; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Clarke E., 1996, ILLUSTRATED HIST BRA; Clarke E, 1996, HUMAN BRAIN SPINAL C; Corbin J, 1988, UNENDING WORK CARE M; Danermark B., 2002, EXPLAINING SOC CRITI; DANNEFJORD P, 2005, SAMHALLSVETENSKAPENS, P13; Dean S, 2000, PSYCHOL REP, V86, P653, DOI 10.2466/pr0.2000.86.2.653; ERIKSSON PS, 2003, J REHABIL MED, V41, P17; Eysenck M.W., 2000, COGNITIVE PSYCHOL ST; Fine M, 2005, AGEING SOC, V25, P601, DOI 10.1017/S0144686X05003600; Finset A, 2002, HODESKADE VIRKNINGER; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Freeman EA, 1997, BRAIN INJURY, V11, P143, DOI 10.1080/026990597123746; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Goldstein K., 1942, AFTEREFFECTS BRAIN I; Graham H., 1983, LABOUR LOVE WOMEN WO, P13; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gustavsson Anders., 2004, SCAND J DISABIL RES, V6, DOI [10.1080/15017410409512639, DOI 10.1080/15017410409512639]; HARRY GJ, 1992, MOL NEUROBIOL, V6, P203; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Honneth A., 1995, STRUGGLE RECOGNITION; INKMANN CM, 2001, 3008493 UMI PAC GRAD; JOHANSSON U, 2004, THESIS UMEA U; Johnson B P, 1995, J Neurosci Nurs, V27, P113; Johnson Susan, 2003, Case Manager, V14, P58, DOI 10.1067/mcm.2003.27; JUMISKO E, 2005, THESIS LULEA U TECHN; KROGSTAD JM, 2001, VAD AR FORVARVAD HJA; Kvale S, 1996, INTERVIEWS INTRO QUA; LEWINGTON P, 1996, THESIS U BRIT COLUMB; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; Luria, 1973, WORKING BRAIN INTRO; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MEAD GH, 1976, MEDVETANDET JAGET SA; MELLERGARD P, 1998, GRUNDLAGGANDE NEUROK; Morse J., 2002, READ ME 1 USERS GUID; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Nordenfelt L, 2003, DISABIL REHABIL, V25, P1075, DOI 10.1080/0963828031000137748; Nordgren C, 2003, J REHABIL MED, V35, P121, DOI 10.1080/16501970310010466; O'Leary CA, 2000, BEHAV INTERVENT, V15, P205, DOI 10.1002/1099-078X(200007/09)15:3<205::AID-BIN56>3.3.CO;2-B; OATLEY K, 1992, ANNU REV PSYCHOL, V43, P55, DOI 10.1146/annurev.ps.43.020192.000415; Oddy M, 2001, BRAIN DAM B, P287; Odman P.-J., 2004, KUNSKAPANDE METODER, P71; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; SJODEN S, 1998, SOM BRO ATT MOTA FOR; Soderback I, 1992, Disabil Rehabil, V14, P30; Stalnacke B.-M., 2005, SKALLSKADADE UMEA 20; STRANDBERG T, 2006, VUXNA FORVARVAD TRAU; *SWED RES COUNC, 2002, FORSK PRINC IN HUM S; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tham K, 2000, AM J OCCUP THER, V54, P398, DOI 10.5014/ajot.54.4.398; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Toglia J. P., 2005, COGNITION OCCUPATION, P29; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298	61	16	16	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0098-1389	1541-034X		SOC WORK HEALTH CARE	Soc. Work Health Care		2009	48	3					276	297	PII 910359364	10.1080/00981380802599240			22	Social Work	Social Work	434WD	WOS:000265303900006	19360531				2021-06-18	
J	Wei, CW; Tharmakulasingam, J; Crawley, A; Kideckel, DM; Mikulis, DJ; Bradbury, CL; Green, RE				Wei, Corie W.; Tharmakulasingam, Januthy; Crawley, Adrian; Kideckel, David M.; Mikulis, David J.; Bradbury, Cheryl L.; Green, Robin E.			Use of Diffusion-Tensor Imaging in Traumatic Spinal Cord Injury to Identify Concomitant Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Diffusion magnetic resonance imaging; Rehabilitation; Spinal cord injuries	CLOSED-HEAD-INJURY; WHITE-MATTER ABNORMALITIES; AXONAL INJURY; SPATIAL STATISTICS; VOXELWISE ANALYSIS; ANISOTROPY; DEFICITS	Objective: To characterize and differentiate cerebral white matter (WM) changes related selectively to traumatic brain injury (TBI) or spinal cord injury (SCI) in patients with SCIs in order to improve diagnostic accuracy of TBI in people with SCI. Design: Diffusion-tensor imaging (DTI)-derived fractional anisotropy (FA) data in WM tracts were compared between a healthy control and 2 patient groups. Between-subject comparisons of FA were performed using region of interest (ROI) analysis and tract-based spatial statistics. Setting: A large, urban inpatient SCI program. Participants: Three groups: SCI and concomitant TBI (SCI with TBI, n=7); SCI without TBI (SCI only, n=15); and healthy control subjects (n=12). Interventions: Not applicable. Main Outcome Measure: FA was used as a measure of cerebral WM integrity. Results: ROI analyses showed reduced FA in the genu and splenium of the corpus callosum and forceps minor in patients with SCI with TBI compared with both healthy controls and patients with SCI only. ROI analyses did not show evidence of FA differences in patients with SCI only compared with controls. Tract-based spatial statistics did not demonstrate between-group differences in FA. Conclusions: DTI is a sensitive tool to detect TBI-related WM damage in patients with SCI who have suffered concomitant TBI. No WM abnormalities on DTI could be attributed to SCI alone, although this finding should be further explored in future studies. Therefore, DTI may be a valuable tool to identify TBI in the SCI population. Further research to produce normative FA values is needed to allow identification of TBI in individual patients with SCI.	[Green, Robin E.] Toronto Rehabil Inst, Univ Ctr, Toronto, ON M5G 2A2, Canada; [Wei, Corie W.] Univ Toronto, Dept Med Imaging, Toronto, ON M5S 1A1, Canada; [Tharmakulasingam, Januthy] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 1A1, Canada; [Kideckel, David M.] Univ Toronto, Univ Hlth Network, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Crawley, Adrian; Mikulis, David J.] Univ Toronto, Toronto Western Hosp, Dept Med Imaging, Toronto, ON M5S 1A1, Canada; [Bradbury, Cheryl L.; Green, Robin E.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A1, Canada	Green, RE (corresponding author), Toronto Rehabil Inst, Univ Ctr, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	green.robin@torontorehab.on.ca	Mikulis, David J/H-5167-2019	Green, Robin/0000-0001-9451-3963; Mikulis, David/0000-0003-3956-0892	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Physicians' Services Incorporated; Ontario Mental Health Foundation [MOP-67072, 05-50, 2005-ABI-392]	Supported by the Canadian Institutes of Health Research, the Physicians' Services Incorporated, and the Ontario Mental Health Foundation (grant nos. MOP-67072, 05-50, 2005-ABI-392).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER AL, 2007, UNDERST COMPLEX SYST, P221; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BUCHANAN LE, 1987, SPINAL CORD INJURY C; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chang CW, 1998, AM J PHYS MED REHAB, V77, P118, DOI 10.1097/00002060-199803000-00007; DAMOISEAUX JS, 2008, HUMAN BRAIN MAPP; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1986, PARAPLEGIA, V24, P97, DOI 10.1038/sc.1986.13; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Focke NK, 2008, NEUROIMAGE, V40, P728, DOI 10.1016/j.neuroimage.2007.12.031; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; GENTRY LR, 1994, RADIOLOGY, V191, P1; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jacka MJ, 2007, CAN J NEUROL SCI, V34, P307, DOI 10.1017/S0317167100006727; JENNET B, 1981, MANAGEMENT HEAD INJU; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NIOGI SN, 2008, AJNR AM J NEURORADIO; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; POVOLNY MA, 1993, J REHABIL, V59, P23; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SMITH SM, 2007, P 13 ANN M ORG HUM B; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; WAXMAN SG, 2002, CLIN NEUROANATOMY; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	55	16	16	1	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2008	89	12		2			S85	S91		10.1016/j.apmr.2008.07.005			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	388DB	WOS:000261999400011	19081446				2021-06-18	
J	Perel, P; Edwards, P; Shakur, H; Roberts, I				Perel, Pablo; Edwards, Phil; Shakur, Haleema; Roberts, Ian			Use of the Oxford Handicap Scale at hospital discharge to predict Glasgow Outcome Scale at 6 months in patients with traumatic brain injury	BMC MEDICAL RESEARCH METHODOLOGY			English	Article							PLACEBO-CONTROLLED TRIAL; HEAD-INJURY; MRC CRASH; ADULTS	Background: Traumatic brain injury (TBI) is an important cause of acquired disability. In evaluating the effectiveness of clinical interventions for TBI it is important to measure disability accurately. The Glasgow Outcome Scale (GOS) is the most widely used outcome measure in randomised controlled trials (RCTs) in TBI patients. However GOS measurement is generally collected at 6 months after discharge when loss to follow up could have occurred. The objectives of this study were to evaluate the association and predictive validity between a simple disability scale at hospital discharge, the Oxford Handicap Scale (OHS), and the GOS at 6 months among TBI patients. Methods: The study was a secondary analysis of a randomised clinical trial among TBI patients (MRC CRASH Trial). A Spearman correlation was estimated to evaluate the association between the OHS and GOS. The validity of different dichotomies of the OHS for predicting GOS at 6 months was assessed by calculating sensitivity, specificity and the C statistic. Uni and multivariate logistic regression models were fitted including OHS as explanatory variable. For each model we analysed its discrimination and calibration. Results: We found that the OHS is highly correlated with GOS at 6 months (spearman correlation 0.75) with evidence of a linear relationship between the two scales. The OHS dichotomy that separates patients with severe dependency or death showed the greatest discrimination (C statistic: 84.3). Among survivors at hospital discharge the OHS showed a very good discrimination (C statistic 0.78) and excellent calibration when used to predict GOS outcome at 6 months. Conclusion: We have shown that the OHS, a simple disability scale available at hospital discharge can predict disability accurately, according to the GOS, at 6 months. OHS could be used to improve the design and analysis of clinical trials in TBI patients and may also provide a valuable clinical tool for physicians to improve communication with patients and relatives when assessing a patient's prognosis at hospital discharge.	[Perel, Pablo; Edwards, Phil; Shakur, Haleema; Roberts, Ian] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England	Perel, P (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	pablo.perel@lshtm.ac.uk; phil.edwards@lshtm.ac.uk; haleema.shakur@lshtm.ac.uk; ian.roberts@lshtm.ac.uk		Edwards, Phil/0000-0003-4431-8822; Shakur-Still, Haleema/0000-0002-6511-109X; /0000-0002-2342-301X			BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; *CRASH TRIAL COLL, 2008, BRIT MED J, V12, P12; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Edwards P, 2005, LANCET, V365, P1957; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136	9	16	17	0	3	BIOMED CENTRAL LTD	LONDON	CURRENT SCIENCE GROUP, MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1471-2288			BMC MED RES METHODOL	BMC Med. Res. Methodol.	NOV 6	2008	8								72	10.1186/1471-2288-8-72			7	Health Care Sciences & Services	Health Care Sciences & Services	391TL	WOS:000262256000001	18990202	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Kapoor, T; Altenhof, W; Howard, A; Rasico, J; Zhu, FC				Kapoor, Tanya; Altenhof, William; Howard, Andrew; Rasico, Jim; Zhu, Fuchun			Methods to mitigate injury to toddlers in near-side impact crashes	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Child safety; Rigid ISOFIX; Flexible LATCH; Numerical modeling; Head and neck injuries; Sled testing	MOTOR-VEHICLE CRASHES; CHILDREN	This research focuses on the injury potential of children seated in forward-facing child safety seats during side impact crashes in a near-side seated position. Side impact dynamic sled tests were conducted by NHTSA at Transportation Research Center Inc. (TRC) using a Hybrid III 3-year-old child dummy seated in a convertible forward/rearward child safety seat. The seat was equipped with a LATCH and a top tether and the dummy was positioned in forward-facing/near-side configuration. The test was completed using an acceleration pulse with a closing speed of 24.1 km/h, in the presence of a rigid wall and absence of a vehicle body. A fully deformable finite element model of a child restraint seat, for side impact crash investigations, has been developed which has also been previously validated for frontal and far side impacts. A numerical model utilizing a Hybrid III 3-year-old dummy, employing a similar set-up as the experimental sled test was generated and simulated using LS DYNA. The numerical model was validated by comparing the head and the chest accelerations, resultant upper and lower neck forces and moments from the experimental and numerical tests. The simulation results were observed to be in good agreement to the experimental observations. A numerical model of the near-side laboratory tests, utilizing a Q3s; child dummy, was also created for parametric studies regarding different ISOFIX configurations. Further, numerical simulations were completed for both the dummy models with rectangular and cross-shaped sections of rigid ISOFIX systems. In addition, studies were conducted to confine lateral movement of the dummy's head by adding energy absorbing foam on the side wings in the vicinity of the contact region of the CRS. It was observed that the use of rigid ISOFIX system reduced the lateral displacement of the CRS and different injury parameters. Addition of energy absorbing foam blocks was effective in further reducing the lateral displacement of the dummy's head. The lateral displacement of the head was reduced by 68 mm by using cross-shaped section ISOFIX with energy absorbing foam near the vicinity of the head of the Hybrid III 3-year-old dummy compared to the flexible LATCH configuration without foam. For the Q3s dummy, the lateral displacement of the head was reduced by 48 mm by utilizing a cross-shaped section rigid ISOFIX system with the addition of energy absorbing foam compared to the flexible LATCH configuration. (C) 2008 Elsevier Ltd. All rights reserved.	[Kapoor, Tanya; Altenhof, William] Univ Windsor, Dept Mech Automot & Mat Engn, Windsor, ON N9B 3P4, Canada; [Howard, Andrew] Hosp Sick Children, Div Orthoped Surg, Toronto, ON M5G 1X8, Canada	Altenhof, W (corresponding author), Univ Windsor, Dept Mech Automot & Mat Engn, 410 Sunset Ave, Windsor, ON N9B 3P4, Canada.	altenh1@uwindsor.ca	Howard, Andrew/C-7163-2009	Howard, Andrew/0000-0001-7226-6471			American society for testing and materials [ASTM], 2004, STAND TEST METH TENS; Arbogast KB, 2004, ACCIDENT ANAL PREV, V36, P585, DOI 10.1016/S0001-4575(03)00065-4; BENDJELLAL F, 2006, P 4 INT C PROT CHILD; CARLSON M, 2007, Q3S 3 YEARS OLD SIDE; CHARLTON J, 2003, PRELIMINARY EVALUATI, P1; *CLEPA, 2004, GRSP3519 CLEPA, P1; Eppinger R., 1999, DEV IMPROVED INJURY; Hallquist J.O., 1998, LS DYNA THEORETICAL; Howard A, 2004, J TRAUMA, V56, P1276, DOI 10.1097/01.TA.0000078883.74947.EB; KLINICH K, 2003, P 19 ESV C; *LS DYNA, 2007, LS DYNA MOD Q3S DUMM; *LS DYNA, 2000, LS DYNA MOD HYBR 3 3; *NAT HIGHW TRAFF S, 2006, 4585 NAT HIGHW TRAFF; National Board of Health and Welfare, 2005, DESCR REG NURS COMP; Newgard CD, 2005, ACCIDENT ANAL PREV, V37, P668, DOI 10.1016/j.aap.2005.03.008; Society of Automotive Engineers (SAE), 2003, SAE J211 1 INSTR I 1; *STAT CAN, 2003, MAJ CAUS DEATH; Turchi R, 2004, INT J CRASHWORTHINES, V9, P419, DOI 10.1533/ijcr.2004.0300; WANG Q, 2006, P 9 INT LS DYNA US C; WANG Q, 2006, SAE 2006 C DETR US A; Weber K., 2000, UMTRI RES REV, V31, P1; 2003, FED REG, V68, P1; 2003, READ REV BRITAX WIZA; 2002, FED REG, V67, P1	24	16	19	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2008	40	6					1880	1892		10.1016/j.aap.2008.07.008			13	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	378UN	WOS:000261349800012	19068290				2021-06-18	
J	Lange, RT; Iverson, GL; Franzen, MD				Lange, Rael T.; Iverson, Grant L.; Franzen, Michael D.			Effects of day-of-injury alcohol intoxication on neuropsychological outcome in the acute recovery period following traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Ethanol; Head injury; Cognition; Neurocognitive; Acute outcome; Risk factors	ACUTE ETHANOL INTOXICATION; GLASGOW COMA SCALE; HEAD-INJURY; SUBSTANCE-ABUSE; INDUCED NEUROTOXICITY; WHITE-MATTER; ASSOCIATION; DISRUPTION; DEFICITS; LEVEL	Some researchers have found that day-of-injury alcohol intoxication is associated with worse outcome following traumatic brain injury (TBI). The purpose of this study is to examine the effects of day-of-injury intoxication on the acute neuropsychological outcome froth TBI. Participants were 36 patients with TBI (18 sober, 18 intoxicated) matched on injury severity characteristics and demographic variables. A larger group of 146 patients (112 sober, 36 intoxicated) with TBI was also selected for analyses; not matched on injury severity or demographic variables. Patients had no history of pre-injury alcoholism and were assessed within 10 days post-injury on 13 cognitive measures. Unexpectedly, patients who were sober at the time of injury performed lower on many of the cognitive measures compared to those who were intoxicated. In contrast to the research literature, these results suggest that individuals who were intoxicated at the time of injury performed similarly, and in some cases, better than those who were sober at the time of injury. Crown Copyright (C) 2008 Published by Elsevier Ltd on behalf of National Academy of Neuropsychology. All rights reserved.	[Lange, Rael T.; Iverson, Grant L.] BC Mental Hlth & Addict Serv, Vancouver, BC V5Z 4CZ, Canada; [Lange, Rael T.; Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 4CZ, Canada	Lange, RT (corresponding author), BC Mental Hlth & Addict Serv, Suite 201,601 W Broadway, Vancouver, BC V5Z 4CZ, Canada.	rlange@bcmhs.bc.ca		Iverson, Grant/0000-0001-7348-9570			Albrecht-Anoschenko J, 2005, ZBL NEUROCHIR, V66, P59, DOI 10.1055/s-2005-836487; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Altura BM, 1999, ALCOHOL, V19, P119, DOI 10.1016/S0741-8329(99)00025-7; ALTURA BM, 1995, ALCOHOL, V12, P433, DOI 10.1016/0741-8329(95)00026-N; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Benton A., 1994, MULTILINGUAL APHASIA; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Biros MH, 1999, ACAD EMERG MED, V6, P1088, DOI 10.1111/j.1553-2712.1999.tb00109.x; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; BOMBARDIER CH, 1995, WESTERN J MED, V162, P150; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Cebere A, 2003, NEUROCHEM RES, V28, P1193, DOI 10.1023/A:1024228412198; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; ChathamShowalter PE, 1996, PSYCHOSOMATICS, V37, P285, DOI 10.1016/S0033-3182(96)71567-0; Christensen M A, 2001, J Neurosci Nurs, V33, P184; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; DANYSZ W, 1992, ALCOHOL CLIN EXP RES, V16, P499, DOI 10.1111/j.1530-0277.1992.tb01407.x; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Gururaj G, 2004, J Indian Med Assoc, V102, P157; Hall D, 2005, SCOT MED J, V50, P24, DOI 10.1177/003693300505000110; Heaton RK, 2004, REVISED COMPREHENSIV; Is M, 2005, NEUROSURG QUART, V15, P60, DOI 10.1097/01.wnq.0000152407.39871.c7; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kongs SK, 2000, WISCONSIN CARD SORTI; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lange RT, 2007, ARCH CLIN NEUROPSYCH, V22, P900; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1097/00000374-200008000-00012; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Reitan R. M., 1992, TRAIL MAKING TEST MA; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1983, REHABILITATION HEAD, P9; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Smith-Seemiller L, 1996, Appl Neuropsychol, V3, P41, DOI 10.1207/s15324826an0301_6; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; TAKADERA T, 1990, BRAIN RES, V537, P109, DOI 10.1016/0006-8993(90)90346-D; Tate PS, 1999, BRAIN INJURY, V13, P767; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; TOBIS JS, 1982, SCAND J REHABIL MED, V14, P83; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	69	16	16	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV-DEC	2008	23	7-8					809	822		10.1016/j.acn.2008.07.004			14	Psychology, Clinical; Psychology	Psychology	384QI	WOS:000261758900007	18768292	Bronze			2021-06-18	
J	Tsaousides, T; Ashman, T; Seter, C				Tsaousides, Theodore; Ashman, Teresa; Seter, Colette			The Psychological Effects of Employment After Traumatic Brain Injury: Objective and Subjective Indicators	REHABILITATION PSYCHOLOGY			English	Article						TBI; employment; traumatic brain injury; quality of life; depression	QUALITY-OF-LIFE; INDIVIDUALS; DEPRESSION; WORK; WORKPLACE; COMMUNITY; MOOD	Objectives: This study examines the effects of objective (level of engagement) and subjective (discrepancy between importance of work and the degree to which work needs are met) indicators of employment on self-reported psychological well-being, quality of life (QoL), and depression for individuals with traumatic brain injury (TBI). Design: Cross-sectional. Setting: Community-based research and training center. Participants: 317 individuals with self-reported TBI under the age of 65 were included in analysis. Main Outcome Measures: Living Life After Traumatic Brain Injury (LLATBI; 1998), Flanagan Scale of Needs (J. C. Flanagan, 1982), Beck Depression Inventory-II (BDI-II; A. T. Beck, R. Steer, & G. Brown, 1996). Results: Only 21% of the present sample experienced similar levels of pre- and postinjury employment. Multiple regressions revealed significant relationships between demographic, objective, and subjective employment indicators and perceived QoL and depression. In addition, significant increments in QoL and depression variance were accounted for by subjective indicators of employment per se. Conclusions: Subjective indicators are additional important measures when assessing the rehabilitation needs and planning treatment for individuals with TBI, as they contribute to further improvements in their QoL and mood.	[Tsaousides, Theodore; Ashman, Teresa; Seter, Colette] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA	Tsaousides, T (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1 Gustave L Levy Pl, New York, NY 10029 USA.	theodore.tsaousides@mssm.edu	Ashman, Teresa/B-1621-2013	Ashman, Teresa/0000-0003-2401-7192			Andrews F. M., 1976, SOCIAL INDICATORS WE; Beck A. T., 1996, BECK DEPRESSION INVE; BIGELOW DA, 1990, PSYCHOSOC REHABIL, V14, P94; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dijkers M., 2002, QUAL LIFE RES, V11, P672; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MICHALOS AC, 1985, SOC INDIC RES, V16, P347, DOI 10.1007/BF00333288; *NY STAT DEP LAB, WORKF IND DAT; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200	29	16	17	0	4	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2008	53	4					456	463		10.1037/a0012579			8	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	381ER	WOS:000261518900004					2021-06-18	
J	Sakoda, E; Igarashi, K; Sun, JY; Kurisu, K; Tashiro, S				Sakoda, Eiichirou; Igarashi, Kazuhiko; Sun, Jiying; Kurisu, Kaoru; Tashiro, Satoshi			Regulation of heme oxygenase-1 by transcription factor Bach1 in the mouse brain	NEUROSCIENCE LETTERS			English	Article						heme oxygenase-1; brain; transcription factor; Bach 1; cold injury model	NEURONAL APOPTOSIS; OXIDATIVE STRESS; GENETIC ABLATION; OLFACTORY-BULB; GRANULE CELLS; COLD INJURY; MICE; EXPRESSION; ADULT; INDUCTION	Oxidative stress has been implicated in tissue damage from traumatic brain injury. Heme oxygenase-1 (HO-1) is an inducible enzyme that degrades prooxidant heme to radical-scavenging biliverdin/bilirubin in order to protect cells from oxidative stress. Although HO-1 is induced after induction of brain damage, the regulatory mechanism of HO-1 in the brain is still unclear. Bach1 is a transcriptional repressor of the HO-1 gene, and plays a critical role in tissue protection from oxidative stress by reperfusion injury of the myocardium. In this study, we examined the role of Bach1 in HO-1 regulation of the various brain sites by investigating the expression of Bach1 and HO-1 in brain tissues of mice bearing Bach1-deficient (Bachl(-/-)) or wild-type (Bach1(+/+)) genes. While the expression levels of Bach1 mRNA in the olfactory bulb were significantly higher than other brain areas, those at the cortex showed the lowest activity. Bach1(-/-) mice showed significantly higher HO-1 mRNA expression levels than Bach1(+/+) mice in all brain sites studied. Moreover, higher induction of HO-1 was observed around damaged tissues after cold injury in Bach1(-/-) than Bach1(+/+) mice. Thus, Bach1 plays an important role in regulating the constitutive and inducible expression levels of HO-1 in the brain. Although a significantly higher level of HO-1 was observed in Bach1(-/-) than Bach1(+/+) mice, genetic ablation of the Bach1 gene failed to show any tissue protective effect after cold injury was inflicted on the cortex. (c) 2008 Elsevier Ireland Ltd. All rights reserved.	[Sakoda, Eiichirou] Natl Hosp Org, Kure Med Ctr, Dept Neurosurg, Hiroshima 7370023, Japan; [Sakoda, Eiichirou; Kurisu, Kaoru] Hiroshima Univ, Grad Sch Biomed Sci, Dept Neurosurg, Hiroshima 730, Japan; [Sakoda, Eiichirou; Sun, Jiying; Tashiro, Satoshi] Hiroshima Univ, RIRBM, Dept Cellular Biol, Hiroshima 730, Japan; [Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan	Sakoda, E (corresponding author), Natl Hosp Org, Kure Med Ctr, Dept Neurosurg, Aoyama chou 3-1, Hiroshima 7370023, Japan.	sakodae@kure-nh.go.jp		Igarashi, Kazuhiko/0000-0002-2470-2475	Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [20659165, 19310037] Funding Source: KAKEN		Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; IGARASHI Y, 2006, NIPPON SHOKAKIBYO GA, V103, P7; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Miwa N, 2005, J NEUROSCI, V25, P5404, DOI 10.1523/JNEUROSCI.1039-05.2005; Morita-Fujimura Y, 1999, NEUROSCI LETT, V267, P201, DOI 10.1016/S0304-3940(99)00327-4; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Omura S, 2005, GENES CELLS, V10, P277, DOI 10.1111/j.1365-2443.2005.00832.x; Ono S, 2002, J NEUROSURG, V96, P1094, DOI 10.3171/jns.2002.96.6.1094; Panahian N, 1999, J NEUROCHEM, V72, P1187; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 1999, J CLIN INVEST, V104, P59, DOI 10.1172/JCI5357; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	21	16	16	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	AUG 1	2008	440	2					160	165		10.1016/j.neulet.2008.04.082			6	Neurosciences	Neurosciences & Neurology	325XX	WOS:000257623400015	18555605				2021-06-18	
J	Zeitzer, MB; Brooks, JM				Zeitzer, Mindy B.; Brooks, J. Margo			In the Line of Fire Traumatic Brain Injury Among Iraq War Veterans	AAOHN JOURNAL			English	Article								Soldiers returning home from Iraq are experiencing an increased number of head injuries related to blasts and explosions compared to soldiers of previous conflicts. These injuries are often undetected until the soldiers return home and have difficulty functioning as they did prior to the war. It is therefore important for occupational health nurses to understand blast injury, its pathophysiology, methods for detecting traumatic brain injury, and how these soldiers can be treated.	[Brooks, J. Margo] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA					National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [1F31NR010432-01, 1F31HS010294-01]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1F31NR010432-01, 1F31HS010294-01]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR010432] Funding Source: NIH RePORTER	This manuscript was developed with financial support by grants 1F31NR010432-01 and 1F31HS010294-01 from the National Institute of Nursing Research and the Agency for Healthcare Research and Quality, respectively. The content is solely the responsibility of. the authors and does not necessarily represent the official views of the National Institute of Nursing Research, the National Institutes of Health, or the Agency for Healthcare Research and Quality.	Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDRASIK F, 1994, SEMIN NEUROL, V14, P60, DOI 10.1055/s-2008-1041060; Arlinghaus K.A., 2007, TXB TRAUMATIC BRAIN, P59; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Centers for Disease Control and Prevention, 2003, REP C MILD TBI INJ U; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; Covey CDC, 2002, J BONE JOINT SURG AM, V84A, P1221, DOI 10.2106/00004623-200207000-00022; Defense and Veterans Brain Injury Center, 2007, BLAST INJ; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; icasualties.org, 2007, IR COAL CAS COUNT; Kapoor N., 2007, TXB TRAUMATIC BRAIN, P405; Keane TM, 2000, EFFECTIVE TREATMENTS FOR PTSD, P18; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; Moore B., 2006, J EMERGENCY PRIMARY, V4; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; PACKARD RC, 1994, SEMIN NEUROL, V14, pU2; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Taylor L. A., 2007, BRAIN INJURY MED PRI, P791; TEASDALE G, 1974, LANCET, V2, P81; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR; Thurman J. D., 2007, BRAIN INJURY MED PRI, P45; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vanderploeg RD, 2000, CLIN GUIDE NEUROPSYC, P3; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906	46	16	16	0	2	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0891-0162			AAOHN J	AAOHN J.	AUG	2008	56	8					347	353		10.3928/08910162-20080801-03			7	Public, Environmental & Occupational Health; Nursing	Public, Environmental & Occupational Health; Nursing	V15BW	WOS:000207778500005	18717301				2021-06-18	
J	McGwin, G; Zoghby, JT; Griffin, R; Rue, LW				McGwin, Gerald, Jr.; Zoghby, Jonathan T.; Griffin, Russell; Rue, Loring W., III			Incidence of golf cart-related injury in the United States	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						golf; injury; incidence; epidemiology	POPULATION; SPORTS	Background: Golf carts have become a popular mode of transportation off of the links because of their small size, low maintenance, and ease of use. Case reports suggest severe, debilitating injuries as a consequence of golf cart incidents. To date, there has been no national population-based study of golf cart-related injuries. Methods: The National Electronic Injury Surveillance System identified individuals who visited participating emergency departments from January 1, 2002 to December 31, 2005 for injuries sustained as a result of golf carts. Results: An estimated 48,255 (95% confidence interval, 35,342-61,108) golf cart-related injuries occurred in the U.S. between 2002 and 2005; the injury rate was 4.14 of 100,000 population. The highest injury rates were observed in 10 to 19 year olds and those aged 80 and older. Male patients had a higher injury rate than female patients, and whites had a higher rate than blacks or Asians. Contusions/abrasions were the most common diagnosis for the hip and lower extremity region; fractures were the most common diagnosis for shoulder and upper extremity region; and intracranial injuries, including concussions, subdural hematomas, and hemorrhage, were the most common diagnosis for head and neck region. The two most common geographic settings of injuries were sports fields such as golf courses (45.0%) and places of residence (16.0%). Conclusion: The popularity of golf carts as a means of transportation calls for mandatory safety standards to be met along with implementation of available safety courses for children who will potentially be operating these vehicles.	[McGwin, Gerald, Jr.] Univ Alabama Birmingham, Dept Surg, Ctr Injury Sci, Sch Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, Sch Med,Div Gen Surg, Birmingham, AL 35294 USA	McGwin, G (corresponding author), Univ Alabama Birmingham, Dept Surg, Ctr Injury Sci, Sch Med, 120 Kracke Bldg,1922 7th Ave S, Birmingham, AL 35294 USA.	mcgwin@uab.edu					*BUY COM ED STAFF, GOLD CARS UT VEH BUY; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Dellinger AM, 2002, AM J EPIDEMIOL, V155, P234, DOI 10.1093/aje/155.3.234; ELIAS J, INSPECTION TESTING L; Gilchrist J., 2004, Morbidity and Mortality Weekly Report, V53, P447; *INS I HIGHW SAF, 2002, STATUS REPORT, V37, P4; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; *NAT GOLD FDN, MIN GOLF PART US; Passaro K T, 1996, Inj Prev, V2, P124, DOI 10.1136/ip.2.2.124; *PGA CONS MARK DEP, PROF EX FORM INT GOL; Rahimi SY, 2005, J NEUROSURG, V102, P163, DOI 10.3171/jns.2005.102.2.0163; Schroeder T., 2001, NEISS SAMPLE DESIGN; Seluga KJ, 2006, ACCIDENT ANAL PREV, V38, P1151, DOI 10.1016/j.aap.2006.04.023; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858; TUNG MY, 2000, SINGAP MED J, V10, P504; United States Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; Wang C, 2003, PHYS GUIDE ASSESSING	17	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2008	64	6					1562	1566		10.1097/TA.0b013e3181238d39			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	313MG	WOS:000256744100026	18545124				2021-06-18	
J	Batchelor, PE; Wills, TE; Hewa, AP; Porritt, MJ; Howells, DW				Batchelor, Peter Egerton; Wills, Taryn Elizabeth; Hewa, Ajith Pedru; Porritt, Michelle Julie; Howells, David William			Stimulation of axonal sprouting by trophic factors immobilized within the wound core	BRAIN RESEARCH			English	Article						sprouting; BDNF; GDNF; dopamine; scaffold; mouse	NERVE GROWTH-FACTOR; ADULT-RAT BRAIN; GUIDE NEURITE OUTGROWTH; SPINAL-CORD; NEUROTROPHIC FACTOR; PERIPHERAL-NERVE; CONCENTRATION GRADIENTS; DOPAMINE TRANSPORTER; IN-VIVO; REACTIVE ASTROCYTES	Traumatic injury to the CNS results in peri-wound sprouting without significant axonal growth beyond the lesion edge. We have previously demonstrated that dopaminergic sprouting in the injured striatum follows an increasing gradient of BDNF and GDNF expression, with sprouting ceasing at the point of maximal factor expression. Progressively more complicated associations of sprouting fibers with increasingly activated microglia and macrophages suggest these factors are localized to the cell surface. To establish whether an increased concentration of immobilized BDNF and GDNF could stimulate axonal growth beyond the lesion edge, both factors were covalently attached to 10 mu m polycarbonate microspheres. These spheres were implanted into the site of striatal injury 1 week after lesioning. A profusion of axons grew from the region of the lesion edge across the surface of the spheres. Some axons traversed the entire site of injury. Ultrastructural examination demonstrated the juxtaposition of regenerating axons to the surface of implanted spheres. CSPG immunostaining demonstrated that, in animals implanted with neurotrophin-microspheres, axonal growth was induced beyond the area of maximal CSPG reactivity. Surprisingly however, CSPG production at the wound edge was greater in control animals than those implanted with neurotrophin-microspheres. overall, we show that axonal growth can be encouraged beyond the wound edge by an elevated concentration of immobilized trophic factors. This growth occurs despite the presence of inhibitory CSPGs at the lesion edge. Axonal growth appears to be stimulated mainly via the direct effects of neurotrophins. However, there also appears to be an indirect mechanism whereby neurotrophins reduce the synthesis of CSPG at the wound edge, making the peri-wound environment more permissive. (C) 2008 Elsevier B.V. All rights reserved.	[Howells, David William] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic 3084, Australia; Univ Melbourne, Austin Hlth, Dept Neurol, Heidelberg, Vic 3084, Australia	Howells, DW (corresponding author), Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic 3084, Australia.	david.howells@unimelb.edu.au		Howells, David/0000-0002-2512-7724			ALONSO G, 1993, J NEUROSCI RES, V34, P523, DOI 10.1002/jnr.490340505; ARGIRO V, 1985, J NEUROSCI RES, V13, P149, DOI 10.1002/jnr.490130111; Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; Batchelor PE, 2000, EUR J NEUROSCI, V12, P3462, DOI 10.1046/j.1460-9568.2000.00239.x; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Batchelor PE, 2002, EUR J NEUROSCI, V15, P826, DOI 10.1046/j.1460-9568.2002.01914.x; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bresjanac M, 2000, EXP NEUROL, V164, P53, DOI 10.1006/exnr.2000.7416; CAJAL SRY, 1928, DEGENERATION REGENER, V1; CILIAX BJ, 1995, J NEUROSCI, V15, P1714; CURTIS R, 1994, NEURON, V12, P191, DOI 10.1016/0896-6273(94)90163-5; Gallo G, 1998, J NEUROSCI, V18, P5403; HAGG T, 1993, EXP NEUROL, V119, P37, DOI 10.1006/exnr.1993.1005; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; Honda S, 1999, NEUROSCI LETT, V275, P203, DOI 10.1016/S0304-3940(99)00769-7; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168; Liebl DJ, 2001, EXP NEUROL, V167, P15, DOI 10.1006/exnr.2000.7548; LONGO FM, 1983, EXP NEUROL, V81, P756, DOI 10.1016/0014-4886(83)90342-4; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Meng SZ, 1999, BRAIN RES, V843, P136, DOI 10.1016/S0006-8993(99)01933-2; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; Moon LDF, 2002, NEUROSCIENCE, V109, P101, DOI 10.1016/S0306-4522(01)00457-2; Moon LDF, 2001, NAT NEUROSCI, V4, P465; Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267; Nakajima K, 1998, GLIA, V24, P272, DOI 10.1002/(SICI)1098-1136(199811)24:3<272::AID-GLIA2>3.0.CO;2-4; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Perez NL, 1997, EXP NEUROL, V145, P196, DOI 10.1006/exnr.1997.6454; POLITIS MJ, 1982, BRAIN RES, V253, P1, DOI 10.1016/0006-8993(82)90667-9; Ramon y Cajal S, 1928, DEGENERATION REGENER, V2; RUSH RA, 1984, NATURE, V312, P364, DOI 10.1038/312364a0; Ryan AF, 2006, AUDIOL NEURO-OTOL, V11, P134, DOI 10.1159/000090686; SHULTS CW, 1995, NEUROREPORT, V6, P1109, DOI 10.1097/00001756-199505300-00009; Takeda H, 2002, N-S ARCH PHARMACOL, V366, P620, DOI 10.1007/s00210-002-0640-0; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; Trupp M, 1997, J NEUROSCI, V17, P3554; TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zheng M, 2000, J NEUROBIOL, V42, P212, DOI 10.1002/(SICI)1097-4695(20000205)42:2<212::AID-NEU5>3.3.CO;2-3	47	16	16	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAY 13	2008	1209						49	56		10.1016/j.brainres.2008.02.098			8	Neurosciences	Neurosciences & Neurology	304YK	WOS:000256144800006	18396265				2021-06-18	
J	Brewer-Smyth, K				Brewer-Smyth, Kathleen			Ethical, regulatory, and investigator considerations in prison research	ADVANCES IN NURSING SCIENCE			English	Article						ethics; prison; prisoner; regulatory; research	DEVELOPMENTAL TRAUMATOLOGY; PSYCHIATRIC-DISORDERS; WOMEN; LEGAL	Although numbers of prison inmates are increasing rapidly, limited research addresses health-related conditions prevalent in prisons. Compelling reasons exist for prison research to address high rates of psychiatric, neurological, and other health-related conditions that may precipitate or result from incarceration, high-risk behaviors, infectious disease transmission, traumatic brain injuries, and other issues related to incarceration. Prison research is critical because inmates are frequently re-incarcerated and released, posing potential risks to themselves and the community. The purpose of this article is to provide a pragmatic overview of ethical, regulatory, and investigator considerations to facilitate critically needed research with vulnerable prison populations.	Univ Delaware, Coll Hlth Sci, Sch Nursing, Newark, DE 19716 USA	Brewer-Smyth, K (corresponding author), Univ Delaware, Coll Hlth Sci, Sch Nursing, 313 McDowell Hall, Newark, DE 19716 USA.	kbsmyth@udel.edu			NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [2 P20 RR0164720-07] Funding Source: Medline		BIGBY ME, 1999, ARCH DERMATOL, V135, P477; Bland RC, 1998, INT J LAW PSYCHIAT, V21, P273, DOI 10.1016/S0160-2527(98)00005-3; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth Kathleen, 2007, J Neurosci Nurs, V39, P361; Brewer-Smyth Kathleen, 2004, Rehabil Nurs, V29, P75; BREWERSMYTH K, 2001, THESIS U PENNSYLVANN; BREWERSMYTH K, 2002, HIGH RISK BEHAV FEMA; BREWERSMYTH K, 2001, NEUROREHAB NEURAL RE, V15, P87; Byrne MW, 2005, J PROF NURS, V21, P223, DOI 10.1016/j.profnurs.2005.05.001; Campbell R, 2005, J INTERPERS VIOLENCE, V20, P127, DOI 10.1177/0886260504268604; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1259, DOI 10.1016/S0006-3223(99)00044-X; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; De Groot A S, 2001, AIDS Read, V11, P34; *DEP HLTH HUM SERV, 2007, PROT HUM SUBJ OPR 46; Drake V K, 1998, Issues Ment Health Nurs, V19, P41, DOI 10.1080/016128498249204; FISHBEIN DH, 1990, CRIMINOLOGY, V28, P27, DOI 10.1111/j.1745-9125.1990.tb01317.x; Fruhwald S, 2005, LANCET, V366, P1242, DOI 10.1016/S0140-6736(05)67327-8; Harkness JM, 1996, JAMA-J AM MED ASSOC, V276, P1672, DOI 10.1001/jama.276.20.1672; Hornblum AllenM, 1999, ACRES SKIN HUMAN EXP; Hutton HE, 2001, PSYCHIATR SERV, V52, P508, DOI 10.1176/appi.ps.52.4.508; Kalmbach KC, 2003, BEHAV SCI LAW, V21, P671, DOI 10.1002/bsl.533; Krivo J, 1999, ARCH DERMATOL, V135, P469, DOI 10.1001/archderm.135.4.469; Krivo JM, 2000, ARCH DERMATOL, V136, P1567, DOI 10.1001/archderm.136.12.1567-a; Lazzarini Z, 2000, AIDS PUBLIC POLICY J, V15, P105; Motta Robert W, 2004, Int J Emerg Ment Health, V6, P67; *NAT I HLTH, 2007, CERT CONF KIOSK; Quina Kathryn, 2007, J Trauma Dissociation, V8, P123; Teplin LA, 1996, ARCH GEN PSYCHIAT, V53, P505; *US DEP JUST BUR J, 2007, CORR STAT	30	16	16	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0161-9268	1550-5014		ADV NURS SCI	Adv. Nurs. Sci.	APR-JUN	2008	31	2					119	127		10.1097/01.ANS.0000319562.84007.22			9	Nursing	Nursing	305FY	WOS:000256164400005	18497588				2021-06-18	
J	Wirtz, SJ; Trent, RB				Wirtz, Stephen J.; Trent, Roger B.			Passive surveillance of shaken baby syndrome using hospital inpatient data	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CHILDREN; STATE	Background: The conference from which these articles came addressed the question of public health surveillance for shaken baby syndrome (SBS) and explores one component of a comprehensive SBS surveillance system that would be relatively easy to implement and maintain: passive surveillance based on hospital inpatient data. Provisional exclusion and inclusion criteria are proposed for a two-level case definition of diagnosed SBS (strict definition) and cases presumed to be SBS (broad definition). The strict SBS definition is based on the single SBS code in the ICD-9-CM (995.55). The broader presumptive SBS definition is based on research studies that have identified a pattern of diagnostic codes often considered part of the clinical diagnosis of SBS. Results: Based on 2006 analyses, California inpatient data are presented for 1998-2004. The strict SBS definition identified 366 cases over the 7 years, whereas the broader definition captured nearly 1000 cases. Annual rates show little fluctuation from the overall rate of 5.1 for strict SBS and 14.0 for broad SBS (per 100,000 children aged <2 years). Selected demographic and outcome characteristics are presented for each definition. The broad definition produces rates that are roughly comparable to those produced in careful clinical and population-based studies that also included children who died without being hospitalized. Conclusions: Despite the limitations of inpatient data, a passive surveillance system like the one proposed here can provide a critical component for a comprehensive SBS surveillance system and may be adequate for some purposes, including identifying high-risk areas or groups for intervention and monitoring trends over time.	[Wirtz, Stephen J.; Trent, Roger B.] Calif Dept Publ Hlth, Epidemiol & Prevent Injury Control Branch, Sacramento, CA 95899 USA	Wirtz, SJ (corresponding author), Calif Dept Publ Hlth, Epidemiol & Prevent Injury Control Branch, MS 7214,POB 997377, Sacramento, CA 95899 USA.	steve.wirtz@cdph.ca.gov			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [200-2005-F-14668, U81/CCU720887, U81/CCU720885] Funding Source: Medline		ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Basile KC, 2002, SEXUAL VIOLENCE SURV; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; *COUNC STAT TERR E, 2005, STAT COLL US CAUS IN; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Ellis A A, 2001, Inj Prev, V7, P316, DOI 10.1136/ip.7.4.316; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Injury Surveillance Workgroup, 2003, CONS REC US HOSP DIS; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kairys SW, 2001, PEDIATRICS, V108, P206; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WJ, 2003, CAN MED ASSOC J, V168, P155; Krug E., 2002, LANCET, P57; Leeb R. T., 2007, CHILD MALTREATMENT S; *MIN PUBL WORKS GO, 2001, JOINT STAT SHAK BAB; MINUS R, 2006, S MEAS INC INFL CHIL; *NAT CTR SHAK BAB, 2006, PREV SHAK BAB SYNDR; *NCIPC CDC, 2001, REC FRAM ECODE GROUP; *NCIPC CDC, CHILD MALTR CDC ACT; Saltzman L.E., 1999, INTIMATE PARTNER VIO; Schnitzer PG, 2008, AM J PUBLIC HEALTH, V98, P296, DOI 10.2105/AJPH.2006.087783; *STAT TERR INJ PRE, INJ SURV WORKGR; Steenkamp M, 2006, INJURY PREV, V12, P3, DOI 10.1136/ip.2006.012518; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Webster RA, 2003, AM J PREV MED, V25, P58, DOI 10.1016/S0749-3797(03)00091-6; WIRTZ S, 2005, 4 ANN INJ PREV SUMM; Zolotor Adam J, 2005, N C Med J, V66, P360	30	16	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	APR	2008	34	4		S			S134	S139		10.1016/j.amepre.2007.11.004			6	Public, Environmental & Occupational Health; Medicine, General & Internal	Public, Environmental & Occupational Health; General & Internal Medicine	279TT	WOS:000254378300007	18374263				2021-06-18	
J	Wright, DW; Clark, PL; Pentz, RD; Hertzberg, V; Kellermann, AL				Wright, David W.; Clark, Pamela L.; Pentz, Rebecca D.; Hertzberg, Vicki; Kellermann, Arthur L.			Enrolling subjects by exception from consent versus proxy consent in trauma care research	ANNALS OF EMERGENCY MEDICINE			English	Article							EMERGENCY RESEARCH CIRCUMSTANCES; ADMINISTRATIONS FINAL RULE; INFORMED-CONSENT; COMMUNITY CONSULTATION; CLINICAL-TRIAL; BRAIN-INJURY; TUSKEGEE SYPHILIS; HEMORRHAGIC-SHOCK; WAIVER; FOOD	Study objective: For clinical research, the consent process plays a critical role in protecting human subjects. In emergency research, proxy consent can impose substantial delays or even render a study infeasible if the intervention involves a highly time-sensitive treatment. The objective of this study is to compare the time required to enroll brain-injured trauma patients in a study with proxy consent versus exception from consent. Methods: We analyzed data from a clinical trial (Progesterone for Traumatic brain injury-Experimental Clinical Treatment-ProTECT) of a promising treatment for acute brain injury that used proxy consent for subject enrollment. Performance metrics using proxy consent (actual study) were compared to assumptions of what would have happened if the study had been conducted with exception from consent (hypothetical study). The total number and monthly rate of enrollees, mean time from injury to initiation of the study treatment, and number of subjects receiving unwanted treatment for any span of time were compared. Results: During the 30-month enrollment period, the actual study accrued 100 consenting subjects (3.3 per month) compared with 122 subjects (4.1 per month) for the hypothetical study. Mean time from injury to initiation of experimental treatment in the actual study was 379.2 standard deviation 118.0 minutes, approximately 6.3 hours, compared with 122 minutes in the hypothetical study. Conclusion: Exception from consent can reduce mean time from injury to initiation of study treatment of trauma patients by 4 hours or more. For a time-critical trauma care intervention, this difference may justify elaborate efforts to comply with the Final Rule.	[Wright, David W.; Clark, Pamela L.; Kellermann, Arthur L.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Hertzberg, Vicki] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Pentz, Rebecca D.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Wright, DW (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA.		Wright, David/F-1209-2013	Wright, David/0000-0002-7145-9105	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000454] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R34 NS055465, 1 RO-1 NS-39097A1] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039097, R34NS055465] Funding Source: NIH RePORTER		[Anonymous], 1991, Fed Regist, V56, P28025; [Anonymous], 1996, Fed Regist, V61, P51498; Baren JM, 1999, ACAD EMERG MED, V6, P1210, DOI 10.1111/j.1553-2712.1999.tb00135.x; Biros MH, 2003, ANN EMERG MED, V42, P550, DOI 10.1067/S0196-0644(03)00490-6; BIROS MH, 1995, JAMA-J AM MED ASSOC, V273, P1283, DOI 10.1001/jama.273.16.1283; Biros MH, 1996, ACAD EMERG MED, V3, P101, DOI 10.1111/j.1553-2712.1996.tb03395.x; Biros MH, 1998, ACAD EMERG MED, V5, P359, DOI 10.1111/j.1553-2712.1998.tb02722.x; Biros MH, 1999, ACAD EMERG MED, V6, P1272, DOI 10.1111/j.1553-2712.1999.tb00144.x; Davis Arlene M, 1998, IRB, V20, P1, DOI 10.2307/3563732; Dix ES, 2004, J INVEST MED, V52, P113, DOI 10.1136/jim-52-02-20; Ernst AA, 2005, ACAD EMERG MED, V12, P1050, DOI 10.1197/j.aem.2005.06.015; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; *I MED, 2006, FUT EM CAR US HLTH S; Kremers MS, 1999, ANN EMERG MED, V33, P224, DOI 10.1016/S0196-0644(99)70399-9; Lewis RJ, 2001, ANN EMERG MED, V38, P397, DOI 10.1067/mem.2001.118223; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McGee G, 2005, ACAD EMERG MED, V12, P1019, DOI 10.1197/j.aem.2005.07.023; Moler FW, 2004, PEDIATRICS, V114, P859, DOI 10.1542/peds.2004-1458; Mosesso VN, 2004, RESUSCITATION, V61, P29, DOI 10.1016/j.resuscitation.2003.11.016; Pape TLB, 2004, J REHABIL RES DEV, V41, P155, DOI 10.1682/JRRD.2004.02.0155; Prentice Ernest D, 1994, IRB, V16, P16, DOI 10.2307/3563576; Prentice Ernest D, 1993, IRB, V15, P1, DOI 10.2307/3563728; Saver Jeffrey L, 2007, Acad Emerg Med, V14, pe57, DOI 10.1197/j.aem.2006.11.023; SAYRE MR, 2005, NATL EMS RES AGENDA; Schmidt TA, 2003, ANN EMERG MED, V41, P79, DOI 10.1067/mem.2003.17; Shah AN, 2003, ANN EMERG MED, V41, P72, DOI 10.1067/mem.2003.14; Sloan EP, 1999, ACAD EMERG MED, V6, P1203; *US FDA, 2006, 1995S 0158 COMM DISC; Valenzuela TD, 2001, NEW ENGL J MED, V345, P689, DOI 10.1056/NEJM200108303450909; Vincent VN, 2005, ACAD EMERG MED, V12, P1031, DOI 10.1197/j.aem.2005.06.021; White RM, 2002, HASTINGS CENT REP, V32, P4, DOI 10.2307/3528121; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201	33	16	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	APR	2008	51	4					355	360		10.1016/j.annemergmed.2007.08.021			6	Emergency Medicine	Emergency Medicine	283PG	WOS:000254648000003	17933428				2021-06-18	
J	Young, AE; Wasiak, R; Webster, BS; Shayne, RGF				Young, Amanda E.; Wasiak, Radoslaw; Webster, Barbara S.; Shayne, Rebecca G. F.			Urban-rural differences in work disability after an occupational injury	SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH			English	Article						disability outcome; geographic variation; return to work; rural health; work-related injury	TRAUMATIC BRAIN-INJURIES; HEALTH; CARE; ILLNESS; CONSEQUENCES; RETURN	Objectives In comparison with their urban counterparts, people living in rural areas have been found to experience higher rates of morbidity and mortality and have inferior health outcomes after illnesses and injuries. The current study sought to determine if this trend extends to work-disability outcomes after work-related injuries. Methods This study was a retrospective cohort study using data on workers' compensation claims. Rurality was defined at the postal-code level on the basis of United States 2000 census data. Work disability was measured using the number of full days a person was off work in the 2 years following an injury. Regression analyses were used to test the association between rurality and the duration of work disability after a work-related bone fracture. Results The claimants with higher rurality experienced less work disability than those with lower rurality. This relationship remained after control for the impact of age, gender, part of body injured, occupation, and industry. Conclusions Rurality was found to be related to work disability. However, rather than being associated with more time off after an injury, as could be expected on the basis of past findings, increased rurality was found to. be associated with less time off work. The findings suggest that features of rural environments, cultures, and behavioral patterns may facilitate return to work.	[Young, Amanda E.; Wasiak, Radoslaw; Webster, Barbara S.; Shayne, Rebecca G. F.] Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA	Young, AE (corresponding author), Liberty Mutual Res Inst Safety, Ctr Disabil Res, 71 Frankland Rd, Hopkinton, MA 01748 USA.	AmandaE.Young@LibertyMutual.com	Young, Amanda/H-8851-2016	Young, Amanda/0000-0002-7288-3469			Adams CE, 2001, J NURS ADMIN, V31, P244; Blackwell TL, 2003, REHABIL COUNS BULL, V46, P54; BURTON JF, 2004, WORKERS COMPENS POLI, V4, P2; CRAFT BJ, 2001, RURAL MENTAL HLT WIN, P19; Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113; Dichraff R M, 1993, AAOHN J, V41, P491; Eberhardt MS, 2004, AM J PUBLIC HEALTH, V94, P1682, DOI 10.2105/AJPH.94.10.1682; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Hart LG, 2005, AM J PUBLIC HEALTH, V95, P1149, DOI 10.2105/AJPH.2004.042432; Hart LG, 2002, J RURAL HEALTH, V18, P211, DOI 10.1111/j.1748-0361.2002.tb00932.x; Heckman TG, 1998, AIDS CARE, V10, P365, DOI 10.1080/713612410; International Labour Office (ILO), 1990, ISCO88 ILO; John WG, 1996, INQUIRY-J HEALTH CAR, V33, P53; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Lee AH, 2003, MED J AUSTRALIA, V179, P289, DOI 10.5694/j.1326-5377.2003.tb05549.x; LEE HJ, 1993, NURS CLIN N AM, V28, P219; MAELAND JG, 1986, SCAND J SOC MED, V14, P183, DOI 10.1177/140349488601400404; Mahmud MA, 2000, J OCCUP ENVIRON MED, V42, P1178, DOI 10.1097/00043764-200012000-00012; Murphy PL, 1996, AM J IND MED, V30, P130, DOI 10.1002/(SICI)1097-0274(199608)30:2<130::AID-AJIM3>3.3.CO;2-A; Pransky G, 2001, CLIN OCCUPATIONAL EN, V1, P829; RICKETTS K, 1999, NONMETROPOLITAN HLTH, P7; Ruser JW, 1999, MON LABOR REV, V122, P11; Sanders KM, 2002, J EPIDEMIOL COMMUN H, V56, P466, DOI 10.1136/jech.56.6.466; Schlenker RE, 2002, J RURAL HEALTH, V18, P359, DOI 10.1111/j.1748-0361.2002.tb00897.x; Schootman M, 1999, BRAIN INJURY, V13, P995; U.S. Census Bureau, 2002, CENS 2000 URB RUR CL; *US BUR CENS, 2003, CENS POP HOUS 2000 S; *US OFF MAN BUDG E, 1987, STAND IND CLASS SIC; Veitch P C, 1996, Aust J Rural Health, V4, P104, DOI 10.1111/j.1440-1584.1996.tb00196.x; Wasiak Radoslaw, 2006, Work, V26, P3; Weil D, 2001, AM J IND MED, V40, P418, DOI 10.1002/ajim.1114; Young AE, 2004, DISABIL REHABIL, V26, P1013, DOI 10.1080/09638280410001702432; 1999, MMWR MORB MORTAL WKL, V48, P461	33	16	16	0	1	SCANDINAVIAN JOURNAL WORK ENVIRONMENT & HEALTH	HELSINKI	TOPELIUKSENKATU 41A, SF-00250 HELSINKI, FINLAND	0355-3140	1795-990X		SCAND J WORK ENV HEA	Scand. J. Work Environ. Health	APR	2008	34	2					158	164		10.5271/sjweh.1217			7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	306VF	WOS:000256275200010	18470437	Other Gold			2021-06-18	
J	Carlotti, APCP; Bohn, D; Matsuno, AK; Pasti, DM; Gowrishankar, M; Halperin, ML				Carlotti, A. P. C. P.; Bohn, D.; Matsuno, A. K.; Pasti, D. M.; Gowrishankar, M.; Halperin, M. L.			Indicators of lean body mass catabolism: emphasis on the creatinine excretion rate	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Article							TOTAL PARENTERAL-NUTRITION; CRITICALLY ILL CHILDREN; NITROGEN-BALANCE; ARGININE METABOLISM; INJURY; SEPSIS; ADULTS; MUSCLE; CARE; AGE	Background: The major stress response to critical illness leads to a catabolic state and loss of lean body mass. Aims: To test whether an increased rate of creatinine excretion might provide unique and timely information to monitor cell catabolism; to relate this information to balances of cell constituents (nitrogen, potassium, phosphate and magnesium); to evaluate the effectiveness of nutritional therapy to reverse this catabolic process. Design: Prospective observational study. Methods: Children with severe traumatic brain injury admitted to the paediatric critical care units of The Hospital for Sick Children, Toronto, Canada and Hospital das Clnicas, Faculty of Medicine of Ribeiro Preto, University of So Paulo, Brazil were studied. Complete 24 h urine collections were obtained for measurement of creatinine excretion rate and daily balances of nitrogen, potassium, phosphate and magnesium. Results: Seventeen patients were studied for 310 days. On Day 1, all had negative balances for protein and phosphate. Balances for these intracellular constituents became positive when protein intake was >= 1 g/kg/day and energy intake was >= 50% of estimated energy expenditure (P < 0.0001). Creatinine excretion rate was positively correlated with the urea appearance rate (r = 0.60; P < 0.0001), and negatively with protein balance (r = -0.45; P < 0.0001). Sepsis developed in four patients; before its clinical detection, there were negative balances for all intracellular markers and an abrupt rise in the excretion of creatinine. Conclusions: Negative balances of intracellular components and an increase in rate of creatinine excretion heralded the onset of catabolism.	[Carlotti, A. P. C. P.; Matsuno, A. K.; Pasti, D. M.] Univ Sao Paulo, Fac Med Ribeirao, Hosp Clin, Dept Paediat, BR-14049900 Ribeirao Preto, SP, Brazil; [Bohn, D.] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Bohn, D.] Univ Toronto, Dept Anaesthesia & Med, Toronto, ON, Canada; [Gowrishankar, M.] Univ Alberta, Stollery Childrens Hosp, Div Paediat Nephrol, Edmonton, AB, Canada; [Halperin, M. L.] Univ Toronto, St Michaels Hosp, Dept Nephrol, Toronto, ON M5B 1W8, Canada	Carlotti, APCP (corresponding author), Univ Sao Paulo, Fac Med Ribeirao, Hosp Clin, Dept Paediat, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	carlotti@fmrp.usp.br	Carlotti, Ana PCP/G-4893-2012; Matsuno, Alessandra Kimie/H-9507-2012	Carlotti, Ana PCP/0000-0003-2760-8801; Matsuno, Alessandra Kimie/0000-0002-3491-1641			AGUILANIU B, 1992, JPEN-PARENTER ENTER, V16, P248, DOI 10.1177/0148607192016003248; ALTMAN PL, 1992, BIOL DATA BOOK, P1990; BISTRIAN BR, 1975, AM J CLIN NUTR, V28, P1148; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Briassoulis G, 2002, J NUTR BIOCHEM, V13, P560, DOI 10.1016/S0955-2863(02)00200-0; Brosnan JT, 2007, ANNU REV NUTR, V27, P241, DOI 10.1146/annurev.nutr.27.061406.093621; Brosnan ME, 2004, J NUTR, V134, p2791S, DOI 10.1093/jn/134.10.2791S; CHEEMADHADLI S, 1993, CAN J PHYSIOL PHARM, V71, P120, DOI 10.1139/y93-017; CLAUSEN T, 1986, PHYSIOL REV, V66, P542; Coss-Bu JA, 2001, AM J CLIN NUTR, V74, P664; DRUML W, 1993, NUTR KIDNEY, P314; GHAZALI S, 1974, ARCH DIS CHILD, V49, P97, DOI 10.1136/adc.49.2.97; Halperin ML, 1998, FLUID ELECTROLYTE AC; HOLLIDAY MA, 1957, PEDIATRICS, V19, P823; IAPICHINO G, 1985, JPEN-PARENTER ENTER, V9, P42, DOI 10.1177/014860718500900142; JUNGAS RL, 1992, PHYSIOL REV, V72, P419; Langley Joanne M, 2005, Pediatr Crit Care Med, V6, pS9, DOI 10.1097/01.PCC.0000161932.73262.D7; Luiking YC, 2005, JPEN-PARENTER ENTER, V29, pS70, DOI 10.1177/01486071050290S1S70; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; POLLACK MM, 1985, JPEN-PARENTER ENTER, V9, P309, DOI 10.1177/0148607185009003309; SCHWARTZ GJ, 1976, J PEDIATR-US, V88, P828, DOI 10.1016/S0022-3476(76)81125-0; Shew S B, 1999, Semin Pediatr Surg, V8, P131; SKOGERBOE KJ, 1990, CLIN CHEM, V36, P752; THRELFALL CJ, 1984, J TRAUMA, V24, P516, DOI 10.1097/00005373-198406000-00009; WALSER M, 1987, JPEN-PARENTER ENTER, V11, pS73, DOI 10.1177/014860718701100510	27	16	19	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725			QJM-INT J MED	QJM-An Int. J. Med.	MAR	2008	101	3					197	205		10.1093/qjmed/hcm127			9	Medicine, General & Internal	General & Internal Medicine	267EG	WOS:000253491700004	18222987	Bronze, Green Published			2021-06-18	
J	Czeiter, E; Pal, J; Kovesdi, E; Bukovics, P; Luckl, J; Doczi, T; Buki, A				Czeiter, Endre; Pal, Jozsef; Kovesdi, Erzsebet; Bukovics, Peter; Luckl, Janos; Doczi, Tamas; Buki, Andras			Traumatic axonal injury in the spinal cord evoked by traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; axonal injury; models of injury; traumatic brain injury	AMYLOID PRECURSOR PROTEIN; HEAD-INJURY; ACCELERATION; MODEL; RATS	Although it is well known that traumatic brain injury ( TBI) evokes traumatic axonal injury ( TAI) within the brain, TBI-induced axonal damage in the spinal cord ( SC) has been less extensively investigated. Detection of such axonal injury in the spinal cord would further the complexity of TBI while also challenging some functional neurobehavioral endpoints frequently used to assess recovery in various models of TBI. To assess TAI in the spinal cord associated with TBI, we analyzed the craniocervical junction ( CCJ), cervico-thoracic ( CT), and thoraco-lumber ( ThL) spinal cord in a rodent model of impact acceleration of TBI of varying severities. Rats were transcardially fixed with aldehydes at 2, 6, and 24 h post-injury ( n = 36); each group included on sham-injured rodent. Semi-serial vibratome sections were reacted with antibodies targeting TAI via alteration in cytoskeletal integrity or impaired axonal transport. Consistent with previous observations in this model, the CCJ contained numerous injured axons. Immunoreactive, damaged axonal profiles were also detected as caudal, as the ThL spinal cord displayed morphological characteristics entirely consistent with those described in the brainstem and the CCJ. Quantitative analyses demonstrated that the occurrence and extent of TAI is positively associated with the impact/energy of injury and negatively with the distance from the brainstem. These observations show that TBI can evoke TAI in regions remote from the injury site, including the spinal cord itself. This finding is relevant to shaken baby syndrome as well as during the analysis of data in functional recovery in various models of TBI.	[Czeiter, Endre; Pal, Jozsef; Kovesdi, Erzsebet; Bukovics, Peter; Luckl, Janos; Doczi, Tamas; Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Bukovics, Peter] Hungarian Acad Sci, Clin Neurosci Res Grp, Pecs, Hungary	Buki, A (corresponding author), 2-7623 Ret Str 2, Pecs, Hungary.	2saturn@gmail.com	Pal, Jozsef/I-3416-2013; Buki, Andras/B-1960-2010; Bukovics, Peter/A-6019-2009; Czeiter, Endre/B-1404-2009; Doczi, Tamas/C-5750-2009; Pal, Jozsef/C-4073-2009	Pal, Jozsef/0000-0001-6468-6409			ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Blumbergs P. C., 2005, HEAD INJURY PATHOPHY, P41; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cornish R, 2000, SPINE, V25, P1227, DOI 10.1097/00007632-200005150-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; LEE VMY, 1987, J NEUROSCI, V7, P3474; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 2001, HEAD TRAUMA, P281; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996	21	16	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2008	25	3					205	213		10.1089/neu.2007.0331			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	282PJ	WOS:000254579400004	18352834	Green Accepted			2021-06-18	
J	Knyazev, GG; Levin, EA; Savostyanov, AN				Knyazev, Gennady G.; Levin, Evgenij A.; Savostyanov, Alexander N.			A failure to stop and attention fluctuations: An evoked oscillations study of the stop-signal paradigm	CLINICAL NEUROPHYSIOLOGY			English	Article						EEG; evoked oscillations; stop-signal task; inhibition; attention	EVENT-RELATED POTENTIALS; INHIBITORY MOTOR CONTROL; TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; DEFICIT/HYPERACTIVITY DISORDER; ERP COMPONENTS; RESPONSES; EEG; IMPULSIVITY; CHILDREN	Objective: It is not always clear whether inhibition or attention deficit underlies a failure to stop a prepared motor response. One possible way to approach this question is to resort to measures of evoked oscillations since functional correlates of different frequency oscillations are relatively well understood. Methods: The present study examined event-related oscillations during a stop-signal task in non-clinical adults. In 25% of trials of an auditory discrimination tasks subjects had to refrain from a prepared motor response. Results: In successful stop trials, the Go N2 peaked later and the Stop N2 peaked earlier than in failed stop trials. Relative to successful, failed stop trials were associated with a larger N1-N2 and Go P3, and a smaller Stop P3 in the central and posterior cortical regions. The latter effect was exclusively determined by evoked delta oscillations, whereas all other frequency bands contributed to enhanced responses in failed comparative to successful stop trials. Conclusions: The sum of presented evidence seems to show that success or failure to stop mostly depends on how the subject prepares for the Go and Stop stimuli in advance. If attention is more directed towards the Stop signal, the stopping succeeds, otherwise it fails. Significance: These data may contribute to understanding the cognitive basis of successful and unsuccessful stopping performance. (C) 2007 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Knyazev, Gennady G.; Levin, Evgenij A.; Savostyanov, Alexander N.] Russian Acad Med Sci, State Res Inst Physiol, Siberian Branch, Novosibirsk 630117, Russia	Knyazev, GG (corresponding author), Russian Acad Med Sci, State Res Inst Physiol, Siberian Branch, Timakova St 4, Novosibirsk 630117, Russia.	G.G.Knyazev@iph.ma.nsc.ru	Savostyanov, Alexander/AAS-6968-2020; Levin, Evgeny A./AAQ-4558-2021; Knyazev, Gennady G/F-6095-2010; Savostyanov, Alexander N./N-3020-2014	Levin, Evgeny A./0000-0002-1338-5881; Knyazev, Gennady G/0000-0002-8628-4678; 			Avila C, 2004, J ABNORM CHILD PSYCH, V32, P295, DOI 10.1023/B:JACP.0000026143.70832.4b; BASAR E, 1984, INT J NEUROSCI, V24, P1, DOI 10.3109/00207458409079530; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Bekker EM, 2005, COGNITIVE BRAIN RES, V22, P221, DOI 10.1016/j.cogbrainres.2004.08.011; Bekker EM, 2005, INT J PSYCHOPHYSIOL, V55, P191, DOI 10.1016/j.ijpsycho.2004.07.005; Belleville S, 2007, NEUROPSYCHOLOGY, V21, P458, DOI 10.1037/0894-4105.21.4.458; Brandeis D, 1998, BEHAV BRAIN RES, V94, P111, DOI 10.1016/S0166-4328(97)00174-5; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; DEJONG R, 1995, J EXP PSYCHOL HUMAN, V21, P498, DOI 10.1037/0096-1523.21.3.498; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimoska A, 2003, BIOL PSYCHIAT, V54, P1345, DOI 10.1016/S0006-3223(03)00703-0; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Farrow M, 2007, J CLIN EXP NEUROPSYC, V29, P235, DOI 10.1080/13803390600657693; Fell J, 2004, J COGNITIVE NEUROSCI, V16, P1595, DOI 10.1162/0898929042568514; Fuentemilla LI, 2006, NEUROIMAGE, V30, P909, DOI 10.1016/j.neuroimage.2005.10.036; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; INTRILIGATOR J, 1995, INT J PSYCHOPHYSIOL, V20, P59, DOI 10.1016/0167-8760(95)00028-Q; Jonkman LM, 2004, CLIN NEUROPHYSIOL, V115, P1537, DOI 10.1016/j.clinph.2004.01.022; Kenemans JL, 2005, INT J PSYCHOPHYSIOL, V58, P59, DOI 10.1016/j.ijpsycho.2005.03.009; Klimesch W, 2000, NEUROSCI LETT, V284, P97, DOI 10.1016/S0304-3940(00)00985-X; Klimesch W, 1999, COGNITIVE BRAIN RES, V7, P493, DOI 10.1016/S0926-6410(98)00056-1; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; LOGAN GD, INHIBITORY PROCESSES, P189; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makinen V, 2005, NEUROIMAGE, V24, P961, DOI 10.1016/j.neuroimage.2004.10.020; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mur M, 2007, J CLIN PSYCHIAT, V68, P1078, DOI 10.4088/JCP.v68n0715; Naito E, 1996, NEUROPSYCHOLOGIA, V34, P565, DOI 10.1016/0028-3932(95)00140-9; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Overtoom CCE, 2002, BIOL PSYCHIAT, V51, P668, DOI 10.1016/S0006-3223(01)01290-2; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Quay HC, 1997, J ABNORM CHILD PSYCH, V25, P7, DOI 10.1023/A:1025799122529; Rodriguez PD, 2007, BEHAV NEUROL, V18, P115, DOI 10.1155/2007/865717; Roschke J, 1997, NEUROPSYCHOBIOLOGY, V35, P108, DOI 10.1159/000119400; SCHACHAR R, 1990, DEV PSYCHOL, V26, P710, DOI 10.1037/0012-1649.26.5.710; Schurmann M, 2001, INT J PSYCHOPHYSIOL, V39, P229, DOI 10.1016/S0167-8760(00)00144-6; Tanji K, 2005, J NEUROSCI, V25, P3287, DOI 10.1523/JNEUROSCI.4948-04.2005; Tannock R, 1998, J CHILD PSYCHOL PSYC, V39, P65, DOI 10.1111/1469-7610.00304; Treitz FH, 2007, AGING NEUROPSYCHOL C, V14, P370, DOI 10.1080/13825580600678442; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Whitmer AJ, 2007, PSYCHOL SCI, V18, P546, DOI 10.1111/j.1467-9280.2007.01936.x; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R	55	16	17	0	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAR	2008	119	3					556	567		10.1016/j.clinph.2007.11.041			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	277ZN	WOS:000254253300006	18164656				2021-06-18	
J	Marwit, SJ; Chibnall, JT; Dougherty, R; Jenkins, C; Shawgo, J				Marwit, Samuel J.; Chibnall, John T.; Dougherty, Rebecca; Jenkins, Chrystal; Shawgo, Jenifer			Assessing pre-death grief in cancer caregivers using the Marwit-Meuser Caregiver Grief Inventory (MM-CGI)	PSYCHO-ONCOLOGY			English	Article						cancer; oncology; caregivers; grief; assessment	ALZHEIMERS-DISEASE; TRAUMATIC GRIEF; DEPRESSION; SCALE; INDIVIDUALS; VALIDATION; EXPERIENCE; SYMPTOMS; DISTRESS; DEMENTIA	The Marwit-Meuser Caregiver Grief Inventory (MM-CGI) was developed and initially validated with caregivers of persons with Alzheimer's disease, and subsequently evaluated with caregivers of persons with brain injury. The present study examined MM-CGI psychometric and validity properties in 75 caregivers of persons with cancer. As with previous studies, high internal consistency reliability of MM-CGI Total Grief and subscale scores (Personal Sacrifice and Burden, Heartfelt Sadness and Longing, and Worry and Felt Isolation) was demonstrated. Construct validity of the subscale scores was supported by differential associations with other caregiver measures of depression, strain, well-being, and family support. Based on these preliminary results, the MM-CGI appears useful for assessing pre-death grief in caregivers of persons with cancer. Copyright (C) 2007 John Wiley & Sons, Ltd.	[Marwit, Samuel J.] Univ Missouri, Dept Psychol, St Louis, MO 63121 USA; [Chibnall, John T.; Jenkins, Chrystal; Shawgo, Jenifer] St Louis Univ, Sch Med, Dept Psychiat, St Louis, MO 63103 USA; [Dougherty, Rebecca] St Louis Univ, Ctr Canc, St Louis, MO 63103 USA	Marwit, SJ (corresponding author), 4540 Laclede Ave,306 St, St Louis, MO 63108 USA.	smarwit@yohoo.com					Adams KB, 2004, DEMENTIA, V3, P195, DOI DOI 10.1177/1471301204042337; Beery LC, 1997, OMEGA-J DEATH DYING, V35, P261, DOI 10.2190/9QT0-XBD0-V8E9-U650; Berg-Weger M, 2000, HEALTH SOC WORK, V25, P255, DOI 10.1093/hsw/25.4.255; Chen JH, 1999, PSYCHOL MED, V29, P367, DOI 10.1017/S0033291798008137; Ensel WM, 1986, SOCIAL SUPPORT LIFE, P51, DOI DOI 10.1016/B978-0-12-450660-2.50011-2; Hebert RS, 2006, J PALLIAT MED, V9, P683, DOI 10.1089/jpm.2006.9.683; Kelly B, 1999, PSYCHO-ONCOLOGY, V8, P237, DOI 10.1002/(SICI)1099-1611(199905/06)8:3<237::AID-PON375>3.0.CO;2-C; Loos C, 1997, DEATH STUD, V21, P501; Marwit SJ, 2006, BRAIN INJURY, V20, P1419, DOI 10.1080/02699050601082214; Marwit SJ, 2002, GERONTOLOGIST, V42, P751, DOI 10.1093/geront/42.6.751; MEUSER TM, 2005, LIVING GRIEF ALZHEIM, P169; Prigerson HG, 2003, AM J GERIAT PSYCHIAT, V11, P309, DOI 10.1176/appi.ajgp.11.3.309; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; PROCIDANO ME, 1983, AM J COMMUN PSYCHOL, V11, P1, DOI 10.1007/BF00898416; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Robinson-Whelen S, 2001, J ABNORM PSYCHOL, V110, P573, DOI 10.1037//0021-843X.110.4.573; Sanders S, 2005, HEALTH SOC WORK, V30, P287, DOI 10.1093/hsw/30.4.287; Sanders S, 2003, SOC WORK HEALTH CARE, V37, P35, DOI 10.1300/J010v37n03_03; Van Doorn C, 1998, J NERV MENT DIS, V186, P566, DOI 10.1097/00005053-199809000-00008; Walker RJ, 1996, HEALTH SOC WORK, V21, P247, DOI 10.1093/hsw/21.4.247	20	16	18	0	9	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	1057-9249			PSYCHO-ONCOL	Psycho-Oncol.	MAR	2008	17	3					300	303		10.1002/pon.1218			4	Oncology; Psychology; Psychology, Multidisciplinary; Social Sciences, Biomedical	Oncology; Psychology; Biomedical Social Sciences	280GJ	WOS:000254413400012	17518412				2021-06-18	
J	Arco, L				Arco, Lucius			Neurobehavioural treatment for obsessive-compulsive disorder in an adult with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	29th Annual Conference of the Australian-Society-for-the-Study-of-Brain-Impairment	APR, 2006	Sydney, AUSTRALIA	Australian Soc Brain Impairment		brain injury rehabilitation; neurobehavioural rehabilitation; obsessive-compulsive disorder; self-regulation; traumatic brain injury	COGNITIVE-BEHAVIOR THERAPY; CLOSED-HEAD-INJURY; DEPRESSION; NEUROPSYCHOLOGY; REHABILITATION; INDIVIDUALS; ADOLESCENTS	Although obsessive-compulsive disorder has been reported as one of many anxiety-related sequelae of brain injury, few empirical data of its responsiveness to psychological intervention are available. In this study, a single participant changing criterion experimental design was used to evaluate a neurobehavioural intervention for compulsive behaviour of an adult with severe traumatic brain injury. The participant, a man aged 24 years, had sustained frontal-temporal lobe brain trauma 12 months earlier, and presented with compulsive counting and voiding of bladder. The neurobehavioural intervention consisted of regular in-home consultations, self-regulation procedures including self-recording of compulsive behaviour, stress-coping strategies, errorless remediation, social reinforcement, and gradual fading of intervention. Baseline showed counting occurred on average 80% of daily hourly intervals, and voiding 12 times per day. Intervention produced elimination of compulsive counting, acceptable voiding at 8 times per day, and reports of the participant's satisfaction with intervention methods and outcomes. At 6 months follow-up, counting remained at zero levels, and voiding had decreased further to 7 times per day.	Praxis Res, Yokine, WA 6060, Australia; [Arco, Lucius] Praxis Res, Perth, WA, Australia	Arco, L (corresponding author), Praxis Res, LPO Box 2065 Dog Swamp, Yokine, WA 6060, Australia.	arco.im@bigpond.com					Abramowitz JS, 1997, J CONSULT CLIN PSYCH, V65, P44, DOI 10.1037/0022-006X.65.1.44; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arco L, 2004, BEHAV THER, V35, P605, DOI 10.1016/S0005-7894(04)80034-0; Barlow D.H., 1984, SINGLE CASE EXPT DES; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; Ducharme JM, 2000, CLIN PSYCHOL REV, V20, P405, DOI 10.1016/S0272-7358(98)00102-0; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Franklin ME, 2002, GUIDE TREATMENTS WOR, V2, P367; Friedlander L, 2006, CLIN PSYCHOL REV, V26, P32, DOI 10.1016/j.cpr.2005.06.010; Greisberg S, 2003, CLIN PSYCHOL REV, V23, P95, DOI 10.1016/S0272-7358(02)00232-5; Hayes S.C., 1996, ADV PSYCHOL, P279; Hayes SC, 2004, BEHAV THER, V35, P639, DOI 10.1016/S0005-7894(04)80013-3; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jacobs H. E., 2000, HDB APPL BEHAV ANAL, P211; Jacobson NS, 1997, BEHAV THER, V28, P435, DOI 10.1016/S0005-7894(97)80092-5; Kant R, 1996, BRAIN INJURY, V10, P55; KAZDIN AE, 1977, BEHAV MODIF, V1, P427, DOI 10.1177/014544557714001; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; Kohlenberg R J, 1996, Prog Behav Modif, V30, P1; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LEWIS FD, 1988, BEHAV THER, V19, P203, DOI 10.1016/S0005-7894(88)80043-1; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Luria, 1973, WORKING BRAIN INTRO; Manchester D, 2001, BRAIN DAM B, P157; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; PACE GM, 1994, J APPL BEHAV ANAL, V27, P301, DOI 10.1901/jaba.1994.27-301; SALKOVSKIS PM, 1997, OX MED PUBL, P179; Slifer KJ, 1997, BRAIN INJURY, V11, P877; STEKETEE G, 2002, ANXIETY ITS DISORDER, P516; Tallis F, 1997, BRIT J CLIN PSYCHOL, V36, P3, DOI 10.1111/j.2044-8260.1997.tb01226.x; Taylor I, 1997, J APPL BEHAV ANAL, V30, P43, DOI 10.1901/jaba.1997.30-43; Wesolowski M. D., 1993, BEHAV RESIDENTIAL TR, V8, P89, DOI DOI 10.1002/BIN; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; WOLF MM, 1978, J APPL BEHAV ANAL, V11, P203, DOI 10.1901/jaba.1978.11-203; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P221	41	16	17	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN	2008	18	1					109	124		10.1080/09602010701656706			16	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	249HD	WOS:000252218000006	18058389				2021-06-18	
J	Darkins, A; Cruise, C; Armstrong, M; Peters, J; Finn, M				Darkins, Adam; Cruise, Cathy; Armstrong, Michael; Peters, John; Finn, Michael			Enhancing access of combat-wounded veterans to specialist rehabilitation services: The VA polytrauma Telehealth Network	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						rehabilitation; telecommunication networks; telemedicine; wounds and injuries	TRAUMATIC BRAIN-INJURY; CASUALTIES	Operations Iraqi Freedom and Enduring Freedom have resulted in U.S. military personnel sustaining combat wounds of unprecedented severity and complexity that necessitate long-term rehabilitation. To meet what are often conflicting requirements in providing severely wounded veterans with timely and convenient access to specialist rehabilitation care, and to enable them to return to their local communities, the Veterans Health Administration has developed a state-of-the-art Polytrauma Telehealth Network that enhances access to such services by linking Veterans Administration rehabilitation facilities. This article describes the clinical, technical, and business process issues involved in the development of this network.	[Darkins, Adam; Peters, John; Finn, Michael] Off Care Coordinat 11CC, Dept Vet Affairs, Vet Hlth Adm, Washington, DC 20420 USA; [Cruise, Cathy] US Dept Vet Affairs, Vet Hlth Adm, Northport, MN USA; [Armstrong, Michael] US Dept Vet Affairs, Vet Hlth Adm, Minneapolis, MN USA	Darkins, A (corresponding author), Off Care Coordinat 11CC, Dept Vet Affairs, Vet Hlth Adm, 810 Vermont Ave NW, Washington, DC 20420 USA.						BABIARZ J, 2005, CONFIGURATION GUIDEL; BITA NLF, 2005, COMMUNICATIONS, V43, P119; BLACK D, 1998, ARCHITECTURE DIFFERE; Bricknell M C M, 2003, J R Army Med Corps, V149, P166; Childress DS, 2002, J REHABIL RES DEV, V39, P1; *DEP VET AFF, 2006, VHA DEC SUPP SYST DS; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Eldar R, 2003, DISABIL REHABIL, V25, P1019, DOI 10.1080/0963828031000137739; GOKA RS, 1994, BRAIN INJ REHABIL, V26, P420; GOODWIN K, 2000, STATE HLTH NOTES, V21, P330; JACOBSON V, 2000, IETF47; JOHNSON T, 2004, H350 INT SOC; King B, 2005, J NATL MED ASSOC, V97, P648; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P7, DOI 10.1016/j.jamcollsurg.2005.03.038; *OFF CAR COORD DEP, 2006, ROUT TEL HLTH ACT DA; *OFF CAR COORD DEP, 2006, ROUT HOM TEL ACT DAT; Pasquina PF, 2006, MIL MED, V171, P206, DOI 10.7205/MILMED.171.3.206; RADCLIFFE M, US LEGAL SYSTEM; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Tenuta Joachim J, 2006, J Am Acad Orthop Surg, V14, pS45; *US DEP HHS, HLTH IT STRAT FRAM A; Wetherall D.J., 1996, P 7 WORKSH ACM SIGOP, P33	23	16	16	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2008	89	1					182	187		10.1016/j.apmr.2007.07.027			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	249LB	WOS:000252228600031	18164352				2021-06-18	
J	Eikelmann, A; Petermann, F; Daseking, M				Eikelmann, Antje; Petermann, Franz; Daseking, Monika			Attention deficit disorders after stroke in childhood	ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE			German	Article						stroke in children; assessment of attention abilities; CBCL; attention deficit disorder	TRAUMATIC BRAIN-INJURY; HYPERACTIVITY DISORDER; CHILDREN; ADOLESCENTS; SKILLS; TERM; TBI; PERFORMANCE; SYMPTOMS; VALIDITY	Objective: The present study investigates whether attention deficits increase after stroke in childhood and identifies influencing factors. Methods: The attentional functions of 78 children who suffered strokes were evaluated by means of neuropsychological assessments for attention abilities, the CBCL/4-18, and a standardized observation of behavior. The results were compared for age at the time of the stroke, affected hemisphere, and localisation. Results: Children and adolescents develop attention deficits due to stroke. There seems to be no influence of sex, age at stroke or localisation of stroke. Children with right-hemispheric brain damage tend to develop more attention deficits than children with left-hemispheric stroke. Conclusions: There is a need for an early diagnosis and the initiation of an effective treatment to avoid collateral disorders and school problems.	[Eikelmann, Antje; Petermann, Franz; Daseking, Monika] Univ Bremen, Zentrum Klin Psychol & Rehabil, DE-28359 Bremen, Germany	Eikelmann, A (corresponding author), Univ Bremen, Zentrum Klin Psychol & Rehabil, Grazer Str 2, DE-28359 Bremen, Germany.	asimonis@uni-bremen.de					Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; BORTZ J, 1998, KURZGEFASSTE STAT KL; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Daseking M, 2003, NERVENARZT, V74, P1088, DOI 10.1007/s00115-003-1588-0; Daseking M, 2008, FORTSCHR NEUROL PSYC, V76, P662, DOI 10.1055/s-2008-1038262; DASEKING M, 2005, SCHLAGANFALLE KINDES; Daseking M, 2007, Z KINDER JUG-PSYCH, V35, P311, DOI 10.1024/1422-4917.35.5.311; Desman C, 2005, KINDH ENTWICKL, V14, P244, DOI 10.1026/0942-5403.14.4.244; Jacobs C, 2007, MONATSSCHR KINDERH, V155, P921, DOI 10.1007/s00112-007-1596-4; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Konrad K, 2007, KINDH ENTWICKL, V16, P7, DOI 10.1026/0942-5403.16.1.7; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Max JE, 2002, J AM ACAD CHILD PSY, V41, P563, DOI 10.1097/00004583-200205000-00014; Max JE, 2004, J INT NEUROPSYCH SOC, V10, P976, DOI 10.1017/S1355617704107066; Max JE, 2004, J INT NEUROPSYCH SOC, V10, P698, DOI 10.1017/S1355617704105092; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2003, J INT NEUROPSYCH SOC, V9, P815, DOI 10.1017/S1355617703960012; Petermann F, 2007, KINDH ENTWICKL, V16, P1, DOI 10.1026/0942-5403.16.1.1; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Trauner DA, 2001, BRAIN, V124, P995, DOI 10.1093/brain/124.5.995; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; VONDERFECHT A, 2004, NEUROREHABILITATION, P71; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; ZIMMER O, 2002, EJPDIRECT A, V1, P1; Zimmermann P., 2002, TESTBATTERIE AUFMERK	31	16	17	0	5	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1422-4917	1664-2880		Z KINDER JUG-PSYCH	Z. Kinder-und Jugendpsy. Psychother.		2008	36	6					419	426		10.1024/1422-4917.36.6.419			8	Psychiatry	Psychiatry	382JA	WOS:000261600900006	19034857				2021-06-18	
J	Shiramizu, H; Masuko, A; Ishizaka, H; Shibata, M; Atsumi, H; Imai, M; Osada, T; Mizokami, Y; Baba, T; Matsumae, M				Shiramizu, Hideki; Masuko, Akihiko; Ishizaka, Hideo; Shibata, Masayoshi; Atsumi, Hideki; Imai, Masaaki; Osada, Takahiro; Mizokami, Yoshihito; Baba, Tanefumi; Matsumae, Mitsunori			Mechanism of injury to the corpus callosum, with particular reference to the anatomical relationship between site of injury and adjacent brain structures	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						corpus callosum injury; head injury; diffuse brain injury; magnetic resonance imaging	CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; TRAUMATIC LESIONS; FEATURES; DAMAGE; MRI	The location of corpus callosum injury was investigated using magnetic resonance imaging in 92 patients. The anatomical relationships in the region around the corpus callosum were also evaluated to clarify involvement in the mechanism of corpus callosum injury in 20 normal volunteers. Lesions in the posterior half of the corpus callosum accounted for 80% of corpus callosum injuries. The falx was increasingly elongated toward the posterior portion of the corpus callosum and the corpus callosum was thinnest at the body-splenium junction in the normal volunteers. The mechanism of corpus callosum injury apparently involves the following factors. The posterior half of the falx is closer to the corpus callosum than the anterior half. Therefore, the anterior part of the corpus callosum easily moves with lateral movement of the cerebral hemispheres, and the strain is likely to be concentrated in the posterior half of the corpus callosum, because the falx greatly limits lateral movement of the hemisphere in the posterior region. The corpus callosum is easily distorted at the thinnest part of the body-splenium junction. Therefore, corpus callosum injury predominantly occurs in the posterior half of the corpus callosum.	[Shiramizu, Hideki; Masuko, Akihiko; Ishizaka, Hideo; Shibata, Masayoshi; Atsumi, Hideki; Imai, Masaaki; Osada, Takahiro; Mizokami, Yoshihito; Baba, Tanefumi; Matsumae, Mitsunori] Tokai Univ, Sch Med, Dept Neurosurg, Kanagawa 2591193, Japan	Matsumae, M (corresponding author), Tokai Univ, Sch Med, Dept Neurosurg, 143 Shimokasuya, Kanagawa 2591193, Japan.						ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Holbourn AHS, 1944, J NEUROSURG, V1, P190, DOI 10.3171/jns.1944.1.3.0190; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; JUNET P, 1938, HELV MED ACTA, V5, P818; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; KOMATSU S, 1979, NEUROSURGERY, V5, P32, DOI 10.1227/00006123-197907010-00005; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lindenberg R, 1964, Clin Neurosurg, V12, P129; LINDENBERG R, 1955, AM J PATHOL, V31, P297; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; ROESSMAN U, 1968, ACTA NEUROPATHOL, V10, P151, DOI 10.1007/BF00691309; ROWBOTHAM GF, 1949, ACUTE INJURIES HEAD, P1; STRICH SJ, 1961, LANCET, V2, P443; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Tokutomi T, 1997, ACT NEUR S, V70, P80; Zarkovic K, 1991, Neurol Croat, V40, P129	22	16	16	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2008	48	1					1	6		10.2176/nmc.48.1			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	253FO	WOS:000252504300001	18219185	Bronze			2021-06-18	
J	Stronach, ST; Turkstra, LS				Stronach, Sheri T.; Turkstra, Lyn S.			Theory of mind and use of cognitive state terms by adolescents with traumatic brain injury	APHASIOLOGY			English	Article							CLOSED-HEAD-INJURY; FALSE-BELIEF TASK; SOCIAL INFORMATION; EXECUTIVE FUNCTION; LOBE CONTRIBUTIONS; LANGUAGE; COMMUNICATION; CHILDREN; DISCOURSE; OUTCOMES	Background: There is growing evidence of impaired social cognition in individuals with traumatic brain injury (TBI). Social cognition tests, however, place demands on domain-general cognitive functions such as auditory working memory, so that test scores might reflect the influence of these factors on test performance rather than domain-specific social cognition impairments. As an alternative, we examined conversations of adolescents with TBI for evidence of cognitive state terms. Methods and Procedures: Participants were 16 adolescents with TBI, who were divided into two groups (TBI-Low and TBI-High) based on scores on a test of theory of mind (ToM), and 8 typically developing (TD) adolescents matched to participants in the TBI groups for age and race. Each participant completed a 3-minute conversation with a peer or researcher partner, and conversations were analysed to determine the number of cognitive state terms relative to total words produced. Outcomes and Results: The TBI-Low group expressed significantly fewer cognitive state terms and significantly fewer self-vs other-referenced terms than either the TBI-High or TD group. There was no significant difference between the TD and TBI-High groups. The findings were not related to generally impoverished language in the TBI-Low group, as the three groups were similar on measures of lexical diversity. Conclusions: The findings support the hypothesis that adolescents with TBI have domain-specific deficits in social cognition, beyond what might be accounted for by the cognitive demands of social cognition tests. Given the relation of social cognitive ability to important life outcomes, these skills should be included in the evaluation of individuals with cognitive-communication disorders after TBI.	[Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA	Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Stronach, Sheri/P-1176-2019	Stronach, Sheri/0000-0002-4794-6210	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC00163]; Wisconsin Alumni Research Fund	This work was supported in part by Grant DC00163 from the National Institute on Deafness and Other Communication Disorders and funding from the Wisconsin Alumni Research Fund, to Dr Turkstra.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adrian JE, 2005, J CHILD LANG, V32, P673, DOI 10.1017/S0305000905006963; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Barrett L, 2007, PHILOS T R SOC B, V362, P561, DOI 10.1098/rstb.2006.1995; BERNDT TJ, 1979, DEV PSYCHOL, V15, P608, DOI 10.1037/0012-1649.15.6.608; BERNDT TJ, 1985, DEV PSYCHOL, V21, P1007, DOI 10.1037/0012-1649.21.6.1007; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Bosacki SL, 2003, J YOUTH ADOLESCENCE, V32, P141, DOI 10.1023/A:1021861902463; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P437, DOI 10.1016/j.neubiorev.2005.08.001; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Clegg J, 2005, J CHILD PSYCHOL PSYC, V46, P128, DOI 10.1111/j.1469-7610.2004.00342.x; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Colle L, 2007, J AUTISM DEV DISORD, V37, P716, DOI 10.1007/s10803-006-0198-7; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.0.CO;2-Z; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Englund NM, 2000, CHILD DEV, V71, P1049, DOI 10.1111/1467-8624.00208; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1985, LANGUAGE NEUROLOGY; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Garrett AS, 2004, ARCH GEN PSYCHIAT, V61, P281, DOI 10.1001/archpsyc.61.3.281; Gillott A., 2004, CHILD LANGUAGE TEACH, V20, P1, DOI [DOI 10.1191/0265659004CT260OA, 10.1191/0265659004ct260oa]; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Hartley L. L., 1995, COGNITIVE COMMUNICAT; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Johnson P, 2006, BRAIN COGNITION, V60, P205; Johnston JR, 2001, INT J LANG COMM DIS, V36, P349, DOI 10.1080/13682820110045838; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 2000, APHASIOLOGY, V14, P339, DOI 10.1080/026870300401397; Miller CA, 2004, INT J LANG COMM DIS, V39, P191, DOI 10.1080/13682820310001616994; Miller CA, 2006, AM J SPEECH-LANG PAT, V15, P142, DOI 10.1044/1058-0360(2006/014); MILLER JF, 1994, SALT GUIDE STANDARD; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Mundy P, 1997, MENT RETARD DEV D R, V3, P343; Mutter B, 2006, PERCEPT MOTOR SKILL, V102, P819, DOI 10.2466/PMS.102.3.819-835; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Sabbagh MA, 2006, PSYCHOL SCI, V17, P74, DOI 10.1111/j.1467-9280.2005.01667.x; Sabers DL, 1996, LANG SPEECH HEAR SER, V27, P102, DOI 10.1044/0161-1461.2702.102; Schultz J, 2004, J COGNITIVE NEUROSCI, V16, P1695, DOI 10.1162/0898929042947874; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Silliman ER, 2003, LANG SPEECH HEAR SER, V34, P236, DOI 10.1044/0161-1461(2003/020); *SPSS INC, 2005, SPSS STAT AN SOFTW V; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Tager-Flusberg H, 1999, INT REV PSYCHIATR, V11, P325, DOI 10.1080/09540269974203; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; VANLEER E, 1999, J COMMUNICATIION DIS, V32, P348; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zanini S, 2005, APHASIOLOGY, V19, P1107, DOI 10.1080/02687030500268977	72	16	16	0	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2008	22	10					1054	1070		10.1080/02687030701632187			17	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	360IP	WOS:000260051500003					2021-06-18	
J	Yasseen, B; Colantonio, A; Ratcliff, G				Yasseen, Baseer; Colantonio, Angela; Ratcliff, Graham			Prescription medication use in persons many years following traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; medication; medical management; therapy	NEUROPATHIC PAIN; UNITED-STATES; EPIDEMIOLOGY; PERSPECTIVE; ADULTS	Background: This research study examined the prevalence of prescription medication use in persons many years following moderate-to-severe traumatic brain injury (TBI). Design: Retrospective cohort study. Setting and subjects: Consecutive records were examined of persons with moderate-to-severe TBI who were discharged from a large rehabilitation hospital in Pennsylvania from 1973-1989. Consenting participants (n = 306) were interviewed, who were traced up to 24 years post-injury. Data on current use of prescription medications, in addition to demographic characteristics and health conditions were collected from the participants. Results: The prevalence of prescription medication was 58.9% in the sample, greater in females (65.6%) than in males (56.1%). The most prescribed medication types were anti-convulsants (25.8%) followed by anti-depressants (8.2%), painkillers (8.2%) and anti-anxiety medications (5.9%). On average, persons with TBI were prescribed 2.64 (SD = 2.14) medications with a range of 1-12. Conclusion: The research findings indicate a high prevalence of prescription medications in persons with past history of TBI. There is also a high prevalence of anti-convulsants medication use.	[Colantonio, Angela] Univ Toronto, Dept Occupat Therapy, Fac Med, Toronto, ON M5G 1V7, Canada; [Yasseen, Baseer] Univ Toronto, Fac Pharm, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON, Canada; [Ratcliff, Graham] Clin Neuropsychol Serv, Pittsburgh, PA USA	Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Therapy, Fac Med, 500 Univ Ave,Room 950, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34740-2]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F33 AGO5856-01A1]; Toronto Rehabilitation InstituteUniversity of Toronto; Toronto Rehabilitation Institute Foundation; Ontario Ministry of Health and Long term CareMinistry of Health and Long-Term Care, Ontario; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F33AG005856] Funding Source: NIH RePORTER	This project was supported by NINDS (NS34740-2) and NIA (F33 AGO5856-01A1), Toronto Rehabilitation Institute, Toronto Rehabilitation Institute Foundation and the Ontario Work Study Program. The Toronto Rehabilitation Institute receives funding from the Ontario Ministry of Health and Long term Care. We are truly grateful to our study participants and staff who made this research possible.	AMAN MG, 1994, J DEV PHYS DISABIL, V6, P87; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; DASTUR DK, 1987, EPILEPSIA, V28, P147, DOI 10.1111/j.1528-1157.1987.tb03641.x; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Hall GC, 2006, PAIN, V122, P156, DOI 10.1016/j.pain.2006.01.030; Jensen TS, 2002, EUR J PAIN, V6, P61, DOI 10.1053/eujp.2001.0324; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LADER MH, 1984, PSYCHOL MED, V14, P203, DOI 10.1017/S0033291700003214; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Savica R, 2007, EUR J NEUROL, V14, P1317, DOI 10.1111/j.1468-1331.2007.01970.x; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TRIMBLE MR, 1985, CLIN NEUROPHARMACOL, V8, P211, DOI 10.1097/00002826-198509000-00002; *US DEP HHS, 2005, CHARTB TRENDS HLTH A; Vespa PM, 2000, CNS DRUGS, V13, P129, DOI 10.2165/00023210-200013020-00006; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; 1999, INT CLASSIFICATION D	20	16	17	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	10					752	757		10.1080/02699050802320132			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	347MJ	WOS:000259145400004	18787984				2021-06-18	
J	Reza, MF; Ikoma, K; Ito, T; Ogawa, T; Mano, Y				Reza, Mohammed Faruque; Ikoma, Katsunori; Ito, Takeya; Ogawa, Taro; Mano, Yukio			N200 latency and P300 amplitude in depressed mood post-traumatic brain injury patients	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							EVENT-RELATED POTENTIALS; CLOSED-HEAD-INJURY; EVOKED-POTENTIALS; ANXIETY; POPULATION; DIAGNOSIS; SCALE	In order to examine the independent and combined effects of depressive symptoms and traumatic brain injury on event-related potential (ERP) components, we classified traumatic brain injury (TBI) patients as depressed and non-depressed mood according to their scores on the Zung Self-rating Depression Scale (SDS). Non-depressed mood post-traumatic brain injury patients (NondepTBI, n = 9), depressed mood post-traumatic brain injury patients (DepTBI, n = 26), and normal healthy control subjects (HC, n = 10) were assessed for N100, N200, and P300 latencies and amplitudes by the auditory "oddball paradigm". DepTBI subjects had significantly prolonged N200 latency and low P300 amplitude compared with the NondepTBI and HC groups. A longer P300 latency in the NondepTBI and DepTBI than in the HC groups was found. A prolongation of N200 latency accompanied by low P300 amplitude may be a characteristic of post-traumatic brain injury patients with depressed mood. Prolonged P300 latency may be more closely associated with TBI than with depression, as it was significantly greater in both the DepTBI and NondepTBI, than in the HC group.	[Reza, Mohammed Faruque; Ikoma, Katsunori; Ito, Takeya; Ogawa, Taro; Mano, Yukio] Hokkaido Univ, Grad Sch Med, Dept Phys Med & Rehabil, Sapporo, Hokkaido 0608638, Japan	Ikoma, K (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Phys Med & Rehabil, N15 W7, Sapporo, Hokkaido 0608638, Japan.	ikoma@med.hokudai.ac.jp	Ikoma, Katsunori/D-8158-2012; , Faruque Reza/L-9994-2016	, Faruque Reza/0000-0002-0302-6623			ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; BARRETT J, 1978, ARCH GEN PSYCHIAT, V35, P741; BRUDER GE, 1991, BIOL PSYCHIAT, V30, P233, DOI 10.1016/0006-3223(91)90108-X; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Chida F, 2004, PSYCHIAT CLIN NEUROS, V58, P420, DOI 10.1111/j.1440-1819.2004.01277.x; CYNTHIA MS, 2001, BRAIN INJURY, V15, P561; DOJONGHE JFM, 1989, PSYCHOL REP, V64, P833; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; GANGADHAR BN, 1993, J AFFECT DISORDERS, V28, P57, DOI 10.1016/0165-0327(93)90077-W; GOODIN DS, 1978, PSYCHOPHYSIOLOGY, V15, P360, DOI 10.1111/j.1469-8986.1978.tb01392.x; Hashiro M, 1997, J DERMATOL SCI, V14, P63, DOI 10.1016/S0923-1811(96)00553-1; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; JORGE RE, 1993, J NERVE MENTAL DISOR, V181, P191; Kibiger G, 2003, J PAIN SYMPTOM MANAG, V26, P705, DOI 10.1016/S0885-3924(03)00237-9; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1982, NEUROBEHAVIOURAL CON, P3; Patel Salil H, 2005, Int J Med Sci, V2, P147; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P334, DOI 10.1111/j.1469-8986.1996.tb01058.x; RUMPL E, 1988, J CLIN NEUROPHYSIOL, V5, P237, DOI 10.1097/00004691-198807000-00002; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SARA G, 1994, J AFFECT DISORDERS, V31, P29, DOI 10.1016/0165-0327(94)90124-4; Spielberg CD, 1966, ANXIETY BEHAV; SQUIRES NK, 1986, EXPT TECHNIQUES HUMA, P386; Urretavizcaya M, 2003, J AFFECT DISORDERS, V74, P293, DOI 10.1016/S0165-0327(02)00016-2; Vandoolaeghe E, 1998, J AFFECT DISORDERS, V48, P105, DOI 10.1016/S0165-0327(97)00165-1; Viggiano MP, 1996, J CLIN EXP NEUROPSYC, V18, P631, DOI 10.1080/01688639608408288; Walters GD, 2001, PERS INDIV DIFFER, V30, P1345, DOI 10.1016/S0191-8869(00)00116-1; ZUNG WWK, 1973, ARCH GEN PSYCHIAT, V29, P328; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	31	16	20	0	10	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	DEC	2007	17	6					723	734		10.1080/09602010601082441			12	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	246EU	WOS:000251991100004	18030646				2021-06-18	
J	Conoyer, JM; Kaylie, DM; Jackson, CG				Conoyer, J. Matthew; Kaylie, David M.; Jackson, C. Gary			Otologic surgery following ear trauma	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article							OSSICULAR RECONSTRUCTION	OBJECTIVES: To investigate common presentations and expected outcomes in patients with traumatically induced otologic dysfunction. STUDY DESIGN: Retrospective case review of patients who underwent otologic surgery for sequelae of otologic trauma over a 28-year period. Patients were stratified into major and minor trauma cohorts. Major trauma was designated as closed head injury with or without temporal bone fracture; lower-energy insults comprised the minor trauma group. Preoperative and postoperative audiograms were obtained and correlated with extent of injury. SETTING: Tertiary referral center. RESULTS: Major trauma accounted for 44.9 percent of all patients. The remaining 55.1 percent suffered minor trauma, of which simple traumatic tympanic membrane perforation was the most common insult (33.6%). Two hundred twenty-seven cases were performed on 214 patients. Pure tone averages improved a significant 20.8 dB to essentially normal levels postoperatively. CONCLUSION: Regardless of injury extent, surgical rehabilitation of conductive losses attains excellent hearing results that surpass those historically reported for the chronic ear population. (C) 2007 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.	Vanderbilt Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Otol Grp Vanderbilt, Nashville, TN 37212 USA	Conoyer, JM (corresponding author), 7209 Med Ctr E,S Tower,1215 21st Ave S, Nashville, TN 37232 USA.	matthew.conoyer@vanderbilt.edu					[Anonymous], 1995, Otolaryngol Head Neck Surg, V113, P186; Brodie HA, 1997, AM J OTOL, V18, P188; CRABTREE JA, 1982, AM J OTOL, V4, P172; Gardner EK, 2004, LARYNGOSCOPE, V114, P65, DOI 10.1097/00005537-200401000-00011; GLASSCOCK ME, 1979, LARYNGOSCOPE, V89, P716; GLASSCOCK ME, 1976, LARYNGOSCOPE, V86, P211, DOI 10.1288/00005537-197602000-00009; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Jackson CG, 1996, AM J OTOL, V17, P7; JACKSON CG, 1983, LARYNGOSCOPE, V93, P981; Kaylie DM, 2006, OTOLARYNG HEAD NECK, V134, P443, DOI 10.1016/j.otohns.2005.10.044; McGrew BM, 2004, LARYNGOSCOPE, V114, P506, DOI 10.1097/00005537-200403000-00023; SHEEHY JL, 1985, AM J OTOL, V6, P80; SMYTH GDL, 1982, OTOLARYNG HEAD NECK, V90, P343; VARTIAINEN E, 1993, AM J OTOL, V14, P301; Wullstein H., 1952, ARCH OHREN NASENKEHL, V161, P422, DOI [10.1007/BF02129204, DOI 10.1007/BF02129204]	15	16	19	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	NOV	2007	137	5					757	761		10.1016/j.otohns.2007.07.017			5	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	229RK	WOS:000250821700012	17967641				2021-06-18	
J	Goozee, J; Murdoch, B; Ozanne, A; Cheng, Y; Hill, A; Gibbon, F				Goozee, Justine; Murdoch, Bruce; Ozanne, Anne; Cheng, Yan; Hill, Anne; Gibbon, Fiona			Lingual kinematics and coordination in speech-disordered children exhibiting differentiated versus undifferentiated lingual gestures	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						children; tongue; kinematics; undifferentiated gestures	TRAUMATIC BRAIN-INJURY; ELECTROMAGNETIC ARTICULOGRAPHY; TONGUE	Background: Electropalatographic investigations have revealed that a proportion of children with articulation/phonological disorders exhibit undifferentiated lingual gestures, whereby the whole of the tongue contacts the palate simultaneously during lingual consonant production. These undifferentiated lingual gestures have been interpreted to reflect a 'motor constraint', with the tongue tip and body incapable of operating independently. Aims: The present study aimed to provide further insight into the speech motor control abilities of children with articulation/phonological disorders by using electromagnetic articulography to track the movements (velocity, acceleration, distance, duration) of, and the coordination between, the tongue tip and tongue body during lingual consonant production. Methods & Procedures: Comparisons were made between two children with persistent articulation/phonological disorders who exhibited differentiated electropalatographic gestures (9.58 and 10 years), one child with persistent articulation/phonological disorder who demonstrated undifferentiated lingual gestures (11 years), and a group of four control children (mean age=10.98 years, standard deviation=0.48). The children were asked to read aloud single-syllable words containing word-initial /t, s, k/ consonants, with tongue tip and tongue body movements recorded using the electromagnetic articulography AG200 system (Carstens Medizinelektronik GmbH, Germany). Outcomes & Results: Kinematic analysis revealed increased kinematic values for /s/ for the two children with articulation/phonological disorders and differentiated electropalatographic gestures compared with the control group. One of these children also exhibited increased /k/ duration. Reduced acceleration was exhibited by one child with differentiated electropalatographic gestures during /t/ production, and by the child with undifferentiated lingual gestures during /k/. Regarding coordination, lag times between the tongue tip and body were variable between and within children. Spatial contribution to consonant production discriminated between the children with differentiated electropalatographic gestures and undifferentiated lingual gestures, with excessive movement of the tongue body exhibited for alveolar consonants by the child with undifferentiated lingual gestures. Conclusions: All three of the children with articulation/phonological disorders demonstrated aberrant lingual kinematics. The child who exhibited undifferentiated lingual gestures further exhibited excess tongue body movement during alveolar consonants, suggestive of poor motor control, an immature or deviant bracing system, and/or a compensatory mechanism to counteract potential disturbances in tongue tip fine motor control. Electromagnetic articulography provided a means of examining speech motor control deficits, including disturbances in tongue movement and coordination, in children with articulation/phonological disorders.	Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia; La Trobe Univ, Sch Human Commun Sci, Bundoora, Vic, Australia; Queen Margaret Univ Coll, Edinburgh, Midlothian, Scotland	Goozee, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	j.goozee@uq.edu.au	Hill, Anne/F-4106-2010; Gibbon, Fiona E/J-8255-2013; Murdoch, Bruce E/C-1397-2012	Hill, Anne/0000-0003-3907-8369; 			Broomfield J, 2004, INT J LANG COMM DIS, V39, P303, DOI 10.1080/13682820310001625589; Cheng HY, 2005, J MED SPEECH-LANG PA, V13, P15; DODD B, 1995, DIFFERANTIAL DIAGNOS; Farnetani E., 1997, HDB PHONETIC SCI, P371; Fisher H., 1971, FISHER LOGEMANN TEST; Fletcher S. G., 1992, ARTICULATION PHYSIOL; Gibbon FE, 2002, PERCEPT MOTOR SKILL, V95, P295, DOI 10.2466/PMS.95.4.295-307; Gibbon FE, 1999, J SPEECH LANG HEAR R, V42, P382, DOI 10.1044/jslhr.4202.382; GIBBON FE, 1999, P ICPHS SAN FRANC CA, P1913; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; GRUNWELL P, 1990, DEV SPEECH DISORDERS; HARDCASTLE WJ, 1976, PHYSIOL SPEECH PRODU; HAYDEN D, 1990, VERBAL MOTOR PRODUCT; HOWARD S, 1998, THESIS U SHEFFIELD S; Howard S. J., 1994, P 3 C INT CLIN PHON, P67; Kuehn D. P., 1976, J PHONETICS, V4, P303; Law J, 2000, INT J LANG COMM DIS, V35, P165, DOI 10.1080/136828200247133; LEONARD LB, 1995, HDB CHILD LANGUAGE, P573; Morley M. E., 1957, DEV DISORDERS SPEECH; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; Nguyen N, 1996, J PHONETICS, V24, P77, DOI 10.1006/jpho.1996.0006; STONE M, 1991, J PHONETICS, V19, P309, DOI 10.1016/S0095-4470(19)30347-X; WEISS CE, 1980, WEISS COMPREHENSIVE; Wilcox K. A., 1999, CHILDRENS SPEECH INT; Yorkston K.M., 1981, ASSESSMENT INTELLIGI	26	16	21	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1368-2822			INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	NOV-DEC	2007	42	6					703	724		10.1080/13682820601104960			22	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	239IE	WOS:000251511200005	17852538				2021-06-18	
J	Patel, P; Meltzer, CC; Mayberg, HS; Levine, K				Patel, Purvak; Meltzer, Carolyn Cidis; Mayberg, Helen S.; Levine, Kay			The role of imaging in United States courtrooms	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN INJURY; DIFFUSION-WEIGHTED MR; WHITE-MATTER CHANGES; CLINICAL-APPLICATIONS; GLUCOSE-METABOLISM; MALPRACTICE ISSUES; FDG-PET; PERFUSION; RADIOLOGY	The rapid evolution of brain imaging techniques has increasingly offered more detailed diagnostic and prognostic information about neurologic and psychiatric disorders and the structural and functional brain changes that may influence behavior. Coupled with these developments is the increasing use of neuroimages in courtrooms, where they are used as evidence in criminal cases to challenge a defendant's competency or culpability and in civil cases to establish physical injury or toxic exposure. Several controversies exist, including the admissibility of neuroimages in legal proceedings, the reliability of expert testimony, and the appropriateness of drawing conclusions in individual cases based on the findings of research uses of imaging technology. This article reviews and discusses the current state of these issues.	Emory Univ Hosp, Dept Radiol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Woodruff Mem Res Bldg, Atlanta, GA 30322 USA; Emory Univ, Atlanta, GA 30322 USA	Meltzer, CC (corresponding author), Emory Univ Hosp, Dept Radiol, 1364 Clifton Rd NE, Atlanta, GA 30322 USA.	cmeltze@emory.edu					Aizenstein HJ, 2004, J COGNITIVE NEUROSCI, V16, P786, DOI 10.1162/089892904970681; *AM COLL RAD, 2002, STAND 2002 2003, P7; *AM MED ASS COUNC, 2000, COD MED ETH, P210; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; BAILEY E, 2000, LOG ANGELES TIM 0615, P3; Benedict RHB, 1998, NEUROREPORT, V9, P121, DOI 10.1097/00001756-199801050-00024; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Berlin L, 2003, AM J ROENTGENOL, V181, P29, DOI 10.2214/ajr.181.1.1810029; Berlin L, 2003, AM J ROENTGENOL, V180, P1515, DOI 10.2214/ajr.180.6.1801515; BUCHSBAUM MS, 1992, ARCH GEN PSYCHIAT, V49, P935; Castillo M, 2000, SEMIN ULTRASOUND CT, V21, P417, DOI 10.1016/S0887-2171(00)90034-9; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Claus JJ, 1996, EUR J NUCL MED, V23, P675, DOI 10.1007/BF00834530; Covarrubias DJ, 2004, ONCOLOGIST, V9, P528, DOI 10.1634/theoncologist.9-5-528; De Reuck J, 2003, EUR NEUROL, V49, P131, DOI 10.1159/000069075; Deshmukh A, 1996, CLIN NUCL MED, V21, P720, DOI 10.1097/00003072-199609000-00010; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; Di Costanzo A, 2006, NEURORADIOLOGY, V48, P622, DOI 10.1007/s00234-006-0102-3; Dumit J, 1999, SCI CONTEXT, V12, P173, DOI 10.1017/S0269889700003355; Ge YL, 2005, ANN NY ACAD SCI, V1064, P202, DOI 10.1196/annals.1340.039; Korf J, 1997, ACTA NEUROL BELG, V97, P200; Kulynych J, 1997, STANFORD LAW REV, V49, P1249, DOI 10.2307/1229252; KULYNYCH J, 1996, JURIMETRICS J, V36, P235; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; Lundbom N, 1999, MAGNET RESON MED, V41, P841, DOI 10.1002/(SICI)1522-2594(199904)41:4<841::AID-MRM25>3.0.CO;2-T; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Meltzer CC, 1999, J GERIATR PSYCH NEUR, V12, P137, DOI 10.1177/089198879901200307; MELTZER CC, 1990, J COMPUT ASSIST TOMO, V14, P561, DOI 10.1097/00004728-199007000-00011; MIRSEN TR, 1991, ARCH NEUROL-CHICAGO, V48, P1015, DOI 10.1001/archneur.1991.00530220031015; MORSE S, 2005, OHIO STATE J CRIMINA, V3, P1; Morse S.J., 2006, OHIO STATE J CRIMINA, V3, P397; Nakamizo A, 2002, J CLIN NEUROSCI, V9, P685, DOI 10.1054/jocn.2002.1146; Narr KL, 2007, NEUROIMAGE, V34, P939, DOI 10.1016/j.neuroimage.2006.08.052; Orbach DB, 2006, J MAGN RESON IMAGING, V24, P16, DOI 10.1002/jmri.20612; Powers WJ, 2003, NEUROIMAG CLIN N AM, V13, P741, DOI 10.1016/S1052-5149(03)00091-1; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Razavi M, 2003, HUM BRAIN MAPP, V20, P227, DOI 10.1002/hbm.10141; Reed LJ, 1999, MEMORY, V7, P599, DOI 10.1080/096582199387779; Ricker JH, 2000, J HEAD TRAUMA REHAB, V15, P859, DOI 10.1097/00001199-200004000-00007; Schaefer PW, 2001, J NEUROIMAGING, V11, P369, DOI 10.1111/j.1552-6569.2001.tb00065.x; Tieleman A, 2007, INVEST RADIOL, V42, P130, DOI 10.1097/01.rli.0000251579.05052.08; Tikkakoski T, 2006, ACTA RADIOL, V47, P445, DOI 10.1080/02841850600692880; TSURUDA JS, 1990, AM J NEURORADIOL, V11, P925; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x; Wilson J, 1996, J NUCL MED, V37, P1256; Yue NC, 1997, RADIOLOGY, V202, P33, DOI 10.1148/radiology.202.1.8988189; 2004, ACR CENSURES RADIOLO; 2005, Patent No. 1868046	53	16	16	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	NOV	2007	17	4					557	+		10.1016/j.nic.2007.07.001			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	236OT	WOS:000251313300015	17983970				2021-06-18	
J	Shelton, C; Shryock, M				Shelton, Charity; Shryock, Meg			Effectiveness of communication/interaction strategies with patients who have neurological injuries in a rehabilitation setting	BRAIN INJURY			English	Article						traumatic brain injury; acquired brain injury; interactions; communication strategies	INDIVIDUALS; APHASIA	Primary objective: A correlational research design was used to examine the relationship between use of interaction strategies and success of interactions between patients with neurological injuries and licensed healthcare providers. It was hypothesized that using specific interaction strategies would increase the success of interactions between patients and staff. Methods and procedures: One hundred and two 5-minute interactions between licensed healthcare providers and adults with neurogenic cognitive-linguistic impairments were videotaped. Staff members involved in the interactions completed a questionnaire stating how successful they felt the interaction was and what positively or negatively impacted the interaction. Five speech-language pathologists viewed the interactions, rated the overall success of each, reported which interaction strategies they observed being used and indicated which strategies they felt most positively impacted the interactions. Results: Use of communication strategies aided the interactions. It was found that as more strategies were used success of the interactions increased. Conclusions: Interactions were aided by the use of communication strategies, especially when multiple strategies were used. Some strategies were more beneficial than others. Training staff in the use of communication strategies may help improve patients' satisfaction and success in rehabilitation.	[Shelton, Charity; Shryock, Meg] Missouri Rehabil Ctr, Traumat Brain Injury Program, Mt Vernon, MO 65712 USA	Shelton, C (corresponding author), Missouri Rehabil Ctr, Traumat Brain Injury Program, 600 N Main, Mt Vernon, MO 65712 USA.	sheltoncf@health.missouri.edu					Braunack-Mayer A, 2001, J CLIN ETHIC, V12, P388; Brown S J, 1994, Clin Nurs Res, V3, P43, DOI 10.1177/105477389400300105; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; Elwyn G, 2001, J EVAL CLIN PRACT, V7, P211, DOI 10.1046/j.1365-2753.2001.00286.x; Gorter S, 2002, J RHEUMATOL, V29, P1496; Hafsteinsdottir TB, 1997, J ADV NURS, V26, P580, DOI 10.1046/j.1365-2648.1997.t01-19-00999.x; JENKINS K, 2002, ESTNA ERCA J, V3, P145; Kaakinen J, 2001, J Am Acad Nurse Pract, V13, P325, DOI 10.1111/j.1745-7599.2001.tb00044.x; MARTIN L, 1989, J AM ACAD NURSE PRAC, V3, P77; Murray LL, 1998, J SPEECH LANG HEAR R, V41, P213, DOI 10.1044/jslhr.4101.213; Murray LL, 1997, J SPEECH LANG HEAR R, V40, P792, DOI 10.1044/jslhr.4004.792; PASHEK GV, 1982, J SPEECH HEAR RES, V25, P377, DOI 10.1044/jshr.2503.377; *REUT, 2003, CALLS DOCT IMPR COMM; Small JA, 2003, J SPEECH LANG HEAR R, V46, P353, DOI 10.1044/1092-4388(2003/028); Tang PC, 1998, J AM MED INFORM ASSN, V5, P563, DOI 10.1136/jamia.1998.0050563; TOMPKINS CA, 1994, J SPEECH HEAR RES, V37, P896, DOI 10.1044/jshr.3704.896; *UB FDN ACT INC, 1996, GUID UN DAT SET MED	17	16	16	0	9	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2007	21	12					1259	1266		10.1080/02699050701716935			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	249HP	WOS:000252219200005	18236201				2021-06-18	
J	Mao, H; Polensek, SH; Goldstein, FC; Holder, CA; Ni, CC				Mao, Hui; Polensek, Sharon H.; Goldstein, Felicia C.; Holder, Chad A.; Ni, Chunchun			Diffusion tensor and functional magnetic resonance imaging of diffuse axonal injury and resulting language impairment	JOURNAL OF NEUROIMAGING			English	Article						diffusion tensor imaging; brain injury; white matter; magnetic resonance imaging; connectivity; fMRI; aphasia	WHITE-MATTER; BRAIN-INJURY; ANATOMY	Diffuse axonal injury (DAI) is a common aftermath of brain trauma. The diagnosis of DAI is often difficult using conventional magnetic resonance imaging (MRI). We report a diffusion tensor imaging (DTI) study of a patient who sustained DAI presenting with language impairment. Fractional anisotropy (FA) and DTI tractography revealed a reduction of white matter integrity in the left frontal and medial temporal areas. White matter damage identified by DTI was correlated with the patient's language impairment as assessed by functional MRI (fMRI) and a neuropsychological exam. The findings demonstrate the utility of DTI for identifying white matter changes secondary to traumatic brain injury (TBI).	Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA	Mao, H (corresponding author), Emory Univ, Sch Med, Dept Radiol, EUH Suite AG10,1364 Clifton Rd, Atlanta, GA 30322 USA.	hmao@emory.edu					Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Mamata H, 2002, AM J NEURORADIOL, V23, P67; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Votaw JR, 1999, NEUROIMAGE, V10, P347, DOI 10.1006/nimg.1999.0471; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640	12	16	17	0	8	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1051-2284			J NEUROIMAGING	J. Neuroimaging	OCT	2007	17	4					292	294		10.1111/j.1552-6569.2007.00146.x			3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	215RP	WOS:000249827000003	17894615				2021-06-18	
J	Oster, TJ; Anderson, A; Filley, CM; Wortzel, HS; Arciniegas, DB				Oster, Timothy J.; Anderson, Alan; Filley, Christopher M.; Wortzel, Hal S.; Arciniegas, David B.			Quetiapine for mania due to traumatic brain injury	CNS SPECTRUMS			English	Article							ATYPICAL ANTIPSYCHOTIC TREATMENT; BIPOLAR DISORDER; HEAD-INJURY; SCHIZOPHRENIA; HALOPERIDOL; RISPERIDONE; OLANZAPINE; PSYCHOSIS; VALPROATE; CARBAMAZEPINE	Secondary mania develops in as many as 9% of persons with traumatic brain injuries. The treatment of posttraumatic mania is not well defined, and agents traditionally used for the treatment of idiopathic manic episodes may not be well suited for use among individuals wit h traumatic brain injuries. Atypical antipsychotics are indicated for the treatment of idiopathic bipolar disorder, and have been used for other purposes among individuals with posttraumatic neu ro psychiatric disturbances. This article offers the first description of the treatment of posttraumatic mania using the atypical antipsychotic quetiapine. Beneficial effects of this agent on posttraumatic mania, cognitive impairments, and functional disability in the subacute post-injury period are described. Possible mechanisms of action are discussed and the need for additional investigation of quetiapine for posttraumatic mania is highlighted.	Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Denver, CO 80262 USA; HealthONE Spalding Rehabil Hosp, Brain Injury Rehabil Unit, Aurora, CO USA; Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Boulder, CO 80309 USA; Denver Vet Affairs Med Ctr, VISN MIRECC 19, Denver, CO USA	Arciniegas, DB (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Campus Box C268-25,4200 E 9th Ave, Denver, CO 80262 USA.	David.Arciniegas@UCHSC.edu	Arciniegas, David/A-3792-2009				[Anonymous], 1997, GUIDE UNIFORM DATA S; Arciniegas DB, 2003, INT REV PSYCHIATR, V15, P328, DOI 10.1080/09540260310001606719; ARCINIEGAS DB, 2000, CURRENT TREATMENT OP, V2, P169; Bennouna M, 2005, J CLIN PSYCHOPHARM, V25, P505, DOI 10.1097/01.jcp.0000177851.31157.66; Bilder RM, 2002, AM J PSYCHIAT, V159, P1018, DOI 10.1176/appi.ajp.159.6.1018; BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; BOUVY PF, 1988, ACTA PSYCHIAT SCAND, V77, P361, DOI 10.1111/j.1600-0447.1988.tb05136.x; Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; Bymaster FP, 2001, EUR J PHARMACOL, V430, P341, DOI 10.1016/S0014-2999(01)01399-1; Cole P, 2004, DRUG TODAY, V40, P837, DOI 10.1358/dot.2004.40.10.863744; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P177, DOI 10.1097/00001199-200303000-00008; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; Harvey PD, 2006, J NEUROPSYCH CLIN N, V18, P54, DOI 10.1176/appi.neuropsych.18.1.54; Harvey PD, 2006, J CLIN PSYCHIAT, V67, P14; Hornstein A, 1989, J Neuropsychiatry Clin Neurosci, V1, P446; Ichikawa J, 2002, BRAIN RES, V956, P349, DOI 10.1016/S0006-8993(02)03570-9; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Krieger D, 2003, NEUROREHABILITATION, V18, P205; MacQueen G, 2003, BIPOLAR DISORD, V5, P53, DOI 10.1111/j.1399-2406.2003.00059.x; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Monji A, 1999, PSYCHOSOMATICS, V40, P448, DOI 10.1016/S0033-3182(99)71215-6; Murai T, 2003, BRAIN INJURY, V17, P355, DOI 10.1080/0269905031000070170; Mustafa B, 2005, J NEUROPSYCH CLIN N, V17, P122, DOI 10.1176/appi.neuropsych.17.1.122; Nasrallah HA, 2002, J CLIN PSYCHIAT, V63, P12; Newman-Tancredi A, 1998, EUR J PHARMACOL, V355, P245, DOI 10.1016/S0014-2999(98)00483-X; Perlis RH, 2006, J CLIN PSYCHIAT, V67, P509, DOI 10.4088/JCP.v67n0401; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Randolph C., 1998, RBANS MANUAL REPEATA; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Serretti A, 2004, CURR MED CHEM, V11, P343, DOI 10.2174/0929867043456043; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; STEWART JT, 1988, J CLIN PSYCHIAT, V49, P74; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temple M J, 2003, J R Army Med Corps, V149, P54; Tyson PJ, 2004, INT J NEUROSCI, V114, P593, DOI 10.1080/00207450490430552; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Velligan DI, 2003, J CLIN PSYCHIAT, V64, P524, DOI 10.4088/JCP.v64n0505; Vieta E, 2005, BIPOLAR DISORD, V7, P21, DOI 10.1111/j.1399-5618.2005.00212.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weickert TW, 2003, NEUROPSYCHOPHARMACOL, V28, P1491, DOI 10.1038/sj.npp.1300216; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; YASSA R, 1994, J GERIATR PSYCH NEUR, V7, P55, DOI 10.1177/089198879400700110; Yatham LN, 2005, J CLIN PSYCHIAT, V66, P40; Yumru M, 2007, J AFFECT DISORDERS, V98, P247, DOI 10.1016/j.jad.2006.08.009	59	16	16	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1092-8529	2165-6509		CNS SPECTRUMS	CNS Spectr.	OCT	2007	12	10					764	769		10.1017/S1092852900015455			6	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	223HE	WOS:000250359900010	17934381				2021-06-18	
J	Shirakawa, T; Nakano, K; Hachiya, NS; Kato, N; Kaneko, K				Shirakawa, Takafumi; Nakano, Kenji; Hachiya, Naomi S.; Kato, Nobumasa; Kaneko, Kiyotoshi			Temporospatial patterns of COX-2 expression and pyramidal cell degeneration in the rat hippocampus after trimethyltin administration	NEUROSCIENCE RESEARCH			English	Article						cyclooxygenase-2 (COX-2); trimethyltin (TMT); CA1; CA3; neuronal degeneration; plasma corticosterone concentration	TRAUMATIC BRAIN-INJURY; RECOMBINANT HUMAN INTERLEUKIN-1-BETA; II GLUCOCORTICOID-RECEPTORS; NECROSIS-FACTOR-ALPHA; NEURONAL DEATH; MESSENGER-RNA; CYCLOOXYGENASE-2 EXPRESSION; TIME-COURSE; CORTICOSTERONE; ISCHEMIA	The temporospatial profile of cyclooxygenase-2 (COX-2) expression and neuronal degeneration following trimethyltim (TMT) administration was investigated in the rat hippocampus region. In the CA] region, significant COX-2 expression was detected on day 3 after TMT administration but pyramidal cell degeneration was detected only on day 5 and thereafter. In the CA3 region, on the other hand, the constitutive COX-2 expression remained unchanged, and more severe pyramidal cell degeneration started on day 3. Concomitant with these observations, we observed that the coadministration of a COX-2 inhibitor prevented such neuronal degeneration only in the CAI region and not in the CA3 region. In addition, COX-2 inhibition did not affect the increase in the plasma corticosterone concentration after TMT administration. Furthermore, the COX-2 inhibitor did not alleviate TMT-induced locomotor hyperactivity in rats, for which inhibitors of corticosterone synthesis are known to be effective. These data suggest that the COX-2-dependent pathway appears to assist TMT-induced degeneration of CA] pyramidal cells but not CA3 pyramidal cells in a corticosterone-independent manner. (C) 2007 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	Astellas Pharma Inc, Drug Safety Res Labs, Drug Discovery Res, Itabashi Ku, Tokyo 1748511, Japan; Astellas Res Serv Co Ltd, Dept Pathol, Itabashi Ku, Tokyo 1748511, Japan; Tokyo Med Univ, Dept Physiol, Shinjuku Ku, Tokyo 1608402, Japan; Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan	Shirakawa, T (corresponding author), Astellas Pharma Inc, Drug Safety Res Labs, Drug Discovery Res, Itabashi Ku, 1-1-8 Azusawa, Tokyo 1748511, Japan.	takafumi.shirakawa@jp.astellas.com					ARIASNEGRETE S, 1995, BIOCHEM BIOPH RES CO, V208, P582, DOI 10.1006/bbrc.1995.1378; Baik EJ, 1999, BRAIN RES, V843, P118, DOI 10.1016/S0006-8993(99)01797-7; BOULDIN TW, 1981, AM J PATHOL, V104, P237; Candore G, 2006, ANN NY ACAD SCI, V1089, P472, DOI 10.1196/annals.1386.008; Casolini P, 2002, J NEUROSCI RES, V68, P337, DOI 10.1002/jnr.10192; CHANG LW, 1983, NEUROBEH TOXICOL TER, V5, P443; Choi JS, 2006, NEUROSCI LETT, V393, P231, DOI 10.1016/j.neulet.2005.09.074; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dayton ET, 1996, J NEUROIMMUNOL, V71, P11, DOI 10.1016/S0165-5728(96)00111-7; DYER RS, 1982, NEUROBEH TOXICOL TER, V4, P141; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; Govoni S, 2001, NEUROSCI LETT, V303, P91, DOI 10.1016/S0304-3940(01)01675-5; Harry GJ, 2002, TOXICOL APPL PHARM, V180, P205, DOI 10.1006/taap.2002.9390; Hayley S, 1999, J NEUROSCI, V19, P5654; Ikeda M, 1996, BRAIN RES, V712, P168, DOI 10.1016/0006-8993(95)01530-2; Imai H, 1998, NEUROTOXICOLOGY, V19, P163; Imai H, 2001, EXP NEUROL, V171, P22, DOI 10.1006/exnr.2001.7725; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Ishikura N, 2001, NEUROSCI LETT, V306, P157, DOI 10.1016/S0304-3940(01)01887-0; Kawaguchi K, 2005, BRAIN RES, V1050, P130, DOI 10.1016/j.brainres.2005.05.038; Kim DK, 2006, INT J EXP PATHOL, V87, P73, DOI 10.1111/j.0959-9673.2006.00457.x; Kim HC, 2000, BRAIN RES, V874, P15, DOI 10.1016/S0006-8993(00)02560-9; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Koistinaho J, 1999, STROKE, V30, P1900, DOI 10.1161/01.STR.30.9.1900; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; LINTHORST ACE, 1994, ENDOCRINOLOGY, V135, P520, DOI 10.1210/en.135.2.520; Liu Y, 2004, NEUROSCI RES, V50, P209, DOI 10.1016/j.neures.2004.06.019; Matsuoka Y, 1999, J CEREBR BLOOD F MET, V19, P1247, DOI 10.1097/00004647-199911000-00009; Nishimura T, 2001, MOL BRAIN RES, V97, P1, DOI 10.1016/S0169-328X(01)00278-9; Nogawa S, 1997, J NEUROSCI, V17, P2746; Parsadaniantz SM, 1999, NEUROENDOCRINOLOGY, V69, P77, DOI 10.1159/000054405; ROBERTSON DG, 1987, TOXICOL PATHOL, V15, P7, DOI 10.1177/019262338701500102; RUPPERT PH, 1982, NEUROBEH TOXICOL TER, V4, P135; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Swanson L.W., 1992, BRAIN MAPS STRUCTURE; Takemiya T, 2006, NEUROSCI RES, V56, P103, DOI 10.1016/j.neures.2006.06.003; Tsunashima K, 1998, SYNAPSE, V29, P333; Tsutsumi S, 2002, EXP NEUROL, V173, P86, DOI 10.1006/exnr.2001.7824; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WOODRUFF ML, 1988, EXP NEUROL, V102, P130, DOI 10.1016/0014-4886(88)90086-6; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T	43	16	16	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102			NEUROSCI RES	Neurosci. Res.	OCT	2007	59	2					117	123		10.1016/j.neures.2007.06.1468			7	Neurosciences	Neurosciences & Neurology	224VQ	WOS:000250475500001	17651852				2021-06-18	
J	Akpinar, E; Koroglu, M; Ptak, T				Akpinar, Erhan; Koroglu, Mert; Ptak, Thomas			Diffusion tensor MR imaging in pediatric head trauma	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						DTL; head trauma; pediatric	WHITE-MATTER INJURY; GLASGOW COMA SCALE; AXONAL INJURY; BRAIN-INJURY; CHILDREN; ABNORMALITIES; SCORE; CT	Purpose: We propose to investigate the fractional anisotropy (FA) values in pediatric patients with closed head trauma and correlate them with the initial Glasgow Coma Scale (GCS). Materials and Methods: A retrospective evaluation of 24 pediatric patients (15 men, 9 women; mean age, 13 years; range, 2-18 years) who underwent both unenhanced head computed tomography and cerebral magnetic resonance imaging (MRI), including the tenser diffusion sequence, within 30 days of the incident. Twenty-two atraumatic control patients (9 men, 13 women; mean age, 9 years; range, 4-17 years) were randomly selected from the records of the radiology department within the same period. Fractional anisotropy measurements were taken from each of 6 major white matter volumes. Data extracted from the record of each subject included GCS, initial head computed tomographic results, and length of hospital stay. Kruskal-Wallis and t tests were used for statistical evaluation. Results: The mean acute score on the GCS was 9.7 +/- 5. Mean duration of hospitalization days was 8.7 +/- 10. Statistically significant differences in mean FA values between trauma and control subjects were noted in corpus callosum. Trauma patients with positive findings on MRI and with GCS less than 10 also had lower FA values than patients with GCS greater than 10 and patients who had normal MRI findings. There was a negative correlation between time to discharge and FA values. Conclusions: In pediatric head trauma, MRI diffusion FA measurements can show abnormalities despite normal-appearing brain MRI findings. Larger investigations are required to verify the stability of correlations.	Hacettepe Univ, Fac Med, Dept Radiol, Ankara, Turkey; Massachusetts Gen Hosp, Harvard Med Sch, Div Emergency Radiol, Boston, MA USA; Suleyman Demirel Univ, Fac Med, Dept Radiol, Isparta, Turkey	Akpinar, E (corresponding author), Hacettepe Univ, Fac Med, Dept Radiol, Ankara, Turkey.	erhan.akpinar@gmail.com					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1984, GREENFIELDS NEUROPAT, V85, P124; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; DUHAIME AC, 1992, PEDIATRICS, V90, P179; GENNARELLI TA, 1991, J EMERGENCY MED, V11, P5; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; Gupta RK, 2006, J MAGN RESON IMAGING, V24, P549, DOI 10.1002/jmri.20677; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jang SH, 2006, RESTOR NEUROL NEUROS, V24, P25; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; SMITH NC, 1995, PARASITOL TODAY, V12, P4; STRICH SJ, 1961, LANCET, V1, P2443; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Teasdale G, 1992, J NEUROTRAUMA S1, V9, P249	28	16	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-8715			J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	SEP-OCT	2007	31	5					657	661		10.1097/RCT.0b013e318033df1a			5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	217RK	WOS:000249964800001	17895772				2021-06-18	
J	Quintana, A; Molinero, A; Florit, S; Manso, Y; Comes, G; Carrasco, J; Giralt, M; Borup, R; Nielsen, FC; Campbell, IL; Penkowa, M; Hidalgo, J				Quintana, Albert; Molinero, Amalia; Florit, Sergi; Manso, Yasmina; Comes, Gemma; Carrasco, Javier; Giralt, Mercedes; Borup, Rehannah; Nielsen, Finn Cilius; Campbell, Iain L.; Penkowa, Milena; Hidalgo, Juan			Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: From gene to behavior	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article; Proceedings Paper	Meeting on Molecular Aspects of Aging and Development Toxciology and Neuroimmuno Communications	2005	Barcelona, SPAIN				TUMOR-NECROSIS-FACTOR; ASTROCYTE-TARGETED EXPRESSION; KAPPA-B ACTIVATION; I PLUS II; METALLOTHIONEIN-I; TRANSGENIC MICE; NERVOUS-SYSTEM; OXIDATIVE STRESS; ISCHEMIC STROKE; MESSENGER-RNA	Cytokines, such as tumour necrosis factor (TNF)-alpha and lymphotoxin-alpha, have been described widely to play important roles in the brain in physiologic conditions and after traumatic injury. However, the exact mechanisms involved in their function have not been fully elucidated. We give some insight on their role by using animals lacking either Type 1 receptor (TNFR1 KO) or Type 2 (TNFR2KO) and their controls (C57Bl/6). Both TNFR1 KO and to a greater extent TNFR2KO mice showed increased exploration/activity neurobehavioral traits in the hole board test, such as rearings, head clippings, and ambulations, compared with wild-type mice, suggesting an inhibitory role of TNFR1/TNFR2 signaling. In contrast, no significant differences were observed in the elevated plus maze test, ruling out a major role of these receptors in the control of anxiety. We next evaluated the response to a freeze injury to the somatosensorial cortex. The effect of the cryolesion on motor function was evaluated with the horizontal ladder beam test, and the results showed that both TNFR1 KO and TNFR2KO mice made fewer errors, suggesting a detrimental role for TNFR1/TNFR2 signaling for coping with brain damage. Expression of similar to 22600 genes was analyzed using an Affymetrix chip (MOE430A) at 0 (unlesioned), 1, or 4 days post-lesion in the three strains. The results show a unique and major role of both TNF receptors on the pattern of gene expression elicited by the injury but also in normal conditions, and suggest that blocking of TNFR1/TNFR2 receptors may be beneficial after a traumatic brain injury. (C) 2006 Wiley-Liss, Inc.	Univ Autonoma Barcelona, Fac Ciencias, Unidad Fisiol Anim, Dept Biol Celular Fisiol & Immunol, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Fac Ciencias, Unidad Fisiol Anim, Inst Neurosci, E-08193 Barcelona, Spain; Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Univ Copenhagen, Fac Hlth Sci, Ctr Inflammat & Metab, Sect Neuroprot, DK-1168 Copenhagen, Denmark	Hidalgo, J (corresponding author), Univ Autonoma Barcelona, Fac Ciencias, Unidad Fisiol Anim, Dept Biol Celular Fisiol & Immunol, E-08193 Barcelona, Spain.	Juan.Hidalgo@uab.es	Quintana, Albert/N-5544-2015; Carrasco, Javier/C-9732-2011; Giralt, Mercedes/K-1626-2014; molinero, amalia/K-2147-2014; Nielsen, Finn Cilius/AAA-4926-2020; Hidalgo, Juan/C-9082-2011	Quintana, Albert/0000-0003-1674-7160; Carrasco, Javier/0000-0001-6436-0863; Giralt, Mercedes/0000-0002-1806-1528; molinero, amalia/0000-0001-8661-8570; Hidalgo, Juan/0000-0003-0921-1122; Manso Sanz, Yasmina/0000-0002-5788-4180; Nielsen, Finn Cilius/0000-0002-9829-1031	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH062231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036979] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH62231] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36979] Funding Source: Medline		Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Armario A, 1998, J NEUROIMMUNOL, V92, P160, DOI 10.1016/S0165-5728(98)00199-4; BLUETHMANN H, 1994, J LEUKOCYTE BIOL, V56, P565; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; CAMPBELL IL, 1994, J IMMUNOL, V152, P716; Campbell IL, 1998, BRAIN RES REV, V26, P327, DOI 10.1016/S0165-0173(97)00038-6; Carrasco J, 1998, EXP NEUROL, V153, P184, DOI 10.1006/exnr.1998.6861; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; Cook JL, 1998, MOL BRAIN RES, V55, P9, DOI 10.1016/S0169-328X(97)00350-1; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.3.CO;2-1; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; Fiore M, 1998, PHYSIOL BEHAV, V63, P571, DOI 10.1016/S0031-9384(97)00514-3; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Gebicke-Haerter PJ, 2005, J NEUROSCI RES, V81, P327, DOI 10.1002/jnr.20479; Gilks CB, 1998, AM J PATHOL, V152, P269; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hidalgo J, 2002, METHOD ENZYMOL, V348, P238, DOI 10.1016/S0076-6879(02)48642-9; Kim GM, 2001, J NEUROSCI, V21, P6617; Kury P, 2004, EUR J NEUROSCI, V19, P1708, DOI 10.1111/j.1460-9568.2004.03226.x; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lee YS, 1999, J AM ASSOC GYN LAP, V6, P59, DOI 10.1016/S1074-3804(99)80042-5; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; Pawlak CR, 2003, NEUROSCI LETT, V341, P205, DOI 10.1016/S0304-3940(03)00184-8; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 1999, J NEUROSCI, V19, P2535; Penkowa M, 2006, FEBS J, V273, P1857, DOI 10.1111/j.1742-4658.2006.05207.x; Penkowa M, 2006, J NEUROSCI RES, V84, P1452, DOI 10.1002/jnr.21043; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Raivich G, 2003, J NEUROSCI RES, V72, P726, DOI 10.1002/jnr.10621; Raivich G, 2002, EXP NEUROL, V178, P186, DOI 10.1006/exnr.2002.8024; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Read SJ, 2001, J CEREBR BLOOD F MET, V21, P755, DOI 10.1097/00004647-200107000-00001; Roth A, 2003, MOL CELL NEUROSCI, V22, P353, DOI 10.1016/S1044-7431(02)00039-8; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Sayer FT, 2002, EXP NEUROL, V175, P282, DOI 10.1006/exnr.2002.7901; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	67	16	16	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	SEP	2007	85	12					2668	2685		10.1002/jnr.21126			18	Neurosciences	Neurosciences & Neurology	212BO	WOS:000249568800016	17131423				2021-06-18	
J	Starling, SP; Sirotnak, AP; Heisler, KW; Ames-Eley, MLB				Starling, Suzanne P.; Sirotnak, Andrew P.; Heisler, Kurt W.; Ames-Eley, Myra L. B.			Inflicted skeletal trauma: The relationship of perpetrators to their victims	CHILD ABUSE & NEGLECT			English	Article						fractures; child abuse; perpetrators	ABUSIVE HEAD TRAUMA; CHILD-ABUSE; FRACTURES; INJURIES; VIOLENCE	Objective: Although inflicted skeletal trauma is a very common presentation of child abuse, little is known about the perpetrators of inflicted skeletal injuries. Studies exist describing perpetrators of inflicted traumatic brain injury, but no study has examined characteristics of perpetrators of inflicted skeletal trauma. Methods: All cases of suspected child physical abuse evaluated by the child abuse evaluation teams at Vanderbilt University Medical Center (January 1996 to August 2000) and at the Children's Hospital at Denver (January 1996 to December 1999) were reviewed for the presence of fractures. All children with inflicted fractures were entered into the study, and demographic data, investigative data, and identity of perpetrators were collected. Results: There were a total of 630 fractures for 194 patients. The median number of fractures per patient was 2, and the maximum was 3 1. Sixty-three percent of children presented with at least one additional abusive injury other than the fracture(s). Perpetrators were identified in 79% of the cases. Nearly 68% of the perpetrators were male; 45% were the biological fathers. The median age of the children abused by males (4.5 months) significantly differed from the median age of those abused by females (10 months) (p =.003). Conclusion: In the cases where a perpetrator of inflicted fractures could be identified, the majority were men, most commonly the biological fathers. Children injured by men were younger than those injured by women. (C) 2007 Elsevier Ltd. All rights reserved.	Childrens Hosp Kings Daughters, Child Abuse Program, Norfolk, VA 23507 USA; Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; Univ Colorado, Childrens Hosp, Dept Pediat, Sch Med, Denver, CO 80202 USA	Starling, SP (corresponding author), Childrens Hosp Kings Daughters, Child Abuse Program, 935 Redgate Ave, Norfolk, VA 23507 USA.						Brenner RA, 1999, PEDIATRICS, V103, P968, DOI 10.1542/peds.103.5.968; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; Cramer KE, 1996, PEDIATR CLIN N AM, V43, P1035, DOI 10.1016/S0031-3955(05)70449-1; Eckenrode J, 2000, JAMA-J AM MED ASSOC, V284, P1385, DOI 10.1001/jama.284.11.1385; HYDEN PW, 1992, PEDIATR CLIN N AM, V39, P1053; Kotch JB, 1999, CHILD ABUSE NEGLECT, V23, P305, DOI 10.1016/S0145-2134(99)00003-4; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; Loder R T, 1991, J Orthop Trauma, V5, P428, DOI 10.1097/00005131-199112000-00007; Mathew MO, 1998, BRIT MED J, V317, P1117; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Starling SP, 2000, SOUTHERN MED J, V93, P463; STARLING SP, 1995, PEDIATRICS, V95, P259; WOLFNER GD, 1993, CHILD ABUSE NEGLECT, V17, P197, DOI 10.1016/0145-2134(93)90040-C; WORLOCK P, 1986, BRIT MED J, V293, P100, DOI 10.1136/bmj.293.6539.100	14	16	16	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134			CHILD ABUSE NEGLECT	Child Abuse Negl.	SEP	2007	31	9					993	999		10.1016/j.chiabu.2007.02.010			7	Family Studies; Psychology, Social; Social Work	Family Studies; Psychology; Social Work	228QX	WOS:000250745700006	17870159				2021-06-18	
J	Thomale, UW; Griebenow, M; Mautes, A; Beyer, TF; Dohse, NK; Stroop, R; Sakowitz, OW; Unterberg, AW; Stover, JF				Thomale, Ulrich W.; Griebenow, Martin; Mautes, Angelika; Beyer, Thomas F.; Dohse, Nils-Kristian; Stroop, Ralf; Sakowitz, Oliver W.; Unterberg, Andreas W.; Stover, John F.			Heterogeneous regional and temporal energetic impairment following controlled cortical impact injury in rats	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; microdialysis; magnetic resonance imaging; bioluminescence imaging; energy metabolism	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID GLUTAMATE; MITOCHONDRIAL DYSFUNCTION; GLUCOSE-UTILIZATION; CEREBRAL PERFUSION; EDEMA FORMATION; TISSUE-DAMAGE; EEG ACTIVITY; AMINO-ACIDS; HEAD-INJURY	Objectives: Following traumatic brain injury metabolic stability is impaired. Duration and reversibility of these changes might be important to guide specific interventions. Methods: To characterize temporal and regional changes in cerebral metabolism, 68 male Sprague-Dawley rats were subjected to a focal cortical contusion. Lesion progression and mitochondrial impairment were determined by magnetic resonance imaging (MRI) and triphenyl tetrazolium chloride (TTC) staining, respectively. Metabolic alterations were determined at hours 6 and 24 and day 7 by measuring extracellular glucose, lactate and hypoxanthine levels with microdialysis catheters placed adjacent and distant to the contusion and by quantifying changes in tissue ATP, lactate and glucose using bioluminescence imaging. Results: The cortical lesion reached its maximal extent at hour 24 and remained confined to the ipsilateral hemisphere. In microdialysate, at hour 6, extracellular hypoxanthine and lactate reached maximal values, thereafter hypoxanthine normalized while lactate remained increased. Extracellular glucose reached the highest values at hour 24 and remained elevated. Bioluminescence imaging revealed heterogeneous changes in areas distant to the contusion. No significant changes were found in ATP content. Slightly elevated tissue glucose until 24 hours in the ipsilateral hemisphere was observed. Following a continuous increase, lactate levels were the highest by 6 hours in the ipsilateral cortex and hippocampus. Discussion: CCI is associated with disturbances in energetic metabolism. Metabolic perturbation is not restricted to the early phase and the contusional region following focal cortical contusion, but also involves hippocampus and primarily uninjured parts of the hemisphere.	Med Univ Berlin, Dept Neurosurg, D-13353 Berlin, Germany; Univ Saarland, Univ Saarlandes Kliniken, Neurosurg Res Lab, D-66421 Homburg, Germany; Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany; Univ Zurich Hosp, Div Surg Intens Care Med, CH-8006 Zurich, Switzerland	Thomale, UW (corresponding author), Med Univ Berlin, Dept Neurosurg, Augustenburger Platz 1,Charite,Campus Virchow, D-13353 Berlin, Germany.	uthomale@charite.de		Misch, Martin/0000-0001-5283-5753			Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Deitmer JW, 2001, RESP PHYSIOL, V129, P71, DOI 10.1016/S0034-5687(01)00283-3; Dong GX, 2001, BRAIN RES, V903, P45, DOI 10.1016/S0006-8993(01)02379-4; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Gronlund KM, 1996, J NEUROPATH EXP NEUR, V55, P832, DOI 10.1097/00005072-199607000-00008; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; KELLY PAT, 1986, NEUROSCIENCE, V19, P257, DOI 10.1016/0306-4522(86)90019-9; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; LITSHITZ J, 2003, J CEREB BLOOD FLOW M, V23, P219; Maeda T, 1997, ACT NEUR S, V70, P102; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Marklund N, 2000, ACTA NEUROCHIR, V142, P1135, DOI 10.1007/s007010070042; Massa SM, 1996, CEREBROVAS BRAIN MET, V8, P95; Mautes AEM, 2001, J MOL NEUROSCI, V16, P33, DOI 10.1385/JMN:16:1:33; Minervini M, 1997, BRAIN RES, V768, P57, DOI 10.1016/S0006-8993(97)00547-7; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Nicholls DG, 1999, ANN NY ACAD SCI, V893, P1, DOI 10.1111/j.1749-6632.1999.tb07813.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Sims NR, 2000, DEV NEUROSCI-BASEL, V22, P366, DOI 10.1159/000017462; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Stover JF, 1997, NEUROSCI LETT, V238, P25, DOI 10.1016/S0304-3940(97)00840-9; Stover JF, 2003, J NEUROTRAUM, V20, P315, DOI 10.1089/089771503765172273; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; SUZUKI H, 1994, J AUTONOM NERV SYST, V49, pS173; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Waagepetersen HS, 2001, GLIA, V35, P246, DOI 10.1002/glia.1089; Weinzierl MR, 2002, J MOL NEUROSCI, V18, P247, DOI 10.1385/JMN:18:3:247; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2001, NEUROL RES, V23, P129, DOI 10.1179/016164101101198460; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505	55	16	16	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	SEP	2007	29	6					594	603		10.1179/016164107X166272			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	218GY	WOS:000250005200013	17535559	Green Accepted			2021-06-18	
J	Hao, H; Shreiber, DI				Hao, Hailing; Shreiber, David I.			Axon kinematics change during growth and development	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD INJURY; CLOSED-HEAD INJURY; OPTIC-NERVE; QUANTITATIVE-ANALYSIS; CYTOSKELETAL CHANGES; MECHANICAL TENSION; STRETCH INJURY; WHITE-MATTER; RAT	The microkinematic response of axons to mechanical stretch was examined in the developing chick embryo spinal cord during a period of rapid growth and myelination. Spinal cords were isolated at different days of embryonic (E) development post-fertilization (E12, E14, E16, and E18) and stretched 0%, 5%, 10%, 15%, and 20%, respectively. During this period, the spinal cord grew similar to 55% in length, and white matter tracts were myelinated significantly. The spinal cords were fixed with paraformaldehyde at the stretched length, sectioned, stained inununohistochemically for neurofilament proteins, and imaged with epifluorescence microscopy. Axons in unstretched spinal cords were undulated, or tortuous, to varying degrees, and appeared to straighten with stretch. The degree of tortuosity (ratio of the segment's pathlength to its end-to-end length) was quantified in each spinal cord by tracing several hundred randomly selected axons. The change in tormosity distributions with stretch indicated that axons switched from non-affine, uncoupled behavior at low stretch levels to affine, coupled behavior at high stretch levels, which was consistent with previous reports of axon behavior in the adult. guinea pig optic nerve (Bain, Shreiber and Meaney, J. Biomech. Eng., 125(6), pp. 798-804). A mathematical model previously proposed by Bain et al. was applied to quantify the transition in kinematic behavior. The results indicated that significant percentages of axons demonstrated purely non-affine behavior at each stage, but that this percentage decreased from 64% at E12 to 30% at E18. The decrease correlated negatively to increases in both length and myelination with development, but the change in axon kinematics could not be explained by stretch applied during physical growth of the spinal cord. The relationship between tissue-level and axonal-level deformation changes with development, which can have important implications in the response to physiological forces experienced during growth and trauma.	Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA	Hao, H (corresponding author), Rutgers State Univ, Dept Biomed Engn, 617 Bowser Rd, Piscataway, NJ 08854 USA.	shreiber@rci.rutgers.edu		Shreiber, David/0000-0001-8248-419X			Abe I, 2004, J ORTHOP RES, V22, P571, DOI 10.1016/j.orthres.2003.08.019; Anderson ES, 2000, J NEUROCYTOL, V29, P755, DOI 10.1023/A:1010994505741; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; BRAY D, 1984, DEV BIOL, V102, P379, DOI 10.1016/0012-1606(84)90202-1; Breig A., 1960, BIOMECHANICS CENTRAL; BUTT AM, 1994, J NEUROCYTOL, V23, P469, DOI 10.1007/BF01184071; Butt AM, 1998, J NEUROCYTOL, V27, P259; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; del Rio-Hortega P, 1922, B SOC ESP BIOL, V9, P25; del Rio-Hortega P., 1924, COMPT REND SOC BIOL, V91, P818; Fass JN, 2003, BIOPHYS J, V85, P623, DOI 10.1016/S0006-3495(03)74506-8; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Heidemann S R, 1991, Curr Opin Neurobiol, V1, P339, DOI 10.1016/0959-4388(91)90050-H; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Lindsey JK, 2000, BIOMETRICS, V56, P81, DOI 10.1111/j.0006-341X.2000.00081.x; MACKLIN WB, 1985, DEV NEUROSCI-BASEL, V7, P170, DOI 10.1159/000112285; MAXWELL WL, 1994, J NEUROCYTOL, V23, P379, DOI 10.1007/BF01666527; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Meaney DF, 2001, J NEUROSURG, V95, P1108; Mills LR, 2004, NEUROIMAGE, V21, P1069, DOI 10.1016/j.neuroimage.2003.10.041; Mueller H, 1999, BIOPHYS J, V76, P1072, DOI 10.1016/S0006-3495(99)77272-3; Nicolet G., 1971, Adv Morphogen, V9, P231; NIEBROJDOBOSZ I, 1980, ACTA NEUROPATHOL, V49, P145, DOI 10.1007/BF00690754; NOLTE J, 1993, HUMAN BRAIN INTRO FU; ODONOVAN M, 1992, J EXP ZOOL, V261, P261, DOI 10.1002/jez.1402610306; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rosenberg LJ, 1997, J NEUROTRAUM, V14, P823, DOI 10.1089/neu.1997.14.823; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; SHRAGER R, 1994, LEASQ; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2001, TISSUE ENG, V7, P131, DOI 10.1089/107632701300062714; STATE FA, 1997, ACTA ANAT, V99, P469	49	16	16	0	1	ASME-AMER SOC MECHANICAL ENG	NEW YORK	THREE PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731			J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	AUG	2007	129	4					511	522		10.1115/1.2746372			12	Biophysics; Engineering, Biomedical	Biophysics; Engineering	200AT	WOS:000248737000006	17655472				2021-06-18	
J	Talvik, I; Mannamaa, M; Juri, P; Leito, K; Poder, H; Hamarik, M; Kool, P; Talvik, T				Talvik, Inga; Mannamaa, Mairi; Juri, Piret; Leito, Kaja; Poder, Haide; Hamarik, Malle; Kool, Pille; Talvik, Tiina			Outcome of infants with inflicted traumatic brain injury (shaken baby syndrome) in Estonia	ACTA PAEDIATRICA			English	Article						inflicted brain injury; shaken baby syndrome; outcome; child abuse	NONACCIDENTAL HEAD-INJURY; CHILDREN	This is a population-based prospective study to identify the long-term outcome of children with inflicted traumatic brain injury (ITBI). Twenty-two survivors were identified and followed up. Only 2 of 22 had no developmental problems at follow-up, 20 of 22 children were having different developmental problems, among them 3 of 22 were severely handicapped. Psychological tests passed 17 of 22, 5 did not pass due to severe handicap (3 children) or were too young (2 patients). Epilepsy was found in 7 of 22, being intractable in 3 cases. Serious motor problems were identified in 5 of 22. Ophthalmologic problems were found in 4 of 22. The most important predictor of adverse outcome was young age at the time of the insult. Conclusion: the outcome of these potentially healthy children is poor. The key question is prevention. Health care professionals should be more concerned about these problems.	Tartu Univ Hosp, Dept Neurol, Childrens Clin, EE-51014 Tartu, Estonia; Childrens Hosp, Tallinn, Estonia	Talvik, I (corresponding author), Tartu Univ Hosp, Dept Neurol, Childrens Clin, 6 Lunini St, EE-51014 Tartu, Estonia.	inga.talvik@kliinikum.ee					Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 1999, DEV MED CHILD NEUROL, V41, P220, DOI 10.1017/S0012162299000481; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; FISCHER H, 1994, CLIN PEDIATR, V33, P696, DOI 10.1177/000992289403301113; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Han D P, 1990, J Pediatr Ophthalmol Strabismus, V27, P299; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; KAUFMAN AS, 1983, ADM SCORING MANUAL; KAUFMAN AS, 1983, INTERPRETATIVE MANUA; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Lichtenberger EO, 2001, CA CH AD PS, P97; Lucke T, 2005, ACTA PAEDIATR, V94, P1330, DOI 10.1080/08035250510028632; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Prasad MR, 2005, ARCH DIS CHILD, V90, P82, DOI 10.1136/adc.2003.045583; Sabbadini M, 2001, J INTELL DISABIL RES, V45, P169, DOI 10.1046/j.1365-2788.2001.00301.x; Sattler J.M., 2001, ASSESSMENT CHILDREN, V4th edn; Schermann L, 2004, ACTA PAEDIATR, V93, P1619, DOI 10.1080/08035250410023386; Swenson J, 1997, Minn Med, V80, P41; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Wechsler D., 1989, MANUAL WECHSLER PRES; Wechsler D., 1991, MANUAL WECHSLER INTE; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037	31	16	16	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	AUG	2007	96	8					1164	1168		10.1111/j.1651-2227.2007.00362.x			5	Pediatrics	Pediatrics	193OD	WOS:000248282500014	17578492				2021-06-18	
J	Engberg, AW				Engberg, Aase W.			A Danish National Strategy for Treatment and Rehabilitation After Acquired Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						centralized rehabilitation; traumatic brain injury		This study describes the establishment of a Danish national strategy for treatment and rehabilitation of acquired brain injury, particularly traumatic brain injury, in 1997. The vision was to create a system of tax-financed continuous treatment, restoration of function, and outpatient rehabilitation. Recommendations and their fulfillment are described. Focus is on the establishment and function of early intensive interdisciplinary rehabilitation after severe traumatic brain injury, centralized as 2 units since the year 2000, each with half the country as uptake area, corresponding to populations of around 2.5 million. Advantages gained by this centralization are increased focus on brain injury so that everybody gets specialized rehabilitation, regardless of the prognosis, the introduction of a database for severe brain injuries with unified measures of function and outcome, and the creation of a basis for method development and interdisciplinary research. Results for the first 3 years also indicate that outcome is improved after centralization.	[Engberg, Aase W.] Copenhagen Univ Hosp, Brain Injury Unit, Dept Neurol Rehabil, Hvidovre, Denmark	Engberg, AW (corresponding author), 354 Copenhagen Univ Hosp, Dept Neurol Rehabil, Hvidovre Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	aae@dadlnet.dk					AFFOLTER F, 1980, INT REHABIL MED, V3, P3; BULLOCK R, 1995, GUIDELINES MANAGEMEN; Butler D.S., 1991, MOBILISATION NERVOUS; CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32; Coombes K, 1996, WEGE ANFANG FRUHREHA, P137; DAVIES PM, 1994, STARTING AGAIN EARLY; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Engberg AW, 2004, ACTA NEUROL SCAND, V110, P281, DOI 10.1111/j.1600-0404.2004.00323.x; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; ENGBERG AW, 2002, UGESKR LAGER, V3, P199; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; HOLLAND AD, 1984, LANGUAGE DISORDERS A, P245; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; LARSEN A, 1991, KAN GENOPTRANING BET; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Liebach Annette, 2007, Ugeskr Laeger, V169, P223; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; LIPP B, 1998, WEGE ANFANG FRUHREHA; PINNER M, 2002, KONSENSUSRAPPORT COM; RUSK H A, 1969, Medical Clinics of North America, V53, P677; Schmidt, 2000, NEUROL REHABIL, V6, P125; Sundhedsstyrelsen (The Danish Health Authority), 1997, BEH TRAUM HJERN TILG; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260	25	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2007	22	4					221	228		10.1097/01.HTR.0000281837.62226.54			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	V87BQ	WOS:000205885400005	17667064				2021-06-18	
J	Hartshorne, TS; Nicholas, J; Grialou, TL; Russ, JM				Hartshorne, Timothy S.; Nicholas, Jude; Grialou, Tina L.; Russ, Joanna M.			Executive function in charge syndrome	CHILD NEUROPSYCHOLOGY			English	Article							BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; DEVELOPMENTAL DISORDERS; MULTIPLE ANOMALIES; CHOANAL ATRESIA; CHILDREN; ASSOCIATION; AUTISM; ATTENTION; PROFILES	This study addressed the presence of executive dysfunction in children with CHARGE syndrome, a genetic disorder with multiple physical anomalies and severe challenging behaviors. Ninety-eight children were included in the study. More than half received clinically significant scores on the Behavior Rating Inventory of Executive Function (BRIEF; Gioia et al., 2000) scales of Shift, Monitor, and the Behavioral Regulation Index, with additional high scores on Inhibit and the Global Executive Composite. Associations were found with the age the child first walked, scores on the Autism Behavior Checklist (ABC; Krug et al., 1993), and being classified as deafblind. Difficulties with making transitions and flexible problem solving, monitoring their work and their effect on others, and acting on impulse, may be related to the behavioral difficulties exhibited by children with CHARGE. Interventions targeting improved self-regulation may help to manage this challenging behavior.	Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA; Vestlandet Resource Ctr, Bergen, Norway	Hartshorne, TS (corresponding author), Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA.	hartslts@cmich.edu					Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bernstein V, 2005, AM J MED GENET A, V133A, P232, DOI 10.1002/ajmg.a.30542; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; BLAKEGREENBERG K, 2003, DISSERT ABSTR, V64, pB408; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Carlson SM, 2005, PSYCHOL SCI, V16, P609, DOI 10.1111/j.1467-9280.2005.01583.x; Cicerone KD, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P246; DAVENPORT SLH, 1986, CLIN GENET, V29, P298; Denckla M.B., 1996, ATTENTION MEMORY EXE, P263; Eaves RC, 2000, PSYCHOL SCHOOLS, V37, P311, DOI 10.1002/1520-6807(200007)37:4<323::AID-PITS2>3.3.CO;2-J; ESLINGER PJ, 2002, NEUROPSYCHOLOGICAL I; Fernell E, 1999, DEV MED CHILD NEUROL, V41, P270, DOI 10.1017/S0012162299000572; Frye D., 1997, REV GEN PSYCHOL, V1, P1, DOI DOI 10.1037/1089-2680.1.2.198; Gilotty L, 2002, CHILD NEUROPSYCHOL, V8, P241, DOI 10.1076/chin.8.4.241.13504; Gioia G., 2000, BEHAV RATING EXECUTI; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Godefroy O, 1997, NEUROLOGY, V49, P695, DOI 10.1212/WNL.49.3.695; Graham JM, 2001, AM J MED GENET, V99, P120, DOI 10.1002/1096-8628(2000)9999:999<00::AID-AJMG1132>3.0.CO;2-J; Graham S., 1996, ATTENTION MEMORY EXE, P349; HALL BD, 1979, J PEDIATR-US, V95, P395, DOI 10.1016/S0022-3476(79)80513-2; Hartshorne TS, 2005, AM J MED GENET A, V133A, P257, DOI 10.1002/ajmg.a.30545; Hartshorne TS, 2005, AM J MED GENET A, V133A, P228, DOI 10.1002/ajmg.a.30541; Hartshorne TS, 2004, MENT HLTH ASPEC DEV, V7, P41; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hughes C., 2002, CHILD ADOL MENT H-UK, V7, P131, DOI DOI 10.1111/1475-3588.00024; KENEALY LE, 2002, DISSERT ABSTR, V63, pB530; KILEYBRABECK K, 2004, DISSERT ABSTR, V64, pB6332; Krug D., 1993, AUTISM SCREENING INS; LIN AE, 1990, AM J MED GENET, V37, P304, DOI 10.1002/ajmg.1320370303; LUBINSKY MS, 1994, AM J MED GENET, V49, P21, DOI 10.1002/ajmg.1320490106; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Nicholas J, 2005, AM J MED GENET A, V133A, P300, DOI 10.1002/ajmg.a.30558; NORMAN DA, 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; PALENCIA B, 2003, DISSERT ABSTR, V64, pB1518; Pennington B.F., 1996, ATTENTION MEMORY EXE, P327; PRATT BM, 2000, DISSERT ABSTR, V60, pB4933; Raqbi F, 2003, DEV MED CHILD NEUROL, V45, P483, DOI 10.1017/S0012162203000896; Salem-Hartshorne N, 2005, AM J MED GENET A, V133A, P262, DOI 10.1002/ajmg.a.30546; Salem-Hartshorne N, 2004, J EARLY INTERVENTION, V26, P292, DOI 10.1177/105381510402600405; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHALLICE T, 1998, PREFRONTAL CORTEX EX, P22; Smith IM, 2005, AM J MED GENET A, V133A, P248, DOI 10.1002/ajmg.a.30544; Souriau J, 2005, AM J MED GENET A, V133A, P278, DOI 10.1002/ajmg.a.30549; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Williams DA, 2005, MOL THER, V12, P2	52	16	16	0	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JUL	2007	13	4					333	344		10.1080/09297040600850944			12	Clinical Neurology	Neurosciences & Neurology	207ZU	WOS:000249290400003	17564850				2021-06-18	
J	Pedraza, O; Smith, GE; Ivnik, RJ; Willis, FB; Ferman, TJ; Petersen, RC; Graff-Radford, NR; Lucas, JA				Pedraza, Otto; Smith, Glenn E.; Ivnik, Robert J.; Willis, Floyd B.; Ferman, Tanis J.; Petersen, Ronald C.; Graff-Radford, Neill R.; Lucas, John A.			Reliable change on the Dementia Rating Scale	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						cognitive aging; Alzheimer's disease; RCI; DRS; MOANS; MOAANS	SPORT CONCUSSION RESEARCH; STANDARD ERROR; FUNCTIONAL DECLINE; CLASSICAL APPROACH; NORMATIVE DATA; CHANGE INDEX; OLDER; JACOBSON	A central role for neuropsychological evaluations is the measurement of change in cognitive functioning over time. However, change scores obtained from repeated neuropsychological assessments may be affected by normal variability because of measurement error and practice effects caused by repeated measurements. The current study uses reliable change estimates to establish normative rates of change on the Dementia Rating Scale from baseline to first follow-up testing among 1080 cognitively normal adults aged 65 and older. Results showed that a 6-point decline by European Americans or a 9-point decline by African American adults within a 9-15 month test-retest interval represents reliable change. Within a 16-24-month test-retest interval, a 7-point decline among European Americans or an 8-point decline among African American adults represents reliable change. In addition, preliminary cross-validation was performed in a clinical comparison sample of another 22 older adults. The findings are discussed in the context of potential clinical and research applications.	Mayo Clin, Coll Med, Dept Psychiat & Psychol, Jacksonville, FL 32224 USA; Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; Mayo Clin, Dept Family Med, Jacksonville, FL 32224 USA; Mayo Clin, Dept Neurol, Rochester, MN USA; Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	Pedraza, O (corresponding author), Mayo Clin, Coll Med, Dept Psychiat & Psychol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	otto.pedraza@mayo.edu		Smith, Glenn/0000-0003-1506-9484	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [3P50 AG016574-07S1] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG016574] Funding Source: NIH RePORTER		Black SA, 2002, J AM GERIATR SOC, V50, P1978, DOI 10.1046/j.1532-5415.2002.50609.x; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre A, 2000, J INT NEUROPSYCH SOC, V6, P362, DOI 10.1017/S1355617700633118; Hinton-Bayre A, 2005, BRIT J SPORT MED, V39, P488; Hinton-Bayre AD, 2005, J INT NEUROPSYCH SOC, V11, P788, DOI 10.1017/S1355617705050940; Hinton-Bayre AD, 2004, J INT NEUROPSYCH SOC, V10, P894, DOI 10.1017/S1355617704106103; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Ivnik R. J., 1990, PSYCHOL ASSESSMENT J, V2, P304, DOI [10.1037/1040-3590.2.3.304, DOI 10.1037/1040-3590.2.3.304]; Jurica PJ., 2001, DEMENTIA RATING SCAL; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P162, DOI 10.1080/13854040590945265; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P536, DOI 10.1076/jcen.20.4.536.1469; Maassen GH, 2006, BRIT J SPORT MED, V40, P829, DOI 10.1136/bjsm.2005.023713; Maassen GH, 2005, BRIT J SPORT MED, V39, P483, DOI 10.1136/bjsm.2004.015594; Maassen GH, 2004, J INT NEUROPSYCH SOC, V10, P902, DOI 10.1017/S1355617704106127; Maassen GH, 2004, J INT NEUROPSYCH SOC, V10, P888, DOI 10.1017/S1355617704106097; McGlinchey JB, 1999, BEHAV RES THER, V37, P1211; Moody-Ayers SY, 2005, J GERONTOL A-BIOL, V60, P933, DOI 10.1093/gerona/60.7.933; Rilling LM, 2005, CLIN NEUROPSYCHOL, V19, P229, DOI 10.1080/13854040590945328; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Temkin NR, 2004, J INT NEUROPSYCH SOC, V10, P899, DOI 10.1017/S1355617704106115	20	16	16	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2007	13	4					716	720		10.1017/S1355617707070920			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	186GJ	WOS:000247766800020	17521486				2021-06-18	
J	Pillay, NS; Kellaway, LA; Kotwal, GJ				Pillay, Nirvana S.; Kellaway, Laurie A.; Kotwal, Girish J.			Vaccinia virus complement control protein significantly improves sensorimotor function recovery after severe head trauma	BRAIN RESEARCH			English	Article						vaccinia virus complement control protein; head trauma; Morris Water Maze; angle board; sensorimotor; fluid percussion injury	PERCUSSION BRAIN-INJURY; ADULT-RAT; FLUID; ACTIVATION; SYSTEM; MODEL; CONSEQUENCES; INFLAMMATION; INHIBITION; CASCADE	Vaccinia virus complement control protein (VCP) is an immunomodulator that inhibits both the classical and alternate pathways of the complement system, therefore preventing cell death and inflammation. VCP has previously been shown to be therapeutically effective in mild and moderate traumatic brain injury models. in this study the efficacy of VCP in a severe head injury model is investigated in Wistar rats. Training in a Morris Water Maze (MWM) commenced 2 days prior stereotaxic surgery. Rats were anesthetized before being subjected to a severe (2.7-3.0 atm) lateral fluid percussion injury (FPI) 3.0 mm lateral to the sagittal suture and 4.5 mm posterior to bregma. Ten microliters of VCP (1.7 mu g/mu l) was injected into the injury site immediately after FPI. Fourteen days post-FPI, rats were tested for spatial learning and memory using the Morris Water Maze, followed by a battery of sensorimotor tests. The latter tests showed statistically significant differences between saline-treated and VCP-treated rats in lateral left pulsion (P=0.001) and tactile placing (p=0.002) on the first 5 days of testing. In addition, significant differences in right lateral pulsion in the first 4 days (p=0.007) of testing was evident. The results suggest that in a severe head injury model, VCP at this dosage favorably influences sensorimotor outcome. (c) 2007 Elsevier B.V. All rights reserved.	Univ Cape Town, Fac Hlth Sci, Div Neurosci, ZA-7700 Rondebosch, South Africa; Univ Cape Town, Fac Hlth Sci, Div Med Virol, ZA-7700 Rondebosch, South Africa; Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	Kotwal, GJ (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Neurosci, ZA-7700 Rondebosch, South Africa.	gjkotw01@gmail.com					Barnum SR, 2002, IMMUNOL RES, V26, P7, DOI 10.1385/IR:26:1-3:007; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kirschfink M, 1997, IMMUNOPHARMACOLOGY, V38, P51, DOI 10.1016/S0162-3109(97)00057-X; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pillay NS, 2005, ANN NY ACAD SCI, V1056, P450, DOI 10.1196/annals.1352.021; Power AE, 2002, BEHAV BRAIN RES, V134, P307, DOI 10.1016/S0166-4328(02)00046-3; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; van der Sluis CK, 1998, INJURY, V29, P281, DOI 10.1016/S0020-1383(97)00199-X; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Yoshioka M, 1996, NEUROSCI LETT, V209, P201, DOI 10.1016/0304-3940(96)12631-8	29	16	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 11	2007	1153						158	165		10.1016/j.brainres.2007.03.056			8	Neurosciences	Neurosciences & Neurology	181FZ	WOS:000247423800018	17467672				2021-06-18	
J	Hebb, MO; Clarke, DB; Tallon, JM				Hebb, Matthew O.; Clarke, David B.; Tallon, John M.			Development of a provincial guideline for the acute assessment and management of adult and pediatric patients with head injuries	CANADIAN JOURNAL OF SURGERY			English	Article							ACUTE SUBDURAL-HEMATOMA; GLASGOW COMA SCALE; INTRACRANIAL INJURY; COMPUTED-TOMOGRAPHY; BRAIN-INJURIES; IMPAIRED CONSCIOUSNESS; NEUROLOGIC EXAMINATION; CLINICAL INDICATORS; EPIDURAL HEMATOMAS; SKULL RADIOGRAPHY	Background: Regionalized approaches to trauma care improve patient outcomes. We developed and distributed a clinical reference poster to standardize the emergency department evaluation and management of patients with traumatic head injuries in hospitals throughout Nova Scotia. Methods: We conducted a MEDLINE literature search to identify publications in the fields of prehospital and emergency management of head injuries. We reviewed and collated select studies to define contemporary standards of care. Results: We derived a 3-tiered decision tool that summarizes the indications for resuscitation, radiography, specialty consultation and transfer of adult and pediatric patients with minor and major head injuries. A guideline poster was constructed and distributed to all provincial emergency departments upon approval by local trauma and critical care staff. Conclusions: This report describes the evidence for a population-based, province-wide assessment and early management tool that was developed for health care personnel who treat patients with head traumas. Comparison of outcome data from pre- and postguideline eras will ultimately shed light on the use of regionalized approaches to managing brain injuries.	Dalhousie Univ, Dept Surg, Div Neurosurg, Halifax, NS B3H 3J5, Canada; Dalhousie Univ, Dept Emergency Med, Halifax, NS B3H 3J5, Canada	Clarke, DB (corresponding author), QEII Hlth Sci Ctr, Div Neurosurg, 1796 Summer St,Rm 3807, Halifax, NS B3H 3A7, Canada.	d.clarke@dal.ca					ACKROYDSOLARZ S, 2002, COMPREHENSIVE REPORT; Barss P., 1998, INJURY PREVENTION IN; BAZZOLI GJ, 1995, JAMA-J AM MED ASSOC, V273, P395; Bergman DA, 1999, PEDIATRICS, V104, P1407; BISHOP M, 1991, AM SURGEON, V57, P737; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; BRAAKMAN R, 1977, CLIN NEUROL NEUROSUR, V80, P104; *BRAIN TRAUM FDN, 2000, MAN PROGN SEV TRAUM; Cheung DS, 1999, EMERG MED CLIN N AM, V17, P9, DOI 10.1016/S0733-8627(05)70044-4; *COLL SURG COMM TR, 1997, ADV TRAUM LIF SUPP D; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dillman D.A., 1978, MAIL TELEPHONE SURVE; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Fielding K, 1990, Aust J Adv Nurs, V7, P13; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Gwinnutt CL, 2001, RESUSCITATION, V48, P17, DOI 10.1016/S0300-9572(00)00314-2; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HILLS MW, 1993, J TRAUMA, V34, P549, DOI 10.1097/00005373-199304000-00011; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Iverson GL, 2000, BRAIN INJURY, V14, P1057; JERET JS, 1993, J TRAUMA, V35, P490, DOI 10.1097/00005373-199309000-00030; *JOINT TASK FORC A, 1993, APLS PED EM MED COUR; KLEINMAN PK, 1992, J PEDIATR-US, V121, P737, DOI 10.1016/S0022-3476(05)81904-3; KRAUS JF, 1987, PEDIATRICS, V79, P501; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; LEONIDAS JC, 1982, PEDIATRICS, V69, P139; LIU M, 1988, CRIT CARE MED, V16, P1191, DOI 10.1097/00003246-198812000-00004; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MORAN SG, 1994, AM SURGEON, V60, P533; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Osmond MH, 2002, J TRAUMA, V52, P8, DOI 10.1097/00005373-200201000-00004; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pickett W, 2001, CAN MED ASSOC J, V165, P288; PIETRZAK M, 1991, AM J EMERG MED, V9, P153, DOI 10.1016/0735-6757(91)90179-N; Quayle KS, 1999, PEDIATR CLIN N AM, V46, P1189, DOI 10.1016/S0031-3955(05)70182-6; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; Rivara FP, 1997, NEW ENGL J MED, V337, P613, DOI 10.1056/NEJM199708283370907; ROS SP, 1992, PEDIATR EMERG CARE, V8, P328, DOI 10.1097/00006565-199212000-00005; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; Ruchholtz S, 1998, INJURY, V29, P115, DOI 10.1016/S0020-1383(97)00150-2; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Savitsky EA, 2000, AM J EMERG MED, V18, P96, DOI 10.1016/S0735-6757(00)90060-3; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; Shane SA, 1997, PEDIATR EMERG CARE, V13, P198, DOI 10.1097/00006565-199706000-00006; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; STEIN SC, 1993, NEUROSURGERY, V33, P339; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; TEASDALE G, 1974, LANCET, V2, P81; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Woolard Deborah J., 1994, Journal of Emergency Medicine, V12, P453, DOI 10.1016/0736-4679(94)90339-5	91	16	16	0	4	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	JUN	2007	50	3					187	194					8	Surgery	Surgery	173AC	WOS:000246844900006	17568490				2021-06-18	
J	Kallakuri, S; Kreipke, CW; Rossi, N; Rafols, JA; Petrov, T				Kallakuri, Srinivasu; Kreipke, Christian W.; Rossi, Noreen; Rafols, Jose A.; Petrov, Theodor			Spatial alterations in endothelin receptor expression are temporally associated with the altered microcirculation after brain trauma	NEUROLOGICAL RESEARCH			English	Article						sensorimotor cortex; hippocampus; neurons; vascular wall; immunocytochemistry	CEREBRAL-ARTERY OCCLUSION; A RECEPTOR; BLOOD-FLOW; RAT MODEL; CORTEX; INJURY; VASOCONSTRICTION; HIPPOCAMPUS; ANTAGONIST; ASTROCYTES	Objectives: To study the cellular distribution of endothelin receptors A and B (ETrA and ETrB) in the post-traumatic sensorimotor cortex and hippocampus. Materials and methods: We inflicted closed head trauma to male Sprague - Dawley rats and visualized ETrA and ETrB immunoreactivity with 3,3'- diaminobenzidine. Results: ETrA immunolabeling was the most prominent in pyramidal neurons 24 and 48 hours post- trauma, while it reached its peak in the microvasculature at hour 4. ETrB immunolabeling was observed in endothelial cells, perivascular neurons, smooth muscle cells (SM) and pericytes, the expression being the most pronounced 24 hours post-trauma. Discussion: The results suggest that the vasoconstrictor effect of endothelin-1 (ET-1) is mediated primarily by ETrA. The dual effects of ETrB are reflected in its vasoconstrictor role at the vascular bed and conversely, in the attenuation of ET-1 availability and synthesis. We conclude that both receptors play a role in the disturbed microvascular autoregulation and in the sustained reduction of blood flow following trauma to the brain.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Petrov, T (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA.	tpetrov@med.wayne.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS039860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		Andersson KE, 2001, UROL CLIN N AM, V28, P233, DOI 10.1016/S0094-0143(05)70134-8; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; ARMSTEAD W, 1999, AM J PHYSIOL, V274, P1884; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; CLOZEL M, 1992, BIOCHEM BIOPH RES CO, V186, P867, DOI 10.1016/0006-291X(92)90826-7; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; FUXE K, 1992, EXP BRAIN RES, V88, P131, DOI 10.1007/BF02259134; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; Granchi S, 2002, MOL HUM REPROD, V8, P1053, DOI 10.1093/molehr/8.12.1053; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; *I LAB AN RES COMM, 1996, NIH PUBL; Just A, 2004, AM J PHYSIOL-RENAL, V286, pF660, DOI 10.1152/ajprenal.00368.2003; Kurokawa K, 1997, J COMP NEUROL, V389, P348, DOI 10.1002/(SICI)1096-9861(19971215)389:2<348::AID-CNE11>3.0.CO;2-H; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Loo LS, 2002, NEUROSCIENCE, V112, P993, DOI 10.1016/S0306-4522(02)00043-X; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MASAKI T, 1993, ENDOCR REV, V14, P256, DOI 10.1210/er.14.3.256; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; Nakagomi S, 2000, NEUROSCIENCE, V101, P441, DOI 10.1016/S0306-4522(00)00345-6; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters C. M., 2001, Society for Neuroscience Abstracts, V27, P2046; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; RANDALL MD, 1989, BRIT J PHARMACOL, V98, P685, DOI 10.1111/j.1476-5381.1989.tb12644.x; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SakuraiYamashita Y, 1997, EUR J PHARMACOL, V338, P199, DOI 10.1016/S0014-2999(97)81949-8; Sanchez R, 2002, J CARDIOVASC PHARM, V39, P652, DOI 10.1097/00005344-200205000-00005; Singer OC, 2003, J CEREBR BLOOD F MET, V23, P605, DOI 10.1097/01.WCB.0000062342.57257.28; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Takahashi A, 1997, ACTA NEUROPATHOL, V93, P354, DOI 10.1007/s004010050627; TEERLINK JR, 1994, CIRCULATION, V90, P2510, DOI 10.1161/01.CIR.90.5.2510; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhang Yundong, 2000, Chin J Traumatol, V3, P185; Zimmermann M, 1998, NEUROSURGERY, V43, P863, DOI 10.1097/00006123-199810000-00083	38	16	18	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2007	29	4					362	368		10.1179/016164107X204675			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	192PM	WOS:000248214200005	17626731				2021-06-18	
J	Kerby, JD; Sainz, JG; Zhang, FY; Hutchings, A; Sprague, S; Farrokhi, FR; Son, M				Kerby, Jeffrey D.; Sainz, Jorge G.; Zhang, Fangyi; Hutchings, Anne; Sprague, Shane; Farrokhi, Farrokh R.; Son, Minnette			Resuscitation from hemorrhagic shock with HBOC-201 in the setting of traumatic brain injury	SHOCK			English	Article; Proceedings Paper	34th Critical Care Congress of the Society-of-Critical-Care-Medicine	2005	Phoenix, AZ	Soc Crit Care Med		hemoglobin-based oxygen carriers; rat model; controlled cortical impact injury	CEREBRAL PERFUSION-PRESSURE; CROSS-LINKED HEMOGLOBIN; CARRYING SOLUTION HBOC-201; LOW-VOLUME RESUSCITATION; HEAD-INJURY; OXYGEN CARRIER; MODEL; EPIDEMIOLOGY; HYPERCAPNIA; DISABILITY	Outcomes after mild or moderate head trauma are worsened with associated hypotension, and secondary brain injury can be reduced with timely resuscitation. This study was performed to investigate HBOC-201 as a resuscitation therapy in a combined hemorrhagic shock and brain injury model. Anesthetized rats sustained moderate brain injury using a controlled cortical impact device, followed by rapid hemorrhage to a mean arterial pressure of 30 mmHg. After 30 min of hypotension, animals were resuscitated with HBOC-201, autologous shed blood (SB), or lactated Ringer solution (LR). Brain injury was assessed by measurements of cerebral blood flow (CBF) and cerebral vasoreactivity to hypercapnia (CVH) using a laser Doppler flowmeter. Contusion volume was evaluated histologically, and cerebral edema was determined by total water content. The HBOC rats required significantly less resuscitation volume versus LR and SB. The CBF was significantly diminished at 60 min after resuscitation with HBOC (70.1% +/- 3.8% baseline) compared with LR (105.8% +/- 10.1% baseline; P < 0.01) and SB (96.8% +/- 5% baseline; P < 0.05). The CVH was preserved in the HBOC and SB groups. The CVH was significantly diminished compared with baseline in the LR group at 30 min after resuscitation and showed a significant loss compared with HBOC at 60 min after resuscitation. The contusion volume for HBOC (45.1 mm(3)) and SB (35.1 mm(3)) was less than LR (63.5 mm(3), P < 0.01). Although CBF was diminished after resuscitation in the HBOC group, HBOC-treated animals maintained CVH and experienced significantly smaller contusion volume than those treated with LR. These results suggest that resuscitation with HBOC-201 protects autoregulatory mechanisms and may reduce secondary brain injury in traumatic brain injury.	Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, Div Pediat Crit Care, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Neurol Surg, Houston, TX USA; Virginia Mason Med Ctr, Dept Neurosurg, Seattle, WA 98101 USA	Kerby, JD (corresponding author), Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, LHRB 112,701 19th St S, Birmingham, AL 35294 USA.	Jeffrey.Kerby@ccc.uab.edu		Kerby, Jeffrey/0000-0001-7368-1124			Arnoldo B D, 2001, Curr Opin Crit Care, V7, P431, DOI 10.1097/00075198-200112000-00010; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Chappell JE, 1996, J TRAUMA, V41, P781, DOI 10.1097/00005373-199611000-00003; Chappell JE, 1997, J NEUROSURG, V86, P131, DOI 10.3171/jns.1997.86.1.0131; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Fitzpatrick CM, 2004, J AM COLL SURGEONS, V199, P693, DOI 10.1016/j.jamcollsurg.2004.07.025; Iadecola C, 1996, AM J PHYSIOL-REG I, V271, pR990; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee SK, 2002, ACAD EMERG MED, V9, P969; McNeil JD, 2001, J TRAUMA, V50, P1063, DOI 10.1097/00005373-200106000-00015; Moore EE, 2005, SHOCK, V24, P197, DOI 10.1097/01.shk.0000180075.76766.fe; Novak L, 1999, J TRAUMA, V47, P834, DOI 10.1097/00005373-199911000-00003; Ortegon DP, 2002, J TRAUMA, V53, P1068, DOI 10.1097/00005373-200212000-00007; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Piper IR, 1998, BRIT J ANAESTH, V80, P639; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sampson JB, 2003, J TRAUMA, V55, P747, DOI 10.1097/01.TA.0000084519.47163.77; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Spahn DR, 2005, CURR PHARM DESIGN, V11, P4099, DOI 10.2174/138161205774913354; Tremper KK, 1997, J CARDIOTHOR VASC AN, V11, P1, DOI 10.1016/S1053-0770(97)90242-1; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; York GB, 2003, J TRAUMA, V55, P873, DOI 10.1097/01.TA.0000092681.17874.6F; ZHANG FG, 1992, J CEREBR BLOOD F MET, V12, P962, DOI 10.1038/jcbfm.1992.133; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963	31	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2007	27	6					652	656		10.1097/01.shk.0000248584.10400.dc			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	173FS	WOS:000246859500010	17505305				2021-06-18	
J	Taber, KH; Hurley, RA				Taber, Katherine H.; Hurley, Robin A.			Traumatic axonal injury: Atlas of major pathways	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							BRAIN-INJURY; WHITE-MATTER; CORTICAL CONNECTIONS; STEREOTAXIC SPACE; TRACTOGRAPHY; MR; AFGHANISTAN; DISSECTION; TOPOGRAPHY; ANATOMY		Salisbury Vet Affairs Med Ctr, Vet Affairs Mid Atlantic Mental Illness Res Educ, Salisbury, NC USA; Salisbury Vet Affairs Med Ctr, Mental Hlth Serv Line, Salisbury, NC USA; Virginia VA Sch Osteopath Med, Div Biomed Sci, Blacksburg, VA USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Wake Forest Univ, Dept Psychiat, Winston Salem, NC 27109 USA; Wake Forest Univ, Dept Radiol, Winston Salem, NC 27109 USA; Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Hurley, RA (corresponding author), Hefner VA Med Ctr, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Robin.Hurley@med.va.gov	Taber, Katherine H/B-8260-2011	Taber, Katherine H/0000-0001-7382-6151			Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Aralasmak A, 2006, J COMPUT ASSIST TOMO, V30, P695, DOI 10.1097/01.rct.0000226397.43235.8b; Barkai G, 2004, PSYCHIAT RES-NEUROIM, V132, P279, DOI 10.1016/j.pscychresns.2004.09.004; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Gutierrez-Cadavid JE., 2005, IMAGING NERVOUS SYST, P869; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Kier EL, 2004, AM J NEURORADIOL, V25, P677; KURCA E, 2006, NEURORADIOLOGY  0620; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; MAKRIS N, 1985, CEREB CORTEX, V15, P854; Mori S., 2005, MRI ATLAS HUMAN WHIT; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; NOLTE J, 2002, HUMAN BRAIN; O'Donnell LJ, 2006, AM J NEURORADIOL, V27, P1032; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pavel D, 2006, BRAIN COGNITION, V60, P211; SCHMAHMANN JD, 2007, BRAIN; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN; Schwab KA, 2006, NEUROLOGY, V66, pA235; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Shin YB, 2006, BRAIN INJURY, V20, P661, DOI 10.1080/02699050600677071; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Uylings HBM, 2005, ANAT EMBRYOL, V210, P423, DOI 10.1007/s00429-005-0042-4; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Zarei M, 2007, J MAGN RESON IMAGING, V25, P48, DOI 10.1002/jmri.20810; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	38	16	16	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	MAY	2007	19	2					100	104					5	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	156RH	WOS:000245666300001					2021-06-18	
J	Turner, R; Vink, R				Turner, Renee; Vink, Robert			Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke	DRUG NEWS & PERSPECTIVES			English	Article							TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; PRIMARY SENSORY NEURONS; SUBSTANCE-P; EDEMA FORMATION; SPINAL-CORD; RECEPTOR EXPRESSION; TACHYKININ; RELEASE; RAT	Each year, 15 million people suffer a stroke, of which 5 million die and 5 million are left permanently disabled. Cerebral swelling is of particular concern following stroke as it accounts for much of the death and disability. However, the mechanisms leading to cerebral swelling are not yet fully understood. Recent studies from our laboratory suggest that neuropeptides, and specifically substance P, may be involved in the injury processes that occur following acute insults to the brain such as stroke and trauma, and may be responsible, in part, for edema formation. Levels of substance P are increased following CNS injury, indicative of neurogenic inflammation, and this is associated with injury to the blood-brain barrier, the development of cerebral edema, cell death and functional deficits. Subsequent studies inhibiting neuropeptide release have consistently shown decreased cerebral edema and improved neurological outcome, while substance P antagonists administered after the insult are efficacious in reducing post-stroke cerebral edema and neurological deficits. The current review summarizes the evidence supporting the benefits of inhibiting neurogenic inflammation to treat ischemic stroke. (C) 2007 Prous Science. All rights reserved.	Univ Adelaide, Discipline Pathol, Adelaide, SA 5005, Australia	Vink, R (corresponding author), Univ Adelaide, Discipline Pathol, Adelaide, SA 5005, Australia.	Robert.Vink@adelaide.edu.au	AM, Robert Vink/S-5616-2019; Vink, Robert/J-7351-2012	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Turner, Renee/0000-0003-4278-8302			Alves RV, 1999, PEPTIDES, V20, P921, DOI 10.1016/S0196-9781(99)00082-0; ANDERSON JJ, 1993, BRAIN RES, V623, P189, DOI 10.1016/0006-8993(93)91426-S; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Bakhai A, 2004, PHARMACOECONOMICS, V22, P11, DOI 10.2165/00019053-200422004-00004; Bath PMW, 2000, BRIT MED BULL, V56, P422, DOI 10.1258/0007142001903067; Bayliss WM, 1901, J PHYSIOL-LONDON, V26, P173; BETZ AL, 1990, ACT NEUR S, V51, P256; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Bruno G, 2003, INT J IMMUNOPATH PH, V16, P67, DOI 10.1177/039463200301600110; Campos MM, 2000, NEUROPEPTIDES, V34, P314, DOI 10.1054/npep.2000.0823; Cao T, 1999, AM J PHYSIOL-REG I, V277, pR476; CHEN HJ, 1992, STROKE, V23, P957, DOI 10.1161/01.STR.23.7.957; Dewey HM, 2001, STROKE, V32, P2409, DOI 10.1161/hs1001.097222; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Gaddum J H, 1934, J Physiol, V83, P1; Gartshore G, 1997, EXP NEUROL, V147, P353, DOI 10.1006/exnr.1997.6635; Gauchy C, 1996, NEUROSCIENCE, V73, P929, DOI 10.1016/0306-4522(96)00099-1; Green AR, 2002, CLIN EXP PHARMACOL P, V29, P1030, DOI 10.1046/j.1440-1681.2002.03767.x; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Heuschmann PU, 2003, STROKE, V34, P1106, DOI 10.1161/01.STR.0000065198.80347.C5; Hill MD, 1998, LANCET, V352, pSIII10; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; Holzer P, 1998, GEN PHARMACOL, V30, P5, DOI 10.1016/S0306-3623(97)00078-5; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kramer JH, 1997, J MOL CELL CARDIOL, V29, P97, DOI 10.1006/jmcc.1996.0255; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; KUROIWA T, 1985, ACTA NEUROPATHOL, V66, P3, DOI 10.1007/BF00698288; Lanzino D J, 2000, Neurosurg Focus, V8, pe3; Lipton P, 1999, PHYSIOL REV, V79, P1431; Malcangio M, 2000, EUR J NEUROSCI, V12, P397, DOI 10.1046/j.1460-9568.2000.00946.x; MATSAS R, 1984, BIOCHEM J, V223, P433, DOI 10.1042/bj2230433; McCarson KE, 1999, NEUROSCIENCE, V93, P361, DOI 10.1016/S0306-4522(99)00102-5; MENZIES SA, 1993, J NEUROSURG, V78, P257, DOI 10.3171/jns.1993.78.2.0257; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOGUCHI K, 1988, MOL BRAIN RES, V4, P31, DOI 10.1016/0169-328X(88)90015-0; NORRIS JW, 1986, BMJ-BRIT MED J, V292, P21, DOI 10.1136/bmj.292.6512.21; OTSUKA M, 1993, PHYSIOL REV, V73, P229; Parker D, 1998, J NEUROSCI, V18, P4800; PERSSON MG, 1991, EUR J PHARMACOL, V205, P295, DOI 10.1016/0014-2999(91)90913-B; QUAST MJ, 1993, MAGN RESON IMAGING, V11, P465, DOI 10.1016/0730-725X(93)90465-P; Ribeiro-da-Silva A, 2000, NEUROPEPTIDES, V34, P256, DOI 10.1054/npep.2000.0834; Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4; Rupniak NMJ, 2000, NEUROPHARMACOLOGY, V39, P1413, DOI 10.1016/S0028-3908(00)00052-6; Schwab S, 1997, NEUROLOGY, V48, P1608, DOI 10.1212/WNL.48.6.1608; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; SHARMA HS, 1990, NEUROSCIENCE, V38, P205, DOI 10.1016/0306-4522(90)90386-I; SHEN KZ, 1992, NEUROSCIENCE, V50, P345, DOI 10.1016/0306-4522(92)90428-5; SKIDGEL RA, 1987, CLIN EXP HYPERTENS A, V9, P243, DOI 10.3109/10641968709164184; Stumm RK, 2001, J NEUROSCI, V21, P798; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Vink R, 2003, ACT NEUR S, V86, P257; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; WOIE K, 1993, CIRC RES, V73, P839, DOI 10.1161/01.RES.73.5.839; WOODCOCK J, 1982, STROKE, V13, P785, DOI 10.1161/01.STR.13.6.785; Yatsu FM, 1972, STROKE, V3, P726, DOI 10.1161/01.STR.3.6.726; Yu ZF, 1997, NEUROREPORT, V8, P2117, DOI 10.1097/00001756-199707070-00006	59	16	19	0	2	PROUS SCIENCE, SAU-THOMSON REUTERS	BARCELONA	398 PROVENCA, 08025 BARCELONA, SPAIN	0214-0934	2013-0139		DRUG NEWS PERSPECT	Drug News Perspect.	MAY	2007	20	4					221	226		10.1358/dnp.2007.20.4.1103527			6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	190RO	WOS:000248076900002	17637934				2021-06-18	
J	Bentz, K; Molcanyi, M; Riess, P; Elbers, A; Pohl, E; Sachinidis, A; Hescheler, J; Neugebauer, E; Schafer, U				Bentz, Kristine; Molcanyi, Marek; Riess, Peter; Elbers, Andrea; Pohl, Esther; Sachinidis, Agapios; Hescheler, Juergen; Neugebauer, Edmund; Schaefer, Ute			Embryonic stem cells produce neurotrophins in response to cerebral tissue extract: Cell line-dependent differences	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						Sprague-Dawley rats; fluid percussion injury; BDNF; NGF; neurotrophin-3	TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; GROWTH-FACTOR PRODUCTION; FLUID-PERCUSSION MODEL; NEURAL TRANSPLANTATION; SPINAL-CORD; IN-VIVO; PRECURSOR CELLS; MESSENGER-RNAS; RAT	In the present study, we compare the capacity of two different embryonic stem (ES) cell lines to secrete neurotrophins in response to cerebral tissue extract derived from healthy or injured rat brains. The intrinsic capacity of the embryonic cell lines BAC7 (feeder cell-dependent cultivation) to release brain-derived neurotrophic factor (BDNF) or neurotrophin-3 (NT-3) exceeded the release of these factors by CGR8 cells (feeder cell-free growth) by factors of 10 and 4, respectively. Nerve growth factor (NGF) was secreted only by BAC7 cells. Conditioning of cell lines with cerebral tissue extract derived from healthy or fluid percussion-injured rat brains resulted in a significant time-dependent increase in BDNF release in both cell lines. The increase in BDNF release by BAC7 cells was more pronounced when cells were incubated with brain extract derived from injured brain. However, differences in neurotrophin release associated with the origin of brain extract were at no time statistically significant. Neutrophin-3 and NGF release was inhibited when cell lines were exposed to cerebral tissue extract. The magnitude of the response to cerebral tissue extract was dependent on the intrinsic capacity of the cell lines to release neurotrophins. Our results clearly demonstrate significant variations in the intrinsic capability of different stem cell lines to produce neurotrophic factors. Furthermore, a significant modulation of neurotrophic factor release was observed following conditioning of cell lines with tissue extract derived from rat brains. A significant modulation of neurotrophin release dependent on the source of cerebral tissue extract used was not observed. (c) 2007 Wiley-Liss, Inc.	Univ Witten Herdecke, Fac Med, IFOM, Inst Res Operat Med, D-51109 Cologne, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Dev Genet, Munich, Germany; Univ Cologne, Fac Med, Clin Neurosurg, D-5000 Cologne 41, Germany; Univ Witten Herdecke, Hosp Merheim, Fac Med, Dept Traumat & Orthoped Surg, D-51109 Cologne, Germany; Univ Cologne, Fac Med, Dept Neurophysiol, D-5000 Cologne 41, Germany	Schafer, U (corresponding author), Univ Witten Herdecke, Fac Med, IFOM, Inst Res Operat Med, Ostmerheimerstr 200, D-51109 Cologne, Germany.	u.schaefer@uni-koeln.de	Sachinidis, Agapios/AAD-4178-2020; Sachinidis, Agapios/AAM-7988-2020				Arnhold S, 2000, J NEUROSURG, V93, P1026, DOI 10.3171/jns.2000.93.6.1026; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P79, DOI 10.1016/0149-7634(95)00063-1; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Iguchi F, 2003, NEUROREPORT, V14, P77, DOI 10.1097/00001756-200301200-00015; Karchewski LA, 2002, EUR J NEUROSCI, V16, P1449, DOI 10.1046/j.1460-9568.2002.02205.x; Lacza Z, 2003, INT J MOL MED, V12, P153; Lacza Z, 2003, BRAIN RES PROTOC, V11, P145, DOI 10.1016/S1385-299X(03)00039-4; Le Belle JE, 2002, BIODRUGS, V16, P389, DOI 10.2165/00063030-200216060-00001; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2003, NEUROSURGERY, V53, P702; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MOCLONYI M, 2007, IN PRESS J NEUROTRAU; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Ricci-Vitiani L, 2006, NEUROL RES, V28, P488, DOI 10.1179/016164106X115134; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009	39	16	17	0	1	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	APR	2007	85	5					1057	1064		10.1002/jnr.21219			8	Neurosciences	Neurosciences & Neurology	157NK	WOS:000245726700013	17335079				2021-06-18	
J	Pueyrredon, F; Spaho, N; Arroyave, I; Vinters, H; Lazareff, J				Pueyrredon, Francisco; Spaho, Natalia; Arroyave, Ivonne; Vinters, Harry; Lazareff, Jorge			Histological findings in cerebellar tonsils of patients with Chiari type I malformation	CHILDS NERVOUS SYSTEM			English	Article						Arnold Chiari malformation; cerebellar disease; ischemia; Purkinje cell; treatment; tonsillectomy	TRAUMATIC BRAIN INJURY; DECOMPRESSION; MANAGEMENT; ISCHEMIA; FOSSA	Cerebellar tonsillectomy is often performed for relief of symptoms associated with Chiari type I malformation (CMI). Nonetheless, the idea of removing supposedly healthy central nervous tissue has been a source of concern for neurosurgeons. The aim of this paper is to determine the histological changes in the cerebellar tonsils of patients with a wide range of symptoms and conditions related to CMI. The cerebellar tonsils of 43 pediatric patients with CMI were sent to pathology for histological examination. The cerebellar tonsils in a great majority of CMI patients can be abnormal. We suggest that the reported histological findings are secondary to injury and ischemia.	Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Div Surg Pathol, Los Angeles, CA 90095 USA	Lazareff, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, POB 957039, Los Angeles, CA 90095 USA.	jlazareff@mednet.ucla.edu					Allen GV, 2001, NEUROSCIENCE, V102, P603, DOI 10.1016/S0306-4522(00)00519-4; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Genitori L, 2000, CHILD NERV SYST, V16, P707, DOI 10.1007/s003810000338; Guyotat J, 1998, ACTA NEUROCHIR, V140, P745, DOI 10.1007/s007010050175; Koga H, 1995, No To Shinkei, V47, P1075; Lazareff JA, 2002, J NEUROSURG, V97, P1018, DOI 10.3171/jns.2002.97.5.1018; Martin LJ, 2000, J CEREBR BLOOD F MET, V20, P153, DOI 10.1097/00004647-200001000-00020; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Munshi I, 2000, NEUROSURGERY, V46, P1384, DOI 10.1097/00006123-200006000-00018; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; Welsh JP, 2002, ADV NEUROL, V89, P331	13	16	18	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	APR	2007	23	4					427	429		10.1007/s00381-006-0252-y			3	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	143UH	WOS:000244750900011	17119980				2021-06-18	
J	Haelewyn, B; Freret, T; Pacary, E; Schumann-Bard, P; Boulouard, M; Bernaudin, M; Bouet, V				Haelewyn, Benoit; Freret, Thomas; Pacary, Emilie; Schumann-Bard, Pascale; Boulouard, Michel; Bernaudin, Myriam; Bouet, Valentine			Long-term evaluation of sensorimotor and mnesic behaviour following striatal NMDA-induced unilateral excitotoxic lesion in the mouse	BEHAVIOURAL BRAIN RESEARCH			English	Article						excitotoxicity; stereotaxy; behaviour; mice; striatum; NMDA; sham surgery	FOCAL CEREBRAL-ISCHEMIA; CAUDATE-PUTAMEN LESIONS; TRAUMATIC BRAIN-INJURY; QUINOLINIC ACID LESION; CORTICAL CELL-CULTURE; HUNTINGTONS-DISEASE; WATER-MAZE; MITOCHONDRIAL DYSFUNCTION; GLUTAMATE NEUROTOXICITY; SPATIAL NAVIGATION	Excitotoxic lesion of the striatum provides a useful model for evaluating the excitotoxic processes involved in neurological disorders, in particular stroke diseases. The behavioural outcome after Such injury is however poorly described. We have therefore investigated the potential behavioural deficits induced by a NMDA-induced excitotoxic unilateral lesion of the lateral part of the striatum, by comparison with a PBS striatal injection (sham procedure), and non-operated mice behaviour. Three groups of male adult Swiss mice were constituted: unilateral NMDA (20 nmol striatal NMDA injection), sham (striatal PBS injection), and control (healthy non-operated mice). From 14 to 29 days post-surgery, sensorimotor and mnesic tests were performed in all groups. After euthanasia, immunohistochemical stainings (NeuN and GFAP) were performed in order to assess the size of the lesion. Straight runway and passive avoidance performances revealed mild deficits related to the excitotoxic NMDA-induced lesion as compared to the sham procedure. Moreover, accelerated rotarod and Morris water maze acquisition performances also revealed deficits related to the surgery, i.e. observed in sham-operated as compared to control mice. NeuN staining revealed no striatal lesion in the sham and non-operated groups in contrast to the NMDA-injected group in which the volume of infarcted striatum was 2.4 +/- 0.3 mm(3). GFAP staining revealed a glial reaction in the lesioned striatum of NMDA animals and at the PBS injection site in sham animals. These results suggest that NMDA-induced excitotoxic lesion induces subtle long-term behavioural deficits in mice. Moreover, this study shows the importance of the sham group to investigate the behavioural deficits after excitotoxic lesion models in mice. (c) 2007 Elsevier B.V. All rights reserved.	Univ Caen, CNRS, UMR 6185, CYCERON, F-14074 Caen, France; Univ Caen, CERMN, EA3915, Pharmacol Physiol Lab, F-14032 Caen, France	Bouet, V (corresponding author), Univ Caen, CNRS, UMR 6185, CYCERON, BP 5229,Bd H Becquerel, F-14074 Caen, France.	bouet@cyceron.fr	BOUET, Valentine/N-9593-2015; freret, thomas/AAA-2491-2019; freret, thomas/B-2068-2012; Bernaudin, Myriam/B-7663-2008; Pacary, Emilie/N-6994-2017; Michel, Boulouard/N-9028-2015	freret, thomas/0000-0002-4446-4451; freret, thomas/0000-0002-4446-4451; Bernaudin, Myriam/0000-0003-0778-3397; Pacary, Emilie/0000-0002-7316-4546; Michel, Boulouard/0000-0003-3825-8659			Abr`amoff M.D., 2005, BIOPHOTONICS INT, V11, P36, DOI [10.1117/1.3589100, DOI 10.1117/1.3589100]; Akita H, 2006, BRAIN RES, V1095, P178, DOI 10.1016/j.brainres.2006.04.039; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BLOCK F, 1993, NEUROSCI LETT, V149, P126, DOI 10.1016/0304-3940(93)90752-7; BOISSIER JR, 1965, ARCH INT PHARMACOD T, V158, P212; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; BOUET V, 2006, EXP NEUROL; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cosi C, 2004, BRAIN RES, V996, P1, DOI 10.1016/j.brainres.2003.09.072; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Francis L, 2000, REV NEUROLOGIA, V30, P1016, DOI 10.33588/rn.3011.99495; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Fricker RA, 1996, BRAIN RES BULL, V41, P409, DOI 10.1016/S0361-9230(96)00083-4; Furtado JCS, 1996, EXP NEUROL, V138, P158, DOI 10.1006/exnr.1996.0054; Garside S, 1996, NEUROSCIENCE, V75, P1065, DOI 10.1016/0306-4522(96)00172-8; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hansson O, 2001, EUR J NEUROSCI, V14, P1492, DOI 10.1046/j.0953-816x.2001.01767.x; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Higgins GA, 2001, NEUROPHARMACOLOGY, V41, P97, DOI 10.1016/S0028-3908(01)00048-X; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Iravani MM, 2004, BRAIN RES, V1029, P103, DOI 10.1016/j.brainres.2004.09.033; Jiang CT, 2005, EXP NEUROL, V191, P154, DOI 10.1016/j.expneurol.2004.08.035; Joel D, 1998, BRAIN RES, V787, P143, DOI 10.1016/S0006-8993(97)01428-5; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Lelong V, 2001, NEUROPHARMACOLOGY, V41, P517, DOI 10.1016/S0028-3908(01)00085-5; Lorenzini CGA, 1999, NEUROBIOL LEARN MEM, V71, P1; Mandir AS, 2000, J NEUROSCI, V20, P8005; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; MITCHELL JA, 1985, BEHAV NEUROSCI, V99, P1074, DOI 10.1037/0735-7044.99.6.1074; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murphy AN, 1999, ANN NY ACAD SCI, V893, P19, DOI 10.1111/j.1749-6632.1999.tb07815.x; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435; OLNEY JW, 1990, PROG BRAIN RES, V86, P37; PISA M, 1988, BEHAV BRAIN RES, V27, P21, DOI 10.1016/0166-4328(88)90106-4; Reddrop C, 2005, STROKE, V36, P1241, DOI 10.1161/01.STR.0000166050.84056.48; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Scattoni ML, 2004, BEHAV BRAIN RES, V152, P375, DOI 10.1016/j.bbr.2003.10.021; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sedelis M, 2000, NEUROREPORT, V11, P1093, DOI 10.1097/00001756-200004070-00037; Szyndler J, 2006, PHARMACOL REP, V58, P75; Trueman RC, 2005, BEHAV BRAIN RES, V159, P313, DOI 10.1016/j.bbr.2004.11.021; WAGNER GC, 1987, PSYCHOPHARMACOLOGY, V92, P470; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6; Winter B, 2004, STROKE, V35, P191, DOI 10.1161/01.STR.0000107188.29688.2C; Winter B, 2005, BIOL PSYCHIAT, V57, P1166, DOI 10.1016/j.biopsych.2005.02.010; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	54	16	17	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 28	2007	178	2					235	243		10.1016/j.bbr.2006.12.023			9	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	154EX	WOS:000245490700008	17250902				2021-06-18	
J	Schmitter-Edgecombe, M; Anderson, JW				Schmitter-Edgecombe, Maureen; Anderson, Jonathan W.			Feeling of knowing in episodic memory following moderate to severe closed-head injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; memory monitoring; metamemory; metacognition	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; SELF-AWARENESS; CONFIDENCE JUDGMENTS; METAMEMORY; KNOWLEDGE; ACCURACY; RECALL; ADULTS; FAMILIARITY	The ability to accurately monitor one's memory is a metacognitive process that is important in everyday life. The authors examined episodic memory feeling-of-knowing (FOK) ratings in 21 moderate to severe closed-head injury (CHI) participants (more than 1 year postinjury) and 21 controls. Participants studied 36 critical cue-target word pairs. Following a brief delay, they were asked to recall the target that corresponded to a given cue. Confidence ratings were made for recalled words, and FOK judgments were made for nonrecalled words in terms of the likelihood of recognizing the target word on a subsequent recognition test. CHI participants demonstrated less accurate recall but accurate ability to judge their recall performance (retrospective memory monitoring). They also demonstrated intact FOK judgments when providing binary judgments but demonstrated difficulties making finer discriminations on an ordinal scale (prospective memory monitoring). These findings suggest that memory monitoring is not a unitary construct. It is proposed that CHI participants may display intact memory monitoring when predictions are based on familiarity assessment but not when continued probing for additional episodic information is required.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA	Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS047690-02, R01 NS047690-03, R01 NS047690-01, R01 NS047690, R01 NS047690-04, R01 NS47690] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A., 1976, MULTILINGUAL APHASIA; BIEMANCOPLAND S, 1994, PSYCHOL AGING, V9, P287, DOI 10.1037/0882-7974.9.2.287; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Brandt J, 1985, DEV NEUROPSYCHOL, V1, P335, DOI 10.1080/87565648509540319; COSTERMANS J, 1992, J EXP PSYCHOL LEARN, V18, P142, DOI 10.1037/0278-7393.18.1.142; Delis DC, 1987, CALIFORNIA VERBAL LE; Fleming JM, 1996, BRAIN INJURY, V10, P1; GERMAN DJ, 1990, NATL COLL ED TEST AD; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; HART JT, 1965, J EDUC PSYCHOL, V56, P208, DOI 10.1037/h0022263; Heaton R., 1981, MANUAL WISCONSIN CAR; Herbert CM, 1989, CLIN REHABIL, V3, P125; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050120517; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Klin CM, 1997, J EXP PSYCHOL LEARN, V23, P1378, DOI 10.1037/0278-7393.23.6.1378; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; KORIAT A, 1993, PSYCHOL REV, V100, P609, DOI 10.1037/0033-295X.100.4.609; Koriat A, 2001, J EXP PSYCHOL LEARN, V27, P34, DOI 10.1037//0278-7393.27.1.34; Koriat A., 2000, OXFORD HDB MEMORY, P333; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Marquie JC, 2000, PSYCHOL AGING, V15, P451, DOI 10.1037//0882-7974.15.3.451; METCALFE J, 1993, PSYCHOL REV, V100, P3, DOI 10.1037/0033-295X.100.1.3; Nelson D. L., 1998, U S FLORIDA WORD ASS; Nelson T. O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI DOI 10.1016/S0079-7421(08)60053-5; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Pannu JK, 2005, J INT NEUROPSYCH SOC, V11, P668, DOI 10.1017/S13556177050873; PAPPAS BA, 1992, J GERONTOL, V47, pP159, DOI 10.1093/geronj/47.3.P159; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; PREVEY ML, 1988, BRAIN COGNITION, V7, P298, DOI 10.1016/0278-2626(88)90004-8; PREVEY ML, 1991, CORTEX, V27, P81, DOI 10.1016/S0010-9452(13)80270-5; REDER LM, 1987, COGNITIVE PSYCHOL, V19, P90, DOI 10.1016/0010-0285(87)90005-3; REDER LM, 1992, J EXP PSYCHOL LEARN, V18, P435, DOI 10.1037/0278-7393.18.3.435; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmitter-Edgecombe M, 2005, BRAIN LANG, V94, P331, DOI 10.1016/j.bandl.2005.01.007; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; Schmitter-Edgecombe M, 2006, NEUROPSYCHOLOGY, V20, P675, DOI 10.1037/0894-4105.20.6.675; SCHNEIBEL RS, 1997, DEV PREFRONTAL CORTE, P241; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; SCHRAW G, 1995, APPL COGNITIVE PSYCH, V9, P321, DOI 10.1002/acp.2350090405; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Smith A., 1991, SYMBOL DIGIT MODALIT; Souchay C, 2004, EXP AGING RES, V30, P179, DOI 10.1080/03610730490274248; Souchay C, 2004, EXP AGING RES, V30, P47, DOI 10.1080/03610730490251478; Souchay C, 2002, NEUROPSYCHOLOGIA, V40, P2386, DOI 10.1016/S0028-3932(02)00075-1; Souchay C, 2000, NEUROPSYCHOLOGY, V14, P299, DOI 10.1037/0894-4105.14.2.299; Souchay C, 2006, J CLIN EXP NEUROPSYC, V28, P828, DOI 10.1080/13803390591000846; *SPSS, 1999, SPSS BAS 9 0 US GUID; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Zachary R.A., 1991, SHIPLEY I LIVING SCA	69	16	17	0	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2007	21	2					224	234		10.1037/0894-4105.21.2.224			11	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	146YJ	WOS:000244970300008	17402822	Green Accepted			2021-06-18	
J	Christ, M; Noack, F; Schroeder, T; Hagmueller, A; Koch, R; May, SA; Morgenstern, U; Ragaller, M; Steinmeier, R				Christ, Melanie; Noack, Frank; Schroeder, Tobias; Hagmueller, Andreas; Koch, Rainer; May, Sven-Axel; Morgenstern, Ute; Ragaller, Maximilian; Steinmeier, Ralf			Continuous cerebral autoregulation monitoring by improved cross-correlation analysis: comparison with the cuff deflation test	INTENSIVE CARE MEDICINE			English	Article						cerebral autoregulation; continuous neuromonitoring; cross-correlation; transcranial Doppler; head injury; subarachnoid hemorrhage	ARTERIAL-BLOOD-PRESSURE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; FLOW VELOCITY; TRANSCRANIAL DOPPLER; PERFUSION-PRESSURE; CEREBROVASCULAR AUTOREGULATION; HUMANS; OSCILLATIONS	Objectives: To improve the cross-correlation method for noninvasive, continuous monitoring of cerebral autoregulation, to evaluate this method in humans with intact and impaired autoregulatory capacity, and to compare it to the cuff deflation test. Design and setting: Prospective study in the intensive care unit of a university hospital. Patients and participants: Fourteen patients with severe head injury, six patients with subarachnoid hemorrhage, and nine healthy volunteers. Interventions and measurements: Middle cerebral artery flow velocities and arterial blood pressure were monitored continuously. Aaslid's thigh cuff tests were performed and results were scored using Tiecks' model for autoregulation index. Data were then collected without any patient manipulation. The mean time delay between slow spontaneous oscillations of blood pressure and middle cerebral artery flow velocity was calculated by cross-correlation analysis. Data are expressed as median (lower/upper quartile). Results: Healthy subjects had a higher autoregulation index than patients, 5.0 (5.0/5.5) vs. 3.3 (2.0/4.5). Slow oscillations of blood pressure and middle cerebral artery flow velocity showed a time delay of -2.0 s (-2.7/-1.7) in healthy subjects but were almost synchronal in patients, -0.07 s (-0.5/0.45). Inter-method agreement in diagnosing an intact or impaired cerebral autoregulation was obtained in 108 of 147 examinations of autoregulation (73.5%) and was considered moderate. Conclusions: Cross-correlation analysis may serve as a simple, noninvasive, and continuous measure of cerebral autoregulation. The time delay of -2.0 s in healthy subjects is in good agreement with other studies. Short-term autoregulation tests and monitoring techniques based on slow spontaneous oscillations should not be used interchangeably.	Tech Univ Dresden, Dept Anesthesiol & Intens Care Med, Carl Gustav Carus Univ Hosp, D-01307 Dresden, Germany; Tech Univ Dresden, Inst Biomed Engn, Dept Elect Engn & Informat Technol, D-01062 Dresden, Germany; Harvard Univ, Sch Med, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Christ, M (corresponding author), Tech Univ Dresden, Dept Anesthesiol & Intens Care Med, Carl Gustav Carus Univ Hosp, Fetscherstasse 74, D-01307 Dresden, Germany.	Melanie.Christ@uniklinikum-dresden.de		Schroeder, Tobias/0000-0002-4439-8060			AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; CHRIST M, 2004, INTENS CARE MED S, V169, P651; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; Eames PJ, 2004, CLIN SCI, V106, P155, DOI 10.1042/CS20030194; ENEVOLDSEN EM, 1977, ACTA NEUROL SCAND, V56, P514; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Johnston AJ, 2004, INTENS CARE MED, V30, P45, DOI 10.1007/s00134-003-2032-4; KIRKHAM FJ, 1986, ULTRASOUND MED BIOL, V12, P15, DOI 10.1016/0301-5629(86)90139-0; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; Kuo TBJ, 2003, CEREBROVASC DIS, V16, P402, DOI 10.1159/000072564; Kuusela Tom A, 2003, BMC Physiol, V3, P11, DOI 10.1186/1472-6793-3-11; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; Mahony PJ, 2000, STROKE, V31, P476, DOI 10.1161/01.STR.31.2.476; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Mascia L, 2003, INTENS CARE MED, V29, P1088, DOI 10.1007/s00134-003-1780-5; Myburgh JA, 2003, INTENS CARE MED, V29, P817, DOI 10.1007/s00134-003-1684-4; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Panerai RB, 2003, ULTRASOUND MED BIOL, V29, P31, DOI 10.1016/S0301-5629(02)00698-1; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Reinhard M, 2003, PHYSIOL MEAS, V24, P27, DOI 10.1088/0967-3334/24/1/303; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Sahuquillo J, 2000, ACTA NEUROCHIR SUPPL, V76, P485; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; Steinmeier R, 2002, J NEUROTRAUM, V19, P1127, DOI 10.1089/08977150260337949; Thees C, 2003, INTENS CARE MED, V29, P386, DOI 10.1007/s00134-002-1625-7; Tiecks FP, 1996, STROKE, V27, P1177, DOI 10.1161/01.STR.27.7.1177; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zwiener U, 2003, INTENS CARE MED, V29, P2277, DOI 10.1007/s00134-003-2007-5	40	16	17	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	FEB	2007	33	2					246	254		10.1007/s00134-006-0451-8			9	Critical Care Medicine	General & Internal Medicine	133QA	WOS:000244026200007	17143638				2021-06-18	
J	Ellis, DY; Davies, GE; Pearn, J; Lockey, D				Ellis, Daniel Y.; Davies, Gareth E.; Pearn, John; Lockey, David			Prehospital rapid-sequence intubation of patients with trauma with a Glasgow Coma Score of 13 or 14 and the subsequent incidence of intracranial pathology	EMERGENCY MEDICINE JOURNAL			English	Article							HOSPITAL ENDOTRACHEAL INTUBATION; EMERGENCY MEDICAL-SERVICE; HEAD-INJURED PATIENTS; BRAIN-INJURY; GUIDELINES; CARE; IMPACT; RISK	Aim: To identify the incidence of intracranial pathology in a population of patients with trauma with an on-scene Glasgow Coma Score ( GCS) of 13 or 14, and the proportion that required prehospital intubation and ventilation. Method: A retrospective review of a prehospital trauma database was carried out over a 12-month period, and 81 patients were reviewed. All had a traumatic mechanism of injury and had an on-scene GCS of 13 or 14 recorded by a prehospital doctor. 43 patients required prehospital rapid-sequence intubation. Overall, 31.5% of patients with a GCS of 13 or 14 had an abnormal computed tomography scan of the head and 20.5% had an intracranial haemorrhage. Results: For this group of patients with trauma with a drop of only one or two points on the GCS, the incidence of intracranial pathology was almost one in three and that of intracranial haemorrhage was one in five.	Royal London Hosp, Dept Prehosp Care, London E1 1BB, England	Ellis, DY (corresponding author), The Cottage,Upper St, Dyrham SN14 8HN, S Gloucestershi, England.	danellis@doctors.org.uk					*AM COLL SURG COMM, 2004, ADV TRAUM LIF SUPP A; Bernard Stephen, 2002, Emerg Med (Fremantle), V14, P406, DOI 10.1046/j.1442-2026.2002.00382.x; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Burton JH, 2006, ANN EMERG MED, V47, P542, DOI 10.1016/j.annemergmed.2006.01.023; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; Chesnut RM, 1997, J TRAUMA, V42, pS19, DOI 10.1097/00005373-199705001-00004; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Davis MJ, 2002, CHEM VAPOR DEPOS, V8, P7, DOI 10.1002/1521-3862(20020116)8:1<7::AID-CVDE7>3.0.CO;2-A; Dunham CM, 2003, J TRAUMA, V55, P162, DOI 10.1097/01.ta.0000083335.93868.2c; GORMAN DF, 1995, INJURY, V26, P51, DOI 10.1016/0020-1383(95)90553-A; Graham CA, 1997, J ACCID EMERG MED, V14, P219; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; HEDGES JR, 1988, ANN EMERG MED, V17, P469, DOI 10.1016/S0196-0644(88)80238-5; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; *NICE, 2003, HEAD INJ TRIAG ASS I; NICHOLL JP, 1995, BRIT MED J, V311, P217, DOI 10.1136/bmj.311.6999.217; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; Piek J, 1998, INTENS CARE MED, V24, P1221, DOI 10.1007/s001340050748; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; SYVERUD SA, 1988, ANN EMERG MED, V17, P236, DOI 10.1016/S0196-0644(88)80114-8; Wang H E, 2001, Prehosp Emerg Care, V5, P40, DOI 10.1080/10903120190940317; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014	30	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	FEB 1	2007	24	2					139	141		10.1136/emj.2006.040428			3	Emergency Medicine	Emergency Medicine	132UH	WOS:000243967200024	17251629	Green Published			2021-06-18	
J	Mikrogianakis, A; Shaye, RE; Griffin, P; Kawesa, S; Lockwood, J; Gendron, NH; Gaboury, I; Merali, Z; MacKenzie, AE; Hutchison, JS				Mikrogianakis, Angelo; Shaye, Rachel E.; Griffin, Phillip; Kawesa, Sarah; Lockwood, Julia; Gendron, Nathalie H.; Gaboury, Isabelle; Merali, Zul; MacKenzie, Alex E.; Hutchison, James S.			Hypoxia alters the expression of inhibitor of apoptosis proteins after brain trauma in the mouse	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; caspase; hypoxia; neuronal apoptosis inhibitor protein; TBI	ENERGY PHOSPHATE-METABOLISM; CORTICAL IMPACT INJURY; X-LINKED INHIBITOR; NEURONAL APOPTOSIS; RAT HIPPOCAMPUS; TRANSGENIC MICE; HEAD-INJURY; CELL-DEATH; XIAP; ISCHEMIA	Hypoxia worsens brain injury following trauma, but the mechanisms remain unclear. The purpose of this study was to determine the effect of traumatic brain injury (TBI) and secondary hypoxia (9% oxygen) on apoptosis-related protein expression, cell death, and behavior. Using a murine weight-drop model, TBI led to an early (6 h) increase followed by a later (24 h) decrease in neuronal apoptosis inhibitor protein (NAIP) expression in the olfactory and motor cortex; in contrast, TBI led to a sustained (6 h to 7 days) increase in NAIP in the striatum. The peak increase in the expression of NAIP (6-12 h) following TBI alone was delayed (1-7 days) when hypoxia was added to TBI. Hypoxia following TBI further depleted other apoptosis inhibitor proteins (IAPs) and activated caspases, as well as increased contusion size and worsened cell death. Hypoxia added to TBI also increased motor and feeding activity on days 2 and 4 compared to TBI alone. Hypoxia without TBI had no effect on the expression of IAPs or cell death. These findings show that IAPs have a potential role in the increased vulnerability of brain cells to hypoxia following TBI, and have implications for configuring future therapies for TBI.	Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Fac Med, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Fac Med, Interdept Div Crit Care, Toronto, ON, Canada; Hosp Sick Children, Dept Pediat, Div Pediat Emergency Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Inst Res, Integrat Biol Program, Toronto, ON M5G 1X8, Canada; Childrens Hosp Eastern Ontario, Inst Res, Genet Mol Lab, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Inst Res, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada; Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada; Univ Ottawa, Fac Med, Dept Pediat, Ottawa, ON, Canada; Univ Ottawa, Fac Med, Dept Biochem, Ottawa, ON, Canada	Hutchison, JS (corresponding author), Hosp Sick Children, Dept Crit Care Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	Jamie.Hutchison@sickkids.ca	Gaboury, Isabelle/B-6868-2011				Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark D, 1999, IEEE INTERNET COMPUT, V3, P13; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clark RSB, 1997, J NEUROSCI, V17, P9172; Conti AC, 1998, J NEUROSCI, V18, P5663; Crocker SJ, 2003, NEUROBIOL DIS, V12, P150, DOI 10.1016/S0969-9961(02)00020-7; Davoodi J, 2004, J BIOL CHEM, V279, P40622, DOI 10.1074/jbc.M405963200; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Holcik M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-5; Hutchison JS, 2001, J NEUROTRAUM, V18, P1333, DOI 10.1089/08977150152725632; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Johnston S A, 1988, Peptides, V9 Suppl 1, P245, DOI 10.1016/0196-9781(88)90250-1; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kugler S, 2000, CELL DEATH DIFFER, V7, P815, DOI 10.1038/sj.cdd.4400712; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; Merali Z, 2003, BIOL PSYCHIAT, V54, P552, DOI 10.1016/S0006-3223(02)01827-9; Mercer EA, 2000, EMBO J, V19, P3597, DOI 10.1093/emboj/19.14.3597; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Okada Y, 2005, J CEREBR BLOOD F MET, V25, P794, DOI 10.1038/sj.jcbfm.9600078; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Trapp T, 2003, MOL CELL NEUROSCI, V23, P302, DOI 10.1016/S1044-7431(03)00013-7; Wang XY, 2004, NEUROBIOL DIS, V16, P179, DOI 10.1016/j.nbd.2004.01.014; Winter B, 2005, BIOL PSYCHIAT, V57, P1166, DOI 10.1016/j.biopsych.2005.02.010; Xu DG, 1999, J NEUROSCI, V19, P5026; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	44	16	18	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2007	24	2					338	353		10.1089/neu.2006.003615			16	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	150AL	WOS:000245187900013	17375998				2021-06-18	
J	Behan, LA; Agha, A				Behan, Lucy Ann; Agha, Amar			Endocrine consequences of adult traumatic brain injury	HORMONE RESEARCH			English	Article; Proceedings Paper	39th International Symposium on Growth Hormone and Growth Factors in Endocrinology and Metabolism	MAY 11-12, 2007	Berlin, GERMANY	Pfizer		traumatic brain injury; hypopituitarism; pituitary	ANTERIOR-PITUITARY DYSFUNCTION; ANTI-DIURETIC HORMONE; INAPPROPRIATE SECRETION; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; ACUTE-PHASE; HIGH-RISK; HYPOPITUITARISM; INSUFFICIENCY	Background: Traumatic brain injury (TBI) is the most common cause of death and disability in young adults living in industrialised countries. Over the last few years, there has been an increasing awareness that hypopituitarism can complicate TBI in a significant proportion of survivors: at least 25% of TBI survivors develop one or more pituitary hormone deficiencies. This remarkably high frequency has changed the traditional concept that hypopituitarism was a rare complication of TBI and suggests that most cases of posttraumatic hypopituitarism remain undiagnosed and untreated in clinical practice. It is therefore reasonable to infer that posttraumatic hypopituitarism may make an important contribution to the high rates of physical and neuropsychiatric morbidity in patients with head injury. Conclusions: There is clearly a need for identification as well as appropriate and timely management of hormone deficiencies in TBI patients to reduce morbidity, aid recovery and rehabilitation and avoid the long-term complications of pituitary failure. Copyright (c) 2007 S. Karger AG, Basel.	[Behan, Lucy Ann; Agha, Amar] Beaumont Hosp, Div Endocrinol, Dublin 7, Ireland; [Behan, Lucy Ann; Agha, Amar] RCSI Med Sch, Dublin, Ireland	Agha, A (corresponding author), Beaumont Hosp, Div Endocrinol, Beaumont Rd, Dublin 7, Ireland.	amaragha@yahoo.com					Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha A, 2005, AM J MED, V118; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BECKER LH, 1973, J TRAUMA, V13, P112; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Boughey JC, 2004, AM SURGEON, V70, P500; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; ESCUMILLA RF, 1942, J CLIN ENDOCRINOLOGY, V2, P65; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KLASBEEK WD, 1980, J NEUROSURG, V53, P519; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; MONSON JP, 2003, EUR J ENDOCRINOL S2, V148, P9; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; TWIJNSTRA A, 1980, CLIN NEUROL NEUROSUR, V82, P263, DOI 10.1016/0303-8467(80)90018-9; VIGERHOETS F, 1988, ACTA NEUROCHIR, V91, P50; Wong M. F. M., 1998, Annals Academy of Medicine Singapore, V27, P340	30	16	17	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0301-0163			HORM RES	Horm. Res.		2007	68			5			18	21		10.1159/000110466			4	Endocrinology & Metabolism	Endocrinology & Metabolism	247OE	WOS:000252088400007	18174698				2021-06-18	
S	Davenport, A		Ronco, C; Bellomo, R; Kellum, JA		Davenport, Andrew			Renal replacement therapy for the patient with acute traumatic brain injury and severe acute kidney injury	ACUTE KIDNEY INJURY	Contributions to Nephrology		English	Article							CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; HEPATIC-ENCEPHALOPATHY; HEMOFILTRATION; MANAGEMENT; DIALYSIS; GUIDE	Fortunately with improvements in initial medical resuscitation, such as the avoidance of nephrotoxins, the incidence of acute kidney injury requiring renal support in patients with acute traumatic brain injury remains low. However the incidence of cerebral hemorrhage in patients on chronic dialysis programs appears to be increasing. By carefully adapting renal replacement to minimize cardiovascular instability and reduce the rate of change of serum osmolality, patient survival in this group of critically ill patients is increasing and starting to approach that of patients with traumatic brain injury without kidney injury. Copyright (C) 2007 S. Karger AG, Basel.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Div Med, Ctr Nephrol, London NW3 2PF, England	Davenport, A (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Div Med, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	andrew.davenport@royalfree.nhs.uk					Andrews PJD, 2006, INTENS CARE MED, V32, P1461, DOI 10.1007/s00134-006-0295-2; BLEI AT, 1993, LANCET, V341, P157, DOI 10.1016/0140-6736(93)90016-A; Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P561; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; DAVENPORT A, 1987, BRIT MED J, V295, P1028, DOI 10.1136/bmj.295.6605.1028; Davenport A, 1999, KIDNEY INT, V56, pS62, DOI 10.1046/j.1523-1755.56.s.72.3.x; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; DAVENPORT A, 1991, CLIN NEPHROL, V35, P151; DAVENPORT A, 1990, NEPHROL DIAL TRANSPL, V5, P192, DOI 10.1093/ndt/5.3.192; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Gondo G, 1989, Neurol Med Chir (Tokyo), V29, P1125, DOI 10.2176/nmc.29.1125; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Lo DS, 2006, THROMB RES, V118, P385, DOI 10.1016/j.thromres.2005.03.031; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Pai MF, 2004, RENAL FAILURE, V26, P165, DOI 10.1081/JDI-120038504; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Selby NM, 2006, PERITON DIALYSIS INT, V26, P328	19	16	20	0	1	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0302-5144	1662-2782	978-3-8055-8271-1	CONTRIB NEPHROL	Contrib.Nephrol.		2007	156						333	339		10.1159/000102124			7	Urology & Nephrology	Urology & Nephrology	BGI03	WOS:000247085200036	17464144				2021-06-18	
J	Egeland, J; Langfjaeran, T				Egeland, Jens; Langfjaeran, Tone			Differentiating malingering from genuine cognitive dysfunction using the trail making test-ratio and stroop interference scores	APPLIED NEUROPSYCHOLOGY			English	Article						malingering; stroop; trail making test	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; DETECTING EXAGGERATION; SUSPECT EFFORT; PERFORMANCE; DEPRESSION; ATTENTION; UTILITY; RATES	Patterns of test performance that are inconsistent with knowledge of brain dysfunction can potentially diffrentiate between malingering and true impairment among litigants with low scores on neuropsychological tests. In this study possible malingerers (11 = 41), impaired (30) or cognitively normal (17) litigants were compared on the Trail Making Test B.-A ratio score and Stroop Interference. The majority of possible malingerers had a low TMT-ratio (< 2.5) and an inverted Stroop effect, whereas the majority of impaired subjects had a high TMT-ratio and specific Stroop interference. Sensitivity to malingering was 61 and 68 percent, and specificity was 57 and 59 percent. This is too low for valid classification of individuals. However, the combination of both measures increases predictability. The clinician is advised to look for other evidence of malingering in cases of simultaneous low TMT-ratio and inverted Stroop. Patients with high TMT-ratio and Stroop interference, should be thoroughly; examined for indications of brain disease.	Vestfold Mental Hlth Care Trust, Dept Res, N-3103 Tonsberg, Norway; Vestfold Mental Hlth Care Trust, No Vestfold Dist Psychiat Ctr, Tonsberg, Norway	Egeland, J (corresponding author), Vestfold Mental Hlth Care Trust, Dept Res, Box 2267, N-3103 Tonsberg, Norway.	jens.egeland@piv.no					Bianchini KJ, 2003, CLIN NEUROPSYCHOL, V17, P574, DOI 10.1076/clin.17.4.574.27946; DELIS D, 1987, CALIFORNIA VERBAL LE; Egeland, 2005, TIDSSKRIFT NORSK PSY, V42, P99; Egeland J, 2003, ACTA PSYCHIAT SCAND, V108, P276, DOI 10.1034/j.1600-0447.2003.00146.x; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; Golden C., 1978, STROOP COLOR WORD TE; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Halstead WC, 1985, HALSTEAD REITAN NEUR; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lemelin S, 1997, J NERV MENT DIS, V185, P542, DOI 10.1097/00005053-199709000-00002; Lu PH, 2004, J CLIN EXP NEUROPSYC, V26, P180, DOI 10.1076/jcen.26.2.180.28082; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morrow L. A., 2001, MED NEUROPSYCHOLOGY; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; Reitan R. M., 1997, DETECTION MALINGERIN; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Slick D., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 2003, CLIN NEUROPSYCHOL, V17, P390, DOI 10.1076/clin.17.3.390.18090; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Tedstone D, 2004, DRUG ALCOHOL DEPEN, V75, P277, DOI 10.1016/j.drugalcdep.2004.03.005	24	16	17	0	6	LAWRENCE ERLBAUM ASSOC INC-TAYLOR & FRANCIS	PHILADELPHIA	325 CHESTNUT STREET, STE 800, PHILADELPHIA, PA 19106 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2007	14	2					113	119		10.1080/09084280701319953			7	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	187ZG	WOS:000247887400006	17523885				2021-06-18	
J	Formisano, R; Barba, C; Buzzi, MG; Newcomb-Fernandez, J; Menniti-Ippolito, F; Zafonte, R; Vinicola, V; Spanedda, F				Formisano, R.; Barba, C.; Buzzi, M. G.; Newcomb-Fernandez, J.; Menniti-Ippolito, F.; Zafonte, R.; Vinicola, V.; Spanedda, F.			The impact of prophylactic treatment on post-traumatic epilepsy after severe traumatic brain injury	BRAIN INJURY			English	Article						late post-traumatic epilepsy; severe traumatic brain injury; prophylactic anti-epileptic treatment; cognitive functioning	SEVERE HEAD-INJURIES; PHARMACOLOGICAL PROPHYLAXIS; SEIZURES; PHENYTOIN; PREVENTION; TOPIRAMATE; CARBAMAZEPINE; LAMOTRIGINE; PREDICTORS; RECOVERY	Aim: To assess the incidence of late post-traumatic epilepsy ( PTE) in patients with very severe traumatic brain injury ( TBI) who either received or did not receive anti-epileptic prophylactic treatment. Methods: Two populations were studied: 55 patients retrospectively and 82 subjects prospectively. Results: Ten patients ( 18%) in the first population showed late PTE. Although the incidence was lower in patients who did not receive prophylactic treatment, the difference between the treated and the non-treated group was not statistically significant. Sixty-nine patients in the second group ( 84%) had prophylactic treatment. Twenty-seven patients ( 39%) suffered from late PTE during the 2-year follow-up period and 17 of them ( 63%) showed EEG epileptic abnormalities. No patient who did not receive preventive therapy suffered from late PTE during the observation period. Conclusions: Due to the negative cognitive effects of anti-epileptic drugs, the preliminary results are of considerable interest for the rehabilitation of patients with very severe TBI.	Rehabil Hosp, IRCCS, Santa Lucia Fdn, Rome, Italy; Newcomb Sci LLC, Houston, TX USA; Natl Inst Hlth, Rome, Italy; Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA	Formisano, R (corresponding author), IRCCS, Fdn Santa Lucia, V Ardeatina 306, I-00179 Rome, Italy.	r.formisano@hsantalucia.it	Buzzi, Maria Gabriella/K-5468-2016	Buzzi, Maria Gabriella/0000-0003-1307-8707; barba, carmen/0000-0001-5445-5842			Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ASKAINEN I, 1999, EPILEPSIA, V40, P584; BICKFORD RG, 1966, HEAD INJURY, P63; BRICOLO A, 1976, CLIN ELECTROENCEPHAL, V7, P184, DOI 10.1177/155005947600700402; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; COURJON J, 1972, HDB ELECTROENCEPHALO, P8; Courjon J.A., 1969, POST TRAUMATIC EPILE, P215; Dauch WA, 1996, ZBL NEUROCHIR, V57, P190; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; EVANS JH, 1962, NEUROLOGY, V12, P665, DOI 10.1212/WNL.12.10.665; Fonseca L C, 1975, Arq Neuropsiquiatr, V33, P318; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HAUSER WA, 1983, PEDIAT HEAD TRAUMA, P241; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; Jennett B, 1975, EPILEPSY NONMISSILE; JENNETT WB, 1969, LANCET, V1, P1023; Marienne J P, 1979, Acta Neurochir Suppl (Wien), V28, P89; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Martin R, 1999, NEUROLOGY, V52, P321, DOI 10.1212/WNL.52.2.321; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; Meador KJ, 2005, NEUROLOGY, V64, P2108, DOI 10.1212/01.WNL.0000165994.46777.BE; MEADOR KJ, 2004, TREATMENT EPILEPSY P, P1215; PAILLAS JE, 1982, B LEGA ITAL EPILEPSI, V39, P11; PENRY JK, 1979, NEUROLOGY, V29, P600; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; Privitera MD, 2003, ACTA NEUROL SCAND, V107, P165, DOI 10.1034/j.1600-0404.2003.00093.x; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; TEASDALE TW, 1974, LANCET, V11, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; VANWOERKOM TCAM, 1982, EUR NEUROL, V21, P227, DOI 10.1159/000115485; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236	47	16	16	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	5					499	504		10.1080/02699050701310994			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	175FI	WOS:000246998000006	17522989				2021-06-18	
B	Godefroy, O; Stuss, D		Godefroy, O; Bogousslavsky, J		Godefroy, Olivier; Stuss, Donald			Dysexecutive syndromes	BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; WHITE-MATTER LESIONS; FRONTAL-LOBE LESIONS; SUSTAINED ATTENTION DEFICITS; SORTING TEST-PERFORMANCE; DUAL-TASK PERFORMANCE; CLOSED-HEAD INJURY; PREFRONTAL CORTEX; WORKING-MEMORY; EXECUTIVE DYSFUNCTION		[Godefroy, Olivier] Univ Hosp, Dept Neurol, F-80054 Amiens, France; [Stuss, Donald] Rotman Res Inst, Toronto, ON, Canada; [Stuss, Donald] Univ Toronto, Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Godefroy, Olivier] Univ Hosp, Lab Neurosci Fonct & Pathol, CNRE FRE 2726, F-80054 Amiens, France	Godefroy, O (corresponding author), Univ Hosp, Dept Neurol, F-80054 Amiens, France.			Godefroy, Olivier/0000-0001-6789-6620			ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexander MP, 2005, NEUROLOGY, V65, P572, DOI 10.1212/01.wnl.0000172912.07640.92; Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A. D., 1986, WORKING MEMORY; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P119, DOI 10.1080/14640746608400019; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Berger A, 2000, NEUROSCI BIOBEHAV R, V24, P3, DOI 10.1016/S0149-7634(99)00046-9; Beversdorf DQ, 1998, NEUROLOGY, V51, P968, DOI 10.1212/WNL.51.4.968; BOGOUSSLAVSKY J, 1991, ACTA NEUROL SCAND, V83, P309, DOI 10.1111/j.1600-0404.1991.tb04708.x; BOGOUSSLAVSKY J, 1986, STROKE, V17, P434, DOI 10.1161/01.STR.17.3.434; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P837, DOI 10.1212/WNL.38.6.837; BOGOUSSLAVSKY J, 1994, EUR NEUROL, V34, P306, DOI 10.1159/000117068; Buccino G, 2003, ACTA NEUROL SCAND, V107, P330, DOI 10.1034/j.1600-0404.2003.00031.x; Burgess P. W., 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; BURGESS PW, 2005, MEASURING MIND SPEED, P215; CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133, DOI 10.1001/archneur.1990.00530020029011; Cowey CM, 1996, MEMORY, V4, P19, DOI 10.1080/741940668; Cramer SC, 1997, STROKE, V28, P2162, DOI 10.1161/01.STR.28.11.2162; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; DALLABARBA G, 1993, CORTEX, V29, P567, DOI 10.1016/S0010-9452(13)80281-X; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; de Bruijn SFTM, 2000, NEUROLOGY, V54, P1687, DOI 10.1212/WNL.54.8.1687; DELIS DC, 1992, NEUROPSYCHOLOGIA, V30, P683, DOI 10.1016/0028-3932(92)90039-O; DELLAROCCHETTA AI, 1993, NEUROPSYCHOLOGIA, V31, P503; Desrosiers J, 1996, STROKE, V27, P1564, DOI 10.1161/01.STR.27.9.1564; DEUTSCH G, 1987, INT J NEUROSCI, V36, P23, DOI 10.3109/00207458709002136; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; DREWE E A, 1975, Cortex, V11, P8; Du AT, 2002, NEUROLOGY, V58, P1635, DOI 10.1212/WNL.58.11.1635; Engstad T, 2003, NEUROEPIDEMIOLOGY, V22, P326, DOI 10.1159/000072921; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fisher C M, 1983, Clin Neurosurg, V31, P9; FLEMINGER S, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003299; Forsyth R., 2003, COCHRANE DB SYST REV, V1; FRITH U, 1989, BRIT J DISORD COMMUN, V24, P123; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; FUSTER JM, 1997, PREFRONTAL CORTEX AN; Ghika-Schmid F, 2000, ANN NEUROL, V48, P220, DOI 10.1002/1531-8249(200008)48:2<220::AID-ANA12>3.0.CO;2-M; Ghika-Schmid F, 1999, NEUROLOGY, V52, P22, DOI 10.1212/WNL.52.1.22; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; Godefroy O, 1999, CORTEX, V35, P1, DOI 10.1016/S0010-9452(08)70782-2; Godefroy O, 2004, REV NEUROL-FRANCE, V160, P899; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Godefroy O, 2002, NEUROPSYCHOLOGIA, V40, P2234, DOI 10.1016/S0028-3932(02)00109-4; GODEFROY O, 1994, NEUROPSYCHOLOGIA, V32, P983, DOI 10.1016/0028-3932(94)90047-7; Godefroy O, 1998, BRAIN, V121, P1545, DOI 10.1093/brain/121.8.1545; GODEFROY O, 1992, ARCH NEUROL-CHICAGO, V49, P1285, DOI 10.1001/archneur.1992.00530360087023; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; Goldman-Rakic P. S., 1987, NERVOUS SYSTEM, P373, DOI DOI 10.1002/CPHY.CP010509; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grigsby J, 1998, J AM GERIATR SOC, V46, P590, DOI 10.1111/j.1532-5415.1998.tb01075.x; HABIB M, 1988, REV NEUROL, V144, P571; Harlow J. M., 1993, HIST PSYCHIATR, V4, P274, DOI [10.1177/0957154X9300401407, DOI 10.1177/0957154X9300401407]; HECAEN H, 1956, TROUBLES MENTAUX COU; Henon H, 1997, STROKE, V28, P2429, DOI 10.1161/01.STR.28.12.2429; Hillis AE, 2000, J NEUROL NEUROSUR PS, V69, P608, DOI 10.1136/jnnp.69.5.608; Hochstenbach J, 1998, J CLIN EXP NEUROPSYC, V20, P503, DOI 10.1076/jcen.20.4.503.1471; Hochstenbach JB, 2003, ARCH PHYS MED REHAB, V84, P1499, DOI 10.1016/S0003-9993(03)00370-8; Hutter B, 2000, NEUROPSYCHOLOGICAL S; HUTTER BO, 1993, NEUROSURGERY, V33, P999; ISHII N, 1986, NEUROLOGY, V36, P340, DOI 10.1212/WNL.36.3.340; Jacobsen C.F., 1936, COMP PSYCHOL, V13, P1, DOI DOI 10.1001/ARCHNEURPSYC.1935.02250150108009; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; JASON GW, 1985, NEUROPSYCHOLOGIA, V23, P483, DOI 10.1016/0028-3932(85)90003-X; JETTER W, 1986, CORTEX, V22, P229, DOI 10.1016/S0010-9452(86)80047-8; Kant R, 1998, BRAIN INJURY, V12, P661, DOI 10.1080/026990598122223; Kramer JH, 2002, J NEUROL NEUROSUR PS, V72, P217, DOI 10.1136/jnnp.72.2.217; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Krolak-Salmon P, 2000, EUR NEUROL, V44, P216, DOI 10.1159/000008239; Kumral E, 2002, EUR J NEUROL, V9, P615, DOI 10.1046/j.1468-1331.2002.00452.x; LAPLANE D, 1981, REV NEUROL, V137, P269; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Leskela M, 1999, EUR J NEUROL, V6, P653, DOI 10.1046/j.1468-1331.1999.660653.x; LEVINE B, 1995, J CLIN EXP NEUROPSYC, V17, P740, DOI 10.1080/01688639508405164; Levine B, 1997, NEUROPSYCHOLOGY, V11, P367, DOI 10.1037/0894-4105.11.3.367; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Lincoln NB, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002842; LJUNGGREN B, 1985, J NEUROSURG, V62, P673, DOI 10.3171/jns.1985.62.5.0673; Luria A. R., 1966, HIGHER CORTICAL FUNC; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; MAHALICK DM, 1993, NEUROSURGERY, V33, P563, DOI 10.1227/00006123-199310000-00003; MALLOY PF, 1994, J NEUROPSYCH CLIN N, V6, P399; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Martin Claudine, 2002, Appl Neuropsychol, V9, P148, DOI 10.1207/S15324826AN0903_3; Mayer SA, 2002, NEUROLOGY, V59, P1750, DOI 10.1212/01.WNL.0000035748.91128.C2; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MENDEZ MF, 1989, NEUROLOGY, V39, P349, DOI 10.1212/WNL.39.3.349; MESSERLI P, 1979, SCHWEIZ ARCH NEUROL, V125, P23; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MISHKIN M, 1964, FRONTAL GRANULAR COR, P219; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Mungas D, 2001, NEUROLOGY, V57, P2229, DOI 10.1212/WNL.57.12.2229; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; NORMAN DA, 1980, 99 CTR HUM INF PROC; O'Brien JT, 2002, ANN NY ACAD SCI, V977, P436, DOI 10.1111/j.1749-6632.2002.tb04849.x; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Pandya DN, 1996, PHILOS T ROY SOC B, V351, P1423, DOI 10.1098/rstb.1996.0127; PEDRAZZI P, 1990, REV NEUROL, V146, P726; PERCHERON G, 1976, REV NEUROL, V132, P297; PERCHERON G, 1976, REV NEUROL, V132, P309; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; PILLON B, 1993, ARCH NEUROL-CHICAGO, V50, P374, DOI 10.1001/archneur.1993.00540040036010; Pohjasvaara T, 2000, ARCH NEUROL-CHICAGO, V57, P1295, DOI 10.1001/archneur.57.9.1295; Pohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x; Pohjasvaara T, 2003, ALZ DIS ASSOC DIS, V17, P236, DOI 10.1097/00002093-200310000-00007; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; RAMIER AM, 1970, REV NEUROL, V123, P17; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; Rasquin SMC, 2002, J NEUROL SCI, V203, P115, DOI 10.1016/S0022-510X(02)00264-2; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Roberts AC, 1996, PHILOS T R SOC B, V351, P1389, DOI 10.1098/rstb.1996.0122; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rolls ET, 2000, ANNU REV PSYCHOL, V51, P599, DOI 10.1146/annurev.psych.51.1.599; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970; Rousseaux M, 1996, REV NEUROL-FRANCE, V152, P678; Roussel-Pieronne M., REV NEUROPS IN PRESS; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Rueckert L, 1998, NEUROPSYCHOLOGIA, V36, P653, DOI 10.1016/S0028-3932(97)00150-4; Rylander G., 1939, ACTA PSYCHIAT NE S20, V113, P3; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Saint-Cyr JA, 2003, J INT NEUROPSYCH SOC, V9, P103, DOI 10.1017/S1355617703910125; SANIDES F, 1970, Zeitschrift fuer Mikroskopisch-Anatomische Forschung (Leipzig), V82, P570; Sarazin M, 2003, J NEUROL, V250, P827, DOI 10.1007/s00415-003-1087-z; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2000, NEUROLOGY, V55, P74, DOI 10.1212/WNL.55.1.74; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; SHALLICE T, 1989, BRAIN, V112, P1587, DOI 10.1093/brain/112.6.1587; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1990, NEUROPSYCHOLOGICAL I, P11, DOI [10.1017/CBO9780511665547.003, DOI 10.1017/CBO9780511665547.003]; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; Shankle WR, 1995, ALZ DIS ASSOC DIS, V9, P233, DOI 10.1097/00002093-199509040-00010; Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; STARKSTEIN SE, 1988, BRAIN, V111, P375, DOI 10.1093/brain/111.2.375; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [DOI 10.1037/0894-4105.8.3.355, 10.1037/0894-4105.8.3.355]; Stuss D. T., 1987, J NEUROLOGICAL REHAB, V1, P19, DOI DOI 10.1177/136140968700100105; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2002, NEUROPSYCHOLOGY, V16, P500, DOI 10.1037//0894-4105.16.4.500; Stuss DT, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P215; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Stuss DT., 1991, AWARENESS DEFICIT BR, P63; Stuss DT., 2000, DIFFERENTIATION STAT, P340; Sunderland A, 1999, STROKE, V30, P949, DOI 10.1161/01.STR.30.5.949; Tariot PN, 1999, J CLIN PSYCHIAT, V60, P684, DOI 10.4088/JCP.v60n1007; Tariot PN, 1998, AM J PSYCHIAT, V155, P54, DOI 10.1176/ajp.155.1.54; TATEMICHI TK, 1993, ANN NEUROL, V33, P568, DOI 10.1002/ana.410330603; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; TIDSWELL P, 1995, NEUROLOGY, V45, P875; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; TRUELLE JL, 1995, NEUROPSY NEUROPSY BE, V8, P14; Tullberg M, 2004, NEUROLOGY, V63, P246, DOI 10.1212/01.WNL.0000130530.55104.B5; UMILTA C, 1992, EUR J COGN PSYCHOL, V4, P21, DOI 10.1080/09541449208406241; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Vataja R, 2003, EUR J NEUROL, V10, P625, DOI 10.1046/j.1468-1331.2003.00676.x; WEILLER C, 1990, ARCH NEUROL-CHICAGO, V47, P1085, DOI 10.1001/archneur.1990.00530100051013; Wheeler M A, 1995, J Int Neuropsychol Soc, V1, P525; Wheeler MA, 2003, CORTEX, V39, P827, DOI 10.1016/S0010-9452(08)70866-9; WIEGERSMA S, 1990, NEUROPSYCHOLOGIA, V28, P95, DOI 10.1016/0028-3932(90)90089-7; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wilson BA, 1996, BEHAV ASSESSMENT DYS; WINOCUR G, 1990, BEHAV NEUROSCI, V104, P544, DOI 10.1037/0735-7044.104.4.544; WOLFE N, 1990, ARCH NEUROL-CHICAGO, V47, P129, DOI 10.1001/archneur.1990.00530020025010	204	16	16	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-52184-261-7				2007							369	406		10.1017/CBO9780511544880.020	10.1017/CBO9780511544880		38	Clinical Neurology	Neurosciences & Neurology	BYC38	WOS:000297924800020					2021-06-18	
J	Thomas, JB; Abo, BN; Wang, HE				Thomas, Jane Boyce; Abo, Benjamin N.; Wang, Henry E.			Paramedic perceptions of challenges in out-of-hospital endotracheal intubation	PREHOSPITAL EMERGENCY CARE			English	Article						emergency medicine; allied health personnel; perceptions; focus groups; qualitative research; intubation	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; EMERGENCY-MEDICINE; SUCCESS; PERSONNEL; EVENTS	Objective. Paramedics often perform endotracheal intubation (ETI), insertion of a breathing tube, on critically ill out-of-hospital patients. Recent studies highlight important paramedic ETI shortcomings including adverse events, errors, and poor outcomes resulting from this procedure. Little is known about workforce perceptions of these events. We sought to identify paramedic and physician perceptions regarding the challenges and pitfalls of out-of-hospital ETI. Methods. We conducted a qualitative study involving paramedic focus groups sessions and individual interviews with Emergency Medical Services ( EMS) physician medical directors. We recorded and transcribed all sessions. We used inductive theory construction to examine, organize, and classify thematic patterns. Results. Fourteen paramedics and 6 physicians participated. Although paramedics and physicians recognized problems with paramedic ETI, all participants strongly felt that paramedics should continue to perform the procedure. Physicians and paramedics disagreed about the ability of paramedics to perform neuromuscular blockade-assisted intubation. Both groups identified aspects of paramedic education, skills acquisition, and maintenance as core issues. Participants also identified broader factors about the structure of emergency services, the role of the medical director, and workforce culture and professionalism. Conclusion. Paramedics and EMS physicians attribute paramedic ETI performance to a myriad of factors involving EMS education, organization, oversight, retention, and professionalism. Efforts to improve ETI must include strategies to address multiple aspects of EMS operations and culture.	Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA	Wang, HE (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, 230 McKee Pl,Suite 400, Pittsburgh, PA 15213 USA.	wanghe@upmc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS013628] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08 HS013628] Funding Source: Medline		Bernard H. R., 2002, RES METHODS ANTHR QU; Bochicchio Grant V, 2003, Curr Opin Crit Care, V9, P524, DOI 10.1097/00075198-200312000-00010; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DELEO BC, 1977, HEART LUNG, V6, P851; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Gabrielli Andrea, 2002, Curr Opin Crit Care, V8, P199, DOI 10.1097/00075198-200206000-00002; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GUSS DA, 1984, AM J EMERG MED, V2, P399, DOI 10.1016/0735-6757(84)90041-X; Harper Janice, 2002, ENDANGERED SPECIES H; JACOBS LM, 1983, JAMA-J AM MED ASSOC, V250, P2175, DOI 10.1001/jama.250.16.2175; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Krathwohl D. R., 1997, METHODS ED SOCIAL SC; Krueger R., 1994, FOCUS GROUPS PRACTIC; Levitan RM, 2004, ANN EMERG MED, V43, P48, DOI 10.1016/S0196-0644(03)00638-3; Lindenbaum S., 1979, KURU SORCERY DIS DAN; Mason J., 2002, QUALITATIVE RES; McDonald C C, 1998, Prehosp Emerg Care, V2, P29, DOI 10.1080/10903129808958836; Miles M.B., 1994, QUALITATIVE DATA ANA; Nolan J D, 2001, Curr Opin Crit Care, V7, P413, DOI 10.1097/00075198-200112000-00008; Scheper-Hughes, 2001, SAINTS SCHOLARS SCHI; STEWART RD, 1984, CHEST, V85, P341, DOI 10.1378/chest.85.3.341; Strauss A. C., 1998, STRATEGIES QUALITATI; Tayal VS, 1999, ACAD EMERG MED, V6, P31, DOI 10.1111/j.1553-2712.1999.tb00091.x; WALLS RM, 1993, ANN EMERG MED, V22, P1008, DOI 10.1016/S0196-0644(05)82743-X; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Zink BJ, 2004, ANN EMERG MED, V44, P451, DOI 10.1016/j.annemergmed.2004.05.001	32	16	16	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1090-3127			PREHOSP EMERG CARE	Prehosp. Emerg. Care		2007	11	2					219	223		10.1080/10903120701205802			5	Emergency Medicine; Public, Environmental & Occupational Health	Emergency Medicine; Public, Environmental & Occupational Health	156CW	WOS:000245626700013	17454812				2021-06-18	
J	Marsh, NV; Kersel, DA				Marsh, Nigel V.; Kersel, Denyse A.			Frequency of behavioural problems at one year following traumatic brain injury: Correspondence between patient and caregiver reports	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							CLOSED-HEAD-INJURY; PSYCHOSOCIAL RECOVERY; ADJUSTMENT; RELATIVES; DISORDER; FAMILY; IMPACT	A group of 62 adults with significant (i.e., ventilation required for > 24 hours) traumatic brain injury (TBI) were assessed approximately one year following their injury. The people with TBI and their primary caregivers completed the patient and relative/friend versions respectively, of the 20-item Head Injury Behaviour Rating Scale (HIBS). Responses by the patient and caregiver groups were compared for the total number of problems reported and the frequency of specific problem behaviours. The caregiver group reported a greater total number of problem behaviours and a higher frequency for 19 of the 20 specific behaviours. These differences between the patients' and caregivers' reports were statistically significant for seven of the 19 problem behaviours. The majority (86%) of these significant differences were on items from the Behavioural Regulation, rather than the Emotional Regulation, subscale of the HIBS. The implications of these findings for the practice of neuropsychological rehabilitation are presented.	Univ New England, Sch Psychol, Armidale, NSW 2351, Australia; Community Treatment Ctr Brain Injury, Glasgow, Lanark, Scotland	Marsh, NV (corresponding author), Univ New England, Sch Psychol, Armidale, NSW 2351, Australia.	nigel.marsh@une.edu.au	Marsh, Nigel V./F-5433-2019	Marsh, Nigel V./0000-0002-4060-6432			Brooks D N, 1979, Int Rehabil Med, V1, P160; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Havill JH, 1998, NEW ZEAL MED J, V111, P161; JENNETT B, 1975, LANCET, V1, P480; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; MARSH NV, 1999, BRAIN DAM B, P175; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Smith L.M., 1995, FAMILY SUPPORT PROGR; TEASDALE G, 1974, LANCET, V2, P81; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742	34	16	17	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	DEC	2006	16	6					684	694		10.1080/09602010500220290			11	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	118JY	WOS:000242939800006	17127573				2021-06-18	
J	Dizon, MLV; Shin, L; Sundholm-Peters, NL; Kang, E; Szele, FG				Dizon, M. L. V.; Shin, L.; Sundholm-Peters, N. L.; Kang, E.; Szele, F. G.			Subventricular zone cells remain stable in vitro after brain injury	NEUROSCIENCE			English	Article						migration; neurogenesis; traumatic brain injury; subependymal zone; fate; mouse	NEURAL STEM-CELLS; ROSTRAL MIGRATORY STREAM; NEURONAL MIGRATION; CORTICAL-LESIONS; CEREBRAL-CORTEX; ADULT MICE; PROGENITORS; ASTROCYTES; PRECURSORS; EXPRESSION	Subventricular zone (SVZ) cells emigrate toward brain injury but relatively few survive. Thus, if they are to be used for repair, ex vivo expansion and autologous transplantation of SVZ cells may be necessary. Since it is unclear how brain injury alters SVZ cell culture, we studied neurosphere formation, differentiation, and migration, after cortical lesions. The number of neurosphere forming cells from lesioned mice was comparable to controls. Also, the proportion of astrocytes and neurons generated in vitro remained unchanged after cortical lesions. Cell emigration from neurospheres was characterized by increased cell-cell contact after injury in adults and neonates. However, neither molecules implicated in SVZ migration nor the extent of migration changed after injury. Thus, neurospheres can be successfully cultured after extensive brain damage, and they are remarkably stable in vitro, suggesting suitability for ex vivo expansion and autologous transplantation. (c) 2006 IBRO. Published by Elsevier Ltd. All rights reserved.	Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Dept Pediat,CMRC Neurobiol Program, Chicago, IL 60614 USA	Szele, FG (corresponding author), Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Dept Pediat,CMRC Neurobiol Program, 2430 N Halsted St,209, Chicago, IL 60614 USA.	f-szele@northwestern.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS053529] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 NS/AG42253-01] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS053529, K08 NS053529-01] Funding Source: Medline		Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Dizon M. L. V., 2005, MAMMALIAN SUBVENTRIC, P210; Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Gotts JE, 2005, J COMP NEUROL, V488, P201, DOI 10.1002/cne.20609; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kearns SM, 2003, EXP NEUROL, V182, P240, DOI 10.1016/S0014-4886(03)00124-9; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Levison SW, 2003, DEV NEUROSCI-BASEL, V25, P184, DOI 10.1159/000072267; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Murase S, 2002, J NEUROSCI, V22, P3568; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Reid CB, 1999, J COMP NEUROL, V403, P106; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Romanko MJ, 2004, J CEREBR BLOOD F MET, V24, P814, DOI 10.1097/01.WCB.0000123906.17746.00; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; SZELE FG, 1995, J NEUROSCI, V15, P4429; Thomas LB, 1996, GLIA, V17, P1; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331	35	16	17	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	OCT 27	2006	142	3					717	725		10.1016/j.neuroscience.2006.06.050			9	Neurosciences	Neurosciences & Neurology	098NW	WOS:000241530600010	16935433				2021-06-18	
J	Pero, S; Incoccia, C; Caracciolo, B; Zoccolotti, P; Formisano, R				Pero, Sergio; Incoccia, Chiara; Caracciolo, Barbara; Zoccolotti, Pierluigi; Formisano, Rita			Rehabilitation of attention in two patients with traumatic brain injury by means of 'attention process training'	BRAIN INJURY			English	Article						brain injury; attention; rehabilitation	CLOSED-HEAD-INJURY; SUSTAINED ATTENTION; DEFICITS; PROGRAM; TASK; PERFORMANCE; MEMORY	Primary objective: This case study aims to evaluate the effectiveness of the Solhberg and Mateer's Attention Process Training ( APT) using a comprehensive evaluation of various attentional processes. Methods and procedures: Two patients with severe traumatic brain injury were given the APT in a chronic phase. Attentional processes were evaluated at various stages before, during and after treatment, using the Testbatterie zur Aufmerksamkeitsprufung and the Test of everyday attention. Main outcomes and results: Both patients showed some degree of recovery, particularly in attentional tasks with a selective component. Lesser improvement was present in the case of tasks mapping on the intensity dimension of attention ( alertness, vigilance). Training achievements were confirmed by the use of a functional scale evaluating attention, pointing to the generality of improvements. Conclusion: The results indicate selective training effects of APT on the attentional disturbances of TBI patients.	Fdn Santa Lucia, IRCCS, Ctr Ric Neuropsicol, I-00179 Rome, Italy; Karolinska Inst, Div Geriatr Epidemiol, Stockholm, Sweden; Univ Roma La Sapienza, Dept Psychol, Rome, Italy	Pero, S (corresponding author), Fdn Santa Lucia, IRCCS, Ctr Ric Neuropsicol, Via Ardeatina 306, I-00179 Rome, Italy.	s.pero@hsantalucia.it	Zoccolotti, Pierluigi/H-4437-2019	Zoccolotti, Pierluigi/0000-0002-6351-2455; Incoccia, Chiara/0000-0003-4068-6548			Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BENYISHAY Y, 1987, NEUROPSYCHOL REHABIL, P165; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; CANTAGALLO A, 1998, RASSEGNA PSICOLOGIA, V15, P137; CAPITANI E, 1999, HDB CLIN EXPT NEUROP, P57; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; FEINSTEIN A, 1994, J CLIN EXP NEUROPSYC, V16, P436, DOI 10.1080/01688639408402654; Gray J. M., 1992, NEUROPSYCHOL REHABIL, V2, P97; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton R., 1993, WISCONSIN CARD SORTI; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P89; LEVIN HS, 1988, SCAND J REHABIL MED, P33; Lienert G.A., 1969, TESTAUFBAU TESTANALY; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; MICELI G, 1994, BATTERIA ANAL DEFICI; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson I. H., 1994, TEST EVERYDAY ATTENT; SAMPSON H, 1961, AUST J PSYCHOL, V13, P185, DOI 10.1080/00049536108256002; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spinnler H, 1987, ITAL J NEUROL SCI, V6, P5; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Sturm W, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P365; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Stuss D. T., 1989, CLIN NEUROPSYCHOL, V3, P145, DOI DOI 10.1080/13854048908403287; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI DOI 10.1080/13854048708520046; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Whyte J, 1997, NEUROPSYCHOLOGIA, V35, P313, DOI 10.1016/S0028-3932(96)00092-9; Zimmermann P., 1992, TESTBATTERIE AUFMERK; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	43	16	17	1	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2006	20	11					1207	1219		10.1080/02699050600983271			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	110DD	WOS:000242357600011	17123937				2021-06-18	
J	Ramani, R				Ramani, Ramachandran			Hypothermia for brain protection and resuscitation	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						brain protection; hypothermia; intracranial pressure; traumatic brain injury	HEAD-INJURED PATIENTS; THERAPEUTIC HYPOTHERMIA; MILD HYPOTHERMIA; ANEURYSM-SURGERY; NEUROPROTECTION; MANAGEMENT; EFFICACY; TRIALS; STROKE	Purpose of review Clinicians are actively looking for an effective brain protection technique. With pharmacologic agents, several phase III trials in stroke, severe traumatic brain injury, and post-cardiac arrest survivors have failed. Hence there is renewed interest in mild to moderate hypothermia for brain protection. Phase III clinical trials with hypothermia have been successful only in post-cardiac arrest survivors and neonatal hypoxic encephalopathy. This review focuses on the possible reasons for our inability to translate into positive clinical trials what is observed consistently in laboratory models. Recent findings Several factors have been identified for the failure of successive hypothermia clinical trials. Patients with severe traumatic brain injury with Glasgow Coma Score of 4-7 on admission and those less than 45 years of age and neonates with hypoxic encephalopathy are more responsive to hypothermia. Similarly, early and effective cooling techniques and titration of hypothermia to a defined endpoint are likely to be more effective. New techniques such as local cooling of the brain and the combination of hypothermia with drugs are being evaluated. Summary Hypothermia can at present be recommended only for post-cardiac arrest survivors and in neonatal hypoxic encephalopathy.	[Ramani, Ramachandran] Yale Univ, Sch Med, New Haven, CT 06520 USA	Ramani, R (corresponding author), Yale Univ, Sch Med, Anesthesia, 333 Cedar St,POB 208051, New Haven, CT 06520 USA.	ramachandran.ramani@yale.edu					Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; De Keyser J, 1999, TRENDS NEUROSCI, V22, P535, DOI 10.1016/S0166-2236(99)01463-0; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Narayan RK, 2001, NEW ENGL J MED, V344, P602, DOI 10.1056/NEJM200102223440810; Plum F, 2001, JAMA-J AM MED ASSOC, V285, P1760, DOI 10.1001/jama.285.13.1760; Polderman KH, 2006, NEW ENGL J MED, V354, P1643; Polderman KH, 2004, CRIT CARE MED, V32, P2558, DOI 10.1097/01.CCM.0000148087.41418.0A; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Wagner KR, 2005, NEUROL RES, V27, P238, DOI 10.1179/016164105X25261; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272	25	16	25	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2006	19	5					487	491		10.1097/01.aco.0000245272.84539.97			5	Anesthesiology	Anesthesiology	V42RZ	WOS:000209632200003	16960479				2021-06-18	
J	Noppens, RR; Christ, M; Brambrink, AM; Koerner, IP; Heimann, A; Kempski, O				Noppens, Ruediger R.; Christ, Michael; Brambrink, Ansgar M.; Koerner, Ines P.; Heimann, Axel; Kempski, Oliver			An early bolus of hypertonic saline hydroxyethyl starch improves long-term outcome after global cerebral ischemia	CRITICAL CARE MEDICINE			English	Article						rats; cerebral ischemia; cerebral resuscitation; hypertonic saline; hydroxyethyl starch; histopathology; neurological deficit; survival	7.5-PERCENT SODIUM-CHLORIDE; SMALL-VOLUME RESUSCITATION; NO-REFLOW PHENOMENON; BLOOD-FLOW; HYPOBARIC HYPOTENSION; HEMORRHAGIC-SHOCK; BRAIN; RATS; MECHANISMS; OCCLUSION	Objective: The beneficial effect of hypertonic saline solutions in the emergency treatment of shock and traumatic brain injury is well described. The present study determines effects of a single bolus of hypertonic saline on long-term survival, neurologic function, and neuronal survival 10 days after global cerebral ischemia. In addition, we evaluated the therapeutic window for hypertonic saline treatment (early vs. delayed application). Design: Laboratory experiment. Setting: University laboratory. Subjects. Male Wistar rats weighing 240-330 g. Interventions. Rats were submitted to temporal global cerebral ischemia using temporary bilateral carotid occlusion combined with hypobaric hypotension. Animals received 7.5% saline/6% hydroxyethyl starch (HHS) or vehicle (NaCl 0.9%) at either 1.5 mins (early treatment) or 31.5 mins (delayed treatment) of reperfusion. Regional cerebral blood flow (rCBF) and physiologic variables were measured during insult and early reperfusion. Animal survival and neurologic function were evaluated throughout the 10-day observation period. Quantification of brain injury was performed on day 10. Measurements and Main Results., Early treatment with HHS resulted in a robust restoration of rCBF after ischemia, reduced postischemic mortality by 77% (9% vs. 39% in vehicle-treated controls), ameliorated neurologic performance (Neuro-Deficit-Score 10 days after insult, 96 +/- 0.7 vs. 85 +/- 1.4, mean +/- SE), and almost blunted neuronal cell death (hippocampal CA1, 2150 +/- 191 vs. 884 +/- 141 neurons/mm(2); cortex, 1746 +/- 91 vs. 1060 +/- 112). In contrast, delayed treatment resulted in no sustained effects. Conclusions. Timing of HHS treatment is critical after experimental global cerebral ischemia to reduce mortality, improve neurologic function, and neuronal survival. Our results suggest that early application of HHS may be a potential neuroprotective strategy after global cerebral ischemia.	Johannes Gutenberg Univ Mainz, Dept Anesthesiol, D-6500 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, D-6500 Mainz, Germany	Noppens, RR (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, D-6500 Mainz, Germany.		Christ, Michael/AAQ-8121-2020	Christ, Michael/0000-0001-7977-0195; Heimann, Axel/0000-0003-2510-3228			AMES A, 1968, AM J PATHOL, V52, P437; AYUS JC, 1985, AM J PHYSIOL, V248, pF711; BEHRMAN SW, 1991, J TRAUMA, V31, P589, DOI 10.1097/00005373-199105000-00001; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Bentsen G, 2004, ACTA ANAESTH SCAND, V48, P1089, DOI 10.1111/j.1399-6576.2004.00497.x; Bhardwaj A, 2000, STROKE, V31, P1694, DOI 10.1161/01.STR.31.7.1694; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Brambrink AM, 1999, J NEUROSCI METH, V92, P111, DOI 10.1016/S0165-0270(99)00100-4; Brambrink AM, 2000, J CEREBR BLOOD F MET, V20, P1425, DOI 10.1097/00004647-200010000-00004; Breil M, 2003, RESUSCITATION, V56, P307, DOI 10.1016/S0300-9572(02)00377-5; Ciesla DJ, 2001, SURGERY, V129, P567, DOI 10.1067/msy.2001.113286; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; DEFELIPPE J, 1980, LANCET, V2, P1002; DIRNAGL U, 1993, NEUROL RES, V15, P128; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; FISCHER EG, 1977, STROKE, V8, P36, DOI 10.1161/01.STR.8.1.36; Fischer M, 2002, RESUSCITATION, V54, P269, DOI 10.1016/S0300-9572(02)00151-X; Fischer M, 1996, RESUSCITATION, V32, P227, DOI 10.1016/0300-9572(96)00953-7; FISHER M, 1995, INTENS CARE MED, V21, P132, DOI 10.1007/BF01726536; GINSBERG MD, 1972, NEUROLOGY, V22, P998, DOI 10.1212/WNL.22.9.998; Hamaguchi S, 2002, CAN J ANAESTH, V49, P745, DOI 10.1007/BF03017456; Hauck EF, 2004, J CEREBR BLOOD F MET, V24, P383, DOI 10.1097/00004647-200404000-00003; Heimann A, 2003, CRIT CARE MED, V31, P2495, DOI 10.1097/01.CCM.0000084893.44650.CB; HEIMANN A, 1994, J CEREBR BLOOD F MET, V14, P1100, DOI 10.1038/jcbfm.1994.144; HURN PD, 1995, J CEREBR BLOOD F MET, V15, P666, DOI 10.1038/jcbfm.1995.82; Jonas J, 2000, SHOCK, V14, P24, DOI 10.1097/00024382-200014010-00005; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kempski O, 1996, ACT NEUR S, V66, P114; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; MANINGAS PA, 1987, CRIT CARE MED, V15, P1121, DOI 10.1097/00003246-198712000-00009; Mazzoni MC, 1995, INT J MICROCIRC, V15, P265, DOI 10.1159/000179028; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; Orlic T, 2002, AM J PHYSIOL-CELL PH, V282, pC1261, DOI 10.1152/ajpcell.00479.2001; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Soehle M, 2001, J NEUROSCI METH, V110, P91, DOI 10.1016/S0165-0270(01)00422-8; Soehle M, 1998, STROKE, V29, P1240, DOI 10.1161/01.STR.29.6.1240; Soupart A, 1996, J NEUROPATH EXP NEUR, V55, P106, DOI 10.1097/00005072-199601000-00011; STRECKER U, 1993, INT CONGR SER, V1031, P63; Uhl E, 2000, J CEREBR BLOOD F MET, V20, P979, DOI 10.1097/00004647-200006000-00010; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664	43	16	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2006	34	8					2194	2200		10.1097/01.CCM.0000228915.94169.B1			7	Critical Care Medicine	General & Internal Medicine	067WU	WOS:000239334100024	16775566				2021-06-18	
J	Boxberg, Y; Salim, C; Soares, S; Baloui, H; Alterio, J; Ravaille-Veron, M; Nothias, F				von Boxberg, Ysander; Salim, Claudio; Soares, Sylvia; Baloui, Hasna; Alterio, Jeanine; Ravaille-Veron, Michele; Nothias, Fatiha			Spinal cord injury-induced up-regulation of AHNAK, expressed in cells delineating cystic cavities, and associated with neoangiogenesis	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						barrier formation; cavitation; inflammation; neoangiogenesis; Wistar rat	BLOOD-BRAIN-BARRIER; PERIPHERAL NERVOUS-SYSTEM; GIANT PROTEIN AHNAK; GENE-EXPRESSION; INHIBITORY MOLECULES; IN-VIVO; REGENERATION; RATS; DEGENERATION; INFLAMMATION	To investigate the molecular basis for the poor regenerative capacity of the mammalian central nervous system (CNS) after injury, we searched for genes whose expression was affected by an adult rat spinal cord hemi-section. Differential screening of a rat spinal cord expression library was performed using polyclonal antibodies raised against lesioned spinal cord tissue. A striking overexpression was found for ahnak, encoding a 700-kDa protein, in normal CNS present only in the blood-brain barrier (BBB) forming vascular endothelial cells. Indeed, very early after spinal cord injury (SCI), high levels of membrane-associated AHNAK are observed on non-neuronal cells invading the lesion site. With time, AHNAK distribution spreads rostrally and caudally concomitant with the process of tissue inflammation and axon degeneration, delineating the interior surface of cystic cavities, mainly in front of barrier-forming astrocytes. Strong overexpression is also observed on vascular endothelial cells reacting to BBB breakdown. Based on our detailed analysis of its spatiotemporal and cellular expression, and its previously described function in BBB, we suggest that AHNAK expression is associated with cell types displaying tissue-protective barrier properties. Our study may thus contribute to the elucidation of the precise molecular and cellular events that eventually render traumatic spinal cord tissue non-permissive for regeneration.	Univ Paris 06, CNRS, UMR 7101, F-75005 Paris, France	Boxberg, Y (corresponding author), Univ Paris 06, CNRS, UMR 7101, 7 Quai St Bernard, F-75005 Paris, France.	ysander.boxberg@snv.jussieu.fr; fatiha.nothias@snv.jussieu.fr		soares, sylvia/0000-0003-2459-6956; Nothias, Fatiha/0000-0002-2497-2096; von Boxberg, Ysander/0000-0001-5886-6155			Alvarez J, 2004, J BIOL CHEM, V279, P12456, DOI 10.1074/jbc.M312177200; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Boveri M, 2006, NEUROSCIENCE, V137, P1193, DOI 10.1016/j.neuroscience.2005.10.011; David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Di Giovanni S, 2005, J BIOL CHEM, V280, P2084, DOI 10.1074/jbc.M411975200; FaberElman A, 1996, J CLIN INVEST, V97, P162, DOI 10.1172/JCI118385; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Gentil BJ, 2003, J HISTOCHEM CYTOCHEM, V51, P339, DOI 10.1177/002215540305100309; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; Gentil EJ, 2005, J CELL PHYSIOL, V203, P362, DOI 10.1002/jcp.20232; Guo J, 2004, NEUROSCI LETT, V355, P177, DOI 10.1016/j.neulet.2003.10.076; Haase H, 2004, FASEB J, V18, P839, DOI 10.1096/fj.03-0446fje; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; HIEDA Y, 1989, J CELL BIOL, V109, P1511, DOI 10.1083/jcb.109.4.1511; Jones LL, 2003, J NEUROSCI, V23, P9276; Kingsley PD, 2001, DEV GROWTH DIFFER, V43, P133; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Kouno M, 2004, J INVEST DERMATOL, V123, P700, DOI 10.1111/j.0022-202X.2004.23412.x; Laskawi R, 1996, ORL J OTO-RHINO-LARY, V58, P13, DOI 10.1159/000276788; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Mason MRJ, 2003, EUR J NEUROSCI, V18, P789, DOI 10.1046/j.1460-9568.2003.02809.x; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Moriarty LJ, 1998, J NEUROL SCI, V155, P121, DOI 10.1016/S0022-510X(97)00203-7; NOTHIAS F, 1993, J COMP NEUROL, V334, P370, DOI 10.1002/cne.903340304; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715; Rezajooi K, 2004, MOL CELL NEUROSCI, V25, P572, DOI 10.1016/j.mcn.2003.10.009; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Stiff T, 2004, DNA REPAIR, V3, P245, DOI 10.1016/j.dnarep.2003.11.001; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004; VONBOXBERG Y, 1994, ANAL BIOCHEM, V219, P32, DOI 10.1006/abio.1994.1227; VONBOXBERG Y, 1988, ANAL BIOCHEM, V169, P372; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Zhang KH, 2004, NEUROSCIENCE, V128, P375, DOI 10.1016/j.neuroscience.2004.07.008	51	16	16	0	9	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2006	24	4					1031	1041		10.1111/j.1460-9568.2006.04994.x			11	Neurosciences	Neurosciences & Neurology	076TE	WOS:000239979800008	16930430				2021-06-18	
J	Barrow, IM; Hough, M; Rastatter, MP; Walker, M; Holbert, D; Rotondo, MF				Barrow, Irene M.; Hough, Monica; Rastatter, Michael P.; Walker, Marianna; Holbert, Donald; Rotondo, Michael F.			The effects of mild traumatic brain injury on confrontation naming in adults	BRAIN INJURY			English	Article						mild traumatic brain injury; naming; reaction time	HEAD-INJURY; PERCEPTUAL DIFFERENTIATION; REACTION-TIME; CATEGORY; OBJECT; DEFICITS; INFORMATION; MEMORY; ACQUISITION; ERRORS	Primary objective: To compare confrontation-naming in adults with MTBI to a group of normal adults under increased processing load conditions. Research design: A randomized block, repeated measures design was used to examine confrontation-naming response latency and accuracy using a computerized experimental program. Methods and procedures: Twenty-four adults having sustained a MTBI (aged 18-53) and 24 age-matched controls named pictures from three levels of vocabulary as quickly and accurately as possible. All MTBI participants were assessed with the Scales of Cognitive Ability for Traumatic Brain Injury (SCATBI) for later comparison. Main outcomes and results: The results revealed a main effect of group (p <= 0.001) for the latency data and a group by vocabulary level interaction (p=0.043) for the accuracy data. No significant correlations were found between response latency and accuracy with performance on the SCATBI. Reaction time measures may reveal inefficiencies not tapped by traditional measures.	Hampton Univ, Dept Communicat Sci & Disorders, Hampton, VA 23668 USA; E Carolina Univ, Brody Sch Med, Dept Commun Sci & Disorders, Greenville, NC USA; E Carolina Univ, Brody Sch Med, Dept Stat, Greenville, NC USA; E Carolina Univ, Brody Sch Med, Dept Surg, Greenville, NC USA	Barrow, IM (corresponding author), Hampton Univ, Dept Communicat Sci & Disorders, 201 Sci & Technol, Hampton, VA 23668 USA.	irene.barrow@hamptonu.edu		Walker, Marianna/0000-0002-6342-9088			ABBOUD H, 2000, SUPERLAB PRO EXPT LA; Adamovich B. B., 1992, SCALES COGNITIVE ABI; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bird H, 2000, BRAIN LANG, V72, P246, DOI 10.1006/brln.2000.2292; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; DELL GS, 1992, COGNITION, V42, P287, DOI 10.1016/0010-0277(92)90046-K; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI [10.1097/00001199-199309000-00003, DOI 10.1097/00001199-199309000-00003]; Ellis AW, 1998, J EXP PSYCHOL LEARN, V24, P515, DOI 10.1037/0278-7393.24.2.515; ELVELT WJ, 1989, SPEAKING INTENTION A; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Garofeanu C, 2004, EXP BRAIN RES, V159, P55, DOI 10.1007/s00221-004-1932-z; Gerlach C, 1999, BRAIN, V122, P2159, DOI 10.1093/brain/122.11.2159; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; Goodglass H, 1999, BRAIN LANG, V66, P294, DOI 10.1006/brln.1998.2014; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Hayden M E, 1997, AAOHN J, V45, P635; Heimer L, 1995, HUMAN BRAIN SPINAL C; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hughes AD, 2003, MEM COGNITION, V31, P401, DOI 10.3758/BF03194398; HUMPHREYS GW, 1987, VISUAL OBJECT PROCES; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JENKINS A, 1986, LANCET, V2, P445; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Laws KR, 2000, BRAIN LANG, V75, P123, DOI 10.1006/brln.2000.2348; Laws KR, 2002, CORTEX, V38, P137, DOI 10.1016/S0010-9452(08)70646-4; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LloydJones T, 1997, MEM COGNITION, V25, P606, DOI 10.3758/BF03211303; LloydJones TJ, 1997, MEM COGNITION, V25, P18, DOI 10.3758/BF03197282; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; Malt BC, 2004, MEM COGNITION, V32, P1346, DOI 10.3758/BF03206325; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MARTIN N, 1989, J MEM LANG, V28, P462, DOI 10.1016/0749-596X(89)90022-3; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MORRISON CM, 1992, MEM COGNITION, V20, P705, DOI 10.3758/BF03202720; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Paivio A., 1971, IMAGERY VERBAL PROCE; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SALMELIN R, 1994, NATURE, V368, P463, DOI 10.1038/368463a0; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; THEIOS J, 1989, PSYCHOL REV, V96, P5, DOI 10.1037/0033-295X.96.1.5; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; VITKOVITCH M, 1993, J EXP PSYCHOL LEARN, V19, P243; VITKOVITCH M, 1991, J EXP PSYCHOL LEARN, V17, P664, DOI 10.1037/0278-7393.17.4.664; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005	63	16	16	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2006	20	8					845	855		10.1080/02699050600832445			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	081ZO	WOS:000240356300007	17060151				2021-06-18	
J	Matsui, T; Ishikawa, T; Takeuchi, H; Kabayashi, K; Maekawa, T				Matsui, Tomohiro; Ishikawa, Toshizo; Takeuchi, Hiroaki; Kabayashi, Kiyoshi; Maekawa, Tsuyoshi			Mild hypothermia promotes pro-inflammatory cytokine production in monocytes	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						hypothermia; monocytes; pro-inflammatory cytokines; anti-inflammatory cytokines; cytokine balance	BLOOD MONONUCLEAR-CELLS; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; MODERATE HYPOTHERMIA; PERIOPERATIVE HYPOTHERMIA; CARDIOPULMONARY BYPASS; ESCHERICHIA-COLI; INFECTION; RELEASE	Hypothermia is often associated with compromised host defenses and infection. Deteriorations of immune functions related to hypothermia have been investigated, but the involvement of cytokines in host defense mechanisms and in infection remains unclear. We have previously shown that mild hypothermia modifies cytokine production by peripheral blood mononuclear cells. In this study, the effects of hypothermia on the monocytic production of several cytokines and nitric oxide (NO) were determined. Monocytes obtained from 10 healthy humans were cultured with lipopolysaccharide (LPS) under hypothermic (33 degrees C) or normothermic (37 degrees C) conditions for 48 hours. We performed flow cytometric analysis for simultaneous measurement of interleukin (IL)-8, IL-1 beta, IL-6, IL-10, IL-12p70, and tumor necrosis factor (TNF)-alpha in culture supernatants. NO production was quantified as accumulation of nitrite in the medium by a colorimetric assay. Compared with normothermia, mild hypothermia raised the levels of IL-1 beta, IL-6, IL-12p70, and TNF-alpha produced by monocytes stimulated with LPS. On calculating the ratios of these elevated cytokines to IL-10, however, only IL-12p70/IL-10 and TNF-alpha/IL-10 ratios were significantly elevated under hypothermic conditions. In contrast, hypothermia did not affect NO production. This study demonstrates that mild hypothermia affects the balance of cytokines produced by monocytes, leading to a pro-inflammatory state. Specifically, monocytic IL-12 and TNF-alpha appear to be involved in the immune alterations observed in mild hypothermia. However, the clinical significance of these phenomena remains to be clarified.	Univ Yamanashi, Sch Med, Dept Lab Sci, Ube, Yamaguchi 7558505, Japan; Kochi Univ, Sch Med, Fac Med, Dept Clin Lab Med, Kochi 780, Japan; Kochi Univ, Sch Med, Dept Emergency & Crit Care Med, Kochi 780, Japan	Matsui, T (corresponding author), Univ Yamanashi, Sch Med, Dept Lab Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	giants-ygc@umin.ac.jp			Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [18791082, 16659410] Funding Source: KAKEN		Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aibiki M, 1999, RESUSCITATION, V41, P263, DOI 10.1016/S0300-9572(99)00052-0; AKRIOTIS V, 1985, J LEUKOCYTE BIOL, V37, P51; Beilin B, 1998, ANESTHESIOLOGY, V89, P1133, DOI 10.1097/00000542-199811000-00013; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cook EB, 2001, J IMMUNOL METHODS, V254, P109, DOI 10.1016/S0022-1759(01)00407-0; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; DE WMR, 1991, J EXP MED, V174, P1209; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Forstot RM, 1995, J CLIN ANESTH, V7, P657, DOI 10.1016/0952-8180(95)00099-2; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; GIRARDIN E, 1992, IMMUNOLOGY, V76, P20; Goebel A, 2000, ANN SURG, V231, P253, DOI 10.1097/00000658-200002000-00015; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Ishikawa K, 2000, J TRAUMA, V49, P912, DOI 10.1097/00005373-200011000-00020; Ishikawa T, 1999, CELL MOL NEUROBIOL, V19, P199, DOI 10.1023/A:1006973026514; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269; Luhm J, 1998, EUR J BIOCHEM, V256, P325, DOI 10.1046/j.1432-1327.1998.2560325.x; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui T, 2004, ACTA ANAESTH SCAND, V48, P205, DOI 10.1111/j.0001-5172.2004.00293.x; MILLER LC, 1993, LANCET, V341, P146, DOI 10.1016/0140-6736(93)90006-3; OSuilleabhain C, 1996, SURGERY, V120, P290, DOI 10.1016/S0039-6060(96)80300-X; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pigula FA, 2001, J THORAC CARDIOV SUR, V121, P366, DOI 10.1067/mtc.2001.112207; Qing M, 2001, SHOCK, V15, P372, DOI 10.1097/00024382-200115050-00007; REILING N, 1994, EUR J IMMUNOL, V24, P1941, DOI 10.1002/eji.1830240836; Russwurm S, 2002, J INTERF CYTOK RES, V22, P215, DOI 10.1089/107999002753536185; SHEFFIELD CW, 1994, ACTA ANAESTH SCAND, V38, P201, DOI 10.1111/j.1399-6576.1994.tb03873.x; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; Trinchieri G, 1996, J LEUKOCYTE BIOL, V59, P505; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; WAAGE A, 1988, J EXP MED, V167, P1987, DOI 10.1084/jem.167.6.1987; Wenisch C, 1996, ANESTH ANALG, V82, P810, DOI 10.1097/00000539-199604000-00023; ZARRABEITIA MT, 1991, BONE MINER, V14, P161, DOI 10.1016/0169-6009(91)90093-F; ZEMBALA M, 1994, EUR J IMMUNOL, V24, P435, DOI 10.1002/eji.1830240225	42	16	20	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2006	18	3					189	193		10.1097/01.ana.0000188639.39844.f6			5	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	059FQ	WOS:000238719100005	16799346				2021-06-18	
J	Landis, J; Hanten, G; Levin, HS; Li, XQ; Ewing-Cobbs, L; Duron, J; High, WM				Landis, Julie; Hanten, Gerri; Levin, Harvey S.; Li, Xiaoqi; Ewing-Cobbs, Linda; Duron, Jackie; High, Walter M., Jr.			Evaluation of the errorless learning technique in children with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Joint Annual Meeting of the American-Congress-of-Rehabilitation-Medicine/American-Society-of-Neurorehabilitation	OCT 25, 2003	Tucson, AZ	Amer Congress Rehabil Med, Amer Soc Neurorehabil		brain injuries; pediatrics; rehabilitation	CLOSED-HEAD INJURY; MEMORY; ADOLESCENTS; REHABILITATION; INDIVIDUALS; AMNESIA; MODEL	Objective: To compare errorless learning with trial-and-error (T&E) learning of declarative facts in children with memory disorders secondary to traumatic brain injury (TBI). Design: Retrospective within-subjects concurrent treatment design. Setting: Participants' school or home. Participants: Thirty-four children, ages 6 to 18 years, with mild, moderate, or severe postacute TBI who met criteria for memory impairment. Intervention: Conditions consisted of an errorless learning method and a T&E method. Within a session, half the items were taught with the errorless learning method and half with the T&E method. Each child received two I-hour sessions a week for 7 weeks. Main Outcome Measures: Relative effectiveness of errorless learning and T&E methods for (1) initial learning and (2) retention over time for learned items. Results: There was an advantage for T&E on initial learning. In children with mild, but not moderate or severe TBI, 2-day retention was better with the errorless learning technique; 7-day retention was better with errorless learning in young children with mild TBI. Seventy-seven-day retention revealed an advantage for errorless learning in younger children with severe TBI. Conclusions: Findings did not support errorless learning as a generalized intervention for learning difficulties after TBI or identify specific age- or injury-severity groups that benefited from this technique.	Univ Houston, Dept Educ Psychol, Houston, TX 77204 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, Houston, TX 77225 USA; Texas Inst Res & Rehabil, Brain Injury Res Ctr, Houston, TX 77225 USA	Landis, J (corresponding author), Univ Houston, Dept Educ Psychol, 491 Farish Hall, Houston, TX 77204 USA.	jalandis@uh.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133 B 990014-01] Funding Source: Medline		Anderson V A, 1999, Pediatr Rehabil, V3, P159; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; COHEN M, 1992, BRAIN COGNITION, V20, P315, DOI 10.1016/0278-2626(92)90024-G; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; EWINGCOBBS L, 1991, J CLIN EXP NEUROPSYC, V13, P93; GLISKY EL, 1993, J HEAD TRAUMA REHAB, V7, P1; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hunkin NM, 1998, NEUROPSYCHOL REHABIL, V8, P433, DOI 10.1080/713755581; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P1255, DOI 10.1016/0028-3932(95)00061-7; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lutz J, 2003, J GEN PSYCHOL, V130, P171, DOI 10.1080/00221300309601283; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Squires EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55, DOI 10.1080/713755494; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Van T Hooft M., 2004, Journal of Educational Computing Research, V30, P295; Warschausky S, 1999, J HEAD TRAUMA REHAB, V14, P373, DOI 10.1097/00001199-199908000-00006; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463	29	16	16	1	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2006	87	6					799	805		10.1016/j.apmr.2006.02.017			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	052AP	WOS:000238203100009	16731215				2021-06-18	
J	Yates, JR; Heyes, MP; Blight, AR				Yates, Jennifer R.; Heyes, Melvyn P.; Blight, Andrew R.			4-Chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						guinea pig; inflammation; kynurenine pathway; macrophage; neurotoxin; spinal cord trauma	SYSTEMIC IMMUNE ACTIVATION; KYNURENINE PATHWAY METABOLISM; TRANSIENT CEREBRAL-ISCHEMIA; RECEPTOR-MEDIATED TOXICITY; TRAUMATIC BRAIN-INJURY; CONVERT L-TRYPTOPHAN; CEREBROSPINAL-FLUID; GLIAL-CELLS; 3-HYDROXYANTHRANILIC ACID; MORPHOMETRIC ANALYSIS	Inflammatory processes within the central nervous system (CNS) contribute significantly to the pathogenesis of a broad range of neurologic diseases, including spinal cord injury (SCI). One mechanism by which immune activation causes neurologic symptoms and tissue injury is via the production of neurotoxins by activated macrophages and microglia. In the present study, the role of the endogenous tryptophan metabolite and neurotoxin quinolinic acid (QUIN) in secondary pathology following traumatic SCI was investigated. Adult Hartley guinea pigs were injured by lateral compression of the spinal cord at the 12th thoracic segment (T12). QUIN had accumulated at the site of injury on day 12 post-injury in proportion to the severity of functional neurologic deficits (as assessed by the cutaneus trunci muscle reflex and motor function score at 5 h post-injury). Systemic administration of the 3-hydroxyanthranilate-3,4-dioxygenase (3-HAD) inhibitor, 4-chloro-3-hydroxyanthranilate (4Cl-3HAA; approximately 100 mg/kg every 12 h, beginning 5 h after injury) attenuated local QUIN production and reduced QUIN accumulation at the site of injury by approximately 50% at day 12, without enhanced accumulations of the neuroprotective metabolite kynurenic acid (KYNA). The severity of secondary functional deficits was also reduced by 4Cl-3HAA. In toluidine blue-stained spinal cord sections, the area of surviving intact white matter at the injury site was increased by approximately 100% in the 4Cl-3HAA-treated group. Sparing of both axons and myelin contributed to this increase. These results support the conclusion that QUIN accumulations at the site of injury contribute to secondary functional deficits and tissue damage following SCI.	Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; Univ N Carolina, Div Neurosurg, Chapel Hill, NC USA; NIMH, Lab Neurotoxicol, Bethesda, MD 20892 USA	Yates, JR (corresponding author), Colby Coll, Dept Psychol, 5550 Mayflower Hill Dr, Waterville, ME 04901 USA.	jryates@colby.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021122] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21122] Funding Source: Medline		BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beagles KE, 1998, J NEUROCHEM, V70, P281; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; BLIGHT AR, 1995, BRAIN, V118, P735, DOI 10.1093/brain/118.3.735; BLIGHT AR, 1991, J NEUROL SCI, V103, P156, DOI 10.1016/0022-510X(91)90159-5; BLIGHT AR, 1990, J COMP NEUROL, V296, P614, DOI 10.1002/cne.902960408; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; BLIGHT AR, 1993, BRAIN RES, V632, P314, DOI 10.1016/0006-8993(93)91167-Q; Blight AR, 1997, J NEUROTRAUM, V14, P89, DOI 10.1089/neu.1997.14.89; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BUTT AM, 1992, NEUROSCI LETT, V146, P108, DOI 10.1016/0304-3940(92)90184-9; Cammer W, 2002, NEUROSCI LETT, V327, P123, DOI 10.1016/S0304-3940(02)00392-0; Cammer W, 2001, BRAIN RES, V896, P157, DOI 10.1016/S0006-8993(01)02017-0; Espey MG, 1997, NEUROREPORT, V8, P431, DOI 10.1097/00001756-199701200-00011; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; GALLO V, 1994, GLIA, V11, P94, DOI 10.1002/glia.440110204; Grant RS, 1998, J NEUROCHEM, V70, P1759; GUILIAN D, 1990, SCIENCE, V250, P1593; HEYES MP, 1990, J CHROMATOGR-BIOMED, V530, P108, DOI 10.1016/S0378-4347(00)82308-7; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Heyes MP, 1997, J NEUROCHEM, V68, P280; HEYES MP, 1988, ANAL BIOCHEM, V174, P349, DOI 10.1016/0003-2697(88)90556-8; Heyes MP, 1997, J NEUROCHEM, V69, P1519; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; Heyes MP, 2001, BRAIN, V124, P1033, DOI 10.1093/brain/124.5.1033; Heyes MP, 1998, FASEB J, V12, P881; IGNATOWICZ E, 1991, NEUROREPORT, V2, P651, DOI 10.1097/00001756-199111000-00004; Jaeger CB, 1997, EXP NEUROL, V144, P381, DOI 10.1006/exnr.1996.6405; Kerr SJ, 1998, AIDS, V12, P355, DOI 10.1097/00002030-199804000-00003; KETTENMANN H, 1984, NEUROSCI LETT, V47, P271, DOI 10.1016/0304-3940(84)90525-1; LEKIEFFRE D, 1990, NEUROSCI LETT, V120, P31, DOI 10.1016/0304-3940(90)90160-B; LEVY DI, 1990, NEUROSCI LETT, V110, P291, DOI 10.1016/0304-3940(90)90862-4; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; MORONI F, 1988, J NEUROCHEM, V51, P177, DOI 10.1111/j.1471-4159.1988.tb04852.x; Morrison PF, 1999, J NEUROCHEM, V72, P2135, DOI 10.1046/j.1471-4159.1999.0722135.x; MURRAY HW, 1992, J INFECT DIS, V165, P513, DOI 10.1093/infdis/165.3.513; MURRAY HW, 1989, INFECT IMMUN, V57, P845, DOI 10.1128/IAI.57.3.845-849.1989; NEFF NH, 1967, J PHARMACOL EXP THER, V158, P214; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; PARLI CJ, 1980, ARCH BIOCHEM BIOPHYS, V203, P161, DOI 10.1016/0003-9861(80)90164-2; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Pemberton LA, 1997, J INTERF CYTOK RES, V17, P589, DOI 10.1089/jir.1997.17.589; Platenik J, 2001, FREE RADICAL RES, V34, P445, DOI 10.1080/10715760100300391; SAITO K, 1993, BIOCHEM J, V291, P11, DOI 10.1042/bj2910011; SAITO K, 1993, J NEUROCHEM, V60, P180, DOI 10.1111/j.1471-4159.1993.tb05836.x; Saito K, 1996, ADV EXP MED BIOL, V398, P407; SAITO K, 1993, J NEUROCHEM, V61, P2061, DOI 10.1111/j.1471-4159.1993.tb07443.x; SAITO K, 1994, NEUROSCI LETT, V178, P211, DOI 10.1016/0304-3940(94)90761-7; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Speciale C, 1996, ADV EXP MED BIOL, V398, P221; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Thomas SR, 1996, J BIOL CHEM, V271, P32714, DOI 10.1074/jbc.271.51.32714; WHETSELL WO, 1989, NEUROSCI LETT, V97, P271, DOI 10.1016/0304-3940(89)90609-5; Wiley CA, 1995, J NEUROVIROL, V1, P328, DOI 10.3109/13550289509111021; WIRSCHING BA, 1989, BEHAV NEUROSCI, V103, P90, DOI 10.1037/0735-7044.103.1.90; Yoshioka A, 1996, J NEUROSCI RES, V46, P427	60	16	17	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2006	23	6					866	881		10.1089/neu.2006.23.866			16	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	056TW	WOS:000238549000004	16774472				2021-06-18	
J	Dahl, E; von Wendt, L; Emanuelson, I				Dahl, E; von Wendt, L; Emanuelson, I			A prospective, population-based, follow-up study of mild traumatic brain injury in children	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						children; MTBI; population-based; prospective; symptoms	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; PROSPECTIVE COHORT; WESTERN SWEDEN; EPIDEMIOLOGY; ADOLESCENTS; SCALE; PAIN; DISABILITY; DISORDER	Objective: Outline the annual incidene of mild traumatic brain injury in children, aged 0-17 years, using the American Congress of Rehabilitation Medicine classification and record the presence of new symptoms up to six months after injury. Settings and methods: The study population comprised all the children in the age group of 0-17 years (a total of 40,984) in an administrative district in south-western Sweden. At[ the individuals registered in the Brain Injury Register, during the periods 1 January to 30 June 1999 and 1 April to 30 September 2000, fulfilling the inclusion criteria defined by American Congress of Rehabilitation Medicine, were included. New symptoms occurring three to six months after the injury were recorded using a mailed 21-item questionnaire. Results: 192 children fulfilled the criteria., yielding an annual incidence of 468/ 100,000 (95% Cl 402-535/100,000). Boys accounted for 57 per cent and fall injuries accounted for 61 per cent of the external causes. New symptoms were reported by 24 per cent of those who answered the questionnaire. Conclusion: This study revealed that the annual incidence of mild traumatic brain injury in children was almost as high as that among adults in the same area and population. (C) 2005 Elsevier Ltd. All rights reserved.	Local Habilitat Ctr So Alvsborg, SE-50182 Boras, Sweden; Univ Helsinki, Hosp Children & Adolescents, Dept Child Neurol, FIN-00014 Helsinki, Finland; Karolinska Inst, Dept Child Neurol, Stockholm, Sweden; Gothenburg Univ, Dept Hlth Women & Children, S-41124 Gothenburg, Sweden	Dahl, E (corresponding author), Local Habilitat Ctr So Alvsborg, SE-50182 Boras, Sweden.	ewa.dahl@vgregion.se					Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ANDERSSON EH, 2004, THESIS U GOTEBORG SW; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, V7, P117; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; Breau LM, 2001, J PEDIATR-US, V138, P721, DOI 10.1067/mpd.2001.112247; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; CASEY R, 1986, PEDIATRICS, V78, P497; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Emanuelson I, 2003, Inj Control Saf Promot, V10, P139, DOI 10.1076/icsp.10.3.139.14553; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mott A, 1997, LANCET, V349, P1874, DOI 10.1016/S0140-6736(96)10343-3; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; Roseveare C A, 1999, Inj Prev, V5, P124; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; Rune V, 1970, ACTA PAEDIATR SC   S, V209, P3; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schulman J, 2002, INJ PREV, V8, P47, DOI 10.1136/ip.8.1.47; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Stallard P, 2002, J PEDIATR PSYCHOL, V27, P209, DOI 10.1093/jpepsy/27.2.209; Svensson E, 2002, J REHABIL MED, V34, P251, DOI 10.1080/165019702760390338; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Von Wild K, 2001, BRAIN INJURY, V15, P273; Walsh TM, 2004, ATTACH HUM DEV, V6, P53, DOI 10.1080/14616730410001663489; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	46	16	17	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2006	37	5					402	409		10.1016/j.injury.2005.09.008			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	037RH	WOS:000237164100007	16375904				2021-06-18	
J	Schopp, LH; Shigaki, CL; Bounds, TA; Johnstone, B; Stucky, RC; Conway, DL				Schopp, Laura H.; Shigaki, Cheryl L.; Bounds, Thomas A.; Johnstone, Brick; Stucky, Renee C.; Conway, Debbie L.			Outcomes in TBI with violent versus nonviolent etiology in a predominantly rural setting	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognition; community integration; function; memory; outcome; rehabilitation; rural; social; violence	TRAUMATIC BRAIN-INJURY; VOCATIONAL OUTCOMES; 1-YEAR	Objective: To evaluate differences in outcome in persons with violent versus nonviolent traumatic brain injury (TBI) etiology. Design: Two-group (violent vs nonviolent) 1-year follow-up study. Setting: Midwestern medical center TBI Model System serving a predominantly rural catchment area. Participants: Forty-five (n = 19 violent TBI etiology; n = 26 nonviolent TBI etiology) inpatients with primary diagnosis of TBI followed up as outpatients I year after injury. Main Outcome Measures: Substance use, income source, employment status, Wechsler Adult Intelligence Scale-Revised (abbreviated version), Logical Memory I and 11 from the Wechsler Memory Scale-Revised, Wide Range Achievement Test-Third Edition Reading subtest, Trail-Making Tests A and B, Rey Auditory Verbal Learning Test, Community Integration Questionnaire, Neurobehavioral Functioning Inventory. Results: Members of the violent group were more likely to be men, of a racial minority, unemployed, and have low income. Substance abuse was common among both groups prior to injury, with significant declines at 1 year. Follow-up also revealed significant group differences in verbal intelligence, social integration, productivity, and source of income, but nonsignificant difference in employment. In all comparisons, more favorable outcomes were found for the nonviolent group. Conclusions: Persons with violent injury etiology have poorer premorbid functioning and are likely to have less favorable outcomes than the general population with TBI. Therefore, persons with violent TBI etiology may require more intensive aftercare programming to promote improved rehabilitation outcomes.	Univ Missouri, Dept Hlth Psychol, Sch Hlth Prof, Columbia, MO 65212 USA; Univ Missouri, Missouri Rehabil Ctr, Mt Vernon, MO USA	Schopp, LH (corresponding author), Univ Missouri, Dept Hlth Psychol, Sch Hlth Prof, DC046-46, Columbia, MO 65212 USA.	schoppL@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A980008] Funding Source: Medline		Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Callahan CD, 1997, ARCH CLIN NEUROPSYCH, V12, P133, DOI 10.1016/S0887-6177(96)00029-7; *CDCP, WEBB INJ STAT QUER R; Chwalisz K, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P537, DOI 10.1037/10361-025; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN S, 1996, NEUROPSYCHOLOGICAL A, P552; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; FARR SP, 1986, HDB CLIN NEUROPSYCHO, P213; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hawkins KA, 2002, ARCH CLIN NEUROPSYCH, V17, P49, DOI 10.1016/S0887-6177(00)00099-8; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; MICHAUD LJ, 1995, J HEAD TRAUMA REHAB, V10, P25, DOI 10.1097/00001199-199510000-00005; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.0.CO;2-Y; REITAN RM, 1986, TRAIM MAKING TEST MA; Schootman M, 1999, BRAIN INJURY, V13, P995; *TRAUM BRAIN INJ M, 2000, TRAUM BRAIN INJ FACT; Wechsler D., 1997, MANUAL WECHSLER MEMO; WILKINSON G, 1993, WRATS WIDE RANGE ACH; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Zafonte RD, 1997, BRAIN INJURY, V11, P403	30	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2006	21	3					213	225		10.1097/00001199-200605000-00002			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	044YL	WOS:000237709600002	16717499				2021-06-18	
J	Duhaime, AC; Saykin, AJ; McDonald, BC; Dodge, CP; Eskey, CJ; Darcey, TM; Grate, LL; Tomashosky, P				Duhaime, AC; Saykin, AJ; McDonald, BC; Dodge, CP; Eskey, CJ; Darcey, TM; Grate, LL; Tomashosky, P			Functional magnetic resonance imaging of the primary somatosensory cortex in piglets	JOURNAL OF NEUROSURGERY			English	Article						trauma; brain injury; functional magnetic resonance imaging; somatosensory cortex; pediatric neurosurgery; animal model; pig	HYPOTHERMIC CIRCULATORY ARREST; TOPOGRAPHIC ORGANIZATION; CARDIOPULMONARY BYPASS; DEPENDENT RESPONSES; NEWBORN PIGS; NEONATAL PIG; BRAIN; MRI; SWINE; REORGANIZATION	Object. The piglet is an excellent model for the developing human brain, and has been used increasingly in various centers for studies of traumatic brain injury and other insults. Unlike rodent or primate models, however, there are few behavioral scales for the piglet, and the available ones are used to test general responsiveness rather than specific functional outcome. The differing behavioral repertoires of animals of different ages provide an additional challenge when age-dependent injury responses are compared. To overcome these experimental limitations of piglets in brain injury research, the authors developed a functional magnetic resonance (fMR) imaging paradigm that can be used to track recovery in the somatosensory cortex over time in anesthetized animals of different ages. Methods. Fifteen fMR imaging studies in eight piglets were performed before and after scaled cortical impact injury to the primary somatosensory cortex subserving snout sensation. Specific anesthetic and imaging protocols enabled visualization of cortical activation, and comparison with somatosensory evoked potentials obtained before and after injury was obtained. A piglet brain template for group-level analysis of these data was constructed, similar to the fMR imaging techniques used in humans, to allow for group comparisons and longitudinal change analysis over time. Conclusions. Loss of function in a specifically traumatized cortical region and its subsequent recovery over time can now be demonstrated visually by fMR imaging in the piglet. Besides its value in understanding intrinsic recovery mechanisms and plasticity at different ages, this functional outcome measure will enable the use of the piglet model in treatment trials specifically designed for the immature brain.	Childrens Hosp Dartmouth, Dept Pediat Neurosurg, Lebanon, NH 03756 USA; Childrens Hosp Dartmouth, Dept Psychiat, Lebanon, NH 03756 USA; Childrens Hosp Dartmouth, Dept Anesthesiol, Lebanon, NH 03756 USA; Childrens Hosp Dartmouth, Dept Radiol, Lebanon, NH 03756 USA; Childrens Hosp Dartmouth, Dept Neurol, Lebanon, NH 03756 USA; Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; Dartmouth Coll Sch Med, Lebanon, NH 03766 USA	Duhaime, AC (corresponding author), Childrens Hosp Dartmouth, Dept Pediat Neurosurg, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	acd@hitchcock.org	Saykin, Andrew/A-1318-2007	Saykin, Andrew/0000-0002-1376-8532	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364] Funding Source: NIH RePORTER		Cioni G, 2001, NEUROREPORT, V12, P1335, DOI 10.1097/00001756-200105250-00009; CRANER SL, 1991, J COMP NEUROL, V306, P24, DOI 10.1002/cne.903060103; CRANER SL, 1991, J COMP NEUROL, V306, P39, DOI 10.1002/cne.903060104; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Hayashi T, 1999, EUR J NEUROSCI, V11, P4451, DOI 10.1046/j.1460-9568.1999.00892.x; Holloway V, 2000, BRAIN, V123, P2432, DOI 10.1093/brain/123.12.2432; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI DOI 10.1016/S1053-8119(18)31587-8; Lahti KM, 1999, MAGNET RESON MED, V41, P412, DOI 10.1002/(SICI)1522-2594(199902)41:2<412::AID-MRM28>3.0.CO;2-3; Leopold DA, 2002, EXP BRAIN RES, V143, P359, DOI 10.1007/s00221-001-0998-0; Loepke AW, 2002, ANESTHESIOLOGY, V97, P1521, DOI 10.1097/00000542-200212000-00026; Makiranta MJ, 2002, MAGN RESON MATER PHY, V15, P27, DOI 10.1016/S1352-8661(02)00121-7; McAllister TW., 2002, J NEUROPSYCHIATRY CL, V14, P116; MCDONALD BC, 2003, J NEUROPSYCHIATRY CL, V15, P282; Mun-Bryce S, 2001, BRAIN RES, V888, P248, DOI 10.1016/S0006-8993(00)03068-7; Okada Y, 1999, CLIN NEUROPHYSIOL, V110, P214, DOI 10.1016/S0013-4694(98)00111-4; Poldrack Russell A, 2002, Top Magn Reson Imaging, V13, P61, DOI 10.1097/00002142-200202000-00005; Priestley MA, 2001, J THORAC CARDIOV SUR, V121, P336, DOI 10.1067/mtc.2001.112338; Sakamoto T, 2001, J THORAC CARDIOV SUR, V122, P339, DOI 10.1067/mtc.2001.115242; Saykin AJ, 2004, BRAIN, V127, P1574, DOI 10.1093/brain/awh177; Saykin AJ, 1999, J INT NEUROPSYCH SOC, V5, P377, DOI 10.1017/S135561779955501X; Souweidane MM, 1999, PEDIATR NEUROSURG, V30, P86, DOI 10.1159/000028768; Willis CKR, 2001, VET OPHTHALMOL, V4, P243, DOI 10.1046/j.1463-5216.2001.00183.x; Wishart HA, 2004, NEUROLOGY, V62, P234, DOI 10.1212/01.WNL.0000103238.91536.5F	26	16	17	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	APR	2006	104	4		S			259	264		10.3171/ped.2006.104.4.259			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	031NC	WOS:000236710300006	16619637				2021-06-18	
J	Lunemann, A; Ullrich, O; Diestel, A; Jons, T; Ninnemann, O; Kovac, A; Pohl, EE; Hass, R; Nitsch, R; Hendrix, S				Lunemann, A; Ullrich, O; Diestel, A; Jons, T; Ninnemann, O; Kovac, A; Pohl, EE; Hass, R; Nitsch, R; Hendrix, S			Macrophage/microglia activation factor expression is restricted to lesion-associated microglial cells after brain trauma	GLIA			English	Article						entorhinal cortex lesion; deafferentiation; CD11b; 1B4	ENTORHINAL CORTEX LESION; DENTATE GYRUS; MULTIPLE-SCLEROSIS; ATHYMIC MICE; INJURY; CNS; IDENTIFICATION; MACROPHAGES; ASTROCYTES; CLONING	After traumatic brain lesion, microglial cells are rapidly activated, migrate toward the sites of injury, and cause secondary damage that accounts for most of the loss of brain function. In the present study, we have characterized a new macrophage/microglia activation factor (MA-F). Using the monocytic cell line U937, we were able to demonstrate that MAF is upregulated after TPA-induced differentiation into macrophages. We have generated a specific antibody against MAY In BV-2 microglial cells, MAF is partially co-localized with 1134, a classical microglial marker. In addition, we have analyzed the in vivo expression patterns of MAF after entorhinal cortex lesion. We were able to show a substantial upregulation of MAF on selected CD11b(+) and IB4(+) macrophages/microglial cells in the deafferented hippocampus and in the perilesional region, while no MAF expression was detectable on the contralateral side. Confocal microscopy revealed a lysosome-like expression pattern in BV-2 cells, as well as in ECL-associated macrophages/microglial cells in vivo. Furthermore, we were able to demonstrate that U937 cells with downregulated MAF converted slower and to a significantly reduced extent to the macrophageal phenotype after TPA treatment. In addition, MAF downregulation in BV-2 microglial cells substantially reduced the phagocytotic uptake of dextran beads. Our data indicate that MAF is expressed in selected macrophages/microglial cells around the lesion and in the degenerating hippocampus after ECL. Furthermore, MAF expression in monocytic cells seems to play a functional role in the differentiation to a phagocytosing phenotype and may be, at least partially, required for phagocytotic activity, specifically in lesioned tissue after brain trauma. (c) 2005 Wiley-Liss, Inc.	Humboldt Univ, Charite Univ Med Berlin, Inst Cell Biol & Neurobiol, Ctr Anat, D-10098 Berlin, Germany; Otto Von Guericke Univ, Inst Immunol, Dept Mol Immunol & Neuroimmunol, Magdeburg, Germany; Humboldt Univ, Charite Univ Med Berlin, Ctr Anat, Inst Electron Microscope & Mol Neuroanat, D-10098 Berlin, Germany; Hannover Med Sch, Dept Biochem & Tumor Biol, Clin Obstet & Gynecol, D-3000 Hannover, Germany	Nitsch, R (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Inst Cell Biol & Neurobiol, Ctr Anat, Schumannstr 20-21, D-10098 Berlin, Germany.	robert.nitsch@charite.de	Hendrix, Sven/F-4059-2010; Hass, Ralf/F-3197-2012; Pohl, Elena E./A-4025-2009; Nitsch, Robert/AAI-9129-2021	Hendrix, Sven/0000-0003-2344-7369; Hass, Ralf/0000-0002-2481-7547; Pohl, Elena E./0000-0002-0604-5950; 			BAIDA GE, 1995, BBA-GENE STRUCT EXPR, V1264, P151, DOI 10.1016/0167-4781(95)00150-F; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; Bechmann I, 2000, ANN NY ACAD SCI, V911, P192; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brauer AU, 2004, FEBS LETT, V563, P41, DOI 10.1016/S0014-5793(04)00244-3; DRENCKHAHN D, 1993, METHOD CELL BIOL, V37, P7, DOI 10.1016/S0091-679X(08)60242-3; Eyupoglu IY, 2003, FASEB J, V17, P1110, DOI 10.1096/fj.02-0825fje; Frotscher M, 1997, TRENDS NEUROSCI, V20, P218, DOI 10.1016/S0166-2236(96)01018-1; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hailer NP, 1999, EUR J NEUROSCI, V11, P3359, DOI 10.1046/j.1460-9568.1999.00808.x; HASS R, 1989, EUR J CELL BIOL, V48, P282; HTAIN WW, 1994, GLIA, V12, P44, DOI 10.1002/glia.440120106; Htain WW, 1997, BRAIN RES, V755, P63, DOI 10.1016/S0006-8993(97)00108-X; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kwidzinski E, 2003, J NEURAL TRANSM-SUPP, P29, DOI 10.1007/978-3-7091-0643-3_2; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; LYNCH G, 1974, BRAIN RES, V69, P1, DOI 10.1016/0006-8993(74)90365-5; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Prudovsky I, 2002, EUR J CELL BIOL, V81, P36, DOI 10.1078/0171-9335-00219; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; Rehli M, 1995, BIOCHEM BIOPH RES CO, V217, P661, DOI 10.1006/bbrc.1995.2825; SCHOEN SW, 1994, EXP NEUROL, V127, P106, DOI 10.1006/exnr.1994.1084; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; VARTANIAN T, 1995, MOL MED, V1, P732, DOI 10.1007/BF03401888	28	16	17	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAR	2006	53	4					412	419		10.1002/glia.20301			8	Neurosciences	Neurosciences & Neurology	020CV	WOS:000235886400009	16342171				2021-06-18	
J	Yeoh, HK; Lind, CRP; Law, AJJ				Yeoh, HK; Lind, CRP; Law, AJJ			Acute transient cerebellar dysfunction and stuttering following mild closed head injury	CHILDS NERVOUS SYSTEM			English	Article						cerebellar dysfunction; stuttering; pediatric; closed head injury; neurogenic	CEREBRAL-BLOOD-FLOW	Introduction: A wide range of pathologies can cause cerebellar dysfunction but there have been few reports of transient dysfunction after mild head injury. There are none describing stuttering as an acute symptom after such injuries. Case report: We report a 12-year-old boy who presented with headache, stuttering speech and truncal and bilateral peripheral cerebellar dysfunction after falling prone from his skateboard. Computed tomographic brain imaging showed normal results. All clinical symptoms and signs had resolved within 24 h obviating further investigation. A follow up clinical interview and examination 4 weeks later revealed no recurrence of cerebellar or speech dysfunction. Conclusion: This is the first reported case of acute transient cerebellar dysfunction and stuttering after mild closed head injury. Neurogenic causes for stuttering are increasingly being recognised.	Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia; Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; Starship Childrens Hosp, Dept Neurosurg, Auckland, New Zealand	Lind, CRP (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Nedlands, WA 6009, Australia.	crplind@free.net.nz	Lind, Christopher/K-3629-2012	Lind, Christopher/0000-0001-9991-1725			Balasubramanian V, 2003, BRAIN COGNITION, V53, P185, DOI 10.1016/S0278-2626(03)00106-4; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cantu R C, 1969, Int Surg, V52, P392; CHESTER CS, 1987, ANN NEUROL, V22, P77; De Nil LF, 2001, NEUROSCI LETT, V302, P77, DOI 10.1016/S0304-3940(01)01671-8; Djaldetti R, 1996, ARCH NEUROL-CHICAGO, V53, P1214, DOI 10.1001/archneur.1996.00550120016003; Foundas AL, 2003, NEUROLOGY, V61, P1378, DOI 10.1212/01.WNL.0000094320.44334.86; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Fumeya Hiroshi, 1994, Neurologia Medico-Chirurgica, V34, P612, DOI 10.2176/nmc.34.612; Gordon N, 2002, DEV MED CHILD NEUROL, V44, P278, DOI 10.1017/S0012162201002067; HAGGARD P, 1995, J NEUROL NEUROSUR PS, V58, P433, DOI 10.1136/jnnp.58.4.433; Helm-Estabrooks Nancy, 1998, Seminars in Speech and Language, V19, P23, DOI 10.1055/s-2008-1064032; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Ludlow CL, 2003, J FLUENCY DISORD, V28, P273, DOI 10.1016/j.jfludis.2003.07.001; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Michell AW, 2001, BRIT J NEUROSURG, V15, P526; Perkins WH, 2001, SCIENCE, V294, P786; WHO, 1977, MAN INT STAT CLASS D, V1	20	16	17	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2006	22	3					310	313		10.1007/s00381-005-1154-0			4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	015IV	WOS:000235546000018	15821946				2021-06-18	
J	Boret, H; Fesselet, J; Meaudre, E; Gaillard, PE; Cantais, E				Boret, H; Fesselet, J; Meaudre, E; Gaillard, PE; Cantais, E			Cerebral microdialysis and PtiO2 for neuro-monitoring before decompressive craniectomy	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						craniectomy; microdialysis; PtiO2; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; BLOOD-FLOW; METABOLISM; PROSTACYCLIN; TOMOGRAPHY; PRESSURE; EDEMA	We report the case of a young patient with post-traumatic, intractable, intracranial hypertension leading to craniectomy. This intracranial hypertension was preceded by focal signs of ischemia diagnosed through P(ti)o(2) monitoring and cerebral microdialysis, and occurred a few hours prior to a decrease in cerebral perfusion pressure below 60 mmHg. The neurological outcome was satisfactory with a Glasgow Outcome Scale of 4 at 3 months. We discuss the potential interest of such neuro-monitoring to determine the optimal time for performing a craniectomy.	St Anne Teaching Mil Hosp, Dept Anesthesiol & Intens Care, Toulon, France; St Anne Teaching Mil Hosp, Dept Neurosurg, Toulon, France	Boret, H (corresponding author), HIA St Anne, Dept Anesthesie Reanimat, F-83500 Toulon, France.	hb-boret@wanadoo.fr					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Gardenfors F, 2004, ACTA ANAESTH SCAND, V48, P1316, DOI 10.1111/j.1399-6576.2004.00522.x; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Munch E, 2000, NEUROSURGERY, V47, P315; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Peerdeman SM, 2003, J NEUROL, V250, P797, DOI 10.1007/s00415-003-1079-z; Sarrafzadeh Asita S, 2003, Curr Neurol Neurosci Rep, V3, P517, DOI 10.1007/s11910-003-0057-2; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Strege RJ, 2003, NEUROL RES, V25, P510, DOI 10.1179/016164103101201742; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591	16	16	17	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	FEB	2006	50	2					252	254		10.1111/j.1399-6576.2005.00862.x			3	Anesthesiology	Anesthesiology	004EG	WOS:000234734200021	16430552				2021-06-18	
J	Kim, H; Colantonio, A; Deber, R; Vernich, L				Kim, H; Colantonio, A; Deber, R; Vernich, L			Discharge destination from acute care after traumatic brain injury	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article								Objective: To identify the impact of private insurance coverage on discharge disposition after a traumatic brain injury (TBI) using injury in a motor vehicle accident (MVA) as a proxy for private insurance, controlling for age and severity of injury. Method. Cross-sectional study. Patients: Patients with TBI discharged between 1993-1994 and 2000-2001 (n = 9,703). Main Outcome Measure: Discharge destination from acute care; controlled odds ratio (OR) and confidence interval (CI) for type of injury. Results: Type of injury, age, and length of stay are significantly associated with discharge destination. However, the motor vehicle accident patients are 56% more likely to be discharged to home with support services than patients with similar injuries from falls. Conclusion: Even in a system with universal coverage, availability of private insurance type is a potential independent determinant of postacute care services. More research is required to determine the effect this relationship has on the cost and outcomes of care for TBI patients.	Univ Toronto, Dept Occupat Therapy, Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada; Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; Univ Toronto, Dept Hlth Policy Management & Evalut, Toronto, ON M5G 1V7, Canada; Univ Toronto, Dept Publ Hlth, Toronto, ON M5G 1V7, Canada	Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Therapy, Toronto Rehabil Inst, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.			Colantonio, Angela/0000-0003-2094-4765; Deber, Raisa/0000-0003-0598-3926			*CAN I HLTH INF, 2001, ONT TRAUM REG 2001A; Canadian Institute for Health Information, 1975, NAT HLTH EXP TRENDS; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Commission on the Future of Health Care in Canada, 2002, BUILD VAL FUT HLTH C; DEBER R, 2004, DELIVERING HLTH CARE, P233; Deber RB, 2003, AM J PUBLIC HEALTH, V93, P20, DOI 10.2105/AJPH.93.1.20; Hoppe E, 1996, PHYSIOTHER CAN, V48, P106; LANDRY M, 2004, MARKET FAILURE ONTAR; LANDRY M, 2005, THESIS U TORONTO TOR; *STAND SEN COMM SO, 2001, HLTH CAN FED ROL STO, V1; *STAND SEN COMM SO, 2002, HLTH CAN FED ROL REC, V6	11	16	16	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	FEB	2006	33	1					48	52		10.1017/S0317167100004686			5	Clinical Neurology	Neurosciences & Neurology	020HC	WOS:000235898300008	16583721	Bronze			2021-06-18	
J	Lye, TC; Grayson, DA; Creasey, H; Piguet, O; Bennett, HP; Ridley, LJ; Kril, JJ; Broe, GA				Lye, TC; Grayson, DA; Creasey, H; Piguet, O; Bennett, HP; Ridley, LJ; Kril, JJ; Broe, GA			Predicting memory performance in normal ageing using different measures of hippocampal size	NEURORADIOLOGY			English	Article						memory; normal; aging; hippocampus; magnetic resonance imaging	TEMPORAL-LOBE EPILEPSY; PROBABLE ALZHEIMERS-DISEASE; SYDNEY OLDER PERSONS; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; VOLUMETRIC MRI; DIAGNOSTIC-VALUE; VERBAL MEMORY; ATROPHY; AMYGDALA	A number of different methods have been employed to correct hippocampal volumes for individual variation in head size. Researchers have previously used qualitative visual inspection to gauge hippocampal atrophy. The purpose of this study was to determine the best measure(s) of hippocampal size for predicting memory functioning in 102 community-dwelling individuals over 80 years of age. Hippocampal size was estimated using magnetic resonance imaging (MRI) volumetry and qualitative visual assessment. Right and left hippocampal volumes were adjusted by three different estimates of head size: total intracranial volume (TICV), whole-brain volume including ventricles (WB+V) and a more refined measure of whole-brain volume with ventricles extracted (WB). We compared the relative efficacy of these three volumetric adjustment methods and visual ratings of hippocampal size in predicting memory performance using linear regression. All four measures of hippocampal size were significant predictors of memory performance. TICV-adjusted volumes performed most poorly in accounting for variance in memory scores. Hippocampal volumes adjusted by either measure of whole-brain volume performed equally well, although qualitative visual ratings of the hippocampus were at least as effective as the volumetric measures in predicting memory performance in community-dwelling individuals in the ninth or tenth decade of life.	Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; Concord Hosp, Dept Radiol, Sydney, NSW, Australia; Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; Prince Wales Med Res Inst, Sydney, NSW, Australia; Univ New S Wales, Sydney, NSW, Australia; Prince Wales Hosp, Sydney, NSW, Australia	Lye, TC (corresponding author), Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia.	tlye@medicine.usyd.edu.au	Piguet, Olivier/C-9658-2011	Piguet, Olivier/0000-0002-6696-1440; Kril, Jillian/0000-0001-9407-8674			BHATIA S, 1993, NEUROLOGY, V43, P2006, DOI 10.1212/WNL.43.10.2006; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bilir E, 1998, NEURORADIOLOGY, V40, P138, DOI 10.1007/s002340050554; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Cahn DA, 1998, J INT NEUROPSYCH SOC, V4, P106, DOI 10.1017/S1355617798001064; CENDES F, 1993, J COMPUT ASSIST TOMO, V17, P206, DOI 10.1097/00004728-199303000-00008; Cheon JE, 1998, AM J NEURORADIOL, V19, P465; COOK MJ, 1992, BRAIN, V115, P1001, DOI 10.1093/brain/115.4.1001; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; deLeon MJ, 1997, NEUROBIOL AGING, V18, P1, DOI 10.1016/S0197-4580(96)00213-8; DELIS D, 1987, CALIFORNIA VERBAL LE; DESMOND PM, 1994, AUST NZ J MED, V24, P547, DOI 10.1111/j.1445-5994.1994.tb01756.x; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Free SL, 1996, EPILEPSIA, V37, P400, DOI 10.1111/j.1528-1157.1996.tb00578.x; Fujioka M, 2000, CEREBROVASC DIS, V10, P2, DOI 10.1159/000016018; GOLOMB J, 1994, LEARN MEMORY, V1, P45; GOLOMB J, 1993, ARCH NEUROL-CHICAGO, V50, P967, DOI 10.1001/archneur.1993.00540090066012; Golomb J, 1996, NEUROLOGY, V47, P810, DOI 10.1212/WNL.47.3.810; Grundman M, 2003, J MOL NEUROSCI, V20, P241, DOI 10.1385/JMN:20:3:241; Grundman M, 2002, J MOL NEUROSCI, V19, P23, DOI 10.1007/s12031-002-0006-6; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Hashimoto M, 2001, NEUROLOGY, V57, P1461, DOI 10.1212/WNL.57.8.1461; Horn R, 1996, DEMENTIA, V7, P182, DOI 10.1159/000106876; Ivnik RJ, 1992, CLIN NEUROPSYCHOL, V6, P49, DOI DOI 10.1080/13854049208401879; IVNIK RJ, 1991, PSYCHOL ASSESSMENT J, V3, P156; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jackson GD, 1998, NEUROLOGY, V51, P78, DOI 10.1212/WNL.51.1.78; Kopelman MD, 2001, J NEUROL NEUROSUR PS, V71, P23, DOI 10.1136/jnnp.71.1.23; Kuzniecky RI, 1997, NEUROLOGY, V49, P774, DOI 10.1212/WNL.49.3.774; Laakso MP, 2000, NEUROPSYCHOLOGIA, V38, P579, DOI 10.1016/S0028-3932(99)00111-6; LAAKSO MP, 1995, J NEURAL TRANSM-PARK, V9, P73, DOI 10.1007/BF02252964; Laakso MP, 1998, NEUROBIOL AGING, V19, P23, DOI 10.1016/S0197-4580(98)00006-2; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; Lye TC, 2004, J NEUROL NEUROSUR PS, V75, P548, DOI 10.1136/jnnp.2003.010223; Martin RC, 2001, NEUROLOGY, V57, P597, DOI 10.1212/WNL.57.4.597; Martin RC, 1999, J INT NEUROPSYCH SOC, V5, P540, DOI 10.1017/S1355617799566083; Mervaala E, 2000, PSYCHOL MED, V30, P117, DOI 10.1017/S0033291799001567; Mori E, 1997, J NEUROL NEUROSUR PS, V63, P214, DOI 10.1136/jnnp.63.2.214; Pantel J, 1997, PSYCHOL MED, V27, P221, DOI 10.1017/S003329179600431X; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Pihlajamaki M, 2003, HIPPOCAMPUS, V13, P67, DOI 10.1002/hipo.10049; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Rosen AC, 2003, BEHAV NEUROSCI, V117, P1150, DOI 10.1037/0735-7044.117.6.1150; ROSSI A, 1994, PSYCHIAT RES, V52, P43, DOI 10.1016/0165-1781(94)90119-8; Scheltens P, 1997, ALZ DIS ASSOC DIS, V11, P63, DOI 10.1097/00002093-199706000-00002; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SOININEN HS, 1994, NEUROLOGY, V44, P1660, DOI 10.1212/WNL.44.9.1660; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; TROSTER AI, 1993, J CLIN EXP NEUROPSYC, V15, P773, DOI 10.1080/01688639308402595; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Visser PJ, 2002, J NEUROL NEUROSUR PS, V72, P491; Wahlund LO, 2000, J NEUROL NEUROSUR PS, V69, P630, DOI 10.1136/jnnp.69.5.630; Waite LM, 2001, J NEUROL NEUROSUR PS, V71, P296, DOI 10.1136/jnnp.71.3.296; Waite LM, 2001, INT J GERIATR PSYCH, V16, P680, DOI 10.1002/gps.404; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521, DOI 10.1001/archneur.1997.00550240071015; Wechsler D, 1987, WMS R MANUAL; WILSON BA, 1995, J CLIN EXP NEUROPSYC, V17, P668, DOI 10.1080/01688639508405157; Wood AG, 2000, J INT NEUROPSYCH SOC, V6, P529, DOI 10.1017/S1355617700655029; Wu CC, 2002, NEUROLOGY, V59, P383, DOI 10.1212/WNL.59.3.383; ZIPURSKY RB, 1994, BIOL PSYCHIAT, V35, P501, DOI 10.1016/0006-3223(94)90097-3	69	16	18	0	4	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0028-3940			NEURORADIOLOGY	Neuroradiology	FEB	2006	48	2					90	99		10.1007/s00234-005-0032-5			10	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	010SV	WOS:000235219100004	16365740				2021-06-18	
J	Sabri, F; Granath, F; Hjalmarsson, A; Aurelius, E; Skoldenberg, B				Sabri, F; Granath, F; Hjalmarsson, A; Aurelius, E; Skoldenberg, B			Modulation of sFas indicates apoptosis in human herpes simplex encephalitis	JOURNAL OF NEUROIMMUNOLOGY			English	Article						herpes simplex encephalitis; apoptosis; cerebrospinal fluid; soluble Fas	TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; SOLUBLE FAS; MULTIPLE-SCLEROSIS; CD95 APO-1/FAS; VIRUS; EXPRESSION; ACTIVATION; FAS/APO-1	Herpes simplex encephalitis (HSE) is the most common cause of non-epidemic, acute and fatal viral encephalitis. A pronounced mortality and morbidity remains in HSE despite antiviral treatment. There is evidence of a vigorous intrathecal immune activity in acute phases of HSE and of persistently increased activity at follow-ups after years. The role of apoptosis of neuronal cells in HSE patients',as a mechanism of damage has been brought up lately. We hypothesize that the severity and the progression of the cerebral injury resulting from HSE can be evaluated by quantitative measurement of a compartment of immune activation molecules i.e. soluble Fas (sFas) involved in apoptosis through the Fas/Fas Ligand pathway. Consecutive cerebrospinal fluid (CSF) samples from a prospectively followed cohort, included in an antiviral treatment trial in HSE, were enrolled for quantitative measurement of sFas using commercial capture ELISA. In total, CSF samples:from 49 patients with HSE, 63 patients with non-HSE encephalitis and 18 healthy individuals were studied. High levels of sFas were expressed in CSF samples collected between days 0-45 after neurological onset in 41/49 (84%) HSE patients, whereas only 21/63 (33%) of non-HSE patients and none of 18 healthy controls demonstrated measurable levels of sFas. Following the consecutive CSF sFas levels over the time and considering the clinical state of patients at admission, their neurological or lethal outcome at 12 months, and antiviral treatment, we observed that HSE patients with severe neurological sequels revealed an increase in changes of CSF sFas as compared to patients with mild or moderate neurological outcome (57.6 +/- 55.6 pg/ml, n=10 versus 26.3 +/- 97.5 pg/ml, n=14; P=0.008). Also HSE patients undergoing vidarabine treatment expressed significantly higher levels of changes of CSF sFas when compared to acyclovir-treated patients (63.7 +/- 52.8 pg/ml, n = 9 versus 26.1 +/- 98.4 pg/ml, n=14; P = 0.003). Interestingly, regardless of the clinical state at admission, and subsequent disease progression of the HSE patients, we could not observe any significant differences in the CSF sFas levels during the first 7 days of neurological symptoms. These observations underline the role of immunological response throughout the course of HSV infection in the brain and the role of the Fas/FasL pathway in particular in disease progression of HSE. The findings further enforce the need of expanding the knowledge of the pathogenesis of HSE to direct to more effective, in particular not only antiviral but also anti-apoptotic or anti-inflammatory treatment. (c) 2005 Published by Elsevier B.V.	Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden; Karolinska Univ Hosp, Dept Med, Div Clin Epidemiol, Stockholm, Sweden	Sabri, F (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden.	farideh.sabri@karolinska.se					AURELIUS E, 1994, J INFECT DIS, V170, P678, DOI 10.1093/infdis/170.3.678; AURELIUS E, 1993, J INFECT DIS, V168, P1248, DOI 10.1093/infdis/168.5.1248; AURELIUS E, 1991, LANCET, V337, P189, DOI 10.1016/0140-6736(91)92155-U; BOOSS J, 1984, YALE J BIOL MED, V57, P751; CASCINO I, 1995, J IMMUNOL, V154, P2706; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; De Milito A, 2000, AIDS RES HUM RETROV, V16, P1379, DOI 10.1089/08892220050140928; DeBiasi RL, 2002, J INFECT DIS, V186, P1547, DOI 10.1086/345375; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; Elovaara I, 1999, ACTA NEUROPATHOL, V98, P355, DOI 10.1007/s004010051094; Felderhoff-Mueser U, 2001, ARCH DIS CHILD, V84, P369, DOI 10.1136/adc.84.4.369; FISCHER U, 2005, CELL DEATH DIFFER; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Kamiyama H, 2004, CANCER SCI, V95, P990, DOI 10.1111/j.1349-7006.2004.tb03188.x; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Martinez-Torres FJ, 2004, NEUROSCI LETT, V368, P274, DOI 10.1016/j.neulet.2004.06.064; MATSUYAMA T, 1994, BRAIN RES, V657, P342, DOI 10.1016/0006-8993(94)90989-X; Mejia ROS, 2001, NEUROSURGERY, V48, P1393; Mogi M, 1996, NEUROSCI LETT, V220, P195, DOI 10.1016/S0304-3940(96)13257-2; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; OWENSCHAUB LB, 1995, CANCER LETT, V94, P1, DOI 10.1016/0304-3835(95)03834-J; Papoff G, 1996, J IMMUNOL, V156, P4622; Perkins D, 2003, J NEUROVIROL, V9, P101, DOI 10.1080/13550280390173427; Sabri F, 2001, J NEUROIMMUNOL, V114, P197, DOI 10.1016/S0165-5728(00)00424-0; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sellner J, 2005, NEUROSCI LETT, V374, P197, DOI 10.1016/j.neulet.2004.10.054; SKOLDENBERG B, 1984, LANCET, V2, P707; SKOLDENBERG B, 1991, SCAND J INFECT DIS, P40; SKOLDENBERG B, IN PRESS J NEUROL; Studahl M, 2000, J NEUROL, V247, P636, DOI 10.1007/s004150070134; TACHIBANA O, 1995, CANCER RES, V55, P5528; Thompson KA, 2000, J NEUROVIROL, V6, P25, DOI 10.3109/13550280009006379; Towfighi A, 2004, NEUROLOGY, V62, P654, DOI 10.1212/01.WNL.0000110188.37546.51; WHITLEY RJ, 1991, DRUGS, V42, P406, DOI 10.2165/00003495-199142030-00005; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Zipp F, 1998, ANN NEUROL, V43, P116, DOI 10.1002/ana.410430120	40	16	16	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	FEB	2006	171	1-2					171	176		10.1016/j.jneuroim.2005.10.003			6	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	009LW	WOS:000235114500017	16325272				2021-06-18	
J	Hu, X; Nenov, V; Bergsneider, M; Martin, N				Hu, Xiao; Nenov, Valeriy; Bergsneider, Marvin; Martin, Neil			A Data mining framework of noninvasive intracranial pressure assessment	BIOMEDICAL SIGNAL PROCESSING AND CONTROL			English	Article						Noninvasive; Intracranial pressure; Data mining; System identification	CEREBRAL PERFUSION-PRESSURE; TRANSCRANIAL DOPPLER; BLOOD-PRESSURE; SPONTANEOUS FLUCTUATIONS; MATHEMATICAL-MODEL; BRAIN-DAMAGE; AUTOREGULATION; IDENTIFICATION; DYNAMICS	The only established technique for intracranial pressure (ICP) measurement is an invasive direct procedure that has been accepted into routine usage in neurosurgical services. However. there are many other scenarios where a noninvasive assessment of ICP is highly desirable. To make a full use of the vast amount Of signals Collected in a typical neurosurgical service environment to realize Such a noninvasive procedure of ICP assessment, a general data mining, framework is proposed in the present work. As a particular implementation of the proposed framework where continuous arterial blood pressure (ABP) and cerebral blood flow velocity (CBFV) are available. We Propose to simulate the unobserved ICP as the Output Of a model built from a database composed of arterial blood pressure. cerebral blood flow velocity and ICP. This model was discovered by exploring, the database with the hemodynamic features extracted from measured ABP and CBFV. This approach was evaluated Using a database composed of 30-min long measurements from nine traumatic brain injury patients. The approach achieved significant improvements of ICP simulation accuracy over several existing noninvasive ICP assessment methods. Particularly its median normalized prediction error for ICP is 39% compared to 51% as obtained by an existing method and its median correlation coefficient between estimated and measured normalized ICP is 0.80 compared to 0.35 achieved by the existing method. The proposed framework is flexible in incorporating other relevant signals besides ABP, CBFV and ICP into the database. It allows for new hemodynamic feature vectors and for adopting new models for ICP estimation. Hence it is worthwhile to evaluate the method using, a larger database and further develop the framework. (c) 2006 Elsevier Ltd. All rights reserved.	[Hu, Xiao; Nenov, Valeriy; Bergsneider, Marvin; Martin, Neil] Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA	Hu, X (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA.	xhu@mednet.ucla.edu; vnenov@mednet.ucla.edu; mbergsneider@mednet.ucla.edu; nmartin@mednet.ucla.edu		Martin, Neil/0000-0002-6565-4131	UCLA Brain Injury Research Center (BIRC) [NINDS RO1 40122-01]; UCLA SPOTRIAS	The present work was funded by, in part, UCLA Brain Injury Research Center (BIRC). NINDS RO1 40122-01, and UCLA SPOTRIAS project.	AASLID R, 1985, P 6 INT S INTR PRESS, P226; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; ANDERSSON P, 1985, INT J CONTROL, V42, P1175, DOI 10.1080/00207178508933420; Avan P, 2000, HEARING RES, V140, P189, DOI 10.1016/S0378-5955(99)00201-4; Belfort MA, 2000, HYPERTENS PREGNANCY, V19, P331, DOI 10.1081/PRG-100101995; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Hagan M. T., 1996, NEURAL NETWORK DESIG; HANLO PW, 1995, ULTRASOUND MED BIOL, V21, P613, DOI 10.1016/0301-5629(94)00147-6; Hu X, 2006, IEEE T BIO-MED ENG, V53, P195, DOI 10.1109/TBME.2005.862546; Hu X, 2004, CLIN NEUROPHYSIOL, V115, P1276, DOI 10.1016/j.clinph.2003.12.030; JENNETT B, 1975, LANCET, V1, P480; Kailath T, 2000, PR H INF SY, pXIX; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; Ljung L., 1999, SYSTEM IDENTIFICATIO, V2nd; Michaeli D, 2002, J NEUROSURG, V96, P1132, DOI 10.3171/jns.2002.96.6.1132; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Overschee P, 1996, SUBSPACE IDENTIFICAT; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089; PIPER IR, 1990, ACT NEUR S, V51, P387; Richards HK, 1999, ACTA NEUROCHIR, V141, P1221, DOI 10.1007/s007010050422; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt B, 2000, J NEUROSURG, V92, P793, DOI 10.3171/jns.2000.92.5.0793; Sherman RW, 2002, BRIT J ANAESTH, V89, P687, DOI 10.1093/bja/aef247; SIDI A, 1995, ANESTH ANALG, V80, P194, DOI 10.1097/00000539-199501000-00032; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; TEASDALE G, 1974, LANCET, V2, P81; Thalen E, 2002, EUR ARCH OTO-RHINO-L, V259, P174, DOI 10.1007/s00405-001-0431-0; Ueno T, 1998, ACT NEUR S, V71, P66; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; URSINO M, 1995, IEEE T BIO-MED ENG, V42, P529, DOI 10.1109/10.387192; URSINO M, 1988, ANN BIOMED ENG, V16, P379, DOI 10.1007/BF02364625; Ursino M, 1997, J APPL PHYSIOL, V82, P1256; VERHAEGEN M, 1992, INT J CONTROL, V56, P1187, DOI 10.1080/00207179208934363; Zhang R, 2000, AM J PHYSIOL-HEART C, V278, pH1848; 1990, P 29 IEEE C DEC CONT, P596	41	16	17	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1746-8094	1746-8108		BIOMED SIGNAL PROCES	Biomed. Signal Process. Control	JAN	2006	1	1					64	77		10.1016/j.bspc.2006.05.003			14	Engineering, Biomedical	Engineering	V83MW	WOS:000205644200007					2021-06-18	
J	Iverson, GL; Lange, RT; Viljoen, H; Brink, J				Iverson, GL; Lange, RT; Viljoen, H; Brink, J			WAIS-III General Ability Index in neuropsychiatry and forensic psychiatry inpatient samples	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						intelligence; WAIS-III; psychiatry; assessment	TRAUMATIC BRAIN INJURY; BASE-RATES; INTELLIGENCE; SCORES	The purpose of this study is to examine the WAIS-III General Ability Index (GAI) in a sample of 33 neuropsychiatry inpatients and 47 forensic psychiatry inpatients. The GAI is comprised of the six subtests that form the Verbal Comprehension and the Perceptual Organization Indexes. The GAI, although highly correlated with the FSIQ, was on average 5.3 points higher in the neuropsychiatry sample and 4.2 points higher in the forensic psychiatry sample. The GAI was significantly higher than the Working Memory and the Processing Speed Indexes in both groups. The GAI, a composite measure of verbal and nonverbal intellect, appears to be an appropriate measure for use in day-to-day clinical practice in neuropsychology. To facilitate clinical use, statistically reliable difference scores between the GAI and the WMI and PSI, for the 95% confidence interval, are presented. (c) 2005 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; Forens Psychiat Hosp, Vancouver, BC V6T 2A1, Canada	Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570			Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hawkins KA, 2001, J INT NEUROPSYCH SOC, V7, P875, DOI 10.1017/S1355617701777119; Lange RT, 2005, CLIN NEUROPSYCHOL, V19, P73, DOI 10.1080/13854040490888549; LANGE RT, CLIN NEUROPSYCHOLOGI; LANGE RT, J CLIN EXPT NEUROPSY; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Prifitera A., 1998, WISC 3 CLIN USE INTE, P1, DOI DOI 10.1016/B978-012564930-8/50002-4; *PSYCH CORP, 1997, WAIS III WMS III TEC; Raiford S. E., 2005, WECHSLER INTELLIGENC; Saklofske DH, 2005, CAN J BEHAV SCI, V37, P44, DOI 10.1037/h0087244; SCHOENBERG MR, CLIN NEUROPSYCHOLOGI; SELLERS AH, 1999, WAIS III GEN ABILITI; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Tulsky DS, 2000, CLIN NEUROPSYCHOL, V14, P451, DOI 10.1076/clin.14.4.451.7202; Wechsler D, 1997, WAIS 3 ADM SCORING M; WEISS LG, 1999, CANADIAN J SCH PSYCH, V14, P1, DOI DOI 10.1177/082957359901400202	18	16	16	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2006	21	1					77	82		10.1016/j.acn.2005.07.007			6	Psychology, Clinical; Psychology	Psychology	006EA	WOS:000234877100007	16162397	Bronze			2021-06-18	
J	Lin, JW; Tsai, SH; Tsai, WC; Chiu, WT; Chu, SF; Lin, CM; Yang, CM; Hung, CC				Lin, Jia-Wei; Tsai, Shih-Han; Tsai, Wan-Chen; Chiu, Wen-Ta; Chu, Shu-Fen; Lin, Chien-Min; Yang, Che-Ming; Hung, Ching-Chang			Survey of traumatic intracranial hemorrhage in Taiwan	SURGICAL NEUROLOGY			English	Article						head injury; traumatic intracranial hemorrhage; traumatic brain injury	HEAD-INJURY; AUSTRALIA; HELMETS; COUNTY	Background: Injury ranked third among the top 10 leading causes of death in Taiwan from 1964 to 1996 and is still among the top 10 presently. Among transportation accidents, motor vehicle -related injury had the highest incidence rate, often resulting in traumatic head injury. Methods: This survey was conducted from July 1, 1994, to June 30, 2002, and was collected from 55 major hospitals in Taiwan. A total of 90 250 patients with TBI were enrolled, and 27 585 cases were identified to have TIH. In this study, SPSS 10.0 (SPSS, Chicago, Ill) was used to process the data. Regarding the rating model itself, reliability and correlation tests were conducted to calculate the coefficiency, and factor analysis was carried out to verify its validity. Results: The incidence rate of male-to-female ratio was 2.65. Traffic injuries (67.6%) were the leading causes of TIH. Among the traffic injuries, motorcycle-related traumatic injuries had the highest incidence rate (69.6%). In the logistic regression analysis, older patients had the highest risk of developing TIH. Patients without a motorcycle helmet had a higher risk (odds ratio, 1.40) of developing TIH than those with a helmet. As regards the types of injuries, pedestrian injury (odds ratio, 1.61) had the highest risk of developing TIH. Conclusions: Although traffic injuries, especially those caused by motorcycles, are the major cause of intracranial hemorrhage, we have to pay due attention to falling, pedestrian, and bicycle injuries, as these are all major causes of intracranial hemorrhage. (c) 2006 Elsevier Inc. All rights reserved.	Taipei Med Univ, Municipal Wanfang Hosp, Dept Neurosci, Taipei 116, Taiwan; Taipei Med Univ, Municipal Wanfang Hosp, Dept Emergency Med, Taipei 116, Taiwan; Taipei Med Univ, Municipal Wanfang Hosp, Dept Nucl Med, Taipei 116, Taiwan; Taipei Med Univ, Municipal Wanfang Hosp, Adm Off, Taipei 116, Taiwan; Taipei Med Univ, Inst Injury Prevent & Control, Taipei 110, Taiwan	Chiu, WT (corresponding author), Taipei Med Univ, Municipal Wanfang Hosp, Dept Neurosci, Taipei 116, Taiwan.	wtchiu@tmu.edu.tw	Carlotti, Carlos G/C-1608-2012	Carlotti, Carlos G/0000-0002-7055-0564			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FRANKOWSKI RF, 1985, EPIDEMIOLOGICAL DE 1, P33; Hung C C, 1991, J Formos Med Assoc, V90, P1227; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1975, LANCET, V1, P480; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; KLAUBER MR, 1981, AM J EPIDEMIOL, V5, P500; KRAUS JF, 1980, J NEUROSURG, V53, P803; KUO JI, 1995, J TAIPEI MED COLL, V24, P36; MCDERMOTT FT, 1995, ANN ROY COLL SURG, V77, P38; PARKISON D, 1985, CAN J SURG, V28, P78; *ROC, 2002, STAT DAT DEP HLTH; Runge J W, 1993, Emerg Med Clin North Am, V11, P241; Schulman J, 2002, INJ PREV, V8, P47, DOI 10.1136/ip.8.1.47; Servadei F, 1985, J Neurosurg Sci, V29, P297; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x; WU DM, 1991, J MED SCI, V12, P104; WU DT, 1991, MED SCI, V12, P104	22	16	16	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.		2006	66			2			S20	S25		10.1016/j.surneu.2006.04.005			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	107OW	WOS:000242181900005	17071250				2021-06-18	
J	Van Hulle, A; Hux, K				Van Hulle, A; Hux, K			Improvement patterns among survivors of brain injury: Three case examples documenting the effectiveness of memory compensation strategies	BRAIN INJURY			English	Article						assistive technology; memory	AIDS	Three case examples illustrate possible patterns of improved functioning that may emerge as survivors of traumatic brain injury (TBI) attempt compensation for persistent memory deficits impeding independent living. The task selected for report was independence in remembering to take regularly-prescribed medications. Strategies applied to promote learning included use of written reminders and use of two assistivetechnology (AT) devices-a wristwatch alarm (WatchMinder (R)) and a digital voice recorder and alarm system (Voice Craft(TM)). With participation in the intervention programme, two of the three individuals demonstrated increased independence in remembering to take medications; the third did not. The case examples illustrate varying responses of people with TBI to intervention using compensatory strategies and AT devices. Professionals and caretakers working with survivors must recognize the uniqueness of each survivor, must adjust intervention programmes accordingly and must be willing to persist in trying to increase functional independence repeatedly for many years post-injury.	Univ Nebraska, Barkley Mem Ctr Speech & Hearing, Lincoln, NE 68506 USA	Hux, K (corresponding author), Univ Nebraska, Barkley Mem Ctr 318N, Lincoln, NE 68506 USA.	khux1@unl.edu	Hux, Karen/AAQ-2078-2020				Delis DC, 2000, CALIFORNIA VERBAL LE; GILES GM, 1989, AM J OCCUP THER, V43, P409, DOI 10.5014/ajot.43.6.409; Hux K, 2003, ASSISTING SURVIVORS OF TRAUMATIC BRAIN INJURY, P169; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kertesz A., 1982, W APHASIA BATTERY; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI [10.1097/00001199-198709000-00009, DOI 10.1097/00001199-198709000-00009]; MOSEY AC, 1993, AOTA SELF STUDY SERI, P23; SANDLER AB, 1992, AM J OCCUP THER, V46, P163, DOI 10.5014/ajot.46.2.163; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; Sohlberg M. M., 2001, COGNITIVE REHABILITA; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; WOODS RT, 1983, BEHAV RES THER, V21, P173, DOI 10.1016/0005-7967(83)90164-X	16	16	16	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2006	20	1					101	109		10.1080/02699050500309684			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	001AQ	WOS:000234505000011	16403705				2021-06-18	
J	Yen, K; Weis, J; Kreis, R; Aghayev, E; Jackowski, C; Thali, M; Boesch, C; Maier, SE; Dirnhofer, R; Lovblad, KO				Yen, K; Weis, J; Kreis, R; Aghayev, E; Jackowski, C; Thali, M; Boesch, C; Maier, SE; Dirnhofer, R; Lovblad, KO			Line-scan diffusion tensor imaging of the posttraumatic brain stem: Changes with neuropathologic correlation	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MULTISLICE COMPUTED-TOMOGRAPHY; FIBER TRACT ANATOMY; WHITE-MATTER; POSTMORTEM; INJURY; MRI	Following trauma, imaging of brain stem lesions is often inconclusive. In a man who suffered a lethal accident, postmortem MR diffusion tensor (DT) imaging of the brain and neuropathologic examination were performed. DT imaging showed a disorganization of fibers in the brain stem that was not found in 2 controls and corresponded to changes on neuropathologic correlation. Diffusion tensor imaging provides an insight into the organization of myelinated structures of the CNS, potentially allowing diagnosis of traumatic fiber tract rupture.	Univ Bern, Inst Forens Med, CH-3012 Bern, Switzerland; Univ Bern, Dept Clin Res, CH-3012 Bern, Switzerland; Univ Bern, Dept Neuroradiol, CH-3012 Bern, Switzerland; Univ Geneva, Dept Neuroradiol, Geneva, Switzerland; Univ Aachen, Inst Pathol, Div Neuropathol, D-5100 Aachen, Germany; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA	Yen, K (corresponding author), Univ Bern, Inst Forens Med, Buehlstr 20, CH-3012 Bern, Switzerland.		Kreis, Roland/F-2550-2010; Boesch, Chris/F-2577-2010; Weis, Joachim/G-1984-2014; Lovblad, Karl/AAF-7678-2020	Kreis, Roland/0000-0002-8618-6875; Boesch, Chris/0000-0001-8498-8543; Weis, Joachim/0000-0003-3280-6773; lovblad, karl-olof/0000-0003-2768-9779			Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Larsson EM, 2004, DEMENT GERIATR COGN, V17, P316, DOI 10.1159/000077162; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Mamata H, 2002, AM J NEURORADIOL, V23, P67; Roberts TPL, 2003, EUR J RADIOL, V45, P185, DOI 10.1016/S0720-048X(02)00305-4; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Watanabe T, 2004, J NEUROSURG, V100, P56, DOI 10.3171/jns.2004.100.1.0056; Yen K, 2005, INT J LEGAL MED, V119, P129, DOI 10.1007/s00414-004-0507-7	12	16	18	0	1	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	JAN	2006	27	1					70	73					4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	004VC	WOS:000234779600025	16418359				2021-06-18	
J	Turkstra, LS				Turkstra, LS			Looking while listening and speaking: Eye-to-face gaze in adolescents with and without traumatic brain injury	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						eye contact; pragmatics; communication; traumatic brain injury	CLOSED-HEAD-INJURY; SOCIAL-SKILLS; CONVERSATIONAL DISCOURSE; NARRATIVES; BEHAVIORS; ABILITIES; RECOVERY; MEMORY; ADULTS	Purpose: The purpose of this study was to address the lack of quantitative data on eye-to-face gaze (also known as eye contact) in the literature on pragmatic communication. The study focused on adolescents and young adults with traumatic brain injury (TBI), as gaze often is included in social skills intervention in this population. Method: Gaze times were calculated for participants with TBI (n = 16) and their typically developing (TD) peers (n = 16) engaged in 3-min extemporaneous conversations. Results: The TD group members looked at the face of their conversation partner an average of 62% of the time while listening and 43% of the time while speaking, versus 67% and 51 %, respectively, for the TBI group. There were no significant between-groups differences in average gaze times, but the within-group variability was significantly greater in the TBI group. Implications: As there was no evidence of a uniform trend in gaze times among participants with TBI, general intervention to increase eye contact does not appear warranted. Instead, goals must consider that gaze is a highly complex behavior, not necessarily indicative of attention to one's partner, and that there are potential reasons for gaze aversion in individuals with cognitive limitations.	Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA	Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu			NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-00163] Funding Source: Medline		Arnold A, 2000, J INTELLECT DEV DIS, V25, P207, DOI 10.1080/13269780050144271; ASHER SR, 1986, SOCIAL WORK ED, V8, P205; Baker SR, 2002, BRIT J CLIN PSYCHOL, V41, P243, DOI 10.1348/014466502760379118; Baron-Cohen S., 1995, MIND BLINDNESS ESSAY; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Bavelas JB, 2000, J LANG SOC PSYCHOL, V19, P163, DOI 10.1177/0261927X00019002001; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1093/joc/52.3.566; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; CHERULNIK PD, 1978, J SOC PSYCHOL, V104, P263, DOI 10.1080/00224545.1978.9924068; Clark HH, 2004, J MEM LANG, V50, P62, DOI 10.1016/j.jml.2003.08.004; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cohen M.J., 1997, CHILDRENS MEMORY SCA; Csikszentmihalyi M., 1984, BEING ADOLESCENT CON; DUNCAN S, 1972, J PERS SOC PSYCHOL, V23, P283, DOI 10.1037/h0033031; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Gueguen N, 2002, J SOC PSYCHOL, V142, P393, DOI 10.1080/00224540209603907; Hansen DJ, 1996, BEHAV MODIF, V20, P281, DOI 10.1177/01454455960203003; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; JENNETT B, 1975, LANCET, V1, P480; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; LAFRANCE M, 1976, J PERS SOC PSYCHOL, V33, P547, DOI 10.1037/0022-3514.33.5.547; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; MARCELLE YM, 1976, THESIS KANSAS STATE; McNeil MR., 1991, CLIN APHASIOL, V20, P21; MIRENDA PL, 1983, J AUTISM DEV DISORD, V13, P397, DOI 10.1007/BF01531588; Murphy NA, 2003, J PERS, V71, P465, DOI 10.1111/1467-6494.7103008; Newtson D, 1993, DYNAMIC SYSTEMS APPR, P241; Noldus LPJJ, 2000, BEHAV RES METH INS C, V32, P197, DOI 10.3758/BF03200802; PARENTE R, 1996, J VOCATIONAL REHABIL, V7, P181; PLACE KS, 1991, DISCOURSE PROCESS, V14, P227, DOI 10.1080/01638539109544783; RAFFAELLI M, 1989, J YOUTH ADOLESCENCE, V18, P567, DOI 10.1007/BF02139074; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; SNOW P, 1995, TRAUMATIC BRAIN INJU, P137; SPENCE SH, 1981, J APPL BEHAV ANAL, V14, P159, DOI 10.1901/jaba.1981.14-159; Stephens J., 1986, J LANG SOC PSYCHOL, V5, P119, DOI [10.1177/0261927X8652003, DOI 10.1177/0261927X8652003]; Turkstra L, 2003, LANG SPEECH HEAR SER, V34, P117, DOI 10.1044/0161-1461(2003/010); Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2001, J COMMUN DISORD, V34, P151, DOI 10.1016/S0021-9924(00)00046-0; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; WIEMANN JM, 1981, HUM COMMUN RES, V7, P302, DOI 10.1111/j.1468-2958.1981.tb00577.x; WINT G, 1965, 3 KILLER MEDITATIONS	52	16	16	0	7	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	DEC	2005	48	6					1429	1441		10.1044/1092-4388(2005/099)			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	022KY	WOS:000236055900014	16478381				2021-06-18	
J	Boden, BP				Boden, BP			Direct catastrophic injury in sports	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS			English	Article							CERVICAL SPINAL STENOSIS; FOOTBALL PLAYERS; PROFESSIONAL FOOTBALL; AMERICAN FOOTBALL; SOCCER PLAYERS; CHEST IMPACTS; SUDDEN-DEATH; CORD; CONCUSSION; HOCKEY	Catastrophic sports injuries are rare but tragic events. Direct (traumatic) catastrophic injury results from participating in the skills of a sport, such as a collision in football. Football is associated with the greatest number of direct catastrophic injuries for all major team sports in the United States. Pole vaulting, gymnastics, ice hockey, and football have the highest incidence of direct catastrophic injuries for sports in which males participate. In most sports, the rate of catastrophic injury is higher at the collegiate than at the high school level. Cheerleading is associated with the highest number of direct catastrophic injuries for all sports in which females participate. Indirect (nontraumatic) injury is caused by systemic failure as a result of exertion while participating in a sport. Cardiovascular conditions, heat illness, exertional hyponatremia, and dehydration can cause indirect catastrophic injury. Understanding the common mechanisms of injury and prevention strategies for direct catastrophic injuries is critical in caring for athletes.	Orthopaed Ctr, Rockville, MD 20850 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Boden, BP (corresponding author), Orthopaed Ctr, 9711 Med Ctr Dr,201, Rockville, MD 20850 USA.						[Anonymous], 1994, J Am Coll Cardiol, V24, P845; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Boden BP, 2004, AM J SPORT MED, V32, P1189, DOI 10.1177/0363546503262161; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Boden BP, 2002, AM J SPORT MED, V30, P791, DOI 10.1177/03635465020300060601; Boden BP, 2001, AM J SPORT MED, V29, P50, DOI 10.1177/03635465010290011301; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; CANTU RC, 1993, MED SCI SPORT EXER, V25, P316; Crisco JJ, 1997, MED SCI SPORT EXER, V29, P26, DOI 10.1097/00005768-199701000-00005; Crisco JJ, 2002, MED SCI SPORT EXER, V34, P1675, DOI 10.1097/00005768-200210000-00021; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; HERZOG RJ, 1991, SPINE, V16, pS178, DOI 10.1097/00007632-199106001-00001; Janda DH, 1998, J TRAUMA, V44, P298, DOI 10.1097/00005373-199802000-00011; JANDA DH, 1995, AM J SPORT MED, V23, P340, DOI 10.1177/036354659502300316; Janda DH, 1992, CLIN J SPORT MED, V2, P172; Kane SM, 2002, AM J SPORT MED, V30, P834, DOI 10.1177/03635465020300061301; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Molsa JJ, 1999, INT J SPORTS MED, V20, P64, DOI 10.1055/s-2007-971095; MUELLER FO, 1996, HK SPORT SCI MONOGRA, V8, P1; *NAT FED STAT HIGH, 2001, BAS 2002 RUL BOOK, P14; *NAT SLEEP FDN, 2002, 2002 SLEEP AM POLL, P1; *NCAA, 2002, 2003 BAS RUL INT, P20; ODOR JM, 1990, AM J SPORT MED, V18, P507, DOI 10.1177/036354659001800510; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Strasburger JF, 2002, NEW ENGL J MED, V347, P1248, DOI 10.1056/NEJMicm020053; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Torg JS, 2002, J BONE JOINT SURG AM, V84A, P112, DOI 10.2106/00004623-200201000-00017; TORG JS, 1994, ORTHOPAEDIC SPORTS M, P417; VIANO DC, 1992, CLIN J SPORT MED, V2, P161	33	16	16	1	11	AMER ACAD ORTHOPAEDIC SURGEONS	ROSEMENT	6300 N RIVER ROAD, ROSEMENT, IL 60018-4262 USA	1067-151X			J AM ACAD ORTHOP SUR	J. Am. Acad. Orthop. Surg.	NOV	2005	13	7					445	454		10.5435/00124635-200511000-00004			10	Orthopedics; Surgery	Orthopedics; Surgery	981DQ	WOS:000233068000004	16272269				2021-06-18	
J	Ganesh, JS; Rogers, CA; Banner, NR; Bonser, RS				Ganesh, JS; Rogers, CA; Banner, NR; Bonser, RS		Royal Coll Surg England London	Donor cause of death and mid-term survival in lung transplantation	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Article							BRAIN-DEATH; INJURY; RISK	Background: The influence of donor cause of death (DCD) on survival after lung transplantation (LTx) is uncertain. This was investigated using data from a national prospective cohort study of adult single and bilateral LTx undertaken between July 1995 and June 2002. Methods: DCD was categorized a priori into vascular and tumor (V), traumatic (T), hylJoxic brain damage (H) and infective (1) causes. All T donor deaths were the result of blunt trauma. Risk factors for early (30 days), late (30 days to 5 years) and overall (5 years) mortality were identified using Cox regression analysis. Results: Of 580 eligible transplants,. DCDs were classified as V (n = 372), T (n = 153), H (n = 38) and I (n = 17). V donors were older (median 42 years) than the others (medians < 27 years) (p < 0.001). T donors were more likely to be of male gender (p < 0.001). Two hundred fifty-nine patients died within 5 years of surgery. The median follow-up time of survivors was 37 months. Unadjusted 5-year Kaplan-Meier survival rates did not vary with DCD (p = 0.6). Cox analysis identified donor age group, recipient diagnosis, pre-operative recipient ventilation, donor-recipient size mismatch, donor-recipient blood group variance, cytomegalovirus (CMV) mismatch and recipient creatinine clearance as predictors of mortality. After adjustment for these risk factors, DCD was not identified as a predictor of early (p = 0.2), late (p = 0.5) or overall mortality (p = 0.4) in LTx recipients. Conclusion: We found that DCD did not affect mid-term survival after LTx.	Royal Coll Surgeons England, Clin Effectiveness Unit, UK Cardiothorac Transplant Audit, Steering Grp, London WC2A 3PN, England	Bonser, RS (corresponding author), Queen Elizabeth Hosp, Cardiac Surg Unit, Birmingham B15 2TH, W Midlands, England.	robert.bonser@uhb.nhs.uk					CAMERON AC, 1996, ANAL COUNT DATA; Ciccone AM, 2002, J THORAC CARDIOV SUR, V123, P429, DOI 10.1067/mtc.2002.120732; COX DR, 1972, J R STAT SOC B, V34, P187; Endo H, 1974, Nihon Kyobu Geka Gakkai Zasshi, V22, P806; Feduska N J Jr, 1994, Clin Transpl, P381; Fiser SM, 2001, J HEART LUNG TRANSPL, V20, P1291, DOI 10.1016/S1053-2498(01)00355-2; Fisher AJ, 2002, J HEART LUNG TRANSPL, V21, P1206, DOI 10.1016/S1053-2498(02)00450-3; NOVITZKY D, 1987, ANN THORAC SURG, V43, P288, DOI 10.1016/S0003-4975(10)60615-7; Oto T, 2004, J HEART LUNG TRANSPL, V23, P309, DOI 10.1016/S1053-2498(03)00192-X; Pessione F, 2003, TRANSPLANTATION, V75, P361, DOI 10.1097/01.TP.0000044171.97375.61; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Pratschke J, 2001, J AM SOC NEPHROL, V12, P2474, DOI 10.1681/ASN.V12112474; ROSENDALE BE, 1992, J HEART LUNG TRANSPL, V11, P72; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Trulock EP, 2003, J HEART LUNG TRANSPL, V22, P625, DOI 10.1016/S1053-2498(03)00182-7; WALLER DA, 1995, J HEART LUNG TRANSPL, V14, P318; WANEBO H, 1972, J THORAC CARDIOV SUR, V64, P537	18	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	OCT	2005	24	10					1544	1549		10.1016/j.healun.2004.11.316			6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	973EU	WOS:000232506500014	16210128				2021-06-18	
J	Enochsson, L; Carlsson-Sanz, S; van der Linden, J				Enochsson, L; Carlsson-Sanz, S; van der Linden, J			The influence of alcohol and time on the S-100B levels of patients with minor head injury	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						alcohol intoxication; minor head injury; S-100B; screening test	TRAUMATIC BRAIN-INJURY; PROTEIN MEASUREMENTS; SERUM; MARKER; DAMAGE	The present study aimed at evaluating the S-100B serum level's reaction to (i) alcohol consumption and (ii) time elapsing between head injury and blood sampling. Nineteen patients with minor head trauma and with at least one of the following symptoms: amnesia, transient loss of consciousness or severe headache, were included in the study. Immediately after arrival venous blood samples were drawn for determination of alcohol concentration and S-100B level. Four hours later a new blood sample was taken for repeat analysis. Twenty-one healthy volunteers drank a moderate amount of alcohol. Blood samples were taken just before alcohol intake and 4 h later. Patients - After 4 h the mean S-100B level had fallen from 0.26 to 0.21 ng/ml (P &LT; 0.01), i.e. a mean decrease of 0.05 ng/ml, 95% confidence limits: 0.02-0.09 ng/ml. The alcohol concentrations also decreased significantly from 2.00 &PLUSMN; 0.27% to 1.31 &PLUSMN; 0.20%, P &LT; 0.001, mean difference = 0.69%, 95% confidence limits: 0.27-1.11%. No difference was found between the S-100B levels of patients whose serum did contain alcohol and the levels of those whose serum did not. Volunteers - The serum alcohol level reached a mean value of 0.81% &PLUSMN; 0.09%. The mean S-100B level rose from 0.077 &PLUSMN; 0.02 ng/ml before alcohol intake to 0.103 &PLUSMN; 0.06 ng/ml, 4 h later (P &LT; 0.01). These data indicate that the time that elapses between trauma and blood test has an effect on the S-100B level. The same goes for the drinking of even a very moderate amount of alcohol. The relative importance of these two sources of error remains to be determined.	Karolinska Univ Hosp, Karolinska Inst, Dept Surg, S-14186 Stockholm, Sweden; Stockholm S Hosp, Dept Emergency Surg, Stockholm, Sweden	Enochsson, L (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Surg, K53,Campus Huddinge, S-14186 Stockholm, Sweden.	lars.enochsson@cfss.ki.se		Enochsson, Lars/0000-0001-8947-4736; Enochsson, Lars/0000-0002-1930-654X			Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391	12	16	16	0	0	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	1351-5101			EUR J NEUROL	Eur. J. Neurol.	JUN	2005	12	6					445	448		10.1111/j.1468-1331.2005.00996.x			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	924XK	WOS:000229014100006	15885048				2021-06-18	
J	Wechsler, B; Kim, H; Gallagher, PR; DiScala, C; Stineman, MG				Wechsler, B; Kim, H; Gallagher, PR; DiScala, C; Stineman, MG			Functional status after childhood traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						traumatic brain injury; children; National Pediatric Trauma Registry; PRM; Functional Independence Measure; Injury Severity Score; outcome prediction	PEDIATRIC INTENSIVE-CARE; CLOSED-HEAD-INJURY; INDEPENDENCE MEASURE; DEVELOPMENTAL PLASTICITY; ENDOTRACHEAL INTUBATION; COMMUNITY INTEGRATION; SEVERITY SCORE; PRISM-III; CHILDREN; RISK	Background: Identification of children after traumatic brain injury (TBI) likely to have functional deficits at trauma center discharge will facilitate care. Methods: Two logistic regression models were derived from data on 4,439 children after TBI 7 to 14 years old enrolled in the National Pediatric Trauma Registry between 1994 and 2001 to predict physical and cognitive disabilities. Results: Children with open or multiple fractures or closed fractures or injured by motor vehicles were 8.2, 3.5, or 2.5 times more likely, respectively, than those without those circumstances to have discharge physical disabilities. Likelihood of cognitive impairment was increased by factors of 3.2 and 5.8 in children obtunded or comatose on arrival. Preexisting cognitive deficits, injury severity, and intubation predicted physical and cognitive disabilities. The C statistic was 0.862 for the motor model and 0.860 for the cognitive model. Conclusion: Predicting the likelihood of morbidity after acute management of childhood TBI can provide information pertinent to providing effective care.	Cleveland Clin Childrens Hosp Rehabil, Rehabil Program, Cleveland, OH USA; Univ Penn, Dept Rehabil Med, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Clin Epidemiol Unit, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Biostat & Epidemiol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Div Pediat Metab & Rehabil, Philadelphia, PA 19104 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Wechsler, B (corresponding author), Cleveland Clin Childrens Hosp, Pediat Rehabil Program, 2801 Martin Luther King,Jr,Dr, Cleveland, OH 44104 USA.	wechsleb@ccf.org					Alaranta H, 2000, Wien Med Wochenschr, V150, P444; *AM AC PED, 2000, MED HOM IN CHILDR SP; Anderson SW, 1999, NAT NEUROSCI, V2, P1032; Beattie T F, 1998, Inj Prev, V4, P228; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Broman S. H., 1995, TRAUMATIC HEAD INJUR; BUCKLEY SL, 1994, J PEDIATR ORTHOPED, V14, P449, DOI 10.1097/01241398-199407000-00005; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Deutsch A, 1996, CRIT REV PHYS REHABI, V8, P267; Fern KT, 1998, J TRAUMA, V45, P489, DOI 10.1097/00005373-199809000-00010; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fuhrer MJ, 1987, REHABILITATION OUTCO, P137; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; GOTSCHALL CS, 1995, J NEUROTRAUM, V12, P611, DOI 10.1089/neu.1995.12.611; Grisoni E, 2001, J TRAUMA, V50, P1106, DOI 10.1097/00005373-200106000-00021; HALEY SM, 1992, PEDIAT EVALUATION DI; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Langlois JA, 2000, TRAUMATIC BRAIN INJU; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MASSAGLI TL, 1994, PEDIATR ANN, V23, P29, DOI 10.3928/0090-4481-19940101-08; Max JE, 1998, BRAIN INJURY, V12, P31; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; *NAT HEAD INJ FDN, 1981, SIL EP; *NIH, 1998, REH PERS TRAUM BRAIN, V16, P1; NORUSIS MJ, 2002, SPSS REGR MOD 10 0; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Randolph AG, 1998, CRIT CARE MED, V26, P1603, DOI 10.1097/00003246-199809000-00036; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Ruttimann UE, 1996, CRIT CARE MED, V24, P78, DOI 10.1097/00003246-199601000-00014; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; *STAT U NEW YORK B, 1998, WEEF SYST CLIN GUID; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Tepas JJ, 1997, J TRAUMA, V43, P258, DOI 10.1097/00005373-199708000-00009; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; *US DEP HHS, 1996, INT CLASS DIS; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; WESSON DE, 1989, J TRAUMA, V29, P589, DOI 10.1097/00005373-198905000-00008; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	64	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2005	58	5					940	949		10.1097/01.TA.0000162630.78386.98			10	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	932PU	WOS:000229566600015	15920407				2021-06-18	
J	Platt, SR; Abramson, CJ; Garosi, LS				Platt, SR; Abramson, CJ; Garosi, LS			Administering corticosteroids in neurologic diseases	COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; GRANULOMATOUS MENINGOENCEPHALOMYELITIS; BACTERIAL-MENINGITIS; CONTROLLED TRIAL; METHYLPREDNISOLONE; DOGS; NALOXONE	The main pharmacologic effects of glucocorticosteroids pertain to their antiinflammatory properties, immunosuppressive effects, and potential tumoricidal role. Central nervous system (CNS) trauma involves multiple and complex pathophysiologic processes that may benefit from corticosteroid administration. Unfortunately, clinical trials of these drugs have not proven that they have a definitive or superior role in treating CNS trauma. CNS inflammation may be infectious, but in many cases a specific pathogen is not confirmed as the cause; in either case, patients may benefit from the actions of steroids in the initial period. Other neurologic diseases, such as cerebrovascular disease, may not benefit from corticosteroid therapy, whereas for some types of neurologic neoplasia, it may be the only beneficial treatment available.	Anim Hlth Trust, Ctr Small Anim Studies, Newmarket, Suffolk, England; Ohio State Univ, Columbus, OH 43210 USA	Platt, SR (corresponding author), Anim Hlth Trust, Ctr Small Anim Studies, Newmarket, Suffolk, England.						Adams R. D., 1997, PRINCIPLES NEUROLOGY; ADDIE DD, 1998, INFECT DIS DOG CAT, P58; Bazarian JJ, 2002, ANN EMERG MED, V40, P515, DOI 10.1067/mem.2002.128780; Behrend EN, 1997, VET CLIN N AM-SMALL, V27, P187, DOI 10.1016/S0195-5616(97)50027-1; Bergamini E, 2003, BIOGERONTOLOGY, V4, P337, DOI 10.1023/B:BGEN.0000006637.48753.07; Boothe D. M., 2001, SMALL ANIMAL CLIN PH, P313; BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BRACKEN MB, 1997, JAMA-J AM MED ASSOC, V277, P1507; BROWN SA, 1992, J AM VET MED ASSOC, V200, P1849; Carlson GD, 2003, J BONE JOINT SURG AM, V85A, P95, DOI 10.2106/00004623-200301000-00015; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; DELATTRE J, 1998, NEUROSURGERY, V22, P1005; DeVita VT, 1997, CANC PRINCIPLES PRAC; Dewey CW, 2000, VET CLIN N AM-SMALL, V30, P207, DOI 10.1016/S0195-5616(00)50010-2; DEWEY CW, 2003, P 21 ACVIM ANN FOR; FENNER WR, 1998, INFECT DIS DOG CAT, P647; FOSTER ES, 1988, J VET INTERN MED, V2, P71, DOI 10.1111/j.1939-1676.1988.tb02796.x; FUNDER JW, 1992, J STEROID BIOCHEM, V43, P389, DOI 10.1016/0960-0760(92)90074-S; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GREENE CE, 1998, INFECT DIS DOG CAT, P9; HALL ED, 1995, J NEUROTRAUM, V12, P245, DOI 10.1089/neu.1995.12.245; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; HAN YY, 2002, ACTA ANAESTHESIOL SI, V40, P53; Harrington ML, 1996, VET CLIN N AM-SMALL, V26, P843, DOI 10.1016/S0195-5616(96)50108-7; JOHNSON JA, 2000, KIRKS CURRENT VET TH, V13, P178; Kabat A G, 1996, Optom Clin, V5, P153; KATO A, 1985, J NEUROSURG, V63, P260, DOI 10.3171/jns.1985.63.2.0260; KOEHLER PJ, 1995, ANTI-CANCER DRUG, V6, P19, DOI 10.1097/00001813-199502000-00002; Kraus KH, 1996, SEMIN VET MED SURG, V11, P201; MacDonald J. M., 2000, Textbook of veterinary internal medicine: diseases of the dog and cat, Volumes 1 and 2., P307; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; McIntyre PB, 1997, JAMA-J AM MED ASSOC, V278, P925, DOI 10.1001/jama.278.11.925; Munana KR, 1998, J AM VET MED ASSOC, V212, P1902; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Neer TM, 1998, INFECT DIS DOG CAT, P139; Neiger R, 2000, J VET INTERN MED, V14, P33, DOI 10.1892/0891-6640(2000)014&lt;0033:GMLIDW&gt;2.3.CO;2; Nuhsbaum MT, 2002, VET OPHTHALMOL, V5, P29, DOI 10.1046/j.1463-5224.2002.00215.x; Olby N, 1999, J VET INTERN MED, V13, P399, DOI 10.1892/0891-6640(1999)013&lt;0399:CCITMO&gt;2.3.CO;2; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Payne RS, 2003, BRAIN RES, V971, P9, DOI 10.1016/S0006-8993(03)02276-5; Platt SR, 2003, J AM ANIM HOSP ASSOC, V39, P337, DOI 10.5326/0390337; PLATT SR, 2003, P 16 ANN ECVN S; Qizilbash N., 2002, COCHRANE DATABASE SY, V2; Thomas WB, 1998, CLIN TECH SMALL AN P, V13, P167, DOI 10.1016/S1096-2867(98)80038-8; TIPOLD A, 2000, KIRKS CURRENT VET TH, V13, P978; TURREL JM, 1984, J AM VET MED ASSOC, V184, P82; VANDEVELDE M, 1998, INFECT DIS DOG CAT, P530; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	52	16	17	0	5	VETERINARY LEARNING SYSTEMS	YARDLEY	780 TOWNSHIP LINE RD, YARDLEY, PA 19067-4200 USA	0193-1903			COMP CONT EDUC PRACT	Compend. Contin. Educ. Pract. Vet.	MAR	2005	27	3					210	+					12	Veterinary Sciences	Veterinary Sciences	909YV	WOS:000227897500011					2021-06-18	
J	Syring, RS				Syring, RS			Assessment and treatment of central nervous system abnormalities in the emergency patient	VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE; INTRACRANIAL-PRESSURE; PULMONARY-EDEMA; DOGS; CATS; RESUSCITATION; HYPERTENSION; INCREASES; SEIZURES	Disease of or injury to the central nervous system is a common reason for hospital admission on an emergency basis in veterinary medicine. Head injuries, seizures, and diseases that lead to intracranial hypertension frequently result in significant alteration of neurologic function. A thorough understanding of the pathophysiologic disturbances that occur during these conditions is paramount for providing stabilizing emergent care. A detailed approach that focuses on meticulous physical evaluation, provision of timely and optimal stabilizing treatment, and continued monitoring can aid in improving outcomes in animals with signs and symptoms of neurologic disease or injury.	Univ Penn, Ryan Vet Hosp, Sch Vet Med, Dept Clin Studies,Sect Crit Care, Philadelphia, PA 19104 USA	Syring, RS (corresponding author), Univ Penn, Ryan Vet Hosp, Sch Vet Med, Dept Clin Studies,Sect Crit Care, 3900 Delancey St, Philadelphia, PA 19104 USA.	resyring@vet.upenn.edu					Angle N, 1998, J TRAUMA, V45, P7, DOI 10.1097/00005373-199807000-00002; Bagley RS, 1996, COMP CONT EDUC PRACT, V18, P605; Bazarian JJ, 2002, ANN EMERG MED, V40, P515, DOI 10.1067/mem.2002.128780; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P513; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; BUSIJA DW, 1980, CIRC RES, V46, P696, DOI 10.1161/01.RES.46.5.696; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Drobatz K. J., 2000, Kirk's current veterinary therapy XIII: small animal practice., P810; DROBATZ KJ, 1995, J AM VET MED ASSOC, V206, P1732; Fenner W. R., 2000, Textbook of veterinary internal medicine: diseases of the dog and cat, Volumes 1 and 2., P552; GANONG WF, 1997, REV MED PHYSL, P553; Gutin P H, 1977, Natl Cancer Inst Monogr, V46, P151; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; Johnston SC, 1996, EPILEPSIA, V37, P428, DOI 10.1111/j.1528-1157.1996.tb00587.x; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KRAMER GC, 1986, SURGERY, V100, P239; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; MIZOI K, 1986, Neurological Research, V8, P75; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; OLIVERJr J. E., 1997, HDB VET NEUROLOGY, P274; Platt SR, 2000, AM J VET RES, V61, P651, DOI 10.2460/ajvr.2000.61.651; Platt SR, 2002, J SMALL ANIM PRACT, V43, P151, DOI 10.1111/j.1748-5827.2002.tb00047.x; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Podell M, 1996, VET CLIN N AM-SMALL, V26, P779, DOI 10.1016/S0195-5616(96)50105-1; PODELL M, 1995, J VET INTERN MED, V9, P68, DOI 10.1111/j.1939-1676.1995.tb03275.x; PROVENCIO JJ, 1998, NEUROLOGIC NEUROSURG, P39; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; SHORES A, 1983, CURRENT VET THERAPY, P847; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Speciale J, 1999, J AM VET MED ASSOC, V214, P663; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521, DOI [10.1089/neu.2000.17.521, DOI 10.1089/NEU.2000.17.521]; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023	39	16	16	1	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0195-5616	1878-1306		VET CLIN N AM-SMALL	Vet. Clin. N. Am.-Small Anim. Pract.	MAR	2005	35	2					343	+		10.1016/j.cvsm.2004.10.007			17	Veterinary Sciences	Veterinary Sciences	901GQ	WOS:000227271400005	15698914				2021-06-18	
J	Urbahns, K; Goldmann, S; Kruger, J; Horvath, E; Schuhmacher, J; Grosser, R; Hinz, V; Mauler, F				Urbahns, K; Goldmann, S; Kruger, J; Horvath, E; Schuhmacher, J; Grosser, R; Hinz, V; Mauler, F			IKCa-channel blockers. Part 2: Discovery of cyclohexadienes	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						IKCa channel; potassium channel; cyclohexadiene; brain edema; water content; cerebral infarction; subdural hematoma; rat	CANNABINOID RECEPTOR AGONIST; K+ CHANNELS	Novel cyclohexadienes have been identified as potent and specific IKCa-channel blockers. In this communication we describe their synthesis as well as their chemical and biological properties. A selected derivative is being enriched in rat brain and reduces the infarct volume, intracranial pressure as well as the water content in a rat subdural hematoma model of traumatic brain injury after iv administration. (C) 2004 Elsevier Ltd. All rights reserved.	Bayer Hlth Care, Pharma Res Ctr, Inst Med Chem, D-42096 Wuppertal, Germany; Bayer Hlth Care, Pharma Res Ctr, Inst Res, CNS, D-42096 Wuppertal, Germany; Bayer Hlth Care, Pharma Res Ctr, Inst Pharmakokinet, D-42096 Wuppertal, Germany	Urbahns, K (corresponding author), AstraZeneca, R&D, Lund, Sweden.	klaus.urbahns@astrazeneca.com					[Anonymous], 1997, [No title captured], Patent No. 19612645; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; ELLORY JC, 1994, BRIT J PHARMACOL, V111, P903, DOI 10.1111/j.1476-5381.1994.tb14823.x; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P147; GOLDMANN S, 1985, Patent No. 3416293; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739; SCHWAB A, 1998, CURR RES ION CHANNEL, V3, P126; Urbahns K, 1998, SYNTHESIS-STUTTGART, P1807; Urbahns K, 2003, BIOORG MED CHEM LETT, V13, P2637, DOI 10.1016/S0960-894X(03)00560-2; URBAHNS K, 1996, Patent No. 698597	15	16	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X			BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JAN 17	2005	15	2					401	404		10.1016/j.bmcl.2004.10.063			4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	887ZU	WOS:000226344800030	15603962				2021-06-18	
J	Barrett, KF; Masel, B; Patterson, J; Scheibel, RS; Corson, KP; Mader, JT				Barrett, KF; Masel, B; Patterson, J; Scheibel, RS; Corson, KP; Mader, JT			Regional CBF in chronic stable TBI treated with hyperbaric oxygen.	UNDERSEA & HYPERBARIC MEDICINE			English	Article							CEREBRAL BLOOD-FLOW; CLOSED-HEAD-INJURY; ISCHEMIC PENUMBRA; BRAIN SPECT; STROKE; RECOVERY; THERAPY; TECHNETIUM-99M-HMPAO; PERFUSION	To investigate whether Hyperbaric Oxygen Therapy (HBO2) could improve neurologic deficits and regional cerebral blood flow (rCBF) in chronic traumatic brain injuries (TBI), the authors employed a nonrandomized control pilot trial. Five subjects, at least three years post head injury, received HBO2. Five head injured controls (HIC) were matched for age, sex, and type of injury. Five healthy subjects served as normal controls. Sixty-eight normal volunteers comprised a reference data bank against which to compare SPECT brain scans. HBO2 subjects received 120 HBO2 in blocks of 80 and 40 treatments with an interval five-month break. Normal controls underwent a single SPECT brain scan, HBO2, and repeat SPECT battery. TBI subjects were evaluated by neurologic, neuropsychometric, exercise testing, and pre and post study MRIs, or CT scans if MRI was contraindicated. Statistical Parametric Mapping was applied to SPECT scans for rCBF analysis. There were no significant objective changes in neurologic, neuropsychometric, exercise testing, MRIs, or rCBF. In this small pilot study, HBO2 did not effect clinical or regional cerebral blood flow improvement in TBI subjects.	Transit Learning Ctr, Galveston, TX USA; Univ Texas, Med Branch, Dept Psychiat, Galveston, TX 77550 USA; Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77550 USA; Univ Texas, Med Branch, Div Hyperbar Med, Galveston, TX 77550 USA	Barrett, KF (corresponding author), Transit Learning Ctr, Galveston, TX USA.						ARTRU F, 1976, EUR NEUROL, V14, P351, DOI 10.1159/000114759; Berrouschot J, 2000, STROKE, V31, P1545, DOI 10.1161/01.STR.31.7.1545; DIPIERO V, 1992, J NEUROL NEUROSUR PS, V55, P990, DOI 10.1136/jnnp.55.11.990; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; FRISTON KJ, 1995, HUM BRAIN MAPP, V0003, P00165, DOI DOI 10.1002/HBM.460030303; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; GRAHAM GD, 1992, STROKE, V23, P333, DOI 10.1161/01.STR.23.3.333; GRIM PS, 1990, JAMA-J AM MED ASSOC, V263, P2216; HAKIM AM, 1987, CAN J NEUROL SCI, V14, P557; Harch PG, 1994, UNDERSEA HYPERB ME S, V21, P30; HARCH PG, 1992, UNDERSEA BIOMED RES, V19, P42; HARRIS HS, 1997, ARCH PHYS MED REHAB, V78, P546; Havelius U, 1997, NEUROLOGY, V49, P1360, DOI 10.1212/WNL.49.5.1360; HOLMAN BL, 1992, J NUCL MED, V33, P1888; Jacobs A, 1996, J NUCL MED, V37, P1605; JAIN KK, 1999, TXB HYPERBARIC MED, P261; Laatsch L, 1997, BRAIN INJURY, V11, P851; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; Neubauer RA, 1998, NEUROL RES, V20, pS33; NEUBAUER RA, 1990, LANCET, V335, P542, DOI 10.1016/0140-6736(90)90777-3; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Patterson JC, 1997, J NUCL MED, V38, P1721; Shimosegawa E, 1997, J NUCL MED, V38, P791; Stamatakis EA, 1999, NEUROIMAGE, V10, P397, DOI 10.1006/nimg.1999.0477; Stockbridge HL, 2002, NUCL MED COMMUN, V23, P537, DOI 10.1097/00006231-200206000-00005; TALAIRACH J, 1988, PLANAR STEREOTACTIC; TERYAMA Y, 1991, SURG NEUROL, V36, P335; Umile EM, 1998, BRAIN INJURY, V12, P577; VOSTRUP S, 1986, ACTA NEUROL SCAND, V74, P439	31	16	17	0	2	UNDERSEA & HYPERBARIC MEDICAL SOC INC	KENSINGTON	10531 METROPOLITAN AVE, KENSINGTON, MD 20895 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	WIN	2004	31	4					395	406					12	Marine & Freshwater Biology; Medicine, Research & Experimental	Marine & Freshwater Biology; Research & Experimental Medicine	884IA	WOS:000226076900003	15686271				2021-06-18	
J	Phipps, E; Harris, D; Brown, N; Harralson, T; Brecher, A; Polansky, M; Whyte, J				Phipps, E; Harris, D; Brown, N; Harralson, T; Brecher, A; Polansky, M; Whyte, J			Investigation of ethnic differences in willingness to enroll in a rehabilitation research registry - A Study of the Northeast Cognitive Rehabilitation Research Network	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						research subjects; research Enrollment; ethnicity; brain injury	MINORITY RECRUITMENT; AFRICAN-AMERICANS; PARTICIPATION; TRIAL; PROSTATE; PATIENT; LUNG	Objective: To investigate differences between African American and white respondents in willingness to enroll in a rehabilitation research registry for future research and to determine if reasons for consenting and refusing to enroll differ by ethnicity. Design: Inpatient recruitment results from 739 African American and white respondents in which patients were admitted to a rehabilitation hospital with a diagnosis of stroke or traumatic brain injury. Results: A similar proportion of African American and white respondents (both patients and surrogates) consented to enroll in the registry (72% of all African American respondents vs. 68% of all white respondents). African Americans and whites provided similar reasons for consenting and refusing to enroll. Demographic variables associated with consent were: higher education, younger age, and facility. The odds of consenting to enroll in the registry were 5 times as high for those who thought they had a great deal to gain from enrollment compared with those who thought they had less to gain and were nearly 2 times as high for those who reported little concern about privacy compared with those who were more concerned about privacy. Conclusions: Ethnicity was not found to be a predictor of willingness to enroll in a study registry. A greater belief of gain and less concern over privacy were associated with willingness to enroll, even after controlling for age, education, facility, and ethnic group.	Thomas Jefferson Univ, Ctr Urban Hlth Policy & Res, Albert Einstein Healthcare Network, Philadelphia, PA 19144 USA; Moss Rehabil Res Inst, Philadelphia, PA USA; Drexel Univ, Sch Publ Hlth, Philadelphia, PA USA	Phipps, E (corresponding author), Thomas Jefferson Univ, Ctr Urban Hlth Policy & Res, Albert Einstein Healthcare Network, 1 Penn Blvd,Wister 4442, Philadelphia, PA 19144 USA.			Whyte, John/0000-0002-4381-1474	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD39621] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039621] Funding Source: NIH RePORTER		APPELBAUM PS, 1987, INFORMED CONSENT LEG, P237; Blackmer J, 2003, BMC MED ETHICS, V4, P2, DOI DOI 10.1186/1472-6939-4-2; BRANDT AM, 1978, HASTINGS CENT REP, V8, P21, DOI 10.2307/3561468; Brown DR, 2003, GERONTOLOGIST, V43, P62, DOI 10.1093/geront/43.1.62; Cheng JD, 2000, J CLIN ONCOL, V18, P421, DOI 10.1200/JCO.2000.18.2.421; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Freeman H P, 1993, Ann Epidemiol, V3, P145; Giuliano AR, 2000, ANN EPIDEMIOL, V10, pS22, DOI 10.1016/S1047-2797(00)00195-2; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; KAPLAN SH, 1995, MED CARE, V33, P1176, DOI 10.1097/00005650-199512000-00002; Karlawish JHT, 2002, J AM GERIATR SOC, V50, P2019, DOI 10.1046/j.1532-5415.2002.50615.x; Kressin Nancy R., 2000, Journal of the National Medical Association, V92, P62; Levkoff S, 2003, GERONTOLOGIST, V43, P18, DOI 10.1093/geront/43.1.18; MILLONUNDERWOOD S, 1993, CANCER NURS, V16, P25; Moye LA, 2002, J NATL MED ASSOC, V94, P272; Phipps Etienne, 1999, Account Res, V6, P215, DOI 10.1080/08989629908573929; ROBERSON NL, 1994, CANCER, V74, P2687, DOI 10.1002/1097-0142(19941101)74:9+<2687::AID-CNCR2820741817>3.0.CO;2-B; Sengupta S, 2000, J ACQ IMMUN DEF SYND, V24, P275; Seto B, 2001, AM J MED SCI, V322, P246, DOI 10.1097/00000441-200111000-00002; Shavers VL, 2002, ANN EPIDEMIOL, V12, P248, DOI 10.1016/S1047-2797(01)00265-4; Simpson NK, 2000, CONTROL CLIN TRIALS, V21, p356S, DOI 10.1016/S0197-2456(00)00102-1; Stallings FL, 2000, CONTROL CLIN TRIALS, V21, p379S, DOI 10.1016/S0197-2456(00)00093-3; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Vastag B, 2003, JAMA-J AM MED ASSOC, V289, P536, DOI 10.1001/jama.289.5.536	25	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	2004	83	12					875	883		10.1097/01.PHM.0000143436.57173.E1			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	874HB	WOS:000225340400001	15624565				2021-06-18	
J	Lobello, SG; Underhill, AT; Fine, PR				Lobello, SG; Underhill, AT; Fine, PR			The reliability and validity of the Life Satisfaction Index-A with survivors of traumatic brain injury	BRAIN INJURY			English	Article							SPINAL-CORD-INJURY; COMMUNITY	Primary objective: To investigate the internal consistency, long-term stability and validity of the Life Satisfaction Index-A (LSI-A) in a sample of survivors of traumatic brain injury (TBI). Research design: Cohort study. Methods and procedures: LSI-A was administered to survivors of TBI at 12, 24, 48 and 60 months post-injury during telephone interviews. Participants rated their quality of life, independence and participation in activities as well as health status at 24 months. Internal consistency was evaluated with Coefficient alpha. Pearson's r was used to investigate score stability. Test validity was explored with Pearson's r and Analysis of Covariance with age and sex as covariates. Experimental interventions: None. Main outcomes and results: Coefficient alphas ranged from 0.85-0.92. Test re-test coefficients ranged from 0.42-0.77. The LSI-A was positively correlated with self-reported quality of life, independence, activity level and health status. Conclusions: The LSI-A is a reliable and valid measure of the construct of life satisfaction among survivors of TBI.	Auburn Univ, Dept Psychol, Montgomery, AL 36124 USA; Univ Alabama, Sch Med, Injury Control Res Ctr, Birmingham, AL USA	Lobello, SG (corresponding author), Auburn Univ, Dept Psychol, POB 244023, Montgomery, AL 36124 USA.	slobello@mail.aum.edu			ODCDC CDC HHS [R49/CCR403641] Funding Source: Medline		ADAMS DL, 1969, J GERONTOL, V24, P470, DOI 10.1093/geronj/24.4.470; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; COHEN RJ, 1999, PSYCHOL TESTING ASSE, P151; *COMM INJ SCAL AM, 1985, ABBR INJ SCAL 1985 R; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; KAPLAN RM, 1989, PSYCHOL TESTING PRIN, P110; Kemp BJ, 1999, DISABIL REHABIL, V21, P241; LOBELLO SG, J REHABILITATION RES, V40, P293; LOHMANN N, 1977, J GERONTOL, V32, P73, DOI 10.1093/geronj/32.1.73; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; RAO V N, 1981, International Journal of Aging and Human Development, V14, P55, DOI 10.2190/DWM4-E05K-CNTD-XNAA; UNDERHILL AT, IN PRESS BRAIN INJUR; Wallace KA, 2002, EDUC PSYCHOL MEAS, V62, P674, DOI 10.1177/0013164402062004009; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9	17	16	18	1	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2004	18	11					1127	1134		10.1080/02699050410001672378			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	863JW	WOS:000224558900005	15545209				2021-06-18	
J	Munirathinam, S; Bahr, BA				Munirathinam, S; Bahr, BA			Repeated contact with subtoxic Soman leads to synaptic vulnerability in hippocampus	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						excitotoxicity; hippocampal slice culture; Soman; spectrin breakdown product; synaptic decline	AGENT-INDUCED SEIZURE; INDUCED BRAIN-DAMAGE; GLUTAMATE RECEPTORS; AMINO-ACIDS; SYNAPSIN-I; CALPAIN; MODEL; INDUCTION; RAT; INTOXICATION	Soman, an anticholinesterase and dangerous nerve agent, produces convulsions, memory impairment, and cell loss in the brain, especially in the hippocampus. Soman-induced accumulation of acetylcholine initiates mechanisms responsible for the development of incapacitating seizures. The prolonged epileptiform nature of these seizures causes the release of another excitatory neurotransmitter, glutamate, which has been linked to the toxic action of the nerve agent. Here, we tested whether subtoxic soman exposures influence the brain's sensitivity to glutamate-based excitotoxicity. Over a 1-week period, hippocampal slice cultures were exposed daily to a transient level of soman that produced no evidence of synaptic deterioration. After the subtoxic soman treatments, however, the tissue became vulnerable to a brief episode of glutamate receptor overstimulation that normally resulted in little or no excitotoxic damage. In those slice cultures treated with subtoxic soman, a decline in synaptic markers as well as an increase in spectrin breakdown occurred 24 hr after the mild excitotoxic event. Exposure to high soman concentrations alone produced similar synaptic degeneration, but without evident cell death, suggesting that synaptic decline is an early neurotoxicological response to the nerve agent. Interestingly, enhanced excitotoxic sensitivity caused the brain tissue to become susceptible to disparate insults initiated before or after the soman contact. These findings indicate that seemingly innocuous soman exposures leave the hippocampus sensitive to the types of insults implicated in traumatic brain injury and stroke. They also warn that asymptomatic contact with soman may lead to progressive synaptopathogenesis and that early indicators of soman exposure are critical to prevent potential brain injury. (C) 2004 Wiley-Liss, Inc.	Univ Connecticut, Dept Pharmaceut Sci, Ctr Drug Discovery, Storrs, CT 06269 USA	Bahr, BA (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Ctr Drug Discovery, Storrs, CT 06269 USA.	bahr@uconn.edu					BAHR BA, 1995, J PHARMACOL EXP THER, V273, P902; Bahr BA, 2002, EXP NEUROL, V174, P37, DOI 10.1006/exnr.2001.7852; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; BAHR BA, 1994, EXP NEUROL, V129, P81, DOI 10.1006/exnr.1994.1149; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; Bahr BA, 1996, NEUROSCIENCE, V74, P707, DOI 10.1016/0306-4522(96)00133-9; Bendiske J, 2002, J NEUROPATH EXP NEUR, V61, P640, DOI 10.1093/jnen/61.7.640; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; BROCK TO, 1987, J NEUROSCI, V7, P931; CARPENTIER P, 1991, BRAIN RES, V541, P293, DOI 10.1016/0006-8993(91)91030-5; Cowan FM, 2001, J APPL TOXICOL, V21, P293, DOI 10.1002/jat.757; de Groot DMG, 2001, J APPL TOXICOL, V21, pS57, DOI 10.1002/jat.812; DESHPANDE SS, 1995, ARCH TOXICOL, V69, P384, DOI 10.1007/s002040050188; FELDMAN RG, 1993, ARCH NEUROL-CHICAGO, V50, P1320, DOI 10.1001/archneur.1993.00540120035010; Filliat P, 1999, NEUROTOXICOLOGY, V20, P535; HARRY GJ, 1985, BRAIN RES, V326, P9, DOI 10.1016/0006-8993(85)91379-4; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Ishikawa K, 1997, BEHAV BRAIN RES, V83, P39, DOI 10.1016/S0166-4328(97)86043-3; Kalivas PW, 2001, NEUROSCIENCE, V104, P129, DOI 10.1016/S0306-4522(01)00054-9; KREYBERG S, 1992, CLIN NEUROPATHOL, V11, P256; LALLEMENT G, 1993, BRAIN RES, V618, P227, DOI 10.1016/0006-8993(93)91270-3; LALLEMENT G, 1991, BRAIN RES, V563, P234, DOI 10.1016/0006-8993(91)91539-D; LALLEMENT G, 1992, NEUROSCI LETT, V139, P104, DOI 10.1016/0304-3940(92)90868-8; LEMERCIER G, 1983, ACTA NEUROPATHOL, V61, P123, DOI 10.1007/BF00697391; MATTSON MP, 1990, NEURON, V4, P105, DOI 10.1016/0896-6273(90)90447-N; McDonough JH, 1997, NEUROSCI BIOBEHAV R, V21, P559, DOI 10.1016/S0149-7634(96)00050-4; Munirathinam S, 2002, TOXICOL APPL PHARM, V185, P111, DOI 10.1006/taap.2002.9534; MUNIRATHINAM S, 2002, TOXICOL SCI S, V58, P1551; Pavlovsky L, 2003, EXP NEUROL, V179, P181, DOI 10.1016/S0014-4886(02)00016-X; PAZDERNIK TL, 1985, NEUROSCIENCE, V14, P823, DOI 10.1016/0306-4522(85)90146-0; Raval AP, 2003, J NEUROSCI, V23, P384; Raveh L, 2003, TOXICOL SCI, V75, P108, DOI 10.1093/toxsci/kfg166; Raveh L, 2002, NEUROTOXICOLOGY, V23, P7, DOI 10.1016/S0161-813X(02)00005-0; Schaller B, 2002, J NEUROL, V249, P1503, DOI 10.1007/s00415-002-0933-8; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SIMAN R, 1989, J NEUROSCI, V9, P1579; Somani S. M, 2001, CHEM WARFARE AGENTS, V441; SPARENBORG S, 1992, NEUROPHARMACOLOGY, V31, P357, DOI 10.1016/0028-3908(92)90068-Z; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Taylor P., 2001, PHARM BASIS THERAPEU, Vtenth, P175; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1046/j.1365-2613.2000.00169.x; WADE JV, 1987, J NEUROCHEM, V49, P645, DOI 10.1111/j.1471-4159.1987.tb02912.x; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wenk GL, 1996, NEUROBIOL AGING, V17, P1, DOI 10.1016/0197-4580(95)02025-X; Wood SJ, 2001, J APPL TOXICOL, V21, pS83, DOI 10.1002/jat.817	45	16	16	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	SEP 1	2004	77	5					739	746		10.1002/jnr.20209			8	Neurosciences	Neurosciences & Neurology	852DL	WOS:000223735300014	15352221				2021-06-18	
J	Daley, ML; Pourcyrous, M; Timmons, SD; Leffler, CW				Daley, ML; Pourcyrous, M; Timmons, SD; Leffler, CW			Assessment of cerebrovascular autoregulation - Changes of highest modal frequency of cerebrovascular pressure transmission with cerebral perfusion pressure	STROKE			English	Article						cerebrovascular disorder; intracranial pressure; brain injuries	TRAUMATIC BRAIN-INJURY	Background and Purpose-Development of a method to continuously assess cerebrovascular autoregulation of patients with traumatic brain injury would facilitate therapeutic intervention and thus reduce secondary complications. Methods-Changes in arterial blood pressure (ABP), intracranial pressure (ICP), cerebral blood flow velocity (CBFV), and pial arteriolar diameter (PAD) induced by acute pressor challenge (norepinephrine; 1 mug/[kg.min]) were evaluated in both uninjured and fluid percussion injured piglets equipped with cranial windows. The linear correlation coefficient and corresponding slope of the regression line of the relationship between highest modal frequency (HMF) of cerebrovascular pressure transmission of ABP to ICP and cerebral perfusion pressure (CPP) were determined for each challenge. Results-For all uninjured piglets, pressor challenge resulted in an inverse relationship between HMF and CPP characterized by significant negative correlation values and negative corresponding regression line slopes with respective group mean values (+/-SD) of -0.50 (+/-0.14) and -0.6 (+/-0.44) Hz/mm Hg, respectively. Consistent with functional autoregulation of the uninjured preparations, pressor challenge resulted in a decrease of PAD, and CBFV remained relatively constant. For all injured piglets, pressor challenge resulted in direct relationship between HMF and CPP, characterized by positive correlation values and corresponding regression line slopes with group mean values of 0.48 (+/-0.21) and 1.13 (+/-2.08) Hz/mm Hg, respectively. Consistent with impaired autoregulation, PAD and CBFV increased during pressor challenge after brain injury. Conclusions-Evaluation of changes of the HMF of cerebrovascular pressure transmission with respect to CPP changes permits continuous monitoring of cerebral autoregulation.	Univ Memphis, Dept Elect & Comp Engn, Memphis, TN 38152 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Obstet Gynecol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA	Daley, ML (corresponding author), Univ Memphis, Dept Elect & Comp Engn, Engn Sci Bldg,Room 208B, Memphis, TN 38152 USA.	mdaley@memphis.edu					ANTSAKLIS JP, 1997, LINEAR SYSTEM, P94; Asano T, 1999, CRIT REV NEUROSURG, V9, P303, DOI 10.1007/s003290050147; Chestnut R. M., 1996, NEUROTRAUMA, P445; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Daley ML, 2003, MED ENG PHYS, V25, P679, DOI 10.1016/S1350-4533(03)00077-8; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; LJUNG L, 1991, SYSTEM IDENTIFICATIO, P8; Oertel M, 2002, ACT NEUR S, V81, P67; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696	11	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	AUG	2004	35	8					1952	1956		10.1161/01.STR.0000133690.94288.c9			5	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	840CZ	WOS:000222835900038	15205491	Bronze			2021-06-18	
J	Dziurdzik, P; Krawczyk, L; Jalowiecki, P; Kondera-Anasz, Z; Menon, L				Dziurdzik, P; Krawczyk, L; Jalowiecki, P; Kondera-Anasz, Z; Menon, L			Serum interleukin-10 in ICU patients with severe acute central nervous system injuries	INFLAMMATION RESEARCH			English	Article						interleukin-10; central nervous system; brain injury; intensive care	TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL ENDOTOXEMIA; CEREBROSPINAL-FLUID; PLASMA-LEVELS; HEAD-INJURY; RELEASE; IL-10; CHILDREN; BLOOD	Rationale:IL-10, the main anti-inflammatory cytokine, may play a pivotal role in cerebral inflammation implicated in the development of brain edema and secondary brain damage after injury. Aim of the study:1) Determining absolute IL-10 serum level and its pattern in critically ill patients with traumatic and non-traumatic acute brain injury. 2) Assessment of prognostic value of serum IL-10 in those patients. Materials and methods:Serum IL-10 levels in 46 adults (multi-profile ICU, teaching hospital) with traumatic brain injury (TBI, N = 18), nontraumatic intracranial hemorrhage (SAH, N = 11) and polytrauma with concomitant brain injury (POL, N = 17) were measured using ELISA. Relationship of IL-10 and initial diagnosis, clinical state, outcome and risk of infection development was evaluated. Results:IL-10 was detectable in the serum of all but one patient on ICU admission (56.6 +/- 91.9 pg/ml; mean +/- SD). No statistically significant differences in IL-10 between TBI, SAH and POL groups as well as between survivors and non-survivors on any day were found. No correlation between IL-10 and GCS or SAPS II was seen. Significant fall in serum IL-10 during the first 4 days of injury in patients of all subgroups was observed. Patients with initial serum IL-10 below 77pg/ml were at significantly higher risk of development of any infection within the first week of injury. Conclusions:After acute brain injury, serum IL-10 in adults is detectable independent of CNS lesion type. Its systemic release is strongly individualized. Serum IL-10 on ICU admission may have some prognostic value to predict development of infection in patients with CNS lesions.	Med Univ Silesia, Chair Anesthesiol Intens Therapy & Emergency Med, Clin Dept Anesthesiol & Intens Care, Katowice, Poland; Med Univ Silesia, Chair & Dept Immunol & Serol, PL-40074 Katowice, Poland	Dziurdzik, P (corresponding author), Wojewodzki Szpital Specjalisty 5, Oddzial Klin Anestezjol & Intensywnej Terapii SAM, Plac Medykow 1, PL-41200 Sosnowiec, Poland.	anestitsos@slam.katowice.pl		Kondera-Anasz, Zdzislawa/0000-0002-4137-0580			Bell MJ, 1997, ACT NEUR S, V70, P96; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DOCKE WD, 1997, SHOCK S, V8, P115; *END INC, HUM ELISA IL 10 KIT; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; GOLDMAN M, 1996, YB INTENSIVE CARE EM, P105; Heesen M, 1996, ACTA NEUROCHIR, V138, P77, DOI 10.1007/BF01411728; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lyons A, 1997, ANN SURG, V226, P450, DOI 10.1097/00000658-199710000-00006; Majetschak M, 2000, CRIT CARE MED, V28, P1847, DOI 10.1097/00003246-200006000-00027; MARCHANT A, 1994, EUR J IMMUNOL, V24, P1167, DOI 10.1002/eji.1830240524; Maskin B, 2001, MEDICINA-BUENOS AIRE, V61, P573; MEERT KL, 1995, CRIT CARE MED, V23, P822, DOI 10.1097/00003246-199505000-00008; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; Partrick DA, 1999, AM J SURG, V178, P564, DOI 10.1016/S0002-9610(99)00240-8; Pelidou SH, 1999, EUR J NEUROL, V6, P437, DOI 10.1046/j.1468-1331.1999.640437.x; Platzer C, 2000, J NEUROIMMUNOL, V105, P31, DOI 10.1016/S0165-5728(00)00205-8; Sherry RM, 1996, J TRAUMA, V40, P613, DOI 10.1097/00005373-199604000-00016; Shimonkevitz R, 1999, SHOCK, V12, P10, DOI 10.1097/00024382-199907000-00002; SPERA PA, 1998, NEUROSCI LETT, V51, P89; Taniguchi T, 1999, CRIT CARE MED, V27, P1262, DOI 10.1097/00003246-199907000-00005; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051	29	16	18	0	4	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	AUG	2004	53	8					338	343		10.1007/s00011-004-1265-1			6	Cell Biology; Immunology	Cell Biology; Immunology	846EH	WOS:000223297500001	15316663				2021-06-18	
J	Holmes, JF; Palchak, MJ; Conklin, MJ; Kuppermann, N				Holmes, JF; Palchak, MJ; Conklin, MJ; Kuppermann, N			Do children require hospitalization after immediate posttraumatic seizures?	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine	MAY, 2003	BOSTON, MA	Soc Acad Emergency Med			MINOR HEAD-INJURY; PREDICTORS; TRAUMA; RISK	Study objective: We determine whether children with immediate posttraumatic seizures require hospitalization for observation of possible neurologic complications. Methods: This was a prospective observational cohort study of children younger than 18 years with blunt head trauma resulting in immediate posttraumatic seizures. Patients were examined by faculty emergency physicians and underwent cranial computed tomography (CT) scanning. Children were divided into 2 cohorts according to the presence or absence of traumatic brain injury on cranial CT scan, with the a priori assumption that children with posttraumatic seizures who have abnormal cranial CT scan results require hospitalization. The outcomes of interest were neurologic complications (including further seizure activity or neurologic deficits) or the necessity for neurosurgical intervention. Medical records of hospitalized patients were reviewed, and patients discharged from the emergency department (ED) were contacted by telephone approximately 1 week after hospital discharge to identify those who developed short-term neurologic complications. Results: Sixty-three children with a median age of 7 years (interquartile range 3 to 14 years) had posttraumatic seizures, and all but 1 child underwent cranial CT imaging. Ten (16%; 95% confidence interval [CI] 8% to 27%) patients had traumatic brain injuries on CT scan, and all were hospitalized. Three of these 10 patients underwent craniotomy, and 2 patients had further seizure activity. Fifty-two patients had normal cranial CT scan results, and 20 patients were hospitalized for observation. Telephone follow-up was obtained in 31 of the 32 patients with normal CT scan results who were discharged from the ED. None of the 52 patients (0%; 95% CI 0% to 5.6%) with normal cranial CT scan results had further seizure activity or required neurosurgical interventions. Conclusion: Children with normal neurologic examination results and normal cranial CT scan results after immediate posttraumatic seizures are at low risk for further short-term complications that require immediate hospitalization. These children may be considered for discharge home from the ED.	Univ Calif Davis, Ctr Med, Div Emergency Med, Sacramento, CA 95817 USA; Univ Calif Dave, Sch Med, Dept Internal Med, Sacramento, CA USA; Univ Calif Dave, Sch Med, Dept Pediat, Sacramento, CA USA	Holmes, JF (corresponding author), Univ Calif Davis, Ctr Med, Div Emergency Med, PSSB 2100,2315 Stockton Blvd, Sacramento, CA 95817 USA.	jfholmes@ucdavis.edu					Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; GRAND W, 1974, J NEUROL NEUROSUR PS, V37, P178, DOI 10.1136/jnnp.37.2.178; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; ROS S P, 1989, Pediatric Emergency Care, V5, P216, DOI 10.1097/00006565-198912000-00003; Spencer MT, 2003, AM J EMERG MED, V21, P111, DOI 10.1053/ajem.2003.50031	10	16	16	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	2004	43	6					706	710		10.1016/j.annemergmed.2003.11.008			5	Emergency Medicine	Emergency Medicine	825JT	WOS:000221753700002	15159700				2021-06-18	
J	Mendez, DR; Cherian, L; Moore, N; Arora, T; Liu, PK; Robertson, CS				Mendez, DR; Cherian, L; Moore, N; Arora, T; Liu, PK; Robertson, CS			Oxidative DNA lesions in a rodent model of traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						oxidative DNA damage; oxidative DNA lesions; traumatic brain injury	CORTICAL IMPACT INJURY; NITRIC-OXIDE SYNTHASE; FOREBRAIN ISCHEMIA-REPERFUSION; ALZHEIMERS-DISEASE; CELL-DEATH; RAT-BRAIN; STRAND BREAKS; MOUSE-BRAIN; IN-VIVO; DAMAGE	Background: Oxidative DNA lesions have not been well studied in traumatic brain injury (TBI). Methods: TBI was induced with a controlled cortical impact injury in rats. Brain tissue was examined for 8-hydroxy-2'-deoxyguanosine (oh8dG) using monoclonal antibodies at different time frames; 15 minutes (n = 4), 30 minutes (n = 7), 60 minutes (n = 6), and 240 minutes (n = 5). The control group consisted of sham-operated animals undergoing the same surgery without the controlled cortical impact injury (n = 5). Results: An elevation of oh8dG was detected in the nuclear and perinuclear (mitochondrial) regions of the ipsilateral cortex, but seldom in those of the contralateral cortex. The amount of oh8dG in those animals with TBI was significant in all time frames when compared with sham-operated controls (p < 0.001). The oh8dG levels were more prominent at 15 minutes (p < 0.0001) when compared with controls. Conclusion: Oxidative DNA lesions occurred in this model of TBI maximally early after TBI. This suggests that oh8dGs may affect genetic material of the brain and that oh8dGs may adversely affect gene expression that occurs early after head injury.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Neuroradiol,Dept Radiol, Charlestown, MA USA	Mendez, DR (corresponding author), Baylor Coll Med, Dept Pediat, 6621 Fannin St,Room A210, Houston, TX 77030 USA.	drmendez@texaschildrenshospital.org			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045845, R01NS034810, P01NS038660] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS034810-04S1, NS045845, R01 NS045845-01, NS38660, R01 NS034810-04, NS34810, R01 NS045845] Funding Source: Medline		ALTHAUS JS, 1993, MOL CHEM NEUROPATHOL, V20, P147, DOI 10.1007/BF02815368; Bogdanov M, 2000, FREE RADICAL BIO MED, V29, P652, DOI 10.1016/S0891-5849(00)00349-X; BREEN AP, 1995, BIOL MED, V118, P1033; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Cameron P, 1995, AUST NZ J SURG, V65, P848, DOI 10.1111/j.1445-2197.1995.tb00574.x; *CDC, 1988, INJ CONTR, P244; *CDC, 1982, MMWR-MORBID MORTAL W, V31, P599; Chen J, 1997, J NEUROCHEM, V69, P232; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Clark RSB, 1997, J NEUROSCI, V17, P9172; Conti AC, 1998, J NEUROSCI, V18, P5663; Cui JK, 2000, FASEB J, V14, P955; Cui JK, 1999, J NEUROCHEM, V73, P1164, DOI 10.1046/j.1471-4159.1999.0731164.x; DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O; Doder M, 1999, J NEUROL NEUROSUR PS, V66, P380, DOI 10.1136/jnnp.66.3.380; Fabian RH, 1998, J NEUROTRAUM, V15, P433, DOI 10.1089/neu.1998.15.433; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hayashi T, 1999, BRAIN RES, V832, P159, DOI 10.1016/S0006-8993(99)01409-2; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Huang DY, 2000, FASEB J, V14, P407; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Lin LH, 2000, J NEUROCHEM, V74, P1098; Liu PK, 2001, TRENDS NEUROSCI, V24, P581, DOI 10.1016/S0166-2236(00)01918-4; Liu PK, 1996, J NEUROSCI, V16, P6795; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Mesenge C, 1996, J NEUROTRAUM, V13, P11, DOI 10.1089/neu.1996.13.11; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Nunomura A, 1999, J NEUROSCI, V19, P1959; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; PARK EM, 1992, P NATL ACAD SCI USA, V89, P3375, DOI 10.1073/pnas.89.8.3375; RINK A, 1995, AM J PATHOL, V147, P1575; Schulz JB, 1995, J NEUROSCI, V15, P8419; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Won MH, 1999, BRAIN RES, V836, P70, DOI 10.1016/S0006-8993(99)01611-X; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	48	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2004	56	6					1235	1240		10.1097/01.TA.0000130759.62286.0E			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	839UT	WOS:000222811100013	15211131				2021-06-18	
J	Vakil, E; Blachstein, H; Rochberg, J; Vardi, M				Vakil, E; Blachstein, H; Rochberg, J; Vardi, M			Characterization of memory impairment following closed-head injury in children using the Rey Auditory Verbal Learning Test (AVLT)	CHILD NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DEVELOPMENTAL NORMS; RETRIEVAL; SEVERITY; RECOVERY; DISSOCIATION; SENSITIVITY; COMPONENTS	Memory impairment following closed-head injury (CHI) in children is well documented. Characterization of the memory deficits of children with CHI could contribute to the prediction of academic performance and rehabilitation of these children. Twenty-five children who sustained closed-head injury and 25 matched controls were administered the Rey Auditory Verbal Learning Test (AVLT). The advantage of this memory test is that a number of memory components are measured simultaneously, thus enabling us to study the relations between different aspects of memory within the same patient sample. The findings indicate that the Rey AVLT is a good test for characterization of impaired verbal memory in children following CHI. Transformation of scores derived from the Rey AVLT to Z-scores enables us to determine the relative effect of CHI in children on different memory scores. Raw scores were more vulnerable than relational ones, derived as the difference between two raw scores (e.g., learning, Trial 5 - 1), to closed-head injury in children, and scores reflecting word span were the least vulnerable. The results are discussed in terms of the possible contribution of the frontal lobes, which are frequently affected in closed-head injuries, to memory performance.	Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; Loewenstein Hosp & Rehabil Ctr, Raanana, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	vakile@mail.biu.ac.il					Bishop J., 1990, CLIN NEUROPSYCHOL, V4, P133, DOI DOI 10.1080/13854049008401506; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Dalla Barba G, 2002, J CLIN EXP NEUROPSYC, V24, P633, DOI 10.1076/jcen.24.5.633.1008; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 1989, CALIFORNIA VERBAL LE; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Duchnick JJ, 2002, J CLIN EXP NEUROPSYC, V24, P840, DOI 10.1076/jcen.24.6.840.8405; Forrester G., 1991, CLIN NEUROPSYCHOL, V5, P345, DOI DOI 10.1080/13854049108404102; GEFFEN GM, 1994, BRAIN INJURY, V8, P405, DOI 10.3109/02699059409150992; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLATZKY RL, 1980, HUMAN MEMORY; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Moscovitch M., 1989, VARIETIES MEMORY CON, P133; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Stuss D.T., 1986, FRONTAL LOBES; Vakil E, 2002, BRAIN COGNITION, V50, P304, DOI 10.1016/S0278-2626(02)00515-8; Vakil E, 1998, CHILD NEUROPSYCHOL, V4, P161, DOI 10.1076/chin.4.3.161.3173; Vakil E, 1997, CLIN NEUROPSYCHOL, V11, P356, DOI 10.1080/13854049708400464; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; VAKIL E, 1994, J CLIN PSYCHOL, V50, P240, DOI 10.1002/1097-4679(199403)50:2<240::AID-JCLP2270500215>3.0.CO;2-5; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 1991, WECHSLER INTELLIGENC; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	38	16	16	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JUN	2004	10	2					57	66		10.1080/09297040490911078			10	Clinical Neurology	Neurosciences & Neurology	863TN	WOS:000224586100001	15590485				2021-06-18	
J	Small, SL				Small, SL			A biological model of aphasia rehabilitation: Pharmacological perspectives	APHASIOLOGY			English	Article; Proceedings Paper	33rd Annual Clinical Aphasiology Conference	MAY, 2003	Orcas Isl, WA				MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN INJURY; ACUTE ISCHEMIC-STROKE; MOTOR RECOVERY; DOUBLE-BLIND; POSTSTROKE DEPRESSION; BEHAVIORAL RECOVERY; FUNCTIONAL RECOVERY; OPEN-LABEL; BROMOCRIPTINE TREATMENT	Background: Aphasia is a multi-modality disturbance of speech, language, and memory caused by neurological injury, particularly stroke. Aims : This review article views aphasia as fundamentally a disease of the brain, and aims to survey biological treatments for aphasia that address amelioration of brain injury. Main Contribution: The review examines the effects of different drugs on both direct and indirect mechanisms of neural circuit reorganisation, gauged through effects on multi-modal measures of speech, language, and memory. Based on this review, therapists might choose to analyse and change the pharmacological state of their patients with aphasia. Conclusions: We conclude that (a) both biological and behavioural therapies affect brain repair and reorganisation; (b) pharmacotherapy is not yet proven, but has promise, but only when accompanied by concomitant behavioural therapy; (c) the most important biological interventions that can be accomplished at present are to withdraw certain drugs that impede aphasia recovery and to administer anti-depressants to all patients with major or minor post-stroke depression.	Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	Small, SL (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave,MC-2030, Chicago, IL 60637 USA.	small@uchicago.edu		Small, Steven/0000-0002-5293-6172			AARSLAND D, 1994, BRAIN, V117, P1377, DOI 10.1093/brain/117.6.1377; ALBERT ML, 1988, NEUROLOGY, V38, P877, DOI 10.1212/WNL.38.6.877; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; BERGMAN PS, 1951, NEUROLOGY, V1, P471, DOI 10.1212/WNL.1.11-12.471; Berthier ML, 2003, NEUROLOGY, V60, P1218, DOI 10.1212/01.WNL.0000055871.82308.41; BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; BOYESON MG, 1994, AM J PHYS MED REHAB, V73, P76, DOI 10.1097/00002060-199404000-00002; Boyeson MG, 1996, STROKE, V27, P2145; BOYESON MG, 1984, ANN M SOC NEUROSCIEN, V10, P68; BRACCO L, 1984, NEUROSCI LETT, V50, P301, DOI 10.1016/0304-3940(84)90503-2; Bragoni M, 2000, NEUROL SCI, V21, P19, DOI 10.1007/s100720070114; BROWN RM, 1974, ACTA PHYSIOL SCAND, V90, P789, DOI 10.1111/j.1748-1716.1974.tb05647.x; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; *CEBM, 2003, VOL 2003; CLARK ANG, 1979, J AM GERIATR SOC, V27, P174, DOI 10.1111/j.1532-5415.1979.tb06442.x; COHEN HP, 1975, J NEUROSURG, V43, P32, DOI 10.3171/jns.1975.43.1.0032; Connors John J 3rd, 2002, Rev Cardiovasc Med, V3 Suppl 2, pS92; CRISOSTOMO EA, 1988, ANN NEUROL, V23, P94, DOI 10.1002/ana.410230117; DARLEY FL, 1977, CLIN APHASIOL, V7, P91; De Keyser J, 1999, TRENDS NEUROSCI, V22, P535, DOI 10.1016/S0166-2236(99)01463-0; DeDeyn PP, 1997, STROKE, V28, P2347, DOI 10.1161/01.STR.28.12.2347; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DOWNHILL JE, 1994, J NERV MENT DIS, V182, P425, DOI 10.1097/00005053-199408000-00001; ENDERBY P, 1994, CLIN NEUROPHARMACOL, V17, P320, DOI 10.1097/00002826-199408000-00003; FEENEY DM, 1985, BRAIN RES, V342, P352, DOI 10.1016/0006-8993(85)91135-7; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1983, PSYCHOPHARMACOLOGY, V79, P67, DOI 10.1007/BF00433018; FERE C, 1886, REV GEN CLIN THERAPE, V785; Friel KM, 1998, SOMATOSENS MOT RES, V15, P173, DOI 10.1080/08990229870745; Fruehwald S, 2003, J NEUROL, V250, P347, DOI 10.1007/s00415-003-1014-3; GIL R, 1995, J NEUROL, V242, P251, DOI 10.1007/BF00919600; Giurgea C E, 1983, Acta Psychiatr Belg, V83, P349; GOLDBERG E, 1982, Journal of Clinical Neuropsychology, V4, P219, DOI 10.1080/01688638208401131; Goldstein Larry B, 2003, Phys Med Rehabil Clin N Am, V14, pS125, DOI 10.1016/S1047-9651(02)00060-8; Goldstein LB, 2000, NEUROPHARMACOLOGY, V39, P852, DOI 10.1016/S0028-3908(99)00249-X; Goldstein LB, 1999, REV NEUROL-FRANCE, V155, P731; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; Goldstein LB, 1998, RESTORATIVE NEUROLOGY, P241; GOLDSTEIN LB, 1987, ANN NEUROL, V22, P159; Goldstein LB, 1997, PHARMACOL BIOCHEM BE, V58, P1151, DOI 10.1016/S0091-3057(97)00324-9; Goldstein LB, 1998, ARCH NEUROL-CHICAGO, V55, P454, DOI 10.1001/archneur.55.4.454; Goldstein LB, 2000, DRUG SAFETY, V22, P13, DOI 10.2165/00002018-200022010-00002; Grade C, 1998, ARCH PHYS MED REHAB, V79, P1047, DOI 10.1016/S0003-9993(98)90169-1; Greener J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD000424]; GROTTA JC, 1987, NEW ENGL J MED, V317, P1505, DOI 10.1056/NEJM198712103172405; Gupta SR, 1995, NEUROLOGY, V45, P2170, DOI 10.1212/WNL.45.12.2170; GUPTA SR, 1992, ARCH PHYS MED REHAB, V73, P373, DOI 10.1016/0003-9993(92)90012-L; GUSTAFSON Y, 1995, DRUG AGING, V7, P298, DOI 10.2165/00002512-199507040-00005; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Helmuth L, 2003, SCIENCE, V299, P1300, DOI 10.1126/science.299.5611.1300; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; Huber W, 1997, ARCH PHYS MED REHAB, V78, P245, DOI 10.1016/S0003-9993(97)90028-9; Huber W, 1999, PHARMACOPSYCHIATRY, V32, P38, DOI 10.1055/s-2007-979235; Hughes JD, 2000, BRAIN LANG, V71, P96, DOI 10.1006/brln.1999.2223; Jacobs DH, 1996, NEUROCASE, V2, P83; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jambaque I, 1998, J CHILD NEUROL, V13, P296, DOI 10.1177/088307389801300614; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Kaufer, 2001, J NEUROPSYCHIATRY CL, V13, P140; Kent TA, 1999, J NEUROSCI RES, V55, P357, DOI 10.1002/(SICI)1097-4547(19990201)55:3<357::AID-JNR11>3.0.CO;2-W; Kessler J, 2000, STROKE, V31, P2112, DOI 10.1161/01.STR.31.9.2112; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Koller G, 2003, NEUROPSYCHOBIOLOGY, V48, P87, DOI 10.1159/000072883; Kondziolka D, 2002, J CLIN NEUROSCI, V9, P225, DOI 10.1054/jocn.2001.1043; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kondziolka Douglas, 2003, Phys Med Rehabil Clin N Am, V14, pS153, DOI 10.1016/S1047-9651(02)00057-8; LAZARUS LW, 1992, J CLIN PSYCHIAT, V53, P447; LECOURS AR, 1983, APHASIOLOGY; LINN L, 1947, ARCH NEURO PSYCHIATR, V58, P357, DOI 10.1001/archneurpsyc.1947.02300320108007; LIPSEY JR, 1984, LANCET, V1, P297; Lutsep H, 2001, Curr Opin Investig Drugs, V2, P1732; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; MACLENNAN DL, 1991, CLIN APHASIOL, V21, P145; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McCloskey M., 1989, PSYCHOL LEARNING MOT, V24, P109; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Montanez S, 2000, BRAIN RES, V860, P29, DOI 10.1016/S0006-8993(00)01951-X; MORRIS PLP, 1992, MED J AUSTRALIA, V157, P239, DOI 10.5694/j.1326-5377.1992.tb137126.x; Mula M, 2003, NEUROLOGY, V60, P1104, DOI 10.1212/01.WNL.0000056637.37509.C6; Mulrow C.D., 1998, SYSTEMATIC REV SYNTH; Neville HJ, 1998, CURR OPIN NEUROBIOL, V8, P254, DOI 10.1016/S0959-4388(98)80148-7; Nudo RJ, 1999, REV NEUROL, V155, P713; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OLSON L, 1994, J NEUROL, V242, pS12, DOI 10.1007/BF00939233; Orgogozo JM, 1999, PHARMACOPSYCHIATRY, V32, P25, DOI 10.1055/s-2007-979233; Pashek GV, 2003, BRAIN LANG, V87, P179, DOI 10.1016/S0093-934X(03)00259-1; PETERSEN RC, 1977, PSYCHOPHARMACOLOGY, V52, P283, DOI 10.1007/BF00426713; PORCH B, 1985, Society for Neuroscience Abstracts, V11, P52; Porch BE, 1967, PORCH INDEX COMMUNIC, V1; ROBINSON R, 1998, CLIN NEUROPSYCHIATRY; ROBINSON RG, 1975, NATURE, V255, P332, DOI 10.1038/255332a0; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Robinson RG, 2000, AM J PSYCHIAT, V157, P351, DOI 10.1176/appi.ajp.157.3.351; ROBINSON RG, 1980, BRAIN RES, V181, P202, DOI 10.1016/0006-8993(80)91271-8; Rocamora N, 1996, J NEUROSCI, V16, P4411; SABE L, 1992, NEUROLOGY, V42, P1637, DOI 10.1212/WNL.42.8.1637; Sabel BA, 1997, BRAIN PLASTICITY; Sackett D. L., 2000, EVIDENCE BASED MED P, V2nd; SAIJA A, 1988, Journal of Neurotrauma, V5, P161, DOI 10.1089/neu.1988.5.161; SARNO MT, 1972, J SPEECH HEAR RES, V15, P42, DOI 10.1044/jshr.1501.42; SCHALLERT T, 1992, PHYS MED REHABIL, V6, P375; Sherman SJ, 2003, BEHAV NEUROSCI, V117, P526, DOI 10.1037/0735-7044.117.3.526; Singh A, 1998, CAN J PSYCHIAT, V43, P921, DOI 10.1177/070674379804300907; Small S. L., 2001, HDB ADULT LANGUAGE D, P397; SMALL SL, 1994, STROKE, V25, P1282, DOI 10.1161/01.STR.25.6.1282; Small SL, 2000, BRAIN LANG, V71, P227, DOI 10.1006/brln.1999.2256; SMALL SL, 2001, HDB NEUROPSYCHOLOGY, V3, P335; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; St John MF, 1998, FOREIGN LANGUAGE LEARNING, P231; STARKSTEIN SE, 1991, J NEUROPSYCH CLIN N, V3, P276; STARKSTEIN SE, 1989, BRIT J PSYCHIAT, V154, P170, DOI 10.1192/bjp.154.2.170; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Taffe MA, 1999, COGNITIVE BRAIN RES, V8, P203, DOI 10.1016/S0926-6410(99)00021-X; Tanaka Y, 1997, LANCET, V350, P116, DOI 10.1016/S0140-6736(05)61820-X; *TASK FORC DSM IV, 1994, DIAGN STAT MAN MENT, V4; van de Weg FB, 1999, CLIN REHABIL, V13, P268, DOI 10.1191/026921599672495022; VERNON M W, 1991, Drugs and Aging, V1, P17; Walker-Batson D, 2000, BRAIN LANG, V71, P252, DOI 10.1006/brln.1999.2262; Walker-Batson D., 1991, CLIN APHASIOL, V20, P137; WALKERBATSON D, 1995, STROKE, V26, P2254, DOI 10.1161/01.STR.26.12.2254; WEST R, 1965, J SPEECH HEAR RES, V8, P57, DOI 10.1044/jshr.0801.57; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; Wong ICK, 2000, DRUG SAFETY, V23, P35, DOI 10.2165/00002018-200023010-00003; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8; Zhang WR, 1999, BRAIN RES, V842, P211, DOI 10.1016/S0006-8993(99)01818-1; Zlokovic BV, 1997, NEUROSURGERY, V40, P805, DOI 10.1097/00006123-199704000-00028	136	16	17	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	MAY-JUL	2004	18	5-7					473	492		10.1080/02687030444000156			20	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	817NC	WOS:000221183200006					2021-06-18	
J	Tate, RL; Pfaff, A; Veerabangsa, A; Hodgkinson, AE				Tate, RL; Pfaff, A; Veerabangsa, A; Hodgkinson, AE			Measuring psychosocial recovery after brain injury: Change versus competency	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; outcome assessment (health care); rehabilitation; social adjustment	COMMUNITY INTEGRATION QUESTIONNAIRE; NEUROBEHAVIORAL RATING-SCALE; HEAD-INJURY; REHABILITATION SERVICES; DISABILITY; OUTCOMES; RELIABILITY; HANDICAP; HEALTH; IMPACT	Objectives: To determine the psychometric properties of an alternative form of the Sydney Psychosocial Reintegration Scale (SPRS) that focuses on competency of functioning (Form B) as opposed to the original form that examines change from the premorbid level (Form A). Design: Descriptive correlational study. Ratings were made by 2 treating clinicians on patients at discharge and I week later by using Forms A and B of the SPRS. A subset of 25 close relatives of the patients also completed the 2 SPRS forms and the London Handicap Scale at patient discharge. Setting: Inpatient brain injury rehabilitation unit. Participants: Sixty-six people with brain injury. Interventions: Not applicable. Main Outcome Measure: The SPRS is a 12-item questionnaire, rated on a 7-point scale, that measures function in occupational, interpersonal, and living skills domains. Results: The internal consistency of Form B was high (alpha=.90), as was stability (intraclass correlation coefficient [ICC]=.90) and interrater agreement (ICC=.84). Similarly, good psychometric properties were found for Form A for internal consistency (a=.90), stability (ICC=.90) and interrater agreement (ICC=.82), which replicated previous findings with this form. Comparability between forms was excellent (ICC=.97), and correspondence between ratings of the clinician and close relatives on Forms A and B was fair to good (ICC=.57, ICC=.67, respectively). Conclusions: Form B of the SPRS has psychometric properties equally sound to those of Form A. It is anticipated that there will be many advantages in having alternative forms of the same instrument, thus enabling measurement of psychosocial integration from different perspectives.	Royal Rehabil Ctr Sydney, Rehabil Studies Unit, Ryde, NSW 1680, Australia; Univ Sydney, Dept Med, Rehabil Studies Unit, Ryde, NSW, Australia; Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia	Tate, RL (corresponding author), Royal Rehabil Ctr Sydney, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	rtate@med.usyd.edu.au					Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Cardol M, 1999, DISABIL REHABIL, V21, P97, DOI 10.1080/096382899297819; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dahl TH, 2002, J REHABIL MED, V34, P201, DOI 10.1080/165019702760279170; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers MPJM, 2000, ARCH PHYS MED REHAB, V81, pS63, DOI 10.1053/apmr.2000.20627; Gray DB, 2000, ARCH PHYS MED REHAB, V81, pS10, DOI 10.1053/apmr.2000.20616; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; Harwood R H, 1994, Qual Health Care, V3, P11, DOI 10.1136/qshc.3.1.11; Heilbronner R L, 1989, Brain Inj, V3, P387, DOI 10.3109/02699058909004562; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; NEWITT H, 2002, THESIS U MELBOURNE M; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Stilwell P, 1999, NEUROPSYCHOL REHABIL, V9, P277, DOI 10.1080/096020199389374; Stilwell P, 1998, CLIN REHABIL, V12, P521, DOI 10.1191/026921598673761855; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1053/apmr.2000.4436; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; *WHO, 1980, MAN CLASS REL CONS D; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2001, INT CLASS FUNCT DIS	38	16	16	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2004	85	4					538	545		10.1016/j.apmr.2003.08.078			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	810MM	WOS:000220708400003	15083428				2021-06-18	
J	Hang, CH; Shi, JX; Li, JS; Wu, W; Li, WQ; Yin, HX				Hang, Chun-Hua; Shi, Ji-Xin; Li, Jie-Shou; Wu, Wei; Li, Wei-Qin; Yin, Hong-Xia			Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction	WORLD JOURNAL OF GASTROENTEROLOGY			English	Article							SPINAL AFFERENTS; NITRIC-OXIDE; CCK; RESPONSES; MUSCLE; CGRP; INHIBITION; MODULATION; ENDOTOXIN; GASTRIN	AIM: To study the alterations of brain-gut peptides following traumatic brain injury (TBI) and to explore the underlying significance of these peptides in the complicated gastrointestinal dysfunction. METHODS: Rat models of focal traumatic brain injury were established by impact insult method, and divided into 6 groups (6 rats each group) including control group with sham operation and TBI groups at postinjury 3, 12, 24, 72 h, and d 7. Blood and proximal jejunum samples were taken at time point of each group and gross observations of gastrointestinal pathology were recorded simultaneously. The levels of vasoactive intestinal peptide (VIP) in plasma, calcitonin gene-related peptide (CGRP) and cholecystokinin (CCK) in both plasma and jejunum were measured by enzyme immunoassay (EIA). Radioimmunoassay (RIA) was used to determine the levels of VIP in jejunum. RESULTS: Gastric distension, delayed gastric emptying and intestinal dilatation with a large amount of yellowish effusion and thin edematous wall were found in TBI rats through 12 h and 72 h, which peaked at postinjury 72 h. As compared with that of control group (247.8 +/- 29.5 ng/L), plasma VIP levels were significantly decreased at postinjury 3, 12 and 24 h (106.7 +/- 34.1 ng/L, 148.7 +/- 22.8 ng/L, 132.8 +/- 21.6 ng/L, respectively), but significantly increased at 72 h (405.0 +/- 29.8 ng/L) and markedly declined on d 7 (130.7 +/- 19.3 ng/L). However, Plasma levels CCK and CGRP were significantly increased through 3 h and 7 d following TBI (126-691% increases), with the peak at 72 h. Compared with control (VIP, 13.6 +/- 1.4 ng/g; CGRP, 70.6 +/- 17.7 ng/g); VIP and CGRP levels in jejunum were significantly increased at 3 h after TBI (VIP, 35.4 +/- 5.0 ng/g; CGRP, 103.8 +/- 22.1 ng/g), and declined gradually at 12 h and 24 h (VIP, 16.5 +/- 1.8 ng/g, 5.5 +/- 1.4 ng/g; CGRP, 34.9 +/- 9.7 ng/g, 18.5 +/- 7.7 ng/g), but were significantly increased again at 72 h (VIP, 48.7 +/- 9.5 ng/g; CGRP, 142.1 +/- 24.3 ng/g), then declined in various degrees on d 7 (VIP, 3.8 +/- 1.1 ng/g; CGRP, 102.5 +/- 18.1 ng/g). The CCK levels in jejunum were found to change in a similar trend as that in plasma with the concentrations of CCK significantly increased following TBI (99-517% increases) and peaked at 72 h. CONCLUSION: Traumatic brain injury can lead to significant changes of brain-gut peptides in both plasma and small intestine, which may be involved in the pathogenesis of complicated gastrointestinal dysfunction.	[Hang, Chun-Hua; Shi, Ji-Xin; Wu, Wei; Yin, Hong-Xia] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu Provinc, Peoples R China; [Li, Jie-Shou; Li, Wei-Qin] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Gen Surg, Nanjing 210002, Jiangsu Provinc, Peoples R China	Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Provinc, Peoples R China.	hang1965@public1.ptt.js.cn	Yin, Hong/AAC-5784-2020		Scientific Research Foundation of the Chinese [01Z011]	Supported by the Scientific Research Foundation of the Chinese PLA Key Medical Programs during the 10<SUP>th</SUP> Five-Year Plan Period, No. 01Z011	BROWN TH, 1989, GASTROINTEST ENDOSC, V35, P37, DOI 10.1016/S0016-5107(89)72683-3; Chen ZY, 2001, SHIJIE HUAREN XIAOHU, V9, P59; Delgado M, 1999, J IMMUNOL, V162, P1200; Du YP, 2001, WORLD J GASTROENTERO, V7, P275; ESPAT NJ, 1995, J SURG RES, V58, P719, DOI 10.1006/jsre.1995.1113; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FORSTER ER, 1990, AM J PHYSIOL, V258, pG552; GERNER T, 1979, SCAND J GASTROENTERO, V14, P73, DOI 10.3109/00365527909179848; Grider JR, 1987, GASTROENTEROLOGY, V92, P175, DOI 10.1016/0016-5085(87)90855-9; GRUNDY D, 1995, AM J PHYSIOL-GASTR L, V268, pG355; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Gue M, 1996, SEMIN NEUROL, V16, P235, DOI 10.1055/s-2008-1040980; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hayashi K, 1997, REGUL PEPTIDES, V72, P131, DOI 10.1016/S0167-0115(97)01051-3; Higham A, 1997, GUT, V41, P24, DOI 10.1136/gut.41.1.24; JACKSON MD, 1989, ARCH PHYS MED REHAB, V70, P553; JOYCE CD, 1990, SURGERY, V108, P1097; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Li LS, 2003, WORLD J GASTROENTERO, V9, P553, DOI 10.3748/wjg.v9.i3.553; Li W, 2000, WORLD J GASTROENTERO, V6, P93, DOI 10.3748/wjg.v6.i1.93; LI Y, 1993, J CLIN INVEST, V92, P418, DOI 10.1172/JCI116583; Ling YL, 2001, WORLD J GASTROENTERO, V7, P667; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Maggi CA, 1996, REGUL PEPTIDES, V61, P27, DOI 10.1016/0167-0115(95)00133-6; MELEAGROS L, 1994, GUT, V35, P1701, DOI 10.1136/gut.35.12.1701; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Onuoha G, 2001, BURNS, V27, P17, DOI 10.1016/S0305-4179(00)00073-5; PATAKY DM, 1990, NEUROSCIENCE, V36, P247, DOI 10.1016/0306-4522(90)90366-C; PEDOTO MJ, 1995, ARCH PHYS MED REHAB, V76, P871, DOI 10.1016/S0003-9993(95)80555-9; PENDLETON RG, 1987, J PHARMACOL EXP THER, V241, P110; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; PINCUS DW, 1990, NATURE, V343, P564, DOI 10.1038/343564a0; Rogers RC, 1996, NEUROSCI BIOBEHAV R, V20, P57, DOI 10.1016/0149-7634(95)00040-L; Said SI, 2000, REGUL PEPTIDES, V93, P21, DOI 10.1016/S0167-0115(00)00174-9; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; Schwartz GJ, 1997, AM J PHYSIOL-REG I, V272, pR1726; Shoji E, 1997, DIGEST DIS SCI, V42, P915, DOI 10.1023/A:1018860313674; Tuncel N, 1998, ANN NY ACAD SCI, V865, P309, DOI 10.1111/j.1749-6632.1998.tb11191.x; VARRO A, 1988, NEUROSCIENCE, V26, P927, DOI 10.1016/0306-4522(88)90109-1; WANG X, 1992, CIRC SHOCK, V36, P21; Wang X, 2002, WORLD J GASTROENTERO, V8, P540, DOI 10.3748/wjg.v8.i3.540; Wang X, 1996, BRIT J PHARMACOL, V118, P2164, DOI 10.1111/j.1476-5381.1996.tb15658.x; Wang X, 1999, J NEUROIMMUNOL, V94, P95, DOI 10.1016/S0165-5728(98)00230-6; Xu MY, 1998, WORLD J GASTROENTERO, V4, P524, DOI 10.3748/wjg.v4.i6.524; Yao YL, 2001, WORLD J GASTROENTERO, V7, P399; Zittel TT, 1998, SURGERY, V123, P518, DOI 10.1067/msy.1998.88090; ZITTEL TT, 1994, ANN SURG, V219, P79, DOI 10.1097/00000658-199401000-00013	47	16	18	0	4	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1007-9327	2219-2840		WORLD J GASTROENTERO	World J. Gastroenterol.	MAR 15	2004	10	6					875	880					6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	V19UH	WOS:000208096800022	15040036				2021-06-18	
J	Federman, DG; Kravetz, JD; Ruser, CB; Judson, PH; Kirsner, RS				Federman, DG; Kravetz, JD; Ruser, CB; Judson, PH; Kirsner, RS			Vogt-Koyanagi-Harada syndrome and ulcerative colitis	SOUTHERN MEDICAL JOURNAL			English	Article						brain injury; ulcerative colitis; Vogt-Koyanagi-Harada syndrome	HODGKINS-DISEASE; ASSOCIATION	The Vogt-Koyanagi-Harada (VKH) syndrome is an uncommon disorder characterized by uveitis and neurologic and cutaneous abnormalities, including tinnitus, vertigo, headache, meningoencephalitis, vitiligo, alopecia, and poliosis. The VKH syndrome has been reported to occur in association with other autoimmune disorders. We report a case of a patient with severe ulcerative colitis who developed VKH syndrome. We postulate that the patient's history of a traumatic brain injury might have been responsible for an abnormal "immunologic milieu" and the occurrence of ulcerative colitis, VKH syndrome, and severe reactive arthritis.	VA Connecticut HCS, West Haven, CT 06516 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Retina Consultants PC, Hartford, CT USA; Univ Miami, Sch Med, Dept Dermatol, Miami, FL 33152 USA	Federman, DG (corresponding author), VA Connecticut HCS, 11ACSL,950 Campbell Ave, West Haven, CT 06516 USA.	daniel.federman@med.va.gov					BENIZ J, 1991, RETINA-J RET VIT DIS, V11, P275, DOI 10.1097/00006982-199111030-00001; Chi Hyung-In, 1994, Journal of Dermatology (Tokyo), V21, P683; CHUAH SY, 1991, POSTGRAD MED J, V67, P476, DOI 10.1136/pgmj.67.787.476; CIPRIANI D, 1989, J NEUROL, V236, P303, DOI 10.1007/BF00314462; HAMMER H, 1974, BRIT J OPHTHALMOL, V58, P773, DOI 10.1136/bjo.58.9.773; Hettler D L, 1992, J Am Optom Assoc, V63, P90; IVERSEN TH, 1986, ACTA OPHTHALMOL, V64, P235; JAGGARAO N, 1989, POSTGRAD MED J, V65, P587, DOI 10.1136/pgmj.65.766.587; Jovic NS, 1996, POSTGRAD MED J, V72, P495, DOI 10.1136/pgmj.72.850.495; Lisianyi M I, 1997, Fiziol Zh, V43, P3; MAEZAWA N, 1982, OPHTHALMOLOGICA, V185, P179, DOI 10.1159/000309240; Matsuda H, 1970, Nippon Ganka Gakkai Zasshi, V74, P1107; MOORTHY RS, 1995, SURV OPHTHALMOL, V39, P265, DOI 10.1016/S0039-6257(05)80105-5; ORMANTAEV KS, 1998, ZH VOPR NEIROKHIR IM, V4, P27; Rathinam SR, 1999, OPHTHALMOLOGY, V106, P635, DOI 10.1016/S0161-6420(99)90129-X; Read R W, 2000, Curr Opin Ophthalmol, V11, P437, DOI 10.1097/00055735-200012000-00009; Wong SS, 1999, DERMATOLOGY, V198, P65, DOI 10.1159/000018067	17	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0038-4348			SOUTH MED J	South.Med.J.	FEB	2004	97	2					169	171		10.1097/01.SMJ.0000100263.99708.10			3	Medicine, General & Internal	General & Internal Medicine	831CY	WOS:000222171700014	14982267				2021-06-18	
J	Ptak, R; Schnider, A				Ptak, R; Schnider, A			Disorganised memory after right dorsolateral prefrontal damage	NEUROCASE			English	Article							FRONTAL-LOBE DAMAGE; N-BACK TASKS; WORKING-MEMORY; DECISION-MAKING; ACQUIRED SOCIOPATHY; CORTEX; LESIONS; ORGANIZATION; ACTIVATION; DEFICITS	Neurophysiological and functional brain imaging studies suggest the importance of dorsolateral area 9/46 for modality-independent working memory. However, the behavioural manifestations following isolated damage to this area have not been clearly outlined. Here, we describe the dramatic derangement of pragmatic memory after circumscribed lesion of the right area 9/46. A 52 year-old woman had suffered a traumatic brain injury 13 years ago and sought help for what she thought was a severe memory disorder. She regularly missed appointments and had gradually lost all her friends. She had tried different strategies to compensate for her memory problem, such as writing notes on her wrist or using electronic organizers. Intelligence, attention, verbal long-term memory, and executive functions were normal. Furthermore, experimental exploration demonstrated intact time estimation, attribution of memories to ongoing reality, and anticipation of outcomes. However, she failed to rehearse and manipulate information in working memory (n-back task), confirming the findings of functional imaging studies that the mid-dorsolateral prefrontal cortex is involved in mental manipulation of information. This case exemplifies that an isolated lesion of the right area 9/46 may induce severe failure to schedule actions and memory retrieval, a disorder leading to severely disorganised behaviour and disability.	HUG, Serv Reeduc, CH-1211 Geneva 14, Switzerland	Ptak, R (corresponding author), HUG, Serv Reeduc, 26 Av Beau Sejour, CH-1211 Geneva 14, Switzerland.	Radek.Ptak@hcuge.ch	Ptak, Radek/A-8661-2010	Ptak, Radek/0000-0003-4708-9201			Baddeley AD., 1990, HUMAN MEMORY; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Braver TS, 2001, NEUROIMAGE, V14, P48, DOI 10.1006/nimg.2001.0791; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Carlson S, 1998, CEREB CORTEX, V8, P743, DOI 10.1093/cercor/8.8.743; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; D'Esposito M, 1998, NEUROIMAGE, V8, P274, DOI 10.1006/nimg.1998.0364; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Damasio A., 1994, DESCARTESERROR EMOTI; Damasio A. R., 1993, CLIN NEUROPSYCHOLOGY, V3, P409; Damasio AR, 1996, PREFRONTAL CORTEX EX, P36, DOI [10.1093/acprof:oso/9780198524410.003.0004, DOI 10.1093/ACPROF:OSO/9780198524410.003.0004]; DELUCA J, 1995, J CLIN EXP NEUROPSYC, V17, P100, DOI 10.1080/13803399508406586; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; FUSTER JM, 1997, PREFRONTAL CORTEX; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Johnson MK, 1997, BRAIN COGNITION, V34, P189, DOI 10.1006/brcg.1997.0873; Kolb B., 1990, FUNDAMENTALS HUMAN N; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martinkauppi S, 2000, CEREB CORTEX, V10, P889, DOI 10.1093/cercor/10.9.889; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILNER B, 1985, HUM NEUROBIOL, V4, P137; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Petrides M, 2002, P NATL ACAD SCI USA, V99, P5649, DOI 10.1073/pnas.072092299; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; Ptak R, 2001, BEHAV NEUROSCI, V115, P993, DOI 10.1037//0735-7044.115.5.993; Ragland JD, 2002, NEUROPSYCHOLOGY, V16, P370, DOI 10.1037//0894-4105.16.3.370; Riesen JM, 2001, J NEUROL, V248, P27, DOI 10.1007/s004150170266; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2003, NAT REV NEUROSCI, V4, P662, DOI 10.1038/nrn1179; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; SHALLICE T, 1998, PREFRONTAL CORTEX EX, P22; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; SHAW C, 1994, NEUROPSYCHOLOGIA, V32, P857, DOI 10.1016/0028-3932(94)90023-X; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Wechsler D., 1987, WMS R WECHSLER MEMOR; Wilson B.A., 1996, BADS BEHAV ASSESSMEN	58	16	16	0	12	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1355-4794			NEUROCASE	Neurocase	FEB	2004	10	1					52	59		10.1080/13554790490960495			8	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	830GP	WOS:000222110400007	15849160				2021-06-18	
J	Collignon, FP; Friedman, JA; Piepgras, DG; Pichelmann, MA; McIver, JI; Toussaint, LG; McClelland, RL				Collignon, FP; Friedman, JA; Piepgras, DG; Pichelmann, MA; McIver, JI; Toussaint, LG; McClelland, RL			Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage	NEUROCRITICAL CARE			English	Article						magnesium; subarachnoid hemorrhage; aneurysm; vasospasm; stroke; cerebrovascular	INTRACELLULAR FREE MG-2+; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; IONIZED MAGNESIUM; CONTROLLED TRIAL; NMDA RECEPTOR; SULFATE; RATS; ECLAMPSIA; PREECLAMPSIA	Introduction: Recent evidence suggests that magnesium may be neuroprotective in the setting of cerebral ischemia, and therapeutic magnesium infusion has been proposed for prophylaxis and treatment of delayed ischemic neurological deficit (DIND) resulting from vasospasm in patients with aneurysmal subarachnoid hemorrhage (SAH). We studied the association between serum magnesium levels, the development of DIND, and the outcomes of patients with SAH. Methods: We studied 128 consecutive patients with aneurysmal SAH treated at our institution between 1990 and 1997 who had a serum magnesium level measured at least once during the acute phase of their hospitalization. Delayed ischemic neurological deficit was defined as severe (major focal deficit or coma), moderate (incomplete focal deficit or decreased sensorium without coma), or none. Results: There was no significant difference in mean, minimum, or maximum serum magnesium levels between patients with and without DIND (1.93,1.83, 2.02 versus 1.91, 1.84, 1.97 mg/dL, respectively). Similarly, no difference was found in mean serum magnesium levels among patients with severe (1.94 mg/dL), moderate (1.92 mg/dL), or no DIND (1.91 mg/dL). Analyses of serum magnesium levels before (0-4 days following SAH), during (4-14 days following SAH), and after (greater than 14 days following SAH) the period of highest risk for vasospasm revealed no association with the development or severity of DIND. Permanent deficit or death resulting from vasospasm and Glasgow Outcome Scale score at longest follow-up were similarly unaffected by serum magnesium levels overall or during any time interval. Forty (31.5%) patients were hypomagnesemic (less than 1.7 mg/dL) during hospitalization, but no difference in outcome (p = 0.185) or development of DIND (p = 0.785) was found when compared to patients with normal (1.7-2.1 mg/dL) or high (greater than 2.1 mg/dL) magnesium serum levels. Conclusion: We identified no relationship between serum magnesium levels and the development of DIND or outcome following aneurysmal SAIL Based on these data, magnesium supplementation to normal or high-normal physiological ranges seems unlikely to be beneficial for DIND resulting from vasospasm. However, no inference can be made regarding the value of therapeutic infusion of magnesium to supraphysiological levels.	Dartmouth Hitchcock Med Ctr, Neurosurg Sect, Lebanon, NH 03766 USA; Mayo Clin, Dept Neurol Surg, Rochester, MN USA; Mayo Clin, Dept Biostat, Rochester, MN USA	Friedman, JA (corresponding author), Dartmouth Hitchcock Med Ctr, Neurosurg Sect, 1 Med Ctr Dr, Lebanon, NH 03766 USA.	Jonathan.A.Friedman@hitchcock.org		Toussaint, L. Gerard/0000-0003-0000-7782			ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; ALTURA BM, 1992, BIOCHIM BIOPHYS ACTA, V1111, P271, DOI 10.1016/0005-2736(92)90320-L; ALTURA BM, 1981, FED PROC, V40, P2672; ALTURA BM, 1974, MICROVASC RES, V7, P145, DOI 10.1016/0026-2862(74)90001-6; ALTURA BM, 1994, ALCOHOL CLIN EXP RES, V18, P1057, DOI 10.1111/j.1530-0277.1994.tb00082.x; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; ALTURA BT, 1980, NEUROSCI LETT, V20, P323, DOI 10.1016/0304-3940(80)90168-8; ALTURA BT, 1982, MAGNESIUM EXP CLIN R, V1, P277; Anthony J, 1996, DRUG SAFETY, V15, P188, DOI 10.2165/00002018-199615030-00004; ANTHONY J, 1994, FETAL MATERNAL MED R, V6, P219; BECK DW, 1981, JAMA-J AM MED ASSOC, V246, P1442, DOI 10.1001/jama.246.13.1442; BELFORT MA, 1992, AM J OBSTET GYNECOL, V167, P661, DOI 10.1016/S0002-9378(11)91567-1; BITO LZ, 1969, SCIENCE, V165, P81, DOI 10.1126/science.165.3888.81; Boet R, 2000, NEUROSURGERY, V47, P602, DOI 10.1097/00006123-200009000-00014; BOISVERT DP, 1983, NEW ENGL J MED, V308, P619; Brewer RP, 2001, CLIN NEUROPHARMACOL, V24, P341, DOI 10.1097/00002826-200111000-00005; CHEUNG JY, 1986, NEW ENGL J MED, V314, P1670; Elliott JP, 1998, J NEUROSURG, V88, P277, DOI 10.3171/jns.1998.88.2.0277; Ema M, 1991, Magnes Trace Elem, V10, P269; EVANS S, 1983, NEW ENGL J MED, V309, P1644, DOI 10.1056/NEJM198312293092612; EWLIN RJ, 1988, DIS MONTH, V34, P165; FARBER JL, 1981, AM J PATHOL, V102, P271; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Gee JB, 2001, PEDIATR NEUROL, V25, P304, DOI 10.1016/S0887-8994(01)00317-4; GOLDMAN RS, 1988, NEW ENGL J MED, V319, P1224; HALEY EC, 1992, STROKE, V23, P205, DOI 10.1161/01.STR.23.2.205; HALEY EC, 1993, J NEUROSURG, V78, P537, DOI 10.3171/jns.1993.78.4.0537; HALLAK M, 1992, AM J OBSTET GYNECOL, V167, P1605, DOI 10.1016/0002-9378(92)91749-Z; HELPERN JA, 1993, NEUROLOGY, V43, P1577, DOI 10.1212/WNL.43.8.1577; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; KASS IS, 1988, ANESTHESIOLOGY, V69, P710, DOI 10.1097/00000542-198811000-00012; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kim YJ, 1996, ANESTH ANALG, V83, P1223, DOI 10.1097/00000539-199612000-00016; LEWIS LK, 1988, NEURORADIOLOGY, V30, P59, DOI 10.1007/BF00341945; MacDonald R. Loch, 1997, P1111; Marinov MB, 1996, J NEUROSURG, V85, P117, DOI 10.3171/jns.1996.85.1.0117; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1996, LAB INVEST, V74, P315; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MCLEAN RM, 1994, AM J MED, V96, P63, DOI 10.1016/0002-9343(94)90117-1; MELDRUM BS, 1987, MED BIOL, V65, P153; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; MULLINS PGM, 1995, NEUROREPORT, V6, P1633, DOI 10.1097/00001756-199508000-00011; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OPPELT WW, 1963, AM J PHYSIOL, V205, P959; PRIESTLEY T, 1990, BRAIN RES, V531, P183, DOI 10.1016/0006-8993(90)90772-4; PRITCHARD JA, 1975, AM J OBSTET GYNECOL, V123, P543, DOI 10.1016/0002-9378(75)90042-3; RAM Z, 1991, STROKE, V22, P922, DOI 10.1161/01.STR.22.7.922; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; RYZEN E, 1985, CRIT CARE MED, V13, P19, DOI 10.1097/00003246-198501000-00006; SABAI GM, 1986, NEUROLOGICAL DISORDE, P1; SADEH M, 1989, STROKE, V20, P1273, DOI 10.1161/01.STR.20.9.1273; TAKAKU A, 1979, SURG NEUROL, V12, P137; TROMMER BL, 1988, STROKE, V19, P326, DOI 10.1161/01.STR.19.3.326; VACANTI FX, 1984, STROKE, V15, P695, DOI 10.1161/01.STR.15.4.695; Veyna RS, 2002, J NEUROSURG, V96, P510, DOI 10.3171/jns.2002.96.3.0510; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1990, J NEUROSCI, V10, P3524; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; WATSON KV, 1986, P NATL ACAD SCI USA, V83, P1075, DOI 10.1073/pnas.83.4.1075; WILL AD, 1987, NEUROLOGY, V37, P1555, DOI 10.1212/WNL.37.9.1555; WILLIAMS GD, 1995, MAGNET RESON MED, V33, P853, DOI 10.1002/mrm.1910330618; WOODRUFF GN, 1987, NEUROPHARMACOLOGY, V26, P903, DOI 10.1016/0028-3908(87)90068-2	69	16	17	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2004	1	4					441	448		10.1385/NCC:1:4:441			8	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	945FS	WOS:000230489000006	16174947				2021-06-18	
J	Diaz-Arrastia, R; Gong, YH; Kelly, CJ; Gelman, BB				Diaz-Arrastia, R; Gong, YH; Kelly, CJ; Gelman, BB			Host genetic polymorphisms in human immunodeficiency virus-related neurologic disease	JOURNAL OF NEUROVIROLOGY			English	Article; Proceedings Paper	Joint Symposium on Viral and Host Genetic Factors Regulating HIV/CNS Disease	NOV 20-22, 2002	WASHINGTON, DC	Natl Inst Mental Hlth, Natl Inst Neurol Disorders & Stroke		apolipoprotein E; interleukin-1; tumor necrosis factor	INTERLEUKIN-1 RECEPTOR ANTAGONIST; HIV-ASSOCIATED DEMENTIA; TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; PROMOTER REGION; ALPHA PROMOTER; ALLELE; GENOTYPE; AIDS	The objective of this study was to determine whether host genetic polymorphisms influence the risk of developing human immunodeficiency virus (HIV) encephalitis and vacuolar myelopathy. Allelic association studies were carried out with common polymorphisms in candidate genes that are postulated to play a role in the pathogenesis of HIV-related neurologic complications. The authors studied brains and spinal cords from 270 patients who died of acquired immunodeficiency syndrome (AIDS) from 1989 to 1996. All had complete gross and microscopic pathologic evaluations, and the presence of microglial nodules, multinucleated giant cells, myelin pallor, and vacuolar myelopathy was assessed by an experienced neuropathologist who was blinded to the genotype. DNA was extracted from frozen brain samples, and determination of the presence of the APOE4, TNF-2, IL-1B*2, ILIRN*2 polymorphisms was determined by polymerase chain reaction (PCR) and restricted fragment length polymorphism (RFLP) mapping. The authors did not detect a consistent association between inheritance of candidate polymorphic alleles and the pathologic findings of HIV encephalitis or vacuolar myelopathy. Allelic association studies with candidate genes are powerful techniques that have the potential to contribute to understanding the pathophysiology of HIV-related neurodegeneration. This preliminary study, although including a substantial number of patients, was not sufficiently powered to exclude a modest but clinically significant effects. Future studies will require much larger sample sizes and technical advances to allow screening at larger number of candidate loci.	Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA; Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77550 USA	Diaz-Arrastia, R (corresponding author), Univ Texas, SW Med Ctr, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Ramon.Diaz-Arrastia@UTSouthwestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U01 AI46373] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG17861] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R24 MH59656, R03 MH64889] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R24 NS45491] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH064889, R24MH059656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R24NS045491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG017861] Funding Source: NIH RePORTER		BIOQUE G, 1995, CLIN EXP IMMUNOL, V102, P379; BLAKEMORE AIF, 1994, ARTHRITIS RHEUM, V37, P1380, DOI 10.1002/art.1780370917; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chapman J, 2001, NEUROLOGY, V56, P312, DOI 10.1212/WNL.56.3.312; Cherner M, 2002, NEUROLOGY, V59, P1563, DOI 10.1212/01.WNL.0000034175.11956.79; Childs EA, 1999, NEUROLOGY, V52, P607, DOI 10.1212/WNL.52.3.607; Corder EH, 1998, NAT MED, V4, P1182, DOI 10.1038/2677; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRUCIUS JBA, 1995, LANCET, V346, P979; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; delaConcha EG, 1997, J NEUROIMMUNOL, V80, P172, DOI 10.1016/S0165-5728(97)00153-7; Dunlop O, 1997, ACTA NEUROL SCAND, V95, P315, DOI 10.1111/j.1600-0404.1997.tb00217.x; Emahazion T, 1999, GENE, V238, P315, DOI 10.1016/S0378-1119(99)00330-3; Fazekas F, 2001, NEUROLOGY, V57, P853, DOI 10.1212/WNL.57.5.853; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gelman BB, 1996, ARCH PATHOL LAB MED, V120, P866; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Griffin DE, 1997, J CLIN INVEST, V100, P2948, DOI 10.1172/JCI119847; Huang SL, 1997, AM J RESP CRIT CARE, V156, P1436, DOI 10.1164/ajrccm.156.5.9609138; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lipton SA, 1998, ANNU REV PHARMACOL, V38, P159, DOI 10.1146/annurev.pharmtox.38.1.159; Lucotte G, 1997, HUM BIOL, V69, P253; MANSFIELD JC, 1994, GASTROENTEROLOGY, V106, P637, DOI 10.1016/0016-5085(94)90696-3; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Monforte AD, 2000, NEUROLOGY, V54, P1856; Mrak RE, 1997, J NEUROVIROL, V3, P241, DOI 10.3109/13550289709029465; Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878; PERRUT M, 1998, P 5 M SUP FLUIDS NIC, V1, P1; PLOMIN R, 1994, BEHAV GENET, V24, P107, DOI 10.1007/BF01067815; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Quasney MW, 2001, ANN NEUROL, V50, P157, DOI 10.1002/ana.1284; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Sato-Matsumura KC, 1998, J NEUROIMMUNOL, V91, P89, DOI 10.1016/S0165-5728(98)00161-1; Simpson DM, 1999, CLIN INFECT DIS, V29, P19, DOI 10.1086/520150; Swindells S, 1999, AIDS PATIENT CARE ST, V13, P153, DOI 10.1089/apc.1999.13.153; Tang MX, 1996, AM J HUM GENET, V58, P574; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Zink WE, 1999, FEMS IMMUNOL MED MIC, V26, P233, DOI 10.1111/j.1574-695X.1999.tb01394.x	42	16	16	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1355-0284			J NEUROVIROL	J. Neurovirol.		2004	10			1			67	73		10.1080/13550280490270770			7	Neurosciences; Virology	Neurosciences & Neurology; Virology	801SC	WOS:000220114600011	14982742				2021-06-18	
J	Page, RB; Spott, MA; Krishnamurthy, S; Taleghani, C; Chinchilli, VM				Page, RB; Spott, MA; Krishnamurthy, S; Taleghani, C; Chinchilli, VM			Head injury and pulmonary embolism: A retrospective report based on the Pennsylvania trauma outcomes study	NEUROSURGERY			English	Article						head injury; pulmonary embolus; traumatic brain injury	MAJOR TRAUMA; VENOUS THROMBOEMBOLISM; RISK; STATEWIDE	OBJECTIVE: We retrospectively examined the database of the Pennsylvania Trauma a Systems Foundation to determine the risk of pulmonary embolism in adult patients sustaining isolated head trauma or multiple injuries, including head trauma, to answer two questions: What is the incidence of symptomatic pulmonary embolism during 3 hospitalization in a trauma center in patients who have sustained a head injury? Are patients with head injuries more at risk for pulmonary embolism than trauma patients without head injuries? METHODS: We determined the total number of adult submissions per year to the Pennsylvania Trauma Outcomes Study from 1992 to 1996. Age, sex, Glasgow Coma Scale score, Abbreviated Injury Score for head injury, injury Severity Score, intensive care unit days, hospital days, and the presence or absence of head injury, spinal injury, pelvic fractures, and/or femur fractures were recorded. Statistical techniques to evaluate their correlation with the incidence of pulmonary embolism included X-2 testing, linear regression analysis, Kendall analysis, and logistic regression analysis. RESULTS: The average incidence of symptomatic pulmonary embolism in head;. injured patients occurring during their acute hospital stay was 0.38%. This rate was not significantly greater than the 0.27% incidence of pulmonary embolism inpatients without head injury. Factors that significantly increased this incidence were age greater than 45 years, Injury Severity Score greater than 15, male sex, and the presence of pelvic or femur fractures or of spinal cord injury. CONCLUSION: We found no evidence that head injury is a significant independent risk factor for development of symptomatic pulmonary embolism during the acute hospitalization of the trauma patient.	Penn State Univ, Milton S Hershey Med Ctr, Div Neurosurg, Coll Med,Dept Surg, Hershey, PA 17033 USA; Penn Trauma Syst Fdn, Dept Neurosurg, Mechanicsburg, PA USA; SUNY Syracuse, Hlth Sci Ctr, Dept Neurosurg, Syracuse, NY 13210 USA; Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA	Page, RB (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Div Neurosurg, Coll Med,Dept Surg, POB 850, Hershey, PA 17033 USA.			Krishnamurthy, Satish/0000-0001-7808-7407			[Anonymous], 1972, JAMA, V220, P717; BUERGER PM, 1993, AM SURGEON, V59, P505; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; GILLOTT AR, 1989, J TRAUMA, V29, P1667, DOI 10.1097/00005373-198912000-00015; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; Hollander M., 1999, NONPARAMETRIC STAT M; HOYT DB, 1993, J TRAUMA, V35, P524, DOI 10.1097/00005373-199310000-00005; JENNETT B, 1976, LANCET, V1, P1031; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; MIKE V, 1982, STAT MED RES; OMALLEY KF, 1990, J TRAUMA, V30, P748, DOI 10.1097/00005373-199006000-00018; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; Spain DA, 1997, J TRAUMA, V42, P463, DOI 10.1097/00005373-199703000-00014; TuttleNewhall JE, 1997, J TRAUMA, V42, P90, DOI 10.1097/00005373-199701000-00016; WISNER DH, 1992, ARCH SURG-CHICAGO, V127, P111	16	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JAN	2004	54	1					143	148		10.1227/01.NEU.0000097514.60813.1B			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	761ZA	WOS:000187944300033	14683551				2021-06-18	
J	Beaudry, M; Spence, JD				Beaudry, M; Spence, JD			Motor vehicle accidents: the most common cause of traumatic vertebrobasilar ischemia	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRANSIENT GLOBAL AMNESIA; WHIPLASH; MIGRAINE; BRAIN; INSUFFICIENCY; POSITION; INJURY	Background: Recent media exposure of strokes from chiropractic manipulation have focused attention on traumatic vertebrobasilar ischemia. However, chiropractic manipulation, while the easiest cause to recognize, is probably not the most common cause of this condition. Methods: We reviewed all consecutive cases of traumatic vertebrobasilar ischemia referred to a single neurovascular practice over 20 years, from the office files and hospital records. Results: There were 80 patients whose vertebrobasilar ischemia was attributed to neck trauma. Five were diagnosed as due to chiropractic manipulation, but the commonest attributed cause was motor vehicle accidents (MVAs), which accounted for 70 cases; one was a sports injury, and five were industrial accidents. In some cases neck pain from an MVA led to chiropractic manipulation, so the cause may have been compounded. In most vehicular cases the diagnosis had been missed, even denied, by the neurologists and neurosurgeons initially involved. The longest delay between the injury and the onset of delayed symptoms was five years. Conclusions: Traumatic vertebrobasilar ischemia is most often due to MVAs; the diagnosis is often missed, in part because of the delay between injury and onset of symptoms and, in part, we hypothesize, because of reluctance of doctors to be involved in medicolegal cases.	Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, London, ON N6G 2V2, Canada; Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada	Spence, JD (corresponding author), Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, Siebens Drake Bldg,1400 Western Rd, London, ON N6G 2V2, Canada.		Spence, J. David/K-6396-2013	Spence, J. David/0000-0001-7478-1098			AUER RN, 1994, J NEUROL NEUROSUR PS, V57, P500, DOI 10.1136/jnnp.57.4.500; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P223, DOI 10.1212/WNL.38.2.223; BOGOUSSLAVSKY J, 1988, CURR OPIN NEUROL NEU, V1, P63; CAPLAN LR, 1985, STROKE, V16, P1030, DOI 10.1161/01.STR.16.6.1030; CAPLAN LR, 1986, STROKE PATHOPHYSIOLO, P570; FISHER CM, 1982, NEUROLOGY, V32, P667, DOI 10.1212/WNL.32.6.667; FISHER CM, 1986, CAN J NEUROL SCI, V13, P1; HAAS DC, 1988, J NEUROSURG, V68, P181, DOI 10.3171/jns.1988.68.2.0181; HAAS DC, 1986, BRAIN, V109, P251, DOI 10.1093/brain/109.2.251; HART RG, 1983, S CER DIS, P155; HOFSTAD H, 1985, J NEUROL NEUROSUR PS, V48, P956, DOI 10.1136/jnnp.48.9.956; HUGHES JT, 1979, CEREBRAL ARTERIAL SP; JACOME DE, 1986, HEADACHE, V26, P515, DOI 10.1111/j.1526-4610.1986.hed2610515.x; Jeret JS, 2002, CEREBROVASC DIS, V13, P210, DOI 10.1159/000047778; MAS JL, 1987, STROKE, V18, P1037, DOI 10.1161/01.STR.18.6.1037; Mayer SA, 1996, NEUROLOGY, V47, P552, DOI 10.1212/WNL.47.2.552; MOKRI B, 1988, J NEUROSURG, V68, P189, DOI 10.3171/jns.1988.68.2.0189; NICHELLI P, 1983, STROKE, V14, P617, DOI 10.1161/01.STR.14.4.617; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; SCHNEIDE.RC, 1970, J NEUROSURG, V33, P363, DOI 10.3171/jns.1970.33.4.0363; SCHNEIDER RC, 1959, NEUROLOGY, V9, P643, DOI 10.1212/WNL.9.10.643; SHERMAN DG, 1981, STROKE, V12, P2, DOI 10.1161/01.STR.12.1.2; SJAASTAD O, 1983, CEPHALALGIA, V3, P249, DOI 10.1046/j.1468-2982.1983.0304249.x; Stopford JSB, 1916, J ANAT PHYSIOL, V50, P131; TETTENBORN B, 1993, NEUROLOGY, V43, P471, DOI 10.1212/WNL.43.3_Part_1.471; THIE A, 1988, HEADACHE, V28, P183, DOI 10.1111/j.1526-4610.1988.hed2803183.x; VANDEKELFT E, 1992, STROKE, V23, P114, DOI 10.1161/01.STR.23.1.114; VIKTRUP L, 1995, STROKE, V26, P2194, DOI 10.1161/01.STR.26.11.2194; VINCHON M, 1995, NEUROSURGERY, V36, P839, DOI 10.1227/00006123-199504000-00027; Weintraub M I, 1995, J Neuroimaging, V5, P16; WEINTRAUB MI, 1993, JAMA-J AM MED ASSOC, V269, P2085, DOI 10.1001/jama.1993.03500160051022; WINSTON KR, 1987, HEADACHE, V27, P452, DOI 10.1111/j.1526-4610.1987.hed2708452.x	34	16	16	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2003	30	4					320	325		10.1017/S0317167100003024			6	Clinical Neurology	Neurosciences & Neurology	744WN	WOS:000186656000006	14672263	Bronze			2021-06-18	
J	Elovic, EP				Elovic, EP			Anterior pituitary dysfunction after traumatic brain injury, part I	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							TESTOSTERONE; PREVALENCE; MEN		Kessler Med Rehabil Res & Educ Corp, TBI Res Lab, W Orange, NJ 07052 USA	Elovic, EP (corresponding author), Kessler Med Rehabil Res & Educ Corp, TBI Res Lab, 1199 Pleasant Valley W, W Orange, NJ 07052 USA.						Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Larsen PR, 2003, WILLIAMS TXB ENDOCRI, P423; LARSEN PR, 2003, WILLIAMS TXB ENDOCRI; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Melmed S, 2003, WILLIAMS TXB ENDOCRI, P177; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Seidman SN, 2002, AM J PSYCHIAT, V159, P456, DOI 10.1176/appi.ajp.159.3.456; Stewart PM, 2003, WILLIAMS TXB ENDOCRI, P491, DOI 10.1097/00060793-200106000-00001; Wagner GJ, 1998, GEN HOSP PSYCHIAT, V20, P209, DOI 10.1016/S0163-8343(98)00024-3	14	16	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					541	543		10.1097/00001199-200311000-00008			3	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200008	14707884				2021-06-18	
J	Suchy, Y; Leahy, B; Sweet, JJ; Lam, CS				Suchy, Y; Leahy, B; Sweet, JJ; Lam, CS			Behavioral dyscontrol scale deficits among traumatic brain injury patients, part II: Comparison to other measures of executive functioning	CLINICAL NEUROPSYCHOLOGIST			English	Article							CARD SORTING TEST; OBSESSIVE-COMPULSIVE DISORDER; FRONTAL-LOBE FUNCTION; NEUROPSYCHOLOGICAL DEFICITS; TEST-PERFORMANCE; WORD FLUENCY; HEAD-INJURY; LESIONS; MEMORY; TESTS	The clinical utility of the Behavioral Dyscontrol Scale (BDS) was compared to that of verbal fluency, the Trail Making Test, and the Stroop Color-Word Test, as well as measures of processing speed/cognitive efficiency and manual dexterity. The ability of these measures to classify 49 TBI patients into frontal versus nonfrontal and mild to moderate versus severe groups was examined. The results showed that the Fluid Intelligence Factor of the BDS improved classifications above and beyond traditional executive measures, but was particularly successful at classifying patients who sustained mild injuries. In contrast, traditional executive instruments were successful at lesion location classifications only among the patients with severe injuries. Severity classifications were successful both for traditional measures of processing speed/cognitive efficiency and for the Motor Programming Factor of the BDS, but only among patients with nonfrontal injuries. These results demonstrate that severity of injury may be an important moderator of tests' sensitivity to frontal lobe involvement.	Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; IIT, Chicago, IL 60616 USA; Evanston NW Healthcare, Evanston, IL USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Suchy, Y (corresponding author), Univ Utah, Dept Psychol, 380 S 1530 E,Rm 502, Salt Lake City, UT 84112 USA.	yana.suchy@psych.utah.edu		Suchy, Yana/0000-0001-6513-565X			Ahola K, 1996, BRAIN COGNITION, V31, P1, DOI 10.1006/brcg.1996.0021; Allen DN, 2000, PSYCHIAT RES, V93, P33, DOI 10.1016/S0165-1781(00)00112-8; Amieva H, 1998, J CLIN EXP NEUROPSYC, V20, P280, DOI 10.1076/jcen.20.2.280.1161; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Bond M. R., 1986, NEUROPSYCHOLOGICAL A; Borkowska A, 2002, PROG NEURO-PSYCHOPH, V26, P1349, DOI 10.1016/S0278-5846(02)00300-7; Borkowska A, 2001, BIPOLAR DISORD, V3, P88, DOI 10.1034/j.1399-5618.2001.030207.x; BORNSTEIN RA, 1986, INT J CLIN NEUROPSYC, V8, P18; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; Cohen MJ, 2000, ARCH CLIN NEUROPSYCH, V15, P267, DOI 10.1016/S0887-6177(99)00017-7; Cools R, 2000, BRAIN COGNITION, V43, P108; deZubicaray G, 1996, CLIN NEUROPSYCHOL, V10, P245, DOI 10.1080/13854049608406687; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Fassino S, 2002, INT J EAT DISORDER, V31, P274, DOI 10.1002/eat.10028; Fos L A, 2000, Appl Neuropsychol, V7, P140, DOI 10.1207/S15324826AN0703_4; Golden C., 1978, STROOP COLOR WORD TE; GRIGSBY J, 1995, ARCH GERONTOL GERIAT, V21, P167, DOI 10.1016/0167-4943(95)00636-Y; GRIGSBY J, 1993, ARCH PHYS MED REHAB, V74, P1350, DOI 10.1016/0003-9993(93)90091-N; GRIGSBY J, 1992, PERCEPT MOTOR SKILL, V74, P883, DOI 10.2466/PMS.74.3.883-892; Grigsby J., 1996, BEHAV DYSCONTROL SCA; HECK ET, 1986, J CLIN EXP NEUROPSYC, V8, P313, DOI 10.1080/01688638608401321; Heffernan TM, 2001, HUM PSYCHOPHARM CLIN, V16, P607, DOI 10.1002/hup.349; Jurado MA, 2001, PSYCHIAT RES, V104, P213, DOI 10.1016/S0165-1781(01)00322-5; KAYE K, 1990, J AM GERIATR SOC, V38, P1304, DOI 10.1111/j.1532-5415.1990.tb03452.x; Kim MS, 2002, J PSYCHIAT RES, V36, P257, DOI 10.1016/S0022-3956(02)00017-1; Landro NI, 2001, NEUROPSY NEUROPSY BE, V14, P233; Leahy B, 2003, CLIN NEUROPSYCHOL, V17, P474, DOI 10.1076/clin.17.4.474.27941; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2nd; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; MARENCO S, 1993, PSYCHIAT RES-NEUROIM, V50, P177, DOI 10.1016/0165-1781(93)80012-T; Matthews C, 1964, INSTRUCTION MANUAL A; Mead LA, 2002, J INT NEUROPSYCH SOC, V8, P735, DOI 10.1017/S1355617702860015; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Moritz S, 2002, ARCH CLIN NEUROPSYCH, V17, P477, DOI 10.1016/S0887-6177(01)00130-5; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; PONTIUS AA, 1980, J NERV MENT DIS, V168, P111, DOI 10.1097/00005053-198002000-00008; Ravnkilde B, 2002, J CLIN EXP NEUROPSYC, V24, P534, DOI 10.1076/jcen.24.4.534.1033; REISCHIES FM, 2001, Z FUER NEUROPSYCHOLO, V12, P42; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; ROZENTHAL M, 2000, J BRASILEIRO PSIQUIA, V49, P5; Salthouse TA, 1996, NEUROPSYCHOLOGY, V10, P272, DOI 10.1037/0894-4105.10.2.272; Schatzberg AF, 2000, AM J PSYCHIAT, V157, P1095, DOI 10.1176/appi.ajp.157.7.1095; Schwartz S, 2001, NEUROPSYCHOLOGIA, V39, P1209, DOI 10.1016/S0028-3932(01)00053-7; SEGALOWITZ SJ, 1992, J CLIN EXPT NEUROPSY, V52, P658; Smith ML, 2000, J DEV PHYS DISABIL, V12, P317, DOI 10.1023/A:1009480013237; Spreen O., 1991, COMPENDIUM NEUROPSYC; Steffens DC, 2001, BIOL PSYCHIAT, V50, P358, DOI 10.1016/S0006-3223(01)01165-9; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Suchy Y, 2003, J CLIN EXP NEUROPSYC, V25, P190, DOI 10.1076/jcen.25.2.190.13640; Suchy Y, 1997, CLIN NEUROPSYCHOL, V11, P258, DOI 10.1080/13854049708400454; Suchy Y, 1999, CLIN NEUROPSYCHOL, V13, P487, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT487; SWIRSKYSACCHETTI T, 1992, NEUROLOGY, V42, P1291, DOI 10.1212/WNL.42.7.1291; Sylvester CYC, 2002, NEUROPSYCHOLOGY, V16, P197, DOI 10.1037//0894-4105.16.2.197; Szatkowska I, 2000, ACTA NEUROBIOL EXP, V60, P503; Tierney MC, 2001, ARCH NEUROL-CHICAGO, V58, P1654, DOI 10.1001/archneur.58.10.1654; Tripp G, 2002, AUST NZ J PSYCHIAT, V36, P771, DOI 10.1046/j.1440-1614.2002.01093.x; VANDENBROEK MD, 1993, BRIT J CLIN PSYCHOL, V32, P333; Vilkki JA, 2002, NEUROPSYCHOLOGIA, V40, P340, DOI 10.1016/S0028-3932(01)00090-2; *WAR DEP ADJ GEN O, 1944, ARM IND TEST BATT; Wildgruber D, 2000, CLIN REHABIL, V14, P272, DOI 10.1191/026921500676524726	70	16	16	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	2003	17	4					492	506		10.1076/clin.17.4.492.27949			15	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	776XV	WOS:000189145400006	15168914				2021-06-18	
J	Yoshiya, K; Tanaka, H; Kasai, K; Irisawa, T; Shiozaki, T; Sugimoto, H				Yoshiya, K; Tanaka, H; Kasai, K; Irisawa, T; Shiozaki, T; Sugimoto, H			Profile of gene expression in the subventricular zone after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cDNA microarrays; in situ hybridization; neural stem cell; RT-PCR; subventricular zone; traumatic brain injury	GROWTH-INHIBITORY FACTOR; CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELL; RAT-BRAIN; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; MAMMALIAN FOREBRAIN; MICROARRAY ANALYSIS; ALZHEIMERS-DISEASE	Neural stem cells, which reside in the subventricular zone (SVZ) and dentate gyrus (DG) of adult mammals, give rise to new neurons throughout life. However, these neural stem cells do not appear to contribute to regeneration in the damaged central nervous system. Following traumatic brain injury (TBI) in adult rats, the number of proliferating cells labeled with bromodeoxyuridine (BrdU) is significantly increased in the bilateral SVZ and DG; however, these proliferating cells do not contribute to effective regeneration in the damaged area. To gain insight into the molecular mechanisms of these biological actions, changes in gene expression in the SVZ after brain trauma were examined by cDNA microarray. Of 9,596 genes screened, 97 were upregulated and 204 were down-regulated. Classifying these genes according to their function suggests that TBI affects a broad range of cellular functions. The validity of the data was confirmed by RT-PCR. The expression of some genes localized in the SVZ was confirmed by in situ hybridization. This combined strategy is effective for comprehensive analysis of the pathophysiological changes in the SVZ after brain injury and should contribute to the understanding of the molecular events that occur after injury. In the future, this may enable regeneration of the damaged central nervous system.	Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka 5650871, Japan	Yoshiya, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.				Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15390545] Funding Source: KAKEN		ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ANEZAKI T, 1995, NEUROCHEM INT, V27, P89, DOI 10.1016/0197-0186(94)00170-Y; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; CATTANEO E, 1991, TRENDS NEUROSCI, V14, P338, DOI 10.1016/0166-2236(91)90158-Q; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Endres M, 1999, J CLIN INVEST, V103, P347, DOI 10.1172/JCI4953; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; HOZUMI I, 1995, BRAIN RES, V688, P143, DOI 10.1016/0006-8993(95)00522-R; Hozumi I, 1996, BRAIN RES, V741, P197, DOI 10.1016/S0006-8993(96)00912-2; Hwang SY, 1999, DEV GENES EVOL, V209, P120, DOI 10.1007/s004270050234; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KUBO T, 2002, J NEUROCHEM, V83, P67; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Liu JL, 1998, J NEUROSCI, V18, P7768; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Luo YQ, 2002, J NEUROCHEM, V83, P1481, DOI 10.1046/j.1471-4159.2002.01260.x; Magavi SS, 2000, NATURE, V405, P951; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; MEANS AR, 1994, FEBS LETT, V349, P1; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Parent JM, 1997, J NEUROSCI, V17, P3727; Pende M, 1997, J NEUROSCI, V17, P1291; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; TSUJI S, 1992, EMBO J, V11, P4843, DOI 10.1002/j.1460-2075.1992.tb05590.x; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; van Praag H, 1999, NAT NEUROSCI, V2, P266; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; YUGICHI T, 1995, J NEUROTRAUM, V12, P299; Yuguchi T, 1997, J CEREBR BLOOD F MET, V17, P745	45	16	17	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2003	20	11					1147	1162		10.1089/089771503770802844			16	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	747BE	WOS:000186784600001	14651803				2021-06-18	
J	Kiening, KL; Schoening, WN; Stover, JF; Unterberg, AW				Kiening, KL; Schoening, WN; Stover, JF; Unterberg, AW			Continuous monitoring of intracranial compliance after severe head injury: relation to data quality, intracranial pressure and brain tissue PO2	BRITISH JOURNAL OF NEUROSURGERY			English	Article						cerebral oxygenation; multimodal cerebral monitoring; traumatic brain injury	SPIEGELBERG COMPLIANCE MONITOR; MULTICENTER ASSESSMENT; OXYGEN-SATURATION; COMPLIANCE DEVICE; HYDROCEPHALUS; PO-2	The objective of the present study was to test the new continuous intracranial compliance (cICC) device in terms of data quality, relationship to intracranial pressure (ICP) and brain tissue oxygenation (PtiO(2)). A total of 10 adult patients with severe traumatic brain injury underwent computerized monitoring of arterial blood pressure, ICP, cerebral perfusion pressure, end-tidal CO2, cICC and PtiO(2) providing a total of 1726 h of data. ( 1) The data quality assessed by calculating the 'time of good data quality' (TGDQ, %), i.e. the median duration of artefact-free time as a percentage of total monitoring time reached 98 and 99% for ICP and PtiO(2), while cICC measurements were free of artefacts in only 81%. ( 2) Individual regression analysis showed broad scattered correlation between cICC and ICP ranging from low (r= 0.05) to high (r = 0.52) correlation coefficients. ( 3) From 225 episodes of increased ICP ( ICP 420 mmHg 410 min), only 37 were correctly predicted by a preceding decline in cICC to pathological values (<0.5 ml/mmHg). ( 4) In all episodes of cerebral hypoxia ( PtiO2 <10 mmHg >10min), cICC was not pathologically altered. Based on the present results, we conclude that the current hardware and software version of the cICC monitoring system is unsatisfactory concerning data quality, prediction of increased ICP and revelance of cerebral hypoxic episodes.	Humboldt Univ, Virchow Med Ctr, Dept Neurosurg, Berlin, Germany	Kiening, KL (corresponding author), Univ Med Ctr, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	karl.kiening@gmx.de					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bardt TF, 1998, ACTA NEUROCHIR, V140, P357, DOI 10.1007/s007010050109; DEARDEN NM, 1993, ACTA NEUROCHIR, P91; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Piper I, 2000, ACTA NEUROCHIR SUPPL, V76, P491; Piper I, 1999, BRIT J NEUROSURG, V13, P581, DOI 10.1080/02688699943097; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P597, DOI [10.1089/neu.2000.17.597, DOI 10.1089/NEU.2000.17.597]; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Yau Y, 2002, ACTA NEUROCHIR SUPPL, V81, P167; Yau YH, 2000, J NEUROSURG, V93, P1072, DOI 10.3171/jns.2000.93.6.1072; Yau YH, 2002, ACT NEUR S, V81, P181; Yau YH, 2002, ACT NEUR S, V81, P171	20	16	19	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	AUG	2003	17	4					311	318		10.1080/02688690310001601199			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	722FC	WOS:000185363900003	14579896				2021-06-18	
J	Shackelford, DA; Yeh, RY				Shackelford, DA; Yeh, RY			Activation of extracellular signal-regulated kinases (ERK) during reperfusion of ischemic spinal cord	MOLECULAR BRAIN RESEARCH			English	Article						MAP kinase; ERK; JNK/SAPK; ischemia; reperfusion; spinal cord	FOCAL CEREBRAL-ISCHEMIA; TRANSIENT FOREBRAIN ISCHEMIA; DEPENDENT PROTEIN-KINASE; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; NEURONAL CELL-LINE; MAP-KINASE; TYROSINE PHOSPHORYLATION; REACTIVE ASTROCYTES; OXIDATIVE STRESS	The extracellular signal-regulated kinases (ERK) participate in numerous signaling pathways and are abundantly expressed in the CNS. It has been proposed that ERK activation promotes survival in models of neuronal injury. Inhibition of MEK, the upstream kinase that activates ERK, however, leads to neuroprotection in models of cerebral ischemia and trauma, suggesting that in this context ERK activation contributes to cellular damage. The effect of ischemia and reperfusion on activity and expression of ERK was investigated using a reversible model of rabbit spinal cord ischemia. Active ERK was observed in naive animals, which decreased during 15 to 60 min of ischemia. Upon reperfusion, a robust activation of ERK was observed in animals occluded for 60 min that remained permanently paraplegic. Immunohistochemical analyses revealed increased staining of phosphorylated ERK (PERK) in glial cells and faint nuclear staining in motor neurons of animals occluded for 60 min and reperfused for 18 h. In contrast ERK activity did not increase in animals occluded for 15 min that regained motor function. No evidence of increased pERK immunoreactivity in motor neurons or nuclear translocation was noted in these animals. ERK1 was demonstrated to be identical to a p46 c-Jun/ATF-2 kinase previously shown to be activated by reperfusion after a 60-min occlusion. The results suggest that activation of ERK during reperfusion of ischemic spinal cord participates in the cellular pathways leading to neuronal damage. (C) 2003 Elsevier B.V. All rights reserved.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Shackelford, DA (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS28121] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS028121] Funding Source: NIH RePORTER		Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; BOULTON TG, 1991, CELL REGUL, V2, P357; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CAMPOSGONZALEZ R, 1992, J NEUROCHEM, V59, P1955, DOI 10.1111/j.1471-4159.1992.tb11032.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; Flood DG, 1998, J COMP NEUROL, V398, P373, DOI 10.1002/(SICI)1096-9861(19980831)398:3<373::AID-CNE6>3.0.CO;2-X; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Gu ZL, 2000, BRAIN RES, V860, P157, DOI 10.1016/S0006-8993(00)02006-0; Gu ZL, 2001, BRAIN RES, V901, P79, DOI 10.1016/S0006-8993(01)02275-2; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1089, DOI 10.1097/00004647-200007000-00008; HU BR, 1994, J NEUROCHEM, V62, P1357; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Irving EA, 2000, MOL BRAIN RES, V77, P65, DOI 10.1016/S0169-328X(00)00043-7; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Kanterewicz BI, 1998, J NEUROCHEM, V70, P1009; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mandell JW, 1999, NEUROREPORT, V10, P3567, DOI 10.1097/00001756-199911260-00019; Mandell JW, 2001, GLIA, V34, P283, DOI 10.1002/glia.1062; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Murray B, 1998, P NATL ACAD SCI USA, V95, P11975, DOI 10.1073/pnas.95.20.11975; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Noshita N, 2002, J NEUROSCI, V22, P7923; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Park JA, 1999, J NEUROCHEM, V73, P450, DOI 10.1046/j.1471-4159.1999.0730450.x; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Roy M, 1999, TRENDS NEUROSCI, V22, P419, DOI 10.1016/S0166-2236(99)01435-6; Runden E, 1998, J NEUROSCI, V18, P7296; Saluja I, 1999, NEUROCHEM RES, V24, P669, DOI 10.1023/A:1021004525979; Satoh T, 2000, NEUROSCI LETT, V288, P163, DOI 10.1016/S0304-3940(00)01229-5; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; SEGER R, 1995, FASEB J, V9, P726; SHACKELFORD DA, 1993, J NEUROCHEM, V61, P738; Shackelford DA, 1999, J NEUROSCI, V19, P4727; Shackelford DA, 2001, MOL BRAIN RES, V94, P178, DOI 10.1016/S0169-328X(01)00245-5; SHACKELFORD DA, 1997, CELL BIOL LAB HDB, V4, P466; Shamloo M, 1999, NEUROSCIENCE, V93, P81, DOI 10.1016/S0306-4522(99)00137-2; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; Tan SL, 1998, J NEUROCHEM, V71, P95; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wu DC, 2000, J CEREBR BLOOD F MET, V20, P1320, DOI 10.1097/00004647-200009000-00007; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; ZIVIN JA, 1982, ARCH NEUROL-CHICAGO, V39, P408, DOI 10.1001/archneur.1982.00510190026008; ZIVIN JA, 1986, STROKE, V17, P509, DOI 10.1161/01.STR.17.3.509	59	16	16	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	JUL 23	2003	115	2					173	186		10.1016/S0169-328X(03)00206-7			14	Neurosciences	Neurosciences & Neurology	713FW	WOS:000184847300009	12877988				2021-06-18	
J	Kennedy, RE; Nakase-Thompson, R; Nick, TG; Sherer, M				Kennedy, RE; Nakase-Thompson, R; Nick, TG; Sherer, M			Use of the cognitive test for delirium in patients with traumatic brain injury	PSYCHOSOMATICS			English	Article							CONFUSION ASSESSMENT METHOD; OLDER HOSPITAL PATIENTS; DIFFERENTIAL-DIAGNOSIS; PRACTICAL SCALE; VALIDATION; ICU; INSTRUMENTS; PROGNOSIS; AMNESIA; STATE	The sensitivity and specificity of the Cognitive Test for Delirium, which was originally developed for use in intensive care units, were tested in a group of patients with traumatic brain injury who were admitted to a neurorehabilitation center Sixty-five consecutive patients were evaluated weekly by using the DSM-IV criteria for delirium and the Cognitive Test for Delirium. Complete ratings were available for 249 of 304 weekly observations. Analysis of the receiver operating characteristic curve suggested an optimum cutoff score of less than 22 for identification of delirium by using the Cognitive Test for Delirium, with a sensitivity of 72% and a specificity of 71% compared with the DSM-IV diagnosis. The results suggest that the Cognitive Test for Delirium provides an acceptable level of differentiation between delirious and nondelirious patients with traumatic brain injury.	Univ Mississippi, Med Ctr, Dept Psychiat, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Prevent Med, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA; Methodist Rehabil Ctr, Dept Neuropsychol, Jackson, MS USA	Kennedy, RE (corresponding author), Virginia Commonwealth Univ, Dept Psychiat, Med Coll Virginia Campus,Box 980268, Richmond, VA 23298 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A980035] Funding Source: Medline		American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bettin KM, 1998, AM J GERIAT PSYCHIAT, V6, P296; COLE MG, 1993, CAN MED ASSOC J, V149, P41; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; Grant I, 1987, NEUROBEHAVIORAL RECO, P234; Hagen C., 1972, LEVELS COGNITIVE FUN; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; KANE FJ, 1993, SOUTHERN MED J, V86, P985, DOI 10.1097/00007611-199309000-00001; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; MURRAY AM, 1993, J GERONTOL, V48, pM181, DOI 10.1093/geronj/48.5.M181; MYSIW WJ, 1995, NEUROREHABILITATION, V5, P197, DOI 10.3233/NRE-1995-5302; OKeeffe S, 1997, J AM GERIATR SOC, V45, P174, DOI 10.1111/j.1532-5415.1997.tb04503.x; OKeeffe ST, 1997, J AM GERIATR SOC, V45, P470, DOI 10.1111/j.1532-5415.1997.tb05173.x; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SMITH MJ, 1995, J PAIN SYMPTOM MANAG, V10, P35, DOI 10.1016/0885-3924(94)00066-T; *STAT CORP, 2001, STAT REF MAN REL 7 0; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; TAYLOR D, 1993, J NEUROL NEUROSUR PS, V56, P742, DOI 10.1136/jnnp.56.7.742; TEASDALE G, 1974, LANCET, V2, P81; THOMAS RI, 1988, ARCH GEN PSYCHIAT, V45, P937; Thompson R, 2001, J INT NEUROPSYCH SOC, V7, P177; THOMPSON RN, 2002, J INT NEUROPSYCH SOC, V8, P219; Trzepacz Paula T., 1994, P189; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Trzepacz PT, 1996, PSYCHIAT CLIN N AM, V19, P429, DOI 10.1016/S0193-953X(05)70299-9; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P433; TRZEPACZ PT, 1994, GEN HOSP PSYCHIAT, V16, P397, DOI 10.1016/0163-8343(94)90115-5; TRZEPACZ PT, 1997, AM PSYCHIAT PRESS TX, P447; TRZEPASC PT, 1994, PSYCHOSOMATICS, V35, P375; Wise MG, 1996, TXB CONSULTATION LIA, P258	38	16	18	0	9	AMER PSYCHIATRIC PRESS, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	JUL-AUG	2003	44	4					283	289		10.1176/appi.psy.44.4.283			7	Psychiatry; Psychology	Psychiatry; Psychology	694CQ	WOS:000183756600002	12832593				2021-06-18	
J	Putukian, M; Echemendia, RJ				Putukian, M; Echemendia, RJ			Psychological aspects of serious head injury in the competitive athlete	CLINICS IN SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN INJURY; SPORTS INJURIES; CHILDREN; RESPONSES; DISORDER; STRESS; RISK	In addition to the physical aspects of athletic injury, there are psychological aspects to consider. These are important during all phases of injury management: the acute injury, the rehabilitative process, and the return-to-play progression. Emotional disturbances are often associated with mild traumatic brain injury (mTBI) both directly and indirectly. Evaluating the athlete with mTBI can be made more difficult by the need to distinguish the physical and the emotional effects of injury and to differentiate the emotional factors directly related to the brain injury from those that arise indirectly (eg, reaction to being held out of play). This article discusses some of the psychological issues related to evaluating the head injured athlete.	Penn State Univ, University Pk, PA 16803 USA; Milton S Hershey Med Ctr, Dept Orthopaed & Rehabil, Hershey, PA 17033 USA	Putukian, M (corresponding author), Penn State Univ, 1850 E Pk Ave,Suite 112, University Pk, PA 16803 USA.		Echemendia, Ruben/R-6939-2019	Echemendia, Ruben/0000-0001-6116-8462			ANDERSEN MB, 1988, J SPORT EXERCISE PSY, V10, P294, DOI 10.1123/jsep.10.3.294; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; BRUCE DA, 1984, PRIMARY CARE, V11, P175; CHAN CS, 1988, PERCEPT MOTOR SKILL, V66, P875, DOI 10.2466/pms.1988.66.3.875; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Garrick J G, 1981, Phys Sportsmed, V9, P115, DOI 10.1080/00913847.1981.11711015; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Harris JKJ, 2001, BRAIN INJURY, V15, P223; KELLEY MJ, 1990, J SPORT MED PHYS FIT, V30, P202; KEUBLERROSS E, 1969, DEATH DYING; KRAUS JF, 1987, HEAD INJURY, P1; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P349; LINDER DE, 1989, J SPORT EXERCISE PSY, V11, P270, DOI 10.1123/jsep.11.3.270; LITTLE JC, 1979, PSYCHIAT ANN, V9, P148; McDonald SA, 1990, SPORT PSYCHOL, V4, P261; MCGOWAN RW, 1994, J SPORT MED PHYS FIT, V34, P299; McNair D.M., 1971, MANUAL PROFILE MOOD; Morrey MA, 1999, CLIN J SPORT MED, V9, P63, DOI 10.1097/00042752-199904000-00004; *NCAA, 1996, INJ SURV SYST 1984 1; PEDERSEN P, 1986, Athletic Training, V21, P312; PUTUKIAN M, 2001, PRINCIPLES PRACTICE, P331; PUTUKIAN M, 2002, PEDIAT SPORTS MED PR, V28, P266; ROSENBERG M, 1968, SOC ADOLESCNET SELF; Smith AM, 1996, SPORTS MED, V22, P391, DOI 10.2165/00007256-199622060-00006; SMITH AM, 1990, SPORTS MED, V9, P352, DOI 10.2165/00007256-199009060-00004; SMITH AM, 1993, MAYO CLIN PROC, V68, P939, DOI 10.1016/S0025-6196(12)62265-4; SMITH AM, 1994, J ATHL TRAINING, V29, P337; SMITH AM, 1990, MAYO CLIN PROC, V65, P38, DOI 10.1016/S0025-6196(12)62108-9; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; WEISS MR, 1986, ATHLETIC TRAINING, V21, P104; Wiese-Bjornstal D. M., 1995, ATHLETIC TRAINING SP, V1, P16; ZARICZNYJ B, 1980, AM J SPORT MED, V8, P318, DOI 10.1177/036354658000800504	37	16	16	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JUL	2003	22	3					617	+		10.1016/S0278-5919(02)00100-X			15	Sport Sciences	Sport Sciences	692LT	WOS:000183663100015	12852690				2021-06-18	
J	Villaverde-Gonzalez, R; Fernandez-Villalba, E; Moreno-Escribano, A; Alias-Linares, E; Garcia-Santos, JM				Villaverde-Gonzalez, R; Fernandez-Villalba, E; Moreno-Escribano, A; Alias-Linares, E; Garcia-Santos, JM			Foreign language syndrome as a first sign of multiple sclerosis	REVISTA DE NEUROLOGIA			Spanish	Article						aphasia; demyelinating lesions; foreign accent syndrome; multiple sclerosis; pseudotumoral lesions	APHASIC STATUS EPILEPTICUS; ACCENT SYNDROME; DEMYELINATING DISEASE; DIAGNOSTIC-CRITERIA; MRI; LESION; GUIDELINES; PATIENT; TUMOR	Introduction. Foreign accent syndrome (FAS) is a little known disorder affecting language which has been described in a few cases after acute strokes or traumatic brain injuries, but until now has not been reported in multiple sclerosis (MS). It is characterised by the appearance of what is perceived to be a foreign accent in the language of the patient. Although it could be included within the dysprosodias that accompany motor aphasias it should be considered as an entity in its own right, since it may appear without the accompanying aphasia. Aphasia is an infrequent manifestation of MS and even less so when it appears as an initial symptom of the disease. When it does occur it usually accompanies large demyelinating lesions in the dominant hemisphere, and it is usually of a motor type. Case report. Patient, aged 38 years, who presented FAS that accompanied mild non-fluent aphasia as the first manifestation of MS with pseudotumoral lesions. Initially the clinical features were interpreted as a somatoform disorder, which delayed diagnosis. Conclusions. Like aphasia, FAS can occur in MS as a manifestation of a cortical language disorder. It is important to recognise this in order to prevent mistaken diagnoses.	Univ Murcia, Hosp Jose Maria Morales Mesegur, Neurol Sect, E-30008 Murcia, Spain; Univ Murcia, Hosp Jose Maria Morales Mesegur, Serv Radiol, E-30008 Murcia, Spain			Villalba, Emiliano Fernandez/AAP-1187-2021	VILLAVERDE, RAMON/0000-0002-0064-8910			ACHIRON A, 1992, NEUROLOGY, V42, P2195, DOI 10.1212/WNL.42.11.2195; Arnett PA, 1996, NEUROLOGY, V47, P576, DOI 10.1212/WNL.47.2.576; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; Carbary TJ, 2000, BRAIN COGNITION, V43, P78; Devere TR, 2000, ARCH NEUROL-CHICAGO, V57, P1207, DOI 10.1001/archneur.57.8.1207; Di Majo L, 2002, NEUROL SCI, V23, P79, DOI 10.1007/s100720200030; Ernst T, 1998, NEUROLOGY, V51, P1486, DOI 10.1212/WNL.51.5.1486; GRAFFRADFORD NR, 1986, BRAIN LANG, V28, P86, DOI 10.1016/0093-934X(86)90093-3; GURD JM, 1988, NEUROPSYCHOLOGIA, V26, P237, DOI 10.1016/0028-3932(88)90077-2; Kearns Kevin P., 1997, P1; Khan OA, 1997, NEUROLOGY, V48, P1330, DOI 10.1212/WNL.48.5.1330; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MOEN I, 1991, BRAIN LANG, V41, P538, DOI 10.1016/0093-934X(91)90173-X; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Primavera A, 1996, EUR NEUROL, V36, P374, DOI 10.1159/000117296; Saindane AM, 2002, AM J NEURORADIOL, V23, P1378; SCHIFF HB, 1983, ARCH NEUROL-CHICAGO, V40, P720, DOI 10.1001/archneur.1983.04050110038005; SELIGER GM, 1992, STROKE, V23, P1655, DOI 10.1161/01.STR.23.11.1655; Silva HCA, 1999, ARQ NEURO-PSIQUIAT, V57, P921, DOI 10.1590/S0004-282X1999000600004; TAKAYAMA Y, 1993, NEUROLOGY, V43, P1361, DOI 10.1212/WNL.43.7.1361; Trinka E, 2002, J NEUROL, V249, P782, DOI 10.1007/s00415-002-0705-5; Trinka E, 2001, ARCH NEUROL-CHICAGO, V58, P133, DOI 10.1001/archneur.58.1.133; ZAGZAG D, 1993, AM J SURG PATHOL, V17, P537, DOI 10.1097/00000478-199306000-00001	25	16	18	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	JUN 1	2003	36	11					1035	1039		10.33588/rn.3611.2002609			5	Clinical Neurology	Neurosciences & Neurology	696HU	WOS:000183882200009	12808499				2021-06-18	
J	Barrow, IM; Hough, M; Rastatter, MP; Walker, M; Holbert, D; Rotondo, MF				Barrow, IM; Hough, M; Rastatter, MP; Walker, M; Holbert, D; Rotondo, MF			Can within-category naming identify subtle cognitive deficits in the mild traumatic brain-injured patient?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	15th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 16-19, 2002	ORLANDO, FLORIDA	Eastern Assoc Surg Trauma		mild traumatic brain injury (MTBI); category; speed; accuracy; reaction time	CLOSED-HEAD-INJURY; REACTION-TIME; PERCEPTUAL DIFFERENTIATION; ATTENTION DEFICITS; MEMORY; CHILDREN; LESIONS; ACCESS; TASK; PERFORMANCE	Background: This investigation examined the effect of a speeded, computer-controlled task on detecting differences in latency and accuracy of within-category name generation in adults having sustained a mild traumatic brain injury (MTBI). Methods: Twenty-four adults in acute recovery and 24 age-matched controls were instructed to view 72 pictures on a computer monitor, and then name another item be-longing to the same category as the visual stimulus as quickly as possible. Results: The MTBI group demonstrated significantly longer latencies (p < 0.001) and lower accuracy (p < 0.001) than the control group. Both groups displayed similar patterns of response, although the MTBI group produced significantly more perseverative errors (p < 0.001). No significant correlations were found between performance on the Scales of Cognitive Ability for Traumatic Brain Injury and response latency or accuracy. Conclusion: The MTBI group performed the task significantly slower and less accurately than controls. Reaction time measures may prove more sensitive than traditional assessment measures in detecting subtle difficulties.	E Carolina Univ, Sch Allied Hlth Sci, Dept Commun Sci & Disorders, Greenville, NC USA; E Carolina Univ, Dept Surg, Greenville, NC USA	Barrow, IM (corresponding author), 704 Amberline Court, Chesapeake, VA 23322 USA.			Walker, Marianna/0000-0002-6342-9088			ABBOUD H, 1997, SUPERLAB PRO EXPT LA; Adamovich B. B., 1992, SCALES COGNITIVE ABI; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Baddeley A. D., 1994, Neuropsychology, V8, P485, DOI [10.1037/0894-4105.8.4.485., 10.1037/0894-4105.8.4.485]; Barrow IM, 2000, AM J SPEECH-LANG PAT, V9, P310, DOI 10.1044/1058-0360.0904.310; BIGGS TC, 1990, AM J PSYCHOL, V103, P81, DOI 10.2307/1423260; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; DELL GS, 1992, COGNITION, V42, P287, DOI 10.1016/0010-0277(92)90046-K; Gerlach C, 1999, BRAIN, V122, P2159, DOI 10.1093/brain/122.11.2159; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Hayden M E, 1997, AAOHN J, V45, P635; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hough MS, 1997, BRAIN INJURY, V11, P801; HUMPHREYS GW, 1987, VISUAL OBJECT PROCES; JENKINS A, 1986, LANCET, V2, P445; KAPUR S, 1994, NEUROREPORT, V5, P2193, DOI 10.1097/00001756-199410270-00051; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kopelman MD, 1998, NEUROPSYCHOLOGIA, V36, P785, DOI 10.1016/S0028-3932(97)00167-X; LA HEIJ W, 1990, BRIT J PSYCHOL, V81, P511; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVELT WJM, 1989, SPEAKING INTENTION A; LloydJones T, 1997, MEM COGNITION, V25, P606, DOI 10.3758/BF03211303; LloydJones TJ, 1997, MEM COGNITION, V25, P18, DOI 10.3758/BF03197282; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MARTIN N, 1989, J MEM LANG, V28, P462, DOI 10.1016/0749-596X(89)90022-3; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NOVOA OP, 1987, BRAIN LANG, V30, P206, DOI 10.1016/0093-934X(87)90099-X; Paivio A., 1971, IMAGERY VERBAL PROCE; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; REEDER KP, 1994, ARCH CLIN NEUROPSYCH, V9, P491, DOI 10.1016/0887-6177(94)90040-X; RICHARDSON JTE, 1984, CORTEX, V20, P413, DOI 10.1016/S0010-9452(84)80009-X; Robinson-Boone KA, 1999, J MED SPEECH-LANG PA, V7, P47; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; SALMELIN R, 1994, NATURE, V368, P463, DOI 10.1038/368463a0; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; THEIOS J, 1989, PSYCHOL REV, V96, P5, DOI 10.1037/0033-295X.96.1.5; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; VITKOVITCH M, 1993, J EXP PSYCHOL LEARN, V19, P243; VITKOVITCH M, 1991, J EXP PSYCHOL LEARN, V17, P664, DOI 10.1037/0278-7393.17.4.664; Wrightson P, 1998, NEW ZEAL MED J, V111, P99; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924; Zwaagstra R, 1996, J CLIN EXP NEUROPSYC, V18, P383, DOI 10.1080/01688639608408995	59	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2003	54	5					888	895		10.1097/01.TA.0000057150.60668.7C			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	687BN	WOS:000183356100016	12777901				2021-06-18	
J	Mayer, NH; Pelensky, J; Whyte, J; Fidler-Sheppard, R				Mayer, NH; Pelensky, J; Whyte, J; Fidler-Sheppard, R			Characterization and correlates of medical and rehabilitation charges for traumatic brain injury during acute rehabilitation hospitalization	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; hospital charges; inpatients; rehabilitation	STAY; LENGTH; IMPACT	Objective: To identify factors associated with specific categories of charges during acute inpatient rehabilitation treatment after traumatic brain injury (TBI). Design: Prospective observational study. Setting: A single Traumatic Brain Injury Model Systems (TBIMS) center. Participants: Eighty-four consecutive TBIMS patients. One exploratory analysis also included all 350 patients with TBI admitted during 1999. Interventions: Not applicable. Main Outcome Measures: Average daily charges for specific categories of resource use (eg, room and board, rehabilitation therapies, functional labs). Results: Room and board and rehabilitation therapy accounted for almost 90% of average daily charges. There was no linear component of change in average daily charges, but certain categories of charges were significantly higher during the first week than thereafter. Functional status at rehabilitation admission correlated with charges for respiratory, medical, and surgical supplies and with pharmacy and radiology, but not the other categories. Specific medical variables also correlated with specific charge categories. Focused chart reviews of patients with low and high charges in specific categories led to the formulation of additional predictive hypotheses. Conclusion: Certain categories of charges correlated with functional scores and acute medical variables that are known before admission to acute inpatient rehabilitation, allowing for better inpatient admission planning under prospective payment. Further research is needed to identify and correlate resource use that is bundled within the room and board category.	Albert Einstein Healthcare Network, MossRehab, Drucker Brain Injury Ctr, Jefferson Hlth Syst, Philadelphia, PA 19141 USA; Temple Univ, Sch Med, Dept Rehabil Med, Philadelphia, PA 19122 USA; Thomas Jefferson Univ, Dept Rehabil Med, Philadelphia, PA 19107 USA; Moss Rehabil Res Inst, Philadelphia, PA USA	Mayer, NH (corresponding author), Albert Einstein Healthcare Network, MossRehab, Drucker Brain Injury Ctr, Jefferson Hlth Syst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.			Whyte, John/0000-0002-4381-1474			COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; *CTR MED MED SERV, 2001, FED REGISTER, V66, P152; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; Foster J, 1996, AACN Clin Issues, V7, P168, DOI 10.1097/00044067-199602000-00016; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Haas JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199702000-00003; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; 1998, REHABILITATION TRAUM	11	16	16	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					242	248		10.1053/apmr.2003.50101			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	643QV	WOS:000180872700014	12601656				2021-06-18	
J	Stringer, AY				Stringer, AY			Cognitive rehabilitation practice patterns: A survey of American hospital association rehabilitation programs	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMATIC BRAIN-INJURY; STROKE; EPIDEMIOLOGY; DISABILITY; AMNESIA	Results of a survey of cognitive rehabilitation (CRT) practice patterns are reported. Of 270 programs contacted, 45% responded. Most patients were under age 65, had a stroke or brain injury, and underwent individual CRT for attention or memory problems while hospitalized. CRT typically lasted 1-6 months and cost $130 per session. Rehearsal and compensation approaches were employed equally, while computer-based procedures were infrequent. Speech and occupational therapists provided services more than neuropsychologists and few programs incorporated neuropsychological testing. Results suggest opportunities for research and expansion of neuropsychological practice and highlight the need for better communication between researchers and clinicians.	Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA	Stringer, AY (corresponding author), Emory Univ, Dept Rehabil Med, 1441 Clifton Rd NE, Atlanta, GA 30322 USA.	anthony_stringer@emoryhealthcare.org					BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; BUTLER RW, 1988, J NEUROLOGICAL REHAB, V2, P97; CHESTNUT RM, 1999, J HEAD TRAUMA REHAB, V14, P277; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Clare L, 2000, J CLIN EXP NEUROPSYC, V22, P132, DOI 10.1076/1380-3395(200002)22:1;1-8;FT132; Clare L, 1999, NEUROCASE, V5, P37, DOI 10.1080/13554799908404063; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; GLISKY EL, 1992, NEUROPSYCHOLOGIA, V30, P899, DOI 10.1016/0028-3932(92)90034-J; GLISKY EL, 1992, J HEAD TRAUMA REHAB, V7, P1; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HARTER GW, 1987, REHABILITATION COGNI, P95; Kuller LH, 2000, EPIDEMIOL REV, V22, P14, DOI 10.1093/oxfordjournals.epirev.a018011; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; Lincoln NB, 2002, J NEUROL NEUROSUR PS, V72, P93, DOI 10.1136/jnnp.72.1.93; MACKAY LE, 1994, J HEAD TRAUMA REHAB, V9, P11; Matthews E, 1991, GLOBAL BIOGEOCHEM CY, V5, P3, DOI 10.1029/90GB02311; Mazmanian Paul E., 1993, Brain Injury, V7, P319, DOI 10.3109/02699059309034958; Nadolne MJ, 2001, J INT NEUROPSYCH SOC, V7, P675, DOI 10.1017/S1355617701766039; Ruff R, 1991, COGNITIVE REHABILITA, P23; Sohlberg MM, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199604000-00007; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298; WILLER B, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P18; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	27	16	16	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	2003	17	1					34	44		10.1076/clin.17.1.34.15625			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	707XM	WOS:000184535300003	12854009				2021-06-18	
J	van der Heijden, P; Donders, J				van der Heijden, P; Donders, J			A confirmatory factor analysis of the WAIS-III in patients with traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							MEMORY MALINGERING TOMM; WISC-III; REPLICATION; SAMPLE; INTELLIGENCE; CHILDREN; SCORES	Maximum likelihood confirmatory factor analysis was performed on the WAIS-III data of a sample of 166 patients with traumatic brain injury (TBI). Four competing hypothetical models were tested for model fit and parsimony. A four-factor model composed of Verbal Comprehension, Perceptual Organization, Working Memory, and Processing Speed, identical to that proposed for the standardization sample, provided the best fit to the clinical data. The results support the construct validity of these four factors in patients with TBI.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA	Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.						Arnau RC, 2000, ASSESSMENT, V7, P237, DOI 10.1177/107319110000700304; Benton A. L., 1994, CONTRIBUTIONS NEUROP; Browne M.W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1996, CHILD NEUROPSYCHOL, V2, P185, DOI 10.1080/09297049608402251; Gorsuch R. L., 1983, FACTOR ANAL; Hatcher L, 1994, STEP STEP APPROACH U; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Kaufman AS, 2001, ASSESSMENT, V8, P267, DOI 10.1177/107319110100800303; Kaufman AS, 1999, ESSENTIALS WAIS 3 AS; Konold TR, 1997, J PSYCHOEDUC ASSESS, V15, P123, DOI 10.1177/073428299701500203; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MILLIS SR, 1997, M INT NEUR SOC BERG; NETEMEYER RG, 1990, J APPL PSYCHOL, V75, P148, DOI 10.1037/0021-9010.75.2.148; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; ROID GH, 1993, J PSYCHOEDUC ASSESS, P6; Ryan JJ, 2001, ARCH CLIN NEUROPSYCH, V16, P151, DOI 10.1016/S0887-6177(99)00061-X; Saklofske DH, 2000, PSYCHOL ASSESSMENT, V12, P436, DOI 10.1037/1040-3590.12.4.436; *SAS I, 1990, SAS STAT US GUID VER, V1; Smith A., 1991, SYMBOL DIGIT MODALIT; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; THOMPSON B, 1992, EDUC PSYCHOL MEAS, V52, P69, DOI 10.1177/001316449205200107; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; Ward LC, 2000, PSYCHOL ASSESSMENT, V12, P341, DOI [10.1037/1040-3590.12.3.341, 10.1037//1040-3590.12.3.341]; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler, 1997, WAIS 3 WMS 3 TECHNIC; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 1991, WECHSLER INTELLIGENC; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	34	16	16	0	5	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	2003	25	1					59	65		10.1076/jcen.25.1.59.13627			7	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	666YD	WOS:000182203300006	12607172				2021-06-18	
J	Prins, ML; Povlishock, JT; Phillips, LL				Prins, ML; Povlishock, JT; Phillips, LL			The effects of combined fluid percussion traumatic brain injury and unilateral entorhinal deafferentation on the juvenile rat brain	DEVELOPMENTAL BRAIN RESEARCH			English	Article						traumatic brain injury; entorhinal lesion; synaptic plasticity; development; deafferentation; synaptic reorganization	CEREBRAL BLOOD-FLOW; DENTATE GYRUS; HISTOCHEMICAL EVIDENCE; GLUCOSE-METABOLISM; CORTICAL LESION; AXONAL INJURY; HEAD-INJURY; TIME-COURSE; ADULT-RAT; IMMATURE	The current study was designed to address the effects of traumatic brain injury (TBI) on plasticity and reorganization in the juvenile brain. Given that two of the major pathological sequelae of TBI involve a generalized neuroexcitation insult and diffuse axonal injury, we have employed models of these pathologies, delivered either independently or in combination, to examine their effects on injury-induced synaptic reorganization of the dentate gyrus in the developing rat. Postnatal day 28 rats received either sham, central fluid percussion traumatic brain injury (TBI), unilateral entorhinal cortical lesion (UEC), or TBI+UEC (TUEC) injury. Cognitive performance was assessed in the Morris water maze (MWM) between 11 and 15 days post-injury and the brains were processed for synaptophysin immunohistochemistry and routine electron microscopy. The MWM results revealed that TBI or UEC lesions delivered independently do not produce significant morbidity in P28 rats. However, when these injuries are combined, they reveal significant deficits in the MWM, accompanied by measurable changes in the distribution of presynaptic synaptophysin immunoreactivity over the deafferented dentate molecular layer. These observations are further supported by qualitative ultrastructural alterations in synaptic architecture in the same subregions of the dentate neuropil. The present findings show that the resilience of the immature brain following TBI is reduced when neuroexcitatory insult is combined with deafferentation. Moreover, when deafferented tissue is assessed morphologically, evidence exists for aberrant plasticity and abnormal synaptic reorganization in the juvenile brain. (C) 2002 Elsevier Science B.V. All rights reserved.	Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA	Prins, ML (corresponding author), Univ Calif Los Angeles, Div Neurosurg, NPI 18-228,Box 957039, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587, NS07288-13] Funding Source: Medline		Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; COTMAN CW, 1973, P NATL ACAD SCI USA, V70, P3473, DOI 10.1073/pnas.70.12.3473; DUPREE JL, 1994, J NEUROSCI RES, V39, P567, DOI 10.1002/jnr.490390508; ELBADAWI A, 1967, J HISTOCHEM CYTOCHEM, V15, P580, DOI 10.1177/15.10.580; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Kennard MA, 1936, AM J PHYSIOL, V115, P138; KOLB B, 1991, BEHAV BRAIN RES, V43, P51, DOI 10.1016/S0166-4328(05)80051-8; KOLB B, 1988, BEHAV BRAIN RES, V28, P259, DOI 10.1016/0166-4328(88)90129-5; KOLB B, 1987, BEHAV BRAIN RES, V26, P119, DOI 10.1016/0166-4328(87)90161-6; KRAUS JF, 1987, PEDIATRICS, V79, P501; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; LYNCH G, 1972, BRAIN RES, V42, P311, DOI 10.1016/0006-8993(72)90533-1; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NADLER JV, 1977, J COMP NEUROL, V171, P561, DOI 10.1002/cne.901710409; Phillips LL, 1998, HIPPOCAMPUS, V8, P390, DOI 10.1002/(SICI)1098-1063(1998)8:4<390::AID-HIPO7>3.0.CO;2-L; Phillips LL, 1997, J NEUROSCI RES, V49, P197; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; PHILLIPS LL, 1987, MOL BRAIN RES, V2, P251, DOI 10.1016/0169-328X(87)90032-5; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; PRINS ML, IN PRESS J NEUROTRAU; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; STEWARD O, 1976, SCIENCE, V194, P426, DOI 10.1126/science.982024; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	37	16	17	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-3806			DEV BRAIN RES	Dev. Brain Res.	JAN 13	2003	140	1					93	104	PII S0165-3806(02)00588-6	10.1016/S0165-3806(02)00588-6			12	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	640KV	WOS:000180688800009	12524180				2021-06-18	
J	Malmvik, J; Herbertsson, P; Josefsson, PO; Hasserius, R; Besjakov, J; Karlsson, MK				Malmvik, J; Herbertsson, P; Josefsson, PO; Hasserius, R; Besjakov, J; Karlsson, MK			Fracture of the radial head and neck of Mason types II and III during growth: a 14-25 year follow-up	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						children; fracture; long-term; radial head; radial neck	CHILDREN; REDUCTION	Twenty-four individuals, who were 16 years of age or younger when they sustained a fracture of the radial head or neck, were examined at a mean of 19 years (range 14-25 years) after injury. The 12 girls and 12 boys were a mean age of 11 years (range 5-16 years) when the fracture was sustained. Two were excluded due to late resection of the radial head following persisting pain. The fractures, which were of Mason type II in 19 and type III in three cases, were treated by mobilization in eight cases, plaster in eight, open reduction and internal fixation in three and closed reduction and plaster in three. At the follow-up examination, 19 (86%) had no complaints, while three (14%) had occasional pain. Flexion was decreased in the formerly injured compared with the uninjured elbow (139 + 8degrees versus 142+/-5degrees; P<0.05). None had developed elbow osteoarthritis. Isolated, closed fracture of the radial head and neck during growth has a favourable, long-term outcome.	UMAS, Univ Hosp, Dept Orthopaed & Radiol, Malmo, Sweden	Karlsson, MK (corresponding author), Malmo Univ Hosp, Dept Orthopaed, SE-20502 Malmo, Sweden.						AKESSON K, 1992, OSTEOPOROSIS INT, V2, P201, DOI 10.1007/BF01623927; BLOUNT WP, 1955, FRACTURES CHILDREN, P56; COLTON CL, 1973, INJURY, V5, P121, DOI 10.1016/S0020-1383(73)80088-9; FOWLES JV, 1986, J PEDIATR ORTHOPED, V6, P51; HENRIKSON B, 1969, ACTA ORTHOP SCAND, V40, P246, DOI 10.3109/17453676908989505; JEFFERY CC, 1950, J BONE JOINT SURG BR, V32, P314; JONES ERL, 1971, J BONE JOINT SURG BR, V53, P423; JONSSON B, 1994, J EPIDEMIOL COMMUN H, V48, P489, DOI 10.1136/jech.48.5.489; LINDHAM S, 1979, ACTA ORTHOP SCAND, V50, P79, DOI 10.3109/17453677909024093; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; MERCHAN ECR, 1994, J TRAUMA, V37, P812; MERCHAN ECR, 1991, ORTHOPEDICS, V14, P697; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; NEWMAN JH, 1977, INJURY, V9, P114, DOI 10.1016/0020-1383(77)90004-3; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; Patterson RF, 1934, J BONE JOINT SURG, V16, P695; PESUDO JV, 1982, CLIN ORTHOP RELAT R, V169, P215; RADOMISLI TE, 1998, CLIN ORTHOP RELAT R, V353, P30; REIDY JA, 1963, J BONE JOINT SURG AM, V45, P1355, DOI 10.2106/00004623-196345070-00002; SALTER RB, 1963, J BONE JOINT SURG AM, V45, P587, DOI 10.2106/00004623-196345030-00019; SPONSELLER PD, 1994, HAND CLIN, V10, P495; STEELE JA, 1992, J BONE JOINT SURG BR, V74, P760; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; TACHDJIAN MO, 1972, PEDIATRIC ORTHOPEDIC, P1613; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013; VAHVANEN V, 1978, ACTA ORTHOP SCAND, V49, P32, DOI 10.3109/17453677809005720	26	16	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JAN	2003	12	1					63	68		10.1097/00009957-200301000-00012			6	Orthopedics; Pediatrics	Orthopedics; Pediatrics	640FK	WOS:000180677500012	12488775				2021-06-18	
J	Mukherjee, D; Reis, JP; Heller, W				Mukherjee, D; Reis, JP; Heller, W			Women living with traumatic brain injury: Social isolation, emotional functioning and implications for psychotherapy	WOMEN & THERAPY			English	Article						women; psychotherapy; traumatic brain injury; social functioning; emotional functioning		Women living with Traumatic Brain Injury (TBI) typically experience social and emotional sequelae that can be effectively addressed in the context of a psychotherapeutic relationship. Traumatic Brain Injuries can affect the full range of human functioning, from activities of daily living to experiencing a coherent sense of self. In this article, we focus on two issues, social isolation and emotional functioning, that encompass a number of key challenges facing women with TBI and are common and fruitful foci of psychotherapy. Social isolation includes marginalization in multiple communities, the invisibility of cognitive disabilities, difficulties in interpersonal relationships, and difficulties in employment and access to transportation. Emotional functioning includes posttraumatic stress symptoms, loss of self-esteem, anxiety, depression, anger, and shame. Two exemplary cases are used to illustrate the themes and underscore the complexities and realities of adjusting to TBI. Recommendations for therapists and consumers are woven throughout the paper.	Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; Rehabil Inst Chicago, Hlth Resource Ctr Women Disabil, Chicago, IL USA; Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; Univ Illinois, Beckman Inst, Champaign, IL 61820 USA	Mukherjee, D (corresponding author), Univ Chicago, MacLean Ctr Clin Med Eth, AMB W732,MC 6098,5841 S Maryland Ave, Chicago, IL 60637 USA.			Mukherjee, Debjani/0000-0002-8233-8608			Bergquist TF, 1994, J HEAD TRAUMA REHAB, V9, P50, DOI 10.1097/00001199-199412000-00007; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Gill C. J., 1994, REFRAMING WOMENS HLT, P357; HELLER W, 1997, NEUROPSYCHOLOGY NEUR, P398; LANGER KG, 1992, AM J PSYCHOTHER, V46, P620; Lewis L., 1991, AWARENESS DEFICIT BR, P223; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Mukherjee D, 2001, REHABIL PSYCHOL, V46, P82, DOI 10.1037/0090-5550.46.1.82; MUKHERJEE D, 2000, THESIS U ILLINOIS UR; *NIH, 1998, REH PERS TRAUM BRAIN, V16, P1; PENNEBAKER JW, 1995, EMOTION DISCLOSURE H, P671; Pollack Irwin W., 1994, P671; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1994, BRAIN INJURY NEUROPS, P173; PRIGATANO GP, 1999, COGNITIVE NEUROREHAB; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; STEWART JE, 2000, THESIS U ILLINOIS UR; *US GAO, 1998, GAOHEHS9855; WORTMAN CB, 1989, J CONSULT CLIN PSYCH, V57, P349, DOI 10.1037/0022-006X.57.3.349	22	16	16	0	11	HAWORTH PRESS INC	BINGHAMTON	10 ALICE ST, BINGHAMTON, NY 13904-1580 USA	0270-3149			WOMEN THER	Women Ther.		2003	26	1-2					3	26		10.1300/J015v26n01_01			24	Psychology, Multidisciplinary; Women's Studies	Psychology; Women's Studies	689YK	WOS:000183520400003					2021-06-18	
J	O'Neil-Pirozzi, TM; Momose, KJ; Mello, J; Lepak, P; McCabe, M; Connors, JJ; Lisiecki, DJ				O'Neil-Pirozzi, TM; Momose, KJ; Mello, J; Lepak, P; McCabe, M; Connors, JJ; Lisiecki, DJ			Feasibility of swallowing interventions for tracheostomized individuals with severely disordered consciousness following traumatic brain injury	BRAIN INJURY			English	Article							HEAD TRAUMA; ASPIRATION; TRACHEOTOMY	Primary objective: To report the ability of 12 tracheostomized acute rehabilitation hospital inpatients with severely disordered consciousness post-traumatic brain injury (TBI) to participate in an objective swallowing assessment. Research design: Post hoc analysis of data from a larger, prospective blinded comparison study. Methods and procedures: Subjects completed a modified barium swallow (MBS) study. Food/drink and tracheostomy tube management recommendations were made. Main outcomes and results: All subjects participated successfully during an MBS. Post-MBS, 10 subjects began receiving small amounts of food and/or drink. Prior to hospital discharge, all subjects received some food and/or drink and were extubated. Subjects were deemed representative of this patient population and, from a swallowing perspective, other tracheostomized patient populations at the same facility. Conclusions: Clinicians should routinely consider tracheostomized, acute rehabilitation hospital inpatients with severely disordered consciousness post-TBI potential MBS candidates. Implications and continued research needs are discussed.	Northeastern Univ, Boston, MA 02115 USA; Spaulding Rehabil Hosp, Boston, MA USA	O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, 103 Forsyth Bldg, Boston, MA 02115 USA.	toneilpi@lynx.dac.neu.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC003848] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03 DC 3848] Funding Source: Medline		ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BONE DK, 1974, ANN THORAC SURG, V18, P30, DOI 10.1016/S0003-4975(10)65714-1; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; CURTIS JL, 1997, DEGLUTITION ITS DISO, P99; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Groher Michael E., 1994, Dysphagia, V9, P233, DOI 10.1007/BF00301916; HAGAN C, 1979, REHABILITATION HEAD, P87; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; JEAN A, 1979, BRAIN RES, V178, P567, DOI 10.1016/0006-8993(79)90715-7; Keren O, 2001, BRAIN INJURY, V15, P531, DOI 10.1080/02699050010007371; KLINGBEIL GEG, 1988, ARCH PHYS MED REHAB, V69, P493; Langmore S., 2001, ENDOSCOPIC EVALUATIO, P1; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Lazarus CL, 1989, J HEAD TRAUMA REHAB, V4, P34; Leder SB, 1999, J HEAD TRAUMA REHAB, V14, P448, DOI 10.1097/00001199-199910000-00005; Leder SB, 2000, LARYNGOSCOPE, V110, P641, DOI 10.1097/00005537-200004000-00019; Linden P., 1993, Dysphagia, V8, P170, DOI 10.1007/BF01354535; LOGEMANN J, 1982, ANN CONV AM SPEECH L; LOGEMANN J A, 1990, Dysphagia, V4, P202, DOI 10.1007/BF02407266; Logemann J. A., 1998, EVALUATION TREATMENT; MACKAY L, 1993, DYSPHAGIA, V8, P161; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Martin Bonnie J. W., 1994, Dysphagia, V9, P1; MILLER AJ, 1982, PHYSIOL REV, V62, P129; Miller AJ, 1997, DEGLUTITION ITS DISO, P43; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; ONEILPIROZZI TM, IN PRESS DYSPHAGIA; Piguet O, 1999, BRAIN INJURY, V13, P829, DOI 10.1080/026990599121223; SMITH GJ, 1985, HEAD INJURY REHABILI, P275; SPLAINGARD ML, 1988, ARCH PHYS MED REHAB, V69, P637; TEASDALE G, 1974, LANCET, V2, P81; Whyte J., 1999, REHABILITATION ADULT, P435; Wilson SL, 1996, BRAIN INJURY, V10, P807, DOI 10.1080/026990596123927	37	16	16	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2003	17	5					389	399		10.1080/0269905031000070251			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	660MQ	WOS:000181837300003	12745711				2021-06-18	
J	Yamamoto, T; Mori, K; Maeda, M				Yamamoto, T; Mori, K; Maeda, M			Assessment of prognostic factors in severe traumatic brain injury patients treated by mild therapeutic cerebral hypothermia therapy	NEUROLOGICAL RESEARCH			English	Article						cerebral perfusion pressure; hypothermia; intracranial pressure; jugular venous blood oxygen saturation; prognosis; traumatic brain injury	SEVERE HEAD-INJURY; NITRIC-OXIDE SYNTHESIS; MODERATE HYPOTHERMIA; NEURONAL INJURY; METABOLIC-RATE; BLOOD-FLOW; TEMPERATURE; MANAGEMENT; ISCHEMIA; RELEASE	This study analyzed the predictable factors of outcome such as neuro-para meters and systemic complications to elucidate the indications for therapeutic hypothermia. In our institute, 35 patients with severe head injury (Glasgow Coma Scale 3-7) were treated with mild hypothermia therapy (33degrees-35degreesC). Twenty-two of these 35 patients underwent complete neuromonitoring and outcome assessments by Glasgow Outcome Scale (GOS) at three months after injury. GOS of hypothermia group was significantly better than another patient group which was treated without mild hypothermia therapy. The hypothermia group was divided into two groups: good outcome (GOOD) (good recovery or moderate disability; n = 9, 40.9%) and poor outcome (POOR) (severe disability, vegetative state, or death, n = 13, 59.1%). The mean age (mean 30.2 years, range 9-46) was significantly lower in GOOD than in POOR (mean 45.2 years, range 17-62). Patients aged over 50 years had poor outcome. CPP was significantly higher in GOOD during hypothermia. All patients with thrombocytopenia had poor outcome. Hypothermia therapy can improve outcome in patients with traumatic brain injury who are younger than 50 years old, without severe brain damage, and if improvement of cerebral perfusion is expected. Systemic complications must be prevented as far as possible by combination with other therapies.	Juntendo Univ, Izunagaoka Hosp, Dept Neurosurg, Izunagaoka Cho, Shizuoka 4102295, Japan	Yamamoto, T (corresponding author), Juntendo Univ, Izunagaoka Hosp, Dept Neurosurg, 1129 Nagaoka, Izunagaoka Cho, Shizuoka 4102295, Japan.						Alkan T, 2001, NEUROSURG QUART, V11, P96, DOI 10.1097/00013414-200106000-00003; Aoki A, 2002, NEUROL RES, V24, P271, DOI 10.1179/016164102101199909; Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHOPP M, 1991, STROKE, V22, P37, DOI 10.1161/01.STR.22.1.37; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; FREWEN TC, 1989, CRIT CARE MED, V17, P912, DOI 10.1097/00003246-198909000-00015; Fujisawa H, 1999, J NEUROTRAUM, V16, P1083, DOI 10.1089/neu.1999.16.1083; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KADER A, 1994, NEUROSURGERY, V35, P272, DOI 10.1227/00006123-199408000-00013; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MICHENFELDER JD, 1991, ANESTHESIOLOGY, V75, P130, DOI 10.1097/00000542-199107000-00021; Mori K, 1998, NEUROL RES, V20, P719; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; REULER JB, 1978, ANN INTERN MED, V89, P519, DOI 10.7326/0003-4819-89-4-519; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	30	16	17	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	DEC	2002	24	8					789	795		10.1179/016164102101200906			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	622PR	WOS:000179655900008	12500702				2021-06-18	
J	Zhou, F; Braddock, JF; Hu, Y; Zhu, XW; Castellani, RJ; Smith, MA; Drew, KL				Zhou, F; Braddock, JF; Hu, Y; Zhu, XW; Castellani, RJ; Smith, MA; Drew, KL			Microbial origin of glutamate, hibernation and tissue trauma: an in vivo microdialysis study	JOURNAL OF NEUROSCIENCE METHODS			English	Article; Proceedings Paper	9th International Conference on In Vivo Methods Monitoring Molecules in Neuroscience	JUN 16-19, 2001	UNIV COLL DUBLIN, DUBLIN, IRELAND	Natl Univ Ireland	UNIV COLL DUBLIN	excitotoxicity; microdialysis; Ralstonia; hibernation; penetrating brain injury; Pseudomonas; Burkholderia	GAMMA-AMINOBUTYRIC-ACID; EXCITATORY AMINO-ACIDS; GROUND-SQUIRRELS; BRAIN INJURY; EXTRACELLULAR GLUTAMATE; RELEASE; CALCIUM; SUPPRESSION; MENINGITIS; METABOLISM	Using quantitative microdialysis in hibernating Arctic ground squirrels (AGS), striatal glutamate concentrations ([glu](dia)) progressively increased to approximately 200 muM after 3 days of microdialysis in euthermic but not hibernating ground squirrels. Initially, the progressive increase in [glu](dia) was thought to be related to greater tissue response in euthermic animals. Alternatively, given the vastly different body temperatures between the two groups (37 vs. 3 degreesC), glutamate might have originated from microbes," replicating at a faster rate in the warmer animals. To test these hypotheses, microdialysis was repeated using sterile technique and tissue response surrounding the probe tract was assessed in hematoxylin and eosin stained sections. Using sterile microdialysis technique, traumatic tissue response was greater in euthermic compared to hibernating tissue. However, sterile microdialysis abolished the progressive increase in glutamate. To confirm the microbial origin of glutamate we monitored [glu](dia), collected in vitro from probes immersed in glutamine-rich liquid medium incubated at 37 degreesC. In vitro, [glu](dia) increased as much as in vivo. Two bacteria isolated from in vitro dialysate and liquid medium were both identified as Ralstonia pickettii. Growth of these isolates as well as glutamate release was enhanced when glutamine rather than NH4NO3 was added to the medium suggesting the bacteria utilize glutamine preferentially over ammonium as a nitrogen source. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Alaska, Inst Arctic Biol, Dept Chem & Biochem, Fairbanks, AK 99775 USA; Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	Drew, KL (corresponding author), Univ Alaska, Inst Arctic Biol, Dept Chem & Biochem, POB 757000, Fairbanks, AK 99775 USA.		Smith, Mark A/A-9053-2009; Zhu, Xiongwei/A-9629-2009; Drew, Kelly L/B-7995-2013; Castellani, Rudy J/A-9555-2009	Zhu, Xiongwei/0000-0003-2092-6508; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS041069, R01NS038648] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38648, NS41069-01] Funding Source: Medline		Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; BURKOVSKI A, 1995, ARCH MICROBIOL, V164, P24; Drew KL, 1999, BRAIN RES, V851, P1, DOI 10.1016/S0006-8993(99)01969-1; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; DREW KL, 1991, J NEUROCHEM, V57, P1927, DOI 10.1111/j.1471-4159.1991.tb06405.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; FRERICHS KU, 1995, AM J PHYSIOL-REG I, V268, pR445; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Gentile NT, 1996, NEUROCHEM RES, V21, P947, DOI 10.1007/BF02532345; Glazer AN, 1995, MICROBIAL BIOTECHNOL; GUERRAROMERO L, 1993, PEDIATR RES, V33, P510, DOI 10.1203/00006450-199305000-00018; HU Y, 1998, SOC NEUR ABSTR, P676; Kaufman B A, 1990, Infect Dis Clin North Am, V4, P677; LACY S, 1991, J HOSP INFECT, V17, P45; LYMAN CP, 1948, J EXP ZOOL, V109, P55, DOI 10.1002/jez.1401090105; MCKENNA, 1968, P SOC EXP BIOL MED, V129, P720; Neidhardt F., 1990, PHYSL BACTERIAL CELL; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Osborne PG, 1999, BRAIN RES, V839, P1, DOI 10.1016/S0006-8993(99)01627-3; PHILLIPS I, 1972, LANCET, V1, P1258; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; SIDKY YA, 1969, P SOC EXP BIOL MED, V132, P760; SNAPP BD, 1981, PHYSIOL ZOOL, V54, P297, DOI 10.1086/physzool.54.3.30159944; Spranger M, 1996, ARCH NEUROL-CHICAGO, V53, P992, DOI 10.1001/archneur.1996.00550100066016; TOEIN O, 2001, AM J PHYSIOL, V281, pR572; WESTERINK BHC, 1988, N-S ARCH PHARMACOL, V337, P373, DOI 10.1007/BF00169526; White D, 1995, PHYSL BIOCH PROKARYO; Xue CJ, 1996, J NEUROCHEM, V67, P352; Zhou F, 2001, AM J PATHOL, V158, P2145, DOI 10.1016/S0002-9440(10)64686-X	31	16	17	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2002	119	2					121	128	PII S0165-0270(02)00177-2	10.1016/S0165-0270(02)00177-2			8	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	610RZ	WOS:000178975700003	12323415				2021-06-18	
J	Duchnick, JJ; Vanderploeg, RD; Curtiss, G				Duchnick, JJ; Vanderploeg, RD; Curtiss, G			Identifying retrieval problems using the California Verbal Learning Test	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; RECOGNITION-RECALL DISCREPANCIES; CLOSED-HEAD INJURY; MEMORY DEFICITS; PATTERNS; CVLT; ACQUISITION; COMA	Wilde, Boake, and Sherer (1995) examined the discrepancy between Long Delayed Free Recall (LDFR) and Recognition Discriminability (RD)-the California Verbal Learning Test (CVLT) index thought to indicate the presence of memory retrieval problems-and found little evidence to recommend its use in traumatic brain injury (TBI). The present investigation re-examined this index from the perspective of a continuum of retrieval deficit severity. CVLT performance was examined in 122 TBI patients, and 2 retrieval deficit indicators of varying severity were evaluated. Memory-impaired control groups were matched with retrieval deficit groups on initial acquisition and demographic characteristics. Individuals with a LDFR/RD discrepancy did not show predicted differences on other CVLT indices of retrieval problems, similar to the findings of Wilde et al. (1995). In contrast, individuals with a consistent discrepancy between free recall and semantic cued recall (Short and Long Delay) had greater improvement with recognition cueing and made fewer intrusive errors than controls. Individuals who benefited from semantic cues (where retrieval of the target word is still required) also benefited from recognition cues (where retrieval demands are minimal). Evidence supported the existence of a continuum of retrieval deficit severity. An LDFR/RD discrepancy without performance improvement from semantic cueing appears to indicate a more severe retrieval deficit, whereas performance improvement from both recognition and semantic cueing indicates less severe retrieval deficits.	James A Haley Vet Hosp, Psychol Serv 116B, Tampa, FL 33612 USA; Univ S Florida, Dept Psychiat, Tampa, FL 33620 USA; Univ S Florida, Dept Psychol, Tampa, FL 33620 USA	Duchnick, JJ (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, Tampa, FL 33612 USA.		Curtiss, Glenn/ABB-5566-2020				Baum KM, 1996, CLIN NEUROPSYCHOL, V10, P340; Cicchetti DV, 1997, J CLIN EXP NEUROPSYC, V19, P144, DOI 10.1080/01688639708403844; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DELIS D, 1987, CALIFORNIA VERBAL LE; DELIS DC, 2000, CALIFORNIA VERBAL LE; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Fuerst DR, 1997, J CLIN EXP NEUROPSYC, V19, P149, DOI 10.1080/01688639708403845; Hart R. P., 1994, NEUROPSYCHOLOGY, V8, P325, DOI [10.1037/0894-4105.8.3.325, DOI 10.1037/0894-4105.8.3.325]; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MASSMAN PJ, 1990, J CLIN EXP NEUROPSYC, V12, P729, DOI 10.1080/01688639008401015; NOVACK TA, 1995, CLIN NEUROPSYCHOL, V9, P38; Spencer J, 1998, CLIN NEUROPSYCHOL, V12, P296; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Veiel HOF, 1997, J CLIN EXP NEUROPSYC, V19, P141, DOI 10.1080/01688639708403843; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; Wilde MC, 1997, J CLIN EXP NEUROPSYC, V19, P153, DOI 10.1080/01688639708403846	22	16	17	1	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	SEP	2002	24	6					840	851		10.1076/jcen.24.6.840.8405			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	611UM	WOS:000179036200012	12424657				2021-06-18	
J	Harris, CH; Smith, RS; Helmer, SD; Gorecki, JP; Rody, RB				Harris, CH; Smith, RS; Helmer, SD; Gorecki, JP; Rody, RB			Placement of intracranial pressure monitors by non-neurosurgeons	AMERICAN SURGEON			English	Article							SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; AGGRESSIVE TREATMENT; MANAGEMENT; EXPERIENCE; MANNITOL	Maintaining adequate cerebral perfusion is important in the treatment of patients with closed head injury. Placement of an intracranial pressure (ICP) monitor is necessary to determine both ICP and the cerebral perfusion pressure and serves as a guide to the contemporary management of traumatic brain injury. Insertion of such monitoring devices historically has been performed by neurosurgeons, but others including general (trauma) surgeons have successfully inserted simple ICP monitors. The purpose of this study was to assess the efficacy of ICP monitor placement and to compare the complication rates for ICP monitor placement by general surgery residents, trauma surgeons, and staff neurosurgeons. We retrospectively reviewed the medical records of trauma patients with cerebral injury who required insertion of parenchymal ICP monitors from January 1994 to January 1999. Monitor placement was performed by staff neurosurgeons, general surgical residents, and trauma surgeons. Surgical residents received appropriate training in the placement of ICP monitors from attending trauma surgeons and neurosurgeons. Records were examined for demographic variables such as age, gender, mechanism of injury, admission Glasgow Coma Score, and Injury Severity Score. Records were also reviewed for duration of ICP monitoring and for complications (i.e., intracranial hemorrhage after monitor placement, monitor-related infection, monitor malfunction, and monitor displacement). One hundred fifty-seven monitors were placed in 146 patients with intracranial injury. Surgical residents placed 87 ICP monitors without neurosurgical or trauma attending surgeons at the bedside and 43 with immediate supervision by general surgeons or neurosurgeons. Neurosurgeons placed 26 monitors without the participation of residents, and an attending trauma surgeon placed one monitor without the involvement of a resident or a neurosurgeon. There were no major technical complications, no episodes of catheter-induced intracranial hemorrhage, and no infectious complications. These data suggest that simple ICP monitors may be inserted by non-neurosurgeons without significant problems or complications. The low complication rate associated with this procedure was similar for neurosurgeons and non-neurosurgeons. We believe that insertion of simple parenchymal ICP monitors should be considered a core skill for trauma surgeons and should be included in surgical residency training. Insertion of ICP monitors by non-neurosurgeons is a potential method of improving the care of patients with brain injury in geographic areas that are underserved by neurosurgeons.	Univ Kansas, Sch Med, Dept Surg, Wichita, KS 67214 USA; Via Christi Reg Med Ctr, Dept Emergency Med, Wichita, KS USA; Via Christi Reg Med Ctr, Dept Neurosurg, Wichita, KS USA; Via Christi Reg Med Ctr, Dept Med Educ, Wichita, KS USA; Via Christi Reg Med Ctr, Dept Surg, Wichita, KS USA	Smith, RS (corresponding author), Univ Kansas, Sch Med, Dept Surg, 929 N St Francis, Wichita, KS 67214 USA.			Helmer, Stephen/0000-0002-8760-7950			BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; EDDY VA, 1995, AM SURGEON, V61, P24; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; TASKER RC, 1991, NEUROPEDIATRICS, V22, P47, DOI 10.1055/s-2008-1071416	13	16	16	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2002	68	9					787	790					4	Surgery	Surgery	661YA	WOS:000181916500012	12356151				2021-06-18	
J	Korinth, MC; Ince, A; Banghard, W; Huffmann, BC; Gilsbach, JM				Korinth, MC; Ince, A; Banghard, W; Huffmann, BC; Gilsbach, JM			Pterional orbita decompression in orbital hemorrhage and trauma	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						orbital trauma; retrobulbar hemorrhage; retrobulbar hematoma; trauma; visual loss; orbital decompression	RETROBULBAR HEMORRHAGE; IMMEDIATE DECOMPRESSION; OPTIC-NERVE; ORBITOPATHY; DIAGNOSIS; BLINDNESS; HEMATOMA	Background: This article presents a series of patients with traumatic retrobulbar hematoma and orbital trauma, treated with extended pterional orbital decompression. Methods: Fifteen patients, showing symptomatic retrobulbar hematoma or symptoms of orbital injury after various trauma mechanisms, were treated with deep lateral orbital decompression and removal of orbital blood/bone fragments via this approach. Preoperative and postoperative course, neuroradiologic findings, additional brain or facial injuries, and outcome of eye function are analyzed in detail. Results: Mean delay between trauma and decompression was 70 hours (3 days), with a range from 2 hours to 15 days. Proptosis decreased in all patients and visual acuity improved or remained normal in nine patients and stayed defective in four. Impaired extraocular movements and pupillary changes recovered in 10 patients. Apart from one case of permanent deficit of the frontal branch of the facial nerve, no severe complications were seen. Conclusion The presented pterional orbital decompression represents an effective alternative approach for patients with sight-threatening retrobulbar hematoma or orbital trauma, especially in cases that require direct access to damaged structures and maximal decompression of the orbit. Immediate detection and treatment of orbital hematomas is mandatory for acceptable outcome of eye function.	Univ Hosp, Rhein Westfal TH Aachen, Dept Neurosurg, D-52057 Aachen, Germany; Univ Hosp, Rhein Westfal TH Aachen, Dept Ophthalmol, D-52057 Aachen, Germany	Korinth, MC (corresponding author), Univ Hosp, Rhein Westfal TH Aachen, Dept Neurosurg, D-52057 Aachen, Germany.						Amagasaki K, 1998, NEUROL MED-CHIR, V38, P221, DOI 10.2176/nmc.38.221; BAILEY WK, 1993, J ORAL MAXIL SURG, V51, P780, DOI 10.1016/S0278-2391(10)80422-7; CIONNI RJ, 1991, OPHTHALMOLOGY, V98, P1153; Ghufoor K, 1998, INJURY, V29, P139, DOI 10.1016/S0020-1383(97)00129-0; GILSBACH JM, 1988, NEUROSURG REV, V11, P167, DOI 10.1007/BF01794683; GILSBACH JM, 1994, SKULL BASE SURG, V4, P72, DOI 10.1055/s-2008-1058973; Gocer AI, 1996, NEUROSURG REV, V19, P169, DOI 10.1007/BF00512047; Goldberg RA, 1995, OPHTHALMIC PLAST REC, V11, P245, DOI 10.1097/00002341-199512000-00004; Goodall KL, 1999, INJURY, V30, P485, DOI 10.1016/S0020-1383(99)00137-0; Hislop WS, 1996, BRIT J ORAL MAX SURG, V34, P289, DOI 10.1016/S0266-4356(96)90004-2; HISLOP WS, 1994, INJURY, V25, P663, DOI 10.1016/0020-1383(94)90009-4; LIU D, 1993, AM J OPHTHALMOL, V116, P34, DOI 10.1016/S0002-9394(14)71740-4; MORRIS TA, 1985, J MAXILLOFAC SURG, V13, P129, DOI 10.1016/S0301-0503(85)80032-1; ORD RA, 1981, BRIT J ORAL SURG, V19, P202, DOI 10.1016/0007-117X(81)90005-6; Rosdeutscher JD, 1998, ANN PLAS SURG, V41, P618, DOI 10.1097/00000637-199812000-00006; Saussez Sven, 1998, Rhinology (Utrecht), V36, P37; STOLL W, 1994, HNO, V42, P685; STOLL W, 1988, J CRANIO MAXILL SURG, V16, P308, DOI 10.1016/S1010-5182(88)80068-4; THYNE G M, 1992, New Zealand Dental Journal, V88, P60; Wen HT, 2001, OPER TECH NEUROSURG, V4, P60, DOI DOI 10.1053/OTNS.2001.25567; WOOD GD, 1986, BRIT J ORAL MAX SURG, V24, P12, DOI 10.1016/0266-4356(86)90033-1; YOUNG CW, 1994, OPHTHALMIC PLAST REC, V10, P137	22	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2002	53	1					73	78		10.1097/00005373-200207000-00015			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	573BR	WOS:000176809900020	12131393				2021-06-18	
J	Csokay, A; Pataki, G; Nagy, L; Belan, K				Csokay, A; Pataki, G; Nagy, L; Belan, K			Vascular tunnel construction in the treatment of severe brain swelling caused by trauma and SAH. (Evidence based on intra-operative blood flow measure)	NEUROLOGICAL RESEARCH			English	Article						traumatic brain swelling; decompressive craniectomy; vascular tunnel	SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; CEREBRAL EDEMA; INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; MANAGEMENT; BIOMECHANICS; CRANIOTOMY; PRESSURE; SUPPORT	Decompressive craniectomy with durotomy, is possible as a last resort therapy for severe traumatic brain swelling. Although the method successfully diminishes the ICP, partial or total vascular insufficiency occurs in the herniated part of the brain. The actual cause of the insufficiency is most likely due to the compression of the cortical veins and arteries supplying the herniated brain, caused by shearing and pressure forces between the dural edge and brain tissue. Furthermore venous congestion may induce edema in the protruding parts of the brain, thus further compromising neurone viability. The new surgical technique consists of a stellate type durotomy and the creation of a vascular tunnel around the main cortical veins and arteries, with the aim that the vessels do not become compressed by the dural or bone edge. The effect of the novel vascular tunnel technique was proven by measuring the blood flow of the protected and nonprotected veins with Doppler UH, intra-operatively. In the last two years 28 patients were operated on with this method. One case of edema was caused by SAH. All were in severe GCS 3 or GCS 4 status, with more than 30 mmHg ICP. In comparison with the traditional surgical and nonsurgical treatment, where the reported mortality rates are 80%-90% in these severe cases the mortality rate was reduced to 40%, and recovery (GOS 4, 5) rate also increased significantly. With this technique the ICP was significantly reduced and further edema and vascular insufficiency was prevented. This was due to protection of the arterial circulation and venous drainage of the herniated part of the brain, by the formation of a vascular tunnel at the durotomy edges.	Natl Inst Traumatol, H-1081 Budapest, Hungary	Csokay, A (corresponding author), Natl Inst Traumatol, Fiumei Ut 17, H-1081 Budapest, Hungary.	parkdros@elender.hu	Guo, Ruyan/E-1714-2011; Bhalla, Amar S/E-2203-2011	Guo, Ruyan/0000-0002-7661-6042; 			Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Bagley RS, 1996, AM J VET RES, V57, P116; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; COSKAY A, 2001, HUNGARIAN MED J, V142, P75; Csokay A, 2001, ACTA NEUROCHIR, V143, P173, DOI 10.1007/s007010170125; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GAAB MR, 1990, ACT NEUR S, V51, P326; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Harrington ML, 1996, AM J VET RES, V57, P1659; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HATASHITA S, 1988, STROKE, V19, P91, DOI 10.1161/01.STR.19.1.91; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Hieu PD, 1996, CHILD NERV SYST, V12, P270; KERR FWL, 1968, P M MAYO CLIN STAFF, V43, P852; KIRKHAM FJ, 1986, DEV MED CHILD NEUROL, V28, P506; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Munch E, 2000, NEUROSURGERY, V47, P315; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; RINALDI A, 1990, ACT NEUR S, V51, P394; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; WHITFIELD P, 1995, STROKE, V26, P1125; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717	34	16	18	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2002	24	2			SI		157	160	UNSP 0161-6412/02/020157-04	10.1179/016164102101199701			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	521YR	WOS:000173869400007	11877899				2021-06-18	
J	Nishioka, T; Maeda, Y; Tomogane, Y; Nakano, A; Arita, N				Nishioka, T; Maeda, Y; Tomogane, Y; Nakano, A; Arita, N			Unexpected delayed rupture of the vertebral-posterior inferior cerebellar artery aneurysms following closed head injury	ACTA NEUROCHIRURGICA			English	Article						aneurysm; delayed rupture; PICA; repair; trauma	TRAUMATIC ANEURYSM; SUBARACHNOID HEMORRHAGE; CEREBRAL-ARTERIES; BASILAR ARTERY; SECONDARY	Subarachnoid haemorrhage secondary to closed head injury is rarely associated with traumatic aneurysms of the posterior circulation. We report two cases of ruptured vertebral-posterior inferior cerebellar artery (VA-PICA) pseudoaneurysms following closed head injuries. In each case, there was no associated penetrating injury or skull fracture. The first patient was kicked followed by disturbed consciousness. The computerized tomography (CT) scan on admission and cerebral angiography on the 11th day after the trauma revealed a massive subarachnoid haemorrhage (SAH) with pan-ventricular haemorrhage and an aneurysm of the right PICA near its origin. Further ruptures occurred on the 12th, 15th, and 66th day, and he died on the 69th day. The second patient complained of persistent headache and nausea following a fight on the previous day. A CT scan and angiography on the 1st day after the trauma showed posterior fossa SAH with fourth ventricular blood and a tiny protrusion of the left VA-PICA. On the 14th day, repeated angiography revealed a remarkable growth of the aneurysm, followed by the second rupture. The repair of the VA-PICA junction was urgently performed with successful exclusion of the aneurysm. To our knowledge, only eight cases of traumatic aneurysms located at the VA or the PICA near its origin have been reported. When intraventricular blood is found with massive subarachnoid blood or with posterior fossa SAH, this omnious complication should be considered. Traumatic VA-PICA pseudoaneurysms are curable by refined microsurgical techniques, if diagnosed in time.	Ishikiriseiki Hosp, Dept Neurosurg, Higashiosaka, Osaka 5798026, Japan; Hyogo Med Univ, Dept Neurosurg, Nishinomiya, Hyogo, Japan	Nishioka, T (corresponding author), Ishikiriseiki Hosp, Dept Neurosurg, 18-28 Yayoi Cho, Higashiosaka, Osaka 5798026, Japan.						ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BANK WO, 1978, AM J ROENTGENOL, V130, P975, DOI 10.2214/ajr.130.5.975; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BOSTROM K, 1992, FORENSIC SCI INT, V53, P61, DOI 10.1016/0379-0738(92)90133-H; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; CASEY ATH, 1994, BRIT J NEUROSURG, V8, P97, DOI 10.3109/02688699409002401; COCKRILL HH, 1977, J NEUROSURG, V46, P377, DOI 10.3171/jns.1977.46.3.0377; CROWELL RM, 1995, SURG MANAGEMENT NEUR, P377; DECK JHN, 1986, ARCH PATHOL LAB MED, V110, P489; DIAL DL, 1937, AM J SURG, V35, P2; DOWLING G, 1988, AM J FOREN MED PATH, V9, P23, DOI 10.1097/00000433-198803000-00007; Drake C G, 1979, Clin Neurosurg, V26, P96; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; HEROS RC, 1996, NEUROSURGERY, V2, P2357; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; HUDGINS RJ, 1983, J NEUROSURG, V58, P381, DOI 10.3171/jns.1983.58.3.0381; MCDONALD EJ, 1976, AM J ROENTGENOL, V126, P792, DOI 10.2214/ajr.126.4.792; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; MORARD M, 1991, NEUROSURGERY, V29, P438, DOI 10.1227/00006123-199109000-00018; PARKINSON D, 2000, SCHMIDEK SWEET OPERA, V2, P1296; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; Proust F, 1997, J NEUROSURG, V87, P950, DOI 10.3171/jns.1997.87.6.0950; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; REZAI AR, 1994, SURG NEUROL, V42, P312, DOI 10.1016/0090-3019(94)90399-9; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; Sahjpaul RL, 1998, J NEUROSURG, V89, P822, DOI 10.3171/jns.1998.89.5.0822; Schuster JM, 1999, NEUROSURGERY, V45, P1465, DOI 10.1097/00006123-199912000-00039; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; SMITH DR, 1970, J NEUROSURG, V32, P357, DOI 10.3171/jns.1970.32.3.0357; Sure U, 1999, CHILD NERV SYST, V15, P354, DOI 10.1007/s003810050411; WORTZMAN D, 1980, SURG NEUROL, V13, P329; Yasui T, 2000, NEUROSURGERY, V46, P196	35	16	18	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		2002	144	8					839	845		10.1007/s00701-002-0952-3			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	588KU	WOS:000177701300028	12181696				2021-06-18	
J	Beaumont, A; Hayasaki, K; Marmarou, A; Barzo, P; Fatouros, P; Corwin, F				Beaumont, A; Hayasaki, K; Marmarou, A; Barzo, P; Fatouros, P; Corwin, F			Contrasting effects of dopamine therapy in experimental brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral perfusion pressure; dopamine; edema; magnetic resonance spectroscopy; secondary insult; traumatic brain injury	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; PERFUSION-PRESSURE; INTRACRANIAL HYPERTENSION; ARTERIAL-PRESSURE; IMPACT INJURY; TRAUMA; EDEMA; AUTOREGULATION; MORTALITY	Management of cerebral perfusion pressure (CPP) is thought to be important for the treatment of traumatic brain injury (TBI). Vasopressors have been advocated as a method of increasing mean arterial blood pressure (mABP) and cerebral perfusion pressure (CPP) in the face of rising intracranial pressure (ICP). There are unresolved issues and theoretical risks about this therapy. This study therefore examined the effects of dopamine on physiological and MRI/MRS parameters in (1) a rodent model of rapidly rising intracranial pressure, caused by diffuse injury with secondary insult and (2) a model of cortical contusion. Dopamine was capable of restoring CPP in the model of rapidly rising ICP. This CPP restoration was associated with a partial restoration of CBF. Two profiles of change in the Apparent Diffusion Coefficient of water (ADC(W)) were seen; one in which ADC(W) recovered to baseline, and one in which ADC(W) remained persistently low. Dopamine did not alter these profiles. MRI assessed tissue water content was increased four hours after injury and dopamine increased cerebral water content in both subgroups of injury; significantly in the group with a persistently low ADC(W) (p < 0.01). In contusional injury, dopamine significantly worsened edema in both the ipsi- and contralateral hippocampus and temporal cortex. This occurred in the absence of ADC(W) changes, except in the contralateral hippocampus, where both water content and ADC(W) values rose with treatment, suggesting extracellular accumulation of water. In conclusion, although dopamine is capable of partially restoring CBF after injury, situations exist in which dopamine therapy worsens the swelling process. It is possible therefore that subgroups of patients exist who experience adverse effects of vasopressor treatment, and consequently the effects of vasopressor therapy in the clinical setting need to be more carefully evaluated.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiat Phys, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Physiol, Richmond, VA 23298 USA	Marmarou, A (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA.		Beaumont, Andrew/AAJ-7457-2020				ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; AUKLAND K, 1964, CIRC RES, V14, P164, DOI 10.1161/01.RES.14.2.164; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P115; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; CHAN KH, 1993, NEUROSURGERY, V32, P547; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; DeWitt DS, 1997, J NEUROTRAUM, V14, P931, DOI 10.1089/neu.1997.14.931; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; EDVINSSON L, 1985, BRIT J PHARMACOL, V85, P403, DOI 10.1111/j.1476-5381.1985.tb08875.x; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Krimer LS, 1998, NAT NEUROSCI, V1, P286; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MARION DW, 1993, J NEUROSURG, V78, pA347; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1975, J NEUROL NEUROSUR PS, V38, P657, DOI 10.1136/jnnp.38.7.657; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, INTRACRANIAL PRESSUR, P508; NAG S, 1977, LAB INVEST, V36, P150; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; NEWFIELD P, 1980, CRIT CARE MED, V8, P254, DOI 10.1097/00003246-198004000-00123; Paolin A, 1998, J TRAUMA, V44, P495, DOI 10.1097/00005373-199803000-00012; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1990, J TRAUMA, V30, P949; SCHUTTA HS, 1968, BRAIN, V91, P281, DOI 10.1093/brain/91.2.281; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; WESTERGAARD E, 1977, ACTA NEUROPATHOL, V37, P141, DOI 10.1007/BF00692060; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	46	16	16	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2001	18	12					1359	1372		10.1089/08977150152725650			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	504RE	WOS:000172869000006	11780866				2021-06-18	
J	Csokay, A; Nagy, L; Novoth, B				Csokay, A; Nagy, L; Novoth, B			Avoidance of vascular compression in decompressive surgery for brain edema caused by trauma and tumor ablation	NEUROSURGICAL REVIEW			English	Article; Proceedings Paper	Traumatic Brain Injury Symposium EBIS	SEP 20-23, 2000	PARIS, FRANCE			decompressive surgery; traumatic brain swelling; operative technique; vascular tunnel	HEAD-INJURY; CEREBRAL EDEMA; CRANIECTOMY; BIOMECHANICS; SUPPORT; RAT	Background. In case of severe brain swelling especially caused by trauma or other operative manipulation (tumor ablation), decompressive craniectomy with durotomy has not resulted in significant chances of recovery. Decompressive craniectomy has been defined only as an option within guidelines. Method. A new operative technique was developed to improve the efficacy of decompressive surgery. With an increase in intracranial pressure (ICP) threatening with brainstem herniation, wide bilateral craniectomy was carried out, followed by dura opening and subsequent formation of a vascular tunnel in a simple way -using hemostatic sponge cushions around the main cortical veins at the entering points of the herniated area. The maintenance of vessel patency prevents the herniated brain segment from venous congestion, i.e., from further swelling and necrosis. Results. Twenty operations with traumatic brain edema were performed using this vascular tunnel method. All patients were exposed to surgery in the state of coma. One operation was performed after tumor removal. The results were promising in comparison with the well-known surgical or conservative treatment. Discussion. Applying very strict selection criteria (Glasgow coma scale <6, signs of severe edema on CT, or intracranial pressure permanently greater than or equal to 30 mmHg) in this small series of patients with severe brain injury, good results were achieved using the new operative technique. In case of postoperative edema after tumor ablation, it also showed promising results.	Natl Inst Traumatol, Dept Neurosurg, H-1039 Budapest, Hungary	Csokay, A (corresponding author), Natl Inst Traumatol, Dept Neurosurg, Fiumei Ut 17, H-1039 Budapest, Hungary.	parkdros@elender.hu					Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Brain Trauma Foundation, 1995, GUID MAN SEV HEAD IN; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; CSOKAY A, 2000, CHILDS NERV SYST S, V16, P371; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GAAB MR, 1990, ACT NEUR S, V51, P326; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HATASHITA S, 1988, STROKE, V19, P91, DOI 10.1161/01.STR.19.1.91; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; ISHII S, 1983, INTRACRANIAL PRESSUR, P549; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; RINALDI A, 1990, ACT NEUR S, V51, P394; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Shigemori M, 1979, Acta Neurochir Suppl (Wien), V28, P195; Shimada K, 1999, SPINAL CORD, V37, P410, DOI 10.1038/sj.sc.3100858; WHITFIELD P, 1995, STROKE, V26, P1125; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717	29	16	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	DEC	2001	24	4					209	213		10.1007/s101430100158			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	505VY	WOS:000172937300010	11778828				2021-06-18	
J	Esmail, S; Esmail, Y; Munro, B				Esmail, S; Esmail, Y; Munro, B			Sexuality and disability: The role of health care professionals in providing options and alternatives for couples	SEXUALITY AND DISABILITY			English	Article						sexuality; disability; relationships; P-LI-SS-IT model	SPINAL-CORD INJURY; TRAUMATIC BRAIN INJURY; PARTNER EXPERIENCES; ADJUSTMENT; QUALITY; MARRIAGE; IMPACT; LIFE	Disability affects both the individual and his/her partner and, if health care professionals are to work with clients in a holistic manner they will need to include the partner. A comprehensive review of the literature was completed to examine the impact of disability on sexuality as it relates to couple relationships and to explore strategies health care providers can utilize to help couples deal with these issues. The literature describes some common intervention strategies that have been shown to be effective in helping couples affected by disability or illness address the issue of sexuality. Specific concerns and difficulties faced by couples are also identified. Finally, the various intervention strategies will be incorporated into a framework known as the P-LI-SS-IT model. With this framework, health care providers will be able to determine the client's needs, as well as assess their own level of comfort and expertise in dealing with this very important task.	Univ Alberta, Fac Rehabil Med, Dept Occupat Therapy, Edmonton, AB T6G 2G4, Canada; Univ Alberta, Capital Hlth Author, Edmonton, AB, Canada; Univ Alberta, Dept Human Ecol, Edmonton, AB, Canada	Esmail, S (corresponding author), Univ Alberta, Fac Rehabil Med, Dept Occupat Therapy, Rm 2-12 Corbett Hall, Edmonton, AB T6G 2G4, Canada.						ABRAMS KS, 1981, PARAPLEGIA, V19, P253, DOI 10.1038/sc.1981.49; Anderson L., 1992, CANADIAN J HUMAN SEX, V1, P177; Annon J., 1974, BEHAV TREATMENT SEXU; Annon JS, 1976, BEHAV TREATMENT SEXU; BERNARDO ML, 1981, REHABIL LIT, V43, P213; BROWN JS, 1986, SOC SCI MED, V23, P313, DOI 10.1016/0277-9536(86)90353-9; CHIPOURAS S, 1979, SEX DISABIL, V2, P301; CHUBON RA, 1981, SEX DISABIL, V4, P3, DOI 10.1007/BF01102460; COHEN BD, 1976, ARCH PHYSICAL MED RE, V5, P473; CONINE TA, 1984, REHABILITATION PSYCH; CREWE NM, 1988, ARCH PHYS MED REHAB, V69, P435; CREWE NM, 1993, REPRODUCTIVE ISSUES FOR PERSONS WITH PHYSICAL DISABILITIES, P141; Dailey D., 1984, RENAL FAMILY, V6, P2; DAVID A, 1977, PARAPLEGIA, V15, P198, DOI 10.1038/sc.1977.29; De Kleijin-de Vrankrijker M. W., 1998, INTRO DISABILITY, P11; DEVIVO MJ, 1995, ARCH PHYS MED REHAB, V76, P130, DOI 10.1016/S0003-9993(95)80022-0; DeVivo MJ, 1996, REHABIL PSYCHOL, V41, P321, DOI 10.1037/h0092836; DICKERFRIEDMAN J, 1997, OT PRACTICE, P20; DUCHARME S, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI DOI 10.1097/00001199-199005020-00007; Feigin R, 1998, MARRIAGE FAM REV, V27, P71, DOI 10.1300/J002v27n01_06; GAMEL C, 1993, J ADV NURS, V18, P1219, DOI 10.1046/j.1365-2648.1993.18081219.x; HOCH Z, 1977, ARCH PHYS MED REHAB, V58, P413; Kennedy M., 1987, CANADIAN J OCCUPATIO, V54, P189; KESTER BL, 1988, REHABIL COUNS BULL, V32, P4; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; KREUTER M, 1994, PARAPLEGIA, V32, P225, DOI 10.1038/sc.1994.42; Kreuter M, 1996, ARCH PHYS MED REHAB, V77, P541, DOI 10.1016/S0003-9993(96)90292-0; KREUTER M, 1994, PARAPLEGIA, V32, P759, DOI 10.1038/sc.1994.122; LICHTENSTEIN J, 1991, DISS ABSTR INT A, V51, P10; McAlonan S, 1996, AM J OCCUP THER, V50, P826, DOI 10.5014/ajot.50.10.826; McNeff Elizabeth A., 1997, P595; MILLER L, 1994, J COGNITIVE REHABILI, V12, P12; Milligan MS, 1998, SEX DISABIL, V16, P117, DOI 10.1023/A:1023080009783; Montagu A., 1978, TOUCHING HUMAN SIGNI; NEISTADT ME, 1986, AM J OCCUP THER, V40, P542, DOI 10.5014/ajot.40.8.542; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; RATHUS SA, 1997, HUMAN SEXUALITY WORL; Rintala DH, 1997, SEX DISABIL, V15, P219, DOI 10.1023/A:1024717313923; RODOCKER M, 1981, SEXUALITY PHYSICAL D, P277; ROLLAND JS, 1994, J MARITAL FAM THER, V20, P327, DOI 10.1111/j.1752-0606.1994.tb00125.x; SADOUGHI W, 1971, Archives of Physical Medicine and Rehabilitation, V52, P311; Sandel M. Elizabeth, 1997, P221; SCHULER M, 1982, J SEX MARITAL THER, V8, P241, DOI 10.1080/00926238208405826; Sipski Marca L., 1997, P3; THORNGRAY BE, 1983, REHABIL LIT, V44, P138; Urey J R, 1987, Rehabil Nurs, V12, P26; UREY JR, 1987, ARCH PHYS MED REHAB, V68, P69; Vargo F., 1984, J APPL REHABIL COUNS, V15, P28; Whitehead T. L., 1993, Journal of Burn Care and Rehabilitation, V14, P221, DOI 10.1097/00004630-199303000-00018; WHO, 1975, ED TREATM HUM SEX TR; WILLIAMS SE, 1993, ARCH PHYS MED REHAB, V74, P361; Wilson M E, 1988, Oncol Nurs Forum, V15, P49; Yim SY, 1998, SPINAL CORD, V36, P826, DOI 10.1038/sj.sc.3100714; YOSHIDA KK, 1994, SEX DISABIL, V12, P179, DOI 10.1007/BF02547904	55	16	17	0	3	KLUWER ACADEMIC-HUMAN SCIENCES PRESS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0146-1044			SEX DISABIL	Sex. Disabil.	WIN	2001	19	4					267	282		10.1023/A:1017905425599			16	Rehabilitation	Rehabilitation	528ZL	WOS:000174275500004					2021-06-18	
J	Ozveren, MF; Uchida, K; Erol, FS; Tiftikci, MT; Cobanoglu, B; Kawase, T				Ozveren, MF; Uchida, K; Erol, FS; Tiftikci, MT; Cobanoglu, B; Kawase, T			Isolated abducens nerve paresis associated with incomplete Horner's syndrome caused by petrous apex fracture - Case report and anatomical study	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						abducens nerve; incomplete Horner's syndrome; petrous apex fracture; sympathetic plexus	PALSY; MECHANISM; INJURY	A 17-year-old male presented with a wound on the right temporal region, oozing hemorrhagic necrotic brain tissue and cerebrospinal fluid, following a fall. Computed tomography showed temporoparietal and petrous apex fractures on the right. Neurological examination revealed abducens nerve paresis, ptosis, and myosis on the right side. The patient was treated surgically for the removal of the free bony fragments at the fracture site and to close the dural tear. The abducens nerve paresis, ptosis, and myosis persisted at the 3rd monthly postoperative follow-up examination. The anatomy of the abducens nerve at the petroclival region was studied in four cadaveric heads. Two silicone-injected heads were used for microsurgical dissections and two for histological sections. The abducens nerve has three different angulations in the petroclival region, located at the dural entrance porus, the petrous apex, and the lateral wall of the cavernous segment of the internal carotid artery. The abducens nerve had fine anastomoses with the trigeminal nerve and the periarterial sympathetic plexus. There were fibrous connections extending inside the venous space of the petroclival area. The abducens nerve seems to be vulnerable to damage in the petroclival region, either directly by trauma to its dural porus and petrous apex or indirectly by stretching of the nerve through the nervous and/or fibrous connections. Concurrent functional loss of the abducens nerve and the periarterial sympathetic plexus clinically manifested as incomplete Horner's syndrome in our patient.	Firat Univ, Sch Med, Dept Neurosurg, Arastirma Hastanesi, TR-23200 Elazig, Turkey; Firat Univ, Sch Med, Dept Pathol, TR-23200 Elazig, Turkey; Keio Univ, Sch Med, Dept Neurosurg, Tokyo 160, Japan	Ozveren, MF (corresponding author), Firat Univ, Sch Med, Dept Neurosurg, Arastirma Hastanesi, TR-23200 Elazig, Turkey.						ANSON J, 1991, NEUROSURGERY, V29, P89, DOI 10.1227/00006123-199107000-00015; ARIAS MJ, 1985, NEUROSURGERY, V16, P232, DOI 10.1227/00006123-198502000-00020; CSERR HF, 1971, PHYSIOL REV, V51, P273; Destrieux C, 1997, J NEUROSURG, V87, P67, DOI 10.3171/jns.1997.87.1.0067; GUTMAN I, 1986, OPHTHALMOLOGY, V93, P913; HARDMAN JM, 1991, TXB NEUROPATHOLOGY, P962; Kanpolat Y, 1999, NEUROSURGERY, V44, P1364; KRIVOSIC I, 1987, CAVERNOUS SINUS, P117; LAZOW SK, 1995, J ORAL MAXIL SURG, V53, P1197, DOI 10.1016/0278-2391(95)90634-7; OVERBEEKE J J V, 1991, Neurosurgery (Baltimore), V29, P838; PARKINSON D, 1978, ANAT REC, V191, P221, DOI 10.1002/ar.1091910207; SCHNEIDER RC, 1971, J NEUROSURG, V34, P33, DOI 10.3171/jns.1971.34.1.0033; STRIPH GG, 1988, J CLIN NEURO-OPHTHAL, V8, P13; Takagi H, 1976, No Shinkei Geka, V4, P963; Turner JWA, 1943, BRAIN, V66, P140; UMANSKY F, 1992, LARYNGOSCOPE, V102, P1285, DOI 10.1288/00005537-199211000-00016; Uzan M, 1996, Eur Spine J, V5, P275, DOI 10.1007/BF00301333; Ziyal IM, 1998, ACTA NEUROCHIR, V140, P201, DOI 10.1007/s007010050086	18	16	18	0	3	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0387-2572			NEUROL MED-CHIR	Neurol. Med.-Chir.	OCT	2001	41	10					494	498		10.2176/nmc.41.494			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	481ZM	WOS:000171550400012	11760384	Bronze			2021-06-18	
J	Isaksson, J; Hillered, L; Olsson, Y				Isaksson, J; Hillered, L; Olsson, Y			Cognitive and histopathological outcome after weight-drop brain injury in the rat: influence of systemic administration of monoclonal antibodies to ICAM-1	ACTA NEUROPATHOLOGICA			English	Article						adhesion molecules; brain injury; ICAM-1; Morris-Water maze; rat	INTERCELLULAR-ADHESION MOLECULE-1; CEREBRAL-ARTERY OCCLUSION; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD-INJURY; SPINAL-CORD INJURY; CENTRAL-NERVOUS-SYSTEM; ISCHEMIC CELL-DAMAGE; NEUTROPHIL ACCUMULATION; CONTUSION TRAUMA; EXPRESSION	The aim of this study was to evaluate whether treatment with the anti-ICAM-1 antibody 1A29 influences functional or histopathological outcome following severe controlled cortical contusion in rats. The spatial learning deficits were studied using Morris water maze (MWM) paradigm in which the animals were given four daily acquisition trials for four consecutive days, starting on day 10 post-injury. Both 1A29-treated (n=8) and vehicle-treated (n=8) traumatized animals needed longer time than sham-operated rats (n=8) to find the hidden escape platform on days 11, 12 and 13. Compared to shams, significantly increased escape latency was noted on day 12 in vehicle-treated group and on days 12 and 13 in 1A29-treated animals. MWM performance did not differ significantly between the two trauma groups. Histopathological evaluation of the injured brains 15 days after trauma revealed ipsilateral cortical cavitation as well as ipsilateral hippocampal and thalamic lesions. MAP2 immunostaining showed a nonsignificant tendency towards more pronounced hippocampal injury in the 1A29-treated animals. Image analysis of glial fibrillary acidic protein- and ionized calcium binding adapter molecule 1-immunostained sections revealed astrocytic activation in the ipsilateral thalamus and microglial activation in both ipsilateral thalamus and hippocampus of traumatized animals, but no significant differences between the trauma groups. In summary, this study shows that spatial memory deficits occur following a weight-drop injury to the rat brain. Treatment with the anti-ICAM-1 antibody 1A29 did not significantly change the recorded functional or histopathological measures of outcome.	Univ Uppsala Hosp, Res Grp Neuropathol, Dept Genet & Pathol, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Neurosci, Neurosurg Sect, Uppsala, Sweden	Isaksson, J (corresponding author), Univ Uppsala Hosp, Res Grp Neuropathol, Dept Genet & Pathol, S-75185 Uppsala, Sweden.						Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; BERGERSWEENEY J, 1994, J NEUROSCI, V14, P4507; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Cotran RS, 1998, PATHOL BIOL, V46, P164; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Farooque M, 1999, NEUROREPORT, V10, P131, DOI 10.1097/00001756-199901180-00024; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fujie K, 1999, EUR J PHARMACOL, V374, P117, DOI 10.1016/S0014-2999(99)00268-X; FUJITA H, 1994, ARCH BIOCHEM BIOPHYS, V309, P62, DOI 10.1006/abbi.1994.1085; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Grady MS, 1999, J NEUROTRAUM, V16, P13, DOI 10.1089/neu.1999.16.13; Hamada Y, 1996, J NEUROCHEM, V66, P1525; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Isaksson J, 1997, ACTA NEUROPATHOL, V94, P16, DOI 10.1007/s004010050666; Isaksson J, 1999, J NEUROTRAUM, V16, P165, DOI 10.1089/neu.1999.16.165; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nishimura Y, 1996, TRANSPLANTATION, V61, P99, DOI 10.1097/00007890-199601150-00020; Olschowka JA, 1997, BRAIN BEHAV IMMUN, V11, P273, DOI 10.1006/brbi.1997.0506; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Ranefall P, 1997, ANAL CELL PATHOL, V15, P145, DOI 10.1155/1997/304073; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Shibayama M, 1996, J NEUROTRAUM, V13, P801, DOI 10.1089/neu.1996.13.801; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; SOBEL RA, 1990, AM J PATHOL, V136, P1309; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Taoka Y, 1998, BRAIN RES, V799, P264, DOI 10.1016/S0006-8993(98)00459-4; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; WASHINGTON R, 1994, ANN NEUROL, V35, P89, DOI 10.1002/ana.410350114; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; ZHANG RL, 1995, STROKE, V26, P1438, DOI 10.1161/01.STR.26.8.1438; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747; Zou LB, 1999, NEUROSCIENCE, V92, P819, DOI 10.1016/S0306-4522(99)00029-9	62	16	20	0	3	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	SEP	2001	102	3					246	256					11	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	470UD	WOS:000170888800006	11585249				2021-06-18	
J	Holtzer, S; Vigue, B; Ract, C; Samii, K; Escourrou, P				Holtzer, S; Vigue, B; Ract, C; Samii, K; Escourrou, P			Hypoxia-hypotension decreases pressor responsiveness to exogenous catecholamines after severe traumatic brain injury in rats	CRITICAL CARE MEDICINE			English	Article						experimental traumatic brain injury; hypoxia-hypotension; phenylephrine; alpha-1 adrenergic stimulation; pressor responsiveness; arterial pressure; intracranial pressure; cerebral perfusion pressure	CLOSED-HEAD INJURY; HEMORRHAGIC-SHOCK; AXONAL INJURY; INTRACRANIAL-PRESSURE; RESPONSES; MODEL; DYSFUNCTION; MUSCLE; CELLS	Objective. To quantify the phenylephrine pressor responsiveness after severe brain injury combined with hypoxia-hypotension, and to study the respective roles of brain injury and hypoxia-hypotension in the observed alteration. Design: Randomized study. Setting. Accredited animal laboratory. Subjects: Adult Sprague Dawley rats. Interventions: Anesthetized animals were assigned to control, brain injury, hypoxia-hypotension, and brain injury combined with hypoxia-hypotension groups. Brain injury was induced with an impact-acceleration device. During the 15-min hypoxia-hypotension, arterial oxygen pressure was decreased to 40 torr (5.3 kPa) and mean arterial pressure to 30 mm Hg. Thirty-six of the 53 included rats were alive at the end of hypoxia-hypotension (nine animals per group). In an additional group (Hypo, n = 8), mean arterial pressure was lowered to the level observed in brain injury combined with hypoxia-hypotension with pentobarbital infusion. Sixty minutes after injuries (T60), animals received 0.1, 1, and 10 mug/kg phenylephrine in a random order. Pressor responsiveness to phenylephrine was defined as maximal postinjection minus preinjection mean arterial pressure. Measurements and Main Results, During hypoxia-hypotension, mortality was higher and residual restored blood volume was lower (p < .01) in the animals with brain injury and hypoxia-hypotension compared with hypoxia-hypotension alone. At T60, mean arterial pressure (mm Hg) was lower (p < .01) in the brain injury group (83 +/- 22) compared with controls (110 +/- 10) and in brain injury combined with hypoxia-hypotension (76 +/- 18) compared with controls and hypoxia-hypotension (107 +/- 14). Pressor responsiveness (mm Hg) to 1 and 10 mug/kg phenylephrine was less (p < .05) in brain injury combined with hypoxia-hypotension (15 +/- 6 and 44 +/- 8) and hypoxia-hypotension (15 +/- 3 and 44 +/- 8) compared with controls (26 +/- 2 and 57 +/- 11). No significant difference was observed for phenylephrine pressor responsiveness between controls and the Hypo group (25 +/- 5 and 66 +/- 7). Conclusions, Combination of brain injury and hypoxia-hypotension induces a severe hemodynamic alteration associated with a decreased pressor responsiveness to phenylephrine. Transient hypoxia-hypotension is responsible for the depressed alpha -1 adrenergic reactivity.	Univ Paris Sud, Fac Med Bicetre, Physiol Lab, UPRESS EA 2704, F-94275 Le Kremlin Bicetre, France; Univ Paris Sud, Fac Med Bicetre, Lab Anesthesiol, F-94275 Le Kremlin Bicetre, France	Holtzer, S (corresponding author), Ctr Hosp Univ Beaujon APHP, Dept Anesthesie Reanimat, 110 Blvd Gen Leclerc, F-92118 Clichy, France.	sabine.holtzer@bjn.ap-hop-paris.fr					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; DeWitt D S, 1995, New Horiz, V3, P376; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; Gao H, 1996, FREE RADICAL BIO MED, V21, P591, DOI 10.1016/0891-5849(96)00157-8; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; KIRKEBY OJ, 1995, J NEUROSURG, V83, P1067, DOI 10.3171/jns.1995.83.6.1067; KITA H, 1994, ACTA NEUROCHIR, P452; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609010-00010; LENOBLE JLML, 1987, ARCH INT PHARMACOD T, V289, P82; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856; MONTASSER A, 1994, J NEUROSURG, V80, P301; Nagashima M, 1997, GEN PHARMACOL, V28, P721, DOI 10.1016/S0306-3623(96)00356-4; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; PERBECK L, 1982, ACTA CHIR SCAND, V148, P3; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; STEINFATH M, 1992, BRIT J PHARMACOL, V107, P185, DOI 10.1111/j.1476-5381.1992.tb14484.x; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; VANDENBRINK WA, 1994, ACT NEUR S, V60, P456; WANG P, 1993, AM J PHYSIOL, V265, pH973; WATKINS MT, 1995, AM J PHYSIOL-HEART C, V268, pH749; WAYDHAS C, 1992, ARCH SURG-CHICAGO, V127, P460; WILSON SP, 1982, J NEUROSCI, V2, P1150; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; ZHAO KS, 1985, MICROVASC RES, V30, P143, DOI 10.1016/0026-2862(85)90046-9	36	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2001	29	8					1609	1614		10.1097/00003246-200108000-00018			6	Critical Care Medicine	General & Internal Medicine	465FZ	WOS:000170580100018	11505138				2021-06-18	
J	Qureshi, AI; Suri, FK; Ling, GSF; Khan, J; Guterman, LR				Qureshi, AI; Suri, FK; Ling, GSF; Khan, J; Guterman, LR			Absence of early proinflammatory cytokine expression in experimental intracerebral hemorrhage	NEUROSURGERY			English	Article; Proceedings Paper	53rd Annual Meeting of the American-Academy-of-Neurology	APR 05-12, 2001	PHILADELPHIA, PA	Amer Acad Neurol		cerebrospinal fluid; cytokines; interleukins; intracerebral hemorrhage; tissue necrosis factor	TUMOR-NECROSIS-FACTOR; BRAIN-BARRIER PERMEABILITY; CEREBRAL-BLOOD-FLOW; FACTOR-ALPHA; TNF-ALPHA; INTRACRANIAL-PRESSURE; INJURY; EDEMA; RAT; IL-6	OBJECTIVE: We sought to analyze the regional concentrations of proinflammatory cytokines in the acute period of intracerebral hemorrhage (ICH) and to test the hypothesis that ICH is associated with the expression of proinflammatory cytokines in the acute period. Although the expression of cytokines and their role in neuronal injury and inflammation is well characterized in cerebral ischemia and head injury, no information exists regarding expression of cytokines in ICH. METHODS: We introduced ICH in eight anesthetized mongrel dogs by autologous blood injection (6 ml) under arterial pressure in the deep white matter adjacent to the left basal ganglia. Samples of arterial blood and cerebrospinal fluid were collected, and tissue extracts were prepared from different regions of the brain for immunoassay of tumor necrosis factor alpha, interleukin (IL)-1 beta, and IL-6 concentrations in animals with and without ICH. RESULTS: The tumor necrosis factor alpha levels (+/- standard error) in the cerebrospinal fluid 1 hour after ICH did not differ significantly between the ICH group and the control group (7.1 +/- 1.3 pg/ml versus 10.8 +/- 2.3 pg/ml, P = 0.22). Levels in the perihematoma region in the ICH group (96.6 +/- 3.1 pg/ml) were not significantly different from those in the control group (93.4 +/- 6.7 pg/ml, P = 0.7). IL-6 levels (+/- standard error) in the perihematoma region in the ICH group (116.3 +/- 13.3 pg/ml) did not differ significantly from those in corresponding regions in the control group (122.3 +/- 12.8 pg/ml, P = 0.7). IL-1 beta levels were below 5 pg/ml in serum, cerebrospinal fluid, and extracts of different brain regions. CONCLUSION: The early pathophysiology of ICH does not involve significant expression of tumor necrosis factor a either in the perihematoma region or other regions of the brain. The observation suggests that the pathophysiology of ICH in the acute period is different from both cerebral ischemia and traumatic brain injury.	SUNY Buffalo, Dept Neurosurg, Buffalo, NY USA; SUNY Buffalo, Toshiba Stroke Res Ctr, Buffalo, NY USA; Uniformed Serv Univ Hlth Sci, Div Crit Care Med, Bethesda, MD 20814 USA	Qureshi, AI (corresponding author), Millard Fillmore Hosp, Dept Neurosurg, 3 Gates Circle, Buffalo, NY 14209 USA.	aiqureshi@hotmail.com		Qureshi, Adnan/0000-0003-4962-540X			Arvin B, 1995, ANN NY ACAD SCI, V765, P62, DOI 10.1111/j.1749-6632.1995.tb16561.x; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; BULLOCK R, 1988, SURG NEUROL, V29, P101, DOI 10.1016/0090-3019(88)90065-1; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; KANNO T, 1993, STROKE S, V24, P96; KIM KS, 1992, LYMPHOKINE CYTOK RES, V11, P293; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; LISK DR, 1994, NEUROLOGY, V44, P133, DOI 10.1212/WNL.44.1.133; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; MOHLER KM, 1993, J IMMUNOL, V151, P1548; NATH FP, 1986, J NEUROSURG, V65, P697, DOI 10.3171/jns.1986.65.5.0697; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Qureshi AI, 1999, CRIT CARE MED, V27, P965, DOI 10.1097/00003246-199905000-00036; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; QURESHI AI, 1995, STROKE, V26, P1764, DOI 10.1161/01.STR.26.10.1764; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TROST LC, 1994, ANAL BIOCHEM, V220, P149, DOI 10.1006/abio.1994.1311; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; ZUCKER K, 1994, LYMPHOKINE CYTOK RES, V13, P191	29	16	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	AUG	2001	49	2					416	420		10.1097/00006123-200108000-00027			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	457MQ	WOS:000170141700086	11504118				2021-06-18	
J	[Anonymous]				[Anonymous]			Antiseizure prophylaxis for penetrating brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							POST-TRAUMATIC EPILEPSY; HEAD-INJURY; POSTTRAUMATIC SEIZURES; MISSILE WOUNDS; PREVENTION; PHENYTOIN									AARABI B, 2000, NEUROSURG FOCUS, V8; ADELOYE A, 1971, Ghana Medical Journal, V10, P56; ADELOYE A, 1971, J NEUROL NEUROSUR PS, V34, P98, DOI 10.1136/jnnp.34.1.98; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ascroft PB, 1941, BMJ-BRIT MED J, V1941, P739, DOI 10.1136/bmj.1.4193.739; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; MEIROWSKY AM, 1982, MIL MED, V147, P632; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALAZAR AM, 1999, MISSILE WOUNDS HEAD, V2, P281; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Wagstaffe WW, 1928, LANCET, V2, P861; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; WHITTY CWM, 1947, BRAIN, V70, P416, DOI 10.1093/brain/70.4.416; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236	18	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2001	51	2		S			S41	S43					3	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	464LR	WOS:000170534500009	11505199				2021-06-18	
J	Mueller, FO; Marshall, SW; Kirby, DP				Mueller, FO; Marshall, SW; Kirby, DP			Injuries in Little League Baseball from 1987 through 1996 - Implications for prevention	PHYSICIAN AND SPORTSMEDICINE			English	Article							COMMOTIO CORDIS; CHEST IMPACTS; SOFTBALL; RISK	BACKGROUND: Baseball is a very popular team sport in the United States, but there has been concern with the number of injuries and fatalities. OBJECTIVE: This study describes the incidence of injuries to Little League Baseball, Inc, players from 5 to 12 years old from 1987 through 1996. METHODS: Descriptive statistical analyses of injuries derived from Little League Baseball, Inc, insurance data from 17,221,210 player-years of follow-up in the 10-year study period. An average of 1,722,121 children participated every year. RESULTS: During the study, there were 29,038 injuries and an injury rate of 1.69 injuries per 1,000 participants per season. Ball-related injuries totaled 15,266, and batters had the greatest number of ball injuries. There were 12,306 facial and teeth injuries, mostly in defensive players. Sliding was associated with 60% of the injuries to base runners. Approximately 25% of the injuries were considered severe (fractures, dislocations, and concussions), and 13 players died. CONCLUSION: Based on the data, youth baseball appears to be a very safe sport, but there are areas where injury prevention is possible. Data and additional attention are needed concerning face mask use for players in the field, modified balls for minimizing contact injuries, education on sliding technique, and use of safety bases for runners.	Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Jury Prevent Res Ctr, Chapel Hill, NC 27599 USA; Little League Baseball Inc, Williamsport, PA USA	Mueller, FO (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, CB-8700,209 Fetzer Gym, Chapel Hill, NC 27599 USA.			Marshall, Stephen/0000-0002-2664-9233			*BAS SOFTB COUNC, 1996, BAS REP PART AM NAT, P1; CAVENESS LS, 1988, INT OPHTHALMOL CLIN, V28, P238, DOI 10.1097/00004397-198802830-00015; Crisco JJ, 1997, MED SCI SPORT EXER, V29, P26, DOI 10.1097/00005768-199701000-00005; Hosey RG, 2000, AM J SPORT MED, V28, P360, DOI 10.1177/03635465000280031301; Janda DH, 1998, J TRAUMA, V44, P298, DOI 10.1097/00005373-199802000-00011; Janda DH, 1993, CLIN J SPORT MED, V3, P78; Janda DH, 1992, CLIN J SPORT MED, V2, P172; KYLE SB, 1996, YOUTH BASEBALL PROTE; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Pasternack JS, 1996, PEDIATRICS, V98, P445; RISSER WL, 1994, PEDIATRICS, V93, P690; SENDRE RA, 1994, AM J SPORT MED, V22, P450, DOI 10.1177/036354659402200403; Vincent GM, 2000, PHYSICIAN SPORTSMED, V28, P31, DOI 10.3810/psm.2000.11.1285; Vinger PF, 1999, ARCH OPHTHALMOL-CHIC, V117, P354, DOI 10.1001/archopht.117.3.354; Vinger PF, 1997, JAMA-J AM MED ASSOC, V277, P142, DOI 10.1001/jama.277.2.142; Yen KL, 2000, PEDIATR EMERG CARE, V16, P215, DOI 10.1097/00006565-200006000-00021	16	16	18	0	7	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000 USA	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	JUL	2001	29	7					41	48		10.3810/psm.2001.07.874			8	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	447XN	WOS:000169597900012	20086581				2021-06-18	
J	Quan, L; Zhu, BL; Oritani, S; Ishida, K; Fujita, MQ; Maeda, H				Quan, L; Zhu, BL; Oritani, S; Ishida, K; Fujita, MQ; Maeda, H			Intranuclear ubiquitin immunoreactivity in the pigmented neurons of the substantia nigra in fire fatalities	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						ubiquitin; pigmented substantia nigra neurons immunohistochemistry; fire fatality; physical activity	HEAT-SHOCK-PROTEIN; TRAUMATIC BRAIN INJURY; ISCHEMIC BRAIN; MESSENGER-RNA; NEURODEGENERATIVE DISEASES; AXONAL INJURY; C-FOS; HYPERTHERMIA; EXPRESSION; STRESS	To evaluate the significance of immunohistochemical staining of ubiquitin (heat shock protein) in the midbrain for medico-legal investigation of death in fires. we examined forensic autopsy cases of fire fatalities (n = 35) in comparison with controls (n = 27; brain stem injury, acute myocardial infarction and carbon monoxide poisoning other than fire fatality). There were two intranuclear staining patterns in the nuclei of pigmented substantia nigra neurons: a type of inclusion (possible Marinesco bodies) and a diffuse staining. Percentage of nuclear ubiquitin positivity (Ub-positive %) in fire fatalities (2.7-44.7%; mean, 18.5%) was significantly higher than in brain stem injury (n = 9; 0-10.4%; mean, 4.5%) and myocardial infarction (n = 14; 1.5-14.6%; mean, 6.9%), independently of blood carboxyhemoglobin (COHb) levels. Age-dependent increase in Ub-positive % was observed in lower COHb (< 60%) cases. The intranuclear diffuse ubiquitin staining was not observed in cases of high blood cyanide level (> 1.0 mug/ml). These observations showed that intranuclear ubiquitin immunoreactivity of the pigmented substantia nigra neurons in the midbrain was induced by severe stress in fires.	Osaka City Univ, Sch Med, Dept Legal Med, Osaka 5458585, Japan	Quan, L (corresponding author), Osaka City Univ, Sch Med, Dept Legal Med, Asahimachi 1-4-3, Osaka 5458585, Japan.						Abe H, 1996, ADV NEUROL, V71, P451; Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; BROWN IR, 1990, J NEUROSCI RES, V25, P14, DOI 10.1002/jnr.490250103; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; DICKSON DW, 1990, LAB INVEST, V63, P87; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Funayama Masato, 1994, Research and Practice in Forensic Medicine, V37, P169; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hirai S, 1977, Nihon Ronen Igakkai Zasshi, V14, P6; Hirai S., 1968, ADV NEUROL SCI, V12, P845; Ichinose H, 1999, Adv Neurol, V80, P195; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; Ikeda K, 1974, Seishin Shinkeigaku Zasshi, V76, P778; Ikeda Takuya, 1992, Research and Practice in Forensic Medicine, V35, P81; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; KITAMURA O, 1994, INT J LEGAL MED, V107, P69, DOI 10.1007/BF01225492; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kubo Shin-Ichi, 1994, Research and Practice in Forensic Medicine, V37, P159; Kurimura M, 1997, Rinsho Shinkeigaku, V37, P963; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEESTMA JE, 1969, ARCH PATHOL, V88, P431; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; Marinesco G, 1902, CR HEBD ACAD SCI, V135, P1000; MORRISONBOGORAD M, 1995, J NEUROCHEM, V64, P235; Nogami M, 1999, INT J LEGAL MED, V112, P351, DOI 10.1007/PL00007703; NOLTE J, 1999, HUMAN BRAIN INTRO IT, P450; NOWAK TS, 1990, J NEUROCHEM, V54, P451, DOI 10.1111/j.1471-4159.1990.tb01893.x; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; OHTANI S, 1993, J MED TECHNOL, V37, P1391; Okamoto K, 1981, Rinsho Shinkeigaku, V21, P781; ORITANI S, 1997, P 35 M INT ASS FOR T, P366; Pagano M, 1997, FASEB J, V11, P1067; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; SEITE R, 1971, BRAIN RES, V34, P277, DOI 10.1016/0006-8993(71)90281-2; SEITE R, 1972, J PHYSIOL-PARIS, V65, P502; Sharma HS, 1998, PROG BRAIN RES, V115, P351; Sharma HS, 1998, PROG BRAIN RES, V115, P297; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Sharp FR, 1998, ANN NEUROL, V44, P581, DOI 10.1002/ana.410440402; SHOJI T, 1997, NIPPON HOIGAKU ZASSH, V51, P77; TIPTON KF, 1993, ADV NEUROL, V60, P186; TYTELL M, 1993, ADV NEUROL, V59, P293; TYTELL M, 1994, J NEUROSCI RES, V38, P19, DOI 10.1002/jnr.490380105; Tytell M, 1998, MOL CHEM NEUROPATHOL, V35, P97, DOI 10.1007/BF02815118; WEISS JH, 1994, NEUROSCIENCE, V60, P659, DOI 10.1016/0306-4522(94)90494-4; Westman J, 1998, PROG BRAIN RES, V115, P207; Yu SP, 1999, SCIENCE, V284, P336, DOI 10.1126/science.284.5412.336; YUEN P, 1963, J NEUROL NEUROSUR PS, V26, P178, DOI 10.1136/jnnp.26.2.178; Zipfel GJ, 1999, NEW ENGL J MED, V341, P1543, DOI 10.1056/NEJM199911113412011	57	16	20	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0937-9827			INT J LEGAL MED	Int. J. Legal Med.	JUL	2001	114	6					310	315		10.1007/s004140000192			6	Medicine, Legal	Legal Medicine	457DY	WOS:000170122900002	11508795				2021-06-18	
J	Bezner, JR; Hunter, DL				Bezner, JR; Hunter, DL			Wellness perception in persons with traumatic brain injury and its relation to functional independence	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						activities of daily living; brain injuries; quality of life; rehabilitation; reproducibility of results	QUALITY-OF-LIFE; SELF-RATED HEALTH; FOLLOW-UP; MORTALITY; REHABILITATION; PREDICTORS; INDICATORS; OUTCOMES	Objectives: To test the reliability and validity of a perceptual wellness measure in persons after traumatic brain injury (TBI) and to determine whether a relation exists between functional independence and wellness perceptions in the same population. Design: Survey research. Setting: A private, residential brain injury program. Participants: A convenience sample of 49 patients (43 men, 6 women) with TBI whose mean age was 32.1 years (range, 18-61 yr) and mean time since injury was 10.47 years (range, 1-21 yr). Main Outcome Measures: The Perceived Wellness Survey (PWS) assessed wellness. The PWS has 6 subscales measuring physical, psychologic, emotional, intellectual, spiritual, and social wellness. The FIM (TM) instrument was used to measure functional status. Results: The mean PWS score (15.99) for the sample was comparable to published samples of adults (mean, 15.31-16.51); however, the reliability of the composite score (alpha = .58) and the subscales (alpha = .32-.64) was less than that obtained in previous samples (composite alpha = 0.91; subscale alpha = .64-.81). The correlations between the PWS and the FTM scores were not significant, Conclusions: The PWS in its composite form is a reliable measure for use with persons with TBI. The finding that perceived wellness and functional independence were not related suggests that these constructs are unique and thus should both be measured. The measurement of perceptions will enable the provider to consider a client holistically and to develop programs that address quality of lire issues. Further, because perceptions influence behaviors, understanding a person's perceptions in multiple dimensions may provide a useful and necessary framework for developing intervention programs that address behavioral and cognitive issues that are important to that person. (C) 2001 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	SW Texas State Univ, Dept Phys Therapy, San Marcos, TX 78666 USA	Bezner, JR (corresponding author), SW Texas State Univ, Dept Phys Therapy, 601 Univ Dr, San Marcos, TX 78666 USA.						Adams T, 1997, AM J HEALTH PROMOT, V11, P208, DOI 10.4278/0890-1171-11.3.208; Adams T, 1998, AM J HLTH STUD, V14, P212; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; Antonovsky A, 1988, UNRAVELING MYSTERY H; Bergquist TF, 1994, J HEAD TRAUMA REHAB, V9, P50, DOI 10.1097/00001199-199412000-00007; COHEN S, 1986, J PERS SOC PSYCHOL, V50, P963, DOI 10.1037/0022-3514.50.5.963; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1994, SOC INDIC RES, V31, P103, DOI 10.1007/BF01207052; Evans RW., 1998, NEUROL REPORT, V22, P144; Fuhrer MJ, 1987, REHABILITATION OUTCO, P137; FYLKESNES K, 1991, SOC SCI MED, V32, P141, DOI 10.1016/0277-9536(91)90053-F; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; IDLER EL, 1990, AM J PUBLIC HEALTH, V80, P446, DOI 10.2105/AJPH.80.4.446; KAPLAN GA, 1983, AM J EPIDEMIOL, V117, P292, DOI 10.1093/oxfordjournals.aje.a113541; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Pain K, 1998, J REHABIL, V64, P5; Portney LG., 1993, FDN CLIN RES APPL PR, V3rd; PROCIDANO ME, 1983, AM J COMMUN PSYCHOL, V11, P1, DOI 10.1007/BF00898416; PROCIDANO ME, 1992, ADV PERS AS, V9, P1; ROTH E, 1990, CLIN REHABIL, V4, P277, DOI DOI 10.1177/026921559000400405; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Warren L, 1996, J REHABIL RES DEV, V33, P404; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	30	16	16	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2001	82	6					787	792		10.1053/apmr.2001.23269			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	439KK	WOS:000169115900012	11387584				2021-06-18	
J	Keren, O; Cohen, M; Lazar-Zweker, I; Groswasser, Z				Keren, O; Cohen, M; Lazar-Zweker, I; Groswasser, Z			Tracheotomy in severe TBI patients: sequelae and relation to vocational outcome	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; TRACHEAL INTUBATION; COMPLICATIONS	The aim of the present study was to find the influence of performing tracheotomy on outcome of severe TBI patients. TBI patients, many of them intubated during the very acute phase post-injury, who remain unconscious for more than a few days, undergo tracheotomy to provide a reliable long term artificial airway. Tracheotomy, although being a simple elective surgical procedure, may have a negative influence on the rehabilitation process. Tracheotomy was performed in 25% (n = 69) of 277 consecutive severe TBI patients admitted to the rehabilitation department during 3 years. In seven patients (10%), tracheotomy was performed immediately after injury due to cranio-facial trauma, in 18 patients (29%) due to respiratory disturbances, in 42 patients (55%) after prolonged intubation, and in two patients (6%) due to combined problems. Forty-five per cent of patients with tracheotomy suffered from respiratory disturbances and 8.6% from complications of tracheotomy. Longer periods of unconsciousness and mechanical ventilation were significantly associated with respiratory complications ( p < 0.0001 and p < 0.001, respectively). However, presence of tracheotomies per se, did not affect vocational rehabilitation.	Loewentein Rehabil Hosp, IL-43100 Raanana, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Groswasser, Z (corresponding author), Loewentein Rehabil Hosp, 278 Achuza St,POB 3, IL-43100 Raanana, Israel.	zeevgros@ccsg.tau.ac.il					BLANC VF, 1974, ANESTH ANALG, V53, P202; CITTAPIETROLUNGO TJ, 1993, ARCH PHYS MED REHAB, V74, P905; DUNHAM CM, 1984, J TRAUMA, V24, P120, DOI 10.1097/00005373-198402000-00005; KLINGBEIL GEG, 1988, ARCH PHYS MED REHAB, V69, P493; MACKENZIE CF, 1984, CRITICAL CARE MONITO, V4, P1; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; SPLAINGARD ML, 1989, ARCH PHYS MED REHAB, V70, P318; WEICKER W, 1982, ZBL CHIR, V107, P945; WHITED RE, 1984, LARYNGOSCOPE, V94, P367; Wilson B, 1994, BRAIN INJURY NEUROPS, P85	12	16	17	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2001	15	6					531	536		10.1080/02699050010007371			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	439VE	WOS:000169137600006	11394972				2021-06-18	
J	McCauley, SR; Hannay, HJ; Swank, PR				McCauley, SR; Hannay, HJ; Swank, PR			Use of the Disability Rating Scale recovery curve as a predictor of psychosocial outcome following closed-head injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Proceedings Paper	27th Annual Meeting of the International-Neuropsychological-Society	FEB 10-13, 1999	BOSTON, MASSACHUSETTS	Int Neuropsychol Soc		closed-head injury; growth curves; outcome measures; outcome prediction; Disability Rating Scare	TRAUMATIC BRAIN INJURY; INDIVIDUAL GROWTH; EVOKED-POTENTIALS; RELATIVES VIEW; VALIDITY; PATIENT; MODELS	Rapid rate of recovery has been associated with better outcome following closed-head injuries, but few studies have compellingly demonstrated this. This study used growth curve analyses of Disability Rating Scale (DRS) scores at acute hospitalization discharge, 1, 3, and 6 months post injury in a sample of 55 patients with a closed-head injury. Six month post-injury outcome measures were taken from significant other (SO) responses on the NYU Head Injury Family Interview (NYU-HIFI) including severity and burden ratings of affective/neurobehavioral disturbance, cognitive deficits, and physical/dependency status. Rate of recovery (linear and curvilinear recovery curve components) was significantly related to the level of affective/neurobehavioral severity, and the severity and burden of SO-perceived cognitive deficits. Only the intercept of the DRS recovery curve was associated with the SO-perceived severity and burden of physical/dependency status. Growth curve modeling is a meaningful and powerful tool in predicting head injury outcome.	Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Univ Houston, Dept Psychol, Houston, TX 77004 USA; Univ Texas, Hlth Sci Ctr, Dept Nursing, Houston, TX USA	McCauley, SR (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 6560 Fannin,Suite 1144,Box 67, Houston, TX 77030 USA.			Hannay, H. Julia/0000-0001-7023-912X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1984, J CLIN NEUROPSYCHOL, V6, P71, DOI 10.1080/01688638408401198; BROOKS DN, 1984, CLOSED HEAD INJURY P; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bryk A.S., 1987, HIERARCHICAL LINEAR; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Francis DJ, 1996, J EDUC PSYCHOL, V88, P3, DOI 10.1037/0022-0663.88.1.3; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; GIANCINO JT, 1991, ARCH PHYSICAL MED RE, V72, P897; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; HEDRICK WP, 1995, BRAIN INJURY, V9, P563, DOI 10.3109/02699059509008215; JENNETT B, 1975, LANCET, V7905, P480; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Malec JF., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1977, ARCH PHYS MED REHAB, V58, P333; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; RAPPAPORT M, 1991, CLIN ELECTROENCEPHAL, V22, P199, DOI 10.1177/155005949102200407; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RAPPAPORT M, 1990, CLIN ELECTROENCEPHAL, V21, P188, DOI 10.1177/155005949002100406; Rappaport M, 1989, J HEAD TRAUMA REHAB, V4, P45; RAPPAPORT M, 1986, J HEAD TRAUMA REHABI, P00015, DOI DOI 10.1097/00001199-198603000-00005; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685; SCHENTZEL SJ, 1993, THESIS WALDEN U CHIC; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x	47	16	16	0	2	CAMBRIDGE UNIV PRESS	PORT CHESTER	110 MIDLAND AVE, PORT CHESTER, NY 10573-9863 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2001	7	4					457	467		10.1017/S1355617701744025			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	436RE	WOS:000168948600003	11396548				2021-06-18	
J	Teng, CJ; Bhalerao, S; Lee, ZL; Farber, J; Morris, H; Foran, T; Tucker, W				Teng, CJ; Bhalerao, S; Lee, ZL; Farber, J; Morris, H; Foran, T; Tucker, W			The use of bupropion in the treatment of restlessness after a traumatic brain injury	BRAIN INJURY			English	Article							AKATHISIA; MECHANISM; AGITATION	The occurrence of restlessness after a traumatic brain injury (TBI) is common. Severe restlessness can be a barrier in the multidisciplinary treatment of patients with TBI. The following case describes a patient with restlessness after a head-on motor vehicle accident. The patient was tachycardic, diaphoretic, demonstrating decerebrate posturing and a Rancho Los Amigos Stage II-III. Significant left lower leg restlessness was severe enough to cause bruising and ulceration. A multidisciplinary look was taken at the effects of using different neurotransmitter modulators in the treatment of restlessness after a TBI. Current biology treatment options include the use of medications that either modulate dopamine or noradrenaline alone. Bupropion effects both the dopaminergic and noradrenergic pathways. In the following case, the patient's restlessness was resistant to almost every medication employed. The only medication that proved to be effective in significantly reducing the patient's restlessness was bupropion. The evidence for the use of bupropion in the treatment of restlessness after a TBI has never been discussed previously, aside from anecdotal accounts. It is hoped that this case will prove insight into another treatment option for patients who have severe restlessness.	Univ Toronto, St Michaels Hosp, Dept Psychiat, Sch Med, Toronto, ON M5B 1W8, Canada	Bhalerao, S (corresponding author), Univ Toronto, St Michaels Hosp, Dept Psychiat, Sch Med, 30 Bond St,4M-028B, Toronto, ON M5B 1W8, Canada.	bhaleraos@8mh.toronto.on.ca					ASCHER JA, 1995, J CLIN PSYCHIAT, V56, P395; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Chandler M C, 1988, Brain Inj, V2, P309; COHEN BM, 1991, BIOL PSYCHIAT, V29, P1215, DOI 10.1016/0006-3223(91)90329-K; COOPER BR, 1994, NEUROPSYCHOPHARMACOL, V11, P133, DOI 10.1038/npp.1994.43; FRIEDMAN EH, 1990, J NEUROL NEUROSUR PS, V53, P1017, DOI 10.1136/jnnp.53.11.1017-a; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; Jauss M, 1998, PHARMACOPSYCHIATRY, V31, P146, DOI 10.1055/s-2007-979317; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; Silver BV, 1996, BRAIN INJURY, V10, P609; STEWART J, 1989, J NEUROL NEUROSUR PS, V52, P1200, DOI 10.1136/jnnp.52.10.1200; VASSOUT A, 1993, J RECEPTOR RES, V13, P341, DOI 10.3109/10799899309073665	13	16	16	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2001	15	5					463	467		10.1080/02699050010005931			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	431TW	WOS:000168648700009	11350660				2021-06-18	
J	Zurita, M; Vaquero, J; Oya, S; Montilla, J				Zurita, M; Vaquero, J; Oya, S; Montilla, J			Functional recovery in chronic paraplegic rats after co-grafts of fetal brain and adult peripheral nerve tissue	SURGICAL NEUROLOGY			English	Article						paraplegia; neural grafts; spinal cord injury	SPINAL-CORD; ADRENAL-MEDULLA; INJURY; REGENERATION; TRANSPLANTS	BACKGROUND In recent years, experimental studies have sought some type of functional improvement in traumatic paraplegia by transplanting neural tissue into the injured spinal cord. The aim of this work is to study the possibility of functional recovery in chronic paraplegic rats after cotransplantation of fetal cerebral tissue and adult peripheral nerve tissue. METHODS Seventy adult female Wistar rats were subjected to spinal cord injury at the T6-T8 lever, causing complete paraplegia. Three months later, in 50 rats (grafted group) the injured spinal cord tissue received a graft of fetal brain cortex associated with crushed adult peripheral nerve. All the animals (grafted and control groups) were subjected to daily rehabilitation procedures from the first week after the injury, and evaluated weekly for motor and sensory recovery. Statistical analysis of different behavioral data between control and grafted animals was performed using the Kruskal-Wallis ANOVA and the nonparametric Wilcoxon test. RESULTS Between 8 and 12 months after transplantation, progressive signs of functional recovery were observed in the grafted animals, associated with an increase in muscle mass in the lower extremities, findings that were significantly different from those in nongrafted animals (p < 0.05). At this time, donor cerebral tissue is integrated into previously injured spinal cord and results in formation of bundles of nerve fibers that emerge from the area of the transplant and surround the spinal cord beneath the lesion. CONCLUSIONS Delayed co-transplantation of fetal cerebral tissue and peripheral nerve tissue can be used to achieve anatomical remodeling and long-term functional recovery in rats rendered paraplegic as result of severe spinal cord injury. These findings support the possibility of functional recovery after chronic traumatic paraplegia. (C) 2001 by Elsevier Science Inc.	Autonomous Univ Madrid, Serv Neurochirurg, Clin Puerta de Hierro, Mapfre Med Fdn,Neurosci Res Unit, Madrid, Spain	Vaquero, J (corresponding author), Autonomous Univ Madrid, Serv Neurochirurg, Clin Puerta de Hierro, Mapfre Med Fdn,Neurosci Res Unit, San Martin de Porres 4, Madrid, Spain.						BERNSTEIN JJ, 1995, PARAPLEGIA, V33, P250, DOI 10.1038/sc.1995.57; DATE I, 1990, BRAIN RES, V537, P33, DOI 10.1016/0006-8993(90)90336-A; DOERING LC, 1992, EXP NEUROL, V118, P253, DOI 10.1016/0014-4886(92)90182-P; EGAR M, 1972, EXP NEUROL, V37, P422, DOI 10.1016/0014-4886(72)90085-4; FAWCETT J, 1995, PARAPLEGIA, V33, P491, DOI 10.1038/sc.1995.108; MATTHEWS MA, 1979, ACTA NEUROPATHOL, V45, P27, DOI 10.1007/BF00691801; NORLANDER RH, 1978, J COMP NEUROL, V180, P349; Ramon y Cajal S., 1914, STUDIES DEGENERATION, VII; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; REIER PJ, 1992, J NEUROTRAUM, V9, pS223; Reier PJ, 1986, ASTROCYTES, V3, P263; Sugar O, 1940, J NEUROPHYSIOL, V3, P1; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; TATOR CH, 1973, J NEUROSURG, V39, P52, DOI 10.3171/jns.1973.39.1.0052; Tello JF, 1911, TRAB LAB INVEST BIOL, V9, P123; VAQUERO J, 1981, ACTA NEUROCHIR, V59, P209, DOI 10.1007/BF01406350; WALLACE MC, 1987, SURG NEUROL, V27, P209, DOI 10.1016/0090-3019(87)90031-0; WEI Y, 1998, PAIN, V74, P115; Zompa EA, 1997, J NEUROTRAUM, V14, P479, DOI 10.1089/neu.1997.14.479; Zurita M, 2000, SURG NEUROL, V54, P117, DOI 10.1016/S0090-3019(00)00287-1; ZURITA M, 1994, POLYTRAUMATIZED, P343	21	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	MAY	2001	55	5					249	254		10.1016/S0090-3019(01)00442-6			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	445GM	WOS:000169449800001	11516457				2021-06-18	
J	Heath, DL; Vink, R				Heath, DL; Vink, R			Subdural hematoma following traumatic brain injury causes a secondary decline in brain free magnesium concentration	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; magnetic resonance; neurotrauma; outcome; treatment	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; RATS; STROKE; MODEL; EFFICACY; THERAPY	A number of studies have demonstrated that neurologic motor and cognitive deficits induced by traumatic brain injury (TBI) can be attenuated with administration of magnesium salts, However, many severe traumatic brain injuries have a significant hematoma that develops subsequent to the primary events, and it is unclear whether magnesium salts are effective in this situation. In the present study, an impact-acceleration rodent model of TBI was used to produce an injury that causes an extensive subdural hematoma in over 50% of injured animals. At 30 min after TBI, rats were randomly administered 250 mu moles/kg intravenous MgSO4 or equal volume saline before being monitored by magnetic resonance spectroscopy for 8 h to determine brain intracellular free magnesium concentration. Animals were then assessed for neurologic motor deficits over 1 week using a rotarod device, followed by postmortem examination for presence of subdural hematoma. Animals with subdural hematoma treated with MgSO4 showed no improvement in motor outcome when compared to nontreated controls. Animals with no visible subdural hematoma demonstrated a significant improvement (p < 0.05 by ANOVA) in rotarod scores with MgSO4 treatment, Brain free magnesium concentration in the magnesium treated/hematoma group demonstrated a biphasic decline made up of an immediate initial decline, recovery of brain magnesium levels with MgSO4 treatment, and then a significant second magnesium decline (p < 0.05). Such a secondary decline did not occur in the Mg treated/no hematoma animals. Our results suggest that development of a subdural hematoma following TBI results in a decline in brain magnesium, even after bolus administration of magnesium salts. Such effects of hematoma development will need to be considered in trials examining efficacy of magnesium salts as an intervention following TBI.	James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia	Vink, R (corresponding author), James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia.		AM, Robert Vink/S-5616-2019; Vink, Robert/J-7351-2012	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P191, DOI 10.1007/BF01808958; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; Muir KW, 1998, MAGNESIUM RES, V11, P43; PANTER SS, 1992, J NEUROTRAUM, V9, P47, DOI 10.1089/neu.1992.9.47; Regan RF, 1998, J NEUROCHEM, V70, P77; Schmid-Elsaesser R, 1999, NEUROSURGERY, V44, P163, DOI 10.1097/00006123-199901000-00100; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Suzuki M, 1997, GEN PHARMACOL, V28, P119, DOI 10.1016/S0306-3623(96)00148-6; VINK R, 1989, BIOCHEM BIOPH RES CO, V165, P913, DOI 10.1016/S0006-291X(89)80053-1; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yang Y, 2000, NEUROSCI LETT, V285, P119, DOI 10.1016/S0304-3940(00)01048-X	27	16	16	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2001	18	4					465	469		10.1089/089771501750171074			5	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	425TP	WOS:000168308000009	11336446				2021-06-18	
J	Eilig, I; Rachinsky, M; Artru, AA; Alonchin, A; Kapuler, V; Tarnapolski, A; Shapira, Y				Eilig, I; Rachinsky, M; Artru, AA; Alonchin, A; Kapuler, V; Tarnapolski, A; Shapira, Y			The effect of treatment with albumin, hetastarch, or hypertonic saline on neurological status and brain edema in a rat model of closed head trauma combined with uncontrolled hemorrhage and concurrent resuscitation in rats	ANESTHESIA AND ANALGESIA			English	Article							ISOVOLEMIC HEMODILUTION; 5-PERCENT DEXTROSE; ONCOTIC PRESSURE; CEREBRAL EDEMA; RAPID INFUSION; FLUID THERAPY; OSMOLALITY; INJURY; SHOCK	In rats subjected to closed head trauma (CHT) plus uncontrolled hemorrhage, giving 0.3 mL of 0.9% saline per 0.1 mL of blood lost did not restore mean arterial blood pressure (MAP) or improve neurological severity score (NSS). In CHT without hemorrhage, giving 20% albumin or 10% hetastarch improved NSS. We hypothesized that these latter treatments would also improve NSS after CHT plus uncontrolled hemorrhage. Rats were randomly assigned to one of seven groups. Experimental conditions were CHT (yes or no), uncontrolled hemorrhage (yes or no), and fluid given to replace blood loss (none; 10% hetastarch, 20% albumin, or 3% saline [0.1 mL per 0.1 mt of blood lost]; or 0.9% saline [0.3 mt per 0.1 mL of blood lost]). NSS (0-25 scale, where 0 = no impairment) was determined at 1, 4, and 24 h, and brain water content was determined at 24 h after CHT. NSS (median +/- range) at 24 h was 11 +/- 6 when no fluid was given; 16 +/- 5 with 10% hetastarch; 14 +/- 5 with 20% albumin; 12 +/- 4 with 3% saline; and 13 +/- 4 with 0.9% saline given (not significant). In addition, brain water content and MAP did not differ among the groups receiving CHT with or without uncontrolled hemorrhage. In our model of CHT plus uncontrolled hemorrhage in rats, giving 10% hetastarch, 20% albumin, 3% saline, or 0.9% saline failed to improve NSS, brain water content, or MAP.	Ben Gurion Univ Negev, Soroka Med Ctr, Dept Pediat Surg, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Dept Neurosurg, IL-84105 Beer Sheva, Israel; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol, IL-84105 Beer Sheva, Israel	Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Box 356540,1959 NE Pacific St, Seattle, WA 98195 USA.						Chorny I, 1999, J NEUROSURG ANESTH, V11, P273, DOI 10.1097/00008506-199910000-00008; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; GOSLINGA H, 1992, STROKE, V23, P181, DOI 10.1161/01.STR.23.2.181; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; KEE DB, 1987, CEREBRAL BLOOD FLOW, P173; LEE SH, 1994, J NEUROSURG, V80, P469, DOI 10.3171/jns.1994.80.3.0469; POOLE GV, 1986, CRIT CARE MED, V14, P629, DOI 10.1097/00003246-198607000-00009; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Talmor D, 1999, ANESTH ANALG, V89, P950, DOI 10.1097/00000539-199910000-00024; Talmor D, 1998, ANESTH ANALG, V86, P1225, DOI 10.1097/00000539-199806000-00017; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; WARNER DS, 1988, ANESTHESIOLOGY, V68, P86, DOI 10.1097/00000542-198801000-00014; WISNER D, 1989, J SURG RES, V46, P49, DOI 10.1016/0022-4804(89)90181-9; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010; Zornow MH, 1997, TXB NEUROANESTHESIA, P117	20	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	MAR	2001	92	3					669	675		10.1213/00000539-200103000-00023			7	Anesthesiology	Anesthesiology	405JW	WOS:000167157100022	11226099				2021-06-18	
J	Xiong, Y; Peterson, PL; Lee, CP				Xiong, Y; Peterson, PL; Lee, CP			Alterations in cerebral energy metabolism induced by traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						antioxidants; brain mitochondria; calcium channel blockers; energy metabolism; oxidative stress; traumatic brain injury	SEVERE HEAD-INJURY; TRANSIENT FOREBRAIN ISCHEMIA; CALCIUM-CHANNEL BLOCKER; BLOOD-FLOW; MITOCHONDRIAL DYSFUNCTION; N-ACETYLCYSTEINE; OXIDATIVE-METABOLISM; CEREBROSPINAL-FLUID; LIPID-PEROXIDATION; RATS	Energy metabolism of the brain is unique, possessing high aerobic metabolism with no significant capacity for anaerobic glycolysis and limited tissue stores of glucose. A steady supply of oxygen and glucose is essential in order to maintain cerebral function and integrity. Extensive research in experimental and human head injury has been conducted regarding the delivery of oxygen and outcome. This research has provided evidence which indicates that in addition to the availability of oxygen and glucose, other factors, such as perturbation of mitochondrial energy transducing processes which also follow head trauma, play significant roles. In this paper, the salient findings from biochemical studies of experimental and clinical brain injury are summarized and indicate that the mitochondrial respiratory chain-linked oxidative phosphorylation and calcium transport are compromised by trauma-induced brain injury and support the idea that oxidative stress and perturbation of cellular calcium homeostasis play significant roles in traumatic brain injury.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA	Lee, CP (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield St, Detroit, MI 48201 USA.	cplee@med.wayne.edu		Xiong, Ye/0000-0001-9770-6031			Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; BASFORD RE, 1967, METHOD ENZYMOL, V10, P96; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bowersox S, 1997, DRUG METAB DISPOS, V25, P379; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRAUGHLER JM, 1985, J NEUROCHEM, V45, P1288, DOI 10.1111/j.1471-4159.1985.tb05555.x; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; CADOUXHUDSON TAD, 1990, ACTA NEUROCHIR, V104, P1, DOI 10.1007/BF01842884; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK JB, 1970, J BIOL CHEM, V245, P4724; CORCORAN GB, 1986, J PHARMACOL EXP THER, V238, P54; Davey GP, 1997, J NEUROCHEM, V69, P2564; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313; Hall ED, 1996, ACT NEUR S, V66, P107; Hall ED, 1996, J NEUROSCI RES, V44, P293, DOI 10.1002/(SICI)1097-4547(19960501)44:3<293::AID-JNR10>3.0.CO;2-6; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1990, BEHAV BRAIN RES, V37, P119, DOI 10.1016/0166-4328(90)90087-U; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; Jiang XB, 1999, NEUROL MED-CHIR, V39, P649, DOI 10.2176/nmc.39.649; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly G S, 1998, Altern Med Rev, V3, P114; KNUCKEY NW, 1995, STROKE, V26, P305, DOI 10.1161/01.STR.26.2.305; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lai J C, 1979, Methods Enzymol, V55, P51; Landolt H, 1996, EUR J ANAESTH, V13, P269, DOI 10.1046/j.1365-2346.1996.00975.x; Lee C. P., 1993, V2, P41; LEE CP, 1994, CURR TOP BIOENERG, V17, pR11; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LUST WD, 1985, CEREBRAL ENERGY META, P79; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MCHENRY LC, 1978, CEREBRAL CIRCULATION; MCINTOSH TK, 1988, AM J PHYSIOL, V254, pR785; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Petit PX, 1997, MOL CELL BIOCHEM, V174, P185, DOI 10.1023/A:1006848205880; PRASAD MR, 1994, J NEUROCHEM, V63, P773; PROCTOR HJ, 1988, J TRAUMA, V28, P347, DOI 10.1097/00005373-198803000-00010; Ritter A M, 1994, Neurosurg Clin N Am, V5, P633; Robertson C S, 1995, New Horiz, V3, P410; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROSENTHAL RE, 1990, CEREBRAL ISCHEMIA RE, P289; Rossen R, 1943, ARCH NEURO PSYCHIATR, V50, P510; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SCIAMANNA MA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P223, DOI 10.1016/0167-4889(92)90180-J; SCIAMANNA MA, 1993, ARCH BIOCHEM BIOPHYS, V305, P215, DOI 10.1006/abbi.1993.1414; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHIRAISHI K, 1989, J CEREBR BLOOD F MET, V9, P765, DOI 10.1038/jcbfm.1989.110; Siesj_o B K, 1978, BRAIN ENERGY METABOL; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SIMS NR, 1991, J NEUROCHEM, V56, P1836, DOI 10.1111/j.1471-4159.1991.tb03438.x; SIMS NR, 1987, J NEUROCHEM, V49, P1367, DOI 10.1111/j.1471-4159.1987.tb01001.x; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vinas FC, 1998, CRIT REV NEUROSURG, V8, P31, DOI 10.1007/s003290050058; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WAGNER KR, 1985, J NEUROSURG, V63, P88, DOI 10.3171/jns.1985.63.1.0088; Whittingham TS, 1990, CEREBRAL ISCHEMIA RE, P101; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; ZHANG Y, 1990, J BIOL CHEM, V265, P16330	87	16	27	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					129	138		10.1179/016164101101198460			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	422DX	WOS:000168104200004	11320591				2021-06-18	
J	McPherson, KM; McNaughton, H; Pentland, B				McPherson, KM; McNaughton, H; Pentland, B			Information needs of families when one member has a severe brain injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain injury; carers; information; rehabilitation	CASE-MANAGEMENT; STROKE; CARERS; IMPACT; WANT	Despite calls for health and social services to respond to the needs of informal carers, there is little evidence to guide practioners in the best way to provide support and/or information in situations of complex need such as brain injury. This study addressed such an intervention in a prospective descriptive study, using both qualitative and quantitative methodology. Eighty-nine patients who had been admitted to a regional neurorehabilitation unit for management of traumatic or haemorrhagic brain injuries were consecutively discharged to the community over a period of 12 months. Eighty-two of these people identified a carer who agreed to be interviewed at approximately six weeks after discharge regarding their concerns. The study identified that even soon after discharge from inpatient rehabilitation, carers wanted more information. In many cases the need for information was unrelated to either the severity of injury or level of functional deficit. In addition, requests for information were in many cases not sought spontaneously, but required prompting. Such findings have implications if interventions in this field are to have the optimum chance of succeeding in providing support and assistance.	Wellington Sch Med, Dept Med, Wellington, New Zealand; Scottish Brian Injury Rehabil Serv, Edinburgh, Midlothian, Scotland	McPherson, KM (corresponding author), Wellington Sch Med, Dept Med, POB 7343, Wellington, New Zealand.			McPherson, Kath/0000-0003-0487-8497; McPherson, Kathryn/0000-0003-1240-8882			BECKER S, 1999, WERE THIS TOGETHER; Bostrom J, 1996, APPL NURS RES, V9, P47, DOI 10.1016/S0897-1897(96)80402-2; Brereton L, 1997, J CLIN NURS, V6, P425, DOI 10.1111/j.1365-2702.1997.tb00339.x; Exall K, 1999, Nurs Times, V95, P50; Grahn G, 1996, Eur J Cancer Care (Engl), V5, P182, DOI 10.1111/j.1365-2354.1996.tb00231.x; GRONWALL DMA, 1998, HEAD INJURY FACTS GU; Hall K. M., 1992, NEUROREHABILITATION, V2, DOI [10.3233/NRE-1992-2410, DOI 10.3233/NRE-1992-2410]; Hanger HC, 1998, CLIN REHABIL, V12, P45, DOI 10.1191/026921598668677675; HUBERT J, 1995, LIFE HEAD INJURY; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; Kreutzer JS, 1997, J HEAD TRAUMA REHAB, V12, P63, DOI 10.1097/00001199-199712000-00006; LINDBERG M, 1996, CLIN REHABIL, V10, P69; Low JTS, 1999, SOC SCI MED, V49, P711, DOI 10.1016/S0277-9536(99)00194-X; Mant J, 1998, CLIN REHABIL, V12, P465, DOI 10.1191/026921598668972226; Marshall M, 1996, BRIT MED J, V312, P523, DOI 10.1136/bmj.312.7030.523; Martin J, 1988, PREVALENCE DISABILIT; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; MCLEAN J, 1991, J ADV NURS, V16, P559, DOI 10.1111/j.1365-2648.1991.tb01691.x; McPherson KM, 1997, INT J REHABIL RES, V20, P1, DOI 10.1097/00004356-199703000-00001; PATTON MQ, 1989, QUALITATIVE METHODS; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; SANDER A, 1999, REHABILITATION ADULT, P199; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Slevin ML, 1996, BRIT J CANCER, V74, P1275, DOI 10.1038/bjc.1996.529; Smith N, 1999, Community Nurse, V5, P15; SORYAL I, 1992, CLIN REHABIL, V6, P103; STRAUSS AL, 1990, BASICS QUALITATIVE R, P249; THOMPSON C, 1999, COCHRANE LIB; Waterman H, 1996, J ADV NURS, V24, P960, DOI 10.1111/j.1365-2648.1996.tb02932.x; Wiles R, 1998, J ADV NURS, V28, P794, DOI 10.1046/j.1365-2648.1998.00709.x	30	16	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2000	23	4					295	301		10.1097/00004356-200023040-00005			7	Rehabilitation	Rehabilitation	385DF	WOS:000165986200005	11192565				2021-06-18	
J	Xu, H; Aibiki, M; Seki, K; Ogura, S; Yokono, S; Ogli, K				Xu, H; Aibiki, M; Seki, K; Ogura, S; Yokono, S; Ogli, K			Effects of induced hypothermia on renal sympathetic nerve activity and baroreceptor reflex in urethane-anesthetized rabbits	CRITICAL CARE MEDICINE			English	Article						arterial baroreceptors; autonomic nervous system; baroreflex sensitivity; catecholamines; induced hypothermia	TRAUMATIC BRAIN INJURY; HEART-RATE; MODERATE HYPOTHERMIA; CARDIOPULMONARY BYPASS; CIRCULATORY ARREST; CATECHOLAMINE; SYSTEM; VARIABILITY; RESPONSES; HUMANS	Objective: To evaluate the role of the autonomic nervous system in hemodynamic changes during induced hypothermia. Design: Prospective, randomized animal study. Setting: An animal research laboratory in a medical university. Subjects: A total of 29 anesthetized rabbits. Interventions: Animals were anesthetized by intraperitoneal urethane. After tracheostomy and administration of gallamine, respiration was maintained by mechanical ventilatory support. The animals were divided into five groups (one control and the four experimental groups); animals were treated with an intact neuraxis and normothermia (control group), animals with an intact neuraxis (intact group), cervical vagotomized animals (vagotomy group), the carotid sinus and aortic nerves denervated animals (SAD group), and animals with SAD plus vagotomy (SADV group). The left renal sympathetic nerves were exposed by a retroperitoneal approach. Measurements and Main Results:We examined the effects of surface cooling on HR, mean arterial pressure, central venous pressure, and renal sympathetic nerve activity (RSNA) in the animals. Changes of baroreflex sensitivity and plasma catecholamines were also measured simultaneously. Surface cooling caused progressive and profound decreases in DC in all experimental groups. In all groups, RSNAs increased at the early phase, which were followed by return to the precooling level. Conclusions: Hemodynamics and RSNA during induced hypothermia are regulated by mechanisms other than the baroreceptor reflex system, possibly the dermal cold receptors. Suppression of the baroreflex occurred on HR but not on RSNA during hypothermia, which may indicate direct effects of hypothermia on the heart. RSNA responses may be activated earlier than systemic catecholamine responses during induced hypothermia.	Kagawa Med Univ Hosp, Intens Care Unit, Kita Ku, Kagawa 7610793, Japan	Aibiki, M (corresponding author), Kagawa Med Univ Hosp, Intens Care Unit, Kita Ku, 1750-1 Ikenobe, Kagawa 7610793, Japan.			Ogura, Shinji/0000-0001-7686-6001			Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; AIBIKI M, 1994, AM J PHYSIOL, V266, pR790; AIBIKI M, 1988, HIGH ALTITUDE MED SC, P126; BARAKA A, 1994, BRIT J ANAESTH, V73, P418, DOI 10.1093/bja/73.3.418; BIGELOW WG, 1950, AM J PHYSIOL, V160, P125, DOI 10.1152/ajplegacy.1949.160.1.125; BLACK PR, 1976, J SURG RES, V20, P49, DOI 10.1016/0022-4804(76)90083-4; Broman M, 1998, ACTA PHYSIOL SCAND, V163, P241, DOI 10.1046/j.1365-201x.1998.00356.x; CARRUBA MO, 1987, EUR J PHARMACOL, V134, P15, DOI 10.1016/0014-2999(87)90126-9; CHEN RYZ, 1978, AM J PHYSIOL, V235, pH136; CHEN RYZ, 1977, AM J PHYSIOL, V233, P605; CHERNOW B, 1983, CRIT CARE MED, V11, P677, DOI 10.1097/00003246-198309000-00001; CHURCHILLDAVIDS.HC, 1953, LANCET, V14, P1011; COOKSON BA, 1955, AM J PHYSIOL, V182, P447; CORK RC, 1983, ANESTH ANALG, V62, P211; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; ESLER M, 1984, AM J PHYSIOL, V247, pE21; FRANK SM, 1995, ANESTHESIOLOGY, V82, P83, DOI 10.1097/00000542-199501000-00012; GALLEGO R, 1979, J NEUROPHYSIOL, V42, P665; GREEN JF, 1979, CIRC RES, V44, P411, DOI 10.1161/01.RES.44.3.411; Hayano J, 1997, AM HEART J, V134, P411, DOI 10.1016/S0002-8703(97)70075-9; HOELDTKE RD, 1983, J LAB CLIN MED, V101, P772; KAUL SU, 1973, BRIT J ANAESTH, V45, P433, DOI 10.1093/bja/45.5.433; KIMURA T, 1994, ANESTHESIOLOGY, V80, P694, DOI 10.1097/00000542-199403000-00032; KOYAMA S, 1992, AM J PHYSIOL, V262, pR579; Liu JL, 1996, AM J PHYSIOL-REG I, V270, pR1361; Ma D, 1998, BRIT J ANAESTH, V80, P68; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MATSUKAWA K, 1993, AM J PHYSIOL, V265, P792; MAYFIELD SR, 1989, J DEV PHYSIOL, V11, P331; NOSE H, 1982, JPN J PHYSIOL, V32, P831; REVES JG, 1982, CIRCULATION, V66, P49, DOI 10.1161/01.CIR.66.1.49; RITTENHOUSE EA, 1974, ANN THORAC SURG, V17, P63, DOI 10.1016/S0003-4975(10)65062-X; SCHNEIDER FH, 1966, AM J PHYSIOL, V211, P890; Seki K, 1997, J AUTONOM NERV SYST, V64, P49, DOI 10.1016/S0165-1838(97)00016-7; Spyer KM, 1988, AUTONOMIC FAILURE TX, P56; Tokunaga S, 1996, CARDIOVASC RES, V31, P769, DOI 10.1016/S0008-6363(96)00021-1; WONG KC, 1983, WESTERN J MED, V138, P227; WOOD M, 1980, CAN ANAESTH SOC J, V27, P125, DOI 10.1007/BF03007773; Xu H, 1998, J AUTONOM NERV SYST, V71, P48, DOI 10.1016/S0165-1838(98)00061-7; Zheng F, 1996, EXP PHYSIOL, V81, P409, DOI 10.1113/expphysiol.1996.sp003945	40	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	DEC	2000	28	12					3854	3860		10.1097/00003246-200012000-00019			7	Critical Care Medicine	General & Internal Medicine	388NB	WOS:000166186200013	11153626				2021-06-18	
J	Shum, D; Short, L; Tunstall, J; O'Gorman, JG; Wallace, G; Shephard, K; Murray, R				Shum, D; Short, L; Tunstall, J; O'Gorman, JG; Wallace, G; Shephard, K; Murray, R			Performance of children with traumatic brain injury on a 4-disk version of the Tower of London and the Porteus Maze	BRAIN AND COGNITION			English	Article								The aim of this study was to assess planning ability in children with traumatic brain injury (TBI) using a 4-disk Tower of London (TOL) and the Porteas Maze. Participants were 10, 6-10 years old, and 12, 11-16 years old, children with moderate to severe TBI and 15, 6-10 years old and 15, 11-16 years old controls. On both tests, children in the older age group performed significantly better than children in the younger age group. On the TOL, children with TBI performed significantly more poorly than the controls on the 5 complex problems but not on the 5 simple problems. There was no effect for TBI on Porteus Maze performance. Results confirm the adverse impact of TBI on planning ability in children but point to subtleties in assessing it, (C) 2000 Academic Press.	Griffith Univ, Neuropsychol Unit, Brisbane, Qld 4111, Australia; Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia; Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia; Univ Queensland, Mater Childrens Hosp, Brisbane, Qld 4101, Australia; Royal Childrens Hosp, Brisbane, Qld, Australia	Shum, D (corresponding author), Griffith Univ, Neuropsychol Unit, Brisbane, Qld 4111, Australia.		Shum, David/A-3914-2008; Wallace, Geoff/H-1252-2013	Shum, David/0000-0002-4810-9262; Wallace, Geoff/0000-0001-9306-3542			LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Porteus S.D., 1965, PORTEUS MAZE TEST 50; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082	5	16	16	0	5	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					59	62					4	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300015					2021-06-18	
J	Hwang, SK; Kim, SL				Hwang, SK; Kim, SL			Infantile head injury, with special reference to the development of chronic subdural hematoma	CHILDS NERVOUS SYSTEM			English	Article						infant head injury; chronic subdural hematoma		An infantile head injury has unique features in that infants are totally helpless and dependent on their parents, and biomechanical characteristics of the skull and brain are very different from those of other age groups. The authors reviewed a total of 16 infant head injury patients under 12 months of age who were treated in our hospital from 1989 to 1997. Birth head injury was excluded. The most common age group was 3-5 months. Early seizures were noted in 7 cases, and motor weakness in 6. Three patients with acute intracranial hematoma and another 3 with depressed skull fracture were operated on soon after admission. Chronic subdural hematomas (SDHs) developed in 3 infants. Initial CT scans showed a small amount of SDH that needed no emergency operation. Resolution of the acute SDH and development of subdural hygroma appeared on follow-up CT scans within 2 weeks of injury. TWO of these infants developed early seizures. Chronic SDH was diagnosed on the 68th and 111th days after the injuries were sustained, respectively. The third patient was the subject of close follow-up with special attention to the evolution of chronic SDH in view of our experience in the previous 2 cases, and was found to have developed chronic SDH on the 90th day after injury. All chronic SDH patients were successively treated by subduro-peritoneal shunting. In conclusion, the evolution of chronic SDH from acute SDH is relatively common following infantile head injury. Infants with head injuries, especially if they are associated with acute SDH and early development of subdural hygroma, should be carefully followed up with special attention to the possible development of chronic SDH.	Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Chung Ku, Taegu 700721, South Korea	Hwang, SK (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Chung Ku, 50 Samdukdong, Taegu 700721, South Korea.						Aoki N, 1976, No Shinkei Geka, V4, P391; AOKI N, 1990, J NEUROSURG, V73, P201, DOI 10.3171/jns.1990.73.2.0201; COLLINS WF, 1961, J PEDIATR-US, V58, P482, DOI 10.1016/S0022-3476(61)80180-7; Ingraham FD, 1944, J PEDIATR-US, V24, P1, DOI 10.1016/S0022-3476(44)80138-X; James HE, 1985, BRAIN INSULTS INFANT, P179; Matson DD, 1969, NEUROSURGERY INFANCY; MCCORMICK MC, 1981, AM J DIS CHILD, V135, P159, DOI 10.1001/archpedi.1981.02130260051015; MCLAURIN R L, 1989, Neurosurgical Review, V12, P219, DOI 10.1007/BF01790652; MCLAURIN RL, 1971, J NEUROSURG, V34, P753, DOI 10.3171/jns.1971.34.6.0753; MCLAURIN RL, 1986, PRINCIPLES PEDIAT NE, P183; Misra M, 1996, SURG NEUROL, V46, P378, DOI 10.1016/S0090-3019(96)00188-7; MIYAGAMI M, 1979, SHONI NO NOSHINKEI, V4, P41; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; ROSENBLUTH PR, 1962, JAMA-J AM MED ASSOC, V179, P759, DOI 10.1001/jama.1962.03050100013003; SMITH MD, 1975, J TRAUMA, V15, P987, DOI 10.1097/00005373-197511000-00008; YAMAMOTO S, 1978, SHONI NO NOSHINKEI, V3, P162	18	16	16	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	SEP	2000	16	9					590	594		10.1007/s003810000312			5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	359LH	WOS:000089612000012	11048634				2021-06-18	
J	Poggi, G; Calori, G; Mancarella, G; Colombo, E; Profice, P; Martinelli, F; Triscar, C; Castelli, E				Poggi, G; Calori, G; Mancarella, G; Colombo, E; Profice, P; Martinelli, F; Triscar, C; Castelli, E			Visual disorders after traumatic brain injury in developmental age	BRAIN INJURY			English	Article							PEDIATRIC HEAD TRAUMA; CHILDREN; INFANTS; ABNORMALITIES; DYSFUNCTION; IMPAIRMENT; SEX	Visual disorders secondary to TBI are common, often multiple, associated with complex clinical pictures; in developmental age they may particularly interfere with the development process, and compromise the rehabilitation and outcome processes. The aim of this study is to identify visual disorders in 56 post-traumatic children admitted to the Traumatic Brain Injury Unit. All patients underwent a complete clinical, neurological and neuroophthalmological assessment. Correlations were studied between visual disorders and clinical parameters of acute phase, age at trauma, neuroimaging data and outcome, in order to identify possible risk factors for their occurrence. A high incidence was found of complex visual disorders following head trauma: decreased visual acuity, together with a convergence oculo-motor deficit, is the most frequently detected deficit. Trauma severity, indicated by duration of coma, is associated with most of the visual disorders and appears to be the main risk factor conducive to their appearance.	IRCCS E Medea, I-23842 Bosisio Parini LC, Italy; IRCCS, HS Raffaele, Epidemiol Unit, Milan, Italy	Poggi, G (corresponding author), IRCCS E Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini LC, Italy.		Boneschi, Filippo Martinelli/H-8592-2012; Poggi, Geraldina/K-4490-2016; Castelli, Enrico/J-1887-2012	Poggi, Geraldina/0000-0003-0589-6347; martinelli boneschi, filippo/0000-0002-9955-1368; Profice, Paolo/0000-0001-9923-9246			ALEXANDER PK, 1990, J VISUAL IMPAIRMENT, V84, P373; ANDERSON DP, 1980, CAN J SURG, V23, P163; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; BERNEY J, 1994, CHILD NERV SYST, V10, P509, DOI 10.1007/BF00335073; BERNEY J, 1994, CHILD NERV SYST, V10, P517, DOI 10.1007/BF00335074; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; CHATRIAN GE, 1984, J CLIN NEUROPHYSIOL, V1, P3; Cohen A H, 1992, J Am Optom Assoc, V63, P530; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; DROSTE PJ, 1991, OPHTHALMOLOGY, V98, P1513; Dutton G, 1996, EYE, V10, P302, DOI 10.1038/eye.1996.64; ELISEVICH KV, 1984, SURG NEUROL, V22, P565, DOI 10.1016/0090-3019(84)90433-6; FLEISS JL, 1980, STATISTICAL METHODS, P58; Fowler MS, 1996, J NEUROL, V243, P86; GOOD WV, 1994, SURV OPHTHALMOL, V38, P351, DOI 10.1016/0039-6257(94)90073-6; HELLERSTEIN FL, 1995, J AM OPTOM ASSOC, V66, P634; JENNETT B, 1975, LANCET, V1, P480; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Lanners J, 1999, J INTELL DISABIL RES, V43, P1, DOI 10.1046/j.1365-2788.1999.43120106.x; Max JE, 1998, BRAIN INJURY, V12, P31; PADULA WV, 1988, POSTTRAUMA VISION SY, P167; PADULA WV, 1992, J OPTOM VIS DEV, V23, P4; PIPER JDA, 1992, TECTONOPHYSICS, V201, P17, DOI 10.1016/0040-1951(92)90173-4; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; SACHER P, 1987, SCHWEIZ MED WSCHR, V117, P656; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; STANWORTH A, 1974, BRIT J OPHTHALMOL, V58, P266, DOI 10.1136/bjo.58.3.266; TEASDALE G, 1974, LANCET, V2, P81; TELLER DY, 1986, DEV MED CHILD NEUROL, V28, P779; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; Tierney D W, 1988, J Am Optom Assoc, V59, P614; UZZELL BP, 1988, ARCH NEUROL-CHICAGO, V45, P420, DOI 10.1001/archneur.1988.00520280066017; VOGEL MS, 1992, J AM OPTOM ASSOC, V63, P567; Webb C, 1996, BRAIN INJURY, V10, P303, DOI 10.1080/026990596124476	35	16	16	0	7	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2000	14	9					833	845		10.1080/026990500421930			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	357YT	WOS:000089530300006	11030456				2021-06-18	
J	Hayden, ME; Moreault, AM; LeBlanc, J; Plenger, PM				Hayden, ME; Moreault, AM; LeBlanc, J; Plenger, PM			Reducing level of handicap in traumatic brain injury: An environmentally based model of treatment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; ecological validity; environmental variables; outcome; reducing handicap; treatment	REHABILITATION; PREDICTION; DOMAIN; COMA; WORK	A treatment model is described that has as its primary focus reducing the lever of handicap of individuals with traumatic brain injury (TBI) by addressing the interaction between critical environmental variables and areas of deficit. The model focuses on two primary environmental variables-degree of distraction tolerated and degree of structure required by each individual to function optimally. These variables are systematically addressed in treatment through environmental simulations within the clinic. hn outcome measurement system (Pate Environmentally Relevant Program Outcome System [PERPOS]) is presented that quantities the level of handicap throughout treatment and at discharge as a function of the interplay between deficit and environment. Data are provided that validate the PERPOS scores through comparison with qualitative descriptors of day-to-day functioning in several domains. Outcome data indicate the participants in this treatment model made significant gains with regard to reduction of handicap.	Pate Rehabil, Dallas, TX USA; Sabine Valley Ctr, Marshall Valley Ctr, Marshall, TX 75670 USA							BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; BENYISHAY Y, 1983, REHABILITATION BRAIN; BUTTERS MA, 1993, J CLIN EXP NEUROPSYC, V15, P219, DOI 10.1080/01688639308402559; Cicerone KD, 1999, J HEAD TRAUMA REHAB, V14, P316, DOI 10.1097/00001199-199906000-00011; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; GLISKY EL, 1988, J LEARN DISABIL-US, V21, P333, DOI 10.1177/002221948802100604; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HART T, 1986, CLIN NEUROPSYCHOLOGY; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; HAYDEN ME, 1997, AM ASS OCCUP HLTH NU, V42, P635; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; HEINSSEN RK, 1996, COGNITIVE REHABILITA; JACOBS HE, 1987, J HEAD TRAUMA REHAB, V2, P37; Jennett B, 1981, MANAGEMENT HEAD INJU; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sherer M, 1999, BRAIN INJURY, V13, P973; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; TEASDALE G, 1974, LANCET, V2, P81; Varney N. R., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI DOI 10.1097/00001199-199303000-00005; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU	32	16	16	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	2000	15	4					1000	1021		10.1097/00001199-200008000-00004			22	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	340DK	WOS:000088517700004	10876172				2021-06-18	
J	Zhang, L; Dhillon, HS; Barron, S; Hicks, RR; Prasad, RM; Seroogy, KB				Zhang, L; Dhillon, HS; Barron, S; Hicks, RR; Prasad, RM; Seroogy, KB			Effects of chronic ethanol administration on expression of BDNF and trkB mRNAs in rat hippocampus after experimental brain injury	MOLECULAR BRAIN RESEARCH			English	Article						traumatic brain injury; fluid percussion; chronic ethanol; neurotrophin; neurotrophin receptor; in situ hybridization; neuronal plasticity	NEUROTROPHIC FACTOR; MESSENGER-RNA; UP-REGULATION; AMINO-ACIDS; NEURONS; CONSUMPTION; RECEPTOR; TRAUMA; GENE; PROTEIN	Previous evidence indicates that both chronic alcohol treatment and traumatic brain injury modulate expression of certain neurotrophins and neurotrophin receptors in cortical tissue. However, the combined effects of chronic alcohol and brain trauma on expression of neurotrophins and their receptors have not been investigated. In the present study, we examined the effects of 6 weeks of chronic ethanol administration on lateral fluid percussion (FP) brain injury-induced alterations in expression of mRNAs for the neurotrophin brain-derived neurotrophic factor (BDNF) and its high affinity receptor, trkB, in rat hippocampus. In both the control- (pair-fed isocaloric sucrose) diet and the chronic ethanol-diet groups, unilateral FP brain injury induced a bilateral increase in levels of both BDNF and trkB mRNAs in the dentate gyrus granule cell layer, and of BDNF mRNA in hippocampal region CA3. However, no significant differences in expression were found between the control-diet and ethanol-diet groups, in either the sham-injured or FP-injured animals. These findings suggest that 6 weeks of chronic ethanol administration does not alter the plasticity of hippocampal BDNF/trkB expression in response to experimental brain injury. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; Univ Kentucky, Dept Psychol, Lexington, KY 40536 USA; Univ Kentucky, Dept Clin Sci, Lexington, KY 40536 USA	Seroogy, KB (corresponding author), Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA.	kseroog@pop.uky.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034264, R01NS035164] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34264, NS35164] Funding Source: Medline		Baek JK, 1996, MOL BRAIN RES, V40, P161; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; BOMBARDIER CH, 1995, WESTERN J MED, V162, P150; BRENNAN CH, 1989, NEUROPHARMACOLOGY, V28, P1303, DOI 10.1016/0028-3908(89)90003-8; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CREWS FT, 1993, NIAAA RES MONOGRAPH, V22, P355; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HAYES RL, 1995, NEUROSCI LETT, V191, P121, DOI 10.1016/0304-3940(95)11561-X; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; IORIO KR, 1992, MOL PHARMACOL, V41, P1142; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kokaia Z, 1996, MOL BRAIN RES, V38, P139, DOI 10.1016/0169-328X(96)00002-2; Lauterborn JC, 1996, J NEUROSCI, V16, P7428; Luo J, 1998, BRAIN RES REV, V27, P157, DOI 10.1016/S0165-0173(98)00009-5; MACLENNAN AJ, 1995, NEUROSCI LETT, V197, P105; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCMULLEN PA, 1984, J COMP NEUROL, V225, P111, DOI 10.1002/cne.902250112; MICHAELIS EK, 1978, BIOCHEM PHARMACOL, V27, P1685, DOI 10.1016/0006-2952(78)90179-X; Mitchell JJ, 1998, DEV BRAIN RES, V105, P241, DOI 10.1016/S0165-3806(97)00182-X; MOCHETTI I, 1995, J NEUROTRAUM, V12, P853; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Numan S, 1999, J COMP NEUROL, V403, P295, DOI 10.1002/(SICI)1096-9861(19990118)403:3<295::AID-CNE2>3.0.CO;2-L; PADMAPERUMA B, 1995, NEUROSCI RES COMMUN, V16, P121; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PRASAD MR, 1994, J NEUROCHEM, V63, P773; Prasad RM, 1997, J NEUROTRAUM, V14, P919, DOI 10.1089/neu.1997.14.919; Seabold GK, 1998, DEV BRAIN RES, V108, P139, DOI 10.1016/S0165-3806(98)00043-1; Seroogy K., 1997, NEUROCHEMISTRY PRACT, P121; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Tate PS, 1999, BRAIN INJURY, V13, P767; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Walker D. W., 1993, NIAAA MONOGRAPH, P231; WALKER DW, 1978, NEUROPSYCHOLOGIA, V16, P545, DOI 10.1016/0028-3932(78)90082-9; WALKER DW, 1992, NEUROSCI LETT, V147, P77, DOI 10.1016/0304-3940(92)90778-6; WALKER DW, 1980, SCIENCE, V209, P711, DOI 10.1126/science.7394532; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Zhang LX, 1999, J NEUROTRAUM, V16, P243, DOI 10.1089/neu.1999.16.243	48	16	18	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	JUN 23	2000	79	1-2					174	179		10.1016/S0169-328X(00)00124-8			6	Neurosciences	Neurosciences & Neurology	344ZM	WOS:000088791000019	10925157				2021-06-18	
J	Switzer, JA; Nork, SE; Routt, MLC				Switzer, JA; Nork, SE; Routt, MLC			Comminuted fractures of the iliac wing	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						iliac fracture; comminuted; unstable; degloving	PELVIC RING FRACTURES; INTERNAL-FIXATION; DEGLOVING INJURIES; MULTIPLE TRAUMA; CLASSIFICATION; HEMORRHAGE; MANAGEMENT; DISRUPTIONS	Purpose: Comminuted iliac fractures are uncommon and difficult to treat. The purpose of this study is to further delineate the fractures, to present a management protocol, and to evaluate the results of treatment. Design: Retrospective clinical study. Setting: Level one trauma center at Harborview Medical Center. Patients: During a sixty-eight-month period, 695 patients with pelvic ring disruptions were treated at a level one trauma center. Thirteen (1.9%) of these patients had a severely comminuted iliac fracture. All patients were men, ranging in age from twenty to eighty years (mean, 38 years). These patients were polytraumatized and had a mean Injury Severity Score of 23. Eleven of the thirteen patients had severe iliac and flank degloving injuries. Five patients had open fractures, one with fecal contamination requiring diverting colostomy. Six patients with clinical signs of hemodynamic instability had local arterial injuries associated with their fractures. All five patients with extension of the fracture into the greater sciatic notch were found to have a local arterial injury on angiography. One patient had a lumbosacral plexopathy on the fractured side. Four patients had traumatic brain injuries. Intervention: All thirteen patients were treated operatively. Routine pelvic external fixation was not possible because of the iliac comminution. Stable internal fixation was accomplished by an anterior iliac surgical exposure using lag screw and plate combinations. The open wounds and degloving injuries were treated with irrigation, debridement, and closed suction drain age. Main Outcome Measurements: Healing and stability of fixation were assessed clinically and on pelvic radiographs. Results: Comminuted iliac fractures were divided into two patient groups, according to associated pelvic ring disruption. Follow-up evaluations were available for all patients at a mean of eighteen months after injury. There were no deaths. All of the fractures healed clinically and radiographically. In one patient, fecal contamination caused a polymicrobial wound infection, and this patient had an associated delay in union of the fracture. Another patient with an open fracture developed a deep wound infection. Both infections responded to local management and antibiotics. There were no complications associated with the degloving injuries. Conclusions: Comminuted iliac fractures occur in two distinct patterns and are associated with numerous local injuries that complicate management. Management protocols should include early open reduction and stable internal fixation. Traumatic open wounds should not be closed primarily. Primary closure with closed suction drainage is effective in the management of associated degloving injuries. Extension of the fracture into the greater sciatic notch warrants further evaluation with pelvic angiography.	Univ Washington, Harborview Med Ctr, Dept Orthopaed Surg, Seattle, WA 98104 USA	Routt, MLC (corresponding author), Univ Washington, Harborview Med Ctr, Dept Orthopaed Surg, 325 9Th Ave,Box 359798, Seattle, WA 98104 USA.			Switzer, Julie/0000-0002-4834-1643			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BIROLINI D, 1990, J TRAUMA, V30, P492, DOI 10.1097/00005373-199030040-00023; Borrelli J, 1996, J ORTHOP TRAUMA, V10, P165, DOI 10.1097/00005131-199604000-00004; BUCHANAN JR, 1980, CLIN ORTHOP RELAT R, P164; BUCHOLZ RW, 1981, J BONE JOINT SURG AM, V63, P400, DOI 10.2106/00004623-198163030-00013; BURGESS AR, 1990, J TRAUMA, V30, P848, DOI 10.1097/00005373-199007000-00015; CORMACK GC, 1985, PLAST RECONSTR SURG, V75, P342, DOI 10.1097/00006534-198503000-00008; CRYER HM, 1988, J TRAUMA, V28, P973, DOI 10.1097/00005373-198807000-00011; DALAL SA, 1989, J TRAUMA, V29, P981, DOI 10.1097/00005373-198907000-00012; DAVIDSON BS, 1993, J TRAUMA, V35, P36, DOI 10.1097/00005373-199307000-00006; Gansslen A, 1996, INJURY, V27, P13, DOI 10.1016/S0020-1383(96)90106-0; GOLDSTEIN A, 1986, J TRAUMA, V26, P325; GRUEN GS, 1994, J TRAUMA, V36, P706, DOI 10.1097/00005373-199405000-00019; Hak DJ, 1997, J TRAUMA, V42, P1046, DOI 10.1097/00005373-199706000-00010; HANSON PB, 1991, J BONE JOINT SURG BR, V73, P325; Henderson R C, 1989, J Orthop Trauma, V3, P41, DOI 10.1097/00005131-198903010-00008; HUDSON DA, 1992, PLAST RECONSTR SURG, V89, P853, DOI 10.1097/00006534-199205000-00013; KLEIN SR, 1992, J CARDIOVASC SURG, V33, P349; Kottmeier SA, 1996, CLIN ORTHOP RELAT R, P46; KUDSK KA, 1981, J TRAUMA, V21, P835, DOI 10.1097/00005373-198110000-00002; LATENSER BA, 1991, J TRAUMA, V31, P28, DOI 10.1097/00005373-199101000-00006; LUNT H R W, 1970, Injury, V2, P121, DOI 10.1016/S0020-1383(70)80011-0; MATTA JM, 1989, CLIN ORTHOP RELAT R, P83; Mayo K., 1990, TECH ORTHOP, V4, P24, DOI [10.1097/00013611-199001000-00004, DOI 10.1097/00013611-199001000-00004]; MCMURTRY R, 1980, CLIN ORTHOP RELAT R, P22; MEARS DC, 1980, CLIN ORTHOP RELAT R, P65; MORENO C, 1986, J TRAUMA, V26, P987, DOI 10.1097/00005373-198611000-00005; MUCHA P, 1988, SURG CLIN N AM, V68, P757; ONEILL PA, 1996, CLIN ORHTOP, V329, P60; PENNAL GF, 1980, CLIN ORTHOP RELAT R, P12; PERRY JJ, 1980, CLIN ORTHOPAEDICS, V151, P141; RICHARDSON JD, 1982, J TRAUMA, V22, P533, DOI 10.1097/00005373-198207000-00002; ROTHENBERGER D, 1978, J TRAUMA, V18, P184, DOI 10.1097/00005373-197803000-00006; Routt MLC, 1996, J TRAUMA, V40, P784, DOI 10.1097/00005373-199605000-00018; Simonian PT, 1997, INJURY, V28, P469, DOI 10.1016/S0020-1383(97)00112-5; SLATIS P, 1972, ACTA CHIR SCAND, V138, P799; TILE M, 1980, CLIN ORTHOP RELAT R, P56; TILE M, 1988, J BONE JOINT SURG BR, V70, P1; Tile M., 1984, FRACTURES PELVIS ACE; WEBB L, 1991, ORTHOP T, V15, P801; Webb L X, 1990, J Orthop Trauma, V4, P376, DOI 10.1097/00005131-199012000-00002; WEIS EB, 1984, J TRAUMA, V24, P983, DOI 10.1097/00005373-198411000-00010	42	16	18	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	MAY	2000	14	4					270	276		10.1097/00005131-200005000-00008			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	326CC	WOS:000087713500008	10898200				2021-06-18	
J	Avellino, AM; Loeser, JD				Avellino, AM; Loeser, JD			Intrathecal baclofen for the treatment of intractable spasticity of spine or brain etiology	NEUROMODULATION			English	Article						baclofen; cerebral palsy; multiple sclerosis; programmable intrathecal pump; spasticity; spinal cord injury; traumatic brain injury	CEREBRAL-PALSY; PROGRAMMABLE PUMP; INFUSION; ORIGIN; INJURY; DELIVERY; THERAPY	Objective, To determine the long-term relief of spasticity and complication rates in patients who underwent placement of a programmable intrathecal baclofen pump for treatment of medically intractable spasticity of spine or brain etiology. Methods, Sixty-two consecutive adult patients who underwent placement of a programmable pump were retrospectively reviewed. Results, Spasticity was clinically and statistically significantly decreased in all patients. Catheter-related kinks, breaks, dislodgments, and disconnections were the most common complications followed by drug-related effects, infections, and wound complications. Conclusions. Intrathecal baclofen is a very effective strategy for the relief of medically intractable spasticity of spine or brain etiology, Even though 36% of patients have required revisions, no patient has experienced any long-term morbidity. Patients and their primary care givers have been pleased with the long-term effects of this therapy upon qualify of life.	Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA	Loeser, JD (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Box 356470,1959 NE Pacific St, Seattle, WA 98195 USA.						ABEL NA, 1994, ARCH PHYS MED REHAB, V75, P54; AKMAN MN, 1993, PARAPLEGIA, V31, P516, DOI 10.1038/sc.1993.84; Albright AL, 1998, J NEUROSURG, V88, P73, DOI 10.3171/jns.1998.88.1.0073; ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; Albright AL, 1996, J CHILD NEUROL, V11, pS29, DOI 10.1177/0883073896011001S05; Albright AL, 1996, J CHILD NEUROL, V11, P77, DOI 10.1177/088307389601100202; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Kroin JS, 1992, PARENTERAL DRUG THER, P67; LOUBSER PG, 1991, PARAPLEGIA, V29, P48, DOI 10.1038/sc.1991.7; Mertens P, 1995, ADV STER F, V11, P17; MEYTHALER JM, 1992, AM J PHYS MED REHAB, V71, P321, DOI 10.1097/00002060-199212000-00003; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Middel B, 1997, J NEUROL NEUROSUR PS, V63, P204, DOI 10.1136/jnnp.63.2.204; MULLERSCHWEFE G, 1989, J NEUROSURG, V71, P273, DOI 10.3171/jns.1989.71.2.0273; NANCE P, 1995, CAN J NEUROL SCI, V22, P22, DOI 10.1017/S0317167100040452; OCHS G, 1989, J NEUROL NEUROSUR PS, V52, P933, DOI 10.1136/jnnp.52.8.933; Ordia JI, 1996, J NEUROSURG, V85, P452, DOI 10.3171/jns.1996.85.3.0452; PENN RD, 1992, J NEUROSURG, V77, P236, DOI 10.3171/jns.1992.77.2.0236; PENN RD, 1995, J NEUROSURG, V83, P215, DOI 10.3171/jns.1995.83.2.0215; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Saltuari L, 1992, Acta Neurol (Napoli), V14, P195; SEITZ RJ, 1995, J NEUROL, V242, P618, DOI 10.1007/BF00866910; Stayer C, 1997, NEUROLOGY, V49, P1591, DOI 10.1212/WNL.49.6.1591	26	16	16	0	1	BLACKWELL SCIENCE INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	1094-7159			NEUROMODULATION	Neuromodulation	APR	2000	3	2					75	81		10.1046/j.1525-1403.2000.00075.x			7	Medicine, Research & Experimental; Clinical Neurology	Research & Experimental Medicine; Neurosciences & Neurology	319HD	WOS:000087334700003	22151402				2021-06-18	
J	York, J; Arrillaga, A; Graham, R; Miller, R				York, J; Arrillaga, A; Graham, R; Miller, R			Fluid resuscitation of patients with multiple injuries and severe closed head injury: Experience with an aggressive fluid resuscitation strategy	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	59th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 16-18, 1999	BOSTON, MASSACHUSETTS	Amer Assoc Surgery Trauma			PERFUSION	Background: Despite increasing experimental and clinical evidence to the contrary, a dichotomy of management strategies of the patient with multiple injuries still exists, based on the presence or absence of traumatic brain injury. Many still advocate fluid restriction or small volume resuscitation if traumatic brain injury is present. Purpose: To demonstrate results of aggressive fluid resuscitation in a prospective case series of patients with multiple injuries and with severe head injury. Methods: Thirty-four patients with Glasgow Coma Scale score less than or equal to 8 and Injury Severity Score greater than or equal to 16 were enrolled into the study over a period of 18 months. Fluid resuscitation was guided in part by cerebral perfusion pressures (mean cerebral perfusion pressures > 80) as well as by hemodynamic monitoring and evidence of end organ perfusion. Overall fluid intake, intensive care unit fluid balance, presence or absence of hypoxia, hypotension, or both, were analyzed. Ninety- and 180-day Glasgow Outcome Scale and Disability Rating Scale scores were also obtained. Results: By using an aggressive fluid resuscitation strategy, secondary insults were avoided in 74% of the patients. A good functional outcome,vas achieved in 74% and mortality was impressively low at 6%. Conclusion: Fluid restriction is not necessary to achieve good results in the severely injured patient who also has a severe head injury.	Greenville Hosp Syst, Dept Trauma Surg, Div Med Educ & Res, Greenville, SC 29605 USA	York, J (corresponding author), Greenville Hosp Syst, Dept Trauma Surg, Div Med Educ & Res, Greenville, SC 29605 USA.						BORDER JR, 1995, J TRAUMA, V39, P12, DOI 10.1097/00005373-199507000-00002; Bullock MR, 1996, J NEUROTRAUM, V13, P643; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Kirton OC, 1999, NEW HORIZ-SCI PRACT, V7, P87; MeierHellmann A, 1997, CRIT CARE MED, V25, P399, DOI 10.1097/00003246-199703000-00005; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SHIRES GT, 1994, PRINCIPLES SURG, P119	8	16	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2000	48	3					376	379		10.1097/00005373-200003000-00002			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	295QT	WOS:000085979900003	10744272				2021-06-18	
J	Allgulander, C; Nilsson, B				Allgulander, C; Nilsson, B			Victims of criminal homicide in Sweden: A matched case-control study of health and social risk factors among all 1,739 cases during 1978-1994	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							UNITED-STATES; VIOLENT DEATH; BRAIN INJURY; ALCOHOL; WOMEN; HOME	Objective: The psychiatric and medical characteristics of victims of homicide have not been systematically studied and are often confounded by race. This study was undertaken to determine health and social factors contributing to the risk of being murdered in the Swedish, predominantly Caucasian population. Method: All 1,739 homicides between 1978 and 1994 in Sweden were studied in terms of variables in national case registers regarding health, crimes, immigration, and marital status. The same data were extracted for matched comparison persons in the general population, with controls for time of exposure. The data were analyzed by conditional logistic regression on matched pairs. Results: Traumatic brain injury, physical abuse, alcohol dependence, and criminal recidivism conferred risk of being murdered. Conclusions: To the authors' knowledge, this is the first report of traumatic brain injury, in both men and women, as a risk factor for being murdered. Brain injury may mark risk-taking behavior in general or may cause provocative behavior.	Karolinska Inst, Radiumhemmet, Div Psychiat, Stockholm, Sweden; Karolinska Inst, Radiumhemmet, Div Canc Epidemiol, Stockholm, Sweden	Allgulander, C (corresponding author), Huddinge Hosp, M57, S-14186 Huddinge, Sweden.		McCarthy, Jodie/B-5760-2012				Bailey JE, 1997, ARCH INTERN MED, V157, P777, DOI 10.1001/archinte.157.7.777; BRESLOW NE, 1980, INT AGENCY RES CANC, V32; CENTERWALL BS, 1984, AM J PUBLIC HEALTH, V74, P813, DOI 10.2105/AJPH.74.8.813; Decker, 1993, JUSTICE Q, V10, P585, DOI [10.1080/07418829300092031, DOI 10.1080/07418829300092031]; GOODMAN RA, 1986, AM J PUBLIC HEALTH, V76, P144, DOI 10.2105/AJPH.76.2.144; GUDJONSSON GH, 1990, ACTA PSYCHIAT SCAND, V82, P49; Hwang SW, 1997, ANN INTERN MED, V126, P625, DOI 10.7326/0003-4819-126-8-199704150-00007; Ikeda RM, 1997, AM J PREV MED, V13, P396; KELLERMANN AL, 1992, J TRAUMA, V33, P1, DOI 10.1097/00005373-199207000-00001; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; LINDQVIST P, 1991, BRIT J ADDICT, V86, P321; LINDQVIST P, 1995, NORD J PSYCHIAT, V49, P17, DOI 10.3109/08039489509011879; Norstrom T, 1998, ADDICTION, V93, P689, DOI 10.1046/j.1360-0443.1998.9356895.x; PONZER S, 1996, PUBLIC HLTH, V110, P42; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rivara FP, 1997, JAMA-J AM MED ASSOC, V278, P569, DOI 10.1001/jama.278.7.569; SAVITZ LD, 1991, DEVIANT BEHAV, V12, P19, DOI 10.1080/01639625.1991.9967865; Sosin DM, 1996, BRAIN INJURY, V10, P47; TARDIFF K, 1995, J FORENSIC SCI, V40, P387; Tiihonen J, 1997, AM J PSYCHIAT, V154, P1711, DOI 10.1176/ajp.154.12.1711; VOLAVKA J, 1995, NEUROBIOLOGY VIOLENC; Wikstrom Per-Olof, 1991, J CRIME JUSTICE, V14, P71; Wilson, 1988, HOMICIDE; WOLFGANG ME, 1957, J CRIM LAW CRIM, V48, P1, DOI 10.2307/1140160; 1997, YB NORD STAT 1996	25	16	16	0	3	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0002-953X			AM J PSYCHIAT	Am. J. Psychiat.	FEB	2000	157	2					244	247		10.1176/appi.ajp.157.2.244			4	Psychiatry	Psychiatry	281PC	WOS:000085169000015	10671394				2021-06-18	
J	McAdoo, DJ; Robak, G; Xu, GY; Hughes, MG				McAdoo, DJ; Robak, G; Xu, GY; Hughes, MG			Adenosine release upon spinal cord injury	BRAIN RESEARCH			English	Article						adenosine; excitatory amino acid; microdialysis; spinal cord injury; theophylline	AMINO-ACID RELEASE; RAT CEREBRAL-CORTEX; TRAUMATIC BRAIN INJURY; GLUTAMATE RELEASE; SUPERIOR COLLICULUS; SECONDARY DAMAGE; POTENTIAL ROLE; MICRODIALYSIS; HIPPOCAMPUS; ISCHEMIA	The hypothesis that release of adenosine following spinal cord injury (SCI) may provide neuroprotective feedback is explored. Consistent with this hypothesis, substantial release of adenosine, estimated to reach 100 mu M in the extracellular space, was detected by microdialysis sampling immediately following contusion SCI. There is also considerable release of excitatory amino acids following SCI. The latter was not affected by administration of the general adenosine receptor antagonist theophylline and the A, antagonist 8-cyclopentyl-1,3-dipropylxanthine, implying that the adenosine released following SCI does not significantly influence the release of neurotoxic amino acids. Administration of the concentration of glutamate released upon SCI into the spinal cord caused only about 1% as much release of adenosine as did injury, evidence that elevated excitatory amino acids do not elicit an appreciable fraction of the release of adenosine that follows SCI. Results obtained suggest that release of endogenous adenosine is not neuroprotective by blocking release of excitatory amino acids following SCI. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77555 USA	McAdoo, DJ (corresponding author), Univ Texas, Med Branch, Inst Marine Biomed, 301 Univ Blvd, Galveston, TX 77555 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [11255] Funding Source: Medline		Akpek EA, 1999, SPINE, V24, P128, DOI 10.1097/00007632-199901150-00006; Allen A.R., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CLARK GD, 1989, CLIN PERINATOL, V16, P459; DEMONTIGNY P, 1987, ANAL CHEM, V59, P1096, DOI 10.1021/ac00135a007; Dora CD, 1998, J NEUROTRAUM, V15, P473, DOI 10.1089/neu.1998.15.473; DUX E, 1990, BRAIN RES, V516, P248, DOI 10.1016/0006-8993(90)90925-2; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FERN R, 1994, J NEUROPHYSIOL, V72, P2609; FREDHOLM BB, 1988, TRENDS PHARMACOL SCI, V9, P130, DOI 10.1016/0165-6147(88)90194-0; GERBER U, 1989, J PHYSIOL-LONDON, V417, P567, DOI 10.1113/jphysiol.1989.sp017819; GLOBUS MYT, 1991, NEUROSCI LETT, V127, P39, DOI 10.1016/0304-3940(91)90889-2; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HAGBERG H, 1987, J NEUROCHEM, V49, P227, DOI 10.1111/j.1471-4159.1987.tb03419.x; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; HEROLD JA, 1994, J THORAC CARDIOV SUR, V107, P536, DOI 10.1016/S0022-5223(12)70100-9; HERON A, 1993, BRAIN RES, V608, P27, DOI 10.1016/0006-8993(93)90769-J; HIRAI H, 1995, J NEUROPHYSIOL, V74, P950; HIRAI H, 1994, EUR J PHARMACOL, V256, P65, DOI 10.1016/0014-2999(94)90617-3; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; KAKU T, 1994, BRAIN RES, V658, P39, DOI 10.1016/S0006-8993(09)90008-7; KAUPPINEN RA, 1988, NEUROSCIENCE, V27, P175, DOI 10.1016/0306-4522(88)90228-X; Kochanek PM, 1997, ACT NEUR S, V70, P109; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Liu D. X., 1995, Corona- and related viruses: current concepts in molecular biology and pathogenesis Laval, Quebec, Canada 27 August-1 September 1994., P405; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LIU DX, 1993, J NEUROTRAUM, V10, P349, DOI 10.1089/neu.1993.10.349; LONNROTH P, 1987, AM J PHYSIOL, V253, pE228; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MATUSZEWSKI BK, 1987, ANAL CHEM, V59, P1102, DOI 10.1021/ac00135a008; MILLER LP, 1992, J NEUROTRAUM, V9, pS563; MORRISON PF, 1991, J NEUROCHEM, V57, P103, DOI 10.1111/j.1471-4159.1991.tb02105.x; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OKADA Y, 1980, EUR J PHARMACOL, V68, P483; OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335, DOI 10.1038/sj.npp.1380292; OREGAN MH, 1992, NEUROSCI LETT, V138, P169, DOI 10.1016/0304-3940(92)90498-V; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PHILLIS JW, 1991, J NEUROCHEM, V56, P644, DOI 10.1111/j.1471-4159.1991.tb08198.x; RUDOLPHI KA, 1992, CEREBROVAS BRAIN MET, V4, P346; SIMPSON RE, 1992, J NEUROCHEM, V58, P1683, DOI 10.1111/j.1471-4159.1992.tb10041.x; SORKIN LS, 1988, J NEUROSCI METH, V23, P131, DOI 10.1016/0165-0270(88)90185-9; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; WOJCIK WJ, 1982, J NEUROCHEM, V39, P280, DOI 10.1111/j.1471-4159.1982.tb04736.x; Xu GY, 1998, NEUROSCIENCE, V86, P1011, DOI 10.1016/S0306-4522(98)00063-3	47	16	16	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JAN 31	2000	854	1-2					152	157		10.1016/S0006-8993(99)02333-1			6	Neurosciences	Neurosciences & Neurology	280UN	WOS:000085122300018	10784116				2021-06-18	
J	Eder, HG; Legat, JA; Gruber, W				Eder, HG; Legat, JA; Gruber, W			Traumatic brain stem lesions in children	CHILDS NERVOUS SYSTEM			English	Article						children; Glasgow Coma Scale; Glasgow Outcome Scale; prognosis; traumatic brain stem lesions	SEVERE HEAD-INJURY; DIFFUSE AXONAL INJURY; COMPUTED-TOMOGRAPHY; OUTCOME PREDICTION; MR; FEATURES; PRESSURE; AGE; CT	Glasgow Coma Scale (GCS) scores on admission may be predictors of outcome in patients with brain injuries. This study correlated the outcomes of children with traumatic brain stem lesions with their initial GCS scores and morphological patterns of injury as shown on computed tomography (CT) or magnetic resonance (MR) imaging. During the last 16 years, we have treated 1,108 children with brain injuries. The entire series included only 21 (1.9%) children who had clinical signs of brain stem lesions with morphological correlates on CT or MR imaging. Clinical findings were assessed according to the GCS and compared with scores on the Glasgow Outcome Scale (GOS). Of these 21 children, 16 (76%) had morphological lesions seen on CT scans. In 5 (24%) of the children only the MR images revealed brain stem lesions and their CT scans were negative. Generalized severe brain swelling was present in 6 cases (28%). There was a significant difference in GOS scores between patients with initial GCS scores of 3 and 4 and those with GCS scores between 5 and 7 (P<0.02). Children with intracranial pressure higher than 40 mmHg had poorer outcomes than patients whose intracranial pressure was lower, but the differences were not significant. Outcome did not correlate significantly with morphological patterns of injury or the presence of extracranial injuries. The GCS is a reliable indicator of severity of injury and of outcome in children with brain stem injuries. MR imaging was more sensitive than CT in detecting brain stem lesions.	Karl Franzens Univ Graz, Dept Pediat, A-8036 Graz, Austria; Sch Med, A-8036 Graz, Austria	Eder, HG (corresponding author), Karl Franzens Univ Graz, Dept Neurosurg, Auenbruggerpl 29, A-8036 Graz, Austria.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1979, CHILD BRAIN, V5, P174; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; FACCO E, 1986, CHILD NERV SYST, V2, P67; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GOSCINSKI I, 1995, ACTA NEUROCHIR, V134, P16, DOI 10.1007/BF01428496; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Holbourn AHS, 1943, LANCET, V2, P438; HUMPHREYS RP, 1998, CONCEPTS PEDIAT NEUR, P230; JENNETT B, 1975, LANCET, V1, P480; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; ROUSSEAUX M, 1989, REV NEUROL, V145, P384; Shigemori M, 1992, Acta Neurochir Suppl (Wien), V55, P37	31	16	16	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JAN	2000	16	1					21	24		10.1007/s003810050005			4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	275VH	WOS:000084840500005	10672425				2021-06-18	
J	Kelly, JP				Kelly, JP			Concussion in sports and recreation	SEMINARS IN NEUROLOGY			English	Article						brain concussion; sports injury; traumatic brain injury; sports concussion guidelines	TRAUMATIC BRAIN INJURY; CEREBRAL CONCUSSION; HEAD-INJURIES; NEUROPSYCHOLOGICAL ASSESSMENT; CONTACT-SPORTS; GUIDELINES; MANAGEMENT	More than 800 sports-related concussions occur in the United Stares each day, sometimes involving high-profile athletes whose injuries reach public awareness through sports broadcasts and news media. Although nonphysicians are often present and relied upon for the detection of concussion in the sports setting, the proper diagnosis and management of this neurological problem require a physician's thoughtful attention to the athlete's signs and symptoms, This article offers a diagnostic protocol and treatment recommendations as well as a useful grading scale and management strategy for return to competition.	Chicago Neurol Inst, Dept Neurol, Chicago, IL 60611 USA	Kelly, JP (corresponding author), Chicago Neurol Inst, Dept Neurol, 233 E Erie St,Suite 704, Chicago, IL 60611 USA.						American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BAILES JE, 1999, SPORTS RELATED CONCU; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cooper PR, 1993, HEAD INJURY; Farber M, 1994, SPORTS ILLUSTRATED, p[38, 39, 46]; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; HOVDA DA, 1994, SOC NEUROSCI, V20, P85; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kelly J, 1997, JAMA-J AM MED ASSOC, V277, P1190; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, pV, DOI 10.1097/00001199-199804000-00001; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Narayan RK, 1996, NEUROTRAUMA; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PLUM F, 1986, DIAGNOSIS STUPOR COM, P349; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; STONE JL, 1993, HEAD INJURY ITS COMP; TORG JS, 1995, CURRENT THERAPY SPOR; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44	35	16	16	0	8	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.		2000	20	2					165	171		10.1055/s-2000-9835			7	Clinical Neurology	Neurosciences & Neurology	339NU	WOS:000088484300003	10946735				2021-06-18	
J	Schlund, MW; Pace, G				Schlund, MW; Pace, G			Relations between traumatic brain injury and the environment: feedback reduces maladaptive behaviour exhibited by three persons with traumatic brain injury	BRAIN INJURY			English	Article							NEUROLOGICAL REHABILITATION; INVOLVEMENT	Feedback is a commonly used technique in neurorehabilitation. It functions cu strengthen or weaken select relations between individuals' behaviour and their environment. The study of behaviour-environment relations is a locus of operant psychology, commonly referred to as behaviour analysis. Central to behaviour analysis is die analysis of interrelations among stimuli, behaviour, and consequences. The focus on behaviour-environment relations may have considerable benefits for designing clinical treatment and accounting for successful and unsuccessful treatments, especially psychological interventions for maladaptive behaviour. In the present investigation, three persons with traumatic brain injuries, diagnosed with depression and presenting mild cognitive impairments, received feedback about their maladaptive behaviour. Weekly feedback resulted in general reductions in the variability and frequency of maladaptive behaviour. The results support the utility of giving equal consideration to relations between persons with traumatic brain inury and their environment, despite existing psychological or cognitive impairments. Future research on variables that influence the development and maintenance of behaviour-environment relations, and more generally operant behaviour, may provide a unique perspective on the effect of traumatic brain injury.	Kennedy Krieger Inst, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Schlund, MW (corresponding author), Kennedy Krieger Inst, 333 Cassell Dr,Triad Technol Bldg Suite 4200, Baltimore, MD 21224 USA.						Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; BAER DM, 1968, J APPL BEHAV ANAL, V1, P91, DOI 10.1901/jaba.1968.1-91; Damasio A. R., 1993, CLIN NEUROPSYCHOLOGY, V3, P409; DUBBERT PM, 1984, BEHAV RES THER, V22, P227, DOI 10.1016/0005-7967(84)90003-2; FISHER JE, 1988, 41 ANN SCI M GER SOC; HARRELL M, 1992, COGNITIVE REHABILITA; Lane SD, 1998, DRUG ALCOHOL DEPEN, V51, P239, DOI 10.1016/S0376-8716(98)00045-3; LATTAL KA, 1995, BEHAV ANALYST, V18, P209, DOI 10.1007/BF03392709; MCGLYNN SM, 1990, PSYCHOL BULL, V108, P420, DOI 10.1037/0033-2909.108.3.420; Morris E K, 1982, Behav Anal, V5, P109; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; Pace GM, 1999, BRAIN INJURY, V13, P535; Pace GM, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199602000-00004; PACE GM, 1993, STAFF DEV CLIN INTER, P105; PERONE M, 1982, J GERONTOL, V37, P443, DOI 10.1093/geronj/37.4.443; PETERS MD, 1995, BRAIN INJURY, V9, P543, DOI 10.3109/02699059509008213; SALZINGER K, 1988, BEHAV THEORY BEHAV T, P98; SCHLUND M, 1998, J REHABILITATION OUT, V2, P2; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; SCHLUND MW, IN PRESS BEHAV MODIF; SLIFER KJ, 1993, ARCH PHYS MED REHAB, V74, P810, DOI 10.1016/0003-9993(93)90006-V; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; WOOD R, 1988, J HEAD TRAUMA REHAB, V3, P53	24	16	18	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1999	13	11					889	897					9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	253FZ	WOS:000083547000005	10579660				2021-06-18	
J	Miller, LJ; Mittenberg, W; Carey, VM; McMorrow, MA; Kushner, TE; Weinstein, JM				Miller, LJ; Mittenberg, W; Carey, VM; McMorrow, MA; Kushner, TE; Weinstein, JM			Astereopsis caused by traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							BINOCULAR DEPTH PERCEPTION; STEREOSCOPIC VISION; CHIASMAL SYNDROME; HEAD-INJURY; STEREOPSIS; PERFORMANCE; DRIVERS	Impaired depth perception (astereopsis) has been observed in a variety of cerebral pathologies affecting the posterior parietal lobe. In the current study of 93 consecutive head trauma admissions, 24% had complete astereopsis and 41% performed more than 2 SDs below the orthopedic control group mean. Degree of impairment was related to Glascow Coma Scale score, length of posttraumatic amnesia, reduced visuospatial and memory abilities, and th-e presence of intracranial pathology of the parietal lobes. Impairment was also related to trauma severity in patients without any visualized intracranial pathology, presumably due to diffuse axonal sheaving. Clinically meaningful impairment was observed in 24% of this group; 10% had complete astereopsis. Stereoacuity screening requires I to 2 minutes. Undetected astereopsis may increase risk for subsequent motor vehicle accidents or falls. (C) 1999 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Arizona, Coll Med, Hlth Sci Ctr, Dept Psychiat, Tucson, AZ 85724 USA; Nova SE Univ, Ft Lauderdale, FL 33314 USA; Miami Inst Psychol, Miami, FL USA	Miller, LJ (corresponding author), Univ Arizona, Coll Med, Hlth Sci Ctr, Dept Psychiat, POB 245002, Tucson, AZ 85724 USA.						AMIGO G, 1973, BRIT J OPHTHALMOL, V57, P125, DOI 10.1136/bjo.57.2.125; ATKINSON J, 1976, PERCEPTION, V5, P29, DOI 10.1068/p050029; BENTON AL, 1970, NEUROLOGY, V20, P1084, DOI 10.1212/WNL.20.11.1084; BLAKEMORE C, 1970, VISION RES, V10, P43, DOI 10.1016/0042-6989(70)90060-X; BOWER TGR, 1971, SCI AM, V225, P30, DOI 10.1038/scientificamerican1071-30; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; COOPER J, 1979, J AM OPTOM ASSOC, V50, P41; COOPER J, 1979, J AM OPTOM ASSOC, V50, P821; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Falk N S, 1992, J Am Optom Assoc, V63, P547; FOX R, 1980, SCIENCE, V207, P323, DOI 10.1126/science.7350666; HAMSHER KDS, 1978, INVEST OPHTH VIS SCI, V17, P336; Harrison RJ, 1987, BINOC VIS, V2, P93; HEINZ GW, 1994, AM J OPHTHALMOL, V117, P90, DOI 10.1016/S0002-9394(14)73020-X; Howard I.P., 1995, BINOCULAR VISION STE; HUMPHRISS D, 1987, OPHTHAL PHYSL OPT, V7, P73; JULESZ B, 1986, VISION RES, V26, P1601, DOI 10.1016/0042-6989(86)90178-1; JULESZ B, 1987, FDN CYCLOPEAN PERCEP; KEANE JR, 1993, NEUROLOGY, V43, P2439, DOI 10.1212/WNL.43.12.2439; LEHMANN D, 1975, J NEUROL, V209, P157, DOI 10.1007/BF00312538; LEPORT FE, 1995, ARCH NEUROL-CHICAGO, V52, P925; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; MCKNIGHT AJ, 1991, ACCIDENT ANAL PREV, V23, P225, DOI 10.1016/0001-4575(91)90002-M; MITCHELL DE, 1970, VISION RES, V10, P49, DOI 10.1016/0042-6989(70)90061-1; MITTENBERG W, 1994, ARCH CLIN NEUROPSYCH, V9, P71, DOI 10.1016/0887-6177(94)90015-9; MUNCKFAIRWOOD RC, 1992, PERCEPTION, V21, P747, DOI 10.1068/p210747; PADULA WV, 1988, N ENGL J OPTOM   DEC, P16; POGGIO GF, 1984, ANNU REV NEUROSCI, V7, P379, DOI 10.1146/annurev.ne.07.030184.002115; PTITO A, 1991, BRAIN, V114, P1323, DOI 10.1093/brain/114.3.1323; PTITO M, 1991, NEUROPSYCHOLOGIA, V29, P443, DOI 10.1016/0028-3932(91)90004-R; RICHARDSON ED, 1994, CLIN NEUROPSYCHOL, V8, P416, DOI 10.1080/13854049408402044; Riddoch M., 1989, NEUROPSYCHOLOGY VISU, V1, P79; ROMANO P, 1976, ORTHOPTICS, P11; ROSS JE, 1983, BEHAV BRAIN RES, V7, P99, DOI 10.1016/0166-4328(83)90007-4; RUSSELL WR, 1960, INJURIES BRAIN SPINA, P118; Sattler JM, 1988, ASSESSMENT CHILDREN; SAVINO PJ, 1980, NEUROLOGY, V30, P963, DOI 10.1212/WNL.30.9.963; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; SPIERER A, 1995, AM J OPHTHALMOL, V120, P258, DOI 10.1016/S0002-9394(14)72622-4; *STER OPT CO INC, STER REIND SO 004; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wheatstone C., 1838, PHILOS T ROY SOC LON, V128, P371, DOI DOI 10.1098/RSTL.1838.0019; YEKTA AA, 1989, OPHTHAL PHYSL OPT, V9, P115, DOI 10.1111/j.1475-1313.1989.tb00829.x	45	16	16	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	1999	14	6					537	543					7	Psychology, Clinical; Psychology	Psychology	218YJ	WOS:000081580400007	14590581				2021-06-18	
J	Warschausky, S; Kewman, D; Kay, J				Warschausky, S; Kewman, D; Kay, J			Empirically supported psychological and behavioral therapies in pediatric rehabilitation of TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavioral disorder; brain injury; children; psychology; treatment outcome	TRAUMATIC BRAIN INJURY; OBSESSIVE-COMPULSIVE DISORDER; SOCIAL-ADJUSTMENT; HEAD-INJURY; CHILDREN; ADOLESCENTS; COMPETENCE; INTERVENTIONS; STUDENTS; SETTINGS	This article examines the empirical support for psychological therapies for children with traumatic brain injury (TBI). Empirical support for psychological treatments of noninjured children provides a foundation upon and a framework in which to discuss applications to children with neurobehavioral dysfunction. Behavioral interventions to address externalizing behaviors have received the greatest focus, whereas there is a paucity of work that pertains to internalizing features and prosocial behavior such as assertiveness. Although the systematic study of psychological intervention lags far behind the rapidly increasing knowledge of neurobehavioral sequelae to TBI, there are promising directions that stem from initial findings.	Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA	Warschausky, S (corresponding author), Univ Michigan Hosp, Dept Phys Med & Rehabil, Box 0050, Ann Arbor, MI 49109 USA.	sethaw@umich.edu					AENCIUS A, 1989, BRAIN INJURY, V3, P67; BELLACK AS, 1994, J ABNORM PSYCHOL, V103, P371, DOI 10.1037/0021-843X.103.2.371; Blosser J, 1997, J HEAD TRAUMA REHAB, V12, P21, DOI 10.1097/00001199-199704000-00004; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Borkovec TD, 1998, J CONSULT CLIN PSYCH, V66, P136, DOI 10.1037/0022-006X.66.1.136; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; BRACK UB, 1973, ACTA PAEDOPSYCHIATR, V40, P68; Chambless DL, 1998, J CONSULT CLIN PSYCH, V66, P7, DOI 10.1037/0022-006X.66.1.7; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; COOLEY EA, 1997, STUDENTS ACQUIRED BR; CRASILNE.HB, 1970, INT J CLIN EXP HYP, V18, P145, DOI 10.1080/00207147008415914; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; DEATON AV, 1987, J LEARN DISABIL, V20, P581, DOI 10.1177/002221948702001003; Deaton AV, 1996, REHABIL PSYCHOL, V41, P33, DOI 10.1037/0090-5550.41.1.33; DODGE KA, 1986, MONOGR SOC RES CHILD, V2, P51; DONDERS J, 1993, DEATH STUD, V17, P517, DOI 10.1080/07481189308252636; Ducharme JM, 1996, BEHAV THER, V27, P353, DOI 10.1016/S0005-7894(96)80022-0; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; HORTON AM, 1994, BEHAV INTERVENTIONS; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kazdin AE, 1998, J CONSULT CLIN PSYCH, V66, P19, DOI 10.1037/0022-006X.66.1.19; Kehle TJ, 1996, J LEARN DISABIL, V29, P633, DOI 10.1177/002221949602900607; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Kendall PC, 1998, J CONSULT CLIN PSYCH, V66, P3, DOI 10.1037/0022-006X.66.1.3; LLOYD LF, 1994, BRAIN INJURY, V8, P529, DOI 10.3109/02699059409151005; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; PACE GM, 1994, J APPL BEHAV ANAL, V27, P301, DOI 10.1901/jaba.1994.27-301; PAPWORTH MA, 1989, J BEHAV THER EXP PSY, V20, P265, DOI 10.1016/0005-7916(89)90033-5; PETTIT GS, 1988, CHILD DEV, V59, P107, DOI 10.2307/1130393; Prigatano G. P., 1991, AWARENESS DEFICIT BR; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; SILVER BV, 1992, DEV MED CHILD NEUROL, V34, P539; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; Slifer KJ, 1996, J HEAD TRAUMA REHAB, V11, P39, DOI 10.1097/00001199-199602000-00006; SLIFER KJ, 1995, BRAIN INJURY, V9, P585, DOI 10.3109/02699059509008217; SooMeng K, 1997, INT J CLIN PRACT, V51, P336; SOWERS JA, 1996, ROAD AUTONOMY PROMOT; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; WALLANDER JL, 1987, CLIN PSYCHOL REV, V7, P205, DOI 10.1016/0272-7358(87)90034-1; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Zimmerman MA, 1998, REHABIL PSYCHOL, V43, P3, DOI 10.1037/0090-5550.43.1.3	50	16	16	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1999	14	4					373	383		10.1097/00001199-199908000-00006			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	224LW	WOS:000081901400007	10407210				2021-06-18	
J	McDonald, RPA; Horsburgh, KJ; Graham, DI; Nicoll, JAR				McDonald, RPA; Horsburgh, KJ; Graham, DI; Nicoll, JAR			Mitochondrial DNA deletions in acute brain injury	NEUROREPORT			English	Article						brain; DNA; free radicals; ischaemia; mitochondria; trauma	OXIDATIVE DAMAGE; HEAD-INJURY; DISEASE	WE hypothesized that generation of free radicals following acute brain injury leads to increased accumulation of mitochondrial DNA deletions. We determined the prevalence of two deletions (mtDNA(Delta 4977bp) and mtDNA(Delta 7436bp)) in brain from 53 patients with a shout survival interval (mean 5 days) following transient global cerebral ischaemia due to cardiorespiratory arrest, 14 patients with long survival (mean 8.75 years) following traumatic brain injury and 43 ace-matched controls. A higher prevalence of mtDNA(Delta 4977bp) was found in aged controls. There was a strong correlation between the presence of the two mtDNA deletions in individual cases (p < 0.05). The deletion prevalence did not differ significantly between short-term survivors of global ischaemia (57% mtDNA(Delta 4977bp), 62% mtDNA(Delta 7436bp)) and controls (54% mtDNA(Delta 4977bp), 56% mtDNA(Delta 7436bp)). Unexpectedly, there was a lower prevalence of deleted mtDNA in long-term survivors of traumatic brain injury (14.3% mtDNA(Delta 7436bp), P < 0.05) raising the possibility that free radical-induced accumulation of mtDNA damage may selectively influence the survival of mitochondria or their host. NeuroReport 10:1875-1878 (C) 1999 Lippincott Williams & Wilkins.	Univ Glasgow, Inst Neurol Sci, So Gen Hosp NHS Trust, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland	Nicoll, JAR (corresponding author), Univ Glasgow, Inst Neurol Sci, So Gen Hosp NHS Trust, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland.		Nicoll, James/I-9253-2017	Nicoll, James/0000-0002-9444-7246; Horsburgh, Karen/0000-0002-9620-3691			ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BLANKENSHIP KM, 1993, GENDER SOC, V7, P8, DOI 10.1177/089124393007001002; Bozner P, 1997, J NEUROPATH EXP NEUR, V56, P1356, DOI 10.1097/00005072-199712000-00010; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P328; Graham DI, 1996, NEUROPATH APPL NEURO, V22, P505, DOI 10.1111/j.1365-2990.1996.tb01125.x; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; KIRSCH JR, 1992, J NEUROTRAUM, V9, pS157; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; MORTIMER JA, 1995, RES ADV ALZHEIMERS D, P1; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; REILLY PM, 1991, AM J SURG, V161, P488, DOI 10.1016/0002-9610(91)91120-8; SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0; WHITE BC, 1992, J NEUROCHEM, V58, P1716, DOI 10.1111/j.1471-4159.1992.tb10045.x; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514	16	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	JUN 23	1999	10	9					1875	1878		10.1097/00001756-199906230-00014			4	Neurosciences	Neurosciences & Neurology	212PM	WOS:000081225500017	10501524				2021-06-18	
J	Venkatesh, B; Townsend, S; Boots, RJ				Venkatesh, B; Townsend, S; Boots, RJ			Does splanchnic ischemia occur in isolated neurotrauma? A prospective observational study	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	Annual Scientific Meeting of the Australian-and-New-Zealand-Intensive-Care-Society	OCT 16-19, 1997	HOBART, AUSTRALIA	Australian & New Zealand Intens Care Soc		head injury; intracranial pressure; cerebral perfusion pressure; gastric tonometry; splanchnic; ischemia; outcome; intensive care unit	GASTRIC INTRAMUCOSAL PH; CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; INTRAMURAL PH; BLOOD LACTATE; SEVERE SEPSIS; SEPTIC SHOCK; NOREPINEPHRINE; HEMODYNAMICS; OXYGENATION	Objective: To characterize the incidence and severity of splanchnic ischemia, as defined by gastric tonometry, in patients with isolated severe head injury and to examine the relationship between cerebral hemodynamics and splanchnic ischemia, Design: Prospective observational study. Setting: Neurosurgical intensive care unit in a tertiary referral center. Patients: Ten patients with severe neurotrauma. Interventions: None. Measurements and Main Results: The mean arterial pressure, intracranial pressure, and gastric mucosal Pco(2) measurements were recorded at 15-min intervals. Intramucosal pH was calculated every 3 hrs. All patients received stress ulcer prophylaxis. Nine patients received noradrenaline infusions to maintain a target cerebral perfusion pressure of 70 mm Hg. The mean baseline gastric mucosal Pco(2) and intramucosal pH were 38 +/- 10 torr and 7.38 +/- 0.1 pH units, respectively. Nine patients manifested low intramucosal pH during the study period. Gastric mucosal Pco(2) values ranged from 36 to 132 torr. Intramucosal pH measurements ranged from 6.9 to 7.47. The mucosal gap ranged from -12 to +93 torr (mean +/- SD, 17 +/- 17 torr). The pH gap ranged from -0.1 to +0.54 pH units (mean +/- SD, 0.14 +/- 0.11 pH units). There was no statistically significant relationship between cerebral hemodynamics, the use of inotropes, and gastric mucosal Pco(2), or intramucosal pH. Conclusions: Splanchnic ischemia (intramucosal pH, <7.3) occurs commonly in isolated neurotrauma, with a statistically nonsignificant trend toward development of mucosal ischemia with decreased cerebral perfusion.	Univ Queensland, Royal Brisbane Hosp, Herston, Qld, Australia	Venkatesh, B (corresponding author), Univ Queensland, Royal Brisbane Hosp, Herston, Qld, Australia.		Venkatesh, Bala/F-4700-2010; Boots, Robert/K-1159-2013	Boots, Robert/0000-0002-2436-7654; Venkatesh, Bala/0000-0002-3234-5244			BOUZARTH WF, 1968, SURG GYNECOL OBSTETR, V126, P995; CLIFTON CL, 1991, NEUROSURGERY, V8, P10; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; Deitch E A, 1996, New Horiz, V4, P289; DOGLIO GR, 1991, CRIT CARE MED, V19, P1037, DOI 10.1097/00003246-199108000-00011; FIDDIAN-GREEN R G, 1984, European Surgical Research, V16, P32; FIDDIANGREEN RG, 1982, J SURG RES, V33, P39, DOI 10.1016/0022-4804(82)90007-5; FRIEDMAN G, 1995, CRIT CARE MED, V23, P1184, DOI 10.1097/00003246-199507000-00006; GYS T, 1988, CRIT CARE MED, V16, P1222, DOI 10.1097/00003246-198812000-00009; HIGGINS D, 1994, INTENS CARE MED, V20, P105, DOI 10.1007/BF01707663; Hill D. B., 1992, Journal of the American College of Nutrition, V11, P630; Joynt GM, 1997, ANAESTHESIA, V52, P726, DOI 10.1111/j.1365-2044.1997.173-az0307.x; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Levy B, 1997, INTENS CARE MED, V23, P282, DOI 10.1007/s001340050329; LUNDGREN O, 1989, SPLANCHNIC ISCHEMIA, P29; MARIK PE, 1994, JAMA-J AM MED ASSOC, V272, P1354, DOI 10.1001/jama.272.17.1354; MARIK PE, 1993, CHEST, V104, P225, DOI 10.1378/chest.104.1.225; Marik PE, 1996, CRIT CARE MED, V24, P1498, DOI 10.1097/00003246-199609000-00011; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MCARTHUR CJ, 1995, INTENS CARE MED, V21, P573, DOI 10.1007/BF01700162; MCCAIN CJ, 1991, J LAB CLIN MED, V118, P225; MYBURGH JA, 1996, YB INTENSIVE CARE EM, P723; MYTHEN MG, 1994, INTENS CARE MED, V20, P99, DOI 10.1007/BF01707662; NIMMO W S, 1976, Clinical Pharmacokinetics, V1, P189, DOI 10.2165/00003088-197601030-00002; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; Ott L, 1994, NUTR CRITICAL CARE, P691; PRIEBE HJ, 1995, ACTA ANAESTH SCAND, V39, P1088, DOI 10.1111/j.1399-6576.1995.tb04236.x; RIDDINGTON D, 1994, CRIT CARE MED, V22, P96, DOI 10.1097/00003246-199401000-00019; Riddington DW, 1996, JAMA-J AM MED ASSOC, V275, P1007, DOI 10.1001/jama.275.13.1007; Roberts P R, 1995, New Horiz, V3, P506; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Schlichtig R, 1996, J CRIT CARE, V11, P51, DOI 10.1016/S0883-9441(96)90020-9; TAKALA J, 1994, CRIT CARE MED, V22, P1877; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; VANDERMEER TJ, 1995, CRIT CARE MED, V23, P1217, DOI 10.1097/00003246-199507000-00011; Venkatesh B, 1998, ANAESTH INTENS CARE, V26, P46, DOI 10.1177/0310057X9802600106	37	16	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	JUN	1999	27	6					1175	1180		10.1097/00003246-199906000-00047			6	Critical Care Medicine	General & Internal Medicine	212BW	WOS:000081197300037	10397225				2021-06-18	
J	Shum, D; Jamieson, E; Bahr, M; Wallace, G				Shum, D; Jamieson, E; Bahr, M; Wallace, G			Implicit and explicit memory in children with traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; DOUBLE DISSOCIATION; COMPLETION; PICTURES	This study aimed to investigate whether implicit memory is preserved in children with traumatic brain injury (TBI). A fragmented picture-completion procedure (Snodgrass, Smith, Feenan, & Corwin, 1987) was used to compare implicit and explicit memory of 12 children with severe long-term TBI and 12 controls, matched for age and gender. On the implicit memory task, both the TBI and control groups were found to show significant priming. In addition, the extent of priming for the two groups was not found to be different. On the explicit memory task, however, the TBI group was found to perform significantly more poorly than the control group. These results are consistent with those reported in the adult TBI literature and have implications for understanding and rehabilitating memory impairments in children with TBI.	Griffith Univ, Neuropsychol Unit, Brisbane, Qld 4111, Australia; Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia; Mater Misericordiae Childrens Hosp, Brisbane, Qld, Australia	Shum, D (corresponding author), Griffith Univ, Sch Appl Psychol, Nathan, Qld 4111, Australia.		Wallace, Geoff/H-1252-2013; Baehr, Mathias/K-2188-2014; Shum, David/A-3914-2008	Wallace, Geoff/0000-0001-9306-3542; Shum, David/0000-0002-4810-9262			BARON IS, 1995, PEDIAT NEUROPSYCHOLO; BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; GLISKY EL, 1989, HDB NEUROPSYCHOLOGY, V3, P233; GLISKY EL, 1992, J HEAD TRAUMA REHAB, V7, P1; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; KEANE MM, 1995, BRAIN, V118, P1129, DOI 10.1093/brain/118.5.1129; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; PARKIN AJ, 1988, BRIT J PSYCHOL, V79, P361, DOI 10.1111/j.2044-8295.1988.tb02295.x; ROEDIGER HL, 1990, B PSYCHONOMIC SOC, V28, P373; RUSSO R, 1995, J EXP CHILD PSYCHOL, V59, P566, DOI 10.1006/jecp.1995.1026; RYAN TV, 1996, PAEDIAT NEUROPSYCHOL, P117; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; SNODGRASS JG, 1987, BEHAV RES METH INSTR, V19, P270, DOI 10.3758/BF03203798; SNODGRASS JG, 1990, J EXP PSYCHOL GEN, V119, P276, DOI 10.1037/0096-3445.119.3.276; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SNODGRASS JG, 1988, PERCEPT MOTOR SKILL, V67, P3, DOI 10.2466/pms.1988.67.1.3; SNODGRASS JG, 1990, IMPLICIT MEMORY THEO, P259; SNOW JH, 1994, PAEDIAT TRAUMATIC BR; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; Wilson B. A., 1992, NEUROPSYCHOLOGY MEMO, P315	23	16	17	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1999	21	2					149	158		10.1076/jcen.21.2.149.929			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	226CL	WOS:000082002700001	10425513				2021-06-18	
J	Patt, S; Brodhun, M				Patt, S; Brodhun, M			Neuropathological sequelae of traumatic injury in the brain. An overview	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			brain, injury; head injury; trauma, brain; axonal injury; diffuse; beta amino precursor protein (beta APP); intracranial pressure	DIFFUSE AXONAL INJURY; HEAD-INJURY; CHILDREN	The identification and interpretation of brain damage resulting from head injury is often not easy. The most obvious structural damage, which is identified post-mortem by neuropathologists, may not be the most reliable alteration with regard to clinico-pathological correlations. For example patients with a fracture of the skull, a severe cerebral contusion or a large intracerebral hematoma that is successfully treated can lead to a complete recovery if no other types of brain damage are present. Thus more subtle forms of pathology, which are often present and some of which can only be identified microscopically, may be more important. It is therefore necessary to get deeper insights into the consequences of brain injury. Though of course not exclusively, this aim can be reached by autopsy. Primary traumatic brain lesions result immediately from mechanical injury. Secondary alterations injuries develop through intracranial and extracranial trauma sequelae, which determine the course and outcome of brain damage. Traumatic brain damage can be classified as focal or diffuse. It may sometimes be difficult to distinguish traumatic from ischemic brain injury. One difference, however, is that the initial events of trauma involve mechanical distorsion of the brain. Mechanoporation as traumatic defect in the cell membrane has recently been found to be one of the first steps which leads via ionic influxes to the activation of immediate early genes. Oxygen radicals and cell membrane lipid peroxidation occur also very early. Increased intracellular calcium, activation of phospholipases and calpains furthermore damage the membrane and cytoskeleton and block the axoplasmatic transport, by which delayed cell death can appear. For the description of the extent of traumatically induced brain damage and the possible clinico-pathological correlations it is necessary to take these alterations into consideration as specifically as possible. Neuropathology can contribute to this aim.	Univ Jena, Inst Pathol Neuropathol, D-07740 Jena, Germany	Patt, S (corresponding author), Univ Jena, Inst Pathol Neuropathol, Bachstr 18, D-07740 Jena, Germany.	patt@bach.med.uni-jena.de					ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson RM, 1998, AM J FOREN MED PATH, V19, P1, DOI 10.1097/00000433-199803000-00001; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; ELLISON D, 1998, NEUROPATHOLOGY REFER; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P198; LEESTMA JE, 1997, NEUROPATHOLOGY DIAGN, P500; McIntosh TK, 1996, LAB INVEST, V74, P315; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Pearl GS, 1998, CLIN LAB MED, V18, P39; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	21	16	16	0	6	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					119	123		10.1016/S0940-2993(99)80084-0			5	Pathology; Toxicology	Pathology; Toxicology	177NZ	WOS:000079218000002	10192579				2021-06-18	
J	Zasler, ND				Zasler, ND			Posttraumatic headache: Caveats and controversies	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; headache; head trauma trauma; whiplash	INJURY; SEVERITY	Posttraumatic headache (PTHA) although quite common, is still poorly understood in many ways. This article arm provide opinions, insights, and analysis of some of the ongoing controversies and issues in PTHA assessment and treatment. Topics germane to nomenclature problems, classification criteria, paradoxes regarding headache incidence relative to injury severity, lack of identified medical specialty for referral of patients with PTHA, medicolegal issues, PTHA perpetuating factors, impairment and disability assessment, and research needs are addressed. Recommendations for addressing some of the concerns brought up in this commentary will be focused on in the article's concluding comments. These caveats and controversies will hopefully serve to familiarize readers with some of the inherent difficulties in PTHA management and treatment.	Concuss Care Ctr Virginia LTD, Glen Allen, VA 23060 USA; Tree Life, Glen Allen, VA USA	Zasler, ND (corresponding author), Concuss Care Ctr Virginia LTD, 10120 W Broad St,Suite G, Glen Allen, VA 23060 USA.						American Medical Association, 1993, GUID EV PERM IMP; APPENZELLER O, 1993, WOLFFS HEADACHE OTHE; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; FREEMAN MD, 1997, WHIPLASH INJURIES; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; *INT HEAD SOC HEAD, 1988, CEPHALALGIA, V8; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; NICK J, 1969, RES CLIN STUDIES HEA, V2; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; PACKARD RC, 1993, HEADACHE, V33, P359, DOI 10.1111/j.1526-4610.1993.hed3307359.x; Penfield W, 1936, ARCH NEURO PSYCHIATR, V36, P75, DOI 10.1001/archneurpsyc.1936.02260070083007; RADANOV BP, 1993, BRIT MED J, V307, P652, DOI 10.1136/bmj.307.6905.652; RUSSELL WR, 1933, T MED CHJIR SOC ENDB, V113, P129; SIEGMUND GP, P 41 STAPP CAR CRASH; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Warner JS, 1996, NEUROLOGY, V46, P915, DOI 10.1212/WNL.46.4.915; *WHO, 1997, CEPHALALGIA, V17; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x	19	16	16	0	3	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1999	14	1					1	8		10.1097/00001199-199902000-00003			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	165LT	WOS:000078523100003	9949242				2021-06-18	
J	Melchers, P; Maluck, A; Suhr, L; Scholten, S; Lehmkuhl, G				Melchers, P; Maluck, A; Suhr, L; Scholten, S; Lehmkuhl, G			An early onset rehabilitation program for children and adolescents after traumatic brain injury (TBI): Methods and first results	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						traumatic brain injury; neurotrauma-children; rehabilitation; neuropsychology; neurotrauma-psychotherapy		Survived traumatic brain injuries (TBI) are one of the most serious challenges to the patient's future life. Recent literature increasingly questions the long believed protective effects of functional cerebral plasticity in children. Although TBI in children and adolescents is frequent, they are less frequently admitted to rehabilitation centers as in-patients than adults. This emphasizes the role of out-patient treatment. The progressing study described here aims to achieve a contribution to a comprehensive approach in TBI-rehabilitation for youngsters. A two-stage multimethodal program, starting with stimulation in coma while the patient is on the intensive care unit, and neuropsychological therapy after regaining consciousness is to be evaluated in a controlled, prospective and randomized study. After including nearly 50 % of the planned sample (100 persons), some preliminary results can be mentioned with all applicable caution The effectiveness of the applied therapy can be stated here with respect to the posttraumatic development of intellectual abilities in the 6- and 12 months follow ups. Moreover, in the control group development of psychopathological alterations was found to a considerable degree and also lower ratings in a quality of life questionnaire, compared to the experimental group. It is expected to prove these differences statistically, after the total sample has been included, and thus equal distributions have been achieved in all predictive variables.	Univ Cologne, Klin & Poliklin Psychiat & Psychotherapie Kindes, D-50931 Cologne, Germany	Melchers, P (corresponding author), Univ Cologne, Klin & Poliklin Psychiat & Psychotherapie Kindes, Robert Koch Str 10, D-50931 Cologne, Germany.						BENZ B, IN PRESS RESTORATIVE; BROWN G, 1981, PSYCHIAT SEQUELAE PS, V2, P63; FLECHTNER H, 1998, QUALITATSSICHERUNG L, P175; FLECHTNER H, 1995, LEBENSQUALITAT ONK 2, V82, P217; LEHMKUHL G, 1986, THESIS U HEIDELBERG; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Temple CM, 1997, J CHILD PSYCHOL PSYC, V38, P27, DOI 10.1111/j.1469-7610.1997.tb01504.x; YLVISAKER M, 1985, HEAD INJURY REHABILI	11	16	18	0	5	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		1999	14	2-3					153	160					8	Neurosciences	Neurosciences & Neurology	183XN	WOS:000079579700010	22387511				2021-06-18	
J	Schutze, M; Dauch, WA; Guttinger, M; Hampel-Christiansen, M; Firsching, R				Schutze, M; Dauch, WA; Guttinger, M; Hampel-Christiansen, M; Firsching, R			Risk factors for posttraumatic fits and epilepsies	ZENTRALBLATT FUR NEUROCHIRURGIE			German	Article						antiepileptic prophylaxis; intracranial hemorrhage; brain injury	PROPHYLACTICALLY ADMINISTERED PHENYTOIN; POST-TRAUMATIC SEIZURES; PROPHYLAXIS; FAILURE	There is still a considerable controversy about the usefulness of antiepileptic prophylaxis after traumatic brain injury. Overall incidence of posttraumatic fits and epilepsy's is well known, but an individual decision on prophylaxis requires knowledge about the individual risk. We performed a prospective observational study on 612 patients with traumatic brain injury of every degree of severity. Follow-up by phone call included 96.2% of the study population after 6 month and 91.2% after 36 month, respectively. The overall incidence for early fits (within 7 days after trauma), late fits (up to 36 month) and epilepsy (as defined by the International League Against Epilepsy) was 4.2%, 3.7% and 2.5%, respectively. These incidences increased according to the severity of the trauma, but the most powerful single predictor was intracranial hemorrhage. There was no significant difference related to the hemorrhage localisation. Development of epilepsy was much more common after late fits (48%) than after early fits (17%). These features established a hierarchy of risks for the development of epilepsy: no intracranial hemorrhage/no fit : 1% (4/437), intracranial hemorrhage/no fit : 8% (10/122), intracranial hemorrhage/early fit : 16% (3/19), intracranial hemorrhage/late fit : 53% (7/13). f prophylactic antiepileptic treatment is desired, but should be restricted to patients at high risk. These are patients with intracranial hemorrhage - are a well defined high risk group - when their first fit is a late fit.	Univ Magdeburg, Neurochirurg Klin, D-39120 Magdeburg, Germany; Allgemeines Krankenhaus Eilbeck, Zentrum Schwerst Schadel Hirnverletzte Freien & H, Hamburg, Germany							BAUER J, 1992, NERVENHEILKUNDE, V11, P74; Dauch WA, 1996, ZBL NEUROCHIR, V57, P190; Dugan Ellen M., 1994, Emergency Medicine Clinics of North America, V12, P1081; HAINES SJ, 1983, J NEUROSURG, V59, P730; JENNETT B, 1973, SCOT MED J, P8; KELLY DF, 1989, NEUROSURGERY, V25, P976, DOI 10.1227/00006123-198912000-00022; KUHL DA, 1990, DICP ANN PHARMAC, V24, P277, DOI 10.1177/106002809002400314; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MURRI L, 1992, ITAL J NEUROL SCI, V13, P755, DOI 10.1007/BF02229161; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231	13	16	16	0	2	JOHANN AMBROSIUS BARTH VERLAG	HEIDELBERG	IM WEIHER 10, D-69121 HEIDELBERG, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		1999	60	4					163	167					5	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	273JC	WOS:000084703300001	10674332				2021-06-18	
J	Vogelbaum, MA; Kaufman, BA; Park, TS; Winthrop, AL				Vogelbaum, MA; Kaufman, BA; Park, TS; Winthrop, AL			Management of uncomplicated skull fractures in children: Is hospital admission necessary?	PEDIATRIC NEUROSURGERY			English	Article						skull fracture; admission; epidural hematoma; computed tomography	TRAUMATIC INTRACRANIAL HEMATOMA; HEAD-INJURY; REQUIRE HOSPITALIZATION; SUBDURAL-HEMATOMA; INFANTS; ABUSE; CT; SCAN	Objective: This study was undertaken to determine the necessity for routine hospital admission of children with skull fractures, a normal neurological exam, a normal head CT, and no other injuries ('uncomplicated skull fracture'). Methods: A prospective study of closed-head injuries in children was done over a 2-year period at St. Louis Children's Hospital. All patients with closed head injuries underwent skull radiographs and a head CT scan. From this cohort, children with uncomplicated skull fractures were identified and studied. For comparison, a retrospective analysis was also performed of the hospital admission records of children admitted over a 5-year period (1990-1994) with the diagnosis of epidural hematoma (EDH) to identify the typical time intervals between injury and documentation of the lesion in these cases. Results: Forty-four patients with uncomplicated skull fractures were identified; all had been admitted for observation. Mean age was 1.8 years. Average time between injury and hospital admission was 6.35 h with half of this time being spent in the emergency room. Average LOS was 35 h, but 50% of patients were hospitalized less than 24 h. No patient in this study group suffered a complication related to their inury. Twenty-three patients with EDH had been admitted during the fi-year review period. Slightly more than one-half of patients had their EDH detected within 6 h of injury. The others were diagnosed more than 6 h after injury due to a delay in medical evaluation or a delay in obtaining a computed tomographic (CT) scan after an initial medical evaluation. Conclusions: Patients with uncomplicated skull fractures, in the absence of recurrent emesis and/or evidence of child abuse, can be considered for discharge home. The definition of an uncomplicated skull fracture requires that a head CT be performed on these patients.	Washington Univ, Sch Med, St Louis Childrens Hosp, Dept Neurol Surg, St Louis, MO USA; Washington Univ, Sch Med, St Louis Childrens Hosp, Dept Surg,Div Pediat Surg, St Louis, MO USA	Kaufman, BA (corresponding author), St Louis Childrens Hosp, Dept Neurosurg, 1 Childrens Pl, St Louis, MO 63110 USA.						BELL RS, 1971, NEW ENGL J MED, V284, P236, DOI 10.1056/NEJM197102042840504; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BONADIO WA, 1989, AM J DIS CHILD, V143, P194, DOI 10.1001/archpedi.1989.02150140084025; BOULIS ZF, 1978, BRIT J RADIOL, V51, P851, DOI 10.1259/0007-1285-51-611-851; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; CHAN KH, 1990, CHILD NERV SYST, V6, P27, DOI 10.1007/BF00262262; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; DEITCH D, 1989, NEUROLOGY, V39, P985, DOI 10.1212/WNL.39.7.985; DESMET AA, 1979, AM J ROENTGENOL, V132, P95, DOI 10.2214/ajr.132.1.95; GALBRAITH S, 1976, LANCET, V1, P501; GODANO U, 1992, CHILD NERV SYST, V8, P136, DOI 10.1007/BF00298269; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; HELFER RE, 1977, PEDIATRICS, V60, P533; HUGENHOLTZ H, 1987, CHILD NERV SYST, V3, P266, DOI 10.1007/BF00271820; HYDEN PW, 1992, PEDIATR CLIN N AM, V39, P1053; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; KRAVITZ H, 1969, PEDIATRICS, V44, P869; MANN KS, 1986, CHILD NERV SYST, V2, P258; MERTEN DF, 1984, PEDIATR RADIOL, V14, P272, DOI 10.1007/BF01601874; NELSON EL, 1984, NEUROSURGERY, V15, P318, DOI 10.1227/00006123-198409000-00005; PHILLIPS LA, 1979, JACEP-J AM COLL EMER, V8, P106, DOI 10.1016/S0361-1124(79)80152-5; POON WS, 1992, NEUROSURGERY, V30, P681; READ HS, 1995, INJURY, V26, P333, DOI 10.1016/0020-1383(95)00020-A; ROBERTS F, 1972, AM J ROENTGENOL, V114, P230, DOI 10.2214/ajr.114.2.230; ROS SP, 1992, PEDIATR EMERG CARE, V8, P328, DOI 10.1097/00006565-199212000-00005; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; SHANON A, 1994, PEDIATR EMERG CARE, V10, P322, DOI 10.1097/00006565-199412000-00004; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363	31	16	16	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.	AUG	1998	29	2					96	101		10.1159/000028697			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	138CZ	WOS:000076955000009	9792964				2021-06-18	
J	Palmer, DT; Horn, LJ; Harmon, RL				Palmer, DT; Horn, LJ; Harmon, RL			Botulinum toxin treatment of lumbrical spasticity - A brief report	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						botulinum toxin A; lumbricals; spasticity	INJECTIONS; HAND	Botulinum toxin A has been used to treat wrist and finger spasticity mainly through injection of the forearm flexor muscles. This case study describes its first reported use in managing spastic lumbricals of the hand. A 19-year-old male had significant flexion deformity and hypertonicity of the left wrist and hand, particularly the second through fifth metacarpophalangeal joints, after traumatic brain injury. By using the 0-4 Ashworth scale, spasticity of the lumbricals across the second to fourth metacarpophalangeal joints was rated 2, with persistent clonus of the finger flexors as confirmed by electromyography to the middle and ring fingers, even after botulinum toxin A injection of the flexor digitorum sublimis and profundus muscles. By using the electromyography-guided technique, botulinum toxin A was injected into the first lumbrical of the index finger (12 units), second and third lumbricals of the middle and ring fingers, respectively (15 units each), and fourth lumbrical of the little finger (10 units). At follow-up, clinical and electromyographic examination revealed a significant reduction in tone and clonus of the injected lumbricals. Ashworth scores of the lumbricals from the index to little finger improved to 1. Botulinum toxin A injection of the lumbricals can be beneficial in managing spasticity of these muscles. It is well tolerated and effective at doses of 10 to 15 units. Lumbrical injection of botulinum toxin A is a useful adjunct in our percutaneous armamentarium for managing the spastic hand.	Med Coll Ohio, Dept Phys Med & Rehabil, Toledo, OH 43614 USA	Palmer, DT (corresponding author), Med Coll Ohio, Dept Phys Med & Rehabil, Dowling Hall,3065 Arlington Ave, Toledo, OH 43614 USA.						ASHWORTH B, 1964, PRACTITIONER, V192, P540; COHEN LG, 1989, J NEUROL NEUROSUR PS, V52, P355, DOI 10.1136/jnnp.52.3.355; DAS TK, 1989, POSTGRAD MED J, V65, P208, DOI 10.1136/pgmj.65.762.208; DELAGI EF, 1980, ANATOMIC GUIDE ELECT, P16; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; KARP BI, 1994, NEUROLOGY, V44, P70, DOI 10.1212/WNL.44.1.70; RIVEST J, 1991, MOVEMENT DISORD, V6, P55, DOI 10.1002/mds.870060110; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; VANERMENGEM E, 1979, REV INFECT DIS, V1, P701	11	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL-AUG	1998	77	4					348	350		10.1097/00002060-199807000-00020			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	109VQ	WOS:000075344900014	9715926				2021-06-18	
J	Brown, JIM; Moulton, RJ; Konasiewicz, SJ; Baker, AJ				Brown, JIM; Moulton, RJ; Konasiewicz, SJ; Baker, AJ			Cerebral oxidative metabolism and evoked potential deterioration after severe brain injury: New evidence of early posttraumatic ischemia	NEUROSURGERY			English	Article						brain injury; cerebral ischemia; somatosensory evoked potentials	SEVERE HEAD-INJURY; BLOOD-FLOW; INTRACRANIAL HYPERTENSION; COMATOSE PATIENTS; MECHANISMS; COMMON	BACKGROUND: We commonly observe progressive deterioration in somatosensory evoked potentials (SSEPs) after severe head injury. We had previously been unable to relate this deterioration to raised intracranial pressure but had noted a relationship with decreasing transcranial oxygen extraction (arteriovenous oxygen difference [AVDO(2)]). The purpose of this study was twofold: to prove the hypothesis that deterioration in SSEP values is associated with decreasing AVDO(2) and to test the subsidiary hypotheses that deteriorating SSEPs were the result of either ischemia/reperfusion injury or failure of oxygen extraction/utilization. METHODS: Monitoring of 97 patients with severe traumatic brain injury (Glasgow Coma Scale scores of less than or equal to 8 after resuscitation) included twice daily AVDO(2) measurement and hourly SSEP recording for an average of 5 days. The last 51 patients also underwent 12-hourly measurement of cerebral blood flow (CBF), with calculation of the cerebral metabolic rate of oxygen. Cluster analysis was used to classify patients based on initial AVDO(2) values and subsequent SSEP trends. The time courses of CBF, SSEPs, AVDO(2), and cerebral metabolic rate of oxygen were examined in the groups defined by the cluster analysis. The clinical outcomes considered were survival or nonsurvival and the Glasgow Outcome Scale scores obtained at 3 months or more after injury. RESULTS: Cluster analysis confirmed the association between high initial AVDO(2) values and subsequent SSEP deterioration. Patients in this category initially had significantly higher AVDO(2), lower CBF, and higher cerebral metabolic rates of oxygen but recovered to adequate levels within 24 to 36 hours after injury. SSEP values were initially identical in the patients with normal AVDO(2) values and those with elevated AVDO(2) but differed significantly at 60 hours after injury and beyond. CONCLUSION: The findings of increased oxygen utilization and lowered CBF in the patients with deteriorating SSEPs strongly imply that early ischemia rather than failure of O-2 extraction or utilization is responsible for the associated SSEP deterioration. This issue of defining thresholds for ischemia based on AVDO(2) is confounded by the dependency of CBF and AVDO(2) values on the time after injury.	Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Dept Anesthesia, Toronto, ON M5B 1W8, Canada	Brown, JIM (corresponding author), 38 Shuter St, Toronto, ON M5A 1A6, Canada.						BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HOSSMANN KA, 1993, RESUSCITATION, V26, P225, DOI 10.1016/0300-9572(93)90143-E; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KETY SS, 1945, AM J PHYSIOL, V143, P53; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; KONASIEWICZ SJ, 1994, CAN J NEUROL SCI, V21, P219, DOI 10.1017/S0317167100041196; KRAUSE GS, 1986, AM HEART J, V111, P768, DOI 10.1016/0002-8703(86)90114-6; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MOULTON R, 1991, J TRAUMA, V31, P676, DOI 10.1097/00005373-199105000-00012; MOULTON RJ, 1994, CLIN INVEST MED, V17, P187; MOULTON RJ, 1994, CAN J NEUROL SCI, V21, pS17, DOI 10.1017/S0084255900007567; MUIZELAAR JP, 1985, CENTRAL NERVOUS SYST, P123; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; *SAS I INC, 1987, SAS STAT GUIDE PERSO, P283; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17	21	16	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	1998	42	5					1057	1063		10.1097/00006123-199805000-00060			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	ZK454	WOS:000073322500053	9588550				2021-06-18	
J	Schmitter-Edgecombe, M; Kibby, MK				Schmitter-Edgecombe, M; Kibby, MK			Visual selective attention after severe closed head injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						closed head injury; traumatic brain injury; attention; selective attention; focused attention; divided attention; visual search	FEATURE-INTEGRATION; FOCUSED ATTENTION; REACTION-TIME; SEARCH; PARALLEL	This study investigated the nature of selective attention deficits after severe closed head injury (CHI). Twenty participants with severe CHI (greater than 1 year postinjury) and 20 matched controls completed search and nonsearch visual selective attention tasks under conditions of low (Experiment 1) and high (Experiment 2) target-distracter similarity. In the search situations, participants searched visual displays that contained 1, 4, or 8 items for the targets. In the nonsearch situations, the location of the targets was visually cued with a peripheral arrow. The results revealed that in both the low and high target-distracter similarity search conditions, CHI participants required a longer time than controls to locate and identify the target. In contrast, in the nonsearch condition, CHI participants were able to successfully ignore irrelevant task information when target-distractor similarity was low. However, when target-distracter similarity was high, CHI participants had more difficulty than controls ignoring the irrelevant information. These results suggest that, in comparison to controls, CHI participants may be at a disadvantage in selective attention situations when visual search is required and when the discriminability between targets and distracters is difficult.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA; Univ Memphis, Memphis, TN 38152 USA	Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu	Kibby, Michelle/A-9671-2009	Kibby, Michelle/0000-0002-2161-2108			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BARBER P, 1981, PSYCHOL BULL, V89, P176, DOI 10.1037/0033-2909.89.1.176; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; CATTELL RB, 1973, HDB INDIVIDUAL GROUP; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; COLEGATE RL, 1973, PERCEPT PSYCHOPHYS, V14, P217, DOI 10.3758/BF03212380; DAVIES DR, 1984, VARIETIES ATTENTION, P395; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1992, J EXP PSYCHOL HUMAN, V18, P578, DOI 10.1037/0096-1523.18.2.578; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; ERIKSEN CW, 1972, PERCEPT PSYCHOPHYS, V12, P201, DOI 10.3758/BF03212870; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI DOI 10.1016/S0079-7421(08)60041-9; Heaton R., 1981, MANUAL WISCONSIN CAR; HOLLINGSHEAD AB, 1975, UNPUB 4 FACTOR INDEX; JOHNSTON WA, 1986, ANNU REV PSYCHOL, V37, P43, DOI 10.1146/annurev.ps.37.020186.000355; JONIDES J, 1980, CAN J PSYCHOL, V34, P103, DOI 10.1037/h0081031; KAHNEMAN D, 1973, ATTENTION MEMORY; Kaplan E., 1987, MANUAL CALIFORNIA VE; MCGHIE A, 1969, PATHOLOGY ATTENTION; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; Miller E, 1970, Cortex, V6, P121; NEISSER U, 1963, AM J PSYCHOL, V76, P376, DOI 10.2307/1419778; PLUDE D, 1986, PSYCHOL AGING, V1, P1; Plude D. J., 1985, AGING HUMAN PERFORMA, P47; PLUDE DJ, 1989, PSYCHOL AGING, V4, P98, DOI 10.1037/0882-7974.4.1.98; PRINZMETAL W, 1986, J EXP PSYCHOL HUMAN, V12, P361, DOI 10.1037/0096-1523.12.3.361; SANDSON J, 1988, COGNITIVE APPROACHES, P45; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCIALFA CT, 1994, J GERONTOL B-PSYCHOL, V49, P173; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TOWNSEND JT, 1971, PERCEPT PSYCHOPHYS, V10, P161, DOI 10.3758/BF03205778; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wickens CD, 1984, VARIETIES ATTENTION, P395; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135	42	16	16	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	1998	4	2					144	159		10.1017/S1355617798001441			16	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	103EY	WOS:000075146200006	9529824				2021-06-18	
J	Shiina, G; Onuma, T; Kameyama, M; Shimosegawa, Y; Ishii, K; Shirane, R; Yoshimoto, T				Shiina, G; Onuma, T; Kameyama, M; Shimosegawa, Y; Ishii, K; Shirane, R; Yoshimoto, T			Sequential assessment of cerebral blood flow in diffuse brain injury by I-123-iodoamphetamine single-photon emission CT	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CLOSED-HEAD-INJURY; COMPUTED-TOMOGRAPHY; TECHNETIUM-99M-HMPAO SPECT; METABOLISM; PERFUSION; ISCHEMIA; LESIONS; HUMANS	PURPOSE: Our goal was to elucidate the temporal profile of cerebral circulation and its relationship to prognosis in patients with diffuse brain injury by using single-photon emission CT (SPECT) and I-123-iodoamphetamine (IMP). METHODS: A total of 67 assessments were made in 26 patients with diffuse brain injury (Glasgow Coma Scale score less than or equal to 8). The microsphere method was used for quantifying cerebral blood flow (CBF). The hemispheric CBF was defined as a mean regional CBF (rCBF), and the total cerebral hemispheric CBF (tCBF) as a mean of the bilateral hemispheric CBF, The relationship between patient outcome and tCBF was investigated. RESULTS: The rCBF in patients with diffuse brain injury showed dynamic and global changes with little regional differences. The tCBF values increased in 1 to 3 days, and they were higher in the poor-outcome group than in the good-outcome group. During the period of 14 to 42 days, the tCBF values stayed within normal range in the good-outcome group, whereas they were below normal range in the poor-outcome group. CONCLUSION: Our results revealed a good correlation between patient outcome and CBF values. Quantitative and sequential CBF studies with IMP SPECT are promising for helping to determine the prognosis for patients with diffuse brain injury.	Sendai City Hosp, Dept Neurosurg, Wakabayashi Ku, Sendai, Miyagi 984, Japan; Sendai City Hosp, Dept Radiol, Sendai, Miyagi, Japan; Tohoku Univ, Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan	Shiina, G (corresponding author), Sendai City Hosp, Dept Neurosurg, Wakabayashi Ku, 3-1 Shimizu Kohji, Sendai, Miyagi 984, Japan.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; DONALD WM, 1991, J NEUROSURG, V74, P407; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goncalves J M, 1992, Acta Neurochir Suppl (Wien), V55, P11; Graham D I, 1983, Acta Neurochir Suppl (Wien), V32, P65; GRAY BG, 1992, J NUCL MED, V33, P52; GREENBERG JH, 1990, J NUCL MED, V31, P1364; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1975, LANCET, V1, P480; KUHL DE, 1982, J NUCL MED, V23, P196; KUHL DE, 1975, CIRC RES, V36, P610, DOI 10.1161/01.RES.36.5.610; LEVEILLE J, 1989, J NUCL MED, V30, P1902; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; Matsuda H, 1986, Am J Physiol Imaging, V1, P186; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MURASE K, 1990, MED PHYS, V17, P79, DOI 10.1118/1.596531; NEIRINCKX RD, 1988, J CEREBR BLOOD F MET, V8, pS4, DOI 10.1038/jcbfm.1988.27; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Odano Ikuo, 1994, Japanese Journal of Nuclear Medicine, V31, P223; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; OGAWA A, 1989, Brain and Nerve (Tokyo), V41, P843; OSTERHOLM JL, 1972, J NEUROSURG, V36, P395, DOI 10.3171/jns.1972.36.4.0395; ROPER SN, 1991, J NUCL MED, V32, P1684; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SHEPP LA, 1974, IEEE T NUCL SCI, VNS21, P21, DOI 10.1109/TNS.1974.6499235; SORENSON JA, 1974, INSTRUM NUCL, V2, P311; TEASDALE G, 1974, LANCET, V2, P81; TRAUPE H, 1982, STROKE, V13, P615, DOI 10.1161/01.STR.13.5.615; WINCHELL HS, 1980, J NUCL MED, V21, P947; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	37	16	16	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	FEB	1998	19	2					297	302					6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	YX191	WOS:000072015500018	9504482				2021-06-18	
J	Hall, KM; Wallbom, AS; Englander, J				Hall, KM; Wallbom, AS; Englander, J			Premorbid history and traumatic brain injury	NEUROREHABILITATION			English	Article						premorbid history; traumatic brain injury; outcome; prediction	DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; SUBSTANCE-ABUSE; REHABILITATION; RELIABILITY; PREVALENCE; RECOVERY; CHILDREN; OUTCOMES; RETURN	The literature is replete with studies investigating predictors of outcomes in traumatic brain injury. Few, however, have addressed the premorbid life events and behaviors that may significantly impact the physical, behavioral, cognitive, and/or psychosocial and vocational status of individuals after a traumatic brain injury (TBI). Findings of studies on premorbid history are reviewed and data are presented on a sample of 82 cases on which premorbid psychosocial information, severity of initial injury and outcome status were obtained. Cases were dichotomized into groups at high risk and at low risk for TBI, based on premorbid history. High risk and low risk groups were comparable in the severity of initial injury. Outcomes were defined by the Functional Independence Measure and the Disability Rating Scale scores at 1 year after injury. No differences were found in FIMTM Or DRS scores between those with and without premorbid learning disability, psychiatric history, incarcerations, arrests, academic difficulties, or substance abuse. Explanations for the lack of significant differences are discussed. Based on experience in completing this study, a screening tool incorporating documentation of a number of premorbid factors that might impact status at outcome is presented. (C) 1998 Elsevier Science Ireland Ltd.	Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, Santa Clara, CA USA; Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA	Hall, KM (corresponding author), 950 So Bascom Ave,Suite 2011, San Jose, CA 95128 USA.	khallvmc@aol.com					*AM PSYCH ASS, 1994, DIAGN STAT MAN, V4; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BURKE W H, 1990, Brain Injury, V4, P371, DOI 10.3109/02699059009026190; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; DICKER BG, 1989, J HEAD TRAUMA REHAB, V4, P73; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HALL KM, 1994, ARCH PHYSICAL MED RE, V75, P10; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Heinemann AW, 1994, TOP STROKE REHABIL, V1, P1; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Parmelee D X, 1989, Brain Inj, V3, P295, DOI 10.3109/02699058909029642; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Ruff R. M., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI DOI 10.1097/00001199-199009000-00006; Ruff RM, 1996, NEUROREHABILITATION, V7, P39, DOI 10.3233/NRE-1996-7105; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; *STAT U NEW YORK B, 1996, GUID UN DAT SET MED; Thomsen I V, 1987, Brain Inj, V1, P131, DOI 10.3109/02699058709034452; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560	45	16	16	0	4	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JAN	1998	10	1					3	12		10.1016/S1053-8135(97)00040-1			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	YV946	WOS:000071880300002	24525812				2021-06-18	
J	Leon-Carrion, J; Alarcon, JC; Revuelta, M; Murrillo-Cabezas, F; Dominguez-Roldan, JM; Dominguez-Morales, MR; Machuca-Murga, F; Forastero, P				Leon-Carrion, J; Alarcon, JC; Revuelta, M; Murrillo-Cabezas, F; Dominguez-Roldan, JM; Dominguez-Morales, MR; Machuca-Murga, F; Forastero, P			Executive functioning as outcome in patients after traumatic brain injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article; Proceedings Paper	International Conference on Recent Advances in Neurotraumatology	SEP 08-11, 1996	RIMINI, ITALY	World Federat Neurosurg Soc		executive functions; neurosurgery; Glasgow Outcome Scale; traumatic brain injury; neuropsychological assessment; Tower of Hanoi/Sevilla	SEVERE HEAD-INJURY; COMA; TALK; DETERIORATE; SCALE	The present study was designed to determine how traumatic brain injury affects executive Functioning, to know whether different treatments in the acute phase improve this functioning, and to check whether the severity of the neurocognitive impairment is detected by the Glasgow Outcome Scale (GOS). Ability for problem solving and executive functioning within 2 years after Traumatic Brain Injury (TBI) was examined in 35 conscious survivors. Two groups were formed. One group consisted of 13 patients who needed neurosurgery. The other group was made up of 22 patients without neurosurgical treatment. All were treated in the Neurosurgical Intensive Care Unit and in the Rehabilitation Service. The following variables were registered: Secondary Lesions, Glasgow Coma Scale (GCS), CT, subacute CT. and Glasgow Outcome Scale. Neuropsychological tests administered were Wisconsin Card Sorting Test (WCST) and the Tower of Hanoi/Sevilla. Comparing both groups' test performance (Man Whitney U) we found that a severe traumatic brain injury, whatever the treatment applied in the acute phase, impairs the executive functioning of the patients; this impairment is related to acute pathophysiological events. The neurosurgical intervention does not improve the executive functioning. The Glasgow Outcome Scale does not detect more than 25% of the patients with severe impairment. It is suggested that the Tower of Hanoi/Sevilla could be a good tool to evaluate the executive functioning routinely in TBI patients as outcome. It is also suggested that mild TBI patients must be referred for a complete neuropsychological examination.	Ctr Brain Injury Rehabil, CRE CER R, Sevilla 40108, Spain; Univ Seville, Human Cognit Neuropsychol Lab, Seville, Spain; Univ Seville, Traumatol Hosp Virgen del Rocio, Seville, Spain	Leon-Carrion, J (corresponding author), Ctr Brain Injury Rehabil, CRE CER R, Avda Luis Montoto 113 Edif Cristal Portal B,Mod 1, Sevilla 40108, Spain.		Dominguez-Roldan, Jose-Maria/M-1728-2016; Leon Carrion, Jose/D-5638-2012	Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; 			ANZAI Y, 1979, PSYCHOL REV, V86, P124, DOI 10.1037/0033-295X.86.2.124; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DAIGNEAULT S, 1988, J CLIN EXPT NEUROPSY, P10; GOTT PS, 1991, ARCH NEUROL-CHICAGO, V48, P1267, DOI 10.1001/archneur.1991.00530240071024; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Gronwall D., 1989, ASSESSMENT BEHAV CON, P19; Hecaen H., 1975, PSYCHIAT ASPECTS NEU; HORN S, 1992, Brain Injury, V6, P321, DOI 10.3109/02699059209034946; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KARAT J, 1982, COGNITIVE PSYCHOL, V14, P538, DOI 10.1016/0010-0285(82)90018-4; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LeonCarrion J, 1996, INT J NEUROSCI, V85, P231, DOI 10.3109/00207459608986685; LEONCARRION J, 1991, PERCEPT MOTOR SKILL, V73, P63, DOI 10.2466/pms.1991.73.1.63; LEONCARRION J, IN PRESS SEVILLE COM; LEONCARRION J, 1995, HDB HUMAN NEUROPSYCH; LEONCARRION J, 1997, NEUROPSYCHOLOGICAL R; LEONCARRION J, 1993, WISCONSIN CARD SORTI; LEVIN HS, 1996, CATASTROPHIC BRAIN I; Lezak M., 1989, ASSESSMENT BEHAV CON; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Luria A.R., 1962, HIGHER CORTICAL FUNC; LURIA AR, 1973, PSYCHOL FRONTAL LOBE; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG, V75, P814; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V5, P213, DOI DOI 10.1037/0894-4105.5.3.213; RAEGRANT AD, 1991, ELECTROEN CLIN NEURO, V79, P349, DOI 10.1016/0013-4694(91)90199-E; REILLY PL, 1975, LANCET, V2, P375; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; TORNER JC, 1992, CURR OPIN NEUROL NEU, V5, P831; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630	34	16	17	0	10	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD, PO BOX 90, READING RG1 8JL, BERKS, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1998	94	1-2					75	83		10.3109/00207459808986440			9	Neurosciences	Neurosciences & Neurology	ZW103	WOS:000074374300006	9622801				2021-06-18	
J	DeWitt, DS; Prough, DS; Uchida, T; Deal, DD; Vines, SM				DeWitt, DS; Prough, DS; Uchida, T; Deal, DD; Vines, SM			Effects of nalmefene, CG3703, tirilazad, or dopamine on cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; electroencephalography; free radicals; head injury; hemorrhagic hypotension; opiates; peptides	THYROTROPIN-RELEASING-HORMONE; 7.5-PERCENT SODIUM-CHLORIDE; FLUID PERCUSSION INJURY; HEAD-INJURY; 21-AMINOSTEROID U74006F; ENDOGENOUS OPIOIDS; HYPERTONIC SALINE; MILD HEMORRHAGE; CATS; ISCHEMIA	Hemorrhage after traumatic brain injury (TBI) in cats produces significant decreases in cerebral oxygen delivery (DcereO2) and electroencephalographic (EEG) activity. To determine whether effective treatments for the separate insults of TBI and hemorrhagic shock would also prove effective after the clinically relevant combination of the two, we measured the effects of a K-opiate antagonist (nalmefene), an inhibitor of lipid peroxidation (tirilazad), a thyrotropin-releasing hormone analog (CG3703), a clinically useful presser agent (dopamine) or a saline placebo on cerebral blood flow (CBF), and EEG activity after TBI and mild hemorrhagic hypotension. Cats (n = 40, 8 per group) were anesthetized with 1.6% isoflurane in N2O:O-2 (70:30) and prepared for fluid-percussion TBI and microsphere measurements of CBF. Cats were randomized to receive nalmefene (1 mg/kg), tirilazad (5 mg/kg), CG3703 (2 mg/kg), dopamine (20 mu g.kg(-1) min(-1)) or a saline placebo (2 mi, 0.9% NaCl). Animals were injured (2.2 atm), hemorrhaged to 70% of preinjury blood volume, treated as just described and resuscitated with a volume of 10% hydroxyethyl starch equal to shed blood. CBF was determined and EEG activity recorded before injury, after hemorrhage, and 0, 60, and 120 min after resuscitation (RO, R60, and R120). CBF increased significantly after resuscitation (RO) in the nalmefene-and CG3703-treated groups. CBF did not differ significantly from baseline in any group at R60 or R120. DcereO2 was significantly less than baseline in the saline-, dopamine-, and tirilazad-treated groups at R60 and in the dopamine-, tirilazad-, and CG3703-treated groups at R120. EEG activity remained unchanged in the nalmefene-treated group but deteriorated significantly at R60 or R120 compared to baseline in the other groups. Nalmefene and CG3703 preserved the hyperemic response to hemodilution (otherwise antagonized by TBI), and nalmefene prevented the deterioration in DcereO2 and EEG activity that occurs after TBI and hemorrhage.	Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesia, Winston Salem, NC 27157 USA	DeWitt, DS (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.		Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS19355] Funding Source: Medline		ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1991, CIRC RES, V68, P922, DOI 10.1161/01.RES.68.4.922; BRAUGHLER JM, 1987, J BIOL CHEM, V262, P10438; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; EKSTROMJODAL B, 1982, CRIT CARE MED, V10, P375, DOI 10.1097/00003246-198206000-00008; ELLIS E F, 1989, Journal of Neurotrauma, V6, P31, DOI 10.1089/neu.1989.6.31; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1984, JAMA-J AM MED ASSOC, V252, P1452, DOI 10.1001/jama.252.11.1452; FADEN AI, 1993, J NEUROTRAUM, V10, P101, DOI 10.1089/neu.1993.10.101; GURLL NJ, 1987, CRIT CARE MED, V15, P574, DOI 10.1097/00003246-198706000-00006; HALL E, 1987, BRAIN RES, V435, P170; HALL ED, 1988, J NEUROSURG, V68, P462, DOI 10.3171/jns.1988.68.3.0462; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HOFFBRAND BI, 1969, CARDIOVASC RES, V3, P426, DOI 10.1093/cvr/3.4.426; HOLADAY JW, 1981, SCIENCE, V213, P216, DOI 10.1126/science.6787704; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; PRIOR PF, 1978, BRIT J ANAESTH, V50, P993, DOI 10.1093/bja/50.10.993; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; TANAKA K, 1992, REGUL PEPTIDES, V38, P129, DOI 10.1016/0167-0115(92)90051-U; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VINK R, 1991, AM J PHYSIOL, V261, pR1527; VINK R, 1988, BRAIN RES, V460, P184, DOI 10.1016/0006-8993(88)91221-8; VINK R, 1990, J NEUROSCI, V10, P3524; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95	50	16	17	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	1997	14	12					931	941		10.1089/neu.1997.14.931			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	YU127	WOS:000071685000005	9475374				2021-06-18	
J	Lees, AJ				Lees, AJ			Trauma and Parkinson's disease	REVUE NEUROLOGIQUE			English	Article							HEAD TRAUMA; PERIPHERAL TRAUMA; AFTERMATH; DYSTONIA; MIDBRAIN; TREMOR; INJURY	The relationship between physical trauma and Parkinson's disease is reviewed. Post-traumatic Parkinson's syndrome may occur following cumulative head trauma in contact sports and exceptionally rarely after a single severe closed head injury. It remains uncertain, however, whether physical injury should be considered one aetiological factor in the pathogenesis of Parkinson's disease.	UCL HOSP, LONDON, ENGLAND			Lees, Andrew J/A-6605-2009	Lees, Andrew J/0000-0002-2476-4385			BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BIARY N, 1989, NEUROLOGY, V39, P1103; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Bruetsch WL, 1935, J NERV MENT DIS, V81, P531, DOI 10.1097/00005053-193505000-00004; CARDOSO F, 1995, ARCH NEUROL-CHICAGO, V52, P263, DOI 10.1001/archneur.1995.00540270055019; CARROLL E, 1936, AM J MED SCI, V191, P7066; CLAUDE H, 1939, ANN MED LEG, V19, P173; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; Constantinidis J, 1967, Schweiz Arch Neurol Neurochir Psychiatr, V100, P117; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; CROUZON O, 1929, PRESSE MED, V37, P1325; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; DAVIE CA, 1995, ANN NEUROL, V37, P204, DOI 10.1002/ana.410370211; DE MORSIER G., 1960, PSYCHIAT ET NEUROL, V139, P60; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; FACTOR SA, 1988, MOVEMENT DISORD, V3, P30, DOI 10.1002/mds.870030105; FRIEDMAN JH, 1989, SOUTHERN MED J, V82, P543, DOI 10.1097/00007611-198905000-00002; GODWINAUSTEN R, 1982, J NEUROL NEUROSUR PS, V44, P577; GOETZ CG, 1991, ANN NEUROL, V29, P191, DOI 10.1002/ana.410290213; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Grimberg L, 1934, J NERV MENT DIS, V79, P14, DOI 10.1097/00005053-193401000-00002; HARVEY PKP, 1974, LANCET, V2, P928; HAUSER T, 1991, M ALI BIOGRAPHY; Heyde W, 1932, ARCH PSYCHIAT NERVEN, V97, P600, DOI 10.1007/BF01815563; Holmes G, 1904, BRAIN, V27, P327, DOI 10.1093/brain/27.3.327; Huhn B, 1970, Nervenarzt, V41, P326; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; KOTHBAUER P, 1977, NERVE ENTWICKLUNGEN, P23; KREMER M, 1947, J NEUROL NEUROSUR PS, V10, P49, DOI 10.1136/jnnp.10.2.49; LANG AE, 1995, ARCH NEUROL-CHICAGO, V52, P802, DOI 10.1001/archneur.1995.00540320078015; LINDENBERG R, 1964, Dtsch Z Nervenheilkd, V185, P637; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; NAYERNOURI T, 1985, SURG NEUROL, V24, P263, DOI 10.1016/0090-3019(85)90035-7; Parkinson J, 1817, ESSAY SHAKING PALSY; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; RONDOT P, 1994, J NEUROL NEUROSUR PS, V57, P658, DOI 10.1136/jnnp.57.5.658; RUDELLI R, 1990, ARCH NEUROL-CHICAGO, V39, P570; SAMIE MR, 1990, NEUROLOGY, V40, P62, DOI 10.1212/WNL.40.1.62; SANDYK R, 1983, J NEUROSURG, V58, P298, DOI 10.3171/jns.1983.58.2.0298; SCHOTT GD, 1986, LANCET, V2, P712; SCHOTT GD, 1985, J NEUROL NEUROSUR PS, V48, P698, DOI 10.1136/jnnp.48.7.698; SCHWAB RS, 1968, HDB CLIN NEUROLOGY, V6, P230; SLEVIN JT, 1987, NEUROLOGY, V37, P322, DOI 10.1212/WNL.37.2.322; SNYDER AM, 1985, ANN NEUROL, V18, P544, DOI 10.1002/ana.410180506; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554	51	16	17	0	6	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787			REV NEUROL-FRANCE	Rev. Neurol.	OCT	1997	153	10					541	546					6	Clinical Neurology	Neurosciences & Neurology	YG630	WOS:A1997YG63000002	9684017				2021-06-18	
J	Yorkston, KM; Jaffe, KM; Polissar, NL; Liao, SQ; Fay, GC				Yorkston, KM; Jaffe, KM; Polissar, NL; Liao, SQ; Fay, GC			Written language production and neuropsychological function in children with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CLOSED-HEAD-INJURY; ADOLESCENTS; PERFORMANCE; DISCOURSE; CHILDHOOD; RECOVERY; COHORT	Objective: To establish the early consequences of traumatic brain injury (TBI) on spontaneous written language production in children by examining writing deficits as a function of injury severity and con-elating written performance with neuropsychological data. Design: Case-control cohort study. Setting: Two regional medical centers. Patients: Seventy-six children, aged 8 to 15 years, with mild, moderate, or severe closed head injury were compared with controls who were individually matched on the premorbid characteristics of age, gender, school grade, behavior, and academic performance. Main Outcome Measures: Assessment of written language production and neuropsychological function was undertaken approximately I month following resolution of posttraumatic amnesia. Case-control differences on 16 measures of spontaneous written narratives were computed. Results: Factor analysis and conceptual similarities suggested that the measures of written language fell into five domains: Efficiency, Completeness, General Readability, Error, and Vocabulary. A highly significant, moderate correlation between these measures and severity of injury was found. The highest correlations were found for the written language domains of Efficiency and Completeness and the lowest for the Vocabulary domain. Moderate correlations were also found between measures of written language and neuropsychological function. Conclusions: At 1 month after resolution of posttraumatic amnesia, written language production in children with TBI is negatively correlated with severity of injury. Some aspects of written language production are affected to a greater extent than others. Considerable common around was found between written language production and neuropsychological function. (C) 1997 by the American Congress of Rehabilitation Medicine.	UNIV WASHINGTON, DEPT REHABIL MED, LEARNING SERV, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT REHABIL MED, BEHAV SERV, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT NEUROL SURG, SEATTLE, WA 98195 USA; CHILDRENS HOSP & MED CTR, DEPT REHABIL MED, SEATTLE, WA 98105 USA; UNIV WASHINGTON, DEPT BIOSTAT, SEATTLE, WA 98195 USA; MT WHISPER LIGHT STAT CONSULTING, SEATTLE, WA USA; STATPRO CONSULTANTS, SEATTLE, WA USA	Yorkston, KM (corresponding author), UNIV WASHINGTON, DEPT REHABIL MED, NW NEUROPSYCHOL, BOX 356490, SEATTLE, WA 98195 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [CCR002299/7] Funding Source: Medline		BRUININKS RH, 1984, WOODCOCK JOHNSON P 4; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CROSSON B, 1993, CLIN NEUROPSYCHOL, V7, P250, DOI 10.1080/13854049308401897; Delis DC, 1989, CALIFORNIA VERBAL LE; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FREDERICKSON CH, 1990, DISCOURSE ABILITY BR, P1; GRAHAM S, 1986, J SCHOOL PSYCHOL, V24, P63, DOI 10.1016/0022-4405(86)90043-9; HAMMILL DD, 1978, TEST WRITTEN LANGUAG; Hasbrouck J, 1994, TEACHING EXCEPTIONAL, V26, P18; HUNT KW, 1970, SOC RES CHILD REV MO, V35, P69; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; Jastak S, 1984, WIDE RANGE ACHIEVEME; JENNETT B, 1975, LANCET, V1, P480; JORDAN F M, 1990, Brain Injury, V4, P27; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1995, APHASIOLOGY, V9, P23, DOI 10.1080/02687039508248686; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; LINCOLN RK, 1994, CLIN NEUROPSYCHOL, V8, P140, DOI 10.1080/13854049408401553; NELSON NW, 1991, COMMUNICATION DISORD, P191; Reitan R, 1974, CLIN NEUROPSYCHOLOGY; Stevens J., 1992, APPL MULTIVARIATE ST, V2nd ed.; WALLACH GP, 1994, LANGUAGE LEARNING DI, P2; Wechsler D., 1974, WECHSLER ADULT INTEL; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48	34	16	19	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	1997	78	10					1096	1102		10.1016/S0003-9993(97)90134-9			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	YA044	WOS:A1997YA04400008	9339159				2021-06-18	
J	Michalodimitrakis, EN; Tsatsakis, AM				Michalodimitrakis, EN; Tsatsakis, AM			Vehicular accidents and cardiac concussion - A traumatic connection	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						cardiac concussion; trauma; vehicular accident		Concussion of the heart (commotio cordis) occurs in traffic accidents in which blunt force impact over the precordial area occurs, even in the absence of multiple blunt force injuries, The functional dynamics of the heart, with ventricular arrythmias and conduction disturbances, serve: as the pathophysiological basis of this condition. As a cause of death in vehicular accidents, it is less common than other causes. However, it should be considered in the differential diagnosis, especially in cases with minor or no apparent injuries.		Michalodimitrakis, EN (corresponding author), UNIV CRETE,SCH MED,DEPT FORENS SCI,POB 1393,GR-71409 IRAKLION,GREECE.		Tsatsakis, Aristidis M./H-2890-2013	Tsatsakis, Aristidis M./0000-0003-3824-2462			DIMAIO DJ, 1989, FORENSCI PATHOL, P261; FRASER M, 1984, AM J FOREN MED PATH, V5, P249; FROEDE RC, 1979, J FORENSIC SCI, V24, P752; GRATTAN E, 1973, MODERN TRENDS FORENS, V3, P139; Hedinger Christoph, 1944, CARDIOLOGIA, V8, P1, DOI 10.1159/000164766; LIEDTKE AJ, 1974, AM J PHYSIOL, V226, P377; LINDSEY D, 1978, CHEST, V74, P15, DOI 10.1378/chest.74.1.15; MITTLEMAN R, 1988, J FORENSIC SCI, V35, P1198; PARMLEY LF, 1958, CIRCULATION, V18, P371, DOI 10.1161/01.CIR.18.3.371; Spitz W. U., 1993, SPITZ FISHERS MEDICO, P199; VIANO DC, 1978, J TRAUMA, V18, P452, DOI 10.1097/00005373-197806000-00010	11	16	19	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	1997	18	3					282	284		10.1097/00000433-199709000-00010			3	Medicine, Legal; Pathology	Legal Medicine; Pathology	YA810	WOS:A1997YA81000010	9290876				2021-06-18	
J	Bogan, AM; Livingston, MG; ParryJones, WL; Buston, KM; Wood, SF				Bogan, AM; Livingston, MG; ParryJones, WL; Buston, KM; Wood, SF			The experiential impact of head injury on adolescents: Individual perspectives on longterm outcome	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; FOLLOW-UP; RELATIVES; WORK	Thirty-one young people, who were experiencing chronic sequelae of a head injury sustained at least 1 year previously, were interviewed in-depth about the impact head injury had had on their lives. Their functioning was also assessed using the Offer Self-image Questionnaire (OSIQ-R). The main theme raised by subjects was that they had not received adequate explanation of the emotional problems associated with head injury and relevant support in coming to terms with their condition. Head injury had had a devastating effect on their lives, causing limitations in day-to-day activities, employment, education and relationships, and they scored significantly below norms on the OSIQ-R scale of self-confidence. However, these young people had a predominantly positive attitude towards life, which appeared to be related to their appreciation of how fortunate they had been to survive. They scored significantly above norms on the OSIQ-R scale of Social Functioning. Markers of poor functioning were identified and, in clinical practice, could be used as a method of highlighting those head-injured young people who potentially are most in need of support. The findings have implications for future research directions, service delivery and planning, in that particular weaknesses of current provision are demonstrated and recommendations made for improvements.	UNIV GLASGOW,GLASGOW,LANARK,SCOTLAND							BRENNAN MA, 1981, IRISH MED J, V74, P5; BROOKS D N, 1986, Health Bulletin (Edinburgh), V44, P110; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; FORD B, 1976, MED J AUSTRALIA, V1, P603, DOI 10.5694/j.1326-5377.1976.tb140904.x; GREENWOOD RJ, 1994, BRIT MED J, V308, P1199, DOI 10.1136/bmj.308.6938.1199; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KIRKWOOD BR, 1990, ESSENTIALS MED STAT, P133; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; LISHMAN WA, 1978, ORGANIC PSYCHIATRY P, P23; LIVINGSTON M, 1988, J HEAD TRAUMA REHAB, V3, P6, DOI DOI 10.1097/00001199-198812000-00004; LIVINGSTON M G, 1990, Pediatrician, V17, P255; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1986, BRIT MED J, V293, P742, DOI 10.1136/bmj.293.6549.742; MCMILLAN T, 1993, NEUROLOGICAL REHABIL, P437; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Offer D., 1992, OFFER SELF IMAGE QUE; OPCS [Office of Population Censuses and Surveys], 1991, STAND OCC CLASS; *QUAL SOL RES, 1994, NUD REV 3 0 WIND; RUSSELL WR, 1971, TRAUMATIC AMNESIA; *SPSS INC, 1988, SPSS X US GUID; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE G, 1985, BRIT J HOSP MED  FEB, P67; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WRIGHTSON P, 1989, MILD HEAD INJURY, P245	30	16	16	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1997	11	6					431	443					13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	WZ726	WOS:A1997WZ72600004	9171928				2021-06-18	
J	Zafonte, RD; Lee, CY				Zafonte, RD; Lee, CY			Kernohan-Woltman notch phenomenon: An unusual cause of ipsilateral motor deficit	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SEVERE HEAD-INJURY	Posttraumatic ipsilateral motor deficits are rare and raise etiologic and prognostic concerns for the rehabilitation team. We present two cases with an unusual central neurologic cause of ipsilateral weakness. The first patient was assaulted, with a resultant severe traumatic brain injury. Initial computed tomography showed a large right subdural hematoma (SDH) with significant mass effect. Following a craniotomy for evacuation of the SDH, the patient was noted to have paradoxical right-sided (ipsilateral) motor deficits. Postoperative magnetic resonance imaging (MRI) showed compression of the contralateral (left) cerebral peduncle against the tentorium, thus resulting in ipsilateral (right-sided) motor weakness (the Kernohan-Woltman notch phenomenon). Prior limited reports carried a grave prognosis for these patients. On discharge from inpatient rehabilitation, the patient was functioning at a Rancho Los Amigos Scale VI. The second patient was involved in a motor vehicle accident and was found to have a large left frontotemporal subdural hematoma with shift. A dense left hemiplegia was noted after hematoma evacuation. MRI also showed a right cerebral peduncle hypointensity. At discharge, the patient was rated a Rancho Los Amigos Scale VI, Physiatrists need to be aware of the causes of ipsilateral motor weakness as well as the limitations of prognostic data. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.		Zafonte, RD (corresponding author), WAYNE STATE UNIV,SCH MED,DETROIT MED CTR,REHABIL INST MICHIGAN,DEPT PHYS MED & REHABIL,DETROIT,MI 48201, USA.						ADAMS RD, 1991, PRINCIPLES NEUROLOGY, P42; Davis RL, 1991, TXB NEUROPATHOLOGY; Diaz-Marchan P.G., 1996, NEUROTRAUMA, P137; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JONES KM, 1991, AM J NEURORADIOL, V12, P1238; KERNOHAN JW, 1928, ARCH NEUROL-CHICAGO, P274; MARSHALL SB, 1990, NEUROSCIENCE CRITICA; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	13	16	16	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	1997	78	5					543	545		10.1016/S0003-9993(97)90174-X			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	WY386	WOS:A1997WY38600020	9161379				2021-06-18	
J	Whyte, J; Fleming, M; Polansky, M; Cavallucci, C; Coslett, HB				Whyte, J; Fleming, M; Polansky, M; Cavallucci, C; Coslett, HB			Phasic arousal in response to auditory warnings after traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						attention; arousal; brain injury; reaction time	CLOSED-HEAD-INJURY; REACTION-TIME; ATTENTION; INFORMATION; SCALE; TASK; COMA	Traumatic brain injury (TBI) is believed to have adverse effects on attention, but because of the multifaceted nature of the arousal and attentional network, the precise impact of TBI on various subcomponents of this network remains controversial. As part of a larger program of research on attention in TBI, we studied the effects of auditory warning signals on accuracy, reaction time, and response bias, as indices of phasic arousal in a visual go/no-go task. Warnings were presented randomly at various pre-stimulus intervals to a sample of recently injured patients and control subjects. For each subject and performance index, we examined the time interval required to reach maximal phasic arousal, the degree of performance change occurring at this maximal point, and the ability to maintain this state of increased arousal over longer warning intervals. After adjustment for baseline differences, there were no significant differences between patients and controls in any aspect of performance. Examination of effect sizes suggested that this was not due to limited statistical power, but that any differences between groups, if present, must have been small. In contrast, in our prior research on sustained attention and observable behaviors related to attention, large group differences have been found. These data suggest that mechanisms responsible for auditorily-induced phasic arousal responses are largely preserved in severe TBI. (C) 1997 Elsevier Science Ltd.	TEMPLE UNIV,SCH MED,DEPT PHYS MED & REHABIL,PHILADELPHIA,PA 19122; ALLEGHENY UNIV HLTH SCI,PHILADELPHIA,PA 19102; TEMPLE UNIV,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19122	Whyte, J (corresponding author), MOSS REHABIL RES INST,1200 W TABOR RD,PHILADELPHIA,PA 19141, USA.			Whyte, John/0000-0002-4381-1474			AKRITAS MG, 1991, J AM STAT ASSOC, V86, P457, DOI 10.2307/2290594; ALIVISATOS B, 1989, NEUROPSYCHOLOGIA, V27, P495, DOI 10.1016/0028-3932(89)90054-7; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Bray JamesH., 1985, MULTIVARIATE ANAL VA; BRUYER R, 1989, INT J NEUROSCI, V49, P87, DOI 10.3109/00207458909087043; COSLETT HB, 1987, NEUROLOGY, V37, P957, DOI 10.1212/WNL.37.6.957; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; CURRY SH, 1981, PROGR BRAIN RES, V54, P507; HOLLOWAY FA, 1972, PSYCHOPHYSIOLOGY, V9, P189, DOI 10.1111/j.1469-8986.1972.tb00753.x; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; LEVIN HS, 1989, DEMOS TRAUMATIC BRAI, V2, P53; Macmillan NA, 1991, DETECTION THEORY USE; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NATIV A, 1994, ARCH PHYS MED REHAB, V75, P1322; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSNER MI, 1986, CHRONOMETRIC EXPLORA, P122; POSNER MI, 1986, ENERGETICS HUMAN INF; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIZZO PA, 1978, ELECTROEN CLIN NEURO, V45, P281, DOI 10.1016/0013-4694(78)90012-3; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; TEASDALE G, 1974, LANCET, V2, P81; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; VANWOERKOM TCA, 1977, LANCET, V1, P821; VANZOMEREN AH, 1981, REACTION TIME ATTENT, P9; VANZOMEREN AH, 1987, NEUROBEHAVIORAL RECO; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P940; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; WHYTE J, 1993, REHABILITATION MED P; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8	35	16	16	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	MAR	1997	35	3					313	324		10.1016/S0028-3932(96)00092-9			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	WH248	WOS:A1997WH24800009	9051679				2021-06-18	
J	Starkstein, SE; Sabe, L; Dorrego, MF				Starkstein, SE; Sabe, L; Dorrego, MF			Severe retrograde amnesia after a mild closed head injury	NEUROCASE			English	Article						closed head injury; traumatic brain injury; anterograde amnesia; retrograde amnesia	AUTOBIOGRAPHICAL MEMORY; IMPAIRMENT	We describe a patient (RP) who developed a severe retrograde amnesia in the absence of anterograde memory deficits after a minor closed head injury. The retrograde amnesia affected RP's autobiographical memory as well as his memory for famous people, well known events and semantics. He showed no structural brain lesion on the MRI, but a SPECT study showed right frontal, parietal and thalamic perfusion deficit. While RP could partially relearn some of the lost memories, 1 year after the accident he still showed a dense retrograde amnesia. Our case demonstrates that severe and long-lasting retrograde memory deficits may occur after a 'minor' closed head injury.	RAUL CARRERA INST NEUROL RES,DEPT NEUROPSYCHIAT,BUENOS AIRES,DF,ARGENTINA							Baddeley A.D., 1986, AUTOBIOGRAPHICAL MEM, P225; BROWN JW, 1995, APHASIOLOGY, V9, P163, DOI 10.1080/02687039508248703; DALLORA P, 1989, CORTEX, V25, P197, DOI 10.1016/S0010-9452(89)80037-1; DERENZI E, 1993, CORTEX, V29, P449, DOI 10.1016/S0010-9452(13)80253-5; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; HODGES JR, 1993, BRAIN, V116, P921, DOI 10.1093/brain/116.4.921; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; KOPELMAN MD, 1994, NEUROPSYCHOLOGIA, V32, P675, DOI 10.1016/0028-3932(94)90028-0; KOPELMAN MD, 1991, BRAIN, V114, P117; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; OCONNOR M, 1992, J CLIN EXP NEUROPSYC, V14, P159, DOI 10.1080/01688639208402821; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; YONEDA Y, 1992, EUR NEUROL, V32, P340, DOI 10.1159/000116857	16	16	16	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP	1355-4794			NEUROCASE	Neurocase		1997	3	2					105	109		10.1093/neucas/3.2.105			5	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	XL491	WOS:A1997XL49100003					2021-06-18	
J	Twyman, D				Twyman, D			Nutritional management of the critically ill neurologic patient	CRITICAL CARE CLINICS			English	Article							HEAD-INJURED PATIENTS; ACUTE BRAIN-DAMAGE; SEPTIC MORBIDITY; ABDOMINAL-TRAUMA; FEEDINGS; PEPTIDE; HORMONE; BLUNT	The metabolic sequelae and importance of nutritional support of the patient with severe neurologic injury have received extensive attention. Most of the research of the last 14 years has focused on the nutritional and metabolic management of the patient with head trauma. This article focuses on the metabolic and physiologic consequences of traumatic and ischemic brain injury and the role of nutritional support in their management.		Twyman, D (corresponding author), NUTRASWEET KELCO CO,COMMERCIAL DEV DEPT,1751 LAKE COOK RD,RD BOX 830,DEERFIELD,IL 60015, USA.						BORLASE BC, 1992, SURG GYNECOL OBSTET, V174, P181; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; *CLINT NUTR CO, 1995, MAN CAR NUTR SUPP US; DAMASK MC, 1982, ANESTHESIOLOGY, V57, P213, DOI 10.1097/00000542-198209000-00011; DONALD P, 1994, NUTR RES, V14, P3, DOI 10.1016/S0271-5317(05)80362-8; DREW JH, 1947, J NEUROSURG, V4, P7, DOI 10.3171/jns.1947.4.1.0007; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P115, DOI 10.1007/BF00571658; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P19, DOI 10.1007/BF00735865; HASSETT JM, 1988, SURG GYNECOL OBSTET, V167, P383; KINSELLA JE, 1990, NUTRITION, V6, P24; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; MASCIOLI E, 1988, LIPIDS, V23, P623, DOI 10.1007/BF02535609; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; MEREDITH JW, 1990, J TRAUMA, V30, P825, DOI 10.1097/00005373-199007000-00011; MOORE FA, 1989, J TRAUMA, V29, P916, DOI 10.1097/00005373-198907000-00003; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Nyswonger G D, 1992, J Neurosci Nurs, V24, P220; ONEILL PA, 1991, STROKE, V22, P842, DOI 10.1161/01.STR.22.7.842; OTT L, 1985, JPEN-PARENTER ENTER, V9, P110; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; SAITO H, 1985, ABSTR AM BURN ASS, V17, P27; SAKE JM, 1994, J TRAUMA, V37, P581; TWYMAN D, 1985, JPEN-PARENTER ENTER, V9, P679, DOI 10.1177/0148607185009006679; TWYMAN DL, 1985, SURG FORUM, V26, P515; WEISSMAN C, 1982, CRIT CARE MED, V10, P231, DOI 10.1097/00003246-198203000-00119; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	30	16	18	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0749-0704			CRIT CARE CLIN	Crit. Care Clin.	JAN	1997	13	1					39	&		10.1016/S0749-0704(05)70295-5			13	Critical Care Medicine	General & Internal Medicine	WE065	WOS:A1997WE06500004	9012575				2021-06-18	
J	vonEuler, M; LiLi, M; Whittemore, S; Seiger, A; Sundstrom, E				vonEuler, M; LiLi, M; Whittemore, S; Seiger, A; Sundstrom, E			No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries	JOURNAL OF NEUROTRAUMA			English	Article						memantine; neuroprotection; N-methyl-D-aspartate receptor; spinal cord injury	METHYL-D-ASPARTATE; RECEPTOR ANTAGONIST; ISCHEMIC DAMAGE; AMINO-ACIDS; RAT; MK-801; BRAIN; IMPAIRMENT; RESPONSES; GLUTAMATE	We have investigated the effect of memantine, a clinically used NMDA receptor antagonist, in two experimental animal models of spinal cord injury. The lesions were laser-induced photothrombosis to induce focal spinal cord ischemia and clip compression to mimic traumatic spinal cord injury. Pre- or posttreatment of rats with a dose of memantine (20 mg/kg ip) previously shown to be neuroprotective in cerebral ischemia, failed to affect both the neurological and morphological outcome of ischemic spinal cord injury. Likewise, memantine had no effects on neurological and morphological outcome after experimental traumatic injury. In view of the regional heterogeneity of NMDA receptors, the affinity of memantine for spinal cord NMDA receptors was also determined by studying displacement of [H-3](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-10- imine (MK-801) to rat and human spinal cord homogenates. We found that memantine had an affinity for NMDA receptors in the spinal cord (K-i = 0.58 mu M) that was significantly lower compared to that of the cerebral cortex (K-i = 0.23 mu M) and that the affinity for NMDA receptors in human spinal cord was even lower. We conclude that in view of available data, memantine should not be chosen for clinical studies on neuroprotection in spinal cord injuries and that the lack of protective effect is most likely due to insufficient affinity of memantine for spinal cord NMDA receptors.	HUDDINGE UNIV HOSP, KAROLINSKA INST, DEPT CLIN NEUROSCI & FAMILY MED, DIV GERIATR MED, S-14186 HUDDINGE, SWEDEN; UNIV MIAMI, SCH MED, DEPT NEUROL SURG, MIAMI, FL 33136 USA; UNIV MIAMI, SCH MED, MIAMI PROJECT CURE PARALYSIS, MIAMI, FL 33136 USA				von Euler, Mia/0000-0002-3845-8100			Albin M S, 1965, Surg Forum, V16, P423; BACKHAUSS C, 1992, EUR J PHARMACOL, V215, P265, DOI 10.1016/0014-2999(92)90037-5; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; BORMANN J, 1989, EUR J PHARMACOL, V166, P591, DOI 10.1016/0014-2999(89)90385-3; BRESINK I, 1995, NEUROPHARMACOLOGY, V34, P533, DOI 10.1016/0028-3908(95)00017-Z; BUCHAN A, 1990, J NEUROSCI, V10, P311; CHEN HSV, 1992, J NEUROSCI, V12, P4427; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; ERDO SL, 1991, EUR J PHARMACOL, V198, P215, DOI 10.1016/0014-2999(91)90625-Z; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; GOMEZPINILLA F, 1989, EXP NEUROL, V104, P118, DOI 10.1016/S0014-4886(89)80004-4; HAO JX, 1992, EXP NEUROL, V118, P143, DOI 10.1016/0014-4886(92)90031-K; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HERRERO JF, 1994, NEUROSCI LETT, V165, P37, DOI 10.1016/0304-3940(94)90703-X; KOCHHAR A, 1988, ARCH NEUROL-CHICAGO, V45, P148, DOI 10.1001/archneur.1988.00520260034016; KORNHUBER J, 1989, EUR J PHARMACOL, V166, P589, DOI 10.1016/0014-2999(89)90384-1; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; MINAMISAWA H, 1990, STROKE, V21, P758, DOI 10.1161/01.STR.21.5.758; NIETOSAMPEDRO M, 1991, RESTOR NEUROL NEUROS, V2, P175, DOI 10.3233/RNN-1991-245604; PARSONS CG, 1993, NEUROPHARMACOLOGY, V32, P1337, DOI 10.1016/0028-3908(93)90029-3; PENCALET P, 1993, J NEUROSURG, V78, P603, DOI 10.3171/jns.1993.78.4.0603; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; RIVLIN AS, 1978, SURG NEUROL, V10, P39; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIMPSON RK, 1990, NEUROCHEM RES, V15, P635, DOI 10.1007/BF00973755; Souverbie F, 1996, EUR J PHARMACOL, V307, P347, DOI 10.1016/0014-2999(96)00273-7; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; vonEuler M, 1996, EXP NEUROL, V137, P242, DOI 10.1006/exnr.1996.0023; VONEULER M, 1994, EXP NEUROL, V129, P163, DOI 10.1006/exnr.1994.1157; WATSON BD, 1993, NEUROPROTOCOLS, V3, P3; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; YUM SW, 1990, ARCH NEUROL-CHICAGO, V47, P277, DOI 10.1001/archneur.1990.00530030043014	37	16	16	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	1997	14	1					53	61		10.1089/neu.1997.14.53			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	WK032	WOS:A1997WK03200006	9048311				2021-06-18	
J	Franzen, KM; Roberts, MA; Schmits, D; Verduyn, W; Manshadi, F				Franzen, KM; Roberts, MA; Schmits, D; Verduyn, W; Manshadi, F			Cognitive remediation in pediatric traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article							MILD HEAD-INJURY; DEFICITS	Robinson's (1970) elaborative encoding technique (PQRST) was implemented as the active cognitive intervention strategy to address verbal memory deficits in 2 fourth-grade boys following mild or moderate traumatic brain injury (TBI). A metacognitive reading comprehension technique (Smith & Dauer, 1984) was also implemented for comparison purposes. Single-case methodology was employed using a counterbalanced crossover of the two intervention strategies controlling for the effects of attention. The performance of both boys was significantly better during strategy training with the PQRST technique and approached the performance level of the normal comparison subject. In contrast, the performance of both subjects with TBI remained at, or returned to, baseline levels during the metacognitive intervention. These findings suggest that Robinson's cognitive remediation intervention holds promise in addressing memory and reading comprehension deficits following pediatric traumatic brain injury. Future research should focus on enhancing generalization and transfer of training to classroom assignments.	UNIV NO IOWA,CEDAR FALLS,IA 50614; PHYS MED & REHABIL ASSOCIATES,WATERLOO,IA; UNIV IOWA,UNIV HOSP SCH 351,IOWA CITY,IA 52242							American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Benton A, 1989, MULTILINGUAL APHASIA; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; Doak CC, 1996, TEACHING PATIENTS LO; FRY E, 1977, J READING, V21, P242; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; MUESER AM, 1984, PRACTICING COMPREHEN; NEWCOMER P, 1986, STANDARDIZED READING; Roberts M A, 1994, Appl Neuropsychol, V1, P45, DOI 10.1207/s15324826an0101&2_9; ROBERTS MA, IN PRES APPL NEUROPS; Robinson F. P., 1970, EFFECTIVE STUDY; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Sheslow D., 1990, WIDE RANGE ASSESSMEN; SLIFER KJ, 1993, ARCH PHYS MED REHAB, V74, P810, DOI 10.1016/0003-9993(93)90006-V; SMITH RJ, 1984, J READING, V28, P144; TELZROW CF, 1991, J HEAD TRAUMA REHAB, V6, P23; Wechsler D., 1991, WECHSLER INTELLIGENC; Wilson B.A, 1987, REHABILITATION MEMOR; YLVISAKER M, 1994, ED DIMENSIONS ACQUIR, P121	24	16	17	0	4	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	DEC	1996	2	3					176	184		10.1080/09297049608402250			9	Clinical Neurology	Neurosciences & Neurology	WM941	WOS:A1996WM94100002					2021-06-18	
J	Li, GH; Baker, SP; DiScala, C; Fowler, C; Ling, J; Kelen, GD				Li, GH; Baker, SP; DiScala, C; Fowler, C; Ling, J; Kelen, GD			Factors associated with the intent of firearm-related injuries in pediatric trauma patients	ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE			English	Article							CLOSED HEAD-INJURY; GUNSHOT WOUNDS; PREVENTION PROGRAM; CHILDREN; EXPERIENCE; IMPACT; MOTOR	Objective: To examine the characteristics of unintentional and assaultive firearm-related pediatric injuries treated in trauma centers. Design: Comparative analysis of patients 14 years or younger who were admitted to the trauma centers because of unintentional firearm-related injuries (n=292) vs assaultive firearm-related injuries (n=457). Setting: Sixty-eight trauma centers or children's hospitals in the continental United States and Canada that reported data to the National Pediatric Trauma Registry from January 1, 1990, through December 31, 1994. Main Outcome Measures: Frequency distributions of firearm-related injuries in relation to intent and injury circumstances, odds ratios (ORs) on the intent of injury being assaultive, injury severity scales, and in-hospital fatality rates. Results: The frequency of unintentional firearm-related injuries rose in the afternoons peaking between 4 and 5 PM; they predominantly occurred at home (89%). Assaultive firearm-related injuries peaked sharply between 8 and 9 PM and usually occurred on roads or in other public places (63%). About 3 times as many boys as girls were harmed in firearm-related injuries, Given a firearm-related injury resulting in admission to a trauma center, the adjusted OR of it being assaultive was 2.8 (95% confidence interval [CI], 1.6-4.6) if the victim was a girl, 4.9 (95% CI, 3.1-7.8) if the shooting occurred at night, 2.6 (95% CI, 1.6-4.2) if the shooting occurred on a weekday, and 21.1 (95% CI, 9.1-49.4) if the shooting occurred on a road. Injury patterns and severity were similar between patients with unintentional and assaultive injuries. Overall, 19% of the patients sustained head injuries, which contributed to 90% of the in-hospital deaths. Conclusions: Marked differences in injury circumstances exist between unintentional and assaultive firearm-related injuries among children. The late afternoon hours when many children have come home from school but their parents may still be working have the highest frequency of unintentional firearm-related injuries. The evening peak of assaultive injuries may be related to drug-related and gang-related violence, While it is important to reduce the access of firearms to children, school-based extracurricular and community-based social services should be considered in developing intervention programs.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,CTR INJURY RES & POLICY,BALTIMORE,MD 21287; TUFTS UNIV,SCH MED,DEPT PHYS MED & REHABIL,BOSTON,MA 02111	Li, GH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT EMERGENCY MED,600 N WOLFE ST,BALTIMORE,MD 21287, USA.			Kelen, Gabor/0000-0002-3236-8286	NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R29AA09963-02] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR302486] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R29AA009963] Funding Source: NIH RePORTER		Alexander C S, 1995, Inj Prev, V1, P15, DOI 10.1136/ip.1.1.15; ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; BAKER SP, 1996, INJURY CHILDREN TEEN; BAKER SP, 1992, INJURY FACT BOOK, P149; BARLOW B, 1982, J PEDIATR SURG, V17, P927, DOI 10.1016/S0022-3468(82)80469-7; CHOI E, 1994, J FORENSIC SCI, V39, P685; CHRISTOFFEL KK, 1991, PEDIATRICS, V88, P294; *CTR DIS CONTR PRE, 1995, INJ MORT NAT SUMM IN; DAVIDSON LL, 1994, AM J PUBLIC HEALTH, V84, P580, DOI 10.2105/AJPH.84.4.580; DODGE GG, 1994, AM SURGEON, V60, P401; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; FEERO S, 1995, ANN EMERG MED, V25, P788, DOI 10.1016/S0196-0644(95)70209-1; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; HAKANSON R, 1994, ORTHOPEDICS, V17, P519; Hosmer D, 1989, APPL LOGISTIC REGRES; KIZER KW, 1995, JAMA-J AM MED ASSOC, V273, P1768, DOI 10.1001/jama.273.22.1768; KUHN L, 1994, AM J EPIDEMIOL, V140, P943, DOI 10.1093/oxfordjournals.aje.a117183; LARAQUE D, 1995, J PEDIATR SURG, V30, P1072, DOI 10.1016/0022-3468(95)90344-5; LESCOHIER I, 1993, PEDIATRICS, V91, P721; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LI G, 1995, ADOLESCENT MED STATE, V6, P135; LI G, 1994, J TRAUMA, V38, P871; Moloney-Harmon P A, 1994, Crit Care Nurs Clin North Am, V6, P525; NANCE ML, 1994, J PEDIATR SURG, V29, P39, DOI 10.1016/0022-3468(94)90519-3; OSBERG JS, 1992, AM J PUBLIC HEALTH, V82, P422, DOI 10.2105/AJPH.82.3.422; OSBERG JS, 1990, AM J PHYS MED REHABI, V69, P66; Rice DP, 1989, COST INJURY US REPOR; RIVARA FP, 1995, ANN EMERG MED, V26, P609, DOI 10.1016/S0196-0644(95)70013-7; ROSENBERG ML, 1991, VIOLENCE AM PUBLIC H; RUNYAN CW, 1989, JAMA-J AM MED ASSOC, V262, P2273, DOI 10.1001/jama.262.16.2273; *SAS I INC, 1989, SAS STAT US GUID VER; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; TEPAS JJ, 1989, J PEDIATR SURG, V24, P156, DOI 10.1016/S0022-3468(89)80237-4	35	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	1072-4710			ARCH PEDIAT ADOL MED	Arch. Pediatr. Adolesc. Med.	NOV	1996	150	11					1160	1165		10.1001/archpedi.1996.02170360050008			6	Pediatrics	Pediatrics	VQ855	WOS:A1996VQ85500007	8904856				2021-06-18	
J	Steiger, HJ; Ciessinna, E; Seiler, RW				Steiger, HJ; Ciessinna, E; Seiler, RW			Identification of posttraumatic ischemia and hyperperfusion by determination of the effect of induced arterial hypertension on carbon dioxide reactivity	STROKE			English	Article						cerebral ischemia; head injury; ultrasonics	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; ACUTE BRAIN INJURY; TRANSCRANIAL DOPPLER ULTRASOUND; INTRACRANIAL HYPERTENSION; NEUROLOGICAL STATUS; COMATOSE PATIENTS; PRESSURE; VELOCITY; VASOREACTIVITY	Background and Purpose Both ischemia and hyperperfusion are known phenomena that follow traumatic brain injury. Cerebral carbon dioxide reactivity is diminished in both conditions. Differentiation is important because ischemia is thought to be a major factor of secondary neuronal loss and is potentially amenable to therapy by manipulation of cerebral perfusion pressure. Methods The response of transcranial Doppler-based carbon dioxide reactivity to pharmacologically induced hypertension was studied sequentially in 29 patients with severe to moderate head injury to identify ischemia and luxury perfusion. After simultaneous baseline registration of the carbon dioxide reactivity of both middle cerebral arteries by two-channel transcranial Doppler, systolic arterial pressure was raised approximately 20 mm HE by means of phenylephrine (Neosynephrine) infusion, and the carbon dioxide reactivity test was repeated. Results A significant improvement of impaired (<2%/mm Hg) carbon dioxide reactivity after arterial pressure was raised by 20 mm Hg (signaling ischemia) was found in 32 of 124 evaluated middle cerebral arteries. Further deterioration of impaired reactivity occurred in only four tested hemispheres. While ischemic conditions were identified during the entire study period, hyperperfusion was encountered only after day 3. Conclusions Ischemia after traumatic brain injury is a frequent phenomenon, whereas hyperperfusion is rare. Whether therapeutic optimization of carbon dioxide reactivity can improve the outcome of head-injury patients needs to be evaluated in further studies.	UNIV HOSP BERN,DEPT NEUROSURG,CH-3010 BERN,SWITZERLAND							BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1992, SURG NEUROL, V38, P433, DOI 10.1016/0090-3019(92)90111-Y; CHAN KH, 1993, NEUROSURGERY, V32, P547; CHAN KH, 1992, NEUROSURGERY, V30, P697; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; CRUZ J, 1991, NEUROSURGERY, V29, P743, DOI 10.1227/00006123-199111000-00017; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MUTTAQIN Z, 1993, ACTA NEUROCHIR, V123, P76, DOI 10.1007/BF01476289; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	23	16	16	0	0	AMER HEART ASSOC	DALLAS	7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596	0039-2499			STROKE	Stroke	NOV	1996	27	11					2048	2051		10.1161/01.STR.27.11.2048			4	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	VQ163	WOS:A1996VQ16300021	8898814				2021-06-18	
J	Iverson, GL; Myers, B; Bengtson, ML; Adams, RL				Iverson, GL; Myers, B; Bengtson, ML; Adams, RL			Concurrent validity of a WAIS-R seven-subtest short form in patients with brain impairment	PSYCHOLOGICAL ASSESSMENT			English	Article								The concurrent validity of a Wechsler Adult Intelligence Scale-Revised (WAIS-R) seven-subtest short form was examined in 138 patients with closed-head injuries and 49 patients with presumed dementia. In patients with closed-head injuries, the average short form IQ score was within 1 point of the actual Verbal, Performance, and Full Scale IQ (VIQ, PIQ, and FSIQ) scores. The validity coefficients for these patients ranged from .90 to .95. In patients with presumed dementia, the short form underestimated the average VIQ by nearly 5 points and the average FSIQ by 3.5 points. However, the validity coefficients for these patients were uniformly high (.91 to .95). Examination of the frequency distributions revealed that there was a percentage of patients whose short form IQs and actual IQs were highly discrepant. Research designed to determine the variables that reduce the accuracy of the short form in clinical populations is needed.	UNIV OKLAHOMA,HLTH SCI CTR,DEPT PSYCHIAT & BEHAV SCI,NORMAN,OK 73019				Iverson, Grant/0000-0001-7348-9570			Benedict R. H. B., 1992, PSYCHOL ASSESSMENT, V4, P322, DOI DOI 10.1037//1040-3590.4.3.322; DOPPELT JD, 1956, J CONSULT PSYCHOL, V1, P63; Keppel G., 1982, DESIGN ANAL RES HDB, V2nd; Paolo A. M, 1993, PSYCHOL ASSESSMENT, V5, P425; Schretlen D., 1994, PSYCHOL ASSESSMENT, V6, P188; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; SILVERSTEIN AB, 1985, J CLIN PSYCHOL, V41, P676, DOI 10.1002/1097-4679(198509)41:5<676::AID-JCLP2270410515>3.0.CO;2-K; WARD LC, 1987, J CLIN PSYCHOL, V43, P276, DOI 10.1002/1097-4679(198703)43:2<276::AID-JCLP2270430219>3.0.CO;2-U; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th	10	16	16	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	1996	8	3					319	323		10.1037/1040-3590.8.3.319			5	Psychology, Clinical	Psychology	VK726	WOS:A1996VK72600010					2021-06-18	
J	Emanuelson, I; vonWendt, L; Lundalv, E; Larsson, J				Emanuelson, I; vonWendt, L; Lundalv, E; Larsson, J			Rehabilitation and follow-up of children with severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						traumatic brain injury; children; follow-up	CLOSED-HEAD-INJURY; CEREBRAL-PALSY; TERM; ADOLESCENTS; PERFORMANCE; SEQUELAE; SWEDEN; MEMORY	We studied the outcome of 25 patients [12 girls and 13 boys; mean age 13.7 (SD 3.9 years)] with severe traumatic brain injury (TBI). The Glasgow Coma Scale (GCS) score 6 h after the injury was (mean) 4.5 (SD 2.7), and the mean duration of unconsciousness was 15.8 (SD 10.6) days. Being the mast severely brain-injured children in the health care region, they were all referred to its only regional pediatric rehabilitation center during 1986-1990. At discharge, 1 patient was healthy, 1 was in a vegetative state and 18 had multiple impairments. Motor problems were present in 22, epilepsy in 7 and speech impairment in 14. It was not possible to assess cognition in 3 of the children, and 15 of the remaining 22 fell in the normal range. At follow up 2-6 years after trauma, all 23 survivors reported at least one sequela, and 21 had multiple sequelae. As many as two-thirds had normal I.Q. and only 3 were non-ambulatory, but behavioral and personality disturbances were so disabling that none of the patients in this group had been able to readjust to a normal life in society after the trauma.		Emanuelson, I (corresponding author), BRACKE OSTERGARD REG PEDIAT REHABIL CTR, PB 21062, S-41804 GOTHENBURG, SWEDEN.						BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BILLE B, 1992, PEDIAT HABILITATION; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V7, P526, DOI 10.1080/01688638508401283; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V9, P555; DUSSER A, 1989, ELECTROEN CLIN NEURO, V73, P85, DOI 10.1016/0013-4694(89)90187-9; EIKEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; EMANUELSON I, 1993, IC PS WORKSH BERN; FERNELL E, 1987, ACTA PAEDIATR SCAND, V76, P418, DOI 10.1111/j.1651-2227.1987.tb10492.x; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; HAGBERG B, 1989, ACTA PAEDIATR SCAND, V78, P283, DOI 10.1111/j.1651-2227.1989.tb11071.x; HJERN B, 1962, ARCH DIS CHILD, V37, P113, DOI 10.1136/adc.37.192.113; HOFFER MM, 1973, J BONE JOINT SURG AM, VA 55, P137, DOI 10.2106/00004623-197355010-00014; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kloti J, 1988, Schweiz Rundsch Med Prax, V77, P522; KRAGELOHMANN I, 1994, DEV MED CHILD NEUROL, V36, P473; KRIEL R, 1993, NATURAL HIST VEGETAT, P228; KRIEL RL, 1988, PEDIATR NEUROL, V4, P337, DOI 10.1016/0887-8994(88)90079-3; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; RANTAKALLIO P, 1985, J EPIDEMIOL COMMUN H, V39, P353, DOI 10.1136/jech.39.4.353; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; STOVER SL, 1976, ARCH PHYS MED REHAB, V57, P201; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218	32	16	16	0	4	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	AUG	1996	12	8					460	465		10.1007/BF00261625			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	VH536	WOS:A1996VH53600009	8891364				2021-06-18	
J	Nakata, K; Masuhara, K; Nakamura, N; Shibuya, T; Sugano, N; Matsui, M; Ochi, T; Ohzono, K				Nakata, K; Masuhara, K; Nakamura, N; Shibuya, T; Sugano, N; Matsui, M; Ochi, T; Ohzono, K			Inducible osteonecrosis in a rabbit serum sickness model: Deposition of immune complexes in bone marrow	BONE			English	Article						osteonecrosis; microcirculatory injury; serum sickness; immune complex; animal model	SYSTEMIC LUPUS-ERYTHEMATOSUS; PLATELET-ACTIVATING-FACTOR; AVASCULAR NECROSIS; ARTHUS REACTION; FEMORAL-HEAD; PATHOGENESIS; RAT; ALVEOLITIS	We established inducible osteonecrosis in a rabbit serum sickness model. Osteonecrosis with marrow necrosis could be induced by the intravenous injection of horse serum in two doses separated in time by a period of three weeks, In this model, osteonecrosis could be successfully produced in rabbit femoral metaphysis. The incidence of marrow necrosis was 45% (9 of 20 rabbits) and trabecular necrosis occurred in 6 of 20 rabbits (30%) at 7 days after the second injection of the horse serum, In bone marrow of the femoral metaphysis, extravasation of erythrocytes and the formation of microthrombi in arterioles were often observed in an early stage of the present model and both findings correlate well each other (p = 0.0001). Immune complexes could be demonstrated using immunohistochemistry in bone marrow of the femoral metaphysis as well as in glomeruli of the kidney, Extravasation of erythrocytes in bone marrow of the femoral metaphysis was observed in 8 of 12 (67%) cases with immune complex deposition in the sinusoidal space of the femoral metaphysis and in 12 of 21 (57%) cases with immune complex deposition in glomeruli of the kidney, Immune complex deposition both in the sinusoidal space of femoral bone marrow (p = 0.0385) and in glomeruli of the kidney (p = 0.0209) closely related to extravasation of erythrocytes and microthrombi in arterioles in the early stage of this model, Early microcirculatory injury (extravasation of erythrocytes and microthrombi in arterioles) adjacent to osteonecrosis could be induced by immune complex deposition in femoral bone marrow and might be predictable characteristics for the inducible osteonecrosis in the present serum sickness model, The important findings in this study were that early microcirculatory injury was closely related to the deposition of immune complexes in femoral bone marrow, and that early microcirculatory injury associated with immune complex deposition was located close to osteonecrotic regions.	OSAKA NATL HOSP, DEPT ORTHOPAED SURG, OSAKA, JAPAN	Nakata, K (corresponding author), OSAKA UNIV, SCH MED, DEPT ORTHOPAED SURG, 2-2 YAMADAOKA, SUITA, OSAKA 565, JAPAN.		Sugano, Nobuhiko/AAA-3359-2020	Sugano, Nobuhiko/0000-0002-5305-3179			ABELES M, 1978, ARCH INTERN MED, V138, P750, DOI 10.1001/archinte.138.5.750; BERGSTEIN JM, 1974, J PEDIATR-US, V85, P31, DOI 10.1016/S0022-3476(74)80281-7; BERKOVITS L, 1966, MAGY RADIOL, V18, P24; BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P896, DOI 10.1111/j.1476-5381.1993.tb13897.x; CHANG CC, 1993, SEMIN ARTHRITIS RHEU, V23, P47, DOI 10.1016/S0049-0172(05)80026-5; Cochrane C G, 1973, Adv Immunol, V16, P185, DOI 10.1016/S0065-2776(08)60298-9; CRAWFORD JP, 1985, EXP MOL PATHOL, V42, P175, DOI 10.1016/0014-4800(85)90026-7; CRUESS RL, 1968, J BONE JOINT SURG AM, VA 50, P1577, DOI 10.2106/00004623-196850080-00006; DUBOIS EL, 1960, JAMA-J AM MED ASSOC, V174, P966, DOI 10.1001/jama.1960.03030080028005; FERRETTI M, 1994, J CLIN INVEST, V94, P449, DOI 10.1172/JCI117345; Ficat RP, 1980, ISCHEMIA NECROSIS BO, P53; FISHER DE, 1972, CLIN ORTHOP RELAT R, P200; GOLD EW, 1978, CLIN ORTHOP RELAT R, V135, P272; GOSLING DC, 1987, TRANSPLANTATION, V43, P751, DOI 10.1097/00007890-198705000-00032; HEIMANN WG, 1960, NEW ENGL J MED, V263, P672, DOI 10.1056/NEJM196010062631404; JONES JP, 1966, J BONE JOINT SURG AM, VA 48, P149, DOI 10.2106/00004623-196648010-00015; JONES JP, 1992, CLIN ORTHOP RELAT R, V277, P41; KAWAI K, 1985, J BONE JOINT SURG AM, V67A, P755, DOI 10.2106/00004623-198567050-00010; LANDMANN J, 1987, J BONE JOINT SURG AM, V69A, P1226, DOI 10.2106/00004623-198769080-00017; MALE D, 1993, IMMUNOLOGY, V21, P1; MARTEL W, 1964, ARTHRITIS RHEUM, V7, P717; MATSUI M, 1995, VIRCHOWS ARCH, V427, P205; MATSUI M, 1992, CLIN ORTHOP RELAT R, P61; MULLIGAN MS, 1992, J IMMUNOL, V149, P331; NAITO S, 1993, BONE, V14, P745, DOI 10.1016/8756-3282(93)90206-P; PONS F, 1993, BRIT J PHARMACOL, V109, P234, DOI 10.1111/j.1476-5381.1993.tb13559.x; RAMOS BF, 1994, J IMMUNOL, V152, P1380; Rich AR, 1943, B JOHNS HOPKINS HOSP, V72, P65; Rutishauser E, 1966, Rev Chir Orthop Reparatrice Appar Mot, V52, P197; SIEMSEN JK, 1962, ARTHRITIS RHEUM, V5, P492, DOI 10.1002/art.1780050506; Solomon L, 1973, J Bone Joint Surg Br, V55, P246; VRONINKS P, 1972, SEM HOP PARIS, V48, P3001; WANG GJ, 1977, J BONE JOINT SURG AM, V59, P729, DOI 10.2106/00004623-197759060-00003; WANG GJ, 1984, BONE CIRCULATION, P35; WARREN JS, 1991, CLIN IMMUNOL IMMUNOP, V61, P249, DOI 10.1016/S0090-1229(05)80028-5; WARREN JS, 1992, AM J PATHOL, V141, P551; WILLIAMS TJ, 1986, AGENTS ACTIONS, V19, P66, DOI 10.1007/BF01977260	37	16	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	JUN	1996	18	6					609	615		10.1016/8756-3282(96)00078-6			7	Endocrinology & Metabolism	Endocrinology & Metabolism	UT997	WOS:A1996UT99700018	8806003				2021-06-18	
J	Wolf, AP; Gleckman, AD; Cifu, DX; Ginsburg, PC				Wolf, AP; Gleckman, AD; Cifu, DX; Ginsburg, PC			The prevalence of agitation and brain injury in skilled nursing facilities: A survey	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; BEHAVIOR; PROPRANOLOL; MANAGEMENT; TRAZODONE; DISORDERS; PATIENT; DISEASE	All skilled nursing facilities (SNF) in the state of Connecticut were surveyed to determine the number of residents with a primary diagnosis of brain injury, the incidence of agitation among these residents, and management strategies utilized for agitation in these residents, including consultation with brain injury specialists. One hundred and sixty-two, or 64%, of the SNF responded to the survey, and reported on 140 individuals with a primary diagnosis of brain injury. These individuals were residing in 39, or 24%, of the 162 facilities. Forty-five per cent of these 39 facilities had brain-injured residents who met the definition of agitation presented in the survey. Management of agitation was equally distributed between environmental manipulation, formal behaviour care plans and medications. The availability of specialist consultation was variable and included physiatrists (38%), psychiatrists (67%), neurologists (41%), and psychologists (36%). This survey study defined the prevalence of brain-injured residents in Connecticut's SNF, and examined management strategies for agitation in this patient population.	CONNECTICUT SUBACUTE CORP, WATERBURY, CT 06705 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PHYS MED & REHABIL, RICHMOND, VA 23298 USA; UNIV CONNECTICUT, CTR HLTH SCI, FARMINGTON, CT 06032 USA				Cifu, David/0000-0003-1600-9387			BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; CASSIDY JW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P219; Chandler M C, 1988, Brain Inj, V2, P309; Cifu D X, 1993, Arch Phys Med Rehabil, V74, pS406; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; EDLUND MJ, 1991, INT J PSYCHIAT MED, V21, P173, DOI 10.2190/Q21D-EWW7-53EJ-FUC6; ELLIOTT FA, 1977, ANN NEUROL, V1, P489, DOI 10.1002/ana.410010516; FAUMAN MA, 1978, JAMA-J AM MED ASSOC, V240, P380, DOI 10.1001/jama.240.4.380; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; FRANKOWSKI RF, 1985, CNS TRAUMA STATUS RE, V109, P33; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA, P37; Herbel K, 1990, Rehabil Nurs, V15, P66; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Levine A M, 1988, Brain Inj, V2, P165, DOI 10.3109/02699058809150940; LUDWIG BI, 1989, J NEUROL REHABIL, V3, P147; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; OSHANICK GJ, 1988, PSYCHIATRY, P61; Patterson T S, 1990, Rehabil Nurs, V15, P248; PINNER E, 1988, AM J PSYCHIAT, V145, P1295; RATEY JJ, 1993, PSYCHOPHARMACOL BULL, V29, P65; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; SCHNEIDER LS, 1992, PSYCHOPHARMACOL BULL, V28, P71; SCHROEDER JA, 1994, ANESTHESIA ANALGESIA, V78, P59; SIMPSON DM, 1986, J CLIN PSYCHIAT, V47, P191; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; *STAT CONN DEP PUB, NURS HOM FAC 1994 19, P1; TESAR GE, 1993, HOSP COMMUNITY PSYCH, V44, P329; VANWOERKOM TCAM, 1977, LANCET, V1, P812; WILLIAMS, 1990, REHABILITATION NURSI, V15, P30; ZASLER N D, 1992, Brain Injury, V6, P1, DOI 10.3109/02699059209008117	33	16	16	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	1996	10	4					241	245		10.1080/026990596124412			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UJ541	WOS:A1996UJ54100001	9044689				2021-06-18	
J	Horner, PJ; Reier, PJ; Stokes, BT				Horner, PJ; Reier, PJ; Stokes, BT			Quantitative analysis of vascularization and cytochrome oxidase following fetal transplantation in the contused rat spinal cord	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						angiogenesis; graft; metabolism; spinal cord injury; image analysis	FIBROBLAST GROWTH-FACTOR; BLOOD-BRAIN-BARRIER; ADULT-RATS; FUNCTIONAL-ACTIVITY; METABOLIC-ACTIVITY; NEURONAL-ACTIVITY; GRAFTS; INJURY; ANGIOGENESIS; SURVIVAL	In the normal adult central nervous system, a coupling between energy consumption and vascular density is well established. Likewise, the survival of fetal neural tissue grafts is highly dependent on the establishment of functional vascular integration with the host. However, to what degree graft vascularization and tissue metabolism influence the normal host response to traumatic injury has not been extensively studied. In the present report, embryonic day 14 fetal spinal cord suspension grafts were made into the lesion epicenter of subchronic (10 days) contusion-injured rats. Three months later, intraspinal transplants were analyzed using correlative cytochrome oxidase histochemistry and vascular morphometric analysis. The same approaches were applied to the host spinal cord and injured, non-transplanted animals in order to determine the ability of a graft to alter the level of post-injury vascularization and/or metabolism. In general, graft vascular density was increased over that measured in normal or injured gray matter. Vascular density in gray matter near the host/graft interface was markedly increased when compared to either gray matter of the same spinal level in injured non-grafted animals or normal control spinal gray matter. Vascular changes were not noted in gray matter 3 mm distal to the lesion epicenter (rostral or caudal) in all groups analyzed. Cytochrome oxidase was up-regulated at this time in the graft and gray matter at the host/graft interfaces when compared to either gray matter of the same spinal level in injured, non-grafted animals or that of uninjured controls. These data indicate that an intraspinal transplant placed into the contused adult rat spinal cord reaches a metabolic capacity that is likely to be associated with high levels of oxidative metabolism in the well-vascularized graft neuropil. In addition, transplantation chronically alters vascularization and metabolic patterns of adjacent spinal gray matter following contusion injury. (C) 1996 Wiley-Liss, Inc.	UNIV FLORIDA, COLL MED, DEPT NEUROSCI, GAINESVILLE, FL 32610 USA; UNIV FLORIDA, COLL MED, DEPT NEUROL SURG, GAINESVILLE, FL 32610 USA	Horner, PJ (corresponding author), OHIO STATE UNIV, COLL MED, DEPT PHYSIOL, 302 HAMILTON HALL, 1645 NEIL AVE, COLUMBUS, OH 43212 USA.		Horner, Philip J./AAF-7012-2021				ADAIR TH, 1990, AM J PHYSIOL, V259, pR393; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; BJORKLUND A, 1983, ACTA PHYSIOL SCAND, P1; BLACK JE, 1991, EXP NEUROL, V111, P204, DOI 10.1007/BF01964465; BLIGHT AR, 1991, J NEUROL SCI, V106, P158, DOI 10.1016/0022-510X(91)90253-4; BROADWELL RD, 1994, MICROSC RES TECHNIQ, V27, P471, DOI 10.1002/jemt.1070270603; BROADWELL RD, 1991, EXP NEUROL, V112, P1, DOI 10.1016/0014-4886(91)90110-X; BROADWELL RD, 1990, PROG BRAIN RES, V82, P95; CHALMERS GR, 1992, BRAIN RES, V570, P1, DOI 10.1016/0006-8993(92)90556-O; DIROCCO RJ, 1989, COMPUT MED IMAG GRAP, V13, P81, DOI 10.1016/0895-6111(89)90080-3; DUAN WM, 1993, NEUROSCIENCE, V57, P261, DOI 10.1016/0306-4522(93)90061-J; DUNNETT SJ, 1992, NEURAL TRANSPLANTATI, P57; DYSON SE, 1988, J NEUROSCI, V8, P1822; EBNER FF, 1989, P NATL ACAD SCI USA, V86, P730, DOI 10.1073/pnas.86.2.730; GAGE FH, 1986, NEUROSCIENCE, V17, P89, DOI 10.1016/0306-4522(86)90227-7; GOLDBERGER ME, 1993, EXP NEUROL, V123, P74, DOI 10.1006/exnr.1993.1141; GROSS PM, 1987, J CEREBR BLOOD F MET, V7, P154, DOI 10.1038/jcbfm.1987.38; HEVNER RF, 1990, J NEUROSCI, V10, P1331; HORNER P J, 1991, Society for Neuroscience Abstracts, V17, P235; HORNER PJ, 1993, NEURONAL TRANSPLANTA, P119; HOULE JD, 1989, NEUROSCI LETT, V103, P253, DOI 10.1016/0304-3940(89)90108-0; JAKEMAN LB, 1989, EXP NEUROL, V103, P17, DOI 10.1016/0014-4886(89)90181-7; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; JENSEN JA, 1986, LAB INVEST, V54, P574; KELLY PAT, 1985, EXP BRAIN RES, V58, P570; KNIGHTON DR, 1983, SCIENCE, V221, P1283, DOI 10.1126/science.6612342; KOSHINAGA M, 1993, EXP NEUROL, V120, P32, DOI 10.1006/exnr.1993.1038; KRUM JM, 1988, J COMP NEUROL, V271, P331, DOI 10.1002/cne.902710304; KUGLER P, 1988, HISTOCHEMISTRY, V89, P269, DOI 10.1007/BF00493151; LAWRENCE JM, 1990, NEUROSCIENCE, V37, P431, DOI 10.1016/0306-4522(90)90413-X; LAWRENCE JM, 1984, NEUROSCIENCE, V12, P745, DOI 10.1016/0306-4522(84)90167-2; LU SY, 1991, EXP NEUROL, V113, P109, DOI 10.1016/0014-4886(91)90168-C; MEININGER CJ, 1988, AM J PHYSIOL, V255, pH554; MUFSON EJ, 1987, BRAIN RES, V401, P162, DOI 10.1016/0006-8993(87)91177-2; NEEDELS DL, 1986, NEUROSCIENCE, V18, P517, DOI 10.1016/0306-4522(86)90055-2; NIETOSAMPEDRO M, 1987, ANN NY ACAD SCI, V495, P108, DOI 10.1111/j.1749-6632.1987.tb23670.x; NOBLE LJ, 1990, J COMP NEUROL, V296, P674, DOI 10.1002/cne.902960411; RISAU W, 1988, EMBO J, V7, P959, DOI 10.1002/j.1460-2075.1988.tb02901.x; ROSENSTEIN JM, 1993, EXP NEUROL, V124, P208, DOI 10.1006/exnr.1993.1191; SCHMIDT RH, 1982, J NEUROCHEM, V38, P737, DOI 10.1111/j.1471-4159.1982.tb08693.x; SCHMIDT RH, 1983, NERVE ORGAN TISSUE R, P325; SHARKEY J, 1991, NEUROSCIENCE, V41, P703, DOI 10.1016/0306-4522(91)90361-Q; SHARP FR, 1984, NEUROLOGY, V34, P1305, DOI 10.1212/WNL.34.10.1305; SLOAN DJ, 1991, TRENDS NEUROSCI, V14, P341, DOI 10.1016/0166-2236(91)90159-R; Stahl W L, 1986, Adv Neurol, V44, P681; STOKES B T, 1990, Society for Neuroscience Abstracts, V16, P37; STOKES BT, 1992, EXP NEUROL, V116, P1, DOI 10.1016/0014-4886(92)90171-L; STOKES BT, 1992, J NEUROTRAUM, V9, P129, DOI 10.1089/neu.1992.9.129; STOKES BT, 1991, EXP NEUROL, V111, P312, DOI 10.1016/0014-4886(91)90098-W; STOKES BT, 1990, ADV EXP MED BIOL, V277, P363; SWEETNAM PM, 1991, J NEUROCHEM, V57, P237, DOI 10.1111/j.1471-4159.1991.tb02121.x; TESSLER A, 1988, J COMP NEUROL, V270, P537, DOI 10.1002/cne.902700407; TESSLER A, 1988, PROG BRAIN RES, V78, P213; TVETEN L, 1976, ACTA RADIOL DIAGN, V17, P385, DOI 10.1177/028418517601700401; VANRAAMSDONK W, 1987, ACTA HISTOCHEM, V81, P129, DOI 10.1016/S0065-1281(87)80001-6; Weibel E.R., 1979, STEREOLOGICAL METHOD, V1; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P1031, DOI 10.1002/eji.1830220423; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1986, J COMP NEUROL, V245, P41, DOI 10.1002/cne.902450104; WONGRILEY MTT, 1981, ANN OTO RHINOL LARYN, V90, P30; ZHOU CF, 1986, NEUROSCIENCE, V17, P803, DOI 10.1016/0306-4522(86)90046-1	61	16	16	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	JAN 22	1996	364	4					690	703		10.1002/(SICI)1096-9861(19960122)364:4<690::AID-CNE7>3.0.CO;2-Z			14	Neurosciences; Zoology	Neurosciences & Neurology; Zoology	TT583	WOS:A1996TT58300007	8821455				2021-06-18	
J	Gil, M; Cohen, M; Korn, C; Groswasser, Z				Gil, M; Cohen, M; Korn, C; Groswasser, Z			Vocational outcome of aphasic patients following severe traumatic brain injury	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; SOCIAL-ADJUSTMENT; REHABILITATION; RECOVERY	The incidence and course of aphasia, and its impact on vocational outcome, were determined in a group of 351 patients with severe traumatic brain injury (TBI). Aphasia was found in 11.1%, the common forms being amnestic (56%, 22/39), expressive (10.3%, 4/39) and receptive (10.5%, 8/39), as found on the first language assessment. No age difference was found between the aphasic and non-aphasic patients. Coma was more common in the aphasics than the non-aphasics (95% and 82%, respectively), although its mean duration was shorter. Aphasics had more severe locomotor deficits (p < 0.01, Fisher test) and tended towards more severe cognitive disorders (p = 0.07, Fisher test). There was no difference between the groups in incidence of behavioural disturbances or occupational outcome. Most of the aphasic patients improved after therapy, and two recovered completely. The presence of aphasia did not have negative prognostic implications for occupational outcome.	LOEWENSTEIN HOSP & REHABIL CTR,DEPT TRAUMAT BRAIN INJURY REHABIL,IL-43100 RAANANA,ISRAEL; TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL	Gil, M (corresponding author), LOEWENSTEIN HOSP & REHABIL CTR,DEPT SPEECH & LANGUAGE PATHOL,278 ACHUZA ST,POB 3,IL-43100 RAANANA,ISRAEL.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BENSON DF, 1979, APHASIA ALEXIA AGRAP, P189; CRANBERG LD, 1987, NEUROLOGY, V37, P1165, DOI 10.1212/WNL.37.7.1165; DEJERINE J, 1914, REV NEUROL, V2, P388; EISENSON J, 1964, ADULT APHASIA ASSESS; Goodglass H., 1983, ASSESSMENT APHASIA R; GROSWASSER Z, 1977, SCAND J REHABIL MED, V9, P147; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; KERTESZ A, 1977, BRAIN, V100, P1, DOI 10.1093/brain/100.1.1; Kertesz A., 1982, W APHASIA BATTERY; LECOURS AR, 1983, APHASIOLOGY, P446; LENNENBERG EH, 1967, BIOL F LANGUAGE; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Luria AR., 1970, TRAUMATIC APHASIA; NAJENSON T, 1975, SCAND J REHABIL MED, V7, P101; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; ROSENTHAL M, 1990, REHABILITATION ADULT; SATZ P, 1981, ACQUIRED APHASIA, P399; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TAYLORSARNO M, 1981, ACQUIRED APHASIA, P496; TAYLORSARNO M, 1986, ARCH PHYSICAL MED RE, V76, P400; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WINGFIELD A, 1966, IDENTIFICATION NAMIN; WYCKOFF LH, 1984, THESIS U FLORIDA	30	16	20	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1996	10	1					39	45		10.1080/026990596124700			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	TY049	WOS:A1996TY04900004	8680391				2021-06-18	
J	NILSSON, F; MESSETER, K; GRANDE, PO; ROSEN, I; RYDING, E; NORDSTROM, CH				NILSSON, F; MESSETER, K; GRANDE, PO; ROSEN, I; RYDING, E; NORDSTROM, CH			EFFECTS OF DIHYDROERGOTAMINE ON CEREBRAL-CIRCULATION DURING EXPERIMENTAL INTRACRANIAL HYPERTENSION	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						INTRACRANIAL HYPERTENSION; CEREBRAL BLOOD FLOW; EXTRADURAL MASS; DIHYDROERGOTAMINE; EEG; PIG	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-LESIONS; BLOOD-FLOW; CLINICAL-TRIAL; ERGOTAMINE; PRESSURE; VASOREACTIVITY; DEXAMETHASONE; RESISTANCE; HEMATOMA	Different cerebral vasoconstrictors have recently been suggested for the treatment of raised intracranial pressure (ICP) in patients with severe traumatic brain lesions. Such treatment may be associated with severe side effects. A porcine model simulating an intracranial mass lesion was utilized to examine the haemodynamic cerebral effects of dihydroergotamine (DHE), a recently introduced pharmacological treatment for raised intracranial pressure. Intracranial hypertension was induced by inflation of two tonometric gastric balloons placed extradurally covering the parieto-occipital region bilaterally. The animals were randomized into one group with six animals receiving 1.0 mg of DHE i.v. followed by a continuous infusion of 0.2 mg/h (high dose) and another group of six animals receiving 0.15 mg i.v. followed by 0.03 mg/h (low dose). Measurements of cerebral blood flow (CBF) and arterio-venous difference in oxygen content (Cavo(2)) were performed 5, 20, and 60 min after the DHE infusion. Intracranial pressure (ICP), mean arterial blood pressure (MAP) and cerebral electrical activity (EEG) were recorded continuously In both groups infusion of DHE caused a lasting decrease in ICP probably achieved mainly by a decrease in cerebral blood volume due to constriction of both arterial and venous capacitance vessels. In the group treated with high-dose DHE, but not in that given low-dose DHE, a progressive increase in Cavo(2), a fall in jugular venous pH and an increase in EEG delta activity were observed indicating cerebral hypoxia. The study supports the view that DHE may be a valuable tool in the pharmacological treatment of increased ICP in traumatic brain lesions but underscores the importance of a proper dosage.	UNIV LUND HOSP,DEPT ANAESTHESIA & INTENS CARE,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT CLIN NEUROPHYSIOL,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT NEUROSURG,S-22185 LUND,SWEDEN	NILSSON, F (corresponding author), LUND UNIV,MALMO GEN HOSP,DEPT ANAESTHESIA & INTENS CARE,S-21401 MALMO,SWEDEN.						AKESON J, 1992, ACTA ANAESTH SCAND, V36, P419, DOI 10.1111/j.1399-6576.1992.tb03491.x; ALBRECHT RF, 1987, STROKE, V18, P649, DOI 10.1161/01.STR.18.3.649; ANDERSEN AR, 1987, STROKE, V18, P120, DOI 10.1161/01.STR.18.1.120; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; GLUSA E, 1988, ARCH INT PHARMACOD T, V296, P66; GORDON E, 1971, ACTA ANAESTH SCAND, V15, P193, DOI 10.1111/j.1399-6576.1971.tb05461.x; GRANDE PO, 1990, INTENS CARE MED, V16, P399, DOI 10.1007/BF01735179; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; GRANDE PO, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P319; GUDEMAN SK, 1979, J NEUROSURG, V51, P301, DOI 10.3171/jns.1979.51.3.0301; HACHINSKI V, 1978, STROKE, V9, P594, DOI 10.1161/01.STR.9.6.594; KAUFMAN AM, 1992, J NEUROSURG, V77, P854; KUSHINSKY W, 1982, ADV MICROCIRCULAT, V11, P1; LUNDBERG N, 1959, ACTA PSYCHIAT N S139, V34; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MELLANDER S, 1970, CLIN SCI, V39, P183, DOI 10.1042/cs0390183; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MULLER H, 1988, PHARMACOLOGY, V37, P248, DOI 10.1159/000138473; MULLERSCHWEINIT.E, 1983, GEN PHARMACOL, V14, P95; NILSSON B, 1976, THESIS LUND; NILSSON F, 1995, ACTA ANAESTH SCAND, V39, P827, DOI 10.1111/j.1399-6576.1995.tb04179.x; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; ROQUEBERT J, 1986, ARCH INT PHARMACOD T, V284, P30; ROSSANDA M, 1968, SCAN J CLIN LAB IN S, V102, pR13; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHORBOUGH FW, 1973, STROKE, V4, P674	34	16	16	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	OCT	1995	39	7					916	921		10.1111/j.1399-6576.1995.tb04198.x			6	Anesthesiology	Anesthesiology	RX864	WOS:A1995RX86400011	8848892				2021-06-18	
J	SMITH, DH; GENNARELLI, TA; MCINTOSH, TK				SMITH, DH; GENNARELLI, TA; MCINTOSH, TK			THE POTENTIAL OF 21-AMINOSTEROIDS (LAZAROIDS) AS NEUROPROTECTIVE THERAPIES IN CNS INJURY	CNS DRUGS			English	Article							SPINAL-CORD INJURY; LIPID-PEROXIDATION; TIRILAZAD MESYLATE; CEREBRAL EDEMA; BRAIN INJURY; VITAMIN-E; U74006F; ISCHEMIA; METHYLPREDNISOLONE; RECOVERY	Following injury to the CNS, highly reactive free radicals may produce secondary or delayed tissue damage via peroxidation of lipids in cellular membranes. This extensive generation of free radicals appears to overwhelm natural defence mechanisms, dramatically reducing the levels of endogenous antioxidant compounds. In numerous studies utilising models of CNS injury, treatment with a synthetic antioxidant, the nongrlucocorticoid 21-aminosteroid (lazaroid) tirilazad, has been shown to maintain the level of endogenous antioxidants, improve neurological outcome, decrease cell loss, reduce cerebral oedema formation and improve survival. As a result of these encouraging results, clinical trials have been initiated to evaluate the utility of tirilazad in the treatment of subarachnoid haemorrhage, spinal cord injury, traumatic brain injury and stroke.		SMITH, DH (corresponding author), UNIV PENN,DIV NEUROSURG,240 S 33RD ST,SUITE 105,PHILADELPHIA,PA 19104, USA.		smith, douglas/A-1321-2007				ALTHAUS J S, 1991, Society for Neuroscience Abstracts, V17, P164; Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; ANDERSON DK, 1986, J NEUROTRAUME, V2, P257; Anderson DK, 1991, J NEUROTRAUM, V8, P187, DOI 10.1089/neu.1991.8.187; AUDUS KL, 1991, FREE RADICAL BIO MED, V11, P361, DOI 10.1016/0891-5849(91)90152-S; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BRAUGHLER J, 1987, J BIOL CHEM, V262, P10434; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V7, P125, DOI 10.1016/0891-5849(89)90003-8; BRAUGHLER JM, 1988, J NEUROSURG, V64, P985; BRAUGHLER JM, 1981, J NEUROSURG, V56, P838; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; DEMOPOULOS HB, 1980, ACTA PHYSL SCAND S, V492, P91; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1991, STROKE, V22, P361, DOI 10.1161/01.STR.22.3.361; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; KANAMARU K, 1991, J NEUROSURG, V74, P454, DOI 10.3171/jns.1991.74.3.0454; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LESIUK H, 1991, STROKE, V22, P896, DOI 10.1161/01.STR.22.7.896; MARUKI Y, 1993, STROKE, V24, P724, DOI 10.1161/01.STR.24.5.724; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; PERKINS WJ, 1991, STROKE, V22, P902, DOI 10.1161/01.STR.22.7.902; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; SATO PH, 1992, J NEUROCHEM, V58, P2263, DOI 10.1111/j.1471-4159.1992.tb10972.x; SHAPIRA Y, 1989, Neurological Research, V11, P169; TORNHEIM PA, 1978, J NEUROSURG, V48, P220, DOI 10.3171/jns.1978.48.2.0220; UMEMURA K, 1994, EUR J PHARMACOL, V251, P69, DOI 10.1016/0014-2999(94)90444-8; YOSHIDA S, 1985, J NEUROCHEM, V44, P1593, DOI 10.1111/j.1471-4159.1985.tb08800.x; ZUCCARELLO M, 1989, J NEUROSURG, V71, P98, DOI 10.3171/jns.1989.71.1.0098	34	16	16	0	0	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	1172-7047			CNS DRUGS	CNS Drugs	MAR	1995	3	3					159	164		10.2165/00023210-199503030-00001			6	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	QL201	WOS:A1995QL20100001					2021-06-18	
J	FORMISANO, R; SALTUARI, L; GERSTENBRAND, F				FORMISANO, R; SALTUARI, L; GERSTENBRAND, F			PRESENCE OF KLUVER-BUCY SYNDROME AS A POSITIVE PROGNOSTIC FEATURE FOR THE REMISSION OF TRAUMATIC PROLONGED DISTURBANCES OF CONSCIOUSNESS	ACTA NEUROLOGICA SCANDINAVICA			English	Article						BRAIN INJURY; TRAUMATIC APALLIC SYNDROME; KLUVER-BUCY SYNDROME; SOCIAL INTEGRATION	VEGETATIVE-STATE; INJURY	After severe brain injury a prolonged disturbance of consciousness may occur, sometimes with transient apallic syndrome (awakening without awareness of self and surroundings). Kluver-Bucy is described in the literature as a typical post-traumatic remission phase, in which the patients show an increase of oral automatisms and/or of sexual drive. The study describes Kluver-Bucy syndrome as a sign associated with favourable prognosis in the outcome of traumatic disturbances of consciousness in survivors of head trauma. Seventy-seven patients who had suffered severe brain injury due to traffic accidents entered into the study. All had experienced a relatively benign clinical course since they recovered full awareness, that is were able to communicate with their relatives. The occurrence of prolonged coma, of apallic syndrome and of Kluver-Bucy syndrome are related to outcome date in regards to the patient's work and family function at a mean of 32 months later. In particular, the duration of the apallic syndrome (duration of unconsciousness) was significantly correlated with the global outcome of the patients (p < 0.001).	UNIV INNSBRUCK, INST NEUROL, INNSBRUCK, AUSTRIA	FORMISANO, R (corresponding author), IRCCS, CLIN S LUCIA, CTR REHABIL, V VIGNOLA 75, I-00196 ROME, ITALY.						BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; DOUGHERTY JH, 1981, NEUROLOGY, V31, P991, DOI 10.1212/WNL.31.8.991; GERSTENBRAND F, 1983, NEUROSCI BIOBEHAV R, V7, P413, DOI 10.1016/0149-7634(83)90047-7; Gerstenbrand F., 1967, TRAUMATISCHE APALLIS; GERSTENBRAND F, 1971, REV NEUROL S, V10, P524; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; JENNET B, 1972, LANCET, V1, P737; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; Levy D E, 1978, Ann N Y Acad Sci, V315, P293, DOI 10.1111/j.1749-6632.1978.tb50347.x; Plum F., 1980, DIAGNOSIS STUPOR COM, V3	11	16	16	0	2	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	JAN	1995	91	1					54	57					4	Clinical Neurology	Neurosciences & Neurology	QQ446	WOS:A1995QQ44600010	7732775				2021-06-18	
J	TURKSTRA, LS				TURKSTRA, LS			ELECTRODERMAL RESPONSE AND OUTCOME FROM SEVERE BRAIN INJURY	BRAIN INJURY			English	Article							PERSISTENT VEGETATIVE STATE; CLOSED-HEAD-INJURY; ORIENTING RESPONSE; SCORING CRITERIA; TRAUMATIC COMA; FOLLOW-UP; RECOVERY; HABITUATION; ATTENTION; EMOTION	The relation of electrodermal response measures to outcome from early post-traumatic vegetative state (VS) was investigated in 15 brain-injured and five control subjects. Brain-injured subjects were in acute VS or persistent VS (PVS), or had recovered from acute VS (RVS). Significant group differences were found on all electrodermal response measures, primarily due to the greater amplitude, number and consistency of responses in control subjects. Group differences in electrodermal habituation and orientation to auditory tones reflected the absence of orientation in most RVS subjects and the absence of both habituation and orientation PVS subjects. The groups differed in their response to matching fades and names. All of the control subjects, two of five RVS subjects and none of five acute subjects produced significant responses. Surprisingly, two PVS subjects also produced significant responses. For acute subjects a positive outcome at 6 months post-trauma was associated with early electrodermal startle amplitude and baseline lability. These results indicate that electrodermal responsiveness is generally reduced following acute VS, even in subjects with a relatively good recovery. Greater electrodermal activity in early VS may be associated with better potential for recovery.		TURKSTRA, LS (corresponding author), UNIV ARIZONA, NATL CTR NEUROGEN COMMUN DISORDERS, BLDG 71, TUCSON, AZ 85721 USA.				NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-00030] Funding Source: Medline; ODCDC CDC HHS [CD-01409] Funding Source: Medline		ADHOUTE H, 1992, PHOTODERMATOL PHOTO, V9, P99; ANDERSON NB, 1991, PSYCHOL ASSESSMENT J, V3, P376, DOI DOI 10.1037/1040-3590.3.3.376; ANDREASSI JL, 1989, PSYCHOPHYSIOLOGY HUM; ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; ARTS WFM, 1985, J NEUROL NEUROSUR PS, V48, P1300, DOI 10.1136/jnnp.48.12.1300; BARRY RJ, 1990, PSYCHOPHYSIOLOGY, V27, P94, DOI 10.1111/j.1469-8986.1990.tb02185.x; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; BIRO V, 1989, ACTIV NERV SUPER, V31, P166; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; COHADON F, 1983, BIRTH DEFECTS-ORIG, V19, P375; CRANFORD RE, 1988, HASTINGS CTR REP FEB, P27; DAVIDSON RA, 1992, NEUROPSYCHOLOGIA, V30, P1053, DOI 10.1016/0028-3932(92)90098-7; DEJONG RN, 1985, CLIN NEUROLOGY, V1, P1; Edelberg R., 1972, HDB PSYCHOPHYSIOLOGY, P367; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; FRUTIGER A, 1991, J TRAUMA, V31, P1216, DOI 10.1097/00005373-199109000-00004; Gronwall D, 1989, MILD HEAD INJURY, P153; HAGEN C, 1984, LANGUAGE DISORDERS A; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; HEILMAN KM, 1987, HDB PHYSL 1, V5, P461; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; KEPPELL G, 1982, DESIGN ANAL RES HDB; KIMBLE DP, 1965, NEUROPSYCHOLOGIA, V3, P121, DOI 10.1016/0028-3932(65)90038-2; LACY J, 1958, BRAIN HUM BEHAV, P144; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; LANG PJ, 1992, PSYCHOL SCI, V3, P44, DOI 10.1111/j.1467-9280.1992.tb00255.x; LAPUMA J, 1988, ARCH NEUROL-CHICAGO, V45, P20; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; LEVIN H, 1982, BEHAVIOURAL SEQUELAE; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEVINSON DF, 1985, PSYCHOPHYSIOLOGY, V22, P417, DOI 10.1111/j.1469-8986.1985.tb01626.x; MOLINARI GF, 1991, J NEUROL SCI, V102, P125, DOI 10.1016/0022-510X(91)90059-G; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; OKSENBERG A, 1989, SLEEP 88, P286; Plum F., 1980, DIAGNOSIS STUPOR COM, V3; Rader M.A., 1989, SENSORY STIMULATION; RAPS S P, 1991, Society for Neuroscience Abstracts, V17, P882; ROSENBERG GA, 1977, ANN NEUROL, V2, P167, DOI 10.1002/ana.410020215; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, UNPUB J NEUROSCIENCE; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SAZBON L, 1991, Brain Injury, V5, P3, DOI 10.3109/02699059108998505; SCHURI U, 1979, ARCH PSYCHIAT NERVEN, V227, P143; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TRANEL D, 1989, NEUROPSYCHOLOGIA, V27, P381, DOI 10.1016/0028-3932(89)90046-8; vansZomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VERFAELLIE M, 1991, BRAIN COGNITION, V15, P10, DOI 10.1016/0278-2626(91)90012-W; WATERS WF, 1977, PSYCHOPHYSIOLOGY, V14, P228, DOI 10.1111/j.1469-8986.1977.tb01166.x; WHYTE J, 1986, J HEAD TRAUMA REHAB, V1, P39; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; WYATT R, 1969, PSYCHOPHYSIOLOGY, V6, P133, DOI 10.1111/j.1469-8986.1969.tb02892.x; 1993, ANN NEUROL, V33, P388; 1988, NEUROLOGY, V39, P125	59	16	17	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	1995	9	1					61	80		10.3109/02699059509004573			20	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	QB052	WOS:A1995QB05200009	7874098				2021-06-18	
J	CALLAHAN, CD; JOHNSTONE, B				CALLAHAN, CD; JOHNSTONE, B			THE CLINICAL UTILITY OF THE REY AUDITORY-VERBAL LEARNING TEST IN MEDICAL REHABILITATION	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						NEUROPSYCHOLOGY; REHABILITATION; COGNITIVE FUNCTIONING; MEMORY	AVLT	Recent research has reported the Rey Auditory-Verbal Learning Test Trial V (RAVLT-V) score to be a sensitive indicator of global cognitive functioning, not merely verbal learning skills. The concurrent validity of the RAVLT-V relative to other neuropsychological measures frequently utilized in medical rehabilitation was investigated in a sample of 64 outpatients diagnosed with traumatic brain injury (TBI). The sample was predominantly male (77%), white (97%), youthful (31.4 +/- 11.5 years), high school educated, and an average of 53 months postinjury. Using stepwise multiple regression analysis, a three-variable model consisting of gender, Wechsler Memory Scale-Revised Delayed Memory Index, and Tarilmaking Part B (time) accounted for 61% of the variance in RAVLT-V scores. These findings suggest that in TBI patients, the RAVLT taps not only specific verbal learning and memory, but also global cognitive functions. Sensitivity to diffuse neuropsychological changes and ease/speed of administration make the RAVLT a valuable tool in medical rehabilitation settings.	UNIV MISSOURI,SCH MED,COLUMBIA,MO	CALLAHAN, CD (corresponding author), MEM MED CTR,CTR NEUROMUSCULAR SCI,800 N RUTLEDGE ST,SPRINGFIELD,IL 62781, USA.			Johnstone, Brick/0000-0001-8845-9649			AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Bolla-Wilson K, 1986, DEV NEUROPSYCHOL, V2, P203, DOI 10.1080/87565648609540342; BURTON DB, 1993, ARCH CLIN NEUROPSYCH, V8, P467, DOI 10.1016/0887-6177(93)90047-5; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; DELIS D, 1987, CALIFORNIA VERBAL LE; Franzen M. D., 1989, RELIABILITY VALIDITY; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; HAUT M, 1992, STATE ART REV PHYSIC; HUPPERT FA, 1991, HDB NEUROPSYCHOLOGY, V4; Kreutzer JS, 1993, J HEAD TRAUMA REHAB, V8, P47; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; QUERY WT, 1983, J CLIN PSYCHOL, V39, P136, DOI 10.1002/1097-4679(198301)39:1<136::AID-JCLP2270390125>3.0.CO;2-Q; Reitan RM, 1988, TRAUMATIC BRAIN INJU, VII; REZAI K, 1993, ARCH NEUROL-CHICAGO, V50, P636, DOI 10.1001/archneur.1993.00540060066020; ROSENTHAL M, 1994, TRAUMATIC BRAIN INJU; ROTH DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; RYAN JJ, 1984, INT J CLIN NEUROPSYC, V6, P239; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Spreen O., 1991, COMPENDIUM NEUROPSYC; UCHIYAMA CL, 1994, ARCH CLIN NEUROPSYCH, V9, P215, DOI 10.1016/0887-6177(94)90027-2	23	16	16	0	5	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	1068-9583			J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	SEP	1994	1	3					261	268		10.1007/BF01989627			8	Psychology, Clinical	Psychology	QY244	WOS:A1994QY24400008	24227393				2021-06-18	
J	GEFFEN, GM; BUTTERWORTH, P; FORRESTER, GM; GEFFEN, LB				GEFFEN, GM; BUTTERWORTH, P; FORRESTER, GM; GEFFEN, LB			AUDITORY VERBAL-LEARNING TEST COMPONENTS AS MEASURES OF THE SEVERITY OF CLOSED-HEAD INJURY	BRAIN INJURY			English	Article							MEMORY	Auditory verbal learning and memory was assessed in 18 patients with moderate-severe closed-head injury (CHI). Compared to a matched control group, performance of the CHI subjects on all measures of the Auditory Verbal Learning Test (AVLT) was significantly worse. Discriminant function analysis correctly classified 90% of subjects as CHI or control using the three most reliable measures of the AVLT. Retention of the learning list following the distractor trial varied with severity of injury as indexed by duration of post-traumatic amnesia (PTA). The more severe the injury (longer PTA), the fewer words were recalled after interference (r = -0.72). Susceptibility of verbal memory to retroactive interference is sensitive to the presence and severity of CHI.	UNIV QUEENSLAND & QUEENSLAND HLTH,BRISBANE,AUSTRALIA; JULIA FARR CTR,BEDFORD PK,SA,AUSTRALIA; FLINDERS UNIV S AUSTRALIA,BEDFORD PK,SA 5042,AUSTRALIA				Butterworth, Peter/0000-0002-1531-3881			BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; BROOKS DN, 1983, REHABILITATION HEAD, P185; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; DELLIS DC, 1988, CLIN NEUROPSYCHOLOGI, V2, P188; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GEFFEN GM, IN PRESS ARCH CLIN N; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; HANNAY HJ, 1988, J CLIN EXPT NEUROPSY, V11, P444; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MAYES AR, 1986, NEUROPSYCHOLOGIA, V24, P25, DOI 10.1016/0028-3932(86)90041-2; Nelson H., 1982, NATIONAL ADULT READI; NORUSIS MJ, 1985, SPSS X ADV STATISTIC; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ryan J J, 1986, Arch Clin Neuropsychol, V1, P209; SCHONELL R, 1955, SCHONELL GRADED WORD; VANZOMEREN AH, 1981, REACTION ATTENTION C; Wechsler D., 1974, MANUAL WECHSLER INTE; WECHSLER D, 1967, WECHSLER MEMORY SCAL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WILSON R S, 1979, Journal of Clinical Neuropsychology, V1, P49, DOI 10.1080/01688637908401097	23	16	16	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1994	8	5					405	411		10.3109/02699059409150992			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	NW122	WOS:A1994NW12200002	7951203				2021-06-18	
J	RUIJS, MBM; GABREELS, FJM; THIJSSEN, HOM				RUIJS, MBM; GABREELS, FJM; THIJSSEN, HOM			THE UTILITY OF ELECTROENCEPHALOGRAPHY AND CEREBRAL COMPUTED-TOMOGRAPHY IN CHILDREN WITH MILD AND MODERATELY SEVERE CLOSED-HEAD INJURIES	NEUROPEDIATRICS			English	Article						CLOSED HEAD INJURY; COMA; COMPUTED TOMOGRAPHY; ELECTROENCEPHALOGRAPHY; POSTTRAUMATIC AMNESIA	INTRAVENTRICULAR HEMORRHAGE; TRAUMA	The utility of electroencephalography and computed tomography has been studied in a prospective follow-up study of 54 children with mild and moderately severe closed head injuries. EEG and CT scan were recorded in the acute phase. Furthermore the duration of coma and of post-traumatic amnesia were registrated. During a two years follow up period the presence of residual disorders in various faculties was evaluated at fixed time intervals after discharge. The data have been subjected to correlation analyses to study the relation of EEG and CT scan findings with the severity of the trauma and with the occurrence of long-term sequelae. Both the EEG and the CT scan abnormalities are found to correlate appreciably with the degree of severity and with the occurrence of, in particular, long-term sequelae in the fields of neurological disturbances and school performance. It is concluded that EEG and CT are useful diagnostic tools in children with mild and moderately severe closed head injuries.	UNIV HOSP NIJMEGEN,DEPT CLIN NEUROPHYSIOL,6500 HB NIJMEGEN,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT CHILD NEUROL,6500 HB NIJMEGEN,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT NEURORADIOL,6500 HB NIJMEGEN,NETHERLANDS	RUIJS, MBM (corresponding author), UNIV HOSP NIJMEGEN,INST NEUROL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.						BLUME WT, 1982, ATLAS PEDIATRIC ELEC; Bricolo A, 1979, Acta Neurochir Suppl (Wien), V28, P35; ESPERSEN JO, 1982, ACTA NEUROCHIR, V65, P81, DOI 10.1007/BF01405444; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1983, MANAGEMENT HEAD INJU; KELLAWAY P, 1955, ELECTROEN CLIN NEURO, V7, P497; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KOUFEN H, 1977, EEG-EMG-Z ELEK ELEKT, V8, P29; LANDAUFEREY J, 1980, ELECTROEN CLIN NEURO, V49, P173, DOI 10.1016/0013-4694(80)90364-8; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; MARSHALL LF, 1985, NEUROSURGERY, P1605; MENKES JH, 1980, TXB CLIN NEUROLOGY; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; MINDERHOUD JM, 1984, TRAUMATISCHE HERSENL; MIZRAHI EM, 1984, PEDIATRICS, V73, P419; Niedermeyer E., 1993, ELECTROENCEPHALOGRAP; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; Plum F., 1980, DIAGNOSIS STUPOR COM, V3; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P885; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; RUMPL E, 1979, ELECTROEN CLIN NEURO, V46, P487, DOI 10.1016/0013-4694(79)90002-6; RUSSELL WR, 1971, TRAUMATIC AMNESIA; SHAPIRO K, 1983, PEDIATRIC HEAD TRAUM; SINGER HS, 1978, PEDIATRICS, V62, P819; SNOEK J, 1979, J NEUROL NEUROSUR PS, V42, P25; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004	29	16	16	0	1	HIPPOKRATES VERLAG GMBH	STITTGART	PO BOX 30 05 04 RUDIGERSTRASSE 14, 70469 STITTGART, GERMANY	0174-304X			NEUROPEDIATRICS	Neuropediatrics	APR	1994	25	2					73	77		10.1055/s-2008-1071589			5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	NQ679	WOS:A1994NQ67900003	8072678				2021-06-18	
J	SALZMAN, SK; KELLY, G; CHAVIN, J; WANG, L; PUNIAK, MA; AGRESTA, CA; AZIM, S				SALZMAN, SK; KELLY, G; CHAVIN, J; WANG, L; PUNIAK, MA; AGRESTA, CA; AZIM, S			CHARACTERIZATION OF MIANSERIN NEUROPROTECTION IN EXPERIMENTAL SPINAL TRAUMA - DOSE/ROUTE RESPONSE AND LATE TREATMENT	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							SEROTONIN RECEPTORS; 5-HT1C RECEPTOR; BINDING-SITES; RAT-BRAIN; CORD; 5-HYDROXYTRYPTAMINE; INJURY; CORTEX; DAMAGE; TRH	The neuroprotective action of the 5-hydroxytryptamine (5-HT2/5-HT1C) antagonist mianserin was examined with respect to optimal dosage, route of administration and time of treatment after a moderate spinal impact trauma (50 g.cm by the weight-drop method) to the thoracic region of the rat. in a previous study (Salzman et al., 1991b) a single 1-mg/kg i.v. dose of mianserin improved multiple measures of functional outcome when given 15 min after injury, whereas higher doses (5 and 10 mg/kg i.v.) displayed lesser therapeutic actions as well as pulmonary depressant effects. In these studies, lower dosages of minanserin (0.5 and 0.1 mg/kg i.v.) also were not associated with neuroprotection. Although the 1-mg/kg i.v. dosage again displayed significant efficacy when administered at 15 min delaying treatment to 30 min resulted in only marginal therapeutic actions. Nonetheless, i.p. dosage of 10 mg/kg (but not 2.5 mg/kg) at 15 min retained therapeutic efficacy, suggesting a pharmacodynamic influence. In support of this conclusion, the intrathecal administration of a 50-fold lower dose of minanserin (0.006 mg) at 15 min after injury resulted in neuroprotection that was superior to that of peripheral doses and was retained when this intrathecal dosage was administered at 1 hr after trauma. These results suggest a central mechanism of action for mianserin. Consistent with this was the lack of effect of mianserin (1 mg/kg i.v. at 15 min) upon post-traumatic spinal edema but its ability to reverse the decrease in central 5-HT oxidative metabolism after injury. Moreover, the inability of the selective 5-HT2 antagonist ketanserin to produce this action, as well as its lack of neuroprotective efficacy, indicates the role of central 5-HT1C receptors in the therapeutic mechanism of mianserin.	ALFRED I DUPONT INST, DEPT MED CELL BIOL, SPINAL TRAUMA RES LAB, WILMINGTON, DE USA							Abraham J, 1985, Cent Nerv Syst Trauma, V2, P45; BARBEAU H, 1981, NEUROPHARMACOLOGY, V20, P477, DOI 10.1016/0028-3908(81)90181-7; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; COHEN ML, 1983, BIOCHEM PHARMACOL, V32, P567, DOI 10.1016/0006-2952(83)90541-5; CONN PJ, 1986, P NATL ACAD SCI USA, V83, P4086, DOI 10.1073/pnas.83.11.4086; DAPRADA M, 1979, BRIT J PHARMACOL, V65, P653; ENGEL G, 1986, N-S ARCH PHARMACOL, V332, P1, DOI 10.1007/BF00633189; GOODMAN VG, 1979, J NEUROSURG, V63, P390; JULIUS D, 1988, COLD SPRING HARB SYM, V53, P385, DOI 10.1101/SQB.1988.053.01.046; LIU D, 1990, Journal of Neurotrauma, V7, P219, DOI 10.1089/neu.1990.7.219; MITCHELL R, 1981, EUR J PHARMACOL, V76, P119, DOI 10.1016/0014-2999(81)90020-0; MITCHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; PAPPIUS HM, 1987, J NEUROCHEM, V49, P321, DOI 10.1111/j.1471-4159.1987.tb03433.x; PAZOS A, 1985, BRAIN RES, V346, P205, DOI 10.1016/0006-8993(85)90856-X; PRANZATELLI MR, 1992, J PHARMACOL EXP THER, V261, P161; Puniak MA, 1991, J NEUROTRAUM, V8, P193, DOI 10.1089/neu.1991.8.193; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Salzman S K, 1987, Cent Nerv Syst Trauma, V4, P181; SALZMAN SK, 1991, ANN NEUROL, V30, P533, DOI 10.1002/ana.410300405; SALZMAN SK, 1987, J NEUROSURG, V66, P431, DOI 10.3171/jns.1987.66.3.0431; Salzman SK, 1991, J NEUROTRAUM, V8, P45, DOI 10.1089/neu.1991.8.45; SARUHASHI Y, 1991, J NEUROTRAUMA, V7, P237; SHARMA HS, 1990, ACTA NEUROPATHOL, V80, P12, DOI 10.1007/BF00294216; SHARMA HS, 1988, PHARM CEREBRAL ISCHE, P317; SIEGAL T, 1993, J NEUROSURG, V78, P929, DOI 10.3171/jns.1993.78.6.0929; TARLOV IM, 1957, SPINAL CORD COMPRESS; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; ZIVIN JA, 1976, NEUROLOGY, V26, P99, DOI 10.1212/WNL.26.2.99; ZIVIN JA, 1984, NEUROLOGY, V34, P469, DOI 10.1212/WNL.34.4.469	31	16	16	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	APR	1994	269	1					322	328					7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	NJ323	WOS:A1994NJ32300045	8169839				2021-06-18	
J	MASSAGLI, TL; JAFFE, KM				MASSAGLI, TL; JAFFE, KM			PEDIATRIC TRAUMATIC BRAIN INJURY - PROGNOSIS AND REHABILITATION	PEDIATRIC ANNALS			English	Article										MASSAGLI, TL (corresponding author), CHILDRENS HOSP & MED CTR,DEPT REHABIL MED,CH-71,4800 SAND POINT WAY NE,POB 5371,SEATTLE,WA 98105, USA.							0	16	17	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086	0090-4481			PEDIATR ANN	Pediatr. Annu.	JAN	1994	23	1					29	&		10.3928/0090-4481-19940101-08			0	Pediatrics	Pediatrics	MU563	WOS:A1994MU56300005	8152862				2021-06-18	
J	YOUNGSON, HA; ALDERMAN, N				YOUNGSON, HA; ALDERMAN, N			FEAR OF INCONTINENCE AND ITS EFFECTS ON A COMMUNITY-BASED REHABILITATION PROGRAM AFTER SEVERE BRAIN INJURY - SUCCESSFUL REMEDIATION OF ESCAPE BEHAVIOR USING BEHAVIOR-MODIFICATION	BRAIN INJURY			English	Article								The presence of continence problems following severe traumatic brain injury may be attributable to either organic or psychological factors. In the case of the latter this in turn may lead to the development of behaviours that result in avoidance of or escape from rehabilitation activities. In this paper, a single case study is described in which verbalized fear of incontinence prevented participation within a community rehabilitation programme. Assessment suggested that behaviours that led to escape from this programme were being maintained by negative reinforcement through reduction in anxiety associated with this activity. An intervention was implemented using graded exposure and differential reinforcement of incompatible behaviour. Treatment led to a significant reduction in escape behaviour; this had been maintained and consolidated further at 9-month follow-up. However, no change occurred to the client's prompted self-ratings of anxiety. Reasons for the discrepancy between improvement in behaviour but not self-report are discussed. The potential limitations of using cognitive-behavioural therapy with some survivors of severe traumatic brain injury are also discussed. Finally, comments are made concerning the applicability of the treatment techniques described here in the modification of escape and avoidance behaviours that may be acquired following brain injury. ,	ST ANDREWS HOSP,KEMSLEY UNIT,NORTHAMPTON NN1 5DG,ENGLAND				Alderman, Nick/0000-0002-8523-4142			ALDERMAN N, 1991, Brain Injury, V5, P77, DOI 10.3109/02699059108998516; ALDERMAN N, 1992, PHYSIOTHERAPY, V78, P335; ALDERMAN N, 1990, COGNITIVE REHABILITA, P204; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQ, P183; IWATA BA, 1987, J APPL BEHAV ANAL, V20, P361, DOI 10.1901/jaba.1987.20-361; LISHMAN WA, 1987, ORGANIC PSYCHIATRY; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P52; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; PAPWORTH MA, 1990, J BEHAVIOR THERAPY E, V20, P265; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SAZBON L, 1991, Brain Injury, V5, P3, DOI 10.3109/02699059108998505; TYRON WW, 1982, J APPLIED BEHAVIOUR, V15, P423; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WILSON BA, 1991, HDB BEHAV THERAPY PS, P227; Wood R. L., 1987, BRAIN INJURY REHABIL	19	16	16	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1994	8	1					23	36		10.3109/02699059409150956			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	MQ291	WOS:A1994MQ29100004	8124314				2021-06-18	
J	GORAN, DA; FABIANO, RJ				GORAN, DA; FABIANO, RJ			THE SCALING OF THE KATZ ADJUSTMENT SCALE IN A TRAUMATIC BRAIN INJURY REHABILITATION SAMPLE	BRAIN INJURY			English	Article							BLUNT HEAD-INJURY; SEQUELAE	Based on the KAS-R1 ratings completed by 88 relatives of clients who had enrolled in a post-acute rehabilitation programme, the 10 component groups discerned by Fabiano and Goran [1] were submitted to a classical analysis of tests. Seventy-nine items were found to contribute to the internal consistency of their respective component groups, resulting in alpha values ranging from 0.75 to 0.93 for the component groups. Intercorrelations between components suggested that while some degree of overlap existed between groups, they represented discrete categories of neurobehavioural functioning. Second-order components, as determined by principal-component analysis, discern two significant component groups. These two components correlated moderately, yielding a value of 0-49. The findings indicate that the revised KAS-R1 exhibits considerable potential for clinical utility. Future research is needed to investigate the validity of this instrument in accurately depicting behavioural manifestations of those who have incurred traumatic brain injury.	MICHIGAN STATE UNIV,PSYCHOL ASSOCIATES REHABIL,LANSING,MI 48910; MICHIGAN STATE UNIV,REHABIL COUNSELOR EDUC PROGRAM,LANSING,MI 48910							BOND M, 1984, CLOSED HEAD INJURY P; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CRIPE L, 1991, NEUROPSYCHOLOCIAL EX; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; FABIANO RJ, IN PRESS REHABILITAT; FERGUSON SM, 1969, ARCH GEN PSYCHIAT, V21, P363; FLORHENRY P, 1969, EPILEPSIA, V10, P363, DOI 10.1111/j.1528-1157.1969.tb03853.x; Gainotti G, 1972, Cortex, V8, P41; GINGIS M, 1980, LIMBIC EPILEPSY DYSC; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; GRAHAM JR, 1972, J CLIN PSYCHOL, V28, P380, DOI 10.1002/1097-4679(197207)28:3+<380::AID-JCLP2270280323>3.0.CO;2-B; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; Guilford J. P., 1956, FUNDAMENTAL STATISTI; HAFFEY WJ, 1989, REHABIL PSYCHOL, V34, P147, DOI 10.1037//0090-5550.34.2.147; Heilman KM, 1985, CLIN NEUROPSYCHOLOGY, P377; JACKSON JK, 1989, MAR INT BRAIN INJ S; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Levin H. S., 1985, CENTRAL NERVOUS SYST, P281; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEZAK MD, 1980, 8TH ANN M INT NEUR S; LEZAK MD, 1978, J CLIN PSYCHIAT, V29, P592; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; PRIGATANO GP, 1987, NEUROBEHAVIORAL RECO; ROBINSON RG, 1985, J NERV MENT DIS, V173, P221, DOI 10.1097/00005053-198504000-00003; ROSS ED, 1979, ARCH NEUROL-CHICAGO, V36, P144, DOI 10.1001/archneur.1979.00500390062006; Spiers PA, 1985, PRINCIPLES BEHAVIORA, P289; STENSON H, 1986, TESTAT SUPPLEMENTARY; STRAUSS E, 1982, ARCH NEUROL-CHICAGO, V39, P626, DOI 10.1001/archneur.1982.00510220024005; TEASDALE G, 1984, CLOSED HEAD INJURY P, P4	37	16	17	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY-JUN	1993	7	3					219	229		10.3109/02699059309029674			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	MA170	WOS:A1993MA17000003	8508178				2021-06-18	
J	KITCHENER, PD; BOURREAU, JP; DIAMOND, J				KITCHENER, PD; BOURREAU, JP; DIAMOND, J			NADPH-DIAPHORASE HISTOCHEMISTRY IDENTIFIES ISOLATED ENDOTHELIAL-CELLS AT SITES OF TRAUMATIC INJURY IN THE ADULT-RAT BRAIN	NEUROSCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; CENTRAL NERVOUS-SYSTEM; MAMMALIAN BRAIN; PROTEIN; NEOVASCULARIZATION; PROLIFERATION; MICROGLIA; INTERLEUKIN-1; ANGIOGENESIS; MACROPHAGES	In addition to labelling endothelium, some ependymal cells (including tanycytes), and a subpopulation of neurons, nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase histochemistry of stab lesion sites in the neocortex revealed a large population of cells concentrated within several hundred micrometres of the lesion site. To determine the identity of these cells, NADPH-diaphorase reactivity was compared to binding with either the I-B4 isolectin from Bandeiraea simplicifolia (which has previously been shown to identify endothelial cells and activated mononuclear phagocytes), or a monoclonal antibody (OX-42) that recognizes activated mononuclear phagocytes. Many I-B4 lectin-labelled cells were also NADPH-diaphorase reactive, and other I-B4 lectin-labelled cells were also OX-42 immunoreactive, but co-existence of OX-42 immunoreactivity and NADPH-diaphorase reactivity was not observed. Only a small minority of NADPH-diaphorase-reactive cells did not exhibit I-B4 lectin binding. In contrast to the simple somatic morphology of the majority of NADPH-diaphorase-reactive cells, the I-B4 lectin-negative cells had a ramified appearance, and while readily observed at two days postlesion, they were only rarely seen at three days postlesion. Primary cultures of bovine aortic endothelial cells also exhibited NADPH-diaphorase reactivity which occupied most of the cytoplasm in a filamentous web pattern. Endothelial cells possess a constitutive form of nitric oxide synthase which, as demonstrated in NADPH-diaphorase-reactive neurons, may be the basis of their NADPH-diaphorase reactivity. These findings indicate that NADPH-diaphorase-reactive cells observed at lesion sites are probably angiogenic endothelial cells not associated with extant blood vessels. Thus, NADPH-diaphorase histochemistry offers an effective method of visualizing neovascularization in the brain and other tissues.	MCMASTER UNIV,DIV PHYSIOL & PHARMACOL,SMOOTH MUSCLE RES GRP,HAMILTON L8N 3Z5,ONTARIO,CANADA; MCMASTER UNIV,DEPT BIOMED SCI,DIV NEUROSCI,HAMILTON L8N 3Z5,ONTARIO,CANADA	KITCHENER, PD (corresponding author), UNIV QUEENSLAND,DEPT ANAT SCI,BRISBANE,QLD 4072,AUSTRALIA.			Kitchener, Peter/0000-0003-4324-5270			ADRIAN EK, 1973, J COMP NEUROL, V151, P1, DOI 10.1002/cne.901510102; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; CLIFF WJ, 1963, PHILOS T ROY SOC B, V246, P305, DOI 10.1098/rstb.1963.0008; COFFIN JD, 1991, DEV BIOL, V148, P51, DOI 10.1016/0012-1606(91)90316-U; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; Edelman GM, 1985, CELL CONTACT ADHESIO; FORSTERMANN U, 1991, BIOCHEM PHARMACOL, V42, P1849, DOI 10.1016/0006-2952(91)90581-O; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1988, J NEUROSCI, V8, P2485; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; GRAEBER MB, 1989, J NEUROSCI RES, V22, P103, DOI 10.1002/jnr.490220114; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; HOPE BT, 1989, J HISTOCHEM CYTOCHEM, V37, P653, DOI 10.1177/37.5.2703701; HOPE BT, 1992, TRENDS NEUROSCI, V15, P108; IMAMOTO K, 1977, J COMP NEUROL, V174, P255, DOI 10.1002/cne.901740205; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; KITCHENER PD, 1991, P AUST PHYSL PHARM S, V22, pP186; LAITINEN L, 1987, HISTOCHEM J, V19, P225, DOI 10.1007/BF01680633; LATERRA J, 1991, J NEUROCHEM, V57, P1231, DOI 10.1111/j.1471-4159.1991.tb08284.x; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; Leibovich S J, 1988, Prog Clin Biol Res, V266, P131; LOJDA Z, 1961, J ATHEROSCLER RES, V1, P101, DOI 10.1016/S0368-1319(61)80039-2; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; MITRO A, 1981, BIBLIOTHECA ANATOMIC, V21; MIZUKAWA K, 1989, J COMP NEUROL, V279, P281, DOI 10.1002/cne.902790210; MONCADA S, 1991, PHARMACOL REV, V43, P109; MURPHY LA, 1977, J BIOL CHEM, V252, P4739; OEHMICHEN M, 1983, PROG NEUROPATH, V5, P277; PENFIELD W, 1932, CYTOLOGY CELLULAR PA, V2; RAMONYCAJAL S, 1927, DEGENERATION REGENER, V2; REIDY MA, 1989, AM J PATHOL, V134, P857; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; SCHERERSINGLER U, 1983, J NEUROSCI METH, V9, P229, DOI 10.1016/0165-0270(83)90085-7; SHIGEMATSU K, 1989, BRAIN RES, V501, P215, DOI 10.1016/0006-8993(89)90639-2; SHOLLEY MM, 1984, LAB INVEST, V51, P624; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; VINCENT SR, 1992, NEUROSCIENCE, V46, P755, DOI 10.1016/0306-4522(92)90184-4; ZEMPLENYI T, 1963, ATHEROSCLEROSIS ITS	43	16	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0306-4522			NEUROSCIENCE	Neuroscience	APR	1993	53	3					613	624		10.1016/0306-4522(93)90610-R			12	Neurosciences	Neurosciences & Neurology	KW547	WOS:A1993KW54700002	8487946				2021-06-18	
J	MEGUID, MM; MUSCARITOLI, M				MEGUID, MM; MUSCARITOLI, M			CURRENT USES OF TOTAL PARENTERAL-NUTRITION	AMERICAN FAMILY PHYSICIAN			English	Article								Total parenteral nutrition has become a well-established intervention for the following indications: to sustain life in patients with short-bowel syndrome; for perioperative use in nutritionally deprived patients; to improve quality of life for patients with inflammatory bowel diseases; to assist the healing of enterocutaneous and pancreatic fistulas; for supportive care in patients with acute pancreatitis; as an adjunct to therapy in patients with acute renal or hepatic failure; for hypermetabolic states such as sepsis, trauma, burns and acquired immunodeficiency syndrome; in neonatal and pediatric patients; in transplantation recipients, including bone marrow, renal, cardiac and liver transplants; for precoronary artery bypass graft myocardial glycogen loading; in the field of obstetrics; to enhance survival in patients with closed head injuries; to treat life-threatening anorexia nervosa; in patients with cystic fibrosis and for nutritional support in home use		MEGUID, MM (corresponding author), SUNY SYRACUSE,HLTH SCI CTR,SYRACUSE,NY 13210, USA.							0	16	16	0	1	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	FEB 1	1993	47	2					383	394					12	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	KL872	WOS:A1993KL87200010	8430592				2021-06-18	
J	THEODOROS, D; MURDOCH, BE; STOKES, PD; CHENERY, HJ				THEODOROS, D; MURDOCH, BE; STOKES, PD; CHENERY, HJ			HYPERNASALITY IN DYSARTHRIC SPEAKERS FOLLOWING SEVERE CLOSED HEAD-INJURY - A PERCEPTUAL AND INSTRUMENTAL ANALYSIS	BRAIN INJURY			English	Article								Hypernasality in the dysarthric speech of 20 severely closed-head- injured (CHI) subjects was investigated using both perceptual and instrumental techniques. A perceptual analysis of the speech of the CHI subjects was performed using a four-point rating scale for hypernasality. Instrumental assessment was carried out using a computerized accelerometric technique yielding a nasal coupling index. Results revealed a high incidence of perceived hypernasality (95%) in the speech of subjects in the CHI group. More than half of these subjects exhibited hypernasality of speech to a moderate to severe degree. When compared with a control group matched for age and sex the severely CHI subjects were perceived as being significantly more hypernasal. Instrumental assessment revealed that the functioning of the velopharyngeal valve in the group of CHI subjects was significantly impaired compared to the control group. The study highlighted the need to evaluate the perceptual and instrumental assessment results for the severely CHI subjects on an individual basis. The clinical implications of these findings are discussed.	UNIV QUEENSLAND,DEPT SPEECH & HEARING,BRISBANE,QLD 4072,AUSTRALIA			Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012; Chenery, Helen J/F-5194-2010				Darley F., 1975, MOTOR SPEECH DISORDE; HOLM S, 1979, SCAND J STAT, V6, P65; HORII Y, 1981, CLEFT PALATE J, V18, P279; HORII Y, 1983, J SPEECH HEAR RES, V26, P472, DOI 10.1044/jshr.2603.472; HORII Y, 1980, CLEFT PALATE J, V18, P279; KEARNS KP, 1988, J SPEECH HEAR RES, V31, P131, DOI 10.1044/jshr.3101.131; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LIPPMANN RP, 1981, J SPEECH HEAR RES, V24, P314; Ludlow C., 1983, CLIN DYSARTHRIA, P121; Murdoch B. E., 1987, AUSTR J HUMAN COMMUN, V15, P15; Murdoch Bruce E., 1990, AUSTR J HUMAN COMMUN, V18, P83; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; Sarno M, 1985, SPEECH LANGUAGE EVAL, P323; Weismer G., 1984, DYSARTHRIAS PHYSL AC, P101	14	16	17	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN-FEB	1993	7	1					59	69		10.3109/02699059309008157			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	KZ724	WOS:A1993KZ72400006	8425117				2021-06-18	
J	CRISP, R				CRISP, R			RETURN TO WORK AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION			English	Article							SEVERE HEAD-INJURY; SOCIAL-ADJUSTMENT; FOLLOW-UP; SUPPORTED EMPLOYMENT; REHABILITATION; OUTCOMES; RECOVERY; PERSONALITY; DISABILITY; RELATIVES	Twenty-nine studies that identified variables related to vocational resettlement after onset of traumatic brain injury were reviewed. Although these studies have been characterized by varying standards of clinical severity of impairment and social/vocational outcome, they do provide an indication of critical factors associated with vocational outcome, i.e., severity of injury, cognitive deficits, personality change, psychosocial adaptation, physical impairment, age, pre-injury work/education history, and access to intensive rehabilitation.	COMMONWEALTH REHABIL SERV AUSTRALIA,CROYDON 3136,AUSTRALIA							AINSLEY J, 1989, COGNITIVE REHAB, V7, P28; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; BLAIR JR, 1989, J REHABIL, V55, P46; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN JC, 1975, PSYCHOL MED, V5, P239, DOI 10.1017/S0033291700056592; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; COHEN J, 1985, J APPLIED REHABILITA, V16, P25; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HAFFEY WJ, 1989, REHABIL PSYCHOL, V34, P147, DOI 10.1037//0090-5550.34.2.147; HEATON RK, 1978, J NERV MENT DIS, V166, P408, DOI 10.1097/00005053-197806000-00004; HUMPHREY M, 1980, INJURY, V12, P107, DOI 10.1016/0020-1383(80)90133-3; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P87; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson R, 1987, Int Disabil Stud, V9, P49; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KAY T, 1989, REHABIL PSYCHOL, V34, P159, DOI 10.1037/h0091781; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LONG CJ, 1984, J REHABIL, V50, P39; LONG CJ, 1984, J REHABIL, V50, P70; MATHESON JM, 1982, AUSTR APPROACHES REH, P32; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; Moore R.L., 1990, J APPL REHABILITATIO, V21, P3; Mysiw W J, 1989, Brain Inj, V3, P27, DOI 10.3109/02699058909008070; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; NEWCOMBE F, 1982, INJURY, V14, P111, DOI 10.1016/0020-1383(82)90046-8; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P635, DOI 10.2466/pms.1978.46.2.635; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; OAKESHOTT RJ, 1982, AUSTR APPROACHES REH, P41; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OSTWALD SW, 1989, J APPL REHABILITATIO, V20, P22; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RANSEN J, 1990, COGNITIVE REHABILITA, V8, P8; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; STAPLETON M, 1989, COGNITIVE REHABILITA, V7, P18; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1982, BRAIN IMPAIRMENT; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEHMAN P, 1989, ARCH PHYS MED REHAB, V70, P109; WEHMAN P, 1989, J HEAD TRAUMA REHAB, V4, P66; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	60	16	17	0	5	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109	0022-4154			J REHABIL	J. Rehabil.	OCT-DEC	1992	58	4					27	33					7	Rehabilitation	Rehabilitation	LN424	WOS:A1992LN42400005					2021-06-18	
J	ANTONAK, RF; LIVNEH, H				ANTONAK, RF; LIVNEH, H			A REVIEW OF RESEARCH ON PSYCHOSOCIAL ADJUSTMENT TO IMPAIRMENT AMONG PERSONS WITH EPILEPSY	JOURNAL OF EPILEPSY			English	Article						PSYCHOSOCIAL ADJUSTMENT; EPILEPSY; REACTIONS; ADAPTATION; IMPAIRMENT; INSTRUMENTS; STIGMA		This review begins with a general discussion of the concept of psychosocial adjustment to impairment among persons with epilepsy. The research literature is then reviewed in three areas: (a) research subsuming adjustment within the domain of psychopathology, (b) research focusing on specific psychosocial reactions, and (c) investigations of the characteristics associated with adjustment (e.g., age at onset, seizure type and frequency, societal attitudes). The next sections review the research concerning (a) comparison of adjustment to epilepsy with adjustment to other impairments (e.g., amyotrophic lateral sclerosis, closed head injury), (b) the roots of the poor psychosocial adjustment among persons with epilepsy, and (c) two measures of adjustment specific to epilepsy. Research problems identified in this review are then listed and suggestions for future investigations provided.	PORTLAND STATE UNIV, PORTLAND, OR 97207 USA	ANTONAK, RF (corresponding author), UNIV N CAROLINA, CHARLOTTE, NC 28223 USA.						Ajzen I., 1980, UNDERSTANDING ATTITU, V278; ANTONAK RF, 1982, SOC SCI MED, V16, P1591, DOI 10.1016/0277-9536(82)90170-8; ANTONAK RF, 1988, COMMUNICATION ASSESS, P9; ANTONAK RF, UNPUB J HEAD TRAUMA; ANTONAK RF, UNPUB UINT J PSYCHIA; ARANGIO AJ, 1975, STIGMA EPILEPSY; Arnston P, 1986, PSYCHOPATHOLOGY EPIL, P143; ATHELSTAN G, 1981, HDB SEVERE DISABILIT, P13; AUSTIN JK, 1984, NURS RES, V33, P92; AWARITEFE A, 1985, EPILEPSIA, V26, P1, DOI 10.1111/j.1528-1157.1985.tb05181.x; BAGLEY C, 1972, EPILEPSIA, V13, P33, DOI 10.1111/j.1528-1157.1972.tb04547.x; BATZEL LW, 1991, EPILEPSIA, V32, P202, DOI 10.1111/j.1528-1157.1991.tb05245.x; Bear D., 1984, PSYCHIATRIC ASPECTS, P197; BEITJONES MS, 1985, SOC WORK HEALTH CARE, V11, P17; Beran R G, 1985, Clin Exp Neurol, V21, P183; BERAN RG, 1983, EPILEPSIA, V24, P79, DOI 10.1111/j.1528-1157.1983.tb04869.x; BERAN RG, 1981, EPILEPSIA, V22, P397, DOI 10.1111/j.1528-1157.1981.tb06150.x; BERAN RG, 1987, EPILEPSIA, V28, P107, DOI 10.1111/j.1528-1157.1987.tb03634.x; BERAN RG, 1980, CLIN EXP NEUROL, V17, P69; BLUMER D, 1967, ARCH NEUROL-CHICAGO, V16, P37, DOI 10.1001/archneur.1967.00470190041005; Bridge EA, 1947, NERV CHILD, V6, P11; BROOKS NA, 1982, SOC SCI MED, V16, P2129, DOI 10.1016/0277-9536(82)90262-3; BROUGHTON RJ, 1984, EPILEPSIA, V25, P423, DOI 10.1111/j.1528-1157.1984.tb03438.x; BROWN SW, 1986, BRIT J PSYCHIAT, V148, P300, DOI 10.1192/bjp.148.3.300; CANGER R, 1985, EPILEPSIA, V26, P221, DOI 10.1111/j.1528-1157.1985.tb05409.x; Carter JD, 1947, NERV CHILD, V6, P34; CAVENESS W, 1980, REHABIL COUNS BULL, V21, P509; CAVENESS WF, 1974, EPILEPSIA, V15, P523, DOI 10.1111/j.1528-1157.1974.tb04026.x; COLLINGS JA, 1990, EPILEPSIA, V31, P418, DOI 10.1111/j.1528-1157.1990.tb05497.x; DANESI MA, 1984, EPILEPSIA, V25, P184, DOI 10.1111/j.1528-1157.1984.tb04175.x; DEHAAS AML, 1962, EPILEPSIA, V3, P44, DOI 10.1111/j.1528-1157.1962.tb05233.x; DELL JL, 1986, PSYCHOPATHOLOGY EPIL, P185; DODRILL CB, 1984, EPILEPSIA, V25, P168, DOI 10.1111/j.1528-1157.1984.tb04173.x; DODRILL CB, 1980, EPILEPSIA, V21, P123, DOI 10.1111/j.1528-1157.1980.tb04053.x; DODRILL CB, 1986, EPILEPSIA, V27, P399, DOI 10.1111/j.1528-1157.1986.tb03559.x; DODRILL CB, 1984, EPILEPSIA, V25, P176, DOI 10.1111/j.1528-1157.1984.tb04174.x; DODRILL CB, 1983, EPILEPSY, P341; DORENBAUM D, 1985, CLIN PEDIATR, V24, P634, DOI 10.1177/000992288502401106; DREISBACH M, 1982, J SPEC EDUC, V16, P111, DOI 10.1177/002246698201600111; ELLISON JM, 1982, PSYCHOSOMATICS, V23, P499; Flanagan P J, 1985, Clin Exp Neurol, V21, P189; FRANK RG, 1987, J REHABIL, V53, P43; GALLHOFER B, 1984, PSYCHOPATHOLOGY, V17, P187, DOI 10.1159/000284053; Goffman E., 1963, STIGMA NOTES MANAGEM; GOLDIN GJ, 1975, EPILEPSY REHABILITAT, P66; GOTTESMAN D, 1982, J CONSULT CLIN PSYCH, V50, P381, DOI 10.1037/0022-006X.50.3.381; GUTTELING JM, 1986, EPILEPSIA, V27, P739, DOI 10.1111/j.1528-1157.1986.tb03604.x; HACKNEY A, 1976, EPILEPSIA, V17, P275, DOI 10.1111/j.1528-1157.1976.tb03406.x; HARTLAGE LC, 1972, EPILEPSIA, V13, P21, DOI 10.1111/j.1528-1157.1972.tb04544.x; HAUCK G, 1972, EPILEPSIA, V13, P79, DOI 10.1111/j.1528-1157.1972.tb04554.x; HAWTON K, 1980, J NEUROL NEUROSUR PS, V43, P168, DOI 10.1136/jnnp.43.2.168; HELGESON DC, 1990, EPILEPSIA, V31, P75, DOI 10.1111/j.1528-1157.1990.tb05363.x; HERMANN BP, 1981, J CLIN PSYCHOL, V37, P714, DOI 10.1002/1097-4679(198110)37:4<714::AID-JCLP2270370405>3.0.CO;2-C; HERMANN BP, 1984, PSYCHOL BULL, V95, P451, DOI 10.1037/0033-2909.95.3.451; HERMANN BP, 1990, BRIT J PSYCHIAT, V156, P98, DOI 10.1192/bjp.156.1.98; HERMANN BP, 1980, EPILEPSIA, V21, P15, DOI 10.1111/j.1528-1157.1980.tb04040.x; HERMANN BP, 1980, EPILEPSIA, V21, P691, DOI 10.1111/j.1528-1157.1980.tb04322.x; Hermann BP, 1986, PSYCHOPATHOLOGY EPIL, P5; HERMANN BP, 1988, HDB DEV PHYSICAL DIS, P247; Himmelhoch J, 1984, PSYCHIATRIC ASPECTS, P271; HOARE P, 1986, J PSYCHOSOM RES, V30, P471, DOI 10.1016/0022-3999(86)90086-3; HOLDSWORTH L, 1974, DEV MED CHILD NEUROL, V16, P759; HOLMES DA, 1981, J REHABIL, V47, P20; KAPLAN BJ, 1983, COPING CHRONIC DISEA, P259; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; Kerr W G, 1972, Paraplegia, V10, P94; KLOVE H, 1962, J CLIN PSYCHOL, V18, P149, DOI 10.1002/1097-4679(196204)18:2<149::AID-JCLP2270180214>3.0.CO;2-S; KOGEORGOS J, 1982, BRIT J PSYCHIAT, V140, P236, DOI 10.1192/bjp.140.3.236; LAI CW, 1990, EPILEPSIA, V31, P182, DOI 10.1111/j.1528-1167.1990.tb06304.x; Landisberg S, 1947, AM J MENT DEF, V52, P16; LECHTENBERG R, 1984, EPILEPSY FAMILY; LECHTENBERG R, 1985, DIAGNOSIS TREATMENT; LEONARD BJ, 1984, CHRONIC ILLNESS DISA, P239; LIPOWSKI ZJ, 1970, PSYCHIAT MED, V1, P91, DOI 10.2190/19Q3-9QL8-XYV1-8XC2; LIVANAINEN M, 1980, EPILEPSIA, V21, P413; LIVINGSTON S, 1977, J CLIN CHILD PSYCHOL, V6, P6, DOI 10.1080/15374417709532773; LIVNEH H, 1986, J APPLIED REHABILITA, V17, P56; Livneh H., 1990, J APPL REHABIL COUS, V21, P13, DOI [10.1891/0047-2220.21.4.13, DOI 10.1891/0047-2220.21.4.13]; Livneh H, 1986, J APPLIED REHABILITA, V17, P5; LONG CG, 1979, J CHILD PSYCHOL PSYC, V20, P299, DOI 10.1111/j.1469-7610.1979.tb00516.x; MARTIN JW, 1974, J SCHOOL HEALTH, V44, P144, DOI 10.1111/j.1746-1561.1974.tb07629.x; MASON C, 1990, EPILEPSIA, V31, P95, DOI 10.1111/j.1528-1157.1990.tb05366.x; MATTHEWS CG, 1968, EPILEPSIA, V9, P43, DOI 10.1111/j.1528-1157.1968.tb04956.x; MATTHEWS WS, 1981, PSYCHOSOMATICS, V22, P515; MATTHEWS WS, 1982, EPILEPSIA, V23, P671, DOI 10.1111/j.1528-1157.1982.tb05083.x; MATTSSON A, 1972, PEDIATRICS, V50, P801; MENDEZ MF, 1986, ARCH NEUROL-CHICAGO, V43, P766, DOI 10.1001/archneur.1986.00520080014012; MERKENS MJ, 1989, J DEV BEHAV PEDIATR, V10, P1; OZUMA J, 1979, J NEUROSURG NURS, V11, P242; PARNAS J, 1982, ACTA PSYCHIAT SCAND, V66, P89, DOI 10.1111/j.1600-0447.1982.tb00917.x; PAZZAGLIA P, 1976, EPILEPSIA, V17, P361, DOI 10.1111/j.1528-1157.1976.tb04446.x; PINCUS JH, 1980, NEUROLOGY, V30, P304, DOI 10.1212/WNL.30.3.304; POLLOCK SE, 1990, NURS RES, V39, P300; RADER K, 1986, INT J REHABIL RES, V9, P325; REMSCHMIDT H, 1973, EPILEPSIA, V14, P347, DOI 10.1111/j.1528-1157.1973.tb03970.x; RICHARDSON DW, 1974, CLIN PEDIATR, V13, P121, DOI 10.1177/000992287401300203; ROBERTSON MM, 1983, EPILEPSIA, V24, pS109, DOI 10.1111/j.1528-1157.1983.tb04647.x; RODIN EA, 1973, ARCH GEN PSYCHIAT, V28, P210, DOI 10.1001/archpsyc.1973.01750320044007; RYAN R, 1980, EPILEPSIA, V21, P433, DOI 10.1111/j.1528-1157.1980.tb04091.x; SANDS H, 1972, EPILEPSIA, V13, P87, DOI 10.1111/j.1528-1157.1972.tb04555.x; SCHIFFER RB, 1984, ARCH NEUROL-CHICAGO, V41, P1067, DOI 10.1001/archneur.1984.04050210065016; SCOTT DF, 1978, BRIT J PSYCHIAT, V132, P417, DOI 10.1192/bjp.132.5.417; STANDAGE KF, 1975, PSYCHOL MED, V5, P152, DOI 10.1017/S0033291700056403; STUDE E, 1973, REHABILITATION COUNS, V16, P146; TAN SY, 1986, J CLIN PSYCHOL, V42, P528, DOI 10.1002/1097-4679(198605)42:3<528::AID-JCLP2270420321>3.0.CO;2-5; TARTER RE, 1972, DIS NERV SYST, V33, P763; TELLIER A, 1990, J CONSULT CLIN PSYCH, V58, P531; Temkin O., 1971, FALLING SICKNESS HIS; TERDAL LG, 1981, PSYCHOL BEHAVIORAL A, P147; TIZARD B, 1962, PSYCHOL BULL, V59, P196, DOI 10.1037/h0041102; TROSTLE JA, 1989, NEUROLOGY, V39, P633, DOI 10.1212/WNL.39.5.633; WARD F, 1978, DEV MED CHILD NEUROL, V20, P1; WHITMAN S, 1986, PSYCHOPATHOLOGY EPIL, P284; Whitman S, 1986, PSYCHOPATHOLOGY EPIL; WHITMAN S, 1986, PSYCHOPATHOLOGY EPIL, pR8; WILEY L, 1974, NURSING, V4, P36; Wright GN, 1975, EPILEPSY REHABILITAT, P1; ZIELINSKI JJ, 1972, EPILEPSIA, V13, P133, DOI 10.1111/j.1528-1157.1972.tb04560.x	118	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0896-6974			J EPILEPSY	J. Epilepsy		1992	5	3					194	205		10.1016/S0896-6974(05)80141-0			12	Clinical Neurology	Neurosciences & Neurology	LA886	WOS:A1992LA88600010					2021-06-18	
J	HALL, S; BORNSTEIN, RA				HALL, S; BORNSTEIN, RA			THE RELATIONSHIP BETWEEN INTELLIGENCE AND MEMORY FOLLOWING MINOR OR MILD CLOSED HEAD-INJURY - GREATER IMPAIRMENT IN MEMORY THAN INTELLIGENCE	JOURNAL OF NEUROSURGERY			English	Article						CLOSED HEAD INJURY; INTELLIGENCE; MEMORY	EDUCATION; SEQUELAE; WAIS	This study investigated the performance of patients with minor or mild closed head injury and age/education-matched normal controls on the Wechsler Adult Intelligence Scale-Revised (WAIS-R) and the Wechsler Memory Scale-Revised (WMS-R). The results demonstrated that the control group had significantly higher scores than the patients with closed head injury on all WAIS-R and WMS-R index scores. Further analysis revealed that the patients with closed head injury showed a greater impairment in delayed memory when directly compared to intellectual performance that was not seen in the control group. These results are discussed in relation to findings in patients with more severe closed head injury, the construction of the WAIS-R and the WMS-R, and the performance patterns of the two groups.	OHIO STATE UNIV,COLL MED,DEPT PSYCHIAT,NEUROPSYCHOL LAB,473 W 12TH AVE,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL MED,DIV HLTH PSYCHOL,COLUMBUS,OH 43210							BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BECKER DP, 1979, ARCH NEUROL-CHICAGO, V36, P750, DOI 10.1001/archneur.1979.00500480024005; BIGLER E D, 1981, Clinical Neuropsychology, V3, P13; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; BORNSTEIN RA, 1983, J CLIN PSYCHOL, V39, P470, DOI 10.1002/1097-4679(198307)39:4<470::AID-JCLP2270390403>3.0.CO;2-F; BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; Butters N., 1988, CLIN NEUROPSYCHOL, V2, P133; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; FINLAYSON MAJ, 1977, J CONSULT CLIN PSYCH, V45, P536, DOI 10.1037/0022-006X.45.4.536; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; NEWCOMBE F, 1979, HDB BEHAVIORAL NEURO, V2; RUSSELL EW, 1979, J CLIN PSYCHOL, V35, P611, DOI 10.1002/1097-4679(197907)35:3<611::AID-JCLP2270350325>3.0.CO;2-V; SCHACTER DL, 1977, CORTEX, V8, P150; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th	20	16	16	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	1991	75	3					378	381		10.3171/jns.1991.75.3.0378			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GC311	WOS:A1991GC31100007	1869937				2021-06-18	
J	HAUT, MW; PETROS, TV; FRANK, RG; HAUT, JS				HAUT, MW; PETROS, TV; FRANK, RG; HAUT, JS			SPEED OF PROCESSING WITHIN SEMANTIC MEMORY FOLLOWING SEVERE CLOSED HEAD-INJURY	BRAIN AND COGNITION			English	Article							SPREADING ACTIVATION; LEXICAL DECISION; APHASIA; DEFICIT		W VIRGINIA UNIV,MED CTR,SCH MED,DEPT NEUROL,MORGANTOWN,WV 26506; UNIV N DAKOTA,GRAND FORKS,ND 58201; UNIV MISSOURI,MED CTR,SCH MED,DEPT PHYS MED & REHABIL,COLUMBIA,MO 65201	HAUT, MW (corresponding author), W VIRGINIA UNIV,MED CTR,SCH MED,DEPT BEHAV MED & PSYCHIAT,MORGANTOWN,WV 26506, USA.			Haut, Marc/0000-0003-0235-362X			Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BLUMSTEIN SE, 1982, BRAIN LANG, V17, P301, DOI 10.1016/0093-934X(82)90023-2; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P386, DOI 10.1037/0278-7393.11.2.386; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1988, SCANDINAVIAN J REH S, V20, P33; LORCH RF, 1982, J VERB LEARN VERB BE, V21, P468, DOI 10.1016/S0022-5371(82)90736-8; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V48, P21; MILBERG W, 1981, BRAIN LANG, V14, P371, DOI 10.1016/0093-934X(81)90086-9; Miller E, 1970, Cortex, V6, P121; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; Stuss D. T., 1989, CLIN NEUROPSYCHOL, V3, P145, DOI DOI 10.1080/13854048908403287; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	26	16	17	0	8	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0278-2626			BRAIN COGNITION	Brain Cogn.	SEP	1991	17	1					31	41		10.1016/0278-2626(91)90064-F			11	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	GV410	WOS:A1991GV41000003	1781979				2021-06-18	
J	STEIN, DG				STEIN, DG			FETAL BRAIN-TISSUE GRAFTING AS THERAPY FOR BRAIN DYSFUNCTIONS - UNANSWERED QUESTIONS, UNKNOWN FACTORS, AND PRACTICAL CONCERNS	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						BRAIN DAMAGE AND TREATMENT; NEURAL TRANSPLANTS; GRAFTING INTO CNS; FUNCTIONAL RECOVERY; FUNCTIONAL ASSESSMENT OF NEURAL GRAFTS	ADRENAL CHROMAFFIN CELLS; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; NEURAL TRANSPLANTATION; AGED RATS; HIPPOCAMPAL-NEURONS; HORMONE DEFICIENCY; DOPAMINE NEURONS; CAUDATE-NUCLEUS; SEPTAL GRAFTS	Grafting of embryonic neural tissue into the brains of adult patients is being given serious consideration as therapy for a variety of degenerative and traumatic disorders. It has been argued that neural transplantation can promote functional recovery by replacement of damaged nerve cells, the reestablishment of specific nerve pathways lost as a result of injury, the release of specific neurotransmitters, or the production of factors that promote neuronal growth. This review evaluates the use of transplants to promote recovery from brain injury and highlights the kinds of questions and problems that clinicians need to consider before recommending this form of therapy to patients.		STEIN, DG (corresponding author), RUTGERS STATE UNIV, INST ANIM BEHAV, BRAIN RES & CNS PLASTIC LAB, NEWARK, NJ 07102 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 25685] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS025685] Funding Source: NIH RePORTER		AHLSKOG JE, 1990, MAYO CLIN PROC, V65, P305, DOI 10.1016/S0025-6196(12)62532-4; BACKAY R, 1990, NEURAL TRANSPLANTATI, P603; BACKLUND EO, 1985, NEURAL GRAFTING MAMM, P551; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bjorklund A, 1985, NEURAL GRAFTING MAMM, P3; Bjorklund A., 1985, NEURAL GRAFTING MAMM; BUZSAKI G, 1989, EXP NEUROL, V105, P10, DOI 10.1016/0014-4886(89)90167-2; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; CHOI DW, 1988, J NEUROSCI, V8, P185; CLARKE DJ, 1990, EXP NEUROL, V107, P11, DOI 10.1016/0014-4886(90)90059-2; COLLIER TJ, 1988, BRAIN RES, V448, P77, DOI 10.1016/0006-8993(88)91103-1; COLLIER TJ, 1988, ALZHEIMERS PARKINSON, P291; COLLIER TJ, 1985, HOMEOSTATIC FUNCTION; COTMAN CW, 1988, PROG BRAIN RES, V78, P311; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DAS GD, 1990, NEUROSCI BIOBEHAV R, V14, P389, DOI 10.1016/S0149-7634(05)80061-2; DAS GD, 1983, NEURAL TISSUE TRANSP, P1; DUNBAR GL, 1988, PHARM APPROACHES TRE, P195; Dunn EH, 1917, J COMP NEUROL, V27, P565, DOI 10.1002/cne.900270403; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FIANDACA MS, 1988, PROG BRAIN RES, V78, P287; FINE A, 1990, BRAIN RES REV, V15, P121, DOI 10.1016/0165-0173(90)90014-F; FREED WJ, 1990, SCIENCE, V250, P1434; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; FREED WJ, 1990, EXP NEUROL, V110, P139, DOI 10.1016/0014-4886(90)90026-O; GAGE FH, 1984, SCIENCE, V225, P533, DOI 10.1126/science.6539949; GAGE FH, 1986, J NEUROSCI, V6, P2837; GAGE R, 1989, NEURAL GRAFTING ALZH; GASH DM, 1985, NEUROBIOL AGING, V6, P131, DOI 10.1016/0197-4580(85)90031-4; GASH DM, 1987, J NEURAL TRANSM, P301; GIBSON MJ, 1984, SCIENCE, V225, P949, DOI 10.1126/science.6382608; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GREELEY HT, NEW ENGL J MED, V320, P1093; HANSEN JT, 1990, PROG BRAIN RES, V82, P573; HART T, 1978, BRAIN RES BULL, V3, P245, DOI 10.1016/0361-9230(78)90122-3; HODGES H, 1990, PROG BRAIN RES, V82, P347; IKEGAMI S, 1989, NEUROSCI LETT, V101, P17, DOI 10.1016/0304-3940(89)90433-3; KESSLAK JP, 1986, EXP NEUROL, V92, P377, DOI 10.1016/0014-4886(86)90089-0; KRIEGER DT, 1982, NATURE, V298, P468, DOI 10.1038/298468a0; LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427; LEE SM, 1990, PROG BRAIN RES, V82, P301; LINDEVALL O, 1985, ARCH NEUROL-CHICAGO, V6, P157; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LOPEZLOZANO JJ, 1990, TRANSPL P, V22, P2243; LOW WC, 1985, NEURAL GRAFTING MAMM, P575; MADRAZO I, 1990, TRANSPLANTATION, V49, P1026, DOI 10.1097/00007890-199005000-00047; MADRAZO I, 1988, NEW ENGL J MED, V318, P51; MAHADIK SP, 1988, DRUG DEVELOP RES, V15, P337, DOI 10.1002/ddr.430150402; MATTSON MP, 1990, INT J DEV NEUROSCI, V8, P399, DOI 10.1016/0736-5748(90)90073-B; MUDRICK LA, 1989, EXP BRAIN RES, V76, P333; MUFSON EJ, 1987, BRAIN RES, V401, P162, DOI 10.1016/0006-8993(87)91177-2; NEUHAUS RJ, 1989, NAT REV, V41, P12; NICOLAS MK, 1988, TRANSPLANTATION MAMM, P249; Nieto-Sampedro M, 1988, PHARM APPROACHES TRE, P301; NIETOSAMPEDRO M, 1984, P NATL ACAD SCI-BIOL, V81, P6250, DOI 10.1073/pnas.81.19.6250; NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219; NILSSON OG, 1990, BRAIN RES, V515, P193, DOI 10.1016/0006-8993(90)90596-4; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Polezhaev LV, 1972, LOSS RESTORATION REG; POLLACK IF, 1990, EXP NEUROL, V108, P114, DOI 10.1016/0014-4886(90)90017-M; PORTERASANCHEZ A, 1987, NEUROPLASTICITY NEW, P9; Ramon y Cajal S, 1928, DEGENERATION REGENER; RAO K, 1988, PROG BRAIN RES, V78, P281; Sabel B., 1988, PHARM APPROACHES TRE; SEGAL M, 1989, BRAIN RES, V500, P139, DOI 10.1016/0006-8993(89)90307-7; SILVERMAN AJ, 1990, BIOL REPROD, V42, P29, DOI 10.1095/biolreprod42.1.29; SLADEK JR, 1988, PROG BRAIN RES, V78, P497; STEECECOLLIER K, 1990, EXP NEUROL, V110, P201, DOI 10.1016/0014-4886(90)90031-M; STEIN DG, 1985, BEHAV NEURAL BIOL, V44, P266, DOI 10.1016/S0163-1047(85)90282-1; STEIN DG, 1988, BEHAV NEUROSCI, V102, P260, DOI 10.1037/0735-7044.102.2.260; STEIN DG, 1985, NEUROBIOL AGING, V6, P157, DOI 10.1016/0197-4580(85)90036-3; STEIN DG, 1987, ANN NY ACAD SCI, V495, P444, DOI 10.1111/j.1749-6632.1987.tb23693.x; STEIN DG, 1988, BRAIN INJURY RECOVER, P249; STEWART GR, 1990, EXP NEUROL, V110, P127, DOI 10.1016/0014-4886(90)90057-Y; STODDARD SL, 1989, EXP NEUROL, V104, P218, DOI 10.1016/0014-4886(89)90032-0; SUNDE N, 1984, NATURE, V310, P51, DOI 10.1038/310051a0; TAYLOR JR, 1990, NEURAL TRANSPLANTATI, P573; THOMPSON WG, 1890, NY MED J, V51, P701; WIDNER H, 1988, BRAIN RES REV, V13, P287, DOI 10.1016/0165-0173(88)90010-0; WILL B, 1989, RES PER ALZ, P189; WILL B, 1988, PHARM APPROACHES TRE, P339; WOODRUFF ML, 1990, PROG BRAIN RES, V82, P367; YONG VW, 1989, J NEUROL SCI, V94, P51, DOI 10.1016/0022-510X(89)90217-7	83	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	SEP	1991	3	3					170	189		10.1097/00008506-199109000-00002			20	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	GD661	WOS:A1991GD66100002	10150141				2021-06-18	
J	WOOLF, PD; COX, C; MCDONALD, JV; KELLY, M; NICHOLS, D; HAMILL, RW; FELICIANO, DV				WOOLF, PD; COX, C; MCDONALD, JV; KELLY, M; NICHOLS, D; HAMILL, RW; FELICIANO, DV			EFFECTS OF INTOXICATION ON THE CATECHOLAMINE RESPONSE TO MULTISYSTEM INJURY	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	4TH ANNUAL SCIENTIFIC ASSEMBLY OF THE EASTERN ASSOC FOR SURGERY OF TRAUMA	JAN 17-19, 1991	LONGBOAT KEY, FL	E ASSOC SURG TRAUMA			TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; PLASMA-CATECHOLAMINES; ALCOHOL; STRESS; NECROSIS; ETHANOL	In patients suffering isolated head trauma, we have previously shown that levels of circulating catecholamines obtained within 48 hours of trauma correlate with the severity of brain injury and predict outcome and that intoxication blunts this response. The effects of alcohol on the increase in catecholamines in systemically injured patients, however, have not been well defined. From 1983 to 1990, 78 patients (74% male; median age 30 years) with blunt head and multisystem injury, who also had alcohol levels measured within 5 hours of injury, were studied. Norepinephrine and epinephrine levels were assayed by a radioenzymatic technique. Injury severity was assessed by the admission Glasgow Coma Scale (GCS) score (4-15; median, 12), the Injury Severity Score (ISS) (13-50; median, 25) and the volume of blood products administered within the first 24 hours (0-14.4 L; median, 0.5 L). The impact of alcohol on the norepinephrine response to injury was analyzed using multiple linear regression models, including polynomial interaction terms. Norepinephrine levels significantly (p < 0.0001) correlated with the GCS score and ISS. However, alcohol significantly lowered the norepinephrine response to decreasing GCS score (R = 0.49, p < 0.002) and to increasing ISS (R = 0.51, p < 0.0006). The blunting of the catecholamine response was most marked in those severely injured. The rise in norepinephrine concentrations seen with increasing volume of blood replacement was not affected by intoxication. An association between injury severity and epinephrine levels was also present, but not as consistently. Epinephrine concentrations rose with falling GCS score and with increasing ISS values, but unlike norepinephrine, there were no apparent effects of alcohol on changes in epinephrine levels. Thus, in patients suffering head and multisystem injury, catecholamine changes reflect the severity of injury using three different scalers. Furthermore, intoxication blunts only the norepinephrine component of this important biologic response.	UNIV ROCHESTER,DEPT MED,ROCHESTER,NY 14642; UNIV ROCHESTER,DIV BIOSTAT,ROCHESTER,NY 14642; UNIV ROCHESTER,DIV NEUROSURG,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT NEUROL,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT SURG,ROCHESTER,NY 14642					NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA 7066] Funding Source: Medline		ARKWRIGHT PD, 1982, CIRCULATION, V66, P515, DOI 10.1161/01.CIR.66.3.515; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1985, CENTRAL NERVOUS SYST, P139; CRUICKSHANK JM, 1987, LANCET, V2, P585, DOI 10.1016/s0140-6736(87)92984-9; DAVIES CL, 1984, J TRAUMA, V24, P99, DOI 10.1097/00005373-198402000-00002; DRAPER NR, 1981, APPLIED REGRESSION A; EISENHOFER G, 1986, J PSYCHOSOM RES, V30, P93, DOI 10.1016/0022-3999(86)90070-X; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HOWES LG, 1985, CLIN SCI, V69, P423, DOI 10.1042/cs0690423; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; JAGGER J, 1908, NEUROSURGERY, V15, P303; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; MCLEOD AA, 1982, BRIT HEART J, V47, P221; MUIZELAAR JP, 1985, CENTRAL NERVOUS SYST, P123; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; NEWSOME HH, 1988, J TRAUMA, V28, P1, DOI 10.1097/00005373-198801000-00001; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; TEASDALE G, 1974, LANCET, V2, P81; UDELSMAN R, 1987, J CLIN ENDOCR METAB, V64, P986, DOI 10.1210/jcem-64-5-986; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; WILMORE DW, 1974, ANN SURG, V180, P653, DOI 10.1097/00000658-197410000-00031; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; 1985, ABBREVIATED INJURY S	31	16	17	0	3	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1991	31	9					1271	1276		10.1097/00005373-199109000-00012			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	GH567	WOS:A1991GH56700013	1920559				2021-06-18	
J	RAPPAPORT, M; HEMMERLE, AV; RAPPAPORT, ML				RAPPAPORT, M; HEMMERLE, AV; RAPPAPORT, ML			INTERMEDIATE AND LONG LATENCY SEPS IN RELATION TO CLINICAL DISABILITY IN TRAUMATIC BRAIN INJURY PATIENTS	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article										RAPPAPORT, M (corresponding author), AGNEWS DEV CTR,UC BRAIN FUNCT STUDY UNIT,RES BLDG,SAN JOSE,CA 95134, USA.						ALLISON T, 1987, EVOKED POTENTIALS, V3, pCH6; DATE ES, 1988, CLIN ELECTROENCEPHAL, V19, P144, DOI 10.1177/155005948801900308; JABBARI B, 1987, ELECTROEN CLIN NEURO, V67, P289, DOI 10.1016/0013-4694(87)90115-5; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; LARREA LG, 1988, ELECTROEN CLIN NEURO, V71, P180, DOI 10.1016/0168-5597(88)90003-2; NEWLON PG, 1983, REHABILITATION HEAD, pCH6; RAPPAPORT M, 1985, CLIN ELECTROENCEPHAL, V16, P183, DOI 10.1177/155005948501600404; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rappaport M, 1989, J HEAD TRAUMA REHAB, V4, P45; SCHWARZ G, 1988, Klinische Wochenschrift, V66, P48; SPHELMANN R, 1985, EVOKED POTENTIAL PRI, pCH15; TOMBERG C, 1989, ELECTROEN CLIN NEURO, V74, P347, DOI 10.1016/0168-5597(89)90002-6; VEILLEUX M, 1987, ELECTROEN CLIN NEURO, V68, P415, DOI 10.1016/0168-5597(87)90053-0; ZEMAN BD, 1989, J NEUROL NEUROSUR PS, V52, P242, DOI 10.1136/jnnp.52.2.242	16	16	16	0	0	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	OCT	1990	21	4					188	191		10.1177/155005949002100406			4	Engineering, Biomedical; Clinical Neurology	Engineering; Neurosciences & Neurology	EB322	WOS:A1990EB32200005	2225467				2021-06-18	
J	Chute, DL; Conn, G; Dipasquale, MC; Hoag, M				Chute, Douglas L.; Conn, Gretchen; Dipasquale, Madeline C.; Hoag, Melanie			ProsthesisWare: A New Class of Software Supporting the Activities of Daily Living	NEUROPSYCHOLOGY			English	Article						Cognitive rehabilitation; aphasia; head injury; prosthesis; Macintosh computer; HyperCard		To use the microcomputer as a prosthetic tool in rehabilitation has a number of advantages over using it as a tutor for cognitive retraining. As a tool, the microcomputer program directly addresses ecologically relevant issues in activities of daily living. New classes of software like HyperCard (TM) and MacLaboratory Controller (c), can be readily customized for each patient's needs. Unlike tutors used for cognitive retraining, rehabilitation tools provide prosthetic support that does not presuppose any required reorganization or restructuring of damaged neural tissue. As this new approach to using microcomputers in rehabilitation is implemented, new types and styles of neuropsychological assessment will need to evolve, especially to provide sequential monitoring for adjustments to various iterations of the computer programs. We used the Macintosh (TM) computer with ProsthesisWare tools written in HyperCard for its ease and speed of design. The standard user interface relieves a patient's memory overburden by providing external function and sequencing cues. We present the case of Cecelia R., a patient with an expressive aphasia secondary to a traumatic brain injury. The development of successive approximations of a speech prosthesis for her-SpeakEasy (c), SpeakEasier (c), and SpeakEasiest (c)-illustrates how new hardware and software capabilities permit the rapid iterative design and redesign of cognitive prosthesis tools. This case also illustrates some limitations of the approach and new requirements that would be placed on the rehabilitation environment. We conclude that the emergence of ProsthesisWare constitutes a new application of microcomputers in rehabilitation that offers utilitarian prosthetic aids for the everyday activities of daily living for a select group of people with cognitive impairments.	[Chute, Douglas L.] Drexel Univ, Neuropsychol Program, Philadelphia, PA 19104 USA; Drexel Univ, Software Dev Grp, Philadelphia, PA 19104 USA	Chute, DL (corresponding author), Drexel Univ, Neuropsychol Program, Philadelphia, PA 19104 USA.				Apple Computer, Inc.; Drexel University; Solon Foundation	This work was supported in part by grants to Douglas L. Chute from Apple Computer, Inc., Drexel University, and the Solon Foundation. The authors thank Professor T.T. Hewett for his insights and suggestions.	ACKER MB, 1986, CLIN NEUROPSYCHOL IN, P85; BOWE F, 1984, PERSONAL COMPUTERS S; Bracy O, 1985, COGNITIVE REHABILITA, P10; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; Carr J, 1980, BEHAV MODIFICATION M; CHASE WG, 1981, COGNITIVE SKILLS THE; CHUTE D, 1988, MACLABORATORY PSYCHO; Chute D. L., 1987, ACAD COMP, V2, P40; Chute D. L., 1987, M NAT AC NEUR CHIC; Chute D. L., 1981, M CAN PSYCH ASS TOR; Chute D.L., 1988, SPEAKEASY SPEAKEASIE; CHUTE DL, 1986, BEHAV RES METH INSTR, V18, P205, DOI 10.3758/BF03201023; CHUTE DL, 1987, BEHAV RES METH INSTR, V19, P205, DOI 10.3758/BF03203786; Cohen N.J., 1984, NEUROPSYCHOLOGY MEMO, P83; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; DILLER L, 1981, J CONSULT CLIN PSYCH, V49, P822, DOI 10.1037/0022-006X.49.6.822; Erikson R.C., 1977, PSYCHOL BULL, V84, P1130; Gianutsos R., 1980, J REHABIL, P37; GIANUTSOS R, 1987, REHABIL PSYCHOL, P453; Hayden M.E., 1987, WORKSH M NAT AC NEUR; Hewett T. T., 1986, PEOPLE COMPUTERS DES; Hewett T.T., 1986, BEHAV RES INSTRUMENT, V19, P188; Hutchins S., 1987, J REHABILITATION RES, V25, P340; Incagnoli T., 1986, CLIN APPL NEUROPSYCH, P1; INTONSPETERSON MJ, 1986, J EXP PSYCHOL GEN, V115, P267, DOI 10.1037/0096-3445.115.3.267; Jacoby L.L., 1979, LEVELS PROCESSING HU, P1; JONES GH, 1979, B BRIT PSYCHOL SOC, V32, P165; Lynch W. J., 1988, M PHIL CLIN NEUR GRO; MAYER NH, 1986, CLIN NEUROPSYCHOLOGY, P205; Moscovitch M., 1984, NEUROPSYCHOLOGY MEMO, P104; Parkin A. J., 1987, MEMORY AMNESIA INTRO; Perkey M. N., 1986, BEHAV RES INSTRUMENT, V19, P196; Prigatano G., 1987, J NEUROL NEUROSUR PS, V47, P505; Russell EW, 1987, NEUROPSYCHOLOGY, V1, P2; Schacter DL, 1986, CLIN NEUROPSYCHOLOGY, P257; Schofield J. M., 1981, MICROCOMPUTER BASED; Shute G., 1986, ARCH CLIN NEUROPSYCH, V1, P259; Smith A. L., 1984, Collegiate Microcomputer, V2, P107; Syndulko K., 1983, AGING TECHNOLOGICAL; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; Wilson B. A., 1985, RIVERMEADE BEHAV MEM; Wilson B.A, 1987, REHABILITATION MEMOR; WILSON BA, 1983, EVERYDAY MEMORY ACTI	43	16	16	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology		1988	2	1					41	57		10.1037//0894-4105.2.1.41			17	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	V44JQ	WOS:000209745700005					2021-06-18	
J	DAVIDOFF, G; ROTH, E; MORRIS, J; BLEIBERG, J; MEYER, PR				DAVIDOFF, G; ROTH, E; MORRIS, J; BLEIBERG, J; MEYER, PR			ASSESSMENT OF CLOSED HEAD-INJURY IN TRAUMA-RELATED SPINAL-CORD INJURY	PARAPLEGIA			English	Article									REHABIL INST CHICAGO,DEPT PSYCHOL,ROOM 903,345 E SUPER,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT REHABIL MED,CHICAGO,IL 60611				Bleiberg, Joseph/0000-0003-0867-5494				0	16	16	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0031-1758			PARAPLEGIA	Paraplegia		1986	24	2					97	104		10.1038/sc.1986.13			8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	A9933	WOS:A1986A993300004	3714296	Bronze			2021-06-18	
J	OLBRICH, HM; NAU, HE; ZERBIN, D; LANCZOS, L; LODEMANN, E; ENGELMEIER, MP; GROTE, W				OLBRICH, HM; NAU, HE; ZERBIN, D; LANCZOS, L; LODEMANN, E; ENGELMEIER, MP; GROTE, W			CLINICAL-APPLICATION OF EVENT RELATED POTENTIALS IN PATIENTS WITH BRAIN-TUMORS AND TRAUMATIC HEAD-INJURIES	ACTA NEUROCHIRURGICA			English	Article									UNIV ESSEN GESAMTHSCH KLINIKUM,NEUROSURG CLIN,D-4300 ESSEN 1,FED REP GER	OLBRICH, HM (corresponding author), UNIV ESSEN GESAMTHSCH KLINIKUM,DEPT PSYCHIAT,HUFELANDSTR 55,D-4300 ESSEN 1,FED REP GER.						Brown W S, 1982, Bull Los Angeles Neurol Soc, V47, P91; Callaway E, 1978, EVENT RELATED BRAIN; COURJON J, 1982, CLIN APPLICATIONS EV; GAILLARD AW, 1983, TUTORIALS EVENT RELA; GOODIN DS, 1978, BRAIN, V101, P635, DOI 10.1093/brain/101.4.635; HALGREN E, 1980, SCIENCE, V210, P803, DOI 10.1126/science.7434000; HALLIDAY AM, 1982, EVOKED POTENTIALS CL; JOHNSON R, 1983, 7 INT C EV REL POT B, P182; KNIGHT RT, 1980, ELECTROEN CLIN NEURO, V50, P112, DOI 10.1016/0013-4694(80)90328-4; MICHEL F, 1980, BRAIN LANG, V10, P367, DOI 10.1016/0093-934X(80)90062-0; OKADA YC, 1983, ELECTROEN CLIN NEURO, V55, P417, DOI 10.1016/0013-4694(83)90130-X; OWEN MP, 1980, SURG NEUROL, V12, P271; PERONNET F, 1977, PROGR CLIN NEUROPHYS, V2, P130; PFEFFERBAUM A, 1984, ELECTROEN CLIN NEURO, V59, P104, DOI 10.1016/0168-5597(84)90027-3; RAUDZENS PA, 1982, J NEUROSURG, V57, P341, DOI 10.3171/jns.1982.57.3.0341; RITTER W, 1983, PSYCHOPHYSIOLOGY, V20, P168, DOI 10.1111/j.1469-8986.1983.tb03283.x; Ritter W., 1983, TUTORIALS ERP RES EN, P143; SIMSON R, 1976, ELECTROEN CLIN NEURO, V40, P33, DOI 10.1016/0013-4694(76)90177-2; Syndulko K, 1982, Adv Neurol, V32, P279; VAUGHAN HG, 1970, ELECTROEN CLIN NEURO, V28, P360, DOI 10.1016/0013-4694(70)90228-2; Wood C C, 1980, Prog Brain Res, V54, P51, DOI 10.1016/S0079-6123(08)61605-2; WOOD CC, 1984, ANN NY ACAD SCI, V425, P681, DOI 10.1111/j.1749-6632.1984.tb23595.x; 1977, CIPS COLLEGIUM INT P	23	16	16	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1986	80	3-4					116	122		10.1007/BF01812285			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	C0732	WOS:A1986C073200009	3716890				2021-06-18	
J	FROEDE, RC; LINDSEY, D; STEINBRONN, K				FROEDE, RC; LINDSEY, D; STEINBRONN, K			SUDDEN UNEXPECTED DEATH FROM CARDIAC CONCUSSION (COMMOTIO CORDIS) WITH UNUSUAL LEGAL COMPLICATIONS	JOURNAL OF FORENSIC SCIENCES			English	Article										FROEDE, RC (corresponding author), UNIV ARIZONA,COLL MED,DEPT PATHOL,TUCSON,AZ 85724, USA.							0	16	16	0	1	AMER SOC TESTING MATERIALS	W CONSHOHOCKEN	100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959	0022-1198			J FORENSIC SCI	J. Forensic Sci.		1979	24	4					752	756					5	Medicine, Legal	Legal Medicine	HR364	WOS:A1979HR36400006	541638				2021-06-18	
J	LEWIN, W				LEWIN, W			FACTORS IN THE MORTALITY OF CLOSED HEAD INJURIES	BMJ-BRITISH MEDICAL JOURNAL			English	Article																CAMERON GR, 1948, BRIT MED J, V1, P965, DOI 10.1136/bmj.1.4559.965; Cumings JN, 1942, J NEUROL PSYCHIATRY, V5, P40, DOI 10.1136/jnnp.5.1-2.40; ECHOLS DH, 1950, SURGERY, V28, P801; HIGGINS G, 1951, LANCET, V260, P1295; HIGGINS G, 1953, IN PRESS LANCET; HOWKINS J, 1946, LANCET, V250, P488; JAMES TGI, 1951, LANCET, V261, P45; LEWIN W, 1949, ANN ROY COLL SURG, V5, P240; Munro D., 1938, CRANIO CEREBRAL INJU	9	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal		1953	1	4822					1239	1244		10.1136/bmj.1.4822.1239			6	Medicine, General & Internal	General & Internal Medicine	XV212	WOS:A1953XV21200002	13042203	Green Published			2021-06-18	
J	WARD, JW; CLARK, SL				WARD, JW; CLARK, SL			THE ELECTROENCEPHALOGRAM IN EXPERIMENTAL CONCUSSION AND RELATED CONDITIONS	JOURNAL OF NEUROPHYSIOLOGY			English	Article																Beecher HK, 1938, J NEUROPHYSIOL, V1, P324; BERGER H, 1931, ARCH PSYCHIAT NERVEN, V94, P20; Clark S. L., 1943, SURG GYNECOL OBSTET, V77, P403; CLARK SL, 1945, J NEUROPHYSIOL, V8, P99; Clark SL, 1939, J NEUROPHYSIOL, V2, P19; CLARK SL, 1944, ANAT REC, V88, P10; Cobb WA, 1944, J NEUROL NEUROSUR PS, V7, P96, DOI 10.1136/jnnp.7.3-4.96; Cushing H, 1902, AM J MED SCI, V124, P375, DOI 10.1097/00000441-190209000-00001; DOW RS, 1945, J NEUROPHYSIOL, V8, P161; Dubner HH, 1939, J NEUROPHYSIOL, V2, P142; Forster FM, 1942, ARCH NEURO PSYCHIATR, V47, P449, DOI 10.1001/archneurpsyc.1942.02290030107009; GERMAN WJ, 1944, J NEUROSURG, V1, P350; Gibbs FA, 1940, J NEUROPHYSIOL, V3, P49; GIBBS FA, 1941, T AM NEUROL ASSOC, V67, P143; Grinker RR, 1938, J NEUROPHYSIOL, V1, P573; Groat RA, 1944, AM J PHYSIOL, V141, P0117; Heinbecker P, 1940, J NEUROPHYSIOL, V3, P219; Hoagland H, 1939, J NEUROPHYSIOL, V2, P276; Holbourn AHS, 1943, LANCET, V2, P438; Kennard MA, 1943, J NEUROPHYSIOL, V6, P233; KREMS A. D., 1942, PROC SOC EXP BIOL AND MED, V49, P73; Krohn PL, 1942, LANCET, V1, P252; Lowenbach H, 1940, J NEUROL PSYCHIATRY, V3, P336, DOI 10.1136/jnnp.3.4.336; Mott FW, 1916, LANCET, V1, P331; Obrador S, 1943, J NEUROPHYSIOL, V6, P81; Rubin MA, 1940, J NEUROPHYSIOL, V3, P33; Rubin MA, 1938, J NEUROPHYSIOL, V1, P527; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; Stewart WA, 1941, B JOHNS HOPKINS HOSP, V69, P240; Sugar O, 1938, J NEUROPHYSIOL, V1, P558; TENCATE J, 1940, ARCH NEERL PHYSIOL, V25, P27; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Walter W G, 1937, Proc R Soc Med, V30, P579; Walter WG, 1938, J NEUROL PSYCHIATRY, V1, P359, DOI 10.1136/jnnp.1.4.359; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; Williams D, 1939, BRAIN, V62, P321, DOI 10.1093/brain/62.3.321; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561	37	16	16	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.		1948	11	2					59	74					16	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	XZ785	WOS:A1948XZ78500001	18905648				2021-06-18	
J	Osborn, GR				Osborn, GR			Pulmonary concussion ("Blast")	BMJ-BRITISH MEDICAL JOURNAL			English	Article																[Anonymous], 1940, BRIT MED J, V1, P992; Hadfield G, 1941, BRIT MED J, V1941, P77, DOI 10.1136/bmj.1.4176.77; Hadfield G, 1940, LANCET, V2, P478; Osborn G R, 1940, Br Med J, V2, P317; Ross JM, 1941, BMJ-BRIT MED J, V1941, P79, DOI 10.1136/bmj.1.4176.79; TAYLOR, 1928, PRINCIPLES PRACTICE, V1, P609; TAYLOR, 1928, PRINCIPLES PRACTICE, V1, P613; Zuckerman S, 1940, LANCET, V2, P219; ZUCKERMAN S, 1941, BRIT MED J, V1, P94; 1940, LANCET, V2, P369	10	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN-JUN	1941	1941		1				506	510		10.1136/bmj.1.4187.506			5	Medicine, General & Internal	General & Internal Medicine	V07WL	WOS:000200531500535	20783596	Green Published			2021-06-18	
J	Giromini, L; Barbosa, F; Coga, G; Azeredo, A; Viglione, DJ; Zennaro, A				Giromini, Luciano; Barbosa, Fernando; Coga, Giulia; Azeredo, Andreia; Viglione, Donald J.; Zennaro, Alessandro			Using the inventory of problems-29 (IOP-29) with the Test of Memory Malingering (TOMM) in symptom validity assessment: A study with a Portuguese sample of experimental feigners	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Brain Injury; depression; IOP-29; malingering; order; TOMM	STRUCTURED-INVENTORY; RETENTION TRIAL; RESPONSE BIAS; PERFORMANCE; INJURY; PAIN; VALIDATION; DISABILITY; BELIEFS; ISSUES	This study tested whether combining the Inventory of Problems - 29 (IOP-29) with the Test of Memory Malingering (TOMM) would increase sensitivity in the detection of experimentally feigned mental health problems, compared to using either test alone. Additionally, it also evaluated (a) the effects of administration order of these two tests and (b) the cultural and linguistic applicability of these tests to a European Portuguese population. The IOP-29 and TOMM were administered to a community sample of 100 nonclinical, adult volunteers from Portugal, with the instruction to feign mental health problems. Half were instructed to feign mild traumatic brain injury (mTBI) symptoms, half were instructed to feign major depression. Administration order had no effects on the tests' scores, and both measures produced excellent sensitivity values, ranging from .82 to .98 for the TOMM, and from .88 to 1.00 for the IOP-29, when using standard a priori cutoff scores. More importantly, combining the results of TOMM with those of IOP-29 notably increased sensitivity compared to using either test alone. This study thus supports the use of the IOP-29 together with the TOMM in multimethod symptom validity assessments and provides initial evidence that both tests can be used also in Portugal.	[Giromini, Luciano; Coga, Giulia; Zennaro, Alessandro] Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, TO, Italy; [Barbosa, Fernando; Azeredo, Andreia] Univ Porto, Fac Psychol & Educ Sci, Porto, Portugal; [Viglione, Donald J.] Alliant Int Univ San Diego, Calif Sch Profess Psychol, San Diego, CA USA	Giromini, L (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, TO, Italy.	luciano.giromini@unito.it	Giromini, Luciano/AAF-9386-2019; Barbosa, Fernando/L-3836-2014	Giromini, Luciano/0000-0002-9540-4803; Barbosa, Fernando/0000-0002-3310-5613			Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Booksh RL, 2007, ARCH CLIN NEUROPSYCH, V22, P87, DOI 10.1016/j.acn.2006.11.002; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brislin R.W., 1980, METHODOLOGY-EUR, P389; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher JN., 2001, MINNESOTA MULTIPHASI; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Derogatis L. R, 1994, SCL90 R ADM SCORING; Derogatis LR, 1977, SCL 90 MANUAL I SCOR; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Gervais R.O., 2001, J FORENSIC NEUROPSYC, V2, DOI [DOI 10.1300/J151V02N02_01, https://doi.org/10.1300/J151v02n02_01]; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Giromini L, 2020, J PERS ASSESS, V102, P563, DOI 10.1080/00223891.2019.1566914; Giromini L, 2018, PSYCHOL INJ LAW, V11, P340, DOI 10.1007/s12207-018-9314-1; Gottfried E, 2016, ASSESSMENT, V23, P672, DOI 10.1177/1073191115599640; Gottfried ED, 2017, INT J FORENSIC MENT, V16, P197, DOI 10.1080/14999013.2017.1288667; Green P., 2004, MED SYMPTOM VALIDITY; Green P., 1996, WORD MEMORY TEST USE; Green R.L., 1991, MMPI 2 MMPI INTERPRE; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P117, DOI 10.1016/j.acn.2005.06.009; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson G.L., 2001, J FORENSIC NEUROPSYC, V2, P19, DOI [https://doi.org/10.1300/J151v02n01_02, DOI 10.1300/J151v02n01_02]; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Merten Thomas, 2013, Clínica y Salud, V24, P129, DOI 10.5093/cl2013a14; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey L. C., 1991, PERSONALITY ASSESSME; Morey LC., 2007, PERSONALITY ASSESSME; Mota M., 2008, PSIQUIATRIA PSICOLOG, V2, P23; Rainville J, 1997, SPINE, V22, P2016, DOI 10.1097/00007632-199709010-00016; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rey A., 1958, LEXAMEN CLINIQUE PSY; Rogers R., 2011, RES METHODS FORENSIC, P174; Rogers R., 2018, CLIN ASSESSMENT MALI; Rogers R., 2008, CLIN ASSESSMENT MALI; Ryan JJ, 2010, APPL NEUROPSYCHOL, V17, P246, DOI 10.1080/09084282.2010.499802; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Simoes M., 2012, ANAL PSICOL, V28, P209, DOI [10.14417/ap.269, DOI 10.14417/AP.269]; Slick D., 1997, VICTORIA SYMPTOM VAL; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; Van de Vijver F, 1996, EUR PSYCHOL, V1, P89, DOI 10.1027/1016-9040.1.2.89; van Impelen A, 2014, CLIN NEUROPSYCHOL, V28, P1336, DOI 10.1080/13854046.2014.984763; Viglione DJ, 2001, ASSESSMENT, V8, P237, DOI 10.1177/107319110100800301; Viglione DJ, 2017, J PERS ASSESS, V99, P534, DOI 10.1080/00223891.2016.1233882; Weiner I.B., 2003, HDB PSYCHOL, V10, P95, DOI [DOI 10.1002/0471264385.WEI1005, 10.1002/0471264385.wei1005]; Widows MR., 2005, SIMS STRUCTURED INVE; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; Young G, 2014, INT LIBR ETH LAW NEW, V56, P1, DOI 10.1007/978-94-007-7899-3; Zakzanis K. K., 1998, NEUROPSYCHOLOGICAL D; Zhu JJ, 2000, CLIN NEUROPSYCHOL, V14, P461, DOI 10.1076/clin.14.4.461.7197	63	15	15	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 1	2020	27	6					504	516		10.1080/23279095.2019.1570929			13	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	NR9QH	WOS:000571896700003	30773041				2021-06-18	
J	Mantovani, E; Zucchella, C; Bottiroli, S; Federico, A; Giugno, R; Sandrini, G; Chiamulera, C; Tamburin, S				Mantovani, Elisa; Zucchella, Chiara; Bottiroli, Sara; Federico, Angela; Giugno, Rosalba; Sandrini, Giorgio; Chiamulera, Cristiano; Tamburin, Stefano			Telemedicine and Virtual Reality for Cognitive Rehabilitation: A Roadmap for the COVID-19 Pandemic	FRONTIERS IN NEUROLOGY			English	Article						augmented reality; cognitive; COVID-19; rehabilitation; telemedicine; virtual reality	THERAPY; TELEREHABILITATION; NEUROREHABILITATION; NEUROLOGY; DISEASE	The current COVID-19 pandemic presents unprecedented new challenges to public health and medical care delivery. To control viral transmission, social distancing measures have been implemented all over the world, interrupting the access to routine medical care for many individuals with neurological diseases. Cognitive disorders are common in many neurological conditions, e.g., stroke, traumatic brain injury, Alzheimer's disease, and other types of dementia, Parkinson's disease and parkinsonian syndromes, and multiple sclerosis, and should be addressed by cognitive rehabilitation interventions. To be effective, cognitive rehabilitation programs must be intensive and prolonged over time; however, the current virus containment measures are hampering their implementation. Moreover, the reduced access to cognitive rehabilitation might worsen the relationship between the patient and the healthcare professional. Urgent measures to address issues connected to COVID-19 pandemic are, therefore, needed. Remote communication technologies are increasingly regarded as potential effective options to support health care interventions, including neurorehabilitation and cognitive rehabilitation. Among them, telemedicine, virtual reality, augmented reality, and serious games could be in the forefront of these efforts. We will briefly review current evidence-based recommendations on the efficacy of cognitive rehabilitation and offer a perspective on the role of tele- and virtual rehabilitation to achieve adequate cognitive stimulation in the era of social distancing related to COVID-19 pandemic. In particular, we will discuss issues related to their diffusion and propose a roadmap to address them. Methodological and technological improvements might lead to a paradigm shift to promote the delivery of cognitive rehabilitation to people with reduced mobility and in remote regions.	[Mantovani, Elisa; Federico, Angela; Tamburin, Stefano] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Zucchella, Chiara] Verona Univ Hosp, Neurol Sect, Dept Neurosci, Verona, Italy; [Bottiroli, Sara] Giustino Fortunato Univ, Benevento, Italy; [Bottiroli, Sara; Sandrini, Giorgio] IRCCS Mondino Fdn, Pavia, Italy; [Giugno, Rosalba] Univ Verona, Dept Comp Sci, Verona, Italy; [Sandrini, Giorgio] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy; [Chiamulera, Cristiano] Univ Verona, Dept Diagnost & Publ Hlth, Verona, Italy	Tamburin, S (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	stefano.tamburin@univr.it	Mantovani, Elisa/AAO-8695-2021	Mantovani, Elisa/0000-0003-3717-7697			Alzahrani H, 2018, J PARKINSON DIS, V8, P233, DOI 10.3233/JPD-171250; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Bahar-Fuchs A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003260.pub2; Bartolo Michelangelo, 2020, FRONT NEUROL, V11; Bergquist TF, 1997, NEUROREHABILITATION, V8, P49, DOI 10.3233/NRE-1997-8107; Bird K., 1975, TELEMEDICINE EXPLORA, P89; Bloem BR, 2020, JAMA NEUROL, V77, P927, DOI 10.1001/jamaneurol.2020.1452; Bowen A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub3; Brennan D, 2010, INT J TELEREHABILITA, V2, P31, DOI [10.5195/IJT.2010.6063, 10.5195/ijt.2010.6063]; Burdea G.C., 2003, PRESENCE TELEOPERATO, V12, P663, DOI [10.1162/105474603322955950, DOI 10.1162/105474603322955950]; Cappa SF, 2005, EUR J NEUROL, V12, P665; Centers for Disease Control & Prevention, 2020, PUBL HLTH REC COMM R; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cotelli M, 2019, J TELEMED TELECARE, V25, P67, DOI 10.1177/1357633X17740390; Danzl Megan M, 2012, J Allied Health, V41, P35; Dial HR, 2019, CLIN INTERV AGING, V14, P453, DOI 10.2147/CIA.S178878; Duncan C, 2010, SCOT MED J, V55, P3, DOI 10.1258/rsmsmj.55.1.3; Ferguson C, 2020, AM J HOSP PALLIAT ME, V37, P809, DOI 10.1177/1049909120901525; Ferrer-Garcia M, 2013, J CONTEMP PSYCHOTHER, V43, P207, DOI 10.1007/s10879-013-9240-1; Gaggioli A, 2009, ADV TECHNOLOGIES REH; Gamito P, 2014, INT J DISABILITY HUM, V13, P337, DOI DOI 10.1515/ijdhd-2014-0325; Gamito P, 2017, DISABIL REHABIL, V39, P385, DOI 10.3109/09638288.2014.934925; Gamito P, 2011, VIRTUAL REALITY, P515; Giglioli IAC, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/862942; Griffiths PC, 2018, AM J ALZHEIMERS DIS, V33, P269, DOI 10.1177/1533317518755331; Grossman SN, 2020, NEUROLOGY, V94, P1077, DOI 10.1212/WNL.0000000000009677; Hopwood J, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9548; Isernia S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01206; Khademi M, 2013, IEEE ENG MED BIO, P4613, DOI 10.1109/EMBC.2013.6610575; Khattab S, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1744199; Kovaleva M, 2019, J APPL GERONTOL, V38, P159, DOI 10.1177/0733464817705958; Kumar KS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007935.pub2; Lange B, 2012, DISABIL REHABIL, V34, P1863, DOI 10.3109/09638288.2012.670029; Laver KE, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010255.pub3; Laver KE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008349.pub2; Li JH, 2014, CYBERPSYCH BEH SOC N, V17, P519, DOI 10.1089/cyber.2013.0481; Lohse KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093318; LOPES S, 2018, FRONT PSYCHOL, V0009; Lupinacci G, 2018, DISABIL REHABIL-ASSI, V13, P234, DOI 10.1080/17483107.2017.1306592; Maggio MG, 2020, EXPERT REV MED DEVIC, V17, P473, DOI 10.1080/17434440.2020.1776607; Maggio MG, 2019, J NATL MED ASSOC, V111, P457, DOI 10.1016/j.jnma.2019.01.003; Manera V, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01243; Manera V, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00024; MATAMALAGOMEZ M, 2020, FRONT NEUROL, V0011; McCallum Simon, 2013, Serious Games Development and Applications. 4th International Conference, SGDA 2013. Proceedings: LNCS 8101, P15, DOI 10.1007/978-3-642-40790-1_2; McCann RA, 2014, J ANXIETY DISORD, V28, P625, DOI 10.1016/j.janxdis.2014.05.010; Mishkind MC, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0836-0; Montaner J, 2020, STROKE, V51, P2307, DOI 10.1161/STROKEAHA.120.030106; Moreno Alexander, 2019, Alzheimers Dement (N Y), V5, P834, DOI 10.1016/j.trci.2019.09.016; Moyle W, 2018, GERONTOLOGIST, V58, P478, DOI 10.1093/geront/gnw270; Nesbitt TS, 2000, WESTERN J MED, V173, P169, DOI 10.1136/ewjm.173.3.169-a; PLATZ T, 2020, FRONT NEUROL, V0011; Riva G, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00164; Robert PH, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00054; Rogers JM, 2018, NEUROPSYCHOL REV, V28, P285, DOI 10.1007/s11065-018-9378-4; Rosti-Otajarvi EM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009131.pub3; Rouse R, 2015, DIGIT CREAT, V26, P175, DOI 10.1080/14626268.2015.1100123; Sokolov AA, 2020, CURR OPIN NEUROL, V33, P239, DOI 10.1097/WCO.0000000000000791; Solomon MD, 2020, NEW ENGL J MED, V383, P691, DOI 10.1056/NEJMc2015630; Tarr MJ, 2002, NAT NEUROSCI, V5, P1089, DOI 10.1038/nn948; Tchero H, 2018, J MED INTERNET RES, V20, DOI 10.2196/10867; Teo WP, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00284; Tieri G, 2018, EXPERT REV MED DEVIC, V15, P107, DOI 10.1080/17434440.2018.1425613; Triberti S, 2014, CYBERPSYCH BEH SOC N, V17, P335, DOI 10.1089/cyber.2014.0054; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; Valimaki M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009928.pub2; van der Kuil MNA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00846; van der Linden SD, 2018, J NEURO-ONCOL, V137, P523, DOI 10.1007/s11060-017-2738-8; Weiss PL, 2006, TXB NEURAL REPAIR RE, P182; Wiederhold BK, 2019, CYBERPSYCH BEH SOC N, V22, P3, DOI 10.1089/cyber.2018.29136.bkw; Wiederhold BK, 2018, CYBERPSYCH BEH SOC N, V21, P341, DOI 10.1089/cyber.2018.29114.bkw; Winters JM, 2002, ANNU REV BIOMED ENG, V4, P287, DOI 10.1146/annurev.bioeng.4.112801.121923; Wolf SL, 2002, NEUROLOGIST, V8, P325, DOI 10.1097/00127893-200211000-00001; Wollersheim D., 2010, INT J EMERGING TECHN, V8, P85; World Health Organization, 2010, TEL OPP DEV MEMB STA; Yeroushalmi S, 2020, J TELEMED TELECARE, V26, P400, DOI 10.1177/1357633X19840097; Zhou RJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00597; Zucchella C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01058; Zyda M, 2005, COMPUTER, V38, P25, DOI 10.1109/MC.2005.297	81	15	15	11	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 15	2020	11								926	10.3389/fneur.2020.00926			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	NY2AD	WOS:000576198100001	33041963	DOAJ Gold, Green Published			2021-06-18	
J	Provencio, JJ; Hemphill, JC; Claassen, J; Edlow, BL; Helbok, R; Vespa, PM; Diringer, MN; Polizzotto, L; Shutter, L; Suarez, JI; Stevens, RD; Hanley, DF; Akbari, Y; Bleck, TP; Boly, M; Foreman, B; Giacino, JT; Hartings, JA; Human, T; Kondziella, D; Ling, GSF; Mayer, SA; McNett, M; Menon, DK; Meyfroidt, G; Monti, MM; Park, S; Pouratian, N; Puybasset, L; Rohaut, B; Rosenthal, ES; Schiff, ND; Sharshar, T; Wagner, A; Whyte, J; Olson, DM				Provencio, J. Javier; Hemphill, J. Claude; Claassen, Jan; Edlow, Brian L.; Helbok, Raimund; Vespa, Paul M.; Diringer, Michael N.; Polizzotto, Len; Shutter, Lori; Suarez, Jose, I; Stevens, Robert D.; Hanley, Daniel F.; Akbari, Yama; Bleck, Thomas P.; Boly, Melanie; Foreman, Brandon; Giacino, Joseph T.; Hartings, Jed A.; Human, Theresa; Kondziella, Daniel; Ling, Geoffrey S. F.; Mayer, Stephan A.; McNett, Molly; Menon, David K.; Meyfroidt, Geert; Monti, Martin M.; Park, Soojin; Pouratian, Nader; Puybasset, Louis; Rohaut, Benjamin; Rosenthal, Eric S.; Schiff, Nicholas D.; Sharshar, Tarek; Wagner, Amy; Whyte, John; Olson, DaiWai M.		Neurocritical Care Soc Curing Coma	The Curing Coma Campaign: Framing Initial Scientific Challenges-Proceedings of the First Curing Coma Campaign Scientific Advisory Council Meeting	NEUROCRITICAL CARE			English	Article						Coma; Endotype; Biomarker; Consciousness; Recovery	TRAUMATIC BRAIN-INJURY; WITHDRAWAL; DISORDERS	Coma and disordered consciousness are common manifestations of acute neurological conditions and are among the most pervasive and challenging aspects of treatment in neurocritical care. Gaps exist in patient assessment, outcome prognostication, and treatment directed specifically at improving consciousness and cognitive recovery. In 2019, the Neurocritical Care Society (NCS) launched the Curing Coma Campaign in order to address the "grand challenge" of improving the management of patients with coma and decreased consciousness. One of the first steps was to bring together a Scientific Advisory Council including coma scientists, neurointensivists, neurorehabilitationists, and implementation experts in order to address the current scientific landscape and begin to develop a framework on how to move forward. This manuscript describes the proceedings of the first Curing Coma Campaign Scientific Advisory Council meeting which occurred in conjunction with the NCS Annual Meeting in October 2019 in Vancouver. Specifically, three major pillars were identified which should be considered: endotyping of coma and disorders of consciousness, biomarkers, and proof-of-concept clinical trials. Each is summarized with regard to current approach, benefits to the patient, family, and clinicians, and next steps. Integration of these three pillars will be essential to the success of the Curing Coma Campaign as will expanding the "curing coma community" to ensure broad participation of clinicians, scientists, and patient advocates with the goal of identifying and implementing treatments to fundamentally improve the outcome of patients.	[Provencio, J. Javier] Univ Virginia, Dept Neurol & Neurosci, Charlottesville, VA USA; [Hemphill, J. Claude] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Neurol, Bldg 1,Room 101,1001 Potrero Ave, San Francisco, CA 94110 USA; [Claassen, Jan; Park, Soojin] Columbia Univ, New York Presbyterian Hosp, Irving Med Ctr, Dept Neurol, New York, NY USA; [Edlow, Brian L.; Rosenthal, Eric S.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurocrit Care, Innsbruck, Austria; [Vespa, Paul M.] UCLA, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Vespa, Paul M.; Pouratian, Nader] UCLA, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Diringer, Michael N.; Human, Theresa] Washington Univ, Barnes Jewish Hosp, Dept Neurol, St Louis, MO USA; [Polizzotto, Len] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Shutter, Lori] Univ Pittsburgh, Dept Crit Care Med, UPMC Hlth Syst, Pittsburgh, PA USA; [Shutter, Lori] Univ Pittsburgh, Dept Neurol, UPMC Hlth Syst, Pittsburgh, PA 15260 USA; [Shutter, Lori] Univ Pittsburgh, Dept Neurosurg, UPMC Hlth Syst, Pittsburgh, PA USA; [Suarez, Jose, I; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Suarez, Jose, I; Stevens, Robert D.; Ling, Geoffrey S. F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Suarez, Jose, I; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Hanley, Daniel F.] Johns Hopkins Univ, Div Brain Injury Outcomes, Baltimore, MD USA; [Akbari, Yama] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Akbari, Yama] Univ Calif Irvine, Dept Neurosurg, Irvine, CA USA; [Akbari, Yama] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA; [Bleck, Thomas P.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Boly, Melanie] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Foreman, Brandon] Univ Cincinnati, Coll Med, Gardner Neurosci Inst, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Giacino, Joseph T.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Hartings, Jed A.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Human, Theresa] Washington Univ, Barnes Jewish Hosp, Dept Neurosurg, St Louis, MO 63110 USA; [Kondziella, Daniel] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Copenhagen, Denmark; [Mayer, Stephan A.] New York Med Coll, Dept Neurol, Valhalla, NY 10595 USA; [Mayer, Stephan A.] New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA; [McNett, Molly] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Meyfroidt, Geert] Univ Hosp Leuven, Dept & Lab Intens Care Med, Leuven, Belgium; [Meyfroidt, Geert] Katholieke Univ Leuven, Leuven, Belgium; [Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Puybasset, Louis] Sorbonne Univ, Piti Salpetriere Hosp, AP HP, DMU DREAM,GRC 29,Dept Anesthesiol & Crit Care, F-75013 Paris, France; [Rohaut, Benjamin] Sorbonne Univ, Pitie Salpetriere Hosp, Dept Neurol, NeuroICU, Paris, France; [Schiff, Nicholas D.] Weill Cornell Med, Dept Neurol, New York, NY USA; [Schiff, Nicholas D.] Weill Cornell Med, Dept Neurosci, New York, NY USA; [Schiff, Nicholas D.] Weill Cornell Med, Dept Med Eth, New York, NY USA; [Sharshar, Tarek] Paris Descartes Univ, St Anne Hosp, Neuroanesthesiol & Intens Care Med, Paris, France; [Sharshar, Tarek] Inst Pasteur, Expt Neuropathol, Infect & Epidemiol Dept, Paris, France; [Wagner, Amy] Univ Pittsburgh, Clin & Translat Sci Inst, Dept Phys Med & Rehabil, Dept Neurosci, Pittsburgh, PA USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Olson, DaiWai M.] Univ Texas Southwestern, Dept Neurol & Neurotherapeut, Dallas, TX USA	Hemphill, JC (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Neurol, Bldg 1,Room 101,1001 Potrero Ave, San Francisco, CA 94110 USA.	claude.hemphill@ucsf.edu	Provencio, Jose Javier/AAG-5114-2021; Rohaut, Benjamin/O-9250-2017; Helbok, Raimund/AAA-8361-2021; Giacino, Joseph/AAF-1952-2021; Rosenthal, Eric/A-2085-2017	Provencio, Jose Javier/0000-0003-1298-1806; Rohaut, Benjamin/0000-0001-6752-8756; Giacino, Joseph/0000-0002-7916-9698; Rosenthal, Eric/0000-0003-3900-356X; Shutter, Lori/0000-0002-1390-0628; Hemphill, Claude/0000-0003-4019-7525; Kondziella, Daniel/0000-0001-5562-9808	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR001416] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS105950] Funding Source: Medline		Brogan ME, 2014, J CRIT CARE, V29, P679, DOI 10.1016/j.jcrc.2014.04.014; Giacino Joseph T, 2008, Handb Clin Neurol, V90, P99, DOI 10.1016/S0072-9752(07)01706-X; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Rubin M, 2017, CURR OPIN CRIT CARE, V23, P134, DOI 10.1097/MCC.0000000000000396; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786	6	15	15	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2020	33	1					1	12		10.1007/s12028-020-01028-9		JUN 2020	12	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	MT1KH	WOS:000542494500001	32578124	Green Published, Other Gold			2021-06-18	
J	Bailey, ZS; Nilson, E; Bates, JA; Oyalowo, A; Hockey, KS; Sajja, VSSS; Thorpe, C; Rogers, H; Dunn, B; Frey, AS; Billings, MJ; Sholar, CA; Hermundstad, A; Kumar, C; VandeVord, PJ; Rzigalinski, BA				Bailey, Zachary S.; Nilson, Eric; Bates, John A.; Oyalowo, Adewole; Hockey, Kevin S.; Sajja, Venkata Siva Sai Sujith; Thorpe, Chevon; Rogers, Heidi; Dunn, Bryce; Frey, Aaron S.; Billings, Marc J.; Sholar, Christopher A.; Hermundstad, Amy; Kumar, Challa; VandeVord, Pamela J.; Rzigalinski, Beverly A.			Cerium Oxide Nanoparticles Improve Outcome after In Vitro and In Vivo Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerium oxide; nanoparticles; oxidative stress; traumatic brain injury	OXIDATIVE STRESS; SUPEROXIDE-PRODUCTION; NITRIC-OXIDE; MODEL; NEUROPROTECTION; IMPAIRMENT; RADICALS; DEFICITS; MEMORY; CELLS	Mild traumatic brain injury results in aberrant free radical generation, which is associated with oxidative stress, secondary injury signaling cascades, mitochondrial dysfunction, and poor functional outcome. Pharmacological targeting of free radicals with antioxidants has been examined as an approach to treatment, but has met with limited success in clinical trials. Conventional antioxidants that are currently available scavenge a single free radical before they are destroyed in the process. Here, we report for the first time that a novel regenerative cerium oxide nanoparticle antioxidant reduces neuronal death and calcium dysregulation after in vitro trauma. Further, using an in vivo model of mild lateral fluid percussion brain injury in the rat, we report that cerium oxide nanoparticles also preserve endogenous antioxidant systems, decrease macromolecular free radical damage, and improve cognitive function. Taken together, our results demonstrate that cerium oxide nanoparticles are a novel nanopharmaceutical with potential for mitigating neuropathological effects of mild traumatic brain injury and modifying the course of recovery.	[Bailey, Zachary S.; Oyalowo, Adewole; Sajja, Venkata Siva Sai Sujith; Dunn, Bryce; Hermundstad, Amy; VandeVord, Pamela J.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Nilson, Eric; Bates, John A.; Hockey, Kevin S.; Thorpe, Chevon; Rogers, Heidi; Frey, Aaron S.; Billings, Marc J.; Sholar, Christopher A.; Rzigalinski, Beverly A.] Edward Via Coll Osteopath Med, Dept Pharmacol, Res 2 Bldg,1861 Pratt Dr, Blacksburg, VA 24060 USA; [Kumar, Challa] Harvard Univ, Rowland Inst Sci, Integrated Mesoscale Architectures Sustainable Ca, Cambridge, MA 02138 USA	Rzigalinski, BA (corresponding author), Edward Via Coll Osteopath Med, Dept Pharmacol, Res 2 Bldg,1861 Pratt Dr, Blacksburg, VA 24060 USA.	brzigali@vcom.vt.edu	Sajja, Sujith/I-5289-2019; Nanozymes, Nanozymes/D-8197-2019	Sajja, Sujith/0000-0002-1992-9501; Oyalowo, Adewole/0000-0003-0342-6683; Dunn, Bryce/0000-0002-4399-1516; Thorpe, Chevon/0000-0003-4328-7876			Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Andrievsky GV, 2009, FREE RADICAL BIO MED, V47, P786, DOI 10.1016/j.freeradbiomed.2009.06.016; Aneggi E, 2006, J ALLOY COMPD, V408, P1096, DOI 10.1016/j.jallcom.2004.12.113; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Brahmajothi MV, 2014, ANTIOXID REDOX SIGN, V21, P1823, DOI 10.1089/ars.2013.5664; Celardo I, 2011, ACS NANO, V5, P4537, DOI 10.1021/nn200126a; Celardo I, 2011, NANOSCALE, V3, P1411, DOI 10.1039/c0nr00875c; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Ciofani G, 2013, PHARM RES-DORDR, V30, P2133, DOI 10.1007/s11095-013-1071-y; Cuzzocrea S, 2000, BRAIN RES, V875, P96, DOI 10.1016/S0006-8993(00)02582-8; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Estevez AY, 2011, FREE RADICAL BIO MED, V51, P1155, DOI 10.1016/j.freeradbiomed.2011.06.006; Frey A., 2014, CERIUM OXIDE NANOPAR; Gaskin S, 2010, BEHAV PROCESS, V83, P61, DOI 10.1016/j.beproc.2009.10.003; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Hu GH, 2003, J NEUROSURG, V98, P393, DOI 10.3171/jns.2003.98.2.0393; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Jortner B.S., 2015, SOC TOX ANN M; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; Kohl M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.080402; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Li Y, 2016, ENVIRON TOXICOL PHAR, V44, P25, DOI 10.1016/j.etap.2016.04.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1980, ACTA PHYSIOL SCAND, P19; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Polak P, 2015, NANOMED-NANOTECHNOL, V11, P1467, DOI 10.1016/j.nano.2015.03.005; Pratico D, 2002, ARCH NEUROL-CHICAGO, V59, P972, DOI 10.1001/archneur.59.6.972; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rzigalinski B.A., 2011, NANOMEDICINE HLTH DI, P100; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Rzigalinski BA, 2006, NANOMEDICINE-UK, V1, P399, DOI 10.2217/17435889.1.4.399; Saito I, 1998, NEUROSURGERY, V42, P269, DOI 10.1097/00006123-199802000-00038; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Schreiber D., 1995, P 1995 INT RES C BIO, P233; Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129; Singh N, 2007, ANN NY ACAD SCI, V1122, P219, DOI 10.1196/annals.1403.015; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Tsai YY, 2007, NANOMEDICINE-UK, V2, P325, DOI 10.2217/17435889.2.3.325; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Walkey C, 2015, ENVIRON SCI-NANO, V2, P33, DOI 10.1039/c4en00138a; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Whiting M, 2009, J NEUROTRAUM, V26, pA101; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; Xiang JY, 2016, ACS APPL MATER INTER, V8, P4489, DOI 10.1021/acsami.6b00158; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	56	15	15	4	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1452	1462		10.1089/neu.2016.4644			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000537075800008	27733104	Green Published, Other Gold			2021-06-18	
J	Cordes, T; Lucas, A; Divakaruni, AS; Murphy, AN; Cabrales, P; Metallo, CM				Cordes, Thekla; Lucas, Alfredo; Divakaruni, Ajit S.; Murphy, Anne N.; Cabrales, Pedro; Metallo, Christian M.			Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury	MOLECULAR METABOLISM			English	Article						Itaconate; Succinate dehydrogenase (SDH); Cerebral ischemia/reperfusion (IR); Redox stress; Mitochondrial metabolism; Brain injury	ISCHEMIA-REPERFUSION; SUCCINATE-DEHYDROGENASE; TCA CYCLE; NRF2; MITOCHONDRIA; MECHANISMS; INHIBITION; PATHOPHYSIOLOGY; DYSFUNCTION; PATHWAYS	Objectives: Cerebral ischemia/reperfusion (IR) drives oxidative stress and injurious metabolic processes that lead to redox imbalance, inflammation, and tissue damage. However, the key mediators of reperfusion injury remain unclear, and therefore, there is considerable interest in therapeutically targeting metabolism and the cellular response to oxidative stress. Methods: The objective of this study was to investigate the molecular, metabolic, and physiological impact of itaconate treatment to mitigate reperfusion injuries in in vitro and in vivo model systems. We conducted metabolic flux and bioenergetic studies in response to exogenous itaconate treatment in cultures of primary rat cortical neurons and astrocytes. In addition, we administered itaconate to mouse models of cerebral reperfusion injury with ischemia or traumatic brain injury followed by hemorrhagic shock resuscitation. We quantitatively characterized the metabolite levels, neurological behavior, markers of redox stress, leukocyte adhesion, arterial blood flow, and arteriolar diameter in the brains of the treated/untreated mice. Results: We demonstrate that the "immunometabolite" itaconate slowed tricarboxylic acid (TCA) cycle metabolism and buffered redox imbalance via succinate dehydrogenase (SDH) inhibition and induction of anti-oxidative stress response in primary cultures of astrocytes and neurons. The addition of itaconate to reperfusion fluids after mouse cerebral IR injury increased glutathione levels and reduced reactive oxygen/ nitrogen species (ROS/RNS) to improve neurological function. Plasma organic acids increased post-reperfusion injury, while administration of itaconate normalized these metabolites. In mouse cranial window models, itaconate significantly improved hemodynamics while reducing leukocyte adhesion. Further, itaconate supplementation increased survival in mice experiencing traumatic brain injury (TBI) and hemorrhagic shock. Conclusions: We hypothesize that itaconate transiently inhibits SDH to gradually "awaken" mitochondria! function upon reperfusion that minimizes ROS and tissue damage. Collectively, our data indicate that itaconate acts as a mitochondrial regulator that controls redox metabolism to improve physiological outcomes associated with IR injury. (C) 2019 The Authors. Published by Elsevier GmbH.	[Cordes, Thekla; Lucas, Alfredo; Cabrales, Pedro; Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Divakaruni, Ajit S.; Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Divakaruni, Ajit S.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Metallo, CM (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	cmetallo@ucsd.edu	Cordes, Thekla/AAQ-4465-2020	Cordes, Thekla/0000-0002-8097-191X; Lucas, Alfredo/0000-0001-9439-735X	NIH Common Fund Metabolite Standards Synthesis Core (NHLBI) [HHSN268201300022C]; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01CA188652, R01CA234245]; NSF CAREER AwardNational Science Foundation (NSF)NSF - Office of the Director (OD) [1454425]; Camille and Henry Dreyfus Teacher-Scholar Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HL126945 NHLBI, R01 HL138116 NHLBI, R01NS087611 NINDS, R21NS104513 NINDS]; Deutsche Forschungsgesellschaft, Germany (German Research Foundation)German Research Foundation (DFG) [CO1488/1-1]	We thank all of the members of the Metallo and Cabrales Laboratories, United States for support and helpful discussions. We thank the NIH Common Fund Metabolite Standards Synthesis Core (NHLBI contract no. HHSN268201300022C) for providing isotopic labeled itaconate ([U-<SUP>13</SUP>C<INF>5</INF>]itaconate). This study was supported, in part, by US National Institutes of Health (NIH) grants R01CA188652 and R01CA234245 (C.M.M.), NSF CAREER Award #1454425 (C.M.M.), a Camille and Henry Dreyfus Teacher-Scholar Award (C.M.M.), NIH grants R01 HL126945 NHLBI (P.C.), R01 HL138116 NHLBI (P.C.), R01NS087611 NINDS (A.N.M.), R21NS104513 NINDS (A.N.M.), and Deutsche Forschungsgesellschaft, Germany (German Research Foundation) (CO1488/1-1 to T.C).	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Acosta S, 2012, J THROMB THROMBOLYS, V33, P355, DOI 10.1007/s11239-011-0660-z; ADLER J, 1957, J BIOL CHEM, V229, P865; Andreyev A, 2018, NEUROCHEM INT, V117, P15, DOI 10.1016/j.neuint.2017.10.003; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z; BOOTH AN, 1952, J BIOL CHEM, V195, P697; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Burwell LS, 2008, ANTIOXID REDOX SIGN, V10, P579, DOI 10.1089/ars.2007.1845; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chen FF, 2019, P NATL ACAD SCI USA, V116, P20644, DOI 10.1073/pnas.1908770116; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cordes T, 2019, METHODS MOL BIOL, V1978, P219, DOI 10.1007/978-1-4939-9236-2_14; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Cordes T, 2015, ANNU REV NUTR, V35, P451, DOI 10.1146/annurev-nutr-071714-034243; Dekker SE, 2018, J NEUROSCI RES, V96, P711, DOI 10.1002/jnr.24125; Divakaruni AS, 2017, J CELL BIOL, V216, P1091, DOI 10.1083/jcb.201612067; Divakaruni Ajit S, 2014, Curr Protoc Toxicol, V60, DOI 10.1002/0471140856.tx2502s60; Dorsch Nicholas W C, 2002, Curr Opin Crit Care, V8, P128; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Emmrich R, 1939, HOPPE SEYLERS Z PHYS; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Kim HJ, 2011, METHODS MOL BIOL, V793, P63, DOI 10.1007/978-1-61779-328-8_4; Kohlhauer M, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0727-0; KOOY NW, 1994, FREE RADICAL BIO MED, V16, P149, DOI 10.1016/0891-5849(94)90138-4; Kushnareva YE, 2005, J BIOL CHEM, V280, P28894, DOI 10.1074/jbc.M503090200; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; McCord J.M, 1987, FEDERATION P; Meiser Johannes, 2018, Oncotarget, V9, P32098, DOI 10.18632/oncotarget.25956; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2018, NATURE, V556, P113, DOI [10.1038/nature25986, 10.1038/s41586-018-0353-2]; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mindea Stefan A, 2006, Neurosurg Focus, V21, pE13; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Murakami S, 2015, FREE RADICAL BIO MED, V88, P168, DOI 10.1016/j.freeradbiomed.2015.06.030; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nemeth B, 2016, FASEB J, V30, P286, DOI 10.1096/fj.15-279398; Prakash A, 2015, SHOCK, V44, P272, DOI 10.1097/SHK.0000000000000415; Romero R, 2017, NAT MED, V23, P1362, DOI 10.1038/nm.4407; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sayin VI, 2017, ELIFE, V6, DOI 10.7554/eLife.28083; Seim GL, 2019, NAT METAB, V1, P731, DOI 10.1038/s42255-019-0083-2; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shen HY, 2017, CELL, V171, P771, DOI 10.1016/j.cell.2017.09.051; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Sims CA, 2001, CRIT CARE MED, V29, P1513, DOI 10.1097/00003246-200108000-00003; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; Sun XW, 2019, FASEB J, V33, P12929, DOI 10.1096/fj.201900887RR; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Thompson JW, 2015, J BIOENERG BIOMEMBR, V47, P101, DOI 10.1007/s10863-014-9574-8; Toledo-Pereyra Luis H, 2004, Exp Clin Transplant, V2, P174; Valls-Lacalle L, 2016, CARDIOVASC RES, V109, P374, DOI 10.1093/cvr/cvv279; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wilhelmsen K, 2014, J BIOL CHEM, V289, P13079, DOI 10.1074/jbc.M113.536953; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Zhao DX, 2018, MOL CELL, V69, P699, DOI 10.1016/j.molcel.2018.01.017; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	67	15	15	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2212-8778			MOL METAB	Mol. Metab.	FEB	2020	32						122	135		10.1016/j.molmet.2019.11.019			14	Endocrinology & Metabolism	Endocrinology & Metabolism	KH7QA	WOS:000510843500010	32029222	DOAJ Gold, Green Published			2021-06-18	
J	Alirezaei, Z; Pourhanifeh, MH; Borran, S; Nejati, M; Mirzaei, H; Hamblin, MR				Alirezaei, Zahra; Pourhanifeh, Mohammad Hossein; Borran, Sarina; Nejati, Majid; Mirzaei, Hamed; Hamblin, Michael R.			Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders	MOLECULAR NEUROBIOLOGY			English	Article						Neurofilament light chain; Biomarker; Neurodegenerative disorders; Magnetic resonance imaging; Diffusion tensor imaging	AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBROSPINAL-FLUID BIOMARKERS; MARIE-TOOTH-DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; TRAUMATIC BRAIN-INJURY; WHITE-MATTER DAMAGE; MULTIPLE-SCLEROSIS; NEURODEGENERATIVE DISEASES; DIFFERENTIAL-DIAGNOSIS; PARKINSONS-DISEASE	The search for diagnostic and prognostic biomarkers for neurodegenerative conditions is of high importance, since these disorders may present difficulties in differential diagnosis. Biomarkers with high sensitivity and specificity are required. Neurofilament light chain (NfL) is a unique biomarker related to axonal damage and neural cell death, which is elevated in a number of neurological disorders, and can be detected in cerebrospinal fluid (CSF), as well as blood, serum, or plasma samples. Although the NfL concentration in CSF is higher than that in blood, blood measurement may be easier in practice due to its lesser invasiveness, reproducibility, and convenience. Many studies have investigated NfL in both CSF and serum/plasma as a potential biomarker of neurodegenerative disorders. Neuroimaging biomarkers can also potentially improve detection of CNS-related disorders at an early stage. Magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) are sensitive techniques to visualize neuroaxonal loss. Therefore, investigating the combination of NfL levels with indices extracted from MRI and DTI scans could potentially improve diagnosis of CNS-related disorders. This review summarizes the evidence for NfL being a reliable biomarker in the early detection and disease management in several CNS-related disorders. Moreover, we highlight the correlation between MRI and NfL and ask whether they can be combined.	[Alirezaei, Zahra] Isfahan Univ Med Sci, Sch Med, Dept Med Phys, Esfahan, Iran; [Pourhanifeh, Mohammad Hossein; Mirzaei, Hamed] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran; [Borran, Sarina] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran; [Nejati, Majid] Kashan Univ Med Sci, Anat Sci Res Ctr, Kashan, Iran; [Hamblin, Michael R.] Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, 40 Blossom St, Boston, MA 02114 USA	Mirzaei, H (corresponding author), Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran.; Hamblin, MR (corresponding author), Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, 40 Blossom St, Boston, MA 02114 USA.	zahra.alirezaei@gmail.com; mhph.lord.1996@gmail.com; Sarina.borran@sbmu.ac.ir; mnejatimt@gmail.com; mirzaei-h@kaums.ac.ir; HAMBLIN@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605; mirzaei, hamed/0000-0002-9399-8281	National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI050875, R21AI121700] Funding Source: Medline; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI050875, R21 AI121700] Funding Source: Medline		Abdo WF, 2007, NEUROBIOL AGING, V28, P742, DOI 10.1016/j.neurobiolaging.2006.03.010; Abe A, 2009, J HUM GENET, V54, P94, DOI 10.1038/jhg.2008.13; Abu-Rumeileh S, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-017-0331-1; Acosta-Cabronero J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00266; Agosta F, 2012, CEREB CORTEX, V22, P2705, DOI 10.1093/cercor/bhr288; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Arrambide G, 2016, NEUROLOGY, V87, P1076, DOI 10.1212/WNL.0000000000003085; Baldaranov D, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00567; Barro C, 2018, BRAIN, V141, P2382, DOI 10.1093/brain/awy154; Bergman J, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000271; Burman J, 2014, ACTA NEUROL SCAND, V130, P81, DOI 10.1111/ane.12239; Burns A, 2011, DEMENT GERIATR COGN, V31, P158, DOI 10.1159/000324438; Byrne LM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat7108; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Cai LS, 2018, NEUROPSYCH DIS TREAT, V14, P2241, DOI 10.2147/NDT.S173280; Califf RM, 2018, EXP BIOL MED, V243, P213, DOI 10.1177/1535370217750088; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Chitnis T, 2018, ANN CLIN TRANSL NEUR, V5, P1478, DOI 10.1002/acn3.638; Clement A, 2017, NEUROSCIENCE, V354, P101, DOI 10.1016/j.neuroscience.2017.04.030; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Constantinescu R, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00187; Constantinescu R, 2009, PARKINSONISM RELAT D, V15, P245, DOI 10.1016/j.parkreldis.2008.05.012; Cousins DA, 2012, CNS NEUROSCI THER, V18, P201, DOI 10.1111/j.1755-5949.2011.00280.x; de Jong D, 2007, J NEUROL NEUROSUR PS, V78, P936, DOI 10.1136/jnnp.2006.107326; De Marchis GM, 2018, EUR J NEUROL, V25, P562, DOI 10.1111/ene.13554; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Disanto G, 2016, J NEUROL NEUROSUR PS, V87, P126, DOI 10.1136/jnnp-2014-309690; Duering M, 2018, J STROKE, V20, P228, DOI 10.5853/jos.2017.02565; Feneberg E, 2018, NEUROLOGY, V90, pE22, DOI 10.1212/WNL.0000000000004761; Foerster BR, 2013, ACAD RADIOL, V20, P1099, DOI 10.1016/j.acra.2013.03.017; Fornari E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.014; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gaiani A, 2017, JAMA NEUROL, V74, P525, DOI 10.1001/jamaneurol.2016.5398; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gattringer T, 2017, NEUROLOGY, V89, P2108, DOI 10.1212/WNL.0000000000004645; Gille B., 2018, NEUROPATHOLOGY APPL, V45, P291; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Glass M, 2000, NEUROSCIENCE, V97, P505, DOI 10.1016/S0306-4522(00)00008-7; Goryunov D, 2008, J NEUROCHEM, V104, P1536, DOI 10.1111/j.1471-4159.2007.05103.x; Grossman M, 2014, JAMA NEUROL, V71, P442, DOI 10.1001/jamaneurol.2013.6064; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Haghighi S, 2004, ACTA NEUROL SCAND, V109, P97, DOI 10.1034/j.1600-0404.2003.00197.x; Hakansson I, 2017, EUR J NEUROL, V24, P703, DOI 10.1111/ene.13274; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Halliday GM, 2014, MOVEMENT DISORD, V29, P634, DOI 10.1002/mds.25857; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Henley SMD, 2005, CURR OPIN NEUROL, V18, P698, DOI 10.1097/01.wco.0000186842.51129.cb; Herbert MK, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00091; Herrmann W, 2011, CLIN CHEM LAB MED, V49, P435, DOI 10.1515/CCLM.2011.084; Hoy AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173982; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Huizinga R, 2008, TRENDS IMMUNOL, V29, P54, DOI 10.1016/j.it.2007.11.002; Huizinga R, 2007, J NEUROPATH EXP NEUR, V66, P295, DOI 10.1097/nen.0b013e318040ad5c; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Isgren A, 2017, BRAIN BEHAV IMMUN, V65, P195, DOI 10.1016/j.bbi.2017.05.002; Jakobsson J, 2014, NEUROPSYCHOPHARMACOL, V39, P2349, DOI 10.1038/npp.2014.81; Jeromin A, 2017, ADV NEUROBIOL, V15, P491, DOI 10.1007/978-3-319-57193-5_20; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Kantarci K, 2017, NEUROBIOL AGING, V56, P172, DOI 10.1016/j.neurobiolaging.2017.04.024; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Khalil M, 2016, NEUROLOGY, V87, P1068, DOI 10.1212/WNL.0000000000003107; Koikkalainen J, 2016, NEUROIMAGE-CLIN, V11, P435, DOI 10.1016/j.nicl.2016.02.019; Kuhle J, 2017, NEUROLOGY, V88, P826, DOI 10.1212/WNL.0000000000003653; Kuhle J, 2016, MULT SCLER J, V22, P1550, DOI 10.1177/1352458515623365; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Kuhle J, 2015, NEUROLOGY, V84, P1639, DOI 10.1212/WNL.0000000000001491; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Landqvist Waldo Maria, 2013, BMC Neurol, V13, P54, DOI 10.1186/1471-2377-13-54; Lewczuk P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0404-9; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Lim J, 2015, DEV CELL, V32, P491, DOI 10.1016/j.devcel.2015.02.002; Lin YS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35766-w; Lista S, 2017, NEUROCHEM INT, V108, P355, DOI 10.1016/j.neuint.2017.05.010; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Magdalinou NK, 2017, PARKINSONISM RELAT D, V37, P65, DOI 10.1016/j.parkreldis.2017.01.016; Mahoney CJ, 2015, ANN NEUROL, V77, P33, DOI 10.1002/ana.24296; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; Masjuan J, 2006, NEUROLOGY, V66, P576, DOI 10.1212/01.wnl.0000198253.35119.83; Mattsson N, 2008, MOL MED REP, V1, P757, DOI 10.3892/mmr_00000025; Mattsson N, 2016, EMBO MOL MED, V8, P1184, DOI 10.15252/emmm.201606540; Meeter LH, 2016, ANN CLIN TRANSL NEUR, V3, P623, DOI 10.1002/acn3.325; Meeter LHH, 2018, NEUROLOGY, V90, pE1231, DOI 10.1212/WNL.0000000000005261; Mellgren A, 2007, NEUROLOGY, V69, P1536, DOI 10.1212/01.wnl.0000277635.05973.55; Menke RAL, 2015, ANN CLIN TRANSL NEUR, V2, P748, DOI 10.1002/acn3.212; Miller DB, 2015, METABOLISM, V64, pS40, DOI 10.1016/j.metabol.2014.10.030; Munemoto M, 2011, J CLIN NEUROSCI, V18, P478, DOI 10.1016/j.jocn.2010.07.141; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Niemela V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172762; Niikado Matias, 2018, J GERONTOL A-BIOL, V74, P442; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Norgren N, 2002, HYBRIDOMA HYBRIDOM, V21, P53, DOI 10.1089/15368590252917647; Novakova L, 2017, NEUROLOGY, V89, P2230, DOI 10.1212/WNL.0000000000004683; Novakova L, 2017, J NEUROCHEM, V141, P296, DOI 10.1111/jnc.13881; Novakova L, 2017, MULT SCLER J, V23, P62, DOI 10.1177/1352458516639384; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; Oeckl P, 2016, AMYOTROPH LAT SCL FR, V17, P404, DOI 10.3109/21678421.2016.1167913; Panman JL, 2017, ALZHEIMERS DEMENT, V13, P751, DOI [10.1016/j.jalz.2017.06.992, DOI 10.1016/J.JALZ.2017.06.992]; Perez-Olle R, 2002, J CELL SCI, V115, P4937, DOI 10.1242/jcs.00148; Perez-Olle R, 2004, HUM MOL GENET, V13, P2207, DOI 10.1093/hmg/ddh236; Petzold A, 2007, NEURODEGENER DIS, V4, P185, DOI 10.1159/000101843; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Petzold A, 2009, J NEUROL SCI, V279, P76, DOI 10.1016/j.jns.2008.12.037; Piehl F, 2018, MULT SCLER J, V24, P1046, DOI 10.1177/1352458517715132; Pijnenburg YAL, 2007, DEMENT GERIATR COGN, V23, P225, DOI 10.1159/000099473; Pijnenburg Yolande A L, 2015, Alzheimers Dement (Amst), V1, P505, DOI 10.1016/j.dadm.2015.11.001; Poesen K, 2017, NEUROLOGY, V88, P2302, DOI 10.1212/WNL.0000000000004029; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reiner A, 2011, INT REV NEUROBIOL, V98, P325, DOI [10.1016/B978-0-12-387003-2.00014-8, 10.1016/B978-0-12-381328-2.00014-6]; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Rolstad S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127100; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Rossi D, 2018, J NEUROL, V265, P510, DOI 10.1007/s00415-017-8730-6; Rostgaard N, 2018, NEUROLOGY, V90, pE157, DOI 10.1212/WNL.0000000000004799; Sadaba MC, 2012, J NEUROIMMUNOL, V247, P86, DOI 10.1016/j.jneuroim.2012.03.020; Sako W, 2015, J NEUROL SCI, V352, P84, DOI 10.1016/j.jns.2015.03.041; Sandelius A, 2018, NEUROLOGY, V90, pE518, DOI 10.1212/WNL.0000000000004932; Saporta MA, 2013, NEUROL CLIN, V31, P597, DOI 10.1016/j.ncl.2013.01.009; Scherling CS, 2014, ANN NEUROL, V75, P116, DOI 10.1002/ana.24052; Schreiber S, 2018, J NEUROL, V265, P2633, DOI 10.1007/s00415-018-9043-0; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sharp AH, 1996, NEUROBIOL DIS, V3, P3, DOI 10.1006/nbdi.1996.0002; Silber E, 2002, NEUROLOGY, V58, P1372, DOI 10.1212/WNL.58.9.1372; Siller N, 2019, MULT SCLER J, V25, P678, DOI 10.1177/1352458518765666; Sjogren M, 2000, NEUROLOGY, V54, P1960, DOI 10.1212/WNL.54.10.1960; Skillback T, 2014, NEUROLOGY, V83, P1945, DOI 10.1212/WNL.0000000000001015; SOUSSAN L, 1994, MOL NEUROBIOL, V9, P83, DOI 10.1007/BF02816107; Soylu-Kucharz R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14179-1; Steinacker P, 2018, NEUROLOGY, V91, pE1390, DOI 10.1212/WNL.0000000000006318; Steinacker P, 2017, AMYOTROPH LAT SCL FR, V18, P112, DOI 10.1080/21678421.2016.1241279; Steinacker P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38737; Steinacker P, 2016, J NEUROL NEUROSUR PS, V87, P12, DOI 10.1136/jnnp-2015-311387; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stieltjes B, 2013, DIFFUSION TENSOR IMA; Stoessl AJ, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-5; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Sykova E, 2004, NEUROSCIENCE, V129, P861, DOI 10.1016/j.neuroscience.2004.06.077; Talja I, 2009, ANN NY ACAD SCI, V1173, P130, DOI 10.1111/j.1749-6632.2009.04624.x; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Thompson AGB, 2018, J NEUROL NEUROSUR PS, V89, P955, DOI 10.1136/jnnp-2017-317793; Tiedt S, 2018, NEUROLOGY, V91, pE1338, DOI 10.1212/WNL.0000000000006282; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Timmerman V, 2013, EXP NEUROL, V246, P14, DOI 10.1016/j.expneurol.2012.01.010; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tortelli R, 2015, EUR J NEUROL, V22, P215, DOI 10.1111/ene.12421; Tortelli R, 2012, EUR J NEUROL, V19, P1561, DOI 10.1111/j.1468-1331.2012.03777.x; Traenka C, 2015, CEREBROVASC DIS, V40, P222, DOI 10.1159/000440774; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Verde F, 2019, J NEUROL NEUROSUR PS, V90, P157, DOI 10.1136/jnnp-2018-318704; Villar LM, 2015, EUR J NEUROL, V22, P1169, DOI 10.1111/ene.12579; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Waldo ML, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-54; Wang J, 2012, COCHRANE DATABASE SY, V2; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Weydt P, 2016, ANN NEUROL, V79, P152, DOI 10.1002/ana.24552; Wild EJ, 2007, NEUROSCI LETT, V417, P231, DOI 10.1016/j.neulet.2007.02.053; Wilke C, 2016, J NEUROL NEUROSUR PS, V87, P1270, DOI 10.1136/jnnp-2015-312972; Williams A, 2007, BRAIN, V130, P2554, DOI 10.1093/brain/awm202; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Yarnall AJ, 2013, AGE AGEING, V42, P567, DOI 10.1093/ageing/aft085; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667; Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x; Zetterberg H, 2016, JAMA NEUROL, V73, P60, DOI 10.1001/jamaneurol.2015.3037; Zhai JB, 2007, HUM MOL GENET, V16, P3103, DOI 10.1093/hmg/ddm272; Zhang Yan, 2007, Zhonghua Yi Xue Za Zhi, V87, P2745; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071; Zhou WJ, 2017, NEUROSCI LETT, V650, P60, DOI 10.1016/j.neulet.2017.04.027; Zucchi E, 2018, J NEUROCHEM, V146, P631, DOI 10.1111/jnc.14542	182	15	15	2	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2020	57	1			SI		469	491		10.1007/s12035-019-01698-3			23	Neurosciences	Neurosciences & Neurology	KV1HZ	WOS:000520176200040	31385229	Green Accepted			2021-06-18	
J	Yin, ZY; Han, ZL; Hu, TP; Zhang, SS; Ge, XT; Huang, S; Wang, L; Yu, JW; Li, WZ; Wang, Y; Li, D; Zhao, J; Wang, YF; Zuo, Y; Li, Y; Kong, XD; Chen, FL; Lei, P				Yin, Zhenyu; Han, Zhaoli; Hu, Tianpeng; Zhang, Shishuang; Ge, Xintong; Huang, Shan; Wang, Lu; Yu, Jinwen; Li, Wenzhu; Wang, Yan; Li, Dai; Zhao, Jing; Wang, Yifeng; Zuo, Yan; Li, Ying; Kong, Xiaodong; Chen, Fanglian; Lei, Ping			Neuron-derived exosomes with high miR-21-5p expression promoted polarization of M1 microglia in culture	BRAIN BEHAVIOR AND IMMUNITY			English	Article						TBI; Neuroinflammation; Microglia polarization; miR-21-5p; Exosome	TRAUMATIC BRAIN-INJURY; EXTRACELLULAR VESICLES; MICRORNA EXPRESSION; IN-VITRO; INFLAMMATION; NEUROINFLAMMATION; BIOGENESIS; MECHANISM; APOPTOSIS; DYNAMICS	Background: Neuroinflammation is a characteristic pathological change of acute neurological deficit and chronic traumatic encephalopathy (CTE) after traumatic brain injury (TBI). Microglia are the key cell involved in neuroinflammation and neuronal injury. The type of microglia polarization determines the direction of neuroinflammation. MiR-21-5p elevated in neurons and microglia after TBI in our previous research. In this study, we explore the influence of miR-21-5p for neuroinflammation by regulating microglia polarization. Methods: In this study, PC12 and BV2 used to instead of neuron and microglia respectively. The co-cultured transwell system used to simulate interaction of PC12 and BV2 cells in vivo environment. Results: We found that PC12-derived exosomes with containing miR-21-5p were phagocytosed by microglia and induced microglia polarization, meanwhile, the expression of miR-21-5p was increased in M1 microglia cells. Polarization of Ml microglia aggravated the release of neuroinflammation factors, inhibited the neurite outgrowth, increased accumulation of P-tau and promoted the apoptosis of PC12 cells, which formed a model of cyclic cumulative damage. Simultaneously, we also got similar results in vivo experiments. Conclusions: PC12-derived exosomes with containing miR-21-5p is the essential of this cyclic cumulative damage model. Therefore, regulating the expression of miR-21-5p or the secretion of exosomes may be an important novel strategy for the treatment of neuroinflammation after TBI.	[Yin, Zhenyu; Han, Zhaoli; Hu, Tianpeng; Zhang, Shishuang; Huang, Shan; Wang, Lu; Yu, Jinwen; Li, Wenzhu; Wang, Yan; Li, Dai; Zhao, Jing; Zuo, Yan; Kong, Xiaodong; Lei, Ping] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin, Peoples R China; [Yin, Zhenyu; Han, Zhaoli; Hu, Tianpeng; Zhang, Shishuang; Huang, Shan; Wang, Lu; Yu, Jinwen; Li, Wenzhu; Wang, Yan; Li, Dai; Zhao, Jing; Zuo, Yan; Kong, Xiaodong; Lei, Ping] Tianjin Inst Geriatr, Tianjin, Peoples R China; [Ge, Xintong] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Li, Ying; Chen, Fanglian] Tianjin Neurol Inst, Tianjin, Peoples R China; [Wang, Yifeng] Tianjin Med Univ, Gen Hosp, Dept Crit Care Med, Tianjin, Peoples R China	Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Inst Geriatr, Anshan Rd, Tianjin 300052, Peoples R China.	leiping1974@163.com	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772060, 81501055]; Tianjin Municipal Science and Technology Commission Natural Fund Project [18JCQNJC81100, 18ZXDBSY00090, 19JCQNJC10200]	This work was supported by Grants 81772060 and 81501055 from the National Natural Science Foundation of China, and Grant 18JCQNJC81100, 18ZXDBSY00090 and 19JCQNJC10200 from the Tianjin Municipal Science and Technology Commission Natural Fund Project.	Ando Y, 2013, J AUTOIMMUN, V41, P111, DOI 10.1016/j.jaut.2012.12.013; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Cao HM, 2019, ACS NANO, V13, P3522, DOI 10.1021/acsnano.8b09776; Cen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066503; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chopp M, 2015, EXPERT OPIN EMERG DR, V20, P523, DOI 10.1517/14728214.2015.1061993; Feng MG, 2018, BIOMED PHARMACOTHER, V101, P1003, DOI 10.1016/j.biopha.2018.02.043; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guinea-Viniegra J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008089; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li X, 2018, J ALLERGY CLIN IMMUN, V141, P1634, DOI 10.1016/j.jaci.2017.08.017; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas Andrew I.R., 2017, LANCET NEUROL, V16, P1, DOI 10.1016/51474-4422(17)30371-X; Maria S, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12465; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nazem A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0291-y; Parayath NN, 2018, NANO LETT, V18, P3571, DOI 10.1021/acs.nanolett.8b00689; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sheedy FJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00019; Shefler I, 2014, J ALLERGY CLIN IMMUN, V133, P217, DOI 10.1016/j.jaci.2013.04.035; Simeoli R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01841-5; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Vuckovic S, 2017, BRIT J HAEMATOL, V177, P423, DOI 10.1111/bjh.14561; Yan AJ, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00529; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002	51	15	16	6	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JAN	2020	83						270	282		10.1016/j.bbi.2019.11.004			13	Immunology; Neurosciences; Psychiatry	Immunology; Neurosciences & Neurology; Psychiatry	JY4GG	WOS:000504374700028	31707083				2021-06-18	
J	Stilling, J; Paxman, E; Mercier, L; Gan, LS; Wang, M; Amoozegar, F; Dukelow, SP; Monchi, O; Debert, C				Stilling, Joan; Paxman, Eric; Mercier, Leah; Gan, Liu Shi; Wang, Meng; Amoozegar, Farnaz; Dukelow, Sean P.; Monchi, Oury; Debert, Chantel			Treatment of Persistent Post-Traumatic Headache and Post-Concussion Symptoms Using Repetitive Transcranial Magnetic Stimulation: A Pilot, Double-Blind, Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; post-concussion syndrome; post-traumatic headache; randomized controlled trial; transcranial magnetic stimulation	MILD-TRAUMATIC-BRAIN; DORSOLATERAL PREFRONTAL CORTEX; MIGRAINE PROPHYLAXIS; FUNCTIONAL CONNECTIVITY; BETA-ENDORPHIN; UNITED-STATES; RTMS; INJURY; PAIN; EFFICACY	Persistent post-traumatic headache (PTH) after mild traumatic brain injury is one of the most prominent and highly reported persistent post-concussion symptoms (PPCS). Non-pharmacological treatments, including non-invasive neurostimulation technologies, have been proposed for use. Our objective was to evaluate headache characteristics at 1 month after repetitive transcranial magnetic stimulation (rTMS) treatment in participants with PTH and PPCS. A double-blind, randomized, sham-controlled, pilot clinical trial was performed on 20 participants (18-65 years) with persistent PTH (International Classification of Headache Disorders, 3rd edition) and PPCS (International Classification of Diseases, Tenth Revision). Ten sessions of rTMS therapy (10 Hz, 600 pulses, 70% resting motor threshold amplitude) were delivered to the left dorsolateral pre-frontal cortex. The primary outcome was a change in headache frequency or severity at 1 month post-rTMS. Two-week-long daily headache diaries and clinical questionnaires assessing function, PPCS, cognition, quality of life, and mood were completed at baseline, post-treatment, and at 1, 3, and 6 months post-rTMS. A two-way (treatment x time) mixed analyisis of variance indicated a significant overall time effect for average headache severity (F-(3,F-54) = 3.214; p = 0.03) and a reduction in headache frequency at 1 month post-treatment (#/2 weeks, REAL -5.2 [standard deviation {SD} = 5.8]; SHAM, -3.3 [SD = 7.7]). Secondary outcomes revealed an overall time interaction for headache impact, depression, post-concussion symptoms, and quality of life. There was a significant reduction in depression rating in the REAL group between baseline and 1 month post-treatment, with no change in the SHAM group (Personal Health Questionnaire-9; REAL, -4.3 [SD = 3.7[ p = 0.020]; SHAM, -0.7 [SD = 4.7; p = 1.0]; Bonferroni corrected). In the REAL group, 60% returned to work whereas only 10% returned in the SHAM group (p = 0.027). This pilot study demonstrates an overall time effect on headache severity, functional impact, depression, PPCS, and quality of life after rTMS treatment in participants with persistent PTH; however, findings were below clinical significance thresholds. There was a 100% response rate, no dropouts, and minimal adverse effects, warranting a larger phase II study. Clinicaltrials.gov: NCT03691272.	[Stilling, Joan; Paxman, Eric; Mercier, Leah; Gan, Liu Shi; Wang, Meng; Amoozegar, Farnaz; Dukelow, Sean P.; Monchi, Oury; Debert, Chantel] Univ Calgary, Calgary, AB, Canada; [Mercier, Leah; Gan, Liu Shi; Wang, Meng] Hotchkiss Brain Inst, Calgary, AB, Canada; [Stilling, Joan; Amoozegar, Farnaz; Dukelow, Sean P.; Monchi, Oury; Debert, Chantel] Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Paxman, Eric] Univ Alberta, Dept Med, Edmonton, AB, Canada	Stilling, J (corresponding author), Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, 1403-29 St Northwest, Calgary, AB T2N 2T9, Canada.	joan.stilling@ahs.ca		Debert, Chantel/0000-0002-2704-0438	University of Calgary, Cumming School of Medicine, Clinical Research Fund [CRF17-0107]; Hotchkiss Brain Institute; Department of Clinical Neurosciences	This study was funded through the University of Calgary, Cumming School of Medicine, Clinical Research Fund Grant (CRF17-0107) and the Hotchkiss Brain Institute and Department of Clinical Neurosciences Pilot fund Grant.	Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Brighina F, 2004, J NEUROL SCI, V227, P67, DOI 10.1016/j.jns.2004.08.008; Broadbent HJ, 2011, WORLD J BIOL PSYCHIA, V12, P240, DOI 10.3109/15622975.2010.541281; Brunoni AR, 2017, JAMA PSYCHIAT, V74, P143, DOI 10.1001/jamapsychiatry.2016.3644; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castien RF, 2012, CEPHALALGIA, V32, P710, DOI 10.1177/0333102412449933; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Diana M, 2017, NAT REV NEUROSCI, V18, P685, DOI 10.1038/nrn.2017.113; Dong Y, 2017, EUR J PHYS REHAB MED, V53, P256, DOI 10.23736/S1973-9087.16.04329-X; Duecker F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00210; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Hocke LM, 2018, J NEUROTRAUM, V35, P1224, DOI 10.1089/neu.2017.5365; Kalita J, 2017, CEPHALALGIA, V37, P1222, DOI 10.1177/0333102416675619; Kalita J, 2016, J NEUROL, V263, P2238, DOI 10.1007/s00415-016-8257-2; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Kito S, 2012, BRAIN STIMUL, V5, P547, DOI 10.1016/j.brs.2011.09.004; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kwon M, 2014, PAIN PRACT, V14, P656, DOI 10.1111/papr.12145; Lan MJ, 2016, BRAIN STIMUL, V9, P579, DOI 10.1016/j.brs.2016.02.011; Leung A, 2018, MOL PAIN, V14, DOI 10.1177/1744806918810297; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Misra UK, 2013, J NEUROL, V260, P2793, DOI 10.1007/s00415-013-7072-2; Misra UK, 2013, CEPHALALGIA, V33, P316, DOI 10.1177/0333102412473372; Misra UK, 2012, NEUROL RES, V34, P547, DOI 10.1179/1743132812Y.0000000045; Misra UK, 2017, BRAIN STIMUL, V10, P618, DOI 10.1016/j.brs.2017.02.006; Moussavi Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41923-6; Niu X, 2019, J NEUROL NEUROSUR PS, V90, P326, DOI 10.1136/jnnp-2018-318886; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Provost JS, 2010, EUR J NEUROSCI, V32, P873, DOI 10.1111/j.1460-9568.2010.07333.x; Salazar APS, 2018, ARCH PHYS MED REHAB, V99, P355, DOI 10.1016/j.apmr.2017.07.009; Schwedt TJ, 2015, PAIN MED, V16, P1827, DOI 10.1111/pme.12792; Seminowicz DA, 2017, J PAIN, V18, P1027, DOI 10.1016/j.jpain.2017.03.008; Shehata HS, 2016, J PAIN RES, V9, P771, DOI 10.2147/JPR.S116671; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Stilling J, 2019, BRAIN INJURY, V33, P148; Stilling JM, 2019, HEADACHE, V59, P339, DOI 10.1111/head.13479; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tik M, 2017, NEUROIMAGE, V162, P289, DOI 10.1016/j.neuroimage.2017.09.022; Tripathi GM, 2018, BRAIN RES, V1696, P31, DOI 10.1016/j.brainres.2018.05.046; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wassermann E., 2018, OXFORD HDB TRANSCRAN	53	15	15	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					312	323		10.1089/neu.2019.6692		NOV 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000495445300001	31530227				2021-06-18	
J	Bathini, P; Brai, E; Auber, LA				Bathini, Praveen; Brai, Emanuele; Auber, Lavinia Alberi			Olfactory dysfunction in the pathophysiological continuum of dementia	AGEING RESEARCH REVIEWS			English	Article						Olfaction; Smell loss; Olfactory nerve; Aging; Dementia; Alzheimer's disease; Microbes; Inflammation; Olfactory diagnostics	SIMPLEX-VIRUS TYPE-1; MILD COGNITIVE IMPAIRMENT; MEDIODORSAL THALAMIC NUCLEUS; SMELL IDENTIFICATION TEST; BETA-AMYLOID DEPOSITION; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; ORBITOFRONTAL CORTEX; NEUROFIBRILLARY TANGLES	Sensory capacities like smell, taste, hearing, vision decline with aging, but increasing evidence show that sensory dysfunctions are one of the early signs diagnosing the conversion from physiological to pathological brain state. Smell loss represents the best characterized sense in clinical practice and is considered as one of the first preclinical signs of Alzheimer's and Parkinson's disease, occurring a decade or more before the onset of cognitive and motor symptoms. Despite the numerous scientific reports and the adoption in clinical practice, the etiology of sensory damage as prodromal of dementia remains largely unexplored and more studies are needed to resolve the mechanisms underlying sensory network dysfunction. Although both cognitive and sensory domains are progressively affected, loss of sensory experience in early stages plays a major role in reducing the autonomy of demented people in their daily tasks or even possibly contributing to their cognitive decline. Interestingly, the chemosensory circuitry is devoid of a blood brain barrier, representing a vulnerable port of entry for neurotoxic species that can spread to the brain. Furthermore, the exposure of the olfactory system to the external environment make it more susceptible to mechanical injury and trauma, which can cause degenerative neuroinflammation. In this review, we will summarize several findings about chemosensory impairment signing the conversion from healthy to pathological brain aging and we will try to connect those observations to the promising research linking environmental influences to sporadic dementia. The scientific body of knowledge will support the use of chemosensory diagnostics in the presymptomatic stages of AD and other biomarkers with the scope of finding treatment strategies before the onset of the disease.	[Bathini, Praveen; Auber, Lavinia Alberi] Univ Fribourg, Dept Med, Fribourg, Switzerland; [Brai, Emanuele] VIB KU Leuven, Ctr Brain & Dis Res, Lab Res Neurodegenerat Dis, Leuven, Belgium; [Auber, Lavinia Alberi] Swiss Integrat Ctr Human Hlth, Fribourg, Switzerland	Auber, LA (corresponding author), Swiss Integrat Ctr Human Hlth, Fribourg, Switzerland.	lavinia.alberi@unifr.ch		bathini, praveen/0000-0002-4031-8975	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [163470]; Ministry of Science and Education Switzerland (ESKAS) [2017.0480]; Human Brain ProjectUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [SP8.7]	This project is supported by funds of the Swiss National Science Foundation (N.163470; LA), the Ministry of Science and Education Switzerland (ESKAS No. 2017.0480; PB) and the Human Brain Project (SP8.7; LA).	Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; [Anonymous], 2018, WORLD ALZH REP; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Arnold SE, 2010, ANN NEUROL, V67, P462, DOI 10.1002/ana.21910; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Attems J, 2012, P NATL ACAD SCI USA, V109, P6259, DOI 10.1073/pnas.1203843109; Ayala-Grosso CA, 2015, BRAIN PATHOL, V25, P136, DOI 10.1111/bpa.12169; Bacon AW, 1998, ANN NY ACAD SCI, V855, P723, DOI 10.1111/j.1749-6632.1998.tb10651.x; Bahar-Fuchs A, 2011, INT PSYCHOGERIATR, V23, P1097, DOI 10.1017/S1041610210002371; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Bakkour A, 2013, NEUROIMAGE, V76, P332, DOI 10.1016/j.neuroimage.2013.02.059; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; Bathini P, 2019, NEUROBIOL AGING, V76, P80, DOI 10.1016/j.neurobiolaging.2018.12.006; Bergmann O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018994; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Biella G, 2000, J NEUROPHYSIOL, V83, P1924; Biesbroek G., 2013, PLOS PATHOG, V9; Bodewes R, 2011, AM J PATHOL, V179, P30, DOI 10.1016/j.ajpath.2011.03.026; Boelen E, 2007, NEUROBIOL AGING, V28, P524, DOI 10.1016/j.neurobiolaging.2006.02.014; Borders AS, 2007, J COMP NEUROL, V501, P206, DOI 10.1002/cne.21252; Bower JH, 2006, NEUROLOGY, V67, P494, DOI 10.1212/01.wnl.0000227906.99570.cc; BRAAK H, 1991, ACTA NEUROPATHOL, V81, P261, DOI 10.1007/BF00305867; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Brodie M, 1934, SCIENCE, V79, P235, DOI 10.1126/science.79.2045.235; Brunjes PC, 2010, J COMP NEUROL, V518, P1603, DOI 10.1002/cne.22293; Budson Andrew E, 2012, Pract Neurol, V12, P88, DOI 10.1136/practneurol-2011-000145; Burgos JS, 2006, J VIROL, V80, P5383, DOI 10.1128/JVI.00006-06; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; Calderon-Garciduenas L, 2003, TOXICOL PATHOL, V31, P524, DOI 10.1080/01926230390226645; Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954; Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2010, EXP TOXICOL PATHOL, V62, P91, DOI 10.1016/j.etp.2009.02.117; Calhoun-Haney R, 2005, BRAIN COGNITION, V58, P178, DOI 10.1016/j.bandc.2004.10.004; Chapuis J, 2013, J NEUROSCI, V33, P13449, DOI 10.1523/JNEUROSCI.1387-13.2013; Chen CR, 2014, J NEUROL SURG PART B, V75, P293, DOI 10.1055/s-0033-1361837; Chen MF, 2017, P NATL ACAD SCI USA, V114, P8089, DOI 10.1073/pnas.1620664114; Chen Pan, 2016, F1000Res, V5, DOI 10.12688/f1000research.7431.1; Cheng SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017966; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Child KM, 2018, J NEUROSCI, V38, P6806, DOI 10.1523/JNEUROSCI.3261-17.2018; Choi R, 2018, LARYNGOSCOPE INVEST, V3, P35, DOI 10.1002/lio2.135; Christen-Zaech S, 2003, CAN J NEUROL SCI, V30, P20, DOI 10.1017/S0317167100002389; Chung SD, 2015, AM J RHINOL ALLERGY, V29, P44, DOI 10.2500/ajra.2015.29.4113; Clel T.A., 2003, HDB OLFACTION GUSTAT, P165, DOI DOI 10.1201/9780203911457.CH8; Cohen NA, 2006, ANN OTO RHINOL LARYN, V115, P20; Costanzo RM, 2005, CHEM SENSES, V30, pI133, DOI 10.1093/chemse/bjh150; Courtiol E, 2014, J NEUROPHYSIOL, V111, P1274, DOI 10.1152/jn.00741.2013; Covington JW, 1999, INT J PSYCHOPHYSIOL, V32, P205, DOI 10.1016/S0167-8760(99)00012-4; Cross DJ, 2013, J NUCL MED, V54, P1278, DOI 10.2967/jnumed.112.116558; DANIELLO A, 1992, BRAIN RES, V592, P44, DOI 10.1016/0006-8993(92)91656-Y; DAVIES DC, 1993, NEUROBIOL AGING, V14, P353, DOI 10.1016/0197-4580(93)90121-Q; de Bont N, 1999, J LIPID RES, V40, P680; De Simone R, 2010, SEIZURE-EUR J EPILEP, V19, P383, DOI 10.1016/j.seizure.2010.04.008; Devanand DP, 2015, NEUROLOGY, V84, P182, DOI 10.1212/WNL.0000000000001132; Devanand DP, 2008, BIOL PSYCHIAT, V64, P871, DOI 10.1016/j.biopsych.2008.06.020; Djordjevic J, 2008, NEUROBIOL AGING, V29, P693, DOI 10.1016/j.neurobiolaging.2006.11.014; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Donati D, 2005, J VIROL, V79, P9439, DOI 10.1128/JVI.79.15.9439-9448.2005; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Doty RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00020; DOTY RL, 1987, BRAIN RES BULL, V18, P597, DOI 10.1016/0361-9230(87)90129-8; Doty RL, 2001, LARYNGOSCOPE, V111, P409, DOI 10.1097/00005537-200103000-00008; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030; El-Habashi N, 2010, J NEUROVIROL, V16, P242, DOI 10.3109/13550284.2010.489596; Elisabeth K., 1986, OLFACTORY DYSFUNCTIO, DOI [10.1080/87565648609540332, DOI 10.1080/87565648609540332]; ESKENAZI B, 1986, NEUROPSYCHOLOGIA, V24, P553, DOI 10.1016/0028-3932(86)90099-0; Ezzat K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10192-2; Fahrenhold M, 2018, BRAIN PATHOL, V28, P595, DOI 10.1111/bpa.12564; Falgarone G, 2009, ADV CANCER RES, V104, P139, DOI 10.1016/S0065-230X(09)04008-1; Farbman AI, 1999, J COMP NEUROL, V414, P306, DOI 10.1002/(SICI)1096-9861(19991122)414:3<306::AID-CNE2>3.0.CO;2-#; Federico G, 1999, BRAIN RES, V835, P306, DOI 10.1016/S0006-8993(99)01614-5; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Forster S, 2010, J ALZHEIMERS DIS, V22, P581, DOI 10.3233/JAD-2010-091549; FORTIER I, 1991, AM J IND MED, V20, P495, DOI 10.1002/ajim.4700200405; Francois A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24687; Frenkel D, 2002, P NATL ACAD SCI USA, V99, P5675, DOI 10.1073/pnas.072027199; Friedman JH, 2008, NEUROLOGY, V70, P487, DOI 10.1212/01.wnl.0000279380.25130.ce; Frisoni GB, 2009, J NEUROL, V256, P916, DOI 10.1007/s00415-009-5040-7; FULLER GN, 1990, CLIN NEUROPATHOL, V9, P279; Fulop T, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00362; Gerard HC, 2005, MICROB PATHOGENESIS, V39, P19, DOI 10.1016/j.micpath.2005.05.002; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Geula C, 1996, CEREB CORTEX, V6, P165, DOI 10.1093/cercor/6.2.165; Giannakopoulos Panteleimon, 2009, V24, P20, DOI 10.1159/000197881; Gilbert PE, 2004, J CLIN EXP NEUROPSYC, V26, P779, DOI 10.1080/13803390490509439; Gillet L, 2015, CURR OPIN VIROL, V15, P34, DOI 10.1016/j.coviro.2015.07.007; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Goncalves Stefania, 2016, Curr Otorhinolaryngol Rep, V4, P115; Gonzalez B, 2017, NEUROL CLIN, V35, P175, DOI 10.1016/j.ncl.2017.01.001; Gordon Brian A, 2018, Alzheimers Dement (Amst), V10, P245, DOI 10.1016/j.dadm.2018.02.003; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Gottlieb S, 2000, BRIT MED J, V321, P1100; Grudzien A, 2007, NEUROBIOL AGING, V28, P327, DOI 10.1016/j.neurobiolaging.2006.02.007; Guzman-Sanchez F, 2012, J ALZHEIMERS DIS, V30, P779, DOI 10.3233/JAD-2012-120070; Gylfe A, 2002, SCAND J INFECT DIS, V34, P922, DOI 10.1080/0036554021000026972; Haas JG, 2018, TRENDS NEUROSCI, V41, P570, DOI 10.1016/j.tins.2018.07.001; Halgren E, 1982, Hum Neurobiol, V1, P251; Han PF, 2018, J NEUROTRAUM, V35, P2632, DOI 10.1089/neu.2017.5393; Harberts E, 2011, P NATL ACAD SCI USA, V108, P13734, DOI 10.1073/pnas.1105143108; Hasegawa-Ishii S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10229-w; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Herbert RP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-109; Hill JM, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00009; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Hoffman HJ, 2016, REV ENDOCR METAB DIS, V17, P221, DOI 10.1007/s11154-016-9364-1; Holbrook EH, 2005, LARYNGOSCOPE, V115, P2144, DOI 10.1097/01.MLG.0000181493.83661.CE; Holbrook EH, 2011, LARYNGOSCOPE, V121, P1687, DOI 10.1002/lary.21856; Hong GH, 2016, J IMMUNOL, V196, P2021, DOI 10.4049/jimmunol.1500747; Huttenbrink KB, 2013, DTSCH ARZTEBL INT, V110, P1, DOI 10.3238/arztebl.2013.0001; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2010, J NEUROL SCI, V289, P119, DOI 10.1016/j.jns.2009.08.026; Hussain A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-49; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Iannaccone A, 2005, AM J MED GENET A, V132A, P343, DOI 10.1002/ajmg.a.30512; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Itzhaki RF, 2008, J ALZHEIMERS DIS, V13, P393; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Itzhaki RF, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00202; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; Kalmey J.K., 1998, ANAT REC, DOI [10.1002/(SICI)1097-0185(199807)251:3%3C326::AID-AR7/03E3.0.00;2-T, DOI 10.1002/(SICI)1097-0185(199807)251:3%3C326::AID-AR7/03E3.0.00;2-T]; Kareken DA, 2001, NEUROPSYCHOLOGY, V15, P18, DOI 10.1037//0894-4105.15.1.18; Kattan OM, 2008, J IMMUNOL, V181, P1399, DOI 10.4049/jimmunol.181.2.1399; Kawagoe T, 2007, NEUROREPORT, V18, P683, DOI 10.1097/WNR.0b013e3280bef9a6; KNUPFER L, 1986, International Journal of Geriatric Psychiatry, V1, P3, DOI 10.1002/gps.930010103; Kobayashi M, 2005, CHEM SENSES, V30, pI216, DOI 10.1093/chemse/bjh191; Kondo K, 2010, J COMP NEUROL, V518, P1962, DOI 10.1002/cne.22316; Koskinen K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19438-3; KOSS E, 1988, NEUROLOGY, V38, P1228, DOI 10.1212/WNL.38.8.1228; Kovacs I, 1998, BRAIN RES, V789, P167, DOI 10.1016/S0006-8993(98)00097-3; Kovacs T, 1999, NEUROPATH APPL NEURO, V25, P481; Kril JJ, 2002, ACTA NEUROPATHOL, V103, P370, DOI 10.1007/s00401-001-0477-5; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lachen-Montes M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09481-x; Lane AP, 2010, J NEUROSCI, V30, P2324, DOI 10.1523/JNEUROSCI.4507-09.2010; LEHERICY S, 1993, J COMP NEUROL, V330, P15, DOI 10.1002/cne.903300103; Leibovitch EC, 2018, P NATL ACAD SCI USA, V115, P11292, DOI 10.1073/pnas.1811974115; LEWIS DA, 1987, J NEUROSCI, V7, P1799; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Li W, 2010, BRAIN, V133, P2714, DOI 10.1093/brain/awq209; Little CS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00304; Little CS, 2004, NEUROBIOL AGING, V25, P419, DOI 10.1016/S0197-4580(03)00127-1; Liu CC, 2017, NEURON, V96, P1024, DOI 10.1016/j.neuron.2017.11.013; Lledo PM, 2004, NEUROSCIENTIST, V10, P292, DOI 10.1177/1073858404263460; Lokensgard JR, 2001, J NEUROVIROL, V7, P208; MACDONALD AB, 1987, HUM PATHOL, V18, P759, DOI 10.1016/S0046-8177(87)80252-6; MANN DMA, 1988, MECH AGEING DEV, V42, P1, DOI 10.1016/0047-6374(88)90058-9; Martin C, 2014, J ALZHEIMERS DIS, V39, P849, DOI 10.3233/JAD-131706; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; MIKLOSSY J, 1994, NEUROREPORT, V5, P1201, DOI 10.1097/00001756-199406020-00010; Miklossy J, 2004, J ALZHEIMERS DIS, V6, P639; Miklossy J, 1996, AZHEIMERS RES, V2, P95; Miklossy J, 2008, J ALZHEIMERS DIS, V13, P381; Miklossy J, 2008, J ALZHEIMERS DIS, V13, P357; Miklossy J, 2016, J ALZHEIMERS DIS, V53, P1459, DOI 10.3233/JAD-160451; Miklossy J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-90; Miklossy Judith, 2008, Handb Clin Neurol, V89, P825, DOI 10.1016/S0072-9752(07)01272-9; Moir RD, 2018, ALZHEIMERS DEMENT, V14, P1602, DOI 10.1016/j.jalz.2018.06.3040; Mori I, 2005, J NEUROVIROL, V11, P129, DOI 10.1080/13550280590922793; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mossner R, 2000, ADV RES NEURODEGENER, V8, P345; Mouly A.-M., 2011, NEUROBIOLOGY OLFACTI; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; Mundinano IC, 2011, ACTA NEUROPATHOL, V122, P61, DOI 10.1007/s00401-011-0830-2; Munster VJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00736; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; MURPHY C, 1990, NEUROBIOL AGING, V11, P465, DOI 10.1016/0197-4580(90)90014-Q; Murphy C, 1994, OLFACTION TASTE, P609, DOI [DOI 10.1007/978-4-431-68355-1_251, 10.1007/978-4-431-68355-1_251]; Murphy C, 2009, ANN NY ACAD SCI, V1170, P647, DOI 10.1111/j.1749-6632.2009.04486.x; Nai Q, 2010, NEUROSCIENCE, V169, P882, DOI 10.1016/j.neuroscience.2010.05.010; Nai Q, 2009, J NEUROPHYSIOL, V101, P2472, DOI 10.1152/jn.91187.2008; Nathan BP, 2005, BRAIN RES, V1041, P87, DOI 10.1016/j.brainres.2005.02.011; Nathan BP, 2007, BRAIN RES, V1137, P78, DOI 10.1016/j.brainres.2006.12.036; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Nicolson GL, 2008, LABMEDICINE, V39, P291, DOI 10.1309/96M3BWYP42L11BFU; Nordin S, 1998, ACTA OTO-LARYNGOL, V118, P226; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Okada K., 2014, CELL TISSUE RES, V357, P279; Olofsson JK, 2016, NEUROPSYCHOLOGIA, V85, P1, DOI 10.1016/j.neuropsychologia.2016.03.004; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Parron T, 2011, TOXICOL APPL PHARM, V256, P379, DOI 10.1016/j.taap.2011.05.006; Paskavitz J.F., 1995, J GERIATRIC PSYCNET; Pedro T, 2012, DEMENT GERIATR COGN, V34, P149, DOI 10.1159/000342118; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; Peters JM, 2003, AM J PSYCHIAT, V160, P1995, DOI 10.1176/appi.ajp.160.11.1995; Pisa D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28231-1; Pisa D, 2015, SCI REP-UK, V5, DOI 10.1038/srep15015; Pisa D, 2015, J ALZHEIMERS DIS, V43, P613, DOI 10.3233/JAD-141386; Plailly J, 2008, J NEUROSCI, V28, P5257, DOI 10.1523/JNEUROSCI.5607-07.2008; Plourde JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046605; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Proskynitopoulos P.J., 2016, SURG NEUROL INT, V7, P263; Purves D., 2001, ODORANT RECEPTORS OL; Purves D., 2001, TRANSDUCTION OLFACTO; Quarmley M, 2017, J ALZHEIMERS DIS, V55, P1497, DOI 10.3233/JAD-160842; Quinn K, 2011, MOL THER, V19, P1990, DOI 10.1038/mt.2011.146; Rahayel S, 2012, BEHAV BRAIN RES, V231, P60, DOI 10.1016/j.bbr.2012.02.047; Readhead B, 2018, NEURON, V99, P64, DOI 10.1016/j.neuron.2018.05.023; Reinvang I., 2012, INT J ALZHEIMERS DIS, DOI [10.1155/2012/936272.2012, DOI 10.1155/2012/936272.2012]; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Rey NL, 2018, NEUROBIOL DIS, V109, P226, DOI 10.1016/j.nbd.2016.12.013; Rey NL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.009; Richardson JR, 2014, JAMA NEUROL, V71, P284, DOI 10.1001/jamaneurol.2013.6030; Ridha BH, 2008, J NEUROL, V255, P567, DOI 10.1007/s00415-008-0750-9; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; RUBERG M, 1986, BRAIN RES, V362, P83, DOI 10.1016/0006-8993(86)91401-0; Rudi A.J., 2014, PET SPECT NEUROLOGY; Saiki K., 1994, OLFACTION TASTE, P340, DOI [10.1007/978-4-431-68355-1140, DOI 10.1007/978-4-431-68355-1140]; Saiz-Sanchez D, 2010, EXP NEUROL, V223, P347, DOI 10.1016/j.expneurol.2009.06.010; Saiz-Sanchez D, 2016, EXP NEUROL, V276, P13, DOI 10.1016/j.expneurol.2015.11.009; Saiz-Sanchez D, 2015, BRAIN STRUCT FUNCT, V220, P2011, DOI 10.1007/s00429-014-0771-3; SAPOLSKY RM, 1980, BRAIN BEHAV EVOLUT, V17, P276, DOI 10.1159/000121804; SCHAB FR, 1991, PSYCHOL BULL, V109, P242, DOI 10.1037/0033-2909.109.2.242; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P751; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Schubert CR, 2008, J AM GERIATR SOC, V56, P1517, DOI 10.1111/j.1532-5415.2008.01826.x; SCOTT SA, 1992, ANN NEUROL, V32, P555, DOI 10.1002/ana.410320412; Sela L, 2009, J NEUROSCI, V29, P12059, DOI 10.1523/JNEUROSCI.2114-09.2009; Sellati T.J., 1998, J AM ASS IMMNOL; Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1; Shipley SJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-48; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; SLOTNICK BM, 1990, BRAIN RES, V529, P23, DOI 10.1016/0006-8993(90)90807-N; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spitzer P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32228; STAUBLI U, 1984, P NATL ACAD SCI-BIOL, V81, P5885, DOI 10.1073/pnas.81.18.5885; Steenland K, 2000, ENVIRON HEALTH PERSP, V108, P293, DOI 10.2307/3454346; Stranahan AM, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/108190; Strandberg TE, 2003, STROKE, V34, P2126, DOI 10.1161/01.STR.0000086754.32238.DA; Suzuki Y, 2000, EXP NEUROL, V165, P35, DOI 10.1006/exnr.2000.7465; Tabert MH, 2005, ANN NEUROL, V58, P155, DOI 10.1002/ana.20533; Tekin S, 2001, ANN NEUROL, V49, P355, DOI 10.1002/ana.72.abs; TERLAAK HJ, 1994, ALZ DIS ASSOC DIS, V8, P38, DOI 10.1097/00002093-199408010-00007; Tham WWP, 2011, BRAIN COGNITION, V77, P71, DOI 10.1016/j.bandc.2011.05.008; Tham WWP, 2011, NEUROCASE, V17, P148, DOI 10.1080/13554794.2010.504728; Tham WWP, 2009, BRAIN RES REV, V62, P109, DOI 10.1016/j.brainresrev.2009.09.007; Thomann PA, 2009, J ALZHEIMERS DIS, V17, P213, DOI 10.3233/JAD-2009-1036; Tomlinson JJ, 2017, J NEURAL TRANSM, V124, P721, DOI 10.1007/s00702-017-1726-7; Tzeng NS, 2018, NEUROTHERAPEUTICS, V15, P417, DOI 10.1007/s13311-018-0611-x; Van Hoesen GW, 2000, CEREB CORTEX, V10, P243, DOI 10.1093/cercor/10.3.243; Van Oosten MV, 2001, J BIOL CHEM, V276, P8820, DOI 10.1074/jbc.M009915200; van Riel D, 2015, J PATHOL, V235, P277, DOI 10.1002/path.4461; Vasavada MM, 2017, J ALZHEIMERS DIS, V59, P359, DOI 10.3233/JAD-170310; Veldhuizen MG, 2011, CHEM SENSES, V36, P747, DOI 10.1093/chemse/bjr043; Verbeurgt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096333; VEREECKEN THLG, 1994, NEUROBIOL AGING, V15, P45, DOI 10.1016/0197-4580(94)90143-0; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Weinshenker D, 2008, CURR ALZHEIMER RES, V5, P342, DOI 10.2174/156720508784533286; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Wetter S, 2001, NEUROBIOL AGING, V22, P439, DOI 10.1016/S0197-4580(01)00215-9; Wilson DA, 2001, LEARN MEMORY, V8, P279, DOI 10.1101/lm.42601; Wilson DA, 2014, PROG BRAIN RES, V208, P275, DOI 10.1016/B978-0-444-63350-7.00011-5; Wirth S, 1998, BEHAV BRAIN RES, V91, P49, DOI 10.1016/S0166-4328(97)00102-2; Witt M, 2009, MOVEMENT DISORD, V24, P906, DOI 10.1002/mds.22464; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wozniak MA, 2013, J NEUROIMMUNOL, V257, P7, DOI 10.1016/j.jneuroim.2013.01.005; Wozniak MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025152; Xu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106431; Yang Y, 2001, ACTA NEUROPATHOL, V101, P256; Yasue M, 2015, CURR ALZHEIMER RES, V12, P1006, DOI 10.2174/1567205012666150710105152; Yi HA, 2016, J NEUROL NEUROSUR PS, V87, P425, DOI 10.1136/jnnp-2014-309105; Yin CJ, 2019, NAT MED, V25, P496, DOI 10.1038/s41591-018-0336-8; Yin ZN, 2010, CLIN CHEM LAB MED, V48, P1803, DOI 10.1515/CCLM.2010.354; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Zelano C, 2011, NEURON, V72, P178, DOI 10.1016/j.neuron.2011.08.010; Zhang HL, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/949072; ZIELINSKI BS, 1989, ANAT RECORD, V225, P232, DOI 10.1002/ar.1092250309	294	15	15	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1568-1637	1872-9649		AGEING RES REV	Ageing Res. Rev.	NOV	2019	55								100956	10.1016/j.arr.2019.100956			15	Cell Biology; Geriatrics & Gerontology	Cell Biology; Geriatrics & Gerontology	JF8MJ	WOS:000491638300009	31479764				2021-06-18	
J	Bao, ZY; Fan, L; Zhao, L; Xu, XP; Liu, YL; Chao, HL; Liu, N; You, YP; Liu, Y; Wang, XM; Ji, J				Bao, Zhongyuan; Fan, Liang; Zhao, Lin; Xu, Xiupeng; Liu, Yinlong; Chao, Honglu; Liu, Ning; You, Yongping; Liu, Yan; Wang, Xiaoming; Ji, Jing			Silencing of A20 Aggravates Neuronal Death and Inflammation After Traumatic Brain Injury: A Potential Trigger of Necroptosis	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						necroptosis; inflammation; traumatic brain injury; A20; neuronal death	CASPASE-INDEPENDENT NECROPTOSIS; NF-KAPPA-B; MELATONIN; APOPTOSIS; CELLS; INHIBITION; ACTIVATION; UBIQUITINATION; UBIQUITYLATION; DEGENERATION	Programmed cell death is an important biological process that plays an indispensable role in traumatic brain injury (TBI). Inhibition of necroptosis, a type of programmed cell death, is pivotal in neuroprotection and in preventing associated inflammatory responses. Our results showed that necroptosis occurred in human brain tissues after TBI. Necroptosis was also induced by controlled cortical impact (CCI) injury in a rat model of TBI and was accompanied by high translocation of high-mobility group box-1 (HMGB1) to the cytoplasm. HMGB1 was then passed through the impaired cell membrane to upregulate the receptor for advanced glycation end-products (RAGE), nuclear factor(NF)-kappa B, and inflammatory factors such as interleukin-6 (IL-6), interleukin-1 (IL-1 beta), as well as NACHT, LRR and PYD domains-containing protein 3 (NLRP3). Necroptosis was alleviated by necrostatin-1 and melatonin but not Z-VAD (a caspase inhibitor), which is consistent with the characteristic of caspase-independent signaling. This study also demonstrated that tumor necrosis factor, alpha-induced protein 3 (TNFAIP3, also known as A20) was indispensable for regulating and controlling necroptosis and inflammation after CCI. We found that a lack of A20 in a CCI model led to aggressive necroptosis and attenuated the anti-necroptotic effects of necrostatin-1 and melatonin.	[Bao, Zhongyuan; Fan, Liang; Zhao, Lin; Xu, Xiupeng; Chao, Honglu; Liu, Ning; You, Yongping; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Fan, Liang] Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China; [Liu, Yinlong] Nanjing Med Univ, Suzhou Municipal Hosp, Affiliated Suzhou Hosp, Dept Neurosurg, Suzhou, Peoples R China; [Liu, Yan] Nanjing Med Univ, Sch Pharm, Inst Stem Cell & Neural Regenerat, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaoming] Nanjing Med Univ, Dept Immunol, Nanjing, Jiangsu, Peoples R China	Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	jijing@njmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471269, 81472362, 81372709]; Jiangsu Province's Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK20160047]; Jiangsu Province's Key Discipline of Medicine [XK201117]; Jiangsu Province Medical Key Talent [ZDRCB2016002]; Jiangsu Province Specially Engaged Expert [KF17]; Jiangsu Province Innovative Team; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD)	This study was funded by grants from National Natural Science Foundation of China (Grant Nos. 81471269, 81472362 and 81372709), Jiangsu Province's Natural Science Foundation (Grant No. BK20160047), Jiangsu Province's Key Discipline of Medicine (Grant No. XK201117), Jiangsu Province Medical Key Talent (ZDRCB2016002), Jiangsu Province Specially Engaged Expert (Grant No. KF17), Jiangsu Province Innovative Team (Grant No. NR17) and the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD).	Bi YH, 2017, CELL PHYSIOL BIOCHEM, V43, P481, DOI 10.1159/000480474; Booth LA, 2014, CELL SIGNAL, V26, P549, DOI 10.1016/j.cellsig.2013.11.028; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Cabon L, 2012, CELL DEATH DIFFER, V19, P245, DOI 10.1038/cdd.2011.91; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Chetsawang J, 2017, J EXP NEUROSCI, V11, DOI 10.1177/1179069517719237; Choi HS, 2015, TRANSL RES, V166, P292, DOI 10.1016/j.trsl.2015.04.002; Cui CM, 2017, CELL PHYSIOL BIOCHEM, V42, P1888, DOI 10.1159/000479571; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dondelinger Y, 2016, CELL MOL LIFE SCI, V73, P2165, DOI 10.1007/s00018-016-2191-4; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Esenaliev RO, 2018, J NEUROTRAUM, V35, P1510, DOI 10.1089/neu.2017.5249; Guedes RP, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-122; Gullo F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00500; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Han D, 2016, BRAIN BEHAV IMMUN, V51, P56, DOI 10.1016/j.bbi.2015.07.025; Heckmann BL, 2019, CELL DEATH DIFFER, V26, P41, DOI 10.1038/s41418-018-0195-3; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hirose T, 2013, NATURE, V500, P354, DOI 10.1038/nature12329; Hu LY, 2018, BRAIN BEHAV IMMUN, V68, P132, DOI 10.1016/j.bbi.2017.10.011; Huang ZJ, 2018, CELL DEATH DIFFER, V25, P180, DOI 10.1038/cdd.2017.141; Kinsella S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1143-3; Koshinuma S, 2014, J ANESTH, V28, P235, DOI 10.1007/s00540-013-1716-3; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li JG, 2014, EXP THER MED, V7, P383, DOI 10.3892/etm.2013.1419; Li MF, 2013, CELL PHYSIOL BIOCHEM, V32, P1776, DOI 10.1159/000356611; Liao Y, 2017, ONCOTARGET, V8, P43201, DOI 10.18632/oncotarget.17970; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Liu XW, 2019, INT IMMUNOPHARMACOL, V73, P108, DOI 10.1016/j.intimp.2019.05.005; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Lu JN, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01360; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Manolidis G, 2004, Rom J Physiol, V41, P83; Martens S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.298; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Meng ZY, 2017, J IMMUNOL, V198, P820, DOI 10.4049/jimmunol.1600334; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Ni HB, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00674; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Polykratis A, 2019, NAT CELL BIOL, V21, P731, DOI 10.1038/s41556-019-0324-3; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Ruhl D, 2019, J NEUROSCI, V39, P2951, DOI 10.1523/JNEUROSCI.1384-18.2019; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shen HT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.58; Stengel A, 2011, NEUROGASTROENT MOTIL, V23, pE294, DOI 10.1111/j.1365-2982.2011.01721.x; Su Z, 2016, CELL DEATH DIFFER, V23, P748, DOI 10.1038/cdd.2016.8; Sun W, 2016, FREE RADICAL BIO MED, V92, P61, DOI 10.1016/j.freeradbiomed.2016.01.014; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tian Y, 2014, J PINEAL RES, V56, P1, DOI 10.1111/jpi.12081; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang G, 2016, APOPTOSIS, V21, P121, DOI 10.1007/s10495-015-1192-3; Wang Y, 2014, NEUROSCIENCE, V266, P91, DOI 10.1016/j.neuroscience.2014.02.007; Wen SH, 2017, J CELL MOL MED, V21, P432, DOI 10.1111/jcmm.12987; Witt A, 2017, CELL DEATH DIFFER, V24, P1160, DOI 10.1038/cdd.2017.33; Wong CS, 2014, NEUROSCIENCE, V267, P147, DOI 10.1016/j.neuroscience.2014.02.032; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yang FJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2301903; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Zhan J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0731-3; Zhang XH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1490-8; Zheng Cui-Fang, 2016, World J Gastrointest Pharmacol Ther, V7, P540; Zhu FM, 2017, AM J TRANSL RES, V9, P1694; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	71	15	17	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	SEP 19	2019	12								222	10.3389/fnmol.2019.00222			21	Neurosciences	Neurosciences & Neurology	IZ7TZ	WOS:000487303000002	31607859	DOAJ Gold, Green Published			2021-06-18	
J	Shahror, RA; Linares, GR; Wang, Y; Hsueh, SC; Wu, CC; Chuang, DM; Chiang, YH; Chen, KY				Shahror, Rami Ahmad; Linares, Gabriel R.; Wang, Yun; Hsueh, Shih-Chang; Wu, Chung-Che; Chuang, De-Maw; Chiang, Yung-Hsiao; Chen, Kai-Yun			Transplantation of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						fibroblast growth factor 21; mesenchymal stem cells; neurogenesis; spatial learning and memory; traumatic brain injury	MORRIS WATER MAZE; OBJECT RECOGNITION; PPAR-ALPHA; ABERRANT NEUROGENESIS; HIPPOCAMPAL-LESIONS; PERIRHINAL CORTEX; MEMORY DEFICITS; VALPROIC ACID; MILD; MODERATE	Traumatic brain injury (TBI) is a progressive and complex pathological condition that results in multiple adverse consequences, including impaired learning and memory. Transplantation of mesenchymal stem cells (MSCs) has produced limited benefits in experimental TBI models. Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that has neuroprotective effects, promotes remyelination, enhances angiogenesis, and elongates astrocytic processes. In this study, MSCs were genetically engineered to overexpress FGF21 in order to improve their efficacy in TBI. MSCs overexpressing FGF21 (MSC-FGF21) were transplanted to mouse brain by intracerebroventricular injection 24 h after TBI was induced by controlled cortical impact (CCI). Hippocampus-dependent spatial learning and memory, assessed by the Morris water maze test, was markedly decreased 3-4 weeks after TBI, a deficit that was robustly recovered by treatment with MSC-FGF21, but not MSC-mCherry control. Hippocampus-independent learning and memory, assessed by the novel object recognition test, was also impaired; these effects were blocked by treatment with both MSC-FGF21 and MSC-mCherry control. FGF21 protein levels in the ipsilateral hippocampus were drastically reduced 4 weeks post-TBI, a loss that was restored by treatment with MSC-FGF21, but not MSC-mCherry. MSC-FGF21 treatment also partially restored TBI-induced deficits in neurogenesis and maturation of immature hippocampal neurons, whereas MSC-mCherry was less effective. Finally, MSC-FGF21 treatment also normalized TBI-induced impairments in dendritic arborization of hippocampal neurons. Taken together, the results indicate that MSC-FGF21 treatment significantly improved TBI-induced spatial memory deficits, impaired hippocampal neurogenesis, and abnormal dendritic morphology. Future clinical investigations using MSC-FGF21 to improve post-TBI outcomes are warranted.	[Shahror, Rami Ahmad; Hsueh, Shih-Chang; Chuang, De-Maw; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Shahror, Rami Ahmad; Hsueh, Shih-Chang; Chuang, De-Maw; Chiang, Yung-Hsiao; Chen, Kai-Yun] Natl Hlth Res Inst, Taipei, Taiwan; [Shahror, Rami Ahmad; Hsueh, Shih-Chang; Wu, Chung-Che; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, TMU Neurosci Res Ctr, Taipei, Taiwan; [Linares, Gabriel R.; Chuang, De-Maw] NIMH, Intramural Res Program, NIH, MSC-1363, Bethesda, MD 20892 USA; [Linares, Gabriel R.] Univ Southern Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA; [Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan	Chuang, DM (corresponding author), NIMH, Intramural Res Program, NIH, MSC-1363, Bethesda, MD 20892 USA.; Chen, KY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, 250 Wu Hsing St, Taipei 110, Taiwan.	chuang@mail.nih.gov; kychen08@tmu.edu.tw		Shahror, Rami/0000-0001-6403-9404	Ministry of Science and Technology [MOST 104-2923-B-038-004 -MY2, MOST 107-2314-B-038-063, MOST 107-2314-B-038-042]; Taipei Medical University [TMU 106-5400-004-400, TMU106-5310-001-400]; Intramural Research Program of NIMH, NIH in the USA	This study was supported by Ministry of Science and Technology Grants (MOST 104-2923-B-038-004 -MY2, MOST 107-2314-B-038-063, and MOST 107-2314-B-038-042) and Taipei Medical University (TMU 106-5400-004-400 andTMU106-5310-001-400). We thank the partial support from the Intramural Research Program of NIMH, NIH in the USA and the Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital for generously lending facility support. We also thank Ms. Ioline Henter (NIMH-NIH, USA) for invaluable editorial assistance.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bussey TJ, 1999, J NEUROSCI, V19, P495; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Child KM, 2018, J NEUROSCI, V38, P6806, DOI 10.1523/JNEUROSCI.3261-17.2018; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Czurko A, 1997, P NATL ACAD SCI USA, V94, P2766, DOI 10.1073/pnas.94.6.2766; Donega V, 2015, PEDIATR RES, V78, P520, DOI 10.1038/pr.2015.145; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Good MA, 2007, BEHAV NEUROSCI, V121, P218, DOI 10.1037/0735-7044.121.1.218; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kuroda M, 2017, J CLIN INVEST, V127, P3502, DOI 10.1172/JCI94337; Lai JH, 2019, J NEUROTRAUM, V36, P1054, DOI 10.1089/neu.2018.5949; Langston RF, 2010, HIPPOCAMPUS, V20, P1139, DOI 10.1002/hipo.20714; Leng Y, 2015, MOL PSYCHIATR, V20, P215, DOI 10.1038/mp.2013.192; Leng Y, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw035; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Linares GR, 2016, EXP NEUROL, V281, P81, DOI 10.1016/j.expneurol.2016.04.003; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Makela J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-2; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Mishra SK, 2017, STEM CELL TRANSL MED, V6, P316, DOI 10.5966/sctm.2016-0087; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUMBY DG, 1994, BEHAV NEUROSCI, V108, P11, DOI 10.1037/0735-7044.108.1.11; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Norman G, 2004, BEHAV BRAIN RES, V148, P79, DOI 10.1016/S0166-4328(03)00176-1; Owen BM, 2013, NAT MED, V19, P1153, DOI 10.1038/nm.3250; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Sakata H, 2012, J NEUROSCI, V32, P3462, DOI 10.1523/JNEUROSCI.5686-11.2012; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sun XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090667; Tsai LK, 2011, STROKE, V42, P2932, DOI 10.1161/STROKEAHA.110.612788; Tsai LK, 2010, NEUROPSYCHOPHARMACOL, V35, P2225, DOI 10.1038/npp.2010.97; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang SY, 2013, INT J DEV NEUROSCI, V31, P30, DOI 10.1016/j.ijdevneu.2012.09.004; Wang ZF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19626; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Xu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082997; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942	67	15	15	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2019.6422		AUG 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	IS6VV	WOS:000482290200001	31298621	Bronze, Green Published			2021-06-18	
J	Heyburn, L; Abutarboush, R; Goodrich, S; Urioste, R; Batuure, A; Statz, J; Wilder, D; Ahlers, ST; Long, JB; Sajja, VSSS				Heyburn, Lanier; Abutarboush, Rania; Goodrich, Samantha; Urioste, Rodrigo; Batuure, Andrew; Statz, Jonathan; Wilder, Donna; Ahlers, Stephen T.; Long, Joseph B.; Sajja, Venkata Siva Sai Sujith			Repeated Low-Level Blast Overpressure Leads to Endovascular Disruption and Alterations in TDP-43 and Piezo2 in a Rat Model of Blast TBI	FRONTIERS IN NEUROLOGY			English	Article						blast-induced neurotrauma; blood-brain barrier; Piezo2; TDP-43; low-level blast; training relevant; repeated exposures; cumulative effects	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; EXPOSURE; INFLAMMATION; PERMEABILITY; DEGENERATION; INDUCTION; DAMAGE	Recent evidence linking repeated low-level blast overpressure exposure in operational and training environments with neurocognitive decline, neuroinflammation, and neurodegenerative processes has prompted concern over the cumulative deleterious effects of repeated blast exposure on the brains of service members. Repetitive exposure to low-level primary blast may cause symptoms (subclinical) similar to those seen in mild traumatic brain injury (TBI), with progressive vascular and cellular changes, which could contribute to neurodegeneration. At the cellular level, the mechanical force associated with blast exposure can cause cellular perturbations in the brain, leading to secondary injury. To examine the cumulative effects of repetitive blast on the brain, an advanced blast simulator (ABS) was used to closely mimic "free-field" blast. Rats were exposed to 1-4 daily blasts (one blast per day, separated by 24 h) at 13, 16, or 19 psi peak incident pressures with a positive duration of 4-5 ms, either in a transverse or longitudinal orientation. Blood-brain barrier (BBB) markers (vascular endothelial growth factor (VEGF), occludin, and claudin-5), transactive response DNA binding protein (TDP-43), and the mechanosensitive channel Piezo2 were measured following blast exposure. Changes in expression of VEGF, occludin, and claudin-5 after repeated blast exposure indicate alterations in the BBB, which has been shown to be disrupted following TBI. TDP-43 is very tightly regulated in the brain and altered expression of TDP-43 is found in clinically-diagnosed TBI patients. TDP-43 levels were differentially affected by the number and magnitude of blast exposures, decreasing after 2 exposures, but increasing following a greater number of exposures at various intensities. Lastly, Piezo2 has been shown to be dysregulated following blast exposure and was here observed to increase after multiple blasts of moderate magnitude, indicating that blast may cause a change in sensitivity to mechanical stimuli in the brain and may contribute to cellular injury. These findings reveal that cumulative effects of repeated exposures to blast can lead to pathophysiological changes in the brain, demonstrating a possible link between blast injury and neurodegenerative disease, which is an important first step in understanding how to prevent these diseases in soldiers exposed to blast.	[Heyburn, Lanier; Urioste, Rodrigo; Batuure, Andrew; Wilder, Donna; Long, Joseph B.; Sajja, Venkata Siva Sai Sujith] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA; [Abutarboush, Rania; Goodrich, Samantha; Statz, Jonathan; Ahlers, Stephen T.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD USA; [Abutarboush, Rania; Goodrich, Samantha; Statz, Jonathan] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA	Sajja, VSSS (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.	venkatasivasaisujith.sajja.ctr@mail.mil	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501; Heyburn, Lanier/0000-0001-6228-4801	Defense Health Program [602115HP.3720.001]	This work was supported/funded by work unit number 602115HP.3720.001.A1317 as a part of the Exposure Standards for Repeated Blast program is funded by the Defense Health Program managed by Joint Program Committee 5.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Baralle M, 2013, BIOCHEM SOC T, V41, P1536, DOI 10.1042/BST20130186; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; DVBIC. Defense and Veterans Brain Injury Center, 2018, DOD NUMB TRAUM BRAIN; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Geiseler SJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051362; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hubbard WB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5175249; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Li M, 2016, CLIN NEUROL NEUROSUR, V144, P7, DOI 10.1016/j.clineuro.2016.02.032; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sajja VS, 2018, NEUROMETHODS, V139, P123, DOI 10.1007/978-1-4939-8564-7_8; Sajja VS, 2017, PULMONARY INJURIES S; Schrenk-Siemens K, 2015, NAT NEUROSCI, V18, P10, DOI 10.1038/nn.3894; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Unnikrishnan G, 2019, EFFECTS ANIMAL ORIEN; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wiesner D, 2018, EXP NEUROL, V299, P15, DOI 10.1016/j.expneurol.2017.09.011; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	49	15	15	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 30	2019	10								766	10.3389/fneur.2019.00766			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	IM2HU	WOS:000477814400001	31417481	DOAJ Gold, Green Published			2021-06-18	
J	Brett, BL; Huber, DL; Wild, A; Nelson, LD; McCrea, MA				Brett, Benjamin L.; Huber, Daniel L.; Wild, Alexa; Nelson, Lindsay D.; McCrea, Michael A.			Age of First Exposure to American Football and Behavioral, Cognitive, Psychological, and Physical Outcomes in High School and Collegiate Football Players	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						adolescence; sports; football; concussion; traumatic brain injury; age of first exposure	CHRONIC TRAUMATIC ENCEPHALOPATHY; HEAD IMPACT EXPOSURE; BASE-LINE; NEUROCOGNITIVE PERFORMANCE; SPORTS PARTICIPATION; CONCUSSION SYMPTOMS; POSTURAL STABILITY; SINGLE SEASON; RELIABILITY; SPECTRUM	Background: Although some studies have observed a relationship between age of first exposure (AFE) to American football and long-term outcomes, recent findings in collegiate athletes did not observe a relationship between AFE and more intermediate outcomes at early adulthood. This, however, requires independent replication. Hypothesis: There will be no association between AFE to football and behavioral, cognitive, emotional/psychological, and physical functioning in high school and collegiate athletes. Study Design: Cross-sectional study. Methods: Active high school and collegiate football players (N = 1802) underwent a comprehensive preseason evaluation on several clinical outcome measures. Demographic and health variables that significantly differed across AFE groups were identified as potential covariates. General linear models (GLMs) with AFE as the independent variable were performed for each clinical outcome variable. Similar GLMs that included identified covariates, with AFE as the predictor, were subsequently performed for each clinical outcome variable. Results: After controlling for covariates of age, concussion history, race, and a diagnosis of ADHD, earlier AFE (<12 vs >= 12 years) did not significantly predict poorer performance on any clinical outcome measures (all P > 0.05). A single statistically significant association between AFE group and somatization score was recorded, with AFE Conclusion: In a large cohort of active high school and collegiate football student-athletes, AFE before the age of 12 years was not associated with worse behavioral, cognitive, psychological, and physical (oculomotor functioning and postural stability) outcomes.	[Brett, Benjamin L.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; Huber, Daniel L.; Wild, Alexa; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA	Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.; Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	bbrett@mcw.edu		Huber, Daniel/0000-0003-2079-0647	Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1TR001436]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436] Funding Source: NIH RePORTER	This work was supported by the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research through Award No. W81XWH-14-1-0561. The REDCap electronic database used for this project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Award Number UL1TR001436. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense or the NIH.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Barr WB, 2013, NEUROPSYCHOL REV, V23, P271, DOI 10.1007/s11065-013-9244-3; Brett BL, 2017, DEV NEUROPSYCHOL, V42, P70, DOI 10.1080/87565641.2016.1243114; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2010, OPEN ACCESS J SPORTS, V1, P55; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Derogatis LR, 2001, BRIEF SYMPT INV 18 B; Field A., 2009, DISCOVERING STAT USI; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Gong NJ, 2018, NEUROBIOL DIS, V119, P79, DOI 10.1016/j.nbd.2018.07.020; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; ImPACT Applications, IMM POSTC ASS TEST I; Janigro D, 2018, JAMA NEUROL, V75, P381, DOI 10.1001/jamaneurol.2017.4890; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130507; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Paniccia M, 2018, SPORTS HEALTH, V10, P175, DOI 10.1177/1941738117741651; Patrick CJ, 2013, PSYCHOL ASSESSMENT, V25, P1332, DOI 10.1037/a0034864; Reitan RM., 1985, HALSTEAD REITAN NEUR; Russo Ralph D., US TODAY; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Shao J., 2003, MATH STAT; Solomon GS, 2014, PHYSICIAN SPORTSMED, V42, P26, DOI 10.3810/psm.2014.09.2072; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Turner RW, 2014, J ADOLESCENT HEALTH, V54, pS79, DOI 10.1016/j.jadohealth.2013.10.172; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	58	15	15	3	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL	2019	11	4					332	342		10.1177/1941738119849076			11	Sport Sciences	Sport Sciences	IF7FT	WOS:000473247600006	31173699	Green Published			2021-06-18	
J	McDonald, S; Dalton, KI; Rushby, JA; Landin-Romero, R				McDonald, Skye; Dalton, Katie I.; Rushby, Jacqueline A.; Landin-Romero, Ramon			Loss of white matter connections after severe traumatic brain injury (TBI) and its relationship to social cognition	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; White matter; Diffuse axonal injury; Social cognition	NEUROPSYCHOLOGICAL IMPAIRMENT; EMOTION RECOGNITION; AUDITORY-CORTEX; DEFICITS; METAANALYSIS; PERCEPTION; EMPATHY; MIND; BEHAVIOR; NEUROPATHOLOGY	Adults with severe traumatic brain injury (TBI) often suffer poor social cognition. Social cognition is complex, requiring verbal, non-verbal, auditory, visual and affective input and integration. While damage to focal temporal and frontal areas has been implicated in disorders of social cognition after TBI, the role of white matter pathology has not been examined. In this study 17 adults with chronic, severe TBI and 17 control participants underwent structural MRI scans and Diffusion Tensor Imaging. The Awareness of Social Inference Test (TASIT) was used to assess their ability to understand emotional states, thoughts, intentions and conversational meaning in everyday exchanges. Track-based spatial statistics were used to perform voxelwise analysis of Fractional Anisotropy (FA) and Mean Diffusivity (MD) of white matter tracts associated with poor social cognitive performance. FA suggested a wide range of tracts were implicated in poor TASIT performance including tracts known to mediate, auditory localisation (planum temporale) communication between nonverbal and verbal processes in general (corpus callosum) and in memory in particular (fornix) as well as tracts and structures associated with semantics and verbal recall (left temporal lobe and hippocampus), multimodal processing and integration (thalamus, external capsule, cerebellum) and with social cognition (orbitofrontal cortex, frontopolar cortex, right temporal lobe). Even when controlling for non-social cognition, the corpus callosum, fornix, bilateral thalamus, right external capsule and right temporal lobe remained significant contributors to social cognitive performance. This study highlights the importance of loss of white matter connectivity in producing complex social information processing deficits after TBI.	[McDonald, Skye; Dalton, Katie I.; Rushby, Jacqueline A.] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Landin-Romero, Ramon] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia	McDonald, S (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014; Rushby, Jacqueline/D-1820-2010	McDonald, Skye/0000-0003-0723-6094; Rushby, Jacqueline/0000-0002-5018-638X	ARCAustralian Research Council [15010026]; NHMRCNational Health and Medical Research Council of Australia [1081923]; ARC Centre of Excellence in Cognition and its Disorders Memory NodeAustralian Research Council [CE11000102]; Appenzeller Neuroscience Fellowship in Alzheimer's Disease; NHMRC Centre of Research Excellence in Brain RecoveryNational Health and Medical Research Council of Australia	KD was supported by an ARC Discovery Project 15010026. JR was supported by NHMRC Project Grant 1081923. RLR is supported by the ARC Centre of Excellence in Cognition and its Disorders Memory Node (CE11000102) and by the Appenzeller Neuroscience Fellowship in Alzheimer's Disease. Additional support was provided from the NHMRC Centre of Research Excellence in Brain Recovery and a former ARC DP 1094083.	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Alho K, 2014, HEARING RES, V307, P29, DOI 10.1016/j.heares.2013.08.001; Alink A, 2012, HUM BRAIN MAPP, V33, P969, DOI 10.1002/hbm.21263; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baggio HC, 2012, NEUROPSYCHOLOGIA, V50, P2121, DOI 10.1016/j.neuropsychologia.2012.05.020; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bzdok D, 2012, BRAIN STRUCT FUNCT, V217, P783, DOI 10.1007/s00429-012-0380-y; Carrera E, 2006, NEUROLOGY, V66, P1817, DOI 10.1212/01.wnl.0000219679.95223.4c; Champagne-Lavau M, 2009, J NEUROLINGUIST, V22, P413, DOI 10.1016/j.jneuroling.2009.02.002; Charbonneau S, 2003, NEUROPSYCHOLOGIA, V41, P605, DOI 10.1016/S0028-3932(02)00202-6; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Downey LE, 2015, NEUROIMAGE-CLIN, V8, P640, DOI 10.1016/j.nicl.2015.06.005; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kumfor F, 2016, BRAIN, V139, P986, DOI 10.1093/brain/awv387; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marsh AA, 2014, SOC COGN AFFECT NEUR, V9, P3, DOI 10.1093/scan/nss097; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2018, SOC NEUROSCI-UK, V13, P471, DOI 10.1080/17470919.2017.1356370; Mike A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082422; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Reitan R. M, 1992, TRAIL MAKING TEST; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Rushby JA, 2016, NEUROIMAGE-CLIN, V12, P607, DOI 10.1016/j.nicl.2016.09.017; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Saldert C, 2007, CLIN LINGUIST PHONET, V21, P637, DOI 10.1080/02699200701431056; Schmahmann J, 2006, FIBRE PATHWAYS BRAIN; Shallice, 1997, HAYLING BRIXTON TEST; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Symington SH, 2010, SOC NEUROSCI-UK, V5, P296, DOI 10.1080/17470910903462419; Tate R.L., 1998, J AUSTR NZ PUBLIC HL, V22, P11; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Timmann D, 2010, CORTEX, V46, P845, DOI 10.1016/j.cortex.2009.06.009; Tsivilis D, 2008, NAT NEUROSCI, V11, P834, DOI 10.1038/nn.2149; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wechsler D, 1997, WAIS 3 ADM SCORING M; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Zundorf IC, 2014, BRAIN, V137, P1410, DOI 10.1093/brain/awu044	73	15	15	1	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2019	13	3					819	829		10.1007/s11682-018-9906-0			11	Neuroimaging	Neurosciences & Neurology	IA1VV	WOS:000469351500023	29948905				2021-06-18	
J	Zahniser, E; Nelson, LD; Dikmen, SS; Machamer, JE; Stein, MB; Yuh, E; Manley, GT; Temkin, NR; Adeoye, O; Badjatia, N; Boase, K; Bodien, Y; Bullock, MR; Chesnut, R; Corrigan, JD; Crawford, K; Diaz-Arrastia, R; Duhaime, AC; Ellenbogen, R; Feeser, VR; Ferguson, A; Foreman, B; Gardner, R; Gaudette, E; Giacino, J; Gonzalez, L; Gopinath, S; Gullapalli, R; Hemphill, JC; Hotz, G; Jain, S; Korley, F; Kramer, J; Kreitzer, N; Levin, H; Lindsell, C; Madden, C; Martin, A; McAllister, T; McCrea, M; Merchant, R; Mukherjee, P; Noel, F; Okonkwo, D; Palacios, E; Perl, D; Puccio, A; Rabinowitz, M; Robertson, C; Rosand, J; Sander, A; Satris, G; Schnyer, D; Seabury, S; Sherer, M; Taylor, S; Toga, A; Valadka, A; Vassar, M; Vespa, P; Wang, K; Yue, J; Zafonte, R				Zahniser, Evan; Nelson, Lindsay D.; Dikmen, Sureyya S.; Machamer, Joan E.; Stein, Murray B.; Yuh, Esther; Manley, Geoffrey T.; Temkin, Nancy R.; Adeoye, Opeolu; Badjatia, Neeraj; Boase, Kim; Bodien, Yelena; Bullock, M. Ross; Chesnut, Randall; Corrigan, John D.; Crawford, Karen; Diaz-Arrastia, Ramon; Duhaime, Ann-Christine; Ellenbogen, Richard; Feeser, V. Ramana; Ferguson, Adam; Foreman, Brandon; Gardner, Raquel; Gaudette, Etienne; Giacino, Joseph; Gonzalez, Luis; Gopinath, Shankar; Gullapalli, Rao; Hemphill, J. Claude; Hotz, Gillian; Jain, Sonia; Korley, Frederick; Kramer, Joel; Kreitzer, Natalie; Levin, Harvey; Lindsell, Chris; Madden, Christopher; Martin, Alastair; McAllister, Thomas; McCrea, Michael; Merchant, Randall; Mukherjee, Pratik; Noel, Florence; Okonkwo, David; Palacios, Eva; Perl, Daniel; Puccio, Ava; Rabinowitz, Miri; Robertson, Claudia; Rosand, Jonathan; Sander, Angelle; Satris, Gabriella; Schnyer, David; Seabury, Seth; Sherer, Mark; Taylor, Sabrina; Toga, Arthur; Valadka, Alex; Vassar, Mary; Vespa, Paul; Wang, Kevin; Yue, John; Zafonte, Ross		TRACK-TBI Investigators	The Temporal Relationship of Mental Health Problems and Functional Limitations following mTBI: A TRACK-TBI and TED Study	JOURNAL OF NEUROTRAUMA			English	Article						brain injuries; mental health; patient outcome assessment; traumatic	TRAUMATIC BRAIN-INJURY; DEPRESSION; PREVALENCE	Mental health problems, such as depression and anxiety, are often associated with functional limitations after traumatic brain injury (TBI), prompting researchers to explore which of these TBI-related sequelae tends to precede the other. Past studies among patients with injuries ranging in severity have predominantly reported that functional impairments predict subsequent psychological concerns, rather than the other way around; however, it remains unclear whether this directionality holds for individuals with mild TBI (mTBI). The present study utilized a cross-lagged panel design within a structural equation modeling analytical framework to explore the longitudinal relationships of symptoms of depression and anxiety to functional status among 717 adult mTBI patients, with assessments occurring at 2 weeks and 3 months post-injury. Symptoms of both depression and anxiety significantly predicted subsequent functional limitations (lambda s = -0.21 and -0.25), whereas the reverse effects were nonsignificant (lambda s = -0.05 and -0.03); thus, psychological concerns appeared to function as a precursor to functional impairment. This pattern was particularly pronounced among patients with normal head computed tomography (CT) results; however, results were less clear cut among those subjects whose injuries were accompanied by intracranial abnormalities detected on CT imaging, suggesting the possibility of a more reciprocal relationship in the case of CT-positive mTBI. These results may serve to partially explain the incidence of persistent functional limitations observed among subsets of mTBI patients in past studies. Findings likewise highlight the importance of assessment and treatment for mental health problems after mTBI as an important factor to promote psychological well-being and functional recovery.	[Zahniser, Evan; Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, 325 Ninth Ave,Box 359924, Seattle, WA 98104 USA; [Dikmen, Sureyya S.; Machamer, Joan E.] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Yuh, Esther] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Adeoye, Opeolu; Foreman, Brandon; Kreitzer, Natalie] Univ Cincinnati, Cincinnati, OH 45221 USA; [Badjatia, Neeraj; Gullapalli, Rao] Univ Maryland, College Pk, MD 20742 USA; [Boase, Kim; Chesnut, Randall; Ellenbogen, Richard] Univ Washington, Seattle, WA 98195 USA; [Bodien, Yelena; Rosand, Jonathan] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bullock, M. Ross; Hotz, Gillian] Univ Miami, Coral Gables, FL 33124 USA; [Corrigan, John D.] Ohio State Univ, Columbus, OH 43210 USA; [Crawford, Karen; Gaudette, Etienne; Seabury, Seth; Toga, Arthur] Univ Southern Calif, Los Angeles, CA USA; [Diaz-Arrastia, Ramon] Univ Penn, Philadelphia, PA 19104 USA; [Duhaime, Ann-Christine] Mass Gen Hosp, Boston, MA USA; [Feeser, V. Ramana; Merchant, Randall; Valadka, Alex] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Ferguson, Adam; Gardner, Raquel; Hemphill, J. Claude; Kramer, Joel; Martin, Alastair; Mukherjee, Pratik; Palacios, Eva; Satris, Gabriella; Taylor, Sabrina; Vassar, Mary; Yue, John] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Giacino, Joseph] Spaulding Rehabil Hosp, Boston, MA USA; [Gonzalez, Luis; Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Gopinath, Shankar; Levin, Harvey; Noel, Florence; Robertson, Claudia; Sander, Angelle] Baylor Coll Med, Houston, TX 77030 USA; [Jain, Sonia] Univ San Diego, San Diego, CA 92110 USA; [Korley, Frederick] Univ Michigan, Ann Arbor, MI 48109 USA; [Lindsell, Chris] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Madden, Christopher] UT Southwestern, Dallas, TX USA; [McAllister, Thomas] Indiana Univ, Bloomington, IN 47405 USA; [McCrea, Michael] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Okonkwo, David; Puccio, Ava; Rabinowitz, Miri] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Perl, Daniel] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [Schnyer, David] UT Austin, Austin, TX USA; [Vespa, Paul] Univ Calif Los Angeles, Los Angeles, CA USA; [Wang, Kevin] Univ Florida, Gainesville, FL 32611 USA; [Zafonte, Ross] Harvard Med Sch, Boston, MA 02115 USA	Temkin, NR (corresponding author), Univ Washington, Dept Neurol Surg, 325 Ninth Ave,Box 359924, Seattle, WA 98104 USA.	temkin@uw.edu	Yue, John K/P-1348-2015; Giacino, Joseph/AAF-1952-2021	Yue, John K/0000-0001-9694-7722; Giacino, Joseph/0000-0002-7916-9698; Bodien, Yelena/0000-0003-4858-2903; Hemphill, Claude/0000-0003-4019-7525; Ferguson, Adam/0000-0001-7102-1608	D.O.D. U.S. ArmyUnited States Department of Defense [W81XWH-14-2-0176]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086090]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090] Funding Source: NIH RePORTER	This study was supported by funding from the following grants: D.O.D. U.S. Army W81XWH-14-2-0176 and NIH/NINDS 1U01NS086090.	Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Cheung MWL, 2009, STRUCT EQU MODELING, V16, P267, DOI 10.1080/10705510902751291; Deb S, 1999, AM J PSYCHIAT, V156, P374; Derogatis L., 2000, BRIEF SYMPTOM INVENT; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Dikmen S.S., 1990, ARCH PHYS MED REHAB, V84, P1449; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Joreskog K., 1993, LISREL 8 STRUCTURAL; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P74, DOI DOI 10.1097/00001199-199309000-00009; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kwan JLY, 2011, BEHAV RES METHODS, V43, P730, DOI 10.3758/s13428-011-0088-6; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; PELZ DC, 1964, AM SOCIOL REV, V29, P836, DOI 10.2307/2090866; Perrin PB, 2017, AM J PHYS MED REHAB, V96, P374, DOI 10.1097/PHM.0000000000000644; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RINDSKOPF D, 1984, PSYCHOMETRIKA, V49, P37, DOI 10.1007/BF02294204; Ruff R.M., 2009, BRAIN INJURY, V10, P551; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEMKIN N, 2005, J NEUROTRAUM, V20, P229; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	31	15	15	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1786	1793		10.1089/neu.2018.6172			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600009	30543138	Green Published			2021-06-18	
J	Goetzl, EJ; Ledreux, A; Granholm, AC; Elahi, FM; Goetzl, L; Hiramoto, J; Kapogiannis, D				Goetzl, Edward J.; Ledreux, Aurelie; Granholm, Ann-Charlotte; Elahi, Fanny M.; Goetzl, Laura; Hiramoto, Jade; Kapogiannis, Dimitrios			Neuron-Derived Exosome Proteins May Contribute to Progression From Repetitive Mild Traumatic Brain Injuries to Chronic Traumatic Encephalopathy	FRONTIERS IN NEUROSCIENCE			English	Article						amyloid; cellular prion protein; phospho-tau; synaptogyrin-3; Alzheimer disease	BARRIER DISRUPTION; HEAD IMPACTS; BLOOD; ASSOCIATION; BIOMARKERS; DEMENTIA; INTERLEUKIN-6; EPIDEMIOLOGY; PATHOGENESIS; INFLAMMATION	The recent recognition that Alzheimer disease-like pathology may be found in chronic traumatic encephalopathy (CTE) even after acute mild traumatic brain injury (mTBI) has increased the urgency of elucidating mechanisms, identifying biomarkers predictive of high risk of development of CTE, and establishing biomarker profiles indicative of impactful effects of treatments. Of the many proteins that are loaded into neuron-derived exosomes (NDEs) from damaged neurons after acute TBI, the levels of prion cellular protein (PRPc), coagulation factor XIII (XIIIa), synaptogyrin-3, IL-6, and aquaporins remain elevated for months. Prolonged heightened expression of aquaporins and IL-6 may account for the persistent central nervous system edema and inflammation of CTE. PRPc, XIIIa and synaptogyrin-3 bind and concentrate neurotoxic forms of oligomeric amyloid beta peptides or P-tau for delivery into neurons at or distant from the site of trauma. Our progression factor hypothesis of CTE asserts that physiological neuronal proteins, such as PRPc, XIIIa, synaptogyrin-3, IL-6 and aquaporins, that increase in concentration in neurons and NDEs for months after acute TBI, are etiological contributors to CTE by either direct actions or by recruiting neurotoxic forms of A beta peptides or P-tau. Such progression factors also may be useful new targets for development of drugs to prevent CTE.	[Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ledreux, Aurelie; Granholm, Ann-Charlotte] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO 80208 USA; [Elahi, Fanny M.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Goetzl, Laura] Univ Texas Hlth Sci Ctr Houston, Dept Obstet Gynecol & Reprod Sci, Houston, TX 77030 USA; [Hiramoto, Jade] Univ Calif San Francisco, Dept Surg, Div Vasc Surg, San Francisco, CA USA; [Kapogiannis, Dimitrios] NIA, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Ledreux, A (corresponding author), Univ Denver, Knoebel Inst Hlth Aging, Denver, CO 80208 USA.; Kapogiannis, D (corresponding author), NIA, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA.	edward.goetzl@ucsf.edu; aurelie.ledreux@du.edu; kapogiannisd@nih.gov	Kapogiannis, Dimitrios/AAW-4934-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; Goetzl, Laura/0000-0003-4130-2809	Knoebel Institute for Healthy Aging; Intramural Program of the National Institute on Aging of the NIH; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG023481, ZIAAG000975] Funding Source: NIH RePORTER	The research described was supported by a pilot grant to Drs. Ledreux and Granholm-Bentley from the Knoebel Institute for Healthy Aging and by support of Drs. Mustapic and Kapogiannis from the Intramural Program of the National Institute on Aging of the NIH.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI [10.1089/neu.2008.0738, 10.1089/neu.2008-0738]; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; Dailey NS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00118; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fiandaca MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195318; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goetzl L, 2018, ANN CLIN TRANSL NEUR, V5, P4, DOI 10.1002/acn3.499; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hiramoto JS, 2017, J VASC SURG, V65, P311, DOI 10.1016/j.jvs.2016.08.111; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hur WS, 2019, J BIOL CHEM, V294, P390, DOI 10.1074/jbc.RA118.005352; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kiral FR, 2018, CURR BIOL, V28, pR471, DOI 10.1016/j.cub.2018.02.010; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Morita Y, 2014, J NEUROSCI, V34, P4929, DOI 10.1523/JNEUROSCI.1423-13.2014; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ohara O, 1998, MOL BRAIN RES, V57, P181, DOI 10.1016/S0169-328X(98)00068-0; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Scharfman HE, 2013, NEUROCHEM INT, V63, P702, DOI 10.1016/j.neuint.2013.05.003; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087	54	15	15	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 8	2019	13								452	10.3389/fnins.2019.00452			8	Neurosciences	Neurosciences & Neurology	HX4GW	WOS:000467354100001	31133789	DOAJ Gold, Green Published			2021-06-18	
J	Griemert, EV; Schwarzmaier, SM; Hummel, R; Golz, C; Yang, D; Neuhaus, W; Burek, M; Forster, CY; Petkovic, I; Trabold, R; Plesnila, N; Engelhard, K; Schafer, MK; Thal, SC				Griemert, Eva-Verena; Schwarzmaier, Susanne M.; Hummel, Regina; Goelz, Christina; Yang, Dong; Neuhaus, Winfried; Burek, Malgorzata; Foerster, Carola Y.; Petkovic, Ivan; Trabold, Raimund; Plesnila, Nikolaus; Engelhard, Kristin; Schaefer, Michael K.; Thal, Serge C.			Plasminogen activator inhibitor-1 augments damage by impairing fibrinolysis after traumatic brain injury	ANNALS OF NEUROLOGY			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS; GENE-EXPRESSION; PAI-1; COMPLEX; MICE; THROMBOGENESIS; NORMALIZATION; INACTIVATION; COAGULATION	Objective Plasminogen activator inhibitor-1 (PAI-1) is the key endogenous inhibitor of fibrinolysis, and enhances clot formation after injury. In traumatic brain injury, dysregulation of fibrinolysis may lead to sustained microthrombosis and accelerated lesion expansion. In the present study, we hypothesized that PAI-1 mediates post-traumatic malfunction of coagulation, with inhibition or genetic depletion of PAI-1 attenuating clot formation and lesion expansion after brain trauma. Methods We evaluated PAI-1 as a possible new target in a mouse controlled cortical impact (CCI) model of traumatic brain injury. We performed the pharmacological inhibition of PAI-1 with PAI-039 and stimulation by tranexamic acid, and we confirmed our results in PAI-1-deficient animals. Results PAI-1 mRNA was time-dependently upregulated, with a 305-fold peak 12 hours after CCI, which effectively counteracted the 2- to 3-fold increase in cerebral tissue-type/urokinase plasminogen activator expression. PAI-039 reduced brain lesion volume by 26% at 24 hours and 43% at 5 days after insult. This treatment also attenuated neuronal apoptosis and improved neurofunctional outcome. Moreover, intravital microscopy demonstrated reduced post-traumatic thrombus formation in the pericontusional cortical microvasculature. In PAI-1-deficient mice, the therapeutic effect of PAI-039 was absent. These mice also displayed 13% reduced brain damage compared with wild type. In contrast, inhibition of fibrinolysis with tranexamic acid increased lesion volume by 25% compared with vehicle. Interpretation This study identifies impaired fibrinolysis as a critical process in post-traumatic secondary brain damage and suggests that PAI-1 may be a central endogenous inhibitor of the fibrinolytic pathway, promoting a procoagulatory state and clot formation in the cerebral microvasculature. Ann Neurol 2019;85:667-680	[Griemert, Eva-Verena; Hummel, Regina; Goelz, Christina; Yang, Dong; Petkovic, Ivan; Engelhard, Kristin; Schaefer, Michael K.; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Schwarzmaier, Susanne M.] Ludwig Maximilians Univ LMU Munich, Med Ctr, Dept Anesthesiol, Munich, Germany; [Neuhaus, Winfried] Austrian Inst Technol, Dept Hlth & Environm, Mol Diagnost, Vienna, Austria; [Burek, Malgorzata; Foerster, Carola Y.] Univ Wurzburg, Dept Anesthesia & Crit Care, Wurzburg, Germany; [Trabold, Raimund] Univ Munich, Med Ctr, Walter Brendel Ctr Expt Med, Inst Surg Res, Munich, Germany; [Plesnila, Nikolaus] Ludwig Maximilians Univ LMU Munich, Med Ctr, Inst Stroke & Dementia Res ISD, Munich, Germany; [Plesnila, Nikolaus] Munich Cluster Syst Neurol Synergy, Munich, Germany; [Schaefer, Michael K.; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci, Mainz, Germany	Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Plesnila, Nikolaus/T-7522-2019; Thal, Serge/D-6593-2011; Burek, Malgorzata/AAF-3283-2021; Schaefer, Michael K.E./S-1715-2019	Thal, Serge/0000-0002-1222-8729; Burek, Malgorzata/0000-0001-6148-2195; Schaefer, Michael K.E./0000-0001-6055-6244; Neuhaus, Winfried/0000-0002-6552-7183	Focus Program Translational Neurosciences of Johannes Gutenberg University; Advancement Program of the University Medical Center of the Johannes Gutenberg University Mainz	This work was supported by grants from the Focus Program Translational Neurosciences of Johannes Gutenberg University (S.C.T.) and Advancement Program of the University Medical Center of the Johannes Gutenberg University Mainz (E.-V.G.).	[Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Beuth W, 1996, Neurol Neurochir Pol, V30, P427; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dietzmann K, 2000, PATHOL RES PRACT, V196, P15, DOI 10.1016/S0344-0338(00)80017-5; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; EMEIS JJ, 1992, ANN NY ACAD SCI, V667, P249, DOI 10.1111/j.1749-6632.1992.tb51622.x; EMEIS JJ, 1986, J EXP MED, V163, P1260, DOI 10.1084/jem.163.5.1260; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; FUJII S, 1991, CIRCULATION, V83, P645, DOI 10.1161/01.CIR.83.2.645; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giesen PLA, 2000, SEMIN THROMB HEMOST, V26, P379, DOI 10.1055/s-2000-8456; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Griemert EV, 2019, TRANSL STROKE RES, V10, P372, DOI 10.1007/s12975-018-0644-9; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; Huber K, 2001, J THROMB THROMBOLYS, V11, P195, DOI 10.1023/A:1011952602122; Hultman K, 2010, J NEUROSCI RES, V88, P2441, DOI 10.1002/jnr.22412; Johansson L, 2000, STROKE, V31, P26, DOI 10.1161/01.STR.31.1.26; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; Lip GYH, 2002, BLOOD COAGUL FIBRIN, V13, P339, DOI 10.1097/00001721-200206000-00010; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/0897715042664885; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Mahmood A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2073-6; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Nagai N, 2005, J THROMB HAEMOST, V3, P1379, DOI 10.1111/j.1538-7836.2005.01466.x; Neuhaus W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136221; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nishida T, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0201-0; Rupin A, 2001, THROMB HAEMOSTASIS, V86, P1528; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Schucany WR, 2006, COMMUN STAT-THEOR M, V35, P2275, DOI 10.1080/03610920600853308; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; SIMPSON AJ, 1991, J CLIN PATHOL, V44, P139, DOI 10.1136/jcp.44.2.139; Smith LH, 2006, BLOOD, V107, P132, DOI 10.1182/blood-2005-07-2681; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Staib-Lasarzik I, 2014, J NEUROTRAUM, V31, P1664, DOI 10.1089/neu.2013.3243; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Tuttolomondo A, 2009, ATHEROSCLEROSIS, V203, P503, DOI 10.1016/j.atherosclerosis.2008.06.030; VANDERPOLL T, 1991, J EXP MED, V174, P729, DOI 10.1084/jem.174.3.729; VANHINSBERGH VWM, 1988, BLOOD, V72, P1467; Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xin HQ, 2013, NEUROSCI LETT, V542, P81, DOI 10.1016/j.neulet.2013.02.046; Yang D, 2009, J NEUROSCI, V29, P8669, DOI 10.1523/JNEUROSCI.1117-09.2009; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zhuang P, 2015, J CLIN NEUROSCI, V22, P1123, DOI 10.1016/j.jocn.2014.12.027	58	15	15	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	MAY	2019	85	5					667	680		10.1002/ana.25458			14	Clinical Neurology; Neurosciences	Neurosciences & Neurology	HW2DH	WOS:000466492700006	30843275	Other Gold, Green Published			2021-06-18	
J	Kirschen, MP; Francoeur, C; Murphy, M; Traynor, D; Zhang, BQ; Mensinger, JL; Ichord, R; Topjian, A; Berg, RA; Nishisaki, A; Morrison, W				Kirschen, Matthew P.; Francoeur, Conall; Murphy, Marie; Traynor, Danielle; Zhang, Bingqing; Mensinger, Janell L.; Ichord, Rebecca; Topjian, Alexis; Berg, Robert A.; Nishisaki, Akira; Morrison, Wynne			Epidemiology of Brain Death in Pediatric Intensive Care Units in the United States	JAMA PEDIATRICS			English	Article							CONTROVERSIES; WITHDRAWAL; DIAGNOSIS; CHILDREN; SUPPORT; VOLUME; PICU	IMPORTANCE Guidelines for declaration of brain death in children were revised in 2011 by the Society of Critical Care Medicine, American Academy of Pediatrics, and Child Neurology Society. Despite widespread medical, legal, and ethical acceptance, ongoing controversies exist with regard to the concept of brain death and the procedures for its determination. OBJECTIVES To determine the epidemiology and clinical characteristics of pediatric patients declared brain dead in the United States. DESIGN, SETTING. AND PARTICIPANTS This study involved the abstraction of all patient deaths from the Virtual Pediatric Systems national multicenter database between January 1, 2012, and June 30, 2017. All patients who died in pediatric intensive care units (PICUs) were included. MAIN OUTCOMES AND MEASURES Patient demographics, preillness developmental status, severity of illness, cause of death, PICU medical and physical length of stay, and organ donation status, as well as comparison between patients who were declared brain dead vs those who sustained cardiovascular or cardiopulmonary death. RESULTS Of the 15 344 patients who died, 3170 (20.7%) were declared brain dead; 1861 of these patients (58.7%) were male, and 1401(44.2%) were between 2 and 12 years of age. There was a linear association between PICU size and number of patients declared brain dead per year, with an increase of 4.27 patients (95% CI, 3.46-5.08) per 1000-patient increase in discharges (P <.001). The median (interquartile range) of patients declared brain dead per year ranged from 1(0-3) in smaller PICUs (defined as those with <500 discharges per year) to 10 (7-15) for larger PICUs (those with 2000-4000 discharges per year). The most common causative mechanisms of brain death were hypoxic-ischemic injury owing to cardiac arrest (1672 of 3170 [52.7%]), shock and/or respiratory arrest without cardiac arrest (399 of 3170 [12.6%]), and traumatic brain injury (634 of 3170 [20.0%]). Most patients declared brain dead (681of 807 [84.4%]) did not have preexisting neurological dysfunction. Patients who were organ donors (1568 of 3144 [49.9%]) remained in the PICU longer after declaration of brain death compared with those who were not donors (median [interquartile range], 29 [6-41] hours vs 4 [1-8] hours; P <.001). CONCLUSIONS AND RELEVANCE Brain death occurred in one-fifth of PICU deaths. Most children declared brain dead had no preexisting neurological dysfunction and had an acute hypoxic-ischemic or traumatic brain injury. Brain death determinations are infrequent, even in large PICUs, emphasizing the importance of ongoing education for medical professionals and standardization of protocols to ensure diagnostic accuracy and consistency.	[Kirschen, Matthew P.; Zhang, Bingqing; Topjian, Alexis; Berg, Robert A.; Nishisaki, Akira; Morrison, Wynne] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Kirschen, Matthew P.; Ichord, Rebecca] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Kirschen, Matthew P.; Ichord, Rebecca; Topjian, Alexis; Berg, Robert A.; Nishisaki, Akira; Morrison, Wynne] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Francoeur, Conall] Univ Laval, Ctr Hosp Univ Quebec, Ctr Mere Enfant Soleil, Quebec City, PQ, Canada; [Murphy, Marie; Traynor, Danielle] Childrens Hosp Philadelphia, Dept Nursing, Philadelphia, PA 19104 USA; [Mensinger, Janell L.] Drexel Univ, Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA	Kirschen, MP (corresponding author), Childrens Hosp Philadelphia, Dept Crit Care Med, 3401 Civ Ctr Blvd,Wood Ctr,Ste 6108, Philadelphia, PA 19104 USA.	kirschenm@chop.edu	Mensinger, Janell/AAR-3375-2021		Department of Anesthesiology and Critical Care Medicine at Children's Hospital of Philadelphia	Financial support for this study was from the Department of Anesthesiology and Critical Care Medicine at Children's Hospital of Philadelphia.	[Anonymous], 1987, PEDIATRICS, V80, P298; Au AK, 2011, PEDIATR CRIT CARE ME, V12, P566, DOI 10.1097/PCC.0b013e3181fe3420; Ausmus AM, 2018, PEDIATR CRIT CARE ME, V19, P643, DOI 10.1097/PCC.0000000000001548; Burkle CM, 2015, SEMIN NEUROL, V35, P174, DOI 10.1055/s-0035-1547537; Burkle CM, 2011, NEUROLOGY, V76, P837, DOI 10.1212/WNL.0b013e31820e7bbe; Burns JP, 2014, CRIT CARE MED, V42, P2101, DOI 10.1097/CCM.0000000000000498; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Gupta P, 2014, RESUSCITATION, V85, P1473, DOI 10.1016/j.resuscitation.2014.07.016; Lewis A, 2018, NEUROLOGY, V90, P423, DOI 10.1212/WNL.0000000000005033; Lewis A, 2017, J CHILD NEUROL, V32, P975, DOI 10.1177/0883073817724697; Lewis A, 2017, CRIT CARE MED, V45, pE916, DOI 10.1097/CCM.0000000000002452; Lewis A, 2017, NAT REV NEUROL, V13, P505, DOI 10.1038/nrneurol.2017.72; Lewis A, 2016, NEUROLOGY, V87, P827, DOI 10.1212/WNL.0000000000003008; Lewis A, 2016, NEUROCRIT CARE, V24, P481, DOI 10.1007/s12028-015-0209-7; Lewis A, 2016, CHEST, V149, P607, DOI 10.1016/j.chest.2015.09.040; LoPresti MA, 2016, AM J HOSP PALLIAT ME, V33, P291, DOI 10.1177/1049909114565658; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; Markovitz BP, 2016, PEDIATR CRIT CARE ME, V17, P483, DOI 10.1097/PCC.0000000000000697; Mathur M, 2015, SEMIN NEUROL, V35, P116, DOI 10.1055/s-0035-1547540; Meert KL, 2015, PEDIATR CRIT CARE ME, V16, pE231, DOI 10.1097/PCC.0000000000000520; MINK RB, 1992, PEDIATRICS, V89, P961; Nakagawa TA, 2011, PEDIATRICS, V128, pE720, DOI 10.1542/peds.2011-1511; Sands R, 2009, NURS CRIT CARE, V14, P235, DOI 10.1111/j.1478-5153.2009.00348.x; Sharpe D, 2015, PRACTICAL ASSESSMENT, V20, P1, DOI DOI 10.1371/journal.pone.0188709; Shewmon DA, 2017, J CHILD NEUROL, V32, P1104, DOI 10.1177/0883073817736961; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; STAWORN D, 1994, CRIT CARE MED, V22, P1301, DOI 10.1097/00003246-199408000-00014; Stockwell JA, 2011, PEDIATR CRIT CARE ME, V12, P271, DOI 10.1097/PCC.0b013e3181fe27da; Trowbridge A, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2017-4182; Truog RD, 2018, JAMA-J AM MED ASSOC, V320, P335, DOI 10.1001/jama.2018.6990; Truog RD, 2018, JAMA-J AM MED ASSOC, V319, P1859, DOI 10.1001/jama.2018.3441; VERNON DD, 1993, CRIT CARE MED, V21, P1798, DOI 10.1097/00003246-199311000-00035; Virtual Pediatric Systems LLC, 2018, WHO WE AR	33	15	15	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	MAY	2019	173	5					469	476		10.1001/jamapediatrics.2019.0249			8	Pediatrics	Pediatrics	HX6HR	WOS:000467505200015	30882855	Bronze, Green Published			2021-06-18	
J	Kisala, PA; Boulton, AJ; Cohen, ML; Slavin, MD; Jette, AM; Charlifue, S; Hanks, R; Mulcahey, MJ; Cella, D; Tulsky, DS				Kisala, Pamela A.; Boulton, Aaron J.; Cohen, Matthew L.; Slavin, Mary D.; Jette, Alan M.; Charlifue, Susan; Hanks, Robin; Mulcahey, M. J.; Cella, David; Tulsky, David S.			Interviewer-Versus Self-Administration of PROMIS (R) Measures for Adults With Traumatic Injury	HEALTH PSYCHOLOGY			English	Article						spinal cord injury; traumatic brain injury; patient outcomes assessment; PROMIS (R); mode of administration	PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; ITEM RESPONSE THEORY; SPINAL-CORD-INJURY; NEUROLOGICAL DISORDERS; IMPACT; BANKS; BIAS; CRITERIA; DIF	Objective: To assess differential item functioning and observed mean differences across two modes of administration for PROMIS (R) measure scores in a sample of adults with traumatic injury. Method: Items from 7 PROMIS (R) adult measures (v1.0 Physical Function, Fatigue, Pain Interference, Anger, Anxiety, and Depression and v2.0 Social Health-Emotional Support) were administered as fixed-length short forms in random order to a cross-sectional sample. Participants were randomly assigned to interviewer-administered (phone or in-person) or self-administered (via the Assessment Center website) conditions. The research was conducted at 5 medical rehabilitation institutions across the U.S. Participants included 277 adults with spinal cord injury (n = 148) or traumatic brain injury (n = 129). Results: DIF analyses indicated that all items were invariant to mode of administration. There was no significant effect of mode of administration for the majority of PROMIS (R) measures tested. Regarding observed scores, there were small but significant effects of mode of administration on the Emotional Support and Depression measures, with participants in the interview condition reporting better support/fewer symptoms. Conclusions: PROMIS (R) instruments demonstrated measurement equivalence across interviewer-administered and self-administered conditions. These findings are particularly important for research or clinical applications where administration of PROMIS (R) measures by independent web- or tablet-based administration is not ideal, for example with individuals with physical or cognitive disabilities or with individuals who lack computer and/or Internet access. PROMIS (R) v1.0 Depression and PROMIS (R) v2.0 Emotional Support scores displayed a tendency toward social desirability that should be considered when these measures are interviewer-administered.	[Kisala, Pamela A.; Boulton, Aaron J.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Coll Hlth Sci, Newark, DE 19713 USA; [Cohen, Matthew L.] Univ Delaware, Dept Commun Sci & Disorders, Coll Hlth Sci, Newark, DE 19713 USA; [Slavin, Mary D.] Boston Univ, Dept Hlth Law Policy & Management, Sch Publ Hlth, Boston, MA 02215 USA; [Jette, Alan M.] Massachusetts Gen Hosp, Inst Hlth Profess, Boston, MA 02114 USA; [Charlifue, Susan] Craig Hosp, Englewood, CO USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Sch Med, Detroit, MI 48202 USA; [Mulcahey, M. J.] Thomas Jefferson Univ, Dept Occupat Therapy, Coll Hlth Profess, Philadelphia, PA 19107 USA; [Cella, David] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Evanston, IL 60208 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Dept Phys Therapy, Coll Hlth Sci, Newark, DE 19713 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19713 USA	Kisala, PA (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, 540 South Coll Ave, Newark, DE 19713 USA.	pkisala@udel.edu	Cohen, Mathew/W-3982-2019	mulcahey, MJ/0000-0002-0837-714X; Kisala, Pamela/0000-0003-3234-795X; Cohen, Matthew/0000-0001-9609-2461; Tulsky, David/0000-0002-4335-4509	National Institutes of Health (NIH) Common Fund Initiative (Northwestern University) [U54AR057951, U01AR052177, U54AR057943]; National Institutes of Health (NIH) Common Fund Initiative (American Institutes for Research) [U54AR057926]; National Institutes of Health (NIH) Common Fund Initiative (State University of New York, Stony Brook) [U01AR057948, U01AR052170]; National Institutes of Health (NIH) Common Fund Initiative (University of Washington, Seattle) [U01AR057954, U01AR052171]; National Institutes of Health (NIH) Common Fund Initiative (University of North Carolina, Chapel Hill) [U01AR052181]; National Institutes of Health (NIH) Common Fund Initiative (Children's Hospital of Philadelphia) [U01AR057956]; National Institutes of Health (NIH) Common Fund Initiative (Stanford University) [U01AR052158]; National Institutes of Health (NIH) Common Fund Initiative (Boston University) [U01AR057929]; National Institutes of Health (NIH) Common Fund Initiative (University of California, Los Angeles) [U01AR057936]; National Institutes of Health (NIH) Common Fund Initiative (University of Pittsburgh) [U01AR052155]; National Institutes of Health (NIH) Common Fund Initiative (Georgetown University) [U01AR057971]; National Institutes of Health (NIH) Common Fund Initiative (Children's Hospital Medical Center, Cincinnati) [U01AR057940]; National Institutes of Health (NIH) Common Fund Initiative (University of Maryland, Baltimore) [U01AR057967]; National Institutes of Health (NIH) Common Fund Initiative (Duke University) [U01AR052186]; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54-GM104941]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104941] Funding Source: NIH RePORTER	All authors have contributed significantly to the design, analysis and writing of this article. The contents represent original work and have not been published elsewhere. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated. PROMIS (R) was funded with cooperative agreements from the National Institutes of Health (NIH) Common Fund Initiative (Northwestern University, PI: David Cella, U54AR057951, U01AR052177; Northwestern University, PI: Richard C. Gershon, U54AR057943; American Institutes for Research, PI: Susan (San) D. Keller, U54AR057926; State University of New York, Stony Brook, PIs: Joan E. Broderick, and Arthur A. Stone, U01AR057948, U01AR052170; University of Washington, Seattle, PIs: Heidi M. Crane, Paul K. Crane, and Donald L. Patrick, U01AR057954; University of Washington, Seattle, PI: Dagmar Amtmann, U01AR052171; University of North Carolina, Chapel Hill, PIs: Harry A. Guess, Darren A. DeWalt, U01AR052181; Children's Hospital of Philadelphia, PI: Christopher B. Forrest, U01AR057956; Stanford University, PI: James F. Fries, U01AR052158; Boston University, PIs: Alan Jette, Stephen M. Haley, and David Scott Tulsky (University of Michigan, Ann Arbor), U01AR057929; University of California, Los Angeles, PIs: Dinesh Khanna (University of Michigan, Ann Arbor) and Brennan Spiegel, U01AR057936; University of Pittsburgh, PI: Paul A. Pilkonis, U01AR052155; Georgetown University, PIs: Carol. M. Moinpour, (Fred Hutchinson Cancer Research Center, Seattle) and Arnold L. Potosky, U01AR057971; Children's Hospital Medical Center, Cincinnati, PI: Esi M. Morgan DeWitt, U01AR057940; University of Maryland, Baltimore, PI: Lisa M. Shulman, U01AR057967; and Duke University, PI: Kevin P. Weinfurt, U01AR052186). NIH Science Officers on this project have included Deborah Ader, Vanessa Ameen, Susan Czajkowski, Basil Eldadah, Lawrence Fine, Lawrence Fox, Lynne Haverkos, Thomas Hilton, Laura Lee Johnson, Michael Kozak, Peter Lyster, Donald Mattison, Claudia Moy, Louis Quatrano, Bryce Reeve, William Riley, Peter Scheidt, Ashley Wilder Smith, Susana Serrate-Sztein, William Phillip Tonkins, Ellen Werner, Tisha Wiley, and James Witter. The contents of this article use data developed under PROMIS (R). These contents do not necessarily represent an endorsement by the U.S. Federal Government or PROMIS (R). See www.nihpromis.org for additional information on the PROMIS (R) initiative. We would also like to acknowledge an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number U54-GM104941 (PI: Binder-Macleod), which provided salary support for Cohen. Authors have no financial disclosures related to this project.	Baylor C, 2011, AM J SPEECH-LANG PAT, V20, P243, DOI 10.1044/1058-0360(2011/10-0079); Bingham CO, 2016, QUAL LIFE RES, V25, P2109, DOI 10.1007/s11136-016-1246-1; Bjorner JB, 2014, QUAL LIFE RES, V23, P217, DOI 10.1007/s11136-013-0451-4; Bjorner JB, 2014, J CLIN EPIDEMIOL, V67, P108, DOI 10.1016/j.jclinepi.2013.07.016; Bjorner JB, 2007, QUAL LIFE RES, V16, P95, DOI 10.1007/s11136-007-9168-6; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Choi SW, 2011, J STAT SOFTW, V39, P1; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hahn EA, 2004, PSYCHO-ONCOLOGY, V13, P86, DOI 10.1002/pon.719; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hays RD, 2000, MED CARE, V38, P28; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jodoin MG, 2001, APPL MEAS EDUC, V14, P329, DOI 10.1207/S15324818AME1404_2; Jones R. N., 2016, PSYCHOL TEST ASSESSM, V58, P371; Machin D., 2016, QUALITY LIFE; MCHORNEY CA, 1994, MED CARE, V32, P551, DOI 10.1097/00005650-199406000-00002; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Reise SP, 2013, EDUC PSYCHOL MEAS, V73, P5, DOI 10.1177/0013164412449831; Rutherford C, 2016, QUAL LIFE RES, V25, P559, DOI 10.1007/s11136-015-1110-8; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Samejima F., 1969, PSYCHOMETRIC MONOGRA; Scott NW, 2009, J CLIN EPIDEMIOL, V62, P288, DOI 10.1016/j.jclinepi.2008.06.003; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tulsky DS, 2015, J SPINAL CORD MED, V38, P251, DOI [10.1179/2045772315Y.0000000035, 10.1179/2045772315Y.0000000023]; Tulsky DS, 2012, ARCH PHYS MED REHAB, V93, P1722, DOI 10.1016/j.apmr.2012.05.007; US Food and Drug Administration, 2006, GUID IND PAT REP OUT; Wagner LI, 2015, CANCER-AM CANCER SOC, V121, P927, DOI 10.1002/cncr.29104; Wang M, 2017, QUAL LIFE RES, V26, P2973, DOI 10.1007/s11136-017-1640-3; Weaver KE, 2012, CANCER EPIDEM BIOMAR, V21, P2108, DOI 10.1158/1055-9965.EPI-12-0740; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Witter JP, 2016, RHEUM DIS CLIN N AM, V42, P377, DOI 10.1016/j.rdc.2016.01.007; Yu C. Y, 2002, EVALUATING CUTOFF CR, V30	40	15	15	1	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0278-6133	1930-7810		HEALTH PSYCHOL	Health Psychol.	MAY	2019	38	5			SI		435	444		10.1037/hea0000685			10	Psychology, Clinical; Psychology	Psychology	HW6BH	WOS:000466772600013	31045427	Bronze, Green Accepted			2021-06-18	
J	Wang, YQ; Mao, T; Wang, X; Lin, Y; Hou, GQ; Zhu, J; Xie, BS				Wang, Yiqin; Mao, Tian; Wang, Xin; Lin, Yong; Hou, Guoqiang; Zhu, Jun; Xie, Baoshu			Genome-wide screening of altered m6A-tagged transcript profiles in the hippocampus after traumatic brain injury in mice	EPIGENOMICS			English	Article						hippocampus; N6-methyladenosine (m6A); traumatic brain injury (TBI)	MESSENGER-RNA; M(6)A; METHYLATION; EXPRESSION	Aim: To systematically profile RNA m6A modification landscape after traumatic brain injury (TBI) in mice. Materials & methods: Expression of m6A-related genes was detected by quantitative real-time PCR (qPCR). Expression and location of METTL3, a key component of m6A methyltransferase complex, were determined by immunostaining. Genome-wide profiling of m6A-tagged transcripts was conducted by m6A-modified RNA immunoprecipitation sequencing (m6A-RIP-seq) and RNA sequencing (RNA-seq). Results: METTL3 was downregulated after TBI. In total, 922 m6A peaks were differentially expressed as determined by m6A-RIP-seq, with 370 upregulated and 552 downregulated. In addition, we identified differentially expressed hypomethylated and hypermethylated mRNA transcripts. Conclusion: Our data provided novel information regarding m6A modification changes in the early period of TBI, which might be promising therapy targets.	[Wang, Yiqin; Zhu, Jun] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom,Rui Jin Hosp, CNRS LIA Hematol & Canc,Sino French Res Ctr Life, Shanghai 200127, Peoples R China; [Mao, Tian; Lin, Yong; Hou, Guoqiang; Xie, Baoshu] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China; [Wang, Xin] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Anesthesiol, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Xie, Baoshu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China	Zhu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom,Rui Jin Hosp, CNRS LIA Hematol & Canc,Sino French Res Ctr Life, Shanghai 200127, Peoples R China.; Xie, BS (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China.; Xie, BS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China.	zhuj1966@yahoo.com; clairtree@163.com			Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine [BXJ201824]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81770311]	This research was partly supported by Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine (BXJ201824) and partly supported by National Natural Science Foundation of China (No. 81770311). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chang MQ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170166; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Du YZ, 2018, NUCLEIC ACIDS RES, V46, P5195, DOI 10.1093/nar/gky156; Evans LP, 2018, ANN CLIN TRANSL NEUR, V5, P240, DOI 10.1002/acn3.523; Golovina AY, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1160; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li FL, 2016, J BIOMOL SCREEN, V21, P290, DOI 10.1177/1087057115623264; Li MM, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1436-y; Li WB, 2018, ANN CLIN TRANSL NEUR, V5, P552, DOI 10.1002/acn3.552; Li X, 2017, ONCOTARGET, V8, P96103, DOI 10.18632/oncotarget.21726; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Mathiyalagan P, 2019, CIRCULATION, V139, P518, DOI 10.1161/CIRCULATIONAHA.118.033794; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Prins ML, 2016, J CHILD NEUROL, V31, P28, DOI 10.1177/0883073814549244; Scholler E, 2018, RNA, V24, P499, DOI 10.1261/rna.064063.117; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Tong JY, 2018, FRONT MED-PRC, V12, P481, DOI 10.1007/s11684-018-0654-8; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Visvanathan A, 2018, ONCOGENE, V37, P522, DOI 10.1038/onc.2017.351; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang CX, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004880; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang H, 2018, CELL RES, V28, P1035, DOI 10.1038/s41422-018-0082-y; Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Weng YL, 2018, NEURON, V97, P313, DOI 10.1016/j.neuron.2017.12.036; Xie BS, 2018, J NEUROTRAUM, V35, P1659, DOI 10.1089/neu.2017.5468; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Yang Y, 2019, J CLIN ENDOCR METAB, V104, P665, DOI 10.1210/jc.2018-00619; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhao BS, 2017, MOL CELL, V67, P903, DOI 10.1016/j.molcel.2017.09.004; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhao XG, 2018, CANCER BIOMARK, V21, P859, DOI 10.3233/CBM-170791; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhou J, 2018, MOL CELL, V69, P636, DOI 10.1016/j.molcel.2018.01.019	42	15	15	2	14	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1750-1911	1750-192X		EPIGENOMICS-UK	Epigenomics	MAY	2019	11	7					805	819		10.2217/epi-2019-0002			15	Genetics & Heredity	Genetics & Heredity	IM5ID	WOS:000478026700007	30882247				2021-06-18	
J	Sankar, SB; Pybus, AF; Liew, A; Sanders, B; Shah, KJ; Wood, LB; Buckley, EM				Sankar, Sitara B.; Pybus, Alyssa F.; Liew, Amanda; Sanders, Bharat; Shah, Kajol J.; Wood, Levi B.; Buckley, Erin M.			Low cerebral blood flow is a non-invasive biomarker of neuroinflammation after repetitive mild traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Cerebral blood flow; Cytokines; Mild traumatic brain injury; Neuroinflammation; Kinase signaling	DIFFUSE CORRELATION SPECTROSCOPY; IN-VITRO; ACTIVATION; MICROGLIA; VEGF; LIPOPOLYSACCHARIDE; EXPRESSION; PATHWAYS; RECOVERY; PLAYERS	Previous work has shown that non-invasive optical measurement of low cerebral blood flow (CBF) is an acute biomarker of poor long-term cognitive outcome after repetitive mild traumatic brain injury (rmTBI). Herein, we explore the relationship between acute cerebral blood flow and underlying neuroinflammation. Specifically, because neuroinflammation is a driver of secondary injury after TBI, we hypothesized that both glial activation and inflammatory signaling are associated with acute CBF and, by extension, with long-term cognitive outcome after rmTBI. To test this hypothesis, cortical CBF was non-invasively measured in anesthetized mice 4 h after 3 repetitive closed head injuries spaced once-daily, at which time brains were collected. Right hemispheres were fixed for immunohistochemical staining for glial activation markers Iba1 and GFAP while left hemispheres were used to quantify Iba1 and GFAP expression via Western blot as well as 32 cytokines and 21 phospho-proteins in the MAPK, PI3K/Akt, and NF-kappa B pathways using a Luminex multiplexed immunoassay. N = 8/7 injured/sham C57/black-6 adult male mice were studied. Within the injured group, CBF inversely correlated with Iba1 expression (R = -0.86, p < .01). Further, partial least squares regression analysis revealed significant correlations between CBF and expression of multiple pro-inflammatory cytokines, including RANTES and IL-17. Finally, within the injured group, phosphorylation of specific signals in the MAPK and NF-kappa B intracellular signaling pathways (e.g., p38 MAPK and NF-kappa B) were significantly positively correlated with Iba1. In total, our data indicate that acute cerebral blood flow after rmTBI is a biomarker of underlying neuroinflammatory pathology.	[Sankar, Sitara B.; Pybus, Alyssa F.; Liew, Amanda; Sanders, Bharat; Shah, Kajol J.; Wood, Levi B.; Buckley, Erin M.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Sankar, Sitara B.; Pybus, Alyssa F.; Liew, Amanda; Sanders, Bharat; Shah, Kajol J.; Wood, Levi B.; Buckley, Erin M.] Emory Univ, Atlanta, GA 30322 USA; [Sankar, Sitara B.; Pybus, Alyssa F.; Wood, Levi B.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Wood, Levi B.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Buckley, Erin M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	Wood, LB; Buckley, EM (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Wood, LB; Buckley, EM (corresponding author), Emory Univ, Atlanta, GA 30322 USA.; Wood, LB (corresponding author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.; Wood, LB (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Buckley, EM (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	levi.wood@me.gatech.edu; erin.buckley@emory.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS104801]; Woodruff School of Mechanical Engineering at Georgia Tech; Coulter Department of Biomedical Engineering at Georgia Tech; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS104801] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [grant number R21NS104801] and start-up funds from the Woodruff School of Mechanical Engineering at Georgia Tech and from the Coulter Department of Biomedical Engineering at Georgia Tech and Emory.	Ances BM, 2009, NEUROLOGY, V73, P702, DOI 10.1212/WNL.0b013e3181b59a97; Armstead WA, 2006, EUR J PHARMACOL, V529, P129, DOI 10.1016/j.ejphar.2005.08.059; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Buckley EM, 2015, J CEREBR BLOOD F MET, V35, P1995, DOI 10.1038/jcbfm.2015.161; CHAO CC, 1992, J IMMUNOL, V149, P2736; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Eriksson L, 2013, MULTI MEGAVARIATE DA, V3rd; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Farley MM, 2018, ANNU REV PATHOL-MECH, V13, P93, DOI 10.1146/annurev-pathol-012414-040354; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GOODWIN JL, 1995, BRAIN RES, V692, P207, DOI 10.1016/0006-8993(95)00646-8; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 1997, J BIOL CHEM, V272, P28853, DOI 10.1074/jbc.272.46.28853; Hanisch UK, 1996, SYNAPSE, V24, P104, DOI 10.1002/(SICI)1098-2396(199610)24:2<104::AID-SYN2>3.0.CO;2-J; Ikeda-Matsuo Y, 2005, J NEUROCHEM, V94, P1546, DOI 10.1111/j.1471-4159.2005.03302.x; IOM NRC, 2014, SPORTS RELATED CONCU; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; PATTERSON MS, 1995, APPL OPTICS, V34, P22, DOI 10.1364/AO.34.000022; Rothschild D. E., 2018, J LEUKOCYTE BIOL, DOI [10.1002/JLB.3MIR0817-346RFtR, DOI 10.1002/JLB.3MIR0817-346RFTR]; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Sanchez A, 2010, NEUROPEPTIDES, V44, P323, DOI 10.1016/j.npep.2010.04.002; Simmons AJ, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156282; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Waisman A, 2015, ACTA NEUROPATHOL, V129, P625, DOI 10.1007/s00401-015-1402-7; Wu LM, 2019, J CEREBR BLOOD F MET, V39, P2196, DOI 10.1177/0271678X18786633; Xia MQ, 2000, J NEUROIMMUNOL, V108, P227, DOI 10.1016/S0165-5728(00)00285-X	40	15	16	3	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	APR	2019	124						544	554		10.1016/j.nbd.2018.12.018			11	Neurosciences	Neurosciences & Neurology	HM1NH	WOS:000459217800048	30592976	Green Accepted			2021-06-18	
J	Ventresca, M				Ventresca, Matt			The Curious Case of CTE: Mediating Materialities of Traumatic Brain Injury	COMMUNICATION & SPORT			English	Article						traumatic brain injury; concussion; chronic traumatic encephalopathy; media discourse; neuroscience	ENCEPHALOPATHY; CONCUSSION; FOOTBALL; MASCULINITY; SCIENCE; HEALTH	This article investigates how media discourses are sites for multiple "becomings" of chronic traumatic encephalopathy (CTE), a neurobiological condition associated with repetitive brain trauma. I explain that these discourses are contexts in which multiple actors (journalists, scientists, athletes, and sports organizations) struggle to represent the material complexities of CTE through competing ways of knowing. My analysis reveals two tensions underlying debates about sport-related traumatic brain injury. First, my examination reveals discursive clashes between emotionally charged representations of CTE as an urgent public health problem and commentary cautioning audiences about the scientific uncertainty surrounding CTE. I illuminate how, in the face of this uncertainty, scientific conclusiveness remains privileged as the basis for meaningful action to improve athletes' health. Second, inconsistencies across representations I examined illustrate how CTE defies a straightforward material-semiotic divide. These contradictions demonstrate how the materialities of CTE exceed the medico-scientific and lay discourses through which the condition is commonly known. I argue that such limitations should not enable stakeholders to overlook calls for drastic changes to how sports are played or deflect questions about how sports violence impacts athletes' lives. Instead, this level of uncertainty should accelerate (rather than delay) challenges to socially acceptable levels of sports violence.	[Ventresca, Matt] Georgia Inst Technol, Sch Hist & Sociol, Old Civil Engn Bldg,G17,221 Bobby Dodd Way, Atlanta, GA 30332 USA	Ventresca, M (corresponding author), Georgia Inst Technol, Sch Hist & Sociol, Old Civil Engn Bldg,G17,221 Bobby Dodd Way, Atlanta, GA 30332 USA.	matt.ventresca@gatech.edu		Ventresca, Matt/0000-0003-2863-5692			Adelson E., 2017, YAHOO SPORTS    0606; Almasy S., 2015, JUDGE APPROVES NFL C; Altheide D., 2002, CREATING FEAR NEWS C; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; [Anonymous], 2016, GUARDIAN; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Bachynski K. E., 2017, INJURY PREVENTION; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Branch J, 2015, BOY ICE LIFE DEATH D; Brennan Christine, 2016, US TODAY; Breslow J. M., 2015, PBS FRONTLINE; Brossard D, 2013, P NATL ACAD SCI USA, V110, P14096, DOI 10.1073/pnas.1212744110; Cabot J., 2017, MEDIA DISCOURSES CON; Casper M. J., 2012, DISABILITY STUDIES Q, V32, DOI [10.18061/DSQ.V32I2.3189, DOI 10.18061/DSQ.V32I2.3189]; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Clarke AE, 2003, AM SOCIOL REV, V68, P161, DOI 10.2307/1519765; Concussion Legacy Foundation, 2016, WHAT IS CTE; de Jong IM, 2016, SCI ENG ETHICS, V22, P1107, DOI 10.1007/s11948-015-9684-7; Draper K., 2016, DEADSPIN        0720; Dumit Joseph, 2004, PICTURING PERSONHOOD; Engber D., 2015, SLATE; Engber D., 2012, SLATE; EPSTEIN S, 1995, SCI TECHNOL HUM VAL, V20, P408, DOI 10.1177/016224399502000402; ESPN Staff, 2017, RES STUD CONF CTE FI; Fainaru-Wada M., 2013, LEAGUE DENIAL NFL CO; Frost S, 2011, FEM PHILOS COLLECT, P69, DOI 10.1007/978-1-4020-6835-5_4; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gartland Dan, 2017, SPORTS ILLUSTRATED; Goldberg DS, 2013, J LEGAL MED, V34, P157, DOI 10.1080/01947648.2013.800792; Golen J., 2016, APNEWS          1103; Haraway D. J, 1997, MODEST WITNESS 2 MIL; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Henne K., 2017, SPORT SCI TECHN SESS; Hull K, 2015, J SPORT SOC ISSUES, V39, P78, DOI 10.1177/0193723514558928; Hurley Robert, 1990, HIST SEXUALITY VOLUM, VI; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Junod T., 2017, T BRADYS MOST DANGER; Kalter L., 2018, BOSTON HERALD; King S., 2005, QUALITATIVE METHODS, P21; Kirk M., 2013, LEAGUE DENIAL NFLS C; Klein J. Z., 2011, NY TIMES; Klimas J., 2011, POPULAR MECH; Kounang N., 2016, MORE ATHLETES PLEDGE; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Landesman P., 2015, CONCUSSION MOTION PI; Leonard P., 2016, NEW YORK DAILY NEWS; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Lomangino K., 2018, JOURNALISTS DROP BAL; Maese R., 2017, WASHINGTON POST; Malcolm D, 2017, SPORT MED HLTH MEDIC; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; Markula P, 2011, QUALITATIVE RESEARCH FOR PHYSICAL CULTURE, P1, DOI 10.1057/9780230305632; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McIndoe S., 2017, GUARDIAN; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mirtle J, 2015, GLOBE MAIL; Morrison DR, 2017, ROUTL RES SPORT CULT, P156; Oates T., 2017, FOOTBALL MANLINESS U; Omalu B., 2015, NY TIMES; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Patton M.Q., 2002, QUALITATIVE RES EVAL; Payne M., 2017, WASHINGTON POST; Peters HP, 2013, P NATL ACAD SCI USA, V110, P14102, DOI 10.1073/pnas.1212745110; Pitts-Taylor V, 2016, BRAINS BODY NEUROSCI; Rabinow P., 1996, ESSAYS ANTHR REASON; Rose N., 2013, NEURO NEW BRAIN SCI; Russo M., 2011, MINNESOTA STAR  0907; Shaver R., 2015, US TODAY; Smerconish, 2017, CNN             0810; Smith B., 2016, GLOBE MAIL; Starkman R., 2011, TORONTO STAR; Sullivan S., 2007, RACE EPISTEMOLOGIES, P1; Thompson P., 2017, CHICAGO TRIBUNE; Thornton D.J., 2011, BRAIN CULTURE NEUROS; Waldby C., 2000, VISIBLE HUMAN PROJEC; Workewych AM, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117720057; Yasinkas P., 2017, SPORTING NEWS   0404	82	15	15	0	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	APR	2019	7	2					135	156		10.1177/2167479518761636			22	Communication; Hospitality, Leisure, Sport & Tourism	Communication; Social Sciences - Other Topics	HM8ZS	WOS:000459773100001					2021-06-18	
J	Zhang, L; Wang, HD; Zhou, XM; Mao, L; Ding, K; Hu, ZG				Zhang, Li; Wang, Handong; Zhou, Xiaoming; Mao, Lei; Ding, Ke; Hu, Zhigang			Role of mitochondrial calcium uniporter-mediated Ca2+ and iron accumulation in traumatic brain injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						Ca2+; iron; mitochondrial calcium uniporter; neuroprotection; traumatic brain injury	RUTHENIUM RED; NEURONAL APOPTOSIS; RYANODINE RECEPTOR; OXIDATIVE STRESS; DYSFUNCTION; POLYAMINES; MODEL; MODULATION; PROTEINS; PROTECTS	Previous studies have suggested that the cellular Ca2+ and iron homeostasis, which can be regulated by mitochondria! calcium uniporter (MCU), is associated with oxidative stress, apoptosis and many neurological diseases. However, little is known about the role of MCU-mediated Ca2+ and iron accumulation in traumatic brain injury (TBI). Under physiological conditions, MCU can be inhibited by ruthenium red (RR) and activated by spermine (Sper). In the present study, we used RR and Sper to reveal the role of MCU in mouse and neuron TBI models. Our results suggested that the Ca2+ and iron concentrations were obviously increased after TBI. In addition, TBI models showed a significant generation of reactive oxygen species (ROS), decrease in adenosine triphosphate (ATP), deformation of mitochondria, up-regulation of deoxyribonucleic acid (DNA) damage and increase in apoptosis. Blockage of MCU by RR prevented Ca2+ and iron accumulation, abated the level of oxidative stress, improved the energy supply, stabilized mitochondria, reduced DNA damage and decreased apoptosis both in vivo and in vitro. Interestingly, Sper did not increase cellular Ca2+ and iron concentrations, but suppressed the Ca2+ and iron accumulation to benefit the mice in vivo. However, Sper had no significant impact on TBI in vitro. Taken together, our data demonstrated for the first time that blockage of MCU-mediated Ca2+ and iron accumulation was essential for TBI. These findings indicated that MCU could be a novel therapeutic target for treating TBI.	[Zhang, Li; Wang, Handong; Zhou, Xiaoming; Mao, Lei; Ding, Ke; Hu, Zhigang] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	njhdwang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672503, 81702484]	This work was supported by Grants from the National Natural Science Foundation of China (No. 81672503 and 81702484).	Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Braun G, 2015, BRIT J PHARMACOL, V172, P1728, DOI 10.1111/bph.13019; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; De Stefani D, 2015, BBA-MOL CELL RES, V1853, P2006, DOI 10.1016/j.bbamcr.2015.04.008; Di Lisa F, 2009, J MOL CELL CARDIOL, V46, P775, DOI 10.1016/j.yjmcc.2009.03.006; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GILAD GM, 1992, BIOCHEM PHARMACOL, V44, P401, DOI 10.1016/0006-2952(92)90428-L; Gille G, 2011, J NEURAL TRANSM, V118, P349, DOI 10.1007/s00702-010-0503-7; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Jain S, 2016, PHYSIOL BEHAV, V164, P140, DOI 10.1016/j.physbeh.2016.05.052; Jakob R, 2014, NEUROSCI LETT, V575, P7, DOI 10.1016/j.neulet.2014.05.026; Kalac P, 2014, FOOD CHEM, V161, P27, DOI 10.1016/j.foodchem.2014.03.102; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Liang LP, 2008, J NEUROSCI, V28, P11550, DOI 10.1523/JNEUROSCI.3016-08.2008; Liang N, 2014, J NEURAL TRANSM, V121, P593, DOI 10.1007/s00702-014-1166-6; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; MA JJ, 1993, J GEN PHYSIOL, V102, P1031, DOI 10.1085/jgp.102.6.1031; Malecot CO, 1998, BRIT J PHARMACOL, V124, P465, DOI 10.1038/sj.bjp.0701854; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Owens K, 2013, TRANSL STROKE RES, V4, P618, DOI 10.1007/s12975-013-0278-x; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Paupe V, 2017, BIOCH BIOPHYS RES CO; PEGG AE, 1995, INT J BIOCHEM CELL B, V27, P425, DOI 10.1016/1357-2725(95)00007-C; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Potts Mathew B, 2006, NeuroRx, V3, P143; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Salvi M, 2004, BBA-BIOMEMBRANES, V1661, P113, DOI 10.1016/j.bbamem.2003.12.005; Sato D, 2016, BIOPHYS J, V110, P382, DOI 10.1016/j.bpj.2015.12.009; Sripetchwandee J, 2014, ACTA PHYSIOL, V210, P330, DOI 10.1111/apha.12162; Sripetchwandee J, 2013, LIFE SCI, V92, P298, DOI 10.1016/j.lfs.2013.01.004; Sun M, 2015, J NEUROTRAUM, V32, P66, DOI 10.1089/neu.2012.2432; Urrutia PJ, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00038; Utkina-Sosunova IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062448; Vergun O, 2003, BIOPHYS J, V85, P3358, DOI 10.1016/S0006-3495(03)74755-9; Wang C, 2015, NEUROCHEM RES, V40, P1739, DOI 10.1007/s11064-015-1657-3; WESTERGAARD E, 1973, J COMP NEUROL, V152, P17, DOI 10.1002/cne.901520103; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yan HY, 2015, MOL NEUROBIOL, V52, P1637, DOI 10.1007/s12035-014-8942-z; Yan HY, 2015, BIOCHEM BIOPH RES CO, V456, P835, DOI 10.1016/j.bbrc.2014.12.073; Yang Q, 2016, CELL DEATH DIFFER, V23, P1850, DOI 10.1038/cdd.2016.71; Yang YQ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00287; Zhang L, 2017, J LAB PRECIS MED, V2, P2, DOI DOI 10.1038/srep46763; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang L, 2016, CELL MOL NEUROBIOL, V36, P131, DOI 10.1007/s10571-015-0227-1; Zhao LT, 2015, BIOCHEM BIOPH RES CO, V461, P537, DOI 10.1016/j.bbrc.2015.04.066; Zhao Q, 2013, MOL MED REP, V7, P1073, DOI 10.3892/mmr.2013.1321; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00948	55	15	16	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	APR	2019	23	4					2995	3009		10.1111/jcmm.14206			15	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	HR2MD	WOS:000462970200063	30756474	DOAJ Gold, Green Published			2021-06-18	
J	Rubin, LH; Tierney, R; Kawata, K; Wesley, L; Lee, JH; Blennow, K; Zetterberg, H; Langford, D				Rubin, Leah H.; Tierney, Ryan; Kawata, Keisuke; Wesley, Leroy; Lee, Jong Hyun; Blennow, Kaj; Zetterberg, Henrik; Langford, Dianne			NFL blood levels are moderated by subconcussive impacts in a cohort of college football players	BRAIN INJURY			English	Article						Subconcussive; traumatic brain injury; neurofilament light chain; biomarker; head impact kinematics	SERUM NEUROFILAMENT LIGHT; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; BIOMARKERS; PROTEIN; DISEASE; CHAIN	Introduction: Repetitive subconcussive head impacts in contact/collision sports such as in US football are believed to contribute to long-term brain changes and chronic symptoms. However, the lack of tools to measure the effects of repeated subconcussion limits our understanding of potential contributions to neuropathological alterations including cellular damage. Methods: We examined subconcussive head impacts using an accelerometer-embedded mouthguard on changes in blood levels of neurofilament light (NFL) chain in 18 Division I college football players. Plasma levels of NFL and clinical symptoms were assessed at pre-post practices. The frequency and linear and rotational head accelerations recorded via the mouthguard were examined in relation to NFL plasma changes. Results: The frequency and magnitude of head impacts associated with increased NFL levels. The greater numbers of hits and head accelerations associated with greater pre- to post-practice NFL level increases (p < 0.05). Greater pre- to post-practice increases in NFL also associated with greater pre- to post-practice increases in S100 beta (p < 0.001), but not with total tau. Years of football experience and concussion history did not associate with changes in NFL. Conclusion: Acute changes in NFL may be a clinically useful peripheral marker in tracking acute brain damage in collegiate football players, and other contact sports.	[Rubin, Leah H.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Tierney, Ryan] Temple Univ, Sch Publ Hlth, Dept Kinesiol, Philadelphia, PA 19122 USA; [Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Bloomington, IN 47405 USA; [Wesley, Leroy; Lee, Jong Hyun; Langford, Dianne] Temple Univ, Dept Neurosci, Lewis Katz Sch Med, MERB 750,3500 North Broad St, Philadelphia, PA 19140 USA; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England	Langford, D (corresponding author), Temple Univ, Dept Neurosci, Lewis Katz Sch Med, MERB 750,3500 North Broad St, Philadelphia, PA 19140 USA.	tdl@temple.edu			Pennsylvania Athletic Trainers' Society; Temple University Office of the Vice Provost for Research	This work was supported by the Pennsylvania Athletic Trainers' Society; Temple University Office of the Vice Provost for Research [NA]; Athole Jacobi, MD [n/a].	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164912; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Jonsson M, 2010, EUR J NEUROL, V17, P377, DOI 10.1111/j.1468-1331.2009.02808.x; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Lepinoux-Chambaud C, 2013, HISTOCHEM CELL BIOL, V140, P13, DOI 10.1007/s00418-013-1101-1; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	25	15	15	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					456	462		10.1080/02699052.2019.1565895			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100008	30776989				2021-06-18	
J	Zhang, H; Yan, XZ; Li, H; Jin, R; Fu, HF				Zhang, Hong; Yan, Xuzhong; Li, Heng; Jin, Rui; Fu, HongFeng			Real-Time Alarming, Monitoring, and Locating for Non-Hard-Hat Use in Construction	JOURNAL OF CONSTRUCTION ENGINEERING AND MANAGEMENT			English	Article						Non-hard-hat use (NHU); Infrared beam detector; Thermal infrared sensor; Radio-frequency identification (RFID); Web and smartphone application; Cloud server; Internet of Things (IoT); Safety inspection	TRAUMATIC BRAIN-INJURIES; SAFETY; WORKERS; VISION; SYSTEM; IDENTIFICATION; BEHAVIOR	Non-hard-hat use (NHU) is related to many construction accidents, so NHU inspection is crucial to safety management, in which automatic NHU monitoring plays an essential role. Existing computer vision-based NHU inspection methods lack capabilities in identifying workers and helping take real-time action. Previous sensor-based NHU inspection methods require direct skin contact, which would be uncomfortable for workers. In addition, previous sensor-based methods could be deceived by objects other than human heads and could not achieve real-time alarms. This study aims to address these problems by implementing real-time alarming, monitoring, and locating for NHU in construction based on sensor, mobile, web, and cloud techniques. A smart hard-hat system is developed using an Internet of Things (IoT)-based architecture including (1) a hard hat with an infrared beam detector and thermal infrared sensor for nonintrusive NHU detection; (2) radio-frequency identification (RFID) triggers for locating NHU with an average detection error of less than 10 cm; (3) a smartphone application for personalized warnings; (4) a web application for data visualization and alarms for managers; and (5) a cloud sever for data storage and retrieval. The proposed system enables both workers and managers to take timely actions against NHU. The system performance is evaluated in a laboratory test and validated in a field application. It is indicated that the proposed system is accurate and reliable, showing potential to promote safety inspection and supervision in construction.	[Zhang, Hong; Yan, Xuzhong; Fu, HongFeng] Zhejiang Univ, Inst Construct Management, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Heng] Hong Kong Polytech Univ, Dept Bldg & Real Estate, Fac Construct & Environm, Hung Hom,Kowloon, 11 Yuk Choi Rd, Hong Kong 999077, Peoples R China; [Jin, Rui] Zhejiang Construct Engn Grp Co Ltd, 232 Wensan Rd, Hangzhou 310058, Zhejiang, Peoples R China	Yan, XZ (corresponding author), Zhejiang Univ, Inst Construct Management, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	jgzhangh@zju.edu.cn; 11512075@zju.edu.cn; heng.li@polyu.edu.hk; py255650708@126.com; 21712261@zju.edu.cn	Li, Heng/B-2821-2015	Li, Heng/0000-0002-3187-9041			Ball K, 2010, LABOR HIST-UK, V51, P87, DOI 10.1080/00236561003654776; Barro-Torres S, 2012, COMPUT COMMUN, V36, P42, DOI 10.1016/j.comcom.2012.01.005; Cabahug RR, 2014, MINDANAO J SCI TECHN, V12, P12; Cavazza N, 2009, J SAFETY RES, V40, P277, DOI 10.1016/j.jsr.2009.06.002; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Fang Q, 2018, AUTOMAT CONSTR, V85, P1, DOI 10.1016/j.autcon.2017.09.018; Flin R, 2000, SAFETY SCI, V34, P177, DOI 10.1016/S0925-7535(00)00012-6; Fung IWH, 2014, SAFETY SCI, V65, P70, DOI 10.1016/j.ssci.2013.12.014; Giebe K., 2013, ELIMINATING GAPS PPE; Han S, 2013, AUTOMAT CONSTR, V35, P131, DOI 10.1016/j.autcon.2013.05.001; Han S, 2013, J COMPUT CIVIL ENG, V27, P635, DOI 10.1061/(ASCE)CP.1943-5487.0000279; Hume A., 1995, P INT C BIOM IMP; Jeong BY, 1998, APPL ERGON, V29, P355, DOI 10.1016/S0003-6870(97)00077-X; Kanan R, 2018, AUTOMAT CONSTR, V88, P73, DOI 10.1016/j.autcon.2017.12.033; Kelm A, 2013, AUTOMAT CONSTR, V36, P38, DOI 10.1016/j.autcon.2013.08.009; Kim H, 2018, J COMPUT CIVIL ENG, V32, DOI 10.1061/(ASCE)CP.1943-5487.0000731; Kim J, 2018, AUTOMAT CONSTR, V87, P297, DOI 10.1016/j.autcon.2017.12.016; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; Konstantinou E, 2018, J CONSTR ENG M, V144, DOI 10.1061/(ASCE)CO.1943-7862.0001508; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Levitt R.E., 1987, CONSTRUCTION SAFETY; Li H, 2017, AUTOMAT CONSTR, V80, P95, DOI 10.1016/j.autcon.2017.02.006; Lombardi DA, 2009, ACCIDENT ANAL PREV, V41, P755, DOI 10.1016/j.aap.2009.03.017; Marks ED, 2013, CONSTR MANAG ECON, V31, P636, DOI 10.1080/01446193.2013.783705; Martin-Garin A, 2018, AUTOMAT CONSTR, V87, P201, DOI 10.1016/j.autcon.2017.12.017; Park MW, 2016, AUTOMAT CONSTR, V72, P129, DOI 10.1016/j.autcon.2016.08.039; Park MW, 2015, J CONSTR ENG M, V141, DOI 10.1061/(ASCE)CO.1943-7862.0000974; SangUk Han, 2012, Proceedings of the 2012 Construction Research Congress, P1032; Seo J, 2015, ADV ENG INFORM, V29, P239, DOI 10.1016/j.aei.2015.02.001; Shan Du, 2011, 2011 3rd International Conference on Computer Research and Development (ICCRD 2011), P25, DOI 10.1109/ICCRD.2011.5763846; Shrestha K., 2015, J CONSTRUCTION ENG, V2015, P1; Yan XZ, 2017, ADV ENG INFORM, V34, P152, DOI 10.1016/j.aei.2017.11.001; Yan XZ, 2017, AUTOMAT CONSTR, V74, P2, DOI 10.1016/j.autcon.2016.11.007; Yang J, 2011, ADV ENG INFORM, V25, P736, DOI 10.1016/j.aei.2011.04.001; Zhang Z., 2009, THESIS	36	15	15	4	64	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9364	1943-7862		J CONSTR ENG M	J. Constr. Eng. Manage.	MAR 1	2019	145	3							04019006	10.1061/(ASCE)CO.1943-7862.0001629			13	Construction & Building Technology; Engineering, Industrial; Engineering, Civil	Construction & Building Technology; Engineering	HJ6BR	WOS:000457268900005					2021-06-18	
J	Ruet, A; Bayen, E; Jourdan, C; Ghout, I; Meaude, L; Lalanne, A; Pradat-Diehl, P; Nelson, G; Charanton, J; Aegerter, P; Vallat-Azouvi, C; Azouvi, P				Ruet, Alexis; Bayen, Eleonore; Jourdan, Claire; Ghout, Idir; Meaude, Layide; Lalanne, Astrid; Pradat-Diehl, Pascale; Nelson, Gaelle; Charanton, James; Aegerter, Philippe; Vallat-Azouvi, Claire; Azouvi, Philippe			A Detailed Overview of Long-Term Outcomes in Severe Traumatic Brain Injury Eight Years Post-injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; outcome; longitudinal study; adult; independence; return to work	QUALITY-OF-LIFE; PROGNOSTIC-FACTORS; HEAD-INJURY; FOLLOW-UP; PSYCHOSOCIAL ADJUSTMENT; WORK; RETURN; MODERATE; PREDICTORS; RECOVERY	Background and aims: Severe traumatic brain injury is a leading cause of acquired persistent disabilities, and represents an important health and economic burden. However, the determinants of long-term outcome have rarely been systematically studied in a prospective longitudinal study of a homogeneous group of patients suffering exclusively from severe TBI Methods: Prospective observational study of an inception cohort of adult patients with severe traumatic brain injury in the Parisian area (PariS-TBI). Outcome was assessed with face-to-face interview 8 years after Traumatic Brain Injury, focusing on impairments, activity limitations, and participation restriction. Results: Five hundred and four patients were included between 2005 and 2007. At 8-year follow-up, 261 patients were deceased, 128 were lost to follow-up, 22 refused to participate, and 86 were finally evaluated. Age, gender, initial injury severity did not significantly differ between evaluated patients and lost to follow-up, but the latter were more frequently students or unemployed. Mean age was 41.9 (SD 13.6), 79% were male, median initial Glasgow Coma Scale Score was 6. The most frequent somatic complaints concerned balance (47.5%), motricity (31%), and headaches (36%), but these were less frequent than cognitive complaints (Memory 71%, Slowness 68%, Concentration 67%). According to the Hospital Anxiety and Depression Scale (HADS), 25 % had a score >8 for anxiety and 23.7% for depression. According to the Extended Glasgow Outcome Scale, 19.8% remained severely disabled, 46.5% moderately disabled, 33.7% had a good recovery. Older age, longer education duration, lower functional status upon intensive care discharge, and more severe 8-year dysexecutive problems were significantly associated with a lower Extended Glasgow Outcome Scale score in multivariable analysis. At 8 years, 48.7% of patients were employed in a productive job. Of those, 38% declared a salary loss since traumatic brain injury. Unemployment was significantly associated with lower 1-year GOSE score and more severe 8-year dysexecutive problems. Conclusions: These results from an inception cohort study highlight the fact that long-term outcome after severe TBI is determined by a complex combination of injury-related, demographic and neuropsychological factors. Long after the injury, persisting impairments still interfere with social integration, and participation.	[Ruet, Alexis] CHRU, Dept Phys Med & Rehabil, Caen, France; [Ruet, Alexis; Vallat-Azouvi, Claire; Azouvi, Philippe] Univ Versailles St Quentin, Lab Rech Clin & Sante Publ Handicaps Psych Cognit, EA4047, Montigny Le Bretonneux, France; [Ruet, Alexis; Azouvi, Philippe] INSERM, U1077, EPHE, Neuropsychol & Imagerie Memoire Humaine, Caen, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Hop La Pitie Salpetriere, APHP, Phys Med & Rehabil Dept, Paris, France; [Bayen, Eleonore] Sorbonne Univ GRC18, Paris, France; [Jourdan, Claire] CHRU, Lapeyronie Hosp, Dept Phys Med & Rehabil, Montpellier, France; [Ghout, Idir; Meaude, Layide; Aegerter, Philippe] Ambroise Pare Hosp, APHP, Unite Rech Clin Paris Ile De France Ouest, Boulogne, France; [Lalanne, Astrid] Hop Raymond Poincare, APHP, Dept Phys Med & Rehabil, Garches, France; [Pradat-Diehl, Pascale] Sorbonne Univ GRC18, Lab Imagerie Biomed, INSERM, U1146, Paris, France; [Nelson, Gaelle; Charanton, James] CRFTC, Reg Reference Ctr Bain Injury Parisan Area, Paris, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, Antenne UEROS SAMSAH92 UGECAM IDF, Garches, France; [Vallat-Azouvi, Claire] Univ Paris 08, Lab Psychopathol & Neuropsychol, EA 2027, St Denis, France	Ruet, A (corresponding author), CHRU, Dept Phys Med & Rehabil, Caen, France.; Ruet, A (corresponding author), Univ Versailles St Quentin, Lab Rech Clin & Sante Publ Handicaps Psych Cognit, EA4047, Montigny Le Bretonneux, France.; Ruet, A (corresponding author), INSERM, U1077, EPHE, Neuropsychol & Imagerie Memoire Humaine, Caen, France.	ruet-a@chu-caen.fr	RUET, Alexis/L-8726-2015	RUET, Alexis/0000-0002-5080-5734; AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health (Programme hospitalier de recherche clinique) [AOM04084]; AP-HP (Departement de la recherche clinique et du developpement) - Institut de recherche en sante publique (IRESP)	The authors thank all members of the CRFTC Steering Committee (Center ressource francilien des traumatises craniens) for their valuable help. The first part of this study and the 8 year evaluation was funded by a grant from the French Ministry of Health (Programme hospitalier de recherche clinique 2004 and 2012, AOM04084) and sponsored by AP-HP (Departement de la recherche clinique et du developpement). The second part of this study was funded by a grant from the Institut de recherche en sante publique (IRESP).	Agresti A., 2007, INTRO CATEGORICAL DA; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; Azouvi P, 2015, NEUROPSYCHOL REHABIL, V25, P864, DOI 10.1080/09602011.2014.990907; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Chesnel C, 2018, CLIN REHABIL, V32, P692, DOI 10.1177/0269215517734294; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Diaz AP, 2014, REV BRAS PSIQUIATR, V36, P213, DOI 10.1590/1516-4446-2013-1303; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Foster M, 2000, BRAIN INJURY, V14, P1035; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Fraser R, 2006, J VOCAT REHABIL, V25, P141; HOLM S, 1979, SCAND J STAT, V6, P65; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jaeger M., 2014, Annals of Physical and Rehabilitation Medicine, V57, P436, DOI 10.1016/j.rehab.2014.06.001; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Kostanjsek N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S3; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Palm S, 2017, J REHABIL MED, V49, P228, DOI 10.2340/16501977-2190; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Sharpe D., 2015, PRACTICAL ASSESSMENT, V20, P10; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vallat-Azouvi C, 2018, J NEUROSCI RES, V96, P601, DOI 10.1002/jnr.24180; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	64	15	15	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 21	2019	10								120	10.3389/fneur.2019.00120			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	HM2MG	WOS:000459297400001	30846966	DOAJ Gold, Green Published			2021-06-18	
J	Xue, M; Zhang, XW; Liu, F; Chang, W; Xie, JF; Xu, JY; Yang, Y; Qiu, HB				Xue, Ming; Zhang, Xiwen; Liu, Feng; Chang, Wei; Xie, Jianfeng; Xu, Jingyuan; Yang, Yi; Qiu, Haibo			Effects of chloride content of intravenous crystalloid solutions in critically ill adult patients: a meta-analysis with trial sequential analysis of randomized trials	ANNALS OF INTENSIVE CARE			English	Article						Lactated Ringers; Plasma-Lyte 148; 0.9% Saline; Critically ill patients; In-hospital mortality; Renal outcome	ACUTE KIDNEY INJURY; LACTATED RINGERS SOLUTION; PLASMA-LYTE 148; FLUID RESUSCITATION; INTENSIVE-CARE; BALANCED CRYSTALLOIDS; NORMAL SALINE; MANAGEMENT; MULTICENTER; ACIDOSIS	Intravenous crystalloid solutions are administered commonly for critically ill patients. We performed this meta-analysis of randomized trials with trial sequential analysis (TSA) to evaluate effects of chloride content of intravenous crystalloid solutions on clinical outcomes among critically ill adult patients. Electronic databases were searched up to June 1, 2018, for randomized trials of use of balanced crystalloids versus 0.9% saline solutions in critically ill adult patients. The outcome variables included mortality, renal outcomes, serum content alterations and organ function. Subgroup analysis was conducted according to patient settings, types or volume of crystalloid fluid, or among sepsis versus non-sepsis, TBI versus non-TBI or subpopulations by the categories of baseline kidney function. Random errors were evaluated by trial sequential analysis. Eight studies with 19,301 patients were analyzed. A trend of in-hospital survival benefit with no statistical difference could be observed with balanced crystalloids compared with 0.9% saline (RR 0.92, 95% CI 0.85-1.0, p = 0.06). The use of balanced crystalloid solutions was associated with longer RRT-free days (SMD 0.09, 95% CI 0.06-0.12, p < 0.001), less risk of increase in serum concentrations of chloride (SMD - 1.23, 95% CI - 1.59 to - 0.87, p < 0.001) and sodium (SMD - 1.28, 95% CI - 1.65 to - 0.92, p < 0.001), less risk of decline in serum base deficit (SMD - 0.58, 95% CI - 0.98 to - 0.18, p = 0.004), longer ventilator-free days (SMD 0.08, 95% CI 0.05-0.11, p < 0.001) and vasopressor-free days (SMD 0.04, 95% CI 0.00-0.07, p = 0.02). Subgroup analysis showed that balanced crystalloid solutions were associated with a reduced in-hospital mortality rate among septic patients (RR 0.86, 95% CI 0.75-0.98; p = 0.02) and non-traumatic brain injury patients (RR 0.90, 95% CI 0.82-0.99, p = 0.02), while the TSA results indicated a larger sample size is still in need. Limited evidence supported statistical survival benefit with balanced crystalloid solutions, while it benefited in reducing organ support duration and fluctuations in serum electrolyte and base excess and was associated with decreased in-hospital mortality in subpopulation with sepsis and non-TBI. Large-scale rigorous randomized trials with better designs are needed to provide robust evidence for clinical management. Trial registration The protocol for this meta-analysis was registered on PROSPERO: International prospective register of systematic reviews (CRD42018102661), <ExternalRef><RefSource>https://www.crd.york.ac.uk/prospero/#recordDetails</RefSource><RefTarget Address="https://www.crd.york.ac.uk/prospero/#recordDetails" TargetType="URL" /></ExternalRef>.	[Xue, Ming; Zhang, Xiwen; Liu, Feng; Chang, Wei; Xie, Jianfeng; Xu, Jingyuan; Yang, Yi; Qiu, Haibo] Southeast Univ, Sch Med, Zhongda Hosp, Dept Crit Care Med, Nanjing 210009, Jiangsu, Peoples R China	Qiu, HB (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Crit Care Med, Nanjing 210009, Jiangsu, Peoples R China.	haiboq2000@163.com			Jiangsu Provincial Key Medical Discipline [ZDXKA2016025]; National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81601723]; Jiangsu Provincial Key Research and Development program [SBE2018750279]	Dr. Haibo Qiu received grant support from Jiangsu Provincial Key Medical Discipline (Grant No. ZDXKA2016025) and the National Natural Science Foundations of China (Grants 81571874). Dr. Yi Yang received grant support from Jiangsu Provincial Key Research and Development program (Grant No. SBE2018750279). Dr. Jianfeng Xie received grant support from the National Natural Science Foundations of China (Grant No. 81601723). The funding sources had no role in study design and conduct, the data collection, analysis and management or manuscript review and approval.	Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Awad S, 2008, CLIN NUTR, V27, P179, DOI 10.1016/j.clnu.2008.01.008; Boer C, 2018, BRIT J ANAESTH, V120, P384, DOI 10.1016/j.bja.2017.10.022; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Ertmer C, 2014, CRIT CARE, V18, DOI 10.1186/cc13764; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; Hammond NE, 2017, CRIT CARE RESUSC, V19, P239; Hartmann AF, 1932, J CLIN INVEST, V11, P327, DOI 10.1172/JCI100414; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Huang LL, 2018, INT J SURG, V51, P1, DOI 10.1016/j.ijsu.2018.01.003; Kawano-Dourado L, 2018, ANESTH ANALG, V126, P513, DOI 10.1213/ANE.0000000000002641; Lobo DN, 2014, KIDNEY INT, V86, P1096, DOI 10.1038/ki.2014.105; Mendes PV, 2017, SHOCK, V47, P30, DOI 10.1097/SHK.0000000000000697; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Ringer S, 1882, J Physiol, V3, P195; Rochwerg B, 2014, ANN INTERN MED, V161, P347, DOI 10.7326/M14-0178; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Semler MW, 2017, AM J RESP CRIT CARE, V195, P1362, DOI 10.1164/rccm.201607-1345OC; Takil A, 2002, ANESTH ANALG, V95, P294, DOI 10.1213/01.ANE.0000020188.49502.39; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Torlund K, 2011, USER MANUAL TRIAL SE, P1; Van Zyl DG, 2012, QJM-INT J MED, V105, P337, DOI 10.1093/qjmed/hcr226; Verma B, 2016, CRIT CARE RESUSC, V18, P205; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Winters ME, 2017, J EMERG MED, V53, P928, DOI 10.1016/j.jemermed.2017.08.093; Young JB, 2014, ANN SURG, V259, P255, DOI 10.1097/SLA.0b013e318295feba; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zampieri FG, 2017, CRIT CARE RESUSC, V19, P175; Zayed YZM, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0320-x	35	15	16	0	6	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2110-5820			ANN INTENSIVE CARE	Ann. Intensive Care	FEB 13	2019	9								30	10.1186/s13613-019-0506-y			16	Critical Care Medicine	General & Internal Medicine	HL7PY	WOS:000458934700001	30758680	DOAJ Gold, Green Published			2021-06-18	
J	Bhowmick, S; D'Mello, V; Abdul-Muneer, PM				Bhowmick, Saurav; D'Mello, Veera; Abdul-Muneer, P. M.			Synergistic Inhibition of ERK1/2 and JNK, Not p38, Phosphorylation Ameliorates Neuronal Damages After Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Fluid percussion injury; Mitogen-activated protein kinase; Neurodegeneration	ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; MAP KINASE; OXIDATIVE STRESS; SIGNALING PATHWAYS; ANIMAL-MODEL; IN-VITRO; NEUROINFLAMMATION; MECHANISMS; APOPTOSIS	Mitogen-activated protein (MAP) kinases are serine/threonine protein kinases that play a critical role in signal transduction and are activated by phosphorylation in response to a variety of pathophysiology stimuli. While MAP kinase signaling has a significant role in the pathophysiology of several neurodegenerative diseases, the precise function of activation of MAP kinase in traumatic brain injury (TBI) is unknown. Therefore, it is important to study the role of MAP kinase signaling in TBI-associated neurological ailments. In this study, using an in vitro stretch injury model in rat embryo neuronal cultures and the in vivo fluid percussion injury (FPI) model in rats, we explored the role of MAP kinase signaling in the mechanisms of cell death in TBI. Our study demonstrated that the stretch injury in vitro and FPI in vivo upregulated the phosphorylation of MAP kinase proteins ERK1/2 and JNK, but not p38. Using ERK1/2 inhibitor U0126, JNK inhibitor SP600125, and p38 inhibitor SB203580, we validated the role of MAP kinase proteins in the activation of NF-kB and caspase-3. By immunofluorescence and western blotting, further, we demonstrated the role of ERK1/2 and JNK phosphorylation in neurodegeneration by analyzing cell death proteins annexin V and Poly-ADP-Ribose-Polymerase p85. Interestingly, combined use of ERK1/2 and JNK inhibitors further attenuated the cell death in stretch-injured neurons. In conclusion, this study could establish the significance of MAP kinase signaling in the pathophysiology of TBI and may have significant implications for developing therapeutic strategies using ERK1/2 and JNK inhibitors for TBI-associated neurological complications.	[Bhowmick, Saurav; D'Mello, Veera; Abdul-Muneer, P. M.] Hackensack Meridian Hlth JFK Med Ctr, JFK Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA	Abdul-Muneer, PM (corresponding author), Hackensack Meridian Hlth JFK Med Ctr, JFK Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA.	Mohammed.Muneer@hackensackmeridian.org	Bhowmick, Saurav/Y-6011-2019	Abdul-Muneer, P. M/0000-0001-8231-4385	JFK Neuroscience Institute at Hackensack Meridian Health JFK Medical Center, Edison NJ	This work was funded by the JFK Neuroscience Institute at Hackensack Meridian Health JFK Medical Center, Edison NJ to P.M. Abdul-Muneer.	Abdul-Muneer PM, 2018, MOL NEUROBIOL, V55, P5937, DOI 10.1007/s12035-017-0811-0; Abdul-Muneer PM, 2018, MOL NEUROBIOL, V55, P5901, DOI 10.1007/s12035-017-0812-z; Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V62, P291, DOI 10.1016/j.bbi.2017.02.014; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Augustine C, 2014, NEUROSCIENCE, V274, P1, DOI 10.1016/j.neuroscience.2014.05.009; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Chen X, 2010, BRAIN RES, V1357, P104, DOI 10.1016/j.brainres.2010.07.082; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chernigovskaya EV, 2017, DOKL BIOCHEM BIOPHYS, V476, P296, DOI 10.1134/S1607672917050015; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Crown ED, 2008, EXP NEUROL, V213, P257, DOI 10.1016/j.expneurol.2008.05.025; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Huang QY, 2016, EXP NEUROL, V277, P296, DOI 10.1016/j.expneurol.2015.10.010; Ittner AA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0149-z; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Johnson GVW, 2003, EXP NEUROL, V183, P263, DOI 10.1016/S0014-4886(03)00268-1; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim SJ, 2017, BIOCHEM BIOPH RES CO, V493, P358, DOI 10.1016/j.bbrc.2017.09.017; Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; KURINO M, 1995, J NEUROCHEM, V65, P1282; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mattson MP, 2003, NEUROMOL MED, V4, P109, DOI 10.1385/NMM:4:1-2:109; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Nicholls DG, 1998, BIOFACTORS, V8, P287, DOI 10.1002/biof.5520080317; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rehman SU, 2018, CEREB CORTEX, V28, P2854, DOI 10.1093/cercor/bhx164; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Saporito MS, 2002, PROGR MED CHEM, V40, P23, DOI 10.1016/S0079-6468(08)70081-X; Schulze-Osthoff K, 1997, IMMUNOBIOLOGY, V198, P35, DOI 10.1016/S0171-2985(97)80025-3; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Skaper SD, 1998, MOL CELL NEUROSCI, V12, P179, DOI 10.1006/mcne.1998.0714; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; Sun J, 2016, J MOL NEUROSCI, V59, P90, DOI 10.1007/s12031-016-0717-8; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tai TY, 2017, NEUROSCIENCE, V349, P35, DOI 10.1016/j.neuroscience.2017.02.024; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Taylor DM, 2013, J NEUROSCI, V33, P2313, DOI 10.1523/JNEUROSCI.4965-11.2013; von Leden RE, 2017, J NEUROTRAUM, V34, P755, DOI 10.1089/neu.2016.4486; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; Zhao WQ, 2002, NEUROBIOL DIS, V11, P166, DOI 10.1006/nbdi.2002.0520	74	15	15	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	FEB	2019	56	2					1124	1136		10.1007/s12035-018-1132-7			13	Neurosciences	Neurosciences & Neurology	HN8TY	WOS:000460470300026	29873042				2021-06-18	
J	Giampa, C; Alvino, A; Magatti, M; Silini, AR; Cardinale, A; Paldino, E; Fusco, FR; Parolini, O				Giampa, Carmela; Alvino, Alessandra; Magatti, Marta; Silini, Antonietta R.; Cardinale, Antonella; Paldino, Emanuela; Fusco, Francesca R.; Parolini, Ornella			Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						human amniotic mesenchymal stem/stromal cells; Huntington's disease; microglia; neuroinflammation; secretome	MESENCHYMAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; MUTANT HUNTINGTIN; BRAIN-INJURY; MINOCYCLINE; EXPRESSION; PARKINSONS; GENE; ACTIVATION	Inflammation significantly impacts the progression of Huntington's disease (HD) and the mutant HTT protein determines a pro-inflammatory activation of microglia. Mesenchymal stem/stromal cells (MSC) from the amniotic membrane (hAMSC), and their conditioned medium (CM-hAMSC), have been shown to possess protective effects in vitro and in vivo in animal models of immune-based disorders and of traumatic brain injury, which have been shown to be mediated by their immunomodulatory properties. In this study, in the R6/2 mouse model for HD we demonstrate that mice treated with CM-hAMSC display less severe signs of neurological dysfunction than saline-treated ones. CM-hAMSC treatment significantly delayed the development of the hind paw clasping response during tail suspension, reduced deficits in rotarod performance, and decreased locomotor activity in an open field test. The effects of CM-hAMSC on neurological function were reflected in a significant amelioration in brain pathology, including reduction in striatal atrophy and the formation of striatal neuronal intranuclear inclusions. In addition, while no significant increase was found in the expression of BDNF levels after CM-hAMSC treatment, a significant decrease of microglia activation and inducible nitric oxide synthase levels were observed. These results support the concept that CM-hAMSC could act by modulating inflammatory cells, and more specifically microglia.	[Giampa, Carmela; Alvino, Alessandra; Parolini, Ornella] Univ Cattolica Sacro Cuore, Ist Anat Umana & Biol Cellulare, Rome, Italy; [Giampa, Carmela; Alvino, Alessandra] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy; [Magatti, Marta; Silini, Antonietta R.; Parolini, Ornella] Fdn Poliambulanza, Ctr Ric E Menni, Brescia, Italy; [Cardinale, Antonella; Paldino, Emanuela; Fusco, Francesca R.] Santa Lucia Fdn IRCCS, Lab Neuroanat, Rome, Italy	Parolini, O (corresponding author), Univ Cattolica Sacro Cuore, Ist Anat Umana & Biol Cellulare, Rome, Italy.; Parolini, O (corresponding author), Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy.	ornella.parolini@unicatt.it	PAROLINI, ORNELLA/ABI-7862-2020; Parolini, Ornella/C-7946-2013	Parolini, Ornella/0000-0002-5211-6430	Contributo MIUR 5 x 1000 [2015]; Universita Cattolica del Sacro Cuore [linea D1-2017, linea D1-2018]	Contributo MIUR 5 x 1000, Grant/Award Number: 2015; Universita Cattolica del Sacro Cuore, Grant/Award Number: "linea D1-2017" and "linea D1-2018"	Adibhatla RM, 2002, BRAIN RES, V938, P81, DOI 10.1016/S0006-8993(02)02447-2; Bouchard J, 2012, J NEUROSCI, V32, P18259, DOI 10.1523/JNEUROSCI.4008-12.2012; Bradford J, 2010, J BIOL CHEM, V285, P10653, DOI 10.1074/jbc.M109.083287; Cha JH, 2004, NEUROLOGY, V63, P547; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Colpo GD, 2017, CNS NEUROL DISORD-DR, V16, P936, DOI 10.2174/1871527316666170613084801; Crotti A, 2015, TRENDS IMMUNOL, V36, P364, DOI 10.1016/j.it.2015.04.007; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Deckel AW, 2001, J NEUROSCI RES, V64, P99, DOI 10.1002/jnr.1057; Deng P, 2016, NEURAL REGEN RES, V11, P702, DOI 10.4103/1673-5374.182682; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; Diguet E, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.10818; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Dobson L, 2016, J NEUROCHEM, V137, P782, DOI 10.1111/jnc.13553; Farr OM, 2015, METABOLISM, V64, P114, DOI 10.1016/j.metabol.2014.07.004; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Fink KD, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt341; Fujita K, 2011, PLACENTA, V32, P737, DOI 10.1016/j.placenta.2011.07.001; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; HALL JG, 1977, J PHYSIOL-LONDON, V272, pP52; Hanna DMF, 2015, PROG NEURO-PSYCHOPH, V60, P36, DOI 10.1016/j.pnpbp.2015.02.005; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hsiao HY, 2014, HUM MOL GENET, V23, P4328, DOI 10.1093/hmg/ddu151; Hussain G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00144; Im W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059438; Kerkis I, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0248-1; Kondoh T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00018; La Fata G, 2014, NUTRIENTS, V6, P5453, DOI 10.3390/nu6125453; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; Lescaudron L, 2012, CURR MED CHEM, V19, P6018; Lin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025586; Lisi L, 2017, NEUROSCI LETT, V645, P106, DOI 10.1016/j.neulet.2017.02.076; Lo Furno D, 2018, J CELL PHYSIOL, V233, P3982, DOI 10.1002/jcp.26192; Lovaas E, 1997, Adv Pharmacol, V38, P119; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Magatti M, 2016, PLACENTA TREE LIFE, P91, DOI DOI 10.1201/B19620-11; Magatti Marta, 2016, Methods Mol Biol, V1416, P233, DOI 10.1007/978-1-4939-3584-0_13; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menzie J, 2013, BRAIN SCI, V3, P877, DOI 10.3390/brainsci3020877; Miguez A, 2015, HUM MOL GENET, V24, P4958, DOI 10.1093/hmg/ddv218; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Perez-Severiano F, 2002, BRAIN RES, V951, P36, DOI 10.1016/S0006-8993(02)03102-5; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Pollock K, 2016, MOL THER, V24, P965, DOI 10.1038/mt.2016.12; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Schwarz H, 2010, MOVEMENT DISORD, V25, P2219, DOI 10.1002/mds.23236; Silini AR, 2017, CELL TRANSPLANT, V26, P531, DOI 10.3727/096368916X693699; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Smeland OB, 2012, NEUROCHEM INT, V61, P100, DOI 10.1016/j.neuint.2012.04.008; Snyder BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009347; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Stack EC, 2007, EXPERT OPIN INV DRUG, V16, P1933, DOI 10.1517/13543784.16.12.1933; Steidinger TU, 2011, J NEUROCHEM, V116, P334, DOI 10.1111/j.1471-4159.2010.07112.x; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Thomas M, 2004, MOVEMENT DISORD, V19, P692, DOI 10.1002/mds.20018; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Yang HM, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00193; Yuste JE, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00322; Zeng W, 2015, EXP THER MED, V9, P283, DOI 10.3892/etm.2014.2133; Zhang J, 2001, J NEUROCHEM, V76, P855, DOI 10.1046/j.1471-4159.2001.00080.x; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	64	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	FEB	2019	23	2					1581	1592		10.1111/jcmm.14113			12	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	HM8KM	WOS:000459729900080	30585395	DOAJ Gold, Green Published			2021-06-18	
J	Giudice, JS; Park, G; Kong, K; Bailey, A; Kent, R; Panzer, MB				Giudice, J. Sebastian; Park, Gwansik; Kong, Kevin; Bailey, Ann; Kent, Richard; Panzer, Matthew B.			Development of Open-Source Dummy and Impactor Models for the Assessment of American Football Helmet Finite Element Models	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Hybrid-III; Anthropomorphic test device; Helmet impact testing; Computational model; Material properties	NATIONAL OPERATING COMMITTEE; PROFESSIONAL FOOTBALL; HYBRID III; BRAIN-INJURY; CONCUSSION; PERFORMANCE; STANDARDS	The objective of this study was to develop and validate a set of Hybrid-III head and neck (HIII-HN) and impactor models that can be used to assess American football design modifications with established dummy-based injury metrics. The model was validated in two bare-head impact test configurations used by the National Football League and research groups to rank and assess helmet performance. The first configuration was a rigid pendulum impact to three locations on the HIII head (front, rear, side) at 3m/s. The second configuration was a set of eight 5.5m/s impacts to the HIII head at different locations using a linear impactor with a compliant end cap. The ISO/TS 18571 objective rating metric was used to quantify the correlation between the experimental and model head kinematics (linear and rotational velocity and acceleration) and neck kinetics (neck force and moment). The HIII-HN model demonstrated good correlation with overall mean ISO scores of 0.69-0.78 in the pendulum impacts and 0.65-0.81 in the linear impacts. These publically available models will serve as an in silico design platform that will be useful for investigating novel football helmet designs and studying human head impact biomechanics, in general.	[Giudice, J. Sebastian; Kong, Kevin; Kent, Richard; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, Dept Mech & Aerosp Engn, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA; [Park, Gwansik; Bailey, Ann; Kent, Richard] Biomech Consulting & Res Biocore LLC, 1621 Quail Run, Charlottesville, VA 22911 USA	Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, Dept Mech & Aerosp Engn, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	panzer@virginia.edu		Giudice, Sebastian/0000-0003-1074-4890	Football Research, Inc. (FRI); Biomechanics Consulting and Research, LLC (Biocore)	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI) and Biomechanics Consulting and Research, LLC (Biocore). The views expressed are solely those of the authors and do not represent those of Biocore, FRI, or any of their affiliates or funding sources. The authors would like to thank our collaborators in the "Engineering Roadmap: Numerical Crowdsourcing Project'' for their support and feedback of this work (teams from Wake Forest University, University of Waterloo, and KTH Royal Institute of Technology). The authors also acknowledge Virginia Tech Helmet Lab and BioKinetics and Associates, Ltd. for generating the pendulum and linear impactor test data.	Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Barbat S., 2013, OBJECTIVE RATING MET; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Chang LT, 2003, J CHIN INST ENG, V26, P835, DOI 10.1080/02533839.2003.9670838; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Davis Matthew L, 2016, Stapp Car Crash J, V60, P509; Funk J., 2017, NFL LINEAR IMPACTOR; Funk JR, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039673; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gehre C., 2009, P 21 INT TECHN C ENH; Hallquist J.O., 2007, LS DYNA KEYW US MAN, P970; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Kaleps I., 1988, SAE TECHNICAL PAPER; Kaleps I, 1988, MEASUREMENT HYBRID 3; Kostopoulos V, 2002, COMPOS PART B-ENG, V33, P99, DOI 10.1016/S1359-8368(01)00066-X; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; Mustafa H, 2015, PROC TECH, V20, P91, DOI 10.1016/j.protcy.2015.07.016; National Football League (NFL), 2017, 2017 HELM LAB TEST P; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2017, ND00217M17A NOCSAE; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NHTSA, 2008, 20814 NHTSA TP; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; SAE, 2007, J2111 SAE S; SAE, 1998, US MAN 50 PERC MAL H; Spittle E. K., 1992, HYBRID 2 HYBRID 3 DU; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Teng TL, 2013, P I MECH ENG L-J MAT, V227, P82, DOI 10.1177/1464420712451806; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Wood GW, 2010, SAE INT J MATER MANU, V3, P186, DOI 10.4271/2010-01-0383	36	15	15	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	FEB	2019	47	2					464	474		10.1007/s10439-018-02155-3			11	Engineering, Biomedical	Engineering	HI3XA	WOS:000456383600011	30341737				2021-06-18	
J	Milders, M				Milders, Maarten			Relationship between social cognition and social behaviour following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; social behaviour; social outcome; social cognition	EMOTION PERCEPTION; HEAD-INJURY; FUNCTIONAL OUTCOMES; FACIAL EXPRESSION; RECOGNITION; IMPAIRMENTS; DEFICITS; MIND; SCHIZOPHRENIA; SATISFACTION	Objective: To present an overview of studies that investigated associations between social cognition functions (social cue perception, empathy, understanding intentions) and social behaviour or social outcome following traumatic brain injury (TBI). Methods: The literature search was conducted in the Medline, PsycInfo, Cochrane Library and Web of Science databases. Main criteria for selection were that the participants were adult persons with TBI, social cognition as well as social behaviour or social outcome post-TBI was assessed and correlations between social cognition and social behaviour or outcome were reported. Average correlations were calculated based on weighted summation of the correlations from the individual studies. Results: Of the 511 publications identified in the search, 13 were selected. Ten of these assessed emotion recognition, six assessed understanding of intentions and two assessed empathy. Average correlations between social cognition performance and post-injury social behaviour or outcome were significant for each of the three social cognition functions; poorer performance was associated with poorer outcome. Effect sizes varied from small to moderate (understanding intentions) to moderate (emotion recognition) to large (empathy). Conclusions: The associations were in line with models of social cognition and proposals that impairments in social cognition may underlie social behaviour difficulties and poor social outcome following TBI.	[Milders, Maarten] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands	Milders, M (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuropsychol, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	m.v.milders@vu.nl					Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baguley I, 2006, J HEAD TRAUMA REHAB, V19, P314; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Borenstein M., 2009, INTRO METAANALYSIS; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corrigan PW, 1997, PSYCHIATRY, V60, P309, DOI 10.1080/00332747.1997.11024809; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2015, CURR OPIN PSYCHIATR, V28, P133, DOI 10.1097/YCO.0000000000000139; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Katsifaraki M, 2014, BRAIN INJURY, V28, P1389, DOI 10.3109/02699052.2014.919538; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Osborne-Crowley K, 2016, NEUROPSYCHOLOGY, V30, P820, DOI 10.1037/neu0000293; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Saxton ME, 2013, NEUROREHABILITATION, V33, P263, DOI 10.3233/NRE-130954; Schmidt SJ, 2011, SCHIZOPHRENIA BULL, V37, pS41, DOI 10.1093/schbul/sbr079; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Wood RL, 2001, BRAIN DAM B, P3; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	55	15	15	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		62	68		10.1080/02699052.2018.1531301			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400008	30325217	Bronze			2021-06-18	
J	Albrecht, JS; Barbour, L; Abariga, SA; Rao, V; Perfetto, EM				Albrecht, Jennifer S.; Barbour, Lauren; Abariga, Samuel A.; Rao, Vani; Perfetto, Eleanor M.			Risk of Depression after Traumatic Brain Injury in a Large National Sample	JOURNAL OF NEUROTRAUMA			English	Article						depression; epidemiology; traumatic brain injury	MAJOR DEPRESSION; NEUROPSYCHIATRIC DISTURBANCES; CLAIMS DATA; DISORDER; EPIDEMIOLOGY; AGE; ASSOCIATION; COMORBIDITY; PREDICTORS; DISEASE	Depression is associated with poorer recovery after traumatic brain injury (TBI), yet awareness of depression risk post-TBI among providers and patients is low. The aim of this study was to estimate risk of depression post-TBI among adults 18 years of age and older and to identify risk factors associated with developing depression post-TBI. We conducted a retrospective, matched cohort study using claims data for privately insured and Medicare Advantage enrollees in a large U.S. health plan. Adults 18 years of age diagnosed with TBI (n=207,354) with 12 months continuous insurance coverage pre-TBI and 24 months post-TBI were matched to controls without TBI (n=414,708). We identified the presence of depression on any in- or outpatient claim occurring during the study period (both before and after TBI). Of the initial 622,062 individuals, 62,963 (10%) had depression pre-TBI and were excluded from incidence calculations. Incidence of depression post-TBI was 79.5 (95% confidence interval [CI], 78.5,80.5) per 1,000 person-years compared to 33.5 (95% CI, 33.1,34.0) per 1,000 person-years for those without TBI. The adjusted hazard ratio for depression post-TBI was 1.83 (95% CI, 1.79,1.86). We observed effect modification by sex and age, with males and older adults at increased risk. History of neuropsychiatric disturbances pre-TBI was the strongest predictor of depression post-TBI. Risk of depression increases substantially post-TBI. Groups at increased risk include those with a history of neuropsychiatric disturbances, older adults, and men. This study highlights the importance of long-term monitoring for depression post-TBI.	[Albrecht, Jennifer S.; Barbour, Lauren; Abariga, Samuel A.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Albrecht, Jennifer S.] OptumLabs, Cambridge, MA USA; [Rao, Vani] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Perfetto, Eleanor M.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Perfetto, Eleanor M.] Natl Hlth Council, Washington, DC USA	Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 South Pine St,MSTF 334 C, Baltimore, MD 21201 USA.	jalbrecht@som.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274	AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01 HS024560] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER		Albrecht JS, 2017, ARCH PHYS MED REHAB, V98, P2548, DOI 10.1016/j.apmr.2017.06.007; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; BLAZER D, 1991, J GERONTOL, V46, pM210, DOI 10.1093/geronj/46.6.M210; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chen S, 2016, BIOMETRICS, V72, P596, DOI 10.1111/biom.12433; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Mannix R., 2013, NEUROSURGERY, V73, P134; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marr AL., 2004, CENTRAL NERVOUS SYST; Noyes K, 2011, PSYCHIAT SERV, V62, P1159, DOI 10.1176/ps.62.10.pss6210_1159; OptumLabs, 2017, OPT OPT DAT WAR OLDW; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Solberg LI, 2006, AM J MED QUAL, V21, P238, DOI 10.1177/1062860606288243; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ., 1995, GUIDELINES SURVEILLA; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	42	15	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					300	307		10.1089/neu.2017.5608			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800013	29808770				2021-06-18	
J	Epstein, D; Goodman, LA				Epstein, Deborah; Goodman, Lisa A.			DISCOUNTING WOMEN: DOUBTING DOMESTIC VIOLENCE SURVIVORS' CREDIBILITY AND DISMISSING THEIR EXPERIENCES	UNIVERSITY OF PENNSYLVANIA LAW REVIEW			English	Article							INTIMATE PARTNER-VIOLENCE; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; VICTIMS; LEGAL; BIAS; EYEWITNESS; IDENTITY; IMPACT; ABUSE	In recent months, we've seen an unprecedented wave of testimonials about the serious harms women all too frequently endure. The #MeToo moment, the #WhyIStayed campaign, and the Larry Nassar sentencing hearings have raised public awareness not only about workplace harassment, domestic violence, and sexual abuse, but also about how routinely women survivors face a Gaslight-style gauntlet of doubt, disbelief, and outright dismissal of their stories. This pattern is particularly disturbing in the justice system, where women face a legal twilight zone: laws meant to protect them and deter further abuse often fail to achieve their purpose, because women telling stories of abuse by their male partners are simply not believed. To fully grasp the nature of this new moment in gendered power relations-and to cement the significant gains won by these public campaigns-we need to take a full, considered look at when, how, and why the justice system and other key social institutions discount women's credibility. We use the lens of intimate partner violence to examine the ways in which women's credibility is discounted in a range of legal and social service system settings. First, judges and others improperly discount as implausible women's stories of abuse, based on a failure to understand both the symptoms arising from neurological and psychological trauma, and the practical constraints on survivors' lives. Second, gatekeepers unjustly discount women's personal trustworthiness, based on both inaccurate interpretations of survivors' courtroom demeanor and negative cultural stereotypes about women and their motivations for seeking assistance. Moreover, even when a woman manages to overcome all the initial modes of institutional skepticism that minimize her account of abuse, she often finds that the systems designed to furnish her with help and protection dismiss the importance of her experiences. Instead, all too often, the arbiters of justice and social welfare adopt and enforce legal and social policies and practices with little regard for how they perpetuate patterns of abuse. Two distinct harms arise from this pervasive pattern of credibility discounting and experiential dismissal. First, the discrediting of survivors constitutes its own psychic injury-an institutional betrayal that echoes the psychological abuse women suffer at the hands of individual perpetrators. Second, the pronounced, nearly instinctive penchant for devaluing women's testimony is so deeply embedded within survivors' experience that it becomes a potent, independent obstacle to their efforts to obtain safety and justice. The reflexive discounting of women's stories of domestic violence finds analogs among the kindred diminutions and dismissals that harm so many other women who resist the abusive exercise of male power, from survivors of workplace harassment to victims of sexual assault on and off campus. For these women, too, credibility discounts both deepen the harm they experience and create yet another impediment to healing and justice. Concrete, systematic reforms are needed to eradicate these unjust, gender-based credibility discounts and experiential dismissals, and to enable women subjected to male abuses of power at long last to trust the responsiveness of the justice system.	[Epstein, Deborah] Georgetown Univ, Ctr Law, Domest Violence Clin, Washington, DC 20057 USA; [Goodman, Lisa A.] Boston Coll, Lynch Sch Educ, Dept Counseling Dev & Educ Psychol, Chestnut Hill, MA 02167 USA	Epstein, D (corresponding author), Georgetown Univ, Ctr Law, Domest Violence Clin, Washington, DC 20057 USA.						Abbott HP, 2008, CAMBRIDGE INTRO LIT, P40; ACLU, 2015, SILENCED NUIS ORD PU, P22; ACLU, 2015, RESP FIELD SEX ASS D; Adams Betty, 2014, PRESS HERALD    0603; Adams TM, 2006, J BLACK STUD, V36, P938, DOI 10.1177/0021934704274072; AM. BAR ASS'N, CUST DEC CAS DOM VIO; AMSTERDAM AG, 2000, MINDING LAW, P110; [Anonymous], 2003, FINAL REPORT PENNSYL, P405; [Anonymous], 2017, COMMUNICATION; [Anonymous], 2012, WASH POST; [Anonymous], COMMUNICATION; [Anonymous], 2018, COMMUNICATION; [Anonymous], 2017, COMMUNICATION; [Anonymous], 2014, NATL PUB RADIO; [Anonymous], 2016, CIVIL VOICES    0630; [Anonymous], 2014, WHAT IS GASL; [Anonymous], YOUR GROUND BOY ASKS; [Anonymous], 2017, COMMUNICATION; [Anonymous], 2018, COMMUNICATION; [Anonymous], 2013, WSMV            0425; [Anonymous], 2014, COMMUNICATION; [Anonymous], 2018, COMMUNICATION; [Anonymous], 2018, COMMUNICATION; [Anonymous], 2010, CNN; [Anonymous], 2018, COMMUNICATION; [Anonymous], 1944, GASLIGHT; [Anonymous], 2012, WBAL TV TELEVIS 0904; [Anonymous], 2017, COMMUNICATION; Association AP, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bailey A., 2014, SOC EPISTEMOL, V3, P62; Balos Beverly, 2006, TEMP POL CIV RTS L R, V15, P557; Balos Beverly, 2006, TEMP POL CIV RTS L R, V15, P567; BANCROFT LUNDY, 2002, BATTERER PARENT, P15; Barasch Amy, 2015, SLATE; Beck JG, 2007, PROF PSYCHOL-RES PR, V38, P629, DOI 10.1037/0735-7028.38.6.629; BECKER FN, 2013, CRIME FREE LEGAL PRA, P1; Bennett L, 1999, J INTERPERS VIOLENCE, V14, P761, DOI 10.1177/088626099014007006; BERGMAN PAUL, 2013, TRIAL ADVOCACY NUTSH, P58; Berman GL, 1996, J APPL PSYCHOL, V81, P170, DOI 10.1037/0021-9010.81.2.170; BERMAN GL, 1995, LAW HUMAN BEHAV, V19, P79, DOI 10.1007/BF01499074; BLACK MICHELE C., 2010, NATL INTIMATE PARTNE, P2; Blow CM, 2014, NY TIMES; Bond CEW, 2014, BRIT J CRIMINOL, V54, P849, DOI 10.1093/bjc/azu034; Brea Jennifer, 2017, BOS GLOBE; Brewer N, 2004, J APPL SOC PSYCHOL, V34, P493, DOI 10.1111/j.1559-1816.2004.tb02558.x; Brewer N, 1999, APPL COGNITIVE PSYCH, V13, P297, DOI 10.1002/(SICI)1099-0720(199908)13:4<297::AID-ACP578>3.0.CO;2-S; Briggs Lakisha, 2015, GUARDIAN; Briquelet Kate, 2015, DAILY BEAST; Brownridge DA, 2006, AGGRESS VIOLENT BEH, V11, P514, DOI 10.1016/j.avb.2006.01.009; BUREAU OF JUSTICE STATISTICS U. S. DEP'T OF JUSTICE, 2005, FAM VIOL STAT INCL S, P2; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Campbell R, 2008, AM PSYCHOL, V63, P702, DOI 10.1037/0003-066X.63.8.702; CAMUS ALBERT, 1942, STRANGER, p[8, 20, 64]; CAMUS ALBERT, 1988, STRANGER, p[8, 20, 64]; Carlin A, 2016, UCLA LAW REV, V63, P450; Cattaneo LB, 2005, TRAUMA VIOLENCE ABUS, V6, P141, DOI 10.1177/1524838005275088; Chang Emily, 2018, VANITY FAIR; CHAVKIN DAVID, 2002, CLIN LEGAL ED TXB LA, P93; Chemaly Soraya, 2013, ROLE REBOOT     1119; Chen EH, 2008, ACAD EMERG MED, V15, P414, DOI 10.1111/j.1553-2712.2008.00100.x; Codrea-Rado A, 2017, NY TIMES; COKER AL, AM J PUB HLTH, V90, P553; Coker D., 2000, UC DAVIS L REV, V33, P1009; Coker Donna, 2000, UC DAVIS L REV, V33, P1021; Conner Dana Harrington, 2009, AM U J GENDER SOC PO, V17, P174; Conner Dana Harrington, 2009, AM U J GENDER SOC PO, V17, P163; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Crocker Lizzie, 2014, DAILY BEAST; CRON LISA, 2012, WIRED STORY WRITERS, P185; David Lynch Found, 2017, YOUTUBE; Davis Aaron C., 2014, WASH POST; Davis Kevin, 2012, ABA J, V98, p[37, 37]; Desmarais SL, 2009, LAW HUMAN BEHAV, V33, P470, DOI 10.1007/s10979-008-9165-5; Desmond M, 2013, AM SOCIOL REV, V78, P117, DOI 10.1177/0003122412470829; Desmond Matthew, 2012, AM SOCIOL REV, V78, P132; Devine PG, 2012, J EXP SOC PSYCHOL, V48, P1267, DOI 10.1016/j.jesp.2012.06.003; DONNA STIENSTRA ET AL. FED. JUDICIAL CTR., 2011, ASSISTANCE PROSE LIT, P21; Dotson K, 2011, HYPATIA, V26, P236, DOI 10.1111/j.1527-2001.2011.01177.x; Duncan Martha Grace, 2017, HARV J L GENDER 0919; Dutton M A, 1999, Violence Vict, V14, P89; Dutton MA, 2003, HOFSTRA LAW REV, V21, P1191; Dutton Mary Ann, 1993, HOFSTRA L REV, V21, P1221; Dutton Mary Ann, 1999, VIOLENCE VICTIMS, V14, P101; EDELMAN PETER, 2017, NOT CRIME BE POOR CR, P135; Ehlers A, 2004, MEMORY, V12, P403, DOI 10.1080/09658210444000025; Epstein D., 2003, AM U J GENDER SOC PO, V11, P465; Epstein Deborah, 1999, YALE JL FEMINISM, V11, P3; Epstein Deborah, 2003, AM U J GENDER SOC PO, V11, P467; Epstein Deborah, 2018, NY TIMES; Fessler Pam, 2016, NATL PUBLIC RADIO; Fleury R E, 1998, Violence Vict, V13, P333; Fleury Ruth E., 1998, VIOLENCE VICTIMS, V13, P342; Fleury-Steiner RE, 2006, J COMMUNITY PSYCHOL, V34, P327, DOI 10.1002/jcop.20102; FREUD SIGMUND, 1963, AUTOBIOGRAPHICAL STU, P62; FREUD SIGMUND, 1925, AUTOBIOGRAPHICAL STU, P62; Fricker M., 2007, EPISTEMIC INJUSTICE, DOI [10.1093/acprof:oso/9780198237907.001.0001, DOI 10.1093/ACPROF:OSO/9780198237907.001.0001]; Fugere Patty Mullahy, 2014, HUFFINGTON POST 0221; Garay-Serratos Maria E., 2015, L A TIMES; Gilbert S., 2018, ATLANTIC; Gilman M.E., 2014, AM U J GENDER SOCIAL, V22, P247; Gilman Michele Estrin, 2014, AM U J GENDER SOC PO, V22, P249; Glaser J, 2008, J EXP SOC PSYCHOL, V44, P164, DOI 10.1016/j.jesp.2007.01.002; GODSIL RACHEL D., 2016, 2 SCI EQUALITY EFFEC, P12; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Goodman LA, 2011, PSYCHOL VIOLENCE, V1, P79, DOI 10.1037/a0022977; GOODMAN LISA A., 2009, LISTENING BATTERED W, P107; GROSE CAROLYN, 2017, LAWYERS CLIENTS NARR, P15; Gutowski Ellen, 2018, INTIMATE PARTNER VIO; Haberman Clyde, 2014, NY TIMES; Haberman Maggie ., 2018, NY TIMES; Hanna C, 1996, HARVARD LAW REV, V109, P1849, DOI 10.2307/1342079; Hanna Cheryl, 1996, HARVARD LAW REV, V109, P1878; Hare SC, 2010, J FAM VIOLENCE, V25, P765, DOI 10.1007/s10896-010-9334-4; Herman JL, 2005, VIOLENCE AGAINST WOM, V11, P571, DOI 10.1177/1077801205274450; Herman Judith, 1984, NATION, P293; HERMAN JUDITH LEWIS, 1997, TRAUMA RECOVERY, P37; Holt S, 2008, CHILD ABUSE NEGLECT, V32, P797, DOI 10.1016/j.chiabu.2008.02.004; Hopper J., 2018, PSYCHOL TODAY; Howard Greg, 2014, DEADSPIN        0731; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Institute for Children and Poverty, 2002, HIDD MIGR WHY NEW YO; Ivy Veronica, 2017, ROUTLEDGE HDB EPISTE, P167, DOI [10.4324/9781315212043-16, DOI 10.4324/9781315212043]; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Jay, 2005, LATE REGISTRATION; Jeltsen M., 2015, HUFFINGTON POST; Johnson Margaret, 2009, UC DAVIS L REV, V42, P1107; Johnson Margaret, 2010, CARDOZO L REV, V32, P566; Johnson Margaret, 2010, CARDOZO L REV, V32, P536; Johnson Margaret E., 2010, CARDOZO L REV, V32, p[519, 519]; Johnson Margaret E., 2009, UC DAVIS L REV, V42, P1143; Johnson MP, 2005, J FAM ISSUES, V26, P322, DOI 10.1177/0192513X04270345; Johnston JR, 2005, FAM COURT REV, V43, P283, DOI 10.1111/j.1744-1617.2005.00029.x; Johnston Janet R., 2005, FAM CT REV, V43, P290; Jones L., 2001, TRAUMA VIOLENCE ABUS, V2, P99, DOI 10.1177/1524838001002002001; Jones Loring, 2001, TRAUMA VIOLENCE ABUS, V2, P100; Kane John L., 2007, LITIG, V33, P31; Kane John L., 2007, LITIG, V33, P32; KEILITZ SUSAN L., 1997, CIVIL PROTECTION ORD, P12; King Donna J., 2017, DEPAUL J WOMEN GENDE, V6, P1; King Donna J., 2017, DEPAUL J WOMEN GENDE, V6, P29; Kirsch Thomas L., 2001, WM MARY J WOMEN L, V7, P387; KIRSCH TL, 2001, WM MARY J WOMEN L, V7, P383; Kitchener Caroline, 2018, ATLANTIC; Kohn L. S, 2003, J GENDER SOCIAL POLI, V11, P733; Kohn Laurie S., 2003, AM U J GENDER SOC PO, V11, P742; Kuennen T.L., 2010, BYU L REV, V2, P515; Kuennen Tamara L., 2010, BYU L REV, V2010, P585; Lancer Darlene, 2018, PSYCHOL TODAY; LEGAL SERVS. CORP, 2017, JUST GAP MEAS UNM CI, P52; Levin R., 2004, PATHWAYS HOMELESSNES; Levinson Justin, 2017, FLORIDA LAW REV, V69, P63; Levinson Justin D., 2017, FLA L REV, V69, P104; Lewis Brigitte, 2016, ASIA PAC POL SO 0906; LOGAN TK, 2015, NATL DOMESTIC VIOLEN, P9; LYON ELEANOR, 2008, M SURV NEEDS MULT ST, piv; MacKinnon Catherine A., 2018, NY TIMES; Mahoney P., 2001, SOURCEBOOK VIOLENCE, P143; MARKS G, 1987, PSYCHOL BULL, V102, P72, DOI 10.1037/0033-2909.102.1.72; Masson Jeffrey Moussaieff, 1984, ASSAULT TRUTH FREUDS; MASSON JEFFREY MOUSSAIEFF, 1984, ASSAULT TRUTH FREUDS, P107; MAYER JANE, 1994, STRANGE JUSTICE SELL; MCCRAY R, 2017, SLATE; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P634, DOI 10.1177/1077801208319283; Meier JS, 2009, J CHILD CUSTODY, V6, P232, DOI 10.1080/15379410903084681; Meier Joan S., 1993, HOFSTRA L REV, V21, P1313; Meier Joan S., 2017, LAW INEQ, V35, P328; MEIER JS, 2017, LAW INEQ, V0035; Meier JS, 1993, HOFSTRA L REV, V21, P1295; Morabito Nate, 2016, WJHL            0911; Murphy Jane C., 1993, HOFSTRA L REV, V21, P1275; MURPHY JC, 1993, HOFSTRA L REV, V21, P1243; Nadasen Premilla, 2007, BLACK WOMEN GENDER F, V1, P52, DOI DOI 10.5406/BLACWOMEGENDFAMI.1.2.0052; Nagle JE, 2014, BEHAV SCI LAW, V32, P195, DOI 10.1002/bsl.2112; Nagle Jacklyn E., 2014, BEHAV SCI L, V32, P203; NAT'L CTR, 2017, INTIMATE PARTNER VIO; NAT'L INST. OF NEUROLOGICAL DISORDERS & STROKE, TRAUM BRAIN INJ HOP; National Quality Forum, 2013, PREP COURT PROC SURV, P1; Paquette Danielle, 2017, WASH POST; Park Sandra S., 2016, MSNBC           0325; PARTNERS FOR PEACE, 2016, UND TRAUM INJ CONC S; Pico-Alfonso MA, 2005, NEUROSCI BIOBEHAV R, V29, P181, DOI 10.1016/j.neubiorev.2004.08.010; Pimpare Stephen, 2017, WASH POST; Platt M, 2009, VIOLENCE WOMEN FAMIL, P185; Porter E., 2015, NY TIMES; POSTMUS JL, AFFILIA, V15, P244; Potter R., 1999, PSYCHIAT PSYCHOL LAW, V6, P97, DOI [10.1080/13218719909524952, DOI 10.1080/13218719909524952]; Potter Rob, 1999, PSYCHIAT PSYCHOL LAW, V6, P101; Pressley Nelson, 2018, WASH POST; Przekop M., 2011, SEATTLE J SOCIAL JUS, V9, P1053; Przekop Mary, 2011, SEATTLE J SOC JUST, V9, P1078; Rachlinski JJ, 2009, NOTRE DAME LAW REV, V84, P1195; Rand Joseph W., 2000, CONN L REV, V33, P42; RAND JW, 2000, CONN L REV, V33, P1; Raphael J, 2004, VIOLENCE AGAINST WOM, V10, P1354, DOI 10.1177/1077801204269350; Raphael Jody, 2003, AM U J GENDER SOC PO, V11, P367; Raphael Jody, 2003, J GENDER SOC POLY L, V11, P369; read S., 1975, STANDARD EDITION COM; Rhodes NR, 1998, AGGRESS VIOLENT BEH, V3, P391, DOI 10.1016/S1359-1789(97)00025-6; Riger S, 2002, J INTERPERS VIOLENCE, V17, P184, DOI 10.1177/0886260502017002005; Riger Stephanie, 2002, J INTERPERS VIOLENCE, V17, P198; Robbins M., 2014, CNN; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; RYCROFT C, 1984, NEW YORK REV BOOKS, V31, P3; Salerno JM, 2015, LAW HUMAN BEHAV, V39, P581, DOI 10.1037/lhb0000147; Savion Leah, 2009, J SCHOLARSHIP TEACHI, V9, P81; Savion Leah, 2009, J SCHOLARSHIP TEACHI, V9, P87; Schafran L. H., 1995, JUDGES J, V34, P5; Schafran Lynn Hecht, 1995, BEST AM BAR ASS SECT, V34, P40; Schafran Lynn Hecht, 1995, JUDGES J, P42; Schmelzer Elise, 2016, WASH POST; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Smith CP, 2014, AM PSYCHOL, V69, P575, DOI 10.1037/a0037564; SMITH Holly, 2016, U MASS L REV, V11, P64; Snyder R. L., 2015, NEW YORKER; Solan L, 2008, COLUMBIA LAW REV, V108, P1268; Solnit Rebecca, 2014, HARPERS MAGAZINE, P4; Stark Evan, 2012, REPRESENTING B UNPUB; STATE OF MD. ADMIN. OFFICE OF THE COURTS, 2017, DOM VIOL MONTHL SUMM; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; Stoever JK, 2017, WASH LAW REV, V92, P861; STORR A, 1984, NEW YORK TIMES BK R, P3; Strack GB, 2001, J EMERG MED, V21, P303, DOI 10.1016/S0736-4679(01)00399-7; Swent Jeannette F., 1996, S CAL REV L WOMENS S, V6, P1; Swent Jeannette F., 1996, S CAL REV L WOMENS S, V6, P61; TJADEN PATRICIA, 2000, EXTENT NATURE AND CO, P52; Tolman RM, 2000, J SOC ISSUES, V56, P655, DOI 10.1111/0022-4537.00190; Tuerkheimer D, 2017, U PENN LAW REV, V166, P1; Tuerkheimer Deborah, 2017, U PENN LAW REV, V166, P3; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2018, J WOMENS HEALTH, V27, P735, DOI 10.1089/jwh.2017.6838; VAN DER KOLK BESSEL, 2014, BODY KEEPS SCORE BRA, P182; Wash. Legal Clinic for the Homeless, 2017, PUBLIC; Witt, 2002, MIND ONES OWN FEMINI, P154; Women of Color Network, 2006, FACTS STATS DOM VIOL; World Health Organization, 2012, UND ADDR VIOL WOM IN; Wright CV, 2012, J TRAUMA STRESS, V25, P675, DOI 10.1002/jts.21754; Yarbrough M., 2000, J GENDER RACE JUST, V3, P625; Yarbrough Marilyn, 2000, J GENDER RACE JUST, V3, P629; Young K, 2001, SUB-STANCE, P72; Zacharek S., 2017, TIME; 2017, HOUSING NEEDS VICTIM, P1	243	15	15	0	12	UNIV PENN LAW SCH	PHILADELPHIA	3400 CHESTNUT ST, PHILADELPHIA, PA 19104-6204 USA	0041-9907			U PENN LAW REV	Univ. Pa. Law Rev.	JAN	2019	167	2					399	461					63	Law	Government & Law	HZ4TG	WOS:000468843200003					2021-06-18	
J	Johnson, RW; Ng, KWP; Dietz, AR; Hartman, ME; Baty, JD; Hasan, N; Zaidman, CM; Shoykhet, M				Johnson, Ryan W.; Ng, Kay W. P.; Dietz, Alexander R.; Hartman, Mary E.; Baty, Jack D.; Hasan, Nausheen; Zaidman, Craig M.; Shoykhet, Michael			Muscle atrophy in mechanically-ventilated critically ill children	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ICU-ACQUIRED WEAKNESS; ELECTRICAL-IMPEDANCE MYOGRAPHY; RISK-FACTORS; METABOLIC-RESPONSE; POLYNEUROPATHY; DYSFUNCTION; ULTRASOUND; PARESIS; INJURY	Importance ICU-acquired muscle atrophy occurs commonly and worsens outcomes in adults. The incidence and severity of muscle atrophy in critically ill children are poorly characterized. Objective To determine incidence, severity and risk factors for muscle atrophy in critically ill children. Design, setting and participants A single-center, prospective cohort study of 34 children receiving invasive mechanical ventilation for >= 48 hours. Patients 1 week- 18 years old with respiratory failure and without preexisting neuromuscular disease or skeletal trauma were recruited from a tertiary Pediatric Intensive Care Unit (PICU) between June 2015 and May 2016. We used serial bedside ultrasound to assess thickness of the diaphragm, biceps brachii/brachialis, quadriceps femoris and tibialis anterior. Serial electrical impedance myography (EIM) was assessed in children >1 year old. Medical records were abstracted from an electronic database. Exposures Respiratory failure requiring endotracheal intubation for >= 48 hours. Main outcome and measures The primary outcome was percent change in muscle thickness. Secondary outcomes were changes in EIM-derived fat percentage and "quality". Results Of 34 enrolled patients, 30 completed >= 2 ultrasound assessments with a median interval of 6 (IQR 6-7) days. Mean age was 5.42 years, with 12 infants <1 year (40%) and 18 children >1 year old (60%). In the entire cohort, diaphragm thickness decreased 11.1% (95%CI, -19.7% to -2.52%) between the first two assessments or 2.2%/day. Quadriceps thickness decreased 8.62% (95%CI, -15.7% to -1.54%) or 1.5%/day. Biceps (-1.71%; 95%CI, -8.15% to 4.73%) and tibialis (0.52%; 95%CI, -5.81% to 3.40%) thicknesses did not change. Among the entire cohort, 47% (14/30) experienced diaphragm atrophy (defined a priorias >= 10% decrease in thickness). Eighty three percent of patients (25/30) experienced atrophy in >= 1 muscle group, and 47% (14/30)-in >= 2 muscle groups. On multivariate linear regression, increasing age and traumatic brain injury (TBI) were associated with greater muscle loss. EIM revealed increased fat percentage and decreased muscle "quality". Conclusions and relevance In children receiving invasive mechanical ventilation, diaphragm and other skeletal muscle atrophy is common and rapid. Increasing age and TBI may increase severity of limb muscle atrophy. Prospective studies are required to link muscle atrophy to functional outcomes in critically ill children.	[Johnson, Ryan W.; Hartman, Mary E.; Shoykhet, Michael] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA; [Ng, Kay W. P.; Dietz, Alexander R.; Zaidman, Craig M.] Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA; [Ng, Kay W. P.] Natl Univ, Dept Med, Singapore, Singapore; [Dietz, Alexander R.] Blue Sky Neurol, Englewood, CO USA; [Baty, Jack D.] Washington Univ, Div Biostat, Sch Med, St Louis, MO 63110 USA; [Hasan, Nausheen] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Shoykhet, Michael] Childrens Natl Med Ctr, Childrens Res Inst, Washington, DC 20010 USA	Shoykhet, M (corresponding author), Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA.; Shoykhet, M (corresponding author), Childrens Natl Med Ctr, Childrens Res Inst, Washington, DC 20010 USA.	mshoykhet@childrensnational.org		Shoykhet, Michael/0000-0001-5031-2377	Washington University [ICTS CTSA808]	This work was supported by MS (Washington University ICTS CTSA808). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banwell BL, 2003, NEUROLOGY, V61, P1779, DOI 10.1212/01.WNL.0000098886.90030.67; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Corpeno R, 2014, J PHYSIOL-LONDON, V592, P3859, DOI 10.1113/jphysiol.2014.277962; Curley MAQ, 2006, PEDIATR CRIT CARE ME, V7, P107, DOI 10.1097/01.PCC.0000200955.40962.38; De Jonghe B, 2004, INTENS CARE MED, V30, P1117, DOI 10.1007/s00134-004-2174-z; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; de Letter MACJ, 2001, CRIT CARE MED, V29, P2281, DOI 10.1097/00003246-200112000-00008; Dejonghe B, 2009, CERAMICS-ART PERCEPT, P37; Demoule A, 2013, AM J RESP CRIT CARE, V188, P213, DOI 10.1164/rccm.201209-1668OC; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Field-Ridley A, 2016, PEDIATR CRIT CARE ME, V17, P53, DOI 10.1097/PCC.0000000000000538; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; Garnacho-Montero J, 2005, CRIT CARE MED, V33, P349, DOI 10.1097/01.CCM.0000153521.41848.7E; Gerovasili V, 2009, CRIT CARE, V13, DOI 10.1186/cc8123; Glau CL, 2018, PEDIATR CRIT CARE ME, V19, P406, DOI 10.1097/PCC.0000000000001485; Goligher EC, 2018, AM J RESP CRIT CARE, V197, P204, DOI 10.1164/rccm.201703-0536OC; Gruther W, 2008, J REHABIL MED, V40, P185, DOI 10.2340/16501977-0139; Hermans G, 2014, AM J RESP CRIT CARE, V190, P410, DOI 10.1164/rccm.201312-2257OC; Hirose T, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.02.010; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; KANEHISA H, 1994, EUR J APPL PHYSIOL, V68, P148, DOI 10.1007/BF00244028; Khemani RG, 2017, CRIT CARE MED, V45, pE798, DOI 10.1097/CCM.0000000000002433; Koch S, 2011, J NEUROL NEUROSUR PS, V82, P287, DOI 10.1136/jnnp.2009.192997; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; LEIJTEN FSS, 1995, JAMA-J AM MED ASSOC, V274, P1221, DOI 10.1001/jama.274.15.1221; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Lu ZH, 2016, RESP CARE, V61, P1316, DOI 10.4187/respcare.04746; Mtaweh H, 2014, PEDIATR CRIT CARE ME, V15, P242, DOI 10.1097/PCC.0000000000000041; Ng KW, 2018, MUSCLE NERVE; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Rodriguez PO, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.04.010; Sanchez B, 2017, NEUROTHERAPEUTICS, V14, P107, DOI 10.1007/s13311-016-0491-x; Shahidi B, 2018, J NEUROTRAUM, V35, P398, DOI 10.1089/neu.2017.5172; Sharshar T, 2009, CRIT CARE MED, V37, P3047, DOI 10.1097/CCM.0b013e3181b027e9; Tarulli A, 2005, NEUROLOGY, V65, P451, DOI 10.1212/01.wnl.0000172338.95064.cb; Valla FV, 2017, PEDIATR CRIT CARE ME, V18, pE339, DOI 10.1097/PCC.0000000000001235; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wieske L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0937-2; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Zaidman CM, 2015, MUSCLE NERVE, V52, P592, DOI 10.1002/mus.24611; Zaidman CM, 2014, MUSCLE NERVE, V50, P124, DOI 10.1002/mus.24117	44	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2018	13	12							e0207720	10.1371/journal.pone.0207720			16	Multidisciplinary Sciences	Science & Technology - Other Topics	HE9NT	WOS:000453779300015	30566470	DOAJ Gold, Green Published			2021-06-18	
J	Ko, J; Hemphill, M; Yang, Z; Sewell, E; Na, YJ; Sandsmark, DK; Haber, M; Fisher, SA; Torre, EA; Svane, KC; Omelchenko, A; Firestein, BL; Diaz-Arrastia, R; Kim, J; Meaney, DF; Issadore, D				Ko, J.; Hemphill, M.; Yang, Z.; Sewell, E.; Na, Y. J.; Sandsmark, D. K.; Haber, M.; Fisher, S. A.; Torre, E. A.; Svane, K. C.; Omelchenko, A.; Firestein, B. L.; Diaz-Arrastia, R.; Kim, J.; Meaney, D. F.; Issadore, D.			Diagnosis of traumatic brain injury using miRNA signatures in nanomagnetically isolated brain-derived extracellular vesicles	LAB ON A CHIP			English	Article							C-TERMINAL HYDROLASE; INTRACRANIAL LESIONS; CIRCULATING EXOSOMES; CEREBROSPINAL-FLUID; SERUM-LEVELS; BIOMARKERS; PROTEIN; MILD; DAMAGE; MICROVESICLES	The accurate diagnosis and clinical management of traumatic brain injury (TBI) is currently limited by the lack of accessible molecular biomarkers that reflect the pathophysiology of this heterogeneous disease. To address this challenge, we developed a microchip diagnostic that can characterize TBI more comprehensively using the RNA found in brain-derived extracellular vesicles (EVs). Our approach measures a panel of EV miRNAs, processed with machine learning algorithms to capture the state of the injured and recovering brain. Our diagnostic combines surface marker-specific nanomagnetic isolation of brain-derived EVs, biomarker discovery using RNA sequencing, and machine learning processing of the EV miRNA cargo to minimally invasively measure the state of TBI. We achieved an accuracy of 99% identifying the signature of injured vs. sham control mice using an independent blinded test set (N = 77), where the injured group consists of heterogeneous populations (injury intensity, elapsed time since injury) to model the variability present in clinical samples. Moreover, we successfully predicted the intensity of the injury, the elapsed time since injury, and the presence of a prior injury using independent blinded test sets (N = 82). We demonstrated the translatability in a blinded test set by identifying TBI patients from healthy controls (AUC = 0.9, N = 60). This approach, which can detect signatures of injury that persist across a variety of injury types and individual responses to injury, more accurately reflects the heterogeneity of human TBI injury and recovery than conventional diagnostics, opening new opportunities to improve treatment of traumatic brain injuries.	[Ko, J.; Hemphill, M.; Yang, Z.; Sewell, E.; Torre, E. A.; Meaney, D. F.; Issadore, D.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Na, Y. J.] Columbia Univ Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10032 USA; [Sandsmark, D. K.; Haber, M.; Diaz-Arrastia, R.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fisher, S. A.; Kim, J.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kim, J.] Univ Penn, Dept Comp & Informat Sci, 200 S 33Rd St, Philadelphia, PA 19104 USA; [Issadore, D.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Svane, K. C.; Omelchenko, A.; Firestein, B. L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Meaney, D. F.] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA	Issadore, D (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Issadore, D (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	daveissadore@gmail.com	Yang, Zijian/AAO-9763-2021	Ko, Jina/0000-0002-4941-4234; Firestein, Bonnie/0000-0002-1679-3565; Omelchenko, Anton/0000-0001-7396-2815; Meaney, David/0000-0002-0954-4122	New Jersey Commission on Brain Injury Research [CSCR14IRG005]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 088276]; Allen Foundation [U01 NS086090]; Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program, the National Institute of Health [1R21CA182336-01A1]; American Cancer Society - CEOs Against Cancer - CA Division Research Scholar GrantAmerican Cancer Society [RSG-15-227-01-CSM]; National Science Foundation's CAREER Award [1554200]; Hartwell Individual Research Award; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R33CA206907, R21CA182336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH118170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090] Funding Source: NIH RePORTER	We thank Tawny Meredith-Duliba and Erika Silverman from the Diaz-Arrastia lab at Penn for collecting and processing clinical samples that were used for this study. Funding was provided by the New Jersey Commission on Brain Injury Research (CSCR14IRG005) to DI, DM, and BF, NIH NS 088276 to DM, Allen Foundation to DM and DI, U01 NS086090 to RDA, the Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program, the National Institute of Health: 1R21CA182336-01A1 to DI and JK, and DI was supported by an American Cancer Society - CEOs Against Cancer - CA Division Research Scholar Grant, (RSG-15-227-01-CSM), the National Science Foundation's CAREER Award (#1554200), and The Hartwell Individual Research Award.	Adams JD, 2008, P NATL ACAD SCI USA, V105, P18165, DOI 10.1073/pnas.0809795105; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Battista D., 2015, FRONT NEUROL, V6, P110; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bruce ED, 2015, MOL CELL NEUROSCI, V66, P103, DOI 10.1016/j.mcn.2015.03.017; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Carrel D, 2009, J NEUROSCI, V29, P8248, DOI 10.1523/JNEUROSCI.5287-08.2009; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; De K., 2001, ACTA NEUROL SCAND, V103, P175; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Feldmann M., 2014, J BIOL METHODS, V1, pell; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Hadzimichalis NM, 2010, SCHIZOPHR RES, V124, P248, DOI 10.1016/j.schres.2010.05.009; Haun JB, 2010, WIRES NANOMED NANOBI, V2, P291, DOI 10.1002/wnan.84; He M, 2014, LAB CHIP, V14, P3773, DOI 10.1039/c4lc00662c; Hernandez K, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00006; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hyun KA, 2016, ANALYST, V141, P382, DOI 10.1039/c5an01762a; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Jeong S, 2016, ACS NANO, V10, P1802, DOI 10.1021/acsnano.5b07584; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kanwar SS, 2014, LAB CHIP, V14, P1891, DOI 10.1039/c4lc00136b; Ko J, 2018, LAB CHIP, V18, P395, DOI 10.1039/c7lc00955k; Ko J, 2017, ACS NANO, V11, P11182, DOI 10.1021/acsnano.7b05503; Ko J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31215; Ko J, 2016, LAB CHIP, V16, P3049, DOI 10.1039/c6lc00487c; Ko J, 2016, ANALYST, V141, P450, DOI 10.1039/c5an01610j; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Liong M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2745; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; Muluneh M, 2014, ADV HEALTHC MATER, V3, P1078, DOI 10.1002/adhm.201300502; Muluneh M, 2014, ADV DRUG DELIVER REV, V66, P101, DOI 10.1016/j.addr.2013.09.013; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Ping JL, 2016, ACS NANO, V10, P8700, DOI 10.1021/acsnano.6b04110; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Schreiber S, 2008, SMALL, V4, P270, DOI 10.1002/smll.200700116; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shao HL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7999; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Sharma A., 2014, PLOS ONE, V9; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Willms E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22519; Xia N, 2006, BIOMED MICRODEVICES, V8, P299, DOI 10.1007/s10544-006-0033-0; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Yuana Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.21494; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhao Z, 2016, LAB CHIP, V16, P489, DOI 10.1039/c5lc01117e	76	15	17	1	19	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1473-0197	1473-0189		LAB CHIP	Lab Chip	DEC 7	2018	18	23					3617	3630		10.1039/c8lc00672e			14	Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience & Nanotechnology; Instruments & Instrumentation	Biochemistry & Molecular Biology; Chemistry; Science & Technology - Other Topics; Instruments & Instrumentation	HB0VS	WOS:000450737200005	30357245	Green Accepted			2021-06-18	
J	Papa, L; Slobounov, SM; Breiter, HC; Walter, A; Bream, T; Seidenberg, P; Bailes, JE; Bravo, S; Johnson, B; Kaufman, D; Molfese, DL; Talavage, TM; Zhu, DC; Knollmann-Ritschel, B; Bhomia, M				Papa, Linda; Slobounov, Semyon M.; Breiter, Hans C.; Walter, Alexa; Bream, Tim; Seidenberg, Peter; Bailes, Julian E.; Bravo, Stephen; Johnson, Brian; Kaufman, David; Molfese, Dennis L.; Talavage, Thomas M.; Zhu, David C.; Knollmann-Ritschel, Barbara; Bhomia, Manish		Concussion Neuroimaging Consortium	Elevations in MicroRNA Biomarkers in Serum Are Associated with Measures of Concussion, Neurocognitive Function, and Subconcussive Trauma over a Single National Collegiate Athletic Association Division I Season in Collegiate Football Players	JOURNAL OF NEUROTRAUMA			English	Article						athletes; biomarkers; cognition, diagnosis; collegiate; concussion; football; mild traumatic brain injury; miRNA; prognosis sports; subconcussive impacts	DEFAULT MODE NETWORK; HEAD IMPACT EXPOSURE; BRAIN-INJURY; YOUTH; DIAGNOSIS	This prospective controlled observational cohort study assessed the performance of a novel panel of serum microRNA (miRNA) biomarkers on indicators of concussion, subconcussive impacts, and neurocognitive function in collegiate football players over the playing season. Male collegiate student football athletes participating in a Division I Football Bowl Subdivision of the National Collegiate Athletic Association (NCAA) were enrolled. There were a total of 53 participants included in the study, 30 non-athlete control subjects and 23 male collegiate student football athletes. Neurocognitive assessments and blood samples were taken within the week before the athletic season began and within the week after the last game of the season and measured for a panel of pre-selected miRNA biomarkers. All the athletes had elevated levels of circulating miRNAs at the beginning of the season compared with control subjects (p < 0.001). Athletes with the lowest standard assessment of concussion (SAC) scores at the beginning of the season had the highest levels of miRNAs. The area under the curve (AUC) for predicting pre-season SAC scores were miR-195 (0.90), miR-20a (0.89), miR-151-5p (0.86), miR-505* (0.85), miR-9-3p (0.77), and miR-362-3p (0.76). In athletes with declining neurocognitive function over the season, concentrations of miRNAs increased over same period. There were significant negative correlations with miR-505* (p = 0.011), miR-30d (p = 0.007), miR-92 (p = 0.033), and (p = 0.008). The miRNAs correlating with balance problems were miR-505* (p = 0.007), miR-30d (p = 0.028), and miR-151-5p (p = 0.023). Those correlating with poor reaction times were miR-20a (0.043), miR-505* (p = 0.049), miR-30d (p = 0.031), miR-92 (p = 0.015), and miR-151-5p (p = 0.044). Select miRNAs were associated with baseline concussion assessments at the beginning of the season and with neurocognitive changes from pre to post-season in collegiate football players. Should these findings be replicated in a larger cohort of athletes, these markers could potentially serve as measures of neurocognitive status in athletes at risk for concussion and subconcussive injuries.	[Papa, Linda] Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 W Underwood,S-200, Orlando, FL 32806 USA; [Papa, Linda] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Slobounov, Semyon M.; Walter, Alexa; Johnson, Brian] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Bream, Tim] Penn State Univ, Athlet Dept, University Pk, PA 16802 USA; [Breiter, Hans C.] Northwestern Univ, Dept Psychiat & Behav Sci, Warren Wright Adolescent Ctr, Chicago, IL 60611 USA; [Seidenberg, Peter] Penn State Coll Med, Dept Orthopaed & Rehabil, University Pk, PA USA; [Seidenberg, Peter] Penn State Coll Med, Dept Family & Community Med, University Pk, PA USA; [Bailes, Julian E.] Univ Chicago, Dept Neurosurg, Northshore Univ Hlth Syst, Pritzker Sch Med, Chicago, IL 60637 USA; [Bravo, Stephen] Sandlake Imaging, Orlando, FL USA; [Kaufman, David] Michigan State Univ, Dept Neurol & Ophthalmol, E Lansing, MI 48824 USA; [Zhu, David C.] Michigan State Univ, Dept Radiol & Psychol, E Lansing, MI 48824 USA; [Molfese, Dennis L.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Knollmann-Ritschel, Barbara; Bhomia, Manish] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	Papa, L (corresponding author), Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 W Underwood,S-200, Orlando, FL 32806 USA.; Bhomia, M (corresponding author), Uniformed Serv Univ Hlth Sci, Henry M Jackson Fdn HJF, Bldg B,3082,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	lpstat@aol.com; manish.bhomia.ctr@usuhs.edu			DMRDP [D10_I_AR_J6_855]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676] Funding Source: NIH RePORTER	The authors thank Dr. Zhao Zhang Li, Bio-Instrumentation Center (BIC), UHUHS, for her help with digital microRNA PCR experiments. The microRNA analysis was funded by DMRDP grant D10_I_AR_J6_855.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Centers for Disease Control and Prevention, 2017, HEADS HLTH CAR PROV; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Fehlmann T, 2016, RNA BIOL, V13, P1084, DOI 10.1080/15476286.2016.1234658; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; NCAA, 2018, EST PROB COMP COLL A; Papa L, 2018, J NEUROTRAUM, V35, P32, DOI 10.1089/neu.2017.4994; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2015, ACAD EMERG MED, V22, P1274, DOI 10.1111/acem.12795; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Reynolds B.B., 2017, BRAIN IMAGING BEHAV; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Tsushima WT, 2018, APPL NEUROPSYCH-CHIL, V7, P14, DOI 10.1080/21622965.2016.1220860	29	15	16	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1343	1351		10.1089/neu.2018.6072		DEC 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000452128200001	30343622	Green Published			2021-06-18	
J	LoBue, C; Cullum, CM; Didehbani, N; Yeatman, K; Jones, B; Kraut, MA; Hart, J				LoBue, Christian; Cullum, C. Munro; Didehbani, Nyaz; Yeatman, Kylee; Jones, Bruce; Kraut, Michael A.; Hart, John, Jr.			Neurodegenerative Dementias After Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							ENVIRONMENTAL RISK-FACTORS; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; LEWY BODIES; EARLIER AGE; HEAD-INJURY; ENCEPHALOPATHY; DIAGNOSIS; PROGRESSION	Traumatic brain injury (TBI) is often considered to be a risk factor for the later development of neurodegenerative conditions, but some findings do not support a link. Differences in research methods, clinical samples, and limitations encountered when assessing and documenting TBI details likely contribute to the mixed reports in the literature. Despite some variability in findings, a review of the literature does provide support for the notion that TBI appears to be associated with earlier onset of some neurodegenerative disorders, although clearly not everyone with a TBI appears to be at an increased risk. Whereas a mechanistic link remains unknown, TBI has been found to initiate an accumulation of pathological processes related to several neurodegenerative disorders. The authors propose a hypothetical model that relates TBI to the development of pathological burden overlapping with some neurodegenerative conditions, in which onset of cognitive/behavioral impairments is hastened in some individuals, but pathological processes stabilize afterward, resulting in a similar course of decline to individuals with dementia who do not have a history of TBI.	[LoBue, Christian; Cullum, C. Munro; Didehbani, Nyaz; Jones, Bruce] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Kraut, Michael A.] Johns Hopkins Univ Hosp, Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; [Yeatman, Kylee; Hart, John, Jr.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA	LoBue, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	Christian.LoBue@utsw.edu	Cullum, C. Munro/AAC-2496-2019	Cullum, C. Munro/0000-0001-9706-5465; Didehbani, Nyaz/0000-0001-6121-5759	NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P3012300-19]; Alzheimer's Disease Center Grant at the University of Texas Southwestern Medical Center; Texas Alzheimer's Research and Care Consortium; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG012300] Funding Source: NIH RePORTER	Supported by the NIH/NIA (P3012300-19) Alzheimer's Disease Center Grant at the University of Texas Southwestern Medical Center and the Texas Alzheimer's Research and Care Consortium.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Boot BP, 2013, NEUROLOGY, V81, P833, DOI 10.1212/WNL.0b013e3182a2cbd1; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, BEHAV NEUROLOGY DEME; Gilbert M, 2014, INT PSYCHOGERIATR, V26, P1593, DOI 10.1017/S1041610214000842; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Hutchinson AD, 2007, J NEUROL NEUROSUR PS, V78, P917, DOI 10.1136/jnnp.2006.100669; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Ng ASL, 2015, ANN NY ACAD SCI, V1338, P71, DOI 10.1111/nyas.12638; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Petersen RC, 2002, ALZHEIMERS DIS ADV E; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548	43	15	15	0	78	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2018	30	1					7	13		10.1176/appi.neuropsych.17070145			7	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	GM3DP	WOS:000437978600003	29061090	Green Accepted, Bronze			2021-06-18	
J	Vuokila, N; Lukasiuk, K; Bot, AM; van Vliet, EA; Aronica, E; Pitkanen, A; Puhakka, N				Vuokila, Niina; Lukasiuk, Katarzyna; Bot, Anna Maria; van Vliet, Erwin A.; Aronica, Eleonora; Pitkanen, Asla; Puhakka, Noora			miR-124-3p is a chronic regulator of gene expression after brain injury	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Big data; Bioinformatics; microRNA; miR-124-3p; Traumatic brain injury	TRACT-BINDING-PROTEIN; GIANT-CELL ASTROCYTOMA; TRAUMATIC BRAIN; MICRORNA EXPRESSION; NEURONAL DIFFERENTIATION; MAMMALIAN TARGET; MTOR INHIBITOR; LEUKEMIA-CELLS; STEM-CELLS; C-JUN	Traumatic brain injury (TBI) initiates molecular and cellular pathologies that underlie post-injury morbidities, including hippocampus-related memory decline and epileptogenesis. Non-coding small RNAs are master regulators of gene expression with the potential to affect multiple molecular pathways. To evaluate whether hippocampal gene expression networks are chronically regulated by microRNAs after TBI, we sampled the dentate gyrus of rats with severe TBI induced by lateral fluid-percussion injury 3months earlier. Ingenuity pathway analysis revealed 30 upregulated miR-124-3p targets, suggesting that miR-124-3p is downregulated post-TBI (z-score=-5.146, p<0.05). Droplet digital polymerase chain reaction (ddPCR) and in situ hybridization confirmed the chronic downregulation of miR-124-3p (p<0.05). Quantitative PCR analysis of two targets, Plp2 and Stat3, indicated that their upregulation correlated with the miR-124-3p downregulation (r=-0.647, p<0.05; r=-0.629, p<0.05, respectively). Immunohistochemical staining of STAT3 confirmed the increased protein expression. STRING analysis showed that 9 of the 30 miR-124-3p targets belonged to a STAT3 network. Reactome analysis and data mining connected the targets especially to inflammation and signal transduction. L1000CDS2 software revealed drugs (e.g., importazole, trichostatin A, and IKK-16) that could reverse the observed molecular changes. The translational value of our data was emphasized by in situ hybridization showing chronic post-traumatic downregulation of miR-124-3p in the dentate gyrus of TBI patients. Analysis of another brain injury model, status epilepticus, highlighted the fact that chronic downregulation of miR-124 is a common phenomenon after brain injury. Together, our findings indicate that miR-124-3p is a chronic modulator of molecular networks relevant to post-injury hippocampal pathologies in experimental models and in humans.	[Vuokila, Niina; Pitkanen, Asla; Puhakka, Noora] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, Kuopio 70211, Finland; [Lukasiuk, Katarzyna; Bot, Anna Maria] Polish Acad Sci, Nencki Inst Expt Biol, 3 Pasteur Str, PL-02093 Warsaw, Poland; [van Vliet, Erwin A.; Aronica, Eleonora] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Aronica, Eleonora] SEIN, Amsterdam, Netherlands	Pitkanen, A; Puhakka, N (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, Kuopio 70211, Finland.	asla.pitkanen@uef.fi; noora.puhakka@uef.fi	van Vliet, Erwin/AAS-4753-2020	van Vliet, Erwin/0000-0001-5747-3202; Lukasiuk, Katarzyna/0000-0002-1582-0920; Aronica, Eleonora/0000-0002-3542-3770	Academy of FinlandAcademy of FinlandEuropean Commission [272249, 273909]; Polish National Science Centre [2015/16/T/NZ4/00175, 2014/15/N/NZ4/04561]; European Union's Seventh Framework Programme (FP7/2007-2013) [602102]	The research leading to these results received funding from the Academy of Finland (AP) Grant nos. (272249, 273909), Polish National Science Centre Grants (2015/16/T/NZ4/00175 and 2014/15/N/NZ4/04561), as well as from the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant agreement no 602102 (EPITARGET). We acknowledge the technical support generously provided by Mr. Jarmo Hartikainen, Mrs. Merja Lukkari, and Mr. Jasper Anink.	Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Attilio PJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8398072; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beukelaers P, 2011, STEM CELLS, V29, P713, DOI 10.1002/stem.616; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Brenes JC, 2016, J COMP NEUROL, V524, P1586, DOI 10.1002/cne.23842; Brennan GP, 2016, CELL REP, V14, P2402, DOI 10.1016/j.celrep.2016.02.042; Buss H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051847; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Cai BZ, 2012, STEM CELLS, V30, P1746, DOI 10.1002/stem.1154; Campbell IL, 2005, BRAIN RES REV, V48, P166, DOI 10.1016/j.brainresrev.2004.12.006; Cardamone M, 2014, J PEDIATR-US, V164, P1195, DOI 10.1016/j.jpeds.2013.12.053; Carmel I, 1999, BIOCHEM PHARMACOL, V58, P273, DOI 10.1016/S0006-2952(99)00093-3; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Folkersma H, 2009, J NUCL MED, V50, P1975, DOI 10.2967/jnumed.109.067512; Forbes DJ, 2015, CURR OPIN CELL BIOL, V35, P78, DOI 10.1016/j.ceb.2015.04.012; Franz DN, 2014, LANCET ONCOL, V15, P1513, DOI 10.1016/S1470-2045(14)70489-9; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gu X, 2016, MOL NEUROBIOL, V53, P6388, DOI 10.1007/s12035-015-9540-4; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Handschick K, 2014, MOL CELL, V53, P193, DOI 10.1016/j.molcel.2013.12.002; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Hu T, 2015, J MOL NEUROSCI, V57, P114, DOI 10.1007/s12031-015-0584-8; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jadhav SP, 2014, J NEUROCHEM, V130, P388, DOI 10.1111/jnc.12731; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Johansson S, 2005, BRAIN, V128, P2961, DOI 10.1093/brain/awh644; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kletsas D, 2004, BIOCHEM PHARMACOL, V67, P1927, DOI 10.1016/j.bcp.2004.01.021; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kok FO, 2012, DEVELOPMENT, V139, P3838, DOI 10.1242/dev.080994; Kollmann K, 2013, CANCER CELL, V24, P167, DOI 10.1016/j.ccr.2013.07.012; Kotulska K, 2013, EUR J PAEDIATR NEURO, V17, P479, DOI 10.1016/j.ejpn.2013.03.002; Kronenberg G, 2010, J NEUROSCI, V30, P3419, DOI 10.1523/JNEUROSCI.4231-09.2010; Kumar S, 2015, ANTI-CANCER AGENT ME, V15, P1297, DOI 10.2174/1871520615666150402093558; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Lunavat TR, 2015, RNA BIOL, V12, P810, DOI 10.1080/15476286.2015.1056975; Lund IV, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162396; Mackowiak B, 2017, MOL PHARMACOL, V92, P75, DOI 10.1124/mol.117.108621; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Mandel G, 2011, P NATL ACAD SCI USA, V108, P16789, DOI 10.1073/pnas.1113486108; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; McClelland S, 2014, ELIFE, V3, DOI 10.7554/eLife.01267; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Miao W, 2015, BRAZ J MED BIOL RES, V48, P433, DOI [10.1590/1414-431X20144012, 10.1590/1414-431x20144012]; Miotto E, 2014, CANCER EPIDEM BIOMAR, V23, P2638, DOI 10.1158/1055-9965.EPI-14-0503; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller S, 2009, STEM CELLS, V27, P431, DOI 10.1634/stemcells.2008-0234; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Nesti E, 2014, P NATL ACAD SCI USA, V111, pE3929, DOI 10.1073/pnas.1414770111; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Owen DR, 2017, J CEREBR BLOOD F MET, V37, P2679, DOI 10.1177/0271678X17710182; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peiffer L, 2014, J CANCER RES CLIN, V140, P1283, DOI 10.1007/s00432-014-1689-0; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Racke FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051059; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rodenas-Ruano A, 2012, NAT NEUROSCI, V15, P1382, DOI 10.1038/nn.3214; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rummel C, 2004, J PHYSIOL-LONDON, V557, P671, DOI 10.1113/jphysiol.2003.058834; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sandhir R, 2014, NEUROCHEM INT, V78, P117, DOI 10.1016/j.neuint.2014.09.009; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Schober K, 2015, INT J LEGAL MED, V129, P701, DOI 10.1007/s00414-014-1129-3; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Soldati C, 2015, J NEUROSCI RES, V93, P1203, DOI 10.1002/jnr.23572; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; Sun HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055693; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Vrana JA, 1999, ONCOGENE, V18, P7016, DOI 10.1038/sj.onc.1203176; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang Y, 2012, EXP BIOL MED, V237, P1424, DOI 10.1258/ebm.2012.012123; Watanabe Y, 2004, GENE DEV, V18, P889, DOI 10.1101/gad.1179004; Weng HC, 2011, BIOMED RES-TOKYO, V32, P135, DOI 10.2220/biomedres.32.135; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; You WD, 2016, CHIN J TRAUMATOL, V19, P11, DOI 10.1016/j.cjtee.2016.01.004; Yu HY, 2017, MOL CANCER THER, V16, P2711, DOI 10.1158/1535-7163.MCT-17-0498; Yu HL, 2015, J NEUROCHEM, V135, P261, DOI 10.1111/jnc.13238; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zhang LL, 2015, HUM MOL GENET, V24, P7221, DOI 10.1093/hmg/ddv422; Zhang SZ, 2015, J CELL PHYSIOL, V230, P2476, DOI 10.1002/jcp.24982; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	139	15	17	0	13	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	DEC	2018	75	24					4557	4581		10.1007/s00018-018-2911-z			25	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	GY9IH	WOS:000448955600006	30155647				2021-06-18	
J	Zeiler, FA; Lee, JK; Smielewski, P; Czosnyka, M; Brady, K				Zeiler, Frederick A.; Lee, Jennifer K.; Smielewski, Peter; Czosnyka, Marek; Brady, Ken			Validation of Intracranial Pressure-Derived Cerebrovascular Reactivity Indices against the Lower Limit of Autoregulation, Part II: Experimental Model of Arterial Hypotension	JOURNAL OF NEUROTRAUMA			English	Article						arterial hypotension; autoregulation; ICP indices; validation	TRAUMATIC BRAIN-INJURY; SWINE MODEL	The aim of this work was to explore the relationship between intracranial pressure (ICP)-derived indices of cerebrovascular reactivity and the lower limit of autoregulation (LLA) during arterial hypotension. We retrospectively reviewed recorded physiological data from piglets that underwent controlled hypotension. Hypotension was induced by inflation of a balloon catheter in the inferior vena cava. ICP, cortical laser Doppler flowmetry (LDF), and arterial blood pressure (ABP) monitoring was conducted. ICP-derived indices were calculated: pressure reactivity index (PRx; correlation between ICP and mean arterial pressure [MAP]); pulse amplitude index (PAx; correlation between pulse amplitude of ICP [AMP] and MAP); and RAC (correlation between AMP and cerebral perfusion pressure [CPP]). LLA was estimated by piece-wise linear regression of CPP versus LDF. We produced error bar plots for PRx, PAx, and RAC against 5-mm Hg bins of CPP, displaying the relationship with the LLA. We compared CPP values at clinically relevant thresholds of PRx, PAx, and RAC to CPP measured at the LLA. Receiver operating curve (ROC) analysis was performed for each index across the LLA using 5-mm Hg bins for CPP. Mean LLA was 36.2 +/- 10.5 mm Hg. Error bar plots demonstrated that PRx, PAx, and RAC increased, with CPP decreasing below the LLA. CPP at clinically relevant thresholds for PRx, PAx, and RAC displayed weak associations with the LLA, indicating that thresholds defined in TBI may not apply to a model of arterial hypotension. ROC analysis indicated that PRx, PAx, and RAC predicted the LLA, with AUCs of: 0.806 (95% confidence interval [CI], 0.750-0.863; p < 0.0001), 0.726 (95% CI, 0.664-0.789; p < 0.0001), and 0.710 (95% CI, 0.646-0.775; p < 0.0001), respectively. Three ICP-derived continuous indices of cerebrovascular reactivity, PRx, PAx, and RAC, were validated against the LLA within this experimental model of arterial hypotension, with PRx being superior.	[Lee, Jennifer K.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Sect Brain Phys, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Brady, Ken] Texas Childrens Hosp, Baylor Coll Med, Pediat Cardiol, Houston, TX 77030 USA	Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca		czosnyka, marek/0000-0003-2446-8006; Zeiler, Frederick/0000-0003-1737-0510	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS080984] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS080984] Funding Source: NIH RePORTER		Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Fraser C.D., 1985, J APPL PHYSIOL, V115, P52; Lee JK, 2012, ANESTH ANALG, V114, P825, DOI 10.1213/ANE.0b013e31824762d5; Lee JK, 2011, CRIT CARE MED, V39, P2337, DOI 10.1097/CCM.0b013e318223b910; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Zeiler FA, 2018, NEUROCRIT CARE, V28, P194, DOI 10.1007/s12028-017-0472-x; Zeiler FA, 2018, J NEUROTRAUM, V35, P314, DOI 10.1089/neu.2017.5364; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3207, DOI 10.1089/neu.2017.5085; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	15	15	15	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2018	35	23					2812	2819		10.1089/neu.2017.5604			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HB1WO	WOS:000450819000007	29808745	Green Published			2021-06-18	
J	Huang, CH; Lin, CW; Lee, YC; Huang, CY; Huang, RY; Tai, YC; Wang, KW; Yang, SN; Sun, YT; Wang, HK				Huang, Chi-Hsien; Lin, Chi-Wei; Lee, Yi-Che; Huang, Chih-Yuan; Huang, Ru-Yi; Tai, Yi-Cheng; Wang, Kuo-Wei; Yang, San-Nan; Sun, Yuan-Ting; Wang, Hao-kuang			Is traumatic brain injury a risk factor for neurodegeneration? A meta-analysis of population-based studies	BMC NEUROLOGY			English	Article						TBI; Dementia; Neurodegeneration; Meta-analysis	HEAD-INJURY; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; ONSET; EXPOSURE	BackgroundTo determine the association of prior traumatic brain injury (TBI) with subsequent diagnosis of neurodegeneration disease.MethodsAll studies from 1980 to 2016 reporting TBI as a risk factor for diagnoses of interest were identified by searching PubMed, Embase, study references, and review articles. The data and study design were assessed by 2 investigators independently. A meta-analysis was performed by RevMan 5.3.ResultsThere were 18 studies comprising 3,263,207 patients. Meta-analysis revealed a significant association of prior TBI with subsequent dementia. The pooled odds ratio (OR) for TBI on development of dementia, FTD and TDP-43 associated disease were 1.93 (95% CI 1.47-2.55, p<0.001), 4.44 (95% CI 3.86-5.10, p<0.001), and 2.97 (95% CI 1.35-6.53, p<0.001). However, analyses of individual diagnoses found no evidence that the risk of Alzheimer's disease, and Parkinson's disease in individuals with previous TBI compared to those without TBI.ConclusionsHistory of TBI is not associated with the development of subsequent neurodegeneration disease. Care must be taken in extrapolating from these results because no suitable criteria define post TBI neurodegenerative processes. Therefore, further research in this area is needed to confirm these questions and uncover the link between TBI and neurodegeneration disease.	[Huang, Chi-Hsien; Lin, Chi-Wei; Huang, Ru-Yi] I Shou Univ, E Da Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Chi-Hsien; Lin, Chi-Wei; Lee, Yi-Che; Huang, Ru-Yi; Wang, Kuo-Wei; Yang, San-Nan; Wang, Hao-kuang] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Lee, Yi-Che] I Shou Univ, E Da Hosp, Dept Nephrol, Kaohsiung, Taiwan; [Huang, Chih-Yuan] Natl Cheng Kung Univ Hosp, Dept Surg, Neurosurg Serv, Tainan, Taiwan; [Tai, Yi-Cheng] I Shou Univ, E Da Hosp, Dept Neurol, Kaohsiung, Taiwan; [Wang, Kuo-Wei; Wang, Hao-kuang] I Shou Univ, E Da Hosp, Dept Neurosurg, 1 Yida Rd, Kaohsiung 82445, Taiwan; [Sun, Yuan-Ting] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Neurol, Tainan, Taiwan	Wang, HK (corresponding author), I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan.; Wang, HK (corresponding author), I Shou Univ, E Da Hosp, Dept Neurosurg, 1 Yida Rd, Kaohsiung 82445, Taiwan.	ed103520@edah.org.tw; ed101393@gmail.com			Center for Database Research, E-DA HEALTHCARE GROUP	This study was supported by Center for Database Research, E-DA HEALTHCARE GROUP.	Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Ferrari R, 2011, CURR ALZHEIMER RES, V8, P273, DOI 10.2174/156720511795563700; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Levy G, 2002, MOVEMENT DISORD, V17, P250, DOI 10.1002/mds.10086; Luukinen H, 2008, ACTA NEUROL SCAND, V118, P153, DOI 10.1111/j.1600-0404.2008.00994.x; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Perrin D., 2015, J NEUROSURG, P1, DOI 10.1016/j.jmbbm.2016.06.013.; Perrine K, 2017, WORLD NEUROSURG; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rugbjerg K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2494; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Spangenberg S, 2009, PARKINSONISM RELAT D, V15, P12, DOI 10.1016/j.parkreldis.2008.02.004; Sundstrom A, 2007, INT PSYCHOGERIATR, V19, P159, DOI 10.1017/S1041610206003498; Tanner CM, 2014, ALZHEIMERS DEMENT, V10, pS213, DOI 10.1016/j.jalz.2014.04.014; Taylor KM, 2015, PARKINSONISM RELAT D; Turner MR, 2010, J NEUROL SCI, V288, P45, DOI 10.1016/j.jns.2009.10.010; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; Zhang BF, 2015, WORLD NEUROSURG, V83, P567, DOI 10.1016/j.wneu.2014.12.010	42	15	15	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	NOV 5	2018	18								184	10.1186/s12883-018-1187-0			8	Clinical Neurology	Neurosciences & Neurology	GZ3DL	WOS:000449267200001	30396335	DOAJ Gold, Green Published			2021-06-18	
J	Crespo-Castrillo, A; Yanguas-Casas, N; Arevalo, MA; Azcoitia, I; Barreto, GE; Garcia-Segura, LM				Crespo-Castrillo, Andrea; Yanguas-Casas, Natalia; Angeles Arevalo, Maria; Azcoitia, Inigo; Barreto, George E.; Garcia-Segura, Luis M.			The Synthetic Steroid Tibolone Decreases Reactive Gliosis and Neuronal Death in the Cerebral Cortex of Female Mice After a Stab Wound Injury	MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Microglia; Neuroinflammation; Neuroprotection; Steroid receptors; Brain trauma	TRAUMATIC BRAIN-INJURY; CORTICAL PERICONTUSIONAL ZONE; RECEPTOR MODULATORS DECREASE; PROGRAMMED CELL-DEATH; ESTROGEN-RECEPTOR; MICROGLIAL ACTIVATION; ANDROGEN RECEPTORS; OXIDATIVE STRESS; UP-REGULATION; ESTRADIOL	Previous studies have shown that estradiol reduces reactive gliosis after a stab wound injury in the cerebral cortex. Since the therapeutic use of estradiol is limited by its peripheral hormonal effects, it is of interest to determine whether synthetic estrogenic compounds with tissue-specific actions regulate reactive gliosis. Tibolone is a synthetic steroid that is widely used for the treatment of climacteric symptoms and/or the prevention of osteoporosis. In this study, we have assessed the effect of tibolone on reactive gliosis in the cerebral cortex after a stab wound brain injury in ovariectomized adult female mice. By 7days after brain injury, tibolone reduced the number of glial fibrillary acidic protein (GFAP) immunoreactive astrocytes, the number of ionized calcium binding adaptor molecule 1 (Iba1) immunoreactive microglia, and the number of microglial cells with a reactive phenotype in comparison to vehicle-injected animals. These effects on gliosis were associated with a reduction in neuronal loss in the proximity to the wound, suggesting that tibolone exerts beneficial homeostatic actions in the cerebral cortex after an acute brain injury.	[Crespo-Castrillo, Andrea; Yanguas-Casas, Natalia; Angeles Arevalo, Maria; Garcia-Segura, Luis M.] Inst Cajal, CSIC, Madrid, Spain; [Yanguas-Casas, Natalia; Angeles Arevalo, Maria; Azcoitia, Inigo; Garcia-Segura, Luis M.] Inst Salud Carlos III, CIBERFES, Madrid, Spain; [Azcoitia, Inigo] Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia	Garcia-Segura, LM (corresponding author), Inst Cajal, CSIC, Madrid, Spain.; Garcia-Segura, LM (corresponding author), Inst Salud Carlos III, CIBERFES, Madrid, Spain.; Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.	gsampaio@javeriana.edu.co; lmgs@cajal.csic.es	Casas, Natalia Yanguas/AAB-6704-2019; Garcia-Segura, Luis M/U-3711-2017; Azcoitia, Inigo/A-6208-2011; Arevalo, Maria-Angeles/J-7000-2014; Barreto, George E./AAD-7420-2020	Casas, Natalia Yanguas/0000-0003-4368-0176; Garcia-Segura, Luis M/0000-0002-2450-2916; Azcoitia, Inigo/0000-0002-5791-9144; Arevalo, Maria-Angeles/0000-0002-4303-9576; Barreto, George E./0000-0002-6644-1971	Ministerio de Economia, Industria y Competitividad (MINECO), Spain [BFU2014-51836-C2-1-R, BFU2017-82754-R]; Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES); Instituto de Salud Carlos III, Madrid, SpainInstituto de Salud Carlos III; Fondos FederEuropean Commission	This work was supported by grants from Ministerio de Economia, Industria y Competitividad (MINECO), Spain (grant numbers BFU2014-51836-C2-1-R and BFU2017-82754-R), Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), and Instituto de Salud Carlos III, Madrid, Spain and Fondos Feder.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Behl C, 1997, MOL PHARMACOL, V51, P535; Beltran-Campos V, 2015, NEUROLOGIA, V30, P401, DOI 10.1016/j.nrl.2014.03.002; Blurton-Jones M, 2001, J COMP NEUROL, V433, P115, DOI 10.1002/cne.1129; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; de Aguiar RB, 2006, PHARMACOL BIOCHEM BE, V85, P689, DOI 10.1016/j.pbb.2006.10.023; Chuffa LGD, 2017, STEROIDS, V118, P93, DOI 10.1016/j.steroids.2016.12.011; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; Diz-Chaves Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-71; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; DonCarlos LL, 2006, NEUROSCIENCE, V138, P801, DOI 10.1016/j.neuroscience.2005.06.020; Escande A, 2009, J STEROID BIOCHEM, V116, P8, DOI 10.1016/j.jsbmb.2009.03.008; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; Finley SK, 1999, J NEUROBIOL, V40, P446; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Genazzani AR, 2006, MENOPAUSE, V13, P57, DOI 10.1097/01.gme.0000191372.79052.d3; Gibbs RB, 2002, NEUROSCIENCE, V113, P907, DOI 10.1016/S0306-4522(02)00239-7; Goc J, 2014, EUR J NEUROSCI, V39, P2151, DOI 10.1111/ejn.12548; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Habib P, 2015, J STEROID BIOCHEM, V146, P3, DOI 10.1016/j.jsbmb.2014.02.018; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hatton WJ, 1999, J COMP NEUROL, V409, P169; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Howard CV, 1998, THREE DIMENSIONAL ME; HOZUMI I, 1990, BRAIN RES, V534, P291, DOI 10.1016/0006-8993(90)90142-X; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Kloss CUA, 2001, EXP NEUROL, V168, P32, DOI 10.1006/exnr.2000.7575; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Lenz KM, 2013, J NEUROSCI, V33, P2761, DOI 10.1523/JNEUROSCI.1268-12.2013; Li CY, 2015, MOL MED REP, V12, P4410, DOI 10.3892/mmr.2015.3942; Li LZ, 2011, NEUROCHEM INT, V58, P126, DOI 10.1016/j.neuint.2010.11.006; Li R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094320; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; MIYAKE T, 1988, BRAIN RES, V451, P133, DOI 10.1016/0006-8993(88)90757-3; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Paxinos G, 2001, THE MOUSE BRAIN IN S; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Perez-Alvarez MJ, 2015, MOL NEUROBIOL, V52, P1690, DOI 10.1007/s12035-014-8963-7; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Petrone AB, 2014, AGING DIS, V5, P340, DOI 10.14336/AD.2014.0500340; Pinto-Almazan R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8630764; Pinto-Almazan R, 2012, J NEUROSCI RES, V90, P878, DOI 10.1002/jnr.22808; Potter KA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046020; Qiu J, 2008, J NEUROENDOCRINOL, V20, P1310, DOI 10.1111/j.1365-2826.2008.01789.x; Reed MJ, 2004, MATURITAS, V48, pS4, DOI 10.1016/j.maturitas.2004.02.013; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Sierra A., 2007, GLIA, V55, P412, DOI [10. 1002/glia. 20468 17203473, DOI 10.1002/GLIA.22867, DOI 10.1002/glia.22867]; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Simoncini T, 2004, J CLIN ENDOCR METAB, V89, P4594, DOI 10.1210/jc.2003-032189; Simoncini T, 2000, MOL CELL ENDOCRINOL, V162, P87, DOI 10.1016/S0303-7207(00)00206-9; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sohrabji F, 2006, ENDOCRINE, V29, P191, DOI 10.1385/ENDO:29:2:191; Sohrabji F, 2015, FRONT NEUROENDOCRIN, V36, P1, DOI 10.1016/j.yfrne.2014.05.003; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Tapia-Gonzalez S, 2008, J ENDOCRINOL, V198, P219, DOI 10.1677/JOE-07-0294; Thakkar R, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12484; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Vergouwen MDI, 2000, BRAIN RES, V878, P88, DOI 10.1016/S0006-8993(00)02713-X; Verheul HAM, 2006, J STEROID BIOCHEM, V102, P195, DOI 10.1016/j.jsbmb.2006.09.037; Verheul HAM, 2007, DRUG METAB DISPOS, V35, P1105, DOI 10.1124/dmd.106.014118; Verheul HAM, 2007, REPROD SCI, V14, P160, DOI 10.1177/1933719106298684; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Zhao TZ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.449	98	15	15	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2018	55	11					8651	8667		10.1007/s12035-018-1008-x			17	Neurosciences	Neurosciences & Neurology	GU7ID	WOS:000445493600033	29582398				2021-06-18	
J	Ewing-Cobbs, L; Cox, CS; Clark, AE; Holubkov, R; Keenan, HT				Ewing-Cobbs, Linda; Cox, Charles S.; Clark, Amy E.; Holubkov, Richard; Keenan, Heather T.			Persistent Postconcussion Symptoms After Injury	PEDIATRICS			English	Article							TRAUMATIC-BRAIN-INJURY; POST-CONCUSSIVE SYMPTOMS; GOOD OLD DAYS; PEDIATRIC CONCUSSION; STRESS SYMPTOMS; RISK-FACTORS; HEAD-INJURY; CHILDREN; ADOLESCENTS; PREDICTORS	PCSs failed to resolve in a striking number of children with mTBI; 40%, especially girls, continued to act differently 1 year after injury. OBJECTIVES:We examined whether preinjury, demographic, and family factors influenced vulnerability to postconcussion symptoms (PCSs) persisting the year after mild traumatic brain injury (mTBI).METHODS:Children with mTBI (n = 119), complicated mild traumatic brain injury (cmTBI) (n = 110), or orthopedic injury (OI) (n = 118), recruited from emergency departments, were enrolled in a prospective, longitudinal cohort study. Caregivers completed retrospective surveys to characterize preinjury demographic, child, and family characteristics. PCSs were assessed using a validated rating scale. With multivariable general linear models adjusted for preinjury symptoms, we examined predictors of PCSs 3, 6, and 12 months after injury in children ages 4 to 8, 9 to 12, and 13 to 15 years at injury. With logistic regression, we examined predictors of chronic PCSs 1 year after traumatic brain injury.RESULTS:Postinjury somatic, emotional, cognitive, and fatigue PCSs were similar in the mTBI and cmTBI groups and significantly elevated compared with the OI group. PCS trajectories varied with age and sex. Adolescents had elevated PCSs that improved; young children had lower initial symptoms and less change. Despite similar preinjury PCSs, girls had elevated symptoms across all time points compared with boys. PCS vulnerability factors included female sex, adolescence, preinjury mood problems, lower income, and family discord. Social capital was a protective factor. PCSs persisted in 25% to 31% of the traumatic brain injury group and 18% of the OI group at 1 year postinjury. The odds of chronic PCSs were almost twice as high in girls as in boys and were >4 times higher in young children with cmTBI than in those with mTBI.CONCLUSIONS:A significant minority of children with mTBI and OI have PCSs that persisted 1 year after injury.	[Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, John P & Katherine G McGovern Med Sch, Childrens Learning Inst, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, John P & Katherine G McGovern Med Sch, Dept Pediat, Houston, TX 77030 USA; [Cox, Charles S.] Univ Texas Hlth Sci Ctr Houston, John P & Katherine G McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA; [Clark, Amy E.; Holubkov, Richard; Keenan, Heather T.] Univ Utah, Dept Pediat, Salt Lake City, UT USA	Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Dept Pediat, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01/CE002188]; National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002188] Funding Source: NIH RePORTER	Supported by the Centers for Disease Control and Prevention (Cooperative Agreement U01/CE002188). Contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. Dr Keenan was also supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (K24HD072984). Neither the Eunice Kennedy Shriver National Institute of Child Health and Human Development nor the Centers for Disease Control and Prevention played a role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the article; or decision to submit the article for publication. Funded by the National Institutes of Health (NIH).	Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Albanese BJ, 2017, PSYCHIAT RES, V252, P242, DOI 10.1016/j.psychres.2017.01.099; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ewing-Cobbs L, 2017, PSYCHONEUROENDOCRINO, V84, P66, DOI 10.1016/j.psyneuen.2017.06.003; Gallo LC, 2009, J PERS, V77, P1707, DOI 10.1111/j.1467-6494.2009.00598.x; Gennarelli TA, 2005, ABBREVIATED INJURY S; Graham R, 2013, SPORTS RELATED CONCU; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jimenez N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2462; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Moore M, 2018, J HEAD TRAUMA REHAB, V33, P177, DOI 10.1097/HTR.0000000000000348; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Runyan DK, 1998, PEDIATRICS, V101, P12, DOI 10.1542/peds.101.1.12; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; TEASDALE G, 1974, LANCET, V2, P81; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yuan WH, 2017, J HEAD TRAUMA REHAB, V32, P378, DOI 10.1097/HTR.0000000000000318; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	52	15	16	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2018	142	5							e20180939	10.1542/peds.2018-0939			13	Pediatrics	Pediatrics	GY7DF	WOS:000448763700023	30323108	Bronze, Green Published			2021-06-18	
J	Neri, M; Frati, A; Turillazzi, E; Cantatore, S; Cipolloni, L; Di Paolo, M; Frati, P; La Russa, R; Maiese, A; Scopetti, M; Santurro, A; Sessa, F; Zamparese, R; Fineschi, V				Neri, Margherita; Frati, Alessandro; Turillazzi, Emanuela; Cantatore, Santina; Cipolloni, Luigi; Di Paolo, Marco; Frati, Paola; La Russa, Raffaele; Maiese, Aniello; Scopetti, Matteo; Santurro, Alessandro; Sessa, Francesco; Zamparese, Rosanna; Fineschi, Vittorio			Immunohistochemical Evaluation of Aquaporin-4 and its Correlation with CD68, IBA-1, HIF-1, GFAP, and CD15 Expressions in Fatal Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; aquaporin; genetic analysis; edema; computed tomography (CT) scan; hypoxia; microglia activation	REVEALS COMPLEX; GROWTH-FACTOR; EDEMA; WATER; ASTROCYTES; FLUID; PATHOPHYSIOLOGY; EPIDEMIOLOGY; MECHANISMS; HIF1-ALPHA	Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. Our understanding of its pathobiology has substantially increased. Following TBI, the following occur, edema formation, brain swelling, increased intracranial pressure, changes in cerebral blood flow, hypoxia, neuroinflammation, oxidative stress, excitotoxicity, and apoptosis. Experimental animal models have been developed. However, the difficulty in mimicking human TBI explains why few neuroprotective strategies, drawn up on the basis of experimental studies, have translated into improved therapeutic strategies for TBI patients. In this study, we retrospectively examined brain samples in 145 cases of death after different survival times following TBI, to investigate aquaporin-4 (AQP4) expression and correlation with hypoxia, and neuroinflammation in human TBI. Antibodies anti-glial fibrillary acid protein (GFAP), aquaporin-4 (AQP4), hypoxia induced factor-1 (HIF-1), macrophage/phagocytic activation (CD68), ionized calcium-binding adapter molecule-1 (IBA-1), and neutrophils (CD15) were used. AQP4 showed a significant, progressive increase between the control group and groups 2 (one-day survival) and 3 (three-day survival). There were further increases in AQP4 immunopositivity in groups 4 (seven-day survival), 5 (14-dayssurvival), and 6 (30-day survival), suggesting an upregulation of AQP4 at 7 to 30 days compared to group 1. GFAP showed its highest expression in non-acute cases at the astrocytic level compared with the acute TBI group. Data emerging from the HIF-1 reaction showed a progressive, significant increase. Immunohistochemistry with IBA-1 revealed activated microglia starting three days after trauma and progressively increasing in the next 15 to 20 days after the initial trauma. CD68 expression demonstrated basal macrophage and phagocytic activation mostly around blood vessels. Starting from one to three days of survival after TBI, an increase in the number of CD68 cells was progressively observed; at 15 and 30 days of survival, CD68 showed the most abundant immunopositivity inside or around the areas of necrosis. These findings need to be developed further to gain insight into the mechanisms through which brain AQP4 is upregulated. This could be of the utmost clinicopathological importance.	[Neri, Margherita] Univ Ferrara, Dept Morphol Expt Med & Surg, Via Fossato Mortara 70, I-44121 Ferrara, Italy; [Frati, Alessandro] Sapienza Univ Rome, St Andrea Hosp, Dept Neurosci Mental Hlth & Sensory Organs, Via Grottarossa 1035, I-00189 Rome, Italy; [Frati, Alessandro; Frati, Paola; La Russa, Raffaele; Fineschi, Vittorio] IRCCS Neuromed, Via Atinense 18, I-86077 Pozzilli, Italy; [Turillazzi, Emanuela; Di Paolo, Marco] Univ Pisa, Inst Legal Med, Dept Surg Pathol Med Mol & Crit Area, Osped Santa Chiara, Via Roma 55, I-56126 Pisa, Italy; [Cantatore, Santina; Sessa, Francesco] Univ Foggia, Osped Colonnello DAvanzo, Dept Clin & Expt Med, Sect Legal Med, Via Aviatori 1, I-71100 Foggia, Italy; [Cipolloni, Luigi; Frati, Paola; La Russa, Raffaele; Maiese, Aniello; Scopetti, Matteo; Santurro, Alessandro; Fineschi, Vittorio] Sapienza Univ Rome, Dept Anat Histol Forens & Orthopaed Sci, Viale Regina Elena 336, I-00185 Rome, Italy; [Zamparese, Rosanna] ASUR Area Vasta 5, Unit Legal Med, Viale Marcello Federici, I-63100 Ascoli Piceno, Italy	Fineschi, V (corresponding author), IRCCS Neuromed, Via Atinense 18, I-86077 Pozzilli, Italy.; Fineschi, V (corresponding author), Sapienza Univ Rome, Dept Anat Histol Forens & Orthopaed Sci, Viale Regina Elena 336, I-00185 Rome, Italy.	margherita.neri@unife.it; alessandro.frati@uniroma1.it; emanuela.turillazzi@unipi.it; santina.cantatore@unifg.it; luigi.cipolloni@uniroma1.it; marco.dipaolo@unipi.it; paola.frati@uniroma1.it; raffaele.larussa@uniroma1.it; aniello.maiese@uniroma1.it; matteo.scopetti@uniroma1.it; alessandro.santurro@uniroma1.it; francesco.sessa@unifg.it; rosanna.zamparese@sanita.marche.it; vfinesc@tin.it	Cipolloni, Luigi/AAS-2680-2020; Sessa, Francesco/G-1754-2018; Scopetti, Matteo/ABD-6466-2020; Fineschi, Vittorio/AAJ-4808-2020; Pesce, Alessandro/AAC-2223-2020; Frati, Alessandro/AAC-2204-2020	Sessa, Francesco/0000-0003-0357-8791; NERI, Margherita/0000-0002-6459-1669; cipolloni, luigi/0000-0001-6464-3249; FRATI, ALESSANDRO/0000-0001-8062-614X; Scopetti, Matteo/0000-0002-7259-3090; Santurro, Alessandro/0000-0001-5491-3719; Fineschi, Vittorio/0000-0002-1686-3236			Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; [Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Barzo P, 1997, ACT NEUR S, V70, P119; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Cartagena CM, 2014, MOL CELL NEUROSCI, V60, P81, DOI 10.1016/j.mcn.2014.04.005; Castejon OJ, 2013, ULTRASTRUCT PATHOL, V37, P417, DOI 10.3109/01913123.2013.831157; Dai WS, 2018, INT J MOL MED, V42, P1716, DOI 10.3892/ijmm.2018.3749; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Filippidis AS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010055; Filippidis AS, 2014, J NEUROTRAUM, V31, P1258, DOI 10.1089/neu.2013.3063; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; FRIGERI A, 1995, J CELL SCI, V108, P2993; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Hoogland ICM, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00110; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; ITO U, 1986, ACTA NEUROCHIR, V79, P120, DOI 10.1007/BF01407455; Castejon OJ, 2015, FOLIA NEUROPATHOL, V53, P173, DOI 10.5114/fn.2015.54419; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Li G, 2018, INT J MOL MED, V42, P1935, DOI 10.3892/ijmm.2018.3802; Lo Pizzo M, 2013, NEUROL SCI, V34, P1309, DOI 10.1007/s10072-012-1233-4; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pinchi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20699-1; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sorani MD, 2008, HUM MUTAT, V29, P1108, DOI 10.1002/humu.20762; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Stokum JA, 2015, NEUROCHEM RES, V40, P317, DOI 10.1007/s11064-014-1374-3; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Sviri GE, 2015, J NEUROSURG, V123, P1188, DOI 10.3171/2014.11.JNS141152; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang GH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101413; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Wolburg H, 2012, MOL ASPECTS MED, V33, P579, DOI 10.1016/j.mam.2012.02.003; Yang M, 2011, ANAT HISTOL EMBRYOL, V40, P299, DOI 10.1111/j.1439-0264.2011.01070.x; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022	63	15	16	1	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	NOV	2018	19	11							3544	10.3390/ijms19113544			19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	HC0ZM	WOS:000451528500260	30423808	DOAJ Gold, Green Published			2021-06-18	
J	Rubin, TG; Catenaccio, E; Fleysher, R; Hunter, LE; Lubin, N; Stewart, WE; Kim, M; Lipton, RB; Lipton, ML				Rubin, Todd G.; Catenaccio, Eva; Fleysher, Roman; Hunter, Liane E.; Lubin, Naomi; Stewart, Walter E.; Kim, Mimi; Lipton, Richard B.; Lipton, Michael L.			MRI-defined White Matter Microstructural Alteration Associated with Soccer Heading Is More Extensive in Women than Men	RADIOLOGY			English	Article							TRAUMATIC-BRAIN-INJURY; SPORTS-RELATED CONCUSSION; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; GENDER-DIFFERENCES; SYMPTOMS; PLAYERS; IMPACT; ABNORMALITIES; REGISTRATION	Purpose: To examine the role of sex in abnormal white matter microstructure after soccer heading as identified by using the diffusion-tensor imaging (DTI) metric fractional anisotropy (FA). Materials and Methods: In this prospective cross-sectional study, 98 individuals who were enrolled in a larger prospective study of amateur soccer players (from 2013 to 2016) were matched 1: 1 for age and history of soccer heading in the prior 12 months. Among the subjects, 49 men (mean age, 25.7 years; range, 18-50 years) and 49 women (mean age, 25.8 years; range, 18-50 years) with median total soccer headings per year of 487 and 469, respectively, underwent 3.0-T DTI. Images were registered to the Johns Hopkins University template. A voxelwise linear regression was fitted for FA with terms for the number of headings during the previous 12 months and its interaction with sex after controlling for the following potential confounders: age, years of education, number of lifetime concussions, and handedness. In the resulting statistical maps, P < .01 indicated a statistically significant difference, with a threshold cluster size larger than 100 mm(3). Results: Among men, three regions were identified in which greater heading exposure was associated with lower FA; eight such regions were identified among women (>100 contiguous voxels, P < .01). In seven of the eight regions identified in women, the association between heading and FA was stronger in women than in men. There was no significant difference of heading with FA between the sexes for any region in which heading was associated with FA among men (P > .01, <100 contiguous voxels). Conclusion: With similar exposure to heading, women exhibit more widespread evidence of microstructural white matter alteration than do men, suggesting preliminary support for a biologic divergence of brain response to repetitive trauma. (c) RSNA, 2018	[Rubin, Todd G.; Fleysher, Roman; Hunter, Liane E.; Lubin, Naomi; Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Radiol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Kim, Mimi; Lipton, Richard B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Lipton, Richard B.] Albert Einstein Coll Med, Dept Neurol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Rubin, Todd G.; Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Lipton, Michael L.] Montefiore Med Ctr, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA; [Lipton, Richard B.] Montefiore Med Ctr, Dept Neurol, 111 E 210th St, Bronx, NY 10467 USA; [Catenaccio, Eva] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Stewart, Walter E.] Sutter Hlth, Walnut Creek, CA USA	Lipton, ML (corresponding author), Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Radiol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Psychiat & Behav Sci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA.	michael.lipton@einstein.yu.edu	Lipton, Richard B/B-5060-2011; Catenaccio, Eva/M-7250-2019	Catenaccio, Eva/0000-0003-0550-207X; Rubin, Todd/0000-0002-2821-5877	National Institutes of Health, National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082432] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Institute of Neurologic Disorders and Stroke (R01 NS082432), and a grant from the Dana Foundation David Mahoney Neuroimaging Program.	Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Caccese JB, 2017, SPORTS BIOMECH, V3141, P1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catenaccio E, 2017, PM&R, V9, P884, DOI 10.1016/j.pmrj.2017.01.005; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FLEET GH, 1975, BIOCHIM BIOPHYS ACTA, V410, P318, DOI 10.1016/0005-2744(75)90234-X; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hoptman MJ, 2008, SCHIZOPHR RES, V106, P115, DOI 10.1016/j.schres.2008.07.023; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Kennedy CL, 2010, GEND ISSUES, V27, P78, DOI 10.1007/s12147-010-9091-y; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Senne JA, SPORT J; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Suri AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142288; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578	46	15	15	0	4	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	NOV	2018	289	2					478	486		10.1148/radiol.2018180217			9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	GX3UJ	WOS:000447652300030	30063172	Bronze, Green Published			2021-06-18	
J	Sterpka, A; Chen, XM				Sterpka, Ashley; Chen, Xuanmao			Neuronal and astrocytic primary cilia in the mature brain	PHARMACOLOGICAL RESEARCH			English	Article						Primary cilia; Astrocytes; Type 3 adenylyl cyclase (AC3); ARL13B; Sonic Hedgehog	GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; JOUBERT SYNDROME; ADENYLYL-CYCLASE; ARL13B VARIANT; CELL-CYCLE; CILIOGENESIS; DISRUPTION; OBESITY; SYSTEM	Primary cilia are tiny microtubule-based signaling devices that regulate a variety of physiological functions, including metabolism and cell division. Defects in primary cilia lead to a myriad of diseases in humans such as obesity and cancers. In the mature brain, both neurons and astrocytes contain a single primary cilium. Although neuronal primary cilia are not directly involved in synaptic communication, their pathophysiological impacts on obesity and mental disorders are well recognized. In contrast, research on astrocytic primary cilia lags far behind. Currently, little is known about their functions and molecular pathways in the mature brain. Unlike neurons, postnatal astrocytes retain the capacity of cell division and can become reactive and proliferate in response to various brain insults such as epilepsy, ischemia, traumatic brain injury, and neurodegenerative beta-amyloid plaques. Since primary cilia derive from the mother centrioles, astrocyte proliferation must occur in coordination with the dismantling and ciliogenesis of astrocyte cilia. In this regard, the functions, signal pathways, and structural dynamics of neuronal and astrocytic primary cilia are fundamentally different. Here we discuss and compare the current understanding of neuronal and astrocytic primary cilia.	[Sterpka, Ashley; Chen, Xuanmao] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA	Chen, XM (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Coll Life Sci & Agr, 46 Coll Rd,Rudman Hall, Durham, NH 03824 USA.	Xuanmao.Chen@unh.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH105746, AG054729, GM113131]; Cole Neuroscience and Behavior Faculty Research Award; UNH Summer TA Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM113131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH105746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG054729] Funding Source: NIH RePORTER	We thank the members of the Chen Laboratory for critical review of the manuscript. This work is supported by National Institutes of Health GrantsMH105746, AG054729 and GM113131 to X.C.; a Cole Neuroscience and Behavior Faculty Research Award to X.C.; and UNH Summer TA Research Fellowship (STAF) to A.S.	Alavi MS, 2018, BIOMED PHARMACOTHER, V98, P222, DOI 10.1016/j.biopha.2017.12.056; Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Bangs FK, 2015, NAT CELL BIOL, V17, P113, DOI 10.1038/ncb3091; Bay SN, 2018, P NATL ACAD SCI USA, V115, P1570, DOI 10.1073/pnas.1706977115; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Berbari NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106576; Berbari NF, 2013, P NATL ACAD SCI USA, V110, P7796, DOI 10.1073/pnas.1210192110; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Braun DA, 2017, COLD SPRING HARB PER, V9; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Brodsky M, 2017, BRAIN RES, V1660, P10, DOI 10.1016/j.brainres.2017.01.010; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Cao Hong, 2016, Integr Obes Diabetes, V2, P225; Carballo GB, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0220-7; Challis RC, 2015, CURR BIOL, V25, P2503, DOI 10.1016/j.cub.2015.07.065; Chen XM, 2016, BIOL PSYCHIAT, V80, P836, DOI 10.1016/j.biopsych.2015.12.012; Chen XM, 2012, J NEUROSCI, V32, P15769, DOI 10.1523/JNEUROSCI.2180-12.2012; Cousminer DL, 2013, HUM MOL GENET, V22, P2735, DOI 10.1093/hmg/ddt104; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Di Pietro C, 2017, CELL MOL NEUROBIOL, V37, P145, DOI 10.1007/s10571-016-0354-3; Doherty D, 2009, SEMIN PEDIATR NEUROL, V16, P143, DOI 10.1016/j.spen.2009.06.002; Endicott SJ, 2018, CURR BIOL, V28, P1643, DOI 10.1016/j.cub.2018.04.014; Falcon-Urrutia P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133567; Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Frost GR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170228; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Green JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046304; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451; Higginbotham H, 2012, DEV CELL, V23, P925, DOI 10.1016/j.devcel.2012.09.019; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jackson PK, 2012, CELL, V151, P697, DOI 10.1016/j.cell.2012.10.027; Kasahara K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03117-y; Kasaharaa K, 2014, ACTA MED OKAYAMA, V68, P317; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lee JH, 2010, NEUROBIOL DIS, V38, P167, DOI 10.1016/j.nbd.2009.12.022; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Lepanto P, 2016, NEUROGENESIS, V3; Liddelow S, 2015, CELL, V162, P1170, DOI 10.1016/j.cell.2015.08.029; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Loktev A. V., 2013, CELL REP; Loskutov YV, 2018, ONCOGENE, V37, P1457, DOI 10.1038/s41388-017-0049-3; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Luo JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138974; Mariani L. E., 2016, MOL BIOL CELL; Marley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046647; Miertzschke M, 2014, BIOCHEM J, V457, P301, DOI 10.1042/BJ20131097; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mok CA, 2010, CLIN GENET, V77, P18, DOI 10.1111/j.1399-0004.2009.01305.x; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moser JJ, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-40; Moser JJ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-37; Moser JJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-448; Mukhopadhyay Saikat, 2013, Cilia, V2, P1, DOI 10.1186/2046-2530-2-1; Myster DL, 2000, CURR BIOL, V10, pR302, DOI 10.1016/S0960-9822(00)00435-8; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Nordman S, 2008, INT J OBESITY, V32, P407, DOI 10.1038/sj.ijo.0803742; O'Connor Amber K, 2013, Cilia, V2, P8, DOI 10.1186/2046-2530-2-8; Oswal A, 2010, OBESITY, V18, P221, DOI 10.1038/oby.2009.228; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Parisi MA, 2009, AM J MED GENET C, V151C, P326, DOI 10.1002/ajmg.c.30229; Park J, 2018, CELL SIGNAL, V44, P138, DOI 10.1016/j.cellsig.2018.01.007; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Pillai V, 2011, BIOL PSYCHIAT, V70, P912, DOI 10.1016/j.biopsych.2011.07.016; Pitman JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110226; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Qiu Liyan, 2016, Int J Physiol Pathophysiol Pharmacol, V8, P95; Rafiullah R, 2017, EUR J HUM GENET, V25, P1324, DOI 10.1038/s41431-017-0031-0; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saeed S, 2018, NAT GENET, V50, P175, DOI 10.1038/s41588-017-0023-6; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Sarkisian MR, 2015, NEUROSCIENTIST, V21, P136, DOI 10.1177/1073858414531074; Schou KB, 2015, EMBO REP, V16, P1099, DOI 10.15252/embr.201540530; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shao J, 2017, CANCER RES, V77, P4000, DOI 10.1158/0008-5472.CAN-16-2461; Shimada IS, 2018, CELL REP, V22, P1169, DOI 10.1016/j.celrep.2018.01.018; Siljee JE, 2018, NAT GENET, V50, P180, DOI 10.1038/s41588-017-0020-9; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sipos E., 2018, J MOL NEUROSCI; Skafidas E, 2014, MOL PSYCHIATR, V19, P504, DOI 10.1038/mp.2012.126; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Song DK, 2018, DIABETES METAB J, V42, P117, DOI 10.4093/dmj.2018.42.2.117; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stergiakouli E, 2014, OBESITY, V22, P2252, DOI 10.1002/oby.20840; Sun Xun, 2012, Cilia, V1, P21, DOI 10.1186/2046-2530-1-21; Thomas S, 2015, EUR J HUM GENET, V23, P621, DOI 10.1038/ejhg.2014.156; Tong CK, 2014, P NATL ACAD SCI USA, V111, P12438, DOI 10.1073/pnas.1321425111; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Volkov P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157776; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Warrington NM, 2015, INT J EPIDEMIOL, V44, P700, DOI 10.1093/ije/dyv077; Weiner Leslie P., 2008, V438, P3, DOI 10.1007/978-1-59745-133-8_1; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Wu L, 2016, OBES REV, V17, P907, DOI 10.1111/obr.12430; Yoshimura K, 2011, GLIA, V59, P333, DOI 10.1002/glia.21105; Youn YH, 2018, AM J PATHOL, V188, P11, DOI 10.1016/j.ajpath.2017.08.031; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zhang Z., 2017, MOL CELL BIOL, V37; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	122	15	16	1	18	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	NOV	2018	137						114	121		10.1016/j.phrs.2018.10.002			8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	HB8QS	WOS:000451356100011	30291873	Green Accepted			2021-06-18	
J	Carteron, L; Solari, D; Patet, C; Quintard, H; Miroz, JP; Bloch, J; Daniel, RT; Hirt, L; Eckert, P; Magistretti, PJ; Oddo, M				Carteron, Laurent; Solari, Daria; Patet, Camille; Quintard, Herve; Miroz, John-Paul; Bloch, Jocelyne; Daniel, Roy T.; Hirt, Lorenz; Eckert, Philippe; Magistretti, Pierre J.; Oddo, Mauro			Hypertonic Lactate to Improve Cerebral Perfusion and Glucose Availability After Acute Brain Injury	CRITICAL CARE MEDICINE			English	Article						brain metabolism; cerebral microdialysis; cerebral perfusion; glucose; hypertonic; lactate	INTRACRANIAL HYPERTENSIVE EPISODES; NUCLEAR-MAGNETIC-RESONANCE; IN-VIVO EVIDENCE; BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; ENERGY-METABOLISM; SODIUM LACTATE; MICRODIALYSIS; OXYGEN; ASTROCYTES	Objectives: Lactate promotes cerebral blood flow and is an efficient substrate for the brain, particularly at times of glucose shortage. Hypertonic lactate is neuroprotective after experimental brain injury; however, human data are limited. Design: Prospective study (clinicaltrials.gov NCT01573507). Setting: Academic ICU. Patients: Twenty-three brain-injured subjects (13 traumatic brain injury/10 subarachnoid hemorrhage; median age, 59 yr [41-65 yr]; median Glasgow Coma Scale, 6 [3-7]). Interventions: Three-hour IV infusion of hypertonic lactate (sodium lactate, 1,000 mmol/L; concentration, 30 mu mol/kg/min) administered 39 hours (26-49hr) from injury. Measurements and Main Results: We examined the effect of hypertonic lactate on cerebral perfusion (using transcranial Doppler) and brain energy metabolism (using cerebral microdialysis). The majority of subjects (13/23 = 57%) had reduced brain glucose availability (baseline pretreatment cerebral microdialysis glucose, < 1 mmol/L) despite normal baseline intracranial pressure (10 [7-15] mm Hg). Hypertonic lactate was associated with increased cerebral microdialysis lactate (+55% [31-80%]) that was paralleled by an increase in middle cerebral artery mean cerebral blood flow velocities (+36% [21-66%]) and a decrease in pulsatility index (-21% [13-26%]; all p < 0.001). Cerebral microdialysis glucose increased above normal range during hypertonic lactate (+42% [30-78%]; p < 0.05); reduced brain glucose availability correlated with a greater improvement of cerebral microdialysis glucose (Spearman r = -0.53; p = 0.009). No significant changes in cerebral perfusion pressure, mean arterial pressure, systemic carbon dioxide, and blood glucose were observed during hypertonic lactate (all p > 0.1). Conclusions: This is the first clinical demonstration that hypertonic lactate resuscitation improves both cerebral perfusion and brain glucose availability after brain injury. These cerebral vascular and metabolic effects appeared related to brain lactate supplementation rather than to systemic effects.	[Carteron, Laurent; Solari, Daria; Patet, Camille; Miroz, John-Paul; Eckert, Philippe; Oddo, Mauro] Univ Lausanne, CHUV, Dept Intens Care Med, Lausanne, Switzerland; [Carteron, Laurent; Solari, Daria; Patet, Camille; Miroz, John-Paul; Oddo, Mauro] Univ Lausanne, CHUV, Neurosci Crit Care Res Grp, Lausanne, Switzerland; [Carteron, Laurent] Univ Bourgogne Franche Comte, Univ Hosp Besancon, Dept Anesthesiol & Intens Care Med, Besancon, France; [Quintard, Herve] Nice Univ Hosp, Dept Anesthesia & Intens Care, Nice, France; [Bloch, Jocelyne; Daniel, Roy T.] Univ Lausanne, Dept Clin Neurosci, Serv Neurosurg, CHUV, Lausanne, Switzerland; [Hirt, Lorenz] Univ Lausanne, Dept Clin Neurosci, Serv Neurol, CHUV, Lausanne, Switzerland; [Magistretti, Pierre J.] King Abdullah Univ Sci & Technol KAUST, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Magistretti, Pierre J.] CHU Vaudois, Dept Psychiat, Ctr Neurosci Psychiat, Lausanne, Switzerland; [Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Neuroenerget & Cellular Dynam, Lausanne, Switzerland	Oddo, M (corresponding author), Univ Lausanne, CHUV, Dept Intens Care Med, Lausanne, Switzerland.; Oddo, M (corresponding author), Univ Lausanne, CHUV, Neurosci Crit Care Res Grp, Lausanne, Switzerland.	mauro.oddo@chuv.ch	MIROZ, John-Paul/AAR-7445-2020; Hirt, Lorenz/G-3553-2010; Bloch, Jocelyne/A-9668-2017	Hirt, Lorenz/0000-0002-2921-5000; Magistretti, Pierre Julius/0000-0002-6678-320X; Bloch, Jocelyne/0000-0002-6405-1590	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [320030_138191, 32003B_155957]; Novartis Foundation for Biomedical Research; Societe Francaise d'Anesthesie et de Reanimation; Fondation des Gueules Cassees; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission	Supported, in part, by grants from the Swiss National Science Foundation (320030_138191 and 32003B_155957 [to Dr. Oddo]), the Novartis Foundation for Biomedical Research (to Dr. Oddo), and the Societe Francaise d'Anesthesie et de Reanimation and the Fondation des Gueules Cassees (both to Dr. Carteron).; Dr. Hirt received other support from Boehringer Ingelheim (speaker fees and travel grants, not related to this work) and research grants not in relation with this work from the Swiss Science Foundation, the Biaggi Foundation, and the Juchum Foundation. Dr. Oddo received support for article research from the Swiss National Science Foundation. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Bergersen LH, 2015, J CEREBR BLOOD F MET, V35, P176, DOI 10.1038/jcbfm.2014.206; Bisri Tatang, 2016, Asian J Neurosurg, V11, P151, DOI 10.4103/1793-5482.145375; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carteron L, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00325; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Gordon GRJ, 2016, ADV EXP MED BIOL, V903, P209, DOI 10.1007/978-1-4899-7678-9_15; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Martin A, 2009, CURR NEUROVASC RES, V6, P82, DOI 10.2174/156720209788185650; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Patet C, 2017, J NEUROL NEUROSUR PS, V88, P332, DOI 10.1136/jnnp-2016-313766; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; Roquilly A, 2013, CRIT CARE, V17, DOI 10.1186/cc12686; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Sanchez-Guerrero A, 2017, J CEREBR BLOOD F MET, V37, P2742, DOI 10.1177/0271678X16674222; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; Sonneville R, 2015, INTENS CARE MED, V41, P192, DOI 10.1007/s00134-014-3577-0; Steinman MQ, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2010.00010, 10.3389/fnint.2016.00010]; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; Vafaee MS, 2012, J CEREBR BLOOD F MET, V32, P1859, DOI 10.1038/jcbfm.2012.89; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111	47	15	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2018	46	10					1649	1655		10.1097/CCM.0000000000003274			7	Critical Care Medicine	General & Internal Medicine	GT4NA	WOS:000444480100019	29923931				2021-06-18	
J	Charriaut-Marlangue, C; Leconte, C; Csaba, Z; Chafa, L; Pansiot, J; Talatizi, M; Simon, K; Moretti, R; Marchand-Leroux, C; Baud, O; Besson, VC				Charriaut-Marlangue, Christiane; Leconte, Claire; Csaba, Zsolt; Chafa, Linda; Pansiot, Julien; Talatizi, Mustapha; Simon, Kristin; Moretti, Raffaella; Marchand-Leroux, Catherine; Baud, Olivier; Besson, Valerie C.			Sex differences in the effects of PARP inhibition on microglial phenotypes following neonatal stroke	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Amygdala; Cortex; Microglial phenotype; Neonatal stroke; Neurobehavioral deficits; Poly (ADP-ribose) polymerase inhibitor	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; CEREBRAL-ISCHEMIA; HYPOXIA-ISCHEMIA; MEMORY DEFICITS; M2 MICROGLIA; FEMALE; INFLAMMATION; ACTIVATION; DIMORPHISM	Neonatal acute ischemic stroke is a cause of neonatal brain injury that occurs more frequently in males, resulting in associated neurobehavioral disorders. The bases for these sex differences are poorly understood but might include the number, morphology and activation of microglia in the developing brain when subjected to stroke. Interestingly, poly (ADP-ribose) polymerase (PARP) inhibition preferentially protects males against neonatal ischemia. This study aims to examine the effects of PJ34, a PARP inhibitor, on microglial phenotypes at 3 and 8 days and on neurobehavioral disorders in adulthood for both male and female P9 mice subjected to permanent middle cerebral artery occlusion (pMCAo). PJ34 significantly reduced the lesion size by 78% and reduced the density of CX3CR1(gfp)-labeled microglial cells by 46% when examined 3 days after pMCAo in male but not in female mice. Eight days after pMCAo, the number of Iba1(+)/Cox-2(+) cells did not differ between male and female mice in the cortical peri-infarct region. In the amygdala, Iba1(+)/Cox-2(+) (Ml-like) cell numbers were significantly decreased in PJ34-treated males but not in females. Conversely, Iba1(+)/Arg-1(+) (M2-like) and Arg-1(+)/Cox-2(+) (Mtransitional) cell numbers were significantly increased in P134-treated females. Regarding neurobehavioral disorders during adulthood, pMCAo induced a motor coordination deficit and a spatial learning deficit in female mice only. PJ34 prevented MBP fibers, motor coordination and learning disorders during adulthood in female mice. Our data show significant sex differences in the effects of PARP inhibition on microglia phenotypes following neonatal ischemia, associated with improved behavior and myelination during adulthood in females only. Our findings suggest that modulating microglial phenotypes may play key roles in behavior disorders and white matter injury following neonatal stroke.	[Charriaut-Marlangue, Christiane; Csaba, Zsolt; Chafa, Linda; Pansiot, Julien; Talatizi, Mustapha; Moretti, Raffaella; Baud, Olivier; Besson, Valerie C.] Univ Paris Diderot, INSERM, PROTECT U1141, Sorbonne Paris Cite,Hop Robert Debre, 48 Blvd Serurier, F-75019 Paris, France; [Leconte, Claire; Simon, Kristin; Marchand-Leroux, Catherine; Besson, Valerie C.] Univ Paris 05, Pharmacol Circulat Cerebrate EA4475, Fac Pharm Paris, Sorbonne Paris Cite, 4 Ave Observ, F-75006 Paris, France; [Baud, Olivier] Childrens Univ Hosp Geneva, Div Neonatol & Pediat Intens Care, Geneva, Switzerland; [Baud, Olivier] Univ Geneva, Geneva, Switzerland	Besson, VC (corresponding author), Univ Paris 05, Pharmacol Circulat Cerebrate EA4475, Fac Pharm Paris, Sorbonne Paris Cite, 4 Ave Observ, F-75006 Paris, France.	valerie.besson@parisdescartes.fr	, CHARRIAUT-MARLANGUE/H-3249-2019; BESSON, VALERIE/AAZ-9989-2020	BESSON, VALERIE/0000-0002-1491-2380	Fondation des Gueules Cassees; Fondation pour la Recherche sur les AVC	We thank Marielle Young-Ten for genotyping and the animal platform team (CRP2 - UMS 3612 CNRS - US25 INSERM-IRD, Faculte de Pharmacie de Paris, Universite Paris Descartes, Paris, France) for animal care. This work was supported by Fondation des Gueules Cassees (VCB; CML; www.gueules-cassees.asso.fr/) and Fondation pour la Recherche sur les AVC (VCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 2017, ACTA NEUROPATHOL, V134, P331, DOI 10.1007/s00401-017-1718-6; Bai P, 2012, FEBS LETT, V586, P3771, DOI 10.1016/j.febslet.2012.09.026; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Berger NA, 2018, BRIT J PHARMACOL, V175, P192, DOI 10.1111/bph.13748; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Charriaut-Marlangue C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010061; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Cismaru AL, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00055; Coq JO, 2016, DEV MED CHILD NEUROL, V58, P7, DOI 10.1111/dmcn.13040; Couturier JY, 2003, EXP NEUROL, V184, P973, DOI 10.1016/S0014-4886(03)00367-4; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Dispersyn G, 2017, J SLEEP RES, V26, P531, DOI 10.1111/jsr.12541; Ducrocq S, 2000, J NEUROCHEM, V74, P2504, DOI 10.1046/j.1471-4159.2000.0742504.x; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Faustino JV, 2011, J NEUROSCI, V31, P12992, DOI 10.1523/JNEUROSCI.2102-11.2011; Ferrazzano P, 2013, CNS NEUROL DISORD-DR, V12, P338, DOI 10.2174/1871527311312030007; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Frisch D, 2013, DEV DISABIL RES REV, V18, P84, DOI 10.1002/ddrr.1131; Golomb MR, 2009, SEMIN FETAL NEONAT M, V14, P318, DOI 10.1016/j.siny.2009.07.003; Golomb MR, 2004, J CHILD NEUROL, V19, P493, DOI 10.1177/08830738040190070301; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; Hamby AM, 2007, STROKE, V38, P632, DOI 10.1161/01.STR.0000250742.61241.79; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Hu XJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050925; Im HY, 2018, HUM BRAIN MAPP, V39, P2725, DOI 10.1002/hbm.24035; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Joly LM, 2003, PEDIATR RES, V53, P776, DOI 10.1203/01.PDR.0000059751.00465.F6; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Krishnan ML, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00422-w; Liu FD, 2011, STROKE, V42, P1090, DOI 10.1161/STROKEAHA.110.594861; Mallard C, 2018, NEUROSCIENCE, DOI [10.1016/j.neuroscience.S0306-4522(18)30039-3, DOI 10.1016/J.NEUROSCIENCE]; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moretti R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0560-4; Nelson KB, 2007, STROKE, V38, P742, DOI 10.1161/01.STR.0000247921.97794.5e; Nissen JC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030561; Pereira LO, 2008, BRAIN RES, V1218, P257, DOI 10.1016/j.brainres.2008.04.010; Pimentel-Coelho PM, 2013, J NEUROSCI, V33, P11556, DOI 10.1523/JNEUROSCI.0535-13.2013; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sanches EF, 2015, NEUROSCIENCE, V290, P581, DOI 10.1016/j.neuroscience.2014.12.074; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Sigurdardottir S, 2010, DEV MED CHILD NEUROL, V52, P1056, DOI 10.1111/j.1469-8749.2010.03698.x; Smith AL, 2015, BRAIN SCI, V5, P220, DOI 10.3390/brainsci5020220; Spychala MS, 2017, J NEUROSCI RES, V95, P462, DOI 10.1002/jnr.23962; Suenaga J, 2015, EXP NEUROL, V272, P109, DOI 10.1016/j.expneurol.2015.03.021; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Taylor GT, 2017, ACTA NEUROBIOL EXP, V77, P254; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Tsuji M, 2010, EXP NEUROL, V226, P285, DOI 10.1016/j.expneurol.2010.09.002; Tyng CM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01454; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	61	15	15	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2018	73						375	389		10.1016/j.bbi.2018.05.022			15	Immunology; Neurosciences; Psychiatry	Immunology; Neurosciences & Neurology; Psychiatry	GU6QO	WOS:000445440900039	29852289				2021-06-18	
J	Howard, L; Dumkrieger, G; Chong, CD; Ross, K; Berisha, V; Schwedt, TJ				Howard, Levi; Dumkrieger, Gina; Chong, Catherine D.; Ross, Katherine; Berisha, Visar; Schwedt, Todd J.			Symptoms of Autonomic Dysfunction Among Those With Persistent Posttraumatic Headache Attributed to Mild Traumatic Brain Injury: A Comparison to Migraine and Healthy Controls	HEADACHE			English	Article						posttraumatic headache; migraine; traumatic brain injury; autonomic dysfunction; orthostatic intolerance	NERVOUS-SYSTEM FUNCTION; US SOLDIERS; CONCUSSION; EXPLOSIONS; MODEL; PAIN	BackgroundObjectiveMost persistent posttraumatic headaches (PPTH) have a phenotype that meets diagnostic criteria for migraine or probable migraine. Although symptoms of autonomic dysfunction have been well described among those with migraine, the presence and relative severity of such symptoms among those with PPTH have yet to be reported. The objective of this study was to assess and compare symptoms of autonomic dysfunction among those with PPTH attributed to mild traumatic brain injury (mTBI) vs migraine vs healthy controls using Composite Autonomic Symptom Score 31 (COMPASS-31) questionnaire scores. MethodsResultsIndividuals with PPTH (n=56) (87.5% of whom had a migraine/probable migraine phenotype), migraine (n=30), and healthy controls (n=36) were prospectively assessed in this cross-sectional cohort study using the COMPASS-31 questionnaire. Total COMPASS-31 scores and individual domain scores (bladder, gastrointestinal, orthostatic intolerance, pupillomotor, secretomotor, vasomotor) were compared between subject groups. COMPASS-31 mean total weighted score was 37.2215.44 in the PPTH group, 27.15 +/- 14.37 in the migraine group, and 11.67 +/- 8.98 for healthy controls. COMPASS-31 mean weighted total scores were significantly higher in those with PPTH vs migraine (P=.014), for PPTH vs healthy controls (P=.001), and for migraine vs healthy controls (P=.001). Those with PPTH had numerically higher scores for all COMPASS-31 domains compared to those with migraine, and the domain scores were significantly higher for orthostatic intolerance (PPTH=4.80 +/- 2.47 vs migraine=3.33 +/- 2.31, P=.027) and bladder (PPTH=1.14 +/- 1.45 vs migraine=0.47 +/- 0.73, P=.020). Among individuals with PPTH, post hoc correlations indicated a positive association between number of total lifetime TBIs with total weighted COMPASS-31 scores (rho=0.32, P=.020), between years lived with headache and vasomotor domain subscores (rho=0.27; P=.044), and between headache frequency with vasomotor domain subscores (rho=0.27; P=.041). ConclusionsSymptoms of autonomic dysfunction were greatest among those with PPTH compared to migraine and healthy controls. Among individuals with PPTH, number of lifetime TBIs was associated with greater symptoms of autonomic dysfunction, while greater headache burden was associated with higher vasomotor domain autonomic dysfunction subscores, potentially indicating that PPTH patients with higher disease burden have an increased risk for having autonomic dysfunction. Symptoms of autonomic dysfunction should be ascertained during the clinical management of patients with PPTH and might be a characteristic that helps differentiate PPTH from migraine.	[Howard, Levi; Dumkrieger, Gina; Chong, Catherine D.; Schwedt, Todd J.] Mayo Clin, Phoenix, AZ USA; [Ross, Katherine] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Berisha, Visar] Arizona State Univ, Tempe, AZ USA	Schwedt, TJ (corresponding author), Mayo Clin, Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	Schwedt.todd@mayo.edu		Berisha, Visar/0000-0001-8804-8874; Dumkrieger, Gina/0000-0001-9519-5370	Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program [W81XWH-15-1-0286]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program under Award No. W81XWH-15-1-0286. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; APPEL S, 1992, HEADACHE, V32, P10, DOI 10.1111/j.1526-4610.1992.hed3201010.x; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Cambron M, 2014, HEADACHE, V54, P655, DOI 10.1111/head.12139; Chong CD, 2018, HEADACHE, V58, P53, DOI 10.1111/head.13223; Classification Committee of the International Headache Society, 2018, INT CLASS HEAD DIS, P1; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; CORTELLI P, 1991, HEADACHE, V31, P457, DOI 10.1111/j.1526-4610.1991.hed3107457.x; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Ettlin D., 2013, INT CLASSIFICATION H, P629; Ghodadra A, 2016, AM J NEURORADIOL, V37, P274, DOI 10.3174/ajnr.A4505; HAVANKAKANNIAINEN H, 1988, HEADACHE, V28, P465, DOI 10.1111/j.1526-4610.1988.hed2807465.x; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Jouzdani SR, 2014, ENVIRON HEALTH PREV, V19, P422, DOI 10.1007/s12199-014-0409-3; Kanjwal K, 2010, CARDIOL J, V17, P482; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2016, FRONT NEUROL, V13, P7; LasFountaine MF, 2017, INT J PSYCHOPHYSIOL; Lau MK, 2013, DTK DUNNET TUKEY KRA; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Matei D, 2015, EUR REV MED PHARMACO, V19, P3922; Miglis MG, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0671-y; Moye LS, 2017, J NEUROSCI RES, V95, P1347, DOI 10.1002/jnr.24001; Muller M, 2005, STROKE, V36, P1886, DOI 10.1161/01.STR.0000177886.94134.92; POGACNIK T, 1993, HEADACHE, V33, P545, DOI 10.1111/j.1526-4610.1993.hed3310545.x; R Core Team, 2016, R LANG ENV STAT COMP; Rabner J, 2016, CLIN AUTON RES, V26, P455, DOI 10.1007/s10286-016-0385-3; Rea NA, 2017, J NEUROL SCI, V377, P35, DOI 10.1016/j.jns.2017.03.032; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sarmento EM, 2007, HEADACHE, V47, P799; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Shechter A, 2002, NEUROLOGY, V58, P422, DOI 10.1212/WNL.58.3.422; Sletten DM, 2012, MAYO CLIN PROC, V87, P1196, DOI 10.1016/j.mayocp.2012.10.013; Suarez GA, 1999, NEUROLOGY, V52, P523, DOI 10.1212/WNL.52.3.523; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Thijs RD, 2006, NEUROLOGY, V66, P1034, DOI 10.1212/01.wnl.0000204186.43597.66; Treister R, 2015, EUR J NEUROL, V22, P1124, DOI 10.1111/ene.12717; Truong JQ, 2018, J OPTOM, V11, P93, DOI 10.1016/j.optom.2016.12.005; Wang JW, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0973-4; Yakinci C, 1999, PEDIATR INT, V41, P529, DOI 10.1046/j.1442-200x.1999.01101.x	48	15	15	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	OCT	2018	58	9					1397	1407		10.1111/head.13396			11	Clinical Neurology	Neurosciences & Neurology	GY8AZ	WOS:000448841600006	30156267	Bronze			2021-06-18	
J	Meletti, S; Lucchi, C; Monti, G; Giovannini, G; Bedin, R; Trenti, T; Rustichelli, C; Biagini, G				Meletti, Stefano; Lucchi, Chiara; Monti, Giulia; Giovannini, Giada; Bedin, Roberta; Trenti, Tommaso; Rustichelli, Cecilia; Biagini, Giuseppe			Low levels of progesterone and derivatives in cerebrospinal fluid of patients affected by status epilepticus	JOURNAL OF NEUROCHEMISTRY			English	Article						allopregnanolone; cerebrospinal fluid; liquid chromatography-electrospray tandem mass spectrometry (LC-MS/MS); progesterone; status epilepticus; gamma-aminobutyric acid type A (GABA(A)) receptor	REFRACTORY STATUS EPILEPTICUS; NEUROACTIVE STEROID-LEVELS; TRAUMATIC BRAIN-INJURY; PILOCARPINE MODEL; CLINICAL-TRIAL; EPILEPSY; ALLOPREGNANOLONE; NEUROSTEROIDS; BIOCHEMISTRY; INDUCTION	Neurosteroids such as allopregnanolone may play a role in epilepsy as positive modulators of inhibitory currents mediated by gamma-aminobutyric acid type A (GABA(A)) receptor. Indeed, these molecules have been consistently shown to be anticonvulsants in animal models, but their role is still unclear in patients. For this reason, we investigated neurosteroids in the cerebrospinal fluid (CSF) of patients with status epilepticus (SE) by liquid chromatography tandem-mass spectrometry. Patients were retrospectively identified within subjects who received a lumbar puncture in the 2007-2017 period. Seventy-three patients (median age 65, ranging from 13 to 94 years; 67% women) with SE were evaluated. Controls (n = 52, median age 53, ranging from 16 to 93 years; 65% women) were patients presenting with symptoms for which a lumbar puncture was required by clinical guidelines, and who were negative at the end of the diagnostic work-up. Progesterone was 64% lower in patients with SE (p < 0.001). With respect to progesterone, upstream pregnenolone sulfate and pregnenolone did not change. Instead, downstream 5 alpha-dihydroprogesterone, pregnanolone and allopregnanolone were, respectively, 49% (p < 0.001), 21% (p < 0.01) and 37% (p < 0.001) lower than in controls. Duration or type of SE, age and sex did not consistently affect CSF neurosteroid levels in the SE cohort. Instead, pregnenolone sulfate (Spearman's rho = 0.4335, p < 0.01), allopregnanolone (rho = 0.4121, p < 0.05) and pregnanolone (rho = 0.592, p < 0.001) levels significantly increased by aging in controls. We conclude that neurosteroidogenesis is defective in patients with SE.	[Meletti, Stefano; Lucchi, Chiara; Bedin, Roberta; Biagini, Giuseppe] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Meletti, Stefano; Lucchi, Chiara; Monti, Giulia; Giovannini, Giada; Biagini, Giuseppe] AOU Modena, Civil Hosp Baggiovara, Dept Neurosci, Modena, Italy; [Meletti, Stefano; Biagini, Giuseppe] Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Modena, Italy; [Trenti, Tommaso] AUSL Modena, Dept Lab Med & Pathol Anat, Modena, Italy; [Rustichelli, Cecilia] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy	Biagini, G (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Via Campi 287, I-41125 Modena, Italy.	gbiagini@unimore.it	Biagini, Giuseppe/I-3227-2013; Trenti, Tommaso/K-8457-2016	Biagini, Giuseppe/0000-0002-7130-2511; Trenti, Tommaso/0000-0001-8093-4011	Ministry of Health of ItalyMinistry of Health, Italy [RF-2011-02350485]; Foundation 'Fondazione Cassa di Risparmio di Modena - FCRM'; Italian Ministry of HealthMinistry of Health, Italy	This study has been supported by Ministry of Health of Italy (RF-2011-02350485). The HPLC-ESI-TQ at the 'Centro Interdipartimentale Grandi Strumenti - CIGS' of the University of Modena and Reggio Emilia was granted by the Foundation 'Fondazione Cassa di Risparmio di Modena - FCRM'. C. Lucchi, G. Monti, G. Giovannini, R. Bedin and C. Rustichelli report no disclosures relevant to the manuscript. S. Meletti, T. Trenti, and G. Biagini received grant support from the Italian Ministry of Health.	Betjemann JP, 2015, LANCET NEUROL, V14, P615, DOI 10.1016/S1474-4422(15)00042-3; Biagini G, 2009, EPILEPSIA, V50, P53, DOI 10.1111/j.1528-1167.2008.01971.x; Broomall E, 2014, ANN NEUROL, V76, P911, DOI 10.1002/ana.24295; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Gaspard N, 2015, NEUROLOGY, V85, P1604, DOI 10.1212/WNL.0000000000001940; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; Herzog AG, 2012, NEUROLOGY, V78, P1959, DOI 10.1212/WNL.0b013e318259e1f9; Herzog AG, 2015, SEIZURE-EUR J EPILEP, V28, P18, DOI 10.1016/j.seizure.2015.02.024; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; Melcangi RC, 2017, J STEROID BIOCHEM, V171, P229, DOI 10.1016/j.jsbmb.2017.04.003; Meletti S, 2017, EPILEPSIA, V58, pE16, DOI 10.1111/epi.13625; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Minicucci F, 2006, EPILEPSIA, V47, P9, DOI 10.1111/j.1528-1167.2006.00870.x; Owen DR, 2017, BIOCHEM J, V474, P3985, DOI 10.1042/BCJ20170648; Ramanujam B, 2016, EPILEPTIC DISORD, V18, P101, DOI 10.1684/epd.2016.0792; Rogawski MA, 2013, EPILEPSIA, V54, P93, DOI 10.1111/epi.12289; Rosenthal ES, 2017, ANN NEUROL, V82, P342, DOI 10.1002/ana.25008; Shorvon S, 2011, BRAIN, V134, P2802, DOI 10.1093/brain/awr215; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smeland OB, 2013, J CEREBR BLOOD F MET, V33, P1090, DOI 10.1038/jcbfm.2013.54; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Storbeck KH, 2015, J STEROID BIOCHEM, V151, P66, DOI 10.1016/j.jsbmb.2014.11.024; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Vaitkevicius H, 2017, ANN CLIN TRANSL NEUR, V4, P411, DOI 10.1002/acn3.408; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Wigginton JG, 2010, CRIT CARE MED, V38, pS620, DOI 10.1097/CCM.0b013e3181f243a9; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	32	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2018	147	2					275	284		10.1111/jnc.14550			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	GZ5VX	WOS:000449499000010	30005125	Bronze			2021-06-18	
J	Liston, K; McDowell, M; Malcolm, D; Scott-Bell, A; Waddington, I				Liston, Katie; McDowell, Mark; Malcolm, Dominic; Scott-Bell, Andrea; Waddington, Ivan			On being 'head strong': The pain zone and concussion in non-elite rugby union	INTERNATIONAL REVIEW FOR THE SOCIOLOGY OF SPORT			English	Article						amateur; concussion; injury; pain; policy; risk; rugby union	INJURY; CULTURE; PLAYERS; SPORT; UNCERTAINTY; MANAGEMENT; CLINICIAN; BODY; RISK	In recent years there has been growing concern about concussion in sport in general and rugby union in particular. The qualitative study reported here draws on interviews (n=20) with adult players in non-elite club rugby union in Ireland in order to explore the frames of reference within which they perceive, give meaning to and manage concussion. Within a sporting subculture which emphasizes lay sporting values - particularly the value of 'playing hurt' - and which reflects a functional view of injury, non-elite players tend to display an irreverent attitude towards concussion which encourages risky behaviours and underplays, ignores or denies the significance of concussion. We analogously describe these beliefs and actions as being 'head strong'. The paper concludes by identifying the contextual contingencies which make the regulation of injuries in rugby union so difficult and by establishing some core principles of public health education campaigns that might be deployed to militate against the high incidence of concussive injury in future.	[Liston, Katie; McDowell, Mark] Ulster Univ, Jordanstown, Newtownabbey, North Ireland; [Malcolm, Dominic] Loughborough Univ Technol, Loughborough, Leics, England; [Scott-Bell, Andrea] Northumbria Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Waddington, Ivan] Norwegian Sch Sport Sci, Oslo, Norway	Liston, K (corresponding author), Ulster Univ, Sch Sport, Jordanstown BT37 0QB, Newtownabbey, North Ireland.	k.liston@ulster.ac.uk		Scott-Bell, Andrea/0000-0002-1022-9023			Adamson C, 1997, SOCIOL HEALTH ILL, V19, P133, DOI 10.1111/1467-9566.ep10934391; Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Archbold P, 2015, BRIT J SPORTS MED, V51; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Bette K.-H., 2004, DOPING PUBLIC POLICY, P101; British Medical Association (BMA), 2002, DRUGS SPORT PRESSURE; Conlon T, 2016, SUNDAY INDEPENDENT; Dunning E., 2008, QUEST EXCITEMENT SPO, V7, P242; Fenton LT, 2010, RES Q EXERCISE SPORT, V81, P212; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Francis N, 2016, SUNDAY INDEPENDENT; Freidson E., 1970, PROFESSION MED; Heikkinen H, 2010, SOC SCI MED, V71, P877, DOI 10.1016/j.socscimed.2010.05.036; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Howe D., 2004, SPORT PROFESSIONALIS; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Joint Committee on Health and Children, 2014, REP CONC SPORT; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V75; Liston K, 2014, NORBERT ELIAS AND EMPIRICAL RESEARCH, P197; Liston K, 2006, SPORT SOC, V9, P388, DOI 10.1080/17430430600673407; Malcolm D, 2002, SOCIOL SPORT J, V19, P149, DOI 10.1123/ssj.19.2.149; Malcolm D, 2006, SOCIOL SPORT J, V23, P376, DOI 10.1123/ssj.23.4.376; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; McLoughlin R, 2014, IRFU SUBMISSION OIRE; Murphy P, 2006, SPORT SOC, V9, P542, DOI 10.1080/17430430600768785; Naidoo J., 2000, HLTH PROMOTION FDN P; O'Driscoll B, 2015, THE TEST; O'Reilly P, 2016, SUNDAY TIMES; Piggin J, 2016, BRIT J SPORTS MED, V51; PILL RM, 1990, MAKING CHANGES STUDY; Pollock A, 2014, TACKLING RUGBY WHAT; Raftery M, 2016, BRIT J SPORTS MED, V51; Rebar C. R, 2011, UNDERSTANDING NURSIN; Roderick M., 2000, International Review for the Sociology of Sport, V35, P165, DOI 10.1177/101269000035002003; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; SCIC, 2016, OP LETT PREV INJ CHI; Scott A., 2012, SOCIAL ORG SPORTS ME, P227; Theberge N, 2007, ROUTL CRIT STUD SPOR, P176; Waddington I., 2000, SPORT HLTH DRUGS; Waddington I., 2016, PERFORMANCE ENHANCEM, V4, P80, DOI DOI 10.1016/J.PEH.2016.03.004; Waddington I., 2012, SOCIAL ORG SPORTS ME, P204; YOUNG K, 1993, SOCIOL SPORT J, V10, P373, DOI 10.1123/ssj.10.4.373	42	15	15	0	12	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1012-6902	1461-7218		INT REV SOCIOL SPORT	Int. Rev. Sociol. Sport	SEP	2018	53	6					668	684		10.1177/1012690216679966			17	Hospitality, Leisure, Sport & Tourism; Sociology	Social Sciences - Other Topics; Sociology	GR5YV	WOS:000442719900002		Green Accepted			2021-06-18	
J	Huang, WH; Bai, XS; Stopper, L; Catalin, B; Cartarozzi, LP; Scheller, A; Kirchhoff, F				Huang, Wenhui; Bai, Xianshu; Stopper, Laura; Catalin, Bogdan; Cartarozzi, Luciana Politti; Scheller, Anja; Kirchhoff, Frank			During Development NG2 Glial Cells of the Spinal Cord are Restricted to the Oligodendrocyte Lineage, but Generate Astrocytes upon Acute Injury	NEUROSCIENCE			English	Article						NG2 glia; differentiation; spinal cord; oligodendrocytes; astrocytes; spinal cord injury	CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; PROGENITOR CELLS; ADULT CNS; NG2-GLIA; FATE; MICE; DIFFERENTIATION; PLASTICITY; PRODUCE	NG2 glia are self-renewal cells widely populating the entire central nervous system (CNS). The differentiation potential of NG2 glia in the brain has been systematically studied. However, the fate of NG2 glia in the spinal cord during development and after injury is still unclear. Here, we took advantage of faithful expression of Cre in NG2-CreERT2 knock-in mice to demonstrate that spinal NG2 glia remain committed to the oligodendrocyte (OL) lineage and generate OLs, but not astrocytes or neurons, during development. However, we found significant age- and region dependent differences in differentiation into OLs. Embryonic or neonatal NG2 glia generated more than 90% of the white matter OLs, but only 50% (embryonic) or 75% (neonatal) of gray matter OLs. Such differences disappeared after myelin completion coinciding with a decrease in the differentiation rate. While we never detected the generation of astrocytes from NG2 glia during spinal cord development, we found a small portion of NG2 glia could generate astrocytes in adult spinal cord upon acute traumatic injury. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Huang, Wenhui; Bai, Xianshu; Stopper, Laura; Catalin, Bogdan; Cartarozzi, Luciana Politti; Scheller, Anja; Kirchhoff, Frank] Univ Saarland, CIPMM, Mol Physiol, D-66421 Homburg, Germany; [Catalin, Bogdan] Univ Med & Pharm Craiova, Expt Res Ctr Normal & Pathol Aging, Craiova 200349, Romania; [Cartarozzi, Luciana Politti] Univ Estadual Campinas, UNICAMP, Lab Nerve Regenerat, Cidade Univ Zeferino Vaz, BR-13083862 Campinas, SP, Brazil	Huang, WH; Kirchhoff, F (corresponding author), Univ Saarland, CIPMM, Mol Physiol, D-66421 Homburg, Germany.	wenhui.huang@uks.eu; frank.kirchhoff@uks.eu	Catalin, Bogdan/M-6683-2019; Scheller, Anja/B-8577-2018; Cartarozzi, Luciana P/S-5717-2018; Catalin, Bogdan/G-2565-2013; Kirchhoff, Frank/B-9335-2008; Huang, Wenhui/M-6227-2013; Bai, Xianshu/AAN-8029-2021	Scheller, Anja/0000-0001-8955-2634; Cartarozzi, Luciana P/0000-0003-1942-800X; Catalin, Bogdan/0000-0002-5706-8722; Kirchhoff, Frank/0000-0002-2324-2761; Huang, Wenhui/0000-0001-9865-0375; Bai, Xianshu/0000-0002-4758-1645	Deutsche Forschungsgemeinschaft DFGGerman Research Foundation (DFG) [SFB 894, SPP 1757, FOR 2289]; European Commission EC-H2020 MSCA-ITN EU-GliaPhD; EC-H2020 FET ProAct Neurofibers; University of Saarland	This work was supported by grants from Deutsche Forschungsgemeinschaft DFG SFB 894, SPP 1757 and FOR 2289 to F.K., from European Commission EC-H2020 MSCA-ITN EU-GliaPhD; and EC-H2020 FET ProAct Neurofibers to F.K.. A.S. W.H. and X.B. were supported by HOMFOR 2015, HOMFORexzellenz2016 and 2017 from the University of Saarland, respectively.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Assinck P, 2017, J NEUROSCI, V37, P8635, DOI 10.1523/JNEUROSCI.2409-16.2017; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041; Garcia-Marques J, 2014, J NEUROSCI, V34, P2305, DOI 10.1523/JNEUROSCI.3060-13.2014; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; Hesp ZC, 2018, J NEUROSCI, V38, P1366, DOI 10.1523/JNEUROSCI.3953-16.2017; Hill RA, 2014, GLIA, V62, P1195, DOI 10.1002/glia.22664; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Huang WH, 2014, GLIA, V62, P896, DOI 10.1002/glia.22648; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2016, BRAIN RES, V1638, P116, DOI 10.1016/j.brainres.2015.08.013; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sakry D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001993; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Tognatta R, 2016, GLIA; Tripathi RB, 2011, J NEUROSCI, V31, P6809, DOI 10.1523/JNEUROSCI.6474-10.2011; Vigano F, 2016, BRAIN RES, V1638, P129, DOI 10.1016/j.brainres.2015.09.012; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	34	15	16	2	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 10	2018	385						154	165		10.1016/j.neuroscience.2018.06.015			12	Neurosciences	Neurosciences & Neurology	GM6VW	WOS:000438316600014	29913244				2021-06-18	
J	Liou, YJ; Wei, HT; Chen, MH; Hsu, JW; Huang, KL; Bai, YM; Su, TP; Li, CT; Yang, AC; Tsai, SJ; Lin, WC; Chen, TJ				Liou, Ying-Jay; Wei, Han-Ting; Chen, Mu-Hong; Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Su, Tung-Ping; Li, Cheng-Ta; Yang, Albert C.; Tsai, Shih-Jen; Lin, Wei-Chen; Chen, Tzeng-Ji			Risk of Traumatic Brain Injury Among Children, Adolescents, and Young Adults With Attention-Deficit Hyperactivity Disorder in Taiwan	JOURNAL OF ADOLESCENT HEALTH			English	Article						ADHD; Traumatic brain injury; ADHD medications	DEFICIT/HYPERACTIVITY DISORDER; EXECUTIVE FUNCTION; ASSOCIATION; POPULATION; MEDICATION; ADHD; STIMULANT; BEHAVIOR	Purpose: Previous studies suggested that patients with attention-deficit hyperactivity disorder (ADHD) were prone to health-risk behaviors and accidents. However, the relationship of ADHD with the risk of traumatic brain injury (TBI) remained uncertain. Methods: Using the Taiwan National Health Insurance Research Database, 72,181 children (aged 3-11 years), adolescents (12-17 years), and young adults (18-29 years) with ADHD and 72,181 age-/sex matched controls were enrolled between 2001 and 2009, and followed up to the end of 2011 in our study. Those who developed any TBI during the follow-up period were identified. Results: Children, adolescents, and young adults with ADHD had a higher incidence of developing any TBI (9.8% vs. 2.2%, p < .001), such as skull fracture (.2% vs. .1%, p < .001) and concussion (4.3% vs. 1.0%, p < .001), than the controls did. Cox regression analysis with the adjustment of demographic data, psychiatric comorbidities, and ADHD medications showed that ADHD was related to an increased risk of subsequent TBI (hazard ratio: 4.57, 95% confidence interval: 4.31-4.85), and indicated that long-term use of ADHD medication was associated with a reduced likelihood of subsequent TBI (hazard ratio: .93, 95% confidence interval: .87.99). Conclusions: Patients with ADHD had an increased risk of developing any TBI compared with the controls. Long-term use of ADHD medications would reduce this risk. Our findings suggested that the public health government and clinicians should pay more attention to the TBI risk among patients with ADHD, and further indicated the importance of the optimal treatment for ADHD. (C) 2018 Society for Adolescent Health and Medicine. All rights reserved.	[Liou, Ying-Jay; Wei, Han-Ting; Chen, Mu-Hong; Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Su, Tung-Ping; Li, Cheng-Ta; Yang, Albert C.; Tsai, Shih-Jen; Lin, Wei-Chen] Taipei Vet Gen Hosp, Dept Psychiat, 201,Shih Pai Rd,Sec 2, Taipei 11217, Taiwan; [Liou, Ying-Jay; Chen, Mu-Hong; Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Su, Tung-Ping; Li, Cheng-Ta; Yang, Albert C.; Tsai, Shih-Jen; Lin, Wei-Chen] Natl Yang Ming Univ, Dept Psychiat, Coll Med, Taipei, Taiwan; [Wei, Han-Ting] Taipei City Hosp, Div Psychiat, Kunming Branch, Taipei, Taiwan; [Wei, Han-Ting] Taipei City Hosp, Branch Linsen Chinese Med & Kunming, Taipei, Taiwan; [Su, Tung-Ping] Cheng Hsin Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan	Liou, YJ; Chen, MH (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, 201,Shih Pai Rd,Sec 2, Taipei 11217, Taiwan.	yjliou@mail2000.com.tw; kremer7119@gmail.com	Tsai, Shih-Jen/AAK-7944-2020; Li, Cheng-Ta/AAI-5759-2021; Chen, TJ/AAH-8430-2021	Tsai, Shih-Jen/0000-0002-9987-022X; Li, Cheng-Ta/0000-0002-0670-1153; Chen, Mu-Hong/0000-0001-6516-1073	Taipei Veterans General HospitalTaipei Veterans General Hospital [V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181]	The study was supported by grant from Taipei Veterans General Hospital (V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181). The funding source had no role in any process of our study.	Adeleye AO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00695; Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; [Anonymous], 1999, JAMA, V282, P974; [Anonymous], 2010, LANCET, V9, P331; Asherson P, 2016, LANCET PSYCHIAT, V3, P568, DOI 10.1016/S2215-0366(16)30032-3; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chen MH, 2016, DIABETES CARE, V39, P788, DOI 10.2337/dc15-1807; Chen MH, 2015, BRIT J PSYCHIAT, V206, P302, DOI 10.1192/bjp.bp.113.143610; Chen VCH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173762; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gobbo MA, 2014, EUR NEUROPSYCHOPHARM, V24, P1425, DOI 10.1016/j.euroneuro.2014.06.006; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Kieling RR, 2011, EUR PSYCHIAT, V26, P23, DOI 10.1016/j.eurpsy.2010.03.004; Lee SH, 2015, SE ASIAN J TROP MED, V46, P924; Li CT, 2012, BRIT J PSYCHIAT, V200, P45, DOI 10.1192/bjp.bp.110.086983; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Lin JW, 2008, ACT NEUR S, V101, P113; Liu CY, 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Nikolas MA, 2016, J CHILD PSYCHOL PSYC, V57, P141, DOI 10.1111/jcpp.12491; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Philip P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138004; Pope CN, 2016, J DEV BEHAV PEDIATR, V37, P702, DOI 10.1097/DBP.0000000000000353; Pope CN, 2017, ACCIDENT ANAL PREV, V98, P123, DOI 10.1016/j.aap.2016.09.030; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Rowland AS, 2018, J CHILD PSYCHOL PSYC, V59, P213, DOI 10.1111/jcpp.12775; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Wang YP, 2014, AM J PSYCHIAT, V171, P54, DOI 10.1176/appi.ajp.2013.12111467; Wilens TE, 2003, PEDIATRICS, V111, P179, DOI 10.1542/peds.111.1.179	35	15	15	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	AUG	2018	63	2					233	238		10.1016/j.jadohealth.2018.02.012			6	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Psychology; Public, Environmental & Occupational Health; Pediatrics	GR4OQ	WOS:000442593400017	29970331				2021-06-18	
J	Register-Mihalik, JK; Williams, RM; Marshall, SW; Linnan, LA; Mihalik, JP; Guskiewicz, KM; McLeod, TCV				Register-Mihalik, Johna K.; Williams, Richelle M.; Marshall, Stephen W.; Linnan, Laura A.; Mihalik, Jason P.; Guskiewicz, Kevin M.; McLeod, Tamara C. Valovich			Demographic, Parental, and Personal Factors and Youth Athletes' Concussion-Related Knowledge and Beliefs	JOURNAL OF ATHLETIC TRAINING			English	Article						brain injury; sports; concussion education; theory of planned behavior; socioecological model	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; FOOTBALL PLAYERS; SOCIOECOLOGICAL FRAMEWORK; REPORTING BEHAVIORS; PHYSICAL-ACTIVITY; HEALTH-PROMOTION; SEX-DIFFERENCES; SOCCER PLAYERS; SOCIAL ECOLOGY	Context: Currently, significant attention is focused on improving care for patients with concussions through legislative mandates that include educational interventions. Few researchers have examined young athletes' concussion knowledge and the factors that may influence their knowledge. Objective: To use the socioecological model to examine demographic, parental, and personal factors associated with youth athletes' knowledge of concussion. Our ultimate goal is to inform the planning and implementation of youth sport concussion-related interventions. Design: Cross-sectional survey. Setting: Gymnasium and classroom. Patients or Other Participants: North Carolina and Arizona youth athletes (n = 225; age = 8 to 15 years) active in football, boys' or girls' soccer, boys' or girls' ice hockey, or boys' or girls' lacrosse in 2012-2013. Main Outcome Measure(s): Participants completed a validated, self-administered survey. The intention and belief measures were guided by the theory of planned behavior. Perceptions of concussion and intention to seek care were examined using descriptive statistics. Athletes' concussion knowledge was modeled using linear regressions and generalized estimating equations, with child demographic and personal factors and parental knowledge and attitudes about concussion as predictors. Results: Geography, sport, parental attitudes toward concussion, and athlete age were associated with athlete knowledge in the univariable analyses (P < .10). In the multivariable model, geographic location (North Carolina versus Arizona, mean difference [MD] = 2.2, 95% confidence interval [CI] = 1.1, 3.2), sport (girls' soccer versus girls' lacrosse, MD = 2.2, 95% CI = 0.7, 3.6), more favorable parental attitudes toward concussion (MD = 1.2 for a 2-standard deviation shift; 95% CI = 0.3, 2.1), and older age (>12 years, MD = 1.6; 95% CI = 0.5, 2.6) were associated with better knowledge about concussion. Conclusions: Geographic location, sport, parental attitudes about concussion, and athlete's age influenced athletes' concussion-related perceptions, indicating the need to address multiple levels of the socioecological model when targeting youth sport interventions. Parental interventions that translate to an improved culture of youth sport by improving youth athletes' perceptions and experiences are key areas for future work.	[Register-Mihalik, Johna K.; Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.; Marshall, Stephen W.] Univ N Carolina, Gillings Sch Global Publ Hlth, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Linnan, Laura A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Williams, Richelle M.] AT Still Univ, Dept Res Support, Mesa, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ USA	Register-Mihalik, JK (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, CB 8700, Chapel Hill, NC 27599 USA.	johnakay@email.unc.edu	McLeod, Tamara/AAU-9435-2020	Williams, Richelle/0000-0003-4728-7443	National Operating Committee on Standards for Athletic Equipment; Injury Control Research Center award from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention [R49/CE002479]	Funding for this work was provided in part by a grant from the National Operating Committee on Standards for Athletic Equipment. The opinions expressed herein are those of the authors and do not necessarily reflect the opinions of the committee. The National Operating Committee on Standards for Athletic Equipment had no involvement in the study other than providing funding. No other interests were related to this work. Dr Marshall was partially supported by an Injury Control Research Center award (R49/CE002479) from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.	Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Bickell NA, 2012, J CLIN ONCOL, V30, P1791, DOI 10.1200/JCO.2011.38.7605; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Donaldson CD, 2016, PREV SCI, V17, P606, DOI 10.1007/s11121-016-0656-1; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Guo D, CLIN J SPORT MED; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kwon S, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0383-9; LaBella C, 2014, JAMA-J AM MED ASSOC, V312, P739, DOI 10.1001/jama.2014.6668; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Myrdal CN, 2017, PHYSICIAN SPORTSMED, V45, P286, DOI 10.1080/00913847.2017.1345569; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schoeppe S, 2016, PEDIATR EXERC SCI, V28, P466, DOI 10.1123/pes.2015-0236; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; Stokols D, 1996, AM J HEALTH PROMOT, V10, P247, DOI 10.4278/0890-1171-10.4.247; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06	40	15	15	2	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2018	53	8					768	775		10.4085/1062-6050-223-17			8	Sport Sciences	Sport Sciences	GW7OJ	WOS:000447157700008	30198745	Green Published, Bronze			2021-06-18	
J	Thau-Zuchman, O; Gomes, RN; Dyall, SC; Davies, M; Priestley, JV; Groenendijk, M; De Wilde, MC; Tremoleda, JL; Michael-Titus, AT				Thau-Zuchman, Orli; Gomes, Rita N.; Dyall, Simon C.; Davies, Meirion; Priestley, John V.; Groenendijk, Martine; De Wilde, Martijn C.; Tremoleda, Jordi L.; Michael-Titus, Adina T.			Brain Phospholipid Precursors Administered Post-Injury Reduce Tissue Damage and Improve Neurological Outcome in Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain phospholipids; functional improvement; medical multi-nutrient; neuroplasticity; neuroprotection; traumatic brain injury	CONTROLLED CORTICAL IMPACT; MILD ALZHEIMERS-DISEASE; CLOSED-HEAD-INJURY; PROTEIN 18 KDA; MICROGLIAL CELLS; HIPPOCAMPAL NEUROGENESIS; PHOSPHATIDE PRECURSORS; COGNITIVE IMPAIRMENT; DOCOSAHEXAENOIC ACID; REACTIVE ASTROCYTES	Traumatic brain injury (TBI) leads to cellular loss, destabilization of membranes, disruption of synapses and altered brain connectivity, and increased risk of neurodegenerative disease. A significant and long-lasting decrease in phospholipids (PLs), essential membrane constituents, has recently been reported in plasma and brain tissue, in human and experimental TBI. We hypothesized that supporting PL synthesis post-injury could improve outcome post-TBI. We tested this hypothesis using a multi-nutrient combination designed to support the biosynthesis of PLs and available for clinical use. The multi-nutrient, Fortasyn((R)) Connect (FC), contains polyunsaturated omega-3 fatty acids, choline, uridine, vitamins, cofactors required for PL biosynthesis, and has been shown to have significant beneficial effects in early Alzheimer's disease. Male C57BL/6 mice received a controlled cortical impact injury and then were fed a control diet or a diet enriched with FC for 70 days. FC led to a significantly improved sensorimotor outcome and cognition, reduced lesion size and oligodendrocyte loss, and it restored myelin. It reversed the loss of the synaptic protein synaptophysin and decreased levels of the axon growth inhibitor, Nogo-A, thus creating a permissive environment. It decreased microglia activation and the rise in beta-amyloid precursor protein and restored the depressed neurogenesis. The effects of this medical multi-nutrient suggest that support of PL biosynthesis post-TBI, a new treatment paradigm, has significant therapeutic potential in this neurological condition for which there is no satisfactory treatment. The multi-nutrient tested has been used in dementia patients and is safe and well tolerated, which would enable rapid clinical exploration in TBI.	[Thau-Zuchman, Orli; Gomes, Rita N.; Davies, Meirion; Priestley, John V.; Tremoleda, Jordi L.; Michael-Titus, Adina T.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Neurosci & Trauma, London, England; [Groenendijk, Martine; De Wilde, Martijn C.] Nutricia Res Nutricia Adv Med Nutr, Utrecht, Netherlands; [Dyall, Simon C.] Bournemouth Univ, Royal London House, Bournemouth, Dorset, England	Thau-Zuchman, O (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Neurosci & Trauma, 4 Newark St, London E1 2AT, England.	o.thau-zuchman@qmul.ac.uk		Gomes, Rita/0000-0003-4237-2024; Thau-Zuchman, Orli/0000-0003-0403-7962; Dyall, Simon/0000-0001-7591-4219	Centre for Trauma Sciences, Barts Charity grant	O.T.Z., M.D., and J.L.T. were supported by the Centre for Trauma Sciences, Barts Charity grant. M.G. and M.C.d.W. are employees of Nutricia Research. A.M.T. is a scientific consultant for Nutricia Research.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; An CR, 2016, TRANSL STROKE RES, V7, P512, DOI 10.1007/s12975-016-0483-5; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bourourou M, 2016, NEUROPHARMACOLOGY, V108, P60, DOI 10.1016/j.neuropharm.2016.04.040; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brown CE, 2008, NEUROSCIENTIST, V14, P139, DOI 10.1177/1073858407309854; Brown CE, 2010, J CEREBR BLOOD F MET, V30, P783, DOI 10.1038/jcbfm.2009.241; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cansev M, 2005, BRAIN RES, V1058, P101, DOI 10.1016/j.brainres.2005.07.054; Cansev M, 2015, NEUROBIOL AGING, V36, P344, DOI 10.1016/j.neurobiolaging.2014.07.021; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; de Waal H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086558; de Wilde MC, 2016, ALZHEIMERS DEMENT, V12, P633, DOI 10.1016/j.jalz.2015.12.005; de Wilde MC, 2011, J ALZHEIMERS DIS, V27, P327, DOI 10.3233/JAD-2011-110635; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dyall SC, 2007, NEUROBIOL AGING, V28, P424, DOI 10.1016/j.neurobiolaging.2006.01.002; Dyall SC, 2016, NEUROPHARMACOLOGY, V107, P387, DOI 10.1016/j.neuropharm.2016.03.055; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gaskin S, 2010, BEHAV PROCESS, V83, P61, DOI 10.1016/j.beproc.2009.10.003; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; GLENN JA, 1992, J ANAT, V180, P109; Gray C, 1998, BRAIN INJURY, V12, P429, DOI 10.1080/026990598122548; Haar CV, 2016, BRAIN RES, V1640, P114, DOI 10.1016/j.brainres.2015.12.030; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Israelsson C, 2014, RESTOR NEUROL NEUROS, V32, P717, DOI 10.3233/RNN-140419; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamphuis PJ, 2009, EUR J NEUROL, V16, P12, DOI 10.1111/j.1468-1331.2009.02737.x; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kulkarni SK, 2007, METHOD FIND EXP CLIN, V29, P343; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Moessinger C, 2014, BMC CELL BIOL, V15, DOI 10.1186/s12860-014-0043-3; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Pallier PN, 2015, NEUROBIOL DIS, V82, P504, DOI 10.1016/j.nbd.2015.09.007; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Purdon AD, 2002, NEUROCHEM RES, V27, P1641, DOI 10.1023/A:1021635027211; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rikkert MGMO, 2015, J ALZHEIMERS DIS, V44, P471, DOI 10.3233/JAD-141305; Roebuck-Spencer T, 2014, HDB NEUROPSYCHOLOGY, P3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; Scheltens P, 2010, ALZHEIMERS DEMENT, V6, P1, DOI 10.1016/j.jalz.2009.10.003; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soininen H, 2017, LANCET NEUROL, V16, P965, DOI 10.1016/S1474-4422(17)30332-0; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; SUSARLA BTS, 2014, ASN NEURO, V6; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Tress O, 2012, J NEUROSCI, V32, P7499, DOI 10.1523/JNEUROSCI.0392-12.2012; Ulus IH, 1998, NEUROCHEM RES, V23, P727, DOI 10.1023/A:1022455325657; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; van Wijk N, 2014, J ALZHEIMERS DIS, V38, P459, DOI 10.3233/JAD-130998; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Volz LJ, 2015, BRAIN STRUCT FUNCT, V220, P1093, DOI 10.1007/s00429-013-0702-8; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wurtman RJ, 2006, BRAIN RES, V1088, P83, DOI 10.1016/j.brainres.2006.03.019; Wurtman RJ, 2010, NUTR REV, V68, pS88, DOI 10.1111/j.1753-4887.2010.00344.x; Wurtman RJ, 2009, ANNU REV NUTR, V29, P59, DOI 10.1146/annurev-nutr-080508-141059; Wurtman Richard J., 2009, V99, P71, DOI 10.1159/000192998; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	128	15	16	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					25	42		10.1089/neu.2017.5579		JUL 2018	18	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000439793700001	29768974	Green Published, Green Accepted, Other Gold			2021-06-18	
J	Sabirzhanov, B; Faden, AI; Aubrecht, T; Henry, R; Glaser, E; Stoica, BA				Sabirzhanov, Boris; Faden, Alan I.; Aubrecht, Taryn; Henry, Rebecca; Glaser, Ethan; Stoica, Bogdan A.			MicroRNA-711-Induced Downregulation of Angiopoietin-1 Mediates Neuronal Cell Death	JOURNAL OF NEUROTRAUMA			English	Article						angiopoietin-1 (Ang-1); cell death; microRNA (miRNA); traumatic brain injury	TRAUMATIC BRAIN-INJURY; ALTERED EXPRESSION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; APOPTOSIS; ACTIVATION; RECEPTOR; BARRIER; TARGETS	Angiopoietin-1 (Ang-1) is a well-known endothelial growth factor, but its effects on neurons have yet to be elucidated. We show that Ang-1 is rapidly downregulated in the injured brain after controlled cortical impact (CCI), a mouse experimental traumatic brain injury (TBI) model and in etoposide-induced neuronal apoptosis in vitro. Ang-1 treatment inhibits etoposide-induced upregulation of proapoptotic B-cell lymphoma 2 (Bcl-2) family members Noxa, p53 upregulated modulator of apoptosis (Puma), Bcl-2 interacting mediator of cell death (Bim), and Bcl-2-associated X protein (Bax); reduces markers of caspase-dependent (cytochrome c release/caspase activation) and caspase-independent (apoptosis-inducing factor release) pathways; and limits neuronal cell death. Ang-1 treatment phosphorylates receptors Tunica interna endothelial cell kinase 2 (Tie2), and beta 1-integrin and limits the etoposide-induced decrease in protein kinase B (Akt) activity. Blocking Tie2 and beta 1-integrin signaling reduces Ang-1 neuroprotective effects. After both TBI and etoposide treatment microRNA (miR)-711 are upregulated, consistent with its putative role as a negative regulator of Ang-1. We show that miR-711 directly targets the Ang-1 messenger RNA (mRNA), decreasing Ang-1 expression. Increased levels of miR-711 and Ang-1 mRNA are found in the RNA-induced silencing complex complex site of miR-mediated degradation of target mRNAs after etoposide treatment and the miR-711mimic downregulates Ang-1. Administration of miR-711 inhibitor elevates Ang-1 after TBI whereas Ang-1 administration increases Akt activation; reduces Puma, Noxa, Bim, and Bax levels; and attenuates caspase-dependent and -independent neuronal apoptosis 24h after TBI. Ang-1 also attenuates neuronal degeneration, increases gene expression of molecules that maintain blood-brain barrier integrity, and reduces post-traumatic lesion volume/edema 24h after TBI. Although we only observed short-term neuroprotective effects after Ang-1 administration, miR-711-dependent downregulation of Ang-1, followed by Akt pathway inhibition, may play a role in neuronal cell death after neuronal injury in vitro and after experimental TBI.	Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA	Sabirzhanov, B; Stoica, BA (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Ctr Shock Trauma & Anesthesiol Res, Bressler Res Bldg,655 West Baltimore St,8th Floor, Baltimore, MD 21201 USA.	bsabirzhanov@som.umaryland.edu; bstoica@som.umaryland.edu	STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434; Faden, Alan I./0000-0003-0128-2348; Henry, Rebecca/0000-0001-8548-1170	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS091191, R01 NS096002]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096002, R01NS091191] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) grants R01 NS091191 to A.I.F. and R01 NS096002 to B.A.S and B.S.	Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Akhter R, 2014, J BIOL CHEM, V289, P10812, DOI 10.1074/jbc.M113.519355; Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Hellwig K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0161-y; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kosacka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032881; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; LEE JH, 2013, J PRIVACY CONFIDENTI, V5, P5, DOI DOI 10.5345/JKIBC.2013.13.5.506; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lim JS, 2015, NEUROBIOL DIS, V81, P203, DOI 10.1016/j.nbd.2014.11.001; Lin TN, 2001, J CEREBR BLOOD F MET, V21, P690, DOI 10.1097/00004647-200106000-00007; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Lista S, 2017, EXPERT REV NEUROTHER, V17, P47, DOI 10.1080/14737175.2016.1204234; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; OCALLAGHAN JP, 1988, NEUROTOXICOL TERATOL, V10, P445, DOI 10.1016/0892-0362(88)90006-2; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Pietrzak M, 2011, J NEUROCHEM, V117, P1033, DOI 10.1111/j.1471-4159.2011.07279.x; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sabirzhanov B, 2012, J NEUROCHEM, V123, P542, DOI 10.1111/j.1471-4159.2012.07927.x; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Shin HY, 2010, J NEUROSCI RES, V88, P1052, DOI 10.1002/jnr.22274; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Wu Q, 2015, BIOMED REP, V3, P611, DOI 10.3892/br.2015.477; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yakovlev AG, 2004, J BIOL CHEM, V279, P28367, DOI 10.1074/jbc.M313526200; Yakovlev AG, 2001, J NEUROSCI, V21, P7439; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhao JL, 2015, J CELL PHYSIOL, V230, P1895, DOI 10.1002/jcp.24920; Zhou LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079805	63	15	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2462	2481		10.1089/neu.2017.5572		JUL 2018	20	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000438198500001	29774773	Green Published			2021-06-18	
J	Nolan, A; Hennessy, E; Krukowski, K; Guglielmetti, C; Chaumeil, MM; Sohal, VS; Rosi, S				Nolan, Amber; Hennessy, Edel; Krukowski, Karen; Guglielmetti, Caroline; Chaumeil, Myriam M.; Sohal, Vikaas S.; Rosi, Susanna			Repeated Mild Head Injury Leads to Wide-Ranging Deficits in Higher-Order Cognitive Functions Associated with the Prefrontal Cortex	JOURNAL OF NEUROTRAUMA			English	Article						disinhibition; prefrontal cortex; repetitive mild traumatic brain injury; social memory; working memory	TRAUMATIC BRAIN-INJURY; ENGINEERED ROTATIONAL ACCELERATION; WORKING-MEMORY; IMPACT MODEL; NEUROBEHAVIORAL CHANGES; PYRAMIDAL NEURONS; SOCIAL COGNITION; RISK; SEVERITY; CONCUSSION	Traumatic brain injury (TBI) has long been identified as a precipitating risk factor for higher-order cognitive deficits associated with the frontal and prefrontal cortices (PFC). In addition, mild repetitive TBI (rTBI), in particular, is being steadily recognized to increase the risk of neurodegenerative disease. Thus, further understanding of how mild rTBI changes the pathophysiology of the brain to lead to cognitive impairment is warranted. The current models of rTBI lack knowledge regarding chronic higher-order cognitive functions and the underlying neuronal physiology, especially functions involving the PFC. Here, we establish that five repeated mild hits, allowing rotational acceleration of the head, lead to chronic deficits in PFC-dependent functions such as social behavior, spatial working memory, and environmental response with concomitant microgliosis and a small decrease in the adaptation rate of layer V pyramidal neurons in the medial PFC (mPFC). However, structural damage is not seen on in vivo T2-weighted magnetic resonance imaging (MRI), and extensive intrinsic excitability changes in layer V pyramidal neurons of the mPFC are not observed. Thus, this rTBI animal model can recapitulate chronic higher-order cognitive impairments without structural damage on MR imaging as observed in humans.	[Nolan, Amber; Hennessy, Edel; Krukowski, Karen; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Nolan, Amber; Hennessy, Edel; Krukowski, Karen; Guglielmetti, Caroline; Chaumeil, Myriam M.; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Nolan, Amber] Univ Calif San Francisco, Dept Anat Pathol, San Francisco, CA 94143 USA; [Guglielmetti, Caroline; Chaumeil, Myriam M.] Univ Calif San Francisco, Surbeck Lab Adv Imaging, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Sohal, Vikaas S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Rosi, Susanna] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA	Rosi, S (corresponding author), Zuckerberg San Francisco Gen Hosp, Bldg 1,Room 101,1001 Potrero Ave, San Francisco, CA 94110 USA.	susanna.rosi@ucsf.edu	Hennessy, Edel/H-4438-2019	Hennessy, Edel/0000-0003-4024-0802; Chaumeil, Myriam/0000-0002-2110-4613	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096718, R21NS087458, R01NS095831]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG056770]; David Mahoney Neuroimaging Grant from the Dana Foundation [CA-0114728];  [CalBRAIN349087]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG056770] Funding Source: NIH RePORTER	This work was supported by research grants: NIH/NINDS R21NS096718, NIH/NINDS R21NS087458, NIH/NIA R01AG056770, CalBRAIN349087, NIH/NINDS R01NS095831, and a David Mahoney Neuroimaging Grant from the Dana Foundation (CA-0114728).	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Chou A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151418; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feng X, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2389; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gilmartin MR, 2013, J NEUROSCI, V33, P10910, DOI 10.1523/JNEUROSCI.0144-13.2013; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Kim EJ, 2015, NEURON, V88, P1253, DOI 10.1016/j.neuron.2015.11.002; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lee AT, 2014, NEURON, V81, P61, DOI 10.1016/j.neuron.2013.10.031; Leo L.M., 2014, BIOPROTOCOL, V9, DOI [10.21769/BioProtoc.1211, DOI 10.21769/BIOPROTOC.1211]; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Martins AT, 2012, NEURAL REGEN RES, V7, P101, DOI 10.3969/j.issn.1673-5374.2012.02.004; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Riga D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00230; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Sekerli M, 2004, IEEE T BIO-MED ENG, V51, P1665, DOI 10.1109/TBME.2004.827531; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Xiao H, 2017, BRAIN INJURY, V31, P1331, DOI 10.1080/02699052.2017.1319576; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P706, DOI 10.1038/jcbfm.2014.247	71	15	15	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2425	2434		10.1089/neu.2018.5731		JUL 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437230700001	29732949	Green Published			2021-06-18	
J	Gagner, C; Landry-Roy, C; Bernier, A; Gravel, J; Beauchamp, MH				Gagner, Charlotte; Landry-Roy, Catherine; Bernier, Annie; Gravel, Jocelyn; Beauchamp, Miriam H.			Behavioral consequences of mild traumatic brain injury in preschoolers	PSYCHOLOGICAL MEDICINE			English	Article						Traumatic brain injury; childhood; behavioral problems; preschool period	5-YEAR FOLLOW-UP; HEAD-INJURY; PSYCHIATRIC-DISORDERS; BIRTH COHORT; CHILDREN; PREDICTORS; OUTCOMES; RECOVERY; RISK; AGE	Background. Pediatric traumatic brain injury (TBI) is a leading cause of long-term disability in children and adolescents worldwide. Amongst the wide array of consequences known to occur after pediatric TBI, behavioral impairments are among the most widespread and may particularly affect children who sustain injury early in the course of development. The aim of this study was to investigate the presence of internalizing and externalizing behavioral problems 6 months after preschool (i.e. 18-60 months old) mild TBI. Methods. This work is part of a prospective, longitudinal cohort study of preschool TBI. Participants (N = 229) were recruited to one of three groups: children with mild TBI, typically developing children and orthopedic injured (OI) children. Mothers of children in all three groups completed the Child Behavior Checklist as a measure of behavioral outcomes 6-month post-injury. Demographics, injury-related characteristics, level of parental distress, and estimates of pre-injury behavioral problems were also documented. Results. The three groups did not differ on baseline characteristics (e.g. demographics and pre-injury behavioral problems for the mild TBI and OI groups) and level of parental distress. Mothers' ratings of internalizing and externalizing behaviors were higher in the mild TBI group compared with the two control groups. Pre-injury behavioral problems and maternal distress were found to be significant predictors of outcome. Conclusion. Our results show that even in its mildest form, preschool TBI may cause disruption to the immature brain serious enough to result in behavioral changes, which persist for several months post-injury.	[Gagner, Charlotte; Landry-Roy, Catherine; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Gagner, Charlotte; Landry-Roy, Catherine; Gravel, Jocelyn; Beauchamp, Miriam H.] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada	Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Beauchamp, MH (corresponding author), Ste Justine Hosp Res Ctr, Montreal, PQ, Canada.	miriam.beauchamp@umontreal.ca			Canadian Health Research Fund (CIHR) [MOP111036]	We are grateful for the work of Cindy Beaudoin and the members of the LION project. We also thank the Emergency Department team, in particular, Maryse Lagace, Ramona Cook, and the "PIEUVRES' group for their assistance with recruitment. All phases of this study were supported by the Canadian Health Research Fund (CIHR), grant number MOP111036.	Abidin R.R., 1990, PARENTING STRESS IND; Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beaudoin C., 2017, 12 WORLD C BRAIN INJ; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Christensen A., 1992, PSYCHOL ASSESSMENT, V4, P419, DOI DOI 10.1037/1040-3590.4.4.419; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Emond A, 2007, CHILD PSYCHIAT HUM D, V38, P221, DOI 10.1007/s10578-007-0058-5; Giza CC, 2006, INDIAN J NEUROTRAUM, V3, P19; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hirshfeld-Becker DR, 2007, J DEV BEHAV PEDIATR, V28, P225, DOI 10.1097/01.DBP.0000268559.34463.d0; Innocenti GM, 2007, PROG BRAIN RES, V164, P23, DOI 10.1016/S0079-6123(07)64002-3; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Langberg JM, 2010, J EMOT BEHAV DISORD, V18, P41, DOI 10.1177/1063426608330792; LERNER JA, 1985, J AM ACAD CHILD PSY, V24, P42, DOI 10.1016/S0002-7138(09)60408-8; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mesman J, 2001, J AM ACAD CHILD PSY, V40, P1029, DOI 10.1097/00004583-200109000-00011; Miller G, 2010, SCIENCE, V328, P297, DOI 10.1126/science.328.5976.297; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Neece CL, 2012, AJIDD-AM J INTELLECT, V117, P48, DOI 10.1352/1944-7558-117.1.48; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Petty CR, 2008, J ANXIETY DISORD, V22, P532, DOI 10.1016/j.janxdis.2007.04.003; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schoemaker K, 2013, J ABNORM CHILD PSYCH, V41, P457, DOI 10.1007/s10802-012-9684-x; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SHODA Y, 1990, DEV PSYCHOL, V26, P978, DOI 10.1037/0012-1649.26.6.978; Thurber S., 2012, ARCH ASSESSMENT PSYC, V2, P73; Treutler CM, 2003, J ABNORM CHILD PSYCH, V31, P13, DOI 10.1023/A:1021765114434; van der Veen-Mulders L, 2016, EUROPEAN CHILD ADOLE, V26, P365; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	50	15	15	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	JUL	2018	48	9					1551	1559		10.1017/S0033291717003221			9	Psychology, Clinical; Psychiatry; Psychology	Psychology; Psychiatry	GJ8OR	WOS:000435649900017	29173217				2021-06-18	
J	Goverover, Y; Chiaravalloti, N; Genova, H; DeLuca, J				Goverover, Yael; Chiaravalloti, Nancy; Genova, Helen; DeLuca, John			A randomized controlled trial to treat impaired learning and memory in multiple sclerosis: The self-GEN trial	MULTIPLE SCLEROSIS JOURNAL			English	Article						Cognition; memory; transfer; activities of daily living; multiple sclerosis; randomized clinical trial	EVALUATE DISEASE PROGRESSION; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; FUNCTIONAL ASSESSMENT; COGNITIVE IMPAIRMENT; GENERATION; STANDARDIZATION; REHABILITATION; SATISFACTION; PERFORMANCE	Background: Difficulties in learning and memory are among the most persistent and frequently reported cognitive symptoms in individuals with multiple sclerosis (MS). Objective: To examine the efficacy of the self-generation learning program (self-GEN trial) that consist of behavioral intervention sessions, teaching self-generation technique while using metacognitive strategies to improve learning and memory abilities in persons with MS. Additionally, the treatment aimed to address generalization of the treatment to activities of daily living. Methods: This double-blind, placebo-controlled, randomized clinical trial included 35 participants with clinically definite MS, 19 in the treatment group and 16 in the placebo control group. Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory and a repeat assessment immediately post-treatment. Results: The treatment group showed significantly improved learning and memory, self-regulation, and metacognition relative to the placebo post-treatment. Similar results were noted on measures of depression, functional status, and quality of life (QOL). Conclusion: This study provides initial Class I evidence that the self-GEN behavioral intervention improves memory, self-regulation, functional status, affective symptomatology, and QOL in patients with MS.	[Goverover, Yael] NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA; [Goverover, Yael; Chiaravalloti, Nancy; Genova, Helen; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [Chiaravalloti, Nancy; Genova, Helen; DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA	Goverover, Y (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA.	yg243@nyu.edu		Chiaravalloti, Nancy/0000-0003-2943-7567	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [PP2098]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the National Multiple Sclerosis Society (Grant No. PP2098).	Arnett PA, 2004, ARCH CLIN NEUROPSYCH, V19, P507, DOI 10.1016/j.acn.2003.07.006; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; BAUM C, 1993, GERONTOLOGIST, V33, P403, DOI 10.1093/geront/33.3.403; Brenk A, 2008, EUR NEUROL, V60, P304, DOI 10.1159/000157885; Cella DF, 1996, NEUROLOGY, V47, P129, DOI 10.1212/WNL.47.1.129; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; Delis D., 2000, CVLT 2 CALIFORNIA VE; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DeWinstanley PA, 2004, MEM COGNITION, V32, P945, DOI 10.3758/BF03196872; deWinstanley PA, 1997, MEMORY, V5, P401, DOI 10.1080/741941392; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; GILEWSKI MJ, 1992, PSYCHOL AGING, V7, P298, DOI 10.1037/h0090381; Goverover Y, 2008, ARCH PHYS MED REHAB, V89, P1514, DOI 10.1016/j.apmr.2007.11.059; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Goverover Y, 2016, MULT SCLER J, V22, P544, DOI 10.1177/1352458515593637; Goverover Y, 2014, NEUROPSYCHOL REHABIL, V24, P155, DOI 10.1080/09602011.2013.868815; Goverover Y, 2013, J CLIN EXP NEUROPSYC, V35, P775, DOI 10.1080/13803395.2013.824553; Goverover Y, 2010, ARCH PHYS MED REHAB, V91, P252, DOI 10.1016/j.apmr.2009.09.022; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Hohol MJ, 1999, MULT SCLER, V5, P349, DOI 10.1191/135245899678846375; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Josman N., 2000, OCCUPATIONAL THERAPY, V7, P246, DOI DOI 10.1002/0TI.126; Kulasegaram K, 2012, ADV HEALTH SCI EDUC, V17, P489, DOI 10.1007/s10459-011-9326-z; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; Toglia JP, 1993, CONTEXTUAL MEMORY TE; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Zogg JB, 2012, J BEHAV MED, V35, P47, DOI 10.1007/s10865-011-9341-9	37	15	15	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	JUL	2018	24	8					1096	1104		10.1177/1352458517709955			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	GK3RI	WOS:000436062400012	28485659				2021-06-18	
J	Porter, KE; Stein, MB; Martis, B; Avallone, KM; McSweeney, LB; Smith, ER; Simon, NM; Gargan, S; Liberzon, I; Hoge, CW; Rauch, SAM				Porter, Katherine E.; Stein, Murray B.; Martis, Brian; Avallone, Kimberly M.; McSweeney, Lauren B.; Smith, Erin R.; Simon, Naomi M.; Gargan, Sean; Liberzon, Israel; Hoge, Charles W.; Rauch, Sheila A. M.			Postconcussive symptoms (PCS) following combat-related traumatic brain injury (TBI) in Veterans with posttraumatic stress disorder (PTSD): Influence of TBI, PTSD, and depression on symptoms measured by the Neurobehavioral Symptom Inventory (NSI)	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article							HEAD-INJURY; AFGHANISTAN; DEPLOYMENT; IRAQ; SOLDIERS; HEALTH; PREDICTORS; MECHANISMS; COMPLAINTS; EXPOSURE	Mild traumatic brain injury (mTBI) is commonly reported in recent combat Veterans. While the majority resolve, some Veterans develop postconcussive symptoms (PCS). Previous research suggests these symptoms are not specific to head injury and are often associated with psychiatric symptoms. The current study examines the relative contributions of posttraumatic stress, depressive symptoms, and TBI on postconcussive symptoms, and explores whether the relationship remains after controlling for symptom overlap. Two hundred eighteen combat Veterans from Operation Iraqi Freedom (OIF), Operation Enduring Freedom (OEF), and Operation New Dawn (OND) provided the data for this study as part of a baseline evaluation for inclusion into larger treatment study for posttraumatic stress disorder (PTSD). Participants completed the Brief Traumatic Brain Injury Screen (BTBIS), Neurobehavioral Symptom Inventory (NSI), PTSD Checklist-Stressor Version (PCL-S), Beck Depression Inventory-II (BDI-II). Significant differences in NSI total score between individuals with and without history of TBI were not found. A series of regression analyses demonstrated that Depression and PTSD were significant predictors of NSI score even after removal of NSI symptoms that overlap with PTSD or depression. TBI status was also a significant predictor of PCS in most models, but its relative contribution was much smaller than that of depression and PTSD. Within PTSD symptoms, hyperarousal cluster was a significant predictor of NSI scores. Findings demonstrate that depression and PTSD are related to PCS beyond similarities in construct. Further, within a primarily PTSD treatment-seeking population, these psychiatric symptoms appear to be a stronger contributor than TBI.	[Porter, Katherine E.; Martis, Brian; Avallone, Kimberly M.; McSweeney, Lauren B.; Smith, Erin R.; Liberzon, Israel] VA Ann Arbor Healthcare Syst, 2215 Fuller Rd,116C, Ann Arbor, MI 48105 USA; [Porter, Katherine E.; Martis, Brian; Avallone, Kimberly M.; Smith, Erin R.; Gargan, Sean; Liberzon, Israel] Univ Michigan, Ann Arbor, MI 48109 USA; [Stein, Murray B.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA; [McSweeney, Lauren B.; Rauch, Sheila A. M.] Emory Univ, Sch Med, Atlanta, GA USA; [Simon, Naomi M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Simon, Naomi M.] NYU, Sch Med, New York, NY USA; [Hoge, Charles W.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Rauch, Sheila A. M.] Atlanta VA Med Ctr, Atlanta, GA USA	Porter, KE (corresponding author), VA Ann Arbor Healthcare Syst, 2215 Fuller Rd,116C, Ann Arbor, MI 48105 USA.	katherine.porter2@va.gov	Rauch, Sheila A.M./K-4450-2015	Stein, Murray/0000-0001-9564-2871; Liberzon, Israel/0000-0002-4990-556X	U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command (MRMC; Randomized Controlled Trial of Sertraline, Prolonged Exposure Therapy, and Their Combination in OEF/OIF Combat Veterans with PTSD) [W81XWH-11-1-0073]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]	This work was supported by the U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command (MRMC; Randomized Controlled Trial of Sertraline, Prolonged Exposure Therapy, and Their Combination in OEF/OIF Combat Veterans with PTSD; Grant #W81XWH-11-1-0073); the National Center for Advancing Translational Sciences of the National Institutes of Health (Grant #UL1TR000433). This material is also the result of work supported with resources and the use of facilities at Massachusetts General Hospital, the VA Ann Arbor Healthcare System, Ralph H. Johnson VA Medical Center, and VA San Diego Healthcare System. The views expressed in this article presentation are solely those of the author(s) and do not reflect an endorsement by or the official policy of the Department of Veterans Affairs, Department of Defense, or the U.S. Government, or the official views of the National Institutes of Health.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beck AT., 1996, BECK DEPRESSION INVE, V2; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Department of the Army, 2014, NEUR SYMPT INV REC S; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Howlett J.R., 2016, TRANSLATIONAL RES TR; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kimerling R, 2000, J TRAUMA STRESS, V13, P115, DOI 10.1023/A:1007729116133; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rauch SAM, 2018, CONTEMP CLIN TRIALS, V64, P128, DOI 10.1016/j.cct.2017.10.013; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; Silverberg ND, 2017, J TRAUMA STRESS, V30, P318, DOI 10.1002/jts.22184; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Waldron-Perrine B, 2015, BRAIN INJURY, V29, P1051, DOI 10.3109/02699052.2015.1004742; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Weathers F, 1993, 9 ANN CONV INT SOC T; Williams JL, 2017, MIL MED, V182, pE1645, DOI 10.7205/MILMED-D-16-00221; Zhang J, 2015, J PSYCHOSOM RES, V79, P100, DOI 10.1016/j.jpsychores.2015.06.001	46	15	15	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JUL	2018	102						8	13		10.1016/j.jpsychires.2018.03.004			6	Psychiatry	Psychiatry	GN0LS	WOS:000438660500002	29554536				2021-06-18	
J	Wahlberg, B; Ghuman, H; Liu, JR; Modo, M				Wahlberg, Brendon; Ghuman, Harmanvir; Liu, Jessie R.; Modo, Michel			Ex vivo biomechanical characterization of syringe-needle ejections for intracerebral cell delivery	SCIENTIFIC REPORTS			English	Article							CONVECTION-ENHANCED DELIVERY; RADIALLY BRANCHED DEPLOYMENT; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; NARROW-BORE NEEDLES; SHEAR-STRESS; BIOMACROMOLECULE ADDITION; ISCHEMIC-STROKE; FLOW BEHAVIOR; INJECTION	Intracerebral implantation of cell suspensions is finding its clinical translation with encouraging results in patients with stroke. However, the survival of cells in the brain remains poor. Although the biological potential of neural stem cells (NSCs) is widely documented, the biomechanical effects of delivering cells through a syringe-needle remain poorly understood. We here detailed the biomechanical forces (pressure, shear stress) that cells are exposed to during ejection through different sized needles (20G, 26G, 32G) and syringes (10, 50, 250 mu L) at relevant flow rates (1, 5, 10 mu L/min). A comparison of 3 vehicles, Phosphate Buffered Saline (PBS), Hypothermosol (HTS), and Pluronic, indicated that less viscous vehicles are favorable for suspension with a high cell volume fraction to minimize sedimentation. Higher suspension viscosity was associated with greater shear stress. Higher flow rates with viscous vehicle, such as HTS reduced viability by similar to 10% and also produced more apoptotic cells (28%). At 5 mu L/min ejection using a 26G needle increased neuronal differentiation for PBS and HTS suspensions. These results reveal the biological impact of biomechanical forces in the cell delivery process. Appropriate engineering strategies can be considered to mitigate these effects to ensure the efficacious translation of this promising therapy.	[Wahlberg, Brendon; Modo, Michel] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Ghuman, Harmanvir; Liu, Jessie R.; Modo, Michel] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Ghuman, Harmanvir; Modo, Michel] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Modo, Michel] Ctr Neural Basis Cognit, Pittsburgh, PA 15203 USA	Modo, M (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.; Modo, M (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Modo, M (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.	mmm154@pitt.edu		Ghuman, Harmanvir/0000-0002-9123-7796; Modo, Michel/0000-0003-4436-735X	National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082226]; National Institute for Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB016629]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB016629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082226] Funding Source: NIH RePORTER	This work was partially supported by the National Institute for Neurological Disorders and Stroke (R01NS082226) and the National Institute for Biomedical Imaging and Bioengineering (R01EB016629).	Agashi K, 2009, REGEN MED, V4, P49, DOI 10.2217/17460751.4.1.49; Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Amer MH, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0028-x; Amer MH, 2015, J PHARM PHARMACOL, V67, P640, DOI 10.1111/jphp.12362; Aurand ER, 2014, STEM CELL RES, V12, P11, DOI 10.1016/j.scr.2013.09.013; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bayoussef Z, 2012, J TISSUE ENG REGEN M, V6, pe61, DOI 10.1002/term.482; Brady ML, 2013, STEREOT FUNCT NEUROS, V91, P69, DOI 10.1159/000342492; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Chu JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31847; Claudio R, 2004, REGION ANESTH PAIN M, V29, P201, DOI 10.1016/j.rapm.2003.12.013; Diaz MF, 2017, STEM CELLS, V35, P1259, DOI 10.1002/stem.2587; Dubois-Dauphin M, 2010, STROKE, V41, P1807, DOI 10.1161/STROKEAHA.110.578427; Heng BC, 2009, CELL TRANSPLANT, V18, P1111, DOI 10.3727/096368909X12483162197006; Jiang W, 2011, CELL TRANSPLANT, V20, P1515, DOI 10.3727/096368910X547435; Kalladka D, 2016, LANCET, V388, P787, DOI 10.1016/S0140-6736(16)30513-X; Keung AJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01817; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kondziolka D, 2011, CELL TRANSPLANT, V20, P1901, DOI 10.3727/096368911X566190; Krauze MT, 2005, J NEUROSURG, V103, P923, DOI 10.3171/jns.2005.103.5.0923; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063473; Maisonneuve BGC, 2015, BIOMACROMOLECULES, V16, P275, DOI 10.1021/bm501481y; Maisonneuve BGC, 2013, BIOMACROMOLECULES, V14, P4388, DOI 10.1021/bm401335g; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; McCluskey L, 2008, J NEUROIMMUNOL, V194, P27, DOI 10.1016/j.jneuroim.2007.11.009; Modo MM, 2018, STROKE, V49, P1099, DOI 10.1161/STROKEAHA.117.018293; Morshed KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105357; Nerem RM, 1998, AM J MED SCI, V316, P169, DOI 10.1097/00000441-199809000-00004; Parsha K, 2017, CYTOTHERAPY, V19, P36, DOI 10.1016/j.jcyt.2016.10.006; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Potts Matthew B, 2013, Surg Neurol Int, V4, pS22, DOI 10.4103/2152-7806.109190; Rossetti T, 2016, CELL TRANSPLANT, V25, P645, DOI 10.3727/096368915X690350; Silvestrini MT, 2015, MOL THER, V23, P119, DOI 10.1038/mt.2014.155; Silvestrini MT, 2013, STEREOT FUNCT NEUROS, V91, P92, DOI 10.1159/000343213; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Steinberg GK, 2016, STROKE, V47, P1817, DOI 10.1161/STROKEAHA.116.012995; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Stukel JM, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aa9a4b; Stukel JM, 2016, TISSUE ENG PART B-RE, V22, P173, DOI [10.1089/ten.teb.2015.0380, 10.1089/ten.TEB.2015.0380]; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Torquato S, 2000, PHYS REV LETT, V84, P2064, DOI 10.1103/PhysRevLett.84.2064; Vernon AC, 2011, NEUROCHEM INT, V59, P421, DOI 10.1016/j.neuint.2011.04.001; Whitaker MA, 2011, J MATER SCI-MATER M, V22, P1975, DOI 10.1007/s10856-011-4359-7; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Yin DL, 2010, J NEUROSURG, V113, P240, DOI 10.3171/2010.2.JNS091744	47	15	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 15	2018	8								9194	10.1038/s41598-018-27568-x			17	Multidisciplinary Sciences	Science & Technology - Other Topics	GJ4GQ	WOS:000435338900034	29907825	DOAJ Gold, Green Published			2021-06-18	
J	Baez-Jurado, E; Hidalgo-Lanussa, O; Guio-Vega, G; Ashraf, GM; Echeverria, V; Aliev, G; Barreto, GE				Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Guio-Vega, Gina; Ashraf, Ghulam Md; Echeverria, Valentina; Aliev, Gjumrakch; Barreto, George E.			Conditioned Medium of Human Adipose Mesenchymal Stem Cells Increases Wound Closure and Protects Human Astrocytes Following Scratch Assay In Vitro	MOLECULAR NEUROBIOLOGY			English	Article						Human astrocytes; Brain injury; Conditioned medium; Mesenchymal stem cells; Migration; Scratch	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD-INJURY; HUMAN BONE-MARROW; REACTIVE ASTROCYTES; GLUCOSE DEPRIVATION; MORPHOLOGICAL-CHANGES; NEURITE OUTGROWTH; PARACRINE FACTORS	Astrocytes perform essential functions in the preservation of neural tissue. For this reason, these cells can respond with changes in gene expression, hypertrophy, and proliferation upon a traumatic brain injury event (TBI). Different therapeutic strategies may be focused on preserving astrocyte functions and favor a non-generalized and non-sustained protective response over time post-injury. A recent strategy has been the use of the conditioned medium of human adipose mesenchymal stem cells (CM-hMSCA) as a therapeutic strategy for the treatment of various neuropathologies. However, although there is a lot of information about its effect on neuronal protection, studies on astrocytes are scarce and its specific action in glial cells is not well explored. In the present study, the effects of CM-hMSCA on human astrocytes subjected to scratch assay were assessed. Our findings indicated that CM-hMSCA improved cell viability, reduced nuclear fragmentation, and preserved mitochondrial membrane potential. These effects were accompanied by morphological changes and an increased polarity index thus reflecting the ability of astrocytes to migrate to the wound stimulated by CM-hMSCA. In conclusion, CM-hMSCA may be considered as a promising therapeutic strategy for the protection of astrocyte function in brain pathologies.	[Baez-Jurado, Eliana; Hidalgo-Lanussa, Oscar; Guio-Vega, Gina; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA; [Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Lientur 1457, Concepcion 4080871, Chile; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Moscow Region, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Univ Atlanta, Healthcare Adm, Johns Creek, GA 30097 USA; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile	Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gsampaio@javeriana.edu.co	Valentina Echeverria Moran, BCh/E-7765-2013; Ashraf, Ghulam Md/H-9485-2012; Aliev, Gjumrakch/AAE-7734-2020; Barreto, George E./AAD-7420-2020	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Ashraf, Ghulam Md/0000-0002-9820-2078; Aliev, Gjumrakch/0000-0001-7373-3182; Barreto, George E./0000-0002-6644-1971; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X	PUJ [6260]; Vicerrectoria Academica of PUJ	The authors thank Dr. Camilo Prieto and the staff of the cosmetic surgery in Bogota, Colombia, for the adipose tissue samples. This work was supported by PUJ ID 6260 to GEB and scholarship for doctoral studies awarded by the Vicerrectoria Academica of PUJ to Baez-Jurado E.	Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Aye T, 2011, DIABETES CARE, V34, P1458, DOI 10.2337/dc10-2164; Baez E, 2017, NEUROTOX RES, V32, P163, DOI 10.1007/s12640-017-9733-x; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Beller JA, 2014, NEURAL REGEN RES, V9, P343, DOI 10.4103/1673-5374.128235; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; Brown JIM, 1998, NEUROSURGERY, V42, P1057, DOI 10.1097/00006123-199805000-00060; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Calviello LA, 2017, MINERVA ANESTESIOL, V83, P844, DOI 10.23736/S0375-9393.17.12043-2; Cano V, 2014, NEUROREPORT, V25, P819, DOI 10.1097/WNR.0000000000000180; Chen J, 2015, CELL PHYSIOL BIOCHEM, V37, P1830, DOI 10.1159/000438545; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Ding S, 2014, NEURAL REGEN RES, V9, P2048, DOI 10.4103/1673-5374.147929; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Duncan T, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0567-5; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; FaberElman A, 1995, FASEB J, V9, P1605; Farhan H, 2016, TRENDS CELL BIOL, V26, P241, DOI 10.1016/j.tcb.2015.11.003; FEDOROFF S, 1984, J NEUROSCI RES, V12, P15, DOI 10.1002/jnr.490120103; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; FOKSEANG J, 1995, BRAIN RES, V689, P207, DOI 10.1016/0006-8993(95)00575-B; Frese L, 2016, TRANSFUS MED HEMOTH, V43, P268, DOI 10.1159/000448180; Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13; Gzielo K, 2017, CELL MOL NEUROBIOL, V37, P783, DOI 10.1007/s10571-016-0417-5; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hershey T, 2005, DIABETES CARE, V28, P2372, DOI 10.2337/diacare.28.10.2372; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Huang WY, 2015, J CELL PHYSIOL, V230, P2461, DOI 10.1002/jcp.24981; Huang XQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-145; Ishii T, 2017, J BIOL CHEM, V292, P1240, DOI 10.1074/jbc.M116.748871; Jacobsen CT, 2003, DEV NEUROSCI-BASEL, V25, P207, DOI 10.1159/000072269; Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Johnson KM, 2015, NEUROSCI LETT, V600, P104, DOI 10.1016/j.neulet.2015.06.013; Kane CJM, 2014, ALCOHOL CLIN EXP RES, V38, P384, DOI 10.1111/acer.12244; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim WS, 2008, J DERMATOL SCI, V49, P133, DOI 10.1016/j.jdermsci.2007.08.004; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee DE, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0303-6; Li Z, 2010, INDIAN J BIOCHEM BIO, V47, P359; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meadows EA, 2017, J INT NEUROPSYCH SOC, V23, P451, DOI 10.1017/S1355617717000352; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Mytych J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304575; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI 10.1016/j.mito.2010.10.007; Paco S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2623-4; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Paquet M, 2006, J COMP NEUROL, V494, P752, DOI 10.1002/cne.20854; Pawitan JA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965849; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pirici D, 2009, ROM J MORPHOL EMBRYO, V50, P381; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rutkowska A, 2015, GLIA, V63, P341, DOI 10.1002/glia.22757; Salgado AJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00249; Saur L, 2014, BRAIN STRUCT FUNCT, V219, P293, DOI 10.1007/s00429-012-0500-8; Seaquist ER, 2015, PSYCHOSOM MED, V77, P616, DOI 10.1097/PSY.0000000000000207; Shen CY, 2015, MOL MED REP, V12, P20, DOI 10.3892/mmr.2015.3409; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Song M, 2015, J NEUROSCI RES, V93, P973, DOI 10.1002/jnr.23569; Steele ML, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.018; Stiles MC, 2010, MINERVA MED, V101, P105; Su J, 2012, TRANSL PEDIATR, V1, P108, DOI 10.3978/j.issn.2224-4336.2012.04.06; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun H., 2013, PLOS ONE, V8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8; Tiryaki VM, 2015, NANOMEDICINE-UK, V10, P529, DOI 10.2217/nnm.14.33; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Vardjan N, 2014, GLIA, V62, P566, DOI 10.1002/glia.22626; Walter MNM, 2015, J STEM CELLS REGEN, V11, pP18; Wei X, 2009, NEUROSCI LETT, V462, P76, DOI 10.1016/j.neulet.2009.06.054; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Xiong J., 2006, NEW METHOD STUDYING; Xu C, 2017, INT J NEUROSCI, V127, P1124, DOI 10.1080/00207454.2017.1325884; Yalvac ME, 2013, BRAIN BEHAV IMMUN, V32, P122, DOI 10.1016/j.bbi.2013.03.007; Yamazaki H, 2015, NEUROSCI LETT, V609, P53, DOI 10.1016/j.neulet.2015.10.023; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeng Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119912; Zhang L, 2015, CELL STEM CELL, V17, P735, DOI 10.1016/j.stem.2015.09.012; Zhang L, 2015, TOXICOL LETT, V236, P43, DOI 10.1016/j.toxlet.2015.04.015; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015	116	15	15	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2018	55	6					5377	5392		10.1007/s12035-017-0771-4			16	Neurosciences	Neurosciences & Neurology	GF5FI	WOS:000431991500067	28936798				2021-06-18	
J	Frames, CW; Soangra, R; Lockhart, TE; Lach, J; Ha, DS; Roberto, KA; Lieberman, A				Frames, Christopher W.; Soangra, Rahul; Lockhart, Thurmon E.; Lach, John; Ha, Dong Sam; Roberto, Karen A.; Lieberman, Abraham			Dynamical Properties of Postural Control in Obese Community-Dwelling Older Adults	SENSORS			English	Article						obesity; postural control; nonlinear	TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; UNITED-STATES; BODY-WEIGHT; CEREBRAL CONCUSSION; PHYSICAL-ACTIVITY; BALANCE CONTROL; SWAY; RISK; MEN	Postural control is a key aspect in preventing falls. The aim of this study was to determine if obesity affected balance in community-dwelling older adults and serve as an indicator of fall risk. The participants were randomly assigned to receive a comprehensive geriatric assessment followed by a longitudinal assessment of their fall history. The standing postural balance was measured for 98 participants with a Body Mass Index (BMI) ranging from 18 to 63 kg/m(2), using a force plate and an inertial measurement unit affixed at the sternum. Participants' fall history was recorded over 2 years and participants with at least one fall in the prior year were classified as fallers. The results suggest that body weight/BMI is an additional risk factor for falling in elderly persons and may be an important marker for fall risk. The linear variables of postural analysis suggest that the obese fallers have significantly higher sway area and sway ranges, along with higher root mean square and standard deviation of time series. Additionally, it was found that obese fallers have lower complexity of anterior-posterior center of pressure time series. Future studies should examine more closely the combined effect of aging and obesity on dynamic balance.	[Frames, Christopher W.; Lockhart, Thurmon E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA; [Frames, Christopher W.; Lieberman, Abraham] St Josephs Hosp, Barrow Neurol Inst, MAPC, Phoenix, AZ 85013 USA; [Soangra, Rahul] Chapman Univ, Dept Phys Therapy, Crean Coll Hlth & Behav Sci, Orange, CA 92866 USA; [Lach, John] Univ Virginia, Dept Elect & Comp Engn, Charlottesville, VA 22904 USA; [Ha, Dong Sam] Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp Engn, Blacksburg, VA 24061 USA; [Roberto, Karen A.] Virginia Polytech Inst & State Univ, Ctr Gerontol, Blacksburg, VA 24061 USA	Lockhart, TE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	cframes@asu.edu; soangra@chapman.edu; Thurmon.Lockhart@asu.edu; jlach@virginia.edu; ha@vt.edu; kroberto@vt.edu; abraham.lieberman@dignityhealth.org	Roberto, Karen A./AAC-1805-2019; SOANGRA, RAHUL/C-9625-2014; Lockhart, Thurmon/R-9964-2019	Roberto, Karen A./0000-0003-1153-1811; SOANGRA, RAHUL/0000-0001-9836-1549; Lockhart, Thurmon/0000-0002-7008-5711; Ha, Dong/0000-0003-4838-1773; Lach, John/0000-0002-7105-9996	National Science Foundation-Information and Intelligent Systems (IIS) [1065442, 1547466, 1065262]; National Science Foundation-Smart and Connected Health [1065442, 1547466, 1065262]	This research was supported by the National Science Foundation-Information and Intelligent Systems (IIS) and Smart and Connected Health (1065442, and 1547466, and secondary 1065262).	BALOH RW, 1994, J AM GERIATR SOC, V42, P405, DOI 10.1111/j.1532-5415.1994.tb07489.x; BARTLETT SA, 1986, MED BIOL ENG COMPUT, V24, P219, DOI 10.1007/BF02443942; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; CARROLL JP, 1993, J BIOMECH, V26, P409, DOI 10.1016/0021-9290(93)90004-X; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Dutil M, 2013, AGE, V35, P883, DOI 10.1007/s11357-012-9386-x; Duvigneaud N, 2008, J SPORT MED PHYS FIT, V48, P201; ERA P, 1985, J GERONTOL, V40, P287, DOI 10.1093/geronj/40.3.287; FERNIE GR, 1982, AGE AGEING, V11, P11, DOI 10.1093/ageing/11.1.11; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Fjeldstad Cecilie, 2008, Dyn Med, V7, P4, DOI 10.1186/1476-5918-7-4; Flegal KM, 2004, AM J PUBLIC HEALTH, V94, P1486, DOI 10.2105/AJPH.94.9.1486; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Handrigan GA, 2010, J BIOMECH, V43, P383, DOI 10.1016/j.jbiomech.2009.08.041; Harbourne RT, 2003, DEV PSYCHOBIOL, V42, P368, DOI 10.1002/dev.10110; HASSELKUS BR, 1975, J GERONTOL, V30, P661, DOI 10.1093/geronj/30.6.661; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; Hurley MV, 1998, AGE AGEING, V27, P55, DOI 10.1093/ageing/27.1.55; Jenkins KR, 2004, GERONTOLOGIST, V44, P206, DOI 10.1093/geront/44.2.206; Khandoker AH, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-4; Ko SU, 2010, J BIOMECH, V43, P1104, DOI 10.1016/j.jbiomech.2009.12.004; Kopelman PG, 2000, NATURE, V404, P635; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lockhart T., 2014, FALL RISK PREDICTION; Loughlin PJ, 2003, IEEE ENG MED BIOL, V22, P69, DOI 10.1109/MEMB.2003.1195699; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Melzer I, 2016, OBES RES CLIN PRACT, V10, P151, DOI 10.1016/j.orcp.2015.05.016; Messier SP, 2011, OSTEOARTHR CARTILAGE, V19, P272, DOI 10.1016/j.joca.2010.11.010; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; MURRAY MP, 1980, PHYS THER, V60, P412, DOI 10.1093/ptj/60.4.412; Naugle KM, 2012, ARCH GERONTOL GERIAT, V54, pE134, DOI 10.1016/j.archger.2011.10.017; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Owusu W, 1998, OBES RES, V6, P12, DOI 10.1002/j.1550-8528.1998.tb00309.x; Peeters A, 2004, OBES RES, V12, P1145, DOI 10.1038/oby.2004.143; Peng CK, 1995, J ELECTROCARDIOL, V28, P59, DOI 10.1016/S0022-0736(95)80017-4; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus SM, 2006, BIPOLAR DISORD, V8, P430, DOI 10.1111/j.1399-5618.2006.00375.x; Pincus Steven M., 1995, QUANT NEUROENDOCRINO, V28, P336; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rossi-Izquierdo M, 2016, AGING CLIN EXP RES, V28, P423, DOI 10.1007/s40520-015-0414-4; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Teasdale N, 2007, INT J OBESITY, V31, P153, DOI 10.1038/sj.ijo.0803360; Vaillancourt DE, 2000, CLIN NEUROPHYSIOL, V111, P2046, DOI 10.1016/S1388-2457(00)00467-3; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Wu XF, 2014, NEUROSCI LETT, V583, P49, DOI 10.1016/j.neulet.2014.09.029	59	15	15	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	JUN	2018	18	6							1692	10.3390/s18061692			15	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Chemistry; Engineering; Instruments & Instrumentation	GL0KD	WOS:000436774300026	29794998	DOAJ Gold, Green Published			2021-06-18	
J	Ganslandt, O; Mourtzoukos, S; Stadlbauer, A; Sommer, B; Rammensee, R				Ganslandt, Oliver; Mourtzoukos, Stylianos; Stadlbauer, Andreas; Sommer, Bjoern; Rammensee, Rudolf			Evaluation of a novel noninvasive ICP monitoring device in patients undergoing invasive ICP monitoring: preliminary results	JOURNAL OF NEUROSURGERY			English	Article						intracranial pressure monitoring; diagnostic technique; traumatic brain injury	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE MONITORS; FLUID PRESSURE; INTENSIVE-CARE; CHILDREN; SYSTEM; RISK	OBJECTIVE There is no established method of noninvasive intracranial pressure (NI-ICP) monitoring that can serve as an alternative to the gold standards of invasive monitoring with external ventricular drainage or intraparenchymal monitoring. In this study a new method of NI-ICP monitoring performed using algorithms to determine ICP based on acoustic properties of the brain was applied in patients undergoing invasive ICP (I-ICP) monitoring, and the results were analyzed. METHODS In patients with traumatic brain injury and subarachnoid hemorrhage who were undergoing treatment in a neurocritical intensive care unit, the authors recorded ICP using the gold standard method of invasive external ventricular drainage or intraparenchymal monitoring. In addition, the authors simultaneously measured the ICP noninvasively with a device (the HS-1000) that uses advanced signal analysis algorithms for acoustic signals propagating through the cranium. To assess the accuracy of the NI-ICP method, data obtained using both I-ICP and NI-ICP monitoring methods were analyzed with MATLAB to determine the statistical significance of the differences between the ICP measurements obtained using NI-ICP and I-ICP monitoring. RESULTS Data were collected in 14 patients, yielding 2543 data points of continuous parallel ICP values in recordings obtained from I-ICP and NI-ICP. Each of the 2 methods yielded the same number of data points. For measurements at the >= 17-mm Hg cutoff, which was arbitrarily chosen for this preliminary analysis, the sensitivity and specificity for the NI-ICP monitoring were found to be 0.7541 and 0.8887, respectively. Linear regression analysis indicated that there was a strong positive relationship between the measurements. Differential pressure between NI-ICP and I-ICP was within +/- 3 mm Hg in 63% of data-paired readings and within +/- 5 mm Hg in 85% of data-paired readings. The receiver operating characteristic-area under the curve analysis revealed that the area under the curve was 0.895, corresponding to the overall performance of NI-ICP monitoring in comparison with I-ICP monitoring. CONCLUSIONS This study provides the first clinical data on the accuracy of the HS-1000 NI-ICP monitor, which uses advanced signal analysis algorithms to evaluate properties of acoustic signals traveling through the brain in patients undergoing I-ICP monitoring. The findings of this study highlight the capability of this NI-ICP device to accurately measure ICP noninvasively. Further studies should focus on clinical validation for elevated ICP values.	[Ganslandt, Oliver; Mourtzoukos, Stylianos] Klinikum Stuttgart, Dept Neurosurg, Stuttgart, Germany; [Stadlbauer, Andreas; Sommer, Bjoern; Rammensee, Rudolf] Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany	Ganslandt, O (corresponding author), Katharinenhospital, Klinikum Stuttgart, Kriegsbergstr 60, D-70174 Stuttgart, Germany.	o.ganslandt@klinikum-stuttgart.de	Stadlbauer, Andreas/ABF-6235-2020	Stadlbauer, Andreas/0000-0001-8348-2620			ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; Berlin T, 2008, J NEUROTRAUM, V25, P276; Berlin T, 2015, SPRINGERPLUS, V4, DOI 10.1186/2193-1801-4-10; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Chambers IR, 2001, J NEUROL NEUROSUR PS, V71, P383, DOI 10.1136/jnnp.71.3.383; Collins CDE, 2014, CHILD NERV SYST, V30, P1671, DOI 10.1007/s00381-014-2523-3; Cremer OL, 2008, EUR J ANAESTH, V25, P87, DOI 10.1017/S0265021507003237; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Fernandes HM, 1998, ACT NEUR S, V71, P44; GALETTA S, 1989, J CLIN NEURO-OPHTHAL, V9, P79; Gwer S, 2013, CHILD NERV SYST, V29, P927, DOI 10.1007/s00381-013-2036-5; Hightower Stephanie, 2012, J Spec Oper Med, V12, P19; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Koskinen LOD, 2010, NEUROSURGERY, V67, pE221, DOI [10.1227/01.neu.0000371143.51407.78, 10.1227/01.neu.0000371142.74277.b9, 10.1227/01.NEU.0000371142.74277.B9, 10.1227/01.NEU.0000371143.51407.78]; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; March K, 2005, AACN ADV CRIT CARE, V16, P456, DOI 10.1097/00044067-200510000-00004; McKeating EG, 1998, BRIT J NEUROSURG, V12, P7; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Schimpf Melissa M, 2012, J Trauma Nurs, V19, P160, DOI 10.1097/JTN.0b013e318261cfb4; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Wakerley BR, 2015, J NEUROIMAGING, V25, P111, DOI 10.1111/jon.12100; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	35	15	15	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2018	128	6					1653	1660		10.3171/2016.11.JNS152268			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GP2IM	WOS:000440653000007	28784032	Bronze			2021-06-18	
J	Taylor, AJ; Kim, JH; Ress, D				Taylor, Amanda J.; Kim, Jung Hwan; Ress, David			Characterization of the hemodynamic response function across the majority of human cerebral cortex	NEUROIMAGE			English	Article						Cerebral hemodynamics; fMRI; Neurovascular coupling; Cerebral pathology; Multisensory stimulation	HUMAN VISUAL-CORTEX; SHORT STIMULUS-DURATION; SURFACE-BASED ANALYSIS; EVENT-RELATED FMRI; BLOOD-FLOW; OXYGEN-METABOLISM; BOLD RESPONSE; HUMAN BRAIN; NEGATIVE BOLD; DEFAULT-MODE	A brief (< 4 s) period of neural activation evokes a stereotypical sequence of vascular and metabolic events to create the hemodynamic response function (HRF) measured using functional magnetic resonance imaging (fMRI). Linear analysis of fMRI data requires that the HRF be treated as an impulse response, so the character and temporal stability of the HRF are critical issues. Here, a simple audiovisual stimulus combined with a fast-paced task was used to evoke a strong HRF across a majority, similar to 77%, of cortex during a single scanning session. High spatiotemporal resolution (2-mm voxels, 1.25-s acquisition time) was used to focus HRF measurements specifically on the gray matter for whole brain. The majority of activated cortex responds with positive HRFs, while similar to 27% responds with negative (inverted) HRFs. Spatial patterns of the HRF response amplitudes were found to be similar across subjects. Timing of the initial positive lobe of the HRF was relatively stable across the cortical surface with a mean of 6.1 +/- 0.6 s across subjects, yet small but significant timing variations were also evident in specific regions of cortex. The results provide guidance for linear analysis of fMRI data. More importantly, this method provides a means to quantify neurovascular function across most of the brain, with potential clinical utility for the diagnosis of brain pathologies such as traumatic brain injury.	[Taylor, Amanda J.; Kim, Jung Hwan; Ress, David] Baylor Coll Med, Dept Neurosci Core Adv MRI, Houston, TX 77030 USA	Ress, D (corresponding author), 1 Baylor Plaza S104N, Houston, TX 77030 USA.	ress@bcm.edu		Taylor, Amanda/0000-0002-0947-6297	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HL108143, R01NS095933, K25 HL131997]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K25HL131997, R21HL108143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095933] Funding Source: NIH RePORTER	We thank Michael Beauchamp, Elizabeth Halfen, and John Magnotti for providing thoughtful comments and advice. This work was supported by NIH R21HL108143, NIH R01NS095933, and NIH K25 HL131997.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Bonakdarpour B, 2007, NEUROIMAGE, V36, P322, DOI 10.1016/j.neuroimage.2007.02.035; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Buxton RB, 2012, NEUROIMAGE, V62, P953, DOI 10.1016/j.neuroimage.2012.01.012; Carusone LM, 2002, AM J NEURORADIOL, V23, P1222; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis T. L., 1994, SMR 2 ANN M SAN FRAN, P435; Dilharreguy B, 2003, NEUROIMAGE, V19, P1820, DOI 10.1016/S1053-8119(03)00289-1; Drew PJ, 2011, P NATL ACAD SCI USA, V108, P8473, DOI 10.1073/pnas.1100428108; Drysdale PM, 2010, J THEOR BIOL, V265, P524, DOI 10.1016/j.jtbi.2010.05.026; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fransson P, 1999, MAGN RESON IMAGING, V17, P1, DOI 10.1016/S0730-725X(98)00163-5; Friman O, 2003, NEUROIMAGE, V19, P837, DOI 10.1016/S1053-8119(03)00077-6; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gonzalez-Castillo J, 2015, CEREB CORTEX, V25, P4667, DOI 10.1093/cercor/bhu148; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Griffeth VEM, 2011, NEUROIMAGE, V58, P198, DOI 10.1016/j.neuroimage.2011.05.077; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hernandez L, 2002, NEUROIMAGE, V17, P1018, DOI 10.1006/nimg.2001.1017; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hu XP, 2012, NEUROIMAGE, V62, P1103, DOI 10.1016/j.neuroimage.2012.03.005; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; Huppert TJ, 2007, J CEREBR BLOOD F MET, V27, P1262, DOI 10.1038/sj.jcbfm.9600435; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kannurpatti SS, 2004, J CEREBR BLOOD F MET, V24, P703, DOI 10.1097/01.WCB.0000121232.04853.46; Khan R, 2011, GRAPH MODELS, V73, P313, DOI 10.1016/j.gmod.2010.11.002; Kim J. H., 2013, J CEREB BLOOD FLOW M; Kim JH, 2017, MAGN RESON IMAGING, V39, P53, DOI 10.1016/j.mri.2017.01.019; Kim JH, 2016, NEUROIMAGE, V124, P394, DOI 10.1016/j.neuroimage.2015.08.068; Koide M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/819340; Lin VL, 1999, J CEREBR BLOOD F MET, V19, P853, DOI 10.1097/00004647-199908000-00004; Marshall RS, 2004, CURR OPIN NEUROL, V17, P705, DOI 10.1097/00019052-200412000-00010; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Pfeuffer J, 2003, NEUROIMAGE, V18, P990, DOI 10.1016/S1053-8119(03)00035-1; Puckett AM, 2014, HUM BRAIN MAPP, V35, P5550, DOI 10.1002/hbm.22569; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ress David, 2009, Front Neuroenergetics, V1, P3, DOI 10.3389/neuro.14.003.2009; Ress D, 2007, NEUROIMAGE, V34, P74, DOI 10.1016/j.neuroimage.2006.08.020; Roc AC, 2006, STROKE, V37, P382, DOI 10.1161/01.STR.0000198807.31299.43; Rombouts SARB, 2005, NEUROIMAGE, V26, P1078, DOI 10.1016/j.neuroimage.2005.03.022; ROSTRUP E, 1995, NMR BIOMED, V8, P41, DOI 10.1002/nbm.1940080109; Scolari M, 2015, CURR OPIN BEHAV SCI, V1, P32, DOI 10.1016/j.cobeha.2014.08.003; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shmuel A., 2003, 9 ANN M ORG HUM BRAI; Siegel JS, 2015, J CEREB BLOOD FLOW M; Siero JCW, 2015, MAGN RESON MED, V73, P2283, DOI 10.1002/mrm.25349; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Steffener J, 2010, NEUROIMAGE, V49, P2113, DOI 10.1016/j.neuroimage.2009.11.014; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TURNER R, 1991, MAGNET RESON MED, V22, P159, DOI 10.1002/mrm.1910220117; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; van der Zande FHR, 2005, NEURORADIOLOGY, V47, P114, DOI 10.1007/s00234-004-1274-3; Vazquez AL, 2008, NEUROIMAGE, V42, P49, DOI 10.1016/j.neuroimage.2008.04.024; Wade AR, 2002, NEURON, V36, P993, DOI 10.1016/S0896-6273(02)01138-8; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	79	15	15	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JUN	2018	173						322	331		10.1016/j.neuroimage.2018.02.061			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GD2XB	WOS:000430366000026	29501554	Green Accepted, Bronze			2021-06-18	
J	Rowe, RK; Harrison, JL; Zhang, HT; Bachstetter, AD; Hesson, DP; O'Hara, BF; Greene, MI; Lifshitz, J				Rowe, Rachel K.; Harrison, Jordan L.; Zhang, Hongtao; Bachstetter, Adam D.; Hesson, David P.; O'Hara, Bruce F.; Greene, Mark I.; Lifshitz, Jonathan			Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Diffuse brain injury; Midline fluid percussion; Mouse; Concussion; Cytokines; Tumor necrosis factor	SLEEP REGULATION; MICROGLIAL ACTIVATION; PROTECTIVE ROLE; CELL-DEATH; KAPPA-B; CYTOKINES; MICE; INFLAMMATION; MOUSE; PATHOPHYSIOLOGY	Background: Traumatic brain injury (TBI) begins with the application of mechanical force to the head or brain, which initiates systemic and cellular processes that are hallmarks of the disease. The pathological cascade of secondary injury processes, including inflammation, can exacerbate brain injury-induced morbidities and thus represents a plausible target for pharmaceutical therapies. We have pioneered research on post-traumatic sleep, identifying that injury-induced sleep lasting for 6 h in brain-injured mice coincides with increased cortical levels of inflammatory cytokines, including tumor necrosis factor (TNF). Here, we apply post-traumatic sleep as a physiological bio-indicator of inflammation. We hypothesized the efficacy of novel TNF receptor (TNF-R) inhibitors could be screened using post-traumatic sleep and that these novel compounds would improve functional recovery following diffuse TBI in the mouse. Methods: Three inhibitors of TNF-R activation were synthesized based on the structure of previously reported TNF CIAM inhibitor F002, which lodges into a defined TNFR1 cavity at the TNF-binding interface, and screened for in vitro efficacy of TNF pathway inhibition (I.B phosphorylation). Compounds were screened for in vivo efficacy in modulating post-traumatic sleep. Compounds were then tested for efficacy in improving functional recovery and verification of cellular mechanism. Results: Brain-injured mice treated with Compound 7 (C7) or SGT11 slept significantly less than those treated with vehicle, suggesting a therapeutic potential to target neuroinflammation. SGT11 restored cognitive, sensorimotor, and neurological function. C7 and SGT11 significantly decreased cortical inflammatory cytokines 3 h post-TBI. Conclusions: Using sleep as a bio-indicator of TNF-R-dependent neuroinflammation, we identified C7 and SGT11 as potential therapeutic candidates for TBI.	[Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA; [Harrison, Jordan L.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Basic Med Sci, Phoenix, AZ USA; [Zhang, Hongtao; Hesson, David P.; Greene, Mark I.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bachstetter, Adam D.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Sanders Brown Ctr Aging, Lexington, KY USA; [Bachstetter, Adam D.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [O'Hara, Bruce F.] Univ Kentucky, Dept Biol, Lexington, KY USA	Rowe, RK (corresponding author), Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA.; Rowe, RK (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA.; Rowe, RK (corresponding author), Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA.	rkro222@email.arizona.edu		Bachstetter, Adam/0000-0003-4646-6757; Rowe, Rachel/0000-0002-9034-3159	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS072611]; PCH Mission Support Funds; Diane and Bruce Halle Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31-NS090921]; Science Foundation Arizona Bisgrove Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS090921, R21NS072611] Funding Source: NIH RePORTER	Research reported in this manuscript was supported, in part, by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award numbers R21 NS072611 and PCH Mission Support Funds. The generosity of the Diane and Bruce Halle Foundation and NIH fellowship F31-NS090921 supported JLH during the conduct of these studies. RKR was supported by a Science Foundation Arizona Bisgrove Scholarship during the conduct of these studies.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cavas M, 2005, TOXICOL LETT, V157, P221, DOI 10.1016/j.toxlet.2005.02.003; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Clark IA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-51; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dong Y, 2016, P NATL ACAD SCI USA, V113, P12304, DOI 10.1073/pnas.1605195113; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; Ennaceur A, 1997, BEHAV BRAIN RES, V88, P181, DOI 10.1016/S0166-4328(97)02297-3; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; KRUEGER JM, 1995, ADV NEUROIMMUNOL, V5, P171, DOI 10.1016/0960-5428(95)00007-O; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; KRUEGER JM, 1993, J IMMUNOL, V150, pA82; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Mang GM, 2014, SLEEP, V37, P1383, DOI 10.5665/sleep.3936; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; McShane BB, 2010, J NEUROSCI METH, V193, P321, DOI 10.1016/j.jneumeth.2010.08.024; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Murali R, 2005, P NATL ACAD SCI USA, V102, P10970, DOI 10.1073/pnas.0504301102; Nakachi H, 2012, EUR J PHARMACOL, V679, P132, DOI 10.1016/j.ejphar.2011.12.046; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Rochfort KD, 2015, BIOCHEM SOC T, V43, P702, DOI 10.1042/BST20140319; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Signorell A., 2016, DESCTOOLS TOOLS DESC; Sun YX, 2013, NEUROL SCI, V34, P345, DOI 10.1007/s10072-012-1007-z; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Wang Y, 2013, LAB INVEST, V93, P1024, DOI 10.1038/labinvest.2013.89; Wang YX, 2013, J SURG RES, V182, P127, DOI 10.1016/j.jss.2012.07.071; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	57	15	16	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAY 22	2018	15								154	10.1186/s12974-018-1200-y			14	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	GH0WS	WOS:000433123500002	29789012	DOAJ Gold, Green Published			2021-06-18	
J	Abu Hamdeh, S; Shevchenko, G; Mi, J; Musunuri, S; Bergquist, J; Marklund, N				Abu Hamdeh, Sami; Shevchenko, Ganna; Mi, Jia; Musunuri, Sravani; Bergquist, Jonas; Marklund, Niklas			Proteomic differences between focal and diffuse traumatic brain injury in human brain tissue	SCIENTIFIC REPORTS			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; FATTY-ACID-BINDING; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; AMYLOID-BETA; AXONAL INJURY; HEAD-INJURY; BIOMARKER CANDIDATES; TAU; PATHOLOGY	The early molecular response to severe traumatic brain injury (TBI) was evaluated using biopsies of structurally normal-appearing cortex, obtained at location for intracranial pressure (ICP) monitoring, from 16 severe TBI patients. Mass spectrometry (MS; label free and stable isotope dimethyl labeling) quantitation proteomics showed a strikingly different molecular pattern in TBI in comparison to cortical biopsies from 11 idiopathic normal pressure hydrocephalus patients. Diffuse TBI showed increased expression of peptides related to neurodegeneration (Tau and Fascin, p < 0.05), reduced expression related to antioxidant defense (Glutathione S-transferase Mu 3, Peroxiredoxin-6, Thioredoxindependent peroxide reductase; p < 0.05) and increased expression of potential biomarkers (e.g. Neurogranin, Fatty acid-binding protein, heart p < 0.05) compared to focal TBI. Proteomics of human brain biopsies displayed considerable molecular heterogeneity among the different TBI subtypes with consequences for the pathophysiology and development of targeted treatments for TBI.	[Abu Hamdeh, Sami; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Shevchenko, Ganna; Mi, Jia; Musunuri, Sravani; Bergquist, Jonas] Uppsala Univ, Dept Chem, BMC, Analyt Chem, Uppsala, Sweden; [Mi, Jia; Bergquist, Jonas] Binzhou Med Univ, Med & Pharm Res Ctr, Yantai, Peoples R China	Marklund, N (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden.	niklas.marklund@neuro.uu.se		Marklund, Niklas/0000-0002-9797-5626	Swedish Brain Foundation; Swedish Governmental Agency for Innovation SystemsVinnova; Swedish Research CouncilSwedish Research CouncilEuropean Commission; SRC [6211-2011-4423, 2015-4870]; Lars Hjartat Minne Stiftelse; Stiftelsen for Gamla Tjanarinnor; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31671139]	This work was financed by the Swedish Brain Foundation, the Swedish Governmental Agency for Innovation Systems, and the Swedish Research Council under the framework of EU-ERA-NET NEURON CnsAFlame, Uppsala University Hospital ALF-funds, and Uppsala University. J.B. further acknowledges SRC grant 6211-2011-4423, 2015-4870. Lars Hjartat Minne Stiftelse and Stiftelsen for Gamla Tjanarinnor are also gratefully acknowledged for financial support (GS grants). J.M acknowledges National Natural Science Foundation of China (31671139). We acknowledge Dr. Kristina Guiliana Cesarini for help with cortical biopsies of normal pressure hydrocephalus patients and Dag Sehlin for technical assistance with the A beta ELISA analysis.	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elkhatib N, 2014, CURR BIOL, V24, P1492, DOI 10.1016/j.cub.2014.05.023; Elobeid A, 2016, J NEUROPATH EXP NEUR, V75, P316, DOI 10.1093/jnen/nlw002; Elobeid A, 2015, J NEUROPATH EXP NEUR, V74, P470, DOI 10.1097/NEN.0000000000000191; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Guo LH, 2013, EUR ARCH PSY CLIN N, V263, P553, DOI 10.1007/s00406-013-0405-4; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Herukka SK, 2015, J ALZHEIMERS DIS, V46, P261, DOI 10.3233/JAD-142862; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Manevich Y, 2014, FREE RADICAL BIO MED, V72, P210, DOI 10.1016/j.freeradbiomed.2014.04.002; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Musunuri S, 2014, J PROTEOME RES, V13, P2056, DOI 10.1021/pr401202d; Musunuri S, 2012, ELECTROPHORESIS, V33, P3779, DOI 10.1002/elps.201200474; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Ojo JO, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00057; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; PORTELIUS E, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV267; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Sehlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032014; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sosvorova L, 2014, NEUROENDOCRINOL LETT, V35, P586; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; Stevens RJ, 2011, CURR BIOL, V21, pR402, DOI 10.1016/j.cub.2011.04.020; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tian L, 2014, J ALZHEIMERS DIS, V42, P511, DOI 10.3233/JAD-132192; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Wetterhall M, 2011, ANAL BIOANAL CHEM, V400, P2827, DOI 10.1007/s00216-011-5037-9; Wheble JLC, 2016, J ROY ARMY MED CORPS, V162, P87, DOI 10.1136/jramc-2015-000472; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zanier ER, 2013, BRIT J ANAESTH, V111, P424, DOI 10.1093/bja/aet149; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhou YL, 2016, CHEM-ASIAN J, V11, P805, DOI 10.1002/asia.201501355	72	15	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 1	2018	8								6807	10.1038/s41598-018-25060-0			15	Multidisciplinary Sciences	Science & Technology - Other Topics	GE3KV	WOS:000431113100005	29717219	DOAJ Gold, Green Published			2021-06-18	
J	Murdaugh, DL; Ono, KE; Reisner, A; Burns, TG				Murdaugh, Donna L.; Ono, Kim E.; Reisner, Andrew; Burns, Thomas G.			Assessment of Sleep Quantity and Sleep Disturbances During Recovery From Sports-Related Concussion in Youth Athletes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Adolescent; Brain injury; Child; Rehabilitation; Sleep	HIGH-SCHOOL; COLLEGE-STUDENTS; ACADEMIC-PERFORMANCE; DAYTIME SLEEPINESS; FOOTBALL PLAYERS; SCALE PDSS; IMPACT; PATTERNS; HABITS; SPECIFICITY	Objective: To determine the relation between sleep quantity and sleep disturbances on symptoms and neurocognitive ability during the acute phase (<7d) and after sports-related concussion (SRC; >21d). Design: Prospective inception cohort study. Setting: General community setting of regional middle and high schools. Participants: A sample (N=971) including youth athletes with SRC (n=528) and controls (n=443) (age, 10-18y). Interventions: Not applicable. Main Outcome Measures: Athletes completed the Immediate Post-Concussion Assessment and Cognitive Testing battery. Partial correlation analyses and independent t tests were conducted to assess sleep quantity the night before testing. Multivariate analysis of covariance was used to assess sleep disturbances and their interaction with age. Results: Less sleep quantity was correlated with greater report of cognitive (P=.001) and neuropsychological (P=.024) symptoms specific to prolonged recovery from SRC. Sleep disturbances significantly affect each migraine, cognitive, and neuropsychological symptoms (P<.001). A significant interaction was found between sleep disturbances and age (P=.04) at >21 days post-SRC. Conclusions: Findings emphasize that the continued presence of low sleep quantity and sleep disturbances in youth athletes with SRC should be a specific indicator to health professionals that these athletes are at an increased risk of protracted recovery. Further research should identify additional factors that may interact with sleep to increase the risk of protracted recovery. (C) 2018 by the American Congress of Rehabilitation Medicine	[Murdaugh, Donna L.; Ono, Kim E.; Reisner, Andrew; Burns, Thomas G.] Childrens Healthcare Atlanta, 1547 Clifton Rd NE,Suite 200, Atlanta, GA 30322 USA	Murdaugh, DL (corresponding author), Childrens Healthcare Atlanta, 1547 Clifton Rd NE,Suite 200, Atlanta, GA 30322 USA.	dlmurdaugh@gmail.com		Murdaugh, Donna/0000-0001-8550-8353			Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Buboltz WC, 2001, J AM COLL HEALTH, V50, P131, DOI 10.1080/07448480109596017; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Drake C, 2003, SLEEP, V26, P455; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Graham R., 2014, SPORTS RELATED CONCU; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kelly W.E., 2001, COLL STUD J, V35, P84; Kostyun RO, 2014, AM J SPORTS MED, V133, P1; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mah CD, 2008, SLEEP, V31, pA128; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Mous SE, 2017, APPL NEUROPSYCH-CHIL, V6, P22, DOI 10.1080/21622965.2015.1067214; Neveus T, 2001, ACTA PAEDIATR, V90, P1450; Ohayon MM, 2000, J AM ACAD CHILD PSY, V39, P1549, DOI 10.1097/00004583-200012000-00019; Perez-Chada D, 2007, SLEEP, V30, P1698, DOI 10.1093/sleep/30.12.1698; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Short MA, 2013, NAT SCI SLEEP, V5, P23, DOI 10.2147/NSS.S38369; Trockel MT, 2000, J AM COLL HEALTH, V49, P125, DOI 10.1080/07448480009596294; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3	38	15	15	1	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2018	99	5					960	966		10.1016/j.apmr.2018.01.005			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	GE7CG	WOS:000431387000019	29425698				2021-06-18	
J	Shang, JL; Cheng, Q; Duan, SJ; Li, L; Jia, LY				Shang, Jin-Lin; Cheng, Qing; Duan, Sheng-Jie; Li, Lu; Jia, Li-Ya			Cognitive improvement following ischemia/reperfusion injury induced by voluntary running-wheel exercise is associated with LncMALAT1-mediated apoptosis inhibition	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						ischemia; reperfusion; spontaneous running-wheel; MALAT1; learning and memory; apoptosis	TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; SYNAPTIC PLASTICITY; ENDOTHELIAL-CELLS; NONCODING RNAS; FOCAL ISCHEMIA; EXPRESSION; MALAT1; GENE; RATS	Previous human and animal studies demonstrated that voluntary exercise may improve cognitive function and facilitate neuronal plasticity in ischemia/reperfusion (I/R) models. However, the possible underlying mechanisms remain to be elucidated. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long noncoding RNA (lncRNA), may be associated with the functions and dysfunctions of endothelial cells. The present study investigated whether spontaneous running-wheel (RW) exercise-induced MALAT1 expression changes may be associated with the cognitive improvement of mice following I/R injury. The expression of MALAT1 was evaluated using reverse transcription-quantitative polymerase chain reaction. Artificial MALAT1 and MALAT1 lentiviral mall interfering (siRNA) were used to alter MALAT1 expression levels in vivo. The Morris Water Maze test was performed to evaluate spatial learning and memory retention in the mice. Changes in the apoptotic rates of hippocampal neurons and levels of apoptosis-associated proteins were also detected. The data revealed that MALAT1 increased in the hippocampus of mice in the RW-treated I/R group and that this was associated with neurological, learning and memory improvement, reduced infarction volumes, decreased apoptosis and alterations to expression levels of apoptosis-associated proteins. Following RW training in I/R-injured mice, lentiviral MALAT1 siRNA conduction partially attenuated the protections induced by voluntary RW. However, exogenous MALAT1 treatment increased the protection. The current findings suggested that voluntary RW protected hippocampal neurons from I/R injury and promoted cognitive restoration, which was associated with lncRNA MALAT1-mediated apoptosis inhibition.	[Shang, Jin-Lin; Duan, Sheng-Jie; Li, Lu; Jia, Li-Ya] Changzhi Med Coll, Dept Neurol, Heji Hosp, 271 Taihang East St, Changzhi 046011, Shaanxi, Peoples R China; [Cheng, Qing] Changzhi People Hosp, Dept Geriatr, Changzhi 046011, Shaanxi, Peoples R China	Shang, JL (corresponding author), Changzhi Med Coll, Dept Neurol, Heji Hosp, 271 Taihang East St, Changzhi 046011, Shaanxi, Peoples R China.	jinlinshang139@126.com					Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Burnett MG, 2006, STROKE, V37, P1327, DOI 10.1161/01.STR.0000217305.82123.d8; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dharap A, 2011, STROKE, V42, P1105, DOI 10.1161/STROKEAHA.110.598391; Durukan Aysan, 2010, Exp Transl Stroke Med, V2, P2, DOI 10.1186/2040-7378-2-2; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Hu T, 2015, J MOL NEUROSCI, V57, P114, DOI 10.1007/s12031-015-0584-8; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Joo SP, 2013, NEUROSCIENCE, V243, P149, DOI 10.1016/j.neuroscience.2013.03.062; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Kuete V, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0841-y; Lin XM, 2010, CHINESE MED J-PEKING, V123, P1833, DOI 10.3760/cma.j.issn.0366-6999.2010.14.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Miao W, 2016, MOL MED REP, V14, P2582, DOI 10.3892/mmr.2016.5576; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Moghimi M, 2016, IRAN J BASIC MED SCI, V19, P960; Niland Courtney N., 2012, Frontiers in Genetics, V3, P25, DOI 10.3389/fgene.2012.00025; Puthanveetil P, 2015, J CELL MOL MED, V19, P1418, DOI 10.1111/jcmm.12576; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Thum T, 2014, CIRC RES, V114, P1366, DOI 10.1161/CIRCRESAHA.114.303896; Vaughan L, 2016, AGING NEUROPSYCHOL C, V23, P117, DOI 10.1080/13825585.2015.1058323; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Xin JW, 2017, EXP THER MED, V13, P1225, DOI 10.3892/etm.2017.4095; Xiong XX, 2013, NEUROCHEM INT, V62, P265, DOI 10.1016/j.neuint.2012.11.016; XiYang YB, 2016, MOL NEUROBIOL, V53, P955, DOI 10.1007/s12035-014-9048-3; Yan J, 2016, MOL CLIN ONCOL, V4, P100, DOI 10.3892/mco.2015.657; Zhang J, 2016, EXP NEUROL, V277, P162, DOI 10.1016/j.expneurol.2015.12.014; Zhang Q, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1085-4; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348	38	15	15	0	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2018	41	5					2715	2723		10.3892/ijmm.2018.3484			9	Medicine, Research & Experimental	Research & Experimental Medicine	GB5HU	WOS:000429095900027	29436629	Other Gold, Green Published			2021-06-18	
J	Carlson, SW; Saatman, KE				Carlson, Shaun W.; Saatman, Kathryn E.			Central Infusion of Insulin-Like Growth Factor-1 Increases Hippocampal Neurogenesis and Improves Neurobehavioral Function after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; hippocampus; IGF-1; neurogenesis; TBI	CONTROLLED CORTICAL IMPACT; DENTATE GYRUS; IGF-I; NEURONAL DIFFERENTIATION; GRANULE CELLS; ADULT RATS; MOUSE; MEMORY; AKT; PHOSPHORYLATION	Traumatic brain injury (TBI) produces neuronal dysfunction and cellular loss that can culminate in lasting impairments in cognitive and motor abilities. Therapeutic agents that promote repair and replenish neurons post-TBI hold promise in improving recovery of function. Insulin-like growth factor-1 (IGF-1) is a neurotrophic factor capable of mediating neuroprotective and neuroplasticity mechanisms. Targeted overexpression of IGF-1 enhances the generation of hippocampal newborn neurons in brain-injured mice; however, the translational neurogenic potential of exogenously administered IGF-1 post-TBI remains unknown. In a mouse model of controlled cortical impact, continuous intracerebroventricular infusion of recombinant human IGF-1 (hIGF) for 7 days, beginning 15 min post-injury, resulted in a dose-dependent increase in the number of immature neurons in the hippocampus. Infusion of 10 mu g/day of IGF-1 produced detectable levels of hIGF-1 in the cortex and hippocampus and a concomitant increase in protein kinase B activation in the hippocampus. Both motor function and cognition were improved over 7 days post-injury in IGF-1-treated cohorts. Vehicle-treated brain-injured mice showed reduced hippocampal immature neuron density relative to sham controls at 7 days post-injury. In contrast, the density of hippocampal immature neurons in brain-injured mice receiving acute onset IGF-1 infusion was significantly higher than in injured mice receiving vehicle and equivalent to that in sham-injured control mice. Importantly, the neurogenic effect of IGF-1 was maintained with as much as a 6-h delay in the initiation of infusion. These data suggest that central infusion of IGF-1 enhances the generation of immature neurons in the hippocampus, with a therapeutic window of at least 6h post-injury, and promotes neurobehavioral recovery post-TBI.	[Carlson, Shaun W.; Saatman, Kathryn E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B473 Biomed & Biol Res Bldg, Lexington, KY 40536 USA; [Carlson, Shaun W.] Univ Pittsburgh, Dept Neurol Surg, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA	Saatman, KE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B473 Biomed & Biol Res Bldg, Lexington, KY 40536 USA.	k.saatman@uky.edu		Carlson, Shaun/0000-0002-1413-5075	Kentucky Spinal Cord and Head Injury Research Trust [KSCHIRT 7-20, 14-12A]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS072302, P30 NS051220, F32 NS090748]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS090748] Funding Source: NIH RePORTER	This work was supported by Kentucky Spinal Cord and Head Injury Research Trust grants KSCHIRT 7-20 and 14-12A and National Institutes of Health grants R01 NS072302, P30 NS051220, and F32 NS090748. The authors thank Sindhu K. Madathil, PhD, and Jennifer Brelsfoard for their assistance in these experiments.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; ADAMO M, 1989, MOL NEUROBIOL, V3, P71, DOI 10.1007/BF02935589; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Arsenijevic Y, 1998, J NEUROSCI, V18, P2118; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; BOZYCZKOCOYNE D, 1993, ANN NY ACAD SCI, V692, P311; Brooker GJF, 2000, J NEUROSCI RES, V59, P332, DOI 10.1002/(SICI)1097-4547(20000201)59:3<332::AID-JNR6>3.0.CO;2-2; Brywe KG, 2005, EUR J NEUROSCI, V21, P1489, DOI 10.1111/j.1460-9568.2005.03982.x; Busiguina S, 2000, NEUROBIOL DIS, V7, P657, DOI 10.1006/nbdi.2000.0311; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cai WK, 2012, J NEUROSCI, V32, P9887, DOI 10.1523/JNEUROSCI.0375-12.2012; Carlson SW, 2017, EXP NEUROL, V289, P55, DOI 10.1016/j.expneurol.2016.12.006; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; CLEMMONS DR, 1993, ANN NY ACAD SCI, V692, P10; CONTRERAS PC, 1995, J PHARMACOL EXP THER, V274, P1443; Craig MM, 2015, BEHAV NEUROSCI, V129, P643, DOI 10.1037/bne0000081; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Escartin C, 2004, NEUROREPORT, V15, P2251, DOI 10.1097/00001756-200410050-00022; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.0.CO;2-8; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; GLUCKMAN PD, 1993, ANN NY ACAD SCI, V692, P138; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Guan J, 1996, NEUROREPORT, V7, P632, DOI 10.1097/00001756-199601310-00061; Guan J, 2001, J CEREBR BLOOD F MET, V21, P493, DOI 10.1097/00004647-200105000-00003; Guan J, 2000, BRAIN RES, V859, P286, DOI 10.1016/S0006-8993(00)01988-0; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hatton J, 2006, J NEUROSURG, V105, P843, DOI 10.3171/jns.2006.105.6.843; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Markowska AL, 1998, NEUROSCIENCE, V87, P559, DOI 10.1016/S0306-4522(98)00143-2; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McCurdy RD, 2005, EUR J NEUROSCI, V22, P1581, DOI 10.1111/j.1460-9568.2005.04355.x; Mir S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03641-9; Mustafa A, 1999, DEMENT GERIATR COGN, V10, P446, DOI 10.1159/000017188; Nagaraja Tavarekere N, 2005, Cerebrospinal Fluid Res, V2, P5, DOI 10.1186/1743-8454-2-5; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Pardridge W. M., 1991, PEPTIDE DRUG DELIVER; Paxinos G., 2009, RAT BRAIN STEREOTAXI; Perez-Martin M, 2003, EUR J NEUROSCI, V18, P923, DOI 10.1046/j.1460-9568.2003.02830.x; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rubovitch V, 2011, NEUROCHEM INT, V58, P443, DOI 10.1016/j.neuint.2011.01.009; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; RUDICK RA, 1982, J NEUROSCI METH, V6, P253, DOI 10.1016/0165-0270(82)90088-7; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; SARA VR, 1988, PROG BRAIN RES, V73, P87; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Song Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32095; Stewart-Wallace AM, 1939, BRAIN, V62, P426, DOI 10.1093/brain/62.4.426; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Suto T, 2014, PAIN, V155, P1935, DOI 10.1016/j.pain.2014.05.014; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trejo JL, 2001, J NEUROSCI, V21, P1628; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang J, 2007, J NEUROSCI RES, V85, P1618, DOI 10.1002/jnr.21289; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008	96	15	16	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	13					1467	1480		10.1089/neu.2017.5374		APR 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GJ4CQ	WOS:000430445900001	29455576	Green Published			2021-06-18	
J	Calviello, L; Donnelly, J; Cardim, D; Robba, C; Zeiler, FA; Smielewski, P; Czosnyka, M				Calviello, L.; Donnelly, J.; Cardim, D.; Robba, C.; Zeiler, F. A.; Smielewski, P.; Czosnyka, M.			Compensatory-Reserve-Weighted Intracranial Pressure and Its Association with Outcome After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Intracranial pressure; Brain trauma; Compensatory reserve; Mortality	HEAD-INJURY; NEUROCRITICAL CARE; VOLUME-PRESSURE; PLATEAU WAVES; HYPERTENSION; THRESHOLDS; REACTIVITY; TRIAL; ICP	Objective We introduced 'compensatory-reserve-weighted intracranial pressure (ICP),' named 'weightedICP' for brevity, as a variable that may better describe changes leading to mortality after traumatic brain injury (TBI) over the standard mean ICP. Methods ICP was monitored prospectively in over 1023 sedated and ventilated patients. The RAP coefficient (R-correlation, A-amplitude, and P-pressure) was calculated as the running correlation coefficient between slow changes in the pulse amplitude of ICP and the mean ICP. RAP has a value of 0 on the linear part of the pressure-volume curve and a value of + 1 on the ascending exponential part. Then, RAP decreases towards zero or even becomes negative when ICP increases further-a phenomenon thought to be related to the critical closing of cerebral vessels. In this study, we investigated a derived variable called weightedICP, calculated as ICP*(1 - RAP). Results Mortality after TBI was associated with both elevated ICP and weightedICP. Analysis of variance showed higher values of test statistics for weightedICP (K = 93) than for ICP (K = 64) in outcome categorization. Additionally, receiver operator curve analysis indicated greater area under the curve for weightedICP (0.71) than for ICP (0.67) with respect to associated mortality; however, the difference was not statistically significant (p = 0.12). The best threshold (maximizing sensitivity and specificity) was 19.5 mm Hg for mean ICP, and 8 mm Hg for weightedICP. Mortality rate expressed as a function of mean ICP and weightedICP showed an ascending profile in both cases. Conclusion The proposed variable shows a significant association with mortality following head injury. It is sensitive to both the rising absolute ICP and to the critical deterioration of pressure-volume compensation.	[Calviello, L.; Donnelly, J.; Cardim, D.; Robba, C.; Zeiler, F. A.; Smielewski, P.; Czosnyka, M.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Brain Phys Lab, Cambridge Biomed Campus, Cambridge, England; [Robba, C.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Dept Med, Cambridge, England; [Czosnyka, M.] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Zeiler, F. A.] Univ Cambridge, Dept Anesthesiol, Cambridge, England; [Czosnyka, M.] Cambridge Univ Hosp, Neurosurg Unit, Cambridge Biomed Campus,Box 167, Cambridge CB2 0QQ, England	Czosnyka, M (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Brain Phys Lab, Cambridge Biomed Campus, Cambridge, England.; Czosnyka, M (corresponding author), Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland.; Czosnyka, M (corresponding author), Cambridge Univ Hosp, Neurosurg Unit, Cambridge Biomed Campus,Box 167, Cambridge CB2 0QQ, England.	mc141@medschl.cam.ac.uk	Cardim, Danilo Augusto/B-8447-2012; Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018; Robba, Chiara/AAS-7421-2020	Cardim, Danilo Augusto/0000-0002-9261-1321; Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Zeiler, Frederick/0000-0003-1737-0510; czosnyka, marek/0000-0003-2446-8006	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: Medline		ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cushing H, 1926, 3 CIRCULATION STUDIE; CZOSNYKA M, 1994, INT J CLIN MONIT COM, V11, P223, DOI 10.1007/BF01139874; Czosnyka M, 2005, ACT NEUR S, V95, P341; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Donnelly J, 2017, J CEREBR BLOOD F MET, V37, P694, DOI 10.1177/0271678X16639060; Eide PK, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-14; Hall A, 2016, ACTA NEUROCHIR, V158, P1997, DOI 10.1007/s00701-016-2932-z; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; KUSSKE JA, 1973, J NEUROSURG, V38, P591, DOI 10.3171/jns.1973.38.5.0591; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Smielewski P, 2005, ACT NEUR S, V95, P43; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Varsos GV, 2014, NEUROCRIT CARE, V20, P40, DOI 10.1007/s12028-013-9913-3; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678	27	15	16	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2018	28	2					212	220		10.1007/s12028-017-0475-7			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	GF5GM	WOS:000431994700011	29043546				2021-06-18	
J	Goodrich-Hunsaker, NJ; Abildskov, TJ; Black, G; Bigler, ED; Cohen, DM; Mihalov, LK; Bangert, BA; Taylor, HG; Yeates, KO				Goodrich-Hunsaker, Naomi J.; Abildskov, Tracy J.; Black, Garrett; Bigler, Erin D.; Cohen, Daniel M.; Mihalov, Leslie K.; Bangert, Barbara A.; Taylor, H. Gerry; Yeates, Keith O.			Age- and sex-related effects in children with mild traumatic brain injury on diffusion magnetic resonance imaging properties: A comparison of voxelwise and tractography methods	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						diffusion tensor imaging; mild traumatic brain injury; pediatric; development; white matter integrity	WHITE-MATTER TRACTS; CORTICAL THICKNESS; MRI; DTI; SEGMENTATION; PARAMETERIZATION; MICROSTRUCTURE; REGISTRATION; ADOLESCENCE; RELIABILITY	Although there are several techniques to analyze diffusion-weighted imaging, any technique must be sufficiently sensitive to detect clinical abnormalities. This is especially critical in disorders like mild traumatic brain injury (mTBI), where pathology is likely to be subtle. mTBI represents a major public health concern, especially for youth under 15 years of age. However, the developmental period from birth to 18 years is also a time of tremendous brain changes. Therefore, it is important to establish the degree of age-and sex-related differences. Participants were children aged 8-15 years with mTBI or mild orthopedic injuries. Imaging was obtained within 10 days of injury. We performed tract-based spatial statistics (TBSS), deterministic tractography using Automated Fiber Quantification (AFQ), and probabilistic tractography using TRACULA (TRActs Constrained by UnderLying Anatomy) to evaluate whether any method provided improved sensitivity at identifying group, developmental, and/or sex-related differences. Although there were no group differences from any of the three analyses, many of the tracts, but not all, revealed increases of fractional anisotropy and decreases of axial, radial, and mean diffusivity with age. TBSS analyses resulted in age-related changes across all white matter tracts. AFQ and TRACULA revealed age-related changes within the corpus callosum, cingulum cingulate, corticospinal tract, inferior and superior longitudinal fasciculus, and uncinate fasciculus. The results are in many ways consistent across all three methods. However, results from the tractography methods provided improved sensitivity and better tract-specific results for identifying developmental and sex-related differences within the brain.	[Goodrich-Hunsaker, Naomi J.; Abildskov, Tracy J.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Black, Garrett] Ohio State Univ, Fisher Coll Business, Columbus, OH 43210 USA; [Cohen, Daniel M.; Mihalov, Leslie K.] Nationwide Childrens Hosp, Div Emergency Med, Columbus, OH USA; [Bangert, Barbara A.] Case Western Reserve Univ, Sch Med, Dept Radiol, Cleveland, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Yeates, Keith O.] Univ Calgary, Dept Psychol, 2500 Univ Dr NW,AD254, Calgary, AB T2N 1N4, Canada	Yeates, KO (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW,AD254, Calgary, AB T2N 1N4, Canada.	kyeates@ucalgary.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Predicting Outcomes in Children with Mild Traumatic Brain Injury [1R01HD076885]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD076885] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Predicting Outcomes in Children with Mild Traumatic Brain Injury, 1R01HD076885.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Bookstein F. L, 2001, WORKSH BIOM STAT; Chen Z, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00009; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Concha L, 2012, NEUROLOGY, V79, P455, DOI 10.1212/WNL.0b013e31826170b6; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Drakesmith M, 2016, JAMA PSYCHIAT, V73, P396, DOI 10.1001/jamapsychiatry.2015.3375; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Fink AZ, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150753; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Geng XJ, 2012, NEUROIMAGE, V61, P542, DOI 10.1016/j.neuroimage.2012.03.057; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Goodrich-Hunsaker N., 2017, AUTOMATED FIBER QUAN; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Herting MM, 2012, CEREB CORTEX, V22, P1979, DOI 10.1093/cercor/bhr246; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johnson CP, 2015, NEUROIMAGE-CLIN, V9, P668, DOI 10.1016/j.nicl.2015.10.009; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kodiweera C, 2016, NEUROIMAGE, V128, P180, DOI 10.1016/j.neuroimage.2015.12.033; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lin FC, 2006, NEUROIMAGE, V33, P154, DOI 10.1016/j.neuroimage.2006.03.055; Mirzaalian H, 2016, NEUROIMAGE, V135, P311, DOI 10.1016/j.neuroimage.2016.04.041; Myall NJ, 2013, J CHILD NEUROL, V28, P771, DOI 10.1177/0883073812449693; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Donnell LJ, 2009, NEUROIMAGE, V45, P832, DOI 10.1016/j.neuroimage.2008.12.023; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Robinson Emma C, 2013, Inf Process Med Imaging, V23, P475, DOI 10.1007/978-3-642-38868-2_40; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schmithorst VJ, 2008, HUM BRAIN MAPP, V29, P696, DOI 10.1002/hbm.20431; Schwehm A, 2016, NEUROPSYCHOPHARMACOL, V41, P2473, DOI 10.1038/npp.2016.47; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stephens R, 2009, NEUROREPORT, V20, P1056, DOI 10.1097/WNR.0b013e32832e64b1; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Uda S, 2015, DEV NEUROSCI-BASEL, V37, P182, DOI 10.1159/000373885; van Hemmen J, 2017, CEREB CORTEX, V27, P2994, DOI 10.1093/cercor/bhw156; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Walker L, 2016, NEUROIMAGE, V124, P1125, DOI 10.1016/j.neuroimage.2015.05.083; Wang YY, 2012, BRAIN RES, V1478, P1, DOI 10.1016/j.brainres.2012.08.038; Wassermann D, 2011, LECT NOTES COMPUT SC, V6801, P320, DOI 10.1007/978-3-642-22092-0_27; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yeatman JD, 2011, J COGNITIVE NEUROSCI, V23, P3304, DOI 10.1162/jocn_a_00061; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023	62	15	15	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		626	641		10.1002/jnr.24142			16	Neurosciences	Neurosciences & Neurology	FV2DK	WOS:000424374300013	28984377	Green Accepted			2021-06-18	
J	Pagulayan, KF; Rau, H; Madathil, R; Werhane, M; Millard, SP; Petrie, EC; Parmenter, B; Peterson, S; Sorg, S; Hendrickson, R; Mayer, C; Meabon, JS; Huber, BR; Raskind, M; Cook, DG; Peskind, ER				Pagulayan, Kathleen F.; Rau, Holly; Madathil, Renee; Werhane, Madeleine; Millard, Steven P.; Petrie, Eric C.; Parmenter, Brett; Peterson, Sarah; Sorg, Scott; Hendrickson, Rebecca; Mayer, Cindy; Meabon, James S.; Huber, Bertrand R.; Raskind, Murray; Cook, David G.; Peskind, Elaine R.			Retrospective and Prospective Memory Among OEF/OIF/OND Veterans With a Self-Reported History of Blast-Related mTBI	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain Concussion; Veteran; Iraq War; Memory; PTSD; Cognition	TRAUMATIC BRAIN-INJURY; INTENTIONS SCREENING-TEST; WHITE-MATTER ABNORMALITIES; NEUROPSYCHOLOGICAL OUTCOMES; FUNCTIONAL CONNECTIVITY; EXECUTIVE FUNCTION; OIF/OEF VETERANS; SERVICE MEMBERS; WORKING-MEMORY; HIV-INFECTION	Objectives: To evaluate prospective and retrospective memory abilities in Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) Veterans with and without a self-reported history of blast-related mild traumatic brain injury (mTBI). Methods: Sixty-one OEF/OIF/OND Veterans, including Veterans with a self-reported history of blast-related mTBI (mTBI group; n=42) and Veterans without a self-reported history of TBI (control group; n=19) completed the Memory for Intentions Test, a measure of prospective memory (PM), and two measures of retrospective memory (RM), the California Verbal Learning Test-II and the Brief Visuospatial Memory Test-Revised. Results: Veterans in the mTBI group exhibited significantly lower PM performance than the control group, but the groups did not differ in their performance on RM measures. Further analysis revealed that Veterans in the mTBI group with current PTSD (mTBI/PTSD+) demonstrated significantly lower performance on the PM measure than Veterans in the control group. PM performance by Veterans in the mTBI group without current PTSD (mTBI/PTSD-) was intermediate between the mTBI/PTSD+ and control groups, and results for the mTBI/PTSD- group were not significantly different from either of the other two groups. Conclusions: Results suggest that PM performance may be a sensitive marker of cognitive dysfunction among OEF/OIF/OND Veterans with a history of self-reported blast-related mTBI and comorbid PTSD. Reduced PM may account, in part, for complaints of cognitive difficulties in this Veteran cohort, even years post-injury.	[Pagulayan, Kathleen F.; Rau, Holly; Madathil, Renee; Millard, Steven P.; Petrie, Eric C.; Parmenter, Brett; Peterson, Sarah; Hendrickson, Rebecca; Mayer, Cindy; Meabon, James S.; Raskind, Murray; Peskind, Elaine R.] Vet Affairs Puget Sound Hlth Care Syst, MIRECC, Vet Affairs VA Northwest Network VISN 20, Seattle, WA 98108 USA; [Pagulayan, Kathleen F.; Petrie, Eric C.; Parmenter, Brett; Meabon, James S.; Raskind, Murray; Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Werhane, Madeleine] San Diego State Univ Univ Calif San Diego SDSU UC, San Diego, CA USA; [Werhane, Madeleine; Sorg, Scott] VASDHS, San Diego, CA USA; [Millard, Steven P.; Cook, David G.] Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98108 USA; [Huber, Bertrand R.] Vet Adm, Jamaica Plain, MA USA; [Huber, Bertrand R.] Boston Univ, Dept Neurol, Boston, MA USA; [Cook, David G.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	Pagulayan, KF (corresponding author), VA Puget Sound Hlth Care Syst, Mail Code S-116 MIRECC,1660 South Columbian Way, Seattle, WA 98108 USA.	farkat@u.washington.edu	Hendrickson, Rebecca/I-4923-2017; Madathil, Renee/AAK-5492-2020; Pagulayan, Kati/AAR-9225-2020	Hendrickson, Rebecca/0000-0003-2377-823X; Petrie, Eric/0000-0003-1188-6321	Department of Veterans Affairs VA Clinical Science Research and Development (R&D) Career Development Award [IK2 CX000516, CX001508-02]; Rehabilitation R&D Service Merit Review Award [B77421]; VA Northwest Network MIRECC; Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs, National Institute of Health [T32 AG000258]; Department of Veterans Affairs Office of R&D Medical Research Service; Veterans AffairsUS Department of Veterans Affairs [I01RX001612, I01RX000521] Funding Source: NIH RePORTER	This material is based on work supported by the Department of Veterans Affairs VA Clinical Science Research and Development (R&D) Career Development Award IK2 CX000516 (K.F.P.) and Award CX001508-02 (S.S.); Rehabilitation R&D Service Merit Review Award B77421 (E.R.P.); VA Northwest Network MIRECC (E.R.P., B.R.H., M.A.R., K.F.P., H.R., E.C.P., C.M., J.S.M., B.R.H.); Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs (B.R.H.), National Institute of Health T32 AG000258 (J.S.M.); Department of Veterans Affairs Office of R&D Medical Research Service (D.G.C., E.R.P.); and an anonymous foundation. The authors have no conflicts of interest to report.	Altgassen M, 2009, COGNITION EMOTION, V23, P1041, DOI 10.1080/02699930802284158; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict R., 1997, BRIEF VISUOSPATIAL M; Blake D. D., 1990, BEHAV THER, V13, P187; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Butcher J. N., 1989, MANUAL RESTANDARDIZE; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Contardo C, 2009, ARCH CLIN NEUROPSYCH, V24, P547, DOI 10.1093/arclin/acp046; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Delis DC, 2000, CALIFORNIA VERBAL LE; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Etkin Amit, 2013, Dialogues Clin Neurosci, V15, P419; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Foa EB, 2007, PROLONGED EXPOSURE T; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gonneaud J, 2014, HUM BRAIN MAPP, V35, P3066, DOI 10.1002/hbm.22385; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Grundgeiger T, 2014, MEMORY, V22, P679, DOI 10.1080/09658211.2013.812220; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; JOHNSTONE B, 1995, NEUROREHABILITATION, V5, P75, DOI 10.3233/NRE-1995-5107; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kamat R, 2014, ASSESSMENT, V21, P742, DOI 10.1177/1073191114530774; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P74, DOI DOI 10.1097/00001199-199309000-00009; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; Kliegel M, 2002, PSYCHOL BEITR, V44, P303, DOI DOI 10.1037/0012-1649.44.2.612; Kliegel M., 2008, PROSPECTIVE MEMORY; Kliegel M, 2011, NEUROPSYCHOLOGIA, V49, P2166, DOI 10.1016/j.neuropsychologia.2011.01.024; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Ling J, 2007, PSYCHOSOM MED, V69, P144, DOI 10.1097/PSY.0b013e31802e0f22; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Marshall AM, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00075; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McCrea M.A., 2008, MILD TRAUAMATIC BRAI; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Meabon J.S., 2016, SCI TRANSL MED, V8, P1; Millard S, 2013, ENVSTATS R PACKAGE E; Morey LC., 2007, PERSONALITY ASSESSME; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Newsome MR, 2016, J INT NEUROPSYCH SOC, V22, P631, DOI 10.1017/S1355617716000448; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Parsons TD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00660; Paxton J, 2014, J INT NEUROPSYCH SOC, V20, P673, DOI 10.1017/S1355617714000575; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Poquette AJ, 2013, J INT NEUROPSYCH SOC, V19, P155, DOI 10.1017/S1355617712001051; R Core Team, 2017, R LANG ENV STAT COMP; Raskin S., 2010, MEMORY INTENTIONS TE; Raskin SA, 2012, NEUROPSYCHOL REHABIL, V22, P40, DOI 10.1080/09602011.2011.632908; Raskin SA, 2009, BRAIN IMPAIR, V10, P76, DOI 10.1375/brim.10.1.76; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Resick PA, 2008, COGNITIVE PROCESSING; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Scott J.C., 2016, J INT NEUROPSYCH SOC, V22, P1; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh TN, 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vedhara K., 2004, PSYCHOL HLTH MED, V9; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Weathers F.W., 1993, 9 ANN C ISTSS SAN AN; Wechsler D., 2001, WECHSLER TEST ADULT; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Woods SP, 2011, REHABIL PSYCHOL, V56, P77, DOI 10.1037/a0022753; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zogg JB, 2010, CLIN NEUROPSYCHOL, V24, P945, DOI 10.1080/13854046.2010.501343	99	15	15	1	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2018	24	4					324	334		10.1017/S1355617717001217			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	GA1JR	WOS:000428072200002	29284552				2021-06-18	
J	Wang, P; Lin, CW; Wu, SY; Huang, KL; Wang, Y; Bao, XM; Zhang, F; Huang, ZH; Teng, HL				Wang, Peng; Lin, Chaowei; Wu, Shiyang; Huang, Kelun; Wang, Yu; Bao, Xiaomei; Zhang, Fan; Huang, Zhihui; Teng, Honglin			Inhibition of Autophagy is Involved in the Protective Effects of Ginsenoside Rb1 on Spinal Cord Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Ginsenoside Rb1; Autophagy; Apoptosis	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; UP-REGULATION; CELL-DEATH; MEDIATED AUTOPHAGY; BECLIN 1; APOPTOSIS; NEURONS; RATS; PHOSPHORYLATION	Spinal cord injury (SCI) is a devastating neurological disorder. Autophagy is induced and plays a crucial role in SCI. Ginsenoside Rb1 (Rb1), one of the major active components extracted from Panax Ginseng CA Meyer, has exhibited neuroprotective effects in various neurodegenerative diseases. However, it remains unknown whether autophagy is involved in the neuroprotection of Rb1 on SCI. In this study, we examined the regulation of autophagy following Rb1 treatment and its involvement in the Rb1-induced neuroprotection in SCI and in vitro injury model. Firstly, we found that Rb1 treatment decreased the loss of motor neurons and promoted function recovery in the SCI model. Furthermore, we found that Rb1 treatment inhibited autophagy in neurons, and suppressed neuronal apoptosis and autophagic cell death in the SCI model. Finally, in the in vitro injury model, Rb1 treatment increased the viability of PC12 cells and suppressed apoptosis by inhibiting excessive autophagy, whereas stimulation of autophagy by rapamycin abolished the anti-apoptosis effect of Rb1. Taken together, these findings suggest that the inhibition of autophagy is involved in the neuroprotective effects of Rb1 on SCI.	[Wang, Peng; Lin, Chaowei; Wu, Shiyang; Huang, Kelun; Wang, Yu; Teng, Honglin] Wenzhou Med Univ, Dept Spine Surg, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Peng; Wu, Shiyang; Bao, Xiaomei; Zhang, Fan; Huang, Zhihui] Wenzhou Med Univ, Inst Neurosci, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Peng; Wu, Shiyang; Bao, Xiaomei; Zhang, Fan; Huang, Zhihui] Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou 325035, Zhejiang, Peoples R China	Teng, HL (corresponding author), Wenzhou Med Univ, Dept Spine Surg, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China.; Huang, ZH (corresponding author), Wenzhou Med Univ, Inst Neurosci, Wenzhou 325035, Zhejiang, Peoples R China.; Huang, ZH (corresponding author), Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou 325035, Zhejiang, Peoples R China.	hzhzju021@163.com; honlinten@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571190, 81371350, 31671071]; Foundation of Zhejiang Educational Committee [Y201636785]	This work was supported by National Natural Science Foundation of China (81571190, 81371350, 31671071), and Foundation of Zhejiang Educational Committee (Y201636785).	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Bisicchia E, 2017, MOL NEUROBIOL, V54, P4896, DOI 10.1007/s12035-016-0031-z; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Chen BY, 2015, NEUROCHEM RES, V40, P531, DOI 10.1007/s11064-014-1498-5; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Chen W, 2016, CELL MOL NEUROBIOL, V36, P1057, DOI 10.1007/s10571-015-0299-y; Cheong CU, 2016, MOLECULES, V21, DOI 10.3390/molecules21070898; Cho IH, 2012, J GINSENG RES, V36, P342, DOI 10.5142/jgr.2012.36.4.342; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; Goldshmit Y, 2015, MOL CELL NEUROSCI, V68, P82, DOI 10.1016/j.mcn.2015.04.006; Guo ZS, 2014, J NEUROSCI RES, V92, P1295, DOI 10.1002/jnr.23400; Huang F, 2015, MOL MED REP, V11, P3565, DOI 10.3892/mmr.2015.3162; ISAAC L, 1995, SURG NEUROL, V43, P484, DOI 10.1016/0090-3019(95)80094-W; Jang M, 2016, J PAIN, V17, P282, DOI 10.1016/j.jpain.2015.10.007; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, AUTOPHAGY, V5, P390, DOI 10.4161/auto.5.3.7724; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim SO, 2010, CELL MOL NEUROBIOL, V30, P857, DOI 10.1007/s10571-010-9513-0; Lee MJ, 2016, MOL NEUROBIOL, V53, P1977, DOI 10.1007/s12035-015-9131-4; Lee MS, 2009, J ALZHEIMERS DIS, V18, P339, DOI 10.3233/JAD-2009-1149; Lepine S, 2011, J BIOL CHEM, V286, P44380, DOI 10.1074/jbc.M111.257519; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Lim JH, 1997, NEUROSCI RES, V28, P191, DOI 10.1016/S0168-0102(97)00041-2; Lin CW, 2016, NEUROSCI BULL, V32, P137, DOI 10.1007/s12264-016-0017-x; Luo TF, 2014, INT J MOL SCI, V15, P15426, DOI 10.3390/ijms150915426; Malagelada C, 2006, J NEUROSCI, V26, P9996, DOI 10.1523/JNEUROSCI.3292-06.2006; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Seo JY, 2015, SPINE, V40, P883, DOI 10.1097/BRS.0000000000000845; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Sirbulescu RF, 2010, NEUROSCIENCE, V171, P599, DOI 10.1016/j.neuroscience.2010.09.002; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; Wang Z, 2008, CARDIOVASC DRUG THER, V22, P443, DOI 10.1007/s10557-008-6129-4; Xue JF, 2006, BRAIN RES, V1106, P91, DOI 10.1016/j.brainres.2006.05.106; Yang H, 2009, CELL MOL NEUROBIOL, V29, P455, DOI 10.1007/s10571-008-9337-3; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284; Zhou KL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020466	47	15	17	2	13	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	APR	2018	38	3					679	690		10.1007/s10571-017-0527-8			12	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	FY3IZ	WOS:000426713900010	28762191				2021-06-18	
J	Streijger, F; So, K; Manouchehri, N; Gheorghe, A; Okon, EB; Chan, RM; Ng, B; Shortt, K; Sekhon, MS; Griesdale, DE; Kwon, BK				Streijger, Femke; So, Kitty; Manouchehri, Neda; Gheorghe, Ana; Okon, Elena B.; Chan, Ryan M.; Ng, Benjamin; Shortt, Katelyn; Sekhon, Mypinder S.; Griesdale, Donald E.; Kwon, Brian K.			A Direct Comparison between Norepinephrine and Phenylephrine for Augmenting Spinal Cord Perfusion in a Porcine Model of Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; compression; MAP; microdialysis; oxygenation; porcine model; spinal cord injury; vasopressor support	TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE OXYGENATION; CEREBRAL-BLOOD-FLOW; PRESSURE AUGMENTATION; CORTICAL PERFUSION; DOPAMINE; HEMORRHAGE; MANAGEMENT; SWINE; VALUES	Current clinical guidelines recommend elevating the mean arterial blood pressure (MAP) to increase spinal cord perfusion in patients with acute spinal cord injury (SCI). This is typically achieved with vasopressors such as norepinephrine (NE) and phenylephrine (PE). These drugs differ in their pharmacological properties and potentially have different effects on spinal cord blood flow (SCBF), oxygenation (PO2), and downstream metabolism after injury. Using a porcine model of thoracic SCI, we evaluated how these vasopressors influenced intraparenchymal SCBF, PO2, hydrostatic pressure, and metabolism within the spinal cord adjacent to the injury site. Yorkshire pigs underwent a contusion/compression SCI at T10 and were randomized to receive either NE or PE for MAP elevation of 20 mm Hg, or no MAP augmentation. Prior to injury, a combined SCBF/PO2 sensor, a pressure sensor, and a microdialysis probe were inserted into the spinal cord adjacent to T10 at two locations: a "proximal" site and a "distal" site, 2 mm and 22 mm from the SCI, respectively. At the proximal site, NE and PE resulted in little improvement in SCBF during cord compression. Following decompression, NE resulted in increased SCBF and PO2, whereas decreased levels were observed for PE. However, both NE and PE were associated with a gradual decrease in the lactate to pyruvate (L/P) ratio after decompression. PE was associated with greater hemorrhage through the injury site than that in control animals. Combined, our results suggest that NE promotes better restoration of blood flow and oxygenation than PE in the traumatically injured spinal cord, thus providing a physiological rationale for selecting NE over PE in the hemodynamic management of acute SCI.	[Streijger, Femke; So, Kitty; Manouchehri, Neda; Gheorghe, Ana; Okon, Elena B.; Chan, Ryan M.; Ng, Benjamin; Shortt, Katelyn; Kwon, Brian K.] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada; [Sekhon, Mypinder S.] Univ British Columbia, Vancouver Gen Hosp, Div Crit Care Med, Dept Med, Vancouver, BC, Canada; [Griesdale, Donald E.] Univ British Columbia, Dept Anesthesiol, Vancouver, BC, Canada; [Kwon, Brian K.] Univ British Columbia, Vancouver Spine Surg Inst, Dept Orthopaed, Vancouver, BC, Canada	Kwon, BK (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Orthopaed, Blusson Spinal Cord Ctr, 818 West 10th Ave,6th Floor, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@ubc.ca		Okon, Elena/0000-0001-8568-5771	Wings for Life Spinal Cord Foundation; United States Department of Defense Spinal Cord Injury Research Program; Canada Research Chairs programCanada Research Chairs; VGH & UBC Hospital Foundation	The authors gratefully acknowledge the funding support of the Wings for Life Spinal Cord Foundation, and also the United States Department of Defense Spinal Cord Injury Research Program. Dr. Kwon acknowledges the support of the Canada Research Chairs program and the VGH & UBC Hospital Foundation. The authors also recognize the tremendous support, commitment, and expertise of the staff at the UBC Center for Comparative Medicine (CCM) where these long and complex experiments were performed. These include Dr. Ian Welch (Director), Gordon Gray (Facilities Manager), the clinical veterinarians Dr. Cathy Schuppli, Dr. Shelly McErlane, Dr. Laura Mobrey, Dr. Tamara Godbey, and Dr. Po-Yan Chen, and the amazing team of veterinarian technicians, including Micky Burgess, Kate Cooper, Shanna Dumontier, Kris Gillespie, Rhonda Hildebrandt, Mark Huang, Nicole Jackson, Tina Jorgensen, Stephanie Laprise, Ava McHugh, Kayla Reich, and Belinda To.	Bangash MN, 2012, BRIT J PHARMACOL, V165, P2015, DOI 10.1111/j.1476-5381.2011.01588.x; Brassard P, 2010, J APPL PHYSIOL, V108, P1472, DOI 10.1152/japplphysiol.01206.2009; Catapano JS, 2016, WORLD NEUROSURG, V96, P72, DOI 10.1016/j.wneu.2016.08.053; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Friess SH, 2015, J NEUROTRAUM, V32, P237, DOI 10.1089/neu.2014.3468; Friess SH, 2012, CRIT CARE MED, V40, P2400, DOI 10.1097/CCM.0b013e31825333e6; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Gianotti GC, 2014, ACTA SCI VET, V42; GODDARD J, 1980, J PEDIATR-US, V96, P1057, DOI 10.1016/S0022-3476(80)80641-X; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; KOYAMA K, 1990, PEDIATR NEUROL, V6, P87, DOI 10.1016/0887-8994(90)90039-4; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Kroppenstedt SN, 2002, ACT NEUR S, V81, P225; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; Lucas SJE, 2010, HYPERTENSION, V55, P698, DOI 10.1161/HYPERTENSIONAHA.109.146290; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; Martirosyan NL, 2011, J NEUROSURG-SPINE, V15, P238, DOI 10.3171/2011.4.SPINE10543; Meng L, 2011, BRIT J ANAESTH, V107, P209, DOI 10.1093/bja/aer150; Muzevich KM, 2009, NEUROCRIT CARE, V11, P112, DOI 10.1007/s12028-009-9214-z; Nissen P, 2010, NEUROCRIT CARE, V12, P17, DOI 10.1007/s12028-009-9313-x; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Roy B, 2017, CEREBROVASC DIS, V43, P266, DOI 10.1159/000458536; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Saadoun S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1490-3; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Schomberg DT, 2017, J NEUROTRAUM, V34, P541, DOI 10.1089/neu.2016.4567; Schomberg DT, 2016, TOXICOL PATHOL, V44, P299, DOI 10.1177/0192623315618292; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Soubeyrand M, 2014, EUR SPINE J, V23, P658, DOI 10.1007/s00586-013-3086-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Strauch JT, 2007, ANN THORAC SURG, V83, P2130, DOI 10.1016/j.athoracsur.2007.01.060; Streijger F, 2016, J NEUROTRAUM, V33, P2217, DOI 10.1089/neu.2016.4456; Swindle MM., 2015, SWINE LAB SURG ANEST; Tark BE, 2014, J STROKE CEREBROVASC, V23, P2296, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.018; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; WEI EP, 1975, STROKE, V6, P654, DOI 10.1161/01.STR.6.6.654; Yue J.K., 2017, J NEUROSURG SCI, DOI [10.23736/S0390-561617.04003-6, DOI 10.23736/S0390-561617.04003-6]	47	15	15	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	12					1345	1357		10.1089/neu.2017.5285		MAR 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GJ4ID	WOS:000428574900001	29338544				2021-06-18	
J	Qin, Y; Li, GL; Xu, XH; Sun, ZY; Gu, JW; Gao, FB				Qin, Yang; Li, Gai-Li; Xu, Xian-Hua; Sun, Zhi-Yong; Gu, Jian-Wen; Gao, Fa-Bao			Brain structure alterations and cognitive impairment following repetitive mild head impact: An in vivo MRI and behavioral study in rat	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; In vivo studies; Behavior; MRI; Diffusion tensor imaging	CHRONIC TRAUMATIC ENCEPHALOPATHY; MORRIS WATER MAZE; AXONAL INJURY; MOUSE MODEL; MEMORY; DEFICITS; PATHOPHYSIOLOGY; DEMENTIA; FORCE; DEATH	Mild traumatic brain injury (mTBI) or concussion is a common health issue. Several people repeatedly experience head impact milder than that causing concussion. The present study aimed to confirm the effects of such repeated impact on the brain structure and cognitive abilities. Rat models were established by closed skull weight-drop injury. The animals were anesthetized, subjected to single (s)-sham, s-mTBI, repetitive (r)-sham, and r-mTBI, and recovery times were recorded. MRI, including T2-weighted and diffusion tensor imaging (DTI), as well as, neurological severity scores (mNSS) were assessed for the dynamics of the brain structure and neurological function. Morris water maze (MWM) was used to evaluate the cognitive function. The histological examination of r-mTBI rats revealed the basis of structural changes in the brain. There was no significant difference in the recovery time, MRI, mNSS, and MWM between the s-sham and the s-mTBI groups. Compared with r-sham, r-mTBI induced significant differences in the following aspects. The recovery time was prolonged and beam balance test (BBT) in mNSS increased from day 5. MWM performances were worse even after the BBT was recovered. The volumes of the cortex (CT), hippocampus (HP), and lateral ventricle had changed from day 5, which reached a maximum at day 14. Abnormal DTI parameters were observed in CT, corpus callosum, and HP. Histological analyses showed that both in CT and HP, neuron counts reduced at the end of the experiment. Altogether, these findings indicate that non-symptomatic head injury may result in brain atrophy and cognitive impairment when occurred repeatedly. (C) 2016 Elsevier B.V. All rights reserved.	[Qin, Yang] Third Mil Med Univ, Dept Postgrad, Chongqing, Peoples R China; [Qin, Yang; Sun, Zhi-Yong; Gu, Jian-Wen] Chengdu Mil Gen Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China; [Li, Gai-Li; Xu, Xian-Hua] Chengdu Mil Gen Hosp, Dept Geriatr, Chengdu, Sichuan, Peoples R China; [Gu, Jian-Wen] 306th Hosp PLA, Dept Neurosurg, 9 North Anxiang Chaoyang Dist, Beijing 100101, Peoples R China; [Gao, Fa-Bao] Sichuan Univ, West China Hosp, Dept Radiol, 37 Guoxuexiang, Chengdu 610041, Sichuan, Peoples R China	Gu, JW (corresponding author), 306th Hosp PLA, Dept Neurosurg, 9 North Anxiang Chaoyang Dist, Beijing 100101, Peoples R China.; Gao, FB (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, 37 Guoxuexiang, Chengdu 610041, Sichuan, Peoples R China.	18712482@qq.com; gaofabao@yahoo.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81271395, 81130027]	This work was supported by grants from the National Natural Science Foundation of China (NSFC): Nos. 81271395 (JW Gu) and 81130027 (FB Gao). The authors thank Zhi Q. Wang and Lei Wang for technical assistance with the morris water maze and MRI.	Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gao C, 2014, J CEREBR BLOOD F MET, V34, P1070, DOI 10.1038/jcbfm.2014.56; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liao JC, 2013, MOL MED REP, V7, P1397, DOI 10.3892/mmr.2013.1369; Liu S., 2015, EXP BRAIN RES; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Omalu BI, 2005, NEUROSURGERY, V57, P128; Palacios EM, 2013, J NEUROTRAUM, V30, P1991, DOI 10.1089/neu.2012.2836; Pol-Bodetto S, 2011, BEHAV BRAIN RES, V218, P138, DOI 10.1016/j.bbr.2010.11.043; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RINK A, 1995, AM J PATHOL, V147, P1575; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yoon KJ, 2015, J KOREAN MED SCI, V30, P1496, DOI 10.3346/jkms.2015.30.10.1496; Zhang HA, 2013, ANAT REC, V296, P1207, DOI 10.1002/ar.22715	51	15	16	0	40	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		41	48		10.1016/j.bbr.2016.08.008			8	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400005	27498246				2021-06-18	
J	Toth, A; Kornyei, B; Kovacs, N; Rostas, T; Buki, A; Doczi, T; Bogner, P; Schwarcz, A				Toth, Arnold; Kornyei, Balint; Kovacs, Noemi; Rostas, Tamas; Buki, Andras; Doczi, Tamas; Bogner, Peter; Schwarcz, Attila			Both hemorrhagic and non-hemorrhagic traumatic MRI lesions are associated with the microstructural damage of the normal appearing white matter	BEHAVIOURAL BRAIN RESEARCH			English	Article						MRI; Traumatic brain injury; Susceptibility weighted imaging; Diffusion tensor imaging; Traumatic microbleeds; Diffuse axonal injury	DIFFUSE AXONAL INJURY; BRAIN-INJURY; CORPUS-CALLOSUM; CEREBRAL MICROBLEEDS; HEAD-INJURY; DTI METRICS; ECHO MRI; TENSOR; MILD; MODERATE	Traumatic microbleeds (TMBs) and non-hemorrhagic lesions (NHLs) on MRI are regarded as surrogate markers of diffuse axonal injury. However, the actual relation between lesional and diffuse pathology remained unclear, since lesions were related to clinical parameters, largely influenced by extracranial factors. The aim of this study is to directly compare TMBs, NHLs and their regional features with the co-existing diffuse injury of the normal appearing white matter (NAWM) as measured by diffusion tensor imaging (DTI). Thirty-eight adults with a closed traumatic brain injury (12 mild, 4 moderate and 22 severe) who underwent susceptibility weighted imaging (SWI), Tl-, T2 weighted and FLAIR MRI and routine CT were included in the study. TMB (on SWI) and NHL (on T1-, T2 weighted and FLAIR images) features and Rotterdam scores were evaluated. DTI metrics such as fractional anisotropy (FA) and mean diffusivity (MD) were measured over different NAWM regions. Clinical parameters including age; Glasgow Coma Scale; Rotterdam score; TMB and NHL features were correlated to regional NAWM diffusivity using multiple regression. Overall NHL presence and basal ganglia area TMB load were significantly, negatively correlated with the subcortical NAWM FA values (partial r = -0.37 and -0.36; p = 0.006 and 0.025, respectively). The presence of any NHL, or TMBs located in the basal ganglia area indicates diffuse NAWM damage even after adjusting for clinical and CT parameters. To estimate DAI, a conventional lesional MRI pathology evaluation might at least in part substitute the use of quantitative DTI, which is yet not widely feasible in a clinical setting. (C) 2017 Elsevier B.V. All rights reserved.	[Toth, Arnold; Kornyei, Balint; Kovacs, Noemi; Buki, Andras; Doczi, Tamas; Bogner, Peter; Schwarcz, Attila] Pecs Med Sch, Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary; [Toth, Arnold; Rostas, Tamas; Bogner, Peter] Pecs Med Sch, Dept Radiol, Ifjusag Str 13, H-7624 Pecs, Hungary; [Doczi, Tamas] Diagnost Ctr Pecs, Ret U 2, H-7623 Pecs, Hungary; [Buki, Andras; Doczi, Tamas; Schwarcz, Attila] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary	Toth, A (corresponding author), Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary.	prsarn@gmail.com	Kornyei, Balint/AAK-7548-2020		Hungarian Brain Research Program [KTIA_13_NAP-A-II/8, KTIA_13_NAP-A-II/9, SROP-4.2.2.A-11/1/KONV-2012-0017]; Hungarian Scientific Research FundOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [OTKA/K-120356]	This study was funded by Hungarian Brain Research Program - Grant No. KTIA_13_NAP-A-II/8, Grant No. KTIA_13_NAP-A-II/9, SROP-4.2.2.A-11/1/KONV-2012-0017 and Hungarian Scientific Research Fund Grant No. OTKA/K-120356.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akoudad S, 2013, NEUROLOGY, V81, P1930, DOI 10.1212/01.wnl.0000436609.20587.65; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Di Ieva A., 2015, J NEUROSURG, P1; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Engelter ST, 2000, AM J ROENTGENOL, V175, P425, DOI 10.2214/ajr.175.2.1750425; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Geurts B. H., 2012, BRAIN INJ; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; JENKINS A, 1986, LANCET, V2, P445; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kennedy M. R., 2009, J INT NEUROPSYCHOL S, V15; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kumar R, 2013, BRAIN RES, V1512, P22, DOI 10.1016/j.brainres.2013.03.028; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Schoonjans F, 1995, COMPUT METH PROG BIO, V48, P257, DOI 10.1016/0169-2607(95)01703-8; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Stadlbauer A, 2008, RADIOLOGY, V247, P179, DOI 10.1148/radiol.2471070707; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	71	15	16	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		106	116		10.1016/j.bbr.2017.02.039			11	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400013	28249729				2021-06-18	
J	Aiolfi, A; Khor, D; Cho, J; Benjamin, E; Inaba, K; Demetriades, D				Aiolfi, Alberto; Khor, Desmond; Cho, Jayun; Benjamin, Elizabeth; Inaba, Kenji; Demetriades, Demetrios			Intracranial pressure monitoring in severe blunt head trauma: does the type of monitoring device matter?	JOURNAL OF NEUROSURGERY			English	Article						isolated severe head trauma; ICP monitoring devices; outcomes; traumatic brain injury	BRAIN-INJURY; MORTALITY; IMPACT	OBJECTIVE Intracranial pressure (ICP) monitoring has become the standard of care in the management of severe head trauma. Intraventricular devices (IVDs) and intraparenchymal devices (IPDs) are the 2 most commonly used techniques for ICP monitoring. Despite the widespread use of these devices, very few studies have investigated the effect of device type on outcomes. The purpose of the present study was to compare outcomes between 2 types of ICP monitoring devices in patients with isolated severe blunt head trauma. METHODS This retrospective observational study was based on the American College of Surgeons Trauma Quality Improvement Program database, which was searched for all patients with isolated severe blunt head injury who had an ICP monitor placed in the 2-year period from 2013 to 2014. Extracted variables included demographics, comorbidities, mechanisms of injury, head injury specifics (epidural, subdural, subarachnoid, intracranial hemorrhage, and diffuse axonal injury), Abbreviated Injury Scale (AIS) score for each body area, Injury Severity Score (ISS), vital signs in the emergency department, and craniectomy. Outcomes included 30-day mortality, complications, number of ventilation days, intensive care unit and hospital lengths of stay, and functional independence. RESULTS During the study period, 105,721 patients had isolated severe traumatic brain injury (head AIS score >= 3). Overall, an ICP monitoring device was placed in 2562 patients (2.4%): 1358 (53%) had an IVD and 1204 (47%) had an IPD. The severity of the head AIS score did not affect the type of ICP monitoring selected. There was no difference in the median ISS; ISS > 15; head AIS Score 3, 4, or 5; or the need for craniectomy between the 2 device groups. Unadjusted 30-day mortality was significantly higher in the group with IVDs (29% vs 25.5%, p = 0.046); however, stepwise logistic regression analysis showed that the type of ICP monitoring was not an independent risk factor for death, complications, or functional outcome at discharge. CONCLUSIONS This study demonstrated that compliance with the Brain Trauma Foundation guidelines for ICP monitoring is poor. In isolated severe blunt head injuries, the type of ICP monitoring device does not have any effect on survival, systemic complications, or functional outcome.	[Aiolfi, Alberto; Khor, Desmond; Cho, Jayun; Benjamin, Elizabeth; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, Div Acute Care Surg, Inpatient Tower C,2051 Marengo St,Rm C5L100, Los Angeles, CA 90033 USA	Demetriades, D (corresponding author), Univ Southern Calif, Div Acute Care Surg, Inpatient Tower C,2051 Marengo St,Rm C5L100, Los Angeles, CA 90033 USA.	demetria@usc.edu	INABA, KENJI/AAC-8532-2020; Benjamin, Elizabeth/AAD-2457-2020; Aiolfi, Alberto/ABA-7242-2020	Aiolfi, Alberto/0000-0002-7764-6075			Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Valadka AB, 2015, WORLD NEUROSURG, V84, P211, DOI 10.1016/j.wneu.2015.02.013; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050	14	15	15	1	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2018	128	3					828	833		10.3171/2016.11.JNS162198			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FX7WD	WOS:000426301400021	28548592				2021-06-18	
J	Amick, MM; Meterko, M; Fortier, CB; Fonda, JR; Milberg, WP; McGlinchey, RE				Amick, Melissa M.; Meterko, Mark; Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William P.; McGlinchey, Regina E.			The Deployment Trauma Phenotype and Employment Status in Veterans of the Wars in Iraq and Afghanistan	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; employment; mTBI; PTSD; veterans	BRAIN-INJURY; TEST-PERFORMANCE; US MILITARY; UNEMPLOYMENT; ASSOCIATION; SERVICES	Objectives: To determine the prevalence of comorbid mild traumatic brain injury (mTBI), posttraumatic stress disorder (PTSD), and depression, termed the deployment trauma phenotype (DTP), and its constituent diagnoses' impact on unemployment status in a national cohort of veterans. Setting: Retrospective analysis of the comprehensive TBI evaluation, a Veterans Affairs-wide protocol for assessing TBI, employment status, and psychiatric impressions. Participants: The final data set consisted of 48 821 veterans. Main Outcomes and Measures: Frequency of mTBI, PTSD, and depression in isolation and combinations and their association with unemployment status. Results: Age- and education-adjusted risk ratios (RRs) showed that the mTBI-only group was the least likely to be unemployed, RR = 0.65 (0.59-0.71). By contrast, the greatest likelihood of unemployment was associated with membership in the DTP group, RR = 1.45 (1.36-1.56), and the comorbid PTSD and depression group, RR = 1.39 (1.27-1.52). Furthermore, the DTP was nearly 3 times more prevalent (16.4%) in this sample compared with comorbid PTSD and depression (5.7%), indicating that the DTP conveys risk for unemployment to a significantly greater number of individuals. Conclusions and Relevance: The comorbid and interactive conditions of PTSD, depression, and mTBI, rather than mTBI in isolation, were linked to significant risk for unemployment in this veteran cohort. These findings suggest that multifaceted assessments and interventions to improve postdeployment reintegration are needed.	[Amick, Melissa M.; Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William P.; McGlinchey, Regina E.] Translat Res Ctr TBI & Stress Disorders, Boston, MA USA; [Amick, Melissa M.; Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William P.; McGlinchey, Regina E.] Ctr Geriatr Res Educ & Clin, Boston, MA USA; [Meterko, Mark] VA Boston Healthcare Syst, HSR&D Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Amick, Melissa M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Meterko, Mark] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Fonda, Jennifer R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA	Amick, MM (corresponding author), VA Boston Healthcare Syst, 150 South Huntington Ave, Boston, MA 02130 USA.	Melissa.Amick@Va.gov			Translational Research Center for TBI and Stress Disorders (TRACTS) VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center [B9254-C]; NIH NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258]; VA CSR&D Merit Review Award; VA HSRD [IIR 11-358]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001327, I50RX003001] Funding Source: NIH RePORTER	This study was supported in part by the Translational Research Center for TBI and Stress Disorders (TRACTS) VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center (B9254-C, McGlinchey); NIH NIA K23AG034258 (Fortier); VA CSR&D Merit Review Award (McGlinchey); and VA HSR&D IIR 11-358 (Meterko).	Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; ATKINSON T, 1986, J HEALTH SOC BEHAV, V27, P317, DOI 10.2307/2136947; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P204, DOI 10.1097/HTR.0000000000000168; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU; Erbes CR, 2011, J REHABIL RES DEV, V48, P1159, DOI 10.1682/JRRD.2010.11.0212; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kleylamp M, 2013, SOC SCI RES, V42, P836, DOI 10.1016/j.ssresearch.2012.12.017; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Sturm R, 1999, PSYCHIATR SERV, V50, P1407, DOI 10.1176/ps.50.11.1407; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; U.S. Bureau of Labor Statistics, EMPL STAT CIV NON PO; US Bureau of Labor Statistics, 2009, EMPL STAT VET AG RAC; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanneman ME, 2015, MIL MED, V180, P1052, DOI 10.7205/MILMED-D-14-00682; World Health Organisation (WHO), 2010, MEAS HLTH DIS MAN WH	30	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					E30	E40		10.1097/HTR.0000000000000308			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200004	28422901	Green Accepted			2021-06-18	
J	Brackhan, M; Bascunana, P; Ross, TL; Bengel, FM; Bankstahl, JP; Bankstahl, M				Brackhan, Mirjam; Bascunana, Pablo; Ross, Tobias L.; Bengel, Frank M.; Bankstahl, Jens P.; Bankstahl, Marion			[F-18]GE180 positron emission tomographic imaging indicates a potential double-hit insult in the intrahippocampal kainate mouse model of temporal lobe epilepsy	EPILEPSIA			English	Article						activated microglia; neuroinflammation; positron emission tomography biomarker; translocator protein	TRAUMATIC BRAIN-INJURY; TRANSLOCATOR PROTEIN; MICROGLIAL ACTIVATION; PLASMINOGEN-ACTIVATOR; HIPPOCAMPAL SCLEROSIS; ANTIEPILEPTIC DRUGS; RECURRENT SEIZURES; GLUCOSE-METABOLISM; RAT MODEL; WILD-TYPE	ObjectiveAccumulating evidence suggests that brain inflammation, elicited by epileptogenic insults, is involved in epilepsy development. Noninvasive nuclear imaging of brain inflammation in animal models of epileptogenesis represents a diagnostic invivo approach with potential for direct translation into the clinic. Here, we investigated up-regulation of the translocator protein (TSPO) indicative of microglial activation by serial [F-18]GE180 positron emission tomographic (PET) imaging in a mouse model of temporal lobe epilepsy. MethodsAs epileptogenic insult, a status epilepticus (SE) was induced in mice by intrahippocampal injection of kainate. Post-SE mice injected with kainate and sham-injected mice were subjected to [F-18]GE180 PET scans before SE and at 2days, 5-7days, 2weeks, 3weeks, 7weeks, and 14weeks postinsult. For data evaluation, brain regions ipsilateral and contralateral to the injection site were outlined by coregistration with a standard mouse brain atlas, and percentage of injected dose per cubic centimeter was calculated. In addition, a statistical parametric mapping analysis, comparing post-SE mice to baseline, sham mice to baseline, and post-SE to sham mice was performed. ResultsFollowing SE, elevations in [F-18]GE180 uptake were most prominent in the ipsilateral hippocampus, occurring between 2days and at least 7weeks after SE, with a peak at 5-7days after SE. In the contralateral hippocampus and other epilepsy-associated brain regions, increased tracer uptake was observed with a similar time profile but to a lesser extent. Moderate enhancement of tracer uptake was also evident in mice after sham surgery. SignificanceTSPO invivo imaging reliably detects brain inflammation during epileptogenesis. These inflammatory processes most prominently affect the hippocampus ipsilateral to the injection site. Inflammation induced by the traumatic insult associated with surgery synergistically contributes to total brain inflammation and may also contribute to epileptogenesis. The revealed time course of neuroinflammation will help to identify appropriate time points for anti-inflammatory, potentially antiepileptogenic treatment.	[Brackhan, Mirjam; Bascunana, Pablo; Ross, Tobias L.; Bengel, Frank M.; Bankstahl, Jens P.] Hannover Med Sch, Dept Nucl Med, Hannover, Germany; [Brackhan, Mirjam; Bankstahl, Marion] Univ Vet Med, Dept Pharmacol Toxicol & Pharm, Hannover, Germany; [Brackhan, Mirjam] Univ Oslo, Sect Neuropathol, Dept Pathol, Oslo, Norway; [Brackhan, Mirjam] Oslo Univ Hosp, Oslo, Norway	Bankstahl, M (corresponding author), Univ Vet Med, Dept Pharmacol Toxicol & Pharm, Hannover, Germany.	marion.bankstahl@tiho-hannover.de	BascuAana, Pablo/AAA-4126-2019; Brackhan, Mirjam/AAF-7886-2021; Bengel, Frank/AAR-7353-2020; Ross, Tobias/K-8628-2013	BascuAana, Pablo/0000-0003-2186-8899; Ross, Tobias/0000-0002-0101-2463; Bankstahl, Marion/0000-0002-5775-188X; Bengel, Frank/0000-0003-4529-7963	European Seventh's Framework Program [602102]	European Seventh's Framework Program (FP7/2007-2013), Grant/Award Number: 602102	Amhaoul H, 2014, NEUROSCIENCE, V279, P238, DOI 10.1016/j.neuroscience.2014.08.044; Amhaoul H, 2015, NEUROBIOL DIS, V82, P526, DOI 10.1016/j.nbd.2015.09.004; Arabadzisz D, 2005, EXP NEUROL, V194, P76, DOI 10.1016/j.expneurol.2005.01.029; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Bertoglio D, 2017, BRAIN BEHAV IMMUN, V61, P69, DOI 10.1016/j.bbi.2016.12.015; Bertram EH, 2008, EPILEPSIA, V49, P256, DOI 10.1111/j.1528-1167.2007.01408.x; Bogdanovic RM, 2014, NEUROPHARMACOLOGY, V85, P104, DOI 10.1016/j.neuropharm.2014.05.002; Bouilleret V, 2000, EPILEPSIA, V41, P642, DOI 10.1111/j.1528-1157.2000.tb00223.x; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Brackhan M, 2016, J NUCL MED, V57, P1302, DOI 10.2967/jnumed.116.172494; Brendel M, 2017, J NUCL MED, V58, P1984, DOI 10.2967/jnumed.117.195107; Brendel M, 2016, J NUCL MED, V57, P954, DOI 10.2967/jnumed.115.167858; Breuer H, 2017, J CEREBR BLOOD F MET, V37, P2049, DOI 10.1177/0271678X16659672; Dedeurwaerdere S, 2014, EPILEPSIA, V55, P819, DOI 10.1111/epi.12642; Dedeurwaerdere S, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-60; Deleye S, 2014, NEUROIMAGE, V96, P276, DOI 10.1016/j.neuroimage.2014.04.004; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Duveau V, 2016, CNS NEUROSCI THER, V22, P497, DOI 10.1111/cns.12523; Friedman A., 2012, JASPERS BASIC MECH E, P513; Gershen LD, 2015, JAMA NEUROL, V72, P882, DOI 10.1001/jamaneurol.2015.0941; Gouder N, 2003, EPILEPSIA, V44, P877, DOI 10.1046/j.1528-1157.2003.03603.x; Groticke I, 2008, EXP NEUROL, V213, P71, DOI 10.1016/j.expneurol.2008.04.036; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; James ML, 2017, THERANOSTICS, V7, P1422, DOI 10.7150/thno.17666; Kadam SD, 2017, EPILEPSIA, V58, P10, DOI 10.1111/epi.13903; Klein S, 2015, NEUROPHARMACOLOGY, V90, P53, DOI 10.1016/j.neuropharm.2014.11.008; Klein S, 2015, EXP NEUROL, V263, P263, DOI 10.1016/j.expneurol.2014.09.004; Liu B, 2015, J NEUROSCI, V35, P15716, DOI 10.1523/JNEUROSCI.0996-15.2015; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z; Mirrione MM, 2007, NEUROIMAGE, V38, P34, DOI 10.1016/j.neuroimage.2007.06.032; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Ory D, 2015, NUCL MED BIOL, V42, P753, DOI 10.1016/j.nucmedbio.2015.06.010; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Russmann V, 2017, NEUROIMAGE-CLIN, V15, P35, DOI 10.1016/j.nicl.2017.04.003; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Sridharan S, 2017, MOL IMAGING BIOL, V19, P77, DOI 10.1007/s11307-016-0984-3; Twele Friederike, 2017, Epilepsia Open, V2, P180, DOI 10.1002/epi4.12044; Twele F, 2016, EPILEPSY BEHAV, V55, P47, DOI 10.1016/j.yebeh.2015.11.027; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2014, NEUROBIOL DIS, V63, P74, DOI 10.1016/j.nbd.2013.11.019; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Wadsworth H, 2012, BIOORG MED CHEM LETT, V22, P1308, DOI 10.1016/j.bmcl.2011.12.084; Yankam Njiwa J, 2017, J CEREB BLOOD FLOW M, V37, P1251; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011	50	15	15	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	MAR	2018	59	3					617	626		10.1111/epi.14009			10	Clinical Neurology	Neurosciences & Neurology	FY6YJ	WOS:000427008500013	29364511				2021-06-18	
J	Wolf, GK; Mauntel, GJ; Kretzmer, T; Crawford, E; Thors, C; Strom, TQ; Vanderploeg, RD				Wolf, Gregory K.; Mauntel, Gregory J.; Kretzmer, Tracy; Crawford, Eric; Thors, Christina; Strom, Thad Q.; Vanderploeg, Rodney D.			Comorbid Posttraumatic Stress Disorder and Traumatic Brain Injury: Generalization of Prolonged-Exposure PTSD Treatment Outcomes to Postconcussive Symptoms, Cognition, and Self-Efficacy in Veterans and Active Duty Service Members	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; postconcussive syndrome; postdeployment; posttraumatic stress disorder; rehabilitation; traumatic brain injury; Veteran	NEUROPSYCHOLOGICAL OUTCOMES; PSYCHOMETRIC PROPERTIES; RANDOMIZED-TRIAL; HEALTH; THERAPY; IRAQ; CARE; ASSOCIATIONS; AFGHANISTAN; INVENTORY	Objectives: To examine (a) generalization of the effectiveness of prolonged exposure (PE) therapy for posttraumatic stress disorder (PTSD) in improving postconcussive symptoms (PCSs) and other outcomes in military service members and Veterans (VA) with histories of mild to severe traumatic brain injury (TBI), and (b) factors associated with PCS reduction. Setting: VA polytrauma medical center. Participants: Consecutive referrals for PTSD treatment of Active Duty (n = 17) or Veterans (n = 27) diagnosed with PTSD and TBI (N = 44). Main Outcome Measures: Neurobehavioral Symptom Inventory, Key Behaviors Change Inventory, Self-Efficacy for Symptom Management, Posttraumatic Stress Disorder Checklist, and Beck Depression Inventory, 2nd edition. Design: Post hoc analysis of archival clinical effectiveness program evaluation data. Interventions: PE for PTSD. Results: There were significant improvements on all outcome measures with large effect sizes (Cohen's d ranging from 0.68 to 2.02). Improvement on PCS (Cohen's d = 1.21) was associated with lower levels of VA service-connected disability and PE treatment completion. Conclusion: PE treatment-related improvements for participants with comorbid PTSD and TBI generalize from PTSD outcomes to PCS and other TBI-related outcomes. Positive outcomes were independent of TBI severity, treatment setting, or Veteran status, but dependent upon PE treatment completion and lower levels of VA service-connected disability.	[Wolf, Gregory K.; Mauntel, Gregory J.; Kretzmer, Tracy; Thors, Christina; Vanderploeg, Rodney D.] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Kretzmer, Tracy; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Crawford, Eric] VA Midatlantic Reg Mental Illness Res Educ & Clin, Durham VA Med Ctr, Durham, NC USA; [Crawford, Eric] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Strom, Thad Q.] Univ Minnesota, Med Ctr, Dept Vet Affairs, Minneapolis, MN 55455 USA; [Strom, Thad Q.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA	Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.	Rodney.Vanderploeg@va.gov		Strom, Thad/0000-0001-6743-9999	Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Health AdministrationUS Department of Veterans Affairs; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This research reported was supported by the Department of Veterans Affairs, Veterans Health Administration, and Defense and Veterans Brain Injury Center with resources and the use of facilities at the James A. Haley Veterans' Hospital. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Army, Department of Defense, Department of Veterans Affairs, or US Government.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books, DOI 10.1176/APPI.BOOKS]; Beck AT., 1996, BECK DEPRESSION INVE, V2; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blake D., 2000, CLIN ADM PTSD SCALE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Cahill S.P., 2003, J COGN PSYCHOTHER, V17, P113, DOI [DOI 10.1891/JCOP.17.2.113.57434, 10.1891/jcop.17.2.113.57434]; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Crawford EF, 2017, J NERV MENT DIS, V205, P140, DOI 10.1097/NMD.0000000000000594; Department of Veteran Affairs, 2010, REP VA CONS C PRACT; Drag L, 2013, J HEAD TRAUMA REHAB, V28, P39, DOI 10.1097/HTR.0b013e318263bb61; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; Foa EB, 2007, PROLONGED EXPOSURE T; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Management of Concussion/mTBIWorking Group, 2009, J REHABIL RES DEV, V46, pCP1; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Myers SS, 2013, P NATL ACAD SCI USA, V110, P18753, DOI 10.1073/pnas.1218656110; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rauch SAM, 2009, DEPRESS ANXIETY, V26, P732, DOI 10.1002/da.20518; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strom TQ, 2016, COGN BEHAV PRACT, V23, P148, DOI 10.1016/j.cbpra.2015.03.003; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tuerk PW, 2013, PSYCHOL SERV, V10, P401, DOI 10.1037/a0030549; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907; US Department of Defense Congressional Report, US MIL CAS STAT OP N; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Weathers F. W., 1993, ANN M INT SOC TRAUMA; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	53	15	15	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					E53	E63		10.1097/HTR.0000000000000344			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200006	28926486				2021-06-18	
J	Zhang, HM; Liu, P; Jiang, C; Jin, XQ; Liu, RN; Li, SQ; Zhao, Y				Zhang, Hong-Mei; Liu, Pei; Jiang, Cheng; Jin, Xiao-Qing; Liu, Rui-Ning; Li, Shun-Qing; Zhao, Yan			Notch signaling inhibitor DAPT provides protection against acute craniocerebral injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GAMMA-SECRETASE; RAT; ISCHEMIA; NEUROGENESIS; APOPTOSIS; AUTOPHAGY; PATHWAYS; MOUSE; DEATH	Notch signaling pathway is involved in many physiological and pathological processes. The gamma-secretase inhibitor DAPT inhibits Notch signaling pathway and promotes nerve regeneration after cerebral ischemia. However, neuroprotective effects of DAPT against acute craniocerebral injury remain unclear. In this study, we established rat model of acute craniocerebral injury, and found that with the increase of damage grade, the expression of Notch and downstream protein Hes1 and Hes5 expression gradually increased. After the administration of DAPT, the expression of Notch, Hes1 and Hes5 was inhibited, apoptosis and oxidative stress decreased, neurological function and cognitive function improved. These results suggest that Notch signaling can be used as an indicator to assess the severity of post-traumatic brain injury. Notch inhibitor DAPT can reduce oxidative stress and apoptosis after acute craniocerebral injury, and is a potential drug for the treatment of acute craniocerebral injury.	[Zhang, Hong-Mei; Jiang, Cheng; Jin, Xiao-Qing; Liu, Rui-Ning; Li, Shun-Qing; Zhao, Yan] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan, Hubei, Peoples R China; [Liu, Pei] Hubei Univ Med, Taihe Hosp, Dept Intens Care Unit, Wuhan, Hubei, Peoples R China	Zhao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan, Hubei, Peoples R China.	doctoryanzhao@163.com			Emergency Diagnostic & Therapeutic Center of Central China	This study was financially supported by the "Emergency Diagnostic & Therapeutic Center of Central China." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Xian-Long Zhou for reviewing the manuscript. This study was financially supported by the "Emergency Diagnostic & Therapeutic Center of Central China".	Altmann C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0132-1; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Evin G, 2006, CNS DRUGS, V20, P351, DOI 10.2165/00023210-200620050-00002; Fazio C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.408; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Huang M, 2014, CHINESE MED J-PEKING, V127, P924, DOI 10.3760/cma.j.issn.0366-6999.20132366; Li SY, 2012, NEUROL SCI, V33, P1257, DOI 10.1007/s10072-012-0948-6; Li ZX, 2016, TRANSL STROKE RES, V7, P132, DOI 10.1007/s12975-015-0441-7; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Pazos MC, 2017, MOL CELL ENDOCRINOL, V440, P125, DOI 10.1016/j.mce.2016.11.025; Pei HF, 2015, FREE RADICAL BIO MED, V82, P114, DOI 10.1016/j.freeradbiomed.2015.02.002; RINK A, 1995, AM J PATHOL, V147, P1575; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang ZX, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-56; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhang GS, 2013, CNS NEUROSCI THER, V19, P53, DOI 10.1111/cns.12032; Zhang L, 2016, CELL MOL NEUROBIOL, V36, P131, DOI 10.1007/s10571-015-0227-1; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037	25	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0193037	10.1371/journal.pone.0193037			13	Multidisciplinary Sciences	Science & Technology - Other Topics	FW4LB	WOS:000425283900100	29447233	DOAJ Gold, Green Published			2021-06-18	
J	Clough, M; Mutimer, S; Wright, DK; Tsang, A; Costello, DM; Gardner, AJ; Stanwell, P; Mychasiuk, R; Sun, MJ; Brady, RD; McDonald, SJ; Webster, KM; Johnstone, MR; Semple, BD; Agoston, DV; White, OB; Frayne, R; Fielding, J; O'Brien, TJ; Shultz, SR				Clough, Meaghan; Mutimer, Steven; Wright, David K.; Tsang, Adrian; Costello, Daniel M.; Gardner, Andrew J.; Stanwell, Peter; Mychasiuk, Richelle; Sun, Mujun; Brady, Rhys D.; McDonald, Stuart J.; Webster, Kyria M.; Johnstone, Maddison R.; Semple, Bridgette D.; Agoston, Denes V.; White, Owen B.; Frayne, Richard; Fielding, Joanne; O'Brien, Terence J.; Shultz, Sandy R.			Oculomotor Cognitive Control Abnormalities in Australian Rules Football Players with a History of Concussion	JOURNAL OF NEUROTRAUMA			English	Article						cavum septum pellucidum; cognition; DTI; functional MRI; ocular motor; mild TBI	CAVUM SEPTUM PELLUCIDUM; APPARENT FIBER DENSITY; OCULAR MOTOR MEASURES; FUNCTIONAL CONNECTIVITY; RECURRENT CONCUSSION; SWITCH-COST; TASK; ROBUST; DYSFUNCTION; DEPRESSION	This study used oculomotor, cognitive, and multi-modal magnetic resonance imaging (MRI) measures to assess for neurological abnormalities in current asymptomatic amateur Australian rules footballers (i.e., Australia's most participated collision sport) with a history of sports-related concussion (SRC). Participants were 15 male amateur Australian rules football players with a history of SRC greater than 6 months previously, and 15 sex-, age-, and education-matched athlete control subjects that had no history of neurotrauma or participation in collision sports. Participants completed a clinical interview, neuropsychological measures, and oculomotor measures of cognitive control. MRI investigation involved structural imaging, as well as diffusion tensor imaging and resting-state functional MRI sequences. Despite no group differences on conventional neuropsychological tests and multi-modal MRI measures, Australian rules football players with a history of SRC performed significantly worse on an oculomotor switch task: a measure of cognitive control that interleaves the response of looking towards a target (i.e., a prosaccade) with the response of looking away from a target (i.e., an antisaccade). Specifically, Australian footballers performed significantly shorter latency prosaccades and found changing from an antisaccade trial to a prosaccade trial (switch cost) significantly more difficult than control subjects. Poorer switch cost was related to poorer performance on a number of neuropsychological measures of inhibitory control. Further, when comparing performance on the cognitively more demanding switch task with performance on simpler, antisaccade/prosaccades tasks which require a single response, Australian footballers demonstrated a susceptibility to increased cognitive load, compared to the control group who were unaffected. These initial results suggest that current asymptomatic amateur Australian rules football players with a history of SRC may have persisting, subtle, cognitive changes, which are demonstrable on oculomotor cognitive measures. Future studies are required in order to further elucidate the full nature and clinical relevance of these findings.	[Clough, Meaghan; Fielding, Joanne] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Mutimer, Steven; Costello, Daniel M.; Sun, Mujun; Brady, Rhys D.; Webster, Kyria M.; Semple, Bridgette D.; White, Owen B.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Tsang, Adrian; Frayne, Richard] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Tsang, Adrian; Frayne, Richard] Foothills Med Ctr, Seaman Family MR Res Ctr, Calgary, AB, Canada; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Stanwell, Peter] Univ Newcastle, Sch Hlth Sci, Callaghan, NSW, Australia; [Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [McDonald, Stuart J.; Johnstone, Maddison R.] La Trobe Univ, Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Anat Physiol & Genet, Bethesda, MD USA; [O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic 3004, Australia	Shultz, SR (corresponding author), Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	Frayne, Richard/AAA-9217-2021; Stanwell, Peter/F-9136-2012	Frayne, Richard/0000-0003-0358-1210; Stanwell, Peter/0000-0002-4780-0393; Sun, Mujun/0000-0002-9923-9913; O'Brien, Terence/0000-0002-7198-8621; McDonald, Stuart/0000-0001-5190-3179; White, Owen/0000-0002-2836-7344; Wright, David/0000-0002-7535-8651	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Royal Melbourne Hospital Neuroscience Foundation; Melbourne Neuroscience Institute; La Trobe University (Sport, Exercise, and Rehabilitation RFA); University of MelbourneUniversity of Melbourne; NHMRCNational Health and Medical Research Council of Australia; Berlin-Burns Fellowship; Hotchkiss Brain Institute (HBI), University of Calgary	S.R.S., S.J.M., and T.O.B. acknowledge the Australian National Health and Medical Research Council, the Royal Melbourne Hospital Neuroscience Foundation, the Melbourne Neuroscience Institute, La Trobe University (Sport, Exercise, and Rehabilitation RFA), and the University of Melbourne for funding this study. A.G. and B.S. are supported by NHMRC Early Career Fellowships. A.T. was supported by the Berlin-Burns Fellowship and a travel award provided by the Hotchkiss Brain Institute (HBI), University of Calgary. R.F. is the Hopewell Professor of Brain Imaging, HBI. The authors also thank the staff of the Department of Radiology, The Royal Melbourne Hospital for their assistance with MRI data collection.	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; [Anonymous], 2013, Br J Sports Med, V47, P259; Beck A.T., 1987, MANUAL REVISED BECK; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Clough M, 2015, J NEUROL, V262, P1130, DOI 10.1007/s00415-015-7645-3; Clough M, 2015, J NEUROL, V262, P1138, DOI 10.1007/s00415-015-7644-4; DeSimone JC, 2014, VISION RES, V96, P17, DOI 10.1016/j.visres.2013.12.005; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Golden C., 1978, STROOP COLOR WORD TE; GRONWALL DMA, 1977, PACED AUDITORY SERIA; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Herd SA, 2014, NEUROPSYCHOLOGIA, V62, P375, DOI 10.1016/j.neuropsychologia.2014.04.014; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Jamadar SD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00653; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nelson H., 1991, REVISED NATL ADULT R; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shallice, 1997, HAYLING BRIXTON TEST; Shelton AL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.250; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Silk T, 2013, PSYCHIAT RES-NEUROIM, V213, P186, DOI 10.1016/j.pscychresns.2013.03.001; Smith A., 1973, SYMBOL DIGIT MODALIT; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tsang A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00144; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wechsler D, 1997, WAIS 3 ADM SCORING M; Weiler J, 2014, J NEUROPHYSIOL, V112, P2176, DOI 10.1152/jn.00352.2014; Weiler J, 2012, NEUROSCI LETT, V530, P150, DOI 10.1016/j.neulet.2012.10.007; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	54	15	15	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					730	738		10.1089/neu.2017.5204		FEB 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000424836000001	29228862				2021-06-18	
J	Nishijima, DK; Gaona, SD; Waechter, T; Maloney, R; Blitz, A; Elms, AR; Farrales, RD; Montoya, J; Bair, T; Howard, C; Gilbert, M; Trajano, RP; Hatchel, KM; Faul, M; Bell, JM; Coronado, VC; Vinson, DR; Ballard, DW; Tancredi, DJ; Garzon, H; Mackey, KE; Shahlaie, K; Holmes, JF				Nishijima, Daniel K.; Gaona, Samuel D.; Waechter, Trent; Maloney, Ric; Blitz, Adam; Elms, Andrew R.; Farrales, Roel D.; Montoya, James; Bair, Troy; Howard, Calvin; Gilbert, Megan; Trajano, Renee P.; Hatchel, Kaela M.; Faul, Mark; Bell, Jeneita M.; Coronado, Victor C.; Vinson, David R.; Ballard, Dustin W.; Tancredi, Daniel J.; Garzon, Hernando; Mackey, Kevin E.; Shahlaie, Kiarash; Holmes, James F.		Sacramento Cty Prehosp Res Consort	The Incidence of Traumatic Intracranial Hemorrhage in Head-Injured Older Adults Transported by EMS with and without Anticoagulant or Antiplatelet Use	JOURNAL OF NEUROTRAUMA			English	Article						anticoagulants; field triage; head injuries; older adults	BRAIN-INJURY; PREINJURY WARFARIN; CLOPIDOGREL; RULE; CRITERIA; DEATHS; TRIAGE; AGENTS; RISK; CARE	Field triage guidelines recommend transport of head-injured patients on anticoagulants or antiplatelets to a higher-level trauma center based on studies suggesting a high incidence of traumatic intracranial hemorrhage (tICH). We compared the incidence of tICH in older adults transported by emergency medical services (EMS) with and without anticoagulation or antiplatelet use and evaluated the accuracies of different sets of field triage criteria to identify tICH. This was a prospective, observational study at five EMS agencies and 11 hospitals. Older adults (55 years) with head trauma and transported by EMS from August 2015 to September 2016 were eligible. EMS providers completed standardized data forms and patients were followed through emergency department (ED) or hospital discharge. We enrolled 1304 patients; 1147 (88%) received a cranial computed tomography (CT) scan and were eligible for analysis. Four hundred thirty-four (33%) patients had anticoagulant or antiplatelet use and 112 (10%) had tICH. The incidence of tICH in patients with (11%, 95% confidence interval [CI] 8%-14%) and without (9%, 95% CI 7%-11%) anticoagulant or antiplatelet use was similar. Anticoagulant or antiplatelet use was not predictive of tICH on adjusted analysis. Steps 1-3 criteria alone were not sensitive in identifying tICH (27%), whereas the addition of anticoagulant or antiplatelet criterion improved sensitivity (63%). Other derived sets of triage criteria were highly sensitive (>98%) but poorly specific (<11%). The incidence of tICH was similar between patients with and without anticoagulant or antiplatelet use. Use of anticoagulant or antiplatelet medications was not a risk factor for tICH. We were unable to identify a set of triage criteria that was accurate for trauma center need.	[Nishijima, Daniel K.; Gaona, Samuel D.; Gilbert, Megan; Trajano, Renee P.; Hatchel, Kaela M.; Tancredi, Daniel J.; Garzon, Hernando; Holmes, James F.] UC Davis Sch Med, Dept Emergency Med, Sacramento, CA USA; [Shahlaie, Kiarash] UC Davis Sch Med, Dept Neurol Surg, Sacramento, CA USA; [Waechter, Trent] City Sacramento Fire Dept, Sacramento, CA USA; [Maloney, Ric] Sacramento Metropolitan Fire Dept, Sacramento, CA USA; [Blitz, Adam] Amer Med Response, Sacramento, CA USA; [Elms, Andrew R.; Mackey, Kevin E.] Kaiser Permanente South Sacramento Med Ctr, Sacramento, CA USA; [Vinson, David R.] Kaiser Permanente Sacramento Med Ctr, Sacramento, CA USA; [Farrales, Roel D.] Mercy Gen Hosp, Sacramento, CA USA; [Montoya, James] Sutter Community Hosp, Sacramento, CA USA; [Bair, Troy] Cosumnes Community Serv Dist, Fire Dept, Elk Grove, CA USA; [Howard, Calvin] City Folsom Fire Dept, Folsom, CA USA; [Faul, Mark; Bell, Jeneita M.; Coronado, Victor C.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Vinson, David R.; Ballard, Dustin W.] Kaiser Permanente Div Res, Oakland, CA USA; [Ballard, Dustin W.] Kaiser Permanente San Rafael Med Ctr, San Rafael, CA USA; [Coronado, Victor C.] Bridge Heath, Atlanta, GA USA	Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 St,PSSB 2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu	Tancredi, Daniel J/O-3381-2013; Vinson, David R/AAK-3227-2020	Tancredi, Daniel J/0000-0002-3884-7907; Vinson, David R/0000-0001-6559-1858; Faul, Mark/0000-0002-7683-0348	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177]; Mentored Clinical Research Training Program Award from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This work was funded by the Centers for Disease Control and Prevention (CDC), grant number U01CE002177. The findings and conclusion of this research are those of the authors and do not represent the official views of the U.S. Department of Health and Human Services (DHHS) and the CDC. The inclusion of individuals, programs, or organizations in this article does not constitute endorsement by the U.S. federal government, DHHS, or CDC.; Dr. Nishijima was supported through Mentored Clinical Research Training Program Award (Grant Number UL1TR000002 and linked award KL2TR000134) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	American College of Surgeons Committee on Trauma, 2006, RES OPT CAR INJ PAT; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Brieman L., 1984, CLASSIFICATION REGRE; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Leong LB, 2015, J EMERG MED, V49, P561, DOI 10.1016/j.jemermed.2015.02.023; Lerner EB, 2014, J TRAUMA ACUTE CARE, V76, P1157, DOI 10.1097/TA.0000000000000189; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Newgard CD, 2014, PREHOSP EMERG CARE, V18, P461, DOI 10.3109/10903127.2014.912707; Newgard CD, 2013, J TRAUMA ACUTE CARE, V74, P1298, DOI 10.1097/TA.0b013e31828b7848; Newgard CD, 2011, J TRAUMA, V70, P1345, DOI 10.1097/TA.0b013e3182191a1b; Nishijima DK, 2017, ANN EMERG MED, V70, P127, DOI 10.1016/j.annemergmed.2016.12.018; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Starke RM, 2015, NEUROSURGERY, V77, pN11, DOI 10.1227/01.neu.0000473806.53232.3e; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thibault N., 2016, AM J THER; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Zehtabchi S, 2011, ACAD EMERG MED, V18, P637, DOI 10.1111/j.1553-2712.2011.01083.x	38	15	15	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					750	759		10.1089/neu.2017.5232		FEB 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000424834300001	29108469	Green Published			2021-06-18	
J	Li, X; Wang, HD; Wen, GD; Li, LW; Gao, YY; Zhuang, Z; Zhou, ML; Mao, L; Fan, YW				Li, Xiang; Wang, Handong; Wen, Guodao; Li, Liwen; Gao, Yongyue; Zhuang, Zong; Zhou, Mengliang; Mao, Lei; Fan, Youwu			Neuroprotection by quercetin via mitochondrial function adaptation in traumatic brain injury: PGC-1 alpha pathway as a potential mechanism	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						quercetin; mitochondria; PGC-1 alpha; traumatic brain injury; neuroprotection	EXPERIMENTAL STROKE; OXIDATIVE STRESS; APOPTOSIS; PROTECTS; DYSFUNCTION; BIOGENESIS; RATS; ERYTHROPOIETIN; EXPRESSION; DISEASE	The aim of this study was to investigate the neuroprotective effects of quercetin in mouse models of traumatic brain injury (TBI) and the potential role of the PGC-1 alpha pathway in putative neuroprotection. Wild-type mice were randomly assigned to four groups: the sham group, the TBI group, the TBI+ vehicle group and the TBI+ quercetin group. Quercetin, a dietary flavonoid used as a food supplement, significantly reduced TBI-induced neuronal apoptosis and ameliorated mitochondrial lesions. It significantly accelerated the translocation of PGC-1 alpha protein from the cytoplasm to the nucleus. In addition, quercetin restored the level of cytochrome c, malondialdehyde and superoxide dismutase in mitochondria. Therefore, quercetin administration can potentially attenuate brain injury in a TBI model by increasing the activities of mitochondrial biogenesis via the mediation of the PGC-1 alpha pathway.	[Li, Xiang; Wang, Handong; Wen, Guodao; Li, Liwen; Gao, Yongyue; Zhuang, Zong; Zhou, Mengliang; Mao, Lei; Fan, Youwu] Nanjing Univ, Med Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Wang, HD; Fan, YW (corresponding author), Nanjing Univ, Med Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	njhdwang@hotmail.com; njywfan@163.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371357]; Nanjing Military Region Foundation, PLA Grant [14MS104, 15MS126]	This work was supported by grants from the National Natural Science Foundation of China (81371357) and the Nanjing Military Region Foundation, PLA Grant (14MS104, 15MS126).	Baburamani AA, 2015, INT J MOL SCI, V16, P22509, DOI 10.3390/ijms160922509; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Egger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031272; Escobales N, 2014, J MOL CELL CARDIOL, V77, P136, DOI 10.1016/j.yjmcc.2014.10.009; Fan YW, 2012, BRAIN INJURY, V26, P1267, DOI 10.3109/02699052.2012.672789; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gloryy A, 2014, INT J HYPERTHER, V30, P502, DOI 10.3109/02656736.2014.968641; Go KL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/183469; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Halder S, 2016, BIOL TRACE ELEM RES, V171, P391, DOI 10.1007/s12011-015-0544-8; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Li L, 2015, NEUROCHEM RES, V40, P1555, DOI 10.1007/s11064-015-1623-0; Liu HC, 2012, BRAIN RES, V1474, P73, DOI 10.1016/j.brainres.2012.07.028; Liu P, 2015, RESTOR NEUROL NEUROS, V33, P143, DOI 10.3233/RNN-140446; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Ma SB, 2014, CELL DEATH DIFFER, V21, P1925, DOI 10.1038/cdd.2014.119; McMeekin LJ, 2016, SCHIZOPHRENIA BULL, V42, P1009, DOI 10.1093/schbul/sbv184; Millet A, 2016, J NEUROTRAUM, V33, P1625, DOI 10.1089/neu.2015.4160; Pena-Salazar C, 2014, J NEUROPSYCH CLIN N, V26, pE23, DOI 10.1176/appi.neuropsych.13100276; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Petzold A, 2007, NEUROL RES, V29, P691, DOI 10.1179/016164107X240080; Salvador-Gallego R, 2016, EMBO J, V35, P389, DOI 10.15252/embj.201593384; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Senoo N, 2015, J LIPID RES, V56, P2286, DOI 10.1194/jlr.M060533; Sharma DR, 2015, NEUROTOXICOLOGY, V51, P116, DOI 10.1016/j.neuro.2015.10.002; Simonyan L, 2016, FEBS LETT, V590, P13, DOI 10.1002/1873-3468.12030; Su XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134087; Viswanatha GL, 2013, EUR J PHARMACOL, V720, P286, DOI 10.1016/j.ejphar.2013.10.016; Vlodavsky E, 2017, J CEREBR BLOOD F MET, V37, P166, DOI 10.1177/0271678X15621068; Wang RS, 2013, CELL METAB, V17, P685, DOI 10.1016/j.cmet.2013.03.016; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Zhu HR, 2010, NEUROPHARMACOLOGY, V59, P70, DOI 10.1016/j.neuropharm.2010.03.017; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	39	15	16	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	FEB	2018	22	2					883	891		10.1111/jcmm.13313			9	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FT7VO	WOS:000423361500018	29205806	DOAJ Gold, Green Published			2021-06-18	
J	Lu, HH; Ma, K; Jin, LW; Zhu, H; Cao, RQ				Lu, Huaihai; Ma, Kun; Jin, Liwei; Zhu, He; Cao, Ruiqi			17-estradiol rescues damages following traumatic brain injury from molecule to behavior in mice	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						17beta-estradiol; neuroprotection; NR2B; traumatic brain injury	LONG-TERM POTENTIATION; ESTRADIOL-INDUCED INCREASE; CLOSED-HEAD INJURY; NMDA RECEPTORS; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; 17-BETA-ESTRADIOL; MODEL; RAT; NEUROPROTECTION	Traumatic brain injury (TBI) is a public health concern, and causes cognitive dysfunction, emotional disorders, and neurodegeration, as well. The currently available treatments are all symptom-oriented with unsatifying efficacy. It is highly demanded to understand its underlying mechanisms. Controlled cortical impact (CCI) was used to induce TBI in aged female mice subjected to ovariectomy. Brain damages were assessed with neurological severity score, brain infarction and edema. Morris water maze and elevated plus maze were applied to evaluate the levels of anxiety. Apoptosis in the hippocampus was assayed with Fluoro-Jade B staining and TUNEL staining. Western blot was employed to measure the expression of NMDA receptor subunits and phosphorylation of ERK1/2, and biochemical assays were used to estimate oxidative stress. 17beta-Estradiol (E2) was intraperitoneally administered at 10-80g/kg once per day for 7 consecutive days before or after CCI. Chronic administration of E2 both before and immediately after CCI conferred neuroprotection, reducing neurological severity score, brain infarction, and edema in TBI mice. Additionally, E2 improved many aspects of deleterious effects of TBI on the hippocampus, including neuronal apoptosis, dysfunction in spatial memory, reduction in NR2B, enhancement of oxidative stress, and activation of ERK1/2 pathway. The present study provides clue for the notion that E2 has therapeutic potential for both prevention and intervention of TBI-induced brain damages.	[Lu, Huaihai; Cao, Ruiqi] Hebei Med Univ, Intens Care Unit, Dept Anesthesiol, Hosp 2, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Ma, Kun] Fourth Hosp Shijiazhuang, Dept Anesthesiol, Shijiazhuang, Hebei, Peoples R China; [Jin, Liwei] Youfu Hosp Hebei Prov, Dept Geratol, Shijiazhuang, Hebei, Peoples R China; [Zhu, He] Tianjin Cent Hosp Gyecol & Obstet, Dept Anesthesiol, Tianjin, Peoples R China	Cao, RQ (corresponding author), Hebei Med Univ, Intens Care Unit, Dept Anesthesiol, Hosp 2, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China.	caoruiqilhlh@163.com					Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bi RF, 2001, P NATL ACAD SCI USA, V98, P13391, DOI 10.1073/pnas.241507698; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Brinton RD, 1997, NEUROCHEM RES, V22, P1339, DOI 10.1023/A:1022015005508; Buhmann CB, 2014, DAN MED J, V61; Chen W, 2017, RESTOR NEUROL NEUROS, V35, P217, DOI 10.3233/RNN-160705; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Clayton DA, 2002, J NEUROSCI, V22, P3628; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Foy MR, 1999, J NEUROPHYSIOL, V81, P925; Galvin C, 2014, NEUROPSYCHOPHARMACOL, V39, P2086, DOI 10.1038/npp.2014.56; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Groger M, 2014, BRAIN RES, V1589, P61, DOI 10.1016/j.brainres.2014.08.029; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Heron P, 2001, METAB BRAIN DIS, V16, P187, DOI 10.1023/A:1012593027961; Hilton GD, 2006, EUR J NEUROSCI, V24, P3008, DOI 10.1111/j.1460-9568.2006.05189.x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Krishnamurthy K, 2016, TRANSLATIONAL RES TR; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Lesniak A, 2016, NEUROPHARMACOLOGY, V101, P506, DOI 10.1016/j.neuropharm.2015.10.014; Lewis MC, 2008, BEHAV NEUROSCI, V122, P716, DOI 10.1037/0735-7044.122.3.716; Lopez-Grueso R, 2014, ANTIOXID REDOX SIGN, V20, P236, DOI 10.1089/ars.2012.5112; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Romeo RD, 2005, NEUROENDOCRINOLOGY, V81, P391, DOI 10.1159/000089557; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Smith CC, 2016, HIPPOCAMPUS, V26, P110, DOI 10.1002/hipo.22495; Smith Caroline C, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS130, DOI 10.1016/j.psyneuen.2009.06.003; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Snyder MA, 2011, HIPPOCAMPUS, V21, P398, DOI 10.1002/hipo.20756; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Spampinato SF, 2012, ENDOCRINOLOGY, V153, P5940, DOI 10.1210/en.2012-1799; Vedder LC, 2013, HIPPOCAMPUS, V23, P108, DOI 10.1002/hipo.22068; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6; Xiao C, 2016, NEURON, V90, P333, DOI 10.1016/j.neuron.2016.03.028; Zamani MR, 2000, J NEUROPHYSIOL, V84, P1800; Zhou C, 2014, EUR J PAIN, V18, P649, DOI 10.1002/j.1532-2149.2013.00416.x	52	15	16	0	36	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	FEB	2018	233	2					1712	1722		10.1002/jcp.26083			11	Cell Biology; Physiology	Cell Biology; Physiology	FL9RB	WOS:000414593500086	28681915				2021-06-18	
J	Parthasarathy, AB; Gannon, KP; Baker, WB; Favilla, CG; Balu, R; Kasner, SE; Yodh, AG; Detre, JA; Mullen, MT				Parthasarathy, Ashwin B.; Gannon, Kimberly P.; Baker, Wesley B.; Favilla, Christopher G.; Balu, Ramani; Kasner, Scott E.; Yodh, Arjun G.; Detre, John A.; Mullen, Michael T.			Dynamic autoregulation of cerebral blood flow measured non-invasively with fast diffuse correlation spectroscopy	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral blood flow; cerebral autoregulation; noninvasive monitoring; intrinsic optical imaging; neurocritical care	ACUTE ISCHEMIC-STROKE; NEAR-INFRARED SPECTROSCOPY; CEREBROVASCULAR PRESSURE REACTIVITY; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; TIME-DOMAIN; TRANSCRANIAL DOPPLER; PERFUSION; HEMODYNAMICS; INFANTS	Cerebral autoregulation (CA) maintains cerebral blood flow (CBF) in the presence of systemic blood pressure changes. Brain injury can cause loss of CA and resulting dysregulation of CBF, and the degree of CA impairment is a functional indicator of cerebral tissue health. Here, we demonstrate a new approach to noninvasively estimate cerebral autoregulation in healthy adult volunteers. The approach employs pulsatile CBF measurements obtained using high-speed diffuse correlation spectroscopy (DCS). Rapid thigh-cuff deflation initiates a chain of responses that permits estimation of rates of dynamic autoregulation in the cerebral microvasculature. The regulation rate estimated with DCS in the microvasculature (median: 0.26 s(-1), inter quartile range: 0.19 s(-1)) agrees well (R=0.81, slope=0.9) with regulation rates measured by transcranial Doppler ultrasound (TCD) in the proximal vasculature (median: 0.28 s(-1), inter quartile range: 0.10 s(-1)). We also obtained an index of systemic autoregulation in concurrently measured scalp microvasculature. Systemic autoregulation begins later than cerebral autoregulation and exhibited a different rate (0.55 s(-1), inter quartile range: 0.72 s(-1)). Our work demonstrates the potential of diffuse correlation spectroscopy for bedside monitoring of cerebral autoregulation in the microvasculature of patients with brain injury.	[Parthasarathy, Ashwin B.; Yodh, Arjun G.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Parthasarathy, Ashwin B.] Univ S Florida, Dept Elect Engn, Tampa, FL USA; [Gannon, Kimberly P.; Favilla, Christopher G.; Balu, Ramani; Kasner, Scott E.; Detre, John A.; Mullen, Michael T.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Baker, Wesley B.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Parthasarathy, AB (corresponding author), 4202 Fowler Ave,ENB 118, Tampa, FL 33647 USA.	ashwinbp@usf.edu	Parthasarathy, Ashwin B/ABH-9098-2020	Parthasarathy, Ashwin B/0000-0003-2024-3432; Baker, Wesley/0000-0002-3025-6061	American Heart AssociationAmerican Heart Association [14POST20460161]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25-NS065745, R01-NS060653, P41-EB015893]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060653, R25NS065745] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: We gratefully acknowledge support from the American Heart Association (14POST20460161), and the National Institutes of Health (R25-NS065745, R01-NS060653, P41-EB015893).	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Alexandrov AV, 1999, STROKE, V30, P1604, DOI 10.1161/01.STR.30.8.1604; Aoi MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046794; Atkins ER, 2010, CEREBROVASC DIS, V29, P228, DOI 10.1159/000267845; Baker WB, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.035004; Baker WB, 2014, BIOMED OPT EXPRESS, V5, P4053, DOI 10.1364/BOE.5.004053; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2010, STROKE, V41, P1957, DOI 10.1161/STROKEAHA.109.575167; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Buckley EM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.037007; Buckley EM, 2009, OPT EXPRESS, V17, P12571, DOI 10.1364/OE.17.012571; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Christ M, 2007, INTENS CARE MED, V33, P246, DOI 10.1007/s00134-006-0451-8; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Coolican H., 2014, RES METHODS STAT PSY; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; Diop M, 2011, BIOMED OPT EXPRESS, V2, P2068, DOI 10.1364/BOE.2.002068; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Durduran T, 2009, OPT EXPRESS, V17, P3884, DOI 10.1364/OE.17.003884; Eriksen VR, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.037009; Fantini S, 2014, NEUROIMAGE, V85, P202, DOI 10.1016/j.neuroimage.2013.03.065; Favilla CG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00045; Favilla CG, 2014, STROKE, V45, P1269, DOI 10.1161/STROKEAHA.113.004116; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Goldstein LB, 2000, DRUG SAFETY, V22, P13, DOI 10.2165/00002018-200022010-00002; Hlatky R, 2006, NEUROCRIT CARE, V4, P127, DOI 10.1385/NCC:4:2:127; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Jain V, 2014, J CEREBR BLOOD F MET, V34, P380, DOI 10.1038/jcbfm.2013.214; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Kim MN, 2010, NEUROCRIT CARE, V12, P173, DOI 10.1007/s12028-009-9305-x; Mesquita RC, 2011, PHILOS T R SOC A, V369, P4390, DOI 10.1098/rsta.2011.0232; Mullen MT, 2016, STROKE, V47; Nazir FS, 2005, CEREBROVASC DIS, V19, P77, DOI 10.1159/000082783; Nazir FS, 2004, J HYPERTENS, V22, P989, DOI 10.1097/00004872-200405000-00022; Panerai RB, 2015, AM J PHYSIOL-HEART C, V308, pH688, DOI 10.1152/ajpheart.00887.2014; Reinhard M, 2005, STROKE, V36, P1684, DOI 10.1161/01.STR.0000173183.36331.ee; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Roche-Labarbe N, 2010, HUM BRAIN MAPP, V31, P341, DOI 10.1002/hbm.20868; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; Tgavalekos KT, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.10.101410; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; Verdecchia K, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.027007; Wang DT, 2016, BIOMED OPT EXPRESS, V7, P776, DOI 10.1364/BOE.7.000776; Yu GQ, 2007, OPT EXPRESS, V15, P1064, DOI 10.1364/OE.15.001064; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320	56	15	15	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2018	38	2					230	240		10.1177/0271678X17747833			11	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	FU7VJ	WOS:000424060500004	29231781	Green Published, Bronze			2021-06-18	
J	Suda, S; Aoki, J; Shimoyama, T; Suzuki, K; Sakamoto, Y; Katano, T; Okubo, S; Nito, C; Nishiyama, Y; Mishina, M; Kimura, K				Suda, Satoshi; Aoki, Junya; Shimoyama, Takashi; Suzuki, Kentaro; Sakamoto, Yuki; Katano, Takehiro; Okubo, Seiji; Nito, Chikako; Nishiyama, Yasuhiro; Mishina, Masahiro; Kimura, Kazumi			Stroke-associated infection independently predicts 3-month poor functional outcome and mortality	JOURNAL OF NEUROLOGY			English	Article						Infection; Pneumonia; Prognosis; Stroke	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; PNEUMONIA; CARE	Stroke-associated infection (SAI) is a common and serious complication of stroke. This study aimed to assess the effects of SAI on patient mortality and functional outcome at 3 months after stroke onset. We retrospectively analyzed 809 consecutive patients with acute stroke (517 men and 292 women; median age, 72 years) who were admitted to our department between September 2014 and June 2016. SAI was defined as an infection diagnosed during the hospitalization period. Poor outcome was defined as a modified Rankin Scale (mRS) score of 3-5 or death (mRS score of 6). The effect of SAI on functional outcome was evaluated using a multivariate logistic regression analysis. SAI occurred in 169 patients (20.9%); of these, 106 (62.7%) had pneumonia, 23 (13.6%) had a urinary-tract infection, and 40 (23.7%) had other types of infection. Patients with SAI were older, more likely to be female, had lower body mass indices, had higher stroke severity, and were more likely to have atrial fibrillation and a history of ischemic heart disease than patients without SAI. Poor functional outcome and mortality were more common in patients with SAI than in patients without SAI (poor functional outcome 41.8 vs. 4.8%, mortality 24.3 vs. 3.9%, respectively). After adjusting for age, sex, stroke severity, and various comorbidities, SAI was independently associated with poor functional outcome [odds ratio (OR) 6.88; 95% confidence interval (CI) 3.72-12.73] and mortality (OR 4.45, 95% CI 2.27-8.72) at 3 months after stroke onset. Our results suggest that SAI during the hospitalization period is independently associated with 3-month poor functional outcome and mortality.	[Suda, Satoshi; Aoki, Junya; Shimoyama, Takashi; Suzuki, Kentaro; Sakamoto, Yuki; Katano, Takehiro; Okubo, Seiji; Nito, Chikako; Nishiyama, Yasuhiro; Mishina, Masahiro; Kimura, Kazumi] Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan	Suda, S (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	suda-sa@nms.ac.jp	a, e c°/AAN-2574-2021; Mishina, Masahiro/F-3636-2010	Mishina, Masahiro/0000-0002-8227-0930; , Chikako/0000-0002-0980-5943			Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; Becker KJ, 2014, NEUROCRIT CARE, V21, P140, DOI 10.1007/s12028-013-9899-x; Dasenbrock HH, 2016, WORLD NEUROSURG, V88, P459, DOI 10.1016/j.wneu.2015.10.054; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Doll DN, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0077-5; Egashira Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-105; Evans A, 2001, LANCET, V358, P1586, DOI 10.1016/S0140-6736(01)06652-1; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Kamel H, 2012, ARCH NEUROL-CHICAGO, V69, P576, DOI 10.1001/archneurol.2011.3590; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kwan J, 2007, ACTA NEUROL SCAND, V115, P331, DOI 10.1111/j.1600-0404.2006.00783.x; Miller CM, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0679-9; Minnerup J, 2010, J NEUROL NEUROSUR PS, V81, P198, DOI 10.1136/jnnp.2009.182394; Popovic N, 2013, J STROKE CEREBROVASC, V22, P424, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.003; Sato K, 2014, J STROKE CEREBROVASC, V23, P2511, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.019; Sehara Y, 2007, J NEUROSCI RES, V85, P2167, DOI 10.1002/jnr.21341; Spratt N, 2003, J CLIN NEUROSCI, V10, P665, DOI 10.1016/j.jocn.2002.12.001; Vargas M, 2006, STROKE, V37, P461, DOI 10.1161/01.STR.0000199138.73365.b3; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9	23	15	25	1	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	FEB	2018	265	2					370	375		10.1007/s00415-017-8714-6			6	Clinical Neurology	Neurosciences & Neurology	FV6SJ	WOS:000424711600017	29249057				2021-06-18	
J	Yang, NR; Song, J; Yoon, KW; Seo, EK				Yang, Na Rae; Song, Jihye; Yoon, Kyeong-Wook; Seo, Eui Kyo			How Early Can We Perform Cranioplasty for Traumatic Brain injury After Decompressive Craniectomy? A Retrospective Multicenter Study	WORLD NEUROSURGERY			English	Article						Cranioplasty; Complications; Decompressive craniectomy; Glasgow Coma Scale; Glasgow Outcome Scale; Hematomas; Hydrocephalus; Intracranial hypertension; Retrospective studies; Traumatic brain injury	BONE FLAP RESORPTION; SEVERE HEAD-INJURY; CLINICAL ARTICLE; RISK-FACTORS; CEREBROSPINAL-FLUID; AUTOLOGOUS BONE; CRANIAL DEFECT; COMPLICATIONS; STROKE; PREDICTION	OBJECTIVE: Decompressive craniectomy (DC) is used to treat intractable intracranial hypertension after severe traumatic brain injury (TBI). Cranioplasty (CP) is typically performed weeks or months later. However, the optimal timing for CP is unknown. We aimed to determine the earliest possible time point for CP. METHODS: We retrospectively reviewed brain computed tomography images from 159 patients who underwent CP after DC for TBI at 3 hospitals. We determined the earliest possible day for CP by reviewing the resolution of intracranial pressure in serial brain computed tomography images between DC and CP. The early CP group was defined as the group within the earliest possible timing of CP; other cases constituted the late CP group. We compared complications and the Glasgow Outcome Scale scores at 6 months between groups. RESULTS: The mean initial Glasgow Coma Scale score was 8.33 +/- 3.46. The time interval between DC and CP was 94.75 +/- 143.98 days. The earliest possible timing for CP was determined to be 34.60 +/- 34.36 days after DC. The incidence of complications did not differ significantly between groups, except for ventriculomegaly, which occurred more frequently in the late CP group (P = 0.026). Predictors of good outcome were revision because of infection, preoperative epidural hematoma, early cranioplasty, and no ventriculomegaly after DC. CONCLUSIONS: CP can be performed at around 34 days after DC for TBI. Ventriculomegaly occurred less frequently and the 6-month Glasgow Outcome Scale score was better in the early CP group than in the late CP group.	[Yang, Na Rae; Seo, Eui Kyo] Ewha Womans Univ, Coll Med, Med Ctr, Dept Neurosurg, Seoul, South Korea; [Song, Jihye] Konyang Univ, Konyang Univ Hosp, Coll Med, Dept Neurosurg, Daejeon, South Korea; [Yoon, Kyeong-Wook] Dankook Univ, Coll Med, Dept Neurosurg, Cheonan, Chungnam, South Korea	Seo, EK (corresponding author), Ewha Womans Univ, Coll Med, Med Ctr, Dept Neurosurg, Seoul, South Korea.	drekseo@ewha.ac.kr		Yang, Na Rae/0000-0002-3226-5631			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alperin N, 1996, MAGNET RESON MED, V35, P741, DOI 10.1002/mrm.1910350516; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Di Stefano C, 2016, BRAIN INJURY, V30, P164, DOI 10.3109/02699052.2015.1090013; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Malcolm JG, 2017, NEUROSURGERY; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Salma A, 2016, J NEUROSURG, V124, P280, DOI 10.3171/2015.6.JNS151378; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Thavarajah D, 2012, BRIT J NEUROSURG, V26, P78, DOI 10.3109/02688697.2011.603850; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wen L, 2007, J CRANIOFAC SURG, V18, P526; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	38	15	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2018	110						E160	E167		10.1016/j.wneu.2017.10.117			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FX1ZT	WOS:000425856900024	29101076				2021-06-18	
J	Lindblad, C; Thelin, EP; Nekludov, M; Frostell, A; Nelson, DW; Svensson, M; Bellander, BM				Lindblad, Caroline; Thelin, Eric Peter; Nekludov, Michael; Frostell, Arvid; Nelson, David W.; Svensson, Mikael; Bellander, Bo-Michael			Assessment of Platelet function in Traumatic Brain Injury-A Retrospective Observational Study in the Neuro-Critical Care Setting	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; progressive hemorrhagic injury; platelet aggregation; platelet aggregation inhibitors; multiple electrode aggregometry; cyclooxygenase inhibitors	TRANSFUSION; DYSFUNCTION; COAGULATION; CLASSIFICATION; HEMORRHAGE; ASPIRIN; UTILITY	Background: Despite seemingly functional coagulation, hemorrhagic lesion progression is a common and devastating condition following traumatic brain injury (TBI), stressing the need for new diagnostic techniques. Multiple electrode aggregometry (MEA) measures platelet function and could aid in coagulopathy assessment following TBI. The aims of this study were to evaluate MEA temporal dynamics, influence of concomitant therapy, and its capabilities to predict lesion progression and clinical outcome in a TBI cohort. Material and methods: Adult TBI patients in a neurointensive care unit that underwent MEA sampling were retrospectively included. MEA was sampled if the patient was treated with antiplatelet therapy, bled heavily during surgery, or had abnormal baseline coagulation values. We assessed platelet activation pathways involving the arachidonic acid receptor (ASPI), P2Y(12) receptor, and thrombin receptor (TRAP). ASPI was the primary focus of analysis. If several samples were obtained, they were included. Retrospective data were extracted from hospital charts. Outcome variables were radiologic hemorrhagic progression and Glasgow Outcome Scale assessed prospectively at 12 months posttrauma. MEA levels were compared between patients on antiplatelet therapy. Linear mixed effect models and uni-/multivariable regression models were used to study longitudinal dynamics, hemorrhagic progression and outcome, respectively. Results: In total, 178 patients were included (48% unfavorable outcome). ASPI levels increased from initially low values in a time-dependent fashion (p < 0.001). Patients on cyclooxygenase inhibitors demonstrated low ASPI levels (p < 0.001), while platelet transfusion increased them (p < 0.001). The first ASPI (p = 0.039) and TRAP (p = 0.009) were significant predictors of outcome, but not lesion progression, in univariate analyses. In multivariable analysis, MEA values were not independently correlated with outcome. Conclusion: A general longitudinal trend of MEA is identified in this TBI cohort, even in patients without known antiplatelet therapies. Values appear also affected by platelet inhibitory treatment and by platelet transfusions. While significant in univariate models to predict outcome, MEA values did not independently correlate to outcome or lesion progression in multivariable analyses. Further prospective studies to monitor coagulation in TBI patients are warranted, in particular the interpretation of pathological MEA values in patients without antiplatelet therapies.	[Lindblad, Caroline; Thelin, Eric Peter; Frostell, Arvid; Svensson, Mikael; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge Biomed Campus, Cambridge, England; [Nekludov, Michael; Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden	Bellander, BM (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	bo-michael.bellander@ki.se	Lindblad, Caroline/AAJ-7911-2021; Thelin, Eric Peter/K-2144-2012; Svensson, Mikael/F-8662-2012	Lindblad, Caroline/0000-0003-4952-8597; Thelin, Eric Peter/0000-0002-2338-4364; Svensson, Mikael/0000-0003-1179-7003	NEURO Sweden (Neuroforbundet); ALF (from Stockholms lans landsting) [103000]; Svenska Lakaresallskapet postdoctoral scholarships [SLS-587221]	The authors are grateful to the funding enabling this project, namely, NEURO Sweden (Neuroforbundet), ALF (from Stockholms lans landsting, grant number 103000), and Svenska Lakaresallskapet postdoctoral scholarships (grant number SLS-587221).	Acker JE, 2004, ADV TRAUMA LIFE SUPP; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beynon C, 2015, J CLIN NEUROSCI, V22, P252, DOI 10.1016/j.jocn.2014.07.029; Beynon C, 2013, J CLIN NEUROSCI, V20, P1805, DOI 10.1016/j.jocn.2013.02.022; Beynon C, 2013, CLIN NEUROL NEUROSUR, V115, P2003, DOI 10.1016/j.clineuro.2013.06.002; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Cull JD, 2015, AM SURGEON, V81, P128; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hunt H, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010438.pub2; JENNETT B, 1975, LANCET, V1, P480; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Kuznetsova A., 2016, LMERTEST TESTS LINEA; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Parry PV, 2017, NEUROSURGERY, V80, P92, DOI 10.1227/NEU.0000000000001406; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Tierney N, 2015, NEATO VARIOUS USEFUL; van Buuren S, 2011, J STAT SOFTW, V45, P1; Williams Graham J, 2011, DATA MINING RATTLE R	49	15	15	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 26	2018	9								15	10.3389/fneur.2018.00015			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FT8GE	WOS:000423390000001	29434566	DOAJ Gold, Green Published			2021-06-18	
J	Hofmeijer, J; van Kaam, CR; van de Werff, B; Vermeer, SE; Tjepkema-Cloostermans, MC; van Putten, MJAM				Hofmeijer, Jeannette; van Kaam, C. R.; van de Werff, Babette; Vermeer, Sarah E.; Tjepkema-Cloostermans, Marleen C.; van Putten, Michel J. A. M.			Detecting Cortical Spreading Depolarization with Full Band Scalp Electroencephalography: An Illusion?	FRONTIERS IN NEUROLOGY			English	Article						cortical spreading depolarization; infraslow activity; acute ischemic stroke; traumatic brain injury; full band electroencephalography	CEREBRAL-CORTEX; SUBARACHNOID HEMORRHAGE; MALIGNANT STROKE; MIGRAINE AURA; BRAIN TRAUMA; DC SHIFTS; DEPRESSION; ISCHEMIA; INJURY; EEG	Introduction: There is strong evidence suggesting detrimental effects of cortical spreading depolarization (CSD) in patients with acute ischemic stroke and severe traumatic brain injury. Previous studies implicated scalp electroencephalography (EEG) features to be correlates of CSD based on retrospective analysis of EEG epochs after having detected "CSD" in time aligned electrocorticography. We studied the feasibility of CSD detection in a prospective cohort study with continuous EEG in 18 patients with acute ischemic stroke and 18 with acute severe traumatic brain injury. Methods: Full band EEG with 21 silver/silver chloride electrodes was started within 48 h since symptom onset. Five additional electrodes were used above the infarct. We visually analyzed all raw EEG data in epochs of 1 h. Inspection was directed at detection of the typical combination of CSD characteristics, i.e., (i) a large slow potential change (SPC) accompanied by a simultaneous amplitude depression of > 1Hz activity, (ii) focal presentation, and (iii) spread reflected as appearance on neighboring electrodes with a delay. Results: In 3,035 one-hour EEG epochs, infraslow activity (ISA) was present in half to three quarters of the registration time. Typically, activity was intermittent with amplitudes of 40-220 mu V, approximately half was oscillatory. There was no specific spatial distribution. Relevant changes of ISA were always visible in multiple electrodes, and not focal, as expected in CSD. ISA appearing as "SPC" was mostly associated with an amplitude increase of faster activities, and never with suppression. In all patients, depressions of spontaneous brain activity occurred. However, these were not accompanied by simultaneous SPC, occurred simultaneously on all channels, and were not focal, let alone spread, as expected in CSD. Conclusion: With full band scalp EEG in patients with cortical ischemic stroke or traumatic brain injury, we observed various ISA, probably modulating cortical excitability. However, we were unable to identify unambiguous characteristics of CSD.	[Hofmeijer, Jeannette; van Kaam, C. R.; van de Werff, Babette; van Putten, Michel J. A. M.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Clin Neurophysiol, Enschede, Netherlands; [Hofmeijer, Jeannette; van Kaam, C. R.; van de Werff, Babette; Vermeer, Sarah E.] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands; [Tjepkema-Cloostermans, Marleen C.; van Putten, Michel J. A. M.] Med Spectrum Twente, Dept Clin Neurophysiol, Enschede, Netherlands	Hofmeijer, J (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Clin Neurophysiol, Enschede, Netherlands.; Hofmeijer, J (corresponding author), Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands.	jhofmeijer@rijnstate.nl	van Kaam, Ruud/T-9308-2018				ALADJALOVA NA, 1957, NATURE, V179, P957, DOI 10.1038/179957a0; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; BESSON JM, 1970, AM J PHYSIOL, V218, P284; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hartings JA, 2017, BRAIN, V140, P2673, DOI 10.1093/brain/awx214; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Helbok R, 2017, J CEREBR BLOOD F MET, V37, P1871, DOI 10.1177/0271678X16651269; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Kemp B, 2010, CLIN NEUROPHYSIOL, V121, P1992, DOI 10.1016/j.clinph.2010.05.006; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Lehmenkuhler A, 1999, NEUROSCI LETT, V270, P67, DOI 10.1016/S0304-3940(99)00469-3; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Palva JM, 2012, NEUROIMAGE, V62, P2201, DOI 10.1016/j.neuroimage.2012.02.060; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; Somjen GG., 2004, IONS BRAIN NORMAL FU; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Voipio J, 2003, J NEUROPHYSIOL, V89, P2208, DOI 10.1152/jn.00915.2002; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Winkler MKL, 2017, J CEREBR BLOOD F MET, V37, P1841, DOI 10.1177/0271678X16641424; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Zandt BJ, 2015, REV NEUROSCIENCE, V26, P183, DOI 10.1515/revneuro-2014-0069	33	15	15	0	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 25	2018	9								17	10.3389/fneur.2018.00017			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FT8FF	WOS:000423387500001	29422883	DOAJ Gold, Green Published			2021-06-18	
J	de Rooij, R; Kuhl, E				de Rooij, Rijk; Kuhl, Ellen			Microtubule Polymerization and Cross-Link Dynamics Explain Axonal Stiffness and Damage	BIOPHYSICAL JOURNAL			English	Article							SELF-ASSEMBLY KINETICS; FORCE GENERATION; TAU PROTEINS; STRAIN-RATE; ELONGATION; INJURY; MODEL; NEURONS; STRETCH; BRAIN	Axonal damage is a critical indicator for traumatic effects of physical impact to the brain. However, the precise mechanisms of axonal damage are still unclear. Here, we establish a mechanistic and highly dynamic model of the axon to explore the evolution of damage in response to physical forces. Our axon model consists of a bundle of dynamically polymerizing and depolymerizing microtubules connected by dynamically detaching and reattaching cross-links. Although the probability of cross-link attachment depends exclusively on thermal fluctuations, the probability of detachment increases in the presence of physical forces. We systematically probe the landscape of axonal stretch and stretch rate and characterize the overall axonal force, stiffness, and damage as a direct result of the interplay between microtubule and cross-link dynamics. Our simulations reveal that slow loading is dominated by cross-link dynamics, a net reduction of cross-links, and a gradual accumulation of damage, whereas fast loading is dominated by cross-link deformations, a rapid increase in stretch, and an immediate risk of rupture. Microtubule polymerization and depolymerization decrease the overall axonal stiffness, but do not affect the evolution of damage at timescales relevant to axonal failure. Our study explains different failure mechanisms in the axon as emergent properties of microtubule polymerization, cross-link dynamics, and physical forces. We anticipate that our model will provide insight into causal relations by which molecular mechanisms determine the timeline and severity of axon damage after a physical impact to the brain.	[de Rooij, Rijk; Kuhl, Ellen] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Kuhl, E (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	ekuhl@stanford.edu	Kuhl, Ellen/G-4444-2011	Kuhl, Ellen/0000-0002-6283-935X	Stanford Graduate FellowshipStanford University; Bio-X IIP seed grant Molecular Mechanisms of Chronic Traumatic Encephalopathy; National Science Foundation grant Understanding Neurodegeneration across the Scales [CMMI 1727268]; Humboldt Research AwardAlexander von Humboldt Foundation	This study was supported by the Stanford Graduate Fellowship to R.d.R. and by the Bio-X IIP seed grant Molecular Mechanisms of Chronic Traumatic Encephalopathy, the National Science Foundation grant Understanding Neurodegeneration across the Scales (CMMI 1727268), and the Humboldt Research Award to E.K.	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Ahmed W. W., 2012, FUNDAMENTALS FRONTIE; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Castle BT, 2017, MOL BIOL CELL, V28, P1238, DOI 10.1091/mbc.E16-08-0567; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Coles CH, 2015, CURR BIOL, V25, pR677, DOI 10.1016/j.cub.2015.06.020; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; de Rooij R, 2017, COMPUT MECH, V59, P523, DOI 10.1007/s00466-016-1359-y; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Franze K, 2013, ANNU REV BIOMED ENG, V15, P227, DOI 10.1146/annurev-bioeng-071811-150045; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Garcia-Grajales JA, 2017, COMPUT METHOD APPL M, V314, P147, DOI 10.1016/j.cma.2016.07.032; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goriely A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.138001; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; HAAK RA, 1976, J PHYSIOL-LONDON, V263, P115, DOI 10.1113/jphysiol.1976.sp011624; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Holland MA, 2015, ANN BIOMED ENG, V43, P1640, DOI 10.1007/s10439-015-1312-9; Igaev M, 2014, BIOPHYS J, V107, P2567, DOI 10.1016/j.bpj.2014.09.016; Jakobs M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00441; Kasas S, 2004, BIOL CELL, V96, P697, DOI 10.1016/j.biolcel.2004.09.002; King S, 2012, DYNEINS: STRUCTURE, BIOLOGY AND DISEASE, pXIII; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Krieg M, 2017, ELIFE, V6, DOI [10.7554/eLife.20172, 10.7554/elife.20172]; LAMOUREUX P, 1989, NATURE, V340, P156, DOI 10.1038/340159a0; Lazarus C, 2015, BIOPHYS J, V109, P231, DOI 10.1016/j.bpj.2015.06.029; Lemaitre, 1992, COURSE DAMAGE MECH; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; O'Toole M, 2015, BIOPHYS J, V108, P1027, DOI 10.1016/j.bpj.2015.01.021; Pannese E, 2015, NEUROCYTOLOGY FINE S; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Prahl LS, 2014, METHOD ENZYMOL, V540, P35, DOI 10.1016/B978-0-12-397924-7.00003-0; Recho P, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032410; Roossien DH, 2014, J CELL SCI, V127, P3593, DOI 10.1242/jcs.152611; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Soheilypour M, 2015, BIOPHYS J, V108, P1718, DOI 10.1016/j.bpj.2015.01.030; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; van den Bedem H, 2015, BIOPHYS J, V109, P2215, DOI 10.1016/j.bpj.2015.10.020; Vemu A, 2016, J BIOL CHEM, V291, P12907, DOI 10.1074/jbc.C116.731133; Voelzmann A, 2016, BRAIN RES BULL, V126, P226, DOI 10.1016/j.brainresbull.2016.08.006; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yogev S, 2016, NEURON, V92, P449, DOI 10.1016/j.neuron.2016.09.036; YU WQ, 1994, J NEUROSCI, V14, P2818; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136	65	15	15	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	JAN 9	2018	114	1					201	212		10.1016/j.bpj.2017.11.010			12	Biophysics	Biophysics	FS2FZ	WOS:000419595500021	29320687	Green Published, Bronze			2021-06-18	
J	Badea, A; Kamnaksh, A; Anderson, RJ; Calabrese, E; Long, JB; Agoston, DV				Badea, Alexandra; Kamnaksh, Alaa; Anderson, Robert J.; Calabrese, Evan; Long, Joseph B.; Agoston, Denes V.			Repeated mild blast exposure in young adult rats results in dynamic and persistent microstructural changes in the brain	NEUROIMAGE-CLINICAL			English	Article						White matter injury; Neurodegeneration; Traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; RESONANCE HISTOLOGY ATLAS; CENTRAL-NERVOUS-SYSTEM; WHITE-MATTER; DIFFUSION-TENSOR; SEXUAL-DIFFERENTIATION; FRONTAL-CORTEX; MOUSE MODEL; INJURY; SINGLE	A history of mild traumatic brain injury (mTBI), particularly repeated mTBI (rmTBI), has been identified as a risk factor for late-onset neurodegenerative conditions. The mild and transient nature of early symptoms often impedes diagnosis in young adults who are disproportionately affected by mTBIs. A proportion of the affected population will incur long-term behavioral and cognitive consequences but the underlying pathomechanism is currently unknown. Diffusion tensor imaging (DTI) provides sensitive and quantitative assessment of TBI-induced structural changes, including white matter injury, and may be used to predict long-term outcome. We used DTI in an animal model of blast rmTBI (rmbTBI) to quantify blast-induced structural changes at 7 and 90 days post-injury, and their evolution between the two time points. Young adult male rats (similar to P65 at injury) were exposed to repeated mild blast overpressure, or anesthetized as shams, and their fixed brains were imaged using high-field (7 T) MRI. We found that whole brain volumes similarly increased in injured and sham rats from 7 to 90 days. However, we detected localized volume increases in blast-exposed animals 7 days post-injury, mainly ipsilateral to incident blast waves. Affected regions included gray matter of the frontal association, cingulate, and motor cortex, thalamus, substantia nigra, and raphe nuclei (median and dorsal), as well as white matter of the internal capsule and cerebral peduncle. Conversely, we measured volume reductions in these and other regions, including the hippocampus and cerebellum, at 90 days post-injury. DTI also detected both transient and persistent microstructural changes following injury, with some changes showing distinct ipsilateral versus contralateral side differences relative to blast impact. Early changes in fractional anisotropy (FA) were subtle, becoming more prominent at 90 days in the cerebral and inferior cerebellar peduncles, and cerebellar white matter. Widespread increases in radial diffusivity (RD) and axial diffusivity (primary eigenvalue or E1) at 7 days post-injury largely subsided by 90 days, although RD was more sensitive than E1 at detecting white matter changes. E1 effects in gray and white matter, which paralleled increases in apparent diffusion, were likely more indicative of dysregulated water homeostasis than pathologic structural changes. Importantly, we found evidence for a different developmental trajectory following rmbTBI, as indicated by significant injury x age interactions on volume. Our findings demonstrate that rmbTBI initiates dynamic pathobiological processes that may negatively alter the course of late-stage neurodevelopment and adversely affect long-term cognitive and behavioral outcomes.	[Badea, Alexandra; Anderson, Robert J.; Calabrese, Evan] Duke Univ, Med Ctr, Dept Radiol, Ctr In Vivo Microscopy, Box 3302, Durham, NC 27710 USA; [Kamnaksh, Alaa; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA	Badea, A (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Ctr In Vivo Microscopy, Box 3302, Durham, NC 27710 USA.; Agoston, DV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	alexandra.badea@duke.edu; denes.agoston@usuhs.edu	Badea, Alexandra/ABC-8324-2020; Badea, Alexandra/S-6052-2016	Badea, Alexandra/0000-0001-6621-4560; Badea, Alexandra/0000-0001-6621-4560	United States Army Medical Research Acquisition Activity (USAMRAA) grant [G1702174]; WRAIR grant [G170353315]; NIH/NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB015897, 1S10OD010683-01]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01 AG041211]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R56AG057895, K01AG041211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD010683] Funding Source: NIH RePORTER	We thank the Neurotrauma Team at the Walter Reed Army Institute of Research (WRAIR) for their technical help during the exposures. We also thank Dr. G. Allan Johnson for critically reading the manuscript. This work was supported by the United States Army Medical Research Acquisition Activity (USAMRAA) grant number G1702174, and WRAIR grant number G170353315. Imaging was done at the Center for In Vivo Microscopy, supported through NIH/NIBIB awards P41 EB015897 and 1S10OD010683-01. AB gratefully acknowledges support from NIH/NIA through K01 AG041211.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Agoston D., 2015, MODELING NEUROBEHAVI; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Badea A, 2012, NEUROIMAGE, V63, P1633, DOI 10.1016/j.neuroimage.2012.07.021; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Calabrese E, 2013, NEUROIMAGE, V71, P196, DOI 10.1016/j.neuroimage.2013.01.017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Friston KJ, 2006, STAT PARAMETRIC MAPP; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Gritti A, 2002, J PHYSIOL-PARIS, V96, P81, DOI 10.1016/S0928-4257(01)00083-3; Groeschel S, 2010, INT J DEV NEUROSCI, V28, P481, DOI 10.1016/j.ijdevneu.2010.06.004; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Huang DP, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/9349487; Institute of M, 2013, RET HOM IR AFGH ASS; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kilpatrick L, 2003, NEUROIMAGE, V20, P2091, DOI 10.1016/j.neuroimage.2003.08.006; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kolb B, 1998, BEHAV BRAIN RES, V91, P143, DOI 10.1016/S0166-4328(97)00111-3; Kovesdi E., 2014, TRANSL PROTEOM, V3, P22; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Leow A., 2006, 1 MICCAI WORKSH MATH, P174; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Li J, 2017, NEURORADIOLOGY, V59, P1203, DOI 10.1007/s00234-017-1915-y; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mengler L, 2014, NEUROIMAGE, V84, P35, DOI 10.1016/j.neuroimage.2013.08.034; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pego JM, 2008, EUR J NEUROSCI, V27, P1503, DOI 10.1111/j.1460-9568.2008.06112.x; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Selemon LD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.7; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Somerville LH, 2010, BIOL PSYCHIAT, V68, P416, DOI 10.1016/j.biopsych.2010.04.002; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sumiyoshi A, 2017, NEUROSCI LETT, V642, P168, DOI 10.1016/j.neulet.2016.12.023; Swaab DF, 2007, BEST PRACT RES CL EN, V21, P431, DOI 10.1016/j.beem.2007.04.003; Tanaka-Arakawa MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118760; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; U.S. Department of Health and Human Services, 2009, HEADS FACTS PHYS MIL; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wang R, 2007, P INT SOC MAG RESON, V15, P3720; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	93	15	15	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						60	73		10.1016/j.nicl.2018.01.007			14	Neuroimaging	Neurosciences & Neurology	GH1NG	WOS:000433169000007	29868442	DOAJ Gold, Green Published			2021-06-18	
J	Cecchetto, C; Korb, S; Rumiati, RI; Aiello, M				Cecchetto, Cinzia; Korb, Sebastian; Rumiati, Raffaella Ida; Aiello, Marilena			Emotional reactions in moral decision-making are influenced by empathy and alexithymia	SOCIAL NEUROSCIENCE			English	Article						Moral decision-making; alexithymia; empathy; skin conductance; heart rate variability	VENTROMEDIAL PREFRONTAL DAMAGE; TRAUMATIC BRAIN-INJURY; LINEAR MIXED MODELS; FRONTOTEMPORAL DEMENTIA; AUTONOMIC REACTIVITY; JUDGMENT; CORTEX; ACCEPTABILITY; NEUROSCIENCE; DIMENSIONS	The role of emotional processes in driving moral choices remains debated. In particular, diminished emotional processing and reduced empathy have been associated with unusual high rates of utilitarian responses in moral judgments while, to date, the effects of diminished emotional processing and empathy on moral decision-making have been only partially considered. In this study, we investigated the influence of empathy and alexithymia on behavior and emotional responses while participants performed a moral decision task. Self-report (valence and arousal ratings) and physiological (skin conductance and heart rate) measures were collected during the task. Results showed that empathy and alexithymia shaped emotional reactions to moral decisions but did not bias moral choices. The more empathic the participants, the more dilemmas were perceived as unpleasant and arousing, and the greater the increase in skin conductance. Conversely, alexithymia was characterized by a reduced physiological activation during moral decisions, but normal self-report ratings. Heart rate was not modulated by empathy or alexithymia. These results add new evidence to the field of moral decision showing that empathy and alexithymia modulate emotional reactions to moral decision.	[Cecchetto, Cinzia; Rumiati, Raffaella Ida; Aiello, Marilena] SISSA, Neurosci Area, Trieste, Italy; [Korb, Sebastian] Univ Vienna, Dept Appl Psychol Hlth Dev Enhancement & Interven, Vienna, Austria; [Rumiati, Raffaella Ida] ANVUR, Rome, Italy	Cecchetto, C (corresponding author), SISSA, Insula Lab, Neurosci Area, Via Bonomea 265, Trieste, TS, Italy.	ccecchet@sissa.it	aiello, mari/AAA-9215-2020; Korb, Sebastian/A-6294-2016; Cecchetto, Cinzia/AAW-1113-2020	Korb, Sebastian/0000-0002-3517-3783; Cecchetto, Cinzia/0000-0001-9047-9884			Batson C., 2014, ALTRUISM QUESTION SO; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Bermond B., 1994, BERMOND VORST ALEXIT; Bermond Bob, 2006, Cogn Neuropsychiatry, V11, P332, DOI 10.1080/13546800500368607; Bermond B, 2007, COGNITION EMOTION, V21, P1125, DOI 10.1080/02699930601056989; Bermond B, 2010, INT J PSYCHOPHYSIOL, V75, P227, DOI 10.1016/j.ijpsycho.2009.11.004; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Bloomfield Paul, 2007, MORALITY SELF INTERE; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Brewer R, 2015, J ABNORM PSYCHOL, V124, P589, DOI 10.1037/abn0000076; Cacioppo JT, 2000, HDB EMOTIONS, V2, P173, DOI DOI 10.1017/CBO9780511546396.025; Carrigan B, 2016, BRAIN COGNITION, V108, P88, DOI 10.1016/j.bandc.2016.07.007; Cecchetto C., PROMOTING C IN PRESS; Choe SY, 2011, JUDGM DECIS MAK, V6, P580; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; Christensen JF, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00607; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Crockett MJ, 2015, CURR BIOL, V25, P1852, DOI 10.1016/j.cub.2015.05.021; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Davis M.H, 1980, J PERS SOC PSYCHOL, V10, P85; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2014, PERSPECT PSYCHOL SCI, V9, P525, DOI 10.1177/1745691614545130; Decety J, 2014, TRENDS COGN SCI, V18, P337, DOI 10.1016/j.tics.2014.04.008; Decety J, 2009, MORAL BRAIN: ESSAYS ON THE EVOLUTIONARY AND NEUROSCIENTIFIC ASPECTS OF MORALITY, P109, DOI 10.1007/978-1-4020-6287-2_5; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Flaisch T, 2008, PSYCHOPHYSIOLOGY, V45, P1, DOI 10.1111/j.1469-8986.2007.00600.x; Foot P, 1967, THEORIES OF ETHICS; Franz M, 2003, J PSYCHOPHYSIOL, V17, P203, DOI 10.1027/0269-8803.17.4.203; Gao Y, 2013, J CRIM JUST, V41, P342, DOI 10.1016/j.jcrimjus.2013.06.012; Gleichgerrcht E, 2015, EUR J NEUROL, V22, P1295, DOI 10.1111/ene.12745; Gleichgerrcht E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060418; Gleichgerrcht E, 2011, SOC NEUROSCI-UK, V6, P113, DOI 10.1080/17470919.2010.506751; Glenn AL, 2010, JUDGM DECIS MAK, V5, P497; Goerlich-Dobre KS, 2015, NEUROIMAGE, V122, P20, DOI 10.1016/j.neuroimage.2015.08.014; Goerlich-Dobre KS, 2015, HUM BRAIN MAPP, V36, P3805, DOI 10.1002/hbm.22879; Goerlich-Dobre KS, 2014, NEUROPSYCHOLOGIA, V53, P284, DOI 10.1016/j.neuropsychologia.2013.12.006; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Guttman H, 2002, COMPR PSYCHIAT, V43, P448, DOI 10.1053/comp.2002.35905; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hoffman M. L., 1994, REACHING OUT CARING, V7, P161; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koven NS, 2011, EMOTION, V11, P1255, DOI 10.1037/a0025616; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Langdon R, 2012, EMOTIONS IMAGINATION; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Lotto L, 2014, J BEHAV DECIS MAKING, V27, P57, DOI 10.1002/bdm.1782; Maibom H.L., 2014, EMPATHY AND MORALITY; Martins AT, 2012, JUDGM DECIS MAK, V7, P478; McCulloch CE, 1997, J AM STAT ASSOC, V92, P162, DOI 10.2307/2291460; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; Moretto G, 2010, J COGNITIVE NEUROSCI, V22, P1888, DOI 10.1162/jocn.2009.21367; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nemiah JC, 1976, MODERN TRENDS PSYCHO, Vthird, P430; Neufeld J, 2016, AUTISM RES, V9, P781, DOI 10.1002/aur.1573; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann SA, 2004, INT J PSYCHOPHYSIOL, V53, P183, DOI 10.1016/j.ijpsycho.2004.03.008; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Orelien JG, 2008, COMPUT STAT DATA AN, V52, P1896, DOI 10.1016/j.csda.2007.06.006; Palomba D, 2000, INT J PSYCHOPHYSIOL, V36, P45, DOI 10.1016/S0167-8760(99)00099-9; Patil I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23637; Patil I, 2014, J COGN PSYCHOL, V26, P597, DOI 10.1080/20445911.2014.929137; Patil I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00501; Peasley-Miklus CE, 2016, EMOTION, V16, P164, DOI 10.1037/emo0000086; Pizarro D, 2000, J THEOR SOC BEHAV, V30, P355, DOI 10.1111/1468-5914.00135; Pollatos O, 2011, J PSYCHOSOM RES, V70, P525, DOI 10.1016/j.jpsychores.2010.12.003; Pouga L., 2011, OXFORD HDB SOCIAL NE, P906, DOI DOI 10.1093/OXFORDHB/9780195342161.013.0060; Ranyard R., 2011, HDB PROCESS TRACING; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Sarlo M, 2014, PHYSIOL BEHAV, V130, P127, DOI 10.1016/j.physbeh.2014.04.002; Sarlo M, 2012, J COGNITIVE NEUROSCI, V24, P1018, DOI 10.1162/jocn_a_00146; Shenhav A, 2014, J NEUROSCI, V34, P4741, DOI 10.1523/JNEUROSCI.3390-13.2014; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sturm VE, 2011, NEUROCASE, V17, P242, DOI 10.1080/13554794.2010.532503; Szekely RD, 2015, COGNITION EMOTION, V29, P64, DOI 10.1080/02699931.2014.895300; Tassy S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00229; Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250; Taylor G. J., 1999, DISORDERS AFFECT REG; Thomas BC, 2011, J COGNITIVE NEUROSCI, V23, P2186, DOI 10.1162/jocn.2010.21591; Thomson J.A.K., 1976, ARISTOTLE ETHICS; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Wood A, 2016, TRENDS COGN SCI, V20, P227, DOI 10.1016/j.tics.2015.12.010; Young L, 2012, J ABNORM PSYCHOL, V121, P659, DOI 10.1037/a0027489	96	15	16	4	46	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.		2018	13	2					226	240		10.1080/17470919.2017.1288656			15	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	GB8ZP	WOS:000429364100007	28129727				2021-06-18	
J	Chang, R; Holcomb, JB; Johansson, PI; Pati, S; Schreiber, MA; Wade, CE				Chang, Ronald; Holcomb, John B.; Johansson, Par I.; Pati, Shibani; Schreiber, Martin A.; Wade, Charles E.			PLASMA RESUSCITATION IMPROVED SURVIVAL IN A CECAL LIGATION AND PUNCTURE RAT MODEL OF SEPSIS	SHOCK			English	Article						Endothelium; fluid therapy; septic shock	TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; ENDOTHELIAL GLYCOCALYX; FLUID RESUSCITATION; MORTALITY; TRANSFUSION; THERAPY; MULTICENTER; EXPRESSION; MANAGEMENT	Background: The paradigm shift from crystalloid to plasma resuscitation of traumatic hemorrhagic shock has improved patient outcomes due in part to plasma-mediated reversal of catecholamine and inflammation-induced endothelial injury, decreasing vascular permeability and attenuating organ injury. Since sepsis induces a similar endothelial injury as seen in hemorrhage, we hypothesized that plasma resuscitation would increase 48-h survival in a rat sepsis model. Methods: Adult male Sprague-Dawley rats (375-425 g) were subjected to 35% cecal ligation and puncture (CLP) (t = 0 h). Twenty-two hours post-CLP and prior to resuscitation (t = 22 h), animals were randomized to resuscitation with normal saline (NS, 10 cc/kg/h) or pooled rat fresh frozen plasma (FFP, 3.33 cc/kg/h). Resuscitation under general anesthesia proceeded for the next 6 h (t = 22 h to t = 28 h); lactate was checked every 2 h, and fluid volumes were titrated based on lactate clearance. Blood samples were obtained before (t = 22 h) and after resuscitation (t = 28 h), and at death or study conclusion. Lung specimens were obtained for calculation of wet-to-dry weight ratio. Fisher exact test was used to analyze the primary outcome of 48-h survival. ANOVA with repeated measureswas used to analyze the effect of FFP versus NS resuscitation on blood gas, electrolytes, blood urea nitrogen (BUN), creatinine, interleukin (IL)-6, IL-10, catecholamines, and syndecan-1 (marker for endothelial injury). A two-tailed alpha level of < 0.05 was used for all statistical tests. Results: Thirty-three animals were studied: 14 FFP, 14 NS, and 5 sham. Post-CLP but preresuscitation (t = 22 h) variables between FFP and NS animals were similar and significantly deranged compared with sham animals. FFP significantly increased 48-h survival compared to NS (n = 8 [57%] vs n = 2 [14%]), attenuated the post-resuscitation (t = 28 h) levels of epinephrine (mean 2.2 vs 7.0 ng/mL), norepinephrine, (3.8 vs 8.9 ng/mL), IL-6 (3.8 vs 18.7 ng/mL), and syndecan-1 (21.8 vs 31.0 ng/mL) (all P < 0.05), improved the post-resuscitation PO2 to FiO(2) ratio (353 vs 151), and reduced the pulmonary wet-to-dry weight ratio (5.28 vs 5.94) (all P < 0.05). Conclusion: Compared to crystalloid, plasma resuscitation increased 48-h survival in a rat sepsis model, improved pulmonary function and decreased pulmonary edema, and attenuated markers for inflammation, endothelial injury, and catecholamines.	[Chang, Ronald; Holcomb, John B.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX 77030 USA; [Chang, Ronald; Holcomb, John B.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, McGovern Med Sch, Houston, TX 77030 USA; [Johansson, Par I.] Rigshosp, Capital Reg Blood Bank, Copenhagen, Denmark; [Pati, Shibani] Univ Calif San Francisco, Dept Pathol & Lab Med, San Francisco, CA 94143 USA; [Pati, Shibani] Blood Syst Res Inst, San Francisco, CA USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA	Chang, R (corresponding author), 6410 Fannin St,Suite 1100, Houston, TX 77030 USA.	ronald.chang@uth.tmc.edu		Johansson, Par Ingemar/0000-0001-9778-5964; holcomb, john/0000-0001-8312-9157; chang, ronald/0000-0002-8947-0054	T32 fellowship from NIGMS [5T32GM008792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	RC is supported by a T32 fellowship (grant no. 5T32GM008792) from NIGMS.	Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Balogh Z, 2013, ARCH SURG-CHICAGO, V138, P637; Bro-Jeppesen J, 2016, RESUSCITATION, V107, P71, DOI 10.1016/j.resuscitation.2016.08.006; Cardenas JC, 2016, SHOCK, V45, P166, DOI 10.1097/SHK.0000000000000504; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Chang R, 2017, CRIT CARE CLIN, V33, P15, DOI 10.1016/j.ccc.2016.08.007; Chang R, 2016, SHOCK, V46, P17, DOI 10.1097/SHK.0000000000000577; Chignalia AZ, 2016, SHOCK, V45, P338, DOI 10.1097/SHK.0000000000000513; COLLINS JA, 1971, ANN SURG, V173, P6, DOI 10.1097/00000658-197101000-00002; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Garcia-Alvarez M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0503-3; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Ince C, 2016, SHOCK, V45, P259, DOI 10.1097/SHK.0000000000000473; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johansen ME, 2015, SEMIN THROMB HEMOST, V41, P16, DOI 10.1055/s-0034-1398377; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Lilley E, 2015, SHOCK, V43, P304, DOI 10.1097/SHK.0000000000000318; MAKHMUDOV RM, 1985, COR VASA, V27, P456; Matsuda A, 2005, SHOCK, V24, P364, DOI 10.1097/01.shk.0000180624.36811.97; Ostrowski SR, 2013, CRIT CARE, V17, DOI 10.1186/cc12532; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Raghunathan K, 2015, ANESTHESIOLOGY, V123, P1385, DOI 10.1097/ALN.0000000000000861; Rahbar E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0481-5; Robinson BRH, 2013, J TRAUMA ACUTE CARE, V75, pS61, DOI 10.1097/TA.0b013e31828fa408; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Singleton KD, 2003, EUR SURG RES, V35, P486, DOI 10.1159/000073387; Stevens JP, 2007, INTERMEDIATE STAT MO, P57; Torres LN, 2013, J TRAUMA ACUTE CARE, V75, P759, DOI 10.1097/TA.0b013e3182a92514; TRAVERSO LW, 1986, J TRAUMA, V26, P176, DOI 10.1097/00005373-198602000-00015; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Watson JJJ, 2016, SHOCK, V46, P468, DOI 10.1097/SHK.0000000000000663; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515	37	15	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JAN	2018	49	1					53	61		10.1097/SHK.0000000000000918			9	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	GB8ED	WOS:000429307300009	28591008	Green Accepted			2021-06-18	
J	Giammattei, L; Messerer, M; Oddo, M; Borsotti, F; Levivier, M; Daniel, RT				Giammattei, Lorenzo; Messerer, Mahmoud; Oddo, Mauro; Borsotti, Francois; Levivier, Marc; Daniel, Roy T.			Cisternostomy for Refractory Posttraumatic Intracranial Hypertension	WORLD NEUROSURGERY			English	Article						Cisternostomy; Decompressive craniectomy; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; IMPAIRMENT	BACKGROUND: The current surgical treatment of choice for refractory intracranial hypertension after traumatic brain injury (TBI) is decompressive craniectomy. Despite efficacy in control of intracranial pressure (ICP), its contribution to an improved outcome is debatable. CASE DESCRIPTION: We describe a case of refractory intracranial hypertension successfully managed with cisternostomy. The rationale for this surgical technique is discussed, with a focus on the pathophysiologic processes underlying elevated ICP and its improvement after surgery. CONCLUSION: Cisternostomy proved to have an immediate effect in controlling ICP and improving brain oxygenation and metabolism.	[Giammattei, Lorenzo; Messerer, Mahmoud; Borsotti, Francois; Levivier, Marc; Daniel, Roy T.] Lausanne Univ Hosp, Dept Neurosurg, Lausanne, Switzerland; [Oddo, Mauro] Lausanne Univ Hosp, Dept Intens Care Med, Lausanne, Switzerland	Giammattei, L (corresponding author), Lausanne Univ Hosp, Dept Neurosurg, Lausanne, Switzerland.	lorenzo.giammattei@chuv.ch	Messerer, Mahmoud/AAZ-3527-2020				Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cherian I, 2017, J NEUROSCI RES; Cherian I, 2016, WORLD NEUROSURG, V89, P51, DOI 10.1016/j.wneu.2016.01.072; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Masoudi Mohammad Sadegh, 2016, Bull Emerg Trauma, V4, P161; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2	13	15	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2018	109						460	463		10.1016/j.wneu.2017.10.085			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FR4DD	WOS:000419015000190	29081393				2021-06-18	
J	Gill, J; Mustapic, M; Diaz-Arrastia, R; Lange, R; Gulyani, S; Diehl, T; Motamedi, V; Osier, N; Stern, RA; Kapogiannis, D				Gill, Jessica; Mustapic, Maja; Diaz-Arrastia, Ramon; Lange, Rael; Gulyani, Seema; Diehl, Tom; Motamedi, Vida; Osier, Nicole; Stern, Robert A.; Kapogiannis, Dimitrios			Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel	BRAIN INJURY			English	Article						Exosomes; post-traumatic stress disorder; tau; traumatic brain injury (TBI); inflammation	TRAUMATIC BRAIN-INJURY; PRECLINICAL ALZHEIMERS-DISEASE; POSTTRAUMATIC-STRESS-DISORDER; EXTRACELLULAR VESICLES; BLOOD EXOSOMES; IN-VIVO; ENCEPHALOPATHY; PTSD; PROTEINS; INVENTORY	Objective: Identify biomarkers in peripheral blood that relate to chronic post-concussive and behavioural symptoms following traumatic brain injuries (TBIs) to ultimately improve clinical management. Research design: We compared military personnel with mild TBIs (mTBIs) (n = 42) to those without TBIs (n = 22) in concentrations of tau, amyloid-beta (A beta 42) and cytokines (tumour necrosis factor alpha (TNF alpha, interleukin (IL)-6 and -10) in neuronal-derived exosomes from the peripheral blood. We utilized nanosight technology coupled with ultra-sensitivity immunoassay methods. We also examined the impact of post-concussive and behavioural symptoms including depression and post-traumatic stress disorder (PTSD) on these neuronal-derived markers. Results: We report that concentrations of exosomal tau (F-1,F- (62) = 10.50), A beta 42 (F-1,F- (61) = 5.32) and IL-10 (F-1,F-59 = 4.32) were elevated in the mTBI group compared to the controls. Within the mTBI group, regression models show that post-concussive symptoms were most related to exosomal tau elevations, whereas exosomal IL-10 levels were related to PTSD symptoms. Conclusions: These findings suggest that chronic post-concussive symptoms following an mTBI relate to altered exosomal activity, and that greater tau pathology may underlie chronic post-concussive symptoms that develop following mTBIs. It also suggests that central inflammatory activity contributes to PTSD symptoms following an mTBI, providing necessary insights into the role of inflammation in chronic PTSD symptoms.	[Gill, Jessica; Motamedi, Vida; Osier, Nicole] NINR, Tissue Injury Branch, NIH, Bethesda, MD 20892 USA; [Mustapic, Maja; Gulyani, Seema; Diehl, Tom; Kapogiannis, Dimitrios] NIA, Aging, NIH, Baltimore, MD 21224 USA; [Diaz-Arrastia, Ramon] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Lange, Rael] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Stern, Robert A.] Boston Univ, Neurosurg & Anat & Neurobiol, Alzheimers Dis & CTE Ctr, Boston, MA 02215 USA	Gill, J (corresponding author), NIH, Intramural Res Program, Bldg 10, Bethesda, MD 20892 USA.	gillj@mail.nih.gov	Gill, Gill M/Q-2020-2017; Mustapic, Maja/AAV-3212-2020; Kapogiannis, Dimitrios/AAW-4934-2020; , Bob/ABA-8507-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; 	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; National Institute of Nursing Research, Intramural Research Program; National Institute on Aging, Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)	This work was supported by the The Center for Neuroscience and Regenerative Medicine; National Institute of Nursing Research, Intramural Research Program; and National Institute on Aging, Intramural Research Program.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Armstrong RA, 2016, NEUROPATHOL APPL NEU, V2, P185; Baker S, 2016, J ALZHEIMERS DIS, V54, P1207, DOI 10.3233/JAD-160371; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bersani FS, 2016, BRAIN BEHAV IMMUN, V52, P153, DOI 10.1016/j.bbi.2015.10.015; Bogoslovsky T, 2016, J NEUROTRAUM, V5, P70; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Ebenezer PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160923; Falker C, 2016, J NEUROCHEM, V137, P88, DOI 10.1111/jnc.13514; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Gatson JW, 2016, J NEUROSURG, V124, P1646, DOI 10.3171/2015.6.JNS15639; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Hamlett ED, 2018, FREE RADICAL BIO MED, V114, P110, DOI 10.1016/j.freeradbiomed.2017.08.028; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Jin Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2783-2; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Mac Donald CL, 2016, J NEUROTRAUM, V22, P23; Mac Donald CL, 2016, J NEUROTRAUM, V4, P12; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Nie H, 2014, PROG NEURO-PSYCHOPH, V51, P16, DOI 10.1016/j.pnpbp.2014.01.002; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rajendrana L, 2007, NEURODEGENER DIS, V4, P164, DOI 10.1159/000101841; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Saenz-Cuesta M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00050; Saman S, 2014, J ALZHEIMERS DIS, V40, pS47, DOI 10.3233/JAD-132135; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Tucker Phebe, 2010, Am J Disaster Med, V5, P113; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	60	15	15	4	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1359	1366		10.1080/02699052.2018.1471738			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000007		Green Accepted			2021-06-18	
J	Han, K; Chapman, SB; Krawczyk, DC				Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.			Neuroplasticity of cognitive control networks following cognitive training for chronic traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Rehabilitation; Cognitive function; Resting-state functional connectivity; Neuroplasticity; Cognitive control	INTRINSIC FUNCTIONAL CONNECTIVITY; CINGULO-OPERCULAR NETWORK; DEFAULT-MODE NETWORK; RESTING-STATE FMRI; OF-THE-LITERATURE; CEREBRAL-CORTEX; NUISANCE REGRESSION; SALIENCE NETWORK; WORKING-MEMORY; HEAD MOTION	Cognitive control is the ability to coordinate thoughts and actions to achieve goals. Cognitive control impairments are one of the most persistent and devastating sequalae of traumatic brain injuries (TBI). There have been efforts to improve cognitive control in individuals with post-acute TBI. Several studies have reported changes in neuropsychological measures suggesting the efficacy of cognitive training in improving cognitive control. Yet, the neural substrates of improved cognitive control after training remains poorly understood. In the current study, we identified neural plasticity induced by cognitive control training for TBI using resting-state functional connectivity (rsFC). Fifty-six individuals with chronic mild TBI (9 years post-injury on average) were randomized into either a strategy-based cognitive training group (N = 26) or a knowledge-based training group (active control condition; N = 30) for 8 weeks. We acquired a total of 109 resting-state functional magnetic resonance imaging from 45 individuals before training, immediately post-training, and 3 months post-training. Relative to the controls, the strategy-based cognitive training group showed monotonic increases in connectivity in two cognitive control networks (i.e., cingulo-opercular and fronto-parietal networks) across time points in multiple brain regions (p(voxel) < 0.001, p(cluster) < 0.05). Analyses of brain-behavior relationships revealed that frontoparietal network connectivity over three time points within the strategy-based cognitive training group was positively associated with the trail making scores (p(voxel) < 0.001, p(cluster) < 0.05). These findings suggest that training-induced neuroplasticity continues through chronic phases of TBI and that rsFC can serve as a neuroimaging biomarker of evaluating the efficacy of cognitive training for TBI.	[Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, 2200 West Mockingbird Lane,Mail Stop CBH, Dallas, TX 75235 USA; [Krawczyk, Daniel C.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA	Han, K (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, 2200 West Mockingbird Lane,Mail Stop CBH, Dallas, TX 75235 USA.	kihwan.han@utdallas.edu; schapman@utdallas.edu; daniel.krawczyk@utdallas.edu	Han, Kihwan/I-1984-2019	Han, Kihwan/0000-0002-4574-7306	Department of DefenseUnited States Department of Defense [W81XWH-11-2-0194, W81XWH-11-2-0195]; Meadows Foundation; Sapphire Foundation Distinguished New Scientist Award	This work was supported by the Department of Defense (W81XWH-11-2-0194 to DCK and W81XWH-11-2-0195 to SBC), the Meadows Foundation to DCK and SBC, and the Sapphire Foundation Distinguished New Scientist Award to KH.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Beck AT., 1996, BECK DEPRESSION INVE, V2; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Bertolero MA, 2015, P NATL ACAD SCI USA, V112, pE6798, DOI 10.1073/pnas.1510619112; Binder D., 2008, BRAIN HLTH WORKSHOP; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bright MG, 2017, NEUROIMAGE, V154, P159, DOI 10.1016/j.neuroimage.2016.12.027; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Giglio L, 2016, RADIOLOGY, V280, P202, DOI 10.1148/radiol.2016150710; Delis DC, 2001, D KEFS EXECUTIVE FUN; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fornito A, 2012, P NATL ACAD SCI USA, V109, P12788, DOI 10.1073/pnas.1204185109; Frieden T. R., 2015, REPORT C TRAUMATIC B; Guerra-Carrillo B, 2014, NEUROSCIENTIST, V20, P522, DOI 10.1177/1073858414524442; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Han K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.687; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Jolles D, 2016, DEVELOPMENTAL SCI, V19, P613, DOI 10.1111/desc.12399; Jolles DD, 2013, HUM BRAIN MAPP, V34, P396, DOI 10.1002/hbm.21444; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelly C, 2014, NEUROPSYCHOL REV, V24, P63, DOI 10.1007/s11065-014-9252-y; Keshavan MS, 2017, NEUROIMAGE, V151, P55, DOI 10.1016/j.neuroimage.2016.11.060; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Mackey AP, 2013, J NEUROSCI, V33, P4796, DOI 10.1523/JNEUROSCI.4141-12.2013; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Scheinost D, 2014, NEUROIMAGE, V95, P13, DOI 10.1016/j.neuroimage.2014.03.035; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sestieri C, 2014, J COGNITIVE NEUROSCI, V26, P551, DOI 10.1162/jocn_a_00504; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sheffield JM, 2015, NEUROPSYCHOLOGIA, V73, P82, DOI 10.1016/j.neuropsychologia.2015.05.006; Silk TJ, 2008, BRAIN IMAGING BEHAV, V2, P123, DOI 10.1007/s11682-008-9021-8; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spreng RN, 2014, J NEUROSCI, V34, P14108, DOI 10.1523/JNEUROSCI.2815-14.2014; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Takeuchi H, 2013, CORTEX, V49, P2106, DOI 10.1016/j.cortex.2012.09.007; Tardif CL, 2016, NEUROIMAGE, V131, P55, DOI 10.1016/j.neuroimage.2015.08.047; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Trujillo JP, 2015, HUM BRAIN MAPP, V36, P3703, DOI 10.1002/hbm.22873; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 2001, WECHSLER TEST ADULT; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu XP, 2016, J AFFECT DISORDERS, V200, P275, DOI 10.1016/j.jad.2016.04.046; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	92	15	17	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						262	278		10.1016/j.nicl.2018.01.030			17	Neuroimaging	Neurosciences & Neurology	GH1NG	WOS:000433169000026	29876247	DOAJ Gold, Green Published			2021-06-18	
J	Harriss, A; Walton, DM; Dickey, JP				Harriss, Alexandra; Walton, David M.; Dickey, James P.			Direct player observation is needed to accurately quantify heading frequency in youth soccer	RESEARCH IN SPORTS MEDICINE			English	Article						Soccer; concussion; heading; self-report	NEUROCOGNITIVE PERFORMANCE; EXPOSURE; FOOTBALLERS; FEMALE	In soccer, heading may be related to subsequent neurological impairment. Accurate measures of heading exposure are therefore important. This study evaluated whether 12 female youth players accurately recalled their average number of headers over an entire soccer season (20 games total). Their self-reported average number of headers per game was multiplied by the number of games that they participated in, and were compared to actual number of headers extracted from game video. All players overestimated the number of headers compared to game video. Linear regression analysis indicated that self-reported headers overestimated the number of headers by 51%. While self-reports are a convenient way to estimate heading behaviour, they do not accurately represent the number of headers that players perform. Self-reports of heading exposure should be interpreted with caution.	[Harriss, Alexandra; Dickey, James P.] Western Univ, Sch Kinesiol, 1151 Richmond St,3M Ctr, London, ON N6A 3K7, Canada; [Walton, David M.] Western Univ, Sch Phys Therapy, Elborn Coll, London, ON, Canada	Dickey, JP (corresponding author), Western Univ, Sch Kinesiol, 1151 Richmond St,3M Ctr, London, ON N6A 3K7, Canada.	jdickey@uwo.ca	Walton, David M/C-9902-2015; Dickey, James P/K-6776-2013	Walton, David M/0000-0001-9155-3337; Dickey, James P/0000-0002-4101-835X	Ontario Soccer Association; Burlington Youth Soccer Club	We would like to thank the Ontario Soccer Association, and the Burlington Youth Soccer Club for supporting this study. The authors would like to thank Aakash Naik for help in data acquisition.	Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Chan Y H, 2003, Singapore Med J, V44, P614; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kunz M., 2007, FIFA MAGAZINE, P10; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Metzl JD, 1998, CLIN SPORT MED, V17, P663, DOI 10.1016/S0278-5919(05)70110-1; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Rutherford A, 2005, APPL COGNITIVE PSYCH, V19, P477, DOI 10.1002/acp.1091; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Webbe FM, 2007, J CLIN SPORT PSYCHOL, V1, P379, DOI 10.1123/jcsp.1.4.379	19	15	15	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2018	26	2					191	198		10.1080/15438627.2018.1431534			8	Sport Sciences	Sport Sciences	GA8NL	WOS:000428596900007	29366355				2021-06-18	
J	Hollund, IMH; Olsen, A; Skranes, J; Brubakk, AM; Haberg, AK; Eikenes, L; Evensen, KAI				Hollund, Ingrid Marie Husby; Olsen, Alexander; Skranes, Jon; Brubakk, Ann-Mari; Haberg, Asta K.; Eikenes, Live; Evensen, Kari Anne I.			White matter alterations and their associations with motor function in young adults born preterm with very low birth weight	NEUROIMAGE-CLINICAL			English	Article						Preterm; Brain; Diffusion tensor imaging; Tractography; Motor function; Young adulthood	TRAUMATIC BRAIN-INJURY; ASSESSMENT-TOOL HIMAT; CORPUS-CALLOSUM; FRACTIONAL ANISOTROPY; SPATIAL STATISTICS; DIFFUSION; CHILDREN; AGE; ADOLESCENTS; INFANTS	Very low birth weight (VLBW: <= 1500 g) individuals have an increased risk of white matter alterations and neurodevelopmental problems, including fine and gross motor problems. In this hospital-based follow-up study, the main aim was to examine white matter microstructure and its relationship to fine and gross motor function in 31 VLBW young adults without cerebral palsy compared with 31 term-born controls, at mean age 22.6 +/- 0.7 years. The participants were examined with tests of fine and gross motor function (Trail Making Test-5: TMT-5, Grooved Pegboard, Triangle from Movement Assessment Battery for Children-2: MABC-2 and High-level Mobility Assessment Tool: HiMAT) and diffusion tensor imaging (DTI). Probabilistic tractography of motor pathways of the corticospinal tract (CST) and corpus callosum (CC) was performed. Fractional anisotropy (FA) was calculated in non-crossing (capsula interna in CST, body of CC) and crossing (centrum semiovale) fibre regions along the tracts and examined for group differences. Associations between motor test scores and FA in the CST and CC were investigated with linear regression. Tract-based spatial statistics (TBSS) was used to examine group differences in DTI metrics in all major white matter tracts. The VLBW group had lower scores on all motor tests compared with controls, however, only statistically significant for TMT-5. Based on tractography, FA in the VLBW group was lower in non-crossing fibre regions and higher in crossing fibre regions of the CST compared with controls. Within the VLBW group, poorer fine motor function was associated with higher FA in crossing fibre regions of the CST, and poorer bimanual coordination was additionally associated with lower FA in crossing fibre regions of the CC. Poorer gross motor function was associated with lower FA in crossing fibre regions of the CST and CC. There were no associations between motor function and FA in non-crossing fibre regions of the CST and CC within the VLBW group. In the TBSS analysis, the VLBW group had lower FA and higher mean diffusivity compared with controls in all major white matter tracts. The findings in this study may indicate that the associations between motor function and FA are caused by other tracts crossing the CST and CC, and/or by alterations in the periventricular white matter in the centrum semiovale. Some of the associations were in the opposite direction than hypothesized, thus higher FA does not always indicate better function. Furthermore, widespread white matter alterations in VLBW individuals persist into young adulthood.	[Hollund, Ingrid Marie Husby; Skranes, Jon; Brubakk, Ann-Mari; Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7491 Trondheim, Norway; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Skranes, Jon] Sorlandet Hosp, Dept Pediat, Arendal, Norway; [Haberg, Asta K.] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Haberg, Asta K.] Trondheim Reg & Univ Hosp, St Olavs Hosp, MR Ctr, Dept Radiol & Nucl Med, Trondheim, Norway; [Eikenes, Live] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway; [Evensen, Kari Anne I.] Dept Physiotherapy, Trondheim, Norway	Hollund, IMH (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7491 Trondheim, Norway.	ingridmhusby@gmail.com	Olsen, Alexander/P-5235-2019	Olsen, Alexander/0000-0001-8691-3860; Evensen, Kari Anne I./0000-0002-0129-0164	Research Council of Norway (Researcher program: NEVRONOR) [182663]	The study was funded by the Research Council of Norway (Researcher program: NEVRONOR. Project Number: 182663) and was independent of commercial interest.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; [Anonymous], 2002, GROOV PEG TEST US IN; BAKKETEIG LS, 1993, ACTA OBSTET GYN SCAN, V72, P273, DOI 10.3109/00016349309068037; Barnett, 2007, MOVEMENT ASSESSMENT; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berntsen EM, 2008, NEUROL RES, V30, P968, DOI 10.1179/016164108X323753; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Counsell SJ, 2008, BRAIN, V131, P3201, DOI 10.1093/brain/awn268; de Kieviet JF, 2014, EUR J PAEDIATR NEURO, V18, P126, DOI 10.1016/j.ejpn.2013.09.004; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; Delis D.C., 2001, EXAMINERS MANUAL; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Hollingshead A.B., 1957, 2 FACTOR INDEX SOCIA; Husby IM, 2013, EARLY HUM DEV, V89, P747, DOI 10.1016/j.earlhumdev.2013.05.009; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Jurcoane A, 2016, HUM BRAIN MAPP, V37, P289, DOI 10.1002/hbm.23031; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Li K., 2014, DEV MED CHILD NEUROL; Meng C, 2016, BRAIN STRUCT FUNCT, V221, P2109, DOI 10.1007/s00429-015-1032-9; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pandit AS, 2013, NEURORADIOLOGY, V55, P65, DOI 10.1007/s00234-013-1242-x; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Skranes JS, 1997, NEUROPEDIATRICS, V28, P149, DOI 10.1055/s-2007-973692; SKRANES JS, 1993, NEUROPEDIATRICS, V24, P256, DOI 10.1055/s-2008-1071553; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sripada K, 2015, NEUROIMAGE, V109, P493, DOI 10.1016/j.neuroimage.2015.01.019; Steele CJ, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00289; van Kooij BJM, 2012, AM J NEURORADIOL, V33, P188, DOI 10.3174/ajnr.A2723; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	42	15	15	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	17						241	250		10.1016/j.nicl.2017.10.006			10	Neuroimaging	Neurosciences & Neurology	FX6GA	WOS:000426180300027	29159041	DOAJ Gold, Green Published			2021-06-18	
J	Karagiorgou, O; Evans, JJ; Cullen, B				Karagiorgou, Olga; Evans, Jonathan J.; Cullen, Breda			Post-traumatic growth in adult survivors of brain injury: a qualitative study of participants completing a pilot trial of brief positive psychotherapy	DISABILITY AND REHABILITATION			English	Article						Acquired brain injury; post-traumatic growth; positive psychology; psychotherapy; qualitative	PSYCHOLOGY; VALIDITY	Purpose: Post-traumatic growth (PTG) can occur following acquired brain injury (ABI). It has been proposed that people experiencing psychological distress following ABI may benefit from a positive psychotherapy intervention (PPT) aimed at increasing well-being; PPT may also influence PTG. We aimed to investigate PTG experiences in participants of a positive psychotherapy pilot trial. Methods: ABI survivors who had received PPT or treatment as usual (TAU) were interviewed individually after the end of the trial. Thematic analysis was conducted, to code transcripts for known themes from PTG literature as well as newly emerging themes. Results: Four participants (age = 46-62; n = 3 male; months since injury = 11-20) from the PPT group and three (age = 58-74; n = 2 male; months since injury = 9-22) from the TAU group were interviewed. Six themes were shared across both groups: personal strength, appreciation of life, relating to others, optimism/positive attitude, feeling fortunate compared to others, and positive emotional/behavioral changes. Two themes were expressed by PPT participants only: lifestyle improvements and new possibilities. One TAU participant reported spiritual change. Conclusions: A greater understanding of the development of PTG following ABI may help rehabilitation clinicians to promote better adjustment by focusing on clients' potential for positive change and enhancing their capacity for growth.	[Karagiorgou, Olga; Evans, Jonathan J.; Cullen, Breda] Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Karagiorgou, Olga] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland	Cullen, B (corresponding author), Univ Glasgow, Queen Elizabeth Univ Hosp, Off Block, Glasgow G51 4TF, Lanark, Scotland.	breda.cullen@glasgow.ac.uk	Cullen, Breda/N-3449-2019; Cullen, Breda/C-9154-2012	Cullen, Breda/0000-0002-7259-9505; Cullen, Breda/0000-0002-7259-9505	Dr Mortimer and Theresa Sackler Foundation; Scottish Executive Health Department [CZH/4/778]; Chief Scientist Office [CZH/4/778] Funding Source: researchfish	Breda Cullen is supported by The Dr Mortimer and Theresa Sackler Foundation. The PoPsTAR trial was funded by the Scottish Executive Health Department (Chief Scientist Office) under grant CZH/4/778. The funders had no role in the study design; collection, analysis, and interpretation of data; writing of the report; or decision to submit for publication. The authors declare that there are no other competing interests to disclose.	Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Cullen B, 2018, NEUROPSYCHOL REHABIL, V28, P17, DOI 10.1080/09602011.2015.1131722; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Joseph S, 2012, PSYCHOL TRAUMA-US, V4, P420, DOI 10.1037/a0024740; Karagiorgou O, 2016, J LOSS TRAUMA, V21, P589, DOI 10.1080/15325024.2016.1161427; Lennon A, 2014, BRAIN INJURY, V28, P27, DOI 10.3109/02699052.2013.848378; Seligman M., 2011, FLOURISH NEW UNDERST; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Shakespeare-Finch J, 2013, J LOSS TRAUMA, V18, P572, DOI 10.1080/15325024.2012.734207; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	14	15	15	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	6					655	659		10.1080/09638288.2016.1274337			5	Rehabilitation	Rehabilitation	FY5XL	WOS:000426911500005	28068845	Green Accepted			2021-06-18	
J	Lupu, T; Elbaum, T; Wagner, M; Braw, Y				Lupu, T.; Elbaum, T.; Wagner, M.; Braw, Y.			Enhanced detection of feigned cognitive impairment using per item response time measurements in the Word Memory Test	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Malingering; performance validity test (PVT); response time; simulation; Word Memory Test (WMT)	SYMPTOM VALIDITY TEST; TRAUMATIC BRAIN-INJURY; PERFORMANCE VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; DEFICITS; INFORMATION; DISABILITY; SIMULATION; FRAMEWORK; CLAIMANTS	Response time (RT) is a less obvious outcome measure than conventional accuracy measures used in performance validity tests (PVTs). It is also under less conscious control and is affected by cognitive processes associated with deception. Studies that assessed the utility of RT for the detection of feigned cognitive impairment are however numbered. Moreover, RT variability was not assessed in a clinically used PVT. In the current study, we assessed the utility of RT measures for the detection of feigned cognitive impairment in the Word Memory Test (WMT). Healthy participants (N=90) were randomly assigned to a simulation or control condition and their per-item RTs were recorded while they performed the WMT's immediate recognition (IR) subtest. Simulators had longer mean RTs and larger RT variance than controls. Combining RT measures and the IR-subtest's accuracy score enabled a highly accurate detection of simulators. Moreover, the combined scale demonstrated incremental value (though slight) in predicting group membership beyond the use of the accuracy score as the sole PVT measure. The findings tentatively point toward the usefulness of RT measures to enhance the detection of feigned cognitive impairment. Further studies are needed, however, in order to explore the utility of these measures in clinical settings.	[Lupu, T.; Elbaum, T.; Wagner, M.; Braw, Y.] Ariel Univ, Dept Psychol, POB 3, IL-40700 Ariel, Israel	Braw, Y (corresponding author), Ariel Univ, Dept Psychol, POB 3, IL-40700 Ariel, Israel.	yoramb@ariel.ac.il	Braw, Yoram/AAE-1669-2019	Elbaum, Tomer/0000-0002-4455-6153			Allen LM, 1999, SEVERE TBI SAMPLE PE; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; Boone K. B., 2013, CLIN PRACTICE FORENS; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2014, CLIN NEUROPSYCHOL, V28, P146, DOI 10.1080/13854046.2013.861019; Castiel M, 2012, NEUROPSYCHOL REHABIL, V22, P734, DOI 10.1080/09602011.2012.686884; Cercy S. P., 1997, CLIN ASSESSMENT MALI, P85; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Colangelo A, 2016, ARCH PHYS MED REHAB, V97, P714, DOI 10.1016/j.apmr.2015.12.019; Dandachi-FitzGerald B, 2013, J EXP PSYCHOPATHOL, V4, P46, DOI 10.5127/jep.025511; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Faust D, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P1, DOI 10.1007/978-1-4614-0442-2_1; Fine S, 2016, J BUS PSYCHOL, V31, P51, DOI 10.1007/s10869-015-9398-5; Fox J., 2016, APPL REGRESSION ANAL; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; Green P., 2003, GREENS WORD MEMORY T; Green P., 2005, GREENS WORD MEMORY T; Green P., 1996, WORD MEMORY TEST USE; Green P., 1999, PERFORMANCE NEUROLOG; Green P, 2016, APPL NEUROPSYCH-CHIL, V5, P25, DOI 10.1080/21622965.2014.935378; Green P, 2015, APPL NEUROPSYCH-ADUL, V22, P293, DOI 10.1080/23279095.2014.925903; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Hegedish O, 2013, EUR J PSYCHOL ASSESS, V29, P253, DOI 10.1027/1015-5759/a000154; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heyanka DJ, 2015, ARCH CLIN NEUROPSYCH, V30, P369, DOI 10.1093/arclin/acv025; Hosmer Jr David W., 2013, APPL LOGISTIC REGRES, V398; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Kertzman S, 2006, ISRAEL J PSYCHIAT, V43, P112; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Myers R. H, 2000, CLASSICAL MODERN REG; Nitch S. R., 2007, ASSESSMENT FEIGNED C, P78; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; Rogers R., 2011, RES METHODS FORENSIC, P174; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Strauss E, 1999, CLIN NEUROPSYCHOL, V13, P420, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT420; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Vendemia JMC, 2005, AM J PSYCHOL, V118, P413; Walczyk JJ, 2005, PERS PSYCHOL, V58, P141, DOI 10.1111/j.1744-6570.2005.00484.x; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wogar MA, 1998, BRIT J CLIN PSYCHOL, V37, P327, DOI 10.1111/j.2044-8260.1998.tb01389.x	50	15	15	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	6					532	542		10.1080/23279095.2017.1341410			11	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	GO1LC	WOS:000439712000006	28696772				2021-06-18	
J	McNally, KA; Patrick, KE; LaFleur, JE; Dykstra, JB; Monahan, K; Hoskinson, KR				McNally, Kelly A.; Patrick, Kristina E.; LaFleur, Jacob E.; Dykstra, Jana B.; Monahan, Kerry; Hoskinson, Kristen R.			Brief cognitive behavioral intervention for children and adolescents with persistent post-concussive symptoms: A pilot study	CHILD NEUROPSYCHOLOGY			English	Article						Concussion; Traumatic brain injury; Post-concussion syndrome; Pediatric; Rehabilitation	MILD HEAD-INJURY; TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; REHABILITATION; SPORT; EXPECTATION; PREDICTORS; RECOVERY; ETIOLOGY; OUTCOMES	This study aims to evaluate the efficacy of a brief cognitive behavioral intervention program for children and adolescents experiencing persistent post-concussion symptoms. A total of 31 patients aged 10 to 18 years participated in the intervention. The median time since injury at treatment onset was 95days though the range was large (23-720days). Treatment was on average four sessions in duration. Sessions included concussion education, activity scheduling, sleep hygiene relaxation training, and cognitive restructuring. Outcomes were measured using symptom reports on the Sports Concussion Assessment Tool - Third Edition (SCAT-3) and parent-reported quality of life on the Pediatric Quality of Life Inventory (PedsQL). Mixed-effects models revealed that symptom reports did not decrease prior to the initiation of this treatment, though significant symptom improvement occurred following treatment. Quality of life scores significantly improved across domains, with the largest gains made in the emotional and school domains. Participant characteristics including age, sex, maternal education, and previous mental health problems were not found to be significantly related to treatment outcomes. Contrary to predictions, length of time since injury was not related to symptom changes. The primary limitation of this study is that it lacks randomization and an experimental control group. The results suggest that brief cognitive behavioral intervention may be a promising treatment for children and adolescents experiencing persistent post-concussive symptoms and warrants further investigation.	[McNally, Kelly A.; Patrick, Kristina E.; Dykstra, Jana B.; Monahan, Kerry] Nationwide Childrens Hosp, Sect Pediat Psychol & Neuropsychol, Columbus, OH USA; [McNally, Kelly A.; Hoskinson, Kristen R.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [LaFleur, Jacob E.; Hoskinson, Kristen R.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA	McNally, KA (corresponding author), Nationwide Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH 43205 USA.	kelly.mcnally@nationwidechildrens.org	Hoskinson, Kristen/AAL-9162-2020	Hoskinson, Kristen/0000-0003-4044-9753; McNally, Kelly/0000-0001-9278-9413			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; [Anonymous], 2015, R LANG ENV STAT COMP; Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bates D., 2015, LINEAR MIXED EFFECTS; Beck J.S., 2011, COGNITIVE BEHAV THER; BIJUR PE, 1990, PEDIATRICS, V86, P337; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Ferguson R. J., 1996, SOURCEBOOK PSYCHOL T, P615; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schreurs KMG, 2011, BEHAV RES THER, V49, P908, DOI 10.1016/j.brat.2011.09.004; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varvogli L., 2011, HLTH SCI J, V5, P74, DOI DOI 10.1080/02699930302287; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	39	15	15	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2018	24	3					396	412		10.1080/09297049.2017.1280143			17	Clinical Neurology	Neurosciences & Neurology	FY5UB	WOS:000426900000007	28125932				2021-06-18	
J	Mokhtari, M; Nayeb-Aghaei, H; Kouchek, M; Miri, MM; Goharani, R; Amoozandeh, A; Salamat, SA; Sistanizad, M				Mokhtari, Majid; Nayeb-Aghaei, Hossein; Kouchek, Mehran; Miri, Mir Mohammad; Goharani, Reza; Amoozandeh, Arash; Salamat, Sina Akhavan; Sistanizad, Mohammad			Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury	JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						traumatic brain injury; NSE; GCS; memantine	HEAD-INJURY; PROGNOSTIC VALUE; ISCHEMIC-STROKE; CLINICAL-TRIALS; NEUROPROTECTION; STRATEGIES; GLUTAMATE; PRETREATMENT; ANTAGONIST; PREDICTION	Traumatic brain injury (TBI) is a major cause of disability and death globally. Despite significant progress in neuromonitoring and neuroprotection, pharmacological interventions have failed to generate favorable results. We examined the effect of memantine on serum levels of neuron-specific enolase (NSE), a marker of neuronal damage, and the Glasgow Coma Scale (GCS) in patients with moderate TBI. Patients were randomly assigned to the control group (who received standard TBI management) and the treatment group (who, alongside their standard management, received enteral memantine 30 mg twice daily for 7 days). Patients' clinical data, GCS, findings of head computed tomography, and serum NSE levels were collected during the study. Forty-one patients were randomized into the control and treatment groups, 19 and 22 patients respectively. Baseline characteristics and serum NSE levels were not significantly different between the 2 groups. The mean serum NSE levels for the memantine and the control groups on day 3 were 7.95 +/- 2.86 and 12.33 +/- 7.09 ng/mL, respectively (P = .05), and on day 7 were 5.03 +/- 3.25 and 10.04 +/- 5.72 ng/mL, respectively (P = .003). The mean GCS on day 3 was 12.3 +/- 2.0 and 10.9 +/- 1.9 in the memantine and control groups, respectively (P = .03). Serum NSE levels and GCS changes were negatively correlated (r = -0.368, P = .02). Patients with moderate TBI who received memantine had significantly reduced serum NSE levels by day 7 and marked improvement in their GCS scores on day 3 of the study.	[Mokhtari, Majid; Kouchek, Mehran; Miri, Mir Mohammad; Goharani, Reza; Sistanizad, Mohammad] Shahid Beheshti Univ Med Sci, Dept Crit Care & Anesthesiol, Imam Hossein Hosp, Tehran, Iran; [Nayeb-Aghaei, Hossein; Amoozandeh, Arash] Shahid Beheshti Univ Med Sci, Dept Neurosurg, Imam Hossein Hosp, Tehran, Iran; [Salamat, Sina Akhavan; Sistanizad, Mohammad] Shahid Beheshti Univ Med Sci, Dept Clin Pharm, Fac Pharm, Tehran, Iran	Sistanizad, M (corresponding author), Fac Pharm, Dept Clin Pharm, Niayesh Highway,Valiasr Ave,POB 6153-14155, Tehran, Iran.	sistanizadm@sbmu.ac.ir	Mokhtari, Majid/AAD-6749-2020; Sistanizad, Mohammad/H-4734-2018; Sistanizad, Mohammad/Y-6115-2019	Sistanizad, Mohammad/0000-0002-7836-6411; Sistanizad, Mohammad/0000-0002-7836-6411; Miri, mir mohammad/0000-0003-3918-6802; Mokhtari, Majid/0000-0001-5980-1003; kouchek, mehran/0000-0002-2070-9856	vice chancellery for research affairs of Shahid Beheshti University of Medical Sciences [SBMU-1391-4586]	This study was funded by a grant from the vice chancellery for research affairs of Shahid Beheshti University of Medical Sciences (grant number SBMU-1391-4586).	Annweiler C, 2014, NEUROBIOL AGING, V35, P331, DOI 10.1016/j.neurobiolaging.2013.07.029; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Bisaga A, 2001, PSYCHOPHARMACOLOGY, V157, P1, DOI 10.1007/s002130100739; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P37, DOI DOI 10.1089/NEU.2007.9990; Collins ED, 2007, EXP CLIN PSYCHOPHARM, V15, P228, DOI 10.1037/1064-1297.15.3.228; Dogan A, 1999, ACTA NEUROCHIR, V141, P1107, DOI 10.1007/s007010050491; El-Maraghi S, 2013, EGYPT J CRIT CARE ME, V1, P25, DOI 10.1016/j.ejccm.2012.12.002; Ergun R, 1998, NEUROL RES, V20, P418; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jain KK, 2011, HANDBOOK OF NEUROPROTECTION, P1, DOI 10.1007/978-1-61779-049-2; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kafi H, 2014, IRAN J PHARM RES, V13, P591; Karolczak D, 2013, POL J PATHOL, V64, P196, DOI 10.5114/PJP.2013.38139; Kilic U, 2013, NEUROSCIENCE, V237, P268, DOI 10.1016/j.neuroscience.2013.01.059; Kim YW, 2010, ANN NUCL MED, V24, P363, DOI 10.1007/s12149-010-0360-3; Kutzing MK, 2012, ANN BIOMED ENG, V40, P1170, DOI 10.1007/s10439-011-0494-z; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Makotrova TA, 2013, ZH NEVROL PSIKHIATR, V113, P82; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Montagne A, 2012, STROKE, V43, P2774, DOI 10.1161/STROKEAHA.112.669374; Mukhin A, 1996, J NEUROSCI, V16, P6012; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Rao VLR, 2001, BRAIN RES, V911, P96; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Stein DM, 2011, NEUROCRIT CARE, V14, P200, DOI 10.1007/s12028-010-9496-1; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yanez M, 2014, NEURODEGENER DIS, V13, P171, DOI 10.1159/000357281; Zaheer S, 2013, ANN INDIAN ACAD NEUR, V16, P504, DOI 10.4103/0972-2327.120442; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	40	15	17	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2700	1552-4604		J CLIN PHARMACOL	J. Clin. Pharmacol.	JAN	2018	58	1					42	47		10.1002/jcph.980			6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FQ1FY	WOS:000418102900005	28724200				2021-06-18	
J	Ouellet, S; Philippens, M				Ouellet, S.; Philippens, M.			The multi-modal responses of a physical head model subjected to various blast exposure conditions	SHOCK WAVES			English	Article						Blast neuro-trauma; Headform; Head biomechanics; Injury mechanisms; Intra-cranial pressure	TRAUMATIC BRAIN-INJURY; TRANSMISSION; ATTENUATION; SPEED; SOUND	The local and global biomechanical response of the body to a blast wave is the first step of a sequence that leads to the development of stresses and strains which can exceed the tolerance of brain tissue. These stresses and strains may then lead to neuro-physical changes in the brain and contribute to initiate a cascade of events leading to injury. The specific biomechanical pathways by which the blast energy is transmitted through the head structure are, however, not clearly understood. Multiple transmission mechanisms have been proposed to explain the generation of brain stresses following the impingement of a blast wave on the head. With the use of a physical head model, the work presented here aims at demonstrating that the proposed transmission mechanisms are not mutually exclusive. They are part of a continuum of head responses where, depending on the exposure conditions, a given mechanism may or may not dominate. This article presents the joint analysis of previous blast test results generated with the brain injury protection evaluation device (BIPED) headform under four significantly different exposure conditions. The focus of the analysis is to demonstrate how the nature of the recorded response is highly dependent on the exposure characteristics and consequently, on the method used to reproduce blast exposure in a laboratory environment. The timing and magnitude of the variations in intra-cranial pressures (ICP) were analysed relative to the external pressure field in order to better understand the wave dynamics occurring within the brain structure of the headform. ICP waveforms were also analysed in terms of their energy spectral density to better identify the energy partitioning between the different modes of response. It is shown that the BIPED response is multi-modal and that the energy partitioning between its different modes of response is greatly influenced by exposure characteristics such as external peak overpressure, impulse, blast wave structure, and direction of propagation. Convincing evidence of stresses generated from local skull deformation is presented along with evidence of stress transmission through relative brain-to-skull motion. These findings suggest that research aimed at defining exposure thresholds should not focus on a single stress transmission mechanism or use experimental designs unrepresentative of realistic blast loading conditions that may favour a given mechanism over another.	[Ouellet, S.] Def Res & Dev Canada, 2459 Bravoure Rd, Quebec City, PQ G3J 1X5, Canada; [Philippens, M.] TNO Rijswijk, Lange Kleiweg 137, NL-2288 GJ Rijswijk, Netherlands	Ouellet, S (corresponding author), Def Res & Dev Canada, 2459 Bravoure Rd, Quebec City, PQ G3J 1X5, Canada.	simon.ouellet@drdc-rddc.gc.ca					Appleby-Thomas GJ, 2014, J MECH BEHAV BIOMED, V33, P124, DOI 10.1016/j.jmbbm.2013.05.018; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bir C., 2011, ADA547306 DTIC; Bir C., P HFM 207 NATO S SUR, DOI 10.14339/RTO-MP-HFM-207-27-doc; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Brands D W, 2000, Stapp Car Crash J, V44, P249; Brands D. W. A., 1999, 99SC21 SAE; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cooper GJ, 1996, J TRAUMA, V40, pS105, DOI 10.1097/00005373-199603001-00024; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney AC, 2013, J BATTLEFIELD TECHNO, V16, P1; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Courtney M, 2011, NEUROSURGERY, V68, pE596, DOI 10.1227/NEU.0b013e3182041992; Foster J., 1977, SAE TECHNICAL PAPER, DOI [10.4271/770938, DOI 10.4271/770938]; FRY FJ, 1978, J ACOUST SOC AM, V63, P1576, DOI 10.1121/1.381852; Ganpule S, 2013, THESIS; Glasstone S., 1977, ADA087568 DITC US DE; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Hodgson V. R., 1967, 670911 SAE, DOI [10.4271/670911, DOI 10.4271/670911]; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Josey T., 2016, P PERS ARM SYST S 20; KREMKAU FW, 1981, J ACOUST SOC AM, V70, P29, DOI 10.1121/1.386578; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Merkle AC, 2009, P ASME INT MECH ENG, P91, DOI DOI 10.1115/IMECE2009-11807; Moss WC, 2011, P NATL ACAD SCI USA, V108, pE82, DOI 10.1073/pnas.1101671108; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Ono K., 1980, 801303 SAE, DOI [10.4271/801303, DOI 10.4271/801303]; Ouellet S., 2014, P PERS ARM SYST S 20; Ouellet S., 2012, P PERS ARM SYST S 20; Pichardo S, 2011, PHYS MED BIOL, V56, P219, DOI 10.1088/0031-9155/56/1/014; Roberts J. C., 2014, U.S. Patent, Patent No. 8725449; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; STALNAKER RL, 1971, J BIOMECH, V4, P127, DOI 10.1016/0021-9290(71)90023-6; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Stenfelt S, 2005, J ACOUST SOC AM, V118, P2373, DOI 10.1121/1.2005847; Tikhonravov A. V., 2006, NUM METH PROG, V7, P23; van Dommelen J. A. W., 2009, V2, P249; Viano D. C., 1988, 881708 SAE, DOI [10.4271/881708, DOI 10.4271/881708]; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/cras.8.6.605.19261; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	47	15	15	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	JAN	2018	28	1					19	36		10.1007/s00193-017-0771-3			18	Mechanics	Mechanics	FU0TF	WOS:000423562600003					2021-06-18	
J	Pupillo, E; Poloni, M; Bianchi, E; Giussani, G; Logroscino, G; Zoccolella, S; Chio, A; Calvo, A; Corbo, M; Lunetta, C; Marin, B; Mitchell, D; Hardiman, O; Rooney, J; Stevic, Z; di Poggio, MB; Filosto, M; Cotelli, MS; Perini, M; Riva, N; Tremolizzo, L; Vitelli, E; Damiani, D; Beghi, E				Pupillo, Elisabetta; Poloni, Marco; Bianchi, Elisa; Giussani, Giorgia; Logroscino, Giancarlo; Zoccolella, Stefano; Chio, Adriano; Calvo, Andrea; Corbo, Massimo; Lunetta, Christian; Marin, Benoit; Mitchell, Douglas; Hardiman, Orla; Rooney, James; Stevic, Zorica; di Poggio, Monica Bandettini; Filosto, Massimiliano; Cotelli, Maria Sofia; Perini, Michele; Riva, Nilo; Tremolizzo, Lucio; Vitelli, Eugenio; Damiani, Danira; Beghi, Ettore		EURALS Consortium	Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium	AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION			English	Article						Amyotrophic lateral sclerosis; trauma; case-control; Europe; epidemiology	MOTOR-NEURON DISEASE; PHYSICAL-ACTIVITY; ITALIAN SOCCER; BRAIN-INJURY; RISK-FACTOR; ENCEPHALOPATHY; ASSOCIATION; DIAGNOSIS; ALS	Objectives: To assess the association between amyotrophic lateral sclerosis (ALS) and previous traumatic events, age of trauma, and site of injury. Methods: A population-based case-control study was performed in five European countries (Italy, Ireland, France, United Kingdom, Serbia). Newly diagnosed ALS patients and matched controls were interviewed to collect relevant demographic factors and exposures. Key clinical features at diagnosis were collected in ALS patients. Trauma was any accidental event causing an injury. Injuries were dated and classified according to cause, severity, type, site, and complications. All exposures were censored five years before symptoms onset. Risks were computed as odds ratios (OR) with 95% confidence intervals (CI) using univariate and multivariate conditional logistic regression models. Results: Five hundred and seventy-five ALS patients and 1150 controls were interviewed. Disabling traumatic events predominated in the cases (OR 1.54 (95% CI 1.24-1.92)) and maintained significance after adjustment, with a significant gradient. A history of 2+head injuries was associated with an almost three-fold increased risk of ALS. The risk was almost two-fold when trauma occurred at age 35-54 years. Site of injury was uneventful. Conclusions: Traumatic events leading to functional disability or confined to the head are risk factors for ALS. Traumatic events experienced at age 35-54 years carry the highest risk.	[Pupillo, Elisabetta; Poloni, Marco; Bianchi, Elisa; Giussani, Giorgia; Damiani, Danira; Beghi, Ettore] IRCCS Ist Mario Negri, Lab Malattie Neurol, Milan, Italy; [Logroscino, Giancarlo; Zoccolella, Stefano] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Logroscino, Giancarlo] Univ Bari Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Lecce, Italy; [Chio, Adriano; Calvo, Andrea] Univ Turin, Ctr SLA, Dipartimento Neurosci Rita Levi Montalcini, Turin, Italy; [Corbo, Massimo] CCP, Dept Neurorehabil Sci, Milan, Italy; [Lunetta, Christian] ASST Grande Osped Metropolitano Niguarda, Fdn Serena Onlus, Ctr Clin NEMO, Milan, Italy; [Marin, Benoit] INSERM, Trop Neuroepidemiol, U1094, Limoges, France; [Marin, Benoit] Univ Limoges, UMR S 1094, Inst Neuroepidemiol & Trop Neurol, Trop Neuroepidemiol,CNRS FR GEIST 3503, Limoges, France; [Hardiman, Orla; Rooney, James] Trinity Coll Dublin, Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland; [Stevic, Zorica] Clin Ctr Serbia, Sch Med, Clin Neurol, Belgrade, Serbia; [di Poggio, Monica Bandettini] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy; [Filosto, Massimiliano] Spedali Civil Brescia, Unit Neurol, Brescia, Italy; [Cotelli, Maria Sofia] Osped Esine, Dept Neurol, Brescia, Italy; [Perini, Michele] Osped Gallarate, Div Neurol, Gallarate, Italy; [Riva, Nilo] Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, Dept Neurol, Milan, Italy; [Tremolizzo, Lucio] Univ Milano Bicocca, ALS Unit, Monza, Italy; [Vitelli, Eugenio] Azienda Osped Prov Lodi, Dept Neurol, Lodi, Italy	Beghi, E (corresponding author), IRCCS Mario Negri Inst Pharmacol Res, Lab Neurol Disorders, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	ettore.beghi@marionegri.it	Filosto, Massimiliano/S-9446-2019; Pupillo, Elisabetta/AAA-7385-2020; Bianchi, Elisa/ABF-8173-2020; Bandettini di Poggio, Monica/H-2995-2018; Hardiman, Orla/Y-3441-2019; CALVO, Andrea/K-4141-2016; Cotelli, Maria Sofia/K-4534-2017; MARIN, Benoit/E-2356-2015; Rooney, James/J-9190-2019; Beghi, Ettore/AAA-7426-2020; Giussani, Giorgia/AAA-8029-2020; Pupillo, Elisabetta/ABD-2698-2020; Giussani, Giorgia/E-8057-2017; zoccolella, stefano/AAA-2515-2020	Filosto, Massimiliano/0000-0002-2852-7512; Pupillo, Elisabetta/0000-0003-4420-8076; Bianchi, Elisa/0000-0002-0279-0128; Bandettini di Poggio, Monica/0000-0001-8871-1103; Hardiman, Orla/0000-0003-2610-1291; CALVO, Andrea/0000-0002-5122-7243; Cotelli, Maria Sofia/0000-0002-7010-2809; Rooney, James/0000-0001-6346-0731; Beghi, Ettore/0000-0003-2542-0469; Giussani, Giorgia/0000-0003-2460-3095; Pupillo, Elisabetta/0000-0003-4420-8076; Giussani, Giorgia/0000-0003-2460-3095; Chio, Adriano/0000-0001-9579-5341; Perini, Michele/0000-0003-2311-9760	American ALS Association (ALSA) [1524]; European Community's Health Seventh Framework Programme (FP7) [259867]	This work was supported by the American ALS Association (ALSA)(#1524) and, in part, by the European Community's Health Seventh Framework Programme (FP7) 2007-2013 grant agreement 259867).	Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Beghi Ettore, 2006, Neuromuscul Disord, V16, P46, DOI 10.1016/j.nmd.2005.10.004; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Beretta S, 2003, LANCET NEUROL, V2, P656, DOI 10.1016/S1474-4422(03)00579-9; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Chase Alex, 2015, Nat Rev Neurol, V11, P309, DOI 10.1038/nrneurol.2015.83; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Gargiulo-Monachelli GM, 2014, HORM METAB RES, V46, P433, DOI 10.1055/s-0034-1371891; Harwood CA, 2009, AMYOTROPH LATERAL SC, V10, P191, DOI 10.1080/17482960802549739; KURLAND LT, 1992, J NEUROL SCI, V113, P133, DOI 10.1016/0022-510X(92)90241-C; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Pupillo E, 2012, EUR J NEUROL, V19, P1509, DOI 10.1111/j.1468-1331.2012.03723.x; Pupillo E, 2014, ANN NEUROL, V75, P708, DOI 10.1002/ana.24150; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Seals RM, 2016, AM J EPIDEMIOL, V183, P294, DOI 10.1093/aje/kwv169; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Turner MR, 2010, J NEUROL SCI, V288, P45, DOI 10.1016/j.jns.2009.10.010; Valenti M, 2005, EUR J NEUROL, V12, P223, DOI 10.1111/j.1468-1331.2004.00978.x; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C	26	15	15	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2167-8421	2167-9223		AMYOTROPH LAT SCL FR	Amyotroph. Lateral Scher. Frontotemp. Degenerat.		2018	19	1-2					118	125		10.1080/21678421.2017.1386687			8	Clinical Neurology	Neurosciences & Neurology	FW9QQ	WOS:000425671500017	29063790				2021-06-18	
J	Wang, HF; Wang, ZQ; Ding, Y; Piao, MH; Feng, CS; Chi, GF; Luo, YN; Ge, PF				Wang, Hai-Feng; Wang, Zong-Qi; Ding, Ye; Piao, Mei-Hua; Feng, Chun-Sheng; Chi, Guang-Fan; Luo, Yi-Nan; Ge, Peng-Fei			Endoplasmic reticulum stress regulates oxygen-glucose deprivation-induced parthanatos in human SH-SY5Y cells via improvement of intracellular ROS	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						endoplasmic reticulum stress; oxygen-glucose deprivation; parthanatos; ROS; SH-SY5Y cells	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; GLIOMA-CELLS; POLY(ADP-RIBOSE) POLYMERASE-1; CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; NEURONAL DEATH; ER-STRESS; ACTIVATION; PATHWAY	AimsEndoplasmic reticulum (ER) stress has been demonstrated to regulate neuronal death caused by ischemic insults via activation of apoptosis, but it still remains unclear whether ER stress participates in regulation of parthanatos, a new type of programmed cell death characterized by PARP-1 overactivation and intracellular accumulation of PAR polymer. Methodswe used oxygen-glucose deprivation (OGD) and human SH-SY5Y cells to simulate neuronal damage caused by ischemia. ResultsOxygen-glucose deprivation induced time-dependent death in SH-SY5Y cells, which was accompanied with upregulation of PARP-1, accumulation of PAR polymer, decline of mitochondrial membrane potentials and nuclear translocation of AIF. Pharmacological inhibition of PARP-1 with its specific inhibitor 3AB rescued OGD-induced cell death, as well as prevented PAR polymer accumulation, mitochondrial depolarization, and AIF translocation into nucleus. Similar results could be found when PARP-1 was genetically knocked down with SiRNA. These indicated that OGD triggered parthanatos in SH-SY5Y cells. Then, we found inhibition of overproduction of ROS with antioxidant NAC attenuated obviously OGD-induced parthanatos in SH-SY5Y cells, suggesting ROS regulated OGD-induced parthanatos. Additionally, OGD also induced upregulation of ER stress-related proteins. Mitigation of ER stress with chemical chaperone 4-PBA or trehalose suppressed significantly OGD-induced overproduction of ROS, PARP-1 upregulation, PAR polymer accumulation, and nuclear accumulation of AIF, and cell death in SH-SY5Y cells. ConclusionEndoplasmic reticulum stress regulates OGD-induced parthanatos in human SH-SY5Y cells via improvement of intracellular ROS.	[Wang, Hai-Feng; Wang, Zong-Qi; Ding, Ye; Piao, Mei-Hua; Luo, Yi-Nan; Ge, Peng-Fei] Jilin Univ, Dept Neurosurg, Hosp 1, Changchun, Jilin, Peoples R China; [Wang, Zong-Qi; Ding, Ye; Luo, Yi-Nan; Ge, Peng-Fei] Jilin Univ, Res Ctr Neurosci, Hosp 1, Changchun, Jilin, Peoples R China; [Piao, Mei-Hua; Feng, Chun-Sheng] Jilin Univ, Dept Anesthesiol, Hosp 1, Changchun, Jilin, Peoples R China; [Chi, Guang-Fan] Jilin Univ, Key Lab Pathobiol, Minist Educ, Changchun, Jilin, Peoples R China	Ge, PF (corresponding author), Jilin Univ, Dept Neurosurg, Hosp 1, Changchun, Jilin, Peoples R China.; Ge, PF (corresponding author), Jilin Univ, Res Ctr Neurosci, Hosp 1, Changchun, Jilin, Peoples R China.	gepf@jlu.edu.cn			National Nature and Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372697, 81271215, 81772669, 81771141]; Changbaishan Scholar Project of Jilin Province [2013026]; Scientific Research Foundation of Jilin province [20150414013GH, 20160101127JC]	National Nature and Science Foundation of China, Grant/Award Number: 81372697, 81271215, 81772669 and 81771141; Changbaishan Scholar Project of Jilin Province, Grant/Award Number: 2013026; Scientific Research Foundation of Jilin province, Grant/Award Number: 20150414013GH and 20160101127JC	Akhiani AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089646; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Badiola N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.31; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Chiu LY, 2011, BIOCHEM PHARMACOL, V81, P459, DOI 10.1016/j.bcp.2010.10.016; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Ferreiro E, 2012, Int J Cell Biol, V2012, P735206, DOI 10.1155/2012/735206; Gu NB, 2017, BRAIN RES BULL, V130, P27, DOI 10.1016/j.brainresbull.2016.12.006; Guo F, 2013, CELL MOL NEUROBIOL, V33, P443, DOI 10.1007/s10571-013-9911-1; He C, 2014, NEUROSCIENCE, V258, P254, DOI 10.1016/j.neuroscience.2013.11.024; He ZL, 2017, AM J TRANSL RES, V9, P1075; Jin W, 2016, J NEUROL SCI, V366, P8, DOI 10.1016/j.jns.2016.04.038; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kim HR, 2009, J CELL SCI, V122, P1126, DOI 10.1242/jcs.038430; Lee HJ, 2011, ARCH PHARM RES, V34, P1373, DOI 10.1007/s12272-011-0818-4; Lee Y, 2014, BMB REP, V47, P424, DOI 10.5483/BMBRep.2014.47.8.119; Li Y, 2016, MOL NEUROBIOL; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Liu XR, 2014, TRANSL STROKE RES, V5, P692, DOI 10.1007/s12975-014-0359-5; Lu P, 2014, J NEUROSCI, V34, P15975, DOI 10.1523/JNEUROSCI.2499-14.2014; Luo ZF, 2010, TOXICOL APPL PHARM, V246, P49, DOI 10.1016/j.taap.2010.04.005; Ma DD, 2016, CANCER LETT, V371, P194, DOI 10.1016/j.canlet.2015.11.044; Mohammad G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/510451; Patino P, 2016, NEUROTOXICOLOGY, V57, P61, DOI 10.1016/j.neuro.2016.09.002; Rathnasamy G, 2016, MOL NEUROBIOL, V53, P4713, DOI 10.1007/s12035-015-9389-6; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Su YC, 2016, INT J NEUROSCI, V126, P681, DOI 10.3109/00207454.2015.1059836; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Xin Q, 2014, NEUROCHEM INT, V68, P18, DOI 10.1016/j.neuint.2014.02.001; Yang ZY, 2014, J IMMUNOL, V193, P6114, DOI 10.4049/jimmunol.1400359; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zhang JL, 2013, J SURG RES, V183, P929, DOI 10.1016/j.jss.2013.02.043; Zhao HW, 2016, CANCER LETT, V374, P136, DOI 10.1016/j.canlet.2016.01.055; Zheng LJ, 2017, MOL NEUROBIOL, V54, P3492, DOI 10.1007/s12035-016-9926-y; Zhong F, 2015, J PHOTOCH PHOTOBIO B, V151, P10, DOI 10.1016/j.jphotobiol.2015.06.016; Zhou ZJ, 2017, CANCER LETT, V390, P77, DOI 10.1016/j.canlet.2017.01.004	41	15	16	1	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JAN	2018	24	1					29	38		10.1111/cns.12771			10	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	FQ0XJ	WOS:000418080100003	29045036	Green Published, Bronze			2021-06-18	
J	Wu, LY; Ye, ZN; Zhuang, Z; Gao, Y; Tang, C; Zhou, CH; Wang, CX; Zhang, XS; Xie, GB; Liu, JP; Zhou, ML; Hang, CH; Shi, JX				Wu, Ling-yun; Ye, Zhen-nan; Zhuang, Zong; Gao, Yongyue; Tang, Chao; Zhou, Chen-hui; Wang, Chun-xi; Zhang, Xiang-sheng; Xie, Guang-bin; Liu, Jing-peng; Zhou, Meng-liang; Hang, Chun-hua; Shi, Ji-xin			Biochanin A Reduces Inflammatory Injury and Neuronal Apoptosis following Subarachnoid Hemorrhage via Suppression of the TLRs/TIRAP/MyD88/NF-kappa B Pathway	BEHAVIOURAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; POSSIBLE INVOLVEMENT; SIGNALING PATHWAY; RATS; CELLS; DAMAGE; RECEPTOR; MICE; DIFFERENTIATION	Inflammatory injury and neuronal apoptosis participate in the period of early brain injury (EBI) after subarachnoid hemorrhage (SAH). Suppression of inflammation has recently been shown to reduce neuronal death and neurobehavioral dysfunction post SAH. Biochanin A (BCA), a natural bioactive isoflavonoid, has been confirmed to emerge the anti-inflammatory pharmacological function. This original study was aimed at evaluating and identifying the neuroprotective role of BCA and the underlying molecular mechanism in an experimental Sprague-Dawley rat SAH model. Neurobehavioral function was evaluated via the modified water maze test and modified Garcia neurologic score system. Thus, we confirmed that BCA markedly decreased the activated level of TLRs/TIRAP/MyD88/NF-kappa B pathway and the production of cytokines. BCA also significantly ameliorated neuronal apoptosis which correlated with the improvement of neurobehavioral dysfunction post SAH. These results indicated that BCA may provide neuroprotection against EBI through the inhibition of inflammatory injury and neuronal apoptosis partially via the TLRs/TIRAP/MyD88/NF-kappa B signal pathway.	[Wu, Ling-yun; Zhuang, Zong; Gao, Yongyue; Tang, Chao; Zhou, Chen-hui; Wang, Chun-xi; Zhang, Xiang-sheng; Xie, Guang-bin; Zhou, Meng-liang; Hang, Chun-hua; Shi, Ji-xin] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East ZhongShan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Ye, Zhen-nan] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Guangzhou 510260, Guangdong, Peoples R China; [Ye, Zhen-nan; Liu, Jing-peng; Hang, Chun-hua] Southern Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China	Hang, CH; Shi, JX (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East ZhongShan Rd, Nanjing 210002, Jiangsu, Peoples R China.; Hang, CH (corresponding author), Southern Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com; shijx52@hotmail.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271297, 81371294, 81400980, 81571162, 81501022]	The authors acknowledge the support for this research by grants from the National Natural Science Foundation of China (no. 81271297 for Ji-xin Shi, no. 81371294 for Chun-hua Hang, no. 81400980 for Zong Zhuang, no. 81571162 for Meng-liang Zhou, and no. 81501022 for Xiang-sheng Zhang).	Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Biradar SM, 2014, HUM EXP TOXICOL, V33, P369, DOI 10.1177/0960327113497772; Castoldi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037584; Chen J, 2015, CELL PHYSIOL BIOCHEM, V35, P639, DOI 10.1159/000369725; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Fadakar K, 2014, REV NEUROSCIENCE, V25, P699, DOI 10.1515/revneuro-2013-0069; Gao C, 2009, AUTON NEUROSCI-BASIC, V147, P70, DOI 10.1016/j.autneu.2009.01.010; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Guo ZD, 2016, STROKE, V47, P490, DOI 10.1161/STROKEAHA.115.011223; Jain A, 2015, ANTI-CANCER DRUG, V26, P323, DOI 10.1097/CAD.0000000000000189; Jalaludeen AM, 2015, ENVIRON TOXICOL PHAR, V39, P1221, DOI 10.1016/j.etap.2015.04.020; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Kole L, 2011, EUR J PHARMACOL, V653, P8, DOI 10.1016/j.ejphar.2010.11.026; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee KH, 2005, BIOL PHARM BULL, V28, P1948, DOI 10.1248/bpb.28.1948; Li H, 2017, MOL NEUROBIOL, V54, P755, DOI 10.1007/s12035-016-9703-y; Li H, 2014, BRAIN RES, V1543, P315, DOI 10.1016/j.brainres.2013.11.023; Li W, 2014, MOL NEUROBIOL, V49, P187, DOI 10.1007/s12035-013-8509-4; Ming XD, 2015, LIFE SCI, V136, P36, DOI 10.1016/j.lfs.2015.06.015; Mishra P, 2008, MOL CELL BIOCHEM, V312, P1, DOI 10.1007/s11010-008-9714-8; Oh JS, 2016, BIOCHEM BIOPH RES CO, V477, P723, DOI 10.1016/j.bbrc.2016.06.126; Piegholdt S, 2014, FREE RADICAL BIO MED, V70, P255, DOI 10.1016/j.freeradbiomed.2014.02.025; Pradilla G, 2010, NEUROSURG CLIN N AM, V21, P365, DOI 10.1016/j.nec.2009.10.008; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Szyndler J, 2006, PHARMACOL REP, V58, P75; Wang CX, 2015, BRAIN RES, V1594, P245, DOI 10.1016/j.brainres.2014.10.014; Wang J, 2016, NEUROTOX RES, V30, P486, DOI 10.1007/s12640-016-9648-y; Wang WZ, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/501401; Wang Z, 2013, J PINEAL RES, V55, P399, DOI 10.1111/jpi.12087; Wu LY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00175; Wu WY, 2015, INT J MOL MED, V35, P391, DOI 10.3892/ijmm.2014.2020; Youssef MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30717; Zhang HS, 2016, BRAIN RES, V1643, P130, DOI 10.1016/j.brainres.2016.05.003; Zhong W, 2016, TURKISH NEUROSURGERY, V27; Zhou CH, 2015, BRAIN RES, V1629, P250, DOI 10.1016/j.brainres.2015.10.016; Zhou CH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0415-4	38	15	15	1	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2018	2018								1960106	10.1155/2018/1960106			10	Clinical Neurology	Neurosciences & Neurology	GK1QT	WOS:000435894200001	29971136	DOAJ Gold, Green Published			2021-06-18	
J	Zhou, Y; Wang, HD; Zhou, XM; Fang, I; Zhu, L; Ding, K				Zhou, Yuan; Wang, Han-dong; Zhou, Xiao-ming; Fang, Iang; Zhu, Lin; Ding, Ke			N-acetylcysteine amide provides neuroprotection via Nrf2-ARE pathway in a mouse model o f traumatic brain injury	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Article						N-acetylcysteine amide; traumatic brain injury; nuclear factor erythroid 2-related factor 2; heme oxygenase-1 (HO-1); NAD(P)H: quinine oxidoreductase-1; oxidative stress	INDUCED OXIDATIVE STRESS; MITOCHONDRIAL BIOENERGETICS; FUNCTIONAL RECOVERY; ANTIOXIDANT; PLASMA; MICE	Background: Increasing evidence demonstrate N-acetylcysteine amide (NACA) provides neuroprotection and attenuated oxidative stress in rats following traumatic brain injury (TBI). The nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) signal pathway is activated after TBI and provides a protective effect against TIM. However, the function and mechanism of NACA in mice after TBI remain unknown. This study was to evaluate the neuroprotection of NACA and the potential action of the Nrf2-ARE pathway in a weight-drop mouse model of TBI. Materials and methods: Four groups of animals were randomly divided into sham, TBI, TBI+vehicle, and TBI+NACA (100 mg/kg, administered intraperitoneally). The protein levels of Nrf2, heme oxygenise-1 (HO-1), NAD(P)H: quinine oxidoreductase-1 (NQO1), cleaved caspase-3 and the mRNA levels of HO-1 and NQO1 were detected. The neurobehavior, neuronal degeneration, apoptosis and oxidative stress were also assessed. Results: Treatment with NACA significantly improved neurologic status at days 1 and 3 following TBI. Moreover, NACA promoted Nrf2 activation a day after TBI. The protein and m RNA levels of HO-1 and NQOI were upregulated by NACA. Meanwhile, NACA treatment significantly reduced the level of malondialdehyde (MDA) and enhanced the activity of superoxide dismutase (SOD) and glutathione peroxidase (GPx), which indicated NACA attenuated oxidative stress following TBI. NACA prominently reduced the protein level of cleaved caspase-3 and TUNEL-positive cells, indicating its antiapoptotic effect. Additionally, Fluoro-Jade C staining showed NACA alleviated neuronal degeneration a day after TBI. Conclusions: Our study reveals that NACA potentially provides neuroprotection via the activation of the Nrf2-ARE signaling pathway after TBI in mice.	[Zhou, Yuan; Wang, Han-dong] Nanjing Med Univ, Jinling Hosp, Jinling Sch Clin Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zhou, Xiao-ming; Fang, Iang; Zhu, Lin; Ding, Ke] Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Wang, HD (corresponding author), Nanjing Med Univ, Jinling Hosp, Jinling Sch Clin Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com			Youth Training Project [16QNP042]; Key Clinical Subjects of "Strengthening Health by Science Education" Project in Jiangsu [ZDXKB2016023]; Jinling Hospital of Nanjing [2016017]	This work was financially supported by the Youth Training Project (grant no 16QNP042), the Key Clinical Subjects of "Strengthening Health by Science Education" Project in Jiangsu (grant no ZDXKB2016023), and the Jinling Hospital of Nanjing (grant no 2016017).	Bhatti J, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00744; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dai W, 2018, BRAIN RES BULL, V140, P65, DOI 10.1016/j.brainresbull.2018.03.020; Ding H, 2017, NEUROCHEM INT, V111, P32, DOI 10.1016/j.neuint.2017.04.016; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Hagos FT, 2017, XENOBIOTICA, V47, P346, DOI 10.1080/00498254.2016.1187777; Halstrom A, 2017, J CLIN NEUROSCI, V35, P104, DOI 10.1016/j.jocn.2016.09.006; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Kawoos U, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00219; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Li XK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160026; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Penugonda S, 2005, BRAIN RES, V1056, P132, DOI 10.1016/j.brainres.2005.07.032; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; Semple BD, 2014, EXP NEUROL, V261, P291, DOI 10.1016/j.expneurol.2014.07.013; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Zhang L, 2018, NEUROCHEM INT, V118, P304, DOI 10.1016/j.neuint.2018.05.011; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang XS, 2009, BRAIN RES, V1275, P87, DOI 10.1016/j.brainres.2009.04.008	32	15	15	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2018	12						4117	4127		10.2147/DDDT.S179227			11	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	HD0FA	WOS:000452182100001	30584276	DOAJ Gold, Green Published			2021-06-18	
J	Ferguson, SA; Mouzon, BC; Lynch, C; Lungmus, C; Morin, A; Crynen, G; Carper, B; Bieler, G; Mufson, EJ; Stewart, W; Mullan, M; Crawford, F				Ferguson, Scott A.; Mouzon, Benoit C.; Lynch, Cillian; Lungmus, Carlyn; Morin, Alexander; Crynen, Gogce; Carper, Benjamin; Bieler, Gayle; Mufson, Elliott J.; Stewart, William; Mullan, Michael; Crawford, Fiona			Negative Impact of Female Sex on Outcomes from Repetitive Mild Traumatic Brain Injury in hTau Mice Is Age Dependent: A Chronic Effects of Neurotrauma Consortium Study	FRONTIERS IN AGING NEUROSCIENCE			English	Article						TBI; hTau; tau; neurobehavior; Neuropathology	GENDER-DIFFERENCES; MALE-RATS; ENVIRONMENTAL ENRICHMENT; COGNITIVE RECOVERY; CONTUSION INJURY; CLINICAL-TRIAL; TAU PATHOLOGY; MOUSE MODEL; HEAD-INJURY; PROGESTERONE	Traumatic brain injury (TBI) is a serious public health concernwhich strikes someone every 15 s on average in the US. Even mild TBI, which comprise as many as 75% of all TBI cases, carries long termconsequences. The effects of age and sex on long termoutcome from TBI is not fully understood, but due to the increased risk for neurodegenerative diseases after TBI it is important to understand how these factors influence the outcome from TBI. This study examined the neurobehavioral and neuropathological effects of age and sex on the outcome 15 days following repetitive mild traumatic brain injury (r-mTBI) in mice transgenic for human tau (hTau). These mice express the six human isoforms of tau but do not express endogenous murine tau and they develop tau pathology and memory impairment in an age-dependentmanner. After 5mild impacts, aged femalemice showed motor impairments that were absent in aged male mice, as well as younger animals. Conversely, aged female sham mice outperformed all other groups of aged mice in a Barnes maze spatial memory test. Pathologically, increases in IBA-1 and GFAP staining typically seen in this model of r-mTBI showed the expected increases with both injury and age, but phosphorylated tau stained with CP13 in the hippocampus (reduced in female sham mice compared to males) and PHF1 in the cortex (reduced in female TBI mice compared to male TBI mice) showed the only histological signs of sex-dependent differences in these mice.	[Ferguson, Scott A.; Mouzon, Benoit C.; Lynch, Cillian; Lungmus, Carlyn; Morin, Alexander; Crynen, Gogce; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Ferguson, Scott A.; Mouzon, Benoit C.; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Carper, Benjamin; Bieler, Gayle] RTI Int, Res Triangle Pk, NC USA; [Mufson, Elliott J.] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Stewart, William] Queen Elizabeth Glasgow Univ Hosp, Glasgow, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Ferguson, SA (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Ferguson, SA (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.	sferguson@roskampinstitute.org	Carper, Benjamin A/L-3433-2017	Carper, Benjamin A/0000-0001-5882-2232; Stewart, William/0000-0003-2199-2582	U.S. Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium] [W81XWH-13-2-0095]; U.S. Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick MD [21702-5014]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	This material is based upon work supported by the U.S. Army Medical Research and Material Command and from the U.S. Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium] under Award No. W81XWH-13-2-0095. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred.	Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; Evans TM, 2015, NEUROSCIENCE, V298, P410, DOI 10.1016/j.neuroscience.2015.04.041; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gizzi M, 1996, ARCH NEUROL-CHICAGO, V53, P1299, DOI 10.1001/archneur.1996.00550120111024; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lebouvier T, 2008, BBA-MOL CELL RES, V1783, P188, DOI 10.1016/j.bbamcr.2007.11.005; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Paris D, 2014, J BIOL CHEM, V289, P33927, DOI 10.1074/jbc.M114.608091; Pelligrino DA, 1998, NEUROREPORT, V9, P3285, DOI 10.1097/00001756-199810050-00026; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Shi J, 1998, BRAIN RES, V810, P87, DOI 10.1016/S0006-8993(98)00888-9; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052	50	15	15	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	DEC 22	2017	9								416	10.3389/fnagi.2017.00416			15	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	FQ8IC	WOS:000418605300001	29311903	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Fletcher-Sandersjoo, A; Thelin, EP; Bartek, J; Elmi-Terander, A; Broman, M; Bellander, BM				Fletcher-Sandersjoo, Alexander; Thelin, Eric Peter; Bartek, Jiri, Jr.; Elmi-Terander, Adrian; Broman, Mikael; Bellander, Bo-Michael			Management of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation (ECMO): An observational cohort study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; COMPLICATIONS; DIAGNOSIS; SCALE	Background Intracranial hemorrhage (ICH) is a common complication in adults treated with extracorporeal membrane oxygenation (ECMO). The aim of this study was to identify predictors of outcome and investigate intervention strategies following ICH development in ECMO-treated adult patients. Methods We conducted a retrospective review of adult patients (>= 18 years) who developed an ICH during ECMO treatment at the Karolinska University Hospital (Stockholm, Sweden) between September 2005 and May 2017. Outcome was assessed by 30-day mortality and Glasgow Outcome Scale (GOS) after 6 months. The statistical analysis was supplemented by a case series of patients who were surgically treated for an ICH. Results Sixty-five patients developed an ICH during ECMO treatment. 30-day mortality was 74% (n = 48), and was significantly associated with low level of consciousness at ICH diagnosis (p = 0.036), presence of intraparenchymal hematoma (IPH) (p = 0.049), IPH volume (p = 0.002), presence of intraventricular hemorrhage (p = 0.001), subarachnoid hemorrhage Fisher grade (p<0.001), hydrocephalus (p<0.001), midline shift (p = 0.026) and absent basal cisterns (p<0.001). Among the 30-day survivors (n = 17), 63% (n = 10) had favorable neurological outcome (GOS 4-5) after six months. Five patients were surgically treated for their ICH, some with dire hemorrhagic consequences, however one patient made a complete recovery. Conclusions ICH in adult ECMO patients is associated with a high mortality rate. Outcome predictors can help to identify patients where ICH treatment is indicated. Treating a patient with an ICH during ECMO represents an intricate balance between pro- and anticoagulatory demands. Furthermore, surgical treatment is associated with several risks but may be indicated in life-threatening lesions. Prospective studies are warranted.	[Fletcher-Sandersjoo, Alexander; Bartek, Jiri, Jr.; Elmi-Terander, Adrian; Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Fletcher-Sandersjoo, Alexander; Thelin, Eric Peter; Bartek, Jiri, Jr.; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric Peter] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England; [Bartek, Jiri, Jr.] Rigshosp, Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark; [Bartek, Jiri, Jr.] Karolinska Inst, Dept Med, Stockholm, Sweden; [Broman, Mikael] Karolinska Univ Hosp, Dept Pediat Perioperat Med & Intens Care, ECMO Ctr Karolinska, Stockholm, Sweden; [Broman, Mikael] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Fletcher-Sandersjoo, A (corresponding author), Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden.; Fletcher-Sandersjoo, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	alexander.fletcher-sandersjoo@stud.ki.se	Thelin, Eric Peter/K-2144-2012; Elmi-Terander, Adrian/AAC-7997-2019; Fletcher-Sandersjoo, Alexander/AAH-4198-2019	Thelin, Eric Peter/0000-0002-2338-4364; Elmi-Terander, Adrian/0000-0002-3776-6136; Fletcher-Sandersjoo, Alexander/0000-0002-3558-3045; Broman, Mikael/0000-0003-4124-4581; Bartek Jr., Jiri/0000-0002-2911-1914	Svenska Lakaresallskapet (SE) [SLS-587221]	This was supported by Svenska Lakaresallskapet (SE) (SLS-587221) to EPT The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubron C, 2016, ANN INTENSIVE CARE, P6; Aubron C, 2013, CRIT CARE, V17, DOI 10.1186/cc12681; Broman LM, 2016, FRONT PEDIATR, P4; Broman LM, 2015, CRIT CARE CRITICAL C, P19; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Factora FNF, 2011, J NEUROSURG ANESTH, V23, P30, DOI 10.1097/ANA.0b013e3181eee55e; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Friesenecker BE, 2005, ACTA NEUROCHIR, V147, P993, DOI 10.1007/s00701-005-0568-5; Gerke AK, 2015, BMC RES NOTES, P8; Hampton CR, 2002, ARTIF ORGANS, V26, P902, DOI 10.1046/j.1525-1594.2002.07122.x; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; JENNETT B, 1975, LANCET, V1, P480; Kasirajan V, 1999, EUR J CARDIO-THORAC, V15, P508, DOI 10.1016/S1010-7940(99)00061-5; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kraus M, 2015, OPEN J ANESTHESIOL, V5, P251; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; Lidegran MK, 2007, ACAD RADIOL, V14, P62, DOI 10.1016/j.acra.2006.10.004; Lockie CJA, 2017, CRIT CARE MED, V45, P1642, DOI 10.1097/CCM.0000000000002579; Luyt CE, 2016, INTENS CARE MED, V42, P897, DOI 10.1007/s00134-016-4318-3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Makdisi G, 2015, J THORAC DIS, V7, pE166, DOI 10.3978/j.issn.2072-1439.2015.07.17; McCarthy FH, 2015, SEMIN THORAC CARDIOV, P27; Nasr DM, 2015, J CLIN NEUROL, V11, P383, DOI 10.3988/jcn.2015.11.4.383; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Omar HR, 2016, ASAIO J, V62, P634, DOI 10.1097/MAT.0000000000000368; Safatli Diaa A, 2016, Surg Neurol Int, V7, pS510, DOI 10.4103/2152-7806.187493; Sandersjoo AF, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0223-2; Sauer CM, 2015, ASAIO J, V61, P31, DOI 10.1097/MAT.0000000000000160; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368	34	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190365	10.1371/journal.pone.0190365			17	Multidisciplinary Sciences	Science & Technology - Other Topics	FQ8BI	WOS:000418587400115	29267368	DOAJ Gold, Green Published			2021-06-18	
J	Bodien, YG; Giacino, JT; Edlow, BL				Bodien, Yelena G.; Giacino, Joseph T.; Edlow, Brian L.			Functional MRI Motor imagery Tasks to Detect Command Following in Traumatic Disorders of Consciousness	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; consciousness; awareness; functional magnetic resonance imaging; motor imagery	PERSISTENT VEGETATIVE STATE; COMA RECOVERY SCALE; BRAIN-INJURY; ACUTE CONFUSION; MODEL SYSTEMS; FMRI; DIAGNOSIS; AWARENESS; ACTIVATION; COGNITION	Severe traumatic brain injury impairs arousal and awareness, the two components of consciousness. Accurate diagnosis of a patient's level of consciousness is critical for determining treatment goals, access to rehabilitative services, and prognosis. The bedside behavioral examination, the current clinical standard for diagnosis of disorders of consciousness, is prone to misdiagnosis, a finding that has led to the development of advanced neuroimaging techniques aimed at detection of conscious awareness. Although a variety of paradigms have been used in functional magnetic resonance imaging (fMRI) to reveal covert consciousness, the relative accuracy of these paradigms in the patient population is unknown. Here, we compare the rate of covert consciousness detection by hand squeezing and tennis playing motor imagery paradigms in 10 patients with traumatic disorders of consciousness [ six male, six acute, mean +/- SD age = 27.9 +/- 9.1 years, one coma, four unresponsive wakefulness syndrome, two minimally conscious without language function, and three minimally conscious with language function, per bedside examination with the Coma Recovery Scale-Revised (CRS-R)]. We also tested the same paradigms in 10 healthy subjects (nine male, mean +/- SD age = 28.5 +/- 9.4 years). In healthy subjects, the hand squeezing paradigm detected covert command following in 7/10 and the tennis playing paradigm in 9/10 subjects. In patients who followed commands on the CRS-R, the hand squeezing paradigm detected covert command following in 2/3 and the tennis playing paradigm in 0/3 subjects. In patients who did not follow commands on the CRS-R, the hand squeezing paradigm detected command following in 1/7 and the tennis playing paradigm in 2/7 subjects. The sensitivity, specificity, and accuracy (ACC) of detecting covert command following in patients who demonstrated this behavior on the CRS-R was 66.7, 85.7, and 80% for the hand squeezing paradigm and 0, 71.4, and 50% for the tennis playing paradigm, respectively. Overall, the tennis paradigm performed better than the hand squeezing paradigm in healthy subjects, but in patients, the hand squeezing paradigm detected command following with greater ACC. These findings indicate that current fMRI motor imagery paradigms frequently fail to detect command following and highlight the need for paradigm optimization to improve the accuracy of covert consciousness detection.	[Bodien, Yelena G.; Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Bodien, Yelena G.; Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Lab NeuroImaging Coma & Consciousness, Boston, MA 02114 USA; [Bodien, Yelena G.; Giacino, Joseph T.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02129 USA; [Giacino, Joseph T.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Giacino, Joseph T.] Harvard Med Sch, Boston, MA USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Edlow, Brian L.] Harvard Med Sch, Charlestown, MA USA	Bodien, YG (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA.; Bodien, YG (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Lab NeuroImaging Coma & Consciousness, Boston, MA 02114 USA.; Bodien, YG (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02129 USA.	ybodien@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Bodien, Yelena/0000-0003-4858-2903	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23NS094538]; Center for Integration of Medicine & Innovative Technology (Boston, MA, USA); American Academy of Neurology/American Brain Foundation; James S. McDonnell Foundation; Massachusetts General Hospital Department of Neurology and Division of Neurocritical Care and Emergency Neurology; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538] Funding Source: NIH RePORTER	The authors thank the nursing staffs of the Massachusetts General Hospital Neurosciences ICU, Multidisciplinary ICU, and the Surgical ICU. We also thank Kellie Cahill and the MRI technologists for their assistance with data acquisition. We would like to acknowledge Dylan Tisdall and Andre van der Kouwe (Athinoula A Martinos Center for Biomedical Imaging) and Himanshu Bhat (Siemens Medical Center) for the provision of WIP711D (vNav Motion-Corrected Multiecho MPRAGE) used to acquire MEMPRAGE data. We are grateful to the patients and families in this study for their participation and support. This work was supported by grants from the National Institutes of Health (K23NS094538), the Center for Integration of Medicine & Innovative Technology (Boston, MA, USA), the American Academy of Neurology/American Brain Foundation, the James S. McDonnell Foundation, the Massachusetts General Hospital Department of Neurology and Division of Neurocritical Care and Emergency Neurology, and the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR).	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2009, PROG BRAIN RES, V177, P231, DOI 10.1016/S0079-6123(09)17716-6; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Di HB, 2008, CLIN MED, V8, P502, DOI 10.7861/clinmedicine.8-5-502; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fernandez-Espejo D, 2008, BRAIN INJURY, V22, P882, DOI 10.1080/02699050802403573; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gibson RM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00950; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; JENNETT B, 1972, LANCET, V1, P734; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; KARNI A, 1995, NATURE, V377, P155; Kirsch M, 2017, ANESTH ANALG, V124, P588, DOI 10.1213/ANE.0000000000001721; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moreno DR, 2010, NEUROLOGY, V75, P1871, DOI 10.1212/WNL.0b013e3181feb259; Naci L, 2013, JAMA NEUROL, V70, P1235, DOI 10.1001/jamaneurol.2013.3686; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Rossetti AO, 2015, CLIN NEUROPHYSIOLOGY; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; StataCorp, 2015, Stata Statistical Software: Release 14.; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Wannez S, 2017, J NEUROL, V264, P928, DOI 10.1007/s00415-017-8469-0; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023	48	15	16	1	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 18	2017	8								688	10.3389/fneur.2017.00688			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FQ1XZ	WOS:000418152500001	29326648	DOAJ Gold, Green Published			2021-06-18	
J	McLeod, TCV; Wagner, AJ; Bacon, CEW				McLeod, Tamara C. Valovich; Wagner, Alyssa J.; Bacon, Cailee E. Welch			Lived Experiences of Adolescent Athletes Following Sport-Related Concussion	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; emotional; quality of life; symptoms	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; CLINICAL-OUTCOMES ASSESSMENT; HIGH-SCHOOL; ACADEMIC ACCOMMODATIONS; CONSENSUS STATEMENT; DISABLEMENT MODELS; TRAINING PRACTICE; FOOTBALL PLAYERS; CHILDREN	Background: Previous studies have identified the effect of sport-related concussion on health-related quality of life through the use of patient-reported outcome measures. However, there has been little research exploring the underlying mechanisms that influence these perceptions of health-related quality of life among adolescent athletes who have sustained a sport-related concussion. Purpose: To explore the psychosocial aspects of concussion among adolescent athletes. Study Design: Case series; Level of evidence, 4. Methods: A total of 12 interscholastic athletes (4 girls, 8 boys; mean SD age, 15.7 1.7 years; grade level, 10.2 +/- 1.4) were interviewed via a semistructured interview protocol between 15 and 30 days postinjury. Data analysis was guided by the consensual qualitative research tradition. Themes and categories emerged through consensus by a 3-person research team, and bias was minimized through the use of multiple-analyst triangulation. Results: Participants identified numerous postconcussion symptoms that resulted in increasing difficulty with emotions (eg, irritable, easily frustrated), roles at school (eg, concentration difficulties, fatigue), and roles in their social environment (eg, letting the team down, not being able to contribute to sport). As a result, participants expressed how they tried to minimize or mask symptoms to decrease the potential of being viewed differently by their peers. Conclusion: Adolescent athletes perceived a significant effect of sport-related concussion on numerous areas of psychosocial and emotional health and well-being. Anticipatory guidancewith education regarding the possible signs and symptoms, risk factors, and recovery expectations following a concussionis important to include in postinjury management. A better understanding of sport-related concussion and expected recovery could help to improve perceptions of this injury among interscholastic athletes. Additionally, best practices should be identified to assist health care professionals and school personnel in the development of temporary adjustments or formal academic adjustment policies in the secondary school setting, therefore ensuring that the patients receive the support that they need to maintain their roles as students.	[McLeod, Tamara C. Valovich; Wagner, Alyssa J.; Bacon, Cailee E. Welch] AT Still Univ, Postprofess Athlet Training Program, Mesa, AZ USA; [McLeod, Tamara C. Valovich; Bacon, Cailee E. Welch] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ USA	McLeod, TCV (corresponding author), AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA.	tmcleod@atsu.edu	McLeod, Tamara/AAU-9435-2020		National Operating Committee on Standards for Athletic Equipment	One or more of the authors has declared the following potential conflict of interest or source of funding: This project was funded by the National Operating Committee on Standards for Athletic Equipment.	Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, pe333; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Di Battista A, 2015, BRAIN INJURY, V29, P573, DOI 10.3109/02699052.2014.989905; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Halstead ME, BRIT J SPORT MED, DOI [10. 1136/bjsports-2016-096674 ., DOI 10.1136/BJSP0RTS-2016-096674]; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Hill CE, 1997, COUNS PSYCHOL, V25, P517, DOI 10.1177/0011000097254001; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Nagi S. Z., 1965, SOCIOLOGY REHABILITA, P100; Neal TL, 2015, J ATHL TRAINING, V50, P231, DOI 10.4085/1062-6050-50.3.03; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Valier AR, 2016, ARCH PHYS MED REHAB, V97, P1202, DOI 10.1016/j.apmr.2015.11.015; Valovich McLeod TC, 2015, J ATHL TRAINING, V50, pS115; Valovich McLeod TC, 2017, J ATHL TRAINING, V52, P262; Valovich TC, 2008, J ATHL TRAINING, V43, P437, DOI 10.4085/1062-6050-43.4.437; Vassilyadi M, 2014, PEDIATR NEUROSURG, V50, P196, DOI 10.1159/000431232; Ware J. E., 2008, USERS MANUAL SF 36V2; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Welch Bacon CE, INT J ATHL THER TRAI, DOI [10. 1123/ijatt. 2017-0043 ., DOI 10.1123/IJATT.2017-0043]; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; World Health Organisation, 2002, COMM LANG FUNCT DIS; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	61	15	15	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC 11	2017	5	12							2325967117745033	10.1177/2325967117745033			10	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	FP6RW	WOS:000417754500001	29276716	DOAJ Gold, Green Published			2021-06-18	
J	Jang, SH; Lee, J; Yeo, SS				Jang, Sung Ho; Lee, Jun; Yeo, Sang Seok			Central post-stroke pain due to injury of the spinothalamic tract in patients with cerebral infarction: a diffusion tensor tractography imaging study	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; central post-stroke pain; cerebral infarction; spinothalamic tract; diffusion tensor imaging; neural regeneration	TRAUMATIC BRAIN-INJURY; THALAMO-CORTICAL PATHWAY; SENSORY ABNORMALITIES; NEUROPATHIC PAIN; MECHANISMS; PATHOPHYSIOLOGY; MANAGEMENT	Many studies using diffusion tensor tractography (DTT) have demonstrated that injury of the spinothalamic tract (STT) is the pathogenetic mechanism of central post-stroke pain (CPSP) in intracerebral hemorrhage; however, there is no DTT study reporting the pathogenetic mechanism of CPSP in cerebral infarction. In this study, we investigated injury of the STT in patients with CPSP following cerebral infarction, using DTT. Five patients with CPSP following cerebral infarction and eight age-and sex-matched healthy control subjects were recruited for this study. STT was examined using DTT. Among DTT parameters of the affected STT, fractional anisotropy and tract volume were decreased by more than two standard deviations in two patients (patients 1 and 2) and three patients (patients 3, 4, and 5), respectively, compared with those of the control subjects, while mean diffusivity value was increased by more than two standard deviations in one patient (patient 2). Regarding DTT configuration, all affected STTs passed through adjacent part of the infarct and three STTs showed narrowing. These findings suggest that injury of the STT might be a pathogenetic etiology of CPSP in patients with cerebral infarction.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu, South Korea; [Lee, Jun] Yeungnam Univ, Coll Med, Dept Neurol, Daegu, South Korea; [Yeo, Sang Seok] Dankook Univ, Coll Hlth Sci, Dept Phys Therapy, Chungnam, South Korea	Yeo, SS (corresponding author), Dankook Univ, Coll Hlth Sci, Dept Phys Therapy, Chungnam, South Korea.	eangbul@hanmail.net			National Research Foundation (NRF) of Korea - Korean Government (MSIP) [NRF-2015R1D1A1A01060314]	This work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MSIP), No. NRF-2015R1D1A1A01060314.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; CESARO P, 1991, PAIN, V47, P329, DOI 10.1016/0304-3959(91)90224-L; Devulder J, 2002, ACTA NEUROL BELG, V102, P97; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Flaherty S A, 1996, AANA J, V64, P133; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Hong JH, 2012, EUR NEUROL, V67, P12, DOI 10.1159/000333012; Hong JH, 2010, EUR NEUROL, V64, P163, DOI 10.1159/000319040; Hong JH, 2010, NEUROSCI LETT, V468, P102, DOI 10.1016/j.neulet.2009.10.075; Jang SH, 2016, BRAIN INJURY, V30, P1026, DOI 10.3109/02699052.2016.1146961; Jang SH, 2016, NEURAL REGEN RES, V11, P130, DOI 10.4103/1673-5374.175058; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Kumar B, 2009, ANESTH ANALG, V108, P1645, DOI 10.1213/ane.0b013e31819d644c; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Seghier ML, 2005, J PAIN, V6, P208, DOI 10.1016/j.jpain.2004.11.004; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Seo JP, 2013, BRAIN INJURY, V27, P749, DOI 10.3109/02699052.2013.771794; VESTERGAARD K, 1995, PAIN, V61, P177, DOI 10.1016/0304-3959(94)00140-A; Wang CC, 2017, BEHAV BRAIN RES, V317, P251, DOI 10.1016/j.bbr.2016.09.053; Wasner G, 2008, BRAIN, V131, P2387, DOI 10.1093/brain/awn169; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165	25	15	16	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	DEC	2017	12	12					2021	2024		10.4103/1673-5374.221159			4	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	FS7UZ	WOS:000422615700017	29323041	DOAJ Gold, Green Published			2021-06-18	
J	Ramos-Hryb, AB; Pazini, FL; Kaster, MP; Rodrigues, ALS				Ramos-Hryb, Ana B.; Pazini, Francis L.; Kaster, Manuella P.; Rodrigues, Ana Lucia S.			Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases	CNS DRUGS			English	Article							EARLY BRAIN-INJURY; TRIPLE REUPTAKE INHIBITORS; INDUCED COGNITIVE DEFICITS; ORIGANUM-MAJORANA L.; OLEANOLIC ACID; OXIDATIVE STRESS; MITOCHONDRIAL-FUNCTION; MONOAMINE-OXIDASE; NEXT-GENERATION; OFFICINALIS L.	Ursolic acid is a pentacyclic triterpenoid found in several plants. Despite its initial use as a pharmacologically inactive emulsifier in pharmaceutical, cosmetic and food industries, several biological activities have been reported for this compound so far, including anti-tumoural, anti-diabetic, cardioprotective and hepatoprotective properties. The biological effects of ursolic acid have been evaluated in vitro, in different cell types and against several toxic insults (i.e. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, amyloid-beta peptides, kainic acid and others); in animal models of brain-related disorders (Alzheimer disease, Parkinson disease, depression, traumatic brain injury) and ageing; and in clinical studies with cancer patients and for muscle atrophy. Most of the protective effects of ursolic acid are related to its ability to prevent oxidative damage and excessive inflammation, common mechanisms associated with multiple brain disorders. Additionally, ursolic acid is capable of modulating the monoaminergic system, an effect that might be involved in its ability to prevent mood and cognitive dysfunctions associated with neurodegenerative and psychiatric conditions. This review presents and discusses the available evidence of the possible beneficial effects of ursolic acid for the management of neurodegenerative and psychiatric disorders. We also discuss the chemical features, major sources and potential limitations of the use of ursolic acid as a pharmacological treatment for brain-related diseases.	[Ramos-Hryb, Ana B.; Pazini, Francis L.; Kaster, Manuella P.; Rodrigues, Ana Lucia S.] Univ Fed Santa Catarina, Dept Biochem, Ctr Biol Sci, BR-88040900 Florianopolis, SC, Brazil	Ramos-Hryb, AB (corresponding author), Univ Fed Santa Catarina, Dept Biochem, Ctr Biol Sci, BR-88040900 Florianopolis, SC, Brazil.	alsrodri@gmail.com	Hryb, Ana Belen B R-H Ramos/P-3615-2014; Kaster, Manuella/D-5028-2013; Rodrigues, Ana Lucia/P-6869-2015	Hryb, Ana Belen B R-H Ramos/0000-0003-3376-5977; Kaster, Manuella/0000-0003-0258-6204; Rodrigues, Ana Lucia/0000-0001-6285-8780	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [308723/2013-9, 449436/2014-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, NENASC Project (PRONEX-FAPESC/CNPq) [1262/2012-9]	The authors acknowledge funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), #308723/2013-9 and #449436/2014-4, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, NENASC Project (PRONEX-FAPESC/CNPq) #1262/2012-9. Manuella P. Kaster and Ana Lucia S. Rodrigues are CNPq Research Fellows.	Aarsland D, 2017, NAT REV NEUROL, V13, P217, DOI 10.1038/nrneurol.2017.27; Anderson KN, 2013, NAT SCI SLEEP, V5, P61, DOI 10.2147/NSS.S34842; Bahadori MB, 2016, S AFR J BOT, V106, P1, DOI 10.1016/j.sajb.2015.12.003; Bang HS, 2014, KOREAN J PHYSIOL PHA, V18, P441, DOI 10.4196/kjpp.2014.18.5.441; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Beer B, 2004, J CLIN PHARMACOL, V44, P1360, DOI 10.1177/0091270004269560; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Bodkin JA, 1997, J CLIN PSYCHIAT, V58, P137, DOI 10.4088/JCP.v58n0401; Bredesen DE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-27; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Caligiani A, 2013, FOOD CHEM, V136, P735, DOI 10.1016/j.foodchem.2012.08.011; Chandramu C, 2003, PHYTOTHER RES, V17, P129, DOI 10.1002/ptr.1088; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Chattopadhyay D, 2003, J ETHNOPHARMACOL, V85, P99, DOI 10.1016/S0378-8741(02)00379-3; Chen QH, 2011, ANAL BIOANAL CHEM, V399, P2877, DOI 10.1007/s00216-011-4651-x; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Chin JH, 2014, NEUROLOGY, V83, P349, DOI 10.1212/WNL.0000000000000610; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Chung YK, 2001, MOL CELLS, V11, P137; Colla ARS, 2015, EUR J PHARMACOL, V758, P171, DOI 10.1016/j.ejphar.2015.03.077; Colla ARS, 2014, PHARMACOL BIOCHEM BE, V124, P108, DOI 10.1016/j.pbb.2014.05.015; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Culhaoglu B, 2013, NAT PROD RES, V27, P438, DOI 10.1080/14786419.2012.734820; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dar BA, 2016, EUR J MED CHEM, V111, P26, DOI 10.1016/j.ejmech.2016.01.026; De Angel RE, 2010, NUTR CANCER, V62, P1074, DOI 10.1080/01635581.2010.492092; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Ennaceur A, 2014, PHYSIOL BEHAV, V135, P55, DOI 10.1016/j.physbeh.2014.05.032; Esch T, 2002, NEUROENDOCRINOL LETT, V23, P199; Falkenburger BH, 2016, J NEUROCHEM, V139, P121, DOI 10.1111/jnc.13618; Gao LP, 2005, PHARMAZIE, V60, P62; Gonzalez-Cortazar M, 2013, MOLECULES, V18, P13260, DOI 10.3390/molecules181113260; Gonzalez-Trujano ME, 2012, PLANTA MED, V78, P793, DOI 10.1055/s-0031-1298416; Hane FT, 2017, J ALZHEIMERS DIS, V57, P1, DOI 10.3233/JAD-160882; Heo HJ, 2002, MOL CELLS, V13, P5; Hettema JM, 2008, AM J MED GENET C, V148C, P140, DOI 10.1002/ajmg.c.30171; Hong SY, 2012, MOLECULES, V17, P10831, DOI 10.3390/molecules170910831; Hussain H, 2017, EXPERT OPIN THER PAT, V27, P1061, DOI 10.1080/13543776.2017.1344219; Ibarra A, 2010, PHYTOMEDICINE, V17, P397, DOI 10.1016/j.phymed.2010.01.012; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Jeon SJ, 2015, EUR J PHARMACOL, V762, P443, DOI 10.1016/j.ejphar.2015.06.037; Jetter R, 2001, PLANT PHYSIOL, V126, P1725, DOI 10.1104/pp.126.4.1725; Kashyap D, 2016, LIFE SCI, V146, P201, DOI 10.1016/j.lfs.2016.01.017; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kim JH, 2012, BIOMOL THER, V20, P214, DOI 10.4062/biomolther.2012.20.2.214; Kowalski R, 2007, J AGR FOOD CHEM, V55, P656, DOI 10.1021/jf0625858; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; Leal AS, 2012, BIOORGAN MED CHEM, V20, P5774, DOI 10.1016/j.bmc.2012.08.010; Lee S, 2002, ARCH PHARM RES, V25, P280, DOI 10.1007/BF02976626; Leung A. Y., 1996, ENCY COMMON NATURAL; LEVIN EY, 1960, J BIOL CHEM, V235, P2080; Li LT, 2013, BRAIN RES, V1497, P32, DOI 10.1016/j.brainres.2012.12.032; Liang WN, 2016, ARQ NEURO-PSIQUIAT, V74, P482, DOI 10.1590/0004-282X20160065; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002; Machado DG, 2012, PHARMACOL BIOCHEM BE, V103, P204, DOI 10.1016/j.pbb.2012.08.016; Machado DG, 2013, FOOD CHEM, V136, P999, DOI 10.1016/j.foodchem.2012.09.028; Marks DM, 2008, CURR NEUROPHARMACOL, V6, P338, DOI 10.2174/157015908787386078; Monteiro MC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2949102; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; NITTA A, 1994, NEUROSCI LETT, V170, P63, DOI 10.1016/0304-3940(94)90239-9; Novotny L, 2003, J PHARMACEUT BIOMED, V31, P961, DOI 10.1016/S0731-7085(02)00706-9; Nyola A, 2010, CURR OPIN STRUC BIOL, V20, P415, DOI 10.1016/j.sbi.2010.05.007; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Popoli M, 2000, J NEUROCHEM, V74, P21, DOI 10.1046/j.1471-4159.2000.0740021.x; Prasad S, 2012, CLIN CANCER RES, V18, P4942, DOI 10.1158/1078-0432.CCR-11-2805; Prediger RDS, 2008, J ETHNOPHARMACOL, V120, P465, DOI 10.1016/j.jep.2008.09.018; Qian ZZ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/809714; Rai SN, 2016, J CHEM NEUROANAT, V71, P41, DOI 10.1016/j.jchemneu.2015.12.002; Ramos-Hryb AB, 2017, PHARMACOL REP, V69, P1240, DOI 10.1016/j.pharep.2017.05.009; Richard EJ, 2016, PHYTOTHER RES, V30, P805, DOI 10.1002/ptr.5584; Rollinger JM, 2010, BIOORGAN MED CHEM, V18, P1507, DOI 10.1016/j.bmc.2010.01.010; ROWE EJ, 1949, J AM PHARM ASSOC SCI, V38, P122, DOI 10.1002/jps.3030380303; Santos Claudia Y, 2017, Alzheimers Dement (Amst), V7, P69, DOI 10.1016/j.dadm.2017.01.005; Shan JZ, 2011, CHIN J INTEGR MED, V17, P607, DOI 10.1007/s11655-011-0815-y; Shanmugam MK, 2013, BIOCHEM PHARMACOL, V85, P1579, DOI 10.1016/j.bcp.2013.03.006; Shanmugam MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032476; Shanmugam MK, 2011, INT J CANCER, V129, P1552, DOI 10.1002/ijc.26120; Sharma H, 2015, FUTURE MED CHEM, V7, P2385, DOI 10.4155/fmc.15.134; Shen DD, 2011, J FOOD SCI, V76, pC900, DOI 10.1111/j.1750-3841.2011.02281.x; Shih YH, 2004, NEUROSCI LETT, V362, P136, DOI 10.1016/j.neulet.2004.03.011; Shimohama S, 2003, TRENDS MOL MED, V9, P360, DOI 10.1016/S1471-4914(03)00117-5; Singla RK, 2016, CURR NEUROPHARMACOL; Skolnick P, 2006, CNS DRUG REV, V12, P123, DOI 10.1111/j.1527-3458.2006.00123.x; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Snow WM, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00118; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Szakiel A, 2012, PHYTOCHEM REV, V11, P263, DOI 10.1007/s11101-012-9241-9; Szakiel A, 2012, J AGR FOOD CHEM, V60, P11839, DOI 10.1021/jf3046895; Takahashi RH, 2017, PATHOL INT, V67, P185, DOI 10.1111/pin.12520; Takeda S, 2009, BRAIN RES, V1280, P137, DOI 10.1016/j.brainres.2009.05.035; Tang Siu W, 2017, Mod Trends Pharmacopsychiatry, V31, P107, DOI 10.1159/000470811; Tapondjou LA, 2003, ARCH PHARM RES, V26, P143, DOI 10.1007/BF02976660; Taviano MF, 2007, PHYTOTHER RES, V21, P382, DOI 10.1002/ptr.2076; TOKUDA H, 1986, CANCER LETT, V33, P279, DOI 10.1016/0304-3835(86)90067-4; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Tsai SJ, 2008, J FOOD SCI, V73, pH174, DOI 10.1111/j.1750-3841.2008.00864.x; Vasconcelos MAL, 2006, Z NATURFORSCH C, V61, P477, DOI 10.1515/znc-2006-7-803; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Verano J, 2013, PHARMACOL BIOCHEM BE, V110, P255, DOI 10.1016/j.pbb.2013.07.020; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Wang XH, 2013, EXPERT OPIN DRUG MET, V9, P117, DOI 10.1517/17425255.2013.738667; Wang YZ, 2016, DRUG DES DEV THER, V10, DOI 10.2147/DDDT.S103829; Wang YJ, 2011, NEUROBIOL LEARN MEM, V96, P156, DOI 10.1016/j.nlm.2011.03.010; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; Wilkinson K, 2011, J BIOL CHEM, V286, P34914, DOI 10.1074/jbc.M111.232116; Wojciak-Kosior M, 2007, J PHARMACEUT BIOMED, V45, P337, DOI 10.1016/j.jpba.2007.05.011; Wozniak L, 2015, MOLECULES, V20, P20614, DOI 10.3390/molecules201119721; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu DM, 2013, TOXICOL APPL PHARM, V271, P127, DOI 10.1016/j.taap.2013.04.038; Xia YY, 2011, J CHROMATOGR B, V879, P219, DOI 10.1016/j.jchromb.2010.11.037; Yealland G, 2016, NEUROSCI LETT, V630, P23, DOI 10.1016/j.neulet.2016.06.065; Yoon JH, 2014, J AGR FOOD CHEM, V62, P4911, DOI 10.1021/jf501314g; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Youn K, 2012, PHYTOTHER RES, V26, P1714, DOI 10.1002/ptr.4638; Zhang TT, 2014, INT IMMUNOPHARMACOL, V23, P585, DOI 10.1016/j.intimp.2014.10.009; Zhang TT, 2014, NEUROSCI LETT, V579, P12, DOI 10.1016/j.neulet.2014.07.005; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079; Zhu ZL, 2013, INT J NANOMED, V8, P129, DOI 10.2147/IJN.S38271	126	15	15	2	14	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1172-7047	1179-1934		CNS DRUGS	CNS Drugs	DEC	2017	31	12					1029	1041		10.1007/s40263-017-0474-4			13	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	FR4FN	WOS:000419021200001	29098660				2021-06-18	
J	Shura, RD; Denning, JH; Miskey, HM; Rowland, JA				Shura, Robert D.; Denning, John H.; Miskey, Holly M.; Rowland, Jared A.			Symptom and Performance Validity With Veterans Assessed for Attention-Deficit/Hyperactivity Disorder (ADHD)	PSYCHOLOGICAL ASSESSMENT			English	Article						ADHD; MMPI-2-RF; TOMM; validity; veteran	TRAUMATIC BRAIN-INJURY; SELF-REPORTED SYMPTOMS; RESPONSE BIAS; FEIGNED ADHD; TEST FAILURE; ADULTS; NEUROPSYCHOLOGY; EXAGGERATION; STATEMENT; SOLDIERS	Little is known about attention-deficit/hyperactivity disorder (ADHD) in veterans. Practice standards recommend the use of both symptom and performance validity measures in any assessment, and there are salient external incentives associated with ADHD evaluation (stimulant medication access and academic accommodations). The purpose of this study was to evaluate symptom and performance validity measures in a clinical sample of veterans presenting for specialty ADHD evaluation. Patients without a history of a neurocognitive disorder and tor whom data were av ailable on all measures (n = 114) completed a clinical interview structured on DSM-5 ADHD symptoms, the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF), and the Test of Memory Malingering Trial 1 (TOMM1) as part of a standardized ADHD diagnostic evaluation. Veterans meeting criteria for ADIID were not more likely to overreport symptoms on the MMPI-2-RF nor to fail TOMM1 (score <= 41) compared with those who did not meet criteria. Those who overreported symptoms did not endorse significantly more ADHD symptoms; however, hose who failed TOMMJ did report significantly more ADHD symptoms (g = 0.90). In the total sample, 19.3% failed TOMM1, 44.7% overreported on the MMPI-2-RF, and 8.8% produced both an overreported MMPI-2-RF and invalid TOMM1. F-r had the highest correlation to TOMM1 scores (r = -.30). These results underscore the importance of assessing both symptom and performance validity in a clinical ADHD evaluation with veterans. In contrast to certain other conditions (e.g., mild traumatic brain injury). ADHD as a diagnosis is not related to higher rates of invalid report/performance in veterans.	[Shura, Robert D.] WG Bill Hefner Vet Affairs Med Ctr VAMC, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Shura, Robert D.] WG Bill Hefner Vet Affairs Med Ctr VAMC, Midatlantic Mental Illness Res Educ & Clin Ctr MA, Salisbury, NC USA; [Shura, Robert D.; Miskey, Holly M.] Wake Forest Sch Med, Dept Psychiat & Behav Sci, Winston Salem, NC USA; [Denning, John H.] Ralph H Johnson VAMC, Mental Hlth Care Line, Charleston, SC USA; [Denning, John H.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Miskey, Holly M.] WG Bill Hefner VAMC, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Miskey, Holly M.; Rowland, Jared A.] WG Bill Hefner VAMC, MA MIRECC, Salisbury, NC USA; [Rowland, Jared A.] WG Bill Hefner VAMC, Res & Acad Affairs Serv Line, Salisbury, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA	Shura, RD (corresponding author), Hefner VAMC, 11M-2 MH&BS,1601 Brenner Ave, Salisbury, NC 28144 USA.	Robert.Shura2@va.gov	Shura, Robert D/J-6749-2019; Rowland, Jared A./AAN-3030-2021	Rowland, Jared A./0000-0002-3655-3411; Miskey, Holly/0000-0002-5139-4586; Shura, Robert/0000-0002-9505-0080	W. G. (Bill) Hefner VAMC; Mid-Atlantic Mental Illness Research Education and Clinical Center	This research was supported by resources of the W. G. (Bill) Hefner VAMC and the Mid-Atlantic Mental Illness Research Education and Clinical Center. These results have not been previously presented in any form. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the Department of Defense, or the U.S. government.	American Psychiatric Association, 2013, DAIAGN STAT MAN MENT; Antshel KM, 2010, PSYCHOL MED, V40, P1909, DOI 10.1017/S0033291709992273; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Barkley RA, 2006, ATTENTION DEFICIT HY; Ben-Porath Y.S., 2011, MINNESOTA MULTIPHASI; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boone K. B., 2002, THE B TEST; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Department of Veterans Affairs, 2013, DEP VET AFF ED PROGR; Fazio R. L., 2016, CLIN NEUROPSYCHOL, V31, P1; Flory K, 2006, J CLIN CHILD ADOLESC, V35, P571, DOI 10.1207/s15374424jccp3504_8; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Green P., 2005, GREENS WORD MEMORY T; Harp JP, 2011, PSYCHOL INJ LAW, V4, P32, DOI 10.1007/s12207-011-9100-9; Heaton RK, 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Kessler RC, 2014, JAMA PSYCHIAT, V71, P504, DOI 10.1001/jamapsychiatry.2014.28; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Kuriyan AB, 2013, J ABNORM CHILD PSYCH, V41, P27, DOI 10.1007/s10802-012-9658-z; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Musso MW, 2014, J ATTEN DISORD, V18, P186, DOI 10.1177/1087054712441970; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Shura R. D., 2016, MILITARY PSYCHOL; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Tellegen A., 2011, MINNESOTA MULTIPHASI; Tombaugh TN, 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Williamson KD, 2014, CLIN NEUROPSYCHOL, V28, P1182, DOI 10.1080/13854046.2014.956674; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P165, DOI 10.1093/arclin/acr013	37	15	15	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	DEC	2017	29	12					1458	1465		10.1037/pas0000436			8	Psychology, Clinical	Psychology	FS7JJ	WOS:000419973500005	29227127				2021-06-18	
J	Peacock, WF; Van Meter, TE; Mirshahi, N; Ferber, K; Gerwien, R; Rao, V; Sair, HI; Diaz-Arrastia, R; Korley, FK				Peacock, W. Frank; Van Meter, Timothy E.; Mirshahi, Nazanin; Ferber, Kyle; Gerwien, Robert; Rao, Vani; Sair, Haris Iqbal; Diaz-Arrastia, Ramon; Korley, Frederick K.			Derivation of a Three Biomarker Panel to improve Diagnosis in Patients with Mild Traumatic Brain injury	FRONTIERS IN NEUROLOGY			English	Article						mild brain injury; mild TBI; biomarker; machine learning; neurogranin; neuron-specific enolase; metallothionein	FIBRILLARY ACIDIC PROTEIN; AMYLOID-BETA; HEAD-INJURY; RECURRENT CONCUSSION; MAGNETIC-RESONANCE; OUTCOME PREDICTION; FOOTBALL PLAYERS; PROGNOSTIC VALUE; AXONAL INJURY; SERUM	Background: Nearly 5 million emergency department (ED) visits for head injury occur each year in the United States, of which <10% of patients show abnormal computed tomography (CT) findings. CT negative patients frequently suffer protracted somatic, behavioral, and neurocognitive dysfunction. Our goal was to evaluate biomarkers to identify mild TBI (mTBI) in patients with suspected head injury. Methods: An observational ED study of head-injured and control patients was conducted at Johns Hopkins University (HeadSMART). Head CT was obtained (ACEP criteria) in patients with Glasgow Coma Scale scores of 13-15 and aged 18-80. Three candidate biomarker proteins, neurogranin (NRGN), neuron-specific enolase (NSE), and metallothionein 3 (MT3), were evaluated by immunoassay (samples <24 h from injury). American Congress of Rehabilitation Medicine (ACRM) criteria were used for diagnosis of mTBI patients for model building. Univariate analysis, logistic regression, and random forest (RF) algorithms were used for data analysis in R. Overall, 662 patients were studied. Statistical models were built using 328 healthy controls and 179 mTBI patients. Results: Median time from injury was 5.9 h (IQR, 4.0; range 0.8-24 h). mTBI patients had elevated NSE, but decreased MT3 versus controls (p < 0.01 for each). NRGN was also elevated but within 2-6 h after injury. In the derivation set, the best model to distinguish mTBI from healthy controls used three markers, age, and sex as covariates (C-statistic = 0.91, sensitivity 98%, specificity 72%). Panel test accuracy was validated with the 155 remaining ACRM+ mTBI patients. Applying the RF model to the ACRM+ mTBI validation set resulted in 78% correctly classified as mTBI (119/153). CT positive and CT negative validation subsets were 91% and 75% correctly classified. In samples taken < 2 h from injury, 100% (10/10) samples classified correctly, indicating that hyperacute testing is possible with these biomarker assays. The model accuracy varied from 72-100% overall, and had greater accuracy with increasing severity, as shown by comparing CT+ with CT-(91% versus 75%), and Injury Severity Score >= 16 versus < 16 (88% versus 72%, respectively). Objective blood tests, detecting NRGN, NSE, and MT3, can be used to identify mTBI, irrespective of neuroimaging findings.	[Peacock, W. Frank] Ben Taub Hosp, Dept Emergency Med, Houston, TX 77030 USA; [Van Meter, Timothy E.; Mirshahi, Nazanin; Ferber, Kyle] ImmunArray Inc, Program Neurol Dis, Richmond, VA USA; [Gerwien, Robert] Gerwien Stat Consulting, Newington, CT USA; [Rao, Vani] Johns Hopkins Bayview Med Ctr, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Sair, Haris Iqbal] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA; [Korley, Frederick K.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA	Peacock, WF (corresponding author), Ben Taub Hosp, Dept Emergency Med, Houston, TX 77030 USA.	william.peacock@bcm.edu			ImmunArray, Inc.	This study was funded by ImmunArray, Inc.	Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Friedland D, 2016, J NEUROL NEUROSUR PS, V87, P1068, DOI 10.1136/jnnp-2015-312193; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kaleka KS, 2016, EXP NEUROL, V277, P115, DOI 10.1016/j.expneurol.2015.12.013; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; KUHN M., 2013, APPL PREDICTIVE MODE, V26; Kurtzke JF, 1993, RINSHO SHINKEIGAKU, V4, P1; Lagares A, 2006, NEUROCIRUGIA, V17, P105; Lange RP, 2014, CANCER INVEST, V32, P423, DOI 10.3109/07357907.2014.933237; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Martinho A, 2010, FEBS J, V277, P3427, DOI 10.1111/j.1742-4658.2010.07749.x; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Okita Yuho, 2017, Front Neurosci, V11, P114, DOI 10.3389/fnins.2017.00114; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Peters ME, 2017, BRAIN INJURY, V31, P370, DOI 10.1080/02699052.2016.1231344; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Rozanski M, 2017, CEREBROVASC DIS, V43, P76, DOI 10.1159/000453460; RStudio Team, 2016, RSTUDIO INT DEV R; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sjostedt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130028; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; US EPA, 2000, GUID DAT ASS PRACT M; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yang J, 2015, CLIN BIOCHEM, V48, P843, DOI 10.1016/j.clinbiochem.2015.05.015; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	46	15	15	0	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 30	2017	8								641	10.3389/fneur.2017.00641			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FO1KO	WOS:000416519300003	29250027	DOAJ Gold, Green Published			2021-06-18	
J	Carlozzi, NE; Tulsky, DS; Wolf, TJ; Goodnight, S; Heaton, RK; Casaletto, KB; Wong, AWK; Baum, CM; Gershon, RC; Heinemann, AW				Carlozzi, Noelle E.; Tulsky, David S.; Wolf, Timothy J.; Goodnight, Siera; Heaton, Robert K.; Casaletto, Kaitlin B.; Wong, Alex W. K.; Baum, Carolyn M.; Gershon, Richard C.; Heinemann, Allen W.			Construct Validity of the NIH Toolbox Cognition Battery in Individuals With Stroke	REHABILITATION PSYCHOLOGY			English	Article						NIHTB; NIHTB-CB; cognition; neuropsychological assessment; mental processes; outcomes assessment (health care)	MEASURING EPISODIC MEMORY; TRAUMATIC BRAIN-INJURY; PROCESSING SPEED; WORKING-MEMORY; EXECUTIVE FUNCTION; VISUAL-ACUITY; SORTING TEST; CB; IMPAIRMENT; ADULTS	Objective: The National Institutes of Health (NIH) Toolbox (NIHTB) for the Assessment of Behavior and Neurological Function Cognition Battery (NIHTB-CB) provides a brief assessment (approximately 30 min) of key components of cognition. This article examines construct validity to support the clinical utility of the NIHTB-CB in individuals with stroke. Research Method: A total of 131 individuals with stroke (n = 71 mild stroke; n = 60 moderate/severe stroke) completed the NIHTB-CB. Univariate analyses were conducted to examine the cognitive profiles of the two different stroke groups (mild vs. moderate/severe stroke) on NIHTB-CB measures and composite scores. Pearson correlations were conducted between NIHTB-CB and established measures to examine convergent and discriminant validity. Effect sizes and clinical impairment rates for the different NIHTB-CB measures and composite scores were also examined. Results: Participants experiencing moderate to severe stroke had poorer performance than did individuals with mild stroke on several of the NIHTB cognition measures. Evidence of convergent validity was provided by moderate to strong correlations between the NIHTB measures and the corresponding standard neuropsychological test (Pearson rs ranged from 0.31 to 0.88; median = .60). Evidence of discriminant validity was provided by smaller correlations between different cognitive domains than correlations of measures within the same domain. Effect sizes for composite and subtest scores regarding stroke severity were generally moderate-to-large. In addition, 42% of the sample were exhibiting mild cognitive impairment (i.e., >= 2 low scores on fluid tests). Conclusions: Findings provide support for the construct validity of the NIHTB-CB in individuals with stroke.	[Carlozzi, Noelle E.; Goodnight, Siera] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Wolf, Timothy J.; Wong, Alex W. K.; Baum, Carolyn M.] Washington Univ, Occupat Therapy, St Louis, MO 63130 USA; [Wolf, Timothy J.; Wong, Alex W. K.; Baum, Carolyn M.] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Casaletto, Kaitlin B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Gershon, Richard C.] Northwestern Univ, Dept Med Social Sci, Evanston, IL 60208 USA; [Gershon, Richard C.] Northwestern Univ, Dept Preventat Med, Evanston, IL 60208 USA; [Heinemann, Allen W.] Shirley Ryan AbilityLab, Ctr Rehabil Outcomes Res, Chicago, IL USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Evanston, IL 60208 USA	Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090024]; Federal funds from Blueprint for Neuroscience Research, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHS-N-260-2006-000 07-C]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER	This study is funded in part with the National Institute on Disability, Independent Living, and Rehabilitation Research (H133B090024) and Federal funds from the Blueprint for Neuroscience Research, National Institutes of Health, under Contract HHS-N-260-2006-000 07-C.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Barker-Collo S, 2006, NEUROPSYCHOL REV, V16, P53, DOI 10.1007/s11065-006-9007-5; Bates B, 2005, STROKE, V36, P2049, DOI 10.1161/01.STR.0000180432.73724.AD; Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P34, DOI 10.1111/mono.12033; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Black SE, 2011, J ROY COLL PHYS EDIN, V41, P49, DOI 10.4997/JRCPE.2011.121; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133, DOI 10.1001/archneur.1990.00530020029011; Carlozzi NE, 2017, ARCH CLIN NEUROPSYCH, V32, P555, DOI 10.1093/arclin/acx020; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Carlozzi NE, 2013, MONOGR SOC RES CHILD, V78, P88, DOI 10.1111/mono.12036; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1977, STAT POWER ANAL BEHA, P1; Crowe SF, 2000, ASSESSMENT, V7, P113, DOI 10.1177/107319110000700202; de Bruijn MAAM, 2014, CEREBROVASC DIS, V37, P376, DOI 10.1159/000362592; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Desmond DW, 2004, J NEUROL SCI, V226, P3, DOI 10.1016/j.jns.2004.09.002; Desrosiers J, 2008, NEUROREHAB NEURAL RE, V22, P288, DOI 10.1177/1545968307307116; Dikmen SS, 2014, J INT NEUROPSYCH SOC, V20, P611, DOI 10.1017/S1355617714000460; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Dunn L., 2007, PEABODY PICTURE VOCA, V4th ed.; Edwards Dorothy F, 2006, J Stroke Cerebrovasc Dis, V15, P151, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.001; Enderby P, 1996, DISABIL REHABIL, V18, P238, DOI 10.3109/09638289609166307; Enderby P M, 1987, Int Rehabil Med, V8, P166; Ferris FL, 1996, OPHTHALMOLOGY, V103, P181, DOI 10.1016/S0161-6420(96)30742-2; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; Gontkovsky ST, 2006, INT J NEUROSCI, V116, P1317, DOI 10.1080/00207450500516537; Haut M W, 2000, Appl Neuropsychol, V7, P237, DOI 10.1207/S15324826AN0704_5; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton RK, 2004, REVISED COMPREHENSIV; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Hochstenbach J, 1998, J CLIN EXP NEUROPSYC, V20, P503, DOI 10.1076/jcen.20.4.503.1471; Hochstenbach JB, 2003, ARCH PHYS MED REHAB, V84, P1499, DOI 10.1016/S0003-9993(03)00370-8; Holdnack JA, 2017, ARCH CLIN NEUROPSYCH, V32, P574, DOI 10.1093/arclin/acx032; Kwah LK, 2014, J PHYSIOTHER, V60, P61, DOI 10.1016/j.jphys.2013.12.012; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0000000000000152, 10.1161/CIR.0b013e31828124ad]; National Institutes of Health, 2017, NIH TOOLB ASS NEUR B; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; Salter K., 2008, COGNITIVE DISORDERS; Salter K, 2006, BRAIN INJURY, V20, P559, DOI 10.1080/02699050600744087; Schendel K, 2016, J INT NEUROPSYCH SOC, V22, P695, DOI 10.1017/S1355617716000515; Soros P, 2015, J NEUROL SCI, V354, P17, DOI 10.1016/j.jns.2015.04.022; Sonoda S, 1997, AM J PHYS MED REHAB, V76, P395, DOI 10.1097/00002060-199709000-00010; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Su CY, 2015, ARCH CLIN NEUROPSYCH, V30, P148, DOI 10.1093/arclin/acu057; Tulsky D., 2003, CLIN INTERPRETATION, P43, DOI 10.1016/B978-012703570-3/50006-7; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P409, DOI 10.1037/rep0000201; Tulsky DS, 2014, J INT NEUROPSYCH SOC, V20, P599, DOI 10.1017/S135561771400040X; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; WADE DT, 1985, J NEUROL NEUROSUR PS, V48, P7, DOI 10.1136/jnnp.48.1.7; Wall KJ, 2015, INT J STROKE, V10, P665, DOI 10.1111/ijs.12506; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; White JH, 2009, CAN J OCCUP THER, V76, P81, DOI 10.1177/000841740907600205; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	67	15	15	1	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					443	454		10.1037/rep0000195			12	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	FT1CK	WOS:000422871400005	29265865	Green Accepted, Bronze			2021-06-18	
J	Kelley, ME; Kane, JM; Espeland, MA; Miller, LE; Powers, AK; Stitzel, JD; Urban, JE				Kelley, Mireille E.; Kane, Joeline M.; Espeland, Mark A.; Miller, Logan E.; Powers, Alexander K.; Stitzel, Joel D.; Urban, Jillian E.			Head impact exposure measured in a single youth football team during practice drills	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatrics; football; head impacts; biomechanics; acceleration; concussion; trauma	HIGH-SCHOOL FOOTBALL; CHRONIC TRAUMATIC ENCEPHALOPATHY; LATER-LIFE; PLAYERS; CONCUSSION; COLLEGIATE; SPORT; INJURY; NFL; AGE	OBJECTIVE This study evaluated the frequency, magnitude, and location of head impacts in practice drills within a youth football team to determine how head impact exposure varies among different types of drills. METHODS On-field head impact data were collected from athletes participating in a youth football team for a single season. Each athlete wore a helmet instrumented with a Head Impact Telemetry (HIT) System head acceleration measurement device during all preseason, regular season, and playoff practices. Video was recorded for all practices, and video analysis was performed to verify head impacts and assign each head impact to a specific drill. Eleven drills were identified: dummy/sled tackling, install, special teams, Oklahoma, one-on-one, open-field tackling, passing, position skill work, multiplayer tackle, scrimmage, and tackling drill stations. Generalized linear models were fitted to log-transformed data, and Wald tests were used to assess differences in head accelerations and impact rates. RESULTS A total of 2125 impacts were measured during 30 contact practices in 9 athletes (mean age 11.1 +/- 0.6 years, mean mass 44.9 +/- 4.1 kg). Open-field tackling had the highest median and 95th percentile linear accelerations (24.7g and 97.8g, respectively) and resulted in significantly higher mean head accelerations than several other drills. The multiplayer tackle drill resulted in the highest head impact frequency, with an average of 0.59 impacts per minute per athlete, but the lowest 95th percentile linear accelerations of all drills. The front of the head was the most common impact location for all drills except dummy/sled tackling. CONCLUSIONS Head impact exposure varies significantly in youth football practice drills, with several drills exposing athletes to high-magnitude and/or high-frequency head impacts. These data suggest that further study of practice drills is an important step in developing evidence-based recommendations for modifying or eliminating certain high-intensity drills to reduce head impact exposure and injury risk for all levels of play.	[Kelley, Mireille E.; Miller, Logan E.; Stitzel, Joel D.; Urban, Jillian E.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Winston Salem, NC USA; [Kelley, Mireille E.; Kane, Joeline M.; Miller, Logan E.; Stitzel, Joel D.; Urban, Jillian E.] Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Ste 120, Winston Salem, NC 27106 USA; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC USA	Urban, JE (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Ste 120, Winston Salem, NC 27106 USA.	jurban@wakehealth.edu	Stitzel, Joel/B-4045-2012	Stitzel, Joel/0000-0001-9762-3033; Hernandez, Joeline/0000-0002-3347-2616	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421]; Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award No. R01NS094410. Dr. Jillian Urban was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant No. KL2TR001421. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Special thanks to the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center for providing support for this study. We thank the youth football league's coordinators, coaches, parents, athletes, and athletic trainer, whose support made this study possible. We also thank Megan Anderson and Leslie Hoyt for their valuable assistance in data collection.	Aspen Institute, 2014, ESPNW ASPEN I PROJ P; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Concussion in Sport Group, 2013, BRIT J SPORT MED, V47, P259; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Liao S, 2016, MED SCI SPORT EXER, V48, P1239, DOI 10.1249/MSS.0000000000000896; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pop Warner News Office, 2012, RUL CHANG REG PRACT; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson Steven, 2009, Biomed Sci Instrum, V45, P113; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Sporting Goods Manufacturers Association, 2015, 2012 SPORTS FITN LEI; Sports and Fitness Industry Association, 2013, 2013 SPORTS FITN LEI; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	40	15	15	0	12	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2017	20	5					489	497		10.3171/2017.5.PEDS16627			9	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	FL5JA	WOS:000414270000015	28937917	Green Accepted, Bronze			2021-06-18	
J	Rau, CS; Wu, SC; Chien, PC; Kuo, PJ; Chen, YC; Hsieh, HY; Hsieh, CH				Rau, Cheng-Shyuan; Wu, Shao-Chun; Chien, Peng-Chen; Kuo, Pao-Jen; Chen, Yi-Chun; Hsieh, Hsiao-Yun; Hsieh, Ching-Hua			Prediction of Mortality in Patients with Isolated Traumatic Subarachnoid Hemorrhage Using a Decision Tree Classifier: A Retrospective Analysis Based on a Trauma Registry System	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; subarachnoid hemorrhage; traumatic subarachnoid hemorrhage; mortality; decision tree	BRAIN-INJURY; EXTERNAL VALIDATION; PROGNOSTIC MODELS; HEAD-INJURY; CLINICAL-SIGNIFICANCE; HYPERNATREMIA; IMPACT; RISK; SEVERITY; LEVEL	Background: In contrast to patients with traumatic subarachnoid hemorrhage (tSAH) in the presence of other types of intracranial hemorrhage, the prognosis of patients with isolated tSAH is good. The incidence of mortality in these patients ranges from 0-2.5%. However, few data or predictive models are available for the identification of patients with a high mortality risk. In this study, we aimed to construct a model for mortality prediction using a decision tree (DT) algorithm, along with data obtained from a population-based trauma registry, in a Level 1 trauma center. Methods: Five hundred and forty-five patients with isolated tSAH, including 533 patients who survived and 12 who died, between January 2009 and December 2016, were allocated to training (n = 377) or test (n = 168) sets. Using the data on demographics and injury characteristics, as well as laboratory data of the patients, classification and regression tree (CART) analysis was performed based on the Gini impurity index, using the rpart function in the rpart package in R. Results: In this established DT model, three nodes (head Abbreviated Injury Scale (AIS) score <= 4, creatinine (Cr) <1.4 mg/dL, and age <76 years) were identified as important determinative variables in the prediction of mortality. Of the patients with isolated tSAH, 60% of those with a head AIS >4 died, as did the 57% of those with an AIS score <= 4, but Cr >= 1.4 and age >= 76 years. All patients who did not meet the above-mentioned criteria survived. With all the variables in the model, the DT achieved an accuracy of 97.9% (sensitivity of 90.9% and specificity of 98.1%) and 97.7% (sensitivity of 100% and specificity of 97.7%), for the training set and test set, respectively. Conclusions: The study established a DT model with three nodes (head AIS score <= 4, Cr <1.4, and age <76 years) to predict fatal outcomes in patients with isolated tSAH. The proposed decision-making algorithm may help identify patients with a high risk of mortality.	[Rau, Cheng-Shyuan] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Wu, Shao-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung 83301, Taiwan; [Chien, Peng-Chen; Kuo, Pao-Jen; Chen, Yi-Chun; Hsieh, Hsiao-Yun; Hsieh, Ching-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan	Hsieh, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan.	ersh2127@cloud.cgmh.org.tw; shaochunwu@gmail.com; venu_chien@hotmail.com; bow110470@gmail.com; libe320@yahoo.com.tw; sylvia19870714@hotmail.com; m93chinghua@gmail.com		WU, Shaochun/0000-0002-0984-6921; Hsieh, Ching-Hua/0000-0002-0945-2746	 [CMRPG8F0801]	This research was supported by a grant from CMRPG8F0801. We appreciate the help extended by the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital, with the statistical analysis.	Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL 1998 R; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Carter EL, 2016, BRIT J NEUROSURG, V30, P227, DOI 10.3109/02688697.2016.1139048; Chang LY, 2006, ACCIDENT ANAL PREV, V38, P1019, DOI 10.1016/j.aap.2006.04.009; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Farion K, 2010, J MED SYST, V34, P551, DOI 10.1007/s10916-009-9268-7; Fisher LA, 2006, NEUROCRIT CARE, V5, P180, DOI 10.1385/NCC:5:3:180; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Guilbault RWR, 2017, J INTENSIVE CARE MED, V32, P333, DOI 10.1177/0885066616686924; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hayashi T, 2016, WORLD NEUROSURG, V86, DOI 10.1016/j.wneu.2015.09.108; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Hsieh CH, 2017, BIOMED J, V40, P113, DOI 10.1016/j.bj.2016.10.005; Hsieh CH, 2017, BIOMED J, V40, P121, DOI 10.1016/j.bj.2016.10.006; Kasbekar PU, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00025; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lee JJ, 2014, J NEUROTRAUM, V31, P595, DOI 10.1089/neu.2013.3152; Lin TK, 2012, J TRAUMA ACUTE CARE, V73, P131, DOI 10.1097/TA.0b013e31824aff74; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; Parchani A, 2014, WORLD NEUROSURG, V82, pE639, DOI 10.1016/j.wneu.2014.06.022; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Qureshi AI, 2002, NEUROSURGERY, V50, P749, DOI 10.1097/00006123-200204000-00012; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Shi KQ, 2017, J VIRAL HEPATITIS, V24, P132, DOI 10.1111/jvh.12617; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Stitzel Joel D, 2008, Ann Adv Automot Med, V52, P235; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; TAKEUCHI J, 1960, JAP HEART J, V1, P288, DOI DOI 10.1536/IHJ.1.288; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Wu C, 2012, J TRAUMA ACUTE CARE, V73, P1247, DOI 10.1097/TA.0b013e318265d24e; Zimmerman RK, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1839-x; Zintzaras E, 2007, COMPUT BIOL MED, V37, P637, DOI 10.1016/j.compbiomed.2006.06.001	43	15	15	0	3	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2017	14	11							1420	10.3390/ijerph14111420			10	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	FO1SQ	WOS:000416545200136	29165330	DOAJ Gold, Green Published			2021-06-18	
J	Rau, CS; Wu, SC; Chen, YC; Chien, PC; Hsieh, HY; Kuo, PJ; Hsieh, CH				Rau, Cheng-Shyuan; Wu, Shao-Chun; Chen, Yi-Chun; Chien, Peng-Chen; Hsieh, Hsiao-Yun; Kuo, Pao-Jen; Hsieh, Ching-Hua			Stress-Induced Hyperglycemia, but Not Diabetic Hyperglycemia, Is Associated with Higher Mortality in Patients with Isolated Moderate and Severe Traumatic Brain Injury: Analysis of a Propensity Score-Matched Population	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury (TBI); stress-induced hyperglycemia (SIH); diabetic hyperglycemia (DH); diabetes mellitus (DM); mortality	SURGICAL-SITE INFECTION; ADMISSION HYPERGLYCEMIA; INSULIN-RESISTANCE; GLYCEMIC CONTROL; GLUCOSE	Background: Admission hyperglycemia is associated with higher morbidity and mortality in patients with traumatic brain injury (TBI). Stress-induced hyperglycemia (SIH), a form of hyperglycemia induced by the stress response, is associated with increased patient mortality following TBI. However, admission hyperglycemia occurs not only in SIH but also in patients with diabetic hyperglycemia (DH). Current information regarding whether trauma patients with SIH represent a distinct group with differential outcomes compared to those with DH remains limited. Methods: Serum glucose concentration 200 mg/dL upon arrival at the emergency department was defined as hyperglycemia. Presence of diabetes mellitus (DM) was determined by patient history and/or admission glycated hemoglobin (HbA1c) level 6.5%. In the present study, the patient cohort included those with moderate and severe TBI, as defined by an Abbreviated Injury Scale (AIS) score 3 points in the head, and excluded those who had additional AIS scores 3 points in any other region of the body. A total of 1798 adult patients with isolated moderate to severe TBI were allocated into four groups: SIH (n = 140), DH (n = 187), diabetic normoglycemia (DN, n = 186), and non-diabetic normoglycemia (NDN, n = 1285). Detailed patient information was retrieved from the Trauma Registry System at a level I trauma center between 1 January 2009, and 31 December 2015. Unpaired Student's t- and Mann-Whitney U-tests were used to analyze normally and non-normally distributed continuous data, respectively. Categorical data were compared using the Pearson chi-square or two-sided Fisher's exact tests. Matched patient populations were allocated in a 1:1 ratio according to propensity scores calculated by NCSS software. Logistic regression was used to evaluate the effect of SIH and DH on the adjusted mortality outcome. Results: In patients with isolated moderate to severe TBI, the presence of SIH and DH led to 9.1-fold and 2.3-fold higher odds of mortality, respectively, than patients with NDN. After adjusting for confounding factors, including sex and age, pre-existing co-morbidities, existence of different kinds of intracerebral hemorrhage, and injury severity, patients with SIH still had 6.6-fold higher odds of mortality than those with NDN; however, DH did not present significantly higher adjusted mortality odds. SIH and DH presented different effects on outcomes after TBI. The results also suggested that the pathophysiological effect associated with SIH was different from that of DH. Conclusions: This study demonstrated that patients with SIH and DH had significantly higher mortality than patients with NDN. However, the adjusted mortality was significantly higher only in the selected propensity score-matched patients with SIH and not in those with DH.	[Rau, Cheng-Shyuan] Chang Gung Univ, Coll Med, Dept Neurosurg, Kaohsiung Chang Gung Mem Hosp, Kaohsiung 833, Taiwan; [Wu, Shao-Chun] Chang Gung Univ, Coll Med, Dept Anesthesiol, Kaohsiung Chang Gung Mem Hosp, Kaohsiung 833, Taiwan; [Chen, Yi-Chun; Chien, Peng-Chen; Hsieh, Hsiao-Yun; Kuo, Pao-Jen; Hsieh, Ching-Hua] Chang Gung Univ, Coll Med, Dept Plast Surg, Kaohsiung Chang Gung Mem Hosp, Kaohsiung 833, Taiwan	Hsieh, CH (corresponding author), Chang Gung Univ, Coll Med, Dept Plast Surg, Kaohsiung Chang Gung Mem Hosp, Kaohsiung 833, Taiwan.	ersh2127@cloud.cgmh.org.tw; shaochunwu@gmail.com; libe320@yahoo.com.tw; VENU_CHIEN@hotmail.com; sylvia19870714@hotmail.com; bow110470@gmail.com; m93chinghua@gmail.com		WU, Shaochun/0000-0002-0984-6921; Hsieh, Ching-Hua/0000-0002-0945-2746	 [CMRPG8F0261]	We appreciated the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital for statistics work. This research was supported by a grant from CMRPG8F0261 for Ching-Hua Hsieh.	Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc09-S062, 10.2337/dc12-s064, 10.2337/dc12-S064, 10.2337/dc11-S062]; Bonizzoli M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-69; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Bosarge Patrick L, 2013, Adv Surg, V47, P287; Butcavage K, 2012, J NEUROSCI NURS, V44, pE1, DOI 10.1097/JNN.0b013e3182527656; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Gauglitz GG, 2008, J BURN CARE RES, V29, P683, DOI 10.1097/BCR.0b013e31818481ce; Hill J, 2010, J NEUROTRAUM, V27, P1439, DOI 10.1089/neu.2010.1328; Hsieh CH, 2017, BIOMED J, V40, P113, DOI 10.1016/j.bj.2016.10.005; Hsieh CH, 2017, BIOMED J, V40, P121, DOI 10.1016/j.bj.2016.10.006; Kerby JD, 2012, ANN SURG, V256, P446, DOI 10.1097/SLA.0b013e3182654549; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC11, DOI 10.7860/JCDR/2016/17208.7686; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Leto R, 2015, EUR J EMERG MED, V22, P99, DOI 10.1097/MEJ.0000000000000119; Marik PE, 2013, CRIT CARE MED, V41, pE93, DOI 10.1097/CCM.0b013e318283d124; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mraovic Boris, 2011, J Diabetes Sci Technol, V5, P412; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Patrone C, 2014, LANCET DIABETES ENDO, V2, P256, DOI 10.1016/S2213-8587(13)70125-6; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101161; Ray B, 2017, WORLD NEUROSURG, V100, P208, DOI 10.1016/j.wneu.2017.01.008; Richards JE, 2013, J ORTHOP TRAUMA, V27, P16, DOI 10.1097/BOT.0b013e31825d60e5; Richards JE, 2012, J BONE JOINT SURG AM, V94A, P1181, DOI 10.2106/JBJS.K.00193; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Salim A, 2009, AM SURGEON, V75, P25; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Scalea TM, 2007, ANN SURG, V246, P605, DOI 10.1097/SLA.0b013e318155a789; Smit JWA, 2006, SEMIN CARDIOTHORAC V, V10, P215, DOI 10.1177/1089253206291153; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Yang CJ, 2017, AM J EMERG MED, V35, P1240, DOI 10.1016/j.ajem.2017.03.049; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	37	15	17	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2017	14	11							1340	10.3390/ijerph14111340			10	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	FO1SQ	WOS:000416545200056	29099813	DOAJ Gold, Green Published			2021-06-18	
J	Abosadegh, MM; Rahman, SA; Saddki, N				Abosadegh, Maher M.; Rahman, Shaifulizan Abdul; Saddki, Norkhafizah			Association of traumatic head injuries and maxillofacial fractures: A retrospective study	DENTAL TRAUMATOLOGY			English	Article						facial fracture; maxillofacial fractures; risk factor; traumatic head injuries	FACIAL FRACTURES; COMPUTED-TOMOGRAPHY; BRAIN-INJURIES; IMPACT	Background/AimsThe association of traumatic head injury (THI) with maxillofacial fractures (MFF) is a major health concern worldwide. In spite of the close anatomical proximity of maxillofacial bones to the cranium, the association of THI with MFF is controversial. The aim of this study was to assess the association between THI and MFF. Other factors associated with THI in patients with MFF were also investigated. Materials and MethodsA hospital-based retrospective study was conducted at the OMFS Unit, Hospital USM, Kelantan, Malaysia. From 12 June 2013 to 31 December 2015, 473 patient records with MFF were reviewed to evaluate the association of THI and MFF. ResultsA total of 331 patients (69.98%) presented with concomitant THI. The most common associated THI were cranial bone fractures (68.6%) followed by intracranial injuries and concussion. A significant association existed between the Glasgow coma scale (GCS) score and the presence of THI concomitant MFF with P-value <.001. The univariable logistic regression analysis revealed that age group (31-40years), cause of injury (road traffic accidentRTA), all midface fracture types and most of the mandibular fracture types were statistically associated with the presence of THI. The multivariable logistic regression analysis revealed that the cause of the injury (RTA) and MFF types (nasal bone, zygomatic complex, zygomatic arch, orbital wall, maxillary sinus wall and the alveolar process of mandible fractures) were statistically significantly associated with THI in patients with MFF. ConclusionThere was a high prevalence of THI among patients with MFF (69.98%). RTA, nasal bone, zygomatic complex, zygomatic arch, orbital wall, maxillary sinus wall and mandibular alveolar process fractures were significantly associated with THI in patients who sustained a MFF.	[Abosadegh, Maher M.; Rahman, Shaifulizan Abdul] Univ Sains Malaysia, Sch Dent Sci, Maxillofacial Surg Unit, Kubang Kerian 16150, Kelantan, Malaysia; [Saddki, Norkhafizah] Univ Sains Malaysia, Sch Dent Sci, Dent Publ Hlth Unit, Kubang Kerian 16150, Kelantan, Malaysia	Abosadegh, MM (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Maxillofacial Surg, Kubang Kerian 16150, Kelantan, Malaysia.	maherdental@hotmail.com		Abosadegh, maher/0000-0002-8072-1099			Akheel M, 2014, SCI J PUBLIC HLTH, V2, P29; Alves La-Salete, 2014, Braz. Dent. J., V25, P561, DOI 10.1590/0103-6440201302395; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Arslan ED, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-13; CHANG CJ, 1994, J TRAUMA, V37, P807, DOI 10.1097/00005373-199411000-00017; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Goil P, 2016, INDIAN J APPL RES, V6, P528; Grant AL, 2012, J CRANIOFAC SURG, V23, P1324, DOI 10.1097/SCS.0b013e31825e60ae; HAYTER JP, 1991, BRIT J ORAL MAX SURG, V29, P370, DOI 10.1016/0266-4356(91)90003-N; Hohlrieder M, 2004, INT J ORAL MAX SURG, V33, P389, DOI 10.1016/j.ijom.2003.10.011; Holmgren EP, 2004, J ORAL MAXIL SURG, V62, P913, DOI 10.1016/j.joms.2003.12.026; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Isik D, 2012, ULUS TRAVMA ACIL CER, V18, P200, DOI 10.5505/tjtes.2012.01047; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Khalighi Sigaroudi S. A., 2012, J DENT SHIRAZ, V13, P18; Kloss F, 2008, J CRANIO MAXILL SURG, V36, P372, DOI 10.1016/j.jcms.2007.12.002; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; Marincek B, 2007, AM SOC NEURORADIOLOG, V29, P313; Martin RCG, 2002, AM SURGEON, V68, P477; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Ramli R, 2011, DENT TRAUMATOL, V27, P122, DOI 10.1111/j.1600-9657.2010.00968.x; Salentijn EG, 2014, J CRANIO MAXILL SURG, V42, P705, DOI 10.1016/j.jcms.2013.12.008; SCHELLHAS KP, 1988, ARCH OTOLARYNGOL, V114, P438; Smith Hayden, 2012, J Trauma Nurs, V19, P57, DOI 10.1097/JTN.0b013e31823a4c0e; Tung TC, 2000, J TRAUMA, V49, P420, DOI 10.1097/00005373-200009000-00006; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z; Zhou HH, 2015, DENT TRAUMATOL, V31, P209, DOI 10.1111/edt.12165	29	15	16	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2017	33	5					369	374		10.1111/edt.12349			6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	FH3FX	WOS:000411031700007	28504848				2021-06-18	
J	Cabraser, EJ; Issacharoff, S				Cabraser, Elizabeth J.; Issacharoff, Samuel			THE PARTICIPATORY CLASS ACTION	NEW YORK UNIVERSITY LAW REVIEW			English	Article							PRECLUSION; LITIGATION; OPT	The class action has emerged as the settlement instrument of choice in mass harm cases such as the Volkswagen emissions scandal or the Deepwater Horizon after-math. But the class action has also reemerged in the mass tort context, most notably in the NFL Concussion litigation. After seemingly collapsing following the Amchem and Ortiz Supreme Court decisions of the 1990s, the class action device is getting an important second life in courts today.& para;& para;This Article argues that the new class action has a feature that should increase its doctrinal acceptability: forms of active class member participation. What we term the "participatory class action" emerges from two developments. The first is the technological transformation in the means of communication with class members, and among the class members themselves. The second is that the current class action almost invariably arises from the initial aggregation and centralization of large numbers of individual suits and putative class actions in the Multidistrict Litigation (MDL) process. As a result, classes are comprised not simply of lawyers and absent class members, but of hundreds or even thousands of individual claims, with individuals capable of monitoring the class and represented by independent counsel.& para;& para;With over forty percent of the actively litigated civil cases in federal courts now in the MDL dockets, the transformation in mass resolution is well underway. In these new consolidations, the assumptions of older law about absent class member passivity break down. In the popular typology in academic examination of class actions, class action law should insist on the loyalty of agents and the importance of individual ability to exit as guarantors of systemic legitimacy. In the participatory class action, voice emerges as a critical element, with the capacity of the normally silent class members to assert their interests and their views. As with the need for class action law to move from first-class mail to Twitter, so too must the law embrace the implications of real participation by those represented in the assessment of representational propriety.	[Cabraser, Elizabeth J.] Lieff Cabraser Heiman & Bernstein, San Francisco, CA 94111 USA; [Issacharoff, Samuel] NYU, Sch Law, Constitut Law, New York, NY 10003 USA	Cabraser, EJ (corresponding author), Lieff Cabraser Heiman & Bernstein, San Francisco, CA 94111 USA.						ADVISORY COMM, 2016, REP ADV COMM CIV RUL, P2; Alexandra Bursak Note, 2016, NEW YORK U LAW REV, V91, P1670; [Anonymous], 2017, AN FEBR 8 STAT C; [Anonymous], 2017, E COMMUNICATION; [Anonymous], 2016, COST ISS CHECKS; Baker Lynn A., 1998, VA LAW REV, V84, P1496; Barnard Thomas H., 2014, HOFSTRA LAB EMP L J, V31, P387; BARRETT WP, 1993, FORBES          1011, P52; BERLE ADOLF, 1932, MODERN CORPORATION P, P119; BrownGreer PLC, 2017, NFL CONC SETTL UNPUB; Brummer C, 2004, COLUMBIA LAW REV, V104, P1042, DOI 10.2307/4099367; Brush Pete, 2015, LAW360; Burch EC, 2015, NEW YORK U LAW REV, V90, P71; Burch Elizabeth Chamblee, 2015, NEW YORK U LAW REV, V90, P73; Bursak A, 2016, NEW YORK U LAW REV, V91, P1651; Cabraser EJ, 2005, STANFORD LAW REV, V57, P1475; Cabraser Elizabeth J., 2005, STANFORD LAW REV, V57, P1476; Cabraser Elizabeth J., 2014, G WASH L REV ARGUEND, V82, P85; Cabraser Elizabeth J., 2014, G WASH L REV ARGUEND, V82, P88; Cabraser Elizabeth J., 2015, AKRON L REV, V48, P800; Cabraser Elizabeth J., 2015, AKRON L REV, V48, P757; Chris Brummer Note, 2004, COLUMBIA LAW REV, V104, P1060; COFFEE JC, 1995, COLUMBIA LAW REV, V95, P1343, DOI 10.2307/1123132; COFFEE JC, 1986, COLUMBIA LAW REV, V86, P669, DOI 10.2307/1122577; Coffee JC, 2000, COLUMBIA LAW REV, V100, P370, DOI 10.2307/1123472; Coffee Jr John C., 1986, COLUMBIA LAW REV, V86, P671; Collignon Cassie, 2012, CLASS ACTIONS 101 NE; DUKE LAW CTR, 2014, STAND BEST PRACT LAR, px; Eisenberg T, 2004, VANDERBILT LAW REV, V57, P1529; Erichson HM, 2014, GEORGE WASH LAW REV, V82, P951; Erichson HM, 2011, CORNELL LAW REV, V96, P265; Gershman Jacob, 2017, WALL ST J L BLOG; GRIMES EA, 1980, STANFORD LAW REV, V32, P743, DOI 10.2307/1228461; Grimes Elizabeth A., 1980, STANFORD LAW REV, V32, P747; Hao William, 2016, NORTON ANN SURV BANK, V524, P605; Hao William, 2016, NORTON ANN SURV BANK, V606; Hirschman A. O., 1970, EXIT VOICE LOYALTY R; Issacharoff S, 2002, NOTRE DAME LAW REV, V77, P1057; Issacharoff S, 2006, UCLA LAW REV, V53, P1353; Issacharoff S, 2013, FORDHAM LAW REV, V81, P3165; Issacharoff S, 2009, FORDHAM LAW REV, V78, P1177; Issacharoff Samuel, 2006, UCLA LAW REV, V53, P1415; Issacharoff Samuel, 1999, SUP CT REV, P337, DOI DOI 10.1016/J.JFINECO.2008.08.006; Issacharoff Samuel, 2014, LA LAW REV, V74, P397; Issacharoff Samuel, 1999, SUP CT REV, V1999, P341; Issacharoff Samuel, 2014, LA LAW REV, V74, P413; Judicial Business, 2015, JUD BUS 2015 JUD PAN; Klonoff Robert H., 2016, EMORY LJ, V65, P1589; Koniak Susan P., 2001, HOFSTRA L REV, V30, P129; Koniak Susan P., 2001, HOFSTRA L REV, V30, P132; LLP SEYFARTH SHAW, 2016, 12 ANN WORKPLACE CLA, P14; McKenzie TA, 2012, NEW YORK U LAW REV, V87, P960; McKenzie Troy A., 2012, NEW YORK U LAW REV, V87, P963; MILLER AR, 1979, HARVARD LAW REV, V92, P664, DOI 10.2307/1340397; Miller Arthur R., 1979, HARVARD LAW REV, V92, P665; Nagareda RA, 2002, HARVARD LAW REV, V115, P747, DOI 10.2307/1342662; NAGAREDA RICHARD A., 2007, MASS TORTS WORLD SET, V237-41, P250; Nagareda Richard A., 2002, HARVARD LAW REV, V115, P786; Randazzo Sara, 2016, WALL ST J, pB3; Ratner Morris A., WASH L REV, V92, P785; Ratner Morris A., WASH L REV, V92, P845; Robert H, 2016, EMORY LJ, V65, P1569; Rubenstein William B., 2011, NEWBERG CLASS ACTION, V1; Savage ZB, 2013, NEW YORK U LAW REV, V88, P439; Savage Zachary B., 2013, NEW YORK U LAW REV, V88, P465; Shapiro DL, 1998, NOTRE DAME LAW REV, V73, P913; Silver C, 1998, VA LAW REV, V84, P1465, DOI 10.2307/1073789; Wajert Sean, 2010, MASS TORT DEF B 0604; WEISS EJ, 1995, YALE LAW J, V104, P2053, DOI 10.2307/796992; WRIGHT CHARLES ALAN, 2017, FEDERAL PRACTICE PRO, P1710	70	15	15	0	2	NEW YORK UNIV SCHOOL LAW	NEW YORK	110 WEST THIRD ST, NEW YORK, NY 10012 USA	0028-7881			NEW YORK U LAW REV	N. Y. Univ. Law Rev.	OCT	2017	92	4					846	877					32	Law	Government & Law	FM4WV	WOS:000415030400002					2021-06-18	
J	Resch, JE; Rach, A; Walton, S; Broshek, DK				Resch, Jacob E.; Rach, Amanda; Walton, Samuel; Broshek, Donna K.			Sport Concussion and the Female Athlete	CLINICS IN SPORTS MEDICINE			English	Article						Neurocognitive; Hormone; Concussion; Sex differences	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; KING-DEVICK TEST; COMPUTERIZED NEUROPSYCHOLOGICAL ASSESSMENT; NEUROCOGNITIVE ASSESSMENT TOOLS; 4TH INTERNATIONAL-CONFERENCE; ERROR SCORING SYSTEM; STATES HIGH-SCHOOL; BASE-LINE; SEX-DIFFERENCES	Sport concussion (SC) has emerged as a major health concern in the medical community and general public owing to increased research and media attention, which has primarily focused on male athletes. Female athletes have an equal, if not increased, susceptibility to SC. An ever-growing body of research continues to compare male and female athletes in terms of SC before and after an injury. Clinicians must be cognizant of this literature to make evidence-based clinical decisions when providing care to female athletes and discern between dated and/or unsupported claims in terms of SC.	[Resch, Jacob E.; Walton, Samuel] Univ Virginia, Dept Kinesiol, 210 Emmet St South, Charlottesville, VA 22904 USA; [Rach, Amanda; Broshek, Donna K.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA	Resch, JE (corresponding author), Univ Virginia, Dept Kinesiol, 210 Emmet St South, Charlottesville, VA 22904 USA.	jer6x@virginia.edu		Walton, Samuel/0000-0003-2647-5701			Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; [Anonymous], 2016, INT CONS C CONC SPOR; Arnett P, 2016, SPORTS MED ARTHROSC, V24, P116, DOI 10.1097/JSA.0000000000000123; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown CN, 2007, J ATHL TRAINING, V42, P515; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Cegalis JA, 1991, SOFTWARE TESTING CON; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; De Marco AP, 2016, J CHILD NEUROL, V31, P68, DOI 10.1177/0883073814559645; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Fedor A, 2016, APPL NEUROPSYCH-CHIL, V5, P107, DOI 10.1080/21622965.2014.999770; Ferrara MS, 2001, J ATHL TRAINING, V36, P145; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heinmiller L, 2016, CURR OPIN OPHTHALMOL, V27, P407, DOI 10.1097/ICU.0000000000000296; Horan Lindsay A, 2015, Am Orthopt J, V65, P99, DOI 10.3368/aoj.65.1.99; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King H, 2015, J PHYS ACT HEALTH, V12, P1162, DOI 10.1123/jpah.2014-0356; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Litwack G., 1997, HORMONES; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mihalik JP, 2009, J SCI MED SPORT, V12, P383, DOI 10.1016/j.jsams.2008.05.003; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MOLLERNIELSEN J, 1989, MED SCI SPORT EXER, V21, P126; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Reeser JC, 2015, SPORTS HEALTH, V7, P504, DOI 10.1177/1941738115600143; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Resch JE, 2015, J CHILD NEUROL, V30, P1686, DOI 10.1177/0883073815574335; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, P000012, DOI [10.1136/bmjsem-2015-000012, DOI 10.1136/BMJSEM-2015-000012]; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Smith A., 1982, SYMBOL DIGIT MODALIT; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Spreen O, 2006, COMPENDIUM NEUROPSYC; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Trenerry M.R., 1989, STROOP NEUROPSYCHOLO; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Viano D. C., 1999, J CRASH PREVENTION I, V1, P35; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walsh DV, 2016, J NEUROL SCI, V370, P305, DOI 10.1016/j.jns.2016.09.014; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wechlser D., 1997, WECHSLER ADULT INTEL; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	159	15	15	0	36	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	OCT	2017	36	4					717	739		10.1016/j.csm.2017.05.002			23	Sport Sciences	Sport Sciences	FI7CU	WOS:000412154500010	28886824				2021-06-18	
J	Scheenen, ME; Visser-Keizer, AC; de Koning, ME; van der Horn, HJ; van de Sande, P; van Kessel, M; van der Naalt, J; Spikman, JM				Scheenen, Myrthe E.; Visser-Keizer, Annemarie C.; de Koning, Myrthe E.; van der Horn, Harm J.; van de Sande, Peter; van Kessel, Marlies; van der Naalt, Joukje; Spikman, Jacoba M.			Cognitive Behavioral Intervention Compared to Telephone Counseling Early after Mild Traumatic Brain Injury: A Randomized Trial	JOURNAL OF NEUROTRAUMA			English	Article						cognitive behavioral therapy; intervention; mild traumatic brain injury; telephone counseling	HEAD-INJURY; POSTCONCUSSION SYNDROME; DEPRESSION SCALE; HOSPITAL ANXIETY; FOLLOW-UP; COMPLAINTS; SYMPTOMS; RISK; PREVENTION; STRESS	Many patients do not return to work (RTW) after mild traumatic brain injury (mTBI) because of persistent complaints that are often resistant to therapy in the chronic phase. Recent studies suggest that psychological interventions should be implemented early post-injury to prevent patients from developing chronic complaints. This study is a randomized, controlled trial that examines the effectiveness of a newly developed cognitive behavioral therapy (CBT) intervention (CBTi) compared to telephonic counseling (TC) in at-risk mTBI patients (patients with high reports of early complaints). Patients underwent either five sessions of CBT treatment or five phone conversations starting 4-6 weeks post-trauma. The main outcome measure was RTW 6 and 12 months post-trauma. Secondary measures comprised functional outcome at 6 and 12 months, and depression, anxiety, and reported post-traumatic complaints at 3, 6, and 12 months post-injury. After excluding dropouts, CBTi consisted of 39 patients and TC of 45 patients. No significant differences were found with regard to RTW, with 65% of CBTi patients and 67% of TC patients reporting a RTW at previous level. However, TC patients reported fewer complaints at 3 (8 vs. 6; p = 0.010) and 12 months post-injury (9 vs. 5; p = 0.006), and more patients in the TC group showed a full recovery 12 months post-injury compared to the CBTi group (62% vs. 39%). The results of this study suggest that early follow-up of at-risk patients can have a positive influence on patients' well-being, and that a low-intensive, low-cost telephonic intervention might be more effective than a CBT intervention at improving outcome in at-risk patients.	[Scheenen, Myrthe E.; Visser-Keizer, Annemarie C.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [van de Sande, Peter] Elisabeth Tweesteden Hosp, Dept Med Psychol, Tilburg, Netherlands; [van Kessel, Marlies] Med Spectrum Twente Enschede, Dept Med Psychol, Enschede, Netherlands	Spikman, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.m.spikman@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dawson DR, 2006, BRAIN COGNITION, V60, P214; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Elfering A, 2006, EUR SPINE J, V15, pS32, DOI 10.1007/s00586-005-1047-7; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; IBM. Corp, 2013, IBM SPSS STAT WINDOW; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Rozental A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157503; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Scheenen M. E., 2017, CLIN REHABIL; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Snell D.L., 2011, BRAIN INJURY, V25; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Zedlitz AMEE, 2012, STROKE, V43, P1046, DOI 10.1161/STROKEAHA.111.632117; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	15	15	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2713	2720		10.1089/neu.2016.4885			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700006	28335664				2021-06-18	
J	Schindler, AG; Meabon, JS; Pagulayan, KF; Hendrickson, RC; Meeker, KD; Cline, M; Li, G; Sikkema, C; Wilkinson, CW; Perl, DP; Raskind, MR; Peskind, ER; Clark, JJ; Cook, DG				Schindler, A. G.; Meabon, J. S.; Pagulayan, K. F.; Hendrickson, R. C.; Meeker, K. D.; Cline, M.; Li, G.; Sikkema, C.; Wilkinson, C. W.; Perl, D. P.; Raskind, M. R.; Peskind, E. R.; Clark, J. J.; Cook, D. G.			Blast-related disinhibition and risk seeking in mice and combat Veterans: Potential role for dysfunctional phasic dopamine release	NEUROBIOLOGY OF DISEASE			English	Article						Traumatic brain injury; Novelty; Dopamine; Blast; Veteran; Disinhibition	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE DISORDERS; PERSONALITY-TRAITS; NUCLEUS-ACCUMBENS; INDUCED NEUROTRAUMA; DECISION-MAKING; TEGMENTAL AREA; DRUG-ADDICTION; WAR VETERANS	Mild traumatic brain injury (mTBI) caused by exposure to high explosives has been called the "signature injury" of the wars in Iraq and Afghanistan. There is a wide array of chronic neurological and behavioral symptoms associated with blast-induced mTBI. However, the underlying mechanisms are not well understood. Here we used a battlefield-relevant mouse model of blast-induced mTBI and in vivo fast-scan cyclic voltammetry (FSCV) to investigate whether the mesolimbic dopamine system contributes to the mechanisms underlying blast-induced behavioral dysfunction. In mice, blast exposure increased novelty seeking, a behavior closely associated with disinhibition and risk for subsequent maladaptive behaviors. In keeping with this, we found that veterans with blast-related mTBI reported greater disinhibition and risk taking on the Frontal Systems Behavior Scale (FrSBe). In addition, in mice we report that blast exposure causes potentiation of evoked phasic dopamine release in the nucleus accumbens. Taken together these findings suggest that blast-induced changes in the dopaminergic system may mediate aspects of the complex array of behavioral dysfunctions reported in blast-exposed veterans. Published by Elsevier Inc.	[Schindler, A. G.; Meabon, J. S.; Pagulayan, K. F.; Hendrickson, R. C.; Li, G.; Wilkinson, C. W.; Raskind, M. R.; Peskind, E. R.; Clark, J. J.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Meabon, J. S.; Pagulayan, K. F.; Hendrickson, R. C.; Li, G.; Wilkinson, C. W.; Raskind, M. R.; Peskind, E. R.] VA Puget Sound Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Schindler, A. G.; Meeker, K. D.; Cline, M.; Li, G.; Sikkema, C.; Wilkinson, C. W.; Cook, D. G.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 1660 S Columbian Way, Seattle, WA 98108 USA; [Perl, D. P.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Ctr Neurosci & Regenerat Med, Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Cook, D. G.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Cook, D. G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Cook, DG (corresponding author), VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 1660 S Columbian Way, Seattle, WA 98108 USA.	dgcook@u.washington.edu	Hendrickson, Rebecca/I-4923-2017; Pagulayan, Kati/AAR-9225-2020; Wilkinson, Charles W/N-5969-2017	Hendrickson, Rebecca/0000-0003-2377-823X; Wilkinson, Charles/0000-0002-5390-0294; Cline, Marcella/0000-0002-9590-3725	Department of VA Office of Research and Development Medical Research Service; VA Rehabilitation Research and Development Service Merit Review Grant [B77421]; University of Washington Friends of Alzheimer's Research; UW Royalty Research Fund; Northwest Network Mental Illness Research Education and Clinical Center [CX000561]; Geriatric Research, Education, and Clinical Center (ARDIS) [0005]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AA021121]; Veterans AffairsUS Department of Veterans Affairs [I01RX000521, I01RX001612, I01BX002311, IK2BX003258] Funding Source: NIH RePORTER	This work was supported by the Department of VA Office of Research and Development Medical Research Service (DGC), VA Rehabilitation Research and Development Service Merit Review Grant #B77421 (ERP), University of Washington Friends of Alzheimer's Research (DGC, ERP), UW Royalty Research Fund (DGC), Northwest Network Mental Illness Research Education and Clinical Center (JSM, KFP, MAR, ERP), a Clinical Science R&D Career Development Award Program #CX000561 (KFP), Geriatric Research, Education, and Clinical Center (CWW) (ARDIS No. 0005), and National Institutes of Health #R01AA021121 (AGS, JJC). We would like to thank Scott Ng-Evans for considerable technical assistance.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ball SA, 2005, J RES PERS, V39, P84, DOI 10.1016/j.jrp.2004.09.008; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/nmeth.1412, 10.1038/NMETH.1412]; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DePalma R. G., 2015, COMBAT TBI HIST EPID; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; First M., 1995, STRUCTURED CLIN INTE; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grossbard J, 2017, PSYCHIAT SERV, V68, P48, DOI 10.1176/appi.ps.201500290; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOOKS MS, 1992, BRAIN RES, V587, P306; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jupp B, 2014, BRIT J PHARMACOL, V171, P4729, DOI 10.1111/bph.12787; Jupp B, 2014, NEUROPHARMACOLOGY, V76, P487, DOI 10.1016/j.neuropharm.2013.05.041; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Krebs RM, 2009, BIOL PSYCHIAT, V65, P103, DOI 10.1016/j.biopsych.2008.08.019; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Lawrence AD, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00086; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Malloy J. G. P., 2001, FRONTAL SYSTEMS BEHA; Marinelli M, 2000, J NEUROSCI, V20, P8876; Masse LC, 1997, ARCH GEN PSYCHIAT, V54, P62; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Meil WM, 2016, ADDICT BEHAV, V62, P135, DOI 10.1016/j.addbeh.2016.06.014; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Nadal R, 2002, PSYCHOPHARMACOLOGY, V162, P333, DOI 10.1007/s00213-002-1091-5; Nilsson T, 2010, PSYCHIAT RES, V178, P525, DOI 10.1016/j.psychres.2010.05.016; O'Neil M.E., 2013, COMPLICATIONS MILD T; Olson-Madden JH, 2012, J HEAD TRAUMA REHAB, V27, P370, DOI 10.1097/HTR.0b013e318268d496; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Parker JG, 2011, J NEUROSCI, V31, P17103, DOI 10.1523/JNEUROSCI.1715-11.2011; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Schindler AG, 2016, J NEUROSCI, V36, P3698, DOI 10.1523/JNEUROSCI.4394-15.2016; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seidl JNT, 2015, J CLIN EXP NEUROPSYC, V37, P84, DOI 10.1080/13803395.2014.989817; SHER KJ, 1994, J ABNORM PSYCHOL, V103, P92, DOI 10.1037/0021-843X.103.1.92; Stadlbauer U, 2014, INT J NEUROPSYCHOPH, V17, P407, DOI 10.1017/S1461145713001223; Stopper CM, 2014, NEURON, V84, P177, DOI 10.1016/j.neuron.2014.08.033; Tanielian T, 2008, INVISIBLE WOUNDS WAR; van Gaalen MM, 2006, PSYCHOPHARMACOLOGY, V187, P73, DOI 10.1007/s00213-006-0396-1; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; Zuckerman M., 1994, BEHAV EXPRESSION BIO	62	15	15	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2017	106						23	34		10.1016/j.nbd.2017.06.004			12	Neurosciences	Neurosciences & Neurology	FE5ZW	WOS:000408290800003	28619545				2021-06-18	
J	Wong, AWK; Ng, S; Dashner, J; Baum, MC; Hammel, J; Magasi, S; Lai, JS; Carlozzi, NE; Tulsky, DS; Miskovic, A; Goldsmith, A; Heinemann, AW				Wong, Alex W. K.; Ng, Sheryl; Dashner, Jessica; Baum, M. Carolyn; Hammel, Joy; Magasi, Susan; Lai, Jin-Shei; Carlozzi, Noelle E.; Tulsky, David S.; Miskovic, Ana; Goldsmith, Arielle; Heinemann, Allen W.			Relationships between environmental factors and participation in adults with traumatic brain injury, stroke, and spinal cord injury: a cross-sectional multi-center study	QUALITY OF LIFE RESEARCH			English	Article						Environment; Participation; Stroke; Spinal cord injury; Traumatic brain injury	INSIDER PERSPECTIVE; AFFECTING PERSONS; UNITED-STATES; NIH TOOLBOX; DISABILITIES; PEOPLE; BARRIERS; CLASSIFICATION; INFORMATION; STANDARDS	To develop and evaluate a model of environmental factors-participation relationships for persons with traumatic brain injury (TBI), stroke, and spinal cord injury (SCI), and test whether this model differed across three diagnostic groups, as well as other demographic and clinical characteristics. A cross-sectional observational study included 545 community-dwelling adults with neurological disorders (TBI = 166; stroke = 189; SCI = 190) recruited at three academic medical centers. Participants completed patient-reported measures of environmental factors and participation. The final structural equation model had acceptable fit to the data (CFI = 0.923; TLI = 0.898; RMSEA = 0.085; SRMR = 0.053), explaining 63% of the variance in participation in social roles and activities. Systems, services, and policies had an indirect influence on participation and this relation was mediated by social attitudes and the built and natural environment. Access to information and technology was associated with the built and natural environment which in turn influence on participation (ps < 0.001). The model was consistent across sex, diagnosis, severity/type of injury, education, race, age, marital status, years since injury, wheelchairs use, insurance coverage, personal or household income, and crystallized cognition. Social and physical environments appear to mediate the influence of systems, services, and policies on participation after acquired neurological disorders. These relations are stable across three diagnostic groups and many personal and clinical factors. Our findings inform health and disability policy, and provide guidance for implementing the initiatives in Healthy People 2020 in particular for people with acquired neurological disorders.	[Wong, Alex W. K.; Ng, Sheryl; Dashner, Jessica] Washington Univ, Sch Med, Program Occupat Therapy, 4444 Forest Pk Ave,Campus Box 8505, St Louis, MO 63108 USA; [Wong, Alex W. K.; Dashner, Jessica] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Ng, Sheryl] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Baum, M. Carolyn] Washington Univ, Dept Neurol, Program Occupat Therapy, St Louis, MO USA; [Baum, M. Carolyn] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA; [Hammel, Joy; Magasi, Susan] Univ Illinois, Dept Occupat Therapy, Chicago, IL USA; [Hammel, Joy] Univ Illinois, Dept Disabil & Human Dev, Chicago, IL USA; [Lai, Jin-Shei] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Lai, Jin-Shei] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Sch Med, Ann Arbor, MI 48109 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Miskovic, Ana; Goldsmith, Arielle; Heinemann, Allen W.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA	Wong, AWK (corresponding author), Washington Univ, Sch Med, Program Occupat Therapy, 4444 Forest Pk Ave,Campus Box 8505, St Louis, MO 63108 USA.; Wong, AWK (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wongal@wustl.edu; ephsnhx@nus.edu.sg; dashnerj@wustl.edu; baumc@wustl.edu; hammel@uic.edu; smagas1@uic.edu; js-lai@northwestern.edu; carlozzi@med.umich.edu; dtulsky@udel.edu; amiskovic@ric.org; agoldsmith@ric.org; a-heinemann@northwestern.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509; Wong, Alex/0000-0002-4423-2685; Ng, Sheryl/0000-0001-5046-2666	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services; Administration on Community Living; U.S. Department of Health and Human Services [H133B090024, H133F140037]; Craig H. Neilsen Foundation [290474]	This study was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, the Administration on Community Living, the U.S. Department of Health and Human Services to the Rehabilitation Institute of Chicago (Grant No. H133B090024) and to Washington University in St. Louis (Grant No. H133F140037), and by the Craig H. Neilsen Foundation to Washington University in St. Louis (Grant No. 290474).	ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Berkman L.F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137; Bricout JC, 2006, SCAND J DISABIL RES, V8, P1, DOI 10.1080/15017410500335229; Bronfenbrenner U., 1999, MEASURING ENV LIFE S, P3, DOI [10.1037/10317-001, DOI 10.1037/10317-001]; Browne MW, 1993, SAGE FOCUS EDITIONS, V154, P136, DOI DOI 10.1177/0049124192021002005; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Courtney-Long EA, 2015, MMWR-MORBID MORTAL W, V64, P777, DOI 10.15585/mmwr.MM6429a2; Enderby PM, 1986, DISABIL REHABIL, V8, P166, DOI DOI 10.3109/03790798709166209; Field Marilyn J., 2007, FUTURE DISABILITY AM; Garcia SF, 2015, ARCH PHYS MED REHAB, V96, P596, DOI 10.1016/j.apmr.2014.06.019; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P2231, DOI 10.1001/jama.2015.6405; Gray JA, 2012, DISABIL HEALTH J, V5, P87, DOI 10.1016/j.dhjo.2011.12.002; Hahn EA, 2016, ARCH PHYS MED REHAB, V97, P1284, DOI 10.1016/j.apmr.2016.01.027; Hahn EA, 2010, QUAL LIFE RES, V19, P1035, DOI 10.1007/s11136-010-9654-0; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hammel J, 2006, TOP STROKE REHABIL, V13, P43, DOI 10.1310/5X2G-V1Y1-TBK7-Q27E; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Heinemann AW, 2016, ARCH PHYS MED REHAB, V97, P2113, DOI 10.1016/j.apmr.2016.05.021; Heinemann AW, 2016, QUAL LIFE RES, V25, P2775, DOI 10.1007/s11136-016-1314-6; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Hollingsworth H, 2010, ARCH PHYS MED REHAB, V91, P1174, DOI 10.1016/j.apmr.2010.04.019; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iezzoni LI, 2008, JAMA-J AM MED ASSOC, V299, P332, DOI 10.1001/jama.299.3.332; Keysor JJ, 2005, J REHABIL MED, V37, P37, DOI 10.1080/16501970410014830; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Lai JS, 2016, ARCH PHYS MED REHAB, V97, P2102, DOI 10.1016/j.apmr.2016.06.010; Lawson A, 2006, SYRACUSE J INT L COM, V34, P563; Magasi S, 2015, ARCH PHYS MED REHAB, V96, P569, DOI 10.1016/j.apmr.2014.12.002; National Council on Disability, 2015, US CEL 25 ANN AM DIS; National Spinal Cord Injury Statistical Center, 2016, FACTS FIG GLANC; Office of Disease Prevention and Health Promotion, 2014, HLTH PEOPL 2020; Schulz A, 2004, HEALTH EDUC BEHAV, V31, P455, DOI 10.1177/1090198104265598; Stiens SA, 2002, ARCH PHYS MED REHAB, V83, pS72, DOI 10.1053/apmr.2002.32178; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wang X., 2012, STRUCTURAL EQUATION; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Weltgesundheitsorganisation, 2015, WHO GLOB DIS ACT PLA; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 2001, INT CLASS FUNCT DIS; World Health Organization, 2006, NEUR DIS PUBL HLTH C	50	15	16	0	16	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2017	26	10					2633	2645		10.1007/s11136-017-1586-5			13	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	FH1MS	WOS:000410904700005	28444554				2021-06-18	
J	Zhang, H; Wang, WZ; Jiang, SS; Zhang, Y; Heo, HY; Wang, XL; Peng, Y; Wang, J; Zhou, JY				Zhang, Hong; Wang, Wenzhu; Jiang, Shanshan; Zhang, Yi; Heo, Hye-Young; Wang, Xianlong; Peng, Yun; Wang, Jian; Zhou, Jinyuan			Amide proton transfer-weighted MRI detection of traumatic brain injury in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Amide proton transfer-weighted imaging; hemorrhage; ischemia; neuroinflammation; traumatic brain injury	SATURATION-TRANSFER CEST; CEREBRAL-ISCHEMIA; DIFFUSION TENSOR; ENDOGENOUS PROTEIN; AXONAL INJURY; HEAD-INJURY; 3 TESLA; CONTRAST; STROKE; PATHOPHYSIOLOGY	The purpose of this study was to explore the capability and uniqueness of amide proton transfer-weighted (APTw) imaging in the detection of primary and secondary injury after controlled cortical impact (CCI)-induced traumatic brain injury (TBI) in rats. Eleven adult rats had craniotomy plus CCI surgery under isoflurane anesthesia. Multi-parameter MRI data were acquired at 4.7 T, at eight time points (1, 6 h, and 1, 2, 3, 7, 14, and 28 days after TBI). At one and six hours post-injury, average APTw signal intensities decreased significantly in the impacted and peri-lesional areas due to tissue acidosis. A slightly high APTw signal was seen in the core lesion area with respect to the peri-lesional area, which was due to hemorrhage, as shown by T-2*w. After the initial drop, the APTw signals dramatically increased in some peri-lesional areas at two and three days post-injury, likely due to the secondary inflammatory response. The use of APTw MRI has the potential to introduce a novel molecular neuroimaging approach for the simultaneous detection of ischemia, hemorrhage, and neuroinflammation in TBI.	[Zhang, Hong; Jiang, Shanshan; Zhang, Yi; Heo, Hye-Young; Wang, Xianlong; Zhou, Jinyuan] Johns Hopkins Univ, Div MR Res, Dept Radiol, Baltimore, MD USA; [Zhang, Hong; Peng, Yun] Capital Med Univ, Dept Radiol, Beijing Childrens Hosp, Beijing, Peoples R China; [Wang, Wenzhu; Wang, Jian] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, 720 Rutland Ave,Ross 370B, Baltimore, MD 21205 USA; [Wang, Wenzhu] Huazhong Univ Sci & Technol, Dept Integrated Chinese & West Med, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Wang, J (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, 720 Rutland Ave,Ross 370B, Baltimore, MD 21205 USA.; Zhou, JY (corresponding author), Johns Hopkins Univ, Dept Radiol, 600 N Wolfe St,Pk 336, Baltimore, MD 21287 USA.	jwang79@jhmi.edu; jzhou@mri.jhu.edu	Jiang, Shanshan/O-8265-2019; hong, zhang/AAM-3862-2020; Zhang, Yi/AAC-8377-2019; Wang, Jian/I-4874-2019; Heo, Hye-Young/I-2711-2015	Jiang, Shanshan/0000-0003-2853-9991; Zhang, Yi/0000-0001-8738-1851; Wang, Jian/0000-0003-2291-640X; Heo, Hye-Young/0000-0002-7297-2015	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS083435, R01NS078026, R01EB009731, R01CA166171, R01AT007317]; American Heart AssociationAmerican Heart Association [13GRNT15730001]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81361120392]; "Stimulating and Advancing ACCM Research (StAAR)'' grant from the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB009731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS083435, R01NS078026] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by grants from the National Institutes of Health (R01NS083435, R01NS078026, R01EB009731, R01CA166171, and R01AT007317), the American Heart Association (13GRNT15730001), and the National Natural Science Foundation of China (81361120392), and a "Stimulating and Advancing ACCM Research (StAAR)'' grant from the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Faul M.D., 2010, TRAUMATIC BRAIN INJU; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Grossman R, 2012, J NEURO-ONCOL, V110, P315, DOI 10.1007/s11060-012-0974-5; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; Heo HY, 2016, MAGN RESON MED, V75, P137, DOI 10.1002/mrm.25581; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jeong HK, 2017, EUR RADIOL, V27, P1577, DOI 10.1007/s00330-016-4477-1; Jiang SS, 2016, EUR RADIOL, V26, P64, DOI 10.1007/s00330-015-3805-1; Jin T, 2013, MAGN RESON MED, V69, P760, DOI 10.1002/mrm.24315; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Li CM, 2014, EUR RADIOL, V24, P2631, DOI 10.1007/s00330-014-3241-7; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McVicar N, 2014, J CEREBR BLOOD F MET, V34, P690, DOI 10.1038/jcbfm.2014.12; MORI S, 1995, MAGNET RESON MED, V33, P41, DOI 10.1002/mrm.1910330107; NIH/NINDS, 2015, NIH PUBL; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Sun PZ, 2011, J CEREBR BLOOD F MET, V31, P1743, DOI 10.1038/jcbfm.2011.23; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tee YK, 2014, NMR BIOMED, V27, P1019, DOI 10.1002/nbm.3147; Tietze A, 2014, NMR BIOMED, V27, P163, DOI 10.1002/nbm.3048; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wang MY, 2015, MAGN RESON MED, V74, P42, DOI 10.1002/mrm.25690; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063511; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Watts LT, 2015, J NEUROTRAUM, V32, P1001, DOI 10.1089/neu.2014.3737; Wen ZB, 2010, NEUROIMAGE, V51, P616, DOI 10.1016/j.neuroimage.2010.02.050; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yan K, 2015, MOL IMAGING BIOL, V17, P479, DOI 10.1007/s11307-015-0828-6; Yuan J, 2014, NMR BIOMED, V27, P1239, DOI 10.1002/nbm.3184; Zhang H, 2016, EUR RADIOL, V26, P3368, DOI 10.1007/s00330-015-4188-z; Zhang Y, 2016, J MAGN RESON IMAGING, V43, P756, DOI 10.1002/jmri.25027; Zhao XN, 2011, MAGN RESON MED, V66, P1033, DOI 10.1002/mrm.22891; Zheng SK, 2014, MAGN RESON MED, V71, P1082, DOI 10.1002/mrm.24770; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2006, PROG NUCL MAG RES SP, V48, P109, DOI 10.1016/j.pnmrs.2006.01.001; Zhou JY, 2013, J MAGN RESON IMAGING, V38, P1119, DOI 10.1002/jmri.24067; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	57	15	15	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2017	37	10					3422	3432		10.1177/0271678X17690165			11	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	FI7IV	WOS:000412171300015	28128026	Green Published, Bronze			2021-06-18	
J	Zhao, W; Kuo, C; Wu, L; Camarillo, DB; Ji, SB				Zhao, Wei; Kuo, Calvin; Wu, Lyndia; Camarillo, David B.; Ji, Songbai			Performance Evaluation of a Pre-computed Brain Response Atlas in Dummy Head Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Concussion; Contact sports; Pre-computation; Finite element model; Worcester head injury model	MAXIMUM PRINCIPAL STRAIN; HIGH-SCHOOL FOOTBALL; WHITE-MATTER; CONCUSSION; INJURY; ACCELERATIONS; SPORTS; PREDICTORS; KINEMATICS; MOUTHGUARD	A pre-computed brain response atlas (pcBRA) may have the potential to accelerate the investigation of the biomechanical mechanisms of traumatic brain injury on a large-scale. In this study, we further enhance the technique and evaluate its performance using six degree-of-freedom angular velocity profiles from dummy head impacts. Using the pcBRA to simplify profiles into acceleration-only shapes, sufficiently accurate strain estimates were obtained for impacts with a major dominating velocity peak. However, they were largely under-estimated when substantial deceleration occurred that reversed the direction of the angular velocity. For these impacts, estimation accuracy was substantially improved with a biphasic profile simplification (average correlation coefficient and linear regression slope of 0.92 +/- 0.03 and 0.95 +/- 0.07 for biphasic shapes, respectively, vs. 0.80 +/- 0.06 and 0.80 +/- 0.08 for acceleration-only shapes). Peak maximum principal strain (E > (p)) and cumulative strain damage measure (CSDM) from the estimated strains consistently correlated stronger than kinematic metrics with respect to the baseline E > (p) and CSDM from the directly simulated responses, regardless of the brain region, and by a large margin (e.g., correlation of 0.93 vs. 0.75 compared to Brain Injury Criterion (BrIC) for E > (p) in the whole-brain, and 0.91 vs. 0.47 compared to BrIC for CSDM in the corpus callosum). These findings further support the pre-computation technique for accurate, real-time strain estimation, which could be important to accelerate model-based brain injury studies in the future.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01506 USA; [Kuo, Calvin; Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Wu, Lyndia; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ji, Songbai] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01506 USA.	sji@wpi.edu	Wu, Lyndia/AAQ-1106-2020; Kuo, Calvin/AAH-1933-2019	Wu, Lyndia/0000-0002-8236-032X; Kuo, Calvin/0000-0001-8401-9136; Ji, Songbai/0000-0002-2886-5781	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092853, R21NS088781] Funding Source: NIH RePORTER	Funding is provided by the NIH Grants R01 NS092853 and R21 NS088781.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cai Y., 2017, CONCUSSION CLASSIFIC; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; CDC, 2015, C TRAUM BRAIN INJ US, DOI [10.1161/HYPERTENSIONAHA.111.186106, DOI 10.1161/HYPERTENSIONAHA.111.186106]; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Franklyn Melanie, 2005, Stapp Car Crash J, V49, P1; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Graham R, 2014, SPORTS RELATED CONCU; Hernandez F, 2016, ANN BIOMED ENG, V44, P828, DOI 10.1007/s10439-015-1487-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Ward C., 1980, INTRACRANIAL PRESSUR, DOI [10.4271/801304, DOI 10.4271/801304]; Yanaoka T., 2015, INVESTIGATION INJURY, DOI [10.4271/2015-01-1439, DOI 10.4271/2015-01-1439]; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhao W., 2015, IRCOBI C; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	48	15	15	1	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2017	45	10					2437	2450		10.1007/s10439-017-1888-3			14	Engineering, Biomedical	Engineering	FI4XU	WOS:000411984300017	28710533	Green Accepted			2021-06-18	
J	Yu, YH; Cao, F; Ran, QS; Wang, F				Yu, Yunhu; Cao, Fang; Ran, Qishan; Wang, Fei			Long non-coding RNA Gm4419 promotes trauma-induced astrocyte apoptosis by targeting tumor necrosis factor alpha	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						LncRNA; Gm4419; Traumatic brain injury; Tumor necrosis factor alpha; Apoptosis	INJURY; NEUROINFLAMMATION; NEUROPROTECTION; INFLAMMATION; PLAYERS; CELLS	Traumatic brain injury (TBI) remains a life-threatening disease. Accumulating evidences have showed that neuroinflammatory response is a critical biological event in the progression of TBI induced astrocyte damage. However, the exact mechanisms are not well understood. In this study, we demonstrated that long non-coding RNA (lncRNA) Gm4419 promoted trauma-induced astrocyte apoptosis by up-regulating the expression of inflammatory cytokine tumor necrosis factor alpha (TNF-alpha). We observed that Gm4419 was aberrantly induced after injury on astroglial cells in vitro. Overexpression of Gm4419 in injury-treated astrocytes increased protein expressions of TNF-alpha, Bax, cleaved caspase-3 and cleaved caspase-9, decreased levels of Bcl-2 and CyclinD1, and significantly led to cellular apoptosis. Mechanically, Gm4419 transcript could function as a sponge for miR-466l and miR-466l could target TNF-alpha 3' UTR for degradation and translation inhibition. Therefore, Gm4419 could up-regulate TNF-alpha expression by competitively binding miR-466l and then contribute to inflammatory damage as well as astrocyte apoptosis during TBI. Generally speaking, our findings provide better understandings of the mechanism underlying Gm4419 in trauma-induced neuroinflammation and neurological deficits. Thus, the present study would expand the insight into the novel approaches for TBI therapy. (C) 2017 Elsevier Inc. All rights reserved.	[Yu, Yunhu; Wang, Fei] Zunyi Med Coll, Dept Neurosurg, Affiliated Hosp 3, 98 Fenghuang North Rd, Zunyi 563000, Peoples R China; [Cao, Fang; Ran, Qishan] Zunyi Med Coll, Dept Cerebrovasc, Affiliated Hosp 1, Zunyi, Peoples R China	Yu, YH (corresponding author), Zunyi Med Coll, Dept Neurosurg, Affiliated Hosp 3, 98 Fenghuang North Rd, Zunyi 563000, Peoples R China.	yunhuyu1616@163.com			GuiZhou Province Scientific Award for Society Development [SY[2012] 3118]	This work was supported by GuiZhou Province Scientific Award for Society Development SY[2012] 3118.	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Berman S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7060059; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Ghosal S, 2013, STEM CELLS DEV, V22, P2240, DOI 10.1089/scd.2013.0014; Gu DM, 2015, BIOCHEM BIOPH RES CO, V457, P391, DOI 10.1016/j.bbrc.2015.01.002; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Sen R, 2014, THESCIENTIFICWORLDJO, V2014, DOI DOI 10.1155/2014/896206; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wen YC, 2017, BIOCHEM BIOPH RES CO, V487, P923, DOI 10.1016/j.bbrc.2017.05.005; Yi H, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.451; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhang MK, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0358-z	25	15	19	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	SEP 16	2017	491	2					478	485		10.1016/j.bbrc.2017.07.021			8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FE5ZZ	WOS:000408291100036	28688761				2021-06-18	
J	Galan-Arriero, I; Serrano-Munoz, D; Gomez-Soriano, J; Goicoechea, C; Taylor, J; Velasco, A; Avila-Martin, G				Galan-Arriero, Iriana; Serrano-Munoz, Diego; Gomez-Soriano, Julio; Goicoechea, Carlos; Taylor, Julian; Velasco, Ana; Avila-Martin, Gerardo			The role of Omega-3 and Omega-9 fatty acids for the treatment of neuropathic pain after neurotrauma	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Omega-3,-6 and-9 fatty acids; Spared nerve injury; Spinal cord injury; Neurotrophic factor; Central sensitisation to noxious stimuli; Descending antinociception; Microglia; NMDA receptors	SPINAL-CORD-INJURY; ACTIVATED RECEPTOR-ALPHA; DOCOSAHEXAENOIC ACID; OLEIC-ACID; 2-HYDROXYOLEIC ACID; LIPOXIN A(4); NERVE INJURY; BRAIN-INJURY; MOUSE MODEL; RAT MODEL	Omega-3 polyunsaturated fatty acids (PUFAs), such as docosaexaenoic acid (DHA) and eicosapentaenoic acid (EPA), mediate neuroactive effects in experimental models of traumatic peripheral nerve and spinal cord injury. Cellular mechanisms of PUFAs include reduced neuroinflammation and oxidative stress, enhanced neurotrophic support, and activation of cell survival pathways. Bioactive Omega-9 monounsaturated fatty acids, such as oleic acid (OA) and 2-hydroxy oleic acid (2-OHOA), also show therapeutic effects in neurotrauma models. These FAs reduces noxious hyperreflexia and pain-related anxiety behavior following peripheral nerve injury and improves sensorimotor function following spinal cord injury (SCI), including facilitation of descending inhibitory antinociception. The relative safe profile of neuroactive fatty acids (FAs) holds promise for the future clinical development of these molecules as analgesic agents. This article is part of a Special Issue entitled: Membrane Lipid Therapy: Drugs Targeting Biomembranes edited by Pablo V. Escribia. (C) 2017 Elsevier B.V. All rights reserved.	[Galan-Arriero, Iriana; Serrano-Munoz, Diego; Taylor, Julian; Avila-Martin, Gerardo] Hosp Nacl Paraplej, SESCAM, Sensorimotor Funct Grp, Toledo 45071, Spain; [Gomez-Soriano, Julio] Univ Castilla La Mancha, Nursing & Physiotherapy Fac, GIFTO, Toledo 45072, Spain; [Goicoechea, Carlos] Univ Rey Juan Carlos, Hlth Sci Fac, Pharmacol & Nutr Dept, Madrid 28922, Spain; [Taylor, Julian] Buckinghamshire Healthcare NHS Trust, Natl Spinal Injuries Ctr, Stoke Mandeville Spinal Res, Aylesbury HP21 8AL, Bucks, England; [Taylor, Julian] Univ Oxford, Harris Manchester Coll, Oxford OX1 3TD, England; [Velasco, Ana] Inst Neurociencias Castilla & Leon, Salamanca 37007, Spain	Avila-Martin, G (corresponding author), Hosp Nacl Paraplej, SESCAM, Sensorimotor Funct Grp, Toledo 45071, Spain.	igalan@jccm.es; dserranomu@externas.sescam.jccm.es; julio.soriano@uclm.es; carlos.goicoechea@urjc.es; jscott@sescam.org; anvecri@usal.es; gavila@sescam.jccm.es	Serrano-Munoz, Diego/AAD-2803-2019; Taylor, Julian/AAC-2802-2021; Velasco, Ana/L-6065-2014; Arriero, Iriana Galan/S-2050-2019; Goicoechea, Carlos/H-6890-2015; Gomez-Soriano, Julio/AAE-2990-2019	Serrano-Munoz, Diego/0000-0002-7521-5087; Taylor, Julian/0000-0003-2553-2348; Velasco, Ana/0000-0002-4091-8081; Arriero, Iriana Galan/0000-0002-3291-1963; Goicoechea, Carlos/0000-0002-6226-6934; Gomez-Soriano, Julio/0000-0002-5542-4105	Fundacion Mutua Madrilefla	We are grateful for the support of past and present members of the Sensorimotor Function group, who contributed to the experiments presented in this review. This work is supported by the Fundacion Mutua Madrilefla.	Abdelmoaty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075543; Alberts GL, 2001, MOL PHARMACOL, V60, P1349; Alemany R, 2007, BBA-BIOMEMBRANES, V1768, P964, DOI 10.1016/j.bbamem.2006.09.024; Alemany R, 2006, J LIPID RES, V47, P1762, DOI 10.1194/jlr.M500520-JLR200; Avila-Martin G, 2015, EUR J PAIN, V19, P111, DOI 10.1002/ejp.528; Avila-Martin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026107; Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030; Bento-Abreu A, 2007, J NEUROCHEM, V103, P871, DOI 10.1111/j.1471-4159.2007.04807.x; Berbert AA, 2005, NUTRITION, V21, P131, DOI 10.1016/j.nut.2004.03.023; Brenna JT, 2014, J HUM EVOL, V77, P99, DOI 10.1016/j.jhevol.2014.02.017; Breuer S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-15; Cappa M, 2012, J INHERIT METAB DIS, V35, P899, DOI 10.1007/s10545-011-9432-3; Casas J., 2017, BIOCH BIOPHYS ACTA; Champeil-Potokar G, 2006, EUR J NEUROSCI, V24, P3084, DOI 10.1111/j.1460-9568.2006.05185.x; Chang CY, 2013, J NUTR BIOCHEM, V24, P2127, DOI 10.1016/j.jnutbio.2013.08.004; Ciardo M.G., 2017, BIOCH BIOPHYS ACTA; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Durrenberger PF, 2004, J PERIPHER NERV SYST, V9, P15, DOI 10.1111/j.1085-9489.2004.09104.x; Erkayiran U, 2016, J OBSTET GYNAECOL, V36, P444, DOI 10.3109/01443615.2015.1065230; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Escriba PV, 2015, PROG LIPID RES, V59, P38, DOI 10.1016/j.plipres.2015.04.003; Fandel D, 2013, BRAIN RES, V1535, P89, DOI 10.1016/j.brainres.2013.08.022; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fedorova I, 2001, J PHARMACOL EXP THER, V299, P332; Figueroa JD, 2013, NEUROSCIENCE, V255, P1, DOI 10.1016/j.neuroscience.2013.09.012; Figueroa JD, 2016, J NEUROTRAUM, V33, P1436, DOI 10.1089/neu.2015.4186; Finnerup NB, 2012, CURR PAIN HEADACHE R, V16, P207, DOI 10.1007/s11916-012-0259-x; Foster TS, 2007, DIABETES EDUCATOR, V33, P111, DOI 10.1177/0145721706297450; Gladman SJ, 2012, J NEUROSCI, V32, P563, DOI 10.1523/JNEUROSCI.3371-11.2012; Graeber MB, 2012, EXP NEUROL, V234, P255, DOI 10.1016/j.expneurol.2012.01.007; Granda B, 2003, BRAIN RES, V988, P1, DOI 10.1016/S0006-8993(03)03253-0; Gwak YS, 2009, NEUROSCIENCE, V161, P895, DOI 10.1016/j.neuroscience.2009.03.055; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; JAMES MJ, 1993, J EXP MED, V178, P2261, DOI 10.1084/jem.178.6.2261; Javidan AN, 2014, SPINAL CORD, V52, P378, DOI 10.1038/sc.2014.30; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kanda H, 2013, GLIA, V61, P943, DOI 10.1002/glia.22487; Kien CL, 2013, AM J CLIN NUTR, V97, P689, DOI 10.3945/ajcn.112.051730; Ko GD, 2010, CLIN J PAIN, V26, P168, DOI 10.1097/AJP.0b013e3181bb8533; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Lavado E, 1997, J NEUROCHEM, V69, P721; Lee YH, 2012, ARCH MED RES, V43, P356, DOI 10.1016/j.arcmed.2012.06.011; Lewis MD, 2016, J AM COLL NUTR, V35, P469, DOI 10.1080/07315724.2016.1150796; Lim SN, 2013, EXP NEUROL, V239, P13, DOI 10.1016/j.expneurol.2012.09.015; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Logan Alan C, 2003, Altern Med Rev, V8, P410; Luo CL, 2013, BRAIN RES, V1502, P1, DOI 10.1016/j.brainres.2013.01.037; Luo CM, 2014, J LIPID RES, V55, P1288, DOI 10.1194/jlr.M046466; MARTIN HA, 1988, J NEUROPHYSIOL, V60, P438; Matsui T, 2010, ANESTH ANALG, V111, P554, DOI 10.1213/ANE.0b013e3181e3a2a2; McCracken LM, 1998, BEHAV RES THER, V36, P621, DOI 10.1016/S0005-7967(97)10039-0; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; MOLLGARD K, 1984, DEV BRAIN RES, V13, P49, DOI 10.1016/0165-3806(84)90076-2; Oh YT, 2009, NEUROSCI LETT, V464, P93, DOI 10.1016/j.neulet.2009.08.040; Palacios-Pelaez R, 2010, MOL NEUROBIOL, V41, P367, DOI 10.1007/s12035-010-8139-z; Pamplona FA, 2012, P NATL ACAD SCI USA, V109, P21134, DOI 10.1073/pnas.1202906109; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-6; Perez J, 2005, ANESTH ANALG, V101, P444, DOI 10.1213/01.ANE.0000158469.11775.52; Perez J, 2004, PAIN, V111, P297, DOI 10.1016/j.pain.2004.07.006; Poveda JJ.A., 2017, BIOCH BIOPHYS ACTA; Przegalinski E, 2006, INT J IMMUNOPATH PH, V19, P897, DOI 10.1177/039463200601900419; Ramsden CE, 2015, PAIN, V156, P587, DOI 10.1097/01.j.pain.0000460348.84965.47; Richardson AJ, 2002, PROG NEURO-PSYCHOPH, V26, P233, DOI 10.1016/S0278-5846(01)00254-8; RIZZO WB, 1989, NEUROLOGY, V39, P1415, DOI 10.1212/WNL.39.11.1415; Rodriguez-Rodriguez RA, 2004, J NEUROCHEM, V88, P1041, DOI 10.1046/j.1471-4159.2003.02262.x; Sales C, 2009, REUMATISMO, V61, P10; Saravanan P, 2010, J AM COLL CARDIOL, V55, P410, DOI 10.1016/j.jacc.2009.09.032; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Shah RC, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt224; Shir Y, 2001, ANESTH ANALG, V92, P1029, DOI 10.1097/00000539-200104000-00042; Stender S, 2004, ANN NUTR METAB, V48, P61, DOI 10.1159/000075591; Tabernero A, 2002, J BIOL CHEM, V277, P4240, DOI 10.1074/jbc.M108760200; Taylor J, 2012, PAIN MED, V13, P1457, DOI 10.1111/j.1526-4637.2012.01483.x; Taylor KC, 2017, BBA-BIOMEMBRANES, V1859, P586, DOI 10.1016/j.bbamem.2016.10.023; Trang T, 2004, EUR J PHARMACOL, V491, P21, DOI 10.1016/j.ejphar.2004.03.022; TROEGER MB, 1984, J NEUROCHEM, V42, P1735, DOI 10.1111/j.1471-4159.1984.tb12765.x; Vahidy WH, 2006, EXP BRAIN RES, V174, P781, DOI 10.1007/s00221-006-0672-7; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Xu ZZ, 2013, J NEUROIMMUNE PHARM, V8, P37, DOI 10.1007/s11481-012-9394-8; Zhang XL, 2014, EXP NEUROL, V251, P12, DOI 10.1016/j.expneurol.2013.10.020; Zhao P, 2007, J NEUROSCI, V27, P8893, DOI 10.1523/JNEUROSCI.2209-07.2007; Ziegler D, 2006, DIABETES CARE, V29, P2365, DOI 10.2337/dc06-1216	90	15	15	1	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	1879-2642		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	SEP	2017	1859	9	B		SI		1629	1635		10.1016/j.bbamem.2017.05.003			7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FB2LD	WOS:000405974400013	28495596	Bronze			2021-06-18	
J	Gardner, RC; Peltz, CB; Kenney, K; Covinsky, KE; Diaz-Arrastia, R; Yaffe, K				Gardner, Raquel C.; Peltz, Carrie B.; Kenney, Kimbra; Covinsky, Kenneth E.; Diaz-Arrastia, Ramon; Yaffe, Kristine			Remote Traumatic Brain Injury Is Associated with Motor Dysfunction in Older Military Veterans	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						Falls; Parkinson's disease; Risk factors	MILD PARKINSONIAN SIGNS; ALZHEIMERS-DISEASE; RISK; METAANALYSIS; PREVALENCE; DEMENTIA; OUTCOMES; STATE	Background: Traumatic brain injury (TBI) has been identified as a risk factor for Parkinson's disease (PD). Motor dysfunction among TBI-exposed elders without PD has not been well characterized. We sought to determine whether remote TBI is a risk factor for motor dysfunction on exam and functionally relevant motor dysfunction in day-to-day life among independently living elders without PD. Methods: This is a cross-sectional cohort study of independently living retired military veterans aged 50 or older with (n = 78) and without (n = 85) prior TBI-all without diagnosed PD. To characterize multidimensional aspects of motor function on exam, the Unified Parkinson's Disease Rating Scale (UPDRS) Motor Examination was performed by a board-certified neurologist and used to calculate a modified UPDRS (mUPDRS) global motor score and four domain scores (tremor, rigidity, bradykinesia, and posture/gait). Functionally relevant motor dysfunction was assessed via self-report of falls within the past year. Results: In analyses adjusted for demographics and comorbidities that differed between groups, compared with veterans without TBI, those with moderate-to-severe TBI were more likely to have fallen in past year (33% vs. 14%, risk ratio 2.5 [95% confidence interval 1.1-5.4]), had higher (worse) mUPDRS global motor (p = .03) and posture/gait scores (p = .02), but not higher tremor (p = .70), rigidity (p = .21), or bradykinesia scores (p = .22). Mild TBI was not associated with worse motor function. Conclusions: Remote moderate-to-severe TBI is a risk factor for motor dysfunction-defined as recent falls and impaired posture/gait-among older veterans. TBI-exposed older adults may be ideal candidates for aggressive fall-screening and prevention strategies.	[Gardner, Raquel C.; Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, 4150 Clement St, San Francisco, CA 94121 USA; [Gardner, Raquel C.; Peltz, Carrie B.; Covinsky, Kenneth E.; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Kenney, Kimbra; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Covinsky, Kenneth E.] Univ Calif San Francisco, Div Geriatr, 4150 Clement St, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, 4150 Clement St, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, 4150 Clement St, San Francisco, CA 94121 USA	Gardner, RC (corresponding author), Univ Calif San Francisco, Dept Neurol, 4150 Clement St, San Francisco, CA 94121 USA.	raquel.gardner@ucsf.edu		Gardner, Raquel C./0000-0003-4028-440X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS095755, K24 AG029812, P30 AG044281, K24 AG031155]; American Federation for Aging Research; University of California San Francisco Pepper Center; Global Brain Health Institute; Department of DefenseUnited States Department of Defense; Department of Veterans AffairsUS Department of Veterans Affairs [W81XWH-12-1-0581, W81XWH-12-PHTBI-CENC]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Military Clinical Neurosciences Center of Excellence; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG044281] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (Beeson K23 NS095755 to R.C.G., K24 AG029812 and P30 AG044281 to K.E.C., and K24 AG031155 to K.Y.); the American Federation for Aging Research (to R.C.G.); the University of California San Francisco Pepper Center (to R.C.G. and K.E.C.); the Global Brain Health Institute (to R.C.G.); the Department of Defense and Department of Veterans Affairs (W81XWH-12-1-0581 and W81XWH-12-PHTBI-CENC to K.Y.); and the Center for Neuroscience and Regenerative Medicine and the Military Clinical Neurosciences Center of Excellence (to K.K. and R.D.A.).	Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; Bennett DA, 1999, J GERONTOL A-BIOL, V54, pM191, DOI 10.1093/gerona/54.4.M191; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Buchman AS, 2016, J GERONTOL A-BIOL, V71, P549, DOI 10.1093/gerona/glv153; Buracchio T, 2010, J AM GERIATR SOC, V58, P205, DOI 10.1111/j.1532-5415.2009.02657.x; Bureau USC, 2012, 2012 AM COMM SURV; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Caetano MJD, 2017, J GERONTOL A-BIOL, V72, P1257, DOI 10.1093/gerona/glw171; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fleischman DA, 2007, EXP AGING RES, V33, P59, DOI 10.1080/03610730601006370; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Formisano R, 2014, J HEAD TRAUMA REHAB, V29, P387, DOI 10.1097/HTR.0000000000000027; Frieden T., 2014, REPORT C TRAUMATIC B; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Louis ED, 2006, MOVEMENT DISORD, V21, P411, DOI 10.1002/mds.20735; Louis ED, 2007, MOVEMENT DISORD, V22, P1681, DOI 10.1002/mds.21433; Marshall LM, 2016, J GERONTOL A; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; National Center for Injury Prevention, 2003, MILD TRAUM BRAIN INJ; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Peran P, 2014, J NEUROTRAUM, V31, P642, DOI 10.1089/neu.2013.3103; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Topolski Tari D, 2006, Prev Chronic Dis, V3, pA118; United Nations DoEaSA Population Division Population Estimates and Projections Section. United Nations Department of Economic and Social Affairs Population Division Population Estimates and Projections Section, 2012, DETAILED INDICATORS; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140	33	15	15	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	SEP	2017	72	9					1233	1238		10.1093/gerona/glw341			6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	FD4LC	WOS:000407501600012	28329183	Green Published			2021-06-18	
J	Smart, LR; Mangat, HS; Issarow, B; McClelland, P; Mayaya, G; Kanumba, E; Gerber, LM; Wu, X; Peck, RN; Ngayomela, I; Fakhar, M; Stieg, PE; Hartl, R				Smart, Luke R.; Mangat, Halinder S.; Issarow, Benson; McClelland, Paul; Mayaya, Gerald; Kanumba, Emmanuel; Gerber, Linda M.; Wu, Xian; Peck, Robert N.; Ngayomela, Isidore; Fakhar, Malik; Stieg, Philip E.; Hartl, Roger			Severe Traumatic Brain Injury at a Tertiary Referral Center in Tanzania: Epidemiology and Adherence to Brain Trauma Foundation Guidelines	WORLD NEUROSURGERY			English	Article						Adherence; Guidelines; Mortality; Sub-Saharan Africa; Tanzania; Traumatic brain injury	INCOME COUNTRIES; GLOBAL BURDEN; CARE; IMPACT; MANAGEMENT; MORTALITY; REDUCTION; PROGNOSIS; OUTCOMES; DISEASE	BACKGROUND: Severe traumatic brain injury (TBI) is a major cause of death and disability worldwide. Prospective TBI data from sub-Saharan Africa are sparse. This study examines epidemiology and explores management of patients with severe TBI and adherence to Brain Trauma Foundation Guidelines at a tertiary care referral hospital in Tanzania. METHODS: Patients with severe TBI hospitalized at Bugando Medical Centre were recorded in a prospective registry including epidemiologic, clinical, treatment, and outcome data. RESULTS: Between September 2013 and October 2015, 371 patients with TBI were admitted; 33% (115/371) had severe TBI. Mean age was 32.0 years +/- 20.1, and most patients were male (80.0%). Vehicular injuries were the most common cause of injury (65.2%). Approximately half of the patients (47.8%) were hospitalized on the day of injury. Computed tomography of the brain was performed in 49.6% of patients, and 58.3% were admitted to the intensive care unit. Continuous arterial blood pressure monitoring and intracranial pressure monitoring were not performed in any patient. Of patients with severe TBI, 38.3% received hyperosmolar therapy, and 35.7% underwent craniotomy. The 2-week mortality was 34.8%. CONCLUSIONS: Mortality of patients with severe TBI at Bugando Medical Centre, Tanzania, is approximately twice that in high-income countries. Intensive care unit care, computed tomography imaging, and continuous arterial blood pressure and intracranial pressure monitoring are underused or unavailable in the tertiary referral hospital setting. Improving outcomes after severe TBI will require concerted investment in prehospital care and improvement in availability of intensive care unit resources, computed tomography, and expertise in multidisciplinary care.	[Smart, Luke R.; Peck, Robert N.] Dept Internal Med, Mwanza, Tanzania; [Issarow, Benson] Weill Bugando Sch Med, Mwanza, Tanzania; [Mayaya, Gerald; Kanumba, Emmanuel] Bugando Med Ctr, Dept Neurosurg, Mwanza, Tanzania; [Ngayomela, Isidore] Bugando Med Ctr, Dept Orthoped Surg, Mwanza, Tanzania; [Smart, Luke R.; McClelland, Paul; Peck, Robert N.] Weill Cornell Med, Ctr Global Hlth, New York, NY USA; [Mangat, Halinder S.; Fakhar, Malik] Weill Cornell Med, Dept Neurol, New York, NY 10065 USA; [Mangat, Halinder S.; Stieg, Philip E.; Hartl, Roger] Weill Cornell Med, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10065 USA; [Gerber, Linda M.; Wu, Xian] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA	Mangat, HS (corresponding author), Weill Cornell Med, Dept Neurol, New York, NY 10065 USA.; Mangat, HS (corresponding author), Weill Cornell Med, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10065 USA.	hsm9001@med.cornell.edu	Smart, Luke R./AAI-1561-2020; Mangat, HALINDER/AAN-9153-2020	Smart, Luke R./0000-0003-4083-0060; Mangat, HALINDER/0000-0003-3426-2001; Peck, Robert/0000-0002-4526-2480	Clinical and Translational Science Center (CTSC), National Center for Advancing Translational Sciences (NCATS) [UL1-TR000457-06]; Leonard & Evelyn Lauder Foundation; Eric Javits Family Foundation; William Beecher Scoville Foundation; Colin McDonald family; National Institutes of Health Fogarty Center [TW009337, K01 TW010281-01]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010281, D43TW009337, R25TW009337] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000457] Funding Source: NIH RePORTER	Dr. Linda Gerber and Ms. Xian Wu were supported in part by funds from the Clinical and Translational Science Center (CTSC), National Center for Advancing Translational Sciences (NCATS) grant # UL1-TR000457-06. This work was supported in part by the Leonard & Evelyn Lauder Foundation, Eric Javits Family Foundation, William Beecher Scoville Foundation, Colin McDonald family, and patient donations. L.R.S. received support from the National Institutes of Health Fogarty Center (Grant No. TW009337). R.N.P. received support from the National Institutes of Health Fogarty Center (Grant No. K01 TW010281-01).	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Brazinova A, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0133-z; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Callese TE, 2014, J SURG RES, V190, P104, DOI 10.1016/j.jss.2014.03.029; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Coburger J, 2014, WORLD NEUROSURG, V82, pE1, DOI 10.1016/j.wneu.2012.09.019; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Fatigba HO, 2013, ISRN SURG, V2013; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Geduld H, 2011, EMERG MED J, V28, P794, DOI 10.1136/emj.2010.101683; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kahamba JF, 2013, WORLD NEUROSURG, V80, P255, DOI 10.1016/j.wneu.2011.07.021; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mitchell KB, 2013, CAN J SURG, V56, P199, DOI 10.1503/cjs.028911; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Wait SD, 2010, WORLD NEUROSURG, V73, P610, DOI 10.1016/j.wneu.2010.06.043; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877	38	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2017	105						238	248		10.1016/j.wneu.2017.05.101			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FH3EJ	WOS:000411027600033	28559070	Green Accepted			2021-06-18	
J	Portbury, SD; Hare, DJ; Finkelstein, DI; Adlard, PA				Portbury, Stuart D.; Hare, Dominic J.; Finkelstein, David I.; Adlard, Paul A.			Trehalose improves traumatic brain injury-induced cognitive impairment	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CONTROLLED CORTICAL IMPACT; CELLULAR STRESS RESPONSES; FOOTBALL-LEAGUE PLAYER; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HEAD-INJURY; RAT MODEL; SUBVENTRICULAR ZONE; MEMORY FORMATION	Traumatic brain Injury (TBI) is a significant cause of death and long-term disability for which there are currently no effective pharmacological treatment options. In this study then, we utilized a mouse model of TBI to assess the therapeutic potential of the stable disaccharide trehalose, which is known to protect against oxidative stress, increase levels of chaperone molecules and enhance autophagy. Furthermore, trehalose has demonstrated neuroprotective properties in numerous animal models and has been proposed as a potential treatment for neurodegeneration. As TBI (and associated neurodegenerative disorders) is complicated by a sudden and dramatic change in brain metal concentrations, including iron (Fe) and zinc (Zn), the collective accumulation and translocation of which has been hypothesized to contribute to the pathogenesis of TBI, then we also sought to determine whether trehalose modulated the metal dyshomeostasis associated with TBI. In this study three-monthold C57Bl/6 wildtype mice received a controlled cortical impact TBI, and were subsequently treated for one month with trehalose. During this time animals were assessed on multiple behavioral tasks prior to tissue collection. Results showed an overall significant improvement in the Morris water maze, Y-maze and open field behavioral tests in trehalose-treated mice when compared to controls. These functional benefits occurred in the absence of any change in lesion volume or any significant modulation of biometals, as assessed by laser ablation inductively coupled plasma mass spectrometry. Western blot analysis, however, revealed an upregulation of synaptophysin, doublecortin and brain derived neurotrophic factor protein in trehalose treated mice in the contralateral cortex. These results indicate that trehalose may be efficacious in improving functional outcomes following TBI by a previously undescribed mechanism of action that has relevance to multiple disorders of the central nervous system.	[Portbury, Stuart D.; Hare, Dominic J.; Finkelstein, David I.; Adlard, Paul A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Hare, Dominic J.] Univ Technol Sydney, Elemental Bioimaging, Sydney, NSW, Australia	Adlard, PA (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.	paul.adlard@florey.edu.au	Finkelstein, David/B-9617-2009; Hare, Dominic/H-2481-2011	Finkelstein, David/0000-0002-8167-4917; Hare, Dominic/0000-0002-5922-7643	Australian Research Council Future FellowshipAustralian Research Council [FT120100030]; Australian Research CouncilAustralian Research Council; Agilent Technologies [LP140100095]	P.A.A. is supported by an Australian Research Council Future Fellowship (FT120100030). D.J.H. is supported by an Australian Research Council Linkage Project with Agilent Technologies (LP140100095).	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Ayton S, 2015, NEUROTHERAPEUTICS, V12, P109, DOI 10.1007/s13311-014-0312-z; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Beranger F, 2008, BIOCHEM BIOPH RES CO, V374, P44, DOI 10.1016/j.bbrc.2008.06.094; Calabrese EJ, 2016, PHARMACOL RES, V110, P242, DOI 10.1016/j.phrs.2015.12.021; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Carri MT, 2003, BRAIN RES BULL, V61, P365, DOI 10.1016/S0361-9230(03)00179-5; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3339/fnins.2016.00332, 10.3389/fnins.2016.00332]; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Doering P, 2007, NEUROSCIENCE, V150, P93, DOI 10.1016/j.neuroscience.2007.09.066; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Du J, 2013, J PHARM PHARMACOL, V65, P1753, DOI 10.1111/jphp.12108; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Holler CJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0114-3; Ikeda S, 2013, EXCLI J, V12, P641; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Klevay LM, 2013, MED HYPOTHESES, V81, P995, DOI 10.1016/j.mehy.2013.09.011; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Liu MY, 2013, FOOD CHEM, V136, P485, DOI 10.1016/j.foodchem.2012.09.031; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Portbury SD, 2017, METALLOMICS, V9, P402, DOI 10.1039/c6mt00260a; Portbury SD, 2016, METALLOMICS, V8, P193, DOI 10.1039/c5mt00234f; Portbury SD, 2015, J ALZHEIMERS DIS, V46, P297, DOI 10.3233/JAD-143048; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tanji K, 2015, BIOCHEM BIOPH RES CO, V465, P746, DOI 10.1016/j.bbrc.2015.08.076; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2013.03.005]; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	88	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183683	10.1371/journal.pone.0183683			19	Multidisciplinary Sciences	Science & Technology - Other Topics	FE7CK	WOS:000408365000102	28837626	DOAJ Gold, Green Published			2021-06-18	
J	Sanchez, EJ; Gabler, LF; McGhee, JS; Olszko, AV; Chancey, VC; Crandall, JR; Panzer, MB				Sanchez, Erin J.; Gabler, Lee F.; McGhee, James S.; Olszko, Ardyn V.; Chancey, V. Carol; Crandall, Jeff R.; Panzer, Matthew B.			Evaluation of Head and Brain Injury Risk Functions Using Sub-Injurious Human Volunteer Data	JOURNAL OF NEUROTRAUMA			English	Article						finite element modeling; head kinematics; human research volunteers; injury risk functions	INTRACRANIAL-PRESSURE; CEREBRAL CONCUSSION; TOLERANCE CURVES; ICE HOCKEY; IMPACT; FOOTBALL; ACCELERATION; KINEMATICS; SYSTEM; NEUROTRAUMA	Risk assessment models are developed to estimate the probability of brain injury during head impact using mechanical response variables such as head kinematics and brain tissue deformation. Existing injury risk functions have been developed using different datasets based on human volunteer and scaled animal injury responses to impact. However, many of these functions have not been independently evaluated with respect to laboratory-controlled human response data. In this study, the specificity of 14 existing brain injury risk functions was assessed by evaluating their ability to correctly predict non-injurious response using previously conducted sled tests with well-instrumented human research volunteers. Six degrees-of-freedom head kinematics data were obtained for 335 sled tests involving subjects in frontal, lateral, and oblique sled conditions up to 16 Gs peak sled acceleration. A review of the medical reports associated with each individual test indicated no clinical diagnosis of mild or moderate brain injury in any of the cases evaluated. Kinematic-based head and brain injury risk probabilities were calculated directly from the kinematic data, while strain-based risks were determined through finite element model simulation of the 335 tests. Several injury risk functions substantially over predict the likelihood of concussion and diffuse axonal injury; proposed maximum principal strain-based injury risk functions predicted nearly 80 concussions and 14 cases of severe diffuse axonal injury out of the 335 non-injurious cases. This work is an important first step in assessing the efficacy of existing brain risk functions and highlights the need for more predictive injury assessment models.	[Sanchez, Erin J.; Gabler, Lee F.; Crandall, Jeff R.; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, Charlottesville, VA USA; [McGhee, James S.; Olszko, Ardyn V.; Chancey, V. Carol] US Army Aeromed Res Labs, Ft Rucker, AL USA	Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	mbp2q@virginia.edu	MPH, James S. McGhee MD/AAG-6354-2021		Partnership for Dummy Technology and Biomechanics	The authors would like to thank the Partnership for Dummy Technology and Biomechanics for their support and funding the University of Virginia for this study. Additionally, we would like to thank the Netherlands Organization for Applied Scientific Research (TNO) for providing the processed volunteer head kinematic and sled test data.	Abel J. M., 1978, 780886 SAE, DOI [10.4271/780886, DOI 10.4271/780886]; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bandak F. A., 2001, INT TECHN C ENH SAF; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Chamouard F., 1987, 872195 SAE, DOI [10.4271/872195, DOI 10.4271/872195]; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Ewing C. L., 1972, DTIC DOCUMENT; Ewing C. L., 1977, 770928 SAE, DOI [10.4271/770928, DOI 10.4271/770928]; Ewing C. L., 1975, 780888 SAE, DOI [10.4271/780888, DOI 10.4271/780888]; Ewing C. L., 1976, 760800 SAE, DOI [10.4271/760800, DOI 10.4271/760800]; Ewing C. L., 1969, 690817 SAE, DOI [10.4271/690817, DOI 10.4271/690817]; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gadd C. W., 1962, IMPACT ACCEL STRESS, V977, P141; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Holbourn AHS, 1943, LANCET, V2, P438; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kang HS, 1997, P 41 STAPP CAR CRASH, P329; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Laituri T. R., 2015, 2015011437 SAE, DOI [10.4271/2015-01-1437, DOI 10.4271/2015-01-1437]; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1999, COMP DIFFUSE BRAIN I; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Meaney DF, 1993, ASME CRASHWORTHINESS, V25, P169; Mertz H. J., 1996, 960099 SAE, DOI [10.4271/960099, DOI 10.4271/960099]; Mueller B., 2015, 24 INT TECHN C ENH S; Nahum A., 1993, ACCIDENTAL INJURY BI, P268; National Highway Traffic Safety Administration WebAPIs, 2015, NEW CAR ASS PROGR; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2015, STAND ATHL EQ NOCSAE; Newman J., 1986, P INT RES COUNC BIOM; Newman J, 2000, NEW BIOMECHANICAL 2; Newman J A, 2000, Stapp Car Crash J, V44, P215; NHTSA VSR, QUER BIOM TEST DAT S; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Pascrell WJ, 2009, CLIN NEUROPSYCHOL, V23, P1281, DOI 10.1080/13854040902939319; Patrick L. M., 1963, P 7 STAPP CAR CRASH, V7, P483; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prasad P., 1985, SAE T, V94, P106; Prasad Priya, 2014, Stapp Car Crash J, V58, P175; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stalnaker RL, 1977, VALIDATION STUDIES H; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; Takhounts E. G., 2011, P 22 ENH SAF VEH C; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thibault L. E., 1985, 856022 SAE; Thunnissen J, 1995, P 39 STAPP CAR CRASH, P439, DOI [DOI 10.4271/952721, 10.4271/952721]; Versace J. A., 1971, 710881 SAE, DOI [10.4271/710881, DOI 10.4271/710881]; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/cras.8.6.605.19261; Wismans J., 1987, 872194 SAE, DOI [10.4271/872194, DOI 10.4271/872194]; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	75	15	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2410	2424		10.1089/neu.2016.4681			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400004	28358277				2021-06-18	
